PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hasegawa, T; Shimada, S; Ishida, H; Nakashima, M				Hasegawa, Tatsuya; Shimada, Shoichiro; Ishida, Hitoshi; Nakashima, Masaya			Chafuroside B, an Oolong Tea Polyphenol, Ameliorates UVB-Induced DNA Damage and Generation of Photo-immunosuppression Related Mediators in Human Keratinocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ULTRAVIOLET-RADIATION; IMMUNE SUPPRESSION; CELL-MIGRATION; SKIN-CANCER; INTERLEUKIN-12; IL-12; CYTOKINE; INDUCTION; EXPOSURE	Chafuroside B was recently isolated as a new polyphenolic constituent of oolong tea leaves. However, the effects of chafuroside B on skin function have not been examined. In this study, we investigated the protective effects of chafuroside B against UVB-induced DNA damage, apoptosis and generation of photo-immunosuppression related mediators in cultured normal human epidermal keratinocytes (NHEK). Chafuroside B at 1 mu M attenuated both UVB-induced apoptosis, evaluated in terms of caspase-3/7 activity, and UVB-induced DNA damage, evaluated in terms of formation of cyclobutane pyrimidine dimers (CPD), in NHEK exposed to UVB (20 mJ/cm(2)). In addition, chafuroside B at 0.3 or 1 mu M suppressed the UVB-induced production of interleukin (IL)-10, tumor necrosis factor (TNF)-alpha, and prostaglandin E2 (PGE(2)), as determined by ELISA, and conversely enhanced IL-12 mRNA expression and production, as measured by RT-PCR and ELISA. Further, chafuroside B at 1 mu M also suppressed UVB-induced expression of receptor activator of nuclear factor kappa B ligand (RANKL) mRNA. These results indicate that chafuroside B promotes repair of UVB-induced DNA damage and ameliorates the generation of IL-10, TNF-alpha, PGE(2), and RANKL, all of which are UVB-induced immunosuppression related mediators. These effects of chafuroside B may be mediated at least in part through induction of IL-12 synthesis in human keratinocytes. Because chafuroside B might have practical value as a photoprotective agent, a further study of the in vivo effects of chafuroside B seems warranted.	[Hasegawa, Tatsuya; Shimada, Shoichiro; Nakashima, Masaya] Shiseido Res Ctr, Funct Food Res & Dev Ctr, Yokohama, Kanagawa, Japan; [Ishida, Hitoshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Shiseido Company, Limited; University of Shizuoka	Hasegawa, T (corresponding author), Shiseido Res Ctr, Funct Food Res & Dev Ctr, Yokohama, Kanagawa, Japan.	tatsuya.hasegawa@to.shiseido.co.jp			Shiseido	Shiseido	Funding support for this research was provided entirely by Shiseido. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli RS, 2004, FEBS LETT, V559, P71, DOI 10.1016/S0014-5793(04)00026-2; ARAGANE Y, 1994, J IMMUNOL, V153, P5366; Asadullah K, 1998, J CLIN INVEST, V101, P783, DOI 10.1172/JCI1476; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; CHUNG HT, 1986, J IMMUNOL, V137, P2478; COOPER KD, 1992, P NATL ACAD SCI USA, V89, P8497, DOI 10.1073/pnas.89.18.8497; Cumberbatch M, 1999, BRIT J DERMATOL, V141, P192; de Gruijl FR, 2002, EXP DERMATOL, V11, P37, DOI 10.1034/j.1600-0625.11.s.1.9.x; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Gailani MR, 1996, J NATL CANCER I, V88, P349, DOI 10.1093/jnci/88.6.349; GREWE M, 1993, J INVEST DERMATOL, V101, P528, DOI 10.1111/1523-1747.ep12365904; Halliday GM, 2012, J DERMATOL SCI, V66, P176, DOI 10.1016/j.jdermsci.2011.12.009; Hanneman KK, 2006, DERMATOL CLIN, V24, P19, DOI 10.1016/j.det.2005.08.003; Ichihashi M, 2000, J DERMATOL SCI, V23, pS45, DOI 10.1016/S0923-1811(00)00083-9; Ishida H, 2009, J AGR FOOD CHEM, V57, P6779, DOI 10.1021/jf900032z; Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004; Kripke M L, 1996, Exp Dermatol, V5, P173, DOI 10.1111/j.1600-0625.1996.tb00113.x; KRIPKE ML, 1992, P NATL ACAD SCI USA, V89, P7516, DOI 10.1073/pnas.89.16.7516; Kupas V, 2011, J INVEST DERMATOL, V131, P944, DOI 10.1038/jid.2010.377; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Meeran SM, 2008, J INVEST DERMATOL, V128, P2716, DOI 10.1038/jid.2008.140; MOODYCLIFFE AM, 1994, IMMUNOLOGY, V81, P79; Moriwaki S, 2008, J DERMATOL SCI, V50, P169, DOI 10.1016/j.jdermsci.2007.08.011; MULLER G, 1995, J IMMUNOL, V155, P4661; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Nishigori C, 1996, P NATL ACAD SCI USA, V93, P10354, DOI 10.1073/pnas.93.19.10354; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Onoue S, 2012, EUR J PHARM SCI, V45, P184, DOI 10.1016/j.ejps.2011.11.003; Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; RIVAS JM, 1992, J IMMUNOL, V149, P3865; RUZICKA T, 1983, J INVEST DERMATOL, V81, P300, DOI 10.1111/1523-1747.ep12519287; Schmitt DA, 2000, IMMUNOLOGY, V101, P90, DOI 10.1046/j.1365-2567.2000.00084.x; SCHMITT DA, 1995, J IMMUNOL, V154, P5114; Schwarz A, 2002, NAT CELL BIOL, V4, P26, DOI 10.1038/ncb717; Schwarz A, 1996, J INVEST DERMATOL, V106, P1187, DOI 10.1111/1523-1747.ep12347944; Shreedhar V, 1998, J IMMUNOL, V160, P3783; Slominski A. T., 2013, J STEROID BIOCH MOL; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Toberer F, 2011, EXP DERMATOL, V20, P600, DOI 10.1111/j.1600-0625.2011.01303.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Verschooten L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1016, DOI 10.1562/2006-04-27-IR-884.1; Werth VP, 2003, J INVEST DERMATOL, V120, P116, DOI 10.1046/j.1523-1747.2003.12012.x; Wolf P, 2000, J INVEST DERMATOL, V114, P149, DOI 10.1046/j.1523-1747.2000.00839.x; Yoshiki R, 2009, J INVEST DERMATOL, V129, P705, DOI 10.1038/jid.2008.304	46	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77308	10.1371/journal.pone.0077308	http://dx.doi.org/10.1371/journal.pone.0077308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116222	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200113
J	Jeuland, MA; Fuente, DE; Ozdemir, S; Allaire, MC; Whittington, D				Jeuland, Marc A.; Fuente, David E.; Ozdemir, Semra; Allaire, Maura C.; Whittington, Dale			The Long-Term Dynamics of Mortality Benefits from Improved Water and Sanitation in Less Developed Countries	PLOS ONE			English	Article							LIFE; DISEASE; HEALTH; BURDEN	The problem of inadequate access to water, sanitation and hygiene (WASH) in less-developed nations has received much attention over the last several decades (most recently in the Millennium Development Goals), largely because diseases associated with such conditions contribute substantially to mortality in poor countries. We present country-level projections for WASH coverage and for WASH-related mortality in developing regions over a long time horizon (1975-2050) and provide dynamic estimates of the economic value of potential reductions in this WASH-related mortality, which go beyond the static results found in previous work. Over the historical period leading up to the present, our analysis shows steady and substantial improvements in WASH coverage and declining mortality rates across many developing regions, namely East Asia and the Pacific, Latin America and the Caribbean, Eastern Europe and the Middle East. The economic value of potential health gains from eliminating mortality attributable to poor water and sanitation has decreased substantially, and in the future will therefore be modest in these regions. Where WASH-related deaths remain high (in parts of South Asia and much of Sub-Saharan Africa), if current trends continue, it will be several decades before economic development and investments in improved water and sanitation will result in the capture of these economic benefits. The fact that health losses will likely remain high in these two regions over the medium term suggests that accelerated efforts are needed to improve access to water and sanitation, though the costs and benefits of such efforts in specific locations should be carefully assessed.	[Jeuland, Marc A.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Jeuland, Marc A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Fuente, David E.; Whittington, Dale] Univ N Carolina, Dept City & Reg Planning, Chapel Hill, NC USA; [Ozdemir, Semra] Duke Natl Univ Singapore Grad Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore; [Allaire, Maura C.; Whittington, Dale] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Whittington, Dale] Manchester Business Sch, Manchester M15 6PB, Lancs, England	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Manchester	Jeuland, MA (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.	marc.jeuland@duke.edu	OZDEMİR, Semra/AAV-7871-2021; Ozdemir, Semra/GXW-0913-2022; Fuente, David/AAL-2404-2020	Ozdemir, Semra/0000-0001-7556-1601; 				Ahuja A, 2010, ANNU REV RESOUR ECON, V2, P237, DOI 10.1146/annurev.resource.012809.103919; [Anonymous], 2012, WORLD EC OUTLOOK DAT; [Anonymous], 2012, SYSTEMATIC REV; Cairncross S, 2005, SOC SCI MED, V61, P2212, DOI 10.1016/j.socscimed.2005.04.019; Clasen T, 2007, BRIT MED J; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Galiani S, 2005, J POLIT ECON, V113, P83, DOI 10.1086/426041; Gunther I., 2011, POLICY RES WORKING P; Hall RE, 2007, Q J ECON, V122, P39, DOI 10.1162/qjec.122.1.39; Hutton G, 2012, GLOBAL COSTS BENFITS; Komives K, 2003, INFRASTRUCTURE FOR POOR PEOPLE, P77; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kremer M, 2011, Q J ECON, V126, P145, DOI 10.1093/qje/qjq010; Liu L, LANCET; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P5; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Peace CfS, 2012, POL 4 ANN TIM SER; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Pruss-Ustun A., 2008, SAFER WATER BETTER H; UN, 2012, WORLD POP PROPS 2012; UNICEF, 2012, PROGR DRINK WAT SAN; van Poppel F, 1997, Health Transit Rev, V7, P113; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Waddington H., 2009, WATER SANITATION HYG; Whittington D., 2009, FDN TRENDS MICROECON, V4, P469, DOI DOI 10.1561/0700000030; Whittington D, 2012, WORLD DEV, V40, P1546, DOI 10.1016/j.worlddev.2012.03.004; WHO, 2004, ENV BURDEN DIS DAT; WHO UNICEF, 2012, JOINT MON PROGR JMP; Wolfram C, 2012, J ECON PERSPECT, V26, P119, DOI 10.1257/jep.26.1.119; ZANDEN J. L, 2013, 4 MADD PROJ	32	29	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e74804	10.1371/journal.pone.0074804	http://dx.doi.org/10.1371/journal.pone.0074804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116011	Green Published, gold			2022-12-27	WOS:000325552200003
J	Shi, M; Kumar, SR; Motajo, O; Kretschmer, F; Mu, XQ; Badea, TC				Shi, Melody; Kumar, Sumit R.; Motajo, Oluwaseyi; Kretschmer, Friedrich; Mu, Xiuqian; Badea, Tudor C.			Genetic Interactions between Brn3 Transcription Factors in Retinal Ganglion Cell Type Specification	PLOS ONE			English	Article							DOMAIN FACTOR BRN-3B; AMACRINE CELLS; MOUSE RETINA; SOMATOSENSORY NEURONS; MAMMALIAN RETINA; NERVOUS-SYSTEM; PRIMATE RETINA; VISUAL-SYSTEM; EXPRESSION; DIFFERENTIATION	Background: Visual information is conveyed from the retina to the brain via 15-20 Retinal Ganglion Cell (RGC) types. The developmental mechanisms by which RGC types acquire their distinct molecular, morphological, physiological and circuit properties are essentially unknown, but may involve combinatorial transcriptional regulation. Brn3 transcription factors are expressed in RGCs from early developmental stages, and are restricted in adults to distinct, partially overlapping populations of RGC types. Previously, we described cell autonomous effects of Brn3b (Pou4f2) and Brn3a (Pou4f1) on RGC axon and dendrites development. Methods and Findings: We now have investigated genetic interactions between Brn3 transcription factors with respect to RGC development, by crossing conventional knock-out alleles of each Brn3 gene with conditional knock-in reporter alleles of a second Brn3 gene, and analyzing the effects of single or double Brn3 knockouts on RGC survival and morphology. We find that Brn3b loss results in axon defects and dendritic arbor area and lamination defects in Brn3a positive RGCs, and selectively affects survival and morphology of specific Brn3c (Pou4f3) positive RGC types. Brn3a and Brn3b interact synergistically to control RGC numbers. Melanopsin positive ipRGCs are resistant to combined Brn3 loss but are under the transcriptional control of Isl1, expanding the combinatorial code of RGC specification. Conclusions: Taken together these results complete our knowledge on the mechanisms of transcriptional control of RGC type specification. They demonstrate that Brn3b is required for the correct development of more RGC cell types than suggested by its expression pattern in the adult, but that several cell types, including some Brn3a, Brn3c or Melanopsin positive RGCs are Brn3b independent.	[Shi, Melody; Kumar, Sumit R.; Motajo, Oluwaseyi; Kretschmer, Friedrich; Badea, Tudor C.] NEI, NIH, Bethesda, MD 20892 USA; [Mu, Xiuqian] SUNY Buffalo, Dept Ophthalmol, Ross Eye Inst, Dev Genom Grp, Buffalo, NY 14260 USA; [Mu, Xiuqian] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [Mu, Xiuqian] SUNY Eye Inst, Buffalo, NY USA; [Mu, Xiuqian] Roswell Pk Canc Inst, CCSG Genet Program, Buffalo, NY 14263 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Badea, TC (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	badeatc@mail.nih.gov	Badea, Tudor Constantin/B-1654-2018; Mu, Xiuqian/I-9146-2014	Badea, Tudor Constantin/0000-0003-3086-6713; Mu, Xiuqian/0000-0002-8003-7529	National Eye Institute; NEI [EY020545]; Whitehall Foundation; Research to Prevent Blindness to the Department of Ophthalmology of University at Buffalo; NATIONAL EYE INSTITUTE [R01EY020545, ZIAEY000504] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Whitehall Foundation; Research to Prevent Blindness to the Department of Ophthalmology of University at Buffalo; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was provided by the Intramural Research Program of the National Eye Institute for M. S., S. R. K., O.M., F. K. and T. C. B. and NEI grant EY020545, the Whitehall Foundation and an unrestricted grant from the Research to Prevent Blindness to the Department of Ophthalmology of University at Buffalo to X. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown NL, 2001, DEVELOPMENT, V128, P2497; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jin KX, 2010, J NEUROSCI, V30, P11902, DOI 10.1523/JNEUROSCI.2187-10.2010; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; LEVICK WR, 1975, NATURE, V254, P659, DOI 10.1038/254659a0; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Mao CA, 2008, DEVELOPMENT, V135, P271, DOI 10.1242/dev.009688; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Raymond ID, 2008, MOL VIS, V14, P1559; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Trieu M, 2003, DEVELOPMENT, V130, P111, DOI 10.1242/dev.00194; Troy JB, 2002, PROG RETIN EYE RES, V21, P263, DOI 10.1016/S1350-9462(02)00002-2; TURNER EE, 1994, NEURON, V12, P205, DOI 10.1016/0896-6273(94)90164-3; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XIANG MQ, 1993, NEURON, V11, P689, DOI 10.1016/0896-6273(93)90079-7; XIANG MQ, 1995, J NEUROSCI, V15, P4762; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	71	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76347	10.1371/journal.pone.0076347	http://dx.doi.org/10.1371/journal.pone.0076347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116103	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200051
J	Wrench, AP; Gardner, CL; Siegel, SD; Pagliai, FA; Malekiha, M; Gonzalez, CF; Lorca, GL				Wrench, Algevis P.; Gardner, Christopher L.; Siegel, Sara D.; Pagliai, Fernando A.; Malekiha, Mahsa; Gonzalez, Claudio F.; Lorca, Graciela L.			MglA/SspA Complex Interactions Are Modulated by Inorganic Polyphosphate	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI K-12; FRANCISELLA-TULARENSIS; PSEUDOMONAS-AERUGINOSA; RNA-POLYMERASE; KINASE PPK2; SURVIVAL; IDENTIFICATION; SALMONELLA; REGULATOR	The transcription factors MglA and SspA of Francisella tularensis form a heterodimer complex and interact with the RNA polymerase to regulate the expression of the Francisella pathogenicity island (FPI) genes. These genes are essential for this pathogen's virulence and survival within host cells. Our goal was to determine if an intracellular metabolite modulate these protein/protein interactions. In this study, we identified inorganic polyphosphate (polyP) as a signal molecule that promotes the interaction of MglA and SspA from F. tularensis SCHU S4. Analysis of the Mgla/SspA interaction was carried out using a two-hybrid system. The Escherichia coli reporter strain contained a deletion on the ppK-ppX operon, inhibiting polyP synthesis. The interaction between MglA and SspA was significantly impaired, as was the interaction between the MglA/SspA complex and the regulatory protein, FevR, indicating the stabilizing effect of polyP. In F. tularensis, chromatin immune precipitation studies revealed that in the absence of polyP, binding of the MglA/SspA complex to the promoter region of the pdpD, iglA, fevR and ppK genes is decreased. Isothermal titration calorimetry (ITC) indicated that polyP binds directly to the MglA/SspA complex with high affinity (K-D = 0.3 mu M). These observations directly correlated with results obtained from calorimetric scans (DSC), where a strong shift in the mid-transition temperature (Tm) of the MglA/SspA complex was observed in the presence of polyP.	[Wrench, Algevis P.; Gardner, Christopher L.; Siegel, Sara D.; Pagliai, Fernando A.; Malekiha, Mahsa; Gonzalez, Claudio F.; Lorca, Graciela L.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	glorca@ufl.edu	Pagliai, Fernando A./J-9921-2019	Siegel, Sara/0000-0002-1412-0631; Pagliai, Fernando A./0000-0002-0434-4594; Gardner, Christopher/0000-0001-6416-8476	University of Florida Institute of Food and Agricultural Sciences; STEM Ladder Grant - Miami Dade College	University of Florida Institute of Food and Agricultural Sciences(University of Florida); STEM Ladder Grant - Miami Dade College	This study was partially supported by the University of Florida Institute of Food and Agricultural Sciences and a STEM Ladder Grant - Miami Dade College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; AHN KH, 1990, J BIOL CHEM, V265, P11734; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; CLARK JE, 1986, J BACTERIOL, V168, P1212, DOI 10.1128/jb.168.3.1212-1219.1986; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean RE, 2009, MICROBIOL-SGM, V155, P4104, DOI 10.1099/mic.0.031021-0; Gangaiah D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012142; Grillo-Puertas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050368; Guina T, 2007, J BACTERIOL, V189, P6580, DOI 10.1128/JB.00809-07; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; KULAEV IS, 1983, ADV MICROB PHYSIOL, V24, P83, DOI 10.1016/S0065-2911(08)60385-9; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuoppa K, 2001, FEMS MICROBIOL LETT, V205, P77, DOI 10.1111/j.1574-6968.2001.tb10928.x; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li L, 2007, P NATL ACAD SCI USA, V104, P1794, DOI 10.1073/pnas.0610763104; Lindner SN, 2007, APPL ENVIRON MICROB, V73, P5026, DOI 10.1128/AEM.00600-07; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nickels BE, 2009, METHODS, V47, P53, DOI 10.1016/j.ymeth.2008.10.011; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Richards MI, 2008, J MED MICROBIOL, V57, P1183, DOI 10.1099/jmm.0.2008/001826-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schellhorn HE, 1998, J BACTERIOL, V180, P6283; Schurig-Briccio LA, 2009, J BACTERIOL, V191, P4478, DOI 10.1128/JB.00082-09; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Whipple FW, 1998, NUCLEIC ACIDS RES, V26, P3700, DOI 10.1093/nar/26.16.3700; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WOOD HG, 1988, ANNU REV BIOCHEM, V57, P235, DOI 10.1146/annurev.bi.57.070188.001315; Wrench AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054498; Yang ZX, 2010, MOL MICROBIOL, V77, P618, DOI 10.1111/j.1365-2958.2010.07233.x; Zhang HY, 2002, P NATL ACAD SCI USA, V99, P16678, DOI 10.1073/pnas.262655199; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	55	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76428	10.1371/journal.pone.0076428	http://dx.doi.org/10.1371/journal.pone.0076428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116108	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200055
J	Alborghetti, MR; Furlan, AD; da Silva, JC; Sforca, ML; Honorato, RV; Granato, DC; Migueleti, DLD; Neves, JL; de Oliveira, PSL; Paes-Leme, AF; Zeri, ACD; de Torriani, ICL; Kobarg, J				Alborghetti, Marcos Rodrigo; Furlan, Ariane da Silva; da Silva, Julio Cesar; Sforca, Mauricio Luis; Honorato, Rodrigo Vargas; Granato, Daniela Campos; dos Santos Migueleti, Deivid Lucas; Neves, Jorge L.; Lopes de Oliveira, Paulo Sergio; Paes-Leme, Adriana Franco; de Mattos Zeri, Ana Carolina; Linares de Torriani, Iris Concepcion; Kobarg, Joerg			Structural Analysis of Intermolecular Interactions in the Kinesin Adaptor Complex Fasciculation and Elongation Protein Zeta 1/Short Coiled-Coil Protein (FEZ1/SCOCO)	PLOS ONE			English	Article							NATIVELY UNFOLDED PROTEIN; X-RAY-SCATTERING; GLUTATHIONE TRANSFERASE; NEURITE OUTGROWTH; AXONAL-TRANSPORT; DIMER STABILITY; HUMAN FEZ1; CELLS; EXPRESSION; ACCURACY	Cytoskeleton and protein trafficking processes, including vesicle transport to synapses, are key processes in neuronal differentiation and axon outgrowth. The human protein FEZ1 (fasciculation and elongation protein zeta 1 / UNC-76, in C. elegans), SCOCO (short coiled-coil protein / UNC-69) and kinesins (e. g. kinesin heavy chain / UNC116) are involved in these processes. Exploiting the feature of FEZ1 protein as a bivalent adapter of transport mediated by kinesins and FEZ1 protein interaction with SCOCO (proteins involved in the same path of axonal growth), we investigated the structural aspects of intermolecular interactions involved in this complex formation by NMR (Nuclear Magnetic Resonance), cross-linking coupled with mass spectrometry (MS), SAXS (Small Angle X-ray Scattering) and molecular modelling. The topology of homodimerization was accessed through NMR (Nuclear Magnetic Resonance) studies of the region involved in this process, corresponding to FEZ1 (92-194). Through studies involving the protein in its monomeric configuration (reduced) and dimeric state, we propose that homodimerization occurs with FEZ1 chains oriented in an anti-parallel topology. We demonstrate that the interaction interface of FEZ1 and SCOCO defined by MS and computational modelling is in accordance with that previously demonstrated for UNC-76 and UNC-69. SAXS and literature data support a heterotetrameric complex model. These data provide details about the interaction interfaces probably involved in the transport machinery assembly and open perspectives to understand and interfere in this assembly and its involvement in neuronal differentiation and axon outgrowth.	[Alborghetti, Marcos Rodrigo; Furlan, Ariane da Silva; da Silva, Julio Cesar; Sforca, Mauricio Luis; Honorato, Rodrigo Vargas; Granato, Daniela Campos; dos Santos Migueleti, Deivid Lucas; Neves, Jorge L.; Lopes de Oliveira, Paulo Sergio; Paes-Leme, Adriana Franco; de Mattos Zeri, Ana Carolina; Kobarg, Joerg] CNPEM, LNBio, Campinas, SP, Brazil; [Furlan, Ariane da Silva; de Mattos Zeri, Ana Carolina; Kobarg, Joerg] Univ Estadual Campinas, Dept Bioquim, Programa Posgrad Biol Func & Mol, Inst Biol, Campinas, SP, Brazil; [dos Santos Migueleti, Deivid Lucas; Kobarg, Joerg] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Programa Posgrad Genet & Biol Mol, Inst Biol, Campinas, SP, Brazil; [Linares de Torriani, Iris Concepcion] Univ Estadual Campinas, Dept Condensed Matter Phys, Inst Fis Gleb Wataghin, UNICAMP, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Kobarg, J (corresponding author), CNPEM, LNBio, Campinas, SP, Brazil.	jorg.kobarg@lnbio.cnpem.br	Honorato, Rodrigo/H-9773-2013; Zeri, Ana/AAY-4799-2021; Neves, Jorge Luiz JL/F-8393-2010; Oliveira, Paulo S/K-5588-2013; Kobarg, Jörg/T-4736-2019; da Silva, Julio Cesar/A-5240-2011; NEVES, JORGE LUIZ/AAK-7723-2021; Honorato, Rodrigo Vargas/AAY-9375-2020; Leme, Adriana F Paes/C-9679-2012; Alborghetti, Marcos Rodrigo/K-7547-2012	Honorato, Rodrigo/0000-0001-5267-3002; Zeri, Ana/0000-0003-4169-4523; Neves, Jorge Luiz JL/0000-0003-3853-4529; Kobarg, Jörg/0000-0002-9419-0145; da Silva, Julio Cesar/0000-0001-8035-0550; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Leme, Adriana F Paes/0000-0001-7959-147X; Sforca, Mauricio/0000-0002-3395-1684; Alborghetti, Marcos Rodrigo/0000-0003-4517-5579	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento [471355/2010-0]; Centro Nacional de Pesquisa em Energia e Materiais / Laboratorio Nacional de Biociencias	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centro Nacional de Pesquisa em Energia e Materiais / Laboratorio Nacional de Biociencias	This research was financially supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo (http://www.fapesp.br/), the Conselho Nacional de Pesquisa e Desenvolvimento (http://www.cnpq.br/; through a personal grant to JK: 471355/2010-0) and Centro Nacional de Pesquisa em Energia e Materiais / Laboratorio Nacional de Biociencias (http://www.lnbio.org.br/site/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alborghetti MR, 2010, J PROTEOME RES, V9, P4595, DOI 10.1021/pr100314q; Alborghetti MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017426; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Alves CS, 2006, BIOCHEM J, V393, P523, DOI 10.1042/BJ20051066; Aragao AZB, 2012, J BIOL CHEM, V287, P43071, DOI 10.1074/jbc.M112.364513; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Cavalcanti LP, 2004, REV SCI INSTRUM, V75, P4541, DOI 10.1063/1.1804956; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; de Oliveira JF, 2010, J MOL BIOL, V396, P1053, DOI 10.1016/j.jmb.2009.12.039; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gindhart JG, 2003, MOL BIOL CELL, V14, P3356, DOI 10.1091/mbc.E02-12-0800; Guinier A., 1955, SMALL ANGLE SCATTERI; Hornby JAT, 2002, BIOCHEMISTRY-US, V41, P14238, DOI 10.1021/bi020548d; Huang J, 1996, CANCER LETT, V106, P29, DOI 10.1016/0304-3835(96)04293-0; Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lanza DCF, 2008, EXP CELL RES, V314, P2028, DOI 10.1016/j.yexcr.2008.02.012; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; Lanza DCF, LOW RESOLUTION STRUC, P1; Li Cheng-yu, NEURON, V41, P257, DOI [10.1016/S0896-6273(02)00700-6, DOI 10.1016/S0896-6273(03)00629-9, 10.1016/S0896-6273(03)00847-X, DOI 10.1016/S0896-6273(02)00700-6]; Luo Shuo, 2006, J Biol, V5, P8, DOI 10.1186/jbiol41; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; McKnight NC, 2012, EMBO J, V31, P1, DOI [10.1038/emboj.2012.36, DOI 10.1038/EMB0J.2012.36.PUBMED:22354037]; Moncoq K, 2004, BIOPHYS J, V87, P4056, DOI 10.1529/biophysj.104.048645; Morfini G, 1997, J CELL BIOL, V138, P657, DOI 10.1083/jcb.138.3.657; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakae N, 2008, HUM MOL GENET, V17, P3191, DOI 10.1093/hmg/ddn215; Sato Y, 1998, J NEUROL SCI, V160, P92, DOI 10.1016/S0022-510X(98)00233-0; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; Su Cheng-Wen, 2006, J Biol, V5, P9, DOI 10.1186/jbiol39; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Yu ZQ, 2011, BIPOLAR DISORD, V13, P486, DOI 10.1111/j.1399-5618.2011.00946.x	49	5	5	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76602	10.1371/journal.pone.0076602	http://dx.doi.org/10.1371/journal.pone.0076602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116125	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300071
J	Almeda, R; Wambaugh, Z; Chai, C; Wang, ZC; Liu, ZF; Buskey, EJ				Almeda, Rodrigo; Wambaugh, Zoe; Chai, Chao; Wang, Zucheng; Liu, Zhanfei; Buskey, Edward J.			Effects of Crude Oil Exposure on Bioaccumulation of Polycyclic Aromatic Hydrocarbons and Survival of Adult and Larval Stages of Gelatinous Zooplankton	PLOS ONE			English	Article							CTENOPHORE MNEMIOPSIS-LEIDYI; WATER-SOLUBLE FRACTIONS; AURELIA SP SCYPHOZOA; NO-2 FUEL-OIL; PETROLEUM-HYDROCARBONS; ACCOMMODATED FRACTION; PELAGIC COELENTERATES; INVASIVE CTENOPHORE; MARINE-ENVIRONMENT; JELLYFISH BLOOMS	Gelatinous zooplankton play an important role in marine food webs both as major consumers of metazooplankton and as prey of apex predators (e. g., tuna, sunfish, sea turtles). However, little is known about the effects of crude oil spills on these important components of planktonic communities. We determined the effects of Louisiana light sweet crude oil exposure on survival and bioaccumulation of polycyclic aromatic hydrocarbons (PAHs) in adult stages of the scyphozoans Pelagia noctiluca and Aurelia aurita and the ctenophore Mnemiopsis leidyi, and on survival of ephyra larvae of A. aurita and cydippid larvae of M. leidyi, in the laboratory. Adult P. noctiluca showed 100% mortality at oil concentration >= 20 mu L L-1 after 16 h. In contrast, low or non-lethal effects were observed on adult stages of A. aurita and M. leidyi exposed at oil concentration <= 25 mu L L-1 after 6 days. Survival of ephyra and cydippid larva decreased with increasing crude oil concentration and exposition time. The median lethal concentration (LC50) for ephyra larvae ranged from 14.41 to 0.15 mu L L-1 after 1 and 3 days, respectively. LC50 for cydippid larvae ranged from 14.52 to 8.94 mu L L-1 after 3 and 6 days, respectively. We observed selective bioaccumulation of chrysene, phenanthrene and pyrene in A. aurita and chrysene, pyrene, benzo[a] pyrene, benzo[b] fluoranthene, benzo[k] fluoranthene, and benzo[a] anthracene in M. leidyi. Overall, our results indicate that (1) A. aurita and M. leidyi adults had a high tolerance to crude oil exposure compared to other zooplankton, whereas P. noctiluca was highly sensitive to crude oil, (2) larval stages of gelatinous zooplankton were more sensitive to crude oil than adult stages, and (3) some of the most toxic PAHs of crude oil can be bioaccumulated in gelatinous zooplankton and potentially be transferred up the food web and contaminate apex predators.	[Almeda, Rodrigo; Wambaugh, Zoe; Chai, Chao; Wang, Zucheng; Liu, Zhanfei; Buskey, Edward J.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Wambaugh, Zoe] Humboldt State Univ, Dept Oceanog, Arcata, CA 95521 USA; [Chai, Chao] Qingdao Agr Univ, Coll Resource & Environm, Qingdao, Peoples R China; [Wang, Zucheng] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	University of Texas System; University of Texas Austin; California State University System; California State Polytechnic University, Humboldt; Qingdao Agricultural University; East China Normal University	Almeda, R (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	ralmeda@utexas.edu	Liu, Zhanfei/B-5613-2014; Kang, Sonia/L-4802-2016; ALMEDA, RODRIGO/R-1189-2016; Buskey, Edward/L-8443-2017	Kang, Sonia/0000-0002-0293-5323; ALMEDA, RODRIGO/0000-0002-0090-112X; Buskey, Edward/0000-0002-1729-6640	National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program [OCE-1062745]; BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies')	National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program(National Science Foundation (NSF)NSF - Office of the Director (OD)); BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies')	Zoe Wambaugh was supported by the National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program (grant OCE-1062745). This research was made possible by a grant from BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz M, 2010, POLAR BIOL, V33, P1719, DOI 10.1007/s00300-010-0789-9; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Almeda R, 2013, PLOS ONE IN PRESS; ANDERSON JW, 1974, MAR BIOL, V27, P75, DOI 10.1007/BF00394763; ANDREWS AR, 1974, MAR BIOL, V25, P7, DOI 10.1007/BF00395102; [Anonymous], [No title captured]; Appeltans W., 2013, **NON-TRADITIONAL**; Arai MN, 2001, HYDROBIOLOGIA, V451, P69, DOI 10.1023/A:1011840123140; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Avila T.R., 2010, Journal of the Brazilian Society of Ecotoxicology, V5, P19; BAILEY TG, 1995, MAR ECOL PROG SER, V122, P121, DOI 10.3354/meps122121; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Barata C, 2005, ENVIRON TOXICOL CHEM, V24, P2992, DOI 10.1897/05-189R.1; Barazandeh M, 2004, P 4 INT IR RUSS C, P1407; Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326; Bejarano AC, 2006, J EXP MAR BIOL ECOL, V332, P49, DOI 10.1016/j.jembe.2005.11.006; BERDUGO V, 1977, Marine Pollution Bulletin, V8, P138, DOI 10.1016/0025-326X(77)90154-0; Berrojalbiz N, 2009, ENVIRON SCI TECHNOL, V43, P2295, DOI 10.1021/es8018226; Boese BL, 1997, ARCH ENVIRON CON TOX, V32, P389, DOI 10.1007/s002449900201; Brodersen CC., 1977, INT OIL SPILL C, P575, DOI [10.7901/2169-3358-1977-1-575, DOI 10.7901/2169-3358-1977-1-575]; Calbet A, 2007, MAR BIOL, V151, P195, DOI 10.1007/s00227-006-0468-0; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Cass CJ, 2011, MAR ECOL PROG SER, V439, P127, DOI 10.3354/meps09324; Castonguay M, 2008, CAN J FISH AQUAT SCI, V65, P1528, DOI 10.1139/F08-126; CLARKE A, 1992, J EXP MAR BIOL ECOL, V155, P55, DOI 10.1016/0022-0981(92)90027-8; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; CONOVER RJ, 1971, J FISH RES BOARD CAN, V28, P1327, DOI 10.1139/f71-202; Corner E.D.S., 1978, Advances in Marine Biology, V15, P289; CORNER EDS, 1976, J MAR BIOL ASSOC UK, V56, P121, DOI 10.1017/S0025315400020488; Couillard CM, 2005, ENVIRON TOXICOL CHEM, V24, P1496, DOI 10.1897/04-267R.1; CURL H JR, 1962, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V153, P183; Dalsoren SB, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2005JD006927; De Flora S, 1991, TRENDS BIOL DOSIMETR, P69; DEASON EE, 1982, ESTUAR COAST SHELF S, V15, P121, DOI 10.1016/0272-7714(82)90023-3; DEFLORA S, 1991, MUTAT RES, V258, P285, DOI 10.1016/0165-1110(91)90013-L; Delvigne G.A.L., 1988, OIL CHEM POLLUTION, V4, P281, DOI [10.1016/S0269-8579(88)80003-0, DOI 10.1016/S0269-8579(88)80003-0]; Duesterloh S, 2002, ENVIRON SCI TECHNOL, V36, P3953, DOI 10.1021/es020685y; Duesterloh S, 2002, THESIS U ALASKA FAIR; Ericson G, 1998, CAN J FISH AQUAT SCI, V55, P815, DOI 10.1139/cjfas-55-4-815; Faasse Marco A., 2006, Aquatic Invasions, V1, P270, DOI 10.3391/ai.2006.1.4.9; Fernandez GA, 1977, P S WARM WAT ZOOPL N, P432; French-McCay DP, 2002, ENVIRON TOXICOL CHEM, V21, P2080, DOI 10.1897/1551-5028(2002)021<2080:DAAOAO>2.0.CO;2; Fuentes VL, 2010, HYDROBIOLOGIA, V645, P23, DOI 10.1007/s10750-010-0205-z; GESAMP, 1997, GESAMP REP STUD; Goodbody-Gringley G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045574; Graham WM, 2010, ENVIRON RES LETT; Gray JS, 2002, MAR POLLUT BULL, V45, P46, DOI 10.1016/S0025-326X(01)00323-X; GYLLENBERG G, 1981, ANN ZOOL FENN, V18, P225; Harris R.P., 1977, FATE EFFECTS PETROLE, P286; HEBERT R, 1980, MAR ENVIRON RES, V4, P121, DOI 10.1016/0141-1136(80)90050-1; Hylland K, 2006, J TOXICOL ENV HEAL A, V69, P109, DOI 10.1080/15287390500259327; Jensen LK, 2012, ECOTOX ENVIRON SAFE, V78, P225, DOI 10.1016/j.ecoenv.2011.11.029; Jiang ZB, 2012, MAR ENVIRON RES, V81, P12, DOI 10.1016/j.marenvres.2012.08.003; Jiang Zhibing, 2010, Acta Ecologica Sinica, V30, P8; Jung SW, 2012, J HAZARD MATER, V217, P338, DOI 10.1016/j.jhazmat.2012.03.034; Kerr RA, 2010, SCIENCE, V329, P734, DOI 10.1126/science.329.5993.734; Kvenvolden KA, 2003, GEO-MAR LETT, V23, P140, DOI 10.1007/s00367-003-0135-0; LARSON RJ, 1986, J EXP MAR BIOL ECOL, V99, P107, DOI 10.1016/0022-0981(86)90231-5; LAUGHLIN RB, 1978, MAR BIOL, V47, P87, DOI 10.1007/BF00397022; Lee, 1975, P 1975 INT OIL SPILL, P549; Lee RF, 2012, J PLANKTON RES, V34, P1058, DOI 10.1093/plankt/fbs065; LEE WY, 1978, ENVIRON POLLUT, V15, P167, DOI 10.1016/0013-9327(78)90063-0; LEE WY, 1977, ENVIRON POLLUT, V12, P279, DOI 10.1016/0013-9327(77)90022-2; Lichtenthaler R.G., 1985, INT OIL SPILL C AM P, V1985, P471; LINDEN O, 1979, AMBIO, V8, P244; LINDEN O, 1975, Ambio, V4, P130; LINDEN O, 1976, ENVIRON POLLUT, V10, P239, DOI 10.1016/0013-9327(76)90007-0; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; Lotufo GR, 1998, AQUAT TOXICOL, V44, P1, DOI 10.1016/S0166-445X(98)00072-1; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; MACKIE PR, 1978, MAR POLLUT BULL, V9, P296, DOI 10.1016/0025-326X(78)90252-7; Malej A, 2007, MAR BIOL, V151, P827, DOI 10.1007/s00227-006-0503-1; McAuliffe CD, 1981, IOSC P, V1981, P269; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Mianzan HW, 1996, FISH RES, V27, P69, DOI 10.1016/0165-7836(95)00459-9; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; MIRONOV OG, 1980, HELGOLANDER MEERESUN, V33, P292, DOI 10.1007/BF02414754; Mukherjee B, 2009, ENVIRON ENG SCI, V26, P1725, DOI 10.1089/ees.2009.0159; Muschenheim DK, 2002, SPILL SCI TECHNOL B, V8, P9, DOI 10.1016/S1353-2561(02)00129-9; MYERS MS, 1991, ENVIRON HEALTH PERSP, V90, P7, DOI 10.2307/3430840; Neff J.M., 1981, RESPONSE MARINE ANIM; Neff J.M., 1985, FUNDAMENTALS AQUATIC, P416; Newman M.C., 2003, FUNDAMENTALS ECOTOXI, P458; NRC (National Research Council), 2003, OIL SEA; Ohman MD, 1997, J PLANKTON RES, V19, P1235, DOI 10.1093/plankt/19.9.1235; Pauly D, 2009, HYDROBIOLOGIA, V616, P67, DOI 10.1007/s10750-008-9583-x; Pelletier E, 2006, PHOTOCHEM PHOTOBIOL, V82, P981, DOI 10.1562/2005-09-18-RA-688.1; Pelletier MC, 1997, ENVIRON TOXICOL CHEM, V16, P2190, DOI 10.1002/etc.5620161029; Peters LD, 1997, AQUAT TOXICOL, V38, P67, DOI 10.1016/S0166-445X(96)00838-7; Pitt KA, 2005, J EXP MAR BIOL ECOL, V315, P71, DOI 10.1016/j.jembe.2004.09.007; Pugh P.R., 1989, Progress in Underwater Science, V14, P67; Purcell JE, 1997, ANN I OCEANOGR PARIS, V73, P125; Purcell JE, 2001, DEV HYDROBIOLOGY, V155; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Ramachandran SD, 2004, ECOTOX ENVIRON SAFE, V59, P300, DOI 10.1016/j.ecoenv.2003.08.018; Ramachandran SD, 2006, MAR POLLUT BULL, V52, P1182, DOI 10.1016/j.marpolbul.2006.02.009; Raskoff KA, 2003, BIOL BULL-US, V204, P68, DOI 10.2307/1543497; Riisgard HU, 2012, AQUAT INVASIONS, V7, P147, DOI 10.3391/ai.2012.7.2.001; Roohi A, 2008, MAR ECOL-EVOL PERSP, V29, P421, DOI 10.1111/j.1439-0485.2008.00254.x; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Ruzicka JJ, 2007, CAL COOP OCEAN FISH, V48, P106; Saiz E, 2009, ENVIRON POLLUT, V157, P1219, DOI 10.1016/j.envpol.2008.12.011; Sanchez-Bayo F, 2006, ENVIRON POLLUT, V139, P385, DOI 10.1016/j.envpol.2005.06.016; Seuront L, 2011, PLOS ONE, V6, DOI [10.1371/journal.-pone.0026283, DOI 10.1371/J0URNAL.-P0NE.0026283]; Shiganova TA, 2001, MAR BIOL, V139, P431; SPANGENBERG DB, 1965, J EXP ZOOL, V159, P303, DOI 10.1002/jez.1401590303; SPANGENBERG DB, 1984, MAR ENVIRON RES, V14, P281, DOI 10.1016/0141-1136(84)90083-7; Stark JS, 2003, J EXP MAR BIOL ECOL, V283, P21, DOI 10.1016/S0022-0981(02)00449-5; STRAUGHAN D, 1972, J PETROL TECHNOL, V24, P250, DOI 10.2118/3204-PA; STRAUGHAN D, 1972, MARINE POLLUTION SEA, P00355; Suderman BL, 2002, ENVIRON POLLUT, V120, P787, DOI 10.1016/S0269-7491(02)00169-0; Sullivan LJ, 2004, J PLANKTON RES, V26, P417, DOI 10.1093/plankt/fbh033; Templeman MA, 2010, MAR ENVIRON RES, V69, P63, DOI 10.1016/j.marenvres.2009.08.001; Titelman J, 2006, MAR ECOL PROG SER, V325, P43, DOI 10.3354/meps325043; Turk V, 2008, MAR ECOL-EVOL PERSP, V29, P495, DOI 10.1111/j.1439-0485.2008.00250.x; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; Valiela I, 1991, FUNDAMENTALS AQUATIC, P29; Van Brummelen T., 1998, HDB ENV CHEM, V3, P203; Ventura M, 2006, MAR ECOL PROG SER, V327, P233, DOI 10.3354/meps327233; Walsh G.E., 1978, PRINCIPLES ECOTOXICO, P257; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Whitehead A, 2011, P NATL ACAD SCI USA; Yu HT, 2002, J ENVIRON SCI HEAL C, V20, P149, DOI 10.1081/GNC-120016203	126	69	71	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74476	10.1371/journal.pone.0074476	http://dx.doi.org/10.1371/journal.pone.0074476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116004	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300007
J	D'Archivio, M; Scazzocchio, B; Giammarioli, S; Fiani, ML; Vari, R; Santangelo, C; Veneziani, A; Iacovelli, A; Giovannini, C; Gessani, S; Masella, R				D'Archivio, Massimo; Scazzocchio, Beatrice; Giammarioli, Stefania; Fiani, Maria L.; Vari, Rosaria; Santangelo, Carmela; Veneziani, Augusto; Iacovelli, Annunziata; Giovannini, Claudio; Gessani, Sandra; Masella, Roberta			omega 3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; FATTY-ACID-COMPOSITION; FACTOR-KAPPA-B; COLON-CANCER; PPAR-GAMMA; ADIPOSE-TISSUE; CELL-PROLIFERATION; METABOLIC SYNDROME; IMMUNE CELLS; OBESITY	Objective: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). Methods: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in four groups: normal-weight (BMI 22.0-24.9 Kg/m(2)) and over-weight/obese (BMI 26.0-40.0 Kg/m(2)), affected or not by CRC. To define whether obesity and/or CRC affect the inflammatory status of WAT, the activation of the pro-inflammatory STAT3 and the anti-inflammatory PPAR gamma transcription factors as well as the expression of adiponectin were analyzed by immunoblotting in adipocytes isolated from each group of subjects. Furthermore, to evaluate whether differences in inflammatory WAT environment correlate with specific fatty acid profiles, gas-chromatographic analysis was carried out on WAT collected from all subject categories. Finally, the effect of the omega 3 docosahexaenoic acid treatment on the balance between pro-and anti-inflammatory factors in adipocytes was also evaluated. Results: We provide the first evidence for the existence of a pro-inflammatory environment in WAT of CRC patients, as assessed by the up-regulation of STAT3, and the concomitant decrease of PPAR. and adiponectin with respect to healthy subjects. WAT inflammatory status was independent of obesity degree but correlated with a decreased omega 3-/omega 6-polyunsaturated fatty acid ratio. These observations suggested that qualitative changes, other than quantitative ones, in WAT fatty acid may influence tissue dysfunctions potentially linked to inflammatory conditions. This hypothesis was further supported by the finding that adipocyte treatment with docosahexaenoic acid restored the equilibrium between STAT3 and PPAR gamma. Conclusion: Our results suggest that adipocyte dysfunctions occur in CRC patients creating a pro-inflammatory environment that might influence cancer development. Furthermore, the protective potential of docosahexaenoic acid in re-establishing the equilibrium between pro- and anti-inflammatory factors might represent a useful tool for preventive and therapeutic strategies.	[D'Archivio, Massimo; Scazzocchio, Beatrice; Giammarioli, Stefania; Vari, Rosaria; Santangelo, Carmela; Giovannini, Claudio; Masella, Roberta] Dept Vet Publ Hlth & Food Safety, Rome, Italy; [Fiani, Maria L.; Gessani, Sandra] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Veneziani, Augusto] Univ Cattolica Sacro Cuore, Rome, Italy; [Iacovelli, Annunziata] Fabia Mater Hosp, Rome, Italy	Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	D'Archivio, M (corresponding author), Dept Vet Publ Hlth & Food Safety, Rome, Italy.	maxdar@iss.it	Masella, Roberta/B-4109-2015; D'ARCHIVIO, MASSIMO/B-4106-2015; SANTANGELO, CARMELA/D-5726-2011; VARI', ROSARIA/B-4111-2015; Scazzocchio, Beatrice/AAH-1395-2021; Fiani, Maria Luisa/G-9369-2016; D'Archivio, massimo/Z-4633-2019; scazzocchio, beatrice/B-4110-2015; GIAMMARIOLI, STEFANIA/C-2861-2015; Giovannini, Claudio/A-9168-2013; Gessani, Sandra/K-5151-2016	Masella, Roberta/0000-0002-3173-1573; SANTANGELO, CARMELA/0000-0002-4309-1745; Scazzocchio, Beatrice/0000-0002-5123-3897; Fiani, Maria Luisa/0000-0003-2997-0767; Gessani, Sandra/0000-0002-8451-0758; Rosaria, Vari/0000-0003-0488-6702; Giovannini, Claudio/0000-0002-4228-1264; D'Archivio, Massimo/0000-0001-8104-3421; Giammarioli, Stefania/0000-0002-8080-2331				Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Aleksandrova K, 2011, CANCER PREV RES, V4, P1873, DOI 10.1158/1940-6207.CAPR-11-0218; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-36; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Byeon JS, 2010, INT J CANCER, V127, P2758, DOI 10.1002/ijc.25301; Cai QW, 2012, MOL MED REP, V5, P1438, DOI 10.3892/mmr.2012.849; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; Deng JX, 2007, CURR CANCER DRUG TAR, V7, P91, DOI 10.2174/156800907780006922; Desreumaux P, 2006, ALIMENT PHARM THER, V24, P2, DOI 10.1111/j.1365-2036.2006.03069.x; Donohoe CL, 2010, BRIT J SURG, V97, P628, DOI 10.1002/bjs.7079; Fenton JI, 2010, MOL CARCINOGEN, V49, P700, DOI 10.1002/mc.20644; Fenton JI, 2012, PROSTAGLANDINS LEUKO, V88, P219; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FOLCH J, 1957, J BIOL CHEM, V226, P497; GALANOS DS, 1965, BIOCHIM BIOPHYS ACTA, V98, P278, DOI 10.1016/0005-2760(65)90121-9; Garaulet M, 2001, AM J CLIN NUTR, V74, P585; Guri AJ, 2006, CLIN NUTR, V25, P871, DOI 10.1016/j.clnu.2006.08.006; Han S, 2007, ANTI-CANCER DRUG, V18, P237, DOI 10.1097/CAD.0b013e328011e67d; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Howard JM, 2010, BRIT J SURG, V97, P1020, DOI 10.1002/bjs.7072; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kant P, 2011, NAT REV GASTRO HEPAT, V8, P224, DOI 10.1038/nrgastro.2011.23; Katzmarzyk PT, 2012, CAN J PUBLIC HEALTH, V103, P147, DOI 10.1007/BF03404221; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kristensen K, 1999, BIOCHEM BIOPH RES CO, V259, P624, DOI 10.1006/bbrc.1999.0842; Lichtman MA, 2010, ONCOLOGIST, V15, P1083, DOI 10.1634/theoncologist.2010-0206; Masella R, 2006, FEBS LETT, V580, P2421, DOI 10.1016/j.febslet.2006.03.068; Moon HS, 2011, DIABETES, V60, P1647, DOI 10.2337/db10-1791; Moon HS, 2011, DIABETES CARE, V34, P132, DOI 10.2337/dc10-0518; Moschen AR, 2012, CURR MED CHEM, V19, P5467; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Qiao L, 2008, CANCER LETT, V268, P260, DOI 10.1016/j.canlet.2008.04.003; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Romagnolo Donato F., 2010, Inflammation & Allergy Drug Targets, V9, P181; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Scazzocchio B, 2011, DIABETES, V60, P2234, DOI 10.2337/db10-1461; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; Slagsvold JE, 2010, NUTR CANCER, V62, P611, DOI 10.1080/01635580903532366; Stubbins RE, 2012, NUTR REV, V70, P721, DOI 10.1111/j.1753-4887.2012.00522.x; Sumarac-Dumanovic M, 2009, INT J OBESITY, V33, P151, DOI 10.1038/ijo.2008.216; Turner JJO, 2010, CLIN EXP IMMUNOL, V162, P487, DOI 10.1111/j.1365-2249.2010.04260.x; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Xu XT, 2011, J DIGEST DIS, V12, P234, DOI 10.1111/j.1751-2980.2011.00504.x; Yang YC, 2007, INT J GYNECOL CANCER, V17, P418, DOI 10.1111/j.1525-1438.2006.00866.x; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2013, PROSTAGLANDINS LEUKO, DOI [10.1016/j.plefa.2013.02.005, DOI 10.1016/J.PLEFA.2013.02.005.PUBMED:23465412]	60	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77432	10.1371/journal.pone.0077432	http://dx.doi.org/10.1371/journal.pone.0077432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116229	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300121
J	Devilard, E; Xerri, L; Dubreuil, P; Lopez, M; Reymond, N				Devilard, Elisabeth; Xerri, Luc; Dubreuil, Patrice; Lopez, Marc; Reymond, Nicolas			Nectin-3 (CD113) Interacts with Nectin-2 (CD112) to Promote Lymphocyte Transendothelial Migration	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULE; CELL-CELL ADHESION; VE-CADHERIN; LEUKOCYTE EXTRAVASATION; BETA-CATENIN; N-CADHERIN; PECAM-1; PROTEIN; MEMBER; TRANSMIGRATION	Lymphocyte trafficking and migration through vascular endothelial cells (ECs) in secondary lymphoid tissues is critical for immune protection. In the present study, we investigate the role of nectin cell adhesion molecules for the migration of lymphocytes through ECs. Nectins are key players for the establishment of homotypic and heterotypic cell to cell contacts; they are required for cell to cell adherens junction formation and take part in the transendothelial migration of monocytes during the step of diapedesis, when monocytes migrate through EC junctions. We first show that Nectin-3 (CD113) is the only nectin expressed by T lymphocytes and since nectins are expressed on ECs we explored Nectin-3 potential functions in lymphocyte: EC interactions. We demonstrate that Nectin-2, expressed on ECs, is the major counter-receptor of Nectin-3. A soluble form of Nectin-3 binds to Nectin-2 localized at EC junctions and blocking Nectin-2 trans-interactions with monoclonal antibodies abolishes the binding of soluble Nectin-3 to ECs. Nectin-2 is expressed on High Endothelial venules (HEVs), where lymphocyte homing occurs in vivo. Finally, we show that Nectin-3 trans-interaction with Nectin-2 is essential for the process of lymphocyte transendothelial migration in vitro as targeting with blocking monoclonal antibodies either Nectin-3, expressed on lymphocytes, or Nectin-2, expressed on ECs, inhibits lymphocyte extravasation. The nectin family of CAMs is important for the regulation of endothelial barrier functions and transendothelial migration of immune cells. Our results demonstrate for the first time that Nectin-3 trans-interacts with Nectin-2 to promote lymphocyte and monocyte extravasation.	[Devilard, Elisabeth; Xerri, Luc; Dubreuil, Patrice; Lopez, Marc] Aix Marseille Univ, CRCM, Marseille, France; [Devilard, Elisabeth; Xerri, Luc; Dubreuil, Patrice; Lopez, Marc] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Dubreuil, Patrice] CNRS, INSERM, Lab Hematopoiese & Mecanisme Oncogenese, UMR7258,U1068, Marseille, France; [Lopez, Marc] CNRS, INSERM, Oncol Mol Lab, U1068,UMR7258, Marseille, France; [Reymond, Nicolas] CNRS, CRBM, UMR5237, Lab Tyrosine Kinases & Canc, F-34033 Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Reymond, N (corresponding author), CNRS, CRBM, UMR5237, Lab Tyrosine Kinases & Canc, BP 5051, F-34033 Montpellier, France.	nicolas.reymond@crbm.cnrs.fr	dubreuil, patrice/F-5346-2011; Dubreuil, Patrice/V-4816-2019	dubreuil, patrice/0000-0003-1155-1150; Dubreuil, Patrice/0000-0003-1155-1150	INSERM, Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC) (Label)	INSERM, Institut Paoli-Calmettes(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer (LNCC) (Label)	This work was supported by INSERM, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (LNCC) (Label). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Biswas P, 2005, BIOCHEM BIOPH RES CO, V329, P1225, DOI 10.1016/j.bbrc.2005.02.095; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; BOGEN S, 1994, J EXP MED, V179, P1059, DOI 10.1084/jem.179.3.1059; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Ghislin S, 2011, PIGM CELL MELANOMA R, V24, P504, DOI 10.1111/j.1755-148X.2011.00856.x; Giampietro C, 2012, BLOOD, V119, P2159, DOI 10.1182/blood-2011-09-381012; Ilan N, 1999, J CELL SCI, V112, P3005; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Johnson-Leger C, 2000, J CELL SCI, V113, P921; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; LOPEZ M, 1997, WHITE CELL DIFFER AN, P1081; Luscinskas FW, 2002, SEMIN IMMUNOL, V14, P105, DOI 10.1006/smim.2001.0347; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; Manes TD, 2011, J IMMUNOL, V186, P1763, DOI 10.4049/jimmunol.1002835; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; Reymond N, 2005, FEBS LETT, V579, P2243, DOI 10.1016/j.febslet.2005.03.010; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sullivan DP, 2013, AM J PATHOL, V182, P1031, DOI 10.1016/j.ajpath.2012.11.037; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Umemoto E, 2011, CRIT REV IMMUNOL, V31, P147, DOI 10.1615/CritRevImmunol.v31.i2.40; van Buul JD, 2005, J BIOL CHEM, V280, P21129, DOI 10.1074/jbc.M500898200; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Weber C, 2003, J MOL MED, V81, P4, DOI 10.1007/s00109-002-0391-x; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2	51	16	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77424	10.1371/journal.pone.0077424	http://dx.doi.org/10.1371/journal.pone.0077424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116228	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300120
J	Grisewood, MJ; Gifford, NP; Pantazes, RJ; Li, Y; Cirino, PC; Janik, MJ; Maranas, CD				Grisewood, Matthew J.; Gifford, Nathanael P.; Pantazes, Robert J.; Li, Ye; Cirino, Patrick C.; Janik, Michael J.; Maranas, Costas D.			OptZyme: Computational Enzyme Redesign Using Transition State Analogues	PLOS ONE			English	Article							BETA-GLUCURONIDASE; BIOMOLECULAR SIMULATION; DIRECTED EVOLUTION; LIBRARY DESIGN; PROTEIN; RECOMBINATION; SPECIFICITY; PREDICTION; CATALYSIS; MUTAGENESIS	OptZyme is a new computational procedure for designing improved enzymatic activity (i.e., k(cat) or k(cat)/K-M) with a novel substrate. The key concept is to use transition state analogue compounds, which are known for many reactions, as proxies for the typically unknown transition state structures. Mutations that minimize the interaction energy of the enzyme with its transition state analogue, rather than with its substrate, are identified that lower the transition state formation energy barrier. Using Escherichia coli beta-glucuronidase as a benchmark system, we confirm that K-M correlates (R-2 = 0.960) with the computed interaction energy between the enzyme and the para-nitrophenyl- beta, D-glucuronide substrate, k(cat)/K-M correlates (R-2 = 0.864) with the interaction energy of the transition state analogue, 1,5-glucarolactone, and k(cat) correlates (R-2 = 0.854) with a weighted combination of interaction energies with the substrate and transition state analogue. OptZyme is subsequently used to identify mutants with improved K-M, k(cat), and k(cat)/K-M for a new substrate, para-nitrophenyl-beta, D-galactoside. Differences between the three libraries reveal structural differences that underpin improving K-M, k(cat), or k(cat)/K-M. Mutants predicted to enhance the activity for para-nitrophenyl- beta, D-galactoside directly or indirectly create hydrogen bonds with the altered sugar ring conformation or its substituents, namely H162S, L361G, W549R, and N550S.	[Grisewood, Matthew J.; Gifford, Nathanael P.; Pantazes, Robert J.; Janik, Michael J.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Li, Ye; Cirino, Patrick C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Houston System; University of Houston	Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Cirino, Patrick/AAM-1203-2021; Janik, Michael/AAE-7213-2019; Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Pantazes, Robert/0000-0002-0994-007X	National Science Foundation (nsf.gov) grant [CBET-0967062]	National Science Foundation (nsf.gov) grant(National Science Foundation (NSF))	This research was supported by funding from the National Science Foundation (nsf.gov) grant: CBET-0967062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SUIT 2012 JAG; Arul L, 2008, BIOINFORMATION, V2, P339, DOI 10.6026/97320630002339; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bjelic S, 2013, ACS CHEM BIOL, V8, P749, DOI 10.1021/cb3006227; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; CONCHIE J, 1967, BIOCHEM J, V102, P929, DOI 10.1042/bj1020929; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Faiella M, 2009, NAT CHEM BIOL, V5, P882, DOI 10.1038/nchembio.257; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Frushicheva MP, 2010, P NATL ACAD SCI USA, V107, P16869, DOI 10.1073/pnas.1010381107; Geddie ML, 2004, J BIOL CHEM, V279, P26462, DOI 10.1074/jbc.M401447200; de Andrade DVG, 2012, INT J QUANTUM CHEM, V112, P3164, DOI 10.1002/qua.24102; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hilvert D, 2013, ANNU REV BIOCHEM, V82, P447, DOI 10.1146/annurev-biochem-072611-101825; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Kitaura K, 2009, FRAGMENT MOLECULAR ORBITAL METHOD: PRACTICAL APPLICATIONS TO LARGE MOLECULAR SYSTEMS, P1; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lassila JK, 2007, BIOCHEMISTRY-US, V46, P6883, DOI 10.1021/bi700215x; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; MARSH CA, 1986, CARBOHYD RES, V153, P119, DOI 10.1016/S0008-6215(00)90201-5; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Matsumura I, 1999, NAT BIOTECHNOL, V17, P696, DOI 10.1038/10910; Menon V, 2012, PROG ENERG COMBUST, V38, P522, DOI 10.1016/j.pecs.2012.02.002; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; Moore GL, 2004, AICHE J, V50, P262, DOI 10.1002/aic.10025; Moore GL, 2003, P NATL ACAD SCI USA, V100, P5091, DOI 10.1073/pnas.0831190100; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Ni Y, 2011, APPL MICROBIOL BIOT, V90, P193, DOI 10.1007/s00253-010-3051-z; Otey CR, 2006, PLOS BIOL, V4, P789, DOI 10.1371/journal.pbio.0040112; Pantazes RJ, 2007, PROTEIN ENG DES SEL, V20, P361, DOI 10.1093/protein/gzm030; Powers DC, 2013, ORGANOMETALLICS, V32, P2042, DOI 10.1021/om4000456; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Ray J, 1998, GENOMICS, V48, P248, DOI 10.1006/geno.1997.5189; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Rowe LA, 2003, J MOL BIOL, V332, P851, DOI 10.1016/S0022-2836(03)00972-0; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Saraf MC, 2006, BIOPHYS J, V90, P4167, DOI 10.1529/biophysj.105.079277; Saraf MC, 2003, PROTEIN ENG, V16, P1025, DOI 10.1093/protein/gzg129; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SECEMSKI II, 1972, J BIOL CHEM, V247, P4740; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Vellard M, 2003, CURR OPIN BIOTECH, V14, P444, DOI 10.1016/S0958-1669(03)00092-2; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; Xu CG, 2010, BIORESOURCE TECHNOL, V101, P9560, DOI 10.1016/j.biortech.2010.07.065; Xu G, 2001, CLIN CANCER RES, V7, P3314; Yang WC, 2009, BIOPHYS J, V96, P1931, DOI 10.1016/j.bpj.2008.11.051; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483	68	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75358	10.1371/journal.pone.0075358	http://dx.doi.org/10.1371/journal.pone.0075358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116038	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300026
J	Peng, YH; Li, JJ; Xie, FW; Chen, JF; Yu, YH; Ouyang, XN; Liang, HJ				Peng, Yong-hai; Li, Jian-jun; Xie, Fang-wei; Chen, Jian-fang; Yu, Ying-hao; Ouyang, Xue-nong; Liang, Hou-jie			Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients	PLOS ONE			English	Article							PROTOONCOGENE PIM-1; COLORECTAL-CANCER; STEM-CELLS; KINASE; METASTASIS; APOPTOSIS; AMERICAN; GROWTH	Provirus integration site for Moloney murine leukemia virus (pim-1) is a proto-oncogene that is linked to the development and progression of several cancers. In this study, we evaluated pim-1 expression in tumors, tumor stroma and tumor-adjacent mucosa together as an independent prognostic factor for colon cancer patients. The study included 343 colon cancer patients. Immunohistochemical staining was used to detect pim-1. Multivariate cox regression for disease-free survival (DFS) were used to identify independent prognostic factors. Analytic hierarchy process (AHP) was used to calculate the weight of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa in order to obtain a Pim-1 total score (PTS) for recurrence and survival. Kaplan-Meier DFS curves and OS curves for patients with different pim-1 expression levels were compared using the log-rank test. In this study, four independent prognostic factors were identified for colon cancer patients: pim-1 expression in tumors, tumor stroma, tumor-adjacent mucosa, as well as tumor stage. It has been established that clinical stage is an important prognostic factor for colon cancer patients. However, PTS can identify the patients who are likely to recur not only in the whole radical excision group but also within each stage of this group. Based on the results of this study we can conclude that the PTS combined with clinical staging system may be a better predictor of colon cancer patients' prognosis than using the clinical stage system alone.	[Peng, Yong-hai; Li, Jian-jun; Chen, Jian-fang; Liang, Hou-jie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Xie, Fang-wei; Ouyang, Xue-nong] Fuzhou Gen Hosp, Dept Oncol, Fuzhou, Peoples R China; [Yu, Ying-hao] Fuzhou Gen Hosp, Dept Pathol, Fuzhou, Peoples R China	Army Medical University	Ouyang, XN (corresponding author), Fuzhou Gen Hosp, Dept Oncol, Fuzhou, Peoples R China.	oyxnong@163.com; lianghoujie@sina.com			Natural Science of Fujian Province [009J01184]	Natural Science of Fujian Province	Grant support was provided by Natural Science of Fujian Province (grant number 009J01184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Broussard EK, 2011, J CLIN ONCOL, V29, P601, DOI 10.1200/JCO.2010.32.9078; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chagpar R, 2012, J CLIN ONCOL, V30, P972, DOI 10.1200/JCO.2011.39.6937; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DOMEN J, 1993, J EXP MED, V178, P1665, DOI 10.1084/jem.178.5.1665; Donada M, 2011, J CANCER RES CLIN, V137, P201, DOI 10.1007/s00432-010-0872-1; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Jullumstro E, 2011, COLORECTAL DIS, V13, P512, DOI 10.1111/j.1463-1318.2010.02191.x; Magnuson NS, 2010, FUTURE ONCOL, V6, P1461, DOI 10.2217/FON.10.106; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Nakagoe T, 2003, ANN SURG ONCOL, V10, P163, DOI 10.1245/ASO.2003.05.027; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Nie J, 2012, CARCINOGENESIS, V33, P220, DOI 10.1093/carcin/bgr245; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Perrone EE, 2000, JNCI-J NATL CANCER I, V92, P937, DOI 10.1093/jnci/92.11.937; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Resetkova E, 2010, BREAST CANCER RES TR, V123, P97, DOI 10.1007/s10549-009-0619-3; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rhodes DR, 2003, J NATL CANCER I, V95, P661, DOI 10.1093/jnci/95.9.661; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Warnecke-Eberz U, 2008, ONCOL REP, V20, P619, DOI 10.3892/or_00000050; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	37	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76693	10.1371/journal.pone.0076693	http://dx.doi.org/10.1371/journal.pone.0076693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116137	gold, Green Submitted, Green Published			2022-12-27	WOS:000325501300079
J	Ramsay, JD; Ueti, MW; Johnson, WC; Scoles, GA; Knowles, DP; Mealey, RH				Ramsay, Joshua D.; Ueti, Massaro W.; Johnson, Wendell C.; Scoles, Glen A.; Knowles, Donald P.; Mealey, Robert H.			Lymphocytes and Macrophages Are Infected by Theileria equi, but T Cells and B Cells Are Not Required to Establish Infection In Vivo	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BABESIA-EQUI; MONOCLONAL-ANTIBODIES; PROTOZOAN PARASITE; BOS-TAURUS; ANNULATA; HORSES; PARVA; EXPRESSION; RESISTANT	Theileria equi has a biphasic life cycle in horses, with a period of intraleukocyte development followed by patent erythrocytic parasitemia that causes acute and sometimes fatal hemolytic disease. Unlike Theileria spp. that infect cattle (Theileria parva and Theileria annulata), the intraleukocyte stage (schizont) of Theileria equi does not cause uncontrolled host cell proliferation or other significant pathology. Nevertheless, schizont-infected leukocytes are of interest because of their potential to alter host cell function and because immune responses directed against this stage could halt infection and prevent disease. Based on cellular morphology, Theileria equi has been reported to infect lymphocytes in vivo and in vitro, but the specific phenotype of schizont-infected cells has yet to be defined. To resolve this knowledge gap in Theileria equi pathogenesis, peripheral blood mononuclear cells were infected in vitro and the phenotype of infected cells determined using flow cytometry and immunofluorescence microscopy. These experiments demonstrated that the host cell range of Theileria equi was broader than initially reported and included B lymphocytes, T lymphocytes and monocyte/macrophages. To determine if B and T lymphocytes were required to establish infection in vivo, horses affected with severe combined immunodeficiency (SCID), which lack functional B and T lymphocytes, were inoculated with Theileria equi sporozoites. SCID horses developed patent erythrocytic parasitemia, indicating that B and T lymphocytes are not necessary to complete the Theileria equi life cycle in vivo. These findings suggest that the factors mediating Theileria equi leukocyte invasion and intracytoplasmic differentiation are common to several leukocyte subsets and are less restricted than for Theileria annulata and Theileria parva. These data will greatly facilitate future investigation into the relationships between Theileria equi leukocyte tropism and pathogenesis, breed susceptibility, and strain virulence.	[Ramsay, Joshua D.; Knowles, Donald P.; Mealey, Robert H.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Ueti, Massaro W.; Johnson, Wendell C.; Scoles, Glen A.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA	Washington State University; United States Department of Agriculture (USDA)	Ramsay, JD (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	jdr105@vetmed.wsu.edu	Mealey, Robert/H-1454-2016	Mealey, Robert/0000-0002-7571-1689	Grayson-Jockey Club Research Foundation; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2012-67011-19946]; USDA-ARS CRIS [5348-32000-028D]	Grayson-Jockey Club Research Foundation; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by the Grayson-Jockey Club Research Foundation (www.grayson-jockeyclub.org), the Agriculture and Food Research Initiative Competitive Grant No. 2012-67011-19946 from the USDA National Institute of Food and Agriculture (www.nifa.usda.gov), and USDA-ARS CRIS 5348-32000-028D (www.ars.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN CL, 1988, INFECT IMMUN, V56, P462, DOI 10.1128/IAI.56.2.462-467.1988; BARNETT SF, 1960, J INFECT DIS, V107, P253, DOI 10.1093/infdis/107.3.253; BLANCHARDCHANNELL M, 1994, IMMUNOLOGY, V82, P548; Boulter N, 2000, ADV PARASIT, V44, P41; CAMPBELL JD, 1994, PARASITE IMMUNOL, V16, P501, DOI 10.1111/j.1365-3024.1994.tb00378.x; Cantor GH, 2001, J VIROL, V75, P1689, DOI 10.1128/JVI.75.4.1689-1696.2001; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; CONRAD PA, 1989, PARASITOLOGY, V99, P205, DOI 10.1017/S0031182000058650; DEWAAL DT, 1992, BRIT VET J, V148, P6, DOI 10.1016/0007-1935(92)90061-5; EMERY DL, 1988, PARASITE IMMUNOL, V10, P379, DOI 10.1111/j.1365-3024.1988.tb00228.x; Forsyth LMG, 1999, J COMP PATHOL, V120, P39, DOI 10.1053/jcpa.1998.0256; Glass EJ, 2005, INT J PARASITOL, V35, P337, DOI 10.1016/j.ijpara.2004.12.006; GLASS EJ, 1989, VET IMMUNOL IMMUNOP, V22, P355, DOI 10.1016/0165-2427(89)90171-2; Glass EJ, 2012, VET IMMUNOL IMMUNOP, V148, P178, DOI 10.1016/j.vetimm.2012.03.006; Ibrahim S, 2007, VET IMMUNOL IMMUNOP, V119, P63, DOI 10.1016/j.vetimm.2007.06.034; Jensen K, 2008, INT J PARASITOL, V38, P313, DOI 10.1016/j.ijpara.2007.08.007; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Kinnaird JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066833; KNOWLES DP, 1991, INFECT IMMUN, V59, P2412, DOI 10.1128/IAI.59.7.2412-2417.1991; KNOWLES DP, 1994, INFECT IMMUN, V62, P1909, DOI 10.1128/IAI.62.5.1909-1913.1994; KYDD J, 1994, VET IMMUNOL IMMUNOP, V42, P3, DOI 10.1016/0165-2427(94)90088-4; LUNN DP, 1995, IMMUNOLOGY, V84, P495; McGuire K, 2004, VET IMMUNOL IMMUNOP, V99, P87, DOI 10.1016/j.vetimm.2004.01.003; MCGUIRE TC, 1974, J AM VET MED ASSOC, V164, P70; MCGUIRE TC, 1983, AM J VET RES, V44, P1284; MCGUIRE TC, 1975, CLIN IMMUNOL IMMUNOP, V3, P555, DOI 10.1016/0090-1229(75)90080-X; Mealey RH, 2001, CLIN IMMUNOL, V101, P237, DOI 10.1006/clim.2001.5109; Mealey RH, 2008, VET IMMUNOL IMMUNOP, V121, P8, DOI 10.1016/j.vetimm.2007.07.011; Mealey RH, 2012, CLIN VACCINE IMMUNOL, V19, P100, DOI 10.1128/CVI.05301-11; Mehlhorn H, 1998, PARASITOL RES, V84, P467, DOI 10.1007/s004360050431; MEHLHORN H, 1984, ADV PARASIT, V23, P37, DOI 10.1016/S0065-308X(08)60285-7; MOLTMANN UG, 1983, J PARASITOL, V69, P111, DOI 10.2307/3281285; Morrison WI, 1996, INFECT IMMUN, V64, P557, DOI 10.1128/IAI.64.2.557-562.1996; MORRISON WI, 1981, EXP PARASITOL, V52, P248, DOI 10.1016/0014-4894(81)90080-1; Oliver RA, 1996, VET IMMUNOL IMMUNOP, V50, P173, DOI 10.1016/0165-2427(95)05487-1; Patton KM, 2004, INFECT IMMUN, V72, P7073, DOI 10.1128/IAI.72.12.7073-7083.2004; PERRYMAN LE, 1980, J AM VET MED ASSOC, V176, P1250; PERRYMAN LE, 1978, TRANSPLANTATION, V25, P50, DOI 10.1097/00007890-197802000-00002; PRESTON PM, 1992, RES VET SCI, V53, P230, DOI 10.1016/0034-5288(92)90115-I; REHBEIN G, 1982, Z PARASITENKD, V67, P125, DOI 10.1007/BF00929521; SCHEIN E, 1981, TROPENMED PARASITOL, V32, P223; Schein E., 1988, P197; Shaw MK, 1997, INT J PARASITOL, V27, P457, DOI 10.1016/S0020-7519(97)00015-5; SHAW MK, 1995, J CELL SCI, V108, P1587; Shin EK, 1997, J IMMUNOL, V158, P3565; SPOONER RL, 1989, IMMUNOLOGY, V66, P284; Taylor SD, 2010, J VIROL, V84, P6536, DOI 10.1128/JVI.00218-10; Tindih HS, 2012, INFECT IMMUN, V80, P1267, DOI 10.1128/IAI.05085-11; TUMAS DB, 1994, IMMUNOBIOLOGY, V192, P48, DOI 10.1016/S0171-2985(11)80407-9; Ueti MW, 2008, INFECT IMMUN, V76, P3525, DOI 10.1128/IAI.00251-08; Ueti MW, 2005, J CLIN MICROBIOL, V43, P3755, DOI 10.1128/JCM.43.8.3755-3759.2005; Ueti MW, 2003, J CLIN MICROBIOL, V41, P5803, DOI 10.1128/JCM.41.12.5803-5809.2003; WILER R, 1995, P NATL ACAD SCI USA, V92, P11485, DOI 10.1073/pnas.92.25.11485	53	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76996	10.1371/journal.pone.0076996	http://dx.doi.org/10.1371/journal.pone.0076996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116194	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300111
J	Smits, SM; von Oerthel, L; Hoekstra, EJ; Burbach, JPH; Smidt, MP				Smits, Simone M.; von Oerthel, Lars; Hoekstra, Elisa J.; Burbach, J. Peter H.; Smidt, Marten P.			Molecular Marker Differences Relate to Developmental Position and Subsets of Mesodiencephalic Dopaminergic Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; ANTERIOR NEURAL PLATE; SUBSTANTIA-NIGRA; TYROSINE-HYDROXYLASE; PARKINSONS-DISEASE; PROSOMERIC MODEL; HUMAN EMBRYOS; MIDBRAIN; EXPRESSION; RAT	The development of mesodiencephalic dopaminergic (mdDA) neurons located in the substantia nigra compacta (SNc) and ventral tegmental area (VTA) follow a number of stages marked by distinct events. After preparation of the region by signals that provide induction and patterning, several transcription factors have been identified, which are involved in specifying the neuronal fate of these cells. The specific vulnerability of SNc neurons is thought to root in these specific developmental programs. The present study examines the positions of young postmitotic mdDA neurons to relate developmental position to mdDA subset specific markers. MdDA neurons were mapped relative to the neuromeric domains (prosomeres 1-3 (P1-3), midbrain, and hindbrain) as well as the longitudinal subdivisions (floor plate, basal plate, alar plate), as proposed by the prosomeric model. We found that postmitotic mdDA neurons are located mainly in the floorplate domain and very few in slightly more lateral domains. Moreover, mdDA neurons are present along a large proportion of the anterior/posterior axis extending from the midbrain to P3 in the diencephalon. The specific positions relate to some extent to the presence of specific subset markers as Ahd2. In the adult stage more of such subsets specific expressed genes are present and may represent a molecular map defining molecularly distinct groups of mdDA neurons.	[von Oerthel, Lars; Hoekstra, Elisa J.; Smidt, Marten P.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Smits, Simone M.; von Oerthel, Lars; Burbach, J. Peter H.; Smidt, Marten P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center	Smidt, MP (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X	Korczak Foundation for Autism and Related Disorders, the Netherlands; Netherlands Organization of Scientific Research NWO [903-42-075]; Netherlands Organization of Scientific Research NWO (VICI-ALW) [865.09.002]	Korczak Foundation for Autism and Related Disorders, the Netherlands; Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization of Scientific Research NWO (VICI-ALW)	This work was supported by the Korczak Foundation for Autism and Related Disorders, the Netherlands, and by the Netherlands Organization of Scientific Research NWO (fellowship 903-42-075 and VICI-ALW (865.09.002) to MPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, MOL CELL NEUROSCI, V13, P1, DOI 10.1006/mcne.1998.0730; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brodski C, 2003, J NEUROSCI, V23, P4199; BULFONE A, 1993, J NEUROSCI, V13, P3155; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101; HANAWAY J, 1970, AM J ANAT, V129, P417, DOI 10.1002/aja.1001290404; HANAWAY J, 1971, J COMP NEUROL, V142, P59, DOI 10.1002/cne.901420105; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Lahti L, 2012, DEVELOPMENT, V139, P894, DOI 10.1242/dev.071936; Marin F, 2005, DEV DYNAM, V234, P709, DOI 10.1002/dvdy.20467; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Puelles L, 1998, J COMP NEUROL, V394, P283, DOI 10.1002/(SICI)1096-9861(19980511)394:3<283::AID-CNE2>3.0.CO;2-Y; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shimamura K, 1995, DEVELOPMENT, V121, P3923; SHULTS CW, 1990, NEUROSCIENCE, V38, P427, DOI 10.1016/0306-4522(90)90039-7; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; Simeone A, 1998, EMBO J, V17, P6790, DOI 10.1093/emboj/17.23.6790; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Verney C, 2001, J COMP NEUROL, V429, P22, DOI 10.1002/1096-9861(20000101)429:1<22::AID-CNE3>3.0.CO;2-X; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	37	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76037	10.1371/journal.pone.0076037	http://dx.doi.org/10.1371/journal.pone.0076037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116087	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300046
J	Volker, C; Boedicker, C; Daubenthaler, J; Oetken, M; Oehlmann, J				Voelker, Carolin; Boedicker, Cathinka; Daubenthaler, Jan; Oetken, Matthias; Oehlmann, Joerg			Comparative Toxicity Assessment of Nanosilver on Three Daphnia Species in Acute, Chronic and Multi-Generation Experiments	PLOS ONE			English	Article							SILVER NANOPARTICLES; MAGNA-STRAUS; RISK-ASSESSMENT; KNOWLEDGE GAPS; EXPOSURE; NANOMATERIALS; TOLERANCE; ECOTOXICITY; ACCLIMATION; ORGANISMS	The antibacterial properties of nanosilver have led to a versatile application spectrum including medical purposes and personal care products. However, the increasing use of nanosilver has raised concerns about its environmental impacts. Long-term exposure studies with aquatic invertebrates are essential to assess possible adverse effects on aquatic ecosystems. In the present study, acute (48 h), chronic (21 d) and long-term effects of nanosilver (primary size 15 nm) on five successive generations of three Daphnia species (D. magna, D. pulex, and D. galeata) were investigated. Acute EC50 values of nanosilver were 121 mu g Ag L-1 for D. magna being the least sensitive species and 8.95 and 13.9 mu g Ag L-1 for D. pulex and D. galeata, respectively. Chronic exposure provided EC10 values of 0.92 mu g Ag L-1 for D. magna showing the most sensitive chronic reaction and 2.25 and 3.45 mu g Ag L-1 for D. pulex and D. galeata, respectively. Comparative exposure to AgNO3 revealed a generally higher toxicity of the soluble form of silver. The multi-generation experiments resulted in effects on the population level for all tested species. Exposure of D. magna indicated an increased toxicity of nanosilver in the fifth generation of animals exposed to 10 mu g Ag L-1. Neonates from pre-exposed parental daphnids did not completely recover when transferred into clean water. Exposure of D. pulex and D. galeata revealed not only increasing toxicity in some generations, but also greater tolerance to nanosilver. This study contributes to the assessment of the risk potential of nanosilver on aquatic ecosystems. It shows that effects of nanosilver vary within one genus and change with exposure duration. Therefore, long-term studies considering different aquatic species are needed to better understand the possible effects of nanosilver on aquatic ecosystems.	[Voelker, Carolin; Boedicker, Cathinka; Daubenthaler, Jan; Oetken, Matthias; Oehlmann, Joerg] Goethe Univ Frankfurt, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Volker, C (corresponding author), Goethe Univ Frankfurt, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany.	c.voelker@bio.uni-frankfurt.de	Völker, Carolin/ABG-6320-2020; Oetken, Matthias/C-9906-2010; Oehlmann, Jörg/B-4565-2010	Völker, Carolin/0000-0002-3009-8729; Oehlmann, Jörg/0000-0002-6075-2701	German National Academic Foundation	German National Academic Foundation	This work was funded by by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HJ, 2010, ENVIRON TOXICOL CHEM, V29, P2742, DOI 10.1002/etc.329; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Bossuyt BTA, 2004, ENVIRON TOXICOL CHEM, V23, P2029, DOI 10.1897/03-377; Bradford A, 2009, ENVIRON SCI TECHNOL, V43, P4530, DOI 10.1021/es9001949; BRENDELBERGER H, 1985, J PLANKTON RES, V7, P473, DOI 10.1093/plankt/7.4.473; BURNS CW, 1969, LIMNOL OCEANOGR, V14, P693, DOI 10.4319/lo.1969.14.5.0693; COWGILL UM, 1984, J CRUSTACEAN BIOL, V4, P173, DOI 10.2307/1548014; Eisler R., 1996, SILVER HAZARDS FISH; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; ELENDT BP, 1989, ARCH HYDROBIOL, V116, P415; Farkas J, 2011, ENVIRON INT, V37, P1057, DOI 10.1016/j.envint.2011.03.006; Gaiser BK, 2011, J ENVIRON MONITOR, V13, P1227, DOI 10.1039/c1em10060b; Gaiser BK, 2009, ENV HLTH, V8; Gottschalk F, 2011, ENVIRON POLLUT, V159, P3439, DOI 10.1016/j.envpol.2011.08.023; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Guan R, 2004, ENVIRON SCI TECHNOL, V38, P6051, DOI 10.1021/es049562z; Hammers-Wirtz M, 2000, ENVIRON TOXICOL CHEM, V19, P1856, DOI 10.1002/etc.5620190720; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; High KA, 1997, ENVIRON TOXICOL CHEM, V16, P1111, DOI 10.1002/etc.5620160604; Hoheisel SM, 2012, ENVIRON TOXICOL CHEM, V31, P2557, DOI 10.1002/etc.1978; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kennedy AJ, 2010, ENVIRON SCI TECHNOL, V44, P9571, DOI 10.1021/es1025382; Klaine SJ, 2012, ENVIRON TOXICOL CHEM, V31, P3, DOI 10.1002/etc.733; Klein C., 2011, 24693EN2011 EUR, DOI 10.2788/23079; KLINE ER, 1989, ENVIRON POLLUT, V56, P11, DOI 10.1016/0269-7491(89)90117-6; KOIVISTO S, 1992, HYDROBIOLOGIA, V248, P125, DOI 10.1007/BF00006080; Li T, 2010, ANAL BIOANAL CHEM, V398, P689, DOI 10.1007/s00216-010-3915-1; Lotka A.J., 1913, NATURAL POPULATION N; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; Massarin S, 2010, AQUAT TOXICOL, V99, P309, DOI 10.1016/j.aquatox.2010.05.006; MUNZINGER A, 1990, WATER RES, V24, P845, DOI 10.1016/0043-1354(90)90134-R; Muyssen BTA, 2004, ENVIRON POLLUT, V130, P309, DOI 10.1016/j.envpol.2004.01.003; Muyssen BTA, 2001, ENVIRON TOXICOL CHEM, V20, P2053, DOI 10.1002/etc.5620200926; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; OECD, 2004, OECD GUID TEST CHEM; OECD, 2012, OECD GUID TEST CHEM, V211; Ratte HT, 1999, ENVIRON TOXICOL CHEM, V18, P89, DOI [10.1897/1551-5028(1999)018&lt;0089:BATOSC&gt;2.3.CO;2, 10.1002/etc.5620180112]; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Seeland A, 2012, ENVIRON POLLUT, V168, P161, DOI 10.1016/j.envpol.2012.04.020; STUHLBACHER A, 1992, COMP BIOCHEM PHYS C, V101, P571, DOI 10.1016/0742-8413(92)90088-O; Villarroel MJ, 1999, ECOTOX ENVIRON SAFE, V44, P40, DOI 10.1006/eesa.1999.1817; Volker C, 2013, REV ENVIRON CONTAM T, V223, P81, DOI 10.1007/978-1-4614-5577-6_4; Wang Z, 2012, ENVIRON TOXICOL CHEM, V31, P2408, DOI 10.1002/etc.1964; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; WINNER RW, 1976, J FISH RES BOARD CAN, V33, P1685, DOI 10.1139/f76-215; WoodrowWilson International Center for Scholars, 2011, PROJ EM NAN; Zhao CM, 2012, NANOTOXICOLOGY, V6, P361, DOI 10.3109/17435390.2011.579632; Zhao CM, 2011, ENVIRON TOXICOL CHEM, V30, P885, DOI 10.1002/etc.451; Zhao CM, 2010, ENVIRON SCI TECHNOL, V44, P7699, DOI 10.1021/es101484s	51	85	89	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75026	10.1371/journal.pone.0075026	http://dx.doi.org/10.1371/journal.pone.0075026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116021	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300021
J	Dworkin, MS; Peterson, CE; Gao, WH; Mayor, A; Hunter, R; Negron, E; Fleury, A; Besch, CL				Dworkin, Mark S.; Peterson, Caryn E.; Gao, Weihua; Mayor, Angel; Hunter, Robert; Negron, Edna; Fleury, Alison; Besch, C. Lynn			Efficacy of a Food Safety Comic Book on Knowledge and Self-Reported Behavior for Persons Living with AIDS	PLOS ONE			English	Article							HIV; MORTALITY; RISK; MENINGITIS; SALMONELLA; INFECTIONS; RECOVERY	Introduction: Persons living with AIDS are highly vulnerable to foodborne enteric infections with the potential for substantial morbidity and mortality. Educational materials about foodborne enteric infections intended for this immunocompromised population have not been assessed for their efficacy in improving knowledge or encouraging behavior change. Methods/Results: AIDS patients in four healthcare facilities in Chicago, New Orleans, and Puerto Rico were recruited using fliers and word of mouth to healthcare providers. Those who contacted research staff were interviewed to determine food safety knowledge gaps and risky behaviors. A food safety educational comic book that targeted knowledge gaps was created, piloted, and provided to these patients who were instructed to read it and return at least 2 weeks later for a follow-up interview. The overall food safety score was determined by the number of the 26 knowledge/belief/behavior questions from the survey answered correctly. Among 150 patients who participated in both the baseline and follow-up questionnaire, the intervention resulted in a substantial increase in the food safety score (baseline 59%, post-intervention 81%, p<0.001). The intervention produced a significant increase in all the food safety knowledge, belief, and behavior items that comprised the food safety score. Many of these increases were from baseline knowledge below 80 percent to well above 90%. Most (85%) of the patients stated they made a change to their behavior since receiving the educational booklet. Conclusion: This comic book format intervention to educate persons living with AIDS was highly effective. Future studies should examine to what extent long-term behavioral changes result.	[Dworkin, Mark S.; Peterson, Caryn E.] Univ Illinois, Chicago Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Gao, Weihua] Univ Illinois, Ctr Clin & Translat Sci, Chicago, IL USA; [Mayor, Angel; Hunter, Robert] Univ Cent Caribe, Sch Med, Hosp Univ Ramon Ruiz Arnau, Retrovirus Res Ctr,Internal Med Dept, Bayamon, PR USA; [Negron, Edna] Univ Puerto Rico, Food Sci & Technol Program, Mayaguez, PR USA; [Fleury, Alison; Besch, C. Lynn] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Puerto Rico; University of Puerto Rico Mayaguez; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Dworkin, MS (corresponding author), Univ Illinois, Chicago Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	mdworkin@uic.edu	Gao, Wei/GXH-0380-2022	Mayor, Angel M./0000-0002-7705-837X; Peterson, Caryn/0000-0002-9868-9576	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, National Integrated Food Safety Initiative Program [2009-51110-20173]; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, National Integrated Food Safety Initiative Program; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by an award from the United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, National Integrated Food Safety Initiative Program (Award No. 2009-51110-20173). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, 2009, MMWR-MORBID MORTAL W, V58, P36; CDC, 1999, SAF FOODS WAT GUID P; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Cummings PL, 2010, FOODBORNE PATHOG DIS, V7, P1393, DOI 10.1089/fpd.2010.0588; Dworkin M. S., 2012, Food Protection Trends, V32, P564; Dworkin Mark S, 2013, Food Prot Trends, V33, P32; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Food U.S and Drug Administration Center for Food Safety and Applied Nutrition, 1992, EAT DEF FOOD SAF ADV; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; GRANT IH, 1990, AIDS, V4, P519, DOI 10.1097/00002030-199006000-00004; Guevara RE, 2009, CLIN INFECT DIS, V48, P1507, DOI 10.1086/598935; Heathcock R, 1998, AIDS CARE, V10, P237, DOI 10.1080/09540129850124497; Hoffman EW, 2005, J AM DIET ASSOC, V105, P1597, DOI 10.1016/j.jada.2005.07.035; James S, 2005, HEALTH PROMOT INT, V20, P157, DOI 10.1093/heapro/dah606; JURADO RL, 1993, CLIN INFECT DIS, V17, P224, DOI 10.1093/clinids/17.2.224; Larsen IK, 2011, SCAND J INFECT DIS, V43, P3, DOI 10.3109/00365548.2010.517780; Leonard MK, 2002, AM J MED SCI, V323, P266, DOI 10.1097/00000441-200205000-00007; Liebman Amy K, 2007, J Agromedicine, V12, P33, DOI 10.1300/J096v12n02_04; Meremo Alfred, 2012, Int Arch Med, V5, P28, DOI 10.1186/1755-7682-5-28; Safranek T., 2009, Morbidity and Mortality Weekly Report, V58, P500; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399	21	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e72874	10.1371/journal.pone.0072874	http://dx.doi.org/10.1371/journal.pone.0072874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124447	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100004
J	Laurance, SGW; Jones, D; Westcott, D; Mckeown, A; Harrington, G; Hilbert, DW				Laurance, Susan G. W.; Jones, Dean; Westcott, David; Mckeown, Adam; Harrington, Graham; Hilbert, David W.			Habitat Fragmentation and Ecological Traits Influence the Prevalence of Avian Blood Parasites in a Tropical Rainforest Landscape	PLOS ONE			English	Article							COMMUNITY COMPOSITION; WILD BIRD; BLUE TITS; MALARIA; DEFORESTATION; HOST; TRANSMISSION; BIODIVERSITY; EMERGENCE; DECAY	In the tropical rainforests of northern Australia, we investigated the effects of habitat fragmentation and ecological parameters on the prevalence of blood-borne parasites (Plasmodium and Haemoproteus) in bird communities. Using mist-nets on forest edges and interiors, we sampled bird communities across six study sites: 3 large fragments (20-85 ha) and 3 continuous-forest sites. From 335 mist-net captures, we recorded 28 bird species and screened 299 bird samples with PCR to amplify and detect target DNA. Of the 28 bird species sampled, 19 were infected with Plasmodium and/or Haemoproteus and 9 species were without infection. Over one third of screened birds (99 individuals) were positive for Haemoproteus and/or Plasmodium. In forest fragments, bird capture rates were significantly higher than in continuous forests, but bird species richness did not differ. Unexpectedly, we found that the prevalence of the dominant haemosporidian infection, Haemoproteus, was significantly higher in continuous forest than in habitat fragments. Further, we found that ecological traits such as diet, foraging height, habitat specialisation and distributional ranges were significantly associated with blood-borne infections.	[Laurance, Susan G. W.; Westcott, David; Hilbert, David W.] James Cook Univ, Ctr Trop Environm & Sustainabil Studies TESS, Cairns, Qld, Australia; [Laurance, Susan G. W.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Jones, Dean; Westcott, David; Mckeown, Adam; Harrington, Graham; Hilbert, David W.] CSIRO, Div Ecosyst Sci, Trop Forest Res Ctr, Atherton, Qld, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Laurance, SGW (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Studies TESS, Cairns, Qld, Australia.	susan.laurance@jcu.edu.au	Laurance, Susan/G-6021-2011; McKeown, Adam/D-3170-2011; Hilbert, David W/A-3796-2008; Westcott, David A/G-5559-2010	Laurance, Susan/0000-0002-2831-2933; 	Commonwealth Environment Research Facility MTSRF grant	Commonwealth Environment Research Facility MTSRF grant	This research was funded by a Commonwealth Environment Research Facility MTSRF grant to SL and DWH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Beadell JS, 2005, J PARASITOL, V91, P683, DOI 10.1645/GE-3412RN; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; Bonneaud C, 2009, J TROP ECOL, V25, P439, DOI 10.1017/S0266467409006178; Briant G, 2010, BIOL CONSERV, V143, P2763, DOI 10.1016/j.biocon.2010.07.024; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kettle DS, 1982, MED VET ENTOMOLOGY; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Laurance WF, 2002, J VEG SCI, V13, P595, DOI 10.1111/j.1654-1103.2002.tb02086.x; LAURANCE WF, 1994, BIOL CONSERV, V69, P23, DOI 10.1016/0006-3207(94)90325-5; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lederberg J., 1992, I MED US COMMITTEE; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; LYNAM AJ, 1997, TROPICAL FOREST REMN; Martinez-de la Puente J, 2010, BIOL LETTERS, V6, P663, DOI 10.1098/rsbl.2010.0046; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; McCune B., 2011, PC ORD MULTIVARIATE; Mendes L, 2005, OIKOS, V109, P396, DOI 10.1111/j.0030-1299.2005.13509.x; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Morse Stephen S., 1993, P10; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pizzey G, 2007, FIELD GUIDE BIRDS AU; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; Simpson K., 2010, FIELD GUIDE BIRDS AU, V8th edn; Steiger DM, 2012, J VECTOR ECOL, V37, P69, DOI 10.1111/j.1948-7134.2012.00201.x; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tracey JG, 1982, VEGETATION HUMID TRO; Valkinas G., 2005, AVIAN MALARIA PARASI; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	56	37	37	3	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76227	10.1371/journal.pone.0076227	http://dx.doi.org/10.1371/journal.pone.0076227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124541	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000325489100098
J	Lee, IC; Huang, YH; Su, CW; Wang, YJ; Huo, TI; Lee, KC; Lin, HC				Lee, I-Cheng; Huang, Yi-Hsiang; Su, Chien-Wei; Wang, Yuan-Jen; Huo, Teh-Ia; Lee, Kuei-Chuan; Lin, Han-Chieh			CXCL9 Associated with Sustained Virological Response in Chronic Hepatitis B Patients Receiving Peginterferon Alfa-2a Therapy: A Pilot Study	PLOS ONE			English	Article							INDUCIBLE PROTEIN 10; INTERFERON TREATMENT; NATURAL-HISTORY; VIRUS INFECTION; VIRAL RESPONSE; C VIRUS; HBEAG; LAMIVUDINE; PREDICTS; IL28B	Background and Aims: There is lack of a practical biomarker to predict sustained virological response (SVR) in chronic hepatitis B (CHB) patients undergoing peginterferon alfa-2a (PEG-IFN). The aim of this pilot study was to identify immunological features associated with SVR. Methods: Consecutive 74 CHB patients receiving 24 weeks (for hepatitis B e antigen (HBeAg)-positive) or 48 weeks (for HBeAg-negative) PEG-IFN, were prospectively enrolled. Serum HBV viral loads, hepatitis B surface antigen (HBsAg), CXCL9, IFN-.-inducible protein 10 (IP-10), interferon-gamma (IFN-gamma) and transforming growth factor beta (TGF-beta) were measured at baseline and week 12. SVR was defined as HBeAg seroconversion combined with viral load <2000 IU/mL in HBeAg-positive (n=36), and viral load <2000 IU/mL in HBeAg-negative patients (n= 38) at 48 weeks after the end of treatment. Results: Nineteen patients (25.7%), 7 in HBeAg-positive and 12 in HBeAg-negative, achieved SVR. There were significant declines of HBV DNA, HBsAg, IP-10 and IFN-gamma levels at week 12. In multivariate analysis, pre-treatment CXCL9 >80 pg/mL, HBV DNA <2.5 x 10(7) IU/mL and on-treatment HBV viral load, HBsAg decline >10% at week 12 were predictors of SVR. The performance of CXCL9 in predicting SVR was good in patients with HBV DNA <2.5 x 107 IU/mL, particularly in HBeAg-negative CHB cases (positive predictive value, PPV=64.3%). Conclusions: Pre-treatment CXCL9 level has the potential to select CHB patients who can respond to PEG-IFN, especially in HBeAg-negative patients with low viral loads.	[Lee, I-Cheng; Huang, Yi-Hsiang; Su, Chien-Wei; Huo, Teh-Ia; Lee, Kuei-Chuan; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wang, Yuan-Jen] Taipei Vet Gen Hosp, Hlth Care Ctr, Taipei, Taiwan; [Lee, I-Cheng; Huang, Yi-Hsiang; Su, Chien-Wei; Lee, Kuei-Chuan] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lee, I-Cheng] Natl Yang Ming Univ Hosp, Dept Med, Ilan, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, YH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	yhhuang@vghtpe.gov.tw	Su, Chien-Wei/AHC-8307-2022; Lee, I-Cheng/AAF-5650-2020; Su, Chien-Wei/C-1521-2012	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Huang, Yi-Hsiang/0000-0001-5241-5425	National Science Council [NSC 100-2314-B-010-024]; Taipei Veterans General Hospitals, Taipei, Taiwan [VGH100C-104, VGH101C-147, VGH102C-136]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospitals, Taipei, Taiwan	The study was supported by grants from the National Science Council (NSC 100-2314-B-010-024), and Taipei Veterans General Hospitals (VGH100C-104, VGH101C-147, VGH102C-136), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Fried MW, 2008, HEPATOLOGY, V47, P428, DOI 10.1002/hep.22065; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hong MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030360; Huang YH, 2006, J VIRAL HEPATITIS, V13, P336, DOI 10.1111/j.1365-2893.2005.00688.x; Huang YH, 2003, J VIRAL HEPATITIS, V10, P277, DOI 10.1046/j.1365-2893.2003.00428.x; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Kurelac I, 2012, J INTERF CYTOK RES, V32, P386, DOI 10.1089/jir.2012.0006; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058071; Liaw YF, 2011, HEPATOLOGY, V54, P1591, DOI 10.1002/hep.24555; Liaw YF, 2011, HEPATOLOGY, V53, P2121, DOI 10.1002/hep.24364; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Peng CY, 2012, ALIMENT PHARM THER, V35, P458, DOI 10.1111/j.1365-2036.2011.04973.x; Penna A, 2012, J HEPATOL, V56, P1239, DOI 10.1016/j.jhep.2011.12.032; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; Rijckborst V, 2010, HEPATOLOGY, V52, P454, DOI 10.1002/hep.23722; Sonneveld MJ, 2013, J HEPATOL, V58, P898, DOI 10.1016/j.jhep.2013.01.029; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Sung JJY, 2008, ALIMENT PHARM THER, V28, P1067, DOI 10.1111/j.1365-2036.2008.03816.x; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011; Xia YJ, 2012, J VIRAL HEPATITIS, V19, P509, DOI 10.1111/j.1365-2893.2011.01581.x; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	44	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76798	10.1371/journal.pone.0076798	http://dx.doi.org/10.1371/journal.pone.0076798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124595	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100152
J	Razavi, N; Jann, K; Koenig, T; Kottlow, M; Hauf, M; Strik, W; Dierks, T				Razavi, Nadja; Jann, Kay; Koenig, Thomas; Kottlow, Mara; Hauf, Martinus; Strik, Werner; Dierks, Thomas			Shifted Coupling of EEG Driving Frequencies and fMRI Resting State Networks in Schizophrenia Spectrum Disorders	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DEFAULT MODE NETWORK; EVENT-RELATED FMRI; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; PHASE SYNCHRONIZATION; WORKING-MEMORY; LANGUAGE LATERALIZATION; AUDITORY HALLUCINATIONS; ELECTRODE IMPEDANCE	Introduction: The cerebral resting state in schizophrenia is altered, as has been demonstrated separately by electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) resting state networks (RSNs). Previous simultaneous EEG/fMRI findings in healthy controls suggest that a consistent spatiotemporal coupling between neural oscillations (EEG frequency correlates) and RSN activity is necessary to organize cognitive processes optimally. We hypothesized that this coupling is disorganized in schizophrenia and related psychotic disorders, in particular regarding higher cognitive RSNs such as the default-mode (DMN) and left-working-memory network (LWMN). Methods: Resting state was investigated in eleven patients with a schizophrenia spectrum disorder (n = 11) and matched healthy controls (n = 11) using simultaneous EEG/fMRI. The temporal association of each RSN to topographic spectral changes in the EEG was assessed by creating Covariance Maps. Group differences within, and group similarities across frequencies were estimated for the Covariance Maps. Results: The coupling of EEG frequency bands to the DMN and the LWMN respectively, displayed significant similarities that were shifted towards lower EEG frequencies in patients compared to healthy controls. Conclusions: By combining EEG and fMRI, each measuring different properties of the same pathophysiology, an aberrant relationship between EEG frequencies and altered RSNs was observed in patients. RSNs of patients were related to lower EEG frequencies, indicating functional alterations of the spatiotemporal coupling. Significance: The finding of a deviant and shifted coupling between RSNs and related EEG frequencies in patients with a schizophrenia spectrum disorder is significant, as it might indicate how failures in the processing of internal and external stimuli, as commonly seen during this symptomatology (i.e. thought disorders, hallucinations), arise.	[Razavi, Nadja; Jann, Kay; Koenig, Thomas; Kottlow, Mara; Strik, Werner; Dierks, Thomas] Univ Bern, Dept Psychiat Neurophysiol, Univ Hosp Psychiat, Bern, Switzerland; [Jann, Kay] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Hauf, Martinus] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Hauf, Martinus] Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of California System; University of California Los Angeles; University of Bern; University Hospital of Bern; University of Bern	Razavi, N (corresponding author), Univ Bern, Dept Psychiat Neurophysiol, Univ Hosp Psychiat, Bern, Switzerland.	razavi@puk.unibe.ch	Koenig, Thomas/F-6454-2010; Koenig, Thomas/ABD-2278-2020; Jann, Kay/E-8343-2010; Jann, Kay/AAF-2154-2020; Strik, Werner Konrad/N-7807-2013; Dierks, Thomas/B-7092-2012	Koenig, Thomas/0000-0002-1472-4638; Koenig, Thomas/0000-0002-1472-4638; Strik, Werner Konrad/0000-0001-7108-1993; Dierks, Thomas/0000-0002-4173-5308; Jann, Kay/0000-0003-3574-0538				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreasen NC, 1997, SCIENCE, V275, P1586, DOI 10.1126/science.275.5306.1586; Assaf M, 2009, BRAIN COGNITION, V70, P238, DOI 10.1016/j.bandc.2009.02.007; Bates AT, 2009, SCHIZOPHR RES, V115, P222, DOI 10.1016/j.schres.2009.09.036; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Diederen KMJ, 2010, BRAIN, V133, P3734, DOI 10.1093/brain/awq313; Dierks Th, 2009, EPILEPTOLOGIE, V26, P21; Douaud G, 2009, BRAIN, V132, P2437, DOI 10.1093/brain/awp126; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Federspiel A, 2006, NEUROBIOL DIS, V22, P702, DOI 10.1016/j.nbd.2006.01.015; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; GALDERISI S, 1991, SCHIZOPHR RES, V6, P15, DOI 10.1016/0920-9964(91)90016-K; Galderisi S, 2009, CLIN EEG NEUROSCI, V40, P62, DOI 10.1177/155005940904000206; Gallo A, 2012, NEUROLOGY, V79, P1458, DOI 10.1212/WNL.0b013e31826d5eea; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P921, DOI 10.1093/schbul/sbm045; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hanslmayr S, 2012, HUM BRAIN M IN PRESS; Hayashi M, 1999, PERCEPT MOTOR SKILL, V88, P676, DOI 10.2466/pms.1999.88.2.676; Horn H, 2012, NEUROPSYCHOBIOLOGY, V66, P14, DOI 10.1159/000337133; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Ishii R, 2000, NEUROREPORT, V11, P3283, DOI 10.1097/00001756-200009280-00047; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kappenman ES, 2010, PSYCHOPHYSIOLOGY, V47, P888, DOI 10.1111/j.1469-8986.2010.01009.x; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kim DI, 2009, SCHIZOPHRENIA BULL, V35, P67, DOI 10.1093/schbul/sbn133; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Koch K, 2012, CORTEX IN PRESS; Koenig T, 2008, CLIN NEUROPHYSIOL, V119, P1262, DOI 10.1016/j.clinph.2007.12.023; Koenig T, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/938925; Koenig T, 2010, BRAIN TOPOGR, V23, P233, DOI 10.1007/s10548-010-0142-1; Kottlow M, 2012, CLIN NEUROPHYSIOL, V123, P1536, DOI 10.1016/j.clinph.2011.12.019; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Liu XA, 2011, NEUROIMAGE, V54, P2278, DOI 10.1016/j.neuroimage.2010.10.001; Low MD, 1987, ELECTROENCEPHALOGRAP, P541; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Luchinger R, 2011, NEUROIMAGE, V56, P1493, DOI 10.1016/j.neuroimage.2011.02.050; MacDonald AW, 2003, J ABNORM PSYCHOL, V112, P689, DOI 10.1037/0021-843X.112.4.689; Mandelkow H, 2006, NEUROIMAGE, V32, P1120, DOI 10.1016/j.neuroimage.2006.04.231; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McGuire PK, 1996, PSYCHOL MED, V26, P663, DOI 10.1017/S0033291700037673; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Meda SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007911; Mientus S, 2002, PSYCHIAT RES-NEUROIM, V116, P95, DOI 10.1016/S0925-4927(02)00043-4; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Miyauchi T, 1996, PSYCHIAT CLIN NEUROS, V50, P71, DOI 10.1111/j.1440-1819.1996.tb01666.x; Niedermeyer E., 1987, ELECTROENCEPHALOGRAP, V2nd, P97; Niedermeyer E, 1987, ELECTROENCEPHALOGRAP, P119; Nikulin VV, 2006, NEUROSCIENCE, V137, P647, DOI 10.1016/j.neuroscience.2005.10.031; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; Olbrich S, 2009, NEUROIMAGE, V45, P319, DOI 10.1016/j.neuroimage.2008.11.014; Pascual-Marqui R. D., 2009, IMAGING ELECT NEURON, P49; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Rotarska-Jagiela A, 2009, PSYCHIAT RES-NEUROIM, V174, P9, DOI 10.1016/j.pscychresns.2009.03.002; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Segalowitz SJ, 2010, BRAIN COGNITION, V72, P86, DOI 10.1016/j.bandc.2009.10.003; SHAM PC, 1994, ACTA PSYCHIAT SCAND, V89, P135, DOI 10.1111/j.1600-0447.1994.tb01501.x; Singer W, 2001, ANN NY ACAD SCI, V929, P123; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sommer IEC, 2001, SCHIZOPHR RES, V52, P57, DOI 10.1016/S0920-9964(00)00180-8; Sponheim SR, 2000, BIOL PSYCHIAT, V48, P1088, DOI 10.1016/S0006-3223(00)00907-0; Strijkstra AM, 2003, NEUROSCI LETT, V340, P17, DOI 10.1016/S0304-3940(03)00033-8; Strik WK, 1998, EVOKED POTENTIAL, V108, P406, DOI 10.1016/S0168-5597(98)00021-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka H, 1997, SLEEP, V20, P523, DOI 10.1093/sleep/20.7.523; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Venables NC, 2009, SCHIZOPHRENIA BULL, V35, P826, DOI 10.1093/schbul/sbn021; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; WHO, 2012, ICD 10 CLASS MENT BE; Wolf ND, 2011, J PSYCHIATR NEUROSCI, V36, P366, DOI 10.1503/jpn.110008; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Wu X, 2009, NEUROIMAGE, V45, P1347, DOI 10.1016/j.neuroimage.2008.12.050; Yang CM, 2010, CONSCIOUS COGN, V19, P1084, DOI 10.1016/j.concog.2009.12.017; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	109	23	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76604	10.1371/journal.pone.0076604	http://dx.doi.org/10.1371/journal.pone.0076604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124576	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100133
J	Chen, T; Song, DL; Shan, GL; Wang, K; Wang, YW; Ma, J; Zhong, Y				Chen, Ting; Song, Delu; Shan, Guangliang; Wang, Ke; Wang, Yiwei; Ma, Jin; Zhong, Yong			The Association between Diabetes Mellitus and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RISK-FACTORS; NERVE HEAD; RETINOPATHY; PREVALENCE; PATHOGENESIS; CHOLESTEROL; POPULATION; BIAS	Background: The association of diabetes mellitus (DM) with nonarteritic anterior ischemic optic neuropathy (NAION) has been inconclusive. Purpose: To determine whether DM is associated with an increased risk of NAION. Methods: A comprehensive literature search was performed for published studies reporting both DM and NAION based on PubMed and EMBASE. After reviewing characteristics of all the included studies systematically, meta-analytical method was employed to calculate the pooled odds ratio (OR) and associated 95% confidence interval (CI) from random-effects models. Heterogeneity was assessed by Q-statistic test. Funnel Plot, Begg's and Egger's linear regression test were applied to evaluate publication bias. A sensitivity analysis and meta-regression analysis were also performed to assess the robustness of results. Results: 2,096 participants from 12 case-control studies were pooled for a meta-analysis. The result of meta-analysis of these studies indicated that DM is associated with increased risk of NAION (pooled OR = 1.64, 95% CI = 1.17-2.30; P = 0.004). Sensitivity analysis indicated our findings are robust, and meta-regression analysis revealed no significant effect in terms of geographical area, gender, age of patients with NAION, the year of the publication, source of the controls, and sample size (all p>0.05). Evidence of publication bias was not observed in our study. Conclusion: Meta-analysis suggests that DM might be associated with increased risk of NAION.	[Chen, Ting; Wang, Yiwei; Ma, Jin; Zhong, Yong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ophthalmol, Beijing 100730, Peoples R China; [Chen, Ting; Shan, Guangliang; Wang, Ke; Wang, Yiwei; Ma, Jin; Zhong, Yong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Song, Delu] Univ Penn, Scheie Eye Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shan, Guangliang; Wang, Ke] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Pennsylvania; Pennsylvania Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Ma, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ophthalmol, Beijing 100730, Peoples R China.	majin1912@163.com; yzhong_eye@163.com			Peking Union Medical College Hospital	Peking Union Medical College Hospital	The authors have unrestricted funding from Peking Union Medical College Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; ARNOLD AC, 1994, AM J OPHTHALMOL, V117, P222, DOI 10.1016/S0002-9394(14)73080-6; Asproudis I, 2009, OPEN OPHTHALMOL J, V3, P15, DOI 10.2174/1874364100903010015; Bulboaca Adriana, 2002, Oftalmologia, V53, P52; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Ciulla TA, 2002, ACTA OPHTHALMOL SCAN, V80, P468, DOI 10.1034/j.1600-0420.2002.800503.x; Collignon-Robe NJ, 2004, OPHTHALMOLOGY, V111, P1663, DOI 10.1016/j.ophtha.2004.05.020; Deramo VA, 2003, OPHTHALMOLOGY, V110, P1041, DOI 10.1016/S0161-6420(03)00079-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falavarjani KG, 2009, ARCH IRAN MED, V12, P472; Felekis T, 2010, GRAEF ARCH CLIN EXP, V248, P877, DOI 10.1007/s00417-010-1308-y; Giambene B, 2009, GRAEF ARCH CLIN EXP, V247, P693, DOI 10.1007/s00417-008-0981-6; Glueck CJ, 2004, J LAB CLIN MED, V143, P184, DOI 10.1016/j.lab.2003.10.015; Hattenhauer MG, 1997, AM J OPHTHALMOL, V123, P103, DOI 10.1016/S0002-9394(14)70999-7; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P2275, DOI 10.1016/j.ophtha.2008.08.007; HAYREH SS, 1994, AM J OPHTHALMOL, V118, P766, DOI 10.1016/S0002-9394(14)72557-7; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P603, DOI 10.1016/S0002-9394(14)70067-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jacobson DM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1403, DOI 10.1001/archopht.1997.01100160573008; JOHNSON LN, 1994, J NEURO-OPHTHALMOL, V14, P38; Johnson LN, 1996, J NATL MED ASSOC, V88, P369; Jonas JB, 2009, BRIT J OPHTHALMOL, V93, P703, DOI 10.1136/bjo.2008.155630; KALENAK JW, 1991, ARCH OPHTHALMOL-CHIC, V109, P660, DOI 10.1001/archopht.1991.01080050074032; Kesler A, 2009, ACTA OPHTHALMOL, V87, P216, DOI 10.1111/j.1755-3768.2008.01199.x; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee MS, 2011, OPHTHALMOLOGY, V118, P959, DOI 10.1016/j.ophtha.2011.01.054; Leiba H, 2000, EYE, V14, P828, DOI 10.1038/eye.2000.231; Li J, 2007, BRIT J OPHTHALMOL, V91, P1524, DOI 10.1136/bjo.2006.113803; Markoula S, 2011, MOL VIS, V17, P1254; McGwin G, 2006, BRIT J OPHTHALMOL, V90, P154, DOI 10.1136/bjo.2005.083519; Miller NR, 2011, J NEURO-OPHTHALMOL, V31, pE1, DOI 10.1097/WNO.0b013e31821f955c; Miyamoto K, 1999, Semin Ophthalmol, V14, P233, DOI 10.3109/08820539909069542; Muzaffar S, 2008, BRIT J PHARMACOL, V155, P847, DOI 10.1038/bjp.2008.300; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Odette JD, 2011, ARCH OPHTHALMOL-CHIC, V129, P1106, DOI 10.1001/archophthalmol.2011.209; Palimar P, 1998, EYE, V12, P894, DOI 10.1038/eye.1998.227; Pinna A, 2008, INVEST OPHTH VIS SCI, V49, P1328, DOI 10.1167/iovs.07-1115; Salomon O, 2004, OPHTHALMOLOGY, V111, P184, DOI 10.1016/j.ophtha.2003.05.006; Salomon O, 1999, OPHTHALMOLOGY, V106, P739, DOI 10.1016/S0161-6420(99)90159-8; Schmidt D, 2003, KLIN MONATSBL AUGENH, V220, P774; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Slagle WS, 2009, OPTOMETRY VISION SCI, V86, P395, DOI 10.1097/OPX.0b013e318198927c; Stein JD, 2011, AM J OPHTHALMOL, V152, P989, DOI 10.1016/j.ajo.2011.04.030; TALKS SJ, 1995, EYE, V9, P85, DOI 10.1038/eye.1995.13; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Thurtell MJ, 2008, INT J IMPOT RES, V20, P537, DOI 10.1038/ijir.2008.25; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Weger M, 2002, OPHTHALMOLOGY, V109, P749, DOI 10.1016/S0161-6420(01)01031-4; Weger M, 2001, BRIT J OPHTHALMOL, V85, P803, DOI 10.1136/bjo.85.7.803; Wells GA, 2014, NEWCASTLEOTTAWA SCAL; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; You QS, 2008, GRAEF ARCH CLIN EXP, V246, P1291, DOI 10.1007/s00417-008-0809-4	52	33	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76653	10.1371/journal.pone.0076653	http://dx.doi.org/10.1371/journal.pone.0076653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098798	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500169
J	Gauthy, E; Cuende, J; Stockis, J; Huygens, C; Lethe, B; Collet, JF; Bommer, G; Coulie, PG; Lucas, S				Gauthy, Emilie; Cuende, Julia; Stockis, Julie; Huygens, Caroline; Lethe, Bernard; Collet, Jean-Francois; Bommer, Guido; Coulie, Pierre G.; Lucas, Sophie			GARP Is Regulated by miRNAs and Controls Latent TGF-beta 1 Production by Human Regulatory T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CYCLIC ADENOSINE-MONOPHOSPHATE; TGF-BETA; SELECTIVE DEPLETION; TUMOR-IMMUNITY; REG-CELLS; EXPRESSION; SURFACE; FOXP3; TREG	GARP is a transmembrane protein present on stimulated human regulatory T lymphocytes (Tregs), but not on other T lymphocytes (Th cells). It presents the latent form of TGF-beta 1 on the Treg surface. We report here that GARP favors the cleavage of the pro-TGF-beta 1 precursor and increases the amount of secreted latent TGF-beta 1. Stimulated Tregs, which naturally express GARP, and Th cells transfected with GARP secrete a previously unknown form of latent TGF-beta 1 that is disulfide-linked to GARP. These GARP/TGF-beta 1 complexes are possibly shed from the T cell surface. Secretion of GARP/TGF-beta 1 complexes was not observed with transfected 293 cells and may thus be restricted to the T cell lineage. We conclude that in stimulated human Tregs, GARP not only displays latent TGF-beta 1 at the cell surface, but also increases its secretion by forming soluble disulfide-linked complexes. Moreover, we identified six microRNAs (miRNAs) that are expressed at lower levels in Treg than in Th clones and that target a short region of the GARP 3' UTR. In transfected Th cells, the presence of this region decreased GARP levels, cleavage of pro-TGF-beta 1, and secretion of latent TGF-beta 1.	[Gauthy, Emilie; Cuende, Julia; Stockis, Julie; Huygens, Caroline; Collet, Jean-Francois; Coulie, Pierre G.; Lucas, Sophie] Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium; [Gauthy, Emilie; Cuende, Julia; Stockis, Julie; Huygens, Caroline; Collet, Jean-Francois; Bommer, Guido; Coulie, Pierre G.; Lucas, Sophie] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Lethe, Bernard] Ludwig Inst Canc Res Ltd, Brussels Branch, Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Ludwig Institute for Cancer Research	Lucas, S (corresponding author), Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium.	sophie.lucas@uclouvain.be	; Bommer, Guido/A-8425-2011	Collet, Jean-Francois/0000-0001-8069-7036; Bommer, Guido/0000-0001-6898-4884; Lucas, Sophie/0000-0003-1287-7996; Stockis, Julie/0000-0003-4911-6891	Fonds National pour la Recherche Scientifique (Belgium); Fonds Speciaux de la Recherche (Belgium); Televie grant (Belgium); Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan [29_049]; Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees (Belgium); Fonds J. Maisin (Belgium)	Fonds National pour la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de la Recherche (Belgium); Televie grant (Belgium); Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan; Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees (Belgium); Fonds J. Maisin (Belgium)	E.G., J.S., G.B., J.-F.C. and S.L. are supported by the Fonds National pour la Recherche Scientifique (Belgium). J.C. is supported by a post-doctoral fellowship from the Fonds Speciaux de la Recherche (Belgium) and C. H. is supported by a Televie grant (Belgium). This work was supported by grants from the Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming, by grants from the Belgian Cancer Plan (Action 29_049), the Fonds National pour la Recherche Scientifique (Belgium), the Fondation contre le Cancer (Belgium), the Fondation Salus Sanguinis (Belgium), the Actions de Recherche Concertees (Belgium) and the Fonds J. Maisin (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; de Vries IJM, 2011, CLIN CANCER RES, V17, P841, DOI 10.1158/1078-0432.CCR-10-2227; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Fayyad-Kazan H, 2012, J BIOL CHEM, V287, P9910, DOI 10.1074/jbc.M111.337154; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Jeker LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036684; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Onizuka S, 1999, CANCER RES, V59, P3128; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimizu J, 1999, J IMMUNOL, V163, P5211; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Stockis J, 2009, EUR J IMMUNOL, V39, P869, DOI 10.1002/eji.200838807; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Todorovic V, 2012, J CELL BIOCHEM, V113, P410, DOI 10.1002/jcb.23385; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Zhao J, 2010, CANCER RES, V70, P4850, DOI 10.1158/0008-5472.CAN-10-0283; Zhou QH, 2013, J IMMUNOL, V190, P6579, DOI 10.4049/jimmunol.1202993; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	34	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76186	10.1371/journal.pone.0076186	http://dx.doi.org/10.1371/journal.pone.0076186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098777	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500147
J	Abdali, N; Barth, E; Norouzy, A; Schulz, R; Nau, WM; Kleinekathofer, U; Tauch, A; Benz, R				Abdali, Narges; Barth, Enrico; Norouzy, Amir; Schulz, Robert; Nau, Werner M.; Kleinekathoefer, Ulrich; Tauch, Andreas; Benz, Roland			Corynebacterium jeikeium jk0268 Constitutes for the 40 Amino Acid Long PorACj, Which Forms a Homooligomeric and Anion- Selective Cell Wall Channel	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MATRIX PROTEIN PORIN; CORYNEBACTERIUM-GLUTAMICUM; BIOPHYSICAL CHARACTERIZATION; BIOCHEMICAL-IDENTIFICATION; MYCOBACTERIUM-SMEGMATIS; PHYLOGENETIC ANALYSIS; MYCOLIC ACID; L-LYSINE; GENE	Corynebacterium jeikeium, a resident of human skin, is often associated with multidrug resistant nosocomial infections in immunodepressed patients. C. jeikeium K411 belongs to mycolic acid-containing actinomycetes, the mycolata and contains a channel-forming protein as judged from reconstitution experiments with artificial lipid bilayer experiments. The channel-forming protein was present in detergent treated cell walls and in extracts of whole cells using organic solvents. A gene coding for a 40 amino acid long polypeptide possibly responsible for the pore-forming activity was identified in the known genome of C. jeikeium by its similar chromosomal localization to known porH and porA genes of other Corynebacterium strains. The gene jk0268 was expressed in a porin deficient Corynebacterium glutamicum strain. For purification temporarily histidine-tailed or with a GST-tag at the N-terminus, the homogeneous protein caused channel-forming activity with an average conductance of 1.25 nS in 1M KCl identical to the channels formed by the detergent extracts. Zero-current membrane potential measurements of the voltage dependent channel implied selectivity for anions. This preference is according to single-channel analysis caused by some excess of cationic charges located in the channel lumen formed by oligomeric alpha-helical wheels. The channel has a suggested diameter of 1.4 nm as judged from the permeability of different sized hydrated anions using the Renkin correction factor. Surprisingly, the genome of C. jeikeium contained only one gene coding for a cell wall channel of the PorA/PorH type found in other Corynebacterium species. The possible evolutionary relationship between the heterooligomeric channels formed by certain Corynebacterium strains and the homooligomeric pore of C. jeikeium is discussed.	[Abdali, Narges; Norouzy, Amir; Schulz, Robert; Nau, Werner M.; Kleinekathoefer, Ulrich; Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany; [Barth, Enrico; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Tauch, Andreas] Univ Bielefeld, Inst Genome Res & Syst Biol, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany	University of Bremen; German Research Foundation (DFG); University of Wurzburg; University of Bielefeld	Benz, R (corresponding author), Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany.	roland.benz@uni-wuerzburg.de	Kleinekathöfer, Ulrich/I-2329-2013; Nau, Werner/E-6686-2011	Kleinekathöfer, Ulrich/0000-0002-6114-7431; Nau, Werner/0000-0002-7654-6232; Norouzy, Amir/0000-0002-9712-6755; Benz, Roland/0000-0002-9510-9265	Jacobs University	Jacobs University	Funds by Jacobs University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barksdale L, 1981, PROKARYOTES, P1827; Barreiro C, 2004, J BACTERIOL, V186, P4813, DOI 10.1128/JB.186.14.4813-4817.2004; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1988, ANNU REV MICROBIOL, V42, P359, DOI 10.1146/annurev.mi.42.100188.002043; Benz R., 1994, BACTERIAL CELL WALL, P397; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brune I, 2006, J BIOTECHNOL, V127, P21, DOI 10.1016/j.jbiotec.2006.06.011; CASTELLAN GW, 1983, PHYSICAL CHEM, P769; Chugh JK, 2001, BIOCHEM SOC T, V29, P565, DOI 10.1042/BST0290565; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Costa-Riu N, 2003, J BACTERIOL, V185, P4779, DOI 10.1128/JB.185.16.4779-4786.2003; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; Dorner U, 2004, BBA-BIOMEMBRANES, V1667, P47, DOI 10.1016/j.bbamem.2004.09.001; Eggeling L, 1999, APPL MICROBIOL BIOT, V52, P146, DOI 10.1007/s002530051501; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; FREUDL R, 1992, J BIOTECHNOL, V23, P231, DOI 10.1016/0168-1656(92)90072-H; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; GOODFELLOW M, 1976, J GEN MICROBIOL, V96, P351, DOI 10.1099/00221287-96-2-351; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hallin PF, 2004, BIOINFORMATICS, V20, P3682, DOI 10.1093/bioinformatics/bth423; Hansmeier N, 2007, PROTEOMICS, V7, P1076, DOI 10.1002/pmic.200600833; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Holt JG, 1994, BERGEYS MANUAL DETER, P625; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Hunten P, 2005, MICROBIOL-SGM, V151, P2429, DOI 10.1099/mic.0.27903-0; JACKMAN PJH, 1986, J GEN MICROBIOL, V132, P1911; JOHNSON WD, 1970, ANN NY ACAD SCI, V174, P568, DOI 10.1111/j.1749-6632.1970.tb45582.x; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kinoshita S, 2004, J GEN APPL MICROBIOL, V50, P331; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lechevalier H A, 1971, Adv Appl Microbiol, V14, P47, DOI 10.1016/S0065-2164(08)70539-2; Leuchtenberger W., 1996, BIOTECHNOLOGY, V6, P465; Lichtinger T, 2000, J BACTERIOL, V182, P764, DOI 10.1128/JB.182.3.764-770.2000; Lichtinger T, 1999, FEBS LETT, V454, P349, DOI 10.1016/S0014-5793(99)00844-3; Lichtinger T, 2001, EUR J BIOCHEM, V268, P462; Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MacGregor RR, 1995, PRINCIPLES PRACTICE, P1865; MINNIKIN DE, 1974, FEBS LETT, V39, P322, DOI 10.1016/0014-5793(74)80140-7; Minnikin DE, 1987, CHEMOTHERAPY TROPICA, P19; Mookadam F, 2006, EUR J CLIN MICROBIOL, V25, P349, DOI 10.1007/s10096-006-0145-8; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OCHI K, 1995, INT J SYST BACTERIOL, V45, P653, DOI 10.1099/00207713-45-4-653; Oteo J, 2001, ENFERM INFEC MICR CL, V19, P103, DOI 10.1016/S0213-005X(01)72578-5; PASCUAL C, 1995, INT J SYST BACTERIOL, V45, P724, DOI 10.1099/00207713-45-4-724; Riess FG, 1998, MOL MICROBIOL, V29, P139, DOI 10.1046/j.1365-2958.1998.00914.x; Riess FG, 2000, BBA-BIOMEMBRANES, V1509, P485, DOI 10.1016/S0005-2736(00)00332-1; Riess FG, 2001, J MEMBRANE BIOL, V182, P147, DOI 10.1007/s00232-001-0037-x; RUIMY R, 1995, INT J SYST BACTERIOL, V45, P740, DOI 10.1099/00207713-45-4-740; Sahm H, 1996, ANN NY ACAD SCI, V782, P25, DOI 10.1111/j.1749-6632.1996.tb40544.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Schulz G. E., 2004, BACTERIAL EUKARYOTIC, P25; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Tauch A, 2004, PLASMID, V52, P102, DOI 10.1016/j.plasmid.2004.05.003; Tauch A, 2008, J BIOTECHNOL, V136, P11, DOI 10.1016/j.jbiotec.2008.02.009; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; TRIAS JQ, 1993, J BIOL CHEM, V268, P6234; UDAKA S, 1960, J BACTERIOL, V79, P754, DOI 10.1128/JB.79.5.754-755.1960; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6; YANO I, 1972, FEBS LETT, V23, P352, DOI 10.1016/0014-5793(72)80314-4; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017	81	10	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75651	10.1371/journal.pone.0075651	http://dx.doi.org/10.1371/journal.pone.0075651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116064	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200033
J	Buyyarapu, R; Kantety, RV; Yu, JZ; Xu, ZY; Kohel, RJ; Percy, RG; Macmil, S; Wiley, GB; Roe, BA; Sharma, GC				Buyyarapu, Ramesh; Kantety, Ramesh V.; Yu, John Z.; Xu, Zhanyou; Kohel, Russell J.; Percy, Richard G.; Macmil, Simone; Wiley, Graham B.; Roe, Bruce A.; Sharma, Govind C.			BAC-Pool Sequencing and Analysis of Large Segments of A12 and D12 Homoeologous Chromosomes in Upland Cotton	PLOS ONE			English	Article							X GOSSYPIUM-BARBADENSE; EVOLUTION; GENOME; MAP; ORGANIZATION; ARABIDOPSIS; ANNOTATION	Although new and emerging next-generation sequencing (NGS) technologies have reduced sequencing costs significantly, much work remains to implement them for de novo sequencing of complex and highly repetitive genomes such as the tetraploid genome of Upland cotton (Gossypium hirsutum L.). Herein we report the results from implementing a novel, hybrid Sanger/454-based BAC-pool sequencing strategy using minimum tiling path (MTP) BACs from Ctg-3301 and Ctg-465, two large genomic segments in A12 and D12 homoeologous chromosomes (Ctg). To enable generation of longer contig sequences in assembly, we implemented a hybrid assembly method to process similar to 35x data from 454 technology and 2.8-3x data from Sanger method. Hybrid assemblies offered higher sequence coverage and better sequence assemblies. Homology studies revealed the presence of retrotransposon regions like Copia and Gypsy elements in these contigs and also helped in identifying new genomic SSRs. Unigenes were anchored to the sequences in Ctg-3301 and Ctg-465 to support the physical map. Gene density, gene structure and protein sequence information derived from protein prediction programs were used to obtain the functional annotation of these genes. Comparative analysis of both contigs with Arabidopsis genome exhibited synteny and microcollinearity with a conserved gene order in both genomes. This study provides insight about use of MTP-based BAC-pool sequencing approach for sequencing complex polyploid genomes with limited constraints in generating better sequence assemblies to build reference scaffold sequences. Combining the utilities of MTP-based BAC-pool sequencing with current longer and short read NGS technologies in multiplexed format would provide a new direction to cost-effectively and precisely sequence complex plant genomes.	[Buyyarapu, Ramesh; Kantety, Ramesh V.; Sharma, Govind C.] Alabama A&M Univ, Dept Biol & Environm Sci, Ctr Mol Biol, Normal, AL 35762 USA; [Yu, John Z.; Xu, Zhanyou; Kohel, Russell J.; Percy, Richard G.] ARS, USDA, Southern Plains Agr Res Ctr, Crop Germplasm Res Unit, College Stn, TX USA; [Roe, Bruce A.] Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA; [Macmil, Simone] Univ Otago, Gene Struct & Funct Lab, Dunedin, New Zealand; [Wiley, Graham B.] Oklahoma Med Res Fdn, Arthrit & Immunol Dept, Oklahoma City, OK 73104 USA	Alabama A&M University; United States Department of Agriculture (USDA); University of Oklahoma System; University of Oklahoma - Norman; University of Otago; Oklahoma Medical Research Foundation	Buyyarapu, R (corresponding author), Dow AgroSci, Trait Genet & Technol, Indianapolis, IN USA.	rbuyyarapu@dow.com		Cree, Simone/0000-0002-7349-422X; Buyyarapu, Ramesh/0000-0002-5343-9960	USDA-CSREES [ALAX-011-706, ALAX-011-206]; NSF-PGRP [0703470]	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF-PGRP(National Science Foundation (NSF)NSF - Office of the Director (OD))	The authors would like to acknowledge the funding support for this work by USDA-CSREES grants ALAX-011-706 to RVK, ALAX-011-206 to GCS and NSF-PGRP grant 0703470 to RVK. The authors would like to acknowledge the support offered by Padmini Sripathi during data analysis and submissions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; Brown CT, 2011, APPL ENV MICROBIOLOG; Buyyarapu R, 2009, BAC POOL 454 SEQUENC, pW121; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Green P, 1999, PHRAP SWAT CROSSMATC; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Hawkins JS, 2008, GENOME, V51, P11, DOI [10.1139/G07-099, 10.1139/g07-099]; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Nautiyal S, 2010, P NATL ACAD SCI USA, V107, P12587, DOI 10.1073/pnas.1005173107; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; REINISCH AJ, 1994, GENETICS, V138, P829; Robinson AJ, 2004, BIOINFORMATICS, V20, P1475, DOI 10.1093/bioinformatics/bth104; Roe B, 2004, SHOTGUN LIB CONSTRUC, V255; ROE BA, 1996, DNA ISOLATION SEQUEN; Rong J, 2005, GENOME RES, V15, P1198, DOI 10.1101/gr.3907305; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Shappley ZW, 1996, THEOR APPL GENET, V92, P915, DOI 10.1007/BF00224030; Shappley ZW, 1998, THEOR APPL GENET, V97, P756, DOI 10.1007/s001220050952; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Wiley G, 2009, METHODS GENERATING S; Wilkins T, 2013, PLANT ANIMAL GENOME; Xu ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-108; Zhang MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033644	42	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76757	10.1371/journal.pone.0076757	http://dx.doi.org/10.1371/journal.pone.0076757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116150	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200065
J	Graham, MT; Abram, CL; Hu, YM; Lowell, CA				Graham, Michelle T.; Abram, Clare L.; Hu, Yongmei; Lowell, Clifford A.			Expression of the TEL-Syk Fusion Protein in Hematopoietic Stem Cells Leads to Rapidly Fatal Myelofibrosis in Mice	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MYELOPROLIFERATIVE NEOPLASMS; ACTIVATION; MUTATIONS; KINASE; GENE; LEUKEMOGENESIS; PATHOGENESIS; LYMPHOMA; TARGET	The TEL-Syk fusion protein was isolated from a patient with myelodysplasia with megakaryocyte blasts. Expression of TEL-Syk transforms interleukin-3 (IL-3)-dependent Ba/F3 cells in vitro by deregulating STAT5-mediated signal transduction pathways. In vivo, TEL-Syk expression in pre-B cells blocks B cell differentiation, leading to lymphoid leukemia. Here, we demonstrate that TEL-Syk introduced into fetal liver hematopoietic cells, which are then adoptively transferred into lethally irradiated recipients, leads to an aggressive myelodysplasia with myelofibrosis that is lethal in mice by 60-75 days. Expression of TEL-Syk induces a short-lived myeloexpansion that is rapidly followed by bone marrow failure and extreme splenic/hepatic fibrosis accompanied by extensive apoptosis. The disease is dependent on Syk kinase activity. Analysis of serum from TEL-Syk mice reveals an inflammatory cytokine signature reminiscent of that found in the sera from patients and mouse models of myeloproliferative neoplasms. TEL-Syk expressing cells showed constitutive STAT5 phosphorylation, which was resistant to JAK inhibition, consistent with deregulated cytokine signaling. These data indicate that expression of TEL-Syk in fetal liver hematopoietic cells results in JAK-independent STAT5 phosphorylation ultimately leading to a uniquely aggressive and lethal form of myelofibrosis.	[Graham, Michelle T.; Abram, Clare L.; Hu, Yongmei; Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lowell, CA (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	clifford.lowell@ucsf.edu			US National Institutes of Health [AI65495, AI68150, AI078869]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078869, R01AI065495, R01AI068150] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institutes of Health (AI65495, AI68150 and AI078869 to C. A. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Bisen A, 2013, ADV EXP MED BIOL, V779, P179, DOI 10.1007/978-1-4614-6176-0_8; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Holroyd A, 2011, LEUKEMIA RES, V35, P1279, DOI 10.1016/j.leukres.2011.05.037; Kanie T, 2004, LEUKEMIA, V18, P548, DOI 10.1038/sj.leu.2403266; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; Meester-Smoor MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023620; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nurden P, 2011, BLOOD, V118, P5928, DOI 10.1182/blood-2011-07-365601; Pardanani A, 2012, LEUKEMIA, V26, P693, DOI 10.1038/leu.2011.251; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Rigby S, 2009, J BIOL CHEM, V284, P26871, DOI 10.1074/jbc.M109.034272; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; Takeda Y, 2011, BRIT J HAEMATOL, V153, P589, DOI 10.1111/j.1365-2141.2011.08663.x; Tanaka H, 2010, LEUKEMIA, V24, P197, DOI 10.1038/leu.2009.167; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Thiele J, 2005, SEMIN ONCOL, V32, P380, DOI 10.1053/j.seminoncol.2005.04.010; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Wossning T, 2006, J EXP MED, V203, P2829, DOI 10.1084/jem.20060967; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381	31	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77542	10.1371/journal.pone.0077542	http://dx.doi.org/10.1371/journal.pone.0077542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116232	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200118
J	Sugimoto, K; Ichikawa-Tomikawa, N; Satohisa, S; Akashi, Y; Kanai, R; Saito, T; Sawada, N; Chiba, H				Sugimoto, Kotaro; Ichikawa-Tomikawa, Naoki; Satohisa, Seiro; Akashi, Yushi; Kanai, Risa; Saito, Tsuyoshi; Sawada, Norimasa; Chiba, Hideki			The Tight-Junction Protein Claudin-6 Induces Epithelial Differentiation from Mouse F9 and Embryonic Stem Cells	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; BLASTOCYST FORMATION; GROWTH-FACTORS; EXPRESSION; GENE; OCCLUDIN; POLARITY; DOMAIN; FATE	During epithelialization, cell adhesions and polarity must be established to maintain tissue assemblies and separate the biological compartments in the body. However, the molecular basis of epithelial morphogenesis, in particular, a role of cell adhesion molecules in epithelial differentiation from stem cells, remains unclear. Here, we show that the stable and conditional expression of a tight-junction protein, claudin-6 (Cldn6), triggers epithelial morphogenesis in mouse F9 stem cells. We also demonstrate that Cldn6 induces the expression of other tight-junction and microvillus molecules including Cldn7, occludin, ZO-1 alpha+, and ezrin/radixin/moesin-binding phosphoprotein50. These events were inhibited by attenuation of Cldn6 using RNA interference or the C-terminal half of Clostridium Perfringens enterotoxin. Furthermore, similar results were obtained in mouse embryonic stem cells. Thus, we have uncovered that the Cldn6 functions as a novel cue to induce epithelial differentiation.	[Sugimoto, Kotaro; Sawada, Norimasa] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Satohisa, Seiro; Akashi, Yushi; Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Ichikawa-Tomikawa, Naoki; Kanai, Risa; Chiba, Hideki] Fukushima Med Univ, Sch Med, Dept Basic Pathol, Fukushima, Japan	Sapporo Medical University; Sapporo Medical University; Fukushima Medical University	Chiba, H (corresponding author), Fukushima Med Univ, Sch Med, Dept Basic Pathol, Fukushima, Japan.	hidchiba@fmu.ac.jp	Sugimoto, Kotaro/AAE-9873-2020	Sugimoto, Kotaro/0000-0002-5299-7610	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in Aid for the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Naito Foundation, and the Uehara Memorial Foundation. K. S. received the research fellowship for young scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WJ, 2008, DEV DYNAM, V237, P504, DOI 10.1002/dvdy.21437; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; Chiba H, 2000, EXP CELL RES, V260, P334, DOI 10.1006/excr.2000.5022; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chiba H, 2006, J CELL BIOL, V175, P971, DOI 10.1083/jcb.200608012; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Haakensen VD, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-77; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Kubota H, 2001, EXP CELL RES, V263, P163, DOI 10.1006/excr.2000.5113; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Mitchell LA, 2010, TOXINS, V2, P1595, DOI 10.3390/toxins2071595; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Satohisa S, 2005, EXP CELL RES, V310, P66, DOI 10.1016/j.yexcr.2005.06.025; Sheth B, 1997, DEVELOPMENT, V124, P2027; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Turksen K, 2001, DEV DYNAM, V222, P292, DOI 10.1002/dvdy.1174; Uchida H, 2010, BIOCHEM PHARMACOL, V79, P1437, DOI 10.1016/j.bcp.2010.01.010; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Zhao LN, 2008, AM J PHYSIOL-REG I, V294, pR1856, DOI 10.1152/ajpregu.00862.2007	44	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75106	10.1371/journal.pone.0075106	http://dx.doi.org/10.1371/journal.pone.0075106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116027	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200011
J	Wimuttisuk, W; Tobwor, P; Deenarn, P; Danwisetkanjana, K; Pinkaew, D; Kirtikara, K; Vichai, V				Wimuttisuk, Wananit; Tobwor, Punsa; Deenarn, Pacharawan; Danwisetkanjana, Kannawat; Pinkaew, Decha; Kirtikara, Kanyawim; Vichai, Vanicha			Insights into the Prostanoid Pathway in the Ovary Development of the Penaeid Shrimp Penaeus monodon	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHASE; UNSATURATED FATTY-ACIDS; LONE STAR TICK; EICOSANOID BIOSYNTHESIS; MOLECULAR-CLONING; ARACHIDONIC-ACID; IDENTIFICATION; 9-ALPHA,11-BETA-PROSTAGLANDIN-F2; VITELLOGENESIS; INVERTEBRATES	The prostanoid pathway converts polyunsaturated fatty acids (PUFAs) into bioactive lipid mediators, including prostaglandins, thromboxanes and prostacyclins, all of which play vital roles in the immune and reproductive systems in most animal phyla. In crustaceans, PUFAs and prostaglandins have been detected and often associated with female reproductive maturation. However, the presence of prostanoid biosynthesis genes remained in question in these species. In this study, we outlined the prostanoid pathway in the black tiger shrimp Penaeus monodon based on the amplification of nine prostanoid biosynthesis genes: cytosolic phospholipase A2, hematopoietic prostaglandin D synthase, glutathione-dependent prostaglandin D synthase, prostaglandin E synthase 1, prostaglandin E synthase 2, prostaglandin E synthase 3, prostaglandin F synthase, thromboxane A synthase and cyclooxygenase. TBLASTX analysis confirmed the identities of these genes with 51-99% sequence identities to their closest homologs. In addition, prostaglandin F-2 alpha (PGF(2 alpha)), which is a product of the prostaglandin F synthase enzyme, was detected for the first time in P. monodon ovaries along with the previously identified PUFAs and prostaglandin E-2 (PGE(2)) using RP-HPLC and mass-spectrometry. The prostaglandin synthase activity was also observed in shrimp ovary homogenates using in vitro activity assay. When prostaglandin biosynthesis was examined in different stages of shrimp ovaries, we found that the amounts of prostaglandin F synthase gene transcripts and PGF(2 alpha) decreased as the ovaries matured. These findings not only indicate the presence of a functional prostanoid pathway in penaeid shrimp, but also suggest a possible role of the PGF(2 alpha) biosynthesis in shrimp ovarian development.	[Wimuttisuk, Wananit; Tobwor, Punsa; Deenarn, Pacharawan; Danwisetkanjana, Kannawat; Pinkaew, Decha; Kirtikara, Kanyawim; Vichai, Vanicha] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Wimuttisuk, W (corresponding author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand.	wananit.wim@biotec.or.th	vichai, vanicha/F-2122-2011; Pinkaew, Decha/AAD-3335-2022; Wimuttisuk, Wananit/F-5438-2018	vichai, vanicha/0000-0002-3778-2080; Pinkaew, Decha/0000-0001-8334-1545; Tobwor, Punsa/0000-0002-2274-1147; Wimuttisuk, Wananit/0000-0002-0897-506X	National Science and Technology Development Agency [BT-02-SG-BC-5105, BT-02-SG-BO-5203]	National Science and Technology Development Agency	This work has been supported by the National Science and Technology Development Agency (Grant number BT-02-SG-BC-5105 and BT-02-SG-BO-5203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOWMAN AS, 1995, INSECT BIOCHEM MOLEC, V25, P735, DOI 10.1016/0965-1748(95)00013-L; BRENNER RR, 1987, COMP BIOCHEM PHYS B, V87, P815, DOI 10.1016/0305-0491(87)90394-4; Campbell EM, 2009, PARASITOLOGY, V136, P867, DOI 10.1017/S0031182009990357; Chansela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033154; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GADELHAK GG, 1995, INSECT BIOCHEM MOLEC, V25, P743, DOI 10.1016/0965-1748(95)00014-M; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gonzalez-Felix ML, 2009, J WORLD AQUACULT SOC, V40, P194, DOI 10.1111/j.1749-7345.2009.00242.x; HAMPSON AJ, 1992, BIOCHIM BIOPHYS ACTA, V1124, P143, DOI 10.1016/0005-2760(92)90090-I; Heckmann LH, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-11; Huang JH, 2008, AQUAC RES, V39, P240, DOI 10.1111/j.1365-2109.2007.01868.x; Huang XQ, 2006, BIOORGAN MED CHEM, V14, P3553, DOI 10.1016/j.bmc.2006.01.010; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kashiwagi T, 2000, ACTA NEUROBIOL EXP, V60, P9; Kobayashi T, 2004, BIOCHEM J, V381, P59, DOI 10.1042/BJ20040118; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Kuley E, 2008, INT J FOOD SCI NUTR, V59, P573, DOI 10.1080/09637480701451201; Leelatanawit R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052677; LISTON TE, 1985, P NATL ACAD SCI USA, V82, P6030, DOI 10.1073/pnas.82.18.6030; LOHER W, 1981, P NATL ACAD SCI-BIOL, V78, P7835, DOI 10.1073/pnas.78.12.7835; McKillen DJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-34; Meunpol O, 2005, AQUAC RES, V36, P1216, DOI 10.1111/j.1365-2109.2005.01342.x; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; MURIANA FJG, 1995, BIOCHIMIE, V77, P190, DOI 10.1016/0300-9084(96)88124-7; PAGES M, 1986, PROSTAG OTH LIPID M, V32, P729, DOI 10.1016/0090-6980(86)90195-4; Parent J, 2005, PROSTAG OTH LIPID M, V78, P27, DOI 10.1016/j.prostaglandins.2005.02.005; PEDIBHOTLA VK, 1995, INSECT BIOCHEM MOLEC, V25, P1027, DOI 10.1016/0965-1748(95)00039-X; Preechaphol R, 2010, GENET MOL BIOL, V33, P676, DOI 10.1590/S1415-47572010000400014; RAGAB A, 1991, INSECT BIOCHEM, V21, P321, DOI 10.1016/0020-1790(91)90022-7; Ravid T, 1999, J EXP BIOL, V202, P1819; Reddy PS, 2004, GEN COMP ENDOCR, V135, P35, DOI 10.1016/j.ygcen.2003.08.002; Rowley AF, 2005, J EXP BIOL, V208, P3, DOI 10.1242/jeb.01275; SANDEE D, 2008, PROSTAG OTH LIPID M, V88, P111; Sjogren T, 2013, P NATL ACAD SCI USA, V110, P3806, DOI 10.1073/pnas.1218504110; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Spaziani EP, 1995, PROSTAGLANDINS, V50, P189, DOI 10.1016/0090-6980(95)00124-7; Spaziani EP, 1997, INVERTEBR REPROD DEV, V32, P21, DOI 10.1080/07924259.1997.9672600; Stanley D, 2006, ANNU REV ENTOMOL, V51, P25, DOI 10.1146/annurev.ento.51.110104.151021; Stanley DW, 1998, AM ZOOL, V38, P369; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Tahara D, 2004, COMP BIOCHEM PHYS A, V137, P631, DOI 10.1016/j.cbpb.2003.12.005; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varvas K, 2009, INSECT BIOCHEM MOLEC, V39, P851, DOI 10.1016/j.ibmb.2009.10.002; Waclawik A, 2006, ENDOCRINOLOGY, V147, P210, DOI 10.1210/en.2005-0880; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WATANABE K, 1985, J BIOL CHEM, V260, P7035; Watanabe K, 2003, BIOCHEM BIOPH RES CO, V306, P577, DOI 10.1016/S0006-291X(03)01025-8; XU XL, 1994, AQUACULTURE, V119, P359, DOI 10.1016/0044-8486(94)90300-X	55	43	43	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76934	10.1371/journal.pone.0076934	http://dx.doi.org/10.1371/journal.pone.0076934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116186	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200086
J	Castro, RA; Kubitschek-Barreira, PH; Teixeira, PAC; Sanches, GF; Teixeira, MM; Quintella, LP; Almeida, SR; Costa, RO; Camargo, ZP; Felipe, MSS; de Souza, W; Lopes-Bezerra, LM				Castro, Rafaela A.; Kubitschek-Barreira, Paula H.; Teixeira, Pedro A. C.; Sanches, Glenda F.; Teixeira, Marcus M.; Quintella, Leonardo P.; Almeida, Sandro R.; Costa, Rosane O.; Camargo, Zoilo P.; Felipe, Maria S. S.; de Souza, Wanderley; Lopes-Bezerra, Leila M.			Differences in Cell Morphometry, Cell Wall Topography and Gp70 Expression Correlate with the Virulence of Sporothrix brasiliensis Clinical Isolates	PLOS ONE			English	Article							BETA-KETOADIPATE PATHWAY; SCHENCKII; SPOROTRICHOSIS; PATHOGENICITY; INVOLVEMENT; CLEAVAGE; ANTIBODY; REVEALS; COMPLEX; GLOBOSA	Sporotrichosis is a chronic infectious disease affecting both humans and animals. For many years, this subcutaneous mycosis had been attributed to a single etiological agent; however, it is now known that this taxon consists of a complex of at least four pathogenic species, including Sporothrix schenckii and Sporothrix brasiliensis. Gp70 was previously shown to be an important antigen and adhesin expressed on the fungal cell surface and may have a key role in immunomodulation and host response. The aim of this work was to study the virulence, morphometry, cell surface topology and gp70 expression of clinical isolates of S. brasiliensis compared with two reference strains of S. schenckii. Several clinical isolates related to severe human cases or associated with the Brazilian zoonotic outbreak of sporotrichosis were genotyped and clustered as S. brasiliensis. Interestingly, in a murine subcutaneous model of sporotrichosis, these isolates showed a higher virulence profile compared with S. schenckii. A single S. brasiliensis isolate from an HIV-positive patient not only showed lower virulence but also presented differences in cell morphometry, cell wall topography and abundant gp70 expression compared with the virulent isolates. In contrast, the highly virulent S. brasiliensis isolates showed reduced levels of cell wall gp70. These observations were confirmed by the topographical location of the gp70 antigen using immunoelectromicroscopy in both species. In addition, the gp70 molecule was sequenced and identified using mass spectrometry, and the sequenced peptides were aligned into predicted proteins using Blastp with the S. schenckii and S. brasiliensis genomes.	[Castro, Rafaela A.; Kubitschek-Barreira, Paula H.; Teixeira, Pedro A. C.; Sanches, Glenda F.; Lopes-Bezerra, Leila M.] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Micol Celular & Prote, Rio De Janeiro, Brazil; [Teixeira, Marcus M.; Felipe, Maria S. S.] Univ Brasilia, Inst Ciencias Biol, Lab Biol Mol, Brasilia, DF, Brazil; [Quintella, Leonardo P.] Univ Estado Rio De Janeiro, Fac Ciencias Med, Dept Patol & Labs, Rio De Janeiro, Brazil; [Almeida, Sandro R.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Costa, Rosane O.] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Lab Micol, Rio De Janeiro, Brazil; [Camargo, Zoilo P.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [de Souza, Wanderley] Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Brasilia; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Universidade do Estado do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Lopes-Bezerra, LM (corresponding author), Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Micol Celular & Prote, Rio De Janeiro, Brazil.	leila@uerj.br	Felipe, Maria Sueli/L-6260-2016; Kubitschek-Barreira, Paula/C-1200-2015; almeida, sandro r/F-5816-2012; Camargo, Zoilo P/C-5305-2013; Orofino-Costa, Rosane/AAF-6844-2020	Felipe, Maria Sueli/0000-0003-4347-6853; Kubitschek-Barreira, Paula/0000-0001-9083-2908; almeida, sandro r/0000-0002-0562-1610; Camargo, Zoilo P/0000-0002-2971-7983; Orofino-Costa, Rosane/0000-0002-1603-418X; Sanches, Glenda/0000-0002-9144-1826	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj); CNPq; PRONEX	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX	LMLB is a research fellow of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj), CNPq and PRONEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00409; Almeida-Paes R, 2012, APPL ENVIRON MICROB, V78, P8623, DOI 10.1128/AEM.02414-12; Arrillaga-Moncrieff I, 2009, CLIN MICROBIOL INFEC, V15, P651, DOI 10.1111/j.1469-0691.2009.02824.x; Bonifaz A, 2010, GIORN ITAL DERMAT V, V145, P659; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Teixeira PAC, 2010, MED MYCOL, V48, P687, DOI 10.3109/13693780903453287; Teixeira PAC, 2009, MICROBIOL-SGM, V155, P3730, DOI 10.1099/mic.0.029439-0; Da Rosa D, 2009, REV INST MED TROP SP, V51, P1, DOI 10.1590/S0036-46652009000100001; DELIMAFRANCO D, 2011, SCAND J IMMUNOL, V75, P42; de Oliveira MME, 2010, MYCOPATHOLOGIA, V169, P359, DOI 10.1007/s11046-010-9276-7; Oliveira MME, 2011, MYCOPATHOLOGIA, V172, P257, DOI 10.1007/s11046-011-9437-3; Fernandes GF, 2013, VIRULENCE, V4, P241, DOI 10.4161/viru.23112; Fernandes KSS, 2000, IMMUNOLOGY, V101, P563, DOI 10.1046/j.1365-2567.2000.00125.x; Ghosh A, 2002, MYCOSES, V45, P449, DOI 10.1046/j.1439-0507.2002.d01-121.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Kubitschek-Barreira PH, 2013, J PROTEOMICS, V78, P522, DOI 10.1016/j.jprot.2012.10.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lima OC, 2001, INFECT IMMUN, V69, P6874, DOI 10.1128/IAI.69.11.6874-6880.2001; Lopes-Bezerra LM, 2012, DIMORPHIC FUNGI: THEIR IMPORTANCE AS MODELS FOR DIFFERENTIATION AND FUNGAL PATHOGENESIS, P67; Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009; Madrid IM, 2010, MICROBES INFECT, V12, P162, DOI 10.1016/j.micinf.2009.10.004; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; Marimon R, 2006, J CLIN MICROBIOL, V44, P3251, DOI 10.1128/JCM.00081-06; Mesa-Arango AC, 2002, J CLIN MICROBIOL, V40, P3004, DOI 10.1128/JCM.40.8.3004-3011.2002; Michielse CB, 2012, MOL PLANT PATHOL, V13, P1089, DOI 10.1111/j.1364-3703.2012.00818.x; Nascimento RC, 2005, FEMS IMMUNOL MED MIC, V43, P241, DOI 10.1016/j.femsim.2004.08.004; Nascimento RC, 2008, EUR J IMMUNOL, V38, P3080, DOI 10.1002/eji.200838513; Oliveira DC, 2011, J CLIN MICROBIOL, V49, P3047, DOI 10.1128/JCM.00255-11; Orofino-Costa R, 2013, MED MYCOL CASE REP, V2, P65, DOI 10.1016/j.mmcr.2013.02.004; Queiroz-Telles F, 2011, MED MYCOL, V49, P225, DOI 10.3109/13693786.2010.539631; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Rodrigues AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002281; Rodrigues AM, 2013, MED MYCOL, V51, P405, DOI 10.3109/13693786.2012.719648; Ruiz-Baca E, 2009, MED MYCOL, V47, P185, DOI 10.1080/13693780802165789; Schubach A, 2008, CURR OPIN INFECT DIS, V21, P129, DOI 10.1097/QCO.0b013e3282f44c52; Silva-Vergara MLO, 2012, AM J TROP MED HYG, V86, P477, DOI 10.4269/ajtmh.2012.11-0441; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wuthrich M, 2006, MED MYCOL, V44, P41, DOI 10.1080/13693780500220217; YOSHIIKE T, 1993, MYCOPATHOLOGIA, V123, P69, DOI 10.1007/BF01365082; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Zhang ZY, 2006, MYCOSES, V49, P305, DOI 10.1111/j.1439-0507.2006.01256.x; Zhou X, 2014, FUNGAL DIVERS, V66, P153, DOI 10.1007/s13225-013-0220-2	45	68	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75656	10.1371/journal.pone.0075656	http://dx.doi.org/10.1371/journal.pone.0075656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116065	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300037
J	Miyahara, K; Nouso, K; Saito, S; Hiraoka, S; Harada, K; Takahashi, S; Morimoto, Y; Kobayashi, S; Ikeda, F; Miyake, Y; Shiraha, H; Takaki, A; Okada, H; Amano, M; Hirose, K; Nishimura, SI; Yamamoto, K				Miyahara, Koji; Nouso, Kazuhiro; Saito, Shunsuke; Hiraoka, Sakiko; Harada, Keita; Takahashi, Sakuma; Morimoto, Yuki; Kobayashi, Sayo; Ikeda, Fusao; Miyake, Yasuhiro; Shiraha, Hidenori; Takaki, Akinobu; Okada, Hiroyuki; Amano, Maho; Hirose, Kazuko; Nishimura, Shin-Ichiro; Yamamoto, Kazuhide			Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; ALPHA-1-ACID GLYCOPROTEIN; 5-AMINOSALICYLIC ACID; GLYCOSYLATION; HAPTOGLOBIN; DIAGNOSIS; CANCER	Background: The aims of this study were to determine the change of whole-serum N-glycan profile in ulcerative colitis (UC) patients and to investigate its clinical utility. Methods: We collected serum from 75 UC patients at the time of admission and the same number of age/sex-matched healthy volunteers. Serum glycan profile was measured by comprehensive quantitative high-throughput glycome analysis and was compared with disease activity and prognosis. Results: Out of 61 glycans detected, 24 were differentially expressed in UC patients. Pathway analysis demonstrated that highly sialylated multi-branched glycans and agalactosyl bi-antennary glycans were elevated in UC patients; in addition, the glycan ratio m/z 2378/1914, which also increased in UC, showed the highest Area under Receiver Operating Characteristic curve (0.923) for the diagnosis of UC. Highly sialylated multi-branched glycans and the glycan ratio m/z 2378/1914 were higher in the patients with total colitis, Clinical Activity Index > 10, Mayo endoscopic score 3, or a steroid-refractory status. In particular, the glycan ratio m/z 2378/1914 (above median) was an independent prognostic factor for the need for an operation (hazard ratio, 2.67; 95% confidence interval, 1.04-7.84). Conclusions: Whole-serum glycan profiles revealed that the glycan ratio m/z 2378/1914 and highly sialylated multibranched glycans increase in UC patients, and are correlated with disease activity. The glycan ratio m/z 2378/1914 was an independent predictive factor of the prognosis of UC.	[Miyahara, Koji; Nouso, Kazuhiro; Saito, Shunsuke; Hiraoka, Sakiko; Harada, Keita; Takahashi, Sakuma; Morimoto, Yuki; Kobayashi, Sayo; Ikeda, Fusao; Miyake, Yasuhiro; Shiraha, Hidenori; Takaki, Akinobu; Okada, Hiroyuki; Yamamoto, Kazuhide] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Nouso, Kazuhiro; Ikeda, Fusao] Okayama Univ, Dept Mol Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Okada, Hiroyuki] Okayama Univ Hosp, Dept Endoscopy, Okayama, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Hokkaido Univ, Field Drug Discovery Res, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Amano, Maho; Hirose, Kazuko; Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Med Chem Pharmaceut Co Ltd, Sapporo, Hokkaido, Japan	Okayama University; Okayama University; Okayama University; Hokkaido University; Hokkaido University	Nouso, K (corresponding author), Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	nouso@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 23590976]; Japan Science and Technology Agency (JST); Ministry of Education, Culture, Science, and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 23590976), partly by a grant for "Development of Systems and Technology for Advanced Measurement and Analysis (SENTAN)'' and "The Matching Program for Innovations in Future Drug Discovery and Medical Care'' from the Japan Science and Technology Agency (JST) and the Ministry of Education, Culture, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; AXFORD JS, 1992, J CLIN INVEST, V89, P1021, DOI 10.1172/JCI115643; Azuma Y, 2000, CLIN CHIM ACTA, V294, P93, DOI 10.1016/S0009-8981(99)00248-X; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bekesova S, 2012, J PROTEOMICS, V75, P2216, DOI 10.1016/j.jprot.2012.01.024; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Breda L, 2010, SEMIN ARTHRITIS RHEU, V40, P53, DOI 10.1016/j.semarthrit.2008.12.001; FASSBENDER K, 1991, CLIN CHIM ACTA, V203, P315, DOI 10.1016/0009-8981(91)90304-U; Goodarzi MT, 1998, GLYCOCONJUGATE J, V15, P469, DOI 10.1023/A:1006930902625; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; Hiraoka S, 2012, ANN PHARMACOTHER, V46, P1315, DOI 10.1345/aph.1R210; Ishida H, 2000, TRANSPLANTATION, V69, P59, DOI 10.1097/00007890-200001150-00012; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Nakajima S, 2011, INFLAMM BOWEL DIS, V17, P927, DOI 10.1002/ibd.21459; Nishimura SI, 2011, ADV CARBOHYD CHEM BI, V65, P219, DOI 10.1016/B978-0-12-385520-6.00005-4; Nouso K, 2013, J GASTROENT IN PRESS; Pepys M B, 1977, Ciba Found Symp, P283; Peter S, 2008, INFLAMM BOWEL DIS, V14, P1287, DOI 10.1002/ibd.20398; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; SAVERYMUTTU SH, 1986, GUT, V27, P809, DOI 10.1136/gut.27.7.809; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Shinzaki S, 2008, AM J GASTROENTEROL, V103, P1173, DOI 10.1111/j.1572-0241.2007.01699.x; Shinzaki S, 2012, GASTROENTEROLOGY, V142, P1172, DOI 10.1053/j.gastro.2012.02.008; THOMPSON S, 1993, CLIN CHIM ACTA, V220, P107, DOI 10.1016/0009-8981(93)90011-R; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Vilela EG, 2012, WORLD J GASTROENTERO, V18, P872, DOI 10.3748/wjg.v18.i9.872	31	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74861	10.1371/journal.pone.0074861	http://dx.doi.org/10.1371/journal.pone.0074861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116015	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300016
J	Whear, R; Abdul-Rahman, AK; Boddy, K; Thompson-Coon, J; Perry, M; Stein, K				Whear, Rebecca; Abdul-Rahman, Abdul-Kareem; Boddy, Kate; Thompson-Coon, Jo; Perry, Mark; Stein, Ken			The Clinical Effectiveness of Patient Initiated Clinics for Patients with Chronic or Recurrent Conditions Managed in Secondary Care: A Systematic Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; INFLAMMATORY-BOWEL-DISEASE; HOSPITAL FOLLOW-UP; RHEUMATOID-ARTHRITIS; BREAST-CANCER; SOCIETY	Background: Missed or inappropriate hospital appointments cost the UK National Health Service millions of pounds each year and delay treatment for other patients. Innovative methods of appointment scheduling that are more flexible to patient needs, may improve service quality and preserve resources. Methods: A systematic review of the evidence for the clinical effectiveness of patient initiated clinics in managing long term care for people with chronic or recurrent conditions in secondary care. Seven databases were searched including MEDLINE, Embase and PsycINFO (using the OVID interface), the Cochrane Library of Systematic Reviews and CENTRAL, Science Citation Index Expanded, Social Sciences Citation Index, and Conference Proceedings Citation Index (via the Web of Science interface) from inception to June 2013. Studies comparing patient initiated clinics with traditional consultant-led clinics in secondary care for people with long term chronic or recurrent diseases were included. Included studies had to provide data on clinical or resource use outcomes. Data were extracted and checked by two reviewers using a piloted, standardised data extraction form. Results: Eight studies (n = 1927 individuals) were included. All were conducted in the UK. There were few significant differences in clinical outcomes between the intervention and control groups. In some instances, using the patient initiated clinics model was associated with savings in time and resource use. The risk of harm from using the patient initiated clinic model of organising outpatient care is low. Studies with longer follow-up periods are needed to assess the long term costs and the ongoing risk of potential harms. Conclusions: The UK policy context is ripe for evidence-based, patient-centred services to be implemented, especially where the use of health care resources can be optimised without reducing the quality of care. Implementation of patient initiated clinics should remain cautious, with importance placed on ongoing evaluation of long term outcomes and costs.	[Whear, Rebecca; Abdul-Rahman, Abdul-Kareem; Boddy, Kate; Thompson-Coon, Jo; Stein, Ken] Univ Exeter, Peninsula Collaborat Leadership Appl Hlth Res & C, Inst Hlth Res, Exeter, Devon, England; [Perry, Mark] Plymouth Healthcare Natl Hlth Serv Trust, Rheumatl Dept, Plymouth, Devon, England	University of Exeter	Whear, R (corresponding author), Univ Exeter, Peninsula Collaborat Leadership Appl Hlth Res & C, Inst Hlth Res, Exeter, Devon, England.	r.s.whear@exeter.ac.uk	Coon, Jo Thompson/C-7923-2017; Abdul-Rahman, Abdul-Kareem/O-3390-2013	Coon, Jo Thompson/0000-0002-5161-0234; Abdul-Rahman, Abdul-Kareem/0000-0001-8703-5270; Boddy, Kate/0000-0001-9135-5488; Whear, Rebecca/0000-0002-8379-8198	National Institute of Health Research (NIHR)	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR))	This systematic review was funded by the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for the South West. The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown L, 2002, PSYCHO-ONCOL, V11, P346, DOI 10.1002/pon.576; Chattopadhyay C, 2008, ARTHRITIS RHEUM, V58, pS885; DoH, 2004, CHOOS BOOK PAT CHOIC, P16; DoH, 2005, NAT SERV FRAM LONG T, P106; DoH, 2001, EXP PAT NEW APPR CHR, P35; Hehir M, 2001, RHEUMATOLOGY, V40, P146; HES, 2010, OUTP DAT SHA PROV LE; Hewlett S, 2005, BMJ-BRIT MED J, V330, P171, DOI 10.1136/bmj.38265.493773.8F; Hewlett S, 2000, RHEUMATOLOGY, V39, P990, DOI 10.1093/rheumatology/39.9.990; Kemp K, 2013, J CROHNS COLITIS, V7, pS246; KENNEDY A, 2003, HLTH TECHNOLOGY ASSE, V7; Kirwan JR, 2003, RHEUMATOLOGY, V42, P422, DOI 10.1093/rheumatology/keg130; Koinberg I, 2009, ACTA ONCOL, V48, P99, DOI 10.1080/02841860802314712; Liu N, 2010, M&SOM-MANUF SERV OP, V12, P347, DOI 10.1287/msom.1090.0272; Luqmani R, 2009, RHEUMATOLOGY, V48, P436, DOI 10.1093/rheumatology/ken450a; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; National Institute for Health and Clinical Excellence (NICE), 2009, RHEUMATOID ARTHRITIS; Popay J, 2006, GUIDANCE CONDUCT SYS; Robinson A, 2001, LANCET, V358, P976, DOI 10.1016/S0140-6736(01)06105-0; Robinson LW, 2010, M&SOM-MANUF SERV OP, V12, P330, DOI 10.1287/msom.1090.0270; Rose KD, 2011, ARCH INTERN MED, V171, P1150, DOI 10.1001/archinternmed.2011.168; Sands A, 2009, J PAIN MANAGEMENT, V1, P391; Sheppard C, 2009, EUR J ONCOL NURS, V13, P2, DOI 10.1016/j.ejon.2008.11.005; Turner AM, 2013, PRIM CARE RESP J, V22, P72, DOI 10.4104/pcrj.2013.00013; University of York Centre for Reviews and Dissemination, 2009, SYST REV CRDS GUID U; Whear R, COMMUNICATION; WHO, 2002, INNOVATIVE CARE CHRO; Williams JG, 2000, BRIT MED J, V320, P544, DOI 10.1136/bmj.320.7234.544	28	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74774	10.1371/journal.pone.0074774	http://dx.doi.org/10.1371/journal.pone.0074774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116009	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300012
J	Freeman, AW				Freeman, Alan W.			Motions Add, Orientations Don't, in the Human Visual System	PLOS ONE			English	Article							DIRECTION; CONTRAST; DISCRIMINATION; SELECTIVITY; BANDWIDTHS; MASKING	Humans can distinguish between contours of similar orientation, and between directions of visual motion. There is consensus that both of these capabilities depend on selective activation of tuned neural channels. The bandwidths of these tuned channels are estimated here by modelling previously published empirical data. Human subjects were presented with a rapid stream of randomly oriented gratings, or randomly directed motions, and asked to respond when they saw a target stimulus. For the orientation task, subjects were less likely to respond when two preceding orientations were close to the target orientation but differed from each other, presumably due to a failure of summation. For the motion data, by contrast, subjects were more likely to respond when the vector sum of two previous directions was in the target direction. Fitting a cortical signal-processing model to these data showed that the direction bandwidth of motion sensors is about three times the bandwidth of orientation sensors, and that it is the large bandwidth that allows the summation of motion stimuli. The differing bandwidths of orientation and motion sensors presumably equip them for differing tasks, such as orientation discrimination and estimation of heading, respectively.	Univ Sydney, Discipline Biomed Sci, Lidcombe, Australia	University of Sydney	Freeman, AW (corresponding author), Univ Sydney, Discipline Biomed Sci, Lidcombe, Australia.	Alan.Freeman@sydney.edu.au	Freeman, Alan/A-6613-2008	Freeman, Alan/0000-0003-0563-526X				BALL K, 1979, PERCEPT PSYCHOPHYS, V26, P206, DOI 10.3758/BF03199870; BLAKE R, 1985, VISION RES, V25, P1459, DOI 10.1016/0042-6989(85)90224-X; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; HATSOPOULOS NG, 1991, NEURAL NETWORKS, V4, P303, DOI 10.1016/0893-6080(91)90068-G; Iyer PB, 2011, J VISION, V11, DOI 10.1167/11.3.16; KELLY DH, 1977, OPT ACTA, V24, P107, DOI 10.1080/713819495; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Maurer JP, 2004, EUR J NEUROSCI, V19, P3359, DOI 10.1111/j.0953-816X.2004.03419.x; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Pack CC, 2006, J NEUROSCI, V26, P893, DOI 10.1523/JNEUROSCI.3226-05.2006; PHILLIPS GC, 1984, J OPT SOC AM A, V1, P226, DOI 10.1364/JOSAA.1.000226; RAYMOND JE, 1993, VISION RES, V33, P767, DOI 10.1016/0042-6989(93)90196-4; Roeber U, 2008, J VISION, V8, DOI 10.1167/8.3.15; Shariati NH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034466; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WATAMANIUK SNJ, 1993, J OPT SOC AM A, V10, P16, DOI 10.1364/JOSAA.10.000016; Werner J. S., 2004, VISUAL NEUROSCIENCES, P1060	18	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75947	10.1371/journal.pone.0075947	http://dx.doi.org/10.1371/journal.pone.0075947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124523	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100080
J	Kyte, D; Ives, J; Draper, H; Keeley, T; Calvert, M				Kyte, Derek; Ives, Jonathan; Draper, Heather; Keeley, Thomas; Calvert, Melanie			Inconsistencies in Quality of Life Data Collection in Clinical Trials: A Potential Source of Bias? Interviews with Research Nurses and Trialists	PLOS ONE			English	Article							PATIENT-REPORTED OUTCOMES; PRESCRIBING RESEARCH; ETHICAL-ISSUES; RECOMMENDATIONS; GUIDANCE; PROTOCOL	Background: Patient-reported outcomes (PROs), such as health-related quality of life (HRQL) are increasingly used to evaluate treatment effectiveness in clinical trials, are valued by patients, and may inform important decisions in the clinical setting. It is of concern, therefore, that preliminary evidence, gained from group discussions at UK-wide Medical Research Council (MRC) quality of life training days, suggests there are inconsistent standards of HRQL data collection in trials and appropriate training and education is often lacking. Our objective was to investigate these reports, to determine if they represented isolated experiences, or were indicative of a potentially wider problem. Methods And Findings: We undertook a qualitative study, conducting 26 semi-structured interviews with research nurses, data managers, trial coordinators and research facilitators involved in the collection and entry of HRQL data in clinical trials, across one primary care NHS trust, two secondary care NHS trusts and two clinical trials units in the UK. We used conventional content analysis to analyze and interpret our data. Our study participants reported (1) inconsistent standards in HRQL measurement, both between, and within, trials, which appeared to risk the introduction of bias; (2), difficulties in dealing with HRQL data that raised concern for the well-being of the trial participant, which in some instances led to the delivery of non-protocol driven co-interventions, (3), a frequent lack of HRQL protocol content and appropriate training and education of trial staff, and (4) that HRQL data collection could be associated with emotional and/or ethical burden. Conclusions: Our findings suggest there are inconsistencies in the standards of HRQL data collection in some trials resulting from a general lack of HRQL-specific protocol content, training and education. These inconsistencies could lead to biased HRQL trial results. Future research should aim to develop HRQL guidelines and training programmes aimed at supporting researchers to carry out high quality data collection.	[Kyte, Derek; Ives, Jonathan; Draper, Heather; Keeley, Thomas; Calvert, Melanie] Univ Birmingham, Birmingham, W Midlands, England; [Keeley, Thomas; Calvert, Melanie] Univ Birmingham, MRC Midland Hub Trials Methodol Res, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Calvert, M (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	m.calvert@bham.ac.uk	Calvert, Melanie/F-7055-2011; Ives, Jonathan/ABE-4437-2020	Calvert, Melanie/0000-0002-1856-837X; Ives, Jonathan/0000-0002-5233-5000; kyte, Derek/0000-0002-7679-6741	National Institute for Health Research School for Primary Care Research; Medical Research Council (MRC) Midland Hub for Trials Methodology Research; MRC [G0800808]; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [SPCR-017] Funding Source: researchfish	National Institute for Health Research School for Primary Care Research; Medical Research Council (MRC) Midland Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	DK is supported by a National Institute for Health Research School for Primary Care Research funded PhD studentship. TK is supported by a Medical Research Council (MRC) Midland Hub for Trials Methodology Research funded PhD studentship. MC and HD are members of the MRC Midland Hub for Trials Methodology Research, University of Birmingham, United Kingdom (MRC Grant ID G0800808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiardini I, 2010, ALLERGY, V65, P290, DOI 10.1111/j.1398-9995.2009.02263.x; Basch EM, 2011, VALUE HEALTH, V14, pA10, DOI 10.1016/j.jval.2011.02.060; Brundage M, 2003, QUAL LIFE RES, V12, P395, DOI 10.1023/A:1023404731041; Calvert MJ, 2004, J CLIN PHARM THER, V29, P85, DOI 10.1046/j.0269-4727.2003.00520.x; Calvert MJ, 2003, J CLIN PHARM THER, V28, P513, DOI 10.1046/j.0269-4727.2003.00521.x; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chassany O, 2002, DRUG INF J, V36, P209, DOI 10.1177/009286150203600127; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Corey-Lisle PK, 2012, CANCER-AM CANCER SOC, V118, P461, DOI 10.1002/cncr.26213; Davison B Joyce, 2003, Oncol Nurs Forum, V30, P107, DOI 10.1188/03.ONF.107-114; Edwards Marie, 2002, Can J Nurs Res, V34, P131; EU (European Union), 2005, OFFICIAL J EUROPEAN; Fairclough DL, 1998, STAT MED, V17, P667, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<667::AID-SIM813>3.3.CO;2-Y; Fayers PM, 1997, EUR J CANCER, V33, P20, DOI 10.1016/S0959-8049(96)00412-1; Fayers PM, 2007, QUALITY LIFE ASSESSM; FIELDING N, 2003, INTERVIEWING SAGE BE; FLETCHER A, 1995, BRIT J CLIN PHARMACO, V39, P217, DOI 10.1111/j.1365-2125.1995.tb04439.x; Fletcher Astrid, 1992, British Medical Journal, V305, P1145; Food and Drug Administration U.S. Department of Health and Human Services, 2009, GUID IND PAT REP OUT; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; HOLLOWAY I, 1995, NURS ETHICS, V2, P223, DOI 10.1177/096973309500200305; Hopwood P, 1998, EUR J CANCER, V34, P49, DOI 10.1016/S0959-8049(97)00347-X; Houghton Catherine E, 2010, Nurse Res, V18, P15; Kiebert GM, 1998, STAT MED, V17, P561, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<561::AID-SIM803>3.3.CO;2-J; Kyte DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060684; Leidy N K, 1999, Value Health, V2, P113, DOI 10.1046/j.1524-4733.1999.02210.x; Loftin C, 2011, TEACH LEARN NURS, V6, P139, DOI 10.1016/j.teln.2011.01.005; LUO XM, 2008, CLIN RES REGUL AFF, V25, P197, DOI DOI 10.1080/10601330802471162; MOINPOUR CM, 1989, J NATL CANCER I, V81, P485, DOI 10.1093/jnci/81.7.485; Morse J., 2009, DEV GROUNDED THEORY, V1st; Movsas B, 2003, SEMIN RADIAT ONCOL, V13, P235, DOI 10.1016/S1053-4296(03)00029-8; NICE, 2002, GUID US TRAST TREATM; NSW Nurses & Midwives' Association, 2019, CULT SAF GAP EXP NSW; Perez VAD, 2012, AM J CARDIOL, V110, P1546, DOI 10.1016/j.amjcard.2012.07.012; Poulter K, 1997, GOOD CLIN PRACTICE J, V4, P22; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Reynolds MR, 2012, J AM COLL CARDIOL, V60, P548, DOI 10.1016/j.jacc.2012.03.075; Sackett DL, 2011, CLIN TRIALS, V8, P440, DOI 10.1177/1740774511410995; Saldana J., 2021, CODING MANUAL QUALIT, P1; Silverman D., 2010, DOING QUALITATIVE RE, V3	41	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76625	10.1371/journal.pone.0076625	http://dx.doi.org/10.1371/journal.pone.0076625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124580	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100137
J	Laarakkers, CMM; Wiegerinck, ET; Klaver, S; Kolodziejczyk, M; Gille, H; Hohlbaum, AM; Tjalsma, H; Swinkels, DW				Laarakkers, Coby M. M.; Wiegerinck, Erwin T.; Klaver, Siem; Kolodziejczyk, Maria; Gille, Hendrik; Hohlbaum, Andreas M.; Tjalsma, Harold; Swinkels, Dorine W.			Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform	PLOS ONE			English	Article							SERUM HEPCIDIN; LIQUID-CHROMATOGRAPHY; ROUND-ROBIN; QUANTIFICATION; FERROPORTIN; URINE; VARIABILITY; MUTATION	Mass spectrometry (MS)-based assays for the quantification of the iron regulatory hormone hepcidin are pivotal to discriminate between the bioactive 25-amino acid form that can effectively block the sole iron transporter ferroportin and other naturally occurring smaller isoforms without a known role in iron metabolism. Here we describe the design, validation and use of a novel stable hepcidin-25(+40) isotope as internal standard for quantification. Importantly, the relative large mass shift of 40 Da makes this isotope also suitable for easy-to-use medium resolution linear time-of-flight (TOF) platforms. As expected, implementation of hepcidin-25(+40) as internal standard in our weak cation exchange (WCX) TOF MS method yielded very low inter/intra run coefficients of variation. Surprisingly, however, in samples from kidney disease patients, we detected a novel peak (m/z 2673.9) with low intensity that could be identified as hepcidin-24 and had previously remained unnoticed due to peak interference with the formerly used internal standard. Using a cell-based bioassay it was shown that synthetic hepcidin-24 was, like the -22 and -20 isoforms, a significantly less potent inducer of ferroportin degradation than hepcidin-25. During prolonged storage of plasma at room temperature, we observed that a decrease in plasma hepcidin-25 was paralleled by an increase in the levels of the hepcidin-24, -22 and -20 isoforms. This provides first evidence that all determinants for the conversion of hepcidin-25 to smaller inactive isoforms are present in the circulation, which may contribute to the functional suppression of hepcidin-25, that is significantly elevated in patients with renal impairment. The present update of our hepcidin TOF MS assay together with improved insights in the source and preparation of the internal standard, and sample stability will further improve our understanding of circulating hepcidin and pave the way towards further optimization and standardization of plasma hepcidin assays.	[Laarakkers, Coby M. M.; Wiegerinck, Erwin T.; Klaver, Siem; Tjalsma, Harold; Swinkels, Dorine W.] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands; [Laarakkers, Coby M. M.; Wiegerinck, Erwin T.; Klaver, Siem; Tjalsma, Harold; Swinkels, Dorine W.] Hepcidinanal Com, Nijmegen, Netherlands; [Kolodziejczyk, Maria; Gille, Hendrik; Hohlbaum, Andreas M.] Pieris AG, Freising Weihenstephan, Germany	Radboud University Nijmegen	Swinkels, DW (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands.	d.swinkels@labgk.umcn.nl	Swinkels, Dorine W./H-8098-2014; Girelli, Domenico/B-1183-2008	Swinkels, Dorine W./0000-0002-1040-9446; Girelli, Domenico/0000-0001-9684-1899	European Union [FP7-HEALTH-F4-2011-278408]	European Union(European Commission)	This work was in part funded by the European Union (grant agreement No. FP7-HEALTH-F4-2011-278408; http://www.eurocalin-fp7.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ambaglio I, 2013, HAEMATOLOGICA, V98, P420, DOI 10.3324/haematol.2012.077446; Anderson DS, 2011, ANAL CHEM, V83, P8357, DOI 10.1021/ac2020905; Bansal SS, 2010, RAPID COMMUN MASS SP, V24, P1251, DOI 10.1002/rcm.4512; Campostrini N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/329646; Campostrini N, 2012, J PROTEOMICS, V76, P28, DOI 10.1016/j.jprot.2012.08.006; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Hohlbaum AM, 2011, BLOOD, V118, P314, DOI 10.1182/blood.V118.21.687.687; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; Itkonen O, 2012, CLIN CHIM ACTA, V413, P696, DOI 10.1016/j.cca.2011.12.015; Kemna E, 2005, BLOOD, V106, P3268, DOI 10.1182/blood-2005-05-1873; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Kobold U, 2008, CLIN CHEM, V54, P1584, DOI 10.1373/clinchem.2008.107029; Kroot JJC, 2012, AM J HEMATOL, V87, P977, DOI 10.1002/ajh.23289; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Li Hongyan, 2009, Journal of Pharmacological and Toxicological Methods, V59, P171, DOI 10.1016/j.vascn.2009.02.004; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Nai A, 2011, BLOOD, V118, P4459, DOI 10.1182/blood-2011-06-364034; Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peters HPE, 2012, NEPHROL DIAL TRANSPL, V27, P3923, DOI 10.1093/ndt/gfs164; Peters HPE, 2010, NEPHROL DIAL TRANSPL, V25, P848, DOI 10.1093/ndt/gfp546; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Santini V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023109; Schaap CCM, 2013, CLIN CHEM, V59, P527, DOI 10.1373/clinchem.2012.194977; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Schranz M, 2009, BLOOD CELL MOL DIS, V43, P169, DOI 10.1016/j.bcmd.2009.03.008; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; van Dijk BAC, 2007, BLOOD, V109, P5525, DOI 10.1182/blood-2006-11-058560; van Santen S, 2011, ARTHRITIS RHEUM-US, V63, P3672, DOI 10.1002/art.30623; Ward DG, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-28	37	69	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75518	10.1371/journal.pone.0075518	http://dx.doi.org/10.1371/journal.pone.0075518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124495	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100052
J	Liong, S; Di Quinzio, MKW; Fleming, G; Permezel, M; Georgiou, HM				Liong, Stella; Di Quinzio, Megan K. W.; Fleming, Gabrielle; Permezel, Michael; Georgiou, Harry M.			Is Vitamin D Binding Protein a Novel Predictor of Labour?	PLOS ONE			English	Article							GROUP-SPECIFIC COMPONENT; COMPREHENSIVE PROTEOMIC ANALYSIS; GC-GLOBULIN; SERUM CONCENTRATION; FETAL FIBRONECTIN; PRETERM BIRTH; PLASMA; ACTIN; 25-HYDROXYVITAMIN-D; PHENOTYPE	Vitamin D binding protein (VDBP) has previously been identified in the amniotic fluid and cervicovaginal fluid (CVF) of pregnant women. The biological functions of VDBP include acting as a carrier protein for vitamin D metabolites, the clearance of actin that is released during tissue injury and the augmentation of the pro-inflammatory response. This longitudinal observational study was conducted on 221 healthy pregnant women who spontaneously laboured and delivered either at term or preterm. Serial CVF samples were collected and VDBP was measured by ELISA. Binary logistic regression analysis was performed to assess the utility of VDBP as a predictor of labour. VDBP in the CVF did not change between 20 and 35 weeks' gestation. VDBP measured in-labour was significantly increased 4.2 to 7.4-fold compared to 4-7, 8-14 and 15-28 days before labour (P<0.05). VDBP concentration was 4.3-fold significantly higher at 0-3 days compared to 15-28 days pre-labour (P<0.05). The efficacy of VDBP to predict spontaneous labour onset within 3 days provided a positive and negative predictive value of 82.8% and 95.3% respectively (area under receiver operator characteristic curve = 0.974). This longitudinal study of pregnant women suggests that VDBP in the CVF may be a useful predictor of labour.	[Liong, Stella; Di Quinzio, Megan K. W.; Permezel, Michael; Georgiou, Harry M.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Liong, Stella; Di Quinzio, Megan K. W.; Fleming, Gabrielle; Permezel, Michael; Georgiou, Harry M.] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Georgiou, HM (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia.	harrymg@unimelb.edu.au	Georgiou, A/Prof Harry/C-7143-2008; Liong, Stella/AAQ-5308-2021	Georgiou, A/Prof Harry/0000-0003-0553-9489; Liong, Stella/0000-0001-6131-858X; Di Quinzio, Megan/0000-0003-0220-857X	Medical Research Foundation for Women and Babies; Australian Postgraduate Award scholarship	Medical Research Foundation for Women and Babies; Australian Postgraduate Award scholarship	Financial support for this study was provided by the Medical Research Foundation for Women and Babies. SL is a recipient of an Australian Postgraduate Award scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNER R, 1995, AM J OBSTET GYNECOL, V172, P134, DOI 10.1016/0002-9378(95)90101-9; BIKLE DD, 1985, J CLIN ENDOCR METAB, V61, P969, DOI 10.1210/jcem-61-5-969; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Borges CR, 2008, J PROTEOME RES, V7, P4143, DOI 10.1021/pr8002936; BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172/JCI110072; BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8; BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225, DOI 10.1210/jcem-45-2-225; CLEVE H, 1988, VOX SANG, V54, P215, DOI 10.1111/j.1423-0410.1988.tb03908.x; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Dasari S, 2007, J PROTEOME RES, V6, P1258, DOI 10.1021/pr0605419; Debruyne E, 2011, CLIN CHEM LAB MED, V49, P1855, DOI 10.1515/CCLM.2011.676; Di Quinzio MKW, 2007, AUST NZ J OBSTET GYN, V47, P9, DOI 10.1111/j.1479-828X.2006.00671.x; DiMartino SJ, 1999, J IMMUNOL, V163, P2135; EMERSON DL, 1985, AM J REPROD IM MIC, V7, P15; EMERSON DL, 1983, AM J REPROD IMMUNOL, V4, P185, DOI 10.1111/j.1600-0897.1983.tb00276.x; Ezura Y, 2003, J BONE MINER RES, V18, P1642, DOI 10.1359/jbmr.2003.18.9.1642; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; GUHA C, 1995, HEPATOLOGY, V21, P1675; HADDAD JG, 1982, ARCH BIOCHEM BIOPHYS, V213, P538, DOI 10.1016/0003-9861(82)90581-1; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8; Heng YJ, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.011; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; HOLLIS BW, 1986, J CLIN ENDOCR METAB, V62, P41, DOI 10.1210/jcem-62-1-41; Ito I, 2004, CHEST, V125, P63, DOI 10.1378/chest.125.1.63; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Liong S, 2013, REPRODUCTION, V145, P137, DOI 10.1530/REP-12-0264; Malak TM, 1996, BRIT J OBSTET GYNAEC, V103, P648, DOI 10.1111/j.1471-0528.1996.tb09832.x; Malmstrom E, 2007, MOL HUM REPROD, V13, P333, DOI 10.1093/molehr/gal117; NESTLER JE, 1987, ENDOCRINOLOGY, V120, P1996, DOI 10.1210/endo-120-5-1996; Pereira L, 2007, J PROTEOME RES, V6, P1269, DOI 10.1021/pr0605421; PEREZ HD, 1994, INFLAMMATION, V18, P215, DOI 10.1007/BF01534562; PETERSON PA, 1971, J BIOL CHEM, V246, P7748; PETRINI M, 1984, CLIN IMMUNOL IMMUNOP, V31, P282, DOI 10.1016/0090-1229(84)90248-4; PIQUETTE CA, 1994, J LEUKOCYTE BIOL, V55, P349, DOI 10.1002/jlb.55.3.349; Shaw JLV, 2007, J PROTEOME RES, V6, P2859, DOI 10.1021/pr0701658; Tang LJ, 2007, J PROTEOME RES, V6, P2874, DOI 10.1021/pr0700899; YAMAMOTO N, 1991, P NATL ACAD SCI USA, V88, P8539, DOI 10.1073/pnas.88.19.8539; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17	39	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76490	10.1371/journal.pone.0076490	http://dx.doi.org/10.1371/journal.pone.0076490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124566	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100123
J	MacArthur, CJ; Hausman, F; Kempton, JB; Choi, D; Trune, DR				MacArthur, Carol J.; Hausman, Fran; Kempton, J. Beth; Choi, Dongseok; Trune, Dennis R.			Otitis Media Impacts Hundreds of Mouse Middle and Inner Ear Genes	PLOS ONE			English	Article							ROUND WINDOW MEMBRANE; EXPRESSION PATTERN; UP-REGULATION; PROBE LEVEL; INTERLEUKIN-1-BETA; INFLAMMATION; ACTIVATION; FIBROCYTES; IL-1-BETA; PATHOLOGY	Objective: Otitis media is known to alter expression of cytokine and other genes in the mouse middle ear and inner ear. However, whole mouse genome studies of gene expression in otitis media have not previously been undertaken. Ninety-nine percent of mouse genes are shared in the human, so these studies are relevant to the human condition. Methods: To assess inflammation-driven processes in the mouse ear, gene chip analyses were conducted on mice treated with trans-tympanic heat-killed Hemophilus influenza using untreated mice as controls. Middle and inner ear tissues were separately harvested at 6 hours, RNA extracted, and samples for each treatment processed on the Affymetrix 430 2.0 Gene Chip for expression of its 34,000 genes. Results: Statistical analysis of gene expression compared to control mice showed significant alteration of gene expression in 2,355 genes, 11% of the genes tested and 8% of the mouse genome. Significant middle and inner ear upregulation (fold change >1.5, p<0.05) was seen in 1,081 and 599 genes respectively. Significant middle and inner ear downregulation (fold change <0.67, p<0.05) was seen in 978 and 287 genes respectively. While otitis media is widely believed to be an exclusively middle ear process with little impact on the inner ear, the inner ear changes noted in this study were numerous and discrete from the middle ear responses. This suggests that the inner ear does indeed respond to otitis media and that its response is a distinctive process. Numerous new genes, previously not studied, are found to be affected by inflammation in the ear. Conclusion: Whole genome analysis via gene chip allows simultaneous examination of expression of hundreds of gene families influenced by inflammation in the middle ear. Discovery of new gene families affected by inflammation may lead to new approaches to the study and treatment of otitis media.	[MacArthur, Carol J.; Trune, Dennis R.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [MacArthur, Carol J.; Hausman, Fran; Kempton, J. Beth; Trune, Dennis R.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	MacArthur, CJ (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA.	macarthc@ohsu.edu		Choi, Dongseok/0000-0002-1552-4072	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) [R01 DC009455]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009455, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) grant R01 DC009455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basoglu MS, 2012, INT J PEDIATR OTORHI, V76, P64, DOI 10.1016/j.ijporl.2011.10.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Choi JY, 2007, EUR J PHARMACOL, V567, P19, DOI 10.1016/j.ejphar.2007.04.026; Copeland NG, 2002, SCIENCE, V296, P1617, DOI 10.1126/science.1073127; Cureoglu S, 2005, ACTA OTO-LARYNGOL, V125, P9, DOI 10.1080/00016480410022534; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Faffe DS, 2005, AM J PHYSIOL-LUNG C, V288, pL1040, DOI 10.1152/ajplung.00333.2004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghaheri BA, 2007, OTOLARYNG HEAD NECK, V137, P332, DOI 10.1016/j.otohns.2007.03.020; Ghaheri BA, 2007, LARYNGOSCOPE, V117, P22, DOI 10.1097/01.mlg.0000240170.48584.73; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Juhn SK, 1997, ANN NY ACAD SCI, V830, P130, DOI 10.1111/j.1749-6632.1997.tb51885.x; Kerschner JE, 2010, ARCH OTOLARYNGOL, V136, P819, DOI 10.1001/archoto.2010.123; MacArthur CJ, 2013, OTOL NEUROTOL, V34, P338, DOI 10.1097/MAO.0b013e31827b4d0a; MacArthur CJ, 2011, OTOL NEUROTOL, V32, P508, DOI 10.1097/MAO.0b013e31820e6de4; MacArthur CJ, 2011, LARYNGOSCOPE, V121, P365, DOI 10.1002/lary.21349; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; MEYERHOFF WL, 1978, ANN OTO RHINOL LARYN, V87, P749, DOI 10.1177/000348947808700602; Moon SK, 2007, INFECT IMMUN, V75, P3361, DOI 10.1128/IAI.01886-06; Morris LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039004; Oh S, 2012, J IMMUNOL, V188, P3496, DOI 10.4049/jimmunol.1103182; Page AV, 2011, INFECT DIS CLIN N AM, V25, P803, DOI 10.1016/j.idc.2011.07.007; PAPARELLA MM, 1984, ANN OTO RHINOL LARYN, V93, P623, DOI 10.1177/000348948409300616; Pichichero ME, 2000, PEDIATR INFECT DIS J, V19, P911, DOI 10.1097/00006454-200009000-00034; Schachern P, 2008, ARCH OTOLARYNGOL, V134, P658, DOI 10.1001/archotol.134.6.658; Smirnova MG, 2002, EUR CYTOKINE NETW, V13, P161; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Woo JI, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-314; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhang Q, 2010, ACTA OTO-LARYNGOL, V130, P68, DOI 10.3109/00016480902974183; Zhang Q, 2009, ORL-J OTO-RHIN-LARYN, V71, P70, DOI 10.1159/000182419	32	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75213	10.1371/journal.pone.0075213	http://dx.doi.org/10.1371/journal.pone.0075213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124478	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100035
J	Yang, WJ; Liu, PD; Cui, Q; Wei, DT; Li, WF; Qiu, J; Zhang, QL				Yang, Wenjing; Liu, Peiduo; Cui, Qian; Wei, Dongtao; Li, Wenfu; Qiu, Jiang; Zhang, Qinglin			Directed Forgetting of Negative Self-Referential Information Is Difficult: An fMRI Study	PLOS ONE			English	Article							ATTENTIONAL NETWORKS; UNWANTED MEMORIES; WORKING-MEMORY; TASK; SUPPRESSION; ACTIVATION; STIMULI; EMOTION; BRAIN; DISORDER	A large body of evidence suggested that both emotion and self-referential processing can enhance memory. However, it remains unclear how these two factors influence directed forgetting. This study speculates that directed forgetting of negative self-referential memory is more difficult than forgetting of other-referential memory. To verify this speculation, we combined the directed forgetting paradigm with the self-reference task. The behavioral result suggested that although both self-referential and other-referential information can be directly forgotten, less self-referential information can be forgotten than other-referential information. At the neural level, the forget instruction strongly activated the frontal cortex, suggesting that directed forgetting is not memory decay but an active process. In addition, compared with the negative other-referential information, forgetting of the negative self-referential information were associated with a more widespread activation, including the orbital frontal gyrus (BA47), the inferior frontal gyrus (BA45, BA44), and the middle frontal gyrus. Our results suggest that forgetting of the self-referential information seems to be a more demanding and difficult process.	[Yang, Wenjing; Liu, Peiduo; Wei, Dongtao; Li, Wenfu; Qiu, Jiang; Zhang, Qinglin] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Cui, Qian] Univ Elect Sci & Technol China, Sch Polit Sci & Publ Adm, Chengdu 610054, Peoples R China	Southwest University - China; University of Electronic Science & Technology of China	Qiu, J (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; zhangql@swu.edu.cn	Liu, Peiduo/A-3502-2014	Liu, Peiduo/0000-0001-8022-1791	National Natural Science Foundation of China [31170983]; Fundamental Research Funds for the Central Universities [SWU1309433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (31170983) and the Fundamental Research Funds for the Central Universities (SWU1309433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; [Anonymous], 1990, MODERN LEXICON CHINE; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Barnier AJ, 2007, J EXP PSYCHOL GEN, V136, P301, DOI 10.1037/0096-3445.136.2.301; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; Bastin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029905; Berstrom ZM, 2007, BRAIN RES, V1151, P119, DOI 10.1016/j.brainres.2007.03.014; BJORK RA, 1973, J EXP PSYCHOL, V99, P22, DOI 10.1037/h0034757; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Carretie L, 2009, INT J PSYCHOPHYSIOL, V71, P57, DOI 10.1016/j.ijpsycho.2008.07.006; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Devue C, 2008, ACTA PSYCHOL, V128, P290, DOI 10.1016/j.actpsy.2008.02.004; Dumont M, 2000, CAH PSYCHOL COGN, V19, P171; Duncan J, 2000, TRENDS NEUROSCIENCES; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gould RL, 2003, NEUROIMAGE, V20, P1006, DOI 10.1016/S1053-8119(03)00365-3; Hauswald A, 2009, DIRECTED FORGETTING; Hauswald A, 2011, SOC COGN AFFECT NEUR, V6, P450, DOI 10.1093/scan/nsq061; Hourihan KL, 2006, J EXP PSYCHOL HUMAN, V32, P1354, DOI 10.1037/0096-1523.32.6.1354; Joslyn SL, 2005, MEM COGNITION, V33, P577, DOI 10.3758/BF03195325; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; McNally RJ, 1998, J ABNORM PSYCHOL, V107, P596, DOI 10.1037/0021-843X.107.4.596; Mecklinger A, 2009, BRAIN RES; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Mu Y, 2010, NEUROIMAGE, V53, P757, DOI 10.1016/j.neuroimage.2010.07.008; Nowicka A, 2010, CEREB CORTEX, P1; Nowicka A, 2011, CEREB CORTEX, V21, P539, DOI 10.1093/cercor/bhq117; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Payne BK, 2007, J EXP SOC PSYCHOL, V43, P780, DOI 10.1016/j.jesp.2006.07.005; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Power MJ, 2000, J AFFECT DISORDERS, V57, P147, DOI 10.1016/S0165-0327(99)00084-1; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Symons CS, 1997, PSYCHOL B; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Taylor TL, 2003, Q J EXP PSYCHOL-A, V56, P1349, DOI 10.1080/02724980343000099; Tolin DF, 2002, BEHAV RES THER, V40, P793, DOI 10.1016/S0005-7967(01)00062-6; van Hooff JC, 2011, BRAIN RES, V1392, P80, DOI 10.1016/j.brainres.2011.04.004; Wang G, 2011, ACCESS; Wylie GR, 2007, CEREBRAL CORTEX; Yang W, 2011, BRAIN RES; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	56	18	18	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75190	10.1371/journal.pone.0075190	http://dx.doi.org/10.1371/journal.pone.0075190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124475	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100032
J	Zhang, J; Ke, KF; Liu, Z; Qiu, YH; Peng, YP				Zhang, Jun; Ke, Kai-Fu; Liu, Zhan; Qiu, Yi-Hua; Peng, Yu-Ping			Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of A beta(1-42)-Induced Alzheimer's Disease Model Rats	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BRAIN-BARRIER DISRUPTION; T-CELLS; INFLAMMATION; EXPRESSION; PEPTIDE; FAS; LYMPHOCYTES; DEATH; IL-21	Neuroinflammation, especially innate immunocyte-mediated neuroinflammation, has been reported to participate in pathogenesis of Alzheimer's disease (AD). However, the involvement of adaptive immune cells, such as CD4(+) T lymphocytes, in pathogenesis of AD is not well clarified. Herein, we focus on T helper 17 (Th17) cells, a subpopulation of CD4(+) T cells with high proinflammation, and show the implication of the cells in neurodegeneration of AD. Amyloid beta(1-42) (A beta(1-42)) was bilaterally injected into hippocampus of rats to induce AD. On days 7 and 14 following the A beta(1-42) administration, escape latency of the rats in Morris water maze was increased, expression of amyloid precursor protein was upregulated, but expression of protein phosphatase 2A was downregulated in the hippocampus, and Nissl stain showed neuronal loss and gliosis in CA1 region. Infusion of FITC-linked albumin in blood circulation and combination with immunostaining of hippocampal sections for ROR gamma, a specific transcriptional factor of Th17 cells, demonstrated blood-brain barrier (BBB) disruption and Th17 cells' infiltration into brain parenchyma of AD rats. Expression of Th17 proinflammatory cytokines, interleukin (IL)-17 and IL-22, was increased in the hippocampus, and concentrations of the two cytokines were elevated in both the cerebrospinal fluid and the serum in AD occurrence and development. Compared with intact or saline-treated control rats, AD animals indicated an upregulated expression of Fas and FasL in the hippocampus. Further, the immunofluorescent histochemistry on AD hippocampal sections with NeuN, RORc, Fas and FasL displayed that Fas was principally expressed by neurons and FasL was predominantly expressed by Th17 cells, and that neuronal apoptosis shown by TUNEL and NeuN double-labeled cells increased. These results suggest that Th17 cells, which were infiltrated into AD brain parenchyma, participate in neuroinflammation and neurodegeneration of AD by release of proinflammatory cytokines and by direct action on neurons via Fas/FasL apoptotic pathway.	[Zhang, Jun; Liu, Zhan; Qiu, Yi-Hua; Peng, Yu-Ping] Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China; [Zhang, Jun; Ke, Kai-Fu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Qiu, YH (corresponding author), Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China.	yhqiu@ntu.edu.cn; yppeng@ntu.edu.cn	peng, yu/GXW-2071-2022		National Natural Science Foundation of China [81271323]; Natural Science Foundation of Jiangsu Province of China [BK2010278, BK2011386]; Nantong Applied Research Program of China [BK2012014, BK2012015, CP12012003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Nantong Applied Research Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants 81271323 from the National Natural Science Foundation of China, BK2010278 and BK2011386 from the Natural Science Foundation of Jiangsu Province of China, BK2012014, BK2012015 and CP12012003 from the Nantong Applied Research Program of China, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Fang YJ, 2010, J LEUKOCYTE BIOL, V87, P1019, DOI 10.1189/jlb.0509352; Farkas IG, 2003, ACTA HISTOCHEM, V105, P115, DOI 10.1078/0065-1281-00696; GANDY S, 1994, INT REV NEUROBIOL, V36, P29, DOI 10.1016/S0074-7742(08)60302-5; Giuffrida ML, 2007, J NEUROSCI RES, V85, P623, DOI 10.1002/jnr.21135; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Higuchi M, 2010, INT J GERIATR PSYCH, V25, P604, DOI 10.1002/gps.2381; Iqbal Khalid, 2005, Current Alzheimer Research, V2, P335, DOI 10.2174/1567205054367810; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCDONALD MP, 1994, BEHAV NEURAL BIOL, V62, P60, DOI 10.1016/S0163-1047(05)80059-7; McLarnon JG, 2008, CURR ALZHEIMER RES, V5, P475, DOI 10.2174/156720508785908874; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Passos GF, 2010, BRAIN BEHAV IMMUN, V24, P493, DOI 10.1016/j.bbi.2009.12.003; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Saresella M, 2011, BRAIN BEHAV IMMUN, V25, P539, DOI 10.1016/j.bbi.2010.12.004; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Tzartos JS, 2011, AM J PATHOL, V178, P794, DOI 10.1016/j.ajpath.2010.10.043; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735	30	54	67	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75786	10.1371/journal.pone.0075786	http://dx.doi.org/10.1371/journal.pone.0075786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124514	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100071
J	Barnes, AJ; Hanoch, Y; Martynenko, M; Wood, S; Rice, T; Federman, AD				Barnes, Andrew J.; Hanoch, Yaniv; Martynenko, Melissa; Wood, Stacey; Rice, Thomas; Federman, Alex D.			Physician Trainees' Decision Making and Information Processing: Choice Size and Medicare Part D	PLOS ONE			English	Article							STRATEGY SELECTION; DRUG COVERAGE; NUMERACY; HEALTH; PLAN; PERFORMANCE; KNOWLEDGE	Many patients expect their doctor to help them choose a Medicare prescription drug plan. Whether the size of the choice set affects clinicians' decision processes and strategy selection, and the quality of their choice, as it does their older patients, is an important question with serious financial consequences. Seventy medical students and internal medicine residents completed a within-subject design using Mouselab, a computer program that allows the information-acquisition process to be examined. We examined highly numerate physician trainees' decision processes, strategy, and their ability to pick the cheapest drug plan-as price was deemed the most important factor in Medicare beneficiaries' plan choice-from either 3 or 9 drug plans. Before adjustment, participants were significantly more likely to identify the lowest cost plan when facing three versus nine choices (67.3% vs. 32.8%, p<0.01) and paid significantly less in excess premiums ($60.00 vs. $128.51, p<0.01). Compared to the three-plan condition, in the nine-plan condition participants spent significantly less time acquiring information on each attribute (p<0.05) and were more likely to employ decision strategies focusing on comparing alternate plans across a single attribute (search pattern, p<0.05). After adjusting for decision process and strategy, numeracy, and amount of medical training, the odds were 10.75 times higher that trainees would choose the lowest cost Medicare Part D drug plan when facing 3 versus 9 drug plans (p<0.05). Although employing more efficient search strategies in the complex choice environment, physician trainees experienced similar difficulty in choosing the lowest cost prescription drug plans as older patients do. Our results add further evidence that simplifications to the Medicare Part D decision environment are needed and suggest physicians' role in their patients' Part D choices may be most productive when assisting seniors with forecasting their expected medication needs and then referring them to the Medicare website or helpline.	[Barnes, Andrew J.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Hanoch, Yaniv] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Martynenko, Melissa; Federman, Alex D.] Mt Sinai Sch Med, New York, NY USA; [Wood, Stacey] Scripps Coll, Claremont, CA 91711 USA; [Rice, Thomas] Univ Calif Los Angeles, Los Angeles, CA USA	Virginia Commonwealth University; University of Plymouth; Icahn School of Medicine at Mount Sinai; Claremont Colleges; Scripps College; University of California System; University of California Los Angeles	Barnes, AJ (corresponding author), Virginia Commonwealth Univ, Richmond, VA 23284 USA.	abarnes3@vcu.edu		Hanoch, Yaniv/0000-0001-9453-4588	Robert Wood Johnson Foundation [57585]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was supported in part by a Robert Wood Johnson Foundation Investigator Award in Health Policy Research No. 57585. The views expressed imply no endorsement by the Robert Wood Johnson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaluck J, 2011, AM ECON REV, V101, P1180, DOI 10.1257/aer.101.4.1180; Baicker K, 2012, MILBANK Q, V90, P107, DOI 10.1111/j.1468-0009.2011.00656.x; Barnes AJ, 2012, MED CARE RES REV, V69, P460, DOI 10.1177/1077558711435365; *CONS UN, POL ACT CONS REP; Dhar R, 2000, J CONSUM PSYCHOL, V9, P189, DOI 10.1207/S15327663JCP0904_1; Donohue JM, 2009, AM J GERIATR PHARMAC, V7, P105, DOI 10.1016/j.amjopharm.2009.04.005; Hanoch Y, 2011, HEALTH PSYCHOL, V30, P719, DOI 10.1037/a0023951; Hanoch Y, 2010, HEALTH PSYCHOL, V29, P454, DOI 10.1037/a0019881; Hsu J, 2008, JAMA-J AM MED ASSOC, V299, P1929, DOI 10.1001/jama.299.16.1929; Irani J, 2011, ACAD MED, V86, P539, DOI 10.1097/ACM.0b013e318212eb3f; *KAIS FAM FDN, 2009, MED D; *KAIS FAM FDN, 2005, MED DRUG BEN BEN PER; *KAIS FAM FDN, 2013, MED D; *KAIS FAM FDN, 2012, SEN KNOWL EXP MED OP; *KAIS FAM FDN, 2006, NAT SURV PHARM NAT S; Kling JR, 2012, Q J ECON, V127, P199, DOI 10.1093/qje/qjr055; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Lohse GL, 1996, ORGAN BEHAV HUM DEC, V68, P28, DOI 10.1006/obhd.1996.0087; Lucarelli C, 2012, INT ECON REV, V53, P1155, DOI 10.1111/j.1468-2354.2012.00715.x; Mallya G, 2006, AM FAM PHYSICIAN, V73, P395; MCCALL N, 1986, HEALTH SERV RES, V20, P633; *MED PAC, 2006, REP C INCR VAL MED; PAYNE JW, 1976, ORGAN BEHAV HUM PERF, V16, P366, DOI 10.1016/0030-5073(76)90022-2; PAYNE JW, 1988, J EXP PSYCHOL LEARN, V14, P534, DOI 10.1037/0278-7393.14.3.534; Rao G, 2010, ACAD MED, V85, P1794, DOI 10.1097/ACM.0b013e3181e7218c; Rice T, 2013, ANNU REV PUBL HEALTH, V34, P431, DOI 10.1146/annurev-publhealth-031912-114353; Rice T, 2010, J HEALTH POLIT POLIC, V35, P961, DOI 10.1215/03616878-2010-035; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Thaler R.H., 2021, NUDGE FINAL EDITION; Tseng CW, 2007, JAMA-J AM MED ASSOC, V297, P2596, DOI 10.1001/jama.297.23.2596; Willemsen M. C., 2011, HDB PROCESS TRACING, P19; Winter J, 2006, P NATL ACAD SCI USA, V103, P7929, DOI 10.1073/pnas.0601837103; Wood S, 2011, PSYCHOL AGING, V26, P295, DOI 10.1037/a0022028; Zhou C, 2012, HEALTH AFFAIR, V31, P2259, DOI 10.1377/hlthaff.2012.0087	35	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77096	10.1371/journal.pone.0077096	http://dx.doi.org/10.1371/journal.pone.0077096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116209	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300115
J	Cardoso, AR; Kakimoto, PAHB; Kowaltowski, AJ				Cardoso, Ariel R.; Kakimoto, Pamela A. H. B.; Kowaltowski, Alicia J.			Diet-Sensitive Sources of Reactive Oxygen Species in Liver Mitochondria: Role of Very Long Chain Acyl-CoA Dehydrogenases	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; HIGH-FAT DIET; CALORIC RESTRICTION; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COENZYME-A; SUPEROXIDE; GENERATION; STEATOHEPATITIS	High fat diets and accompanying hepatic steatosis are highly prevalent conditions. Previous work has shown that steatosis is accompanied by enhanced generation of reactive oxygen species (ROS), which may mediate further liver damage. Here we investigated mechanisms leading to enhanced ROS generation following high fat diets (HFD). We found that mitochondria from HFD livers present no differences in maximal respiratory rates and coupling, but generate more ROS specifically when fatty acids are used as substrates. Indeed, many acyl-CoA dehydrogenase isoforms were found to be more highly expressed in HFD livers, although only the very long chain acyl-CoA dehydrogenase (VLCAD) was more functionally active. Studies conducted with permeabilized mitochondria and different chain length acyl-CoA derivatives suggest that VLCAD is also a source of ROS production in mitochondria of HFD animals. This production is stimulated by the lack of NAD(+). Overall, our studies uncover VLCAD as a novel, diet-sensitive, source of mitochondrial ROS.	[Cardoso, Ariel R.; Kakimoto, Pamela A. H. B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo	Kowaltowski, AJ (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	Kowaltowski, Alicia J/H-8698-2012; Rodrigues Cardoso', Ariel/H-3561-2012	Rodrigues Cardoso', Ariel/0000-0002-8741-3734	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo; Coordenadoria de Aperfeicoamento do Pessoal do Ensino Superior; Conselho Nacional de Pesquisa e Desenvolvimento; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento do Pessoal do Ensino Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina	Supported by Fundacao de Amparo a Pesquisa no Estado de Sao Paulo, Coordenadoria de Aperfeicoamento do Pessoal do Ensino Superior, Conselho Nacional de Pesquisa e Desenvolvimento, Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina and the Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Cardoso AR, 2012, FREE RADICAL BIO MED, V52, P2201, DOI 10.1016/j.freeradbiomed.2012.03.008; Cardoso AR, 2010, J BIOENERG BIOMEMBR, V42, P245, DOI 10.1007/s10863-010-9284-9; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; COOK GA, 1987, J BIOL CHEM, V262, P2050; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fridovich I., 1978, CIBA F SYMP, P77; Ge FX, 2010, EXP BIOL MED, V235, P1282, DOI 10.1258/ebm.2010.010095; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Jarmuszkiewicz W, 1998, J BIOL CHEM, V273, P34882, DOI 10.1074/jbc.273.52.34882; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; KIM JJP, 1990, PROG CLIN BIOL RES, V321, P569; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kowaltowski AJ, 2002, J BIOL CHEM, V277, P42802, DOI 10.1074/jbc.M207765200; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Leite ACR, 2010, BBA-BIOENERGETICS, V1797, P1210, DOI 10.1016/j.bbabio.2010.01.034; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; MULLER F, 1978, FREE RADIC BIOL MED, V3, P215; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Rodrigues JV, 2012, FREE RADICAL BIO MED, V53, P12, DOI 10.1016/j.freeradbiomed.2012.04.016; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Schonfeld P, 2009, FREE RADICAL BIO MED, V47, P503, DOI 10.1016/j.freeradbiomed.2009.05.006; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; WILLIAMSON G, 1984, BIOCHEM J, V218, P521, DOI 10.1042/bj2180521; Zou YH, 2006, LIFE SCI, V79, P1100, DOI 10.1016/j.lfs.2006.03.021	53	42	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77088	10.1371/journal.pone.0077088	http://dx.doi.org/10.1371/journal.pone.0077088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116206	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300114
J	Li, XC; Zhang, XW; Zhou, JF; Ma, HY; Liu, ZD; Zhu, L; Yao, XJ; Li, LG; Fang, WH				Li, Xin-Cang; Zhang, Xiao-Wen; Zhou, Jun-Fang; Ma, Hong-Yu; Liu, Zhi-Dong; Zhu, Lei; Yao, Xiao-Juan; Li, Lin-Gui; Fang, Wen-Hong			Identification, Characterization, and Functional Analysis of Tube and Pelle Homologs in the Mud Crab Scylla paramamosain	PLOS ONE			English	Article							TOLL RECEPTOR; SHRIMP; COMPLEX; BINDING; RECOGNITION; CLONING; IRAK-4; FAMILY; GENE	Tube and Pelle are essential components in Drosophila Toll signaling pathway. In this study, we characterized a pair of crustacean homologs of Tube and Pelle in Scylla paramamosain, namely, SpTube and SpPelle, and analyzed their immune functions. The full-length cDNA of SpTube had 2052 bp with a 1578 bp open reading frame (ORF) encoding a protein with 525 aa. A death domain (DD) and a kinase domain were predicted in the deduced protein. The full-length cDNA of SpPelle had 3825 bp with a 3420 bp ORF encoding a protein with 1140 aa. The protein contained a DD and a kinase domain. Two conserved repeat motifs previously called Tube repeat motifs present only in insect Tube or Tube-like sequences were found between these two domains. Alignments and structure predictions demonstrated that SpTubeDD and SpPelleDD significantly differed in sequence and 3D structure. Similar to TubeDD, SpTubeDD contained three common conserved residues (R, K, and R) on one surface that may mediate SpMyD88 binding and two common residues (A and A) on the other surface that may contribute to Pelle binding. By contrast, SpPelleDD lacked similar conservative residues. SpTube, insect Tube-like kinases, and human IRAK4 were found to be RD kinases with an RD dipeptide in the kinase domain. SpPelle, Pelle, insect Pelle-like kinases, and human IRAK1 were found to be non-RD kinases lacking an RD dipeptide. Both SpTube and SpPelle were highly expressed in hemocytes, gills, and hepatopancreas. Upon challenge, SpTube and SpPele were significantly increased in hemocytes by Gram-negative or Gram-positive bacteria, whereas only SpPelle was elevated by White Spot Syndrome Virus. The pull-down assay showed that SpTube can bind to both SpMyD88 and SpPelle. These results suggest that SpTube, SpPelle, and SpMyD88 may form a trimeric complex involved in the immunity of mud crabs against both Gram-negative and Gram-positive bacteria.	[Li, Xin-Cang; Zhou, Jun-Fang; Ma, Hong-Yu; Liu, Zhi-Dong; Zhu, Lei; Yao, Xiao-Juan; Li, Lin-Gui; Fang, Wen-Hong] Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Li, Xin-Cang; Zhou, Jun-Fang; Ma, Hong-Yu; Liu, Zhi-Dong; Zhu, Lei; Yao, Xiao-Juan; Li, Lin-Gui; Fang, Wen-Hong] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Zhang, Xiao-Wen] Henan Normal Univ, Scholl Life Sci, Xinxiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Henan Normal University	Li, XC (corresponding author), Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China.	lixin8687@163.com; fwenhong@163.com			special research grant for the National Nonprofit Institute (East China Sea Fisheries Research Institute) [2011M07]; National Natural Science Foundation of China [31101920, 31301883]; Industry-Academia Cooperation Innovation Fund Projects of Jiangsu Province [BY2012141]; Shanghai Municipal Natural Science Foundation [13ZR1449900]	special research grant for the National Nonprofit Institute (East China Sea Fisheries Research Institute); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Industry-Academia Cooperation Innovation Fund Projects of Jiangsu Province; Shanghai Municipal Natural Science Foundation	This work was supported by a special research grant for the National Nonprofit Institute (East China Sea Fisheries Research Institute) (No. 2011M07), the National Natural Science Foundation of China ((Nos. 31101920, 31301883), the Industry-Academia Cooperation Innovation Fund Projects of Jiangsu Province (No. BY2012141), and Shanghai Municipal Natural Science Foundation (No. 13ZR1449900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts JAJ, 2007, FISH SHELLFISH IMMUN, V23, P504, DOI 10.1016/j.fsi.2006.08.018; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XC, 2013, DEV COMP IMMUNOL, V39, P313, DOI 10.1016/j.dci.2012.11.011; Li XC, 2010, FISH SHELLFISH IMMUN, V28, P942, DOI 10.1016/j.fsi.2010.02.011; Lin ZY, 2012, DEV COMP IMMUNOL, V37, P164, DOI 10.1016/j.dci.2011.09.003; Liu HP, 2009, FISH SHELLFISH IMMUN, V27, P79, DOI 10.1016/j.fsi.2009.02.009; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; Mekata T, 2008, FISH SHELLFISH IMMUN, V24, P122, DOI 10.1016/j.fsi.2007.10.006; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; O'Neill LA, 2013, NAT REV IMMUNOL; Shen BH, 2002, DEVELOPMENT, V129, P1925; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang SA, 2009, J IMMUNOL, V182, P5250, DOI 10.4049/jimmunol.0802970; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Yang CJ, 2008, FISH SHELLFISH IMMUN, V24, P564, DOI 10.1016/j.fsi.2007.12.012; Yang J, 1997, P NATL ACAD SCI USA, V94, P14524, DOI 10.1073/pnas.94.26.14524; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047038	37	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76728	10.1371/journal.pone.0076728	http://dx.doi.org/10.1371/journal.pone.0076728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116143	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300085
J	Rudel, D; Douglas, CD; Huffnagle, IM; Besser, JM; Ingersoll, CG				Rudel, David; Douglas, Chandler D.; Huffnagle, Ian M.; Besser, John M.; Ingersoll, Christopher G.			Assaying Environmental Nickel Toxicity Using Model Nematodes	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PRISTIONCHUS-PACIFICUS; EMERGING MODEL; RISK; SOIL; CARCINOGENESIS; GENETICS; MOTILITY; BEETLE	Although nickel exposure results in allergic reactions, respiratory conditions, and cancer in humans and rodents, the ramifications of excess nickel in the environment for animal and human health remain largely undescribed. Nickel and other cationic metals travel through waterways and bind to soils and sediments. To evaluate the potential toxic effects of nickel at environmental contaminant levels (8.9-7,600 mu g Ni/g dry weight of sediment and 50-800 mu g NiCl2/L of water), we conducted assays using two cosmopolitan nematodes, Caenorhabditis elegans and Pristionchus pacificus. We assayed the effects of both sediment-bound and aqueous nickel upon animal growth, developmental survival, lifespan, and fecundity. Uncontaminated sediments were collected from sites in the Midwestern United States and spiked with a range of nickel concentrations. We found that nickel-spiked sediment substantially impairs both survival from larval to adult stages and adult longevity in a concentration-dependent manner. Further, while aqueous nickel showed no adverse effects on either survivorship or longevity, we observed a significant decrease in fecundity, indicating that aqueous nickel could have a negative impact on nematode physiology. Intriguingly, C. elegans and P. pacificus exhibit similar, but not identical, responses to nickel exposure. Moreover, P. pacificus could be tested successfully in sediments inhospitable to C. elegans. Our results add to a growing body of literature documenting the impact of nickel on animal physiology, and suggest that environmental toxicological studies could gain an advantage by widening their repertoire of nematode species.	[Rudel, David; Douglas, Chandler D.; Huffnagle, Ian M.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Besser, John M.; Ingersoll, Christopher G.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA	University of North Carolina; East Carolina University; United States Department of the Interior; United States Geological Survey	Rudel, D (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	rudeld@ecu.edu			United States Geological Survey (USGS); East Carolina University	United States Geological Survey (USGS)(United States Geological Survey); East Carolina University	Funding was provided by the United States Geological Survey (USGS) and laboratory start up funds from East Carolina University. The USGS provided feedback on experimental design according to field and international monitoring standards. They also provided core resources and materials, i.e. sediments and test water. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Ankley GT, 1996, ENVIRON TOXICOL CHEM, V15, P2056, DOI 10.1002/etc.5620151202; *ASTM, 2012, ASTM ANN BOOK STAND, V1106; ATSDR (Agency for Toxic Substances and Disease Registry), 2005, TOX PROF NICK; Baylis HA, 2007, BIOCHEM SOC T, V35, P129, DOI 10.1042/BST0350129; Besser J.M., 2011, TOXICITY NICKEL SPIK; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P1100, DOI 10.1897/1551-5028(2003)022&lt;1100:AOMTTN&gt;2.0.CO;2; BRENNER S, 1974, GENETICS, V77, P71; Brown Joanne, 2004, BIOS (Ocean Grove), V75, P95, DOI 10.1893/0005-3155(2004)075<0095:TDEONO>2.0.CO;2; Brueske-Hohlfeld Irene, 2009, V472, P3, DOI 10.1007/978-1-60327-492-0_1; Bruinsma JJ, 2008, GENETICS, V179, P811, DOI 10.1534/genetics.107.084384; Cai KZ, 2010, TOXICOL IND HEALTH, V26, P249, DOI 10.1177/0748233710364962; Chu DS, 2013, ADV EXP MED BIOL, V757, P171, DOI 10.1007/978-1-4614-4015-4_7; Costa M, 2003, J ENVIRON MONITOR, V5, P222, DOI 10.1039/b210260a; DONKIN SG, 1993, ARCH ENVIRON CON TOX, V25, P145, DOI 10.1007/BF00212125; Felix MA, 1999, P ROY SOC B-BIOL SCI, V266, P1617, DOI 10.1098/rspb.1999.0823; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fraire-Zamora JJ, 2010, MOL REPROD DEV, V77, P739, DOI 10.1002/mrd.21193; Franzen J, 2012, ECOTOXICOLOGY, V21, P557, DOI 10.1007/s10646-011-0816-9; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Goodman JE, 2011, CRIT REV TOXICOL, V41, P142, DOI 10.3109/10408444.2010.531460; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Hoss S, 2011, ENVIRON INT, V37, P940, DOI 10.1016/j.envint.2011.03.013; Hoss S, 2012, ENVIRON TOXICOL CHEM, V31, P1525, DOI 10.1002/etc.1843; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hubbard E.J.A., 2005, INTRO GERM LINE, P1; Hubbard EJA, 2013, ADV EXP MED BIOL, V757, P101, DOI 10.1007/978-1-4614-4015-4_5; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; ISO, 2010, WAT QUAL DET TOX EFF, P17; Jargar Jameel G., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P77, DOI 10.1515/jbcpp-2012-0013; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kasprzak KS, 2003, J ENVIRON MONITOR, V5, P183, DOI 10.1039/b210538c; Kim S, 2013, ADV EXP MED BIOL, V757, P277, DOI 10.1007/978-1-4614-4015-4_10; Kimble J., 2005, GERMLINE PROLIFERATI, P1; Kiontke Karin, 2005, P1; Ledon-Rettig CC, 2011, EVOL DEV, V13, P391, DOI 10.1111/j.1525-142X.2011.00494.x; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lombardi C, 2003, Eur Ann Allergy Clin Immunol, V35, P52; Lukac N, 2011, J APPL TOXICOL, V31, P144, DOI 10.1002/jat.1574; Martinez-Finley EJ, 2011, METALLOMICS, V3, P271, DOI 10.1039/c0mt00064g; Murphy JT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002013; Peate WF, 2002, AM FAM PHYSICIAN, V66, P1025; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; REGER RB, 1993, OCCUP MED, V8, P185; Robertson S, 2013, ADV EXP MED BIOL, V757, P351, DOI 10.1007/978-1-4614-4015-4_12; Rudel D, 2005, DEV BIOL, V277, P200, DOI 10.1016/j.ydbio.2004.09.021; Schafer WF, 2006, ANNU REV GENET, V40, P487, DOI 10.1146/annurev.genet.40.110405.090527; SCHEDL T, 1988, GENETICS, V119, P43; SHEN HM, 1994, ENVIRON HEALTH PERSP, V102, P275, DOI 10.1289/ehp.94102s1275; Sommer R.J., 2005, EVOLUTION DEV NEMATO, P1; Sommer RJ, 2011, CURR BIOL, V21, pR758, DOI 10.1016/j.cub.2011.06.034; Sommer Ralf J, 2006, WormBook, P1; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Thyssen JP, 2013, CONTACT DERMATITIS, V68, P3, DOI 10.1111/j.1600-0536.2012.02127.x; Wang DY, 2008, ENVIRON POLLUT, V151, P585, DOI 10.1016/j.envpol.2007.04.003; WHO, 2005, NICK DRINK WAT BACKG, P22; Zagury A, 2011, PEDIATR NEPHROL, V26, P915, DOI 10.1007/s00467-011-1825-x	60	12	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77079	10.1371/journal.pone.0077079	http://dx.doi.org/10.1371/journal.pone.0077079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116204	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300113
J	Shen, H; Xu, SJ; Hong, L; Wang, ZM; Ye, WH				Shen, Hao; Xu, Shu-Jun; Hong, Lan; Wang, Zhang-Ming; Ye, Wan-Hui			Growth but Not Photosynthesis Response of a Host Plant to Infection by a Holoparasitic Plant Depends on Nitrogen Supply	PLOS ONE			English	Article							SINK-STIMULATED PHOTOSYNTHESIS; PARASITE CUSCUTA-CAMPESTRIS; NITRATE UPTAKE NITROGEN; MIKANIA-MICRANTHA; STRIGA-HERMONTHICA; BIOMASS ALLOCATION; RICINUS-COMMUNIS; CARBON RELATIONS; GAS-EXCHANGE; ELEVATED CO2	Parasitic plants can adversely influence the growth of their hosts by removing resources and by affecting photosynthesis. Such negative effects depend on resource availability. However, at varied resource levels, to what extent the negative effects on growth are attributed to the effects on photosynthesis has not been well elucidated. Here, we examined the influence of nitrogen supply on the growth and photosynthesis responses of the host plant Mikania micrantha to infection by the holoparasite Cuscuta campestris by focusing on the interaction of nitrogen and infection. Mikania micrantha plants fertilized at 0.2, 1 and 5 mM nitrate were grown with and without C. campestris infection. We observed that the infection significantly reduced M. micrantha growth at each nitrate fertilization and more severely at low than at high nitrate. Such alleviation at high nitrate was largely attributed to a stronger influence of infection on root biomass at low than at high nitrate fertilization. However, although C. campestris altered allometry and inhibited host photosynthesis, the magnitude of the effects was independent of nitrate fertilizations. The infection reduced light saturation point, net photosynthesis at saturating irradiances, apparent quantum yield, CO2 saturated rate of photosynthesis, carboxylation efficiency, the maximum carboxylation rate of Rubisco, and maximum light-saturated rate of electron transport, and increased light compensation point in host leaves similarly across nitrate levels, corresponding to a similar magnitude of negative effects of the parasite on host leaf soluble protein and Rubisco concentrations, photosynthetic nitrogen use efficiency and stomatal conductance across nitrate concentrations. Thus, the more severe inhibition in host growth at low than at high nitrate supplies cannot be attributed to a greater parasite-induced reduction in host photosynthesis, but the result of a higher proportion of host resources transferred to the parasite at low than at high nitrate levels.	[Shen, Hao; Xu, Shu-Jun; Wang, Zhang-Ming; Ye, Wan-Hui] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Xu, Shu-Jun] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Hong, Lan] Zhongkai Univ Agr & Engn, Coll Hort & Landscape Architecture, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhongkai University of Agriculture & Engineering	Shen, H (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	shenhao@scbg.ac.cn			National Key Technologies R&D Program of China [2012BAC07B04]	National Key Technologies R&D Program of China(National Key Technology R&D Program)	This work was funded by the National Key Technologies R&D Program of China (2012BAC07B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barker ER, 1996, NEW PHYTOL, V133, P637, DOI 10.1111/j.1469-8137.1996.tb01932.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CECHIN I, 1994, J EXP BOT, V45, P925, DOI 10.1093/jxb/45.7.925; CECHIN I, 1993, PLANT CELL ENVIRON, V16, P237, DOI 10.1111/j.1365-3040.1993.tb00866.x; Chen H, 2011, BIOL PLANTARUM, V55, P545, DOI 10.1007/s10535-011-0122-7; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; HARLEY PC, 1991, PHOTOSYNTH RES, V27, P169, DOI 10.1007/BF00035838; HARLEY PC, 1992, PLANT CELL ENVIRON, V15, P271, DOI 10.1111/j.1365-3040.1992.tb00974.x; Hieke S, 2002, TREE PHYSIOL, V22, P1249, DOI 10.1093/treephys/22.17.1249; Holm L. G., 1977, WORLDS WORST WEEDS D; HUNT R, 1974, J APPL ECOL, V11, P297, DOI 10.2307/2402022; Irving LJ, 2006, NEW PHYTOL, V169, P493, DOI 10.1111/j.1469-8137.2005.01584.x; Jeschke WD, 1997, J EXP BOT, V48, P915, DOI 10.1093/jxb/48.4.915; Jeschke WD, 1997, PLANT CELL ENVIRON, V20, P47, DOI 10.1046/j.1365-3040.1997.d01-2.x; JESCHKE WD, 1994, J EXP BOT, V45, P801, DOI 10.1093/jxb/45.6.801; JIANG CZ, 1993, PLANT PHYSIOL, V101, P105, DOI 10.1104/pp.101.1.105; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKINO A, 1986, AGR BIOL CHEM TOKYO, V50, P1911, DOI 10.1080/00021369.1986.10867672; Murchie EH, 1999, PLANT PHYSIOL, V119, P553, DOI 10.1104/pp.119.2.553; Navabpour S, 2003, J EXP BOT, V54, P2285, DOI 10.1093/jxb/erg267; Parker C., 1993, PARASITIC WEEDS WORL; PEUKE AD, 1994, J EXP BOT, V45, P741, DOI 10.1093/jxb/45.6.741; PRESS MC, 1990, PLANT CELL ENVIRON, V13, P91, DOI 10.1111/j.1365-3040.1990.tb01281.x; Press MC, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P175; Shen H, 2006, PLANT BIOLOGY, V8, P175, DOI 10.1055/s-2006-923796; Shen H, 2005, J EXP BOT, V56, P1277, DOI 10.1093/jxb/eri128; Shen H, 2007, J EXP BOT, V58, P2929, DOI 10.1093/jxb/erm168; Shen H, 2011, BOT STUD, V52, P89; Vanacker H, 2006, J EXP BOT, V57, P1735, DOI 10.1093/jxb/erl012; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Watling JR, 2001, PLANT BIOLOGY, V3, P244, DOI 10.1055/s-2001-15195; Watling JR, 2000, GLOB CHANGE BIOL, V6, P919, DOI 10.1046/j.1365-2486.2000.00366.x; WOLSWINKEL P, 1974, ACTA BOT NEERL, V23, P48, DOI 10.1111/j.1438-8677.1974.tb00916.x; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x	36	14	15	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75555	10.1371/journal.pone.0075555	http://dx.doi.org/10.1371/journal.pone.0075555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116055	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300033
J	Tolba, MEM; Kobayashi, S; Imada, M; Suzuki, Y; Sugano, S				Tolba, Mohammed E. M.; Kobayashi, Seiki; Imada, Mihoko; Suzuki, Yutaka; Sugano, Sumio			Giardia lamblia Transcriptome Analysis Using TSS-Seq and RNA-Seq	PLOS ONE			English	Article							PRIMITIVE EUKARYOTE; MESSENGER-RNA; GENE; INTESTINALIS; PROMOTER; GENOME; ABUNDANCE	Giardia lamblia is a protozoan parasite that is found worldwide and has both medical and veterinary importance. We applied the transcription start sequence (TSS-seq) and RNA sequence (RNA-seq) techniques to study the transcriptome of the assemblage A WB strain trophozoite. We identified 8000 transcription regions (TR) with significant transcription. Of these regions, 1881 TRs were more than 500 nucleotides upstream of an annotated ORF. Combining both techniques helped us to identify 24 ORFs that should be re-annotated and 60 new ORFs. From the 8000 TRs, we were able to identify an AT-rich consensus that includes the transcription initiation site. It is possible that transcription that was previously thought to be bidirectional is actually unidirectional.	[Tolba, Mohammed E. M.; Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Dept Med Genom, Grad Sch Frontier Sci, Tokyo, Japan; [Tolba, Mohammed E. M.] Assiut Univ, Dept Parasitol, Fac Med, Assiut, Egypt; [Kobayashi, Seiki; Imada, Mihoko] Keio Univ, Sch Med, Dept Infect Dis, Tokyo, Japan	University of Tokyo; Egyptian Knowledge Bank (EKB); Assiut University; Keio University	Tolba, MEM (corresponding author), Univ Tokyo, Dept Med Genom, Grad Sch Frontier Sci, Tokyo, Japan.	essa3eg@yahoo.com	Kobayashi, seiki/L-4026-2013		Tokyo Biochemical Research Foundation (TBRF); Ministry of Education, Culture, Sports, Science and Technology of Japan	Tokyo Biochemical Research Foundation (TBRF); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Mohammed E. M. Tolba was supported by The Tokyo Biochemical Research Foundation (TBRF) for postdoctoral fellowship. This work was in part supported by KAKENHI (Grant-in-Aid for Scientific Research) in the Priority Area of "Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2000, INT J PARASITOL, V30, P475, DOI 10.1016/S0020-7519(99)00191-5; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Ali SA, 2003, CURR OPIN INFECT DIS, V16, P453, DOI 10.1097/00001432-200310000-00012; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Blumenthal T, 2011, CURR BIOL, V21, pR162, DOI 10.1016/j.cub.2011.01.032; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Elmendorf HG, 2001, NUCLEIC ACIDS RES, V29, P4674, DOI 10.1093/nar/29.22.4674; Erlandsen SL, 2013, J EUKARYOT MICROBIOL, V43, P416; Hoff KJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-217; Hoff KJ, 2009, NUCLEIC ACIDS RES, V37, pW101, DOI 10.1093/nar/gkp327; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kamikawa R, 2011, CURR BIOL, V21, P311, DOI 10.1016/j.cub.2011.01.025; Keister DI, 1983, AXENIC CULTURE GIARD; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; MARUYAMA K, 1994, GENE, V138, P171; Monis PT, 1999, MOL BIOL EVOL, V16, P1135, DOI 10.1093/oxfordjournals.molbev.a026204; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Plutzer J, 2010, INT J HYG ENVIR HEAL, V213, P321, DOI 10.1016/j.ijheh.2010.06.005; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Rivero MR, 2010, J PARASITOL, V96, P815, DOI 10.1645/GE-2406.1; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Svard SG, 2003, FEMS MICROBIOL LETT, V218, P3, DOI 10.1016/S0378-1097(02)01107-2; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Thorvaldsdottir H, 2012, INTEGRATIVE GENOMICS; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Yee J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-26; Yoder Jonathan S., 2012, Morbidity and Mortality Weekly Report, V61, P13	34	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76184	10.1371/journal.pone.0076184	http://dx.doi.org/10.1371/journal.pone.0076184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116096	gold, Green Published			2022-12-27	WOS:000325501300051
J	Wei, LJ; Diao, Y; Qi, J; Khokhlov, A; Feng, H; Yan, X; Li, Y				Wei, Lijun; Diao, Yan; Qi, Jing; Khokhlov, Alexander; Feng, Hui; Yan, Xing; Li, Yu			Effect of Change in Spindle Structure on Proliferation Inhibition of Osteosarcoma Cells and Osteoblast under Simulated Microgravity during Incubation in Rotating Bioreactor	PLOS ONE			English	Article							APOPTOSIS	In order to study the effect of microgravity on the proliferation of mammalian osteosarcoma cells and osteoblasts, the changes in cell proliferation, spindle structure, expression of MAD2 or BUB1, and effect of MAD2 or BUB1 on the inhibition of cell proliferation is investigated by keeping mammalian osteosarcoma cells and osteoblasts under simulated microgravity in a rotating wall vessel (2D-RWVS) bioreactor. Experimental results indicate that the effect of microgravity on proliferation inhibition, incidence of multipolar spindles, and expression of MAD2 or BUB1 increases with the extension of treatment time. And multipolar cells enter mitosis after MAD2 or BUB1 is knocked down, which leads to the decrease in DNA content, and decrease the accumulation of cells within multipolar spindles. It can therefore be concluded that simulated microgravity can alter the structure of spindle microtubules, and stimulate the formation of multipolar spindles together with multicentrosomes, which causes the overexpression of SAC proteins to block the abnormal cells in metaphase, thereby inhibiting cell proliferation. By clarifying the relationship between cell proliferation inhibition, spindle structure and SAC changes under simulated microgravity, the molecular mechanism and morphology basis of proliferation inhibition induced by microgravity is revealed, which will give experiment and theoretical evidence for the mechanism of space bone loss and some other space medicine problems.	[Wei, Lijun; Diao, Yan; Qi, Jing; Feng, Hui; Yan, Xing; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Khokhlov, Alexander] Moscow MV Lomonosov State Univ, Sch Biol, Moscow, Russia	Harbin Institute of Technology; Lomonosov Moscow State University	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@hit.edu.cn	Khokhlov, Alexander N/G-3905-2013; 黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022	Khokhlov, Alexander/0000-0001-7454-7023	National Science Foundation of China [30970686]; Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application [SMFA09K03]; Natural Science Foundation of Heilongjiang Province [D200879]; Natural Scientific Research Innovation Foundation of Harbin Institute of Technology [HIT.NSRIF.2008.14]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Natural Scientific Research Innovation Foundation of Harbin Institute of Technology(Harbin Institute of Technology)	This work is funded by National Science Foundation of China (30970686), Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application (SMFA09K03), Natural Science Foundation of Heilongjiang Province (D200879), and Natural Scientific Research Innovation Foundation of Harbin Institute of Technology (HIT.NSRIF.2008.14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Buravkova LB, 2001, ACTA ASTRONAUT, V48, P647, DOI 10.1016/S0094-5765(01)00023-6; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; GUIGNANDON A, 1995, CELL STRUCT FUNCT, V20, P369, DOI 10.1247/csf.20.369; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Kossmehl P, 2003, ENDOCRINOLOGY, V144, P4172, DOI 10.1210/en.2002-0171; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Lewis ML, 2004, J GRAVIT SPACE BIO B, V1, P3; Liedert A, 2004, BIOCHEM BIOPH RES CO, V319, P951, DOI 10.1016/j.bbrc.2004.05.087; Malmanche N, 2006, FEBS LETT, V580, P2888, DOI 10.1016/j.febslet.2006.03.081; RIJKEN PJ, 1991, J CELL SCI, V100, P491; RIJKEN PJ, 1991, AVIAT SPACE ENVIR MD, V62, P32; SiTu ZQ, 2004, CELL CULTURE, P163; Sun CR, 2006, J HARBIN MED U, V1, P70; [谭映军 Tan Yingjun], 2011, [航天医学与医学工程, Space Medicine & Medical Engineering], V24, P13; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Vassy J, 2003, ADV SPACE RES-SERIES, V32, P1595, DOI 10.1016/S0273-1177(03)90400-5; Wang SL, 2008, J PRACT MED, V6, P915; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wu C, 2011, PLOS ONE, V7, P1; Xiong JH, 2003, ACTA ZOOL SINICA, V1, P98; [Zhang Shu 张舒], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P4530; Zhang XY, 2000, CHIN J AEROSPACE MED, V11, P432; [Zheng Hongxia 郑红霞], 2010, [航天医学与医学工程, Space Medicine & Medical Engineering], V23, P416; Zhong JJ, 2006, J XINJIANG MED U, V8, P669	27	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76710	10.1371/journal.pone.0076710	http://dx.doi.org/10.1371/journal.pone.0076710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116140	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300083
J	Armata, IA; Balaj, L; Kuster, JK; Zhang, X; Tsai, SL; Armatas, AA; Multhaupt-Buell, TJ; Soberman, R; Breakefield, XO; Ichinose, H; Sharma, N				Armata, Ioanna A.; Balaj, Leonora; Kuster, John K.; Zhang, Xuan; Tsai, Shelun; Armatas, Andreas A.; Multhaupt-Buell, Trisha J.; Soberman, Roy; Breakefield, Xandra O.; Ichinose, Hiroshi; Sharma, Nutan			Dopa-Responsive Dystonia: Functional Analysis of Single Nucleotide Substitutions within the 5 ' Untranslated GCH1 Region	PLOS ONE			English	Article							GTP CYCLOHYDROLASE-I; HEREDITARY PROGRESSIVE DYSTONIA; MARKED DIURNAL FLUCTUATION; TRANSLATION INITIATION; GENE-EXPRESSION; MUTATION; TETRAHYDROBIOPTERIN; METABOLISM; MECHANISMS; DISORDERS	Background: Mutations in the GCH1 gene are associated with childhood onset, dopa-responsive dystonia (DRD). Correct diagnosis of DRD is crucial, given the potential for complete recovery once treated with L-dopa. The majority of DRD associated mutations lie within the coding region of the GCH1 gene, but three additional single nucleotide sequence substitutions have been reported within the 5' untranslated (5'UTR) region of the mRNA. The biologic significance of these 5' UTR GCH1 sequence substitutions has not been analyzed. Methodology/Principal Findings: Luciferase reporter assays, quantitative real time PCR and RNA decay assays, combined with bioinformatics, revealed a pathogenic 5' UTR GCH1 substitution. The +142C>T single nucleotide 5' UTR substitution that segregates with affected status in DRD patients, substantially attenuates translation without altering RNA expression levels or stability. The +142C>T substitution disrupts translation most likely by creating an upstream initiation start codon (uAUG) and an upstream open reading frame (uORF). Conclusions/Significance: This is the first GCH1 regulatory substitution reported to act at a post-transcriptional level, increasing the list of genetic diseases caused by abnormal translation and reaffirming the importance of investigating potential regulatory substitutions in genetic diseases.	[Armata, Ioanna A.; Balaj, Leonora; Kuster, John K.; Zhang, Xuan; Tsai, Shelun; Multhaupt-Buell, Trisha J.; Breakefield, Xandra O.; Sharma, Nutan] Massachusetts Gen Hosp, Dept Neurogenet, Boston, MA 02114 USA; [Armata, Ioanna A.; Balaj, Leonora; Kuster, John K.; Zhang, Xuan; Tsai, Shelun; Multhaupt-Buell, Trisha J.; Breakefield, Xandra O.; Sharma, Nutan] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Armatas, Andreas A.] Univ Patras, Dept Biol, Rion, Greece; [Soberman, Roy] Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA; [Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Patras; Harvard University; Massachusetts General Hospital; Tokyo Institute of Technology	Armata, IA (corresponding author), Massachusetts Gen Hosp, Dept Neurogenet, Boston, MA 02114 USA.	ionarm999@gmail.com	Armata, Ioanna A./T-7356-2019; Ichinose, Hiroshi/D-8986-2015	Ichinose, Hiroshi/0000-0001-6008-6860; Balaj, Leonora/0000-0003-0931-9715	NIH/NINDS [5P50NS037409]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS 5P50NS037409 (XOB and NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bandmann O, 1998, ANN NEUROL, V44, P649, DOI 10.1002/ana.410440411; Bonafe L, 2001, CLIN CHEM, V47, P477; Bruggemann N, 2010, CURR NEUROL NEUROSCI, V10, P199, DOI 10.1007/s11910-010-0107-5; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Hagenah J, 2005, NEUROLOGY, V64, P908, DOI 10.1212/01.WNL.0000152839.50258.A2; Hirano M, 1997, BIOCHEM BIOPH RES CO, V234, P316, DOI 10.1006/bbrc.1997.6632; Hirayama K, 2001, J NEUROCHEM, V79, P576, DOI 10.1046/j.1471-4159.2001.00583.x; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; ICHINOSE H, 1995, J BIOL CHEM, V270, P10062, DOI 10.1074/jbc.270.17.10062; Ichinose H, 2000, BRAIN DEV-JPN, V22, pS107; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Ichinose H, 2008, CHEM REC, V8, P378, DOI 10.1002/tcr.20166; Inagaki H, 1999, BIOCHEM BIOPH RES CO, V260, P747, DOI 10.1006/bbrc.1999.0976; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Klein C, 2002, NEUROLOGY, V59, P1783, DOI 10.1212/01.WNL.0000035629.04791.3F; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; Lukowski SW, 2011, HUM MUTAT, V32, pE2266, DOI 10.1002/humu.21545; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; Nishiyama N, 2000, BRAIN DEV-JPN, V22, pS102; Nygaard T G, 1988, Adv Neurol, V50, P377; Segawa M, 1976, Adv Neurol, V14, P215; Segawa M, 2011, BRAIN DEV-JPN, V33, P195, DOI 10.1016/j.braindev.2010.10.015; Sharma N, 2011, MOVEMENT DISORD, V26, P2140, DOI 10.1002/mds.23786; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steinberger D, 2007, NEUROGENETICS, V8, P51, DOI 10.1007/s10048-006-0069-6; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V293, P962, DOI 10.1016/S0006-291X(02)00343-1; Tachi N, 2011, EUR J NEUROL, V18, P1191, DOI 10.1111/j.1468-1331.2011.03354.x; Tassin J, 2000, BRAIN, V123, P1112, DOI 10.1093/brain/123.6.1112; Weber Y, 1997, NEUROGENETICS, V1, P125, DOI 10.1007/s100480050018; Witter K, 1996, GENE, V171, P285, DOI 10.1016/0378-1119(95)00886-1; Wu-Chou YH, 2010, AM J MED GENET B, V153B, P903, DOI 10.1002/ajmg.b.31058	33	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76975	10.1371/journal.pone.0076975	http://dx.doi.org/10.1371/journal.pone.0076975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124602	Green Published, gold			2022-12-27	WOS:000325489100159
J	Chang, CF; Li, CJ; Ko, CJ; Teng, TH; Lai, SC; Yang, MC; Chiu, CW; Chou, CC; Chang, CY; Yao, YC; Wu, LH; Wu, HP; Chen, WL; Lin, YR				Chang, Chin-Fu; Li, Chao-Jui; Ko, Chih-Jan; Teng, Tsung-Han; Lai, Shih-Chang; Yang, Mei-Chueh; Chiu, Chun-Wen; Chou, Chu-Chung; Chang, Chih-Yu; Yao, Yung-Chiao; Wu, Lan-Hsin; Wu, Han-Ping; Chen, Wen-Liang; Lin, Yan-Ren			The Post-Resuscitative Urinalysis Associate the Survival of Patients with Non-Traumatic Out-of-Hospital Cardiac Arrest	PLOS ONE			English	Article							BETA-TRACE PROTEIN; INTERNATIONAL LIAISON COMMITTEE; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; SERUM CREATININE; SEPTIC SHOCK; CYSTATIN C; KIDNEY; POPULATION; STATEMENT	Objective: To analyze whether urine output and urinalysis results are predictive of survival and neurologic outcomes in patients with non-traumatic out-of-hospital cardiac arrest (OHCA). Methods: Information was obtained from 1,340 patients with non-traumatic OHCA who had achieved a sustained return of spontaneous circulation (ROSC). Factors that were associated with survival in the post-resuscitative period were evaluated. The association between urine output and fluid challenge in the early resuscitative period was analyzed and compared between the survivors and the non-survivors. The results of the initial urinalysis, including the presence of proteinuria and other findings, were used to evaluate the severity of vascular protein leakage and survival. The association between proteinuria and the neurologic outcomes of the survivors was also analyzed. The clinical features of capillary leakage were examined during the post-resuscitative period. Results: Of the 1,340 patients, 312 survived. A greater urine output was associated with a higher chance of survival. The initial urine output increased in proportion to the amount of fluid that was administered during early resuscitation in the emergency department for the survivors but not for the non-survivors (p<0.05). In the initial urinalysis, proteinuria was strongly associated with survival, and severe proteinuria indicated significantly poorer neurologic outcomes (p<0.05 for both comparisons). Proteinuria was associated with a risk of developing signs of capillary leakage, including body mass index gain and pitting edema (both p<0.001). Conclusion: The severity of proteinuria during the early post-resuscitative period was predictive of survival.	[Chang, Chin-Fu; Lai, Shih-Chang; Yang, Mei-Chueh; Chiu, Chun-Wen; Chou, Chu-Chung; Chang, Chih-Yu; Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Li, Chao-Jui] Chang Gung Univ, Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan; [Ko, Chih-Jan] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan; [Teng, Tsung-Han; Lai, Shih-Chang; Chang, Chih-Yu; Chen, Wen-Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Teng, Tsung-Han] Taichung Hosp, Dept Pathol, Dept Hlth, Taichung, Taiwan; [Chou, Chu-Chung; Lin, Yan-Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yao, Yung-Chiao; Wu, Lan-Hsin] Changhua Christian Hosp, Dept Nursing, Changhua, Taiwan; [Wu, Han-Ping] Buddhist Tzu Chi Gen Hosp, Taichung Branch, Dept Pediat, Taichung, Taiwan	Changhua Christian Hospital; Chang Gung Memorial Hospital; Chang Gung University; Changhua Christian Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Changhua Christian Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Wu, HP (corresponding author), Buddhist Tzu Chi Gen Hosp, Taichung Branch, Dept Pediat, Taichung, Taiwan.	arthur1226@gmail.com; wenurea@yahoo.com.tw; h6213.lac@gmail.com	Lin, Yan-Ren/AAU-4136-2020	Lin, Yan-Ren/0000-0002-9015-2678	Changhua Christian Hospital	Changhua Christian Hospital	The authors Changhua Christian Hospital for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; Cokkinos Philip, 2009, Acute Card Care, V11, P131, DOI 10.1080/17482940903168209; Eppihimer MJ, 1997, SHOCK, V8, P16, DOI 10.1097/00024382-199707000-00004; Erley CM, 2001, CRIT CARE MED, V29, P1544, DOI 10.1097/00003246-200108000-00008; Gando S, 1997, INTENS CARE MED, V23, P1245, DOI 10.1007/s001340050493; Hasper D, 2009, CRIT CARE, V13, DOI 10.1186/cc8144; Heradstveit BE, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-29; Hiratsuka M, 2009, INFLAMM RES, V58, P463, DOI 10.1007/s00011-009-0011-0; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Juraschek SP, 2013, CLIN J AM SOC NEPHRO, V8, P584, DOI 10.2215/CJN.08700812; Kagawa E, 2010, RESUSCITATION, V81, P968, DOI 10.1016/j.resuscitation.2010.03.037; KUROSE I, 1994, CIRC RES, V74, P336, DOI 10.1161/01.RES.74.2.336; Lai S, 2013, J NEUROSCI NEUROENG, V2, P66; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Lin YR, 2010, RESUSCITATION, V81, P410, DOI 10.1016/j.resuscitation.2010.01.006; LIN YR, 2012, J NEUROSCI NEUROENG, V1, P213; Martin-Hernandez H, 2010, MED INTENSIVA, V34, P107, DOI 10.1016/j.medin.2009.09.001; Morimoto Y, 1996, CRIT CARE MED, V24, P1719, DOI 10.1097/00003246-199610000-00020; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Orenes-Pinero E, 2013, CLIN J AM SOC NEPHRO, V8, P873, DOI 10.2215/CJN.08870812; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Spanaus KS, 2010, CLIN CHEM, V56, P740, DOI 10.1373/clinchem.2009.138826; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; Temmesfeld-Wollbruck B, 2007, INTENS CARE MED, V33, P703, DOI 10.1007/s00134-007-0561-y; van Meurs M, 2009, AM J PHYSIOL-RENAL, V297, pF272, DOI 10.1152/ajprenal.00137.2009; Zacharia BE, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/124384	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75172	10.1371/journal.pone.0075172	http://dx.doi.org/10.1371/journal.pone.0075172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124472	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100029
J	Hung, MC; Hsieh, CL; Hwang, JS; Jeng, JS; Wang, JD				Hung, Mei-Chuan; Hsieh, Ching-Lin; Hwang, Jing-Shiang; Jeng, Jiann-Shing; Wang, Jung-Der			Estimation of the Long-Term Care Needs of Stroke Patients by Integrating Functional Disability and Survival	PLOS ONE			English	Article							1ST-EVER ISCHEMIC-STROKE; QUALITY-ADJUSTED SURVIVAL; BARTHEL INDEX; PSYCHOMETRIC CHARACTERISTICS; EXPECTED YEARS; YOUNG-ADULTS; RISK-FACTORS; LIFE LOST; AGED 15; SUBTYPES	Objectives: This study aimed to estimate the dynamic changes of different physical functional disabilities and life-time care needs for patients with stroke. Data Sources and Study Design: We examined a hospital-based cohort including 16,043 patients who had their first stroke during 1995-2010. The Barthel Index (BI) was used to measure disability levels in 1,162 consecutive patients, with a total of 1,294 measurements at the stroke clinics and the rehabilitation wards, and a cross-sectional design. Extraction Methods: The survival function was extrapolated to lifetime by a semi-parametric method and multiplied with proportions of different disabilities over time to obtain the long-term care needs for different stroke subtypes. Principal Findings: On average, stroke patients would suffer at least 0.86 years with mild disability, 1.24 years with moderate disability and 1.39 years with severe disability, as measured by the BI. Among these, patients with a cardio-embolic infarct or intracerebral hemorrhage (ICH) suffered more than 2 years of severe disability. Assistance in bathing was the most common need for care in stroke patients. Conclusions: Among different subtypes of stroke, cardio-embolic infarct and ICH lead to the longest durations of severe physical functional disability. The method presented in this work may also be applied to other chronic diseases and different functional disabilities.	[Hung, Mei-Chuan; Wang, Jung-Der] Natl Cheng Kung Univ Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Hsieh, Ching-Lin] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei 10764, Taiwan; [Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hwang, Jing-Shiang] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Jeng, JS (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	jsjeng@ntu.edu.tw; jdwang121@gmail.com	Hwang, Jing-Shiang/AAP-2835-2021; Hsieh, Ching-Lin/G-6057-2011	Hwang, Jing-Shiang/0000-0002-5807-7583; Hsieh, Ching-Lin/0000-0001-9468-9969; JENG, JIANN-SHING/0000-0002-1456-3686	National Science Council of the Executive Yuan of Taiwan [NSC 102-2314-B-006-029-MY2, NSC 101-2314-B-006-077]	National Science Council of the Executive Yuan of Taiwan	This study is supported by the following two grants of the National Science Council of the Executive Yuan of Taiwan (NSC 102-2314-B-006-029-MY2 and NSC 101-2314-B-006-077). The funding agency has no role or interference in the hypothesis formation, study design, data analysis, inference, or conclusion.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2007, HLTH EXPECTANCY CALC; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x; Della Pietra GL, 2011, STROKE, V42, P2077, DOI 10.1161/STROKEAHA.111.613521; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Hsueh IP, 2001, J FORMOS MED ASSOC, V100, P526; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4; Hwang JS, 1996, STAT MED, V15, P93, DOI 10.1002/(SICI)1097-0258(19960115)15:1<93::AID-SIM155>3.0.CO;2-2; Kimura K, 2004, CEREBROVASC DIS, V18, P47, DOI 10.1159/000078749; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lee ET, 2009, STAT METHODS SURVIVA, P64; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Liu PH, 2013, PREV MED, V56, P309, DOI 10.1016/j.ypmed.2013.02.003; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; Putaala J, 2009, STROKE, V40, P1195, DOI 10.1161/STROKEAHA.108.529883; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Shin SY, 2012, J GERONTOL NURS, V38, P33, DOI 10.3928/00989134-20120807-03; Spengos K, 2010, EUR J NEUROL, V17, P1358, DOI 10.1111/j.1468-1331.2010.03065.x; Turin TC, 2010, STROKE, V41, P1871, DOI 10.1161/STROKEAHA.110.581033; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Xie J., 2007, Morbidity and Mortality Weekly Report, V56, P504; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	28	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75605	10.1371/journal.pone.0075605	http://dx.doi.org/10.1371/journal.pone.0075605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124500	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100057
J	Ito, S; Tanaka, Y; Nishio, N; Thanasegaran, S; Isobe, KI				Ito, Sachiko; Tanaka, Yuriko; Nishio, Naomi; Thanasegaran, Suganya; Isobe, Ken-Ichi			Establishment of Self-Renewable GM-CSF-Dependent Immature Macrophages In Vitro from Murine Bone Marrow	PLOS ONE			English	Article							AORTIC ENDOTHELIUM; CELLS; LINEAGE; BLOOD; HEMATOPOIESIS; RECRUITMENT; PROGENITOR; ACTIVATION; EXPRESSION; MONOCYTES	Macrophages play a key role in the innate immune system. Macrophages are thought to originate from hematopoietic precursors or the yolk sac. Here, we describe the in vitro establishment of self-renewable GM-CSF-dependent immature macrophages (GM-IMs) from murine bone marrow (BM). GM-IMs grow continuously in vitro in conditioned medium containing GM-CSF. The immunophenotype of GM-IMs is F4/80(high) CD11b(high) CD11c(low) Ly6C(low). By comparing gene expression in GM-IMs and BM dendritic cells, we found that GM-IMs expressed lower levels of chemokines, cytokines and their receptors. GM-IMs are round in shape, attach loosely to non-coated culture dishes and have a marked phagocytic capacity. These results indicate that GM-IMs are macrophage precursor cells. Following stimulation with LPS, monocyte-like GM-IMs converted to flat macrophage-like cells that tightly adhered to non-coated culture dishes and produced pro-inflammatory cytokines TNF alpha, IL-6 and IL-1 beta. These results indicated that GM-IMs differentiated to M1 pro-inflammatory macrophages. This was confirmed by stimulation of GM-IMs with IFN gamma, an inducer of M1 markers. GM-IMs showed enhanced expression of M2 macrophage markers such as Arg1 and Retnla following stimulation by Th2 cytokines IL-4 and IL-13. When GM-IMs were injected into mice at sites of wounding, wound repair was enhanced. These results indicate that GM-IMs can differentiate to M2 macrophages. When GM-IMs were injected into clodronate-treated mice, they induced resident macrophage proliferation by producing M-CSF. In conclusion we have established self-renewable GM-CSF-dependent immature macrophages in vitro from murine BM, which differentiate to M1 or M2 macrophages.	[Ito, Sachiko; Tanaka, Yuriko; Nishio, Naomi; Thanasegaran, Suganya; Isobe, Ken-Ichi] Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Nagoya University	Isobe, KI (corresponding author), Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	kisobe@med.nagoya-u.ac.jp	ito, Sachiko/M-4877-2014		Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76943	10.1371/journal.pone.0076943	http://dx.doi.org/10.1371/journal.pone.0076943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124601	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100158
J	Kamalam, BS; Medale, F; Larroquet, L; Corraze, G; Panserat, S				Kamalam, Biju Sam; Medale, Francoise; Larroquet, Laurence; Corraze, Genevieve; Panserat, Stephane			Metabolism and Fatty Acid Profile in Fat and Lean Rainbow Trout Lines Fed with Vegetable Oil: Effect of Carbohydrates	PLOS ONE			English	Article							DIETARY FISH-OIL; MUSCLE FAT; ONCORHYNCHUS-MYKISS; GENE-EXPRESSION; DESATURASE EXPRESSION; GLUCOSE-HOMEOSTASIS; TELEOST FISH; IN-VIVO; REPLACEMENT; SELECTION	The present study investigated the effect of dietary carbohydrates on metabolism, with special focus on fatty acid bioconversion and flesh lipid composition in two rainbow trout lines divergently selected for muscle lipid content and fed with vegetable oils. These lines were chosen based on previously demonstrated potential differences in LC-PUFA synthesis and carbohydrate utilization. Applying a factorial study design, juvenile trout from the lean (L) and the fat (F) line were fed vegetable oil based diets with or without gelatinised starch (17.1%) for 12 weeks. Blood, liver, muscle, intestine and adipose tissue were sampled after the last meal. Feed intake and growth was higher in the L line than the F line, irrespective of the diet. Moderate postprandial hyperglycemia, strong induction of hepatic glucokinase and repressed glucose-6-phosphatase transcripts confirmed the metabolic response of both lines to carbohydrate intake. Further at the transcriptional level, dietary carbohydrate in the presence of n-3 LC-PUFA deficient vegetable oils enhanced intestinal chylomicron assembly, disturbed hepatic lipid metabolism and importantly elicited a higher response of key desaturase and elongase enzymes in the liver and intestine that endorsed our hypothesis. PPAR gamma was identified as the factor mediating this dietary regulation of fatty acid bioconversion enzymes in the liver. However, these molecular changes were not sufficient to modify the fatty acid composition of muscle or liver. Concerning the genotype effect, there was no evidence of substantial genotypic difference in lipid metabolism, LC-PUFA synthesis and flesh fatty acid profile when fed with vegetable oils. The minor reduction in plasma glucose and triglyceride levels in the F line was linked to potentially higher glucose and lipid uptake in the muscle. Overall, these data emphasize the importance of dietary macro-nutrient interface in evolving fish nutrition strategies.	[Kamalam, Biju Sam; Medale, Francoise; Larroquet, Laurence; Corraze, Genevieve; Panserat, Stephane] INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France	INRAE; Universite de Pau et des Pays de l'Adour	Panserat, S (corresponding author), INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France.	panserat@st-pee.inra.fr	Kamalam, Biju Sam/K-8876-2012	Kamalam, Biju Sam/0000-0003-1944-0244; Panserat, Stephane/0000-0002-4479-9868; Medale, Francoise/0000-0002-8083-1298	Indian Council of Agricultural Research (ICAR); Nutrition, Metabolism and Aquaculture unit of the Institut National de la Recherche Agronomique (INRA), France	Indian Council of Agricultural Research (ICAR)(Indian Council of Agricultural Research (ICAR)); Nutrition, Metabolism and Aquaculture unit of the Institut National de la Recherche Agronomique (INRA), France	BS Kamalam was a recipient of the International doctoral fellowship provided by the Indian Council of Agricultural Research (ICAR). This study was supported by internal grants of the Nutrition, Metabolism and Aquaculture unit of the Institut National de la Recherche Agronomique (INRA), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NEW COMPREHENSIVE BI, DOI [DOI 10.1016/S0167-7306(02)36009-5, 10.1016/S0167-7306(02)36009-5]; Bell JG, 2010, AQUACULTURE, V306, P225, DOI 10.1016/j.aquaculture.2010.05.021; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; BERGOT F, 1979, AQUACULTURE, V18, P157, DOI 10.1016/0044-8486(79)90028-0; Calder PC, 2009, BIOFACTORS, V35, P266, DOI 10.1002/biof.42; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geurden I, 2005, PHYSIOL BEHAV, V85, P107, DOI 10.1016/j.physbeh.2005.03.010; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Goetz F, 2010, MOL ECOL, V19, P176, DOI 10.1111/j.1365-294X.2009.04481.x; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hemre GI, 2002, AQUACULT NUTR, V8, P175, DOI 10.1046/j.1365-2095.2002.00200.x; Igarashi M, 2007, J LIPID RES, V48, P2463, DOI 10.1194/jlr.M700315-JLR200; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jump D. B., 2002, Scandinavian Journal of Nutrition/Naringsforskning, V46, P59, DOI 10.1080/11026480213022; Kamalam BS, 2013, COMP BIOCHEM PHYS A, V164, P417, DOI 10.1016/j.cbpa.2012.11.020; Kamalam BS, 2012, J EXP BIOL, V215, P2567, DOI 10.1242/jeb.070581; Kirchner S, 2008, J COMP PHYSIOL B, V178, P429, DOI 10.1007/s00360-007-0235-7; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; Kolditz CI, 2010, BRIT J NUTR, V103, P629, DOI 10.1017/S0007114509992340; Kolditz CI, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-506; Leaver MJ, 2011, COMP BIOCHEM PHYS D, V6, P62, DOI 10.1016/j.cbd.2010.04.002; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Matsuzaka T, 2002, J LIPID RES, V43, P107; Menoyo D, 2005, J ANIM SCI, V83, P2853; Meyer A, 2004, J LIPID RES, V45, P1899, DOI 10.1194/jlr.M400181-JLR200; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; MOORE S, 1968, J BIOL CHEM, V243, P6281; Morais S., 2011, BR J NUTR, V1, P1; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-448; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Panserat S, 2009, AM J PHYSIOL-REG I, V297, pR707, DOI 10.1152/ajpregu.00120.2009; Panserat S, 2000, AM J PHYSIOL-REG I, V278, pR1164, DOI 10.1152/ajpregu.2000.278.5.R1164; Panserat S, 2000, J NUTR BIOCHEM, V11, P22, DOI 10.1016/S0955-2863(99)00067-4; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Parks EJ, 2000, AM J CLIN NUTR, V71, P412; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; POISSON JPG, 1991, J NUTR BIOCHEM, V2, P60, DOI 10.1016/0955-2863(91)90030-9; Polakof S, 2011, J ANIM SCI, V89, P3079, DOI 10.2527/jas.2010-3733; Quillet E, 2005, AQUACULTURE, V245, P49, DOI 10.1016/j.aquaculture.2004.12.014; Quillet E, 2007, AQUACULTURE, V269, P220, DOI 10.1016/j.aquaculture.2007.02.047; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Roberts LD, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r75; Rollin X, 2003, COMP BIOCHEM PHYS B, V134, P349, DOI 10.1016/S1096-4959(02)00264-6; Sanchez-Gurmaches J, 2012, J EXP BIOL, V215, P1373, DOI 10.1242/jeb.061697; Sargent John R., 2002, P181; Seiliez I, 2001, COMP BIOCHEM PHYS B, V130, P83, DOI 10.1016/S1096-4959(01)00410-9; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Stubhaug I, 2005, BBA-MOL CELL BIOL L, V1734, P277, DOI 10.1016/j.bbalip.2005.04.003; SULLIVAN AC, 1971, J NUTR, V101, P265, DOI 10.1093/jn/101.2.265; Tocher DR, 1998, PROG LIPID RES, V37, P73, DOI 10.1016/S0163-7827(98)00005-8; Torstensen B.E., 2010, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	69	46	48	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76570	10.1371/journal.pone.0076570	http://dx.doi.org/10.1371/journal.pone.0076570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124573	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100130
J	van der Wal, A; Tecon, R; Kreft, JU; Mooij, WM; Leveau, JHJ				van der Wal, Annemieke; Tecon, Robin; Kreft, Jan-Ulrich; Mooij, Wolf M.; Leveau, Johan H. J.			Explaining Bacterial Dispersion on Leaf Surfaces with an Individual-Based Model (PHYLLOSIM)	PLOS ONE			English	Article							PLANT-MICROBE INTERACTIONS; PSEUDOMONAS-SYRINGAE; BIOFILM FORMATION; WATER AVAILABILITY; GROWTH; DETACHMENT; DIFFUSION; MOTILITY; COLONIZATION; CUTICLES	We developed the individual-based model PHYLLOSIM to explain observed variation in the size of bacterial clusters on plant leaf surfaces (the phyllosphere). Specifically, we tested how different 'waterscapes' impacted the diffusion of nutrients from the leaf interior to the surface and the growth of individual bacteria on these nutrients. In the 'null' model or more complex 'patchy' models, the surface was covered with a continuous water film or with water drops of equal or different volumes, respectively. While these models predicted the growth of individual bacterial immigrants into clusters of variable sizes, they were unable to reproduce experimentally derived, previously published patterns of dispersion which were characterized by a much larger variation in cluster sizes and a disproportionate occurrence of clusters consisting of only one or two bacteria. The fit of model predictions to experimental data was about equally poor (<5%) regardless of whether the water films were continuous or patchy. Only by allowing individual bacteria to detach from developing clusters and re-attach elsewhere to start a new cluster, did PHYLLOSIM come much closer to reproducing experimental observations. The goodness of fit including detachment increased to about 70-80% for all waterscapes. Predictions of this 'detachment' model were further supported by the visualization and quantification of bacterial detachment and attachment events at an agarose-water interface. Thus, both model and experiment suggest that detachment of bacterial cells from clusters is an important mechanism underlying bacterial exploration of the phyllosphere.	[van der Wal, Annemieke; Tecon, Robin; Leveau, Johan H. J.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Tecon, Robin; Leveau, Johan H. J.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Tecon, Robin] Univ Birmingham, Sch Biosci, Ctr Syst Biol, Birmingham, W Midlands, England; [Mooij, Wolf M.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Mooij, Wolf M.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of California System; University of California Davis; University of Birmingham; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Leveau, JHJ (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	jleveau@ucdavis.edu	van der Wal, Annemieke/F-7411-2012; Leveau, Johan HJ/C-1096-2012; Tecon, Robin/B-2906-2011; Kreft, Jan-Ulrich/B-1234-2008; Mooij, Wolf M/C-2677-2008; KNAW, NIOO-KNAW/A-4320-2012	van der Wal, Annemieke/0000-0003-0261-1203; Leveau, Johan HJ/0000-0002-8376-4553; Tecon, Robin/0000-0002-5665-3073; Kreft, Jan-Ulrich/0000-0002-2351-224X; Mooij, Wolf M/0000-0001-5586-8200; KNAW, NIOO-KNAW/0000-0002-3835-159X	VIDI grant from The Netherlands Organisation for Scientific Research (NWO) [864.06.002]; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation; National Centre for the Replacement [NC/K000683/1] Funding Source: researchfish	VIDI grant from The Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Centre for the Replacement	This work was funded through VIDI grant 864.06.002 (LEVEAU) from The Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell CA, 2002, APPL ENVIRON MICROB, V68, P4604, DOI 10.1128/AEM.68.9.4604-4612.2002; Beattie GA, 2011, ANNU REV PHYTOPATHOL, V49, P533, DOI 10.1146/annurev-phyto-073009-114436; Benedek GB, 2000, PHYS ILLUSTRATIVE EX; BREWER CA, 1991, PLANT CELL ENVIRON, V14, P955, DOI 10.1111/j.1365-3040.1991.tb00965.x; BUNSTER L, 1989, APPL ENVIRON MICROB, V55, P1340, DOI 10.1128/AEM.55.6.1340-1345.1989; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Dens EJ, 2005, INT J FOOD MICROBIOL, V101, P319, DOI 10.1016/j.ijfoodmicro.2004.11.017; Dulla G, 2008, P NATL ACAD SCI USA, V105, P3082, DOI 10.1073/pnas.0711723105; Elfwing A, 2004, APPL ENVIRON MICROB, V70, P675, DOI 10.1128/AEM.70.2.675-678.2004; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hirano SS, 1996, APPL ENVIRON MICROB, V62, P2560, DOI 10.1128/AEM.62.7.2560-2566.1996; Joyner DC, 2000, MICROBIOL-UK, V146, P2435, DOI 10.1099/00221287-146-10-2435; Knoll D, 2000, MICROB ECOL, V40, P33, DOI 10.1007/s002480000012; LEBEN C, 1970, PHYTOPATHOLOGY, V60, P677, DOI 10.1094/Phyto-60-677; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Leveau JHJ, 2006, ANNU PLANT REV, V23, P334; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; LOHAUS G, 1995, BOT ACTA, V108, P270, DOI 10.1111/j.1438-8677.1995.tb00860.x; Monier J. M., 2006, Microbial ecology of aerial plant surfaces, P83, DOI 10.1079/9781845930615.0083; Monier JM, 2004, APPL ENVIRON MICROB, V70, P346, DOI 10.1128/AEM.70.1.346-355.2004; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Perez-Velazquez J, 2012, MATH BIOSCI, V239, P106, DOI 10.1016/j.mbs.2012.04.009; Picioreanu C, 2007, WATER SCI TECHNOL, V55, P337, DOI 10.2166/wst.2007.275; Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Remus-Emsermann MNP, 2010, ISME J, V4, P215, DOI 10.1038/ismej.2009.110; Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Schonherr J, 1996, CUTICLE PERMEABILITY; Schreiber L, 2005, ANN BOT-LONDON, V95, P1069, DOI 10.1093/aob/mci122; Schreiber L, 2005, NEW PHYTOL, V166, P589, DOI 10.1111/j.1469-8137.2005.01343.x; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Stein W., 1990, CHANNELS CARRIERS PU; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Tecon R, 2012, ENVIRON MICROBIOL, V14, P1325, DOI 10.1111/j.1462-2920.2012.02715.x; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; TUKEY HB, 1966, B TORREY BOT CLUB, V93, P385, DOI 10.2307/2483411; van der Wal A, 2011, ENVIRON MICROBIOL, V13, P792, DOI 10.1111/j.1462-2920.2010.02382.x; Wang G, 2013, ISME J, V7, P395, DOI 10.1038/ismej.2012.115; Wilensky U., 1999, NETLOGO; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110	46	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75633	10.1371/journal.pone.0075633	http://dx.doi.org/10.1371/journal.pone.0075633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124501	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100058
J	Dobler, CC; Luu, Q; Marks, GB				Dobler, Claudia C.; Luu, Queenie; Marks, Guy B.			What Patient Factors Predict Physicians' Decision Not to Treat Latent Tuberculosis Infection in Tuberculosis Contacts?	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; UNITED-STATES; RISK; HEPATOTOXICITY; TRANSMISSION; POPULATION; REACTIVITY; AUSTRALIA; ATTITUDES; HEPATITIS	Objective: The study aimed to determine factors that are associated with physicians' decision to offer treatment for latent tuberculosis infection (LTBI) in contacts of patients with tuberculosis. Methods: We performed a nested case-control study in a cohort of contacts of patients with pulmonary tuberculosis who had a tuberculin skin test (TST) >= 10 mm. Cases were those who were offered treatment for LTBI. Controls were randomly selected from those who were not offered treatment for LTBI by the reviewing physician. Odds ratios were estimated by multivariate logistic regression. Results: There were 195 cases and 279 controls. The following factors were significantly (positively or negatively) associated with being offered LTBI treatment in the multivariate analysis: female gender (OR 2.9; 95% CI 1.6-5.5), TST conversion (OR 3.9; 2.0-7.9), TST > 20 mm (OR 4.1; 1.8-9.1, for TST of 21-30 mm and OR 7.9; 2.6-23.8, for TST > 30 mm), sputum smear positive index case (OR 12.7; 4.5-36.1), being overseas-born and immigration more than 2 years ago (OR 0.1; 0.06-0.3), being a health care worker (OR 0.2; 0.1-0.6), being a non-household contact of the TB index case (OR 0.3; 0.2-0.6) and age >35 years (OR 0.2; 0.1-0.5 for age 35 to 54.9 years and OR 0.04; 0.01-0.2 for age >= 55 years). Previous BCG vaccine and chest x-ray findings were not significantly associated with physicians' decision to offer treatment for LTBI. Conclusions: Most factors that influenced physicians' decisions on treatment for LTBI were based on evidence of an association with risk of developing TB or risk of having an adverse reaction to treatment for LTBI. However, the decreased likelihood of offering treatment for LTBI to people born overseas, men and health care workers, was apparently not based on any evidence of risk. Efforts should be made to ensure that these groups are given access to treatment for LTBI.	[Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Luu, Queenie; Marks, Guy B.] Univ New S Wales, Liverpool Hosp, Dept Resp Med, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Liverpool Hospital; University of New South Wales Sydney	Dobler, CC (corresponding author), Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.	cdobler@med.usyd.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Dobler, Claudia/0000-0002-5460-0189	University of Sydney	University of Sydney(University of Sydney)	CCD is supported by a University of Sydney Postgraduate Award Scholarship. There was no other study funding. The funders of the research scholarship had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011; Barry C, 2012, COMMUN DIS INTELL, V36, P82; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Bhanot N, 2012, INT J TUBERC LUNG D, V16, P169, DOI 10.5588/ijtld.11.0232; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Colson PW, 2013, INT J TUBERC LUNG D, V17, P473, DOI 10.5588/ijtld.12.0697; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Dobler Claudia C, 2013, N S W Public Health Bull, V24, P34, DOI 10.1071/NB12099; Dobler CC, 2013, EUR RESPIR J, V41, P1459, DOI 10.1183/09031936.00183812; Dobler CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048900; Dobler CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029563; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; FRANKS AL, 1989, PUBLIC HEALTH REP, V104, P151; Gershon AS, 2004, CLIN INFECT DIS, V39, P667, DOI 10.1086/422995; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2006, INT J TUBERC LUNG D, V10, P1178; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; JOHNSON H, 1995, TUBERCLE LUNG DIS, V76, P122, DOI 10.1016/0962-8479(95)90553-7; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Kunst H, 2010, INT J TUBERC LUNG D, V14, P1374; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Moran-Mendoza O, 2007, INT J TUBERC LUNG D, V11, P1014; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; NSW Department of Health, 2005, POL DIR PREV THER; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76552	10.1371/journal.pone.0076552	http://dx.doi.org/10.1371/journal.pone.0076552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098794	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500165
J	Wang, G; Edwards, H; Caldwell, JT; Buck, SA; Qing, WY; Taub, JW; Ge, YB; Wang, ZH				Wang, Guan; Edwards, Holly; Caldwell, J. Timothy; Buck, Steven A.; Qing, William Y.; Taub, Jeffrey W.; Ge, Yubin; Wang, Zhihong			Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; PLASMA-CONCENTRATIONS; VALPROIC ACID; PHASE-I; CHILDREN; PHARMACOKINETICS; THERAPY; CANCER	High-risk neuroblastoma remains a therapeutic challenge with a long-term survival rate of less than 40%. Therefore, new agents are urgently needed to overcome chemotherapy resistance so as to improve the treatment outcome of this deadly disease. Histone deacetylase (HDAC) inhibitors (HDACIs) represent a novel class of anticancer drugs. Recent studies demonstrated that HDACIs can down-regulate the CHK1 pathway by which cancer cells can develop resistance to conventional chemotherapy drugs. This prompted our hypothesis that combining HDACIs with DNA damaging chemotherapeutic drugs for treating neuroblastoma would result in enhanced anti-tumor activities of these drugs. Treatment of high-risk neuroblastoma cell lines with a novel pan-HDACI, panobinostat (LBH589), resulted in dose-dependent growth arrest and apoptosis in 4 high-risk neuroblastoma cell lines. Further, the combination of panobinostat with cisplatin, doxorubicin, or etoposide resulted in highly synergistic antitumor interactions in the high-risk neuroblastoma cell lines, independent of the sequence of drug administration. This was accompanied by cooperative induction of apoptosis. Furthermore, panobinostat treatment resulted in substantial down-regulation of CHK1 and its downstream pathway and abrogation of the G2 cell cycle checkpoint. Synergistic antitumor interactions were also observed when the DNA damaging agents were combined with a CHK1-specific inhibitor, LY2603618. Contrary to panobinostat treatment, LY2603618 treatments neither resulted in abrogation of the G2 cell cycle checkpoint nor enhanced cisplatin, doxorubicin, or etoposide-induced apoptosis in the high-risk neuroblastoma cells. Surprisingly, LY2603618 treatments caused substantial down-regulation of total CDK1. Despite this discrepancy between panobinostat and LY2603618, our results indicate that suppression of the CHK1 pathway by panobinostat is at least partially responsible for the synergistic antitumor interactions between panobinostat and the DNA damaging agents in high-risk neuroblastoma cells. The results of this study provide a rationale for clinical evaluation of the combination of panobinostat and cisplatin, doxorubicin, or etoposide for treating children with high-risk neuroblastoma.	[Wang, Guan; Taub, Jeffrey W.; Wang, Zhihong] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Wang, Guan; Ge, Yubin] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Edwards, Holly; Qing, William Y.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Edwards, Holly; Qing, William Y.; Ge, Yubin] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; [Caldwell, J. Timothy] Wayne State Univ, Sch Med, MD PhD Program, Detroit, MI USA; [Caldwell, J. Timothy] Wayne State Univ, Sch Med, Canc Biol Program, Detroit, MI USA; [Buck, Steven A.; Taub, Jeffrey W.; Wang, Zhihong] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA	Wayne State University; Jilin University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Children's Hospital of Michigan	Ge, YB (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China.	gey@karmanos.org; Jwang2@med.wayne.edu		Ge, Yubin/0000-0002-8748-716X	Barbara Ann Karmanos Cancer Institute; Hyundai Hope on Wheels; Herrick Foundation; Leukemia Research Life; Ring Screw Textron Endowed Chair for Pediatric Cancer Research; National Cancer Institute [T32 CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531] Funding Source: NIH RePORTER	Barbara Ann Karmanos Cancer Institute; Hyundai Hope on Wheels; Herrick Foundation; Leukemia Research Life; Ring Screw Textron Endowed Chair for Pediatric Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a Start-up Fund from the Barbara Ann Karmanos Cancer Institute, grants from Hyundai Hope on Wheels, the Herrick Foundation, Leukemia Research Life, and the Ring Screw Textron Endowed Chair for Pediatric Cancer Research. Mr. JTC is a predoctoral trainee supported by T32 CA009531 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Brazelle W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014335; BRODEUR GM, 1981, CANCER RES, V41, P4678; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Garcia-Manero G, 2008, BLOOD, V112, P981, DOI 10.1182/blood-2007-10-115873; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; GILBERT F, 1984, CANCER RES, V44, P5444; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Gimsing P, 2008, EUR J HAEMATOL, V81, P170, DOI 10.1111/j.1600-0609.2008.01102.x; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; Goodisman J, 2006, J CLIN PHARMACOL, V46, P443, DOI 10.1177/0091270006286793; HALPERIN EC, 1986, INT J RADIAT ONCOL, V12, P1829, DOI 10.1016/0360-3016(86)90326-3; Hara J, 2012, INT J CLIN ONCOL, V17, P196, DOI 10.1007/s10147-012-0417-5; Hempel G, 2002, CANCER CHEMOTH PHARM, V49, P133, DOI 10.1007/s00280-001-0392-4; Kato Y, 2003, PEDIATR INT, V45, P74, DOI 10.1046/j.1442-200X.2003.01675.x; Klimek VM, 2008, CLIN CANCER RES, V14, P826, DOI 10.1158/1078-0432.CCR-07-0318; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Modak S, 2010, CANCER TREAT REV, V36, P307, DOI 10.1016/j.ctrv.2010.02.006; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Russo C, 1997, MED PEDIATR ONCOL, V28, P284, DOI 10.1002/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E; Wang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052095; Weiss GJ, 2013, INVEST NEW DRUG, V31, P136, DOI 10.1007/s10637-012-9815-9; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Xu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017138; ZAIZEN Y, 1993, J PEDIATR SURG, V28, P766, DOI 10.1016/0022-3468(93)90321-B	33	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76662	10.1371/journal.pone.0076662	http://dx.doi.org/10.1371/journal.pone.0076662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098799	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500170
J	Alvarez-Perez, S; de Vega, C; Herrera, CM				Alvarez-Perez, Sergio; de Vega, Clara; Herrera, Carlos M.			Multilocus Sequence Analysis of Nectar Pseudomonads Reveals High Genetic Diversity and Contrasting Recombination Patterns	PLOS ONE			English	Article							FLORAL NECTAR; MAXIMUM-LIKELIHOOD; SP NOV.; MOSAIC STRUCTURE; FIRE BLIGHT; ECOLOGY; YEASTS; COMMUNITIES; CLONALITY; FLOWERS	The genetic and evolutionary relationships among floral nectar-dwelling Pseudomonas 'sensu stricto' isolates associated to South African and Mediterranean plants were investigated by multilocus sequence analysis (MLSA) of four core housekeeping genes (rrs, gyrB, rpoB and rpoD). A total of 35 different sequence types were found for the 38 nectar bacterial isolates characterised. Phylogenetic analyses resulted in the identification of three main clades [nectar groups (NGs) 1, 2 and 3] of nectar pseudomonads, which were closely related to five intrageneric groups: Pseudomonas oryzihabitans (NG 1); P. fluorescens, P. lutea and P. syringae (NG 2); and P. rhizosphaerae (NG 3). Linkage disequilibrium analysis pointed to a mostly clonal population structure, even when the analysis was restricted to isolates from the same floristic region or belonging to the same NG. Nevertheless, signatures of recombination were observed for NG 3, which exclusively included isolates retrieved from the floral nectar of insect-pollinated Mediterranean plants. In contrast, the other two NGs comprised both South African and Mediterranean isolates. Analyses relating diversification to floristic region and pollinator type revealed that there has been more unique evolution of the nectar pseudomonads within the Mediterranean region than would be expected by chance. This is the first work analysing the sequence of multiple loci to reveal geno- and ecotypes of nectar bacteria.	[Alvarez-Perez, Sergio; de Vega, Clara; Herrera, Carlos M.] CSIC, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Alvarez-Perez, S (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.	sealperez@gmail.com	Herrera, Carlos/AAS-3831-2020; Álvarez-Pérez, Sergio/H-6342-2019; Herrera, Carlos M/A-4088-2008; de Vega, Clara/AAQ-8839-2021; de Vega, Clara/A-5822-2012; Álvarez-Pérez, Sergio/J-5737-2016	Herrera, Carlos/0000-0003-2452-3888; Álvarez-Pérez, Sergio/0000-0002-6587-8995; Herrera, Carlos M/0000-0003-2452-3888; de Vega, Clara/0000-0003-4553-798X; de Vega, Clara/0000-0003-4553-798X; Álvarez-Pérez, Sergio/0000-0002-6587-8995	Ministerio de Ciencia e Innovacion; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia) [P09-RNM- 4517]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia)(Junta de Andalucia)	This work was supported by funds from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia P09-RNM- 4517 to C. M. H.), and Ministerio de Ciencia e Innovacion (Juan de la Cierva Program to C.dV.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Alvarez-Perez S, 2013, INT J SYST EVOL MICR, V63, P1532, DOI 10.1099/ijs.0.043489-0; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; Belisle M, 2012, MICROB ECOL, V63, P711, DOI 10.1007/s00248-011-9975-8; Bodilis J, 2011, MOL BIOL EVOL, V28, P2723, DOI 10.1093/molbev/msr099; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brysch-Herzberg M, 2004, FEMS MICROBIOL ECOL, V50, P87, DOI 10.1016/j.femsec.2004.06.003; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cladera AM, 2004, J BACTERIOL, V186, P5239, DOI 10.1128/JB.186.16.5239-5248.2004; Coenye T, 2003, MICROBIOL-SGM, V149, P77, DOI 10.1099/mic.0.25850-0; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; de Vega C, 2013, AM J BOT, V100, P792, DOI 10.3732/ajb.1200626; de Vega C, 2012, OIKOS, V121, P1878, DOI 10.1111/j.1600-0706.2012.20295.x; de Vega C, 2012, INT J SYST EVOL MICR, V62, P2538, DOI 10.1099/ijs.0.040790-0; de Vega C, 2009, S AFR J BOT, V75, P798, DOI 10.1016/j.sajb.2009.07.016; den Bakker HC, 2010, MOL BIOL EVOL, V27, P2474, DOI 10.1093/molbev/msq155; DEVOS P, 1989, INT J SYST BACTERIOL, V39, P35, DOI 10.1099/00207713-39-1-35; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escalante-Perez M, 2012, PROGR BOT, V74, P239; Farkas A, 2012, TREES-STRUCT FUNCT, V26, P47, DOI 10.1007/s00468-011-0627-x; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Frapolli M, 2012, MOL PHYLOGENET EVOL, V63, P877, DOI 10.1016/j.ympev.2012.02.030; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gimenez-Jurado G, 2003, INT J SYST EVOL MICR, V53, P1665, DOI 10.1099/ijs.0.02470-0; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hao Weilong, 2013, Mob Genet Elements, V3, pe23463; Hasiow-Jaroszewska B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-318; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2011, MOL ECOL, V20, P4395, DOI 10.1111/j.1365-294X.2011.05217.x; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Herrera CM, 2013, ECOLOGY, V94, P273, DOI 10.1890/12-0595.1; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P1827, DOI 10.1098/rspb.2009.2252; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jacquemyn H, 2013, MICROBIOLOGYOPEN, V2, P644, DOI 10.1002/mbo3.103; Jacquemyn H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056917; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KINKEL LL, 1987, OECOLOGIA, V71, P405, DOI 10.1007/BF00378714; Lau JA, 2011, NEW PHYTOL, V192, P215, DOI 10.1111/j.1469-8137.2011.03790.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Manson JS, 2007, ANTON LEEUW INT J G, V92, P37, DOI 10.1007/s10482-006-9132-4; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McVean G, 2002, GENETICS, V160, P1231; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Moore ERB, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P646, DOI 10.1007/0-387-30746-x_21; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Octavia S, 2006, MICROBIOL-SGM, V152, P1099, DOI 10.1099/mic.0.28486-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pozo MI, 2012, FEMS MICROBIOL ECOL, V80, P281, DOI 10.1111/j.1574-6941.2011.01286.x; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; Pusey PL, 1999, PHYTOPATHOLOGY, V89, P39, DOI 10.1094/PHYTO.1999.89.1.39; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryss AY, 2011, ENTOMOLOGICAL REV, V91, P908; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sasu MA, 2010, AM J BOT, V97, P1025, DOI 10.3732/ajb.0900381; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; SMITH JM, 1992, J MOL EVOL, V34, P126; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sorokin A, 2006, APPL ENVIRON MICROB, V72, P1569, DOI 10.1128/AEM.72.2.1569-1578.2006; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; Wicker E, 2012, ISME J, V6, P961, DOI 10.1038/ismej.2011.160; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x	98	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75797	10.1371/journal.pone.0075797	http://dx.doi.org/10.1371/journal.pone.0075797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116076	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200039
J	Arroyave, J; Denton, JSS; Stiassny, MLJ				Arroyave, Jairo; Denton, John S. S.; Stiassny, Melanie L. J.			Are characiform Fishes Gondwanan in Origin? Insights from a Time-Scaled Molecular Phylogeny of the Citharinoidei (Ostariophysi: Characiformes)	PLOS ONE			English	Article							MULTIPLE FOSSIL CALIBRATIONS; DIVERGENCE TIMES; EVOLUTIONARY TREES; BIOGEOGRAPHY; MODEL; MITOCHONDRIAL; TELEOSTEI; SEQUENCE; NUCLEAR; UNCERTAINTY	Fishes of the order Characiformes are a diverse and economically important teleost clade whose extant members are found exclusively in African and Neotropical freshwaters. Although their transatlantic distribution has been primarily attributed to the Early Cretaceous fragmentation of western Gondwana, vicariance has not been tested with temporal information beyond that contained in their fragmentary fossil record and a recent time-scaled phylogeny focused on the African family Alestidae. Because members of the suborder Citharinoidei constitute the sister lineage to the entire remaining Afro-Neotropical characiform radiation, we inferred a time-calibrated molecular phylogeny of citharinoids using a popular Bayesian approach to molecular dating in order to assess the adequacy of current vicariance hypotheses and shed light on the early biogeographic history of characiform fishes. Given that the only comprehensive phylogenetic treatment of the Citharinoidei has been a morphology-based analysis published over three decades ago, the present study also provided an opportunity to further investigate citharinoid relationships and update the evolutionary framework that has laid the foundations for the current classification of the group. The inferred chronogram is robust to changes in calibration priors and suggests that the origins of citharinoids date back to the Turonian (ca 90 Ma) of the Late Cretaceous. Most modern citharinoid genera, however, appear to have originated and diversified much more recently, mainly during the Miocene. By reconciling molecular-clock-with fossil-based estimates for the origins of the Characiformes, our results provide further support for the hypothesis that attributes the disjunct distribution of the order to the opening of the South Atlantic Ocean. The striking overlap in tempo of diversification and biogeographic patterns between citharinoids and the African-endemic family Alestidae suggests that their evolutionary histories could have been strongly and similarly influenced by Miocene geotectonic events that modified the landscape and produced the drainage pattern of Central Africa seen today.	[Arroyave, Jairo; Denton, John S. S.; Stiassny, Melanie L. J.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA; [Arroyave, Jairo] CUNY, Grad Sch, Dept Biol, New York, NY USA; [Arroyave, Jairo] CUNY, Univ Ctr, New York, NY 10021 USA; [Denton, John S. S.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA	American Museum of Natural History (AMNH); City University of New York (CUNY) System; City University of New York (CUNY) System; American Museum of Natural History (AMNH)	Arroyave, J (corresponding author), Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA.	jarroyave@amnh.org	Arroyave, Jairo/AAS-5895-2020	Arroyave, Jairo/0000-0002-5389-1789	AMNH Graduate Student Fellowship; CUNY Science Fellowship; AMNH-RGGS Student Fellowship; Axelrod Research Curatorship; NSF [DEB-0542540]	AMNH Graduate Student Fellowship; CUNY Science Fellowship; AMNH-RGGS Student Fellowship; Axelrod Research Curatorship; NSF(National Science Foundation (NSF))	This research was financially supported by an AMNH Graduate Student Fellowship and a CUNY Science Fellowship to JA, and by an AMNH-RGGS Student Fellowship to JSSD. Funding for supplies and field collections was provided by The Axelrod Research Curatorship and NSF grant DEB-0542540 to MLJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Arroyave J, 2011, MOL PHYLOGENET EVOL, V60, P385, DOI 10.1016/j.ympev.2011.04.016; Beadle L.C., 1974, INLAND WATERS TROPIC, DOI [10.4319/lo.1977.22.5.0972b, DOI 10.4319/LO.1977.22.5.0972B]; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Boulenger GA, 1915, CATALOGUE FRESH WATE; Brady Sean, 2011, American Entomologist, V57, P56; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; BRUNDIN L, 1965, EVOLUTION, V19, P496, DOI 10.2307/2406246; BUCKUP PA, 1991, THESIS U MICHIGAN; Buckup Paulo Andreas, 1998, P123; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; CAREY SW, 1959, TECTONIC APPROACH CO; Chakrabarty P, 2004, FISH FISH, V5, P97, DOI 10.1111/j.1467-2979.2004.00148.x; Chakrabarty P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044083; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Chen WJ, 2013, EVOLUTION, V67, P2218, DOI 10.1111/evo.12104; COENEN E J, 1989, Cybium, V13, P311; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Daget J., 1960, Revue de Zoologie et de Botanique Africaines, V61, P35; Dahdul WM, 2010, SER TELEOST FISH BIO, P441; Day JJ, 2013, SYST BIOL, V62, P351, DOI 10.1093/sysbio/syt001; Donoghue MJ, 2003, INTEGR COMP BIOL, V43, P261, DOI 10.1093/icb/43.2.261; Doucoure CM, 2003, J AFR EARTH SCI, V36, P371, DOI 10.1016/S0899-5362(03)00019-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUTHEIL DB, 1999, MESOZOIC FISHES, V2, P553; Eigenmann C.H., 1909, REPORTS PRINCETON U, V3(3), P225; ESCHMEYER WN, 2013, ATALOG FISHES CALIFO; Eschmeyer WN, 2013, SPECIES FAMILY SUBFA; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; Feibel C.S., 2003, LOTHAGAM DAWN HUMANI, P17; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1982, Q REV BIOL, V57, P379, DOI 10.1086/412935; Filleul A, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)455<0001:ROSDOC>2.0.CO;2; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; George W., 1964, GEOBIOS; Gery Jacques, 2003, Zoologische Abhandlungen (Dresden), V53, P37; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Goudie AS, 2005, GEOMORPHOLOGY, V67, P437, DOI 10.1016/j.geomorph.2004.11.008; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; GREGORY WILLIAM K., 1938, ZOOLOGICA [NEW YORK], V23, P319; Harrison T, 2001, T GEOBIOL, V18, P39; Heath TA, 2012, SYST BIOL, V61, P793, DOI 10.1093/sysbio/sys032; Hennig W., 1966, P263; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LEPICHON X, 1968, J GEOPHYS RES, V73, P3661, DOI 10.1029/JB073i012p03661; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Linder HP, 1995, CLADISTICS, V11, P5, DOI 10.1111/j.1096-0031.1995.tb00002.x; Lipscomb D., 1998, BASICS CLADISTIC ANA; Lloyd GT, 2012, SYST BIOL, V61, P80, DOI 10.1093/sysbio/syr076; Lovejoy NR, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P405; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; MAISEY JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P435; Maisey JG, 2000, CRETACEOUS RES, V21, P281, DOI 10.1006/cres.1999.0195; Malbarba Maria Claudia, 2010, P317; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; McDougall I, 1999, J GEOL SOC LONDON, V156, P731, DOI 10.1144/gsjgs.156.4.0731; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Miller M.A., 2010, P GAT COMP ENV WORKS; Monod T., 1950, Bull Inst franY Afrique noire, V12, P1; Murray AM, 2003, J VERTEBR PALEONTOL, V23, P501, DOI 10.1671/1854; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; NELSON G, 1980, BIOSCIENCE, V30, P339, DOI 10.2307/1307856; Nelson G., 1981, SYSTEMATICS BIOGEORA; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nickum J. G., 2004, GUIDELINES USE FISHE; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637; Otero O, 2008, GEOL SOC SPEC PUBL, V295, P155, DOI 10.1144/SP295.10; PAGE RDM, 1990, SYST ZOOL, V39, P205, DOI 10.2307/2992182; POLL M, 1963, REVISION GENRES NANN; Poll M., 1973, B MUS UM NATL DHISTO, V150, P113; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; REGAN CT, 1911, J NAT HIST, V8, P13; Roberts T.R., 1990, Ichthyological Exploration of Freshwaters, V1, P23; ROBERTS TR, 1967, BULLETIN, V18, P251; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruber L, 2004, MOL PHYLOGENET EVOL, V32, P1010, DOI 10.1016/j.ympev.2004.04.020; Runge J., 2008, LARGE RIVERS GEOMORP, P293; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schwarzer J, 2012, P ROY SOC B-BIOL SCI, V279, P4389, DOI 10.1098/rspb.2012.1667; SEBERG O, 1991, Australian Systematic Botany, V4, P127, DOI 10.1071/SB9910127; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stankiewicz J, 2006, J AFR EARTH SCI, V44, P75, DOI 10.1016/j.jafrearsci.2005.11.008; Stewart Kathlyn M., 2003, P75; Stewart KM, 2001, FISH FISH, V2, P177, DOI 10.1046/j.1467-2960.2001.00052.x; STIASSNY MLJ, 2013, ZOOTAXA IN PRESS; Swofford David L., 1990, P411; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VARI R P, 1981, Proceedings of the Biological Society of Washington, V94, P1076; Vari R.P., 1979, Bulletin of the British Museum (Natural History) Zoology, V36, P261; Vari RP, 2004, P BIOL SOC WASH, V117, P551; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Weitzman S, 1998, ENCY FISHES, P101; Werner Christa, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P221; WILEY EO, 1988, ANNU REV ECOL SYST, V19, P513, DOI 10.1146/annurev.es.19.110188.002501; Wiley EO, 2011, PHYLOGENETICS THEORY; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	130	35	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77269	10.1371/journal.pone.0077269	http://dx.doi.org/10.1371/journal.pone.0077269			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116219	gold, Green Published			2022-12-27	WOS:000325552200111
J	Maaswinkel, H; Zhu, LQ; Weng, W				Maaswinkel, Hans; Zhu, Liqun; Weng, Wei			Assessing Social Engagement in Heterogeneous Groups of Zebrafish: A New Paradigm for Autism-Like Behavioral Responses	PLOS ONE			English	Article							DANIO-RERIO; CIRCLING BEHAVIOR; NEGATIVE SYMPTOMS; MK-801; ANTAGONIST; BUSPIRONE; MODEL; RATS; SCHIZOPHRENIA; DISRUPTION	Because of its highly developed social character, zebrafish is a promising model system for the study of the genetic and neurochemical basis of altered social engagement such as is common in autism and schizophrenia. The traditional shoaling paradigm investigates social cohesion in homogeneous groups of zebrafish. However, the social dynamics of mixed groups is gaining interest from a therapeutic point of view and thus warrants animal modeling. Furthermore, mutant zebrafish are not always available in large numbers. Therefore, we developed a new paradigm that allows exploring shoaling in heterogeneous groups. The effects of MK-801, a non-competitive antagonist of the glutamate N-methyl-D-aspartate (NMDA) receptor, on social cohesion were studied to evaluate the paradigm. The drug has previously been shown to mimic aspects of autism and schizophrenia. Our results show that a single MK-801-treated zebrafish reduced social cohesion of the entire shoal drastically. Preliminary observations suggest that the social dynamics of the shoal as a whole was altered.	[Maaswinkel, Hans; Zhu, Liqun; Weng, Wei] XyZfish, Res & Dev, Ronkonkoma, NY USA		Maaswinkel, H (corresponding author), XyZfish, Res & Dev, Ronkonkoma, NY USA.	hmaaswinkel@xyzfish.com	Zhu, Li/GXH-9801-2022					Akillioglu K, 2012, BEHAV BRAIN RES, V233, P157, DOI 10.1016/j.bbr.2012.04.041; Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931; Brosda J, 2011, PHARMACOL BIOCHEM BE, V99, P22, DOI 10.1016/j.pbb.2011.03.017; Burket JA, 2010, BRAIN RES BULL, V83, P337, DOI 10.1016/j.brainresbull.2010.08.014; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Chen John, 2010, Int J Comp Psychol, V23, P82; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; Cognato GD, 2012, NEUROBIOL LEARN MEM, V98, P321, DOI 10.1016/j.nlm.2012.09.008; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Dvorkin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000638; Echevarria DJ., 2008, INT J COMP PSYCHOL, V21, P19; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Green J, 2012, J NEUROSCI METH, V210, P266, DOI 10.1016/j.jneumeth.2012.07.017; Gururajan A, 2012, J PSYCHOPHARMACOL, V26, P1317, DOI 10.1177/0269881112441865; Horder J, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.53; Krause J, 1999, ANIM BEHAV, V57, P771, DOI 10.1006/anbe.1998.1010; Lindeyer CM, 2010, ANIM BEHAV, V79, P827, DOI 10.1016/j.anbehav.2009.12.024; Maaswinkel H, JOVE IN PRESS; Maaswinkel H, 2013, PHARMACOL BIOCHEM BE, V108, P16, DOI 10.1016/j.pbb.2013.04.009; Maaswinkel H, 2012, BEHAV BRAIN RES, V234, P365, DOI 10.1016/j.bbr.2012.07.014; Maskey M, 2013, J AUTISM DEV DISORD, V43, P851, DOI 10.1007/s10803-012-1622-9; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; Matson JL, 2009, DEV NEUROREHABIL, V12, P122, DOI 10.1080/17518420902936730; Miller NY, 2011, REV NEUROSCIENCE, V22, P17, DOI 10.1515/RNS.2011.004; Moy SS, 2013, NEUROTOXICOL TERATOL, V36, P36, DOI 10.1016/j.ntt.2012.07.007; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; Ng MC, 2012, FISH PHYSIOL BIOCHEM, V38, P1099, DOI 10.1007/s10695-011-9595-8; O'Haire ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057010; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Philpott C, 2012, ZEBRAFISH, V9, P191, DOI 10.1089/zeb.2012.0764; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Rung JP, 2005, PROG NEURO-PSYCHOPH, V29, P827, DOI 10.1016/j.pnpbp.2005.03.004; Saunders JA, 2012, BEHAV BRAIN RES, V234, P233, DOI 10.1016/j.bbr.2012.06.032; Seibt KJ, 2011, BEHAV BRAIN RES, V224, P135, DOI 10.1016/j.bbr.2011.05.034; Sison M, 2011, NEUROBIOL LEARN MEM, V96, P230, DOI 10.1016/j.nlm.2011.04.016; Sison M, 2011, BEHAV BRAIN RES, V220, P331, DOI 10.1016/j.bbr.2011.02.019; Snekser JL., 2010, INT J COMP PSYCHOL, V23, P70; Solomon R, 2007, AUTISM, V11, P205, DOI 10.1177/1362361307076842; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Stewart A, 2010, BEHAV PROCESS, V85, P198, DOI 10.1016/j.beproc.2010.07.009; Swain HA, 2004, NEUROTOXICOL TERATOL, V26, P725, DOI 10.1016/j.ntt.2004.06.009; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Vital C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055503; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Zhu L., 2012, US Patent, Patent No. [8,306,260, 8306260]; Zhu LQ, 2007, PHYSIOL BEHAV, V91, P106, DOI 10.1016/j.physbeh.2007.01.023	51	38	39	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75955	10.1371/journal.pone.0075955	http://dx.doi.org/10.1371/journal.pone.0075955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116082	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200044
J	Raghavan, M; Amrutur, B; Narayanan, R; Sikdar, SK				Raghavan, Mohan; Amrutur, Bharadwaj; Narayanan, Rishikesh; Sikdar, Sujit Kumar			Synconset Waves and Chains: Spiking Onsets in Synchronous Populations Predict and Are Predicted by Network Structure	PLOS ONE			English	Article							GAMMA-OSCILLATIONS; NEURONAL ENSEMBLES; SENSORY RESPONSES; CORTICAL-NEURONS; IN-VIVO; CORTEX; MECHANISMS; DYNAMICS; RHYTHM; SYNCHRONIZATION	Synfire waves are propagating spike packets in synfire chains, which are feedforward chains embedded in random networks. Although synfire waves have proved to be effective quantification for network activity with clear relations to network structure, their utilities are largely limited to feedforward networks with low background activity. To overcome these shortcomings, we describe a novel generalisation of synfire waves, and define 'synconset wave' as a cascade of first spikes within a synchronisation event. Synconset waves would occur in 'synconset chains', which are feedforward chains embedded in possibly heavily recurrent networks with heavy background activity. We probed the utility of synconset waves using simulation of single compartment neuron network models with biophysically realistic conductances, and demonstrated that the spread of synconset waves directly follows from the network connectivity matrix and is modulated by top-down inputs and the resultant oscillations. Such synconset profiles lend intuitive insights into network organisation in terms of connection probabilities between various network regions rather than an adjacency matrix. To test this intuition, we develop a Bayesian likelihood function that quantifies the probability that an observed synfire wave was caused by a given network. Further, we demonstrate it's utility in the inverse problem of identifying the network that caused a given synfire wave. This method was effective even in highly subsampled networks where only a small subset of neurons were accessible, thus showing it's utility in experimental estimation of connectomes in real neuronal-networks. Together, we propose synconset chains/waves as an effective framework for understanding the impact of network structure on function, and as a step towards developing physiology-driven network identification methods. Finally, as synconset chains extend the utilities of synfire chains to arbitrary networks, we suggest utilities of our framework to several aspects of network physiology including cell assemblies, population codes, and oscillatory synchrony.	[Raghavan, Mohan; Amrutur, Bharadwaj] Indian Inst Sci, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India; [Narayanan, Rishikesh; Sikdar, Sujit Kumar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Raghavan, M (corresponding author), Indian Inst Sci, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India.	mohanr@ece.iisc.ernet.in	Narayanan, Rishikesh/C-3191-2009; Raghavan, Mohan/Y-8624-2019	Raghavan, Mohan/0000-0002-9196-8193; Narayanan, Rishikesh/0000-0002-1362-4635	MCIT (Ministry of Communication & Information Technology, Government of India) under project Centre for Excellence in Nanoelectronics - Phase II", Aeronautics and Research Development Board [DARO/08/2021551/M/I DTD 31/05/2010]; Department of Science and Technology, Mathematical Biology program at Indian Institute of Science (IISc) [SR/S4/MS419/07]	MCIT (Ministry of Communication & Information Technology, Government of India) under project Centre for Excellence in Nanoelectronics - Phase II", Aeronautics and Research Development Board; Department of Science and Technology, Mathematical Biology program at Indian Institute of Science (IISc)	The research was supported by grants from the MCIT (Ministry of Communication & Information Technology, Government of India) under the project Centre for Excellence in Nanoelectronics - Phase II", Aeronautics and Research Development Board (DARO/08/2021551/M/I DTD 31/05/2010) and Department of Science and Technology, Mathematical Biology program at Indian Institute of Science (IISc) (SR/S4/MS419/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assisi C, 2011, NEURON, V69, P373, DOI 10.1016/j.neuron.2010.12.019; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Aviel Y, 2002, NEUROCOMPUTING, V44, P285, DOI 10.1016/S0925-2312(02)00352-1; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bosking WH, 1997, J NEUROSCI, V17, P2112; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G., 2009, RHYTHMS BRAIN, DOI [10.1093/acprof:oso/9780195301069.001.0001, DOI 10.1093/ACPROF:OSO/9780195301069.001.0001]; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Gerhard Felipe, 2011, FRONTIERS COMPUTATIO, V5; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Havenith MN, 2011, J NEUROSCI, V31, P8570, DOI 10.1523/JNEUROSCI.2817-10.2011; Heil P, 1997, J NEUROPHYSIOL, V78, P2438, DOI 10.1152/jn.1997.78.5.2438; HERRMANN M, 1995, NETWORK-COMP NEURAL, V6, P403, DOI 10.1088/0954-898X/6/3/006; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Patnaik D, 2008, SCI PROGRAMMING-NETH, V16, P49, DOI [10.1155/2008/324626, 10.3233/SPR-2008-0242]; Raghavan M, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056002; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Shteingart H, 2010, FRONTIERS COMPUTATIO; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Takano H, 2012, J NEUROSCI, V32, P4743, DOI 10.1523/JNEUROSCI.4277-11.2012; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Trengove C, 2012, J COMPUTATIONAL NEUR, P1; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	53	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e74910	10.1371/journal.pone.0074910	http://dx.doi.org/10.1371/journal.pone.0074910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116018	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000325552200005
J	Liang, FF; Liu, CP; Li, LX; Xue, MM; Xie, F; Guo, Y; Bai, L				Liang, Fen-Fen; Liu, Cui-Ping; Li, Li-Xuan; Xue, Min-Min; Xie, Fang; Guo, Yu; Bai, Lan			Activated Effects of Parathyroid Hormone-Related Protein on Human Hepatic Stellate Cells	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; POSTMENOPAUSAL OSTEOPOROSIS; TGF-BETA; FIBROSIS; ENDOTOXIN; FIBROGENESIS; INJURY; ROLES; PTH	Background & Aims: After years of experiments and clinical studies, parathyroid hormone-related protein(PTHrP) has been shown to be a bone formation promoter that elicits rapid effects with limited adverse reaction. Recently, PTHrP was reported to promote fibrosis in rat kidney in conjunction with transforming growth factor-beta1 (TGF-beta 1), which is also a fibrosis promoter in liver. However, the effect of PTHrP in liver has not been determined. In this study, the promoting actions of PTHrP were first investigated in human normal hepatic stellate cells (HSC) and LX-2 cell lines. Methods: TGF-beta 1, alpha-smooth muscle actin (alpha-SMA), matrix metalloproteinase 2 (MMP-2), and collagen I mRNA were quantified by real-time polymerase chain reaction (PCR) after HSCs or LX-2 cells were treated with PTHrP(1-36) or TGF-beta 1. Protein levels were also assessed by western-blot analysis. Alpha-SMA were also detected by immunofluorescence, and TGF-beta 1 secretion was measured with enzyme-linked immunosorbent assay (ELISA) of HSC cell culture media. Results: In cultured human HSCs, mRNA and protein levels of alpha-SMA, collagen I, MMP-2, and TGF-beta 1 were increased by PTHrP treatment. A similar increasing pattern was also observed in LX-2 cells. Moreover, PTHrP significantly increased TGF-beta 1 secretion in cultured media from HSCs. Conclusions: PTHrP activated HSCs and promoted the fibrosis process in LX-2 cells. These procedures were probably mediated via TGF-beta 1, highlighting the potential effects of PTHrP in the liver.	[Liang, Fen-Fen; Liu, Cui-Ping; Li, Li-Xuan; Xue, Min-Min; Xie, Fang] Southern Med Univ, Guangdong Prov Key Lab Gastroenterol, Dept Gastroenterol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Guo, Yu; Bai, Lan] Southern Med Univ, Dept Huiqiao Bldg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Bai, L (corresponding author), Southern Med Univ, Dept Huiqiao Bldg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	bail42251@163.com			National Natural Scientific Foundation of China [81170354]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Scientific Foundation of China (#81170354) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura JA, 2010, J AM SOC NEPHROL, V21, P237, DOI 10.1681/ASN.2009050462; Ardura JA, 2008, AM J PHYSIOL-RENAL, V295, pF415, DOI 10.1152/ajprenal.00018.2008; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bisello A, 2004, ENDOCRINOLOGY, V145, P3551, DOI 10.1210/en.2004-0509; Breitkopf K, 2005, ALCOHOL CLIN EXP RES, V29, p121S, DOI 10.1097/01.alc.0000189284.98684.22; Collier JD, 2002, GUT, V50, P1; Fabrega E, 2000, DIGEST DIS SCI, V45, P703, DOI 10.1023/A:1005435424853; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Funk JL, 1996, MOL MED, V2, P204, DOI 10.1007/BF03401617; FUNK JL, 1993, J CLIN INVEST, V92, P2546, DOI 10.1172/JCI116864; Funk JL, 1997, ENDOCRINOLOGY, V138, P2665, DOI 10.1210/en.138.7.2665; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Henry JG, 1997, J CLIN ENDOCR METAB, V82, P900, DOI 10.1210/jc.82.3.900; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Horwitz MJ, 2010, J CLIN ENDOCR METAB, V95, P1279, DOI 10.1210/jc.2009-0233; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; KEMP BE, 1987, SCIENCE, V238, P1568, DOI 10.1126/science.3685995; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Liu CP, 2011, DIGEST DIS SCI, V56, P993, DOI 10.1007/s10620-010-1375-2; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; N JP, 1975, GASTROENTEROLOGY, V69, P1346; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; URENA P, 1993, ENDOCRINOLOGY, V133, P617, DOI 10.1210/en.133.2.617; Wolzt M, 1997, J CLIN ENDOCR METAB, V82, P2548, DOI 10.1210/jc.82.8.2548; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	30	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76517	10.1371/journal.pone.0076517	http://dx.doi.org/10.1371/journal.pone.0076517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116114	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300061
J	Mendivelso, HA; Camarero, JJ; Obregon, OR; Gutierrez, E; Toledo, M				Mendivelso, Hooz A.; Julio Camarero, J.; Royo Obregon, Oriol; Gutierrez, Emilia; Toledo, Marisol			Differential Growth Responses to Water Balance of Coexisting Deciduous Tree Species Are Linked to Wood Density in a Bolivian Tropical Dry Forest	PLOS ONE			English	Article							SEASONAL-VARIATION; LIFE-HISTORY; CANOPY TREES; PHENOLOGY; TRAITS; RATES; SOIL; CLIMATE; PERIODICITY; DIVERSITY	A seasonal period of water deficit characterizes tropical dry forests (TDFs). There, sympatric tree species exhibit a diversity of growth rates, functional traits, and responses to drought, suggesting that each species may possess different strategies to grow under different conditions of water availability. The evaluation of the long-term growth responses to changes in the soil water balance should provide an understanding of how and when coexisting tree species respond to water deficit in TDFs. Furthermore, such differential growth responses may be linked to functional traits related to water storage and conductance. We used dendrochronology and climate data to retrospectively assess how the radial growth of seven coexisting deciduous tree species responded to the seasonal soil water balance in a Bolivian TDF. Linear mixed-effects models were used to quantify the relationships between basal area increment and seasonal water balance. We related these relationships with wood density and sapwood production to assess if they affect the growth responses to climate. The growth of all species responded positively to water balance during the wet season, but such responses differed among species as a function of their wood density. For instance, species with a strong growth response to water availability averaged a low wood density which may facilitate the storage of water in the stem. By contrast, species with very dense wood were those whose growth was less sensitive to water availability. Coexisting tree species thus show differential growth responses to changes in soil water balance during the wet season. Our findings also provide a link between wood density, a trait related to the ability of trees to store water in the stem, and wood formation in response to water availability.	[Mendivelso, Hooz A.; Toledo, Marisol] Univ Autonoma Gabriel Rene Moreno, IBIF, Santa Cruz, Bolivia; [Mendivelso, Hooz A.; Julio Camarero, J.; Royo Obregon, Oriol] Inst Pirenaico Ecol CSIC, Zaragoza, Spain; [Julio Camarero, J.] Inst Pirenaico Ecol CSIC, ARAID, Zaragoza, Spain; [Julio Camarero, J.; Gutierrez, Emilia] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Camarero, JJ (corresponding author), Inst Pirenaico Ecol CSIC, Zaragoza, Spain.	jjcamarero@ipe.csic.es	Gutierrez, Emilia/O-7568-2014; Camarero, J. Julio/A-8602-2013	Gutierrez, Emilia/0000-0002-6085-5700; Camarero, J. Julio/0000-0003-2436-2922	BBVA Foundation; AECID [11-CAP2-1730]	BBVA Foundation(BBVA Foundation); AECID	This project was funded by BBVA Foundation project "Analisis retrospectivos mediante dendrocronologia para profundizar en la ecologia y mejorar la gestion de los bosques tropicales secos (Dentropicas)'' and AECID project "Regeneracion, crecimiento y modelos dinamicos de bosques tropicales secos: herramientas para su conservacion y para el uso sostenible de especies maderables" (11-CAP2-1730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TR, 2003, PERSPECT PLANT ECOL, V6, P21, DOI 10.1078/1433-8319-00040; Biondi F, 2008, TREE-RING RES, V64, P81, DOI 10.3959/2008-6.1; Borchert R, 1999, IAWA J, V20, P239, DOI 10.1163/22941932-90000687; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Bowman DMJS, 2013, TRENDS PLANT SCI, V18, P11, DOI 10.1016/j.tplants.2012.08.005; Brienen RJW, 2010, OECOLOGIA, V163, P485, DOI 10.1007/s00442-009-1540-5; Bullock Stephen H., 1995, P277, DOI 10.1017/CBO9780511753398.011; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Dirzo R, 2011, SEASONALLY DRY TROPI; Duchesne L, 2003, CAN J FOREST RES, V33, P2074, DOI 10.1139/X03-141; Eamus D, 1999, TRENDS ECOL EVOL, V14, P11, DOI 10.1016/S0169-5347(98)01532-8; Eamus D, 2001, ADV ECOL RES, V32, P113, DOI 10.1016/S0065-2504(01)32012-3; Enquist BJ, 2001, J TROP ECOL, V17, P41, DOI 10.1017/S0266467401001031; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; Janzen D.H., 1988, P130; Killeen TJ, 1998, J TROP ECOL, V14, P803, DOI 10.1017/S0266467498000583; Krepkowski J, 2011, TREES-STRUCT FUNCT, V25, P59, DOI 10.1007/s00468-010-0460-7; Kutscha NP, 1962, COLOR TESTS DIFFEREN; LIEBERMAN D, 1987, J TROP ECOL, V3, P347, DOI 10.1017/S0266467400002327; Lisi CS, 2008, IAWA J, V29, P189, DOI 10.1163/22941932-90000179; Lopez L, 2011, BIOTROPICA, V43, P41, DOI 10.1111/j.1744-7429.2010.00653.x; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; Markesteijn L, 2010, J TROP ECOL, V26, P497, DOI 10.1017/S0266467410000271; Meinzer FC, 1999, OECOLOGIA, V121, P293, DOI 10.1007/s004420050931; Meinzer FC, 2001, TREE PHYSIOL, V21, P19, DOI 10.1093/treephys/21.1.19; Missouri Botanical Garden, 2013, MISS BOT GARD; Mostacedo B., 2007, THESIS U FLORIDA GAI; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; OLIVARES E, 1992, J VEG SCI, V3, P383, DOI 10.2307/3235764; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband WS., 2013, IMAGE J; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; Reyes-Garcia C, 2012, TREES-STRUCT FUNCT, V26, P1317, DOI 10.1007/s00468-012-0708-5; Roig Fidel A., 2005, Dendrochronologia, V22, P187, DOI 10.1016/j.dendro.2005.05.007; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Schongart J, 2006, GLOBAL CHANGE BIOL, V12, P1139, DOI 10.1111/j.1365-2486.2006.01154.x; Schulman E., 1956, Dendroclimatic changes in semiarid America.; SOBRADO MA, 1993, OECOLOGIA, V96, P19, DOI 10.1007/BF00318025; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; Villegas Z, 2009, FOREST ECOL MANAG, V258, P971, DOI 10.1016/j.foreco.2008.10.031; Volland-Voigt F, 2011, TREES-STRUCT FUNCT, V25, P39, DOI 10.1007/s00468-010-0461-6; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; Worbes M, 1995, IAWA J, V16, P337, DOI 10.1163/22941932-90001424; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Zuidema PA, 2009, AM NAT, V174, P709, DOI 10.1086/605981; Zuur Alain F., 2009, P1	59	35	35	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e73855	10.1371/journal.pone.0073855	http://dx.doi.org/10.1371/journal.pone.0073855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116001	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300004
J	Nierkens, V; Hartman, MA; Nicolaou, M; Vissenberg, C; Beune, EJAJ; Hosper, K; van Valkengoed, IG; Stronks, K				Nierkens, Vera; Hartman, Marieke A.; Nicolaou, Mary; Vissenberg, Charlotte; Beune, Erik J. A. J.; Hosper, Karen; van Valkengoed, Irene G.; Stronks, Karien			Effectiveness of Cultural Adaptations of Interventions Aimed at Smoking Cessation, Diet, and/or Physical Activity in Ethnic Minorities. A Systematic Review	PLOS ONE			English	Review							AFRICAN-AMERICAN WOMEN; RANDOMIZED CONTROLLED-TRIAL; COMMUNITY-HEALTH WORKERS; RISK-FACTOR INTERVENTION; BEHAVIORS; PROMOTION; DISEASE; COMMUNICATION; HYPERTENSION; POPULATION	Background: The importance of cultural adaptations in behavioral interventions targeting ethnic minorities in high-income societies is widely recognized. Little is known, however, about the effectiveness of specific cultural adaptations in such interventions. Aim: To systematically review the effectiveness of specific cultural adaptations in interventions that target smoking cessation, diet, and/or physical activity and to explore features of such adaptations that may account for their effectiveness. Methods: Systematic review using MEDLINE, PsycINFO, Embase, and the Cochrane Central Register of Controlled Trials registers (1997-2009). Inclusion criteria: a) effectiveness study of a lifestyle intervention targeted to ethnic minority populations living in a high income society; b) interventions included cultural adaptations and a control group that was exposed to the intervention without the cultural adaptation under study; c) primary outcome measures included smoking cessation, diet, or physical activity. Results: Out of 44904 hits, we identified 17 studies, all conducted in the United States. In five studies, specific cultural adaptations had a statistically significant effect on primary outcomes. The remaining studies showed no significant effects on primary outcomes, but some presented trends favorable for cultural adaptations. We observed that interventions incorporating a package of cultural adaptations, cultural adaptations that implied higher intensity and those incorporating family values were more likely to report statistically significant effects. Adaptations in smoking cessation interventions seem to be more effective than adaptations in interventions aimed at diet and physical activity. Conclusion: This review indicates that culturally targeted behavioral interventions may be more effective if cultural adaptations are implemented as a package of adaptations, the adaptation includes family level, and where the adaptation results in a higher intensity of the intervention. More systematic experiments are needed in which the aim is to gain insight in the best mix of cultural adaptations among diverse populations in various settings, particularly outside the US.	[Nierkens, Vera; Hartman, Marieke A.; Nicolaou, Mary; Vissenberg, Charlotte; Beune, Erik J. A. J.; Hosper, Karen; van Valkengoed, Irene G.; Stronks, Karien] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Hartman, Marieke A.] Publ Hlth Serv Amsterdam, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Nierkens, V (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.nierkens@amc.nl	van Valkengoed, Irene/ABA-1551-2021; van Valkengoed, Irene G.M./B-2974-2013	van Valkengoed, Irene/0000-0002-9306-7831; van Valkengoed, Irene G.M./0000-0002-9306-7831; Stronks, Karien/0000-0002-0921-2232	Department of Public Health of the Academic Medical Center/University of Amsterdam; NATIONAL CANCER INSTITUTE [R25CA057712] Funding Source: NIH RePORTER	Department of Public Health of the Academic Medical Center/University of Amsterdam; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by the Department of Public Health of the Academic Medical Center/University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ard JD, 2008, OBESITY, V16, P306, DOI 10.1038/oby.2007.49; Armstrong R, 2007, GUIDELINES SYSTEMATI; Babamoto KS, 2009, HEALTH EDUC BEHAV, V36, P113, DOI 10.1177/1090198108325911; Bailey EJ, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006580.pub4, 10.1002/14651858.CD006580.pub3]; Becker DM, 2005, CIRCULATION, V111, P1298, DOI 10.1161/01.CIR.0000157734.97351.B2; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; Campbell MK, 2004, HEALTH PSYCHOL, V23, P492, DOI 10.1037/0278-6133.23.5.492; Campbell MK, 1999, PATIENT EDUC COUNS, V36, P157, DOI 10.1016/S0738-3991(98)00132-3; Cene CW, 2008, ETHNIC DIS, V18, P169; Chiang CY, 2009, PUBLIC HEALTH NURS, V26, P240, DOI 10.1111/j.1525-1446.2009.00776.x; Committee on Health and Behavior: Research Practice and Policy Board on Neuroscience and Behavioral Health, 2001, HLTH BEH INT BIOL BE; Connell P, 2008, HEALTH SOC CARE COMM, V16, P165, DOI 10.1111/j.1365-2524.2007.00737.x; Effective Public Health Practice Project (EPHPP), 2009, QUAL ASS TOOL QUANT; Elder JP, 2006, AM J PREV MED, V31, P159, DOI 10.1016/j.amepre.2006.04.001; Elder JP, 2005, HEALTH PSYCHOL, V24, P49, DOI 10.1037/0278-6133.24.1.49; Fitzgibbon Marian L, 2005, J Natl Med Assoc, V97, P1393; Hawthorne K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub2; Institute of Medicine, 2002, SPEAK HLTH ASS HLTH; Jepson RG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-538; Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576; Kocturk-Runefors T, 1990, Bibl Nutr Dieta, P157; Kreuter Matthew W, 2008, J Cancer Surviv, V2, P33, DOI 10.1007/s11764-007-0041-y; Kreuter MW, 2005, PREV MED, V41, P53, DOI 10.1016/j.ypmed.2004.10.013; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lawton J, 2008, ETHNIC HEALTH, V13, P305, DOI 10.1080/13557850701882910; Newton RL, 2004, ETHNIC DIS, V14, P548; Nicolaou M, 2009, J NUTR EDUC BEHAV, V41, P232, DOI 10.1016/j.jneb.2008.05.011; Nollen N, 2007, HEALTH EDUC BEHAV, V34, P911, DOI 10.1177/1090198106294652; Orleans CT, 1998, PREV MED, V27, pSi60; Rambihar VS, 2010, AM HEART J, V159, P1, DOI 10.1016/j.ahj.2009.10.020; Renzaho AMN, 2010, PUBLIC HEALTH NUTR, V13, P438, DOI 10.1017/S136898000999111X; Resnicow K, 2009, HEALTH PSYCHOL, V28, P394, DOI 10.1037/a0015217; Resnicow Ken, 1999, Ethnicity and Disease, V9, P10; Rosen LJ, 2009, PREV MED, V49, P12, DOI 10.1016/j.ypmed.2009.03.010; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Staten LK, 2004, J WOMENS HEALTH, V13, P547, DOI 10.1089/1540999041281133; Wetter DW, 2007, CANCER-AM CANCER SOC, V109, P406, DOI 10.1002/cncr.22360; Whitt-Glover MC, 2009, AM J HEALTH PROMOT, V23, pS33, DOI 10.4278/ajhp.070924101; Woodruff SI, 2002, TOB CONTROL, V11, P361, DOI 10.1136/tc.11.4.361; Yancey Antronette K, 2004, Prev Chronic Dis, V1, pA09; Yanek LR, 2001, PUBLIC HEALTH REP, V116, P68, DOI 10.1093/phr/116.S1.68	41	78	78	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e73373	10.1371/journal.pone.0073373	http://dx.doi.org/10.1371/journal.pone.0073373			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116000	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300003
J	Sharma, P; Stagge, S; Bekker, M; Bettenbrock, K; Hellingwerf, KJ				Sharma, Poonam; Stagge, Stefan; Bekker, Martijn; Bettenbrock, Katja; Hellingwerf, Klaas J.			Kinase Activity of ArcB from Escherichia coli Is Subject to Regulation by Both Ubiquinone and Demethylmenaquinone	PLOS ONE			English	Article							2-COMPONENT SYSTEM; IN-VITRO; TRANSCRIPTIONAL REGULATION; REDOX REGULATION; SENSOR KINASE; QUINONE POOL; SIGNAL; PHOSPHORYLATION; REQUIREMENT; PROTEIN	Expression of the catabolic network in Escherichia coli is predominantly regulated, via oxygen availability, by the two-component system ArcBA. It has been shown that the kinase activity of ArcB is controlled by the redox state of two critical pairs of cysteines in dimers of the ArcB sensory kinase. Among the cellular components that control the redox state of these cysteines of ArcB are the quinones from the cytoplasmic membrane of the cell, which function in 'respiratory' electron transfer. This study is an effort to understand how the redox state of the quinone pool(s) is sensed by the cell via the ArcB kinase. We report the relationship between growth, quinone content, ubiquinone redox state, the level of ArcA phosphorylation, and the level of ArcA-dependent gene expression, in a number of mutants of E. coli with specific alterations in their set of quinones, under a range of physiological conditions. Our results provide experimental evidence for a previously formulated hypothesis that not only ubiquinone, but also demethylmenaquinone, can inactivate kinase activity of ArcB. Also, in a mutant strain that only contains demethylmenaquinone, the extent of ArcA phosphorylation can be modulated by the oxygen supply rate, which shows that demethylmenaquinone can also inactivate ArcB in its oxidized form. Furthermore, in batch cultures of a strain that contains ubiquinone as its only quinone species, we observed that the ArcA phosphorylation level closely followed the redox state of the ubiquinone/ubiquinol pool, much more strictly than it does in the wild type strain. Therefore, at low rates of oxygen supply in the wild type strain, the activity of ArcB may be inhibited by demethylmenaquinone, in spite of the fact that the ubiquinones are present in the ubiquinol form.	[Sharma, Poonam; Bekker, Martijn; Hellingwerf, Klaas J.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Microbial Physiol Grp, Amsterdam, Netherlands; [Sharma, Poonam; Bekker, Martijn; Hellingwerf, Klaas J.] Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Stagge, Stefan; Bettenbrock, Katja] MPI Dynam Komplexer Tech Syst, Magdeburg, Germany	University of Amsterdam	Hellingwerf, KJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Mol Microbial Physiol Grp, Amsterdam, Netherlands.	K.J.Hellingwerf@uva.nl	Bettenbrock, Katja/AAN-5812-2020	Stagge, Stefan/0000-0003-4908-0913	SysMo-SUMO2 project; Erasmus Mundus External Cooperation Window (EMECW) [327]	SysMo-SUMO2 project; Erasmus Mundus External Cooperation Window (EMECW)	This work was supported by the SysMo-SUMO2 project and the Erasmus Mundus External 327 Cooperation Window (EMECW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2003, J BACTERIOL, V185, P204, DOI 10.1128/JB.185.1.204-209.2003; Alexeeva S, 2000, J BACTERIOL, V182, P4934, DOI 10.1128/JB.182.17.4934-4940.2000; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Bekker Martijn, 2006, Science Progress, V89, P213, DOI 10.3184/003685006783238308; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Evans CGT, 1970, CONTINUOUS CULTURE M, V2; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Jeremy MB, 2002, BIOCHEMISTRY, V5th; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Nakamura A, 2011, PLANT CELL PHYSIOL, V52, P815, DOI 10.1093/pcp/pcr034; Oreza LAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038187; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Pena-Sandoval GR, 2005, J BACTERIOL, V187, P3267, DOI 10.1128/JB.187.9.3267-3272.2005; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Sharma P, 2012, APPL ENV MICROBIOL; Sharma P, 2012, FEBS J; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Soballe B, 1998, MICROBIOL-UK, V144, P361, DOI 10.1099/00221287-144-2-361; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0	32	18	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75412	10.1371/journal.pone.0075412	http://dx.doi.org/10.1371/journal.pone.0075412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116043	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300027
J	Tambyah, PA; Sepramaniam, S; Ali, JM; Chai, SC; Swaminathan, P; Armugam, A; Jeyaseelan, K				Tambyah, Paul A.; Sepramaniam, Sugunavathi; Ali, Jaminah Mohamed; Chai, Siaw Ching; Swaminathan, Priyadharshini; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah			microRNAs in Circulation Are Altered in Response to Influenza A Virus Infection in Humans	PLOS ONE			English	Article							EXPRESSION; REPLICATION; CELLS; H1N1; PROTEINS; RNA	Changes in microRNA expression have been detected in vitro in influenza infected cells, yet little is known about them in patients. microRNA profiling was performed on whole blood of H1N1 patients to identify signature microRNAs to better understand the gene regulation involved and possibly improve diagnosis. Total RNA extracted from blood samples of influenza infected patients and healthy controls were subjected to microRNA microarray. Expression profiles of circulating microRNAs were altered and distinctly different in influenza patients. Expression of highly dysregulated microRNAs were validated using quantitative PCR. Fourteen highly dysregulated miRNAs, identified from the blood of influenza infected patients, provided a clear distinction between infected and healthy individuals. Of these, expression of miR-1260, -26a, -335*, -576-3p, -628-3p and -664 were consistently dysregulated in both whole blood and H1N1 infected cells. Potential host and viral gene targets were identified and the impact of microRNA dysregulation on the host proteome was studied. Consequences of their altered expression were extrapolated to changes in the host proteome expression. These highly dysregulated microRNAs may have crucial roles in influenza pathogenesis and are potential biomarkers of influenza.	[Tambyah, Paul A.; Ali, Jaminah Mohamed] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Med,Ctr Translat Med, Singapore 117595, Singapore; [Sepramaniam, Sugunavathi; Chai, Siaw Ching; Swaminathan, Priyadharshini; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Biochem,Ctr Translat Med, Singapore 117595, Singapore; [Jeyaseelan, Kandiah] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia	National University of Singapore; National University of Singapore; Monash University	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Biochem,Ctr Translat Med, Singapore 117595, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	Singapore National Medical Research Council [R-172-000-211-213]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This work was supported and funded by the Singapore National Medical Research Council [R-172-000-211-213]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Buttiglieri S, 2004, J BIOL CHEM, V279, P4136, DOI 10.1074/jbc.M306824200; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kin K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000745; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lee HK, 2010, J MOL DIAGN, V12, P636, DOI 10.2353/jmoldx.2010.100010; Li Yaodong, 2009, Wei Sheng Wu Xue Bao, V49, P1081; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Ma YJ, 2012, J CELL MOL MED, V16, P2539, DOI 10.1111/j.1582-4934.2012.01572.x; Maeda K, 2012, INTERNAL MED, V51, P1931, DOI 10.2169/internalmedicine.51.7487; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Onnis A, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.29; Parnell GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11477; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wright PF, 2007, PHILADELPHIA FIELDS, P1727; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	31	72	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76811	10.1371/journal.pone.0076811	http://dx.doi.org/10.1371/journal.pone.0076811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116168	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300099
J	Tomczak, MT; Heymans, JJ; Yletyinen, J; Niiranen, S; Otto, SA; Blenckner, T				Tomczak, Maciej T.; Heymans, Johanna J.; Yletyinen, Johanna; Niiranen, Susa; Otto, Saskia A.; Blenckner, Thorsten			Ecological Network Indicators of Ecosystem Status and Change in the Baltic Sea	PLOS ONE			English	Article							FOOD-WEB MODELS; REGIME SHIFTS; SOUTHERN BENGUELA; TROPHIC STRUCTURE; MARINE ECOSYSTEM; UPWELLING ECOSYSTEMS; FISHERIES MANAGEMENT; POSSIBLE MECHANISMS; STABILITY; DYNAMICS	Several marine ecosystems under anthropogenic pressure have experienced shifts from one ecological state to another. In the central Baltic Sea, the regime shift of the 1980s has been associated with food-web reorganization and redirection of energy flow pathways. These long-term dynamics from 1974 to 2006 have been simulated here using a food-web model forced by climate and fishing. Ecological network analysis was performed to calculate indices of ecosystem change. The model replicated the regime shift. The analyses of indicators suggested that the system's resilience was higher prior to 1988 and lower thereafter. The ecosystem topology also changed from a web-like structure to a linearized food-web.	[Tomczak, Maciej T.] Stockholm Univ, Balt Sea Ctr, S-10691 Stockholm, Sweden; [Heymans, Johanna J.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Yletyinen, Johanna] Stockholm Univ, Stockholm Resilience Ctr, Nord Ctr Res Marine Ecosyst & Resources Climate C, S-10691 Stockholm, Sweden; [Yletyinen, Johanna; Niiranen, Susa; Otto, Saskia A.; Blenckner, Thorsten] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden	Stockholm University; UHI Millennium Institute; Stockholm University; Stockholm University	Tomczak, MT (corresponding author), Stockholm Univ, Balt Sea Ctr, S-10691 Stockholm, Sweden.	maciej.tomczak@su.se	Yletyinen, Johanna/ABC-5785-2020; Heymans, Johanna J/H-4848-2012	Heymans, Johanna J/0000-0002-7290-8988; Yletyinen, Johanna/0000-0002-7410-6794; Blenckner, Thorsten/0000-0002-6991-7680; Niiranen, Susa/0000-0001-8405-8717	EU [226675]; Swedish FORMAS project "Regime Shifts in the Baltic Sea Ecosystem-Modelling Complex Adaptive Ecosystems and Governance Implications''; Baltic Ecosystem Adaptive Management (BEAM) program; Swedish FORMAS; Norden Top-level Research Initiative sub-programme 'Effect Studies and Adaptation to Climate Change' through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	EU(European Commission); Swedish FORMAS project "Regime Shifts in the Baltic Sea Ecosystem-Modelling Complex Adaptive Ecosystems and Governance Implications''; Baltic Ecosystem Adaptive Management (BEAM) program; Swedish FORMAS(Swedish Research Council Formas); Norden Top-level Research Initiative sub-programme 'Effect Studies and Adaptation to Climate Change' through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	The study has been carried out with financial support from the EU 7th Framework Project KnowSeas (FP7/2007-2013) under grant agreement number 226675 and the Swedish FORMAS project "Regime Shifts in the Baltic Sea Ecosystem-Modelling Complex Adaptive Ecosystems and Governance Implications''. Further, the research leading to these results has received funding from the Baltic Ecosystem Adaptive Management (BEAM) program funded by Swedish FORMAS, and from the Norden Top-level Research Initiative sub-programme 'Effect Studies and Adaptation to Climate Change' through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; Ainsworth CH, 2006, ECOL INDIC, V6, P623, DOI 10.1016/j.ecolind.2005.08.024; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; [Anonymous], 1993, 1993J22 ICES CM; [Anonymous], 2008, 2008BCC04145 ICES CM; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Aydin KY, 2004, AFR J MAR SCI, V26, P289, DOI 10.2989/18142320409504062; BAIRD D, 1993, MAR ECOL PROG SER, V99, P221, DOI 10.3354/meps099221; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bianchi TS, 2000, LIMNOL OCEANOGR, V45, P716, DOI 10.4319/lo.2000.45.3.0716; Bondavalli C, 2000, J BIOGEOGR, V27, P697, DOI 10.1046/j.1365-2699.2000.00423.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V., 1995, ECOL MODEL, V7, P3; Christensen V, 2005, ECOPATH ECOSIM USERS; Coll M, 2006, ECOL MODEL, V198, P53, DOI 10.1016/j.ecolmodel.2006.04.009; Coll M, 2012, FISH FISH, V13, P60, DOI 10.1111/j.1467-2979.2011.00420.x; Coll Marta, 2009, P225, DOI 10.1007/978-1-4020-8636-6_8; Conley DJ, 2009, HYDROBIOLOGIA, V629, P21, DOI 10.1007/s10750-009-9764-2; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Costanza R, 1992, ECOSYSTEM HLTH NEW G; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Cury PM, 2005, ICES J MAR SCI, V62, P430, DOI 10.1016/j.icesjms.2004.12.006; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; Diekmann R., 2010, ICES COOPERATIVE RES, V302, P94; Dunne JA, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P117; Eero M, 2012, MAR POLICY, V36, P235, DOI 10.1016/j.marpol.2011.05.010; FINN JT, 1980, ECOLOGY, V61, P562, DOI 10.2307/1937422; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Heymans JJ, 2000, ECOL MODEL, V131, P97, DOI 10.1016/S0304-3800(00)00275-1; Heymans JJ, 2007, ECOSYSTEMS, V10, P488, DOI 10.1007/s10021-007-9034-y; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Horbowy J, 2005, J APPL ICHTHYOL, V21, P198, DOI 10.1111/j.1439-0426.2005.00596.x; ICES, 2008, 2008ACOM06692 ICES C, V817; ICES, 2012, 2012SSGRSP02178 ICES, P178; IEEP, 2005, REV IND EC STRUCT FU; Jordan F., 2004, Physics of Life Reviews, V1, DOI 10.1016/j.plrev.2004.08.001; Kay J. J., 1989, NETWORK ANAL MARINE, P15, DOI DOI 10.1007/978-3-642-75017-5_2; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Larsson P., 2001, SYSTEMS ANAL BALTIC; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; Lindegren M, 2010, MAR ECOL PROG SER, V402, P239, DOI 10.3354/meps08454; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Mageau MT, 1998, ECOL MODEL, V112, P1, DOI 10.1016/S0304-3800(98)00092-1; Martinez ND, 2006, SFI S SCI C, P163; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McKinnell SM, 2001, PROG OCEANOGR, V49, P1; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Moloney CL, 2005, ICES J MAR SCI, V62, P493, DOI 10.1016/j.icesjms.2004.11.009; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; Niiranen S, 2012, AMBIO, V41, P613, DOI 10.1007/s13280-012-0324-z; Novak M, 2011, ECOLOGY, V92, P836, DOI 10.1890/10-1354.1; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; Odum E, 1969, STRATEGY ECOSYSTEM D, V104, P262; Odum E. P., 1953, FUNDAMENTALS ECOLOGY; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pinnegar JK, 2005, ECOL MODEL, V184, P229, DOI 10.1016/j.ecolmodel.2004.09.003; Plaganyi EE, 2004, AFR J MAR SCI, V26, P261, DOI 10.2989/18142320409504061; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Shannon LJ, 2009, ECOL INDIC, V9, P1078, DOI 10.1016/j.ecolind.2008.12.007; Shannon LJ, 2004, ECOL MODEL, V172, P269, DOI 10.1016/j.ecolmodel.2003.09.011; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thurow F, 1997, ICES J MAR SCI, V54, P444, DOI 10.1006/jmsc.1996.0195; Tomczak MT, 2012, ECOL MODEL, V230, P123, DOI 10.1016/j.ecolmodel.2011.12.014; Tomczak MT, 2009, PROG OCEANOGR, V81, P111, DOI 10.1016/j.pocean.2009.04.017; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Ulanowicz RE, 1997, ECOL MODEL, V95, P1, DOI 10.1016/S0304-3800(96)00032-4; Ulanowicz Robert E., 2000, P99; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Watermeyer KE, 2008, AFR J MAR SCI, V30, P351, DOI 10.2989/AJMS.2008.30.2.11.561; Wulff F., 1989, NETWORK ANAL MARINE	83	54	55	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75439	10.1371/journal.pone.0075439	http://dx.doi.org/10.1371/journal.pone.0075439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116045	Green Published, gold			2022-12-27	WOS:000325501300028
J	Zhao, H; Wang, B; He, JR; Yang, JP; Pan, L; Sun, DF; Peng, JH				Zhao, Hua; Wang, Bo; He, Junrong; Yang, Junpin; Pan, Lei; Sun, Dongfa; Peng, Junhua			Genetic Diversity and Population Structure of Miscanthus sinensis Germplasm in China	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; ENERGY CROP; X-GIGANTEUS; MICROSATELLITE MARKERS; AGRONOMIC TRAITS; ASSOCIATION; BIOMASS; VARIABILITY; SOFTWARE; EUROPE	Miscanthus is a perennial rhizomatous C4 grass native to East Asia. Endowed with great biomass yield, high ligno-cellulose composition, efficient use of radiation, nutrient and water, as well as tolerance to stress, Miscanthus has great potential as an excellent bioenergy crop. Despite of the high potential for biomass production of the allotriploid hybrid M. xgiganteus, derived from M. sacchariflorus and M. sinensis, other options need to be explored to improve the narrow genetic base of M. xgiganteus, and also to exploit other Miscanthus species, including M. sinensis (2n=2x=38), as bioenergy crops. In the present study, a large number of 459 M. sinensis accessions, collected from the wide geographical distribution regions in China, were genotyped using 23 SSR markers transferable from Brachypodium distachyon. Genetic diversity and population structure were assessed. High genetic diversity and differentiation of the germplasm were observed, with 115 alleles in total, a polymorphic rate of 0.77, Nei's genetic diversity index (He) of 0.32 and polymorphism information content (PIC) of 0.26. Clustering of germplasm accessions was primarily in agreement with the natural geographic distribution. AMOVA and genetic distance analyses confirmed the genetic differentiation in the M. sinensis germplasm and it was grouped into five clusters or subpopulations. Significant genetic variation among subpopulations indicated obvious genetic differentiation in the collections, but within-subpopulation variation (83%) was substantially greater than the between-subpopulation variation (17%). Considerable phenotypic variation was observed for multiple traits among 300 M. sinensis accessions. Nine SSR markers were found to be associated with heading date and biomass yield. The diverse Chinese M. sinensis germplasm and newly identified SSR markers were proved to be valuable for breeding Miscanthus varieties with desired bioenergy traits.	[Zhao, Hua; Sun, Dongfa; Peng, Junhua] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Wang, Bo; Pan, Lei] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Wang, Bo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [He, Junrong] Sichuan Acad Agr Sci, Inst Hort, Chengdu, Peoples R China; [Yang, Junpin] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Peoples R China	Huazhong Agricultural University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan Academy of Agricultural Sciences (SAAS); Sichuan Academy of Agricultural Sciences (SAAS)	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	sundongfa@mail.hzau.edu.cn; junhuapeng@yahoo.com	Peng, Junhua/HHZ-2344-2022	Peng, Junhua/0000-0002-8428-3137	Natural National Science Foundation [31100243, 30870233]	Natural National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural National Science Foundation grants 31100243 and 30870233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama H. A., 2010, Natural Science, V2, P247, DOI 10.4236/ns.2010.24036; Atienza SG, 2003, EUPHYTICA, V132, P353, DOI 10.1023/A:1025041926259; Atienza SG, 2003, THEOR APPL GENET, V107, P123, DOI 10.1007/s00122-003-1220-5; Bellamy PE, 2009, BIOMASS BIOENERG, V33, P191, DOI 10.1016/j.biombioe.2008.07.001; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chou CH, 2000, CAN J BOT, V78, P1262, DOI 10.1139/cjb-78-10-1262; Christian D. G., 2001, MISCANTHUS ENERGY FI; Clark L.V., 2013, GENETIC STRUCTURE MI; Clifton-Brown J., 2000, MISCANTHUS ENERGY FI, P46; Clifton-Brown J. C., 2001, EUROPEAN J AGRONOMY, V6, P97; Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Cox CB, 2001, J BIOGEOGR, V28, P511; Deuter M., 2000, EUROPEAN MISCANTHUS, P28; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Greef JM, 1997, GENET RESOUR CROP EV, V44, P185, DOI 10.1023/A:1008693214629; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hastings A, 2009, GCB BIOENERGY, V1, P154, DOI 10.1111/j.1757-1707.2009.01007.x; Hastings A, 2009, GCB BIOENERGY, V1, P180, DOI 10.1111/j.1757-1707.2009.01012.x; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; Heaton EA, 2009, GCB BIOENERGY, V1, P297, DOI 10.1111/j.1757-1707.2009.01022.x; Hernandez P, 2001, THEOR APPL GENET, V102, P616, DOI 10.1007/s001220051688; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050002; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Humphries C., 1999, CLADISTIC BIOGEOGRAP, P21; Hung KH, 2009, CONSERV GENET, V10, P1377, DOI 10.1007/s10592-008-9699-6; Jorgensen U, 2000, NEW PHYTOL, V148, P190, DOI 10.1046/j.1469-8137.2000.00768.x; JORGENSEN U, 2001, MISCANTHUS ENERGY FI, P68; LAFFERTY J, 1994, PLANT BREEDING, V113, P246, DOI 10.1111/j.1439-0523.1994.tb00730.x; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; LINDELAURSEN I, 1993, HEREDITAS, V119, P297, DOI 10.1111/j.1601-5223.1993.00297.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nelson G., 1981, SYSTEMATICS BIOGEOGR, V368, P524; Pressoir G, 2009, PLANT J, V58, P618, DOI 10.1111/j.1365-313X.2009.03802.x; Price L, 2004, BIOMASS BIOENERG, V26, P3, DOI 10.1016/S0961-9534(03)00062-X; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rayburn AL, 2009, PLANT MOL BIOL REP, V27, P184, DOI 10.1007/s11105-008-0070-3; Semere T, 2007, BIOMASS BIOENERG, V31, P20, DOI 10.1016/j.biombioe.2006.07.001; Swaminathan K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-142; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x; Yan WG, 2009, MOL BREEDING, V24, P277, DOI 10.1007/s11032-009-9290-y; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao H, 2011, J INTEGR PLANT BIOL, V53, P232, DOI 10.1111/j.1744-7909.2010.01026.x; Zhou HF, 2011, AM J BOT, V98, pE195, DOI 10.3732/ajb.1100040	60	31	33	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75672	10.1371/journal.pone.0075672	http://dx.doi.org/10.1371/journal.pone.0075672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116066	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300038
J	Ballandras-Colas, A; Naraharisetty, H; Li, X; Serrao, E; Engelman, A				Ballandras-Colas, Allison; Naraharisetty, Hema; Li, Xiang; Serrao, Erik; Engelman, Alan			Biochemical Characterization of Novel Retroviral Integrase Proteins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 DNA INTEGRATION; DERMAL SARCOMA-VIRUS; STRAND TRANSFER; NUCLEOTIDE-SEQUENCE; TARGET SITES; MECHANISM; CONSTRUCTION; REPLICATION; INHIBITION	Integrase is an essential retroviral enzyme, catalyzing the stable integration of reverse transcribed DNA into cellular DNA. Several aspects of the integration mechanism, including the length of host DNA sequence duplication flanking the integrated provirus, which can be from 4 to 6 bp, and the nucleotide preferences at the site of integration, are thought to cluster among the different retroviral genera. To date only the spumavirus prototype foamy virus integrase has provided diffractable crystals of integrase-DNA complexes, revealing unprecedented details on the molecular mechanisms of DNA integration. Here, we characterize five previously unstudied integrase proteins, including those derived from the alpharetrovirus lymphoproliferative disease virus (LPDV), betaretroviruses Jaagsiekte sheep retrovirus (JSRV), and mouse mammary tumor virus (MMTV), epsilonretrovirus walleye dermal sarcoma virus (WDSV), and gammaretrovirus reticuloendotheliosis virus strain A (Rev-A) to identify potential novel structural biology candidates. Integrase expressed in bacterial cells was analyzed for solubility, stability during purification, and, once purified, 3' processing and DNA strand transfer activities in vitro. We show that while we were unable to extract or purify accountable amounts of WDSV, JRSV, or LPDV integrase, purified MMTV and Rev-A integrase each preferentially support the concerted integration of two viral DNA ends into target DNA. The sequencing of concerted Rev-A integration products indicates high fidelity cleavage of target DNA strands separated by 5 bp during integration, which contrasts with the 4 bp duplication generated by a separate gammaretrovirus, the Moloney murine leukemia virus (MLV). By comparing Rev-A in vitro integration sites to those generated by MLV in cells, we concordantly conclude that the spacing of target DNA cleavage is more evolutionarily flexible than are the target DNA base contacts made by integrase during integration. Given their desirable concerted DNA integration profiles, Rev-A and MMTV integrase proteins have been earmarked for structural biology studies.	[Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Engelman, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	alan_engelman@dfci.harvard.edu		Ballandras-Colas, Allison/0000-0003-4735-4984	US National Institutes of Health [R01 AI070042, T32 AI007245]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042, T32AI007245] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants R01 AI070042 and T32 AI007245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, EUR J BIOCH, V150, P1; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Certo JL, 1998, J VIROL, V72, P5408, DOI 10.1128/JVI.72.7.5408-5413.1998; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; DOTAN I, 1995, J VIROL, V69, P456, DOI 10.1128/JVI.69.1.456-468.1995; ENGELMAN A, 1995, J VIROL, V69, P5908, DOI 10.1128/JVI.69.9.5908-5911.1995; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Faschinger A, 2008, J VIROL, V82, P1360, DOI 10.1128/JVI.02098-07; Fodor SK, 2002, J GEN VIROL, V83, P1361, DOI 10.1099/0022-1317-83-6-1361; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; HOLZSCHU DL, 1995, J VIROL, V69, P5320, DOI 10.1128/JVI.69.9.5320-5331.1995; King A.M., 2012, VIRUS TAXONOMY, V9; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Lairmore MD, 2000, P NATL ACAD SCI USA, V97, P6114, DOI 10.1073/pnas.110024497; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; SARID R, 1994, VIROLOGY, V204, P680, DOI 10.1006/viro.1994.1584; SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655; SHIMOTOHNO K, 1980, P NATL ACAD SCI-BIOL, V77, P7357, DOI 10.1073/pnas.77.12.7357; SHIMOTOHNO K, 1980, NATURE, V285, P550, DOI 10.1038/285550a0; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; WATANABE S, 1983, MOL CELL BIOL, V3, P2241, DOI 10.1128/MCB.3.12.2241; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; YORK DF, 1991, J VIROL, V65, P5061, DOI 10.1128/JVI.65.9.5061-5067.1991	37	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76638	10.1371/journal.pone.0076638	http://dx.doi.org/10.1371/journal.pone.0076638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124581	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100138
J	Baptista, IL; Silva, WJ; Artioli, GG; Guilherme, JPLF; Leal, ML; Aoki, MS; Miyabara, EH; Moriscot, AS				Baptista, Igor L.; Silva, Willian J.; Artioli, Guilherme G.; Guilherme, Joao Paulo L. F.; Leal, Marcelo L.; Aoki, Marcelo S.; Miyabara, Elen H.; Moriscot, Anselmo S.			Leucine and HMB Differentially Modulate Proteasome System in Skeletal Muscle under Different Sarcopenic Conditions	PLOS ONE			English	Article							HYDROXY-BETA-METHYLBUTYRATE; KAPPA-B ACTIVATION; RAT SOLEUS MUSCLE; PULMONARY INFLAMMATION; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; GENE-EXPRESSION; MESSENGER-RNAS; IMMOBILIZATION; ATROPHY	In the present study we have compared the effects of leucine supplementation and its metabolite beta-hydroxy-beta-methyl butyrate (HMB) on the ubiquitin-proteasome system and the PI3K/Akt pathway during two distinct atrophic conditions, hindlimb immobilization and dexamethasone treatment. Leucine supplementation was able to minimize the reduction in rat soleus mass driven by immobilization. On the other hand, leucine supplementation was unable to provide protection against soleus mass loss in dexamethasone treated rats. Interestingly, HMB supplementation was unable to provide protection against mass loss in all treatments. While solely fiber type I cross sectional area (CSA) was protected in immobilized soleus of leucine-supplemented rats, none of the fiber types were protected by leucine supplementation in rats under dexamethasone treatment. In addition and in line with muscle mass results, HMB treatment did not attenuate CSA decrease in all fiber types against either immobilization or dexamethasone treatment. While leucine supplementation was able to minimize increased expression of both Mafbx/Atrogin and MuRF1 in immobilized rats, leucine was only able to minimize Mafbx/Atrogin in dexamethasone treated rats. In contrast, HMB was unable to restrain the increase in those atrogenes in immobilized rats, but in dexamethasone treated rats, HMB minimized increased expression of Mafbx/Atrogin. The amount of ubiquitinated proteins, as expected, was increased in immobilized and dexamethasone treated rats and only leucine was able to block this increase in immobilized rats but not in dexamethasone treated rats. Leucine supplementation maintained soleus tetanic peak force in immobilized rats at normal level. On the other hand, HMB treatment failed to maintain tetanic peak force regardless of treatment. The present data suggested that the anti-atrophic effects of leucine are not mediated by its metabolite HMB.	[Baptista, Igor L.; Silva, Willian J.; Leal, Marcelo L.; Miyabara, Elen H.; Moriscot, Anselmo S.] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil; [Artioli, Guilherme G.; Guilherme, Joao Paulo L. F.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Aoki, Marcelo S.] Univ Sao Paulo, Sch Arts Sci & Humanities EACH, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Moriscot, AS (corresponding author), Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil.	moriscot@usp.br	Moriscot, Anselmo S./C-4506-2012; Baptista, Igor Luchini/N-6442-2016; Miyabara, Elen H/E-8143-2012; Guilherme, João Paulo L. F./C-3490-2017; Artioli, Guilherme Giannini/K-5925-2013; Aoki, Marcelo Saldanha/K-5423-2016; Baptista, Igor/ABC-1551-2021	Moriscot, Anselmo S./0000-0003-3098-4613; Baptista, Igor Luchini/0000-0001-5185-0185; Miyabara, Elen H/0000-0002-2325-9571; Guilherme, João Paulo L. F./0000-0001-9165-973X; Artioli, Guilherme Giannini/0000-0001-8463-2213; Aoki, Marcelo Saldanha/0000-0001-7803-6829; Baptista, Igor/0000-0001-5185-0185; Jose Silva, William/0000-0001-6969-3464	State of Sao Paulo Research Foundation, FAPESP [07/57613-3, 12/13071-0]; grant PQ 1D from CNPq; FAPESP [06/61523-7]	State of Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); grant PQ 1D from CNPq; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Igor L. Baptista is the recipient of a scholarship from, the State of Sao Paulo Research Foundation, FAPESP (grant #07/57613-3 and #12/13071-0). Anselmo Moriscot is the recipient of grant PQ 1D from CNPq. This work was funded by FAPESP (grant #06/61523-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSVED T, 1995, ACTA PHYSIOL SCAND, V154, P291, DOI 10.1111/j.1748-1716.1995.tb09913.x; Anthony JC, 2001, J NUTR, V131, p856S, DOI 10.1093/jn/131.3.856S; Aoki MS, 2004, CLIN NUTR, V23, P1176, DOI 10.1016/j.clnu.2004.03.004; Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; BOOTH FW, 1982, J APPL PHYSIOL, V52, P1113; BOOTH FW, 1983, MED SCI SPORT EXER, V15, P415; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Pinheiro CHDJ, 2012, EUR J APPL PHYSIOL, V112, P2531, DOI 10.1007/s00421-011-2224-5; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Gerlinger-Romero F, 2011, GROWTH HORM IGF RES, V21, P57, DOI 10.1016/j.ghir.2010.12.006; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; GUTH L, 1969, EXP NEUROL, V25, P138, DOI 10.1016/0014-4886(69)90077-6; Haegens A, 2012, AM J PHYSIOL-LUNG C, V302, pL103, DOI 10.1152/ajplung.00084.2011; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; KAYALI AG, 1987, AM J PHYSIOL, V252, pE621, DOI 10.1152/ajpendo.1987.252.5.E621; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Langen RCJ, 2012, AM J RESP CELL MOL, V47, P288, DOI 10.1165/rcmb.2011-0119OC; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Liu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015607; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631; Nagasawa T, 2002, J NUTR BIOCHEM, V13, P121, DOI 10.1016/S0955-2863(01)00209-1; Nissen S, 1996, J APPL PHYSIOL, V81, P2095, DOI 10.1152/jappl.1996.81.5.2095; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pattison JS, 2003, J APPL PHYSIOL, V95, P2171, DOI 10.1152/japplphysiol.00500.2003; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Price SR, 1996, MINER ELECTROL METAB, V22, P72; Rowlands DS, 2009, J STRENGTH COND RES, V23, P836, DOI 10.1519/JSC.0b013e3181a00c80; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Smith HJ, 2005, CANCER RES, V65, P277; Soares AG, 2007, MUSCLE NERVE, V36, P685, DOI 10.1002/mus.20866; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1111/j.1753-4887.2007.tb00289.x; Sugawara T, 2008, AMINO ACIDS, V34; Sugawara T, 2007, J NUTR SCI VITAMINOL, V53, P552, DOI 10.3177/jnsv.53.552; TIAO G, 1994, J CLIN INVEST, V94, P2255, DOI 10.1172/JCI117588; Urso ML, 2006, EUR J APPL PHYSIOL, V96, P564, DOI 10.1007/s00421-005-0109-1; Vary TC, 2007, AM J PHYSIOL-ENDOC M, V293, pE188, DOI 10.1152/ajpendo.00037.2007; Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Zanchi NE, 2011, AMINO ACIDS, V40, P1015, DOI 10.1007/s00726-010-0678-0; Zhang P, 2007, MED HYPOTHESES, V69, P310, DOI 10.1016/j.mehy.2006.11.043	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76752	10.1371/journal.pone.0076752	http://dx.doi.org/10.1371/journal.pone.0076752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124592	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100149
J	Garnett, JP; Gray, MA; Tarran, R; Brodlie, M; Ward, C; Baker, EH; Baines, DL				Garnett, James P.; Gray, Michael A.; Tarran, Robert; Brodlie, Malcolm; Ward, Christopher; Baker, Emma H.; Baines, Deborah L.			Elevated Paracellular Glucose Flux across Cystic Fibrosis Airway Epithelial Monolayers Is an Important Factor for Pseudomonas aeruginosa Growth	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; TIGHT JUNCTIONS; SURFACE LIQUID; CELL CULTURE; PH; TRANSPORT; LUNG; HYPERGLYCEMIA; HOMEOSTASIS; SECRETION	People with cystic fibrosis (CF) who develop related diabetes (CFRD) have accelerated pulmonary decline, increased infection with antibiotic-resistant Pseudomonas aeruginosa and increased pulmonary exacerbations. We have previously shown that glucose concentrations are elevated in airway surface liquid (ASL) of people with CF, particularly in those with CFRD. We therefore explored the hypotheses that glucose homeostasis is altered in CF airway epithelia and that elevation of glucose flux into ASL drives increased bacterial growth, with an effect over and above other cystic fibrosis transmembrane conductance regulator (CFTR)-related ASL abnormalities. The aim of this study was to compare the mechanisms governing airway glucose homeostasis in CF and non-CF primary human bronchial epithelial (HBE) monolayers, under normal conditions and in the presence of Ps. aeruginosa filtrate. HBE-bacterial co-cultures were performed in the presence of 5 mM or 15 mM basolateral glucose to investigate how changes in blood glucose, such as those seen in CFRD, affects luminal Ps. aeruginosa growth. Calu-3 cell monolayers were used to evaluate the potential importance of glucose on Ps. aeruginosa growth, in comparison to other hallmarks of the CF ASL, namely mucus hyperviscosity and impaired CFTR-dependent fluid secretions. We show that elevation of basolateral glucose promotes the apical growth of Ps. aeruginosa on CF airway epithelial monolayers more than non-CF monolayers. Ps. aeruginosa secretions elicited more glucose flux across CF airway epithelial monolayers compared to non-CF monolayers which we propose increases glucose availability in ASL for bacterial growth. In addition, elevating basolateral glucose increased Ps. aeruginosa growth over and above any CFTR-dependent effects and the presence or absence of mucus in Calu-3 airway epithelia-bacteria co-cultures. Together these studies highlight the importance of glucose as an additional factor in promoting Ps. aeruginosa growth and respiratory infection in CF disease.	[Garnett, James P.; Baker, Emma H.; Baines, Deborah L.] St Georges Univ London, Div Biomed Sci, London, England; [Gray, Michael A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Brodlie, Malcolm; Ward, Christopher] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	St Georges University London; Newcastle University - UK; University of North Carolina; University of North Carolina Chapel Hill; Newcastle University - UK	Garnett, JP (corresponding author), St Georges Univ London, Div Biomed Sci, London, England.	jgarnett@sgul.ac.uk	Garnett, James/O-7093-2014; Ward, Christopher/B-8175-2013	Garnett, James/0000-0002-4767-020X; Ward, Christopher/0000-0002-6954-9611; Baines, Deborah/0000-0001-7229-0244; Brodlie, Malcolm/0000-0003-4591-8299; Baker, Emma/0000-0002-0871-3721; GRAY, MICHAEL/0000-0002-6774-6283	Wellcome Trust [088304/Z/09/Z]; Medical Research Council [MR/K012770/1]; National Heart, Lung, and Blood Institute [R01 HL108927]; Academy of Medical Sciences (AMS) [AMS-SGCL6-Brodlie] Funding Source: researchfish; Medical Research Council [G0800419] Funding Source: researchfish; MRC [MR/K012770/1, G0800419] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108927] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Wellcome Trust (Grant No: 088304/Z/09/Z), the Medical Research Council (Grant No: MR/K012770/1) and by the National Heart, Lung, and Blood Institute (R01 HL108927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EH, 2007, J APPL PHYSIOL, V102, P1969, DOI 10.1152/japplphysiol.01425.2006; Ballok AE, 2013, J BACTERIOL IN PRESS; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; Brodlie M, 2010, EXP LUNG RES, V36, P101, DOI 10.3109/01902140903165265; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Forrest IA, 2005, EUR RESPIR J, V26, P1080, DOI 10.1183/09031936.05.00141404; Garnett JP, 2013, THORAX, V68, P835, DOI 10.1136/thoraxjnl-2012-203178; Garnett JP, 2012, EUR RESPIR J, V40, P1269, DOI 10.1183/09031936.00052612; Garnett JP, 2012, J IMMUNOL, V189, P373, DOI 10.4049/jimmunol.1200718; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; Jarad N A, 2008, Chron Respir Dis, V5, P29, DOI 10.1177/1479972307085635; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Kalsi KK, 2009, PFLUG ARCH EUR J PHY, V457, P1061, DOI 10.1007/s00424-008-0576-4; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; McIsaac SM, 2012, J LEUKOCYTE BIOL, V92, P977, DOI 10.1189/jlb.0811410; Merlo CA, 2007, CHEST, V132, P562, DOI 10.1378/chest.06-2888; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pezzulo AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016166; Philips BJ, 2005, THORAX, V60, P761, DOI 10.1136/thx.2004.035766; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Randell SH, 2011, METHODS MOL BIOL, V742, P285, DOI 10.1007/978-1-61779-120-8_18; SASAJIMA KI, 1979, BIOCHIM BIOPHYS ACTA, V571, P120, DOI 10.1016/0005-2744(79)90232-8; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zulianello L, 2006, INFECT IMMUN, V74, P3134, DOI 10.1128/IAI.01772-05	32	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76283	10.1371/journal.pone.0076283	http://dx.doi.org/10.1371/journal.pone.0076283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124542	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000325489100099
J	Hu, BJ; Bao, R; Wang, XL; Liu, SS; Tao, TZ; Xie, Q; Yu, XW; Li, JB; Bo, LL; Deng, XM				Hu, Baoji; Bao, Rui; Wang, Xiaolin; Liu, Shanshan; Tao, Tianzhu; Xie, Qun; Yu, Xiongwei; Li, Jinbao; Bo, Lulong; Deng, Xiaoming			The Size of Endotracheal Tube and Sore Throat after Surgery: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CUFF PRESSURE; COMPLAINTS	Background: Recent studies showed that sore throat following endotracheal intubation was a common problem following surgery. The objective of this systematic review and meta-analysis of published randomized controlled trials (RCTs) or cohort studies was to estimate whether the size of endotracheal tube (ETT) affects the incidence of postoperative sore throat (POST) after general anesthesia. Methods: The following databases were searched electronically: PubMed (updated to Dec 2012), EMBASE (updated to 15 Dec 2012), Google scholar, World Health Organization International Clinical Trials Registry Platform (Jul 2011), Chinese BioMedical Literature Database (1978 to Jul 2011), and China National Knowledge Infrastructure (1994 to Jul 2011). Studies comparing the size of endotracheal tube for elective surgery were included. Results: Three trials with a total of 509 female patients were included in the current analysis. The size of ETT used were 6.0 mm and 7.0 mm. Pooled studies from these trials showed that the smaller size of ETT (6.0 mm) significantly decreased the incidence of POST in post-anesthesia care unit (PACU) (RR = 0.56, 95% CI 0.42-0.75, P<0.01) and at 24 h after surgery (RR = 0.69, 95% CI 0.48-0.99, P<0.05). A smaller size of ETT (6.0 mm) was associated with a lower incidence of PH in PACU (RR = 0.69, 95% CI 0.55-0.87, P<0.01), but did not affect the incidence of PH at 24 h after surgery (RR = 0.73, 95% CI 0.46-1.15, P>0.05). Conclusion: Our meta-analysis suggests that patients under general anesthesia with a smaller size of ETT (6.0 mm) were associated with a lower incidence of POST in female patients. More studies with adequate numbers of patients were warranted to evaluate other size of ETT on the incidence of PH and POST after general surgery among different populations.	[Hu, Baoji; Bao, Rui; Wang, Xiaolin; Liu, Shanshan; Tao, Tianzhu; Xie, Qun; Yu, Xiongwei; Li, Jinbao; Bo, Lulong; Deng, Xiaoming] Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China	Naval Medical University	Bo, LL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China.	nbastars@126.com; deng_x@yahoo.com	Hu, Baoji/Z-4796-2019; Deng, Xiaoming/E-2876-2010	Tao, Tianzhu/0000-0001-6853-1324				Al-metwalli RR, 2011, SAUDI J ANAESTH, V5, P185, DOI 10.4103/1658-354X.82795; Al-Qahtani Ali S., 2005, Middle East Journal of Anesthesiology, V18, P179; Biro P, 2005, EUR J ANAESTH, V22, P307, DOI 10.1017/S0265021505000529; Braz JRC, 2004, J CLIN ANESTH, V16, P320, DOI 10.1016/j.jclinane.2004.03.001; Chen Kuan-Ting, 2004, Acta Anaesthesiol Taiwan, V42, P3; Jaensson M, 2012, ACTA ANAESTH SCAND, V56, P1306, DOI 10.1111/j.1399-6576.2012.02771.x; Jaensson M, 2010, ACTA ANAESTH SCAND, V54, P147, DOI 10.1111/j.1399-6576.2009.02166.x; Jaensson Maria, 2012, AANA J, V80, pS67; Jenkins K, 2001, BRIT J ANAESTH, V86, P272, DOI 10.1093/bja/86.2.272; Karlik JB, 2012, SURG INFECT LARCHMT; Liu JH, 2010, ANESTH ANALG, V111, P1133, DOI 10.1213/ANE.0b013e3181f2ecc7; Mencke T, 2006, ANESTH ANALG, V102, P943, DOI 10.1213/01.ane.0000194509.03916.02; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nseir S, 2007, CRIT CARE, V11, DOI 10.1186/cc6142; Park SY, 2011, CAN J ANESTH, V58, P436, DOI 10.1007/s12630-011-9478-6; Porter N E, 1999, AANA J, V67, P49; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Scuderi PE, 2010, ANESTH ANALG, V111, P831, DOI 10.1213/ANE.0b013e3181ee85c7; Shirakami Gotaro, 2005, J Anesth, V19, P93, DOI 10.1007/s00540-004-0297-6; Sole ML, 2009, AM J CRIT CARE, V18, P133, DOI 10.4037/ajcc2009441; STOUT DM, 1987, ANESTHESIOLOGY, V67, P419, DOI 10.1097/00000542-198709000-00025; Tanaka Y, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004081.pub2; Thomas S, 2007, CAN J ANAESTH, V54, P897, DOI 10.1007/BF03026793; Xu YJ, 2012, ACTA ANAESTH SCAND, V56, P1314, DOI 10.1111/j.1399-6576.2012.02768.x	24	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74467	10.1371/journal.pone.0074467	http://dx.doi.org/10.1371/journal.pone.0074467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124452	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100009
J	Kittur, FS; Bah, M; Archer-Hartmann, S; Hung, CY; Azadi, P; Ishihara, M; Sane, DC; Xie, JH				Kittur, Farooqahmed S.; Bah, Mamudou; Archer-Hartmann, Stephanie; Hung, Chiu-Yueh; Azadi, Parastoo; Ishihara, Mayumi; Sane, David C.; Xie, Jiahua			Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; IN-VITRO; PROTECTS; ASIALOERYTHROPOIETIN; BIOSYNTHESIS; EXPRESSION; PROTEINS; INJURY; NEUROPROTECTION; OVEREXPRESSION	Asialo-erythropoietin, a desialylated form of human erythropoietin (EPO) lacking hematopoietic activity, is receiving increased attention because of its broader protective effects in preclinical models of tissue injury. However, attempts to translate its protective effects into clinical practice is hampered by unavailability of suitable expression system and its costly and limit production from expensive mammalian cell-made EPO (rhuEPO(M)) by enzymatic desialylation. In the current study, we took advantage of a plant-based expression system lacking sialylating capacity but possessing an ability to synthesize complex N-glycans to produce cytoprotective recombinant human asialo-rhuEPO. Transgenic tobacco plants expressing asialo-rhuEPO were generated by stably co-expressing human EPO and beta 1,4-galactosyltransferase (GalT) genes under the control of double CaMV 35S and glyceraldehyde-3-phosphate gene (GapC) promoters, respectively. Plant-produced asialo-rhuEPO (asialo-rhuEPO(P)) was purified by immunoaffinity chromatography. Detailed N-glycan analysis using NSI-FTMS and MS/MS revealed that asialo-rhuEPO(P) bears paucimannosidic, high mannose-type and complex N-glycans. In vitro cytoprotection assays showed that the asialo-rhuEPO(P) (20 U/ml) provides 2-fold better cytoprotection (44%) to neuronal-like mouse neuroblastoma cells from staurosporine-induced cell death than rhuEPO(M) (21%). The cytoprotective effect of the asialo-rhuEPO(P) was found to be mediated by receptor-initiated phosphorylation of Janus kinase 2 (JAK2) and suppression of caspase 3 activation. Altogether, these findings demonstrate that plants are a suitable host for producing cytoprotective rhuEPO derivative. In addition, the general advantages of plant-based expression system can be exploited to address the cost and scalability issues related to its production.	[Kittur, Farooqahmed S.; Bah, Mamudou; Hung, Chiu-Yueh; Xie, Jiahua] N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, Durham, NC 27707 USA; [Archer-Hartmann, Stephanie; Azadi, Parastoo; Ishihara, Mayumi] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Sane, David C.] Caril Clin, Roanoke, VA USA; [Sane, David C.] Virginia Tech, Caril Sch Med, Roanoke, VA USA	University of North Carolina; North Carolina Central University; University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University	Xie, JH (corresponding author), N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, Durham, NC 27707 USA.	jxie@nccu.edu		Archer-Hartmann, Stephanie/0000-0001-8752-7363; Xie, Jiahua/0000-0003-2786-0281; Aoki, Mayumi/0000-0002-8368-8546	National Institute of General Medical Sciences [SC3GM088084]; NIH Integrated Biomedical Glycomics Center grant [8P41GM103490]; Startup Fund from Golden LEAF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, SC3GM088084] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Integrated Biomedical Glycomics Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Startup Fund from Golden LEAF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant (SC3GM088084) (http://www.nigms.nih.gov) to JHX, NIH Integrated Biomedical Glycomics Center grant (8P41GM103490) (www.nih.gov) to PA and a Startup Fund from Golden LEAF Foundation (www.goldenleaf.org) to BRITE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Baker JE, 2007, J CARDIOVASC PHARM, V49, P337, DOI 10.1097/FJC.0b013e318040cf81; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Castilho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054836; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Chargelegue D, 2000, TRANSGENIC RES, V9, P187, DOI 10.1023/A:1008976219939; Cheon BY, 2004, TRANSGENIC RES, V13, P541, DOI 10.1007/s11248-004-2737-3; Chill L, 2009, BIOTECHNOL BIOENG, V102, P828, DOI 10.1002/bit.22099; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Conley AJ, 2009, PLANT BIOTECHNOL J, V7, P183, DOI 10.1111/j.1467-7652.2008.00389.x; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; EGRIE JC, 1986, IMMUNOBIOLOGY, V172, P213, DOI 10.1016/S0171-2985(86)80101-2; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fisher JW, 2003, EXP BIOL MED, V228, P1; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Goyal A, 2002, AM J RESP CELL MOL, V26, P224, DOI 10.1165/ajrcmb.26.2.4640; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hung CY, 2013, PLANT PHYSIOL, V161, P1049, DOI 10.1104/pp.112.209247; IMAI N, 1990, EUR J BIOCHEM, V194, P457, DOI 10.1111/j.1432-1033.1990.tb15639.x; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Jelkmann W, 2007, NEPHROL DIAL TRANSPL, V22, P2749, DOI 10.1093/ndt/gfm392; Jez J, 2013, BIOTECHNOL J, V8, P371, DOI 10.1002/biot.201200363; Jin C, 2008, GLYCOBIOLOGY, V18, P235, DOI 10.1093/glycob/cwm137; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Kittur FS, 2012, PLANT CELL REP, V31, P1233, DOI 10.1007/s00299-012-1244-x; Kornfeld R, 1985, ANNU REV BIOCHEM, V54; KRANTZ SB, 1991, BLOOD, V77, P419; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Ma JKC, 1998, NAT MED, V4, P601, DOI 10.1038/nm0598-601; MAITI IB, 1993, P NATL ACAD SCI USA, V90, P6110, DOI 10.1073/pnas.90.13.6110; MASRI KA, 1988, BIOCHEM BIOPH RES CO, V157, P657, DOI 10.1016/S0006-291X(88)80300-0; MATSUMOTO S, 1995, PLANT MOL BIOL, V27, P1163, DOI 10.1007/BF00020889; Mukherjee P, 2001, J NEUROCHEM, V77, P43, DOI 10.1046/j.1471-4159.2001.00167.x; Musa TA, 2009, PLANT BIOTECHNOL REP, V3, P157, DOI 10.1007/s11816-009-0086-7; Musiychuk K, 2013, STEM CELLS DEV, V22, P2326, DOI 10.1089/scd.2012.0489; NARHI LO, 1991, J BIOL CHEM, V266, P23022; Navazio L, 2002, BIOCHEMISTRY-US, V41, P14141, DOI 10.1021/bi0204701; Ogino A, 2010, J AM COLL CARDIOL, V56, P1949, DOI 10.1016/j.jacc.2010.04.068; Okada T, 2007, TRANSPLANTATION, V84, P504, DOI 10.1097/01.tp.0000277672.02783.33; Pankratova S, 2010, BRAIN, V133, P2281, DOI 10.1093/brain/awq101; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Parsons J, 2012, PLANT BIOTECHNOL J, V10, P851, DOI 10.1111/j.1467-7652.2012.00704.x; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; WASLEY LC, 1991, BLOOD, V77, P2624; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; Weise A, 2007, PLANT BIOTECHNOL J, V5, P389, DOI 10.1111/j.1467-7652.2007.00248.x; Weisner C., 2001, J CEREB BLOOD FLOW M, V21, P857; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Yokomaku Y, 2008, J AM SOC NEPHROL, V19, P321, DOI 10.1681/ASN.2007040481	69	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76468	10.1371/journal.pone.0076468	http://dx.doi.org/10.1371/journal.pone.0076468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124563	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100120
J	Li, L; Huang, YZ; Xiao, Y				Li, Lin; Huang, Yanzhao; Xiao, Yi			How to Use Not-Always-Reliable Binding Site Information in Protein-Protein Docking Prediction	PLOS ONE			English	Article							SHAPE COMPLEMENTARITY; SCORING FUNCTION; BIOLOGICAL INFORMATION; BACKBONE FLEXIBILITY; GEOMETRIC DOCKING; PAIR POTENTIALS; ENERGY FUNCTION; INTERFACES; SURFACE; CAPRI	In many protein-protein docking algorithms, binding site information is used to help predicting the protein complex structures. Using correct and accurate binding site information can increase protein-protein docking success rate significantly. On the other hand, using wrong binding sites information should lead to a failed prediction, or, at least decrease the success rate. Recently, various successful theoretical methods have been proposed to predict the binding sites of proteins. However, the predicted binding site information is not always reliable, sometimes wrong binding site information could be given. Hence there is a high risk to use the predicted binding site information in current docking algorithms. In this paper, a softly restricting method (SRM) is developed to solve this problem. By utilizing predicted binding site information in a proper way, the SRM algorithm is sensitive to the correct binding site information but insensitive to wrong information, which decreases the risk of using predicted binding site information. This SRM is tested on benchmark 3.0 using purely predicted binding site information. The result shows that when the predicted information is correct, SRM increases the success rate significantly; however, even if the predicted information is completely wrong, SRM only decreases success rate slightly, which indicates that the SRM is suitable for utilizing predicted binding site information.	[Li, Lin; Huang, Yanzhao; Xiao, Yi] Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China; [Li, Lin] Clemson Univ, Dept Phys, Clemson, SC 29631 USA	Huazhong University of Science & Technology; Clemson University	Huang, YZ (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China.	yzhuang@hust.edu.cn; yxiao@hust.edu.cn		Li, Lin/0000-0001-6447-2398	National Science Foundation of China [11174093, 11074084]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Foundation of China (www.nsfc.gov.cn) under Grant No. 11174093 and 11074084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; Bordner AJ, 2005, PROTEINS, V60, P353, DOI 10.1002/prot.20433; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chung JL, 2006, PROTEINS, V62, P630, DOI 10.1002/prot.20741; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fernandez-Recio J, 2002, PROTEIN SCI, V11, P280, DOI 10.1110/ps.19202; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gottschalk KE, 2004, PROTEIN ENG DES SEL, V17, P183, DOI 10.1093/protein/gzh021; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guharoy M, 2010, PROTEINS, V78, P3219, DOI 10.1002/prot.22821; Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645; Heifetz A, 2002, PROTEIN SCI, V11, P571, DOI 10.1110/ps.26002; Huang B, 2008, GENE, V422, P14, DOI 10.1016/j.gene.2008.06.014; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Huang SY, 2010, PROTEINS, V78, P3096, DOI 10.1002/prot.22797; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Hwang H, 2010, PROTEINS, V78, P3104, DOI 10.1002/prot.22764; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Krippahl L, 2003, PROTEINS, V52, P19, DOI 10.1002/prot.10387; Law DS, 2003, PROTEINS, V52, P33, DOI 10.1002/prot.10395; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Li L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-36; Liang S, 2004, PROTEINS, V57, P548, DOI 10.1002/prot.20238; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Liu SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-280; Liu SY, 2008, BIOINFORMATICS, V24, P2634, DOI 10.1093/bioinformatics/btn497; Lo Conte L, 1999, J MOL BIOL, V285, P2177; [罗丽 LUO Li], 2009, [生物物理学报, Acta Biophysica Sinica], V25, P282; Ma XH, 2005, PROTEINS, V60, P319, DOI 10.1002/prot.20577; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; Qin S, 2007, PROTEINS, V69, P743, DOI 10.1002/prot.21752; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Schueler-Furman O, 2005, PROTEINS, V60, P187, DOI 10.1002/prot.20556; Vakser IA, 1997, PROTEINS, P226; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zhang C, 2005, PROTEINS, V60, P314, DOI 10.1002/prot.20576; Zhou HX, 2001, PROTEINS, V44, P336, DOI 10.1002/prot.1099; Zhou HY, 2002, PROTEINS, V49, P483, DOI 10.1002/prot.10241	62	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75936	10.1371/journal.pone.0075936	http://dx.doi.org/10.1371/journal.pone.0075936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124522	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100079
J	Zhang, CQ; Chen, XX; Zou, RY; Zhou, K; Stephanopoulos, G; Too, HP				Zhang, Congqiang; Chen, Xixian; Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Too, Heng-Phon			Combining Genotype Improvement and Statistical Media Optimization for Isoprenoid Production in E. coli	PLOS ONE			English	Article							ENGINEERED ESCHERICHIA-COLI; HIGH-LEVEL PRODUCTION; LYCOPENE PRODUCTION; PLASMID DNA; PHOSPHOTRANSFERASE SYSTEM; AROMATIC-COMPOUNDS; PATHWAY; BIOSYNTHESIS; PRECURSOR; STRAINS	Isoprenoids are a large and diverse class of compounds that includes many high value natural products and are thus in great demand. To meet the increasing demand for isoprenoid compounds, metabolic engineering of microbes has been used to produce isoprenoids in an economical and sustainable manner. To achieve high isoprenoid yields using this technology, the availability of metabolic precursors feeding the deoxyxylulose phosphate (DXP) pathway, responsible for isoprenoid biosynthesis, has to be optimized. In this study, phosphoenolpyruvate, a vital DXP pathway precursor, was enriched by deleting the genes encoding the carbohydrate phosphotransferase system (PTS) in E. coli. Production of lycopene (a C40 isoprenoid) was maximized by optimizing growth medium and culture conditions. In optimized conditions, the lycopene yield from PTS mutant was seven fold higher than that obtained from the wild type strain. This resulted in the highest reported specific yield of lycopene produced from the DXP pathway in E. coli to date (20,000 mg/g dry cell weight). Both the copy number of the plasmid encoding the lycopene biosynthetic genes and the expression were found to be increased in the optimized media. Deletion of PTS together with a similar optimization strategy was also successful in enhancing the production of amorpha-1,4-diene, a distinct C15 isoprenoid, suggesting that the approaches developed herein can be generally applied to optimize production of other isoprenoids.	[Zhang, Congqiang; Chen, Xixian; Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Too, Heng-Phon] Singapore MIT Alliance, Chem & Pharmaceut Engn, Singapore, Singapore; [Too, Heng-Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT)	Too, HP (corresponding author), Singapore MIT Alliance, Chem & Pharmaceut Engn, Singapore, Singapore.	heng-phon_too@nuhs.edu.sg	Chen, Xixian/AAO-3793-2020; Zhang, Congqiang/ABA-9058-2021; Zhou, Kang/AAI-9969-2021; Zhou, Kang/AAQ-5730-2021	Zhang, Congqiang/0000-0003-1070-8806; Zhou, Kang/0000-0003-0606-7030	Singapore-MIT Alliance (Chemical Pharmaceutical Engineering)	Singapore-MIT Alliance (Chemical Pharmaceutical Engineering)	This work was supported by a grant from Singapore-MIT Alliance (Chemical Pharmaceutical Engineering). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Alper H, 2006, APPL MICROBIOL BIOT, V72, P968, DOI 10.1007/s00253-006-0357-y; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Baez-Viveros JL, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-30; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; Carnes AE, 2005, BIOPROCESS TECHNOL, P36; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; FREEDBERG WB, 1973, J BACTERIOL, V115, P816, DOI 10.1128/JB.115.3.816-823.1973; Gabor E, 2011, EUR J CELL BIOL, V90, P711, DOI 10.1016/j.ejcb.2011.04.002; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HOFMANN KH, 1990, J BASIC MICROB, V30, P37, DOI 10.1002/jobm.3620300111; Islam RS, 2007, BIOTECHNOL PROGR, V23, P785, DOI 10.1021/bp070059a; Iyer PV, 2009, APPL BIOCHEM BIOTECH, V159, P233, DOI 10.1007/s12010-008-8522-7; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Kolewe ME, 2008, MOL PHARMACEUT, V5, P243, DOI 10.1021/mp7001494; Mandenius CF, 2008, BIOTECHNOL PROGR, V24, P1191, DOI 10.1002/btpr.67; Martinez K, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-1; Mokhtari-Hosseini ZB, 2009, BIORESOURCE TECHNOL, V100, P2436, DOI 10.1016/j.biortech.2008.11.024; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; O'Kennedy RD, 2000, J BIOTECHNOL, V76, P175, DOI 10.1016/S0168-1656(99)00187-X; Prather KJ, 2003, ENZYME MICROB TECH, V33, P865, DOI 10.1016/S0141-0229(03)00205-9; Nguyen QT, 2012, FEBS LETT, V586, P2177, DOI 10.1016/j.febslet.2012.02.008; RIESENBERG D, 1991, J BIOTECHNOL, V20, P17, DOI 10.1016/0168-1656(91)90032-Q; RYAN W, 1991, BIOTECHNOL BIOENG, V37, P415, DOI 10.1002/bit.260370504; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Van Noorden R, 2010, NATURE, V466, P672, DOI [10.1038/466672a, 10.1038/467906a]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WEISSENBORN DL, 1992, J BIOL CHEM, V267, P6122; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhang X, 1998, J BACTERIOL, V180, P195, DOI 10.1128/JB.180.2.195-200.1998; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18; Zhou ZX, 2011, BIORESOURCE TECHNOL, V102, P9345, DOI 10.1016/j.biortech.2011.07.120	44	40	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75164	10.1371/journal.pone.0075164	http://dx.doi.org/10.1371/journal.pone.0075164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124471	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100028
J	Zhu, HB; Chen, LL; Zhou, W; Huang, ZT; Hu, JZ; Dai, S; Wang, XW; Huang, XF; He, C				Zhu, Hongbo; Chen, Linlin; Zhou, Wei; Huang, Zhongting; Hu, Jingzi; Dai, Sheng; Wang, Xiaowei; Huang, Xuefeng; He, Chao			Over-Expression of the ATP5J Gene Correlates with Cell Migration and 5-Fluorouracil Sensitivity in Colorectal Cancer	PLOS ONE			English	Article							BOVINE HEART-MITOCHONDRIA; COLON-CANCER; COUPLING FACTOR-6; BIOENERGETIC SIGNATURE; IN-VITRO; SYNTHASE; THERAPY; RESISTANCE; CARCINOMA; SURVIVAL	Recently we found that ATP5J was over-expressed in tissue samples from patients with colorectal cancer. However, the clinical significance and function of the over-expression of ATP5J in these patients remains unclear. We investigated these issues in the current study. Our results indicated that expression of ATP5J was significantly higher in colorectal cancer tissue than in adjacent tissue, and it was also significantly higher in metastatic lymph nodes than in primary cancer tissue (P<0.05). A correlation between ATP5J expression and tumor differentiation was detected, but no correlation with gender, age, T stage, lymph node metastasis, or survival status was observed. Down-regulation of ATP5J expression attenuated the ability of cell migration and increased the sensitivity to 5-fluorouracil (5-Fu) in cells of the DLD1 cell line. Inversely, up-regulation of ATP5J expression enhanced cell migration and decreased 5-Fu sensitivity, suggesting that the function of ATP5J in colorectal cancer might involve cell migration and 5-Fu sensitivity.	[Zhu, Hongbo; Chen, Linlin; Zhou, Wei; Dai, Sheng; Wang, Xiaowei; Huang, Xuefeng; He, Chao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Colorectal Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Hongbo; Zhou, Wei; Huang, Zhongting] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Key Lab Biotherapy Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Jingzi] Aviat Med Evaluat & Training Ctr Airforce Hangzho, Dept Internal Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	He, C (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Colorectal Surg, Hangzhou 310003, Zhejiang, Peoples R China.	drhechao@yahoo.com.cn	dai, sheng/AGQ-0059-2022		National Natural Science Foundation of China [30700970, 81272681]; Fundamental Research Funds for the Central Universities; Program for Innovative Research Team in Zhejiang Province [2010R50046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Innovative Research Team in Zhejiang Province	This work was supported by grants from the National Natural Science Foundation of China (30700970 and 81272681), the Fundamental Research Funds for the Central Universities and Program for Innovative Research Team in Zhejiang Province (2010R50046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2006, ANN SURG ONCOL, V13, P887, DOI 10.1245/ASO.2006.07.003; Bjerregaard H, 2011, DIAGN MOL PATHOL, V20, P212, DOI 10.1097/PDM.0b013e318212e0a9; Chang JK, 2003, REGUL PEPTIDES, V113, P63, DOI 10.1016/S0167-0115(02)00303-8; Chau I, 2002, BRIT MED BULL, V64, P159, DOI 10.1093/bmb/64.1.159; COLLINSON IR, 1994, J MOL BIOL, V242, P408; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Gu J, 2002, ONCOGENE, V21, P4757, DOI 10.1038/sj.onc.1205582; Huang X, 2002, GENE THER, V9, P1379, DOI 10.1038/sj.gt.3301810; JOSHI S, 1989, J BIOL CHEM, V264, P15548; Ju JH, 2007, INT J COLORECTAL DIS, V22, P855, DOI 10.1007/s00384-007-0293-z; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Osanai T, 2005, HYPERTENSION, V46, P1140, DOI 10.1161/01.HYP.0000186483.86750.85; Pathy S, 2012, DIS COLON RECTUM, V55, P900, DOI 10.1097/DCR.0b013e31825afc4e; Reddavide R, 2011, ANTICANCER RES, V31, P555; Rehman MU, 2009, ASIAN PAC J CANCER P, V10, P719; Shailubhai K, 2000, CANCER RES, V60, P5151; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Watts SW, 2005, HYPERTENSION, V46, P1100, DOI 10.1161/01.HYP.0000186476.62399.6c; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763; Zhang L, 2002, GENE THER, V9, P1262, DOI 10.1038/sj.gt.3301797; Zhou J, 2006, CANCER RES, V66, P445, DOI 10.1158/0008-5472.CAN-05-1779; Zhu HB, 2007, INT J CANCER, V121, P1366, DOI 10.1002/ijc.22856	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76846	10.1371/journal.pone.0076846	http://dx.doi.org/10.1371/journal.pone.0076846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124598	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100155
J	Adesso, S; Popolo, A; Bianco, G; Sorrentino, R; Pinto, A; Autore, G; Marzocco, S				Adesso, Simona; Popolo, Ada; Bianco, Giuseppe; Sorrentino, Rosalinda; Pinto, Aldo; Autore, Giuseppina; Marzocco, Stefania			The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; STAGE RENAL-DISEASE; OXIDATIVE STRESS; NITRIC-OXIDE; IMMUNE DYSFUNCTION; NADPH OXIDASE; METHYLGUANIDINE; INFLAMMATION; ACTIVATION	Indoxyl sulphate (IS) is a protein-bound uremic toxin that results from the metabolism of dietary tryptophan normally excreted by kidney through the proximal tubules. Thus the toxin accumulates in the blood of patients with impaired renal function such as in chronic kidney disease (CKD). High IS serum levels in patients with CKD suggest its involvement in CKD progression and in the onset of complications. Its presence in plasma is also a powerful predictor of overall and cardiovascular morbidity/mortality. IS is a well known nephrovascular toxin but very little is known regarding its effects on the immune system and in particular during inflammation. In this study we examined the effect of IS on macrophage activation in response to lipopolysaccharide from E. coli (LPS), a gram negative bacterial endotoxin associated with inflammation and septic shock. To simulate the uremic condition, J774A.1 macrophages were incubated with IS at concentrations observed in uremic patients (1000-62.5 mu M) both alone and during LPS challenge. IS alone induced release of reactive oxygen species (ROS), through a mechanism involving pro- and anti-oxidant systems, and alteration in intracellular calcium homeostasis. When added to J774A.1 macrophages in presence of LPS, IS significantly increased the nitric oxide (NO) release, inducible nitric oxide synthase (iNOS) and cycloxygenase-2 (COX-2) expression. IS pre-treatment was also associated with an increase in tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) production by macrophages stimulated with LPS. Mechanistic studies revealed that IS increased LPS-induced NF-kB nuclear translocation, ROS release and altered calcium concentrations, mainly because of mitochondrial calcium overloading. Moreover also in primary mouse peritoneal macrophages IS enhances the inflammatory response to LPS increasing ROS, NO, iNOS, COX-2, TNF-alpha, IL-6 and NF-kB levels. This study provides evidences that IS stimulates macrophage function and enhances inflammatory reasponse associated with LPS, thus contributing to altered immune response dysfunctions observed in CKD.	[Adesso, Simona; Popolo, Ada; Bianco, Giuseppe; Sorrentino, Rosalinda; Pinto, Aldo; Autore, Giuseppina; Marzocco, Stefania] Univ Salerno, Sch Pharm, Dept Pharm, Fisciano, SA, Italy	University of Salerno	Marzocco, S (corresponding author), Univ Salerno, Sch Pharm, Dept Pharm, Fisciano, SA, Italy.	smarzocco@unisa.it	Sorrentino, Rosalinda/AAK-9540-2020; Marzocco, Stefania/AAI-1493-2020	Popolo, Ada/0000-0002-9843-8443; Sorrentino, Rosalinda/0000-0001-9201-9857	University of Salerno (FARB)	University of Salerno (FARB)	This work was supported by grant from the University of Salerno (FARB 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2002, J LEUKOCYTE BIOL, V71, P1005; Autore G, 1999, LIFE SCI, V65, pPL121, DOI 10.1016/S0024-3205(99)00355-0; Autore G, 2010, MOLECULES, V15, P2028, DOI 10.3390/molecules15032028; Ben Jemia M, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-47; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bianco G, 2012, TOXICON, V59, P644, DOI 10.1016/j.toxicon.2012.02.010; Bianco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052051; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Castilla P, 2008, AM J CLIN NUTR, V87, P1053, DOI 10.1093/ajcn/87.4.1053; Cioffi G, 2006, J NAT PROD, V69, P1323, DOI 10.1021/np060257w; Cohen G, 2007, NEPHROL DIAL TRANSPL, V22, P3381, DOI 10.1093/ndt/gfm210; Cohen G, 2012, TOXINS, V4, P962, DOI 10.3390/toxins4110962; Di Micco L, 2012, CURR HYPERTENS REV, V8, P291, DOI 10.2174/1573402111208040291; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Dugo L, 2004, BRIT J PHARMACOL, V141, P979, DOI 10.1038/sj.bjp.0705683; Fortuno A, 2005, KIDNEY INT, V68, P71; Hauser AB, 2006, PERITON DIALYSIS INT, V28, P183; Hischi S, 1989, DERMATOLOGICA, V179, P68; Holmes CL, 2003, CLIN CHEST MED, V24, P775, DOI 10.1016/S0272-5231(03)00107-2; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Ito S, 2010, J BIOL CHEM, V285, P38869, DOI 10.1074/jbc.M110.166686; Karpati I, 2001, NEPHROL DIAL TRANSPL, V16, P1409, DOI 10.1093/ndt/16.7.1409; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kaysen GA, 2004, J AM SOC NEPHROL, V15, P538, DOI 10.1097/01.ASN.0000111744.00916.E6; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Libetta C, 2011, CLIN BIOCHEM, V44, P1189, DOI 10.1016/j.clinbiochem.2011.06.988; Marzocco S, 2004, FREE RADICAL RES, V38, P1143, DOI 10.1080/10715760410001725517; Marzocco S, 2004, LIFE SCI, V75, P1417, DOI 10.1016/j.lfs.2004.02.031; Marzocco S, 2004, EUR J PHARMACOL, V484, P341, DOI 10.1016/j.ejphar.2003.11.011; Marzocco S, 2013, BLOOD PURIFICAT, V35, P196, DOI 10.1159/000346628; Marzocco S, 2010, NEUROCHEM INT, V57, P518, DOI 10.1016/j.neuint.2010.06.016; Masai N, 2010, CIRC J, V74, P2216, DOI 10.1253/circj.CJ-10-0117; Morena M, 2002, KIDNEY INT, V61, pS109, DOI 10.1046/j.1523-1755.61.s80.20.x; Mozar A, 2011, THER APHER DIAL, V15, P135, DOI 10.1111/j.1744-9987.2010.00885.x; NIWA T, 1988, CLIN CHEM, V34, P2264; Niwa T, 1996, SEMIN NEPHROL, V16, P167; Niwa T, 2001, TXB NEPHROLOGY, P1269; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211; Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373; RADDASSI K, 1994, CELL IMMUNOL, V153, P443, DOI 10.1006/cimm.1994.1041; Raff AC, 2008, CURR OPIN NEPHROL HY, V17, P560, DOI 10.1097/MNH.0b013e32830f45b6; Rodriguez-Ayala E, 2005, ATHEROSCLEROSIS, V180, P333, DOI 10.1016/j.atherosclerosis.2004.12.007; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Stenvinkel P, 2003, J AM SOC NEPHROL, V14, P1927, DOI 10.1097/01.ASN.0000069165.79509.42; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Szabo C, 1995, New Horiz, V3, P2; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thiemermann C, 1994, Adv Pharmacol, V28, P45, DOI 10.1016/S1054-3589(08)60493-7; Thiemermann C, 1997, GEN PHARMACOL-VASC S, V29, P159, DOI 10.1016/S0306-3623(96)00410-7; THIEMERMANN C, 1993, BRIT J PHARMACOL, V110, P177, DOI 10.1111/j.1476-5381.1993.tb13789.x; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	62	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76778	10.1371/journal.pone.0076778	http://dx.doi.org/10.1371/journal.pone.0076778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098806	gold, Green Published			2022-12-27	WOS:000325423500177
J	Lucidarme, J; Findlow, J; Chan, H; Feavers, IM; Gray, SJ; Kaczmarski, EB; Parkhill, J; Bai, XL; Borrow, R; Bayliss, CD				Lucidarme, Jay; Findlow, Jamie; Chan, Hannah; Feavers, Ian M.; Gray, Stephen J.; Kaczmarski, Edward B.; Parkhill, Julian; Bai, Xilian; Borrow, Ray; Bayliss, Christopher D.			The Distribution and 'In Vivo' Phase Variation Status of Haemoglobin Receptors in Invasive Meningococcal Serogroup B Disease: Genotypic and Phenotypic Analysis	PLOS ONE			English	Article							TRANSFERRIN-BINDING PROTEINS; NEISSERIA-MENINGITIDIS; MULTICOMPONENT VACCINE; CONTINGENCY LOCI; FACTOR-H; ANTIBODIES; HPUAB; HMBR; HAPTOGLOBIN; VIRULENCE	Two haemoglobin-binding proteins, HmbR and HpuAB, contribute to iron acquisition by Neisseria meningitidis. These receptors are subject to high frequency, reversible switches in gene expression - phase variation (PV) - due to mutations in homopolymeric (poly-G) repeats present in the open reading frame. The distribution and PV state of these receptors was assessed for a representative collection of isolates from invasive meningococcal disease patients of England, Wales and Northern Ireland. Most of the major clonal complexes had only the HmbR receptor whilst the recently expanding ST-275-centred cluster of the ST-269 clonal complex had both receptors. At least one of the receptors was in an 'ON' configuration in 76.3% of the isolates, a finding that was largely consistent with phenotypic analyses. As PV status may change during isolation and culture of meningococci, a PCR-based protocol was utilised to confirm the expression status of the receptors within contemporaneously acquired clinical specimens (blood/cerebrospinal fluid) from the respective patients. The expression state was confirmed for all isolate/specimen pairs with <15 tract repeats indicating that the PV status of these receptors is stable during isolation. This study therefore establishes a protocol for determining in vivo PV status to aid in determining the contributions of phase variable genes to invasive meningococcal disease. Furthermore, the results of the study support a putative but non-essential role of the meningococcal haemoglobin receptors as virulence factors whilst further highlighting their vaccine candidacy.	[Lucidarme, Jay; Findlow, Jamie; Gray, Stephen J.; Kaczmarski, Edward B.; Bai, Xilian; Borrow, Ray] Publ Hlth England, Manchester, Lancs, England; [Chan, Hannah; Feavers, Ian M.] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Bayliss, Christopher D.] Univ Leicester, Leicester, Leics, England	Public Health England; National Institute for Biological Standards & Control; Wellcome Trust Sanger Institute; University of Leicester	Lucidarme, J (corresponding author), Publ Hlth England, Manchester, Lancs, England.	jay.lucidarme@phe.gov.uk	Parkhill, Julian/G-4703-2011	Parkhill, Julian/0000-0002-7069-5958; Bayliss, Christopher/0000-0002-5564-2145	Meningitis Research Foundation [1002.0]	Meningitis Research Foundation(Meningitis Research Foundation (MRF))	This study was supported by the Meningitis Research Foundation, grant number 1002.0 entitled "Examination of meningococcal haemoglobin receptors as potential vaccine targets". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAALDEEN DAA, 1994, INFECT IMMUN, V62, P2984, DOI 10.1128/IAI.62.7.2984-2990.1994; Arnold R, 2011, VACCINE, V29, P7100, DOI 10.1016/j.vaccine.2011.06.120; Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Bidmos FA, 2011, J CLIN MICROBIOL, V49, P506, DOI 10.1128/JCM.01322-10; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Chen CJ, 2002, J BACTERIOL, V184, P420, DOI 10.1128/JB.184.2.420-426.2002; DANVE B, 1993, VACCINE, V11, P1214, DOI 10.1016/0264-410X(93)90045-Y; Evans NJ, 2010, MICROBIOL-SGM, V156, P1384, DOI 10.1099/mic.0.036475-0; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; HOLBEIN BE, 1981, INFECT IMMUN, V34, P120, DOI 10.1128/IAI.34.1.120-125.1981; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lewis LA, 1999, MOL MICROBIOL, V32, P977, DOI 10.1046/j.1365-2958.1999.01409.x; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Lucidarme J, 2012, THESIS U MANCHESTER; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Omer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017145; Pace D, 2009, VACCINE, V27, pB30, DOI 10.1016/j.vaccine.2009.05.003; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Pintor M, 1996, MICROB PATHOGENESIS, V20, P127, DOI 10.1006/mpat.1996.0012; Riepsamen AH, 2011, J MOL EVOL, V72, P182, DOI 10.1007/s00239-010-9414-3; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; Rokbi B, 2000, INFECT IMMUN, V68, P4938, DOI 10.1128/IAI.68.9.4938-4947.2000; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76932	10.1371/journal.pone.0076932	http://dx.doi.org/10.1371/journal.pone.0076932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098814	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500185
J	Shivarov, V; Ivanova, M; Hadjiev, E; Naumova, E				Shivarov, Velizar; Ivanova, Milena; Hadjiev, Evgueniy; Naumova, Elissaveta			Novel Multiplex Bead-Based Assay for Detection of IDH1 and IDH2 Mutations in Myeloid Malignancies	PLOS ONE			English	Article							LEUKEMIA; PCR; IMMUNOHISTOCHEMISTRY; PERFORMANCE; TECHNOLOGY; GENE; AML	Isocitrate dehydrogenase 1 and 2 (IDH) mutations are frequently found in various cancer types such as gliomas, chondrosarcomas and myeloid malignancies. Their molecular detection has recently gained wide recognition in the diagnosis and prognosis of these neoplasms. For that purpose various molecular approaches have been used but a universally accepted method is still lacking. In this study we aimed to develop a novel bead-based liquid assay using Locked nucleic acids (LNA)-modified oligonucleotide probes for multiplexed detection of the most frequent IDH1 (p.R132C, p.R132G, p.R132H, p.R132L, p.R132S) and IDH2 (p.R140Q, p.R172K) mutations. The method includes four steps: 1) PCR amplification of the targeted fragments with biotinylated primers; 2) Direct hybridization to barcoded microbeads with specific LNA-modified oligonucleotide probes; 3) Incubation with phycoerythrin coupled streptavidin; 4) Acquisition of fluorescent intensities of each set of beads on a flow platform (LuminexCorp., USA). We tested the performance of the assay on both artificial plasmid constructs and on clinical samples from 114 patients with known or suspected myeloid malignancies. The method appeared to be superior to direct sequencing having a much higher sensitivity of 2.5% mutant alleles. Applying this method to patients' samples we identified a total of 9 mutations (one IDH1 p.R132C, seven IDH2 p.R140Q and one IDH2 p.R172K). In conclusion, this method could be successfully implemented in the diagnostic work-up for various tumors known to harbor IDH1/2 mutations (e. g. myeloid malignancies, gliomas, etc.). International initiatives are needed to validate the different existing methods for detection of IDH1/2 mutations in clinical settings.	[Shivarov, Velizar] Natl Hematol Hosp, Lab Hematopathol & Immunol, Sofia, Bulgaria; [Ivanova, Milena; Naumova, Elissaveta] Med Univ, Alexandrovska Univ Hosp, Dept Clin Immunol, Sofia, Bulgaria; [Hadjiev, Evgueniy] Med Univ, Alexandrovska Univ Hosp, Dept Clin Hematol, Sofia, Bulgaria	Medical University Sofia; Medical University Sofia	Shivarov, V (corresponding author), Natl Hematol Hosp, Lab Hematopathol & Immunol, Sofia, Bulgaria.	vshivarov@abv.bg	Shivarov, Velizar/B-4553-2008; Ivanova, MIlena/AAY-9725-2021; Naumova, Elissaveta/AFT-1332-2022	Shivarov, Velizar/0000-0001-5362-7999; 	National Science Fund, Bulgaria [ID_09_157, 5/16.12.2009]	National Science Fund, Bulgaria(National Science Fund of Bulgaria)	This work was supported by Grant ID_09_157 (Contract 5/16.12.2009) of the National Science Fund, Bulgaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, NEURO-ONCOLOGY, V15, P718, DOI 10.1093/neuonc/not015; Boisselier B, 2010, HUM MUTAT, V31, P1360, DOI 10.1002/humu.21365; Bujko M, 2010, MOL DIAGN THER, V14, P163, DOI 10.2165/11537170-000000000-00000; Chou WC, 2010, BLOOD, V116, P495, DOI 10.1182/blood-2010-04-280636; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hafez M, 2010, J MOL DIAGN, V12, P629, DOI 10.2353/jmoldx.2010.090219; Ho PA, 2011, BLOOD, V118, P4561, DOI 10.1182/blood-2011-04-348888; Ibanez M, 2012, J MOL DIAGN, V14, P594, DOI 10.1016/j.jmoldx.2012.06.006; Ivanova MI, 2011, LEUKEMIA RES, V35, P1120, DOI 10.1016/j.leukres.2011.04.012; Jeziskova I, 2013, LEUKEMIA LYMPHOMA, V54, P867, DOI 10.3109/10428194.2012.727414; Laosinchai-Wolf W, 2011, J CLIN PATHOL, V64, P30, DOI 10.1136/jcp.2010.081539; Lin J, 2011, CLIN BIOCHEM, V44, P779, DOI 10.1016/j.clinbiochem.2011.04.014; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Loussouarn D, 2012, INT J ONCOL, V40, P2058, DOI 10.3892/ijo.2012.1404; Milbury CA, 2012, CLIN CHEM, V58, P580, DOI 10.1373/clinchem.2011.176198; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Nomdedeu J, 2012, LEUKEMIA RES, V36, P990, DOI 10.1016/j.leukres.2012.03.019; Noordermeer SM, 2011, BRIT J HAEMATOL, V152, P493, DOI 10.1111/j.1365-2141.2010.08423.x; Pang B, 2013, DIAGN MOL PATHOL, V22, P28, DOI 10.1097/PDM.0b013e31826c7ff8; Paradis FW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-54; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Patel KP, 2011, J MOL DIAGN, V13, P678, DOI 10.1016/j.jmoldx.2011.06.004; Rakheja D, 2012, HUM PATHOL, V43, P1541, DOI 10.1016/j.humpath.2012.05.003; Schnittger S, 2010, BLOOD, V116, P5486, DOI 10.1182/blood-2010-02-267955; Shackelford Rodney E, 2013, Methods Mol Biol, V999, P93, DOI 10.1007/978-1-62703-357-2_6; Shivarov V, 2013, LEUKEMIA LYMPHOMA, V54, P1343, DOI 10.3109/10428194.2012.745526; Shivarov V, 2011, LEUKEMIA LYMPHOMA, V52, P2023, DOI 10.3109/10428194.2011.584995; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Vannucchi AM, 2013, LEUKEMIA IN PRESS; Wallace J, 2003, LEUKEMIA, V17, P1404, DOI 10.1038/sj.leu.2402985; Wu SY, 2010, CLIN CHEM LAB MED, V48, P1103, DOI 10.1515/CCLM.2010.227; Zhou KG, 2012, LEUKEMIA LYMPHOMA, V53, P2423, DOI 10.3109/10428194.2012.695359	34	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76944	10.1371/journal.pone.0076944	http://dx.doi.org/10.1371/journal.pone.0076944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098815	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500186
J	Bombi, P; D'Amen, M; Luiselli, L				Bombi, Pierluigi; D'Amen, Manuela; Luiselli, Luca			From Continental Priorities to Local Conservation: A Multi-Level Analysis for African Tortoises	PLOS ONE			English	Article							SPECIES RICHNESS; SPATIAL SCALE; PROTECTED AREAS; NETWORK; IRREPLACEABILITY; DISTRIBUTIONS; RESOLUTION; SELECTION; PATTERNS; HOTSPOTS	Terrestrial tortoises are the most endangered group of vertebrates but they are still largely ignored for defining global conservation priorities. In this paper, we explored within a hierarchical framework the potential contribution of prioritization studies at the continental scale to the planning of local initiatives for the conservation of African tortoises at the regional level. First, we modeled the distribution of all the African tortoise species, we calculated three indicators of conservation priority (i.e. species richness, conservation value, and complementarity), and we carried out a gap analysis at continental scale. Second, we focused on the most important region for tortoise conservation and performed the same analyses at higher resolution. Finally, we compared the results from the two scales for understanding the degree to which they are complementary. Southern Africa emerged from the continental analysis as the most important region for tortoises. Within this area, the high-resolution analysis pointed out specific core sites for conservation. The relative degree of species protection was assessed similarly at the two different resolutions. Two species appeared particularly vulnerable at both scales. Priority indices calculated at high resolution were correlated to the values calculated for the corresponding cells at low resolution but the congruence was stronger for species richness. Our results suggest to integrate the calculation of conservation value and complementarity into a hierarchical framework driven by species richness. The advantages of large scale planning include its broad perspective on complementarity and the capability to identify regions with greatest conservation potential. In this light, continental analyses allow targeting fine scale studies toward regions with maximum priority. The regional analyses at fine scale allow planning conservation measure at a resolution similar to that required for the practical implementation, reducing the uncertainty associated with low resolution studies.	[Bombi, Pierluigi; D'Amen, Manuela] CNR, Inst Agroenvironm & Forest Biol, Monterotondo, Italy; [D'Amen, Manuela] Corpo Forestale Stato, Ctr Nazl Biodiversita Forestale Bosco Fontana, Verona, Italy; [Luiselli, Luca] Ctr Environm Studies Demetra Srl, Rome, Italy; [Luiselli, Luca] Eni Spa, Dept Environm, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Centre of Environmental Studies DEMETRA s.r.l.; Eni SpA	Bombi, P (corresponding author), CNR, Inst Agroenvironm & Forest Biol, Monterotondo, Italy.	pierluigi.bombi@gmail.com	D'Amen, manuela/K-4170-2015; Luiselli, Luca/AAG-9098-2020; D'Amen, Manuela/L-8272-2016	D'Amen, Manuela/0000-0001-5910-4267; Bombi, Pierluigi/0000-0002-7322-5724				Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2004, BIOL CONSERV, V118, P533, DOI 10.1016/j.biocon.2003.10.006; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bombi P, 2012, J BIOGEOGR, V39, P640, DOI 10.1111/j.1365-2699.2011.02627.x; Bombi P, 2011, DIVERS DISTRIB, V17, P581, DOI 10.1111/j.1472-4642.2011.00769.x; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Branch B., 2008, TORTOISES TERRAPINS; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Burgess Neil, 1997, Bulletin of the African Bird Club, V4, P93; Chirio L., 2007, ATLAS REPTILES CAMER; D'Amen M, 2013, ANIM CONSERV, V16, P370, DOI 10.1111/acv.12016; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Entsminger G.L., 2001, ECOSIM NULL MODELS S; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Groves C. R., 2003, CONSERVATIO IN PRESS; Hacker JE, 1998, BIOL CONSERV, V84, P251, DOI 10.1016/S0006-3207(97)00115-8; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huber PR, 2010, LANDSCAPE ECOL, V25, P683, DOI 10.1007/s10980-010-9447-4; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Iverson J.B., 1992, Smithsonian Herpetological Information Service, P1; IVERSON JB, 1992, HERPETOL J, V2, P77; Iverson JB, 2003, EMYSYSTEM WORLD TURT; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; Larsen FW, 2003, BIODIVERS CONSERV, V12, P599, DOI 10.1023/A:1022448928753; Lehsten V, 2006, ECOGRAPHY, V29, P786, DOI 10.1111/j.0906-7590.2006.04626.x; Luiselli L, 2009, BIODIVERS CONSERV, V18, P1349, DOI 10.1007/s10531-008-9486-1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, BIODIVERS CONSERV, V3, P242, DOI 10.1007/BF00055941; Pressey RL, 2009, C PLAN CONSERVATION; R Core Team, 2021, R LANGUAGE ENV STAT; Rhodin AGJ, 2010, CHELONIANS RES MONOG, V5, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V3.2010; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rouget M, 2003, BIOL CONSERV, V112, P217, DOI 10.1016/S0006-3207(02)00415-9; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Shriner SA, 2006, ECOL APPL, V16, P1660, DOI 10.1890/1051-0761(2006)016[1660:RNBORH]2.0.CO;2; Thuiller W., 2009, BIOMOD SPECIES CLIMA; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Turtle Conservation Fund, 2002, GLOB ACT PLAN CONS T; Turtle Taxonomy Working Group, 2007, Chelonian Research Monographs, V4, P173; Welsch R, 1980, REGRESSION DIAGNOSTI	62	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77093	10.1371/journal.pone.0077093	http://dx.doi.org/10.1371/journal.pone.0077093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116208	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200102
J	Naito, Y; Sawada, H; Oboshi, M; Fujii, A; Hirotani, S; Iwasaku, T; Okuhara, Y; Eguchi, A; Morisawa, D; Ohyanagi, M; Tsujino, T; Masuyama, T				Naito, Yoshiro; Sawada, Hisashi; Oboshi, Makiko; Fujii, Aya; Hirotani, Shinichi; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Eguchi, Akiyo; Morisawa, Daisuke; Ohyanagi, Mitsumasa; Tsujino, Takeshi; Masuyama, Tohru			Increased Renal Iron Accumulation in Hypertensive Nephropathy of Salt-Loaded Hypertensive Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; DAMAGE	Although iron is reported to be associated with the pathogenesis of chronic kidney disease, it is unknown whether iron participates in the pathophysiology of nephrosclerosis. Here, we investigate whether iron is involved in the development of hypertensive nephropathy and the effects of iron restriction on nephrosclerosis in salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP). SHRSP were given either a normal or high-salt diet for 8 weeks. Another subset of SHRSP were fed a high-salt with iron-restricted diet. SHRSP given a high-salt diet developed severe hypertension and nephrosclerosis. As a result, survival rate was decreased after 8 weeks diet. Importantly, massive iron accumulation and increased iron content were observed in the kidneys of salt-loaded SHRSP, along with increased superoxide production, urinary 8-Hydroxy-2 '-deoxyguanosine excretion, and urinary iron excretion; however, these changes were markedly attenuated by iron restriction. Of interest, expression of cellular iron transport proteins, transferrin receptor 1 and divalent metal transporter 1, was increased in the tubules of salt-loaded SHRSP. Notably, iron restriction attenuated the development of severe hypertension and nephrosclerosis, thereby improving survival rate in salt-loaded SHRSP. Taken together, these results suggest a novel mechanism by which iron plays a role in the development of hypertensive nephropathy and establish the effects of iron restriction on salt-induced nephrosclerosis.	[Naito, Yoshiro; Sawada, Hisashi; Oboshi, Makiko; Fujii, Aya; Hirotani, Shinichi; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Eguchi, Akiyo; Morisawa, Daisuke; Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan; [Ohyanagi, Mitsumasa] Hyogo Coll Med, Dept Internal Med, Div Coronary Heart Dis, Nishinomiya, Hyogo 6638501, Japan; [Tsujino, Takeshi] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Naito, Y (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan.	ynaito@hyo-med.ac.jp			JSPS KAKENHI [25460919]; Salt Science Research Foundation [1232]; Takeda Science Foundation; Hyogo Science and Technology Association	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hyogo Science and Technology Association	This study was supported by a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant No. 25460919) and grants from The Salt Science Research Foundation (No. 1232), Takeda Science Foundation, and Hyogo Science and Technology Association (to Y. Naito). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonios TFT, 1996, LANCET, V348, P250, DOI 10.1016/S0140-6736(96)01463-8; CAMARGO MJF, 1993, J HYPERTENS, V11, P31, DOI 10.1097/00004872-199301000-00006; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Fishbane S, 2003, AM J KIDNEY DIS, V41, pS18, DOI 10.1016/S0272-638(03)00373-1; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HARRIS DCH, 1994, CLIN EXP PHARMACOL P, V21, P73, DOI 10.1111/j.1440-1681.1994.tb02472.x; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Luke RG, 1999, NEPHROL DIAL TRANSPL, V14, P2271, DOI 10.1093/ndt/14.10.2271; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580, DOI 10.1016/S0272-6386(12)70222-6; Pillebout E, 2003, J CLIN INVEST, V112, P843, DOI 10.1172/JCI200317647	14	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75906	10.1371/journal.pone.0075906	http://dx.doi.org/10.1371/journal.pone.0075906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116080	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200042
J	Su, Y; Cui, LL; Piao, CS; Li, B; Zhao, LR				Su, Ye; Cui, Lili; Piao, Chunshu; Li, Bin; Zhao, Li-Ru			The Effects of Hematopoietic Growth Factors on Neurite Outgrowth	PLOS ONE			English	Article							NF-KAPPA-B; STEM-CELL FACTOR; COLONY-STIMULATING FACTOR; FACTOR G-CSF; RAT PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; CORTICAL-NEURONS; NERVOUS-SYSTEM; BRAIN; SURVIVAL	Stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) are initially discovered as the essential hematopoietic growth factors regulating bone marrow stem cell proliferation and differentiation, and SCF in combination with G-CSF (SCF+G-CSF) has synergistic effects on bone marrow stem cell mobilization. In this study we have determined the effect of SCF and G-CSF on neurite outgrowth in rat cortical neurons. Using molecular and cellular biology and live cell imaging approaches, we have revealed that receptors for SCF and G-CSF are expressed on the growth core of cortical neurons, and that SCF+G-CSF synergistically enhances neurite extension through PI3K/AKT and NF kappa B signaling pathways. Moreover, SCF+G-CSF induces much greater NF kappa B activation, NF kappa B transcriptional binding and brain-derived neurotrophic factor (BDNF) production than SCF or G-CSF alone. In addition, we have also observed that BDNF, the target gene of NF kappa B, is required for SCF+G-CSF-induced neurite outgrowth. These data suggest that SCF+G-CSF has synergistic effects to promote neurite growth. This study provides new insights into the contribution of hematopoietic growth factors in neuronal plasticity.	[Su, Ye; Cui, Lili; Piao, Chunshu; Li, Bin; Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA; [Cui, Lili; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA; [Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Zhao, LR (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA.	ZHAOL@upstate.edu			National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS060911]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060911] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by The National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), R01 NS060911 to L.R.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; BERNSTEIN SE, 1970, AM J SURG, V119, P448, DOI 10.1016/0002-9610(70)90148-0; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; DEMETRI GD, 1991, BLOOD, V78, P2791; Dhandapani KM, 2005, J NEUROCHEM, V95, P9, DOI 10.1111/j.1471-4159.2005.03319.x; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Duarte RF, 2002, LEUKEMIA LYMPHOMA, V43, P1179, DOI 10.1080/10428190290026231; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Esch T, 1999, J NEUROSCI, V19, P6417; Foehr ED, 2000, J NEUROSCI, V20, P7556; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Kaltschmidt B, 2002, NEUROMOL MED, V2, P299, DOI 10.1385/NMM:2:3:299; Katafuchi T, 2000, LEARN MEMORY, V7, P383, DOI 10.1101/lm.33900; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Kita Y, 1998, J CELL SCI, V111, P907; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCNIECE IK, 1995, J LEUKOCYTE BIOL, V58, P14, DOI 10.1002/jlb.58.1.14; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Motro B, 1996, P NATL ACAD SCI USA, V93, P1808, DOI 10.1073/pnas.93.5.1808; Mullen LM, 2012, BRAIN RES, V1430, P25, DOI 10.1016/j.brainres.2011.10.054; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; Piao CS, 2012, DIFFERENTIATION, V83, P17, DOI 10.1016/j.diff.2011.08.006; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Rabacchi SA, 1999, J NEUROBIOL, V40, P254, DOI 10.1002/(SICI)1097-4695(199908)40:2<254::AID-NEU11>3.0.CO;2-4; Salie R, 2005, INT J DEV NEUROSCI, V23, P587, DOI 10.1016/j.ijdevneu.2005.07.003; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Wirth MJ, 2003, DEVELOPMENT, V130, P5827, DOI 10.1242/dev.00826; Yan Q, 1997, J COMP NEUROL, V378, P135; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; Zhao LR, 2007, STROKE, V38, P2584, DOI 10.1161/STROKEAHA.106.476457; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	52	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75562	10.1371/journal.pone.0075562	http://dx.doi.org/10.1371/journal.pone.0075562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116056	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200028
J	Sun, H; Weng, J; Yu, GC; Massawe, RH				Sun, Heng; Weng, Jian; Yu, Guangchuang; Massawe, Richard H.			A DNA-Based Semantic Fusion Model for Remote Sensing Data	PLOS ONE			English	Article							BIG DATA; ONTOLOGY; INFORMATION; SCIENCE; STORAGE; GENE; XML; WEB	Semantic technology plays a key role in various domains, from conversation understanding to algorithm analysis. As the most efficient semantic tool, ontology can represent, process and manage the widespread knowledge. Nowadays, many researchers use ontology to collect and organize data's semantic information in order to maximize research productivity. In this paper, we firstly describe our work on the development of a remote sensing data ontology, with a primary focus on semantic fusion-driven research for big data. Our ontology is made up of 1,264 concepts and 2,030 semantic relationships. However, the growth of big data is straining the capacities of current semantic fusion and reasoning practices. Considering the massive parallelism of DNA strands, we propose a novel DNA-based semantic fusion model. In this model, a parallel strategy is developed to encode the semantic information in DNA for a large volume of remote sensing data. The semantic information is read in a parallel and bit-wise manner and an individual bit is converted to a base. By doing so, a considerable amount of conversion time can be saved, i.e., the cluster-based multi-processes program can reduce the conversion time from 81,536 seconds to 4,937 seconds for 4.34 GB source data files. Moreover, the size of result file recording DNA sequences is 54.51 GB for parallel C program compared with 57.89 GB for sequential Perl. This shows that our parallel method can also reduce the DNA synthesis cost. In addition, data types are encoded in our model, which is a basis for building type system in our future DNA computer. Finally, we describe theoretically an algorithm for DNA-based semantic fusion. This algorithm enables the process of integration of the knowledge from disparate remote sensing data sources into a consistent, accurate, and complete representation. This process depends solely on ligation reaction and screening operations instead of the ontology.	[Sun, Heng; Weng, Jian] Jinan Univ, Coll Informat Sci & Technol, Dept Comp Sci, Guangzhou, Guangdong, Peoples R China; [Yu, Guangchuang] Jinan Univ, Coll Life Sci & Technol, Key Lab Funct Prot Res, Guangdong Higher Educ Inst,Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Massawe, Richard H.] Jinan Univ, Int Sch, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Sun, H (corresponding author), Jinan Univ, Coll Informat Sci & Technol, Dept Comp Sci, Guangzhou, Guangdong, Peoples R China.	tsunheng@jnu.edu.cn	Yu, Guangchuang/H-4685-2014; YU, Guangchuang/V-7134-2019; Yu, Guangchuang/G-1015-2017; Yu, Guangchuang/GQI-1922-2022	Yu, Guangchuang/0000-0002-6485-8781; Yu, Guangchuang/0000-0002-6485-8781	Natural Science Foundation of China [61272413, 60903178, 61272073]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (Grant No. 61272413, No. 60903178, and No. 61272073) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Afek Y, 2011, SCIENCE, V331, P183, DOI 10.1126/science.1193210; Alterovitz G, 2010, NAT BIOTECHNOL, V28, P128, DOI 10.1038/nbt0210-128; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bancroft C, 2001, SCIENCE, V293, P1763; Batcheller JK, 2010, COMPUT ENVIRON URBAN, V34, P333, DOI 10.1016/j.compenvurbsys.2010.02.008; Blu-ray Disc Association, 2010, WHIT PAP BLUR DISC F; Borresen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048498; Brovko OO, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704181; Bryant B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035703; Calvanese D., 2005, P AAAI 2005, P602; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cyganiak R, 2012, N QUADS EXTENDING N; Figuera JDL, 1993, PHYS REV B, V47, P13043; Fox A, 2011, SCIENCE, V331, P406, DOI 10.1126/science.1198981; Geneves P, 2011, ACM T INTERNET TECHN, V11, DOI 10.1145/1993083.1993087; Gerstein M, 2012, NATURE, V489, P208, DOI 10.1038/489208b; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Glimm B, 2008, J ARTIF INTELL RES, V31, P157, DOI 10.1613/jair.2372; Halvorsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044212; Hastings J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025513; Hendler J, 2003, SCIENCE, V299, P520, DOI 10.1126/science.1078874; Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410; Hussain S, 2013, PROC SPIE, V8639, DOI 10.1117/12.2002782; Imai H, 1982, STEREO REV, V12, P63; Iribarne L, 2011, IEEE T SYST MAN CY A, V41, P730, DOI 10.1109/TSMCA.2011.2132706; Janowicz K, 2012, T GIS, V16, P351, DOI 10.1111/j.1467-9671.2012.01342.x; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Kingston, 2013, KINGST DIG SHIPS ITS; Kneuer C, 2000, BIOCONJUGATE CHEM, V11, P926, DOI 10.1021/bc0000637; Konrath M, 2012, J WEB SEMANT, V16, P52, DOI 10.1016/j.websem.2012.06.002; Lattanzio A, 2013, B AM METEOROL SOC, V94, P205, DOI 10.1175/BAMS-D-11-00230.1; Leida M, 2012, J AMBINET INTELL HUM; Lewis JJ, 2007, INFORM FUSION, V8, P119, DOI 10.1016/j.inffus.2005.09.006; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Lynch C, 2008, NATURE, V455, P28, DOI 10.1038/455028a; Ma XG, 2012, COMPUT GEOSCI-UK, V40, P107, DOI 10.1016/j.cageo.2011.07.018; Mervis J, 2012, SCIENCE, V336, P22, DOI 10.1126/science.336.6077.22; Mimura H, 1997, P IEEE COMPCON 97 SA, P291; Oka H, 2010, SCIENCE, V327, P843, DOI 10.1126/science.1183224; Paun G., 1998, DNA COMPUTING NEW CO, DOI DOI 10.1007/978-3-662-03563-4; Renear AH, 2009, SCIENCE, V325, P828, DOI 10.1126/science.1157784; Rivera R, 2012, IBM SYSTEM STORAGE L; Schneider T, 2012, APPL ONTOL, V7, P357, DOI 10.3233/AO-2012-0111; Sun H, 2005, IEEE GEOSCI REMOTE S, V2, P440, DOI 10.1109/LGRS.2005.853573; Tsou M-H., 2004, J GEOGRAPHICAL SYSTE, V6, P155, DOI [10.1007/s10109-004-0131-6, DOI 10.1007/s10109-004-0131-6]; Tsuboi Y, 2005, INT J INNOV COMPUT I, V1, P755; Wang XS, 2005, NAT BIOTECHNOL, V23, P1099, DOI 10.1038/nbt1139; Wei YX, 2007, COMPUT GEOSCI-UK, V33, P238, DOI 10.1016/j.cageo.2006.06.006; Williams GT, 2010, J WEB SEMANT, V8, P365, DOI 10.1016/j.websem.2010.08.002; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Xu J, 2011, IEEE T NANOBIOSCI, V10, P94, DOI 10.1109/TNB.2011.2160996; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	55	2	2	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77090	10.1371/journal.pone.0077090	http://dx.doi.org/10.1371/journal.pone.0077090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116207	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200101
J	Wang, JX; Shi, X; Johnson, RH; Kelbauskas, L; Zhang, WW; Meldrum, DR				Wang, Jiangxin; Shi, Xu; Johnson, Roger H.; Kelbauskas, Laimonas; Zhang, Weiwen; Meldrum, Deirdre R.			Single-Cell Analysis Reveals Early Manifestation of Cancerous Phenotype in Pre-Malignant Esophageal Cells	PLOS ONE			English	Article							DNA COPY NUMBER; STOCHASTIC GENE-EXPRESSION; HYPOXIA-INDUCIBLE FACTOR; MITOCHONDRIAL-DNA; BARRETTS-ESOPHAGUS; NEOPLASTIC PROGRESSION; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; BREAST-CANCER; TUMOR HYPOXIA	Cellular heterogeneity plays a pivotal role in a variety of functional processes in vivo including carcinogenesis. However, our knowledge about cell-to-cell diversity and how differences in individual cells manifest in alterations at the population level remains very limited mainly due to the lack of appropriate tools enabling studies at the single-cell level. We present a study on changes in cellular heterogeneity in the context of pre-malignant progression in response to hypoxic stress. Utilizing premalignant progression of Barrett's esophagus (BE) as a disease model system we studied molecular mechanisms underlying the progression from metaplastic to dysplastic (pre-cancerous) stage. We used newly developed methods enabling measurements of cell-to-cell differences in copy numbers of mitochondrial DNA, expression levels of a set of mitochondrial and nuclear genes involved in hypoxia response pathways, and mitochondrial membrane potential. In contrast to bulk cell studies reported earlier, our study shows significant differences between metaplastic and dysplastic BE cells in both average values and single-cell parameter distributions of mtDNA copy numbers, mitochondrial function, and mRNA expression levels of studied genes. Based on single-cell data analysis, we propose that mitochondria may be one of the key factors in pre-malignant progression in BE.	[Wang, Jiangxin; Shi, Xu; Johnson, Roger H.; Kelbauskas, Laimonas; Zhang, Weiwen; Meldrum, Deirdre R.] Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	Kelbauskas, L (corresponding author), Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ USA.	lkelbaus@asu.edu; wwzhang8@tju.edu.cn; deirdre.meldrum@asu.edu	Shi, Xu/F-9805-2011; WANG, Jiangxin/AFE-8446-2022	WANG, Jiangxin/0000-0002-9917-067X; Zhang, Weiwen/0000-0001-8305-5653	National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) Center of Excellence in Genomic Sciences (CEGS); National Institutes of Health (NIH) Microscale Life Sciences Center [5 P50 HG002360]; National Institutes of Health (NIH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH) Center of Excellence in Genomic Sciences (CEGS); National Institutes of Health (NIH) Microscale Life Sciences Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding came from the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), Center of Excellence in Genomic Sciences (CEGS) and Microscale Life Sciences Center Grant No. 5 P50 HG002360 (PI D.R.M.) http://www.genome.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Anis YH, 2010, IEEE T AUTOM SCI ENG, V7, P598, DOI 10.1109/TASE.2009.2035709; Ashili SP, 2011, P MICROFLUIDICS BIOM, V7929; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Barrett MT, 2003, CANCER RES, V63, P4211; Bengtsson M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-63; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Boettiger AN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001136; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Brouwer M, 2008, MAR ENVIRON RES, V66, P143, DOI 10.1016/j.marenvres.2008.02.046; Chen G, 2009, ANTIOXID REDOX SIGN, V11, P1083, DOI [10.1089/ars.2008.2321, 10.1089/ARS.2008.2321]; Chen XX, 2001, CARCINOGENESIS, V22, P1119, DOI 10.1093/carcin/22.8.1119; Coco D, 2011, LAB INVEST, V91, p145A; Cormio Antonella, 2012, BMC Res Notes, V5, P279, DOI 10.1186/1756-0500-5-279; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao WM, 2011, J MICROBIOL METH, V85, P221, DOI 10.1016/j.mimet.2011.03.008; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Houston MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025207; Huang HM, 2004, NEUROCHEM RES, V29, P651, DOI 10.1023/B:NERE.0000014835.34495.9c; Jones JB, 2001, CANCER RES, V61, P1299; KADOWAKI T, 1991, EXP CELL RES, V192, P243, DOI 10.1016/0014-4827(91)90182-T; Kelbauskas L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037008; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P10014, DOI 10.1073/pnas.1633614100; Koi M, 2011, J OBSTET GYNAECOL RE, V37, P85, DOI 10.1111/j.1447-0756.2010.01377.x; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Li YZ, 2010, ANAL BIOANAL CHEM, V397, P1853, DOI 10.1007/s00216-010-3754-0; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; Lin CS, 2010, J THORAC CARDIOV SUR, V139, P189, DOI 10.1016/j.jtcvs.2009.04.007; Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Matarrese P, 2001, BIOCHEM J, V355, P587, DOI 10.1042/bj3550587; McIntire M, 2011, LAB INVEST, V91, p159A; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Nordgren IK, 2011, CHEM SOC REV, V40, P4307, DOI 10.1039/c1cs15032d; Olliver JR, 2005, GUT, V54, pA51; Palanca-Wessels MC, 1998, GASTROENTEROLOGY, V114, P295, DOI 10.1016/S0016-5085(98)70480-9; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Reid BJ, 2011, CLIN CANCER RES, V17, P3512, DOI 10.1158/1078-0432.CCR-09-2358; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; St John JC, 2006, METH MOL B, V331, P347; Tang CM, 2013, J GASTROEN HEPATOL, V28, P401, DOI 10.1111/jgh.12038; Taniguchi K, 2009, NAT METHODS, V6, P503, DOI 10.1038/nmeth.1338; Thyagarajan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065968; Torres-Garcia W, 2012, MOL BIOSYST, V8, P804, DOI 10.1039/c2mb05429a; Wang B, 2008, BIOCHEM BIOPH RES CO, V368, P88, DOI 10.1016/j.bbrc.2008.01.036; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Yang YZ, 2013, J CELL BIOCHEM, V114, P967, DOI 10.1002/jcb.24438; Yoshiji H, 1996, CANCER RES, V56, P2013; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zeng J, 2011, ANAL BIOANAL CHEM, V401, P3, DOI 10.1007/s00216-011-5084-2; Zhu HX, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065013	73	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75365	10.1371/journal.pone.0075365	http://dx.doi.org/10.1371/journal.pone.0075365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116039	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200018
J	Bhattacharya, S; Kumar, NM; Ganguli, A; Tantak, MP; Kumar, D; Chakrabarti, G				Bhattacharya, Surela; Kumar, N. Maruthi; Ganguli, Arnab; Tantak, Mukund P.; Kumar, Dalip; Chakrabarti, Gopal			NMK-TD-100, a Novel Microtubule Modulating Agent, Blocks Mitosis and Induces Apoptosis in HeLa Cells by Binding to Tubulin	PLOS ONE			English	Article							ANTIPROLIFERATIVE ACTIVITY; HEPATOCELLULAR-CARCINOMA; COLCHICINE BINDING; BETA-TUBULIN; EXPRESSION; RESISTANCE; DYNAMICS; CANCER; TUMORS; ALPHA	Thiadiazoles are one of the most widely utilized agents in medicinal chemistry, having a wide range of pharmacologic activity. Microtubules (MTs) have always remained a sought-after target in rapidly proliferating cancer cells. We screened for the growth inhibitory effect of synthetic 5-(3-indolyl)-2-substituted-1,3,4-thiadiazoles on cancer cells and identified NMK-TD-100, as the most potent agent. Cell viability experiments using human cervical carcinoma cell line (HeLa cells) indicated that the IC50 value was 1.42 +/- 0.11 mu M for NMK-TD-100 for 48 h treatment. In further study, we examined the mode of interaction of NMK-TD-100 with tubulin and unraveled the cellular mechanism responsible for its anti-tumor activity. NMK-TD-100 induced arrest in mitotic phase of cell cycle, caused decline in mitochondrial membrane potential and induced apoptosis in HeLa cells. Immunofluorescence studies using an anti-a-tubulin antibody showed a significant depolymerization of the interphase microtubule network and spindle microtubule in HeLa cells in a concentration-dependent manner. However, the cytotoxicity of NMK-TD-100 towards human peripheral blood mononuclear cells (PBMC) was lower compared to that in cancer cells. Polymerization of tissue purified tubulin into microtubules was inhibited by NMK-TD-100 with an IC50 value of 17.5 +/- 0.35 mu M. The binding of NMK-TD-100 with tubulin was studied using NMK-TD-100 fluorescence enhancement and intrinsic tryptophan fluorescence of tubulin. The stoichiometry of NMK-TD-100 binding to tubulin is 1: 1 (molar ratio) with a dissociation constant of similar to 1 mu M. Fluorescence spectroscopic and molecular modeling data showed that NMK-TD-100 binds to tubulin at a site which is very near to the colchicine binding site. The binding of NMK-TD-100 to tubulin was estimated to be similar to 10 times faster than that of colchicine. The results indicated that NMK-TD-100 exerted anti-proliferative activity by disrupting microtubule functions through tubulin binding and provided insights into its potential of being a chemotherapeutic agent.	[Bhattacharya, Surela; Ganguli, Arnab; Chakrabarti, Gopal] Univ Calcutta, Dept Biotechnol, Kolkata, India; [Bhattacharya, Surela; Ganguli, Arnab; Chakrabarti, Gopal] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, India; [Kumar, N. Maruthi; Tantak, Mukund P.; Kumar, Dalip] Birla Inst Technol & Sci, Dept Chem, Pilani, Rajasthan, India	University of Calcutta; University of Calcutta; Birla Institute of Technology & Science Pilani (BITS Pilani)	Kumar, D (corresponding author), Birla Inst Technol & Sci, Dept Chem, Pilani, Rajasthan, India.	dalipk@pilani.bits-pilani.ac.in; gcbcg@caluniv.ac.in	Tantak, Mukund/ABD-8443-2021; Ganguli, Arnab/AAO-8635-2020; Narayanam, Maruthi Kumar/F-8726-2011	Tantak, Mukund/0000-0001-9230-7533; Ganguli, Arnab/0000-0001-9939-027X; Narayanam, Maruthi Kumar/0000-0001-8612-5602	DBT, Govt. of India [BT/PR12889/AGR/36/624/2009]	DBT, Govt. of India(Department of Biotechnology (DBT) India)	The work was supported by grant from DBT, Govt. of India (No. BT/PR12889/AGR/36/624/2009) to GC. SB is a Senior Research fellow of University Grants Commission (UGC), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2009, BIOCHEMISTRY-US, V48, P6963, DOI 10.1021/bi900152k; Asbury R, 1996, AM J CLIN ONCOL-CANC, V19, P400, DOI 10.1097/00000421-199608000-00017; BANERJEE A, 1992, J BIOL CHEM, V267, P13335; Bhattacharyya B, 2010, METHOD CELL BIOL, V95, P301, DOI 10.1016/S0091-679X(10)95017-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buolamwini JK, 2005, CURR CANCER DRUG TAR, V5, P57, DOI 10.2174/1568009053332672; Calligaris D, 2010, CELL MOL LIFE SCI, V67, P1089, DOI 10.1007/s00018-009-0245-6; Canavan TP, 2000, AM FAM PHYSICIAN, V61, P1369; Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003; Chhabra S, 2010, J OBSTET GYNAECOL, V30, P725, DOI 10.3109/01443615.2010.501412; Dogan HN, 2002, BIOORGAN MED CHEM, V10, P2893, DOI 10.1016/S0968-0896(02)00143-8; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Foroumadi A, 2003, EUR J MED CHEM, V38, P851, DOI 10.1016/S0223-5234(03)00148-X; Garuti L, 2001, BIOORG MED CHEM LETT, V11, P3147, DOI 10.1016/S0960-894X(01)00639-4; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gupta KK, 2006, FEBS J, V273, P5320, DOI 10.1111/j.1742-4658.2006.05525.x; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kadi AA, 2007, EUR J MED CHEM, V42, P235, DOI 10.1016/j.ejmech.2006.10.003; Kamath K, 2003, CANCER RES, V63, P6026; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kumar D, 2010, EUR J MED CHEM, V45, P4664, DOI 10.1016/j.ejmech.2010.07.023; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LAMBEIR A, 1981, J BIOL CHEM, V256, P3279; Li J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-215; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Paino IMM, 2012, TOXICOL LETT, V215, P119, DOI 10.1016/j.toxlet.2012.09.025; MAS MT, 1985, BIOCHEMISTRY-US, V24, P1634, DOI 10.1021/bi00328a011; Matysiak J, 2007, EUR J MED CHEM, V42, P940, DOI 10.1016/j.ejmech.2006.12.033; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Morris M, 2004, J CLIN ONCOL, V22, P3340, DOI 10.1200/JCO.2004.12.006; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Padmavathi V, 2009, EUR J MED CHEM, V44, P2106, DOI 10.1016/j.ejmech.2008.10.012; Peifer C, 2008, J MED CHEM, V51, P3814, DOI 10.1021/jm8001185; Poorrajab F, 2009, EUR J MED CHEM, V44, P1758, DOI 10.1016/j.ejmech.2008.03.039; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Shen L, 2007, J MED CHEM, V50, P3954, DOI 10.1021/jm070511x; SLADOWSKI D, 1993, J IMMUNOL METHODS, V157, P203, DOI 10.1016/0022-1759(93)90088-O; Tian W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010499; Torfs S, 2012, EUR J CANCER, V48, P1332, DOI 10.1016/j.ejca.2012.01.006; TURNER S, 1988, J MED CHEM, V31, P902, DOI 10.1021/jm00400a003; *US FDA, 2006, FDA APPR 1 DRUG TREA; WARD LD, 1985, METHOD ENZYMOL, V117, P400; Xie ZG, 2008, CANCER CHEMOTH PHARM, V62, P949, DOI 10.1007/s00280-008-0684-z; Yusuf M, 2008, BIOORGAN MED CHEM, V16, P8029, DOI 10.1016/j.bmc.2008.07.056	45	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76286	10.1371/journal.pone.0076286	http://dx.doi.org/10.1371/journal.pone.0076286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116100	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300055
J	Bompard, A; Amat, I; Fauvergue, X; Spataro, T				Bompard, Anais; Amat, Isabelle; Fauvergue, Xavier; Spataro, Thierry			Host-Parasitoid Dynamics and the Success of Biological Control When Parasitoids Are Prone to Allee Effects	PLOS ONE			English	Article							SEX-RATIO; CONSTRAINED OVIPOSITION; DENSITY-DEPENDENCE; POPULATIONS; PREDATOR; COMPETITION; BEHAVIOR; MODELS; MOTH; CONSEQUENCES	In sexual organisms, low population density can result in mating failures and subsequently yields a low population growth rate and high chance of extinction. For species that are in tight interaction, as in host-parasitoid systems, population dynamics are primarily constrained by demographic interdependences, so that mating failures may have much more intricate consequences. Our main objective is to study the demographic consequences of parasitoid mating failures at low density and its consequences on the success of biological control. For this, we developed a deterministic host-parasitoid model with a mate-finding Allee effect, allowing to tackle interactions between the Allee effect and key determinants of host-parasitoid demography such as the distribution of parasitoid attacks and host competition. Our study shows that parasitoid mating failures at low density result in an extinction threshold and increase the domain of parasitoid deterministic extinction. When proned to mate finding difficulties, parasitoids with cyclic dynamics or low searching efficiency go extinct; parasitoids with high searching efficiency may either persist or go extinct, depending on host intraspecific competition. We show that parasitoids suitable as biocontrol agents for their ability to reduce host populations are particularly likely to suffer from mate-finding Allee effects. This study highlights novel perspectives for understanding of the dynamics observed in natural host-parasitoid systems and improving the success of parasitoid introductions.	[Bompard, Anais; Spataro, Thierry] Univ Paris 06, CNRS, ENS, UMR Ecol & Evolut 7625, Paris, France; [Bompard, Anais; Spataro, Thierry] INRA, USC Ecol Populat & Communautes 2031, Paris, France; [Amat, Isabelle] Univ Lyon 1, CNRS, UMR Lab Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France; [Fauvergue, Xavier] Univ Nice Sophia Antipolis, CNRS, INRA, UMR 1355,Inst Sophia Agrobiotech 7254, Sophia Antipolis, France; [Spataro, Thierry] AgroParisTech, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; AgroParisTech	Bompard, A (corresponding author), Univ Paris 06, CNRS, ENS, UMR Ecol & Evolut 7625, Paris, France.	anais.bompard@gmail.com	fauvergue, xavier/B-9108-2012	fauvergue, xavier/0000-0002-3579-7721; Spataro, Thierry/0000-0003-3373-6527	 [ANR-2010-BLAN-1717]		This work was supported by ANR-2010-BLAN-1717 "Sextinction" (http://www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDDINGTON JR, 1978, NATURE, V273, P513, DOI 10.1038/273513a0; BEDDINGTON JR, 1976, J ANIM ECOL, V45, P791, DOI 10.2307/3581; BEDDINGTON JR, 1982, ECOL MODEL, V14, P155, DOI 10.1016/0304-3800(82)90016-3; Bellows TS, 2001, BIOL CONTROL, V21, P199, DOI 10.1006/bcon.2001.0936; BELLOWS TS, 1981, J ANIM ECOL, V50, P139, DOI 10.2307/4037; Bernstein C, 2000, PARASITOID POPULATION BIOLOGY, P41; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Blackwood JC, 2012, P ROY SOC B-BIOL SCI, V279, P2807, DOI 10.1098/rspb.2012.0255; Boukal DS, 2009, POPUL ECOL, V51, P445, DOI 10.1007/s10144-009-0154-4; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; BRIGGS CJ, 1993, AM NAT, V141, P372, DOI 10.1086/285479; Briggs CJ, 2001, THEOR POPUL BIOL, V60, P33, DOI 10.1006/tpbi.2001.1529; Collier TR, 2001, OECOLOGIA, V129, P147, DOI 10.1007/s004420100706; COMINS HN, 1985, J ANIM ECOL, V54, P583, DOI 10.2307/4500; Contarini M, 2009, ENTOMOL EXP APPL, V133, P307, DOI 10.1111/j.1570-7458.2009.00930.x; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cronin JT, 2009, ECOLOGY, V90, P196, DOI 10.1890/08-0208.1; Dennis B., 1989, Natural Resource Modeling, V3, P481; Deredec A, 2006, OIKOS, V112, P667, DOI 10.1111/j.0030-1299.2006.14243.x; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; EMBREE DG, 1966, CAN ENTOMOL, V98, P1159, DOI 10.4039/Ent981159-11; Engelkes T, 2011, BIOCONTROL, V56, P383, DOI 10.1007/s10526-011-9377-3; Fauvergue X, 1998, J EVOLUTION BIOL, V11, P611, DOI 10.1007/s000360050109; FAUVERGUE X, 1995, P NATL ACAD SCI USA, V92, P900, DOI 10.1073/pnas.92.3.900; Fauvergue X, 2008, OECOLOGIA, V156, P913, DOI 10.1007/s00442-008-1037-7; Fauvergue X, 2007, ECOLOGY, V88, P2392, DOI 10.1890/06-1238.1; Fauvergue X, 2013, ENTOMOL EXP APPL, V146, P79, DOI 10.1111/eea.12021; Fauvergue X, 2009, POPUL ECOL, V51, P385, DOI 10.1007/s10144-009-0147-3; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; GODFRAY HCJ, 1988, ECOL ENTOMOL, V13, P283, DOI 10.1111/j.1365-2311.1988.tb00358.x; Grevstad Fritzi S., 1999, Biological Invasions, V1, P313, DOI 10.1023/A:1010037912369; Hall R.W., 1979, Bulletin of the Entomological Society of America, V25, P280; Hardy ICW, 1999, ETHOLOGY, V105, P57, DOI 10.1111/j.1439-0310.1999.tb01220.x; Hardy ICW, 1998, TRENDS ECOL EVOL, V13, P431, DOI 10.1016/S0169-5347(97)01298-6; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; HASSELL MP, 1983, J ANIM ECOL, V52, P889, DOI 10.2307/4462; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Henne DC, 2010, BIOL CONTROL, V55, P63, DOI 10.1016/j.biocontrol.2010.07.001; HOPPER KR, 1993, ECOL ENTOMOL, V18, P321, DOI 10.1111/j.1365-2311.1993.tb01108.x; Jang SRJ, 2006, J DIFFER EQU APPL, V12, P165, DOI 10.1080/10236190500539238; Kapranas A, 2011, J ANIM ECOL, V80, P192, DOI 10.1111/j.1365-2656.2010.01767.x; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Li J, 2012, FLA ENTOMOL, V95, P128, DOI 10.1653/024.095.0120; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Liu H, 2009, ECOL COMPLEX, V6, P337, DOI 10.1016/j.ecocom.2009.01.003; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MAY RM, 1981, J ANIM ECOL, V50, P855, DOI 10.2307/4142; Metzger M, 2008, ECOL ENTOMOL, V33, P167, DOI 10.1111/j.1365-2311.2007.00953.x; Metzger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013505; Meunier J, 2002, ECOL MODEL, V152, P77, DOI 10.1016/S0304-3800(01)00491-4; Moller AP, 2001, OIKOS, V92, P27, DOI 10.1034/j.1600-0706.2001.920104.x; Nicholson A. J., 1935, P ZOOL SOC LOND, V105, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Ode PJ, 1997, OECOLOGIA, V109, P547, DOI 10.1007/s004420050115; Pareja M, 2008, BASIC APPL ECOL, V9, P701, DOI 10.1016/j.baae.2007.10.008; Perez-Lachaud G, 2010, ENTOMOL EXP APPL, V137, P62, DOI 10.1111/j.1570-7458.2010.01037.x; Rusch A, 2011, LANDSCAPE ECOL, V26, P473, DOI 10.1007/s10980-011-9573-7; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STILING P, 1990, American Entomologist, V36, P225; Stiling Peter, 1993, American Entomologist, V39, P31; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Tobin PC, 2013, ENTOMOL EXP APPL, V146, P103, DOI 10.1111/j.1570-7458.2012.01299.x; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Tobin PC, 2009, POPUL ECOL, V51, P373, DOI 10.1007/s10144-009-0144-6; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; VANLENTEREN JC, 1983, AGR ECOSYST ENVIRON, V10, P143, DOI 10.1016/0167-8809(83)90059-2; Verdy A, 2010, ECOL MODEL, V221, P1098, DOI 10.1016/j.ecolmodel.2010.01.005; Wogin MJ, 2013, ENTOMOL EXP APPL, V146, P165, DOI 10.1111/eea.12009; Zhou SR, 2005, THEOR POPUL BIOL, V67, P23, DOI 10.1016/j.tpb.2004.06.007	72	21	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76768	10.1371/journal.pone.0076768	http://dx.doi.org/10.1371/journal.pone.0076768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116153	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300093
J	Peri, S; Devarajan, K; Yang, DH; Knudson, AG; Balachandran, S				Peri, Suraj; Devarajan, Karthik; Yang, Dong-Hua; Knudson, Alfred G.; Balachandran, Siddharth			Meta-Analysis Identifies NF-kappa B as a Therapeutic Target in Renal Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; COPY-NUMBER ALTERATIONS; CELL CARCINOMA-CELLS; GENE-EXPRESSION; SENSITIZES; BORTEZOMIB; CLASSIFICATION; BIOCONDUCTOR; ACTIVATION; REGRESSION	Objective: To determine the expression patterns of NF-kappa B regulators and target genes in clear cell renal cell carcinoma (ccRCC), their correlation with von Hippel Lindau (VHL) mutational status, and their association with survival outcomes. Methods: Meta-analyses were carried out on published ccRCC gene expression datasets by RankProd, a non-parametric statistical method. DEGs with a False Discovery Rate of < 0.05 by this method were considered significant, and intersected with a curated list of NF-kappa B regulators and targets to determine the nature and extent of NF-kappa B deregulation in ccRCC. Results: A highly-disproportionate fraction (similar to 40%; p < 0.001) of NF-kappa B regulators and target genes were found to be up-regulated in ccRCC, indicative of elevated NF-kappa B activity in this cancer. A subset of these genes, comprising a key NF-kappa B regulator (IKBKB) and established mediators of the NF-kappa B cell-survival and pro-inflammatory responses (MMP9, PSMB9, and SOD2), correlated with higher relative risk, poorer prognosis, and reduced overall patient survival. Surprisingly, levels of several interferon regulatory factors (IRFs) and interferon target genes were also elevated in ccRCC, indicating that an 'interferon signature' may represent a novel feature of this disease. Loss of VHL gene expression correlated strongly with the appearance of NF-kappa B- and interferon gene signatures in both familial and sporadic cases of ccRCC. As NF-kappa B controls expression of key interferon signaling nodes, our results suggest a causal link between VHL loss, elevated NF-kappa B activity, and the appearance of an interferon signature during ccRCC tumorigenesis. Conclusions: These findings identify NF-kappa B and interferon signatures as clinical features of ccRCC, provide strong rationale for the incorporation of NF-kappa B inhibitors and/or and the exploitation of interferon signaling in the treatment of ccRCC, and supply new NF-kappa B targets for potential therapeutic intervention in this currently-incurable malignancy.	[Peri, Suraj; Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat & Bioinformat, Philadelphia, PA 19111 USA; [Yang, Dong-Hua] Fox Chase Canc Ctr, Biosample Repository Core Facil, Philadelphia, PA 19111 USA; [Knudson, Alfred G.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Balachandran, Siddharth] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Peri, S (corresponding author), Fox Chase Canc Ctr, Dept Biostat & Bioinformat, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	suraj.peri@fccc.edu; sid.balachandran@fccc.edu			American Cancer Society [RSG-09-195-01-MPC]; Fox Chase Cancer Center; NIH [N01 CN-95037, P30 CA 06927]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN095037] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Fox Chase Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Cancer Society Research Scholar Grant (RSG-09-195-01-MPC) to SB. Additional funds were provided by the Fox Chase Cancer Center via institutional support of the Kidney Cancer Keystone Program, and by NIH grants N01 CN-95037 and P30 CA 06927. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2005, MOL CELL BIOL, V25, P7546, DOI 10.1128/MCB.25.17.7546-7556.2005; An JB, 2005, ONCOGENE, V24, P1563, DOI 10.1038/sj.onc.1208348; An JB, 2007, MOL CANCER THER, V6, P61, DOI 10.1158/1535-7163.MCT-06-0255; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Brooks AD, 2010, MOL CANCER RES, V8, P729, DOI 10.1158/1541-7786.MCR-10-0022; Chen DYT, 2011, MED CLIN N AM, V95, P179, DOI 10.1016/j.mcna.2010.08.021; Cifola I, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-6; Devarajan K, 2011, COMPUT STAT DATA AN, V55, P667, DOI 10.1016/j.csda.2010.06.010; Eisen T, 2012, JNCI-J NATL CANCER I, V104, P93, DOI 10.1093/jnci/djr511; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hudes GR, 2009, CANCER, V115, P2313, DOI 10.1002/cncr.24239; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin ZZ, 2006, BIOMETRIKA, V93, P147, DOI 10.1093/biomet/93.1.147; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lu RQ, 2002, J BIOL CHEM, V277, P16592, DOI 10.1074/jbc.M111440200; Morais C, 2011, INT J BIOCHEM CELL B, V43, P1537, DOI 10.1016/j.biocel.2011.08.003; Nyhan MJ, 2008, BIOCHEM SOC T, V36, P472, DOI 10.1042/BST0360472; Oya M, 2003, CARCINOGENESIS, V24, P377, DOI 10.1093/carcin/24.3.377; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pal SK, 2010, TARGET ONCOL, V5, P131, DOI 10.1007/s11523-010-0145-6; Pirrotta MT, 2011, CURR MED CHEM, V18, P1651, DOI 10.2174/092986711795471293; Qi H, 2003, CANCER RES, V63, P7076; Roos FC, 2010, EMBO MOL MED, V2, P275, DOI 10.1002/emmm.201000081; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; Stoyanova R, 2004, CANCER BIOL THER, V3, P1313, DOI 10.4161/cbt.3.12.1459; Sufan RI, 2004, AM J PHYSIOL-RENAL, V287, pF1, DOI 10.1152/ajprenal.00424.2003; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THAPA RJ, 2013, MOL CANC THER; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; WEI LJ, 1992, STAT MED, V11, P1871, DOI 10.1002/sim.4780111409; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152	55	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76746	10.1371/journal.pone.0076746	http://dx.doi.org/10.1371/journal.pone.0076746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116146	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300088
J	Calvert, C; Ronsmans, C				Calvert, Clara; Ronsmans, Carine			HIV and the Risk of Direct Obstetric Complications: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED DISEASES; TO-CHILD TRANSMISSION; CESAREAN-SECTION; PREGNANT-WOMEN; INFECTED WOMEN; ANTIRETROVIRAL THERAPY; HIV-1-INFECTED WOMEN; POSITIVE WOMEN; PREECLAMPSIA	Background: Women of reproductive age in parts of sub-Saharan Africa are faced both with high levels of HIV and the threat of dying from the direct complications of pregnancy. Clinicians practicing in such settings have reported a high incidence of direct obstetric complications among HIV-infected women, but the evidence supporting this is unclear. The aim of this systematic review is to establish whether HIV-infected women are at increased risk of direct obstetric complications. Methods and findings: Studies comparing the frequency of obstetric haemorrhage, hypertensive disorders of pregnancy, dystocia and intrauterine infections in HIV-infected and uninfected women were identified. Summary estimates of the odds ratio (OR) for the association between HIV and each obstetric complication were calculated through meta-analyses. In total, 44 studies were included providing 66 data sets; 17 on haemorrhage, 19 on hypertensive disorders, five on dystocia and 25 on intrauterine infections. Meta-analysis of the OR from studies including vaginal deliveries indicated that HIV-infected women had over three times the risk of a puerperal sepsis compared with HIV-uninfected women [pooled OR: 3.43, 95% confidence interval (CI): 2.00-5.85]; this figure increased to nearly six amongst studies only including women who delivered by caesarean (pooled OR: 5.81, 95% CI: 2.42-13.97). For other obstetric complications the evidence was weak and inconsistent. Conclusions: The higher risk of intrauterine infections in HIV-infected pregnant and postpartum women may require targeted strategies involving the prophylactic use of antibiotics during labour. However, as the huge excess of pregnancy-related mortality in HIV-infected women is unlikely to be due to a higher risk of direct obstetric complications, reducing this mortality will require non obstetric interventions involving access to ART in both pregnant and non-pregnant women.	[Calvert, Clara; Ronsmans, Carine] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Calvert, C (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	clara.calvert@lshtm.ac.uk			Economic and Social Research Council; Bill & Melinda Gates Foundation; Economic and Social Research Council [1081714] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council and through a grant awarded by the Bill & Melinda Gates Foundation to the U. S. fund for UNICEF to support the Child Health Epidemiology Reference Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim Q, 2010, LANCET, V375, P1948, DOI 10.1016/S0140-6736(10)60747-7; Aboud S, 2009, INT J GYNECOL OBSTET, V107, P202, DOI 10.1016/j.ijgo.2009.07.037; Peret FJA, 2007, REV BRAS GINECOL OBS, V29, P260, DOI 10.1590/S0100-72032007000500007; Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; Azria E, 2010, INT J GYNECOL OBSTET, V111, P161, DOI 10.1016/j.ijgo.2010.05.023; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berer M, 1999, SAFE MOTHERHOOD INIT, P198; Bodkin C, 2006, J CLIN NURS, V15, P735, DOI 10.1111/j.1365-2702.2006.01438.x; Boer K, 2007, BJOG-INT J OBSTET GY, V114, P148, DOI 10.1111/j.1471-0528.2006.01183.x; BRADDICK MR, 1990, AIDS, V4, P1001, DOI 10.1097/00002030-199010000-00009; Calvert C, 2013, AIDS, DOI DOI 10.1097/QAD.1090B1013E32835FD32940; Cavasin H, 2009, INFECT DIS OBSTET GY; Chama CM, 2008, J OBSTET GYNAECOL, V28, P194, DOI 10.1080/01443610801912295; Chamiso D, 1996, E AFR MED J, V73, P805; Chanrachakul B, 2001, INT J GYNECOL OBSTET, V72, P229, DOI 10.1016/S0020-7292(00)00364-7; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; CLOTTEY C, 1993, INFECT DIS CLIN N AM, V7, P753; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; de Groot MR, 2003, INT J GYNECOL OBSTET, V81, P9, DOI 10.1016/S0020-7292(02)00399-5; European HIV Obst Grp, 2004, AIDS, V18, P933, DOI [10.1097/01.aids.0000125910.42055.c1, 10.1097/00002030-200404090-00011]; Figueroa-Damian R, 1999, SALUD PUBLICA MEXICO, V41, P362, DOI 10.1590/S0036-36341999000500003; Frank KA, 2004, OBSTET GYNECOL, V104, P238, DOI 10.1097/01.AOG.0000130066.75671.b2; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Graham W, 2003, WORKSH HIV AIDS AD M; Grubert TA, 1999, LANCET, V354, P1612, DOI 10.1016/S0140-6736(99)03141-4; Haeri S, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.017; Higgens JPT, 2011, COCHRANE HDB SYSTEMA; Higgins JR, 2001, LANCET, V357, P131, DOI 10.1016/S0140-6736(00)03552-2; Kourtis AP, 2006, AIDS, V20, P1823, DOI 10.1097/01.aids.0000244201.11006.1c; LEPAGE P, 1991, AIDS, V5, P295, DOI 10.1097/00002030-199103000-00008; Leroy V, 1998, AIDS, V12, P643, DOI 10.1097/00002030-199806000-00014; Lindgren S, 1996, SCAND J INFECT DIS, V28, P425, DOI 10.3109/00365549609037933; Lionel J, 2008, TROP DOCT, V38, P144, DOI 10.1258/td.2007.070081; Louis J, 2007, OBSTET GYNECOL, V110, P385, DOI 10.1097/01.AOG.0000275263.81272.fc; Louis Judette, 2006, Infect Dis Obstet Gynecol, V2006, P79512; Maiques V, 2010, EUR J OBSTET GYN R B, V153, P27, DOI 10.1016/j.ejogrb.2010.07.001; Maiques-Montesinos V, 1999, ACTA OBSTET GYN SCAN, V78, P789, DOI 10.1034/j.1600-0412.1999.780909.x; Mattar R, 2004, EUR J OBSTET GYN R B, V117, P240, DOI 10.1016/j.ejogrb.2004.04.014; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; MINKOFF HL, 1990, AM J OBSTET GYNECOL, V163, P1598; MMIRO F, 1993, PEDIATR AIDS HIV INF, V4, P67; Montgomery Kristen S, 2003, J Perinat Educ, V12, P16; Moodliar S, 2007, EUR J OBSTET GYN R B, V131, P138, DOI 10.1016/j.ejogrb.2006.05.004; National Institute for Clinical Excellence, 2004, CLIN GUID 13 CAES SE; National Institute for Health and Clinical Excellence, 2011, CAES SECT; NCCMED, 2012, 5 NCCMED; Okong P, 2004, INT J STD AIDS, V15, P669, DOI 10.1258/0956462041944394; Olagbuji BN, 2009, ARCH GYNECOLOGY OBST, V281; Onah HE, 2007, J OBSTET GYNAECOL, V27, P271, DOI 10.1080/01443610701195108; Panburana P, 2003, AUST NZ J OBSTET GYN, V43, P160, DOI 10.1046/j.0004-8666.2003.00027.x; RICH KC, 1995, J INFECT DIS, V172, P1221, DOI 10.1093/infdis/172.5.1221; Rodriguez EJ, 2001, AM J OBSTET GYNECOL, V184, P1108, DOI 10.1067/mob.2001.115179; Roman-Poueriet J, 2009, REV PANAM SALUD PUBL, V26, P315, DOI 10.1590/S1020-49892009001000005; ROSSI G, 1990, AIDS RES HUM RETROV, V6, P261, DOI 10.1089/aid.1990.6.261; Scaradavou A, 2002, BLOOD REV, V16, P73, DOI 10.1054/blre.2001.0188; Sebitloane HM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.053; SEMPRINI AE, 1995, AIDS, V9, P913, DOI 10.1097/00002030-199508000-00013; Singh YA, 2009, J MED SOC, V23, P116; SLOAND EM, 1992, EUR J HAEMATOL, V48, P168; Suy A, 2006, AIDS, V20, P59, DOI 10.1097/01.aids.0000198090.70325.bd; TEMMERMAN M, 1994, OBSTET GYNECOL, V83, P495, DOI 10.1097/00006250-199404000-00002; Turan JM, 2008, JOGNN-J OBST GYN NEO, V37, P588, DOI 10.1111/j.1552-6909.2008.00281.x; UNAIDS, 2011, COUNTD ZER GLOB PLAN; Urbani G, 2001, INT J GYNECOL OBSTET, V74, P9, DOI 10.1016/S0020-7292(01)00380-0; van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c; van Eijk AM, 2007, TROP MED INT HEALTH, V12, P342, DOI 10.1111/j.1365-3156.2006.01787.x; VERKUYL DAA, 1995, LANCET, V346, P293, DOI 10.1016/S0140-6736(95)92171-0; Wandabwa J, 2008, East Afr Med J, V85, P56; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Waweru J., 2009, African Journal of Food, Agriculture, Nutrition and Development, V9, P748; WHO, 2010, ANT THER HIV INF AD; Wimalasundera RC, 2002, LANCET, V360, P1152, DOI 10.1016/S0140-6736(02)11195-0; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zaba B, LANCET IN PRESS; Zvandasara P, 2007, Cent Afr J Med, V53, P43	75	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74848	10.1371/journal.pone.0074848	http://dx.doi.org/10.1371/journal.pone.0074848			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124458	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000325489100015
J	Miklos, AC; Sumpter, M; Zhou, HX				Miklos, Andrew C.; Sumpter, Matthew; Zhou, Huan-Xiang			Competitive Interactions of Ligands and Macromolecular Crowders with Maltose Binding Protein	PLOS ONE			English	Article							LAMBDA-RECEPTOR PROTEIN; ESCHERICHIA-COLI; MALTODEXTRIN TRANSPORT; HIV-1 PROTEASE; STABILITY; NMR; DIFFUSION; AFFINITY; CONSEQUENCES; SPECTROSCOPY	Cellular signaling involves a cascade of recognition events occurring in a complex environment with high concentrations of proteins, polysaccharides, and other macromolecules. The influence of macromolecular crowders on protein binding affinity through hard-core repulsion is well studied, and possible contributions of protein-crowder soft attraction have been implicated recently. Here we present direct evidence for weak association of maltose binding protein (MBP) with a polysaccharide crowder Ficoll, and that this association effectively competes with the binding of the natural ligand, maltose. Titration data over wide ranges of maltose and Ficoll concentrations fit well with a three-state competitive binding model. Broadening of MBP H-1-N-15 TROSY spectra by the addition of Ficoll indicates weak protein-crowder association, and subsequent recovery of sharp NMR peaks upon addition of maltose indicates that the interactions of the crowder and the ligand with MBP are competitive. We hypothesize that, in the Escherichia coli periplasm, the competitive interactions of polysaccharides and maltose with MBP could allow MBP to shuttle between the peptidoglycan attached to the outer membrane and the ATP-binding cassette transporter in the inner membrane.	[Miklos, Andrew C.; Sumpter, Matthew; Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zhou, HX (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	hzhou4@fsu.edu	Zhou, Huan-Xiang/AAH-9836-2020; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016	Zhou, Huan-Xiang/0000-0001-9020-0302; Zhou, Huan-Xiang/0000-0001-9020-0302; Sumpter, Matthew/0000-0001-5854-9686; Miklos, Andrew/0000-0002-1918-8352	National Institutes of Health [R01 GM88187, F32 GM103217]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103217, R01GM088187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health Grants R01 GM88187 and F32 GM103217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends SJR, 2010, J BACTERIOL, V192, P242, DOI 10.1128/JB.01244-09; BAVOIL P, 1981, J BIOL CHEM, V256, P1385; BAVOIL P, 1983, J BACTERIOL, V155, P919, DOI 10.1128/JB.155.2.919-921.1983; Benton LA, 2012, BIOCHEMISTRY-US, V51, P9773, DOI 10.1021/bi300909q; Bohm S, 2013, P NATL ACAD SCI USA, V110, P5492, DOI 10.1073/pnas.1217745110; BRASS JM, 1986, J BACTERIOL, V165, P787, DOI 10.1128/jb.165.3.787-795.1986; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; Bucher D, 2011, BIOCHEMISTRY-US, V50, P10530, DOI 10.1021/bi201481a; Bucher D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002034; Charlton LM, 2008, J AM CHEM SOC, V130, P6826, DOI 10.1021/ja8005995; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dong H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000833; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Harada R, 2013, J AM CHEM SOC, V135, P3696, DOI 10.1021/ja3126992; HAZELBAUER GL, 1971, NATURE-NEW BIOL, V230, P101, DOI 10.1038/newbio230101a0; Hulsmann A, 2000, J BACTERIOL, V182, P6292, DOI 10.1128/JB.182.22.6292-6301.2000; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Ladbury JE, 2012, TRENDS BIOCHEM SCI, V37, P173, DOI 10.1016/j.tibs.2012.01.001; Li CG, 2010, J AM CHEM SOC, V132, P321, DOI 10.1021/ja907966n; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Minh DDL, 2006, J AM CHEM SOC, V128, P6006, DOI 10.1021/ja060483s; Nagarajan S, 2011, BIOPHYS J, V100, P2991, DOI 10.1016/j.bpj.2011.03.065; Qin SB, 2010, J PHYS CHEM LETT, V1, P107, DOI 10.1021/jz900023w; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Rosen J, 2011, J PHYS CHEM B, V115, P2683, DOI 10.1021/jp200625k; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Walker IH, 2010, APPL MICROBIOL BIOT, V88, P187, DOI 10.1007/s00253-010-2696-y; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wang YQ, 2010, J AM CHEM SOC, V132, P9392, DOI 10.1021/ja102296k; Zhang DL, 2012, ACTA BIOCH BIOPH SIN, V44, P703, DOI 10.1093/abbs/gms052; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2013, FEBS LETT, V587, P1053, DOI 10.1016/j.febslet.2013.01.064; Zhou HX, 2013, FEBS LETT, V587, P394, DOI 10.1016/j.febslet.2013.01.030	43	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74969	10.1371/journal.pone.0074969	http://dx.doi.org/10.1371/journal.pone.0074969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124463	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100020
J	Ortuno, VM; Gilgado, JD; Jimenez-Valverde, A; Sendra, A; Perez-Suarez, G; Herrero-Borgonon, JJ				Ortuno, Vicente M.; Gilgado, Jose D.; Jimenez-Valverde, Alberto; Sendra, Alberto; Perez-Suarez, Gonzalo; Herrero-Borgonon, Juan J.			The "Alluvial Mesovoid Shallow Substratum", a New Subterranean Habitat	PLOS ONE			English	Article							COLEOPTERA; DIVERSITY; ECOLOGY; ARANEAE	In this paper we describe a new type of subterranean habitat associated with dry watercourses in the Eastern Iberian Peninsula, the "Alluvial Mesovoid Shallow Substratum" (alluvial MSS). Historical observations and data from field sampling specially designed to study MSS fauna in the streambeds of temporary watercourses support the description of this new habitat. To conduct the sampling, 16 subterranean sampling devices were placed in a region of Eastern Spain. The traps were operated for 12 months and temperature and relative humidity data were recorded to characterise the habitat. A large number of species was captured, many of which belonged to the arthropod group, with marked hygrophilous, geophilic, lucifugous and mesothermal habits. In addition, there was also a substantial number of species showing markedly ripicolous traits. The results confirm that the network of spaces which forms in alluvial deposits of temporary watercourses merits the category of habitat, and here we propose the name of "alluvial MSS". The "alluvial MSS" may be covered or not by a layer of soil, is extremely damp, provides a buffer against above ground temperatures and is aphotic. In addition, compared to other types of MSS, it is a very unstable habitat. It is possible that the "alluvial MSS" may be found in other areas of the world with strongly seasonal climatic regimes, and could play an important role as a biogeographic corridor and as a refuge from climatic changes.	[Ortuno, Vicente M.; Gilgado, Jose D.; Sendra, Alberto; Perez-Suarez, Gonzalo] Univ Alcala De Henares, Dept Ciencias Vida, Fac Biol Ciencias Ambientales & Quim, Madrid, Spain; [Jimenez-Valverde, Alberto] Univ Malaga, Fac Ciencias, Dept Biol Anim, E-29071 Malaga, Spain; [Herrero-Borgonon, Juan J.] Univ Valencia, Fac Ciencias Biol, Dept Bot, Valencia, Spain; [Jimenez-Valverde, Alberto] CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Cambio Global, E-28006 Madrid, Spain	Universidad de Alcala; Universidad de Malaga; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Ortuno, VM (corresponding author), Univ Alcala De Henares, Dept Ciencias Vida, Fac Biol Ciencias Ambientales & Quim, Madrid, Spain.	vicente.ortuno@uah.es	Jimenez-Valverde, Alberto/L-2755-2014	Jimenez-Valverde, Alberto/0000-0001-9962-2106; Sendra, Alberto/0000-0003-1035-3638; Gilgado, Jose D./0000-0003-0484-4000	Spanish Ministry of Science and Innovation [CGL2010-19924]; Ministry of Education and Science programme "Juan de la Cierva"	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Education and Science programme "Juan de la Cierva"	The Spanish Ministry of Science and Innovation for funded this research project (CGL2010-19924) and the Ministry of Education and Science programme "Juan de la Cierva". This research Project (CGL2010-19924) was funded by the Spanish Ministry of Science and Innovation. The Ministry of Education and Science programme "Juan de la Cierva" funded the research activity of one of the authors (A.J-V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Jose Ramon Guzman, 2011, Lampyrid, V1, P22; [Anonymous], 2010, GOOGL EARTH VERS 5 2; Barranco P., 2004, Graellsia, V60, P81; Bates AJ, 2007, EUR J ENTOMOL, V104, P479, DOI 10.14411/eje.2007.068; Bates AJ, 2005, 668 CCW; Belles X., 1987, FAUNA CAVERNICOLA IN; Brolemann HW, 1935, FAUNE FRANCE, V29, P368; Bucciarelli I., 1960, B SOC ENTOMOLOGICA I, V90, P170; Camarasa AM, 2006, NATURALES DESARROLLO, p[167, 10]; Camarasa AM, 2001, ESTUD GEOGRAFICOS, V52, P649; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Delay B., 1981, Memoires de Biospeologie, V8, P45; Dresch J, 1982, GEOGRAPHIE REGIONS A; ESPANOL F., 1965, PUBLICACIONES INST BIOL A PL, V38, P123; ESPANOL F, 1977, Graellsia, V33, P107; ESPANOL F., 1966, PUBL INST BIOL APL, V41, P49; Fresneda Javier, 2007, Boletin de la Asociacion Espanola de Entomologia, V31, P187; Galan Carlos, 1993, Munibe (Ciencias Naturales - Natur Zientziak), V45, P3; Geisthardt M., 2008, Heteropterus Revista de Entomologia, V8, P147; Gers C, 1998, ACTA OECOL, V19, P205, DOI 10.1016/S1146-609X(98)80025-8; Gers C., 1992, THESIS U TOULOUSE 3; Giachino PM, 2010, HYPOGEAN LIFE CONCEP, V132; Ginet R, 1977, INITIATION BIOL ECOL, P345; Hess WN, 1920, BIOL BULL-US, V38, P39, DOI 10.2307/1536232; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; IDE, 2010, JUC VIS INFR DAT ESP; IGME, 1989, AG SUBT COM VAL US C; Jeanne C., 1976, Bulletin Soc linn Bordeaux, V6, P27; Jeannel R, 1943, AVENIR SCI, V1; Jeannel R, 1926, ABEILLE, V32, P221; Jeannel R, 1926, LECHEVALIER PARIS, V7, P334; Juberthie C., 1980, Memoires de Biospeologie, V7, P19; Juberthie C, 2000, ECOSY WORLD, V30, P17; Juberthie C., 1981, Memoires de Biospeologie, V8, P77; Juberthie C, 1994, C JUBERTHIEV DECU EN, P5; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Krantz G., 2009, MANUAL ACAROLOGY; Llobera F, 1989, LITORAL MEDITERRANEO, P378; Lopez Heriberto, 2010, Speleobiology Notes, V2, P7; Margalef R, 1983, LIMNOLOGIA BARCELONA; Martin JP, 2009, INGENIERIA RIOS; Milhous R.T., 1982, GRAVEL BED RIVERS, P819; Morla C, 2003, MONOGRAFIAS JARDIN B, V11, P75; Orghidan T, 1955, ROMANIA, V7, P657; Oromi P., 1986, ACT 9 C INT ESP CAT, V2, P147; Oromi P, 2010, VOLCANES MENSAJEROS, P63; Ortega M., 1991, Limnetica, V7, P11; Ortuno V. M., 1996, Boletin de la Asociacion Espanola de Entomologia, V20, P193; Ortuno Vicente M., 2010, Entomologische Blaetter fuer Biologie und Systematik der Kaefer, V106, P233; Ortuno VM, 2011, J NAT HIST, V45, P1233, DOI 10.1080/00222933.2011.566944; Ortuno VM, 2005, J NAT HIST, V39, P3483, DOI 10.1080/00222930500393046; Ortuno VM, 2007, INVERTEBRADOS ENDEMI, P138; Ortuno VM, 2005, CARABIDAE PENINSULA, V1, P455; Owen J. A., 1995, Entomologist's Record and Journal of Variation, V107, P225; Palmen E, 1969, ATMOSPHERIC CIRCULAT, P603; Palmen E., 1955, TELLUS, V1, P22, DOI [10.1111/j.2153-3490.1949.tb01925.x, DOI 10.1111/J.2153-3490.1949.TB01925.X]; Perez Cueva AJ, 1986, CUADERNOS GEOGRAFIA, V38, P61; Perez-Cueva A, 1983, AGR SOC, V28, P189; Pipan T, 2011, J NAT HIST, V45, P253, DOI 10.1080/00222933.2010.523797; Prieto C, 2011, B SOC ENTOMOLOGICA A, V49, P365; PULIDO A., 1993, REGENERACION CUBIERT, P131; Racovitza E.G., 1907, ARCH ZOOLOGIE EXPT G, V6, P371; Renard KG, 1966, J HYDRAULICS DIVISIO, V92, P33; Rezac M, 2007, J ARACHNOL, V35, P432; Ribera C, 1986, PUBLICACIONES DEP ZO, P51; Ribera C, 2006, INVERTEBRADOS ENDEMI, P91; Ribera C, 1981, ARXIUS CTR EXCURSION, V8, P283; Ribera-Almerje C., 1981, Treballs de la Institucio Catalana d'Historia Natural, V9, P157; Roberts M.J., 1995, COLLINS FIELD GUIDE; Robertson AL, 2010, FUND APPL LIMNOL, V176, P279, DOI 10.1127/1863-9135/2010/0176-0279; RUZICKA V, 1995, PEDOBIOLOGIA, V39, P42; Ruzicka V, 1999, J NAT HIST, V33, P255, DOI 10.1080/002229399300407; Sadler J.P., 2007, HYDROECOLOGY ECOHYDR, P37, DOI DOI 10.1002/9780470010198.CH3; Salgado JM, 2008, FAUNA IBERICA, V31, P799; Salgado JM, 2007, INVERTEBRADOS ENDEMI, P184; Segura FS, 1990, THESIS U VALENCIA VA; Sigpac, 2010, SIST INF GEOGR ID PA; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; Smith DI, 1975, PROCESSES PHYS HUMAN, P130; Suarez ML, 1986, THESIS U MURCIA MURC; Tongiorgi P., 1966, Bulletin of the Museum of Comparative Zoology, V134, P275; Ueno S.-I., 1981, Journal of the Speleological Society of Japan, V6, P11; UENO S-I, 1980, Bulletin of the National Science Museum Series A (Zoology), V6, P195; UENO SI, 1987, ZOOL SCI, V4, P593; Uzquiano Paloma, 1997, Anales del Jardin Botanico de Madrid, V55, P125; Vandel A, 1964, BIOSPEOLOGIE BIOL AN; Velasco J., 1993, Limnetica, V9, P73; Vidal-Abarca M.R., 1992, Limnetica, V8, P151; Vidal-Abarca MR, 1990, SCI GERUNDENSIS, V16, P219; Vila Valenti J, 1961, MEDITERRANEE, V2, P18; Ward RC, 1978, FLOODS GEOGRAPHICAL; Williams D. D., 1987, ECOLOGY TEMPORARY WA; Williams DD, 1996, J N AM BENTHOL SOC, V15, P634, DOI 10.2307/1467813; Zacharda M, 2007, PERMAFROST PERIGLAC, V18, P301, DOI 10.1002/ppp.598; Zaragoza J. A., 1990, DIPUTACION PROVINCIA, V1, P45; Zaragoza J.A., 1988, FAUNA FLORA CIENCIAS, V3, P11; Zaragoza Juan A., 2007, Revista Iberica de Aracnologia, V13, P3	97	53	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76311	10.1371/journal.pone.0076311	http://dx.doi.org/10.1371/journal.pone.0076311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124544	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100101
J	Huang, N; Singh, N; Yoon, K; Loiacono, CM; Kohut, ML; Birt, DF				Huang, Nan; Singh, Navrozedeep; Yoon, Kyoungjin; Loiacono, Christina M.; Kohut, Marian L.; Birt, Diane F.			The Immuno-Regulatory Impact of Orally-Administered Hypericum perforatum Extract on Balb/C Mice Inoculated with H1n1 Influenza A Virus	PLOS ONE			English	Article							ST JOHNS WORT; ALVEOLAR MACROPHAGES; INFECTION; SOCS3; IDENTIFICATION; INFLAMMATION; INVOLVEMENT; INHIBITION; ACTIVATION; SUPPRESSOR	Hypericum perforatum (H. perforatum) ethanol extract has been found to inhibit lipopolysaccharide-induced production of inflammatory mediators and cytokines in cultured macrophages. Therefore, it may be able to protect the host from excessive inflammation during viral infection. In the current study, the immune-regulatory effect of H. perforatum extract was evaluated in A549 lung epithelial cells and BALB/c mice exposed to Influenza A/PR/8/34 H1N1 virus. In A549 cells, the extract (30 mu g/mL) significantly inhibited influenza virus induced monocyte chemotactic protein (MCP)-1 and interferon-gamma induced protein 10 kD (IP-10), but dramatically increased interleukin-6 (IL-6). In mice inoculated intranasally with 10(7.9) EID50 of Influenza A/PR/8/34 H1N1 (high dose), daily oral treatment of H. perforatum extract at a rate of 110 mg/kg of body weight increased lung viral titer, bronchoalveolar lavage (BAL) pro-inflammatory cytokine and chemokine levels, and the infiltration of pro-inflammatory cells in the lung 5 days post-inoculation, as compared to ethanol vehicle treated mice. Transcription of suppressor of cytokine signaling 3 (SOCS3) was increased by H. perforatum extract both in A549 cells and BALB/c mice, which could have interrupted anti-viral immune response and thus led to the inefficient viral clearance and increased lung inflammation. H. perforatum treatment resulted in minor reduction in viral titer without affecting body weight when mice were inoculated with a lower dose (similar to 10(5.0) EID50) and H. perforatum was applied in the later phase of infection. Mice challenged intranasally with high dose of influenza virus (10(7.9) EID50) suffered from a higher mortality rate when dosed with H. perforatum extract. In conclusion, the current study showed that SOCS3 elevation by H. perforatum may cause impaired immune defense against influenza virus infection and lead to higher mortality.	[Huang, Nan; Singh, Navrozedeep; Kohut, Marian L.; Birt, Diane F.] Iowa State Univ, Ctr Res Bot Dietary Supplements, Ames, IA 50011 USA; [Huang, Nan] Iowa State Univ, Interdept Grad Program Nutr Sci, Ames, IA 50011 USA; [Huang, Nan; Birt, Diane F.] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Singh, Navrozedeep; Kohut, Marian L.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Yoon, Kyoungjin] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Loiacono, Christina M.] Anim & Plant Hlth Inspect Serv, USDA, Natl Vet Serv Labs, Pathobiol Lab,Pathol Sect, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Birt, DF (corresponding author), Iowa State Univ, Ctr Res Bot Dietary Supplements, Ames, IA 50011 USA.	dbirt@iastate.edu	Huang, Nan/B-3435-2009; Huang, Nan/J-1916-2019	Huang, Nan/0000-0002-7873-7294; Huang, Nan/0000-0002-7873-7294; Birt, Diane/0000-0002-1784-5582	National Center for Complementary and Alternative [P50 AT004155-06]; Medicine/Office of Dietary Supplements, National Institute of Health; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT004155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES012020] Funding Source: NIH RePORTER	National Center for Complementary and Alternative; Medicine/Office of Dietary Supplements, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is sponsored by P50 AT004155-06 from National Center for Complementary and Alternative and Medicine/Office of Dietary Supplements, National Institute of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the ODS, NCCAM, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Calapai G, 2001, PHARMACOPSYCHIATRY, V34, pS8, DOI 10.1055/s-2001-15507; Davidson BA, 2005, EXP LUNG RES, V31, P323, DOI 10.1080/01902140590918524; Davis JM, 2008, AM J PHYSIOL-REG I, V295, pR505, DOI 10.1152/ajpregu.90319.2008; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Grundmann O, 2010, NEUROPHARMACOLOGY, V58, P767, DOI 10.1016/j.neuropharm.2009.12.014; Hammer KDP, 2010, PHYTOCHEMISTRY, V71, P716, DOI 10.1016/j.phytochem.2010.02.006; HARTSHORN KL, 1990, J LEUKOCYTE BIOL, V47, P176, DOI 10.1002/jlb.47.2.176; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Huang N, 2012, PHYTOCHEMISTRY, V76, P106, DOI 10.1016/j.phytochem.2011.12.001; Huang N, 2011, PHYTOCHEMISTRY, V72, P2015, DOI 10.1016/j.phytochem.2011.07.016; Huang N, 2009, J AGR FOOD CHEM, V57, P10579, DOI 10.1021/jf9023728; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kohut ML, 2009, J INFECT DIS, V200, P1434, DOI 10.1086/606014; Liu Zhao, 2010, Virologica Sinica, V25, P445, DOI 10.1007/s12250-010-3142-0; MAUS UA, 2006, J IMMUNOL, V177, P1817; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Pamer EG, 2009, P NATL ACAD SCI USA, V106, P4961, DOI 10.1073/pnas.0901574106; Paterniti I, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-73; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Viksman MY, 1997, AM J RESP CRIT CARE, V155, P858, DOI 10.1164/ajrccm.155.3.9117017; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76491	10.1371/journal.pone.0076491	http://dx.doi.org/10.1371/journal.pone.0076491			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098792	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500163
J	Lampugnani, ER; Moller, IE; Cassin, A; Jones, DF; Koh, PL; Ratnayake, S; Beahan, CT; Wilson, SM; Bacic, A; Newbigin, E				Lampugnani, Edwin R.; Moller, Isabel E.; Cassin, Andrew; Jones, Daniel F.; Koh, Poh Ling; Ratnayake, Sunil; Beahan, Cherie T.; Wilson, Sarah M.; Bacic, Antony; Newbigin, Ed			In Vitro Grown Pollen Tubes of Nicotiana alata Actively Synthesise a Fucosylated Xyloglucan	PLOS ONE			English	Article							CELL-WALL POLYSACCHARIDES; CALLOSE SYNTHASE; ARABINOGALACTAN PROTEINS; MONOCLONAL-ANTIBODY; CELLULOSE SYNTHASE; GENE FAMILY; ARABIDOPSIS; GENERATION; EXPRESSION; ENCODES	Nicotiana alata pollen tubes are a widely used model for studies of polarized tip growth and cell wall synthesis in plants. To better understand these processes, RNA-Seq and de novo assembly methods were used to produce a transcriptome of N. alata pollen grains. Notable in the reconstructed transcriptome were sequences encoding proteins that are involved in the synthesis and remodelling of xyloglucan, a cell wall polysaccharide previously not thought to be deposited in Nicotiana pollen tube walls. Expression of several xyloglucan-related genes in actively growing pollen tubes was confirmed and xyloglucan epitopes were detected in the wall with carbohydrate-specific antibodies: the major xyloglucan oligosaccharides found in N. alata pollen grains and tubes were fucosylated, an unusual structure for the Solanaceae, the family to which Nicotiana belongs. Finally, carbohydrate linkages consistent with xyloglucan were identified chemically in the walls of N. alata pollen grains and pollen tubes grown in culture. The presence of a fucosylated xyloglucan in Nicotiana pollen tube walls was thus confirmed. The consequences of this discovery to models of pollen tube growth dynamics and more generally to polarised tip-growing cells in plants are discussed.	[Lampugnani, Edwin R.; Koh, Poh Ling; Ratnayake, Sunil; Newbigin, Ed] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Moller, Isabel E.; Cassin, Andrew; Beahan, Cherie T.; Wilson, Sarah M.] Univ Melbourne, Australian Res Council Ctr Excellence Plant Cell, Sch Bot, Melbourne, Vic, Australia; [Bacic, Antony] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Melbourne, Vic, Australia; [Jones, Daniel F.] La Trobe Univ, Dept Bot, Bundoora, Vic 3083, Australia	University of Melbourne; University of Melbourne; University of Melbourne; La Trobe University	Newbigin, E (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	edwardjn@unimelb.edu.au	Lampugnani, Edwin/AAF-4238-2019	Lampugnani, Edwin/0000-0002-3666-7240; Newbigin, Ed/0000-0002-9644-302X; Bacic, Tony/0000-0001-7483-8605	Australian Research Council	Australian Research Council(Australian Research Council)	Funding provided by Australian Research Council (http://arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Brennan M, 2011, MOL PLANT, V4, P144, DOI 10.1093/mp/ssq067; Brownfield L, 2008, BIOCHEM J, V414, P43, DOI 10.1042/BJ20080693; Brownfield L, 2007, PLANT J, V52, P147, DOI 10.1111/j.1365-313X.2007.03219.x; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Chou YH, 2012, PLANT PHYSIOL, V159, P1355, DOI 10.1104/pp.112.199356; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dardelle F, 2010, PLANT PHYSIOL, V153, P1563, DOI 10.1104/pp.110.158881; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Derksen J, 2011, PLANT J, V68, P495, DOI 10.1111/j.1365-313X.2011.04703.x; Doblin MS, 2001, PLANT PHYSIOL, V125, P2040, DOI 10.1104/pp.125.4.2040; Edwards KD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-142; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Ferguson C, 1998, PLANTA, V206, P452, DOI 10.1007/s004250050421; Ferguson C, 1999, PROTOPLASMA, V206, P105, DOI 10.1007/BF01279257; Freshour G, 1996, PLANT PHYSIOL, V110, P1413, DOI 10.1104/pp.110.4.1413; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris P. J., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P201, DOI 10.1079/9780851999043.0201; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Kroeger J, 2012, CURR OPIN PLANT BIOL, V15, P618, DOI 10.1016/j.pbi.2012.09.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; Li HJ, 1999, PLANTA, V208, P528, DOI 10.1007/s004250050590; Li HJ, 1997, PLANT PHYSIOL, V114, P1255, DOI 10.1104/pp.114.4.1255; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mollet Jean-Claude, 2013, Plants (Basel), V2, P107, DOI 10.3390/plants2010107; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Park YB, 2012, PLANT PHYSIOL, V158, P465, DOI 10.1104/pp.111.189779; Perrin RM, 2003, PLANT PHYSIOL, V132, P768, DOI 10.1104/pp.102.016642; PUHLMANN J, 1994, PLANT PHYSIOL, V104, P699, DOI 10.1104/pp.104.2.699; SCHLUPMANN H, 1993, PLANTA, V191, P470, DOI 10.1007/BF00195748; SCHLUPMANN H, 1994, PLANT PHYSIOL, V105, P659, DOI 10.1104/pp.105.2.659; Sims IM, 1996, CARBOHYD RES, V293, P147, DOI 10.1016/0008-6215(96)00142-5; STEER MW, 1989, NEW PHYTOL, V111, P323, DOI 10.1111/j.1469-8137.1989.tb00697.x; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Vogler H, 2013, PLANT J, V73, P617, DOI 10.1111/tpj.12061; Walker M, 2011, PLANT PHYSIOL, V156, P46, DOI 10.1104/pp.111.172692; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P1025, DOI 10.1093/pcp/pce154; York WS, 1996, CARBOHYD RES, V285, P99, DOI 10.1016/0008-6215(96)00029-8; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zabotina OA, 2012, PLANT PHYSIOL, V159, P1367, DOI 10.1104/pp.112.198119	56	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77140	10.1371/journal.pone.0077140	http://dx.doi.org/10.1371/journal.pone.0077140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116212	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200105
J	Liu, GF; Xie, XF; Ye, D; Ye, XH; Tuvshintogtokh, I; Mandakh, B; Huang, ZY; Dong, M				Liu, Guofang; Xie, Xiufang; Ye, Duo; Ye, Xuehua; Tuvshintogtokh, Indree; Mandakh, Bayart; Huang, Zhenying; Dong, Ming			Plant Functional Diversity and Species Diversity in the Mongolian Steppe	PLOS ONE			English	Article							CLIMATE-DRIVEN CHANGES; BIODIVERSITY LOSS; GRASSLAND; HETEROGENEITY; VEGETATION; DOMINANCE; RICHNESS; EVENNESS; DENSITY; BIOMASS	Background: The Mongolian steppe is one of the most important grasslands in the world but suffers from aridization and damage from anthropogenic activities. Understanding structure and function of this community is important for the ecological conservation, but has seldom been investigated. Methodology/Principal Findings: In this study, a total of 324 quadrats located on the three main types of Mongolian steppes were surveyed. Early-season perennial forbs (37% of total importance value), late-season annual forbs (33%) and late-season perennial forbs (44%) were dominant in meadow, typical and desert steppes, respectively. Species richness, diversity and plant functional type (PFT) richness decreased from the meadow, via typical to desert steppes, but evenness increased; PFT diversity in the desert and meadow steppes was higher than that in typical steppe. However, above-ground net primary productivity (ANPP) was far lower in desert steppe than in the other two steppes. In addition, the slope of the relationship between species richness and PFT richness increased from the meadow, via typical to desert steppes. Similarly, with an increase in species diversity, PFT diversity increased more quickly in both the desert and typical steppes than that in meadow steppe. Random resampling suggested that this coordination was partly due to a sampling effect of diversity. Conclusions/Significance: These results indicate that desert steppe should be strictly protected because of its limited functional redundancy, which its ecological functioning is sensitive to species loss. In contrast, despite high potential forage production shared by the meadow and typical steppes, management of these two types of steppes should be different: meadow steppe should be preserved due to its higher conservation value characterized by more species redundancy and higher spatial heterogeneity, while typical steppe could be utilized moderately because its dominant grass genus Stipa is resistant to herbivory and drought.	[Liu, Guofang; Xie, Xiufang; Ye, Duo; Ye, Xuehua; Huang, Zhenying; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Tuvshintogtokh, Indree; Mandakh, Bayart] Mongolian Acad Sci, Inst Bot, Ulaanbaatar, Mongolia; [Xie, Xiufang; Ye, Duo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Hangzhou Normal University; Mongolian Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	yexuehua@ibcas.ac.cn	Ye, Xuehua/I-3116-2013	Ye, Xuehua/0000-0002-5625-9877; Indree, Tuvshintogtokh/0000-0002-3801-3806	External Cooperation Program of the Chinese Academy of Sciences [GJHZ1006]	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This international cooperative work was supported by the External Cooperation Program of the Chinese Academy of Sciences, Grant No. GJHZ1006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[白永飞 Bai Yongfei], 2002, [生态学报, Acta Ecologica Sinica], V22, P1215; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Box EO, 1996, J VEG SCI, V7, P309, DOI 10.2307/3236274; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Buxbaum CAZ, 2007, J ARID ENVIRON, V69, P617, DOI 10.1016/j.jaridenv.2006.11.017; Camargo JA, 1995, OIKOS, V74, P538, DOI 10.2307/3546000; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; CHANETON EJ, 1991, VEGETATIO, V93, P143, DOI 10.1007/BF00033208; Cheng Yunxiang, 2008, Grassland Science, V54, P107, DOI 10.1111/j.1744-697X.2008.00112.x; Craine JM, 2011, OECOLOGIA, V165, P1109, DOI 10.1007/s00442-011-1938-8; DeLucia EH, 2000, GLOBAL CHANGE BIOL, V6, P587, DOI 10.1046/j.1365-2486.2000.00338.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S., 2007, FUNCTIONAL DIVERSITY, P81; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; Elmqvist T., 2010, EC ECOSYSTEMS BIODIV; Fernandez-Gimenez M, 2001, PLANT ECOL, V157, P101, DOI 10.1023/A:1014519206041; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Ho P, 2010, ENVIRON RES, V110, P302, DOI 10.1016/j.envres.2009.12.007; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; IPCC, 2007, CLIM CHANG PHYS SCI; LAJTHA K, 1989, OECOLOGIA, V80, P341, DOI 10.1007/BF00379035; Li B, 1990, STEPPE CHINA; Lockwood Julie L., 2004, P55; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Nakano T, 2008, AGR FOREST METEOROL, V148, P1456, DOI 10.1016/j.agrformet.2008.04.011; Perrings Charles, 1995, P190; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Politis DN, 1999, STAT SINICA, V11, P1105; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Qiao JJ, 2012, J PLANT ECOL, V5, P313, DOI 10.1093/jpe/rtr032; R Development Core Team, 2012, R LANG ENV STAT COMP; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shi Y, 2013, CHINESE SCI BULL, P1; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Sokal R.R., 2012, BIOMETRY; Souto C. P., 2004, Phyton (Buenos Aires), V2004, P39; Su YZ, 2005, CATENA, V59, P267, DOI 10.1016/j.catena.2004.09.001; Sugita M, 2007, J HYDROL, V333, P3, DOI 10.1016/j.jhydrol.2006.07.032; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Wang RZ, 2003, GLOBAL ECOL BIOGEOGR, V12, P249, DOI 10.1046/j.1466-822X.2003.00027.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Westerman RL, 1990, SOIL TESTING PLANT A, P3; Wood A, 2013, ROOT CAUSES BIODIVER, DOI [10.4324/9781315071688, DOI 10.4324/9781315071688]	51	18	23	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77565	10.1371/journal.pone.0077565	http://dx.doi.org/10.1371/journal.pone.0077565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116233	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200119
J	Pennetier, C; Bouraima, A; Chandre, F; Piameu, M; Etang, J; Rossignol, M; Sidick, I; Zogo, B; Lacroix, MN; Yadav, R; Pigeon, O; Corbel, V				Pennetier, Cedric; Bouraima, Aziz; Chandre, Fabrice; Piameu, Michael; Etang, Josiane; Rossignol, Marie; Sidick, Ibrahim; Zogo, Barnabas; Lacroix, Marie-Noelle; Yadav, Rajpal; Pigeon, Olivier; Corbel, Vincent			Efficacy of Olyset (R) Plus, a New Long-Lasting Insecticidal Net Incorporating Permethrin and Piperonil-Butoxide against Multi-Resistant Malaria Vectors	PLOS ONE			English	Article							RESISTANT ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS; TREATED NETS; WEST-AFRICA; PYRETHROID TOLERANCE; PERMANET(R) 3.0; SOUTHERN BENIN; COTE-DIVOIRE; BED NETS; MOSQUITOS	Due to the rapid extension of pyrethroid resistance in malaria vectors worldwide, manufacturers are developing new vector control tools including insecticide mixtures containing at least two active ingredients with different mode of action as part of insecticide resistance management. Olyset (R) Plus is a new long-lasting insecticidal net (LLIN) incorporating permethrin and a synergist, piperonyl butoxide (PBO), into its fibres in order to counteract metabolic-based pyrethroid resistance of mosquitoes. In this study, we evaluated the efficacy of Olyset (R) Plus both in laboratory and field against susceptible and multi-resistant malaria vectors and compared with Olyset (R) Net, which is a permethrin incorporated into polyethylene net. In laboratory, Olyset (R) Plus performed better than Olyset (R) Net against susceptible Anopheles gambiae strain with a 2-day regeneration time owing to an improved permethrin bleeding rate with the new incorporation technology. It also performed better than Olyset (R) Net against multiple resistant populations of An. gambiae in experimental hut trials in West Africa. Moreover, the present study showed evidence for a benefit of incorporating a synergist, PBO, with a pyrethroid insecticide into mosquito netting. These results need to be further validated in a large-scale field trial to assess the durability and acceptability of this new tool for malaria vector control.	[Pennetier, Cedric; Bouraima, Aziz; Sidick, Ibrahim; Zogo, Barnabas] UM1 UM2 CNRS 5290 IRD 224, IRD, Cotonou, Benin; [Pennetier, Cedric; Bouraima, Aziz; Sidick, Ibrahim; Zogo, Barnabas] CREC, Cotonou, Benin; [Chandre, Fabrice; Rossignol, Marie; Lacroix, Marie-Noelle] UM1 UM2 CNRS 5290 IRD 224, IRD, Montpellier, France; [Piameu, Michael; Etang, Josiane] OCEAC, Lab Med Entomol, Yaounde, Cameroon; [Piameu, Michael] Univ Catholique Afrique Cent, Cent Super Sci Sante, Yaounde, Cameroon; [Etang, Josiane] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Yadav, Rajpal] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Pigeon, Olivier] Walloon Agr Res Ctr CRA W, Agr & Nat Environm Dept, Plant Protect Prod & Biocides Physicochem & Resi, Gembloux, Belgium; [Corbel, Vincent] Kasetsart Univ, Dept Entomol, Fac Agr, Bangkok, Thailand	Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; World Health Organization; Kasetsart University	Pennetier, C (corresponding author), UM1 UM2 CNRS 5290 IRD 224, IRD, Cotonou, Benin.	cedric.pennetier@ird.fr	Chandre, Fabrice/Q-3429-2019; Yadav, Rajpal Singh/AAX-4483-2020; Pennetier, Cedric/K-2010-2016; Corbel, VIncent/G-9576-2016	Chandre, Fabrice/0000-0002-1994-9705; Yadav, Rajpal Singh/0000-0001-8264-1204; Pennetier, Cedric/0000-0002-3362-6371; PIAMEU, Michael/0000-0001-7409-3359	WHOPES; Sumitomo Chemical	WHOPES; Sumitomo Chemical	This work was financed by WHOPES and Sumitomo Chemical. Funders participated in the study design and the decision to publish. Funders have no role in the data collection, analysis and preparation of the manuscript.	Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Awolola TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/j.trstmh.2008.08.021; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bingham G, 2007, PEST MANAG SCI, V63, P276, DOI 10.1002/ps.1336; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Corbel V, 2002, PARASITE, V9, P255, DOI 10.1051/parasite/2002093255; CORBEL V, 2006, NEUROTOXICOLOGY, P1; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djogbenou L, 2010, MED VET ENTOMOL; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Etang J, 2003, J MED ENTOMOL, V40, P491, DOI 10.1603/0022-2585-40.4.491; Etang J, 2007, J VECTOR ECOL, V32, P123, DOI 10.3376/1081-1710(2007)32[123:SOMRTD]2.0.CO;2; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Hemingway J, 1998, PHILOS T ROY SOC B, V353, P1695, DOI 10.1098/rstb.1998.0320; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Killeen GF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-160; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2010, T ROY SOC TROP MED H, V104, P758, DOI 10.1016/j.trstmh.2010.08.008; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739; Pennetier C, 2008, EMERG INFECT DIS, V14, P1707, DOI 10.3201/eid1411.071575; Pennetier C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-38; Pennetier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007896; Plowe Christopher V, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS11, DOI 10.1016/j.trstmh.2008.11.002; Ranson H, 2010, TRENDS PARASITOL; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Skovmand O, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-114; Tungu PK, 2008, EVALUATION PERMANET; Van Bortel W, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-248; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2005, WHOCDSWHOPESGCDPP200; WHO, 2006, WHOCDSNTDWHOPESGCDDP; WHO, 2010, 13 WHOPES WORK GROUP; World Health Organization, 2012, 15 WHOPES WORK GROUP; Yewhalaw D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-159	48	71	71	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75134	10.1371/journal.pone.0075134	http://dx.doi.org/10.1371/journal.pone.0075134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116029	Green Published, gold			2022-12-27	WOS:000325552200012
J	Weiskirchen, R; Weimer, J; Meurer, SK; Kron, A; Seipel, B; Vater, I; Arnold, N; Siebert, R; Xu, LM; Friedman, SL; Bergmann, C				Weiskirchen, Ralf; Weimer, Joerg; Meurer, Steffen K.; Kron, Anja; Seipel, Barbara; Vater, Inga; Arnold, Norbert; Siebert, Reiner; Xu, Lieming; Friedman, Scott L.; Bergmann, Carsten			Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2	PLOS ONE			English	Article							LIVER FIBROSIS; EXPRESSION; PROTEINS; MISIDENTIFICATION; IDENTIFICATION; PATHWAYS; CULTURES; BIOLOGY; VIRUS; TOOLS	The human hepatic cell line LX-2 has been described as tool to study mechanisms of hepatic fibrogenesis and the testing of antifibrotic compounds. It was originally generated by immortalisation with the Simian Vacuolating Virus 40 (SV40) transforming (T) antigen and subsequent propagation in low serum conditions. Although this immortalized line is used in an increasing number of studies, detailed genetic characterisation has been lacking. We here have performed genetic characterisation of the LX-2 cell line and established a single-locus short tandem repeat (STR) profile for the cell line and characterized the LX-2 karyotype by several cytogenetic and molecular cytogenetic techniques. Spectral karyotyping (SKY) revealed a complex karyotype with a set of aberrations consistently present in the metaphases analyses which might serve as cytogenetic markers. In addition, various subclonal and single cell aberrations were detected. Our study provides criteria for genetic authentication of LX-2 and offers insights into the genotype changes which might underlie part of its phenotypic features.	[Weiskirchen, Ralf; Meurer, Steffen K.] Rhein Westfal TH Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Weimer, Joerg; Arnold, Norbert] UKSH Campus Kiel, Dept Obstet & Gynaecol, Kiel, Germany; [Kron, Anja; Seipel, Barbara; Bergmann, Carsten] Bioscientia, Ctr Human Genet, Ingelheim, Germany; [Vater, Inga; Siebert, Reiner] Univ Hosp Schleswig Holstein, Inst Human Genet, Kiel, Germany; [Vater, Inga; Siebert, Reiner] Univ Kiel, Kiel, Germany; [Xu, Lieming] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China; [Friedman, Scott L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Bergmann, Carsten] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Bergmann, Carsten] Univ Hosp Freiburg, Clin Res Ctr, Freiburg, Germany	RWTH Aachen University; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Shanghai University of Traditional Chinese Medicine; Icahn School of Medicine at Mount Sinai; RWTH Aachen University; University of Freiburg	Weiskirchen, R (corresponding author), Rhein Westfal TH Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany.	rweiskirchen@ukaachen.de	Arnold, Norbert/E-3012-2010; Weiskirchen, Ralf/O-1734-2018; Siebert, Reiner/A-8049-2010; Weimer, Jörg Paul/E-3472-2010	Arnold, Norbert/0000-0003-4523-8808; Weiskirchen, Ralf/0000-0003-3888-0931; Weimer, Jörg Paul/0000-0002-4528-8509	German Research Foundation (DFG) [SFB/TRR57]; National Institutes of Health [DK56621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056621, R56DK056621] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the German Research Foundation (DFG, SFB/TRR57) and National Institutes of Health (DK56621 to SLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; BRAND KG, 1962, J NATL CANCER I, V28, P147; Cao Q, 2006, J CELL BIOCHEM, V97, P188, DOI 10.1002/jcb.20622; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; DEFENDI V, 1960, J NATL CANCER I, V25, P359; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao Q, 2011, HEPATOLOGY, V54, P1894, DOI 10.1002/hep.24475; Gartler S M, 1967, Natl Cancer Inst Monogr, V26, P167; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; GIRARDI AJ, 1965, J CELL COMPAR PHYSL, V65, P69, DOI 10.1002/jcp.1030650110; Hasegawa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013590; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He H, 2011, HEPATOLOGY, V53, P548, DOI 10.1002/hep.24047; Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Mangasser-Stephan K, 2001, LIVER, V21, P105, DOI 10.1034/j.1600-0676.2001.021002105.x; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Melgar-Lesmes P, 2010, ENDOCRINOLOGY, V151, P5306, DOI 10.1210/en.2010-0754; Meurer SK, 2005, J BIOL CHEM, V280, P3078, DOI 10.1074/jbc.M405411200; Meurer SK, 2012, EUR J CELL BIOL, V91, P450, DOI 10.1016/j.ejcb.2011.09.004; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Okabe H, 2011, ANN SURG ONCOL, V18, P1175, DOI 10.1245/s10434-010-1391-7; Shaffer LG, 2013, ISCN 2013 INT SYST H; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]; Taimr P, 2003, HEPATOLOGY, V37, P87, DOI 10.1053/jhep.2003.50002; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Wang SM, 1996, J VIROL, V70, P8422, DOI 10.1128/JVI.70.12.8422-8430.1996; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Weiskirchen R, 2011, FRONT BIOSCI-LANDMRK, V16, P1939, DOI 10.2741/3832; Woodrow KA, 2009, TISSUE ENG PT A, V15, P1169, DOI 10.1089/ten.tea.2008.0265; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	35	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75692	10.1371/journal.pone.0075692	http://dx.doi.org/10.1371/journal.pone.0075692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116068	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200034
J	Yang, D; Chariyalertsak, C; Wongthanee, A; Kawichai, S; Yotruean, K; Saokhieo, P; Guadamuz, T; Suwanvanichkij, V; Beyrer, C; Chariyalertsak, S				Yang, Daniel; Chariyalertsak, Chonlisa; Wongthanee, Antika; Kawichai, Surinda; Yotruean, Kriengkrai; Saokhieo, Pongpun; Guadamuz, Thomas; Suwanvanichkij, Voravit; Beyrer, Chris; Chariyalertsak, Suwat			Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand	PLOS ONE			English	Article							GAY PRIDE EVENTS; HIV PREVENTION; ANTIRETROVIRAL PROPHYLAXIS; POSTEXPOSURE PROPHYLAXIS; LIMITED KNOWLEDGE; RISK; ATTENDEES; ATTITUDES; INFECTION; BARRIERS	Background: Northern Thailand has a high burden HIV epidemic among MSM and TG. Oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine has demonstrated efficacy in preventing HIV among MSM and TG in Chiang Mai, Thailand. Determinants of PrEP acceptability are needed to gauge the potential uptake of this prevention strategy. Methods: From January to February 2012, 238 MSM and TG participants, who self-reported as HIV-uninfected or of unknown status, completed a self-administered survey on hand-held computers. Participants were recruited by venue-day-time sampling and asked to rate their likelihood of using oral PrEP for HIV prevention with an efficacy of 50%. PrEP acceptability was defined as being "very likely" to use PrEP. Odds ratios and 95% CIs were calculated to identify correlates of acceptability. Results: 131 MSM and 107 TG responded, with mean ages of 23.7 and 21.8, respectively. 24% of MSM engaged primarily in receptive anal sex vs. 74% of TG. 21% of MSM and 44% of TG reported regular medication use. Prior awareness of PrEP was high at 66% among both MSM and TG respondents. 41% of MSM and 37% of TG were "very likely" to use PrEP. Among MSM, factors associated with PrEP acceptability included a prior history of STIs (AOR 4.6; 95% CIs 1.7-12.6), previous HIV testing (AOR 2.4 95% CIs 1.1-5.3), regularly planned sex (AOR 2.8 95% CIs 1.1-7.2), and infrequent sex (AOR 2.9 95% CIs 1.3-6.3). Among TG, factors associated with acceptability included prior awareness of PrEP (AOR 3.3; 95% CIs 1.2-9.0) and having private insurance (AOR 5.0; 95% CIs 1.3-19.0). Conclusion: MSM and TG in Northern Thailand are distinct groups in terms of sexual behaviors, patterns of medication use, and correlates of PrEP acceptability. Efforts to maximize PrEP uptake should include expanded HIV testing services and the provision of financial subsidies to reduce the cost of PrEP.	[Yang, Daniel] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yang, Daniel; Kawichai, Surinda; Suwanvanichkij, Voravit; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wongthanee, Antika; Kawichai, Surinda; Saokhieo, Pongpun; Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Chariyalertsak, Chonlisa; Yotruean, Kriengkrai] Thailand Minist Publ Hlth, Chiang Mai Prov Publ Hlth Off, Chiang Mai, Thailand; [Guadamuz, Thomas] Mahidol Univ, Fac Social Sci & Humanities, Ctr Hlth Policy Studies, Nakhon Pathom, Thailand; [Guadamuz, Thomas] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Chariyalertsak, Suwat] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand	University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chiang Mai University; Ministry of Public Health - Thailand; Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chiang Mai University	Yang, D (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	Daniel.Yang@ucsf.edu		Kawichai, Surinda/0000-0003-0189-4125	National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; Johns Hopkins Fogarty AIDS International Training and Research Program [D43 TW00010-22]; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH085567] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Relief and Recovery Act; Johns Hopkins Fogarty AIDS International Training and Research Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; and National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. The research was also supported, in part, by the Johns Hopkins Fogarty AIDS International Training and Research Program (D43 TW00010-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant R, 2011, ABSTR COMPL OBS RAND; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Kellerman SE, 2006, JAIDS-J ACQ IMM DEF, V43, P376, DOI 10.1097/01.qai.0000234085.18914.d5; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Mansergh G, 2006, FIELD METHOD, V18, P135, DOI 10.1177/1525822X05282267; Mayer KH, 2010, JAIDS-J ACQ IMM DEF, V55, pS122, DOI 10.1097/QAI.0b013e3181fbcb4c; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Schneider J, 2012, AIDS PATIENT CARE ST, V26, P631, DOI 10.1089/apc.2012.0188; Schneider JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011922; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2011, UNAIDS REP GLOB AIDS; Underhill Kristen, 2010, Curr HIV/AIDS Rep, V7, P210, DOI 10.1007/s11904-010-0062-4; van Griensven F., 2006, Morbidity and Mortality Weekly Report, V55, P844; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; van Griensven F, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-13; Voetsch AC, 2007, JAIDS-J ACQ IMM DEF, V46, P378, DOI 10.1097/QAI.0b013e3181576874; Whiteside YO, 2011, AIDS PATIENT CARE ST, V25, P365, DOI 10.1089/apc.2010.0224; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329	34	17	20	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76650	10.1371/journal.pone.0076650	http://dx.doi.org/10.1371/journal.pone.0076650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116132	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200060
J	Cui, J; Petritis, K; Tegeler, T; Petritis, B; Ma, XP; Jin, YF; Gao, SJ; Zhang, J				Cui, Jian; Petritis, Konstantinos; Tegeler, Tony; Petritis, Brianne; Ma, Xuepo; Jin, Yufang; Gao, Shou-Jiang (SJ); Zhang, Jianqiu (Michelle)			Accurate LC Peak Boundary Detection for O-16/O-18 Labeled LC-MS Data	PLOS ONE			English	Article							PEPTIDE DETECTION ALGORITHM; MASS-SPECTROMETRY; PROTEIN QUANTIFICATION; PROTEOMICS; RATIOS; IDENTIFICATION; SOFTWARE; SUITE; TOOL	In liquid chromatography-mass spectrometry (LC-MS), parts of LC peaks are often corrupted by their co-eluting peptides, which results in increased quantification variance. In this paper, we propose to apply accurate LC peak boundary detection to remove the corrupted part of LC peaks. Accurate LC peak boundary detection is achieved by checking the consistency of intensity patterns within peptide elution time ranges. In addition, we remove peptides with erroneous mass assignment through model fitness check, which compares observed intensity patterns to theoretically constructed ones. The proposed algorithm can significantly improve the accuracy and precision of peptide ratio measurements.	[Cui, Jian; Ma, Xuepo; Jin, Yufang; Zhang, Jianqiu (Michelle)] Univ Texas San Antonio, Dept Elect Engn, San Antonio, TX 78249 USA; [Petritis, Konstantinos; Tegeler, Tony; Petritis, Brianne] Translat Genom Res Inst, Ctr Prote, Phoenix, AZ USA; [Gao, Shou-Jiang (SJ)] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Texas System; University of Texas at San Antonio (UTSA); Translational Genomics Research Institute; University of Southern California	Zhang, J (corresponding author), Univ Texas San Antonio, Dept Elect Engn, San Antonio, TX 78249 USA.	michelle.zhang@utsa.edu	Gao, Shou-Jiang/B-8641-2012; Petritis, Konstantinos/AAP-4353-2021	Petritis, Konstantinos/0000-0001-8660-8532; Gao, Shou-Jiang/0000-0001-6194-1742	National Institute on Minority Health and Health Disparities [G12MD007591]; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA124332] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by a grant from the National Institute on Minority Health and Health Disparities (G12MD007591) from the National Institutes of Health (website: http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BAYNE CK, 1984, INT J MASS SPECTROM, V59, P315, DOI 10.1016/0168-1176(84)85105-8; Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eckel-Passow JE, 2006, BIOINFORMATICS, V22, P2739, DOI 10.1093/bioinformatics/btl464; Eckel-Passow Jeanette E, 2010, J Proteomics Bioinform, V3, P314; Geiger T., 2010, NATURE METHODS; Haskins WE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-74; Hero AO, 1996, IEEE T SIGNAL PROCES, V44, P2026, DOI 10.1109/78.533723; Kullback S., 1997, INFORM THEORY STAT; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Leptos KC, 2006, PROTEOMICS, V6, P1770, DOI 10.1002/pmic.200500201; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Mann B, 2008, RAPID COMMUN MASS SP, V22, P3823, DOI 10.1002/rcm.3781; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Renard BY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-355; Sun YT, 2012, BIOINFORMATICS, V28, P564, DOI 10.1093/bioinformatics/btr675; Sun YT, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-490; Valkenborg D, 2012, MASS SPECTROM REV, V31, P96, DOI 10.1002/mas.20339; Wang GH, 2006, ANAL CHEM, V78, P5752, DOI 10.1021/ac060611v; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Ye XY, 2010, ANAL CHEM, V82, P5878, DOI 10.1021/ac101284c; Ye Xiaoying, 2009, Briefings in Functional Genomics & Proteomics, V8, P136, DOI 10.1093/bfgp/eln055; Zhu Q, 2011, INT J PROTEOMICS; Zhu Q, 2010, J PROTEOME RES, V9, P2669, DOI 10.1021/pr100169a; Zhu Q, 2011, J FLUID MECH, V675, P495, DOI 10.1017/S0022112011000334	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e72951	10.1371/journal.pone.0072951	http://dx.doi.org/10.1371/journal.pone.0072951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24115998	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300001
J	Kinoshita, R; Nam, JM; Ito, YM; Hatanaka, KC; Hashimoto, A; Handa, H; Otsuka, Y; Hashimoto, S; Onodera, Y; Hosoda, M; Onodera, S; Shimizu, S; Tanaka, S; Shirato, H; Tanino, M; Sabe, H				Kinoshita, Rumiko; Nam, Jin-Min; Ito, Yoichi M.; Hatanaka, Kanako C.; Hashimoto, Ari; Handa, Haruka; Otsuka, Yutaro; Hashimoto, Shigeru; Onodera, Yasuhito; Hosoda, Mitsuchika; Onodera, Shunsuke; Shimizu, Shinichi; Tanaka, Shinya; Shirato, Hiroki; Tanino, Mishie; Sabe, Hisataka			Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy	PLOS ONE			English	Article							20-YEAR FOLLOW-UP; CONSERVING THERAPY; RISK-FACTORS; LARGE SERIES; CANCER; EXPRESSION; MASTECTOMY; BETA-1-INTEGRIN; SIGNATURE; SURVIVAL	A major problem of current cancer research and therapy is prediction of tumor recurrence after initial treatment, rather than the simple biological characterization of the malignancy and proliferative properties of tumors. Breast conservation therapy (BCT) is a well-approved, standard treatment for patients with early stages of breast cancer, which consists of lumpectomy and whole-breast irradiation. In spite of extensive studies, only 'age' and 'Ki-67 positivity' have been identified to be well correlated with local recurrence after BCT. An Arf6 pathway, activated by GEP100 under receptor tyrosine kinases (RTKs) and employs AMAP1 as its effector, is crucial for invasion and metastasis of some breast cancer cells. This pathway activates beta 1 integrins and perturbs E-cadherin-based adhesions, hence appears to be integral for epithelial-mesenchymal transdifferentiation (EMT). We here show that expression of the Arf6 pathway components statistically correlates with rapid local recurrence after BCT. We retrospectively analyzed four hundred seventy-nine patients who received BCT in Hokkaido University Hospital, and found 20 patients had local recurrence. We then analyzed pathological samples of patients who experienced local recurrence by use of Kaplan-Meier analysis, Stepwise regression analysis and the t-test, coupled with immunostaining, and found that co-overexpression of GEP100 and AMAP1 correlates with rapidity of the local recurrence. Their margin-status, node-positivity, and estrogen receptor (ER)-or progesterone receptor (PgR)positivity did not correlated with the rapidity. This study is the first to show that expression of a certain set of proteins correlates with the rapidity of local recurrence. Our results are useful not only for prediction, but highlight the possibility of developing novel strategies to block local recurrence. We also discuss why mRNAs encoding these proteins have not been identified to correlate with local recurrence by previous conventional gene expression profiling analyses.	[Kinoshita, Rumiko; Nam, Jin-Min; Onodera, Shunsuke; Shimizu, Shinichi; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan; [Hatanaka, Kanako C.] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Hashimoto, Ari; Handa, Haruka; Otsuka, Yutaro; Hashimoto, Shigeru; Onodera, Yasuhito; Sabe, Hisataka] Hokkaido Univ, Grad Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Hosoda, Mitsuchika] Hokkaido Univ Hosp, Dept Breast & Endocrine Surg, Sapporo, Hokkaido 060, Japan; [Tanaka, Shinya; Tanino, Mishie] Hokkaido Univ, Grad Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Tanino, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido, Japan.	tanino@med.hokudai.ac.jp; sabe@med.hokudai.ac.jp	Onodera, Yasuhito/D-7108-2012; Tanaka, Shinya/D-3586-2011; Shirato, Hiroki/A-7068-2010; Kinoshita, Rumiko/ABG-3864-2021; Shimizu, Shinichi/G-4477-2010; Nam, Jin-Min/D-6468-2012; Sabe, Hisataka/GPF-4385-2022	Shimizu, Shinichi/0000-0003-3143-0479; Ito, Yoichi M./0000-0001-5073-0827; Handa, Haruka/0000-0002-8557-7479; Onodera, Yasuhito/0000-0002-0064-9016	Ministry of Education, Science, Sports and Culture of Japan; Mitsubishi Foundation for Natural Sciences; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [24791259]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Grants-in-Aid for Scientific Research [23590323, 24590406] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation for Natural Sciences; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan, Mitsubishi Foundation for Natural Sciences, Takeda Science Foundation to H. Sabe, The Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST program http://www.jsps.go.jp/j-first/gaiyou.html) to H. Shirato, and Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government http://www.jsps.go.jp/j-grantsinaid/square) (No. 24791259) to R. Kinoshita. J.-M. Nam was supported by a grant from the Matching Program for Innovations in Future Drug Discovery and Medical Care from the) square Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manusclipt	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Cheng SH, 2006, J CLIN ONCOL, V24, P4594, DOI 10.1200/JCO.2005.02.5676; Cordes N, 2007, INT J RADIAT BIOL, V83, P753, DOI 10.1080/09553000701639694; Elkhuizen PHM, 1999, INT J RADIAT ONCOL, V45, P73, DOI 10.1016/S0360-3016(99)00158-3; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hay ED, 1995, ACTA ANAT, V154, P8; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; InstituteSas IS, 2012, JMP 10 MOD MULT METH; Jones HA, 2009, J CLIN ONCOL, V27, P4939, DOI 10.1200/JCO.2008.21.5764; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Kreike B, 2009, CLIN CANCER RES, V15, P4181, DOI 10.1158/1078-0432.CCR-08-2644; Kunkler IH, 2012, INT J RADIAT ONCOL, V83, P829, DOI 10.1016/j.ijrobp.2011.08.018; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miyata M, 2008, CELL CYCLE, V7, P3273, DOI 10.4161/cc.7.20.6883; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Nuyten DSA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1614; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989	32	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76791	10.1371/journal.pone.0076791	http://dx.doi.org/10.1371/journal.pone.0076791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116160	Green Published, gold			2022-12-27	WOS:000325501300096
J	Martens, B; Amman, F; Manoharadas, S; Zeichen, L; Orell, A; Albers, SV; Hofacker, I; Blasi, U				Maertens, Birgit; Amman, Fabian; Manoharadas, Salim; Zeichen, Lukas; Orell, Alvaro; Albers, Sonja-Verena; Hofacker, Ivo; Blaesi, Udo			Alterations of the Transcriptome of Sulfolobus acidocaldarius by Exoribonuclease aCPSF2	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTOR; MESSENGER-RNA DEGRADATION; BETA-CASP RIBONUCLEASES; ESCHERICHIA-COLI; SOLFATARICUS; MATURATION; COMPLEX; DECAY; CRENARCHAEOTA; EXPRESSION	Recent studies identified a 5' to 3' exoribonuclease termed Sso-RNase J in the crenarchaeon Sulfolobus solfataricus (Sso), which has been reclassified to the aCPSF2 (archaeal cleavage and polyadenylation specificity factor 2) group of beta-CASP proteins. In this study, the Sso-aCPSF2 orthologue of Sulfolobus acidocaldarius (Saci-aCPSF2) was functionally characterized. Like Sso-aCPSF2, Saci-aCPSF2 degrades RNA with 5' to 3' directionality in vitro. To address the biological significance of Saci-aCPSF2, a deletion mutant was constructed, and the influence of Saci-aCPSF2 on the transcriptome profile was assessed employing high throughput RNA sequencing. This analysis revealed 560 genes with differential transcript abundance, suggesting a considerable role of this enzyme in RNA metabolism. In addition, bioinformatic analyses revealed several transcripts that are preferentially degraded at the 5' end. This was exemplarily verified for two transcripts by Northern-blot analyses, showing for the first time that aCPSF2 proteins play a role in 5' to 3' directional mRNA decay in the crenarchaeal clade of Archaea.	[Maertens, Birgit; Manoharadas, Salim; Zeichen, Lukas; Blaesi, Udo] Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Vienna, Austria; [Amman, Fabian; Hofacker, Ivo] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Orell, Alvaro; Albers, Sonja-Verena] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Amman, Fabian] Univ Leipzig, Dept Comp Sci, D-04109 Leipzig, Germany; [Amman, Fabian] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; Max Planck Society; Leipzig University; Leipzig University	Blasi, U (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Vienna, Austria.	udo.blaesi@univie.ac.at	MANOHARADAS, SALIM/ABC-6986-2020; Hofacker, Ivo L/A-2378-2013; Albers, Sonja-Verena/H-8689-2019	MANOHARADAS, SALIM/0000-0002-1875-5976; Hofacker, Ivo L/0000-0001-7132-0800; Albers, Sonja-Verena/0000-0003-2459-2226; Amman, Fabian/0000-0002-8646-859X	Austrian Science Fund [P21560]; Max Planck Society; FWF project [SFB F43]; Austrian Science Fund (FWF) [P 21560] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Max Planck Society(Max Planck Society); FWF project(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grant P21560 from the Austrian Science Fund to UB. AO and SVA were supported by intramural funds of the Max Planck Society. FA and IH were supported by the FWF project SFB F43 "RNA regulation of the transcriptome".	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berkner S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm449; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; Clout d Orval B, 2010, J BIOL CHEM, V285, P17574; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DEUTSCHER MP, 1993, J BACTERIOL, V175, P4577, DOI 10.1128/JB.175.15.4577-4583.1993; Dominski Z, 2013, BBA-GENE REGUL MECH, V1829, P532, DOI 10.1016/j.bbagrm.2013.01.010; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Franzetti B, 1997, J BACTERIOL, V179, P1180, DOI 10.1128/jb.179.4.1180-1185.1997; Hasenohrl D, 2008, P NATL ACAD SCI USA, V105, P2146, DOI 10.1073/pnas.0708894105; Hasenohrl D, 2011, RNA, V17, P99, DOI 10.1261/rna.2418211; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Pedulla N, 2005, NUCLEIC ACIDS RES, V33, P1804, DOI 10.1093/nar/gki321; Phung DK, 2013, NUCLEIC ACIDS RES, V41, P1091, DOI 10.1093/nar/gks1237; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taverniti V, 2011, MOL MICROBIOL, V82, P1260, DOI 10.1111/j.1365-2958.2011.07888.x; Tourriere H, 2002, BIOCHIMIE, V84, P821, DOI 10.1016/S0300-9084(02)01445-1; Wagner M, 2009, BIOCHEM SOC T, V37, P97, DOI 10.1042/BST0370097	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76569	10.1371/journal.pone.0076569	http://dx.doi.org/10.1371/journal.pone.0076569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116119	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300066
J	Qin, WT; Zhang, JL; Lv, WH; Wang, X; Sun, BW				Qin, Weiting; Zhang, Jinli; Lv, Wanghui; Wang, Xu; Sun, Bingwei			Effect of Carbon Monoxide-Releasing Molecules II-liberated CO on Suppressing Inflammatory Response in Sepsis by Interfering with Nuclear Factor Kappa B Activation	PLOS ONE			English	Article							THERMALLY-INJURED MICE; PROTEIN-KINASE PATHWAY; MYELOPEROXIDASE ACTIVITY; ENDOTHELIAL-CELLS; LEUKOCYTES SEQUESTRATION; MURINE MACROPHAGES; ICAM-1 EXPRESSION; OXIDATIVE STRESS; SMALL-INTESTINE; LUNG INJURY	Sepsis continues to be a challenge in clinic. The rates of mortality in sepsis patients remain high. The present study aimed to investigate the effects and the underlying mechanisms of carbon monoxide-releasing molecules II (CORM-2)-liberated CO on suppressing inflammatory response in sepsis. It was shown that treatment of septic mice with CORM-2 attenuated PMN accumulation, downregulated cytokines production, inhibited expressions of iNOS and NF-kappa B activity in the lung and liver. In parallel, CORM-2 prevented activation of NF-kappa B in LPS-stimulated HUVEC. This was accompanied by a decrease in ROS and NO production, expression of ICAM-1 and subsequent PMN adhesion to HUVEC. These findings demonstrated that CORM-released CO attenuates inflammatory responses by interfering with NF-kappa B activation and therefore decreasing the expression of ICAM-1 and NO production, attenuating the oxidative stress and inflammation in sepsis.	[Qin, Weiting; Zhang, Jinli; Lv, Wanghui; Wang, Xu; Sun, Bingwei] Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Sun, BW (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Jiangsu, Peoples R China.	sunbinwe@hotmail.com			National Natural Science Foundation of China [30772256, 81071546, 81272148]; Jiangsu Provincial Natural Science Foundation [BK2012703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China, No. 30772256, 81071546 and No. 81272148, and Jiangsu Provincial Natural Science Foundation, No. BK2012703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Cakir B, 2005, REGUL PEPTIDES, V125, P135, DOI 10.1016/j.regpep.2004.08.032; Cepinskas G, 1999, CIRC RES, V84, P103; Chapman JT, 2001, AM J PHYSIOL-LUNG C, V281, pL209, DOI 10.1152/ajplung.2001.281.1.L209; Chen LW, 2006, CRIT CARE MED, V34, P142, DOI 10.1097/01.CCM.0000190621.48720.8C; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Coburn RF, 2012, J APPL PHYSIOL, V112, P1949, DOI 10.1152/japplphysiol.00174.2012; Condotta SA, 2013, CRIT REV IMMUNOL, V33, P23, DOI 10.1615/CritRevImmunol.2013006721; Cuschieri J, 2003, J TRAUMA, V54, P104, DOI 10.1097/00005373-200301000-00013; Deveci M, 2000, BURNS, V26, P41, DOI 10.1016/S0305-4179(99)00107-2; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Han EH, 2012, FOOD CHEM TOXICOL, V50, P1616, DOI 10.1016/j.fct.2012.02.006; Hansbrough JF, 1996, J SURG RES, V61, P17, DOI 10.1006/jsre.1996.0074; Harjai M, 2013, ANAESTH INTENS CARE, V41, P175, DOI 10.1177/0310057X1304100207; Hernandez G, 2013, CURR VASC PHARMACOL, V11, P161; Johnson TR, 2003, ANGEW CHEM INT EDIT, V42, P3722, DOI 10.1002/anie.200301634; Karahocagil MK, 2012, CLIN BIOCHEM, V45, P733, DOI 10.1016/j.clinbiochem.2012.03.017; Khalatbary Ali Reza, 2011, Iranian Biomedical Journal, V15, P164, DOI 10.6091/IBJ.1026.2012; Liu DM, 2008, ACTA PHARMACOL SIN, V29, P838, DOI 10.1111/j.1745-7254.2008.00816.x; Lomas JL, 2003, SHOCK, V19, P358, DOI 10.1097/00024382-200304000-00011; Madonna R, 2012, VASC PHARMACOL, V57, P41, DOI 10.1016/j.vph.2012.02.005; Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje; Motterlini R, 2003, CURR PHARM DESIGN, V9, P2525, DOI 10.2174/1381612033453785; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Nakao A, 2003, GUT, V52, P1278, DOI 10.1136/gut.52.9.1278; Odobasic D, 2013, BLOOD, V121, P4195, DOI 10.1182/blood-2012-09-456483; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Ozaki KS, 2012, TRANSPL INT, V25, P107, DOI 10.1111/j.1432-2277.2011.01363.x; Panes J, 1995, AM J PHYSIOL-HEART C, V269, pH1955, DOI 10.1152/ajpheart.1995.269.6.H1955; Park KH, 2013, J IMMUNOL, V190, P6550, DOI 10.4049/jimmunol.1202284; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Piantadosi CA, 2002, ANTIOXID REDOX SIGN, V4, P259, DOI 10.1089/152308602753666316; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rupesh KR, 2010, EUR J MED CHEM, V45, P2141, DOI 10.1016/j.ejmech.2010.01.041; Ryter SW, 2013, KOREAN J INTERN MED, V28, P123, DOI 10.3904/kjim.2013.28.2.123; Sagara Daisuke, 2010, Ann Vasc Dis, V3, P131, DOI 10.3400/avd.AVDoa00930; Sanadgol N, 2010, CLIN BIOCHEM, V43, P968, DOI 10.1016/j.clinbiochem.2010.04.066; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Schwer CI, 2013, INT J BIOCHEM CELL B, V45, P201, DOI 10.1016/j.biocel.2012.09.020; Sriskandan S, 2011, J ROY COLL PHYS EDIN, V41, P339, DOI 10.4997/JRCPE.2011.411; Sun BW, 2007, J BURN CARE RES, V28, P173, DOI 10.1097/BCR.0b013E31802CA491; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sun BW, 2008, INT J BIOL SCI, V4, P176; Sun BW, 2007, J SURG RES, V139, P128, DOI 10.1016/j.jss.2006.08.032; Tse MT, 2013, NAT REV DRUG DISCOV, V12, P334, DOI 10.1038/nrd4016; Wang X, 2012, WORLD J GASTROENTERO, V18, P5719, DOI 10.3748/wjg.v18.i40.5719; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Zhang N, 2013, NAT MED, V19, P500, DOI 10.1038/nm.3110	54	19	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75840	10.1371/journal.pone.0075840	http://dx.doi.org/10.1371/journal.pone.0075840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116078	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300043
J	El Alaoui, MA; Melloul, M; Amine, SA; Stambouli, H; El Bouri, A; Soulaymani, A; El Fahime, E				El Alaoui, Moulay Abdelaziz; Melloul, Marouane; Amine, Sanaa Alaoui; Stambouli, Hamid; El Bouri, Aziz; Soulaymani, Abdelmajid; El Fahime, Elmostafa			Extraction of High Quality DNA from Seized Moroccan Cannabis Resin (Hashish)	PLOS ONE			English	Article							THCA SYNTHASE GENE; RAPID ISOLATION; POLYSACCHARIDE; POLYMORPHISMS; PROTOCOL; SATIVA; PLANTS	The extraction and purification of nucleic acids is the first step in most molecular biology analysis techniques. The objective of this work is to obtain highly purified nucleic acids derived from Cannabis sativa resin seizure in order to conduct a DNA typing method for the individualization of cannabis resin samples. To obtain highly purified nucleic acids from cannabis resin (Hashish) free from contaminants that cause inhibition of PCR reaction, we have tested two protocols: the CTAB protocol of Wagner and a CTAB protocol described by Somma (2004) adapted for difficult matrix. We obtained high quality genomic DNA from 8 cannabis resin seizures using the adapted protocol. DNA extracted by the Wagner CTAB protocol failed to give polymerase chain reaction (PCR) amplification of tetrahydrocannabinolic acid (THCA) synthase coding gene. However, the extracted DNA by the second protocol permits amplification of THCA synthase coding gene using different sets of primers as assessed by PCR. We describe here for the first time the possibility of DNA extraction from (Hashish) resin derived from Cannabis sativa. This allows the use of DNA molecular tests under special forensic circumstances.	[El Alaoui, Moulay Abdelaziz; Melloul, Marouane; Amine, Sanaa Alaoui; El Fahime, Elmostafa] Ctr Sci & Tech Res CNRST, UATRS, Rabat, Morocco; [Stambouli, Hamid; El Bouri, Aziz] Lab Forens Sci Moroccan Gendarmerie Royale LARATE, Rabat, Morocco; [El Alaoui, Moulay Abdelaziz; Soulaymani, Abdelmajid] Univ Ibn Tofail, Fac Sci, Dept Biol, Lab Genet & Biometrie, Kenitra, Morocco	Centre National de la Recherche Scientifique & Technologique (CNRST); Ibn Tofail University of Kenitra	El Alaoui, MA (corresponding author), Ctr Sci & Tech Res CNRST, UATRS, Rabat, Morocco.	elalaoui@cnrst.ma	SOULAYMANI, Abdelmajid a/H-4382-2011; FAHIME, Elmostafa EL/AAC-2146-2020	SOULAYMANI, Abdelmajid a/0000-0002-0964-1029; el fahime, elmostafa/0000-0001-7812-0641; El Alaoui, My Abdelaziz/0000-0002-1555-5194; Melloul, Marouane/0000-0002-1821-7537	Functional Genomic Platform; (UATRS) at the Moroccan Centre for Scientific and Technical Research (CNRST)	Functional Genomic Platform; (UATRS) at the Moroccan Centre for Scientific and Technical Research (CNRST)	This work was supported by the Functional Genomic Platform; (UATRS) at the Moroccan Centre for Scientific and Technical Research (CNRST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1999, PLANT MOL BIOL REP, V17, P281, DOI 10.1023/A:1007692929505; Angeles J. G. C., 2005, Plant Molecular Biology Reporter, V23, P297, DOI 10.1007/BF02772760; Carson DR, 2001, HASHISH ENCY DRUGS A, V2; Cascini F, 2012, FORENSIC SCI INT, V217, P134, DOI 10.1016/j.forsciint.2011.10.041; Coyle HM, 2003, CROAT MED J, V44, P315; Coyle HM, 2003, FORENSIC SCI, V48, P207; Demeke T, 2009, J AOAC INT, V92, P1136; DNA Baser Sequence Assembler v3.x, 2012, HER BIOSOFT SRL ROM; Gilmore S, 2003, FORENSIC SCI INT, V131, P65, DOI 10.1016/S0379-0738(02)00397-3; Horne E. C., 2004, Plant Molecular Biology Reporter, V22, P83, DOI 10.1007/BF02773352; Howard C, 2008, NATL DRUG LAW ENFORC, V29, P1; International Organization for Standardization, 2005, ISO215712005; Jaakola L, 2001, PLANT MOL BIOL REP, V19, P125, DOI 10.1007/BF02772901; Khanuja SPS, 1999, PLANT MOL BIOL REP, V17, P74, DOI 10.1023/A:1007528101452; Kojoma M, 2006, FORENSIC SCI INT, V159, P132, DOI 10.1016/j.forsciint.2005.07.005; Lamitina Lab Protocols, 2007, ETH PREC DNA; Linacre A, 1998, FORENSIC SCI INT, V91, P71, DOI 10.1016/S0379-0738(97)00173-4; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NanoDrop, 2007, NANODROP TECHNICAL S, VT009; Office des Nations Unies contre la drogue et le crime, 2006, B STUP BIL SIT MOND, VLVIII, P1; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Sablok G, 2009, PLANT OMICS, V2, P103; Stambouli H., 2005, ANN TOXICOL ANAL, V17, P79; Terry CF, 2002, J AOAC INT, V85, P768; WAGNER DB, 1987, P NATL ACAD SCI USA, V84, P2097, DOI 10.1073/pnas.84.7.2097	25	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74714	10.1371/journal.pone.0074714	http://dx.doi.org/10.1371/journal.pone.0074714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124454	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100011
J	Li, YQ; Liu, FF; Zhang, XM; Guo, XJ; Ren, MJ; Fu, L				Li, Ya-Qing; Liu, Fang-Fang; Zhang, Xin-Min; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li			Tumor Secretion of CCL22 Activates Intratumoral Treg Infiltration and Is Independent Prognostic Predictor of Breast Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; TGF-BETA; PERIPHERAL-BLOOD; OVARIAN-CANCER; CARCINOMA; MICROENVIRONMENT; PROGRESSION; RECRUITMENT; IMMUNOTHERAPY	It has been reported that dense intratumoral infiltration of Foxp3 (+)Tregs (Tregs) was an independent factor for poor prognosis of breast cancer (BC) patients. However, the cytokines activating the Treg infiltration are not known. This study was undertaken to evaluate the role of CCL22 and TGF-beta 1 in this cascade and their prognostic significance for BC patients. 417 cases of invasive breast cancer were selected from the prior study cohort and the expressions of CCL22 and TGF-beta 1 were assessed by immunohistochemistry. It was identified that tumor secretion of CCL22 was positively correlated with the intratumoral Treg infiltration (P<0.0001), but its association with lymphoid aggregates surrounding the tumor was not proven to be significant (P=0.056). Moreover, CCL22 expression was found to be associated with the tumor histological features known to be related with unfavorable prognosis of patients, including high histological grade (P<0.0001), negative ER (P<0.0001), negative PR (P=0.001), and HER2 amplification (P=0.028). Similar to intratumoral Treg infiltrates, CCL22 tumor secretion correlated with the prognosis of the molecular subtypes of breast carcinoma (P<0.0001). Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively). In contrast, although TGF-beta 1 expression was positively correlated with both Tregs infiltrates into the tumor bed and lymphoid aggregates surrounding the tumor (P=0.023; P=0.046, respectively), its expression was not significantly associated with the molecular subtypes of breast carcinoma and the prognosis of the patients. Our study indicates that both CCL22 and TGF-beta 1 are candidate chemoattractants for intratumoral Foxp3 (+)Tregs infiltration; however, unlike the later, CCL22 is an independent prognostic predictor of BC patients, and it therefore may have the potential to serve as a target for immunotherapeutic strategy of BC.	[Li, Ya-Qing; Liu, Fang-Fang; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc Pathol & Res Lab, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Li, Ya-Qing; Liu, Fang-Fang; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Li, Ya-Qing; Liu, Fang-Fang; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, Xin-Min] Temple Univ Hosp & Med Sch, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA; [Fu, Li] 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fu, L (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc Pathol & Res Lab, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.	fuli@tijmu.edu.cn			National Natural Science Foundation of China [30930038, 81202101, 81172531]; Program for Changjiang Scholars and Innovative Research Team [IRT0743]; Tianjin Medical University; third phase of the 211 Project for Higher Education [2010GSI07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Tianjin Medical University; third phase of the 211 Project for Higher Education	This work was supported by National Natural Science Foundation of China (Grant No. 30930038), Program for Changjiang Scholars and Innovative Research Team (Grant No. IRT0743) to Li Fu, National Natural Science Foundation of China (Grant No. 81202101) to Fang-Fang Liu, National Natural Science Foundation of China (Grant No. 81172531) to Xiao-Jing Guo, as well as Innovation Funding for graduate of Tianjin Medical University, third phase of the 211 Project for Higher Education (Grant No. 2010GSI07) to Ya-Qing Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Our study has not been published, in whole or in part, elsewhere in the peer-reviewed literature.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Bohling SD, 2008, MODERN PATHOL, V21, P1527, DOI 10.1038/modpathol.2008.160; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Conrad C, 2012, CANCER RES, V72, P5240, DOI 10.1158/0008-5472.CAN-12-2271; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Faget J, 2012, CANCER RES, V72, P6130, DOI 10.1158/0008-5472.CAN-12-2409; Faget J, 2011, CANCER RES, V71, P6143, DOI 10.1158/0008-5472.CAN-11-0573; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Herrera ACSA, 2012, CANCER IMMUNOL IMMUN, V61, P2193, DOI 10.1007/s00262-012-1283-8; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Levano KS, 2011, BIOCHEM BIOPH RES CO, V411, P107, DOI 10.1016/j.bbrc.2011.06.102; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Maruyama T, 2010, DIS ESOPHAGUS, V23, P422, DOI 10.1111/j.1442-2050.2009.01029.x; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Miller AM, 2006, J IMMUNOL, V177, P7398, DOI 10.4049/jimmunol.177.10.7398; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Qin XJ, 2009, CLIN CANCER RES, V15, P2231, DOI 10.1158/1078-0432.CCR-08-2641; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Thomachot MC, 2004, INT J CANCER, V110, P710, DOI 10.1002/ijc.20146; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Wang SE, 2011, SIGNAL TRANSDUCT, V2011; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Yigit R, 2010, GYNECOL ONCOL, V117, P366, DOI 10.1016/j.ygyno.2010.01.019; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	37	24	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76379	10.1371/journal.pone.0076379	http://dx.doi.org/10.1371/journal.pone.0076379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124553	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100110
J	Perc, M; Donnay, K; Helbing, D				Perc, Matjaz; Donnay, Karsten; Helbing, Dirk			Understanding Recurrent Crime as System-Immanent Collective Behavior	PLOS ONE			English	Article							ANTISOCIAL PUNISHMENT; ALTRUISTIC PUNISHMENT; INDIRECT RECIPROCITY; EVOLUTIONARY GAMES; COOPERATION; UNEMPLOYMENT; EMERGENCE; DYNAMICS; PROMOTES; HOTSPOTS	Containing the spreading of crime is a major challenge for society. Yet, since thousands of years, no effective strategy has been found to overcome crime. To the contrary, empirical evidence shows that crime is recurrent, a fact that is not captured well by rational choice theories of crime. According to these, strong enough punishment should prevent crime from happening. To gain a better understanding of the relationship between crime and punishment, we consider that the latter requires prior discovery of illicit behavior and study a spatial version of the inspection game. Simulations reveal the spontaneous emergence of cyclic dominance between "criminals", "inspectors", and "ordinary people" as a consequence of spatial interactions. Such cycles dominate the evolutionary process, in particular when the temptation to commit crime or the cost of inspection are low or moderate. Yet, there are also critical parameter values beyond which cycles cease to exist and the population is dominated either by a stable mixture of criminals and inspectors or one of these two strategies alone. Both continuous and discontinuous phase transitions to different final states are possible, indicating that successful strategies to contain crime can be very much counter-intuitive and complex. Our results demonstrate that spatial interactions are crucial for the evolutionary outcome of the inspection game, and they also reveal why criminal behavior is likely to be recurrent rather than evolving towards an equilibrium with monotonous parameter dependencies.	[Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Donnay, Karsten; Helbing, Dirk] Swiss Fed Inst Technol, Chair Sociol Particular Modeling & Simulat, Zurich, Switzerland; [Helbing, Dirk] Swiss Fed Inst Technol, Risk Ctr, Swiss Fed Inst Technol, Zurich, Switzerland	University of Maribor; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Perc, M (corresponding author), Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia.	matjaz.perc@uni-mb.si	Donnay, Karsten/S-2990-2016; Perc, Matjaz/A-5148-2009	Donnay, Karsten/0000-0002-9080-6539; Perc, Matjaz/0000-0002-3087-541X	Slovenian Research Agency [J1-4055]; Future and Emerging Technologies program FP7-COSI-ICT of the European Commission through the project QLectives [231200]; ERC Advanced Investigator Grant "Momentum" [324247]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Future and Emerging Technologies program FP7-COSI-ICT of the European Commission through the project QLectives; ERC Advanced Investigator Grant "Momentum"	This research was supported by the Slovenian Research Agency (Grant No. J1-4055), by the Future and Emerging Technologies program FP7-COSI-ICT of the European Commission through the project QLectives (Grant No. 231200), and by the ERC Advanced Investigator Grant "Momentum" (Grant No. 324247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenhaus R, 2002, HDB GAME THEORY, P51; Barker V, 2010, LAW SOCIAL INQUIRY, V35, P489, DOI 10.1111/j.1747-4469.2010.01192.x; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brantingham PJ, 2012, CRIMINOLOGY, V50, P851, DOI 10.1111/j.1745-9125.2012.00281.x; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Corsaro N, 2009, J EXP CRIMINOL, V5, P63, DOI 10.1007/s11292-008-9065-1; Curtis R, 1998, J CRIM LAW CRIM, V88, P1233, DOI 10.2307/1144256; Doob AN, 2003, CRIME JUSTICE, V30, P143, DOI 10.1086/652230; Dornic I, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.045701; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Eldakar OT, 2008, P NATL ACAD SCI USA, V105, P6982, DOI 10.1073/pnas.0712173105; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fowler JH, 2005, NATURE, V437, pE8, DOI 10.1038/nature04201; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Fowler JH, 2005, NATURE, V433, DOI 10.1038/nature03256; Fox J. A., 1996, TRENDS JUVENILE VIOL; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046707; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gomez-Sorzano G.A., 2006, APPL EC INT DEV, V7, P85; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hobbes Thomas., 1651, LEVIATHAN MATTER FOR; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Johnson N, 2011, SCIENCE, V333, P81, DOI 10.1126/science.1205068; Johnsons B. D., 2006, CRIME DROP AM, P164; LaFree G, 1999, ANNU REV SOCIOL, V25, P145, DOI 10.1146/annurev.soc.25.1.145; LaFree G., 1998, LOSING LEGITIMACY ST; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; Lin MJ, 2008, J HUM RESOUR, V43, P413, DOI 10.1353/jhr.2008.0022; Maguire M., 2002, OXFORD HDB CRIMINOLO, V3rd, P1; McGarrell EF, 2010, J QUANT CRIMINOL, V26, P165, DOI 10.1007/s10940-010-9091-9; Milinski M, 2008, NATURE, V452, P297, DOI 10.1038/452297a; NOWAK MA, 1994, INT J BIFURCAT CHAOS, V4, P33, DOI 10.1142/S0218127494000046; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Raphael S, 2001, J LAW ECON, V44, P259, DOI 10.1086/320275; Rauhut H, 2009, JASSS-J ARTIF SOC S, V12; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Short MB, 2010, SIAM J APPL DYN SYST, V9, P462, DOI 10.1137/090759069; Short MB, 2010, P NATL ACAD SCI USA, V107, P3961, DOI 10.1073/pnas.0910921107; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Skarin B, 2009, C P 27 INT C SYST DY, P1165; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021126; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; Traulsen A, 2012, P ROY SOC B-BIOL SCI, V279, P3716, DOI 10.1098/rspb.2012.0937; Tsebelis George, 1990, RATIONALITY AND SOCI, V2, P255, DOI DOI 10.1177/1043463190002003002; UNODC (United Nations Office on Drugs and Crime), 2011, STAT CRIM; Wilson James Q., 1995, CRIME, P489; Zimring FE., 2007, GREAT AM CRIME DECLI	74	27	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76063	10.1371/journal.pone.0076063	http://dx.doi.org/10.1371/journal.pone.0076063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124533	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100090
J	Roca, H; Hernandez, J; Weidner, S; McEachin, RC; Fuller, D; Sud, S; Schumann, T; Wilkinson, JE; Zaslavsky, A; Li, HW; Maher, CA; Daignault-Newton, S; Healy, PN; Pienta, KJ				Roca, Hernan; Hernandez, James; Weidner, Savannah; McEachin, Richard C.; Fuller, David; Sud, Sudha; Schumann, Taibriana; Wilkinson, John E.; Zaslavsky, Alexander; Li, Hangwen; Maher, Christopher A.; Daignault-Newton, Stephanie; Healy, Patrick N.; Pienta, Kenneth J.			Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer	PLOS ONE			English	Article							MIR-200 FAMILY; TUMOR-METASTASIS; RNA-SEQ; GENE; EXPRESSION; CELLS; ZEB1; MACROPHAGES; PATHWAYS; INVASION	Cell plasticity regulated by the balance between the mesenchymal to epithelial transition (MET) and the opposite program, EMT, is critical in the metastatic cascade. Several transcription factors (TFs) are known to regulate EMT, though the mechanisms of MET remain unclear. We demonstrate a novel function of two TFs, OVOL1 and OVOL2, as critical inducers of MET in human cancers. Our findings indicate that the OVOL-TFs control MET through a regulatory feedback loop with EMT-inducing TF ZEB1, and the regulation of mRNA splicing by inducing Epithelial Splicing Regulatory Protein 1 (ESRP1). Using mouse prostate tumor models we show that expression of OVOL-TFs in mesenchymal prostate cancer cells attenuates their metastatic potential. The role of OVOL-TFs as inducers of MET is further supported by expression analyses in 917 cancer cell lines, suggesting their role as crucial regulators of epithelial-mesenchymal cell plasticity in cancer.	[Roca, Hernan; Zaslavsky, Alexander; Li, Hangwen; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Hernandez, James; Weidner, Savannah; Fuller, David; Sud, Sudha; Schumann, Taibriana; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [McEachin, Richard C.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Daignault-Newton, Stephanie; Healy, Patrick N.] Univ Michigan, Sch Med, Div Biostat, Ctr Comprehens Canc, Ann Arbor, MI USA; [Maher, Christopher A.] Washington Univ, Sch Med, Dept Med, Genome Inst,Div Oncol, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL)	Roca, H (corresponding author), Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA.	rocach@umich.edu			National Institutes of Health [U54-CA163124, U01-CA143055, P50-CA69568, PO1-CA093900]; University of Michigan; NATIONAL CANCER INSTITUTE [P01CA093900, P50CA069568, U54CA163124, T32CA083654, U01CA143055, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U54-CA163124, U01-CA143055, P50-CA69568 and PO1-CA093900 from the National Institutes of Health. KJP is supported as an American Cancer Society Clinical Research Professor and as a Taubman Research Scholar of the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng YS, 2012, J CELL BIOCHEM, V113, P1714, DOI 10.1002/jcb.24041; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; SPREMULLI EN, 1983, J CLIN ONCOL, V1, P496, DOI 10.1200/JCO.1983.1.8.496; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wells J, 2009, J BIOL CHEM, V284, P29125, DOI 10.1074/jbc.M109.008847; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	37	158	166	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76773	10.1371/journal.pone.0076773	http://dx.doi.org/10.1371/journal.pone.0076773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124593	Green Published, gold			2022-12-27	WOS:000325489100150
J	Shen, J; Wei, J; Wang, H; Yang, Y; Yue, GF; Wang, L; Yu, LX; Xie, L; Sun, X; Bian, XY; Zou, ZY; Qian, XP; Guan, WX; Liu, BR				Shen, Jie; Wei, Jia; Wang, Hao; Yang, Yang; Yue, Guofeng; Wang, Lin; Yu, Lixia; Xie, Li; Sun, Xia; Bian, Xinyu; Zou, Zhengyun; Qian, Xiaoping; Guan, Wenxian; Liu, Baorui			SULF2 Methylation Is Associated with In Vitro Cisplatin Sensitivity and Clinical Efficacy for Gastric Cancer Patients Treated with a Modified FOLFOX Regimen	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CELL LUNG-CANCER; HEPARAN-SULFATE; TUMOR-CELLS; BINDING; GROWTH; SURVIVAL; ERCC1; CHEMOTHERAPY; TARGET	Objective: Biomarkers capable of discriminating the patients who are likely to respond to certain chemotherapeutic agents could improve the clinical efficiency. The sulfatases(SULFs) play a critical role in the pathogenesis of a variety of human cancers. Here, we focused our investigation on the prognostic and predictive impact of SULF2 methylation in gastric cancer. Methods: Promoter CpG island methylation of SULF2 was analyzed in 100 gastric cancer samples. The in vitro sensitivity to cisplatin, docetaxel, gemcitabine, irinotecan and pemetrexed were determined by histoculture drug response assay(HDRA). Additionally, 56 gastric cancer patients treated with a modified FOLFOX regimen(biweekly oxaliplatin plus 5-FU and folinic acid) were retrospectively analyzed to further evaluate the prognostic and predictive impact of SULF2 methylation in gastric cancer. Results: Methylated SULF2(SULF2M) was detected in 28 patients, while the remaining 72 patients showed unmethylated SULF2(SULF2U, methylation rate: 28%). Samples with SULF2U were more sensitive to cisplatin than those with SULF2M(inhibition rate: 48.80% vs. 38.15%, P = 0.02), while samples with SULF2M were more sensitive to irinotecan than SULF2U(inhibition rate: 53.61% vs. 40.92%, P = 0.01). There were no association between SULF2 methylation and in vitro sensitivity to docetaxel, gemcitabine and pemetrexed. SULF2 methylation was found to have a significant association with cisplatin efficacy(SULF2M: 57.14%, SULF2U: 80.56%, P = 0.02) and irinotecan efficacy(SULF2M: 89.29%, SULF2U: 62.50%, P = 0.01). Among the 56 patients receiving the modified FOLFOX regimen, a significant association was observed between survival and SULF2 methylation status(SULF2M: 309 days, 95% CI = 236 to 382 days; SULF2U: 481 days, 95% CI = 418 to 490 days; P = 0.02). Multivariate analysis revealed that SULF2 methylation was an independent prognostic factor of overall survival in gastric cancer patients treated with platinum-based chemotherapy. Conclusion: SULF2 methylation is negatively associated with cisplatin sensitivity in vitro. SULF2 methylation may be a novel prognostic biomarker for gastric cancer patients treated with platinum-based chemotherapy.	[Shen, Jie; Wei, Jia; Yang, Yang; Wang, Lin; Yu, Lixia; Xie, Li; Sun, Xia; Bian, Xinyu; Zou, Zhengyun; Qian, Xiaoping; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Ctr Comprehens Canc, Drum Tower Hosp,Med Sch, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Hao; Guan, Wenxian] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China; [Yue, Guofeng] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University	Guan, WX (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	guanwenxiannj@163.com; baoruiliu@nju.edu.cn	Wei, Jia/AAE-9973-2020		National Natural Science Foundation of China [81220108023, 81172094]; Top Six Talents Project of Jiangsu Province [2011ws005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Talents Project of Jiangsu Province	This work was funded by grants from the National Natural Science Foundation of China (Grant No. 81220108023 and 81172094) and Top Six Talents Project of Jiangsu Province (Grant No. 2011ws005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Chau BN, 2009, CANCER RES, V69, P1368, DOI 10.1158/0008-5472.CAN-08-2742; Chen CY, 2011, LUNG CANCER, V74, P132, DOI 10.1016/j.lungcan.2011.01.024; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Fujita Y, 2009, ONCOL REP, V21, P499, DOI 10.3892/or_00000250; FURUKAWA T, 1995, CLIN CANCER RES, V1, P305; Hanauske AR, 2007, INVEST NEW DRUG, V25, P417, DOI 10.1007/s10637-007-9060-9; Hayashi Y, 2009, INTERNAL MED, V48, P203, DOI 10.2169/internalmedicine.48.1659; Hur K, 2012, J PATHOL, V228, P88, DOI 10.1002/path.4055; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kudo K, 2012, ONCOGENE, V31, P4718, DOI 10.1038/onc.2011.610; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Liu L, 2011, LUNG CANCER, V73, P110, DOI 10.1016/j.lungcan.2010.11.004; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Mutze K, 2011, EUR J CANCER, V47, P1817, DOI 10.1016/j.ejca.2011.02.024; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Rosell R, 2010, EXPERT OPIN PHARMACO, V11, P1683, DOI 10.1517/14656566.2010.482101; Shim HJ, 2010, CANCER SCI, V101, P1247, DOI 10.1111/j.1349-7006.2010.01514.x; Tessema M, 2012, ONCOGENE, V31, P4107, DOI 10.1038/onc.2011.577; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Wei J, 2008, BRIT J CANCER, V98, P1398, DOI 10.1038/sj.bjc.6604317; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Wesolowski R, 2009, LANCET ONCOL, V10, P903, DOI 10.1016/S1470-2045(09)70136-6	32	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75564	10.1371/journal.pone.0075564	http://dx.doi.org/10.1371/journal.pone.0075564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124496	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100053
J	Shi, SJ; Wang, LJ; Wang, GD; Guo, ZY; Wei, M; Meng, YL; Yang, AG; Wen, WH				Shi, Sheng-Jia; Wang, Li-Juan; Wang, Guo-Dong; Guo, Zhang-Yan; Wei, Ming; Meng, Yan-Ling; Yang, An-Gang; Wen, Wei-Hong			B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells	PLOS ONE			English	Article							T-CELLS; POTENTIAL MECHANISM; IMMUNE SUPPRESSION; TUMOR; PD-L1; DEATH; IMMUNOTHERAPY; LYMPHOCYTES; SENSITIVITY; INVOLVEMENT	Background And Objective: The investigation concerning the B7-H1 expression in colorectal cancer cells is at an early stage. It is unclear whether B7-H1 expression may have diagnostic or prognostic value in colorectal carcinoma. Additionally, how B7-H1 is associated with the clinical features of colorectal carcinoma is not known. In order to investigate the relationship between B7-H1 and colorectal cancer, we analyzed B7-H1 expression and its effect in clinical specimens and HCT116 cells. Methods: Paraffin-embedded specimens from 143 eligible patients were used to investigate the expression of CD274 by immunohistochemistry. We also examined whether B7-H1 itself may be related to cell proliferation, apoptosis, migration and invasion in colon cancer HCT116 cells. Results: Our results show that B7-H1 was highly expressed in colorectal carcinoma and was significantly associated with cell differentiation status and TNM (Tumor Node Metastasis) stage. Patients with positive B7-H1 expression showed a trend of shorter survival time. Using multivariate analysis, we demonstrate that positive B7-H1 expression is an independent predictor of colorectal carcinoma prognosis. Our results indicate that B7-H1 silencing with siRNA inhibits cell proliferation, migration and invasion. Furthermore, cell apoptosis was also increased by B7-H1 inhibition. Conclusions: Positive B7-H1 expression is an independent predictor for colorectal carcinoma prognosis. Moreover, knockdown of B7-H1 can inhibit cell proliferation, migration and invasion.	[Shi, Sheng-Jia; Guo, Zhang-Yan; Meng, Yan-Ling; Yang, An-Gang; Wen, Wei-Hong] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Wang, Li-Juan] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Peoples R China; [Wang, Guo-Dong; Wei, Ming] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Wang, Guo-Dong] Chinese Peoples Liberat Army, Hosp 323, Dept Comprehens Med, Xian, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University	Yang, AG (corresponding author), Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	agyang@fmmu.edu.cn; wenweihongfmmu@126.com	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022; 温, 家琦/GYV-3177-2022		National Natural Science Foundation of China [30873004, 30973000, 81171924]; Natural Science Foundation of Shan xi Province [2011JM4006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shan xi Province(Natural Science Foundation of Shanxi Province)	This work was supported by the National Natural Science Foundation of China (No.30873004, 30973000 and 81171924) and Natural Science Foundation of Shan xi Province (No.2011JM4006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awwad RA, 2003, CANCER RES, V63, P4731; Betts G, 2012, GUT, V61, P1163, DOI 10.1136/gutjnl-2011-300970; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Deng LF, 2010, CLIN CANCER RES, V16, P4105, DOI 10.1158/1078-0432.CCR-10-1073; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; DROESER RA, 2013, EUR J CANCER; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ghebeh H, 2007, INT J CANCER, V121, P751, DOI 10.1002/ijc.22703; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Haile ST, 2011, J IMMUNOL, V186, P6822, DOI 10.4049/jimmunol.1003682; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hatam LJ, 2012, CLIN CANCER RES, V18, P1925, DOI 10.1158/1078-0432.CCR-11-2941; Hirano F, 2005, CANCER RES, V65, P1089; Hornung M, 2006, EUR J IMMUNOL, V36, P1210, DOI 10.1002/eji.200535332; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lu BF, 2011, IMMUNOL RES, V50, P269, DOI 10.1007/s12026-011-8227-9; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Sawhney RS, 2002, J BIOL CHEM, V277, P75, DOI 10.1074/jbc.M103268200; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Strome SE, 2003, CANCER RES, V63, P6501; Thompson RH, 2007, CLIN CANCER RES, V13, p709S, DOI 10.1158/1078-0432.CCR-06-1868; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wintterle S, 2003, CANCER RES, V63, P7462; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yao Y, 2009, NEURO-ONCOLOGY, V11, P757, DOI 10.1215/15228517-2009-014; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	38	133	148	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76012	10.1371/journal.pone.0076012	http://dx.doi.org/10.1371/journal.pone.0076012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124529	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100086
J	van Oorschot, JWM; Schmitz, JPJ; Webb, A; Nicolay, K; Jeneson, JAL; Kan, HE				van Oorschot, Joep W. M.; Schmitz, Joep P. J.; Webb, Andrew; Nicolay, Klaas; Jeneson, Jeroen A. L.; Kan, Hermien E.			P-31 MR Spectroscopy and Computational Modeling Identify a Direct Relation between Pi Content of an Alkaline Compartment in Resting Muscle and Phosphocreatine Resynthesis Kinetics in Active Muscle in Humans	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; HUMAN CALF MUSCLE; SKELETAL-MUSCLE; IN-VIVO; RELAXATION-TIMES; ATP SYNTHESIS; 3 T; EXERCISE; RECOVERY; RESPIRATION	The assessment of mitochondrial properties in skeletal muscle is important in clinical research, for instance in the study of diabetes. The gold standard to measure mitochondrial capacity non-invasively is the phosphocreatine (PCr) recovery rate after exercise, measured by P-31 Magnetic Resonance spectroscopy (P-31 MRS). Here, we sought to expand the evidence base for an alternative method to assess mitochondrial properties which uses P-31 MRS measurement of the Pi content of an alkaline compartment attributed to mitochondria (Pi(2); as opposed to cytosolic Pi (Pi(1))) in resting muscle at high magnetic field. Specifically, the PCr recovery rate in human quadriceps muscle was compared with the signal intensity of the Pi(2) peak in subjects with varying mitochondrial content of the quadriceps muscle as a result of athletic training, and the results were entered into a mechanistic computational model of mitochondrial metabolism in muscle to test if the empirical relation between Pi(2)/Pi(1) ratio and the PCr recovery was consistent with theory. Localized P-31 spectra were obtained at 7T from resting vastus lateralis muscle to measure the intensity of the Pi(2) peak. In the endurance trained athletes a Pi(2)/Pi(1) ratio of 0.07 +/- 0.01 was found, compared to a significantly lower (p<0.05) Pi(2)/Pi(1) ratio of 0.03 +/- 0.01 in the normally active group. Next, PCr recovery kinetics after in magnet bicycle exercise were measured at 1.5T. For the endurance trained athletes, a time constant t(PCr) 12 +/- 3 s was found, compared to 24 +/- 5s in normally active subjects. Without any parameter optimization the computational model prediction matched the experimental data well (r(2) of 0.75). Taken together, these results suggest that the Pi(2) resonance in resting human skeletal muscle observed at 7T provides a quantitative MR-based functional measure of mitochondrial density.	[van Oorschot, Joep W. M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Schmitz, Joep P. J.] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst AIMMS, Amsterdam, Netherlands; [Schmitz, Joep P. J.] Eindhoven Univ Technol, Dept Biomed Engn, Computat Biol Grp, NL-5600 MB Eindhoven, Netherlands; [Webb, Andrew; Kan, Hermien E.] Leiden Univ, Med Ctr, CJ Gorter Ctr High Field MRI, Dept Radiol, Leiden, Netherlands; [Nicolay, Klaas; Jeneson, Jeroen A. L.] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Jeneson, Jeroen A. L.] Univ Groningen, Univ Med Ctr Groningen, Lab Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Eindhoven University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eindhoven University of Technology; University of Groningen	van Oorschot, JWM (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	j.w.m.oorschot@umcutrecht.nl	Kan, Hermien/L-2385-2013; Webb, Andrew/G-9642-2016	Kan, Hermien/0000-0002-5772-7177; Webb, Andrew/0000-0003-4045-9732; Nicolay, Klaas/0000-0002-4179-616X				ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Bogner W, 2009, MAGN RESON MED, V62, P574, DOI 10.1002/mrm.22057; BROWN TR, 1995, MAGN RESON MED, V33, P417, DOI 10.1002/mrm.1910330316; CHANCE B, 1981, P NATL ACAD SCI-BIOL, V78, P6714, DOI 10.1073/pnas.78.11.6714; Chance B, 2006, NMR BIOMED, V19, P904, DOI 10.1002/nbm.1109; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; Feneson JAL, 2010, MAGN RESON MED, V63, P257, DOI 10.1002/mrm.22179; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; INGJER F, 1979, J PHYSIOL-LONDON, V294, P419, DOI 10.1113/jphysiol.1979.sp012938; Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5; Kan HE, 2010, NMR BIOMED, V23, P995, DOI 10.1002/nbm.1517; KATZ LA, 1988, AM J PHYSIOL, V255, pH189, DOI 10.1152/ajpheart.1988.255.1.H189; Kemp GJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE640, DOI 10.1152/ajpendo.00797.2007; Kemps HMC, 2010, CLIN SCI, V118, P203, DOI 10.1042/CS20090220; Lanza IR, 2010, CURR OPIN CLIN NUTR, V13, P511, DOI 10.1097/MCO.0b013e32833cc93d; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Schar M, 2010, MAGN RESON MED, V63, P419, DOI 10.1002/mrm.22234; Schmitz JPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034118; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; van den Broek NMA, 2010, AM J PHYSIOL-CELL PH, V299, pC1136, DOI 10.1152/ajpcell.00200.2010; van den Broek NMA, 2007, AM J PHYSIOL-CELL PH, V293, pC228, DOI 10.1152/ajpcell.00023.2007; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006	25	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76628	10.1371/journal.pone.0076628	http://dx.doi.org/10.1371/journal.pone.0076628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098796	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500167
J	Yan, XP; Fan, C; Ma, J; Li, JH; Dong, DH; Wang, HH; Ma, F; Zheng, XL; Lv, Y				Yan, Xiaopeng; Fan, Chao; Ma, Jia; Li, Jianhui; Dong, Dinghui; Wang, Haohua; Ma, Feng; Zheng, Xinglong; Lv, Yi			Portacaval Shunt Established in Six Dogs Using Magnetic Compression Technique	PLOS ONE			English	Article							PORTAL-HYPERTENSION; VASCULAR ANASTOMOSIS; MANAGEMENT; SURGERY; MODEL; RINGS; TIPS	Background and Aims: Installing the transjugular intrahepatic portosystemic shunt for portal hypertension is relatively safe, but complications are still high. To explore a new method of portacaval shunt, the magnetic compression technique was introduced into the shunting procedure. Methods: A portal-inferior vena cava shunt was performed on 6 male mongrel dogs by two hemocompatible Nd-Fe-B permanent magnets, parent and daughter. The parent magnet was applied to the inferior vena cava guided by a catheter through the femoral vein. The daughter magnet was moved to the anastomosis position on the portal vein with a balloon catheter through the splenic vein. After the daughter magnet reached the target position, the two magnets acted to compress the vessel wall and hold it in place. Five to 7 days later, under X-ray guidance, the magnets were detached from the vessel wall with a rosch-uchida transjugular liver access set. One month later, histological analysis and portal venography were performed. Results: 5-7 days after the first surgery, a mild intimal hyperplasia in the portal vein and the inferior vena cava, and continuity of the vascular adventitia from the portal vein to the inferior vena cava as observed. During the second surgery, the contrast media could be observed flowing from the portal vein into the inferior vena cava. Portal venography revealed that the portosystemic shunt was still present one month after the second surgery. Conclusions: Magnamosis via a device of novel design was successfully used to establish a portacaval shunt in dogs.	[Yan, Xiaopeng; Fan, Chao; Ma, Jia; Dong, Dinghui; Zheng, Xinglong; Lv, Yi] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi Provinc, Peoples R China; [Fan, Chao] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Li, Jianhui] Xi An Jiao Tong Univ, Shaanxi Prov Peoples Hosp, Coll Med, Dept Surg Oncol,Affiliated Hosp 3, Xian 710049, Shaanxi Provinc, Peoples R China; [Yan, Xiaopeng; Ma, Jia; Li, Jianhui; Dong, Dinghui; Wang, Haohua; Ma, Feng; Zheng, Xinglong; Lv, Yi] Xi An Jiao Tong Univ, XJTU Res Inst Adv Surg Technol & Engn, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University	Lv, Y (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi Provinc, Peoples R China.	luyi169@126.com	Yan, Xiaopeng/GWV-6620-2022		Ministry of Health Subordinates of China [2010105]; National Natural Science Foundation of China [30830099]	Ministry of Health Subordinates of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Key Project of Clinical Discipline of Ministry of Health Subordinates of China (2010105) and the National Natural Science Foundation of China (30830099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2005, J AM COLL SURGEONS, V201, P965, DOI 10.1016/j.jamcollsurg.2005.06.255; Bari K, 2012, WORLD J GASTROENTERO, V18, P1166, DOI 10.3748/wjg.v18.i11.1166; Boyer TD, 2010, HEPATOLOGY, V51, P306, DOI 10.1002/hep.23383; Chattopadhyay S, 2012, HPB, V14, P441, DOI 10.1111/j.1477-2574.2012.00473.x; Colombato L, 2007, J CLIN GASTROENTEROL, V41, pS344, DOI 10.1097/MCG.0b013e318157e500; Cope C, 1999, J VASC INTERV RADIOL, V10, P1379, DOI 10.1016/S1051-0443(99)70248-4; Corbett C, 2012, LIVER INT; Dib N, 2006, CAN MED ASSOC J, V174, P1433, DOI 10.1503/cmaj.051700; Erdmann D, 2004, J VASC SURG, V40, P505, DOI 10.1016/j.jvs.2004.05.026; Fan C, 2012, HEPATOB PANCREAT DIS, V11, P81, DOI 10.1016/S1499-3872(11)60129-X; Gugig R, 2012, WORLD J GASTROENTERO, V18, P1176, DOI 10.3748/wjg.v18.i11.1176; Jing K, 2012, SURG INNOV; Kopelman D, 2007, EXPERT REV MED DEVIC, V4, P821, DOI 10.1586/17434440.4.6.821; OBORA Y, 1978, SURG NEUROL, V9, P117; Pomier-Layrargues G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/167868; Procaccini NJ, 2009, GASTROINTEST ENDOSC, V70, P881, DOI 10.1016/j.gie.2009.03.1169; RAVITCH MM, 1978, AUST NZ J SURG, V48, P444, DOI 10.1111/j.1445-2197.1978.tb04899.x; Saxon RR, 2004, J VASC INTERV RADIOL, V15, P217, DOI 10.1097/01.RVI.0000116862.34422.A5; Shi Y, 2006, TRANSPL P, V38, P3070, DOI 10.1016/j.transproceed.2006.08.174; Zeebregts CJ, 2003, BRIT J SURG, V90, P261, DOI 10.1002/bjs.4063	20	25	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76873	10.1371/journal.pone.0076873	http://dx.doi.org/10.1371/journal.pone.0076873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098809	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500180
J	Zhu, XY; Yang, ZY				Zhu, Xiaoyuan; Yang, Zhiyong			Multi-Scale Spatial Concatenations of Local Features in Natural Scenes and Scene Classification	PLOS ONE			English	Article							REPRESENTATIONS; STATISTICS; SHAPE; PERCEPTION; IMAGES; CORTEX; MODEL; V2	How does the visual system encode natural scenes? What are the basic structures of natural scenes? In current models of scene perception, there are two broad feature representations, global and local representations. Both representations are useful and have some successes; however, many observations on human scene perception seem to point to an intermediate-level representation. In this paper, we proposed natural scene structures, i.e., multi-scale spatial concatenations of local features, as an intermediate-level representation of natural scenes. To compile the natural scene structures, we first sampled a large number of multi-scale circular scene patches in a hexagonal configuration. We then performed independent component analysis on the patches and classified the independent components into a set of clusters using the K-means method. Finally, we obtained a set of natural scene structures, each of which is characterized by a set of dominant clusters of independent components. We examined a range of statistics of the natural scene structures, compiled from two widely used datasets of natural scenes, and modeled their spatial arrangements at larger spatial scales using adjacency matrices. We found that the natural scene structures include a full range of concatenations of visual features in natural scenes, and can be used to encode spatial information at various scales. We then selected a set of natural scene structures with high information, and used the occurring frequencies and the eigenvalues of the adjacency matrices to classify scenes in the datasets. We found that the performance of this model is comparable to or better than the state-of-the-art models on the two datasets. These results suggest that the natural scene structures are a useful intermediate-level representation of visual scenes for our understanding of natural scene perception.	[Zhu, Xiaoyuan; Yang, Zhiyong] Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Yang, Zhiyong] Georgia Regents Univ, James & Jean Culver Vis Discovery Inst, Augusta, GA USA; [Yang, Zhiyong] Georgia Regents Univ, Dept Ophthalmol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Yang, ZY (corresponding author), Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	zhyang@gru.edu			Culver Vision Discovery Institute/GRU; Knights Templar Education Foundation	Culver Vision Discovery Institute/GRU; Knights Templar Education Foundation	This material is based upon work supported by, or in part by, a pilot award from the Culver Vision Discovery Institute/GRU and a pilot award from the Knights Templar Education Foundation (all to ZY). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; BOUREAU YL, 2010, PROC CVPR IEEE, P2559, DOI DOI 10.1109/CVPR.2010.5539963; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Cadieu CF, 2012, NEURAL COMPUT, V24, P827, DOI 10.1162/NECO_a_00247; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Cvetkovic DM, 1995, SPECTRA GRAPHS; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; DiMattina C, 2012, J VISION, V12, DOI 10.1167/12.13.15; Dixit M, 2011, PROC CVPR IEEE, P937, DOI 10.1109/CVPR.2011.5995674; Elder JH, 2002, J VISION, V2, DOI 10.1167/2.4.5; Fei-Fei L, 2005, PROC CVPR IEEE, P524; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Geisler WS, 2009, VISUAL NEUROSCI, V26, P1, DOI 10.1017/S0952523808081005; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; He XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020002; Hegde J, 2008, CURR BIOL, V18, P597, DOI 10.1016/j.cub.2008.03.058; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Huang TK, 2006, J MACH LEARN RES, V7, P85; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kourtzi Zoe, 2011, Annu Rev Neurosci, V34, P45, DOI 10.1146/annurev-neuro-060909-153218; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Lee H., 2008, ADV NEURAL INFORM PR, V20, P873; Li L.-J., 2010, NEURAL INFORM PROCES, P1378; Li LW, 2007, 2007 ASIA-PACIFIC CONFERENCE ON APPLIED ELECTROMAGNETICS, PROCEEDINGS, P1; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Niu ZX, 2012, PROC CVPR IEEE, P2743, DOI 10.1109/CVPR.2012.6247997; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Roe AW, 2012, NEURON, V74, P12, DOI 10.1016/j.neuron.2012.03.011; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; STANDING L, 1973, Q J EXP PSYCHOL, V25, P207, DOI 10.1080/14640747308400340; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tu ZW, 2005, INT J COMPUT VISION, V63, P113, DOI 10.1007/s11263-005-6642-x; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; van Dam ER, 2003, LINEAR ALGEBRA APPL, V373, P241, DOI 10.1016/S0024-3795(03)00483-X; Wu JX, 2011, IEEE T PATTERN ANAL, V33, P1489, DOI 10.1109/TPAMI.2010.224; Wu JR, 2009, CHINESE SCI BULL, V54, P1, DOI 10.1007/s11434-009-0027-4; Xu JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015796; Yang Jun, 2009, Proceedings of the 2009 2nd International Congress on Image and Signal Processing (CISP), DOI 10.1109/CISP.2009.5304123; Yang Z, 2012, VISUAL CORTEX CURREN, P201; Yang ZY, 2004, P NATL ACAD SCI USA, V101, P8745, DOI 10.1073/pnas.0402192101; Yang ZY, 2003, NETWORK-COMP NEURAL, V14, P371, DOI 10.1088/0954-898X/14/3/301; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046686	59	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76393	10.1371/journal.pone.0076393	http://dx.doi.org/10.1371/journal.pone.0076393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098789	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500160
J	Kosugi, S; Natsume, S; Yoshida, K; MacLean, D; Cano, L; Kamoun, S; Terauchi, R				Kosugi, Shunichi; Natsume, Satoshi; Yoshida, Kentaro; MacLean, Daniel; Cano, Liliana; Kamoun, Sophien; Terauchi, Ryohei			Coval: Improving Alignment Quality and Variant Calling Accuracy for Next-Generation Sequencing Data	PLOS ONE			English	Article							END SHORT READS; SNP DISCOVERY; MOLECULAR-SPECTRUM; HUMAN GENOME; DNA; GENOTYPE; BREAKPOINTS; MUTATIONS; DELETIONS; COVERAGE	Accurate identification of DNA polymorphisms using next-generation sequencing technology is challenging because of a high rate of sequencing error and incorrect mapping of reads to reference genomes. Currently available short read aligners and DNA variant callers suffer from these problems. We developed the Coval software to improve the quality of short read alignments. Coval is designed to minimize the incidence of spurious alignment of short reads, by filtering mismatched reads that remained in alignments after local realignment and error correction of mismatched reads. The error correction is executed based on the base quality and allele frequency at the non-reference positions for an individual or pooled sample. We demonstrated the utility of Coval by applying it to simulated genomes and experimentally obtained short-read data of rice, nematode, and mouse. Moreover, we found an unexpectedly large number of incorrectly mapped reads in 'targeted' alignments, where the whole genome sequencing reads had been aligned to a local genomic segment, and showed that Coval effectively eliminated such spurious alignments. We conclude that Coval significantly improves the quality of short-read sequence alignments, thereby increasing the calling accuracy of currently available tools for SNP and indel identification.	[Kosugi, Shunichi; Natsume, Satoshi; Yoshida, Kentaro; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Kosugi, Shunichi] Kazusa DNA Res Inst, Chiba, Japan; [MacLean, Daniel; Cano, Liliana; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England	Iwate Biotechnology Research Center; Kazusa DNA Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kosugi, S (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	skosugi@kazusa.or.jp; terauchi@ibrc.or.jp	Kamoun, Sophien/B-3529-2009; Cano, Liliana M/O-7041-2016; Terauchi, Ryohei/Y-2992-2019; MacLean, Dan/C-7046-2013	Kamoun, Sophien/0000-0002-0290-0315; Cano, Liliana M/0000-0002-7996-4181; Terauchi, Ryohei/0000-0002-0095-4651; Kosugi, Shunichi/0000-0002-5882-9255; MacLean, Dan/0000-0003-1032-0887; Yoshida, Kentaro/0000-0002-3614-1759	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Cultures, Sports and Technology, Japan [23113009]; JSPS KAKENHI [22510217]; Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research [22510217] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Cultures, Sports and Technology, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), the Ministry of Agriculture, Forestry, and Fisheries of Japan and Grant-in-aid for Scientific Research from the Ministry of Education, Cultures, Sports and Technology, Japan to RT (Grant-in-Aid for Scientific Research on Innovative Areas 23113009) and by JSPS KAKENHI Grant Number 22510217. LC, DM, and S. Kamoun were supported by the Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Chan EY, 2009, METHODS MOL BIOL, V578, P95, DOI 10.1007/978-1-60327-411-1_5; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Grimm D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-132; Homer N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r99; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hu X, 2012, BIOINFORMATICS; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malhis N, 2010, BIOINFORMATICS, V26, P1029, DOI 10.1093/bioinformatics/btq092; Martin ER, 2010, BIOINFORMATICS, V26, P2803, DOI 10.1093/bioinformatics/btq526; Miyao A, 2012, PLANT CELL PHYSIOL, V53, P256, DOI 10.1093/pcp/pcr172; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Simola DF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r55; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; You N, 2012, BIOINFORMATICS, V28, P643, DOI 10.1093/bioinformatics/bts001; Zhang J, 2011, BIOINFORMATICS, V27, P3228, DOI 10.1093/bioinformatics/btr563; Zhang Y, 2013, BIOINFORMATICS, V29, P878, DOI 10.1093/bioinformatics/btt065; Zhao Z, 2002, GENOME RES, V12, P1679, DOI 10.1101/gr.287302	45	45	46	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75402	10.1371/journal.pone.0075402	http://dx.doi.org/10.1371/journal.pone.0075402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116042	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200021
J	Sevilla, CA; Dalecki, D; Hocking, DC				Sevilla, Carlos A.; Dalecki, Diane; Hocking, Denise C.			Regional Fibronectin and Collagen Fibril Co-Assembly Directs Cell Proliferation and Microtissue Morphology	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; POLYMERIZATION; MORPHOGENESIS; MICROSCOPY; REGULATOR; ADHESION; BINDING	The extracellular matrix protein, fibronectin stimulates cells to self-assemble into three-dimensional multicellular structures by a mechanism that requires the cell-dependent conversion of soluble fibronectin molecules into insoluble fibrils. Fibronectin also binds to collagen type I and mediates the co-assembly of collagen fibrils into the extracellular matrix. Here, the role of collagen-fibronectin binding in fibronectin-induced cellular self-assembly was investigated using fibronectin-null fibroblasts in an in vitro model of tissue formation. High resolution, two-photon immunofluorescence microscopy was combined with second harmonic generation imaging to examine spatial and temporal relationships among fibronectin and collagen fibrils, actin organization, cell proliferation, and microtissue morphology. Time course studies coupled with simultaneous 4-channel multiphoton imaging identified regional differences in fibronectin fibril conformation, collagen fibril remodeling, actin organization, and cell proliferation during three-dimensional cellular self-assembly. Regional differences in cell proliferation and fibronectin structure were dependent on both soluble fibronectin concentration and fibronectin-collagen interactions. Fibronectin-collagen binding was not necessary for either fibronectin matrix formation or intercellular cohesion. However, inhibiting fibronectin binding to collagen reduced collagen fibril remodeling, decreased fibronectin fibril extension, blocked fibronectin-induced cell proliferation, and altered microtissue morphology. Furthermore, continual fibronectin-collagen binding was necessary to maintain both cell proliferation and microtissue morphology. Collectively, these data suggest that the complex changes in extracellular matrix and cytoskeletal remodeling that mediate tissue assembly are driven, in part, by regional variations in cell-mediated fibronectin-collagen co-assembly.	[Sevilla, Carlos A.; Dalecki, Diane; Hocking, Denise C.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Hocking, Denise C.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Hocking, DC (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.	denise_hocking@urmc.rochester.edu	Hocking, Denise/H-7903-2012	Hocking, Denise/0000-0003-2337-0357; Dalecki, Diane/0000-0001-7114-9732	National Institutes of Health [EB008368, EB008996, GM081513, F31AR057675]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR057675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008368, R01EB008996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants EB008368, EB008996 and GM081513 from the National Institutes of Health. C. S. was supported by NIH predoctoral fellowship F31AR057675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; AKIYAMA S, 2001, URIF FIBRONECTIN CUR, P13; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; da Rocha-Azevedo B, 2013, EXP CELL RES, V319, P546, DOI 10.1016/j.yexcr.2012.10.005; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gildner CD, 2004, AM J PHYSIOL-HEART C, V287, pH46, DOI 10.1152/ajpheart.00859.2003; Gui LQ, 2006, J BIOL CHEM, V281, P34816, DOI 10.1074/jbc.M608611200; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hansen AE, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-89; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hocking DC, 2008, CIRC RES, V102, P372, DOI 10.1161/CIRCRESAHA.107.158501; Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Nogawa H, 1998, DEV DYNAM, V213, P228, DOI 10.1002/(SICI)1097-0177(199810)213:2<228::AID-AJA8>3.0.CO;2-I; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pereira M, 2002, J CELL SCI, V115, P609; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Rebres RA, 1995, AM J PHYSIOL-GASTR L, V269, pG902, DOI 10.1152/ajpgi.1995.269.6.G902; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; ROSSOMANDO E, 1992, MORPHOGENESIS ANAL D; Roy DC, 2013, TISSUE ENG PT A, V19, P558, DOI [10.1089/ten.tea.2012.0257, 10.1089/ten.TEA.2012.0257]; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Salmenpera P, 2008, EXP CELL RES, V314, P3444, DOI 10.1016/j.yexcr.2008.09.004; Sevilla CA, 2010, TISSUE ENG PT A, V16, P3805, DOI [10.1089/ten.tea.2010.0316, 10.1089/ten.TEA.2010.0316]; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; SHIRAISHI I, 1995, ANAT EMBRYOL, V191, P183; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; VANDELEST CHA, 1995, J HISTOCHEM CYTOCHEM, V43, P727, DOI 10.1177/43.7.7608528; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821	46	31	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77316	10.1371/journal.pone.0077316	http://dx.doi.org/10.1371/journal.pone.0077316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116223	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200114
J	Akhras, MS; Pettersson, E; Diamond, L; Unemo, M; Okamoto, J; Davis, RW; Pourmand, N				Akhras, Michael S.; Pettersson, Erik; Diamond, Lisa; Unemo, Magnus; Okamoto, Jennifer; Davis, Ronald W.; Pourmand, Nader			The Sequencing Bead Array (SBA), a Next-Generation Digital Suspension Array	PLOS ONE			English	Article							DIRECT ELECTRICAL DETECTION; PADLOCK PROBES; IN-SITU; DNA; AMPLIFICATION; TECHNOLOGY; ASSAY; CLASSIFICATION; MOLECULES; PRIMERS	Here we describe the novel Sequencing Bead Array (SBA), a complete assay for molecular diagnostics and typing applications. SBA is a digital suspension array using Next-Generation Sequencing (NGS), to replace conventional optical readout platforms. The technology allows for reducing the number of instruments required in a laboratory setting, where the same NGS instrument could be employed from whole-genome and targeted sequencing to SBA broad-range biomarker detection and genotyping. As proof-of-concept, a model assay was designed that could distinguish ten Human Papillomavirus (HPV) genotypes associated with cervical cancer progression. SBA was used to genotype 20 cervical tumor samples and, when compared with amplicon pyrosequencing, was able to detect two additional co-infections due to increased sensitivity. We also introduce in-house software Sphix, enabling easy accessibility and interpretation of results. The technology offers a multi-parallel, rapid, robust, and scalable system that is readily adaptable for a multitude of microarray diagnostic and typing applications, e. g. genetic signatures, single nucleotide polymorphisms (SNPs), structural variations, and immunoassays. SBA has the potential to dramatically change the way we perform probe-based applications, and allow for a smooth transition towards the technology offered by genomic sequencing.	[Akhras, Michael S.; Pettersson, Erik; Diamond, Lisa; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Unemo, Magnus] Orebro Univ Hosp, World Hlth Org Collaborating Ctr Gonorrhoea & Oth, Swedish Reference Lab Pathogen Neisseria, Dept Lab Med, Orebro, Sweden; [Okamoto, Jennifer] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Okamoto, Jennifer] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Pourmand, Nader] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Stanford University; Orebro University; World Health Organization; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Santa Cruz	Pourmand, N (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	pourmand@soe.ucsc.edu	Unemo, Magnus/ABD-6653-2021	Pourmand, Nader/0000-0003-0251-9060	National Institutes of Health [P01-35HG000205]; Carl Tryggers Foundation [CTS 11:5, CTS 12:5]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Tryggers Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this research was provided in part by the National Institutes of Health [P01-35HG000205] and the Carl Tryggers Foundation [CTS 11:5, CTS 12:5] to MSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000915; Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson EP, 2008, SENSOR ACTUAT B-CHEM, V129, P79, DOI 10.1016/j.snb.2007.07.105; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gharizadeh B, 2006, MOL CELL PROBE, V20, P230, DOI 10.1016/j.mcp.2006.01.002; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Jensen MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034373; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Landegren U, 2003, COMP FUNCT GENOM, V4, P525, DOI 10.1002/cfg.326; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myllykangas S, 2011, NAT BIOTECHNOL, V29, P1024, DOI 10.1038/nbt.1996; Natsume T, 2007, CHEM PHYS LETT, V434, P133, DOI 10.1016/j.cplett.2006.12.017; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Nyren Pal, 2007, V373, P1; Pettersson E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl103; Pettersson E, 2008, HUM MUTAT, V29, P323, DOI 10.1002/humu.20655; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Pourmand N, 2006, P NATL ACAD SCI USA, V103, P6466, DOI 10.1073/pnas.0601184103; Pourmand N, 2007, P NATL ACAD SCI USA, V104, P6146, DOI 10.1073/pnas.0700921104; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Sims PA, 2011, NAT METHODS, V8, P575, DOI [10.1038/NMETH.1629, 10.1038/nmeth.1629]; Stahl PL, 2012, ANNU REV BIOCHEM, V81, P359, DOI 10.1146/annurev-biochem-060410-094158; Weibrecht I, 2013, NAT PROTOC, V8, P355, DOI 10.1038/nprot.2013.006; Zhang K, 2012, J AM CHEM SOC, V134, P16488, DOI 10.1021/ja306854d; Zieba A, 2012, NEW BIOTECHNOL, V29, P634, DOI 10.1016/j.nbt.2012.05.004	44	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76696	10.1371/journal.pone.0076696	http://dx.doi.org/10.1371/journal.pone.0076696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116138	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300080
J	Lei, KF; Chen, KH; Tsui, PH; Tsang, NM				Lei, Kin Fong; Chen, Kuan-Hao; Tsui, Po-Hsiang; Tsang, Ngan-Ming			Real-Time Electrical Impedimetric Monitoring of Blood Coagulation Process under Temperature and Hematocrit Variations Conducted in a Microfluidic Chip	PLOS ONE			English	Article							IMPEDANCE; SYSTEM; DEVICE; CASCADE; DESIGN; POINT	Blood coagulation is an extremely complicated and dynamic physiological process. Monitoring of blood coagulation is essential to predict the risk of hemorrhage and thrombosis during cardiac surgical procedures. In this study, a high throughput microfluidic chip has been developed for the investigation of the blood coagulation process under temperature and hematocrit variations. Electrical impedance of the whole blood was continuously recorded by on-chip electrodes in contact with the blood sample during coagulation. Analysis of the impedance change of the blood was conducted to investigate the characteristics of blood coagulation process and the starting time of blood coagulation was defined. The study of blood coagulation time under temperature and hematocrit variations was shown a good agreement with results in the previous clinical reports. The electrical impedance measurement for the definition of blood coagulation process provides a fast and easy measurement technique. The microfluidic chip was shown to be a sensitive and promising device for monitoring blood coagulation process even in a variety of conditions. It is found valuable for the development of point-of-care coagulation testing devices that utilizes whole blood sample in microliter quantity.	[Lei, Kin Fong; Chen, Kuan-Hao] Chang Gung Univ, Grad Inst Med Mechatron, Tao Yuan, Taiwan; [Lei, Kin Fong] Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Tsang, Ngan-Ming] Chang Gung Univ, Sch Tradit Chinese Med, Tao Yuan, Taiwan; [Tsang, Ngan-Ming] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lei, KF (corresponding author), Chang Gung Univ, Grad Inst Med Mechatron, Tao Yuan, Taiwan.	kflei@mail.cgu.edu.tw	Tsui, Po-Hsiang/AHE-7426-2022; Lei, Kin Fong/Q-8340-2018	Lei, Kin Fong/0000-0002-5356-2221; Tsui, Po-Hsiang/0000-0002-5604-1800	Chang Gung Memorial Hospital [CMRPD2B0011]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Financial support came from Chang Gung Memorial Hospital (Project number: CMRPD2B0011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus J. L., 1999, Journal of Medicine (Westbury), V30, P299; Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026; Berney H, 2008, ANALOG DIALOGUE, P42; Bhattacharyya A, 2007, BIOMED MICRODEVICES, V9, P245, DOI 10.1007/s10544-006-9026-2; BLAIR SD, 1987, CLIN LAB HAEMATOL, V9, P91; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; CARPENTER GP, 1994, P SOC PHOTO-OPT INS, V2136, P205, DOI 10.1117/12.180788; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DEVRIES PMJM, 1993, MED BIOL ENG COMPUT, V31, P445, DOI 10.1007/BF02441978; Diercks AH, 2009, ANAL BIOCHEM, V386, P30, DOI 10.1016/j.ab.2008.12.012; Erickson D, 2004, ANAL CHEM, V76, P7269, DOI 10.1021/ac049396d; Fricke H, 1925, J GEN PHYSIOL, V9, P153, DOI 10.1085/jgp.9.2.153; Glawdel T, 2009, MECH RES COMMUN, V36, P75, DOI 10.1016/j.mechrescom.2008.06.015; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; Huang CC, 2006, JPN J APPL PHYS 1, V45, P7191, DOI 10.1143/JJAP.45.7191; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; Lei KF, 2012, JALA-J LAB AUTOM, V17, P330, DOI 10.1177/2211068212454853; Lei KF, 2012, MICROELECTRON ENG, V91, P174, DOI 10.1016/j.mee.2011.10.002; Lei KF, 2012, MICROFLUID NANOFLUID, V12, P117, DOI 10.1007/s10404-011-0854-x; Lei KF, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/10/105802; Lemaire P, 2009, PROCEDIA CHEM, V1, P521, DOI 10.1016/j.proche.2009.07.130; Maasrani M, 1997, MED BIOL ENG COMPUT, V35, P167, DOI 10.1007/BF02530032; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Metref L., 2009, Micro and Nanosystems, V1, P41, DOI 10.2174/1876402910901010041; Murano G, 2000, BASIC CONCEPTS HEMOS; Puckett LG, 2003, BIOSENS BIOELECTRON, V18, P675, DOI 10.1016/S0956-5663(03)00033-2; Ramaswamy B, 2013, SENSOR ACTUAT B-CHEM, V180, P21, DOI 10.1016/j.snb.2011.11.031; ROSENTHAL RL, 1948, J LAB CLIN MED, V33, P1110; Schenone M, 2004, CURR OPIN HEMATOL, V11, P272, DOI 10.1097/01.moh.0000130308.37353.d4; SHUNG KP, 1975, IEEE T BIO-MED ENG, VBM22, P334, DOI 10.1109/TBME.1975.324454; Spence N, 2002, Br J Biomed Sci, V59, P223; Tefferi A, 2000, AM J MED, V109, P141, DOI 10.1016/S0002-9343(00)00449-6; UR A, 1970, NATURE, V226, P269, DOI 10.1038/226269a0; Ur A, 1970, Biomed Eng, V5, P342; Vander AJ, 2001, HUMAN PHYSL MECH BOD; Wang L, 2011, ANAL CHIM ACTA, V687, P12, DOI 10.1016/j.aca.2010.11.056; White GC, 2003, J THROMB HAEMOST, V1, P2267, DOI 10.1046/j.1538-7836.2003.00459.x; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Zhao TX, 1996, J MED ENG TECHNOL, V20, P115, DOI 10.3109/03091909609008389; ZHAO TX, 1993, PHYSIOL MEAS, V14, P145, DOI 10.1088/0967-3334/14/2/006; Zhao TX, 1997, MED BIOL ENG COMPUT, V35, P181, DOI 10.1007/BF02530035	41	39	46	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76243	10.1371/journal.pone.0076243	http://dx.doi.org/10.1371/journal.pone.0076243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116099	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300054
J	Bertelsmeier, C; Guenard, B; Courchamp, F				Bertelsmeier, Cleo; Guenard, Benoit; Courchamp, Franck			Climate Change May Boost the Invasion of the Asian Needle Ant	PLOS ONE			English	Article							LINEPITHEMA-HUMILE MAYR; ARGENTINE ANT; SPECIES DISTRIBUTION; SOLENOPSIS-INVICTA; NICHE; TEMPERATURE; DYNAMICS; CONSEQUENCES; INVASIBILITY; HYMENOPTERA	Following its introduction from Asia to the USA, the Asian needle ant (Pachycondyla chinensis) is rapidly spreading into a wide range of habitats with great negative ecological affects. In addition, the species is a concern for human health because of its powerful, sometimes deadly, sting. Here, we assessed the potential of P. chinensis to spread further and to invade entirely new regions. We used species distribution models to assess suitable areas under current climatic conditions and in 2020, 2050 and 2080. With a consensus model, combining five different modelling techniques, three Global Circulation (climatic) Models and two CO2 emission scenarios, we generated world maps with suitable climatic conditions. Our models suggest that the species currently has a far greater potential distribution than its current exotic range, including large parts of the world landmass, including Northeast America, Southeast Asia and Southeast America. Climate change is predicted to greatly exacerbate the risk of P. chinensis invasion by increasing the suitable landmass by 64.9% worldwide, with large increases in Europe (+210.1%), Oceania (+75.1%), North America (+74.9%) and Asia (+62.7%). The results of our study suggest P. chinensis deserves increased attention, especially in the light of on-going climate change.	[Bertelsmeier, Cleo; Courchamp, Franck] Univ Paris 11, Orsay, France; [Guenard, Benoit] Okinawa Inst Sci & Technol, Biodivers & Biocomplex Unit, Okinawa, Japan	UDICE-French Research Universities; Universite Paris Saclay; Okinawa Institute of Science & Technology Graduate University	Bertelsmeier, C (corresponding author), Univ Paris 11, Orsay, France.	cleo.bertelsmeier@u-psud.fr	Courchamp, Franck/ABE-7204-2020	Courchamp, Franck/0000-0001-7605-4548; Guenard, Benoit/0000-0002-7144-1175; /0000-0001-6782-917X; Bertelsmeier, Cleo/0000-0003-3624-1300	Region Ile-de-France [03-2010/GV-DIM ASTREA]; ANR [2009 PEXT 010 01]	Region Ile-de-France(Region Ile-de-France); ANR(French National Research Agency (ANR))	This paper was supported by Region Ile-de-France (03-2010/GV-DIM ASTREA) and ANR (2009 PEXT 010 01) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril S, 2008, J INSECT PHYSIOL, V54, P265, DOI 10.1016/j.jinsphys.2007.09.009; Abril S, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9701; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bertelsmeier C, 2013, CONSERVATIO IN PRESS, DOI [10.1111/cobi.12093, DOI 10.1111/C0BI.12093]; Bertelsmeier C, 2013, BIOL INVASIONS, V15, P1561, DOI 10.1007/s10530-012-0390-y; BOLTON B., 2007, BOLTONS CATALOGUE AN; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Brightwell RJ, 2010, ENVIRON ENTOMOL, V39, P1659, DOI 10.1603/EN09345; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Cerda X, 1997, J ANIM ECOL, V66, P363, DOI 10.2307/5982; Cristianini N, 2002, AI MAG, V23, P31; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Emery C., 1895, Annali del Museo Genova, Vxxxiv, P450; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzgerald K, 2012, CONSERV BIOL, V26, P525, DOI 10.1111/j.1523-1739.2012.01836.x; Franklin J, 2009, MAPPING SPECIES DIST; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Guenard B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011614; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QH, 2010, ECOGRAPHY, V33, P637, DOI 10.1111/j.1600-0587.2010.06416.x; Heller NE, 2006, ECOL ENTOMOL, V31, P499, DOI 10.1111/j.1365-2311.2006.00806.x; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hoffmann BD, 2010, ANT ECOLOGY, P287; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; IPCC, 2007, BIL 2007 CHANG CLIM, V446; IUCN (International Union for Conservation of Nature) SSC (Species Survival Commission) Invasive Species Specialist Group, 2012, GLOB INV SPEC DAT; Jenkins C.N., 2011, DIVERS DISTRIB, V2011, P1; Jimenez MA, 2011, ECOL LETT, V14, P1227, DOI 10.1111/j.1461-0248.2011.01693.x; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kaiser BA, 2010, RESOUR ENERGY ECON, V32, P566, DOI 10.1016/j.reseneeco.2010.04.007; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; Klamt M, 2011, GLOBAL CHANGE BIOL, V17, P3011, DOI 10.1111/j.1365-2486.2011.02472.x; Lach L, 2010, ANT ECOLOGY, P261; Lessard JP, 2009, INSECT SOC, V56, P149, DOI 10.1007/s00040-009-0006-4; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Lowe S., 2000, ENCY BIOL INVASIONS; Maravelias CD, 2003, MAR ECOL PROG SER, V255, P249, DOI 10.3354/meps255249; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; O'Donnell JA, 2011, GLOBAL CHANGE BIOL, V17, P1461, DOI 10.1111/j.1365-2486.2010.02358.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rabitsch W, 2011, BIOCONTROL, V56, P551, DOI 10.1007/s10526-011-9370-x; Rice ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056281; Rodriguez-Cabal MA, 2012, BIOL INVASIONS, V14, P557, DOI 10.1007/s10530-011-0097-5; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Sloggett JJ, 2012, ENTOMOL SCI, V15, P261, DOI 10.1111/j.1479-8298.2012.00519.x; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Suarez AV, 2010, ANT ECOLOGY, P233; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Walters AC, 2004, ANN ENTOMOL SOC AM, V97, P971, DOI 10.1603/0013-8746(2004)097[0971:COUTTB]2.0.CO;2; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2012, TRENDS ECOL EVOL, V27, P497, DOI 10.1016/j.tree.2012.03.010; Yashiro T, 2010, ZOOTAXA, P39	80	28	29	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75438	10.1371/journal.pone.0075438	http://dx.doi.org/10.1371/journal.pone.0075438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124489	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100046
J	Crepey, P; Pivette, M; Desvarieux, M				Crepey, Pascal; Pivette, Mathilde; Desvarieux, Moise			Potential Impact of Influenza A/H1N1 Pandemic and Hand-Gels on Acute Diarrhea Epidemic in France	PLOS ONE			English	Article							COMMUNICABLE DISEASES; SURVEILLANCE; STRATEGIES	Background: The 2009 A/H1N1 influenza pandemic has received a great deal of attention from public health authorities. Our study examines whether this pandemic and the resulting public health measures could have impacted acute diarrhea, a prevalent, highly transmissible and historically monitored disease. Methods: Using augmentation procedures of national data for the previous five years (2004-2009), we estimated the expected timing and incidence of acute diarrhea in France in 2009-2010 and evaluated differences with the observed. We also reviewed national hand gels for the same period. Findings: Number of episodes of acute diarrhea in France in 2009-2010 was significantly lower than expected until the third week of December (224%, 95% CI [-36%; -9%]), then significantly higher (+40%, 95% CI [22%; 62%]), leading to a surplus of 574,440 episodes. The epidemic was delayed by 5 weeks with a peak 1.3 times higher than expected. Hand-gels sales inversely correlated with incidence of both influenza-like illness and acute diarrheal disease. Among individuals >65 yo, no excess cases of influenza and no excess rebound in acute diarrhea were observed, despite similar delay in the onset of the seasonal diarrheal epidemic. Interpretation: Our results suggest that at least one endemic disease had an unexpected behavior in 2009-2010. Acute diarrhea seems to have been controlled during the beginning of the pandemic in all age groups, but later peaked higher than expected in the younger population. The all-age delay in seasonal onset seems partly attributable to hand-gels use, while the differential magnitude of the seasonal epidemic between young and old, concurrent for both influenza and acute diarrhea, is compatible with disease interaction.	[Crepey, Pascal; Pivette, Mathilde; Desvarieux, Moise] Ecole Hautes Etud Sante Publ Rennes, Sorbonne Paris Cite, Paris, France; [Crepey, Pascal] Aix Marseille Univ, UMR EPV Emergence Pathol Virales 190, Marseille, France; [Pivette, Mathilde] Univ Paris 05, MAP5, Paris, France; [Desvarieux, Moise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Desvarieux, Moise] INSERM, U738, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crepey, P (corresponding author), Ecole Hautes Etud Sante Publ Rennes, Sorbonne Paris Cite, Paris, France.	pascal.crepey@ehesp.fr	Crépey, Pascal/G-5422-2011; Desvarieux, Moise/C-4991-2019	Crépey, Pascal/0000-0003-1852-0752; 	Ecole des Hautes Etudes en Sante Publique	Ecole des Hautes Etudes en Sante Publique	This study was funded by Ecole des Hautes Etudes en Sante Publique. No external funding used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; [Anonymous], WHO REC PAND H1N1 20; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Garenne M, 2008, CAHIERS SOCIOLOGIE D; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; GRMEK MD, 1969, ANN ESC, V24, P1473; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kish JL, 1965, SURVEY SAMPLING; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Longini IM, 2005, POPULATION; McNeill Alfred, 2003, COLUMBIAN EXCHANGE B, P13; McNeill WilliamH., 1998, PLAGUES PEOPLES; Noymer A, 2000, POPULATION DEV REV; Noymer A, 2010, PLAGUES EPIDEMICS IN, P137; Secretariat General de la Defense Nationale, 2009, PLAN NAT PREV LUTT P; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; US Department of Health and Human Services, 2005, HHS PAND INFL PLAN; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Weil-Olivier Catherine, 2010, Rev Prat, V60, P1388; WHO, 2009, PAND H1N1 2009 UPD; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2010, EMERG INFECT DIS, V16, P10	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75226	10.1371/journal.pone.0075226	http://dx.doi.org/10.1371/journal.pone.0075226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124479	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100036
J	Ho, CL; Lin, CY; Ka, SM; Chen, A; Tasi, YL; Liu, ML; Chiu, YC; Hua, KF				Ho, Chen-Lung; Lin, Chai-Yi; Ka, Shuk-Man; Chen, Ann; Tasi, Yu-Ling; Liu, May-Lan; Chiu, Yi-Chich; Hua, Kuo-Feng			Bamboo Vinegar Decreases Inflammatory Mediator Expression and NLRP3 Inflammasome Activation by Inhibiting Reactive Oxygen Species Generation and Protein Kinase C-alpha/delta Activation	PLOS ONE			English	Article							NF-KAPPA-B; PHENOLIC ANTIDIARRHEIC INGREDIENTS; SIGNAL-TRANSDUCTION; WOOD CREOSOTE; SECRETION; ACID; INTERLEUKIN-1-BETA; COMPOUND; MEDICINE; IMMUNITY	Bamboo vinegar (BV), a natural liquid derived from the condensation produced during bamboo charcoal production, has been used in agriculture and as a food additive, but its application to immune modulation has not been reported. Here, we demonstrated that BV has anti-inflammatory activities both in vitro and in vivo. BV reduced inducible nitric oxide synthase expression and nitric oxide levels in, and interleukin-6 secretion by, lipopolysaccharide-activated macrophages without affecting tumor necrosis factor-a secretion and cyclooxygenase-2 expression. The mechanism for the anti-inflammatory effect of BV involved decreased reactive oxygen species production and protein kinase C-alpha/delta activation. Furthermore, creosol (2-methoxy-4-methylphenol) was indentified as the major anti-inflammatory compound in BV. Impaired cytokine expression and NLR family, pyrin domain-containing 3 (NLRP3) inflammasome activation was seen in mice treated with creosol. These findings provide insights into how BV regulates inflammation and suggest that it may be a new source for the development of anti-inflammatory agents or a healthy supplement for preventing and ameliorating inflammation-and NLRP3 inflammasome-related diseases, including metabolic syndrome.	[Ho, Chen-Lung] Taiwan Forestry Res Inst, Div Wood Cellulose, Taipei, Taiwan; [Lin, Chai-Yi; Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Chen, Ann] Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan; [Tasi, Yu-Ling] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, May-Lan] Toko Univ, Dept Nutr Sci, Chiayi, Taiwan; [Chiu, Yi-Chich] Natl Ilan Univ, Dept Biomechatron Engn, Ilan, Taiwan	National Ilan University; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Ilan University	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.	kuofenghua@gmail.com			National Science Council, Taiwan [NSC 102-2628-B-197-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by National Science Council, Taiwan (contract grant number NSC 102-2628-B-197-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakabe Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2797, DOI 10.1271/bbb.60317; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chao LK, 2008, FOOD CHEM TOXICOL, V46, P220, DOI 10.1016/j.fct.2007.07.016; Chen YX, 2010, CHEMOSPHERE, V78, P1177, DOI 10.1016/j.chemosphere.2009.12.029; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandez AP, 2010, CURR PHARM DESIGN, V16, P2837; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Higa JK, 2011, BRIT J NUTR, V106, P1810, DOI 10.1017/S0007114511002157; Higa JK, 2011, CYTOKINE, V55, P18, DOI 10.1016/j.cyto.2011.02.019; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Hua KF, 2012, INFLAMM RES, V61, P1107, DOI 10.1007/s00011-012-0503-1; Huang TT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01374; Huang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041383; Jeong HJ, 2011, J MED FOOD, V14, P53, DOI 10.1089/jmf.2010.1232; Jiao JJ, 2007, J AGR FOOD CHEM, V55, P10086, DOI 10.1021/jf0716533; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; JODAI S, 1989, MOKUZAI GAKKAISHI, V35, P555; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Kimura Y, 2002, BIOL PHARM BULL, V25, P1026, DOI 10.1248/bpb.25.1026; Kuge T, 2003, PHARMACOTHERAPY, V23, P1391, DOI 10.1592/phco.23.14.1391.31940; Li L, 2012, VITAM HORM, V90, P375, DOI 10.1016/B978-0-12-398313-8.00014-2; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lin HC, 2006, J FAC AGR KYUSHU U, V51, P5; Lin HC, 2006, Q J FOREST RES TAIWA, V28, P51; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Marumoto S, 2012, J AGR FOOD CHEM, V60, P9106, DOI 10.1021/jf3021317; Matsushima N, 2007, EUR J PHARMACOL, V567, P59, DOI 10.1016/j.ejphar.2007.03.034; McLafferty F.W., 1989, WILEY NBS REGISTRY M, V1; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Momose T, 1997, ORGANIC ANAL, P147; Moriguchi N, 2007, BIOCHEM PHARMACOL, V73, P385, DOI 10.1016/j.bcp.2006.09.025; Nakamichi N, 2010, J NEUROSCI RES, V88, P2483, DOI 10.1002/jnr.22399; OGATA N, 1995, PHARMACOLOGY, V51, P195, DOI 10.1159/000139335; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Perez-Prieto LJ, 2003, J AGR FOOD CHEM, V51, P5444, DOI 10.1021/jf0345292; Ruttanavut J, 2012, HISTOL HISTOPATHOL, V27, P1333, DOI 10.14670/HH-27.1333; Said SN, 2010, PLOS ONE, V5; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shiah T.C., 2006, J AGR, V3, P1; Shin HY, 2003, IMMUNOPHARM IMMUNOT, V25, P377, DOI 10.1081/IPH-120024505; Su SC, 2006, CLIN CHIM ACTA, V374, P106, DOI 10.1016/j.cca.2006.05.045; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uchimura T., 2000, ISSUES BAMBOO CHARCO, P138; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024	58	32	33	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75738	10.1371/journal.pone.0075738	http://dx.doi.org/10.1371/journal.pone.0075738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124509	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100066
J	Kloverpris, HN; Jackson, A; Handley, A; Hayes, P; Gilmour, J; Riddell, L; Chen, FB; Atkins, M; Boffito, M; Walker, BD; Ackland, J; Sullivan, M; Goulder, P				Kloverpris, Henrik N.; Jackson, Akil; Handley, Amanda; Hayes, Peter; Gilmour, Jill; Riddell, Lynn; Chen, Fabian; Atkins, Mark; Boffito, Marta; Walker, Bruce D.; Ackland, Jim; Sullivan, Mark; Goulder, Philip			Non-Immunogenicity of Overlapping Gag Peptides Pulsed on Autologous Cells after Vaccination of HIV Infected Individuals	PLOS ONE			English	Article							CLINICAL-TRIALS; DENDRITIC CELLS; T-CELLS; PHASE-1 SAFETY; DNA VACCINE; RESPONSES; REPLICATION; IMMUNITY; IMMUNIZATION; EFFICACY	Background: HIV Gag-specific CD4+ and CD8+ T-cell responses are important for HIV immune control. Pulsing overlapping Gag peptides on autologous lymphocytes (OPAL) has proven immunogenic and effective in reducing viral loads in multiple pigtail macaque studies, warranting clinical evaluation. Methodology: We performed a phase I, single centre, placebo-controlled, double-blinded and dose-escalating study to evaluate the safety and preliminary immunogenicity of a novel therapeutic vaccine approach 'OPAL-HIV-Gag(c)'. This vaccine is comprised of 120 15mer peptides, overlapping by 11 amino acids, spanning the HIV Gag C clade sequence proteome, pulsed on white blood cells enriched from whole blood using a closed system, followed by intravenous reinfusion. Patients with undetectable HIV viral loads (<50 copies/ml plasma) on HAART received four administrations at week 0, 4, 8 and 12, and were followed up for 12 weeks post-treatment. Twenty-three people were enrolled in four groups: 12 mg (n = 6), 24 mg (n = 7), 48 mg (n = 2) or matching placebo (n = 8) with 18 immunologically evaluable. T-cell immunogenicity was assessed by IFN gamma ELIspot and intracellular cytokine staining (ICS). Results: The OPAL-HIV-Gag(c) peptides were antigenic in vitro in 17/17 subjects. After vaccination with OPAL-HIV-Gag(c), 1/6 subjects at 12 mg and 1/6 subjects at 24 mg dose groups had a 2- and 3-fold increase in ELIspot magnitudes from baseline, respectively, of Gag-specific CD8+ T-cells at week 14, compared to 0/6 subjects in the placebo group. No Gag-specific CD4+ T-cell responses or overall change in Rev, Nef, Tat and CMV specific responses were detected. Marked, transient and self-limiting lymphopenia was observed immediately post-vaccination (4 hours) in OPAL-HIV-Gag(c) but not in placebo recipients, with median fall from 1.72 to 0.67 million lymphocytes/mL for active groups (P<0.001), compared to post-placebo from 1.70 to 1.56 lymphocytes/ml (P = 0.16). Conclusion/Significance: Despite strong immunogenicity observed in several Macaca nemestrina studies using this approach, OPAL-HIV-Gag(c) was not significantly immunogenic in humans and improved methods of generating high-frequency Gag-specific T-cell responses are required.	[Kloverpris, Henrik N.; Goulder, Philip] Univ Oxford, Dept Paediat, Oxford, England; [Jackson, Akil; Boffito, Marta] Chelsea & Westminster Hosp, St Stephens AIDS Trust St Stephens Ctr, London, England; [Handley, Amanda; Sullivan, Mark] Med Dev, Melbourne, Vic, Australia; [Hayes, Peter; Gilmour, Jill; Atkins, Mark] Univ London Imperial Coll Sci Technol & Med, IAVI Human Immunol Lab, London, England; [Riddell, Lynn] Northhamptonshire Healthcare Natl Hlth Serv Trust, Northhampton Gen Hosp, Dept Genitourinary Med, Cliftonville, Northhampton, England; [Chen, Fabian] Royal Berkshire Hosp, Dept Sexual Hlth, Reading RG1 5AN, Berks, England; [Kloverpris, Henrik N.] Univ Kwazulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV K RITH, Durban, KwaZulu Natal, South Africa; [Kloverpris, Henrik N.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Walker, Bruce D.; Goulder, Philip] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ackland, Jim] Global Biosolut, Craigeburn, Vic, Australia	University of Oxford; Imperial College London; Imperial College London; International AIDS Vaccine Initiative; Royal Berkshire Hospital; University of Kwazulu Natal; University of Copenhagen; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute	Kloverpris, HN (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	henrik.kloverpris@k-rith.org		Sullivan, Mark/0000-0003-3049-1034; Jackson, Akil/0000-0002-4574-544X; Kloverpris, Henrik/0000-0002-2165-3313	Phillip T; Susan M Ragon Foundation	Phillip T; Susan M Ragon Foundation	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding for this project was provided by the Phillip T and Susan M Ragon Foundation. Medicines Development was a study Sponsor, as defined in the US Code of Federal Regulations, Title 21, Chapter I, Subchapter D, Subpart D, Part 312.50.	Bansal A, 2008, J VIROL, V82, P6458, DOI 10.1128/JVI.00068-08; BARNES E, 2012, SCI TRANSL MED, V4; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Chea S, 2005, J VIROL, V79, P3748, DOI 10.1128/JVI.79.6.3748-3757.2005; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Connolly NC, 2008, CLIN VACCINE IMMUNOL, V15, P284, DOI 10.1128/CVI.00221-07; De Rose R, 2008, VIROLOGY, V378, P201, DOI 10.1016/j.virol.2008.06.006; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; De Rose R, 2008, J MED PRIMATOL, V37, P69, DOI 10.1111/j.1600-0684.2008.00329.x; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Haining WN, 2008, CLIN CANCER RES, V14, P5626, DOI 10.1158/1078-0432.CCR-08-0526; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Ide F, 2006, J MED VIROL, V78, P711, DOI 10.1002/jmv.20612; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris H, 2010, J IMMUNOL METHODS, V356, P70, DOI 10.1016/j.jim.2010.01.014; Kloverpris H, 2009, AIDS, V23, P1329, DOI 10.1097/QAD.0b013e32832d9b00; Kloverpris HN, 2013, J VIROL, V87, P2628, DOI 10.1128/JVI.02131-12; Kundu SK, 1998, AIDS RES HUM RETROV, V14, P551, DOI 10.1089/aid.1998.14.551; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Liang XP, 2005, J VIROL, V79, P12321, DOI 10.1128/JVI.79.19.12321-12331.2005; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mothe B, 2011, PLOS ONE, V7; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tavel JA, 2007, JAIDS-J ACQ IMM DEF, V44, P601, DOI 10.1097/QAI.0b013e3180417cb6; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74389	10.1371/journal.pone.0074389	http://dx.doi.org/10.1371/journal.pone.0074389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124451	Green Published, gold			2022-12-27	WOS:000325489100008
J	Rebholz-Schuhmann, D; Kim, JH; Yan, Y; Dixit, A; Friteyre, C; Hoehndorf, R; Backofen, R; Lewin, I				Rebholz-Schuhmann, Dietrich; Kim, Jee-Hyub; Yan, Ying; Dixit, Abhishek; Friteyre, Caroline; Hoehndorf, Robert; Backofen, Rolf; Lewin, Ian			Evaluation and Cross-Comparison of Lexical Entities of Biological Interest (LexEBI)	PLOS ONE			English	Article							GENE-ONTOLOGY; PROTEIN; ABBREVIATIONS; ANNOTATION; SUPPORT	Motivation: Biomedical entities, their identifiers and names, are essential in the representation of biomedical facts and knowledge. In the same way, the complete set of biomedical and chemical terms, i.e. the biomedical "term space'' (the "Lexeome''), forms a key resource to achieve the full integration of the scientific literature with biomedical data resources: any identified named entity can immediately be normalized to the correct database entry. This goal does not only require that we are aware of all existing terms, but would also profit from knowing all their senses and their semantic interpretation (ambiguities, nestedness). Result: This study compiles a resource for lexical terms of biomedical interest in a standard format (called "LexEBI''), determines the overall number of terms, their reuse in different resources and the nestedness of terms. LexEBI comprises references for protein and gene entries and their term variants and chemical entities amongst other terms. In addition, disease terms have been identified from Medline and PubmedCentral and added to LexEBI. Our analysis demonstrates that the baseforms of terms from the different semantic types show only little polysemous use. Nonetheless, the term variants of protein and gene names (PGNs) frequently contain species mentions, which should have been avoided according to protein annotation guidelines. Furthermore, the protein and gene entities as well as the chemical entities, both do comprise enzymes leading to hierarchical polysemy, and a large portion of PGNs make reference to a chemical entity. Altogether, according to our analysis based on the Medline distribution, 401,869 unique PGNs in the documents contain a reference to 25,022 chemical entities, 3,125 disease terms or 1,576 species mentions. Conclusion: LexEBI delivers the complete biomedical and chemical Lexeome in a standardized representation (http://www.ebi.ac.uk/Rebholz-srv/LexEBI/). The resource provides the disease terms as open source content, and fully interlinks terms across resources.	[Rebholz-Schuhmann, Dietrich] Univ Zurich, Dept Computat Linguist, Zurich, Switzerland; [Rebholz-Schuhmann, Dietrich; Kim, Jee-Hyub; Yan, Ying; Dixit, Abhishek; Friteyre, Caroline; Lewin, Ian] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Hoehndorf, Robert] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Backofen, Rolf] Univ Freiburg, D-79106 Freiburg, Germany	University of Zurich; European Molecular Biology Laboratory (EMBL); University of Cambridge; University of Freiburg	Rebholz-Schuhmann, D (corresponding author), Univ Zurich, Dept Computat Linguist, Zurich, Switzerland.	rebholz@ebi.ac.uk	Hoehndorf, Robert/H-6127-2019	Hoehndorf, Robert/0000-0001-8149-5890; Dixit, Abhishek/0000-0001-9543-5901; Kim, Jee-Hyub/0000-0002-0359-2887; Rebholz-Schuhmann, Dietrich/0000-0002-1018-0370; Backofen, Rolf/0000-0001-8231-3323	EC STREP project "BOOTStrep" [FP6-028099]; EU Support Action grant under the 7th EU Framework Programme within Theme "Intelligent Content and Semantics'' [231727, ICT 2007.4.2]	EC STREP project "BOOTStrep"; EU Support Action grant under the 7th EU Framework Programme within Theme "Intelligent Content and Semantics''	This work was funded by the EC STREP project "BOOTStrep" (FP6-028099, www.bootstrep.org) and the EU Support Action grant 231727 under the 7th EU Framework Programme within Theme "Intelligent Content and Semantics'' (ICT 2007.4.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bada M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-161; Beisswanger E, 2008, STUD HEALTH TECHNOL, V136, P9; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Bodenreider O, 2002, P ACL 02 WORKSH NAT, V3, P53, DOI DOI 10.3115/1118149.1118157; Bodenreider Olivier, 2006, AMIA Annu Symp Proc, P46; Callahan Alison, 2011, J Biomed Semantics, V2 Suppl 2, pS3, DOI 10.1186/2041-1480-2-S2-S3; Casher O, 2006, J CHEM INF MODEL, V46, P2396, DOI 10.1021/ci060139c; Clare A, 2011, P 2011 WORKSH SEM PU; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Degtyarenko K, 2007, NUCL ACIDS RES; Dinarelli Marco, 2012, EACL 2012, P174; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Fleischmann A, 2004, NUCLEIC ACIDS RES, V32, pD434, DOI 10.1093/nar/gkh119; Gaudan S, 2005, BIOINFORMATICS, V21, P3658, DOI 10.1093/bioinformatics/bti586; Gaudan S, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/342746; GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008; Hakenberg J, 2011, BIOINFORMATICS; Harrow I, 2012, DRUG DISCOVERY TODAY; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Hoehndorf R, 2012, BRIEF BIOINFORMATICS; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kim JJ, 2008, BIOINFORMATICS, V24, P1410, DOI 10.1093/bioinformatics/btn117; Kim Jung-Jae, 2011, J Biomed Semantics, V2 Suppl 5, pS3, DOI 10.1186/2041-1480-2-S5-S3; Kirsch H, 2006, INT J MED INFORM, V75, P496, DOI 10.1016/j.ijmedinf.2005.06.011; Kuo CJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S7; Leitner F, 2010, NAT BIOTECHNOL, V28, P897, DOI 10.1038/nbt0910-897; Liu HF, 2006, BIOINFORMATICS, V22, P103, DOI 10.1093/bioinformatics/bti749; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; McEntyre JR, 2011, NUCLEIC ACIDS RES, V39, pD58, DOI 10.1093/nar/gkq1063; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Navigli Roberto, 2012, ARTIFICIAL INTELLIGE; Ogren PV, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P174; Ogren PV, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P214; Pezik P, 2008, BUILDING EVALUATING; Rebholz-Schuhmann D, 2005, PLOS BIOL, V3, P188, DOI 10.1371/journal.pbio.0030065; Rebholz-Schuhmann D, 2013, PERFORMANCE AN UNPUB; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Rebholz-Schuhmann Dietrich, 2011, J Biomed Semantics, V2 Suppl 5, pS11, DOI 10.1186/2041-1480-2-S5-S11; Rinaldi F, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas021; Rinaldi F, 2011, ARTIF INTELL MED, V52, P107, DOI 10.1016/j.artmed.2011.04.011; Roos M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S10-S9; Rzhetsky A, 2006, P NATL ACAD SCI USA, V103, P4940, DOI 10.1073/pnas.0600591103; Schofield PN, 2010, DIS MODEL MECH, V3, P281, DOI 10.1242/dmm.002790; Schwartz Ariel S, 2003, Pac Symp Biocomput, P451; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Sohn S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-402; Spasic I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S5; Thompson P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-397; Tsuruoka Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S2; Verspoor K, 2009, BIOINFORMATICS, V25, pI77, DOI 10.1093/bioinformatics/btp195; Waagmeester A, 2009, OMICS, V13, P367, DOI 10.1089/omi.2009.0029; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Yeganova L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S3-S6	58	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75185	10.1371/journal.pone.0075185	http://dx.doi.org/10.1371/journal.pone.0075185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124474	Green Published, gold, Green Accepted			2022-12-27	WOS:000325489100031
J	Taibi, AV; Lighthouse, JK; Grady, RC; Shroyer, KR; Holdener, BC				Taibi, Andrew V.; Lighthouse, Janet K.; Grady, Richard C.; Shroyer, Kenneth R.; Holdener, Bernadette C.			Development of a Conditional Mesd (Mesoderm Development) Allele for Functional Analysis of the Low-Density Lipoprotein Receptor-Related Family in Defined Tissues	PLOS ONE			English	Article							CRE RECOMBINASE; MICE	The Low-density lipoprotein receptor-Related Protein (LRP) family members are essential for diverse processes ranging from the regulation of gastrulation to the modulation of lipid homeostasis. Receptors in this family bind and internalize a diverse array of ligands in the extracellular matrix (ECM). As a consequence, LRPs regulate a wide variety of cellular functions including, but not limited to lipid metabolism, membrane composition, cell motility, and cell signaling. Not surprisingly, mutations in single human LRPs are associated with defects in cholesterol metabolism and development of atherosclerosis, abnormalities in bone density, or aberrant eye vasculature, and may be a contributing factor in development of Alzheimer's disease. Often, members of this diverse family of receptors perform overlapping roles in the same tissues, complicating the analysis of their function through conventional targeted mutagenesis. Here, we describe development of a mouse Mesd (Mesoderm Development) conditional knockout allele, and demonstrate that ubiquitous deletion of Mesd using Cre-recombinase blocks gastrulation, as observed in the traditional knockout and albino-deletion phenotypes. This conditional allele will serve as an excellent tool for future characterization of the cumulative contribution of LRP members in defined tissues.	[Taibi, Andrew V.; Lighthouse, Janet K.; Grady, Richard C.; Holdener, Bernadette C.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Shroyer, Kenneth R.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Holdener, BC (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	bernadette.holdener@stonybrook.edu	Lighthouse, Janet/Q-2026-2019	Lighthouse, Janet/0000-0001-9838-6113	National Institutes of Health [GM53964, CA123071]; NYSTEM [C026716]; NATIONAL CANCER INSTITUTE [R01CA123071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported in part by National Institutes of Health grant to BCH (GM53964) and to Drs. Robert Haltiwanger and BCH (CA123071). Adenovirus was produced by the Stony Brook University Stem Cell Core Facility funded by NYSTEM (C026716). No additional external funding was received for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Kohler C, 2011, STRUCTURE, V19, P337, DOI 10.1016/j.str.2010.12.022; Lighthouse JK, 2011, DEV DYNAM, V240, P577, DOI 10.1002/dvdy.22477; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75782	10.1371/journal.pone.0075782	http://dx.doi.org/10.1371/journal.pone.0075782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124512	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100069
J	Liao, WC; Wang, YJ; Huang, MC; Tseng, GF				Liao, Wen-Chieh; Wang, Yueh-Jan; Huang, Min-Chuan; Tseng, Guo-Fang			Methylcobalamin Facilitates Collateral Sprouting of Donor Axons and Innervation of Recipient Muscle in End-to-Side Neurorrhaphy in Rats	PLOS ONE			English	Article							NERVE REGENERATION; SCHWANN-CELLS; PLEIOTROPHIN; REPAIR; VITAMIN-B-12; DEFICIENCY; COAPTATION; NEUROPATHY; PATHWAYS; RECOVERY	Using ulnar nerve as donor and musculocutaneous nerve as recipient we found earlier that end-to-side neurorrhaphy resulted in weak functional reinnervation after lengthy survival. End-to-side neurorrhaphy however is the sole choice of nerve repair at times and has the advantage of conserving donor nerve function. Here, we investigated whether myelination-enhancing agent methylcobalamin and motoneuron trophic factor pleiotrophin enhances the recovery after end-to-side neurorrhaphy. Methylcobalamin significantly increased the expression of growth associated protein 43 and S100 protein and beta III tubulin in musculocutaneous nerve 1 month after neurorrhaphy suggesting the ingrowth of ulnar axonal sprouts in reactive Schwann cell environment. Upper limb functional test, compound muscle action potential measurements, motor end plate counts, and axon and myelin analyses showed that methylcobalamin treatment alone or with pleiotrophin improved the recovery significantly, 3 and 6 months post-surgery. There were fewer axons, closer in number to that of the intact recipient nerve, found in the distal repaired nerve of the methylcobalamin-treated than that of the vehicle control, suggesting that methylcobalamin facilitates axonal maturation and eliminates supernumerary sprouts. In conclusion, our results showed that methylcobalamin does indeed enhance the recovery of peripheral nerve repaired in end-to-side configuration.	[Liao, Wen-Chieh] Chung Shan Med Univ, Fac Med, Dept Anat, Taichung, Taiwan; [Liao, Wen-Chieh] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Wang, Yueh-Jan; Tseng, Guo-Fang] Tzu Chi Univ, Dept Anat, Coll Med, Hualien, Taiwan; [Huang, Min-Chuan] Natl Taiwan Univ, Coll Med, Inst Anat & Cell Biol, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Tzu Chi University; National Taiwan University	Tseng, GF (corresponding author), Tzu Chi Univ, Dept Anat, Coll Med, Hualien, Taiwan.	guofang@mail.tcu.edu.tw		HUANG, MIN-CHUAN/0000-0002-0704-3447; Liao, Wen Chieh/0000-0001-7848-2124	Tzu-Chi University [TCIRP 95003, 98006]; National Science council of Taiwan [NSC101-2320- B-320-001, NSC101-2320-B-040-003]	Tzu-Chi University; National Science council of Taiwan(Ministry of Science and Technology, Taiwan)	The study is supported by grants from the Tzu-Chi University (TCIRP 95003 and 98006 to YJW and GFT) and National Science council of Taiwan (NSC101-2320- B-320-001 to GFT; NSC101-2320-B-040-003 to WCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeda K, 2006, PLAST RECONSTR SURG, V117, P1194, DOI 10.1097/01.prs.0000201460.54187.d7; Alfonsi E, 1984, Minerva Med, V75, P1727; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Beris A, 2007, J NEUROTRAUM, V24, P909, DOI 10.1089/neu.2006.0165; BEUCHE W, 1984, J NEUROCYTOL, V13, P767, DOI 10.1007/BF01148493; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Chang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053444; Chen JR, 2010, NEUROSCIENCE, V167, P414, DOI 10.1016/j.neuroscience.2010.02.028; Chen YG, 1998, J HAND SURG-AM, V23A, P1025, DOI 10.1016/S0363-5023(98)80010-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Geuna S, 2006, BRAIN RES REV, V52, P381, DOI 10.1016/j.brainresrev.2006.05.002; Guntinas-Lichius O, 2007, NEUROSURGERY, V61, P1276, DOI 10.1227/01.neu.0000306107.70421.a4; HAN YF, 2011, CHIN J HEMORHEOL, V21, P761; Izumi Yuishin, 2007, Brain and Nerve (Tokyo), V59, P1141; KONG X, 2004, EYE SCI, V20, P171; Ladak A, 2011, NEUROSURGERY, V68, P1654, DOI 10.1227/NEU.0b013e31821246a8; Li JB, 2010, NUTR NEUROSCI, V13, P79, DOI 10.1179/147683010X12611460763607; Liao WC, 2010, NEUROSCIENCE, V171, P934, DOI 10.1016/j.neuroscience.2010.09.036; Liao WC, 2009, J ANAT, V215, P506, DOI 10.1111/j.1469-7580.2009.01135.x; Lovblad KO, 1997, PEDIATR RADIOL, V27, P155, DOI 10.1007/s002470050090; Matsuda K, 2005, J RECONSTR MICROSURG, V21, P581, DOI 10.1055/s-2005-922439; Matsumoto M, 1999, J RECONSTR MICROSURG, V15, P281, DOI 10.1055/s-2007-1000102; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Miller A, 2005, J NEUROL SCI, V233, P93, DOI 10.1016/j.jns.2005.03.009; Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P103; Mizukami H, 2011, EUR J CLIN INVEST, V41, P442, DOI 10.1111/j.1365-2362.2010.02430.x; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; RHODE BM, 1995, OBES SURG, V5, P154, DOI 10.1381/096089295765557953; Sato Y, 2005, J NEUROL SCI, V231, P13, DOI 10.1016/j.jns.2004.12.005; Scalabrino G, 2006, TRENDS MOL MED, V12, P247, DOI 10.1016/j.molmed.2006.04.008; Schmidhammer R, 2009, EXP NEUROL, V217, P388, DOI 10.1016/j.expneurol.2009.03.027; SCHRIMSHER GW, 1992, EXP NEUROL, V117, P287, DOI 10.1016/0014-4886(92)90138-G; Streppel M, 2002, EUR J NEUROSCI, V15, P1327, DOI 10.1046/j.1460-9568.2002.01971.x; VITERBO F, 1994, PLAST RECONSTR SURG, V94, P1038, DOI 10.1097/00006534-199412000-00019; Viterbo F, 1992, Rev Paul Med, V110, P267; Viterbo Fausto, 2009, Plast Reconstr Surg, V124, pe351, DOI 10.1097/PRS.0b013e3181bf8471; Vrbova G, 2009, EUR J NEUROSCI, V30, P366, DOI 10.1111/j.1460-9568.2009.06847.x; Yamatsu K, 1976, Nihon Yakurigaku Zasshi, V72, P269	39	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76302	10.1371/journal.pone.0076302	http://dx.doi.org/10.1371/journal.pone.0076302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098787	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500158
J	Molderings, GJ; Haenisch, B; Bogdanow, M; Fimmers, R; Nothen, MM				Molderings, Gerhard J.; Haenisch, Britta; Bogdanow, Manuela; Fimmers, Rolf; Noethen, Markus M.			Familial Occurrence of Systemic Mast Cell Activation Disease	PLOS ONE			English	Article							TYROSINE KINASE; KIT MUTATION; MASTOCYTOSIS; CLASSIFICATION; FIBROMYALGIA; PATHOGENESIS; DIAGNOSTICS; DISORDER; CRITERIA; THERAPY	Systemic mast cell activation disease (MCAD) comprises disorders characterized by an enhanced release of mast cell mediators accompanied by accumulation of dysfunctional mast cells. Demonstration of familial clustering would be an important step towards defining the genetic contribution to the risk of systemic MCAD. The present study aimed to quantify familial aggregation for MCAD and to investigate the variability of clinical and molecular findings (e. g. somatic mutations in KIT) among affected family members in three selected pedigrees. Our data suggest that systemic MCAD pedigrees include more systemic MCAD cases than would be expected by chance, i.e., compared with the prevalence of MCAD in the general population. The prevalence of MCAD suspected by symptom self-report in first-degree relatives of patients with MCAD amounted to approximately 46%, compared to prevalence in the general German population of about 17% (p < 0.0001). In three families with a high familial loading of MCAD, the subtype of MCAD and the severity of mediator-related symptoms varied between family members. In addition, genetic alterations detected in KIT were variable, and included mutations at position 816 of the amino acid sequence. In conclusion, our data provide evidence for common familial occurrence of MCAD. Our findings observed in the three pedigrees together with recent reports in the literature suggest that, in familial cases (i.e., in the majority of MCAD), mutated disease-related operator and/or regulator genes could be responsible for the development of somatic mutations in KIT and other proteins important for the regulation of mast cell activity. Accordingly, the immunohistochemically different subtypes of MCAD (i.e. mast cell activation syndrome and systemic mastocytosis) should be more accurately regarded as varying presentations of a common generic root process of mast cell dysfunction, than as distinct diseases.	[Molderings, Gerhard J.; Haenisch, Britta; Noethen, Markus M.] Univ Hosp Bonn, Inst Human Genet, Bonn, Germany; [Haenisch, Britta] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Haenisch, Britta] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany; [Haenisch, Britta] Univ Bonn, Dept Psychiat, Bonn, Germany; [Bogdanow, Manuela; Fimmers, Rolf] Univ Hosp Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Molderings, GJ (corresponding author), Univ Hosp Bonn, Inst Human Genet, Bonn, Germany.	molderings@uni-bonn.de		Nothen, Markus/0000-0002-8770-2464	B. Braun-Stiftung; Forderclub Mastzellforschung e.V.	B. Braun-Stiftung; Forderclub Mastzellforschung e.V.	This study was supported by grants from the B. Braun-Stiftung and the Forderclub Mastzellforschung e.V.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Kar S, 2013, HAEMATOLOGICA, V98, P107, DOI 10.3324/haematol.2012.064048; Akin C, 2010, J ALLERGY CLIN IMMUN, V126, P1099, DOI 10.1016/j.jaci.2010.08.035; Alfter K, 2009, LIVER INT, V29, P181, DOI 10.1111/j.1478-3231.2008.01839.x; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Blanco I, 2010, CLIN RHEUMATOL, V29, P1403, DOI 10.1007/s10067-010-1474-7; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; Broesby-Olsen S, 2012, J ALLERGY CLIN IMMUN, V130, P806, DOI 10.1016/j.jaci.2012.04.013; Burks KD, 2005, J INVEST MED, V53, pS300; Bursztejn AC, 2009, J INVEST DERMATOL, V129, P2528; Frieling T, 2011, Z GASTROENTEROL, V49, P191, DOI 10.1055/s-0029-1245707; Haenisch B, 2012, IMMUNOLOGY, V137, P197, DOI 10.1111/j.1365-2567.2012.03627.x; Hamilton MJ, 2011, J ALLERGY CLIN IMMUN, V128, P147, DOI 10.1016/j.jaci.2011.04.037; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Lucas HJ, 2006, INT J IMMUNOPATH PH, V19, P5; Molderings GJ, 2006, DEUT MED WOCHENSCHR, V131, P2095, DOI 10.1055/s-2006-951337; Molderings GJ, 2007, SCAND J GASTROENTERO, V42, P1045, DOI 10.1080/00365520701245744; Molderings GJ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-10; Molderings GJ, 2010, IMMUNOGENETICS, V62, P721, DOI 10.1007/s00251-010-0474-8; Seidel H, 2011, THROMB HAEMOSTASIS, V106, P987, DOI 10.1160/TH11-05-0351; Soucie E, 2012, BLOOD, V120, P4846, DOI 10.1182/blood-2011-12-397588; Spector MS, 2012, LEUKEMIA, V26, P1422, DOI 10.1038/leu.2011.354; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2013, ALLERGY, V68, P417, DOI 10.1111/all.12126; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; Wohrl S, 2013, J INVEST DERMATOL, V133, P839, DOI 10.1038/jid.2012.394; Zanotti R, 2013, J ALLERGY CLIN IMMUN, V131, P605, DOI 10.1016/j.jaci.2012.11.040; Zhang LY, 2006, LEUKEMIA RES, V30, P373, DOI 10.1016/j.leukres.2005.08.015	31	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76241	10.1371/journal.pone.0076241	http://dx.doi.org/10.1371/journal.pone.0076241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098785	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500156
J	Wu, CC; Lin, YM; Gao, J; Winston, JH; Cheng, LK; Shi, XZ				Wu, Chester C.; Lin, You-Min; Gao, Jerry; Winston, John H.; Cheng, Leo K.; Shi, Xuan-Zheng			Are Interstitial Cells of Cajal Involved in Mechanical Stress-Induced Gene Expression and Impairment of Smooth Muscle Contractility in Bowel Obstruction?	PLOS ONE			English	Article							MOTILITY DYSFUNCTION; ICC	Background and Aims: The network of interstitial cells of Cajal (ICC) is altered in obstructive bowel disorders (OBD). However, whether alteration in ICC network is a cause or consequence of OBD remains unknown. This study tested the hypothesis that mechanical dilation in obstruction disrupts the ICC network and that ICC do not mediate mechanotranscription of COX-2 and impairment of smooth muscle contractility in obstruction. Methods: Medical-grade silicon bands were wrapped around the distal colon to induce partial obstruction in wild-type and ICC deficient (W/W-v) mice. Results: In wild-type mice, colon obstruction led to time-dependent alterations of the ICC network in the proximal colon segment. Although unaffected on days 1 and 3, the ICC density decreased markedly and the network was disrupted on day 7 of obstruction. COX-2 expression increased, and circular muscle contractility decreased significantly in the segment proximal to obstruction. In W/Wv control mice, COX-2 mRNA level was 4.0 (+/- 1.1)-fold higher (n=4) and circular muscle contractility was lower than in wild-type control mice. Obstruction further increased COX-2 mRNA level in W/Wv mice to 7.2 (+/- 1.0)-fold vs. W/Wv controls [28.8 (+/- 4.1)-fold vs. wild-type controls] on day 3. Obstruction further suppressed smooth muscle contractility in W/Wv mice. However, daily administration of COX-2 inhibitor NS-398 significantly improved muscle contractility in both W/Wv sham and obstruction mice. Conclusions: Lumen dilation disrupts the ICC network. ICC deficiency has limited effect on stretch-induced expression of COX-2 and suppression of smooth muscle contractility in obstruction. Rather, stretch-induced COX-2 plays a critical role in motility dysfunction in partial colon obstruction.	[Wu, Chester C.; Lin, You-Min; Winston, John H.; Shi, Xuan-Zheng] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Gao, Jerry; Cheng, Leo K.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Cheng, Leo K.] Vanderbilt Univ, Depertment Surg, Nashville, TN 37235 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Auckland; Vanderbilt University	Shi, XZ (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA.	xushi@utmb.edu			National Institute of Health (NIH) [DK082563]; NIH [DK064775]; University of Auckland Health Research Doctoral Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064775, R01DK082563] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Auckland Health Research Doctoral Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health (NIH) (DK082563 to XZS). LKC was supported in part by NIH DK064775. JG was supported by a University of Auckland Health Research Doctoral Scholarship, a Freemason Postgraduate Scholarship and a R. H. T. Bates Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; FAUSSONEPELLEGRINI MS, 1985, J SUBMICR CYTOL PATH, V17, P673; Gao J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0421; Goyal RK, 2010, AM J PHYSIOL-GASTR L, V298, pG10, DOI 10.1152/ajpgi.00426.2009; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; Isozaki K, 1997, AM J GASTROENTEROL, V92, P332; Jordan G L Jr, 1980, Adv Surg, V14, P259; Li F, 2012, AM J PHYSIOL-GASTR L, V303, pG646, DOI 10.1152/ajpgi.00440.2011; Lin YM, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01918.x; Lin YM, 2012, AM J PHYSIOL-GASTR L, V302, pG267, DOI 10.1152/ajpgi.00326.2011; Okada T, 2010, J PEDIATR SURG, V45, pE11, DOI 10.1016/j.jpedsurg.2010.03.024; Okishio Yutaka, 2005, Journal of Smooth Muscle Research, V41, P163, DOI 10.1540/jsmr.41.163; Russell J., 1990, BOWEL OBSTRUCTION, P28; Sanders KM, 1999, NEUROGASTROENT MOTIL, V11, P311; Sarna SK, 2008, AM J PHYSIOL-GASTR L, V294, pG372, DOI 10.1152/ajpgi.00344.2007; Shi XZ, 2007, GASTROENTEROLOGY, V132, P1388, DOI 10.1053/j.gastro.2007.02.016; Shi XZ, 2011, AM J PHYSIOL-GASTR L, V300, pG99, DOI 10.1152/ajpgi.00379.2010; Summers RW, 1999, TXB GASTROENTEROLOGY, V1, P715; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P279, DOI 10.1053/gast.1996.v111.pm8690192; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600; Welch J.P., 1990, BOWEL OBSTRUCTION, P59; Won KJ, 2006, NEUROGASTROENT MOTIL, V18, P53, DOI 10.1111/j.1365-2982.2005.00718.x; Won KJ, 2005, P NATL ACAD SCI USA, V102, P14913, DOI 10.1073/pnas.0503628102; Zarate N, 2003, GUT, V52, P966, DOI 10.1136/gut.52.7.966	25	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76222	10.1371/journal.pone.0076222	http://dx.doi.org/10.1371/journal.pone.0076222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098782	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500152
J	Bi, LK; Zhang, CX; Li, KW; Fan, XX; Xu, KW; Han, JL; Huang, H; Liu, H; Dong, W; Yang, XY; Huang, J; Lin, TX				Bi, Liangkuan; Zhang, Caixia; Li, Kaiwen; Fan, Xinxiang; Xu, Kewei; Han, Jinli; Huang, Hai; Liu, Hao; Dong, Wen; Yang, Xiangyun; Huang, Jian; Lin, Tianxin			Robotic Partial Nephrectomy for Renal Tumors Larger than 4 cm: A Systematic Review and Meta-analysis	PLOS ONE			English	Review							LAPAROSCOPIC PARTIAL NEPHRECTOMY; ASSISTED PARTIAL NEPHRECTOMY; LEARNING-CURVE; OUTCOMES; IMPACT	Background: With the establishment of minimally invasive surgery in society, the robot has been increasingly widely used in the urologic field, including in partial nephrectomy. This study aimed to comprehensively summarize the currently available evidence on the feasibility and safety of robotic partial nephrectomy for renal tumors of >4 cm. Method and Findings: An electronic database search of PubMed, Scopus, Web of Science, and the Cochrane Library was performed. This systematic review and meta-analysis was based on all relevant studies that assessed robotic partial nephrectomy for renal tumors of >4 cm. Five studies were included. The meta-analysis involved 3 studies from 11 institutions including 154 patients, while the narrative review involved the remaining 2 studies from 5 institutions including 64 patients. In the meta-analysis, the mean ischemic time, operation time, and console time was 28, 319, and 189 minutes, respectively. The estimated blood loss and length of stay was 317 ml and 3.8 days, respectively. The rates of conversion, positive margins, intraoperative complications, postoperative complications, hilar clamping, and collecting system repair were 7.0%, 3.5%, 7.0%, 9.8%, 93.9%, and 47.5%, respectively. The narrative review showed results similar to those of the meta-analysis. Conclusions: Robotic partial nephrectomy is feasible and safe for renal tumors of >4 cm with an acceptable warm ischemic time, positive margin rate, conversion rate, complication rate, operation time, estimated blood loss, and length of stay.	[Bi, Liangkuan; Zhang, Caixia; Li, Kaiwen; Fan, Xinxiang; Xu, Kewei; Han, Jinli; Huang, Hai; Liu, Hao; Dong, Wen; Yang, Xiangyun; Huang, Jian; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Liangkuan; Zhang, Caixia; Li, Kaiwen; Fan, Xinxiang; Xu, Kewei; Han, Jinli; Huang, Hai; Liu, Hao; Dong, Wen; Yang, Xiangyun; Huang, Jian; Lin, Tianxin] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	yehjn@yahoo.cn; tianxinl@sina.com	Huang, Huang/AAN-5671-2020; han, jinli/AAA-4159-2022	Fan, Xinxiang/0000-0001-8495-6488	National Natural Science Foundation of China [81071688, 30972983, 81172431, 91029742, 81101519]; Guangdong Province Natural Scientific Foundation [07117366, 6104605]; Yat-sen Scholarship for Young Scientists; Clinical Key Project of Public Health Ministry; Program for New Century Excellent Talents in University [NCET-10-0852]; Natural Science Foundation of Guangdong Province [S2011040003777]; Fundamental Research Funds for the Central Universities; New Teacher Foundation of Ministry of Education [200805581124]; Doctor Start Fund of Natural Science Foundation of Guangdong Province [9451008901003001]; Youth Funds of National Natural Science Foundation of China [30901488]; Science and technology planning projection of Guangdong Province [2012B031800109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Scientific Foundation; Yat-sen Scholarship for Young Scientists; Clinical Key Project of Public Health Ministry; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); New Teacher Foundation of Ministry of Education; Doctor Start Fund of Natural Science Foundation of Guangdong Province; Youth Funds of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology planning projection of Guangdong Province	This work was supported by The National Natural Science Foundation of China (81071688, 30972983, 81172431, 91029742, and 81101519); Guangdong Province Natural Scientific Foundation (07117366, 6104605); the Yat-sen Scholarship for Young Scientists (to Tianxin Lin); the Clinical Key Project of Public Health Ministry (to Jian Huang); the Program for New Century Excellent Talents in University (NCET-10-0852, to Tianxin Lin); the Natural Science Foundation of Guangdong Province (S2011040003777); the Fundamental Research Funds for the Central Universities 2011(to Liangkuan Bi); New Teacher Foundation of Ministry of Education (200805581124); Doctor Start Fund of Natural Science Foundation of Guangdong Province (9451008901003001); the Youth Funds of National Natural Science Foundation of China (30901488); and Science and technology planning projection of Guangdong Province (2012B031800109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumarzouk OM, 2012, EUR UROL, V62, P1023, DOI 10.1016/j.eururo.2012.06.038; Deklaj T, 2010, J ENDOUROL, V24, P1603, DOI 10.1089/end.2009.0312; Eng MK, 2009, J ENDOUROL, V23, P439, DOI 10.1089/end.2008.0223; Ficarra V, 2012, WORLD J UROL, V30, P665, DOI 10.1007/s00345-012-0943-9; Froghi S, 2013, BJU INT, V112, pE322, DOI 10.1111/bju.12053; Gettman MT, 2004, UROLOGY, V64, P914, DOI 10.1016/j.urology.2004.06.049; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Gupta GN, 2013, UROL ONCOL-SEMIN ORI, V31, P51, DOI 10.1016/j.urolonc.2010.10.008; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Kaouk JH, 2011, UROLOGY, V78, P1338, DOI 10.1016/j.urology.2011.08.007; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lavery HJ, 2011, JSLS-J SOC LAPAROEND, V15, P291, DOI 10.4293/108680811X13071180407357; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Masson-Lecomte A, 2013, EUR J SURG ONCOL; Minervini A, 2011, EXPERT REV ANTICANC, V11, P1779, DOI [10.1586/era.11.182, 10.1586/ERA.11.182]; Mir SA, 2011, J ENDOUROL, V25, P447, DOI 10.1089/end.2010.0510; Mottrie A, 2010, EUR UROL, V58, P127, DOI 10.1016/j.eururo.2010.03.045; Patel MN, 2010, EUR UROL, V57, P310, DOI 10.1016/j.eururo.2009.11.024; Permpongkosol S, 2006, J UROLOGY, V176, P1984, DOI 10.1016/j.juro.2006.07.033; Petros F, 2012, J ENDOUROL, V26, P642, DOI 10.1089/end.2011.0340; Pierorazio PM, 2011, UROLOGY, V78, P813, DOI 10.1016/j.urology.2011.04.065; Porpiglia F, 2010, WORLD J UROL, V28, P525, DOI 10.1007/s00345-010-0518-6; Rais-Bahrami S, 2008, UROLOGY, V72, P580, DOI 10.1016/j.urology.2008.05.027; Simmons MN, 2009, UROLOGY, V73, P1077, DOI 10.1016/j.urology.2008.11.059; Simmons MN, 2009, EUR UROL, V55, P199, DOI 10.1016/j.eururo.2008.07.039; Sprenkle PC, 2012, EUR UROL, V61, P593, DOI 10.1016/j.eururo.2011.11.040; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Yu HY, 2012, J UROLOGY, V187, P1392, DOI 10.1016/j.juro.2011.11.089	29	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75050	10.1371/journal.pone.0075050	http://dx.doi.org/10.1371/journal.pone.0075050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116024	gold, Green Submitted, Green Published			2022-12-27	WOS:000325552200008
J	Lane, MA; Kimber, M; Khokha, MK				Lane, Maura A.; Kimber, Megan; Khokha, Mustafa K.			Breeding Based Remobilization of Tol2 Transposon in Xenopus tropicalis	PLOS ONE			English	Article							MEDAKA FISH; GENE-TRAP; TRANSGENIC LINES; DNA TRANSPOSONS; ELEMENT; IDENTIFICATION; EXPRESSION; GENOME	Xenopus is a powerful model for studying a diverse array of biological processes. However, despite multiple methods for transgenesis, relatively few transgenic reporter lines are available and commonly used. Previous work has demonstrated that transposon based strategies are effective for generating transgenic lines in both invertebrate and vertebrate systems. Here we show that the Tol2 transposon can be remobilized in the genome of X. tropicalis and passed through the germline via a simple breeding strategy of crossing transposase expressing and transposon lines. This remobilization system provides another tool to exploit transgenesis and opens new opportunities for gene trap and enhancer trap strategies.	[Lane, Maura A.; Kimber, Megan; Khokha, Mustafa K.] Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, New Haven, CT 06511 USA	Yale University	Khokha, MK (corresponding author), Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, New Haven, CT 06511 USA.	mustafa.khokha@yale.edu			NIH/NCRR [1R21RR025168]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025168] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	NIH/NCRR 1R21RR025168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Balciunas D, 2005, ZEBRAFISH, V1, P335, DOI 10.1089/zeb.2005.1.335; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Bonin CP, 2004, GENETICS, V167, P1801, DOI 10.1534/genetics.104.027557; CALVI BR, 1991, CELL, V66, P465, DOI 10.1016/0092-8674(81)90010-6; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Doherty JR, 2007, DEV DYNAM, V236, P2808, DOI 10.1002/dvdy.21321; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Hirsch N, 2002, DEV DYNAM, V225, P522, DOI 10.1002/dvdy.10188; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Koga A, 2004, ADV BIOPHYS, V38, P161, DOI 10.1016/S0065-227X(04)80151-5; Koga A, 1996, NATURE, V383, P30, DOI 10.1038/383030a0; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Liao HK, 2012, DEV DYNAM, V241, P415, DOI 10.1002/dvdy.23725; Liu XJ, 2006, BIOL REPROD, V74, P1016, DOI 10.1095/biolreprod.105.049403; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Offield MF, 2000, DEVELOPMENT, V127, P1789; Ogino H, 2006, MECH DEVELOP, V123, P103, DOI 10.1016/j.mod.2005.11.006; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Wallingford JB, 2010, CURR BIOL, V20, pR263, DOI 10.1016/j.cub.2010.01.012; Yergeau DA, 2007, NAT PROTOC, V2, P2975, DOI 10.1038/nprot.2007.428; Yergeau Donald A, 2012, Methods Mol Biol, V917, P111, DOI 10.1007/978-1-61779-992-1_6; Yergeau DA, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-15; Yergeau DA, 2010, METHODS, V51, P92, DOI 10.1016/j.ymeth.2010.03.001; Yergeau DA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-11; Yergeau DA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S11	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76807	10.1371/journal.pone.0076807	http://dx.doi.org/10.1371/journal.pone.0076807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116167	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200074
J	Maity, A; Yadav, S; Verma, CS; Dastidar, SG				Maity, Atanu; Yadav, Seema; Verma, Chandra S.; Dastidar, Shubhra Ghosh			Dynamics of Bcl-xL in Water and Membrane: Molecular Simulations	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; GENERALIZED BORN; PEPTIDE COMPLEX; CELL-DEATH; FAMILY PROTEINS; LIGAND-BINDING; FORCE-FIELDS; BCL-X(L); INHIBITOR; APOPTOSIS	The Bcl2 family of proteins is capable of switching the apoptotic machinery by directly controlling the release of apoptotic factors from the mitochondrial outer membrane. They have 'pro' and 'anti'-apoptotic subgroups of proteins which antagonize each other's function; however a detailed atomistic understanding of their mechanisms based on the dynamical events, particularly in the membrane, is lacking. Using molecular dynamics simulations totaling 1.6 mu s we outline the major differences between the conformational dynamics in water and in membrane. Using implicit models of solvent and membrane, the simulated results reveal a picture that is in agreement with the 'hit- and run' concept which states that BH3-only peptides displace the tail (which acts as a pseudo substrate of the protein itself) from its binding pocket; this helps the membrane association of the protein after which the BH3 peptide becomes free. From simulations, Bcl-xL appears to be auto-inhibited by its C-terminal tail that embeds into and covers the hydrophobic binding pocket. However the tail is unable to energetically compete with BH3-peptides in water. In contrast, in the membrane, neither the tail nor the BH3-peptides are stable in the binding pocket and appear to be easily dissociated off as the pocket expands in response to the hydrophobic environment. This renders the binding pocket large and open, thus receptive to interactions with other protein partners. Principal components of the motions are dramatically different in the aqueous and in the membrane environments and provide clues regarding the conformational transitions that Bcl-xL undergoes in the membrane, in agreement with the biochemical data.	[Maity, Atanu; Yadav, Seema; Dastidar, Shubhra Ghosh] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India; [Verma, Chandra S.] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Department of Science & Technology (India); Bose Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Dastidar, SG (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	sgd@jcbose.ac.in		Maity, Atanu/0000-0002-7795-692X	Department of Biotechnology, Government of India [BT/PR793/BID/7/370/2011]; CSIR, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This project (BT/PR793/BID/7/370/2011) is supported by the funding from the Department of Biotechnology, Government of India. AM receives funding from CSIR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bhat V, 2012, J MOL BIOL, V416, P57, DOI 10.1016/j.jmb.2011.12.015; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dastidar SG, 2011, CELL CYCLE, V10, P82, DOI 10.4161/cc.10.1.14345; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Gemperli AC, 2005, J AM CHEM SOC, V127, P1596, DOI 10.1021/ja0441211; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Im W, 2005, P NATL ACAD SCI USA, V102, P6771, DOI 10.1073/pnas.0408135102; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaufmann SH, 2000, BIOESSAYS, V22, P1007, DOI 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.3.CO;2-W; Kaufmann T, 2004, TRENDS CELL BIOL, V14, P8, DOI 10.1016/j.tcb.2003.11.005; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Lee EF, 2011, STRUCTURE, V19, P1467, DOI 10.1016/j.str.2011.07.015; Li MY, 2008, J MOL MODEL, V14, P957, DOI 10.1007/s00894-008-0342-8; Ling BP, 2012, J MOL GRAPH MODEL, V35, P1, DOI 10.1016/j.jmgm.2012.01.005; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lugovskoy AA, 2002, J AM CHEM SOC, V124, P1234, DOI 10.1021/ja011239y; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Wolf A, 2013, J MOL MODEL, V19, P539, DOI 10.1007/s00894-012-1563-4; Yang CY, 2011, ACS MED CHEM LETT, V2, P280, DOI 10.1021/ml100276b; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	62	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76837	10.1371/journal.pone.0076837	http://dx.doi.org/10.1371/journal.pone.0076837			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116174	Green Published, gold			2022-12-27	WOS:000325552200078
J	Price, CI; Rae, V; Duckett, J; Wood, R; Gray, J; McMeekin, P; Rodgers, H; Portas, K; Ford, GA				Price, Christopher I.; Rae, Victoria; Duckett, Jay; Wood, Ruth; Gray, Joanne; McMeekin, Peter; Rodgers, Helen; Portas, Karen; Ford, Gary A.			An Observational Study of Patient Characteristics Associated with the Mode of Admission to Acute Stroke Services in North East, England	PLOS ONE			English	Article							PREHOSPITAL DELAY; CARE	Objective: Effective provision of urgent stroke care relies upon admission to hospital by emergency ambulance and may involve pre-hospital redirection. The proportion and characteristics of patients who do not arrive by emergency ambulance and their impact on service efficiency is unclear. To assist in the planning of regional stroke services we examined the volume, characteristics and prognosis of patients according to the mode of presentation to local services. Study design and setting: A prospective regional database of consecutive acute stroke admissions was conducted in North East, England between 01/09/10-30/09/11. Case ascertainment and transport mode were checked against hospital coding and ambulance dispatch databases. Results: Twelve acute stroke units contributed data for a mean of 10.7 months. 2792/3131 (89%) patients received a diagnosis of stroke within 24 hours of admission: 2002 arrivals by emergency ambulance; 538 by private transport or non-emergency ambulance; 252 unknown mode. Emergency ambulance patients were older (76 vs 69 years), more likely to be from institutional care (10% vs 1%) and experiencing total anterior circulation symptoms (27% vs 6%). Thrombolysis treatment was commoner following emergency admission (11% vs 4%). However patients attending without emergency ambulance had lower inpatient mortality (2% vs 18%), a lower rate of institutionalisation (1% vs 6%) and less need for daily carers (7% vs 16%). 149/155 (96%) of highly dependent patients were admitted by emergency ambulance, but none received thrombolysis. Conclusion: Presentations of new stroke without emergency ambulance involvement were not unusual but were associated with a better outcome due to younger age, milder neurological impairment and lower levels of pre-stroke dependency. Most patients with a high level of pre-stroke dependency arrived by emergency ambulance but did not receive thrombolysis. It is important to be aware of easily identifiable demographic groups that differ in their potential to gain from different service configurations.	[Price, Christopher I.; Rodgers, Helen; Ford, Gary A.] Newcastle Univ, Stroke Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rae, Victoria; Wood, Ruth; Gray, Joanne; McMeekin, Peter] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Duckett, Jay] North East Ambulance Serv NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Portas, Karen] North England Cardiovasc Network, Darlington, Durham, England	Newcastle University - UK; Newcastle University - UK	Price, CI (corresponding author), Newcastle Univ, Stroke Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.i.m.price@ncl.ac.uk	Ford, Gary/AAY-6405-2020	Ford, Gary/0000-0001-8719-4968; McMeekin, Peter/0000-0003-0946-7224; Price, Christopher/0000-0003-3566-3157; gray, joanne/0000-0001-6157-230X	NIHR Programme Grant for Applied Research [RP-PG-0606-1241]; National Institute for Health Research [NF-SI-0507-10249, RP-PG-0606-1241] Funding Source: researchfish; Stroke Association [TSAPMF2013/02] Funding Source: researchfish	NIHR Programme Grant for Applied Research; National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association	This research was funded by an NIHR Programme Grant for Applied Research (RP-PG-0606-1241). The views and opinions expressed here are those of the authors and do not necessarily reflect those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2011, EUR J NEUROL, V18, P850, DOI 10.1111/j.1468-1331.2010.03258.x; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P474; Audebert HJ, 2006, STROKE, V37, P1822, DOI 10.1161/01.STR.0000226741.20629.b2; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Bray Janet E, 2005, Prehosp Emerg Care, V9, P297, DOI 10.1080/10903120590962382; Bray JE, 2011, STROKE, V42, P2154, DOI 10.1161/STROKEAHA.110.612036; Cramer SC, 2012, STROKE, V43, P1089, DOI 10.1161/STROKEAHA.111.635334; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Heuschmann PU, 2011, NEUROLOGY, V76, P159, DOI 10.1212/WNL.0b013e318206ca1e; Intercollegiate Stroke Working Party, 2011, NAT SENT STROK CLIN; Kamel H, 2012, JAMA-J AM MED ASSOC, V307, P1026, DOI 10.1001/jama.2012.285; Kerns JM, 2011, AM J THER, V18, P81, DOI 10.1097/MJT.0b013e3181e123cd; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; Kim YS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-2; Kleindorfer D, 2010, AM J EMERG MED, V28, P607, DOI 10.1016/j.ajem.2009.02.016; Kwok CS, 2012, J AM GERIATR SOC, V60, P726, DOI 10.1111/j.1532-5415.2011.03889.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Mikulik R, 2011, CEREBROVASC DIS, V32, P342, DOI 10.1159/000330339; Mohammad Yousef M, 2008, J Vasc Interv Neurol, V1, P83; Mosley I, 2007, STROKE, V38, P361, DOI 10.1161/01.STR.0000254528.17405.cc; Nagaraja N, 2012, J NEUROL SCI, V314, P88, DOI 10.1016/j.jns.2011.10.022; National Audit Office, 2005, RED BRAIN DAM FAST A; Price CI, 2009, EXPERT REV NEUROTHER, V9, P211, DOI 10.1586/14737175.9.2.211; Quain DA, 2008, MED J AUSTRALIA, V189, P429, DOI 10.5694/j.1326-5377.2008.tb02114.x; Rymer MM, 2003, STROKE, V34, pE58, DOI 10.1161/01.STR.0000071107.66925.93; Saposnik G, 2011, STROKE, V42, P3421, DOI 10.1161/STROKEAHA.111.623116; Spark JI, 2011, MED J AUSTRALIA, V195, P16, DOI 10.5694/j.1326-5377.2011.tb03181.x; *STROK UN TRAL COL, 2003, ORG INP STROK UN CAR; Teuschl Y, 2010, INT J STROKE, V5, P187, DOI 10.1111/j.1747-4949.2010.00428.x; Turan Tanya N, 2005, J Stroke Cerebrovasc Dis, V14, P272, DOI 10.1016/j.jstrokecerebrovasdis.2005.07.002; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Weir NU, 2005, J NEUROL NEUROSUR PS, V76, P863, DOI 10.1136/jnnp.2004.053462	32	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76997	10.1371/journal.pone.0076997	http://dx.doi.org/10.1371/journal.pone.0076997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116195	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000325552200092
J	Secher, T; Samba-Louaka, A; Oswald, E; Nougayrede, JP				Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe			Escherichia coli Producing Colibactin Triggers Premature and Transmissible Senescence in Mammalian Cells	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; PERSISTENT DNA-DAMAGE; CELLULAR SENESCENCE; OXIDATIVE STRESS; CANCER; FIBROBLASTS; EXPRESSION; PML; P53; INFLAMMATION	Cellular senescence is an irreversible state of proliferation arrest evoked by a myriad of stresses including oncogene activation, telomere shortening/dysfunction and genotoxic insults. It has been associated with tumor activation, immune suppression and aging, owing to the secretion of proinflammatory mediators. The bacterial genotoxin colibactin, encoded by the pks genomic island is frequently harboured by Escherichia coli strains of the B2 phylogenetic group. Mammalian cells exposed to live pks+ bacteria exhibit DNA-double strand breaks (DSB) and undergo cell-cycle arrest and death. Here we show that cells that survive the acute bacterial infection with pks+ E. coli display hallmarks of cellular senescence: chronic DSB, prolonged cell-cycle arrest, enhanced senescence-associated beta-galactosidase (SA-beta-Gal) activity, expansion of promyelocytic leukemia nuclear foci and senescence-associated heterochromatin foci. This was accompanied by reactive oxygen species production and pro-inflammatory cytokines, chemokines and proteases secretion. These mediators were able to trigger DSB and enhanced SA-beta-Gal activity in bystander recipient cells treated with conditioned medium from senescent cells. Furthermore, these senescent cells promoted the growth of human tumor cells. In conclusion, the present data demonstrated that the E. coli genotoxin colibactin induces cellular senescence and subsequently propel bystander genotoxic and oncogenic effects.	[Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] INRA, USC 1360, F-31931 Toulouse, France; [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] Fac Med Toulouse, INSERM, UMR 1043, F-31073 Toulouse, France; [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] CNRS, UMR 5282, Toulouse, France; [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] Univ Toulouse, UPS, CPTP, Toulouse, France; [Oswald, Eric] CHU Toulouse, Hop Purpan, Serv Bacteriol Hyg, Toulouse, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Nougayrede, JP (corresponding author), INRA, USC 1360, F-31931 Toulouse, France.	jean-philippe.nougayrede@toulouse.inra.fr	SECHER, Thomas/P-4795-2016; Nougayrede, Jean-Philippe/I-6362-2019; Samba-Louaka, Ascel/H-7073-2016	Nougayrede, Jean-Philippe/0000-0002-6802-1890; Oswald, Eric/0000-0002-3017-0081; Samba-Louaka, Ascel/0000-0003-4417-6254	French fondation ARC pour la recherche sur le cancer [SFI20101201751]; Agence Nationale de la Recherche [ANR-10-CESA-0011, ANR-09-MIE-005]; INRA [AO-blanc-2010]; conseil regional de Midi-Pyrenees [12050986]	French fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA; conseil regional de Midi-Pyrenees(Region Occitanie)	This work was made possible by financial support SFI20101201751 from the French fondation ARC pour la recherche sur le cancer, by the Agence Nationale de la Recherche (ANR-10-CESA-0011) and grant AO-blanc-2010 from INRA. Thomas Secher was supported by the Agence Nationale de la Recherche (ANR-09-MIE-005) and by the conseil regional de Midi-Pyrenees (12050986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Audebert M, 2010, TOXICOL LETT, V199, P182, DOI 10.1016/j.toxlet.2010.08.022; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chen QM, 2000, J CELL SCI, V113, P4087; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Ferbeyre G, 2000, GENE DEV, V14, P2015; Frippiat C, 2000, EXP GERONTOL, V35, P733, DOI 10.1016/S0531-5565(00)00167-4; Gordon DM, 2005, MICROBIOL-SGM, V151, P15, DOI 10.1099/mic.0.27425-0; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Ohtani S, 2004, MOL CANCER THER, V3, P93; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126; WANG X, 2013, CANCER PREV RES, V6, P971; Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040; Wang XM, 2012, GASTROENTEROLOGY, V142, P543, DOI 10.1053/j.gastro.2011.11.020; Yang YH, 2012, CANCER RES, V72, P5219, DOI 10.1158/0008-5472.CAN-12-1463; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	69	76	76	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77157	10.1371/journal.pone.0077157	http://dx.doi.org/10.1371/journal.pone.0077157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116215	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200107
J	Tan, A; Goh, D; Farhatnia, Y; Natasha, G; Lim, J; Teoh, SH; Rajadas, J; Alavijeh, MS; Seifalian, AM				Tan, Aaron; Goh, Debbie; Farhatnia, Yasmin; Natasha, G.; Lim, Jing; Teoh, Swee-Hin; Rajadas, Jayakumar; Alavijeh, Mohammad S.; Seifalian, Alexander M.			An Anti-CD34 Antibody-Functionalized Clinical-Grade POSS-PCU Nanocomposite Polymer for Cardiovascular Stent Coating Applications: A Preliminary Assessment of Endothelial Progenitor Cell Capture and Hemocompatibility	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; IN-SITU ENDOTHELIALIZATION; INFRAINGUINAL EPTFE GRAFTS; SIROLIMUS-ELUTING STENTS; HUMAN PERIPHERAL-BLOOD; BYPASS GRAFT; VITRO ENDOTHELIALIZATION; REGENERATIVE MEDICINE; PLATELET-ADHESION; VIVO	In situ endothelialization of cardiovascular implants has emerged in recent years as an attractive means of targeting the persistent problems of thrombosis and intimal hyperplasia. This study aimed to investigate the efficacy of immobilizing anti-CD34 antibodies onto a POSS-PCU nanocomposite polymer surface to sequester endothelial progenitor cells (EPCs) from human blood, and to characterize the surface properties and hemocompatibility of this surface. Amine-functionalized fumed silica was used to covalently conjugate anti-CD34 to the polymer surface. Water contact angle, fluorescence microscopy, and scanning electron microscopy were used for surface characterization. Peripheral blood mononuclear cells (PBMCs) were seeded on modified and pristine POSS-PCU polymer films. After 7 days, adhered cells were immunostained for the expression of EPC and endothelial cell markers, and assessed for the formation of EPC colonies. Hemocompatibility was assessed by thromboelastography, and platelet activation and adhesion assays. The number of EPC colonies formed on anti-CD34-coated POSS-PCU surfaces was not significantly higher than that of POSS-PCU (5.0+/-1.0 vs. 1.7+/-0.6, p>0.05). However, antibody conjugation significantly improved hemocompatibility, as seen from the prolonged reaction and clotting times, decreased angle and maximum amplitude (p<0.05), as well as decreased platelet adhesion (76.8+/-7.8 vs. 8.4+/-0.7, p<0.05) and activation. Here, we demonstrate that POSS-PCU surface immobilized anti-CD34 antibodies selectively captured CD34(+) cells from peripheral blood, although only a minority of these were EPCs. Nevertheless, antibody conjugation significantly improves the hemocompatibility of POSS-PCU, and should therefore continue to be explored in combination with other strategies to improve the specificity of EPC capture to promote in situ endothelialization.	[Tan, Aaron; Goh, Debbie; Farhatnia, Yasmin; Natasha, G.; Seifalian, Alexander M.] UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London, England; [Tan, Aaron; Goh, Debbie; Natasha, G.] UCL, UCL Med Sch, London, England; [Lim, Jing; Teoh, Swee-Hin] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 639798, Singapore; [Rajadas, Jayakumar] Stanford Univ, Biomat & Adv Drug Delivery Lab, Sch Med, Stanford, CA 94305 USA; [Alavijeh, Mohammad S.] Pharmidex Pharmaceut Serv Ltd, London, England; [Seifalian, Alexander M.] Royal Free London NHS Fdn Trust, London, England	University of London; University College London; University of London; University College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University; University of London; University College London; Royal Free London NHS Foundation Trust	Seifalian, AM (corresponding author), UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London, England.	a.seifalian@ucl.ac.uk	Seifalian, Alexander M/I-6028-2013; Rajadas, Jayakumar/AHC-0630-2022; Alavijeh, Mo/AFU-7249-2022	Seifalian, Alexander M/0000-0002-1180-3322; G, Natasha/0000-0002-9262-4595; Rajadas, Jayakumar/0000-0001-6520-3923; Tan, Aaron/0000-0002-8935-0773; seifalian, Alexander/0000-0002-8334-9376; Alavijeh, Mo/0000-0002-2136-8344	Engineering and Physical Sciences Research Council (EPSRC) - Industrial CASE	Engineering and Physical Sciences Research Council (EPSRC) - Industrial CASE	This research was supported by funding from the Engineering and Physical Sciences Research Council (EPSRC) - Industrial CASE. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED M., 2011, THESIS; Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051; Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034; Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13; Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Brito LA, 2010, J BIOMED MATER RES A, V93A, P325, DOI 10.1002/jbm.a.32488; Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53; Chiang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031799; Chong MSK, 2009, BIOMATERIALS, V30, P2241, DOI 10.1016/j.biomaterials.2008.12.056; Chong MSK, 2010, TISSUE ENG PT A, V16, P2485, DOI [10.1089/ten.tea.2009.0680, 10.1089/ten.TEA.2009.0680]; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dambisya YM, 1996, BLOOD COAGUL FIBRIN, V7, P678, DOI 10.1097/00001721-199610000-00003; de Mel A, 2011, THESIS; de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597; Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1016/S0039-6060(99)70025-5; Duckers Henricus J, 2007, EuroIntervention, V3, P67; Duckers Henricus J, 2007, EuroIntervention, V3, P350; EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x; Eunju O, 2011, FASEB J, V25, P159, DOI 10.1096/fj.10-162040; Farb A, 2007, NEW ENGL J MED, V356, P984, DOI 10.1056/NEJMp068304; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Ghanbari Alanagh H, 2011, THESIS; Ghanbari H, 2010, ACTA BIOMATER, V6, P4249, DOI 10.1016/j.actbio.2010.06.015; Goh D, 2013, MOL PHARMACEUT, V10, P1279, DOI 10.1021/mp3006616; Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023; Greenhalgh J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004587.pub2; Heyligers J, 2006, NOVEL STRATEGIES IMP, P53; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z; Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006; Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b; Kidane AG, 2009, ACTA BIOMATER, V5, P2409, DOI 10.1016/j.actbio.2009.02.025; KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Larsen K, 2012, EUR HEART J, V33, P120, DOI 10.1093/eurheartj/ehr196; Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.3.CO;2-F; Markway BD, 2008, TISSUE ENG PART C-ME, V14, P97, DOI 10.1089/ten.tec.2007.0300; Marois Y., 2000, BIOCOMPATIBILITY POL; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3; Melchiorri AJ, 2013, TISSUE ENG PART B-RE, V19, P292, DOI [10.1089/ten.TEB.2012.0577, 10.1089/ten.teb.2012.0577]; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Motwani MS, 2011, BIOTECHNOL APPL BIOC, V58, P2, DOI 10.1002/bab.10; Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015; Niccoli G, 2010, J AM COLL CARDIOL, V56, P1783, DOI 10.1016/j.jacc.2010.06.045; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Punshon G, 2008, CELL PROLIFERAT, V41, P321, DOI 10.1111/j.1365-2184.2008.00523.x; Punshon G, 2011, BIOTECHNOL APPL BIOC, V58, P328, DOI 10.1002/bab.47; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rashid ST, 2008, FASEB J, V22, P2084, DOI 10.1096/fj.07-096586; Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407; Scott EA, 2008, BIOMATERIALS, V29, P4481, DOI 10.1016/j.biomaterials.2008.08.003; Silber S, 2011, EUROINTERVENTION, V6, P819, DOI 10.4244/EIJV6I7A141; Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042; Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A; Tan A, 2013, J BIOTECHNOL, V164, P151, DOI 10.1016/j.jbiotec.2013.01.020; Tan A, 2010, CURR PHARM DESIGN, V16, P3848, DOI 10.2174/138161210794455058; Tang Y, 2009, POLYM ADVAN TECHNOL, V20, P1, DOI 10.1002/pat.1229; Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI [10.1089/ten.teb.2009.0527, 10.1089/ten.TEB.2009.0527]; Wendel HP, 2010, INT J CARDIOL, V145, P115, DOI 10.1016/j.ijcard.2009.06.020; Yazdani S. K., 2012, J INTERV CARDIOL, V4, P169, DOI DOI 10.2217/ICA.11.99	69	36	37	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77112	10.1371/journal.pone.0077112	http://dx.doi.org/10.1371/journal.pone.0077112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116210	Green Published, gold			2022-12-27	WOS:000325552200103
J	Zhang, AL; Chi, XJ; Luo, GJ; Hei, ZQ; Xia, H; Luo, CF; Wang, YL; Mao, XW; Xia, ZY				Zhang, Ailan; Chi, Xinjin; Luo, Gangjian; Hei, Ziqing; Xia, Hua; Luo, Chenfang; Wang, Yanling; Mao, Xiaowen; Xia, Zhengyuan			Mast Cell Stabilization Alleviates Acute Lung Injury after Orthotopic Autologous Liver Transplantation in Rats by Downregulating Inflammation	PLOS ONE			English	Article							INTESTINAL ISCHEMIA-REPERFUSION; PLATELET-ACTIVATING-FACTOR; FC-GAMMA-RI; CROMOLYN SODIUM; PULMONARY-EDEMA; TNF-ALPHA; VASCULAR-PERMEABILITY; AIRWAY INFLAMMATION; UP-REGULATION; KAPPA-B	Background: Acute lung injury (ALI) is one of the most severe complications after orthotopic liver transplantation. Amplified inflammatory response after transplantation contributes to the process of ALI, but the mechanism underlying inflammation activation is not completely understood. We have demonstrated that mast cell stabilization attenuated inflammation and ALI in a rodent intestine ischemia/reperfusion model. We hypothesized that upregulation of inflammation triggered by mast cell activation may be involve in ALI after liver transplantation. Methods: Adult male Sprague-Dawley rats received orthotopic autologous liver transplantation (OALT) and were executed 4, 8, 16, and 24 h after OALT. The rats were pretreated with the mast cell stabilizers cromolyn sodium or ketotifen 15 min before OALT and executed 8 h after OALT. Lung tissues and arterial blood were collected to evaluate lung injury. beta-hexosaminidase and mast cell tryptase levels were assessed to determine the activation of mast cells. Tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta and IL-6 in serum and lung tissue were analyzed by enzyme-linked immunosorbent assay. Nuclear factor-kappa B (NF-kappa B) p65 translocation was assessed by Western blot. Results: The rats that underwent OALT exhibited severe pulmonary damage with a high wet-to-dry ratio, low partial pressure of oxygen, and low precursor surfactant protein C levels, which corresponded to the significant elevation of pro-inflammatory cytokines, beta-hexosaminidase, and tryptase levels in serum and lung tissues. The severity of ALI progressed and maximized 8 h after OALT. Mast cell stabilization significantly inhibited the activation of mast cells, downregulated pro-inflammatory cytokine levels and translocation of NF-kappa B, and attenuated OALT-induced ALI. Conclusions: Mast cell activation amplified inflammation and played an important role in the process of post-OALT related ALI.	[Zhang, Ailan; Chi, Xinjin; Luo, Gangjian; Hei, Ziqing; Luo, Chenfang; Wang, Yanling] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Hua] Luzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Luzhou City, Peoples R China; [Mao, Xiaowen; Xia, Zhengyuan] Univ Hong Kong, Dept Anesthesiol, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Southwest Medical University; University of Hong Kong	Hei, ZQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China.	heiziqing@sina.com	Irwin, Michael Garnet/C-4286-2009; Irwin, Michael Garnet/GLR-9714-2022; chen, chaojin/M-6701-2014	Irwin, Michael Garnet/0000-0001-5801-274X; Irwin, Michael Garnet/0000-0001-5801-274X; Hei, Zi-qing/0000-0001-7466-2769	National Natural Science Foundation of China [30972858]; Natural Science Foundation of Guangdong Province, China [S2012010008930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	The study was supported by the National Natural Science Foundation of China (NO. 30972858) and the Natural Science Foundation of Guangdong Province, China (NO. S2012010008930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieff AI, 1999, CHEST, V115, P1371, DOI 10.1378/chest.115.5.1371; BERNSTEIN IL, 1972, J ALLERGY CLIN IMMUN, V50, P235, DOI 10.1016/0091-6749(72)90017-6; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chevrel G, 2005, ANN RHEUM DIS, V64, P1257, DOI 10.1136/ard.2004.032359; CRAPS L, 1983, PHARMATHERAPEUTICA, V3, P314; Gan XL, 2012, INFLAMMATION, V35, P1144, DOI 10.1007/s10753-011-9422-5; Glasgow SC, 2005, SURGERY, V138, P64, DOI 10.1016/j.surg.2005.03.005; Glasgow SC, 2007, AM J PHYSIOL-LUNG C, V293, pL491, DOI 10.1152/ajplung.00009.2007; GRANT SM, 1990, DRUGS, V40, P412, DOI 10.2165/00003495-199040030-00006; Guo Na, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P74; Gurkan OU, 2011, EXP LUNG RES, V37, P575, DOI 10.3109/01902148.2011.620680; He X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001527; Hei ZQ, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-42; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hofbauer B, 1998, GASTROENTEROLOGY, V115, P1238, DOI 10.1016/S0016-5085(98)70096-4; Huang PJ, 2012, INJURY, V43, P1250, DOI 10.1016/j.injury.2011.12.027; Jiang A, 2012, WORLD J GASTROENTERO, V18, P323, DOI 10.3748/wjg.v18.i4.323; Jin EJ, 2003, CANCER-AM CANCER SOC, V97, P703, DOI 10.1002/cncr.11087; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Kalia N, 2005, J GASTROEN HEPATOL, V20, P1032, DOI 10.1111/j.1440-1746.2005.03767.x; Kiupel M, 2004, VET PATHOL, V41, P371, DOI 10.1354/vp.41-4-371; Kox M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034431; Kuehn Hye Sun, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0738s91; Li Gang-Shan, 2002, Hepatobiliary Pancreat Dis Int, V1, P330; Li Shang-Rong, 2008, Zhonghua Yi Xue Za Zhi, V88, P3049; MAZUREK N, 1983, NATURE, V303, P528, DOI 10.1038/303528a0; MAZUREK N, 1980, NATURE, V286, P722, DOI 10.1038/286722a0; MEDICI TC, 1989, CHEST, V96, P1252, DOI 10.1378/chest.96.6.1252; Menoret A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040184; MONIE RD, 1982, BRIT J DIS CHEST, V76, P383, DOI 10.1016/0007-0971(82)90074-2; Mueller AR, 2004, BEST PRACT RES CL GA, V18, P881, DOI 10.1016/j.bpg.2004.07.004; MYLONAKARAYANNI C, 1990, J ASTHMA, V27, P87, DOI 10.3109/02770909009073302; O'Mahony DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051104; Okayama Y, 2003, EUR J IMMUNOL, V33, P1450, DOI 10.1002/eji.200323563; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Parkash J, 2011, EXP THER MED, V2, P21, DOI 10.3892/etm.2010.161; Reuter S, 2010, YONSEI MED J, V51, P797, DOI 10.3349/ymj.2010.51.6.797; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; ROMANSKI B, 1983, ALLERGOL IMMUNOPATH, V11, P34; Ruh J, 2000, ACTA PHYSIOL SCAND, V170, P137, DOI 10.1046/j.1365-201x.2000.00760.x; Santone DJ, 2008, AM J PHYSIOL-HEART C, V294, pH2456, DOI 10.1152/ajpheart.00925.2007; SHAPIRO GG, 1985, PHARMACOTHERAPY, V5, P156; Shiraishi Y, 2005, J PHARMACOL EXP THER, V312, P954, DOI 10.1124/jpet.104.078212; SIROIS MG, 1994, BRIT J PHARMACOL, V111, P1111, DOI 10.1111/j.1476-5381.1994.tb14859.x; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Su X, 2005, J IMMUNOL, V175, P2598, DOI 10.4049/jimmunol.175.4.2598; Sur R, 2007, INT IMMUNOPHARMACOL, V7, P555, DOI 10.1016/j.intimp.2007.01.009; Takizawa T, 2005, J PHARMACOL SCI, V98, P99, DOI 10.1254/jphs.SCZ050138; Tran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023660; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Walcher F, 1996, J SURG RES, V61, P244, DOI 10.1006/jsre.1996.0111; Webster JD, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-85; Woolhiser MR, 2001, EUR J IMMUNOL, V31, P3298, DOI 10.1002/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U; Yang HW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-37; Yost CS, 2001, CHEST, V119, P219, DOI 10.1378/chest.119.1.219; Zhao HF, 2009, HEPATOB PANCREAT DIS, V8, P247; Zimmerman GA, 2004, TRENDS MOL MED, V10, P245, DOI 10.1016/j.molmed.2004.03.009	59	29	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75262	10.1371/journal.pone.0075262	http://dx.doi.org/10.1371/journal.pone.0075262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116032	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200014
J	Kizach, J; Nyvad, AM; Christensen, KR				Kizach, Johannes; Nyvad, Anne Mette; Christensen, Ken Ramshoj			Structure before Meaning: Sentence Processing, Plausibility, and Subcategorization	PLOS ONE			English	Article							UNBOUNDED DEPENDENCIES; LEXICAL GUIDANCE; COMPREHENSION; CONSTRAINTS; ONLINE; SERIAL	Natural language processing is a fast and automatized process. A crucial part of this process is parsing, the online incremental construction of a syntactic structure. The aim of this study was to test whether a wh-filler extracted from an embedded clause is initially attached as the object of the matrix verb with subsequent reanalysis, and if so, whether the plausibility of such an attachment has an effect on reaction time. Finally, we wanted to examine whether subcategorization plays a role. We used a method called G-Maze to measure response time in a self-paced reading design. The experiments confirmed that there is early attachment of fillers to the matrix verb. When this attachment is implausible, the off-line acceptability of the whole sentence is significantly reduced. The on-line results showed that G-Maze was highly suited for this type of experiment. In accordance with our predictions, the results suggest that the parser ignores (or has no access to information about) implausibility and attaches fillers as soon as possible to the matrix verb. However, the results also show that the parser uses the subcategorization frame of the matrix verb. In short, the parser ignores semantic information and allows implausible attachments but adheres to information about which type of object a verb can take, ensuring that the parser does not make impossible attachments. We argue that the evidence supports a syntactic parser informed by syntactic cues, rather than one guided by semantic cues or one that is blind, or completely autonomous.	[Kizach, Johannes; Nyvad, Anne Mette; Christensen, Ken Ramshoj] Aarhus Univ, Dept Aesthet & Commun, Aarhus, Denmark	Aarhus University	Kizach, J (corresponding author), Aarhus Univ, Dept Aesthet & Commun, Aarhus, Denmark.	engjk@hum.au.dk		Nyvad, Anne Mette/0000-0001-9554-6716; Christensen, Ken Ramshoj/0000-0001-8758-240X	Danish Ministry of Science, Technology and Innovation (the MindLab project, Aarhus University); Danish Council for Independent Research; Faculty of Arts, Aarhus University	Danish Ministry of Science, Technology and Innovation (the MindLab project, Aarhus University); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Faculty of Arts, Aarhus University	This research project was supported by grants from The Danish Ministry of Science, Technology and Innovation (the MindLab project, Aarhus University), from The Danish Council for Independent Research, and from The Faculty of Arts, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR; Boland JE, 1995, J MEM LANG, V34, P774, DOI 10.1006/jmla.1995.1034; Christensen KR, 2013, J PSYCHOLINGUIST RES, V42, P51, DOI 10.1007/s10936-012-9210-x; Fanselow Gisbert, 2006, GRADIENCE GRAMMAR GE, P291, DOI [10.1093/acprof:oso/9780199274796.003.0015, DOI 10.1093/ACPROF:OSO/9780199274796.003.0015]; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Fodor Janet Dean, 1998, REANALYSIS SENTENCE, P101; Forster KI, 2009, BEHAV RES METHODS, V41, P163, DOI 10.3758/BRM.41.1.163; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FRAZIER L, 1987, ATTENTION PERFORM, P559; Frazier L., 1996, CONSTRUAL; GARNSEY SM, 1989, J PSYCHOLINGUIST RES, V18, P51, DOI 10.1007/BF01069046; Gibson E, 2000, J PSYCHOLINGUIST RES, V29, P231, DOI 10.1023/A:1005153330168; Gibson E, 2003, ENCY COGNITIVE SCI, P1137; Gibson E.A.F., 1991, THESIS CARNEGIE MELL; Gorrell Paul, 1995, SYNTAX PARSING; Hawkins J, 2003, EFFICIENCY COMPLEXIT; Hawkins JA, 1994, PERFORMANCE THEORY O; HOLM S, 1979, SCAND J STAT, V6, P65; Kizach J, 2012, RUSS LINGUIST, V36, P251, DOI 10.1007/s11185-012-9096-0; Lau Ellen F., HYPERACTIVE IN PRESS; Lewis RL, 2000, J PSYCHOLINGUIST RES, V29, P241, DOI 10.1023/A:1005105414238; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; MILLER GA, 1963, HDB MATH PSYCHOL, P421; MITCHELL DC, 1987, ATTENTION PERFORM, P601; Pickering MJ, 2003, LANG COGNITIVE PROC, V18, P469, DOI 10.1080/01690960344000017; Pritchett B.L., 1992, GRAMMATICAL COMPETEN; R Development Core Team, 2009, R LANG ENV STAT COMP, P409; SHAPIRO LP, 1987, COGNITION, V27, P219, DOI 10.1016/S0010-0277(87)80010-0; Shetreet E, 2009, NEUROIMAGE, V48, P707, DOI 10.1016/j.neuroimage.2009.07.001; Smith N. J., 2013, COGNITION IN PRESS; Staub A, 2007, J EXP PSYCHOL LEARN, V33, P550, DOI 10.1037/0278-7393.33.3.550; STOWE LA, 1991, LANG SPEECH, V34, P319, DOI 10.1177/002383099103400402; Stowe Laurie A., 1986, LANG COGNITIVE PROC, V1, P227, DOI DOI 10.1080/01690968608407062; Traxler MJ, 1996, J MEM LANG, V35, P454, DOI 10.1006/jmla.1996.0025; TRUESWELL JC, 1993, J EXP PSYCHOL LEARN, V19, P528, DOI 10.1037/0278-7393.19.3.528; van Gompel RPG, 2001, PSYCHON B REV, V8, P851, DOI 10.3758/BF03196228; Venables WN., 2002, MODERN APPL STAT S 4; Witzel N, 2012, J PSYCHOLINGUIST RES, V41, P105, DOI 10.1007/s10936-011-9179-x	38	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76326	10.1371/journal.pone.0076326	http://dx.doi.org/10.1371/journal.pone.0076326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116101	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300056
J	Chu, ZT; Abu-Baker, S; Palascak, MB; Ahmad, SA; Franco, RS; Qi, XY				Chu, Zhengtao; Abu-Baker, Shadi; Palascak, Mary B.; Ahmad, Syed A.; Franco, Robert S.; Qi, Xiaoyang			Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer	PLOS ONE			English	Article							SPHINGOLIPID ACTIVATOR PROTEINS; ACID BETA-GLUCOSIDASE; SAPOSIN-C; MEMBRANE INTERACTIONS; CELL-LINES; PHOSPHATIDYLSERINE; CERAMIDE; BINDING; DESTABILIZATION; EXPRESSION	Only a small number of promising drugs target pancreatic cancer, which is the fourth leading cause of cancer deaths with a 5-year survival of less than 5%. Our goal is to develop a new biotherapeutic agent in which a lysosomal protein (saposin C, SapC) and a phospholipid (dioleoylphosphatidylserine, DOPS) are assembled into nanovesicles (SapC-DOPS) for treating pancreatic cancer. A distinguishing feature of SapC-DOPS nanovesicles is their high affinity for phosphatidylserine (PS) rich microdomains, which are abnormally exposed on the membrane surface of human pancreatic tumor cells. To evaluate the role of external cell PS, in vitro assays were used to correlate PS exposure and the cytotoxic effect of SapC-DOPS in human tumor and nontumorigenic pancreatic cells. Next, pancreatic tumor xenografts (orthotopic and subcutaneous models) were used for tumor targeting and therapeutic efficacy studies with systemic SapC-DOPS treatment. We observed that the nanovesicles selectively killed human pancreatic cancer cells in vitro by inducing apoptotic death, whereas untransformed cells remained unaffected. This in vitro cytotoxic effect correlated to the surface exposure level of PS on the tumor cells. Using xenografts, animals treated with SapC-DOPS showed clear survival benefits and their tumors shrank or disappeared. Furthermore, using a double-tracking method in live mice, we showed that the nanovesicles were specifically targeted to orthotopically-implanted, bioluminescent pancreatic tumors. These data suggest that the acidic phospholipid PS is a biomarker for pancreatic cancer that can be effectively targeted for therapy utilizing cancer-selective SapC-DOPS nanovesicles. This study provides convincing evidence in support of developing a new therapeutic approach to pancreatic cancer.	[Chu, Zhengtao; Abu-Baker, Shadi; Palascak, Mary B.; Franco, Robert S.; Qi, Xiaoyang] Univ Cincinnati Coll Med, Dept Internal Med, Div Hematol Oncol, Cincinnati, OH USA; [Ahmad, Syed A.] Univ Cincinnati Coll Med, Dept Surg, Cincinnati, OH USA; [Qi, Xiaoyang] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Qi, XY (corresponding author), Univ Cincinnati Coll Med, Dept Internal Med, Div Hematol Oncol, Cincinnati, OH USA.	xiaoyang.qi@uc.edu			NIH/NCI [1R01CA158372-01, 1R43CA117283-01]; New Drug State Key Project [009ZX09102-205]; NATIONAL CANCER INSTITUTE [R01CA158372] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New Drug State Key Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH/NCI Grants Number 1R01CA158372-01 (to Qi), 1R43CA117283-01(to Qi and Xu), and New Drug State Key Project Grant Number 009ZX09102-205 (to Qi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Baker Shadi, 2012, J Cancer Ther, V3, P321; Allison A C, 1974, J Clin Pathol Suppl (R Coll Pathol), V7, P43; [Anonymous], 2000, METABOLIC MOL BASES; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; BOYER MJ, 1993, ADV CANCER RES, V60, P269; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chua ZT, 2005, ANN NY ACAD SCI, V1053, P237, DOI 10.1196/annals.1344.021; Ditaranto-Desimone K, 2003, BRAIN RES BULL, V59, P523, DOI 10.1016/S0361-9230(02)00948-6; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; Hamdan R, 2007, BIOCHEMISTRY-US, V46, P10612, DOI 10.1021/bi700621j; Harzer K, 1997, FEBS LETT, V417, P270, DOI 10.1016/S0014-5793(97)01302-1; Hendrich AB, 2003, CURR DRUG TARGETS, V4, P23, DOI 10.2174/1389450033347172; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; HIRAIWA M, 1993, ARCH BIOCHEM BIOPHYS, V303, P326, DOI 10.1006/abbi.1993.1291; HOELZL DF, 1969, NEW ENGL J MED, V280, P761, DOI 10.1056/NEJM196904032801406; Hoffmann D, 2006, MOL CANCER THER, V5, P2013, DOI 10.1158/1535-7163.MCT-06-0128; Jendrossek V., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P343, DOI 10.2174/1568011033482341; Kaimal V, 2011, MOL IMAGING BIOL, V13, P886, DOI 10.1007/s11307-010-0417-7; Kang R, 2012, AM J CANCER RES, V2, P383; Kilkus J, 2003, J NEUROSCI RES, V72, P65, DOI 10.1002/jnr.10549; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; MORIMOTO S, 1990, P NATL ACAD SCI USA, V87, P3493, DOI 10.1073/pnas.87.9.3493; Qi XY, 2009, CLIN CANCER RES, V15, P5840, DOI 10.1158/1078-0432.CCR-08-3285; Qi XY, 2004, ARCH BIOCHEM BIOPHYS, V424, P210, DOI 10.1016/j.abb.2004.02.023; QI XY, 1994, J BIOL CHEM, V269, P16746; Qi XY, 2001, J BIOL CHEM, V276, P27010, DOI 10.1074/jbc.M101075200; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; Ran S, 2002, INT J RADIAT ONCOL, V54, P1479, DOI 10.1016/S0360-3016(02)03928-7; Unger C, 1996, J CANCER RES CLIN, V122, P189, DOI 10.1007/BF01209645; UTSUGI T, 1991, CANCER RES, V51, P3062; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; VAUPEL P, 1989, CANCER RES, V49, P6449; Wallach D F, 1969, Curr Top Microbiol Immunol, V47, P152; Wallach D F, 1978, Pathobiol Annu, V8, P189; Wang Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P43, DOI 10.1016/S0003-9861(03)00219-4; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; You HX, 2003, BIOPHYS J, V84, P2043, DOI 10.1016/S0006-3495(03)75012-7; You HX, 2001, FEBS LETT, V503, P97, DOI 10.1016/S0014-5793(01)02700-4	42	32	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75507	10.1371/journal.pone.0075507	http://dx.doi.org/10.1371/journal.pone.0075507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124494	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100051
J	Gupta, S; Utoft, R; Hasseldam, H; Schmidt-Christensen, A; Hannibal, TD; Hansen, L; Fransen-Pettersson, N; Agarwal-Gupta, N; Rozell, B; Andersson, A; Holmberg, D				Gupta, Shashank; Utoft, Regine; Hasseldam, Henrik; Schmidt-Christensen, Anja; Hannibal, Tine Dahlbaek; Hansen, Lisbeth; Fransen-Pettersson, Nina; Agarwal-Gupta, Noopur; Rozell, Bjorn; Andersson, Asa; Holmberg, Dan			Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; TIME-COURSE; MRI; EXPRESSION; QUANTIFICATION; INFLAMMATION; PEPTIDE; MICE; VISUALIZATION	Multiple Sclerosis (MS) is a progressive autoimmune inflammatory and demyelinating disease of the central nervous system (CNS). T cells play a key role in the progression of neuroinflammation in MS and also in the experimental autoimmune encephalomyelitis (EAE) animal models for the disease. A technology for quantitative and 3 dimensional (3D) spatial assessment of inflammation in this and other CNS inflammatory conditions is much needed. Here we present a procedure for 3D spatial assessment and global quantification of the development of neuroinflammation based on Optical Projection Tomography (OPT). Applying this approach to the analysis of rodent models of MS, we provide global quantitative data of the major inflammatory component as a function of the clinical course. Our data demonstrates a strong correlation between the development and progression of neuroinflammation and clinical disease in several mouse and a rat model of MS refining the information regarding the spatial dynamics of the inflammatory component in EAE. This method provides a powerful tool to investigate the effect of environmental and genetic forces and for assessing the therapeutic effects of drug therapy in animal models of MS and other neuroinflammatory/neurodegenerative disorders.	[Gupta, Shashank; Schmidt-Christensen, Anja; Hannibal, Tine Dahlbaek; Hansen, Lisbeth; Fransen-Pettersson, Nina; Holmberg, Dan] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Gupta, Shashank; Schmidt-Christensen, Anja; Hannibal, Tine Dahlbaek; Hansen, Lisbeth; Fransen-Pettersson, Nina; Holmberg, Dan] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Gupta, Shashank; Rozell, Bjorn; Holmberg, Dan] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Utoft, Regine; Andersson, Asa] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Hasseldam, Henrik; Agarwal-Gupta, Noopur] Univ Copenhagen, Dept Biomed Sci, BRIC, Copenhagen, Denmark; [Agarwal-Gupta, Noopur] Univ Copenhagen, Inst Cellular & Mol Med, Copenhagen, Denmark	University of Copenhagen; Lund University; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Holmberg, D (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	dan.holmberg@med.lu.se	Hasseldam, Henrik/G-8810-2017; Schmidt-Christensen, Anja/L-6284-2016	Schmidt-Christensen, Anja/0000-0001-5813-9118; /0000-0003-4360-7710; Fransen Pettersson, Nina/0000-0002-5049-1544; Hasseldam, Henrik/0000-0002-4515-5343; Hannibal, Tine/0000-0001-8036-6704	Lundbeck foundation; Skleroseforeningen; Swedish research council; Danish Research Council	Lundbeck foundation(Lundbeckfonden); Skleroseforeningen; Swedish research council(Swedish Research CouncilEuropean Commission); Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by grants from The Lundbeck foundation, Skleroseforeningen, The Swedish research council and the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2013, EXP NEUROL, V240, P130, DOI 10.1016/j.expneurol.2012.11.004; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Alanentalo T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000430; Baeten K, 2008, J NEUROIMMUNOL, V195, P1, DOI 10.1016/j.jneuroim.2007.11.008; Barkhof F, 2012, NAT REV NEUROL, V8, P13, DOI 10.1038/nrneurol.2011.190; Begolka WS, 1998, J IMMUNOL, V161, P4437; Boretius S, 2006, NMR BIOMED, V19, P41, DOI 10.1002/nbm.999; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Espejo C, 2005, NEUROSCIENCE, V132, P1135, DOI 10.1016/j.neuroscience.2005.01.057; Filippi M, 1996, BRAIN, V119, P1349, DOI 10.1093/brain/119.4.1349; Gareau PJ, 2002, J MAGN RESON IMAGING, V16, P28, DOI 10.1002/jmri.10136; JANSSON L, 1991, EUR J IMMUNOL, V21, P693, DOI 10.1002/eji.1830210323; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; Lycklama G, 2003, LANCET NEUROL, V2, P555, DOI 10.1016/S1474-4422(03)00504-0; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Morrissey SP, 1996, BRAIN, V119, P239, DOI 10.1093/brain/119.1.239; Muller YD, 2013, AM J TRANSPLANT, V13, P1093, DOI 10.1111/ajt.12138; Nessler S, 2007, BRAIN, V130, P2186, DOI 10.1093/brain/awm105; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Recks MS, 2011, NEUROSCI LETT, V494, P227, DOI 10.1016/j.neulet.2011.03.021; Robinson KM, 2010, MOL IMAGING BIOL, V12, P240, DOI 10.1007/s11307-009-0272-6; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Skundric DS, 2005, CURR NEUROVASC RES, V2, P349, DOI 10.2174/156720205774322601; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Stosic-Grujicic S, 2004, CLIN EXP IMMUNOL, V136, P49, DOI 10.1111/j.1365-2249.2004.02418.x; Traboulsee Anthony L, 2006, Adv Neurol, V98, P125; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P774, DOI 10.1002/jmri.21678; Zargari M, 2007, NEUROSCI LETT, V412, P24, DOI 10.1016/j.neulet.2006.08.033	33	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76330	10.1371/journal.pone.0076330	http://dx.doi.org/10.1371/journal.pone.0076330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124545	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100102
J	Lunn, D; Gaddipati, SR; Tucker, GA; Lycett, GW				Lunn, Daniel; Gaddipati, Sanyasi R.; Tucker, Gregory A.; Lycett, Grantley W.			Null Mutants of Individual RABA Genes Impact the Proportion of Different Cell Wall Components in Stem Tissue of Arabidopsis thaliana	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; MEMBRANE TRAFFICKING; VESICLE TRAFFICKING; GOLGI BODIES; BREFELDIN-A; ROOT-CELLS; POLYSACCHARIDES; PROTEINS; GTPASES; PLANTS	In Arabidopsis, and other plants, the RABA GTPases (orthologous to the Rab11a of mammals) have expanded in number and diversity and have been shown to belong to eight sub clades, some of which have been implicated in controlling vesicles that traffic cell wall polymers and enzymes that synthesise or modify them to the cell wall. In order to investigate this, we have investigated whether T-DNA insertion knockouts of individual RABA genes belonging to different sub clades, impact on the composition of the plant cell wall. Single gene knockouts of the RABA1, RABA2 and RABA4 sub clades primarily affected the percentage composition of pectin, cellulose and hemicellulose within the cell wall, respectively, despite having no obvious phenotype in the whole plant. We hypothesise that vesicles carrying specific types of cargoes from the Golgi to the cell surface may be regulated by particular sub types of RABA proteins, a finding that could have wider implications for how trafficking systems work and could be a useful tool in cell wall research and other fields of plant biology.	[Lunn, Daniel; Gaddipati, Sanyasi R.; Tucker, Gregory A.; Lycett, Grantley W.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of Nottingham	Lycett, GW (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	grantley.lycett@nottingham.ac.uk	Lycett, Grantley/B-1553-2008	Lycett, Grantley/0000-0001-6283-9440; Tejeda-Lunn, Daniel/0000-0002-9386-1568; Tucker, Gregory/0000-0002-3377-9132	Targetted Priority Studentship in Bioenergy from BBSRC [BB/G017964/1]; BBSRC [BB/G01616X/1]; Biotechnology and Biological Sciences Research Council [BB/G01616X/1] Funding Source: researchfish	Targetted Priority Studentship in Bioenergy from BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DL was supported by a Targetted Priority Studentship in Bioenergy (number BB/G017964/1) from BBSRC (http://www.bbsrc.ac.uk). SRG, as a part of LACE (Lignocellulose agricultural waste to ethanol), was also supported by a BBSRC grant (number BB/G01616X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Baluska F, 2005, PROTOPLASMA, V225, P141, DOI 10.1007/s00709-005-0095-5; binZainal Z, 1996, BBA-MOL CELL RES, V1314, P187, DOI 10.1016/S0167-4889(96)00133-4; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brown D, 2011, PLANT J, V66, P401, DOI 10.1111/j.1365-313X.2011.04501.x; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Chen LM, 1998, PLANT J, V16, P385, DOI 10.1046/j.1365-313x.1998.00301.x; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Chow CM, 2008, PLANT CELL, V20, P101, DOI 10.1105/tpc.107.052001; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; De Caroli M, 2011, PLANT J, V65, P295, DOI 10.1111/j.1365-313X.2010.04421.x; de Graaf BHJ, 2005, PLANT CELL, V17, P2564, DOI 10.1105/tpc.105.033183; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Lanubile R, 1997, J EXP BOT, V48, P1925, DOI 10.1093/jexbot/48.316.1925; Leucci MR, 2007, PLANTA, V225, P1001, DOI 10.1007/s00425-006-0407-9; Lu CG, 2001, PLANT CELL, V13, P1819, DOI 10.1105/tpc.13.8.1819; Lunn D, 2013, PLANT PHYSIOL BIOCH, V66, P91, DOI 10.1016/j.plaphy.2013.02.005; Lycett G, 2008, J EXP BOT, V59, P4061, DOI 10.1093/jxb/ern255; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; MOORE PJ, 1991, J CELL BIOL, V112, P589, DOI 10.1083/jcb.112.4.589; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rehman RU, 2008, PLANT CELL PHYSIOL, V49, P751, DOI 10.1093/pcp/pcn051; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Szumlanski AL, 2009, PLANT CELL, V21, P526, DOI 10.1105/tpc.108.060277; Toyooka K, 2009, PLANT CELL, V21, P1212, DOI 10.1105/tpc.108.058933; Wightman R, 2010, PLANT PHYSIOL, V153, P427, DOI 10.1104/pp.110.154666; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Zeef LAH, 2006, MEXP 265 TRANSCRIPTI	39	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75724	10.1371/journal.pone.0075724	http://dx.doi.org/10.1371/journal.pone.0075724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124508	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100065
J	May, KA; Solomon, JA				May, Keith A.; Solomon, Joshua A.			Four Theorems on the Psychometric Function	PLOS ONE			English	Article							CONTRAST DISCRIMINATION; PROBABILITY SUMMATION; UNCERTAINTY EXPLAINS; HUMAN-VISION; SLOPE; THRESHOLD; MASKING; NOISE	In a 2-alternative forced-choice (2AFC) discrimination task, observers choose which of two stimuli has the higher value. The psychometric function for this task gives the probability of a correct response for a given stimulus difference, Delta x. This paper proves four theorems about the psychometric function. Assuming the observer applies a transducer and adds noise, Theorem 1 derives a convenient general expression for the psychometric function. Discrimination data are often fitted with a Weibull function. Theorem 2 proves that the Weibull "slope" parameter, beta, can be approximated by beta(Noise) x beta(Transducer), where beta(Noise) is the beta of the Weibull function that fits best to the cumulative noise distribution, and beta(Transducer) depends on the transducer. We derive general expressions for beta(Noise) and beta(Transducer), from which we derive expressions for specific cases. One case that follows naturally from our general analysis is Pelli's finding that, when d' proportional to (Delta x)(b), beta approximate to beta(Noise) x b. We also consider two limiting cases. Theorem 3 proves that, as sensitivity improves, 2AFC performance will usually approach that for a linear transducer, whatever the actual transducer; we show that this does not apply at signal levels where the transducer gradient is zero, which explains why it does not apply to contrast detection. Theorem 4 proves that, when the exponent of a power-function transducer approaches zero, 2AFC performance approaches that of a logarithmic transducer. We show that the power-function exponents of 0.4-0.5 fitted to suprathreshold contrast discrimination data are close enough to zero for the fitted psychometric function to be practically indistinguishable from that of a log transducer. Finally, Weibull beta reflects the shape of the noise distribution, and we used our results to assess the recent claim that internal noise has higher kurtosis than a Gaussian. Our analysis of beta for contrast discrimination suggests that, if internal noise is stimulus-independent, it has lower kurtosis than a Gaussian.	[May, Keith A.; Solomon, Joshua A.] City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England	City University London	May, KA (corresponding author), City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England.	keith@keithmay.org	May, Keith/F-8686-2011	May, Keith/0000-0001-8114-5989	EPSRC [EP/H033955/1]; Engineering and Physical Sciences Research Council [EP/H033955/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by EPSRC grant EP/H033955/1 to Joshua Solomon (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird CM, 2002, J OPT SOC AM A, V19, P1267, DOI 10.1364/JOSAA.19.001267; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; Fechner GT, 1912, CLASSICAL PSYCHOL SE; FOLEY JM, 1981, VISION RES, V21, P1041, DOI 10.1016/0042-6989(81)90009-2; Georgeson MA, 2006, VISION RES, V46, P4294, DOI 10.1016/j.visres.2005.08.024; Hasselblatt B., 2003, 1 COURSE DYNAMICS PA; Henning GB, 2007, J VISION, V7, DOI 10.1167/7.1.3; Henning GB, 2002, J OPT SOC AM A, V19, P1259, DOI 10.1364/JOSAA.19.001259; Kaernbach C, 2001, PERCEPT PSYCHOPHYS, V63, P1389, DOI 10.3758/BF03194550; KingSmith PE, 1997, VISION RES, V37, P1595, DOI 10.1016/S0042-6989(96)00310-0; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Kontsevich LL, 2002, VISION RES, V42, P1771, DOI 10.1016/S0042-6989(02)00091-3; LAMING D, 1989, BEHAV BRAIN SCI, V12, P277, DOI 10.1017/S0140525X00048676; Laming D, 2013, J OPT SOC AM A, V30, P300, DOI 10.1364/JOSAA.30.000300; LEEK MR, 1992, PERCEPT PSYCHOPHYS, V51, P247, DOI 10.3758/BF03212251; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; LEGGE GE, 1978, VISION RES, V18, P69, DOI 10.1016/0042-6989(78)90079-2; LEGGE GE, 1981, VISION RES, V21, P457, DOI 10.1016/0042-6989(81)90092-4; LEGGE GE, 1978, VISION RES, V18, P959, DOI 10.1016/0042-6989(78)90024-X; MAYER MJ, 1986, J OPT SOC AM A, V3, P1166, DOI 10.1364/JOSAA.3.001166; McIlhagga WH, 2012, J VISION, V12, DOI 10.1167/12.10.9; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; NACHMIAS J, 1981, VISION RES, V21, P215, DOI 10.1016/0042-6989(81)90115-2; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Neri P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016014; OREGAN JK, 1989, PERCEPT PSYCHOPHYS, V46, P434, DOI 10.3758/BF03210858; PELLI DG, 1987, VISION RES, V27, P119, DOI 10.1016/0042-6989(87)90148-9; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; Solomon JA, 2007, SPATIAL VISION, V20, P45, DOI 10.1163/156856807779369715; Solomon JA, 2009, ATTEN PERCEPT PSYCHO, V71, P435, DOI 10.3758/APP.71.3.435; Strasburger H, 2001, PERCEPT PSYCHOPHYS, V63, P1348, DOI 10.3758/BF03194547; STROMEYER CF, 1974, VISION RES, V14, P1409, DOI 10.1016/0042-6989(74)90016-9; SWETS JA, 1961, PSYCHOL REV, V68, P301, DOI 10.1037/0033-295X.68.5.301; SWIFT DJ, 1983, VISION RES, V23, P495, DOI 10.1016/0042-6989(83)90124-4; TANNER WP, 1958, J ACOUST SOC AM, V30, P922, DOI 10.1121/1.1909408; TANNER WP, 1954, PSYCHOL REV, V61, P401, DOI 10.1037/h0058700; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Wallis SA, 2013, VISION RES, V76, P1, DOI 10.1016/j.visres.2012.09.019; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WILSON HR, 1980, BIOL CYBERN, V38, P171, DOI 10.1007/BF00337406; Yu C, 2003, J VISION, V3, P527, DOI 10.1167/3.8.1	47	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74815	10.1371/journal.pone.0074815	http://dx.doi.org/10.1371/journal.pone.0074815			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124456	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000325489100013
J	Mirza, M; Volz, C; Karlstetter, M; Langiu, M; Somogyi, A; Ruonala, MO; Tamm, ER; Jagle, H; Langmann, T				Mirza, Myriam; Volz, Cornelia; Karlstetter, Marcus; Langiu, Monica; Somogyi, Aleksandra; Ruonala, Mika O.; Tamm, Ernst R.; Jaegle, Herbert; Langmann, Thomas			Progressive Retinal Degeneration and Glial Activation in the CLN6(nclf) Mouse Model of Neuronal Ceroid Lipofuscinosis: A Beneficial Effect of DHA and Curcumin Supplementation	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN; DISEASE; CLN6; MUTATIONS; MICROGLIA; CELLS; MICE; GENE; NEUROPATHOLOGY; SURVIVAL	Neuronal ceroid lipofuscinosis (NCL) is a group of neurodegenerative lysosomal storage disorders characterized by vision loss, mental and motor deficits, and spontaneous seizures. Neuropathological analyses of autopsy material from NCL patients and animal models revealed brain atrophy closely associated with glial activity. Earlier reports also noticed loss of retinal cells and reactive gliosis in some forms of NCL. To study this phenomenon in detail, we analyzed the ocular phenotype of CLN6(nclf) mice, an established mouse model for variant-late infantile NCL. Retinal morphometry, immunohistochemistry, optokinetic tracking, electroretinography, and mRNA expression were used to characterize retinal morphology and function as well as the responses of Muller cells and microglia. Our histological data showed a severe and progressive degeneration in the CLN6(nclf) retina co-inciding with reactive Muller glia. Furthermore, a prominent phenotypic transformation of ramified microglia to phagocytic, bloated, and mislocalized microglial cells was identified in CLN6(nclf) retinas. These events overlapped with a rapid loss of visual perception and retinal function. Based on the strong microglia reactivity we hypothesized that dietary supplementation with immuno-regulatory compounds, curcumin and docosahexaenoic acid (DHA), could ameliorate microgliosis and reduce retinal degeneration. Our analyses showed that treatment of three-week-old CLN6(nclf) mice with either 5% DHA or 0.6% curcumin for 30 weeks resulted in a reduced number of amoeboid reactive microglia and partially improved retinal function. DHA-treatment also improved the morphology of CLN6(nclf) retinas with a preserved thickness of the photoreceptor layer in most regions of the retina. Our results suggest that microglial reactivity closely accompanies disease progression in the CLN6(nclf) retina and both processes can be attenuated with dietary supplemented immuno-modulating compounds.	[Mirza, Myriam] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Mirza, Myriam; Karlstetter, Marcus; Jaegle, Herbert] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Volz, Cornelia; Langmann, Thomas] Univ Regensburg, Dept Ophthalmol, D-93053 Regensburg, Germany; [Langiu, Monica; Somogyi, Aleksandra; Ruonala, Mika O.] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany; [Tamm, Ernst R.] Univ Regensburg, Inst Human Anat & Embryol, D-93053 Regensburg, Germany	University of Regensburg; University of Cologne; University of Regensburg; Goethe University Frankfurt; University of Regensburg	Langmann, T (corresponding author), Univ Regensburg, Dept Ophthalmol, D-93053 Regensburg, Germany.	thomas.langmann@uk-koeln.de	Langmann, Thomas/HHZ-9814-2022; Volz, Cornelia/ABB-4451-2021; Tamm, Ernst/AAB-9772-2019; Somogyi, Aleksandra/P-5267-2018; Jägle, Herbert/GPP-2945-2022	Langmann, Thomas/0000-0001-6826-529X; Tamm, Ernst/0000-0002-6679-8743; Langiu, Monica/0000-0003-0719-8999; Somogyi, Aleksandra/0000-0003-3079-2849	NCL foundation; Auerbach foundation; NCL group Germany; Stock foundation; DFG [LA1203/6-2, 8-1]	NCL foundation; Auerbach foundation; NCL group Germany; Stock foundation; DFG(German Research Foundation (DFG))	This study was supported by the NCL foundation, the Auerbach foundation, the NCL group Germany, the Stock foundation, and the DFG (LA1203/6-2 and 8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2012, J NEUROSCI RES, V90, P575, DOI 10.1002/jnr.22783; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ebert S, 2009, J NEUROCHEM, V110, P1863, DOI 10.1111/j.1471-4159.2009.06286.x; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Goebel HH, 1999, MOL GENET METAB, V66, P367, DOI 10.1006/mgme.1999.2808; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Groh J, 2013, BRAIN, V136, P1083, DOI 10.1093/brain/awt020; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; He LF, 2010, BRAIN RES, V1339, P60, DOI 10.1016/j.brainres.2010.04.014; Hlawatsch J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060633; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jang S, 2010, NUTR REV, V68, P719, DOI 10.1111/j.1753-4887.2010.00336.x; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kanninen KM, 2013, BIOL OPEN, V2, P635, DOI 10.1242/bio.20134804; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P241, DOI 10.1007/BF00710254; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P299, DOI 10.1007/BF00710270; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Lei B, 2006, J NEUROSCI RES, V84, P1139, DOI 10.1002/jnr.21008; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Martin RE, 2004, MOL VIS, V10, P199; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McGill TJ, 2012, INVEST OPHTH VIS SCI, V53, P6232, DOI 10.1167/iovs.12-9569; Miller JN, 2013, HUM MOL GENET, V22, P2723, DOI 10.1093/hmg/ddt120; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Seehafer SS, 2011, J NEUROIMMUNOL, V230, P169, DOI 10.1016/j.jneuroim.2010.08.024; Siintola E, 2006, BBA-MOL BASIS DIS, V1762, P857, DOI 10.1016/j.bbadis.2006.05.006; Staropoli JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038310; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; TARKKANEN A, 1977, J PEDIATR OPHTHALMOL, V14, P235; Thelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035493; Thelen M, 2012, J NEUROSCI RES, V90, P568, DOI 10.1002/jnr.22773; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708	43	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75963	10.1371/journal.pone.0075963	http://dx.doi.org/10.1371/journal.pone.0075963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124525	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100082
J	Phetsouphanh, C; Xu, Y; Amin, J; Seddiki, N; Procopio, F; Sekaly, RP; Zaunders, JJ; Kelleher, AD				Phetsouphanh, Chansavath; Xu, Yin; Amin, Janaki; Seddiki, Nabila; Procopio, Francesco; Sekaly, Rafick Pierre; Zaunders, John J.; Kelleher, Anthony D.			Characterization of Transcription Factor Phenotypes within Antigen-Specific CD4+T Cells Using Qualitative Multiplex Single-Cell RT-PCR	PLOS ONE			English	Article							CD4(+) T-CELLS; GENE-EXPRESSION; CYTOKINE PRODUCTION; QUANTIFICATION; COEXPRESSION; DIFFERENTIATION; ASSAY; CD25	Current research on antigen specific CD4+ T cells indicates that there is functional and phenotypic heterogeneity within these populations, but the extent of this heterogeneity is poorly described. The CD134/CD25 assay allows live isolation of antigen specific cells in vitro for down-stream molecular analysis. Antigen specific CD4+ T cells were examined at the molecular level by lineage specific transcription factor profiling using qualitative multiplex single cell RT-PCR and Lock Nucleic Acid (LNA) probes allowed unbiased amplification and delineation of expression of Tbx21, Gata3, Rorc, Foxp3 and Bcl-6. It overcomes the limitations of previous assays by allowing identification of transcription factor mRNA in single antigen specific cells with high sensitivity (down to 10 femtograms) and specificity. Patterns of responses can be robustly characterized using,200 cells based on exact binomial calculations. These results are reproducible with a CV of approximate to 6%. The patterns of heterogeneity are stable within an individual antigen specific response but vary between responses to different antigens. Responses to CMV have a Th1 predominant profile (35.6% of responding cells expressing tbx21) whereas responses to Tetanus Toxoid have a Th2 biased profile (22% of responding cells expressing gata3), with unexpectedly high levels of Treg cells found in both populations. Here we describe a methodology that allows live isolation of Ag specific cells and transcription factor profiling at a single cell level to robustly delineate the different CD4+ T cell subsets within this population. This novel method is a powerful tool that can be used to study CD4+ T cell heterogeneity within extremely small populations of cells and where cell numbers are limited.	[Phetsouphanh, Chansavath; Xu, Yin; Amin, Janaki; Seddiki, Nabila; Zaunders, John J.; Kelleher, Anthony D.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Phetsouphanh, Chansavath; Xu, Yin; Seddiki, Nabila; Zaunders, John J.; Kelleher, Anthony D.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Procopio, Francesco; Sekaly, Rafick Pierre] VGTI, Port St Lucie, FL USA	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Vaccine & Gene Therapy Institute of Florida	Phetsouphanh, C (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	c.phetsouphanh@amr.org.au	Phetsouphanh, Chansavath/AAS-4832-2020; Zaunders, John/J-6553-2012; Procopio, Francesco/ABD-8065-2021	Zaunders, John/0000-0002-5912-5989; Amin, Janaki/0000-0003-2161-9366; Phetsouphanh, Chansavath/0000-0001-6617-5995; Seddiki, Nabila/0000-0002-0379-8527	NHMRC [510488]; Australian Government Department of Health and Ageing	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This research was funded by NHMRC-Program grant 510488. AK was supported by an NHMRC Practitioner Fellowship. The Kirby Institute receives funding through the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection, analysis, decision to publish or preparation of manuscript.	Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cossman J, 2001, J HISTOCHEM CYTOCHEM, V49, P799, DOI 10.1177/002215540104900617; Cox JH, 2005, AIDS RES HUM RETROV, V21, P68, DOI 10.1089/aid.2005.21.68; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Garba ML, 2001, J IMMUNOL METHODS, V258, P193, DOI 10.1016/S0022-1759(01)00491-4; Gentile D, 2006, ALLERGY ASTHMA PROC, V27, P197, DOI 10.2500/aap.2006.27.2857; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Jena PK, 1996, J IMMUNOL METHODS, V190, P199, DOI 10.1016/0022-1759(95)00277-4; Keoshkerian E, 2012, J IMMUNOL METHODS, V375, P148, DOI 10.1016/j.jim.2011.10.004; Krishna S, 2005, P NATL ACAD SCI USA, V102, P4771, DOI 10.1073/pnas.0406415102; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Mackay John, 2007, Methods Mol Biol, V353, P237; Modlin RL, 1993, J INVEST DERMATOL, V102, P828; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Phillips JK, 2000, AUTON NEUROSCI-BASIC, V86, P1, DOI 10.1016/S1566-0702(00)00245-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; Tamura Toshiki, 2009, Nihon Hansenbyo Gakkai Zasshi, V78, P271; Todd R, 2002, TRENDS MOL MED, V8, P254, DOI 10.1016/S1471-4914(02)02350-X; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; Walter U, 2000, EUR J IMMUNOL, V30, P1224, DOI 10.1002/1521-4141(200004)30:4<1224::AID-IMMU1224>3.0.CO;2-B; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Zaunders JJ, 2009, J IMMUNOL, V183, P2827, DOI 10.4049/jimmunol.0803548; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	33	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74946	10.1371/journal.pone.0074946	http://dx.doi.org/10.1371/journal.pone.0074946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124462	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100019
J	Scharff-Poulsen, P; Pedersen, PA				Scharff-Poulsen, Peter; Pedersen, Per Amstrup			Saccharomyces cerevisiae-Based Platform for Rapid Production and Evaluation of Eukaryotic Nutrient Transporters and Transceptors for Biochemical Studies and Crystallography	PLOS ONE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; KINASE-A PATHWAY; PLASMA-MEMBRANE; YEAST; EXPRESSION; MECHANISM; GLUCOSE; PURIFICATION; ACTIVATION; PROTEINS	To produce large quantities of high quality eukaryotic membrane proteins in Saccharomyces cerevisiae, we modified a high-copy vector to express membrane proteins C-terminally-fused to a Tobacco Etch Virus (TEV) protease detachable Green Fluorescent Protein (GFP)-8His tag, which facilitates localization, quantification, quality control, and purification. Using this expression system we examined the production of a human glucose transceptor and 11 nutrient transporters and transceptors from S. cerevisiae that have not previously been overexpressed in S. cerevisiae and purified. Whole-cell GFP-fluorescence showed that induction of GFP-fusion synthesis from a galactose-inducible promoter at 15 degrees C resulted in stable accumulation of the fusions in the plasma membrane and in intracellular membranes. Expression levels of the 12 fusions estimated by GFP-fluorescence were in the range of 0.4 mg to 1.7 mg transporter pr. liter cell culture. A detergent screen showed that n-dodecyl-beta-D-maltopyranoside (DDM) is acceptable for solubilization of the membrane-integrated fusions. Extracts of solubilized membranes were prepared with this detergent and used for purifications by Ni-NTA affinity chromatography, which yielded partially purified full-length fusions. Most of the fusions were readily cleaved at a TEV protease site between the membrane protein and the GFP-8His tag. Using the yeast oligopeptide transporter Ptr2 as an example, we further demonstrate that almost pure transporters, free of the GFP-8His tag, can be achieved by TEV protease cleavage followed by reverse immobilized metal-affinity chromatography. The quality of the GFP-fusions was analysed by fluorescence size-exclusion chromatography. Membranes solubilized in DDM resulted in preparations containing aggregated fusions. However, 9 of the fusions solubilized in DDM in presence of cholesteryl hemisuccinate and specific substrates, yielded monodisperse preparations with only minor amounts of aggregated membrane proteins. In conclusion, we developed a new effective S. cerevisiae expression system that may be used for production of high-quality eukaryotic membrane proteins for functional and structural analysis.	[Scharff-Poulsen, Peter; Pedersen, Per Amstrup] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Scharff-Poulsen, Peter] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Scharff-Poulsen, P (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	PSPoulsen@bio.ku.dk; PAPedersen@bio.ku.dk	Scharff-Poulsen, Peter/A-3556-2014; Pedersen, Per Amstrup/M-4592-2014	Scharff-Poulsen, Peter/0000-0002-5332-9331; Pedersen, Per Amstrup/0000-0001-8648-9748	Danish Research Council for Technology and Production; Danish National Advanced Technology Foundation (IBISS)	Danish Research Council for Technology and Production; Danish National Advanced Technology Foundation (IBISS)	This study was supported by grants from the Danish Research Council for Technology and Production to Morten Kielland-Brandt (IVC) and to Per Amstrup Pedersen and a grant from the Danish National Advanced Technology Foundation (IBISS) to Per Amstrup Pedersen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bomholt J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056431; Cesareni G, 1987, GENETIC ENG PRINCIPL, V9, P135, DOI DOI 10.1007/978-1-4684-5377-5_9; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew David, 2012, Methods Mol Biol, V866, P191, DOI 10.1007/978-1-61779-770-5_16; ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jorgensen JR, 2001, BIOCHEMISTRY-US, V40, P7301, DOI 10.1021/bi0029503; Karhumaa K, 2010, J CELL BIOCHEM, V110, P920, DOI 10.1002/jcb.22605; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Lamb RF, 2012, FEBS J, V279, P2624, DOI 10.1111/j.1742-4658.2012.08659.x; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Newstead S, 2011, BIOCHEM SOC T, V39, P1353, DOI 10.1042/BST0391353; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Pedersen PA, 1996, J BIOL CHEM, V271, P2514, DOI 10.1074/jbc.271.5.2514; Poulsen P, 2005, BIOCHEM SOC T, V33, P261, DOI 10.1042/BST0330261; Poulsen P, 2008, MOL MEMBR BIOL, V25, P164, DOI 10.1080/09687680701771917; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shiroishi M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-78; Shiroishi M, 2011, METHODS, V55, P281, DOI 10.1016/j.ymeth.2011.08.015; Sonoda Y, 2010, FEBS LETT, V584, P2539, DOI 10.1016/j.febslet.2010.04.015; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stolarczyk E, 2010, AM J PHYSIOL-ENDOC M, V298, pE1078, DOI 10.1152/ajpendo.00737.2009; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Wickersham LJ, 1951, USDA TECH B, V1029; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089	50	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76851	10.1371/journal.pone.0076851	http://dx.doi.org/10.1371/journal.pone.0076851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124599	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100156
J	Hoffmann, H; Rath, T				Hoffmann, Holger; Rath, Thomas			Future Bloom and Blossom Frost Risk for Malus domestica Considering Climate Model and Impact Model Uncertainties	PLOS ONE			English	Article							PHENOLOGICAL MODELS; WINTER CHILL; SPRING FROST; FRUIT-TREES; APPLE; TIME; TRENDS; DAMAGE; CROPS; DATES	The future bloom and risk of blossom frosts for Malus domestica were projected using regional climate realizations and phenological (= impact) models. As climate impact projections are susceptible to uncertainties of climate and impact models and model concatenation, the significant horizon of the climate impact signal was analyzed by applying 7 impact models, including two new developments, on 13 climate realizations of the IPCC emission scenario A1B. Advancement of phenophases and a decrease in blossom frost risk for Lower Saxony (Germany) for early and late ripeners was determined by six out of seven phenological models. Single model/single grid point time series of bloom showed significant trends by 2021-2050 compared to 1971-2000, whereas the joint signal of all climate and impact models did not stabilize until 2043. Regarding blossom frost risk, joint projection variability exceeded the projected signal. Thus, blossom frost risk cannot be stated to be lower by the end of the 21st century despite a negative trend. As a consequence it is however unlikely to increase. Uncertainty of temperature, blooming date and blossom frost risk projection reached a minimum at 2078-2087. The projected phenophases advanced by 5.5 d K-1, showing partial compensation of delayed fulfillment of the winter chill requirement and faster completion of the following forcing phase in spring. Finally, phenological model performance was improved by considering the length of day.	[Hoffmann, Holger; Rath, Thomas] Leibniz Univ Hannover, Inst Biol Prod Syst, D-30167 Hannover, Germany	Leibniz University Hannover	Hoffmann, H (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany.	hhoffmann@uni-bonn.de	Hoffmann, Holger/H-3165-2019; Hoffmann, Holger/A-8169-2013	Hoffmann, Holger/0000-0001-9811-5065; Hoffmann, Holger/0000-0001-9811-5065	Ministry for Science and Culture of Lower Saxony within the network KLIFF - climate impact and adaptation research in Lower Saxony	Ministry for Science and Culture of Lower Saxony within the network KLIFF - climate impact and adaptation research in Lower Saxony	The study was supported by the Ministry for Science and Culture of Lower Saxony within the network KLIFF - climate impact and adaptation research in Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2011, ACTA HORTIC, V919, P65; Bai J, 2011, ADV ATMOS SCI, V28, P564, DOI 10.1007/s00376-010-9219-8; Blanke MM, 2011, ACTA HORTIC, V922, P381; Blanke M, 2009, ERWERBS-OBSTBAU, V51, P101, DOI 10.1007/s10341-009-0086-3; Blumel K, 2012, AGR FOREST METEOROL, V164, P10, DOI 10.1016/j.agrformet.2012.05.001; Bowman AW, 1997, APPL SMOOTHING TECHN; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; Chitu E, 2011, ACTA HORTIC, V919, P57; Chmielewski F, 2005, ANN METEOROL, V41, P488; Chmielewski F, 2009, KLIO KLIMAWANDEL OBS; Chmielewski FM, 2005, INT J BIOMETEOROL, V50, P96, DOI 10.1007/s00484-005-0275-1; Chmielewski FM, 2004, AGR FOREST METEOROL, V121, P69, DOI 10.1016/S0168-1923(03)00161-8; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Chmielewski FM, 2011, METEOROL Z, V20, P487, DOI 10.1127/0941-2948/2011/0258; Chuine I, 1998, PLANT CELL ENVIRON, V21, P455, DOI 10.1046/j.1365-3040.1998.00299.x; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Cox DR, 1966, STAT ANAL SERIES EVE; Deque M, 2007, CLIMATIC CHANGE, V81, P53, DOI 10.1007/s10584-006-9228-x; Dosio A, 2012, J GEOPHYS RES-ATMOS, P117; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; Fan Xiao-chun, 2010, Shengtaixue Zazhi, V29, P50; Farajzadeh M, 2009, METEOROL APPL, V17, P45; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Hakkinen R, 1998, TREE PHYSIOL, V18, P707; Harrington CA, 2010, FOREST ECOL MANAG, V259, P798, DOI 10.1016/j.foreco.2009.06.018; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hoffmann H, 2012, ACTA HORTIC, V957, P289; Hoffmann H, 2012, EUR J HORTIC SCI, V77, P241; Hoffmann H, 2012, THEOR APPL CLIMATOL, V110, P129, DOI 10.1007/s00704-012-0618-x; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; Jacob D, 2009, REMO AIB SCENARIO; Juroszek P, 2012, EUR J PLANT PATHOL, P1; Kaukoranta T, 2010, AGR FOOD SCI, V19, P144, DOI 10.2137/145960610791542352; Keuler K, 2009, CLIMATE SIMULATION C, DOI [10.1594/WDCC/CLM_A1B_1_D2, DOI 10.1594/WDCC/CLM_]; Kunz A, 2011, ACTA HORTIC, V903, P1121, DOI 10.17660/ActaHortic.2011.903.156; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Legave JM, 2008, J HORTIC SCI BIOTECH, V83, P76, DOI 10.1080/14620316.2008.11512350; Luedeling E, 2012, SCI HORTIC-AMSTERDAM, V144, P218, DOI 10.1016/j.scienta.2012.07.011; Luedeling E, 2009, ERWERBS-OBSTBAU, V51, P81, DOI 10.1007/s10341-009-0085-4; Luedeling E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006166; Luedeling E, 2009, AGR ECOSYST ENVIRON, V133, P23, DOI 10.1016/j.agee.2009.04.016; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Meier U., 1994, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V46, P141; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Piani C, 2010, THEOR APPL CLIMATOL, V99, P187, DOI 10.1007/s00704-009-0134-9; Rea R, 2006, INT J BIOMETEOROL, V51, P1, DOI 10.1007/s00484-006-0043-x; Rodrigo J, 2000, SCI HORTIC-AMSTERDAM, V85, P155, DOI 10.1016/S0304-4238(99)00150-8; Rojas R, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017461; Rugienius R, 2009, ACTA HORTIC, V825, P117, DOI 10.17660/ActaHortic.2009.825.14; Scheifinger H, 2003, THEOR APPL CLIMATOL, V74, P41, DOI 10.1007/s00704-002-0704-6; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sugiura T., 2010, Acta Horticulturae, P85; Sunley RJ, 2006, J HORTIC SCI BIOTECH, V81, P949, DOI 10.1080/14620316.2006.11512181; Tooke F, 2010, J EXP BOT, V61, P2853, DOI 10.1093/jxb/erq165; van der Linden P., 2009, ENSEMBLES CLIMATE CH; Yip S, 2011, J CLIMATE, V24, P4634, DOI 10.1175/2011JCLI4085.1	60	35	35	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75033	10.1371/journal.pone.0075033	http://dx.doi.org/10.1371/journal.pone.0075033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116022	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200006
J	Oguma, T; Hirai, T; Niimi, A; Matsumoto, H; Muro, S; Shigematsu, M; Nishimura, T; Kubo, Y; Mishima, M				Oguma, Tsuyoshi; Hirai, Toyohiro; Niimi, Akio; Matsumoto, Hisako; Muro, Shigeo; Shigematsu, Michio; Nishimura, Takashi; Kubo, Yoshiro; Mishima, Michiaki			Limitations of Airway Dimension Measurement on Images Obtained Using Multi-Detector Row Computed Tomography	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CT; VALIDATION; ACCURACY; ASTHMA; LUMEN; COPD	Objectives: (a) To assess the effects of computed tomography (CT) scanners, scanning conditions, airway size, and phantom composition on airway dimension measurement and (b) to investigate the limitations of accurate quantitative assessment of small airways using CT images. Methods: An airway phantom, which was constructed using various types of material and with various tube sizes, was scanned using four CT scanner types under different conditions to calculate airway dimensions, luminal area (Ai), and the wall area percentage (WA%). To investigate the limitations of accurate airway dimension measurement, we then developed a second airway phantom with a thinner tube wall, and compared the clinical CT images of healthy subjects with the phantom images scanned using the same CT scanner. The study using clinical CT images was approved by the local ethics committee, and written informed consent was obtained from all subjects. Data were statistically analyzed using one-way ANOVA. Results: Errors noted in airway dimension measurement were greater in the tube of small inner radius made of material with a high CT density and on images reconstructed by body algorithm (p<0.001), and there was some variation in error among CT scanners under different fields of view. Airway wall thickness had the maximum effect on the accuracy of measurements with all CT scanners under all scanning conditions, and the magnitude of errors for WA% and Ai varied depending on wall thickness when airways of <1.0-mm wall thickness were measured. Conclusions: The parameters of airway dimensions measured were affected by airway size, reconstruction algorithm, composition of the airway phantom, and CT scanner types. In dimension measurement of small airways with wall thickness of <1.0 mm, the accuracy of measurement according to quantitative CT parameters can decrease as the walls become thinner.	[Oguma, Tsuyoshi; Hirai, Toyohiro; Matsumoto, Hisako; Muro, Shigeo; Mishima, Michiaki] Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan; [Niimi, Akio] Nagoya City Univ, Dept Med Oncol & Immunol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Shigematsu, Michio] Sumitomo Hosp, Dept Resp Med, Osaka, Japan; [Nishimura, Takashi] Kyoto Katsura Hosp, Dept Resp Med, Kyoto, Japan; [Kubo, Yoshiro] Kansai Elect Power Hosp, Dept Respirol, Osaka, Japan	Kyoto University; Nagoya City University; Sumitomo Hospital	Hirai, T (corresponding author), Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan.	t_hirai@kuhp.kyoto-u.ac.jp			JSPS KAKENHI [22590861]; Ministry from Health, Labour and Welfare, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry from Health, Labour and Welfare, Japan	This study was partly supported by JSPS KAKENHI Grant No. 22590861 and a grant to the Respiratory Failure Research Group from the Ministry from Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kim N, 2008, KOREAN J RADIOL, V9, P226, DOI 10.3348/kjr.2008.9.3.226; King GG, 2000, AM J RESP CRIT CARE, V161, P574, DOI 10.1164/ajrccm.161.2.9812073; Montaudon M, 2007, RADIOLOGY, V242, P563, DOI 10.1148/radiol.2422060029; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Niimi A, 2003, AM J RESP CRIT CARE, V168, P983, DOI 10.1164/rccm.200211-1268OC; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1440-1843.2006.00899.x; Reinhardt JM, 1997, IEEE T MED IMAGING, V16, P820, DOI 10.1109/42.650878; Robinson TE, 2009, ACAD RADIOL, V16, P1134, DOI 10.1016/j.acra.2009.02.018; Saba OI, 2003, J APPL PHYSIOL, V95, P1063, DOI 10.1152/japplphysiol.00962.2002; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Takahashi M, 2011, EUR J RADIOL, V80, pE524, DOI 10.1016/j.ejrad.2010.12.035; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798	17	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76381	10.1371/journal.pone.0076381	http://dx.doi.org/10.1371/journal.pone.0076381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116105	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200053
J	Vivant, AL; Garmyn, D; Maron, PA; Nowak, V; Piveteau, P				Vivant, Anne-Laure; Garmyn, Dominique; Maron, Pierre-Alain; Nowak, Virginie; Piveteau, Pascal			Microbial Diversity and Structure Are Drivers of the Biological Barrier Effect against Listeria monocytogenes in Soil	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MILKING EQUIPMENT; COMMUNITY; SURVIVAL; CONTAMINATION; INVASION; BIODIVERSITY; PREVALENCE; BACTERIA; BIOFILM	Understanding the ecology of pathogenic organisms is important in order to monitor their transmission in the environment and the related health hazards. We investigated the relationship between soil microbial diversity and the barrier effect against Listeria monocytogenes invasion. By using a dilution-to-extinction approach, we analysed the consequence of eroding microbial diversity on L. monocytogenes population dynamics under standardised conditions of abiotic parameters and microbial abundance in soil microcosms. We demonstrated that highly diverse soil microbial communities act as a biological barrier against L. monocytogenes invasion and that phylogenetic composition of the community also has to be considered. This suggests that erosion of diversity may have damaging effects regarding circulation of pathogenic microorganisms in the environment.	[Vivant, Anne-Laure; Garmyn, Dominique; Piveteau, Pascal] Univ Bourgogne, Agroecol UMR1347, Dijon, France; [Vivant, Anne-Laure; Garmyn, Dominique; Maron, Pierre-Alain; Nowak, Virginie; Piveteau, Pascal] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Maron, Pierre-Alain; Nowak, Virginie] INRA, Agroecol UMR1347, Plateforme GenoSol, F-21034 Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Piveteau, P (corresponding author), Univ Bourgogne, Agroecol UMR1347, Dijon, France.	piveteau@u-bourgogne.fr		Garmyn, Dominique/0000-0003-4693-6026	French state through the National Agency for Research [ANR-11-INBS-0001]; Regional Council of Burgundy [PARI AGRALE 11]	French state through the National Agency for Research; Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work, through the involvement of technical facilities of the GenoSol platform of the infrastructure ANAEE-Services, received a grant from the French state through the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001), as well as a grant from the Regional Council of Burgundy (reference PARI AGRALE 11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; Arrouays Dominique, 2002, Comptes Rendus de l'Academie d'Agriculture de France, V88, P93; Baumann K, 2013, BIOGEOCHEMISTRY, V114, P201, DOI 10.1007/s10533-012-9800-6; Beuchat LR, 1996, FOOD CONTROL, V7, P223, DOI 10.1016/S0956-7135(96)00039-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; De Luca G, 1998, ZBL HYG UMWELTMED, V201, P269; Dowe MJ, 1997, J FOOD PROTECT, V60, P1201, DOI 10.4315/0362-028X-60.10.1201; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; FENLON DR, 1985, J APPL BACTERIOL, V59, P537, DOI 10.1111/j.1365-2672.1985.tb03357.x; Forslund A, 2012, WATER RES, V46, P5917, DOI 10.1016/j.watres.2012.08.011; Franklin RB, 2006, MICROB ECOL, V52, P280, DOI 10.1007/s00248-006-9033-0; Garland JL, 1999, FEMS MICROBIOL ECOL, V30, P333, DOI 10.1111/j.1574-6941.1999.tb00661.x; Garrec N, 2003, FEMS IMMUNOL MED MIC, V35, P275, DOI 10.1016/S0928-8244(02)00443-1; Garrido V, 2009, FOOD CONTROL, V20, P986, DOI 10.1016/j.foodcont.2008.11.013; Goulet V, 1998, J INFECT DIS, V177, P155, DOI 10.1086/513814; Griffiths BS, 2008, BIOL FERT SOILS, V44, P745, DOI 10.1007/s00374-007-0257-z; Grolleau E., 2004, ETUDE GESTION SOLS, V11, P255; Hallin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051962; Ho AJ, 2007, PREV VET MED, V80, P287, DOI 10.1016/j.prevetmed.2007.03.005; IIDA T, 1991, J VET MED SCI, V53, P873, DOI 10.1292/jvms.53.873; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Latorre AA, 2010, J DAIRY SCI, V93, P2792, DOI 10.3168/jds.2009-2717; Latorre AA, 2009, APPL ENVIRON MICROB, V75, P1315, DOI 10.1128/AEM.01826-08; Lemunier M, 2005, APPL ENVIRON MICROB, V71, P5779, DOI 10.1128/AEM.71.10.5779-5786.2005; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ma JC, 2012, ENVIRON SCI TECHNOL, V46, P12154, DOI 10.1021/es302738z; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Maron PA, 2011, CR BIOL, V334, P403, DOI 10.1016/j.crvi.2010.12.003; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; McLaughlin HP, 2011, ARCH MICROBIOL, V193, P775, DOI 10.1007/s00203-011-0716-7; Morales A, 1996, FEMS MICROBIOL ECOL, V20, P155, DOI 10.1016/0168-6496(96)00020-7; Moshtaghi H., 2009, Indian Journal of Veterinary Research, V18, P1; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Nonaka L, 2010, ENV MICROBIOL REP, V2, P465, DOI 10.1111/j.1758-2229.2010.00178.x; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Voidarou C, 2011, ANAEROBE, V17, P320, DOI 10.1016/j.anaerobe.2011.05.004; Xiuping Jiang, 2004, Journal of Food Protection, V67, P1676	56	69	72	7	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76991	10.1371/journal.pone.0076991	http://dx.doi.org/10.1371/journal.pone.0076991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116193	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200091
J	Crisan, M; Taulescu, M; Crisan, D; Cosgarea, R; Parvu, A; Catoi, C; Drugan, T				Crisan, Maria; Taulescu, Marian; Crisan, Diana; Cosgarea, Rodica; Parvu, Alina; Catoi, Cornel; Drugan, Tudor			Expression of Advanced Glycation End-Products on Sun-Exposed and Non-Exposed Cutaneous Sites during the Ageing Process in Humans	PLOS ONE			English	Article							INCREASED ACCUMULATION; IN-VITRO; SKIN; PROTEIN; AGES; N-EPSILON-(CARBOXYMETHYL)LYSINE; GENERATION; RECEPTOR; TISSUES; MODEL	The glycation process is involved in both the intrinsic (individual, genetic) and extrinsic (ultraviolet light, polution and lifestyle) aging processes, and can be quantified at the epidermal or dermal level by histological, immunohistochemical (IHC), or imagistic methods. Our study is focused on a histological and immunohistological comparison of sun-protected regions versus sun-exposed regions from different age groups of skin phototype III subjects, related to the aging process. Skin samples collected from non-protected and UV protected regions of four experimental groups with different ages, were studied using histology and IHC methods for AGE-CML [N(epsilon)-(carboxymethyl) lysine]. A semi-quantitative assessment of the CML expression in the microvascular endothelium and dermal fibroblasts was performed. The Pearson one-way ANOVA was used to compare data between the groups. In the dermis of sun-exposed skin, the number and the intensity of CML positive cells in both fibroblasts and endothelial cells (p<0.05) was higher compared to sun-protected skin, and was significantly increased in older patients. The sun-exposed areas had a more than 10% higher AGE-CML score than the protected areas. No statistically significant correlation was observed between the histological score and the IHC expression of CML. We concluded that in healthy integument, the accumulation of final glycation products increases with age and is amplified by ultraviolet exposure. The study provides new knowledge on differences of AGE-CML between age groups and protected and unprotected areas and emphasizes that endothelium and perivascular area are most affected, justifying combined topical and systemic therapies.	[Crisan, Maria] Iuliu Hatieganu Univ Med & Pharm, Dept Histol, Cluj Napoca, Romania; [Taulescu, Marian; Catoi, Cornel] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Pathol, Cluj Napoca, Romania; [Crisan, Diana; Cosgarea, Rodica] Iuliu Hatieganu Univ Med & Pharm, Dermatol Clin, Cluj Napoca, Romania; [Parvu, Alina] Iuliu Hatieganu Univ Med & Pharm, Dept Pathophysiol, Cluj Napoca, Romania; [Drugan, Tudor] Iuliu Hatieganu Univ Med & Pharm, Dept Med Informat, Cluj Napoca, Romania	Iuliu Hatieganu University of Medicine & Pharmacy; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy	Taulescu, M (corresponding author), Univ Agr Sci & Vet Med, Fac Vet Med, Dept Pathol, Cluj Napoca, Romania.	taulescumarian@yahoo.com	Drugan, Tudor/N-1405-2014; crisan, maria/AAA-8119-2021; Crisan, Maria/AAA-4298-2019; Taulescu, Marian/C-6594-2012	Drugan, Tudor/0000-0003-0097-262X; Taulescu, Marian/0000-0002-8987-6038	University of Medicine; University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca (Romania) [2624/2008]	University of Medicine; University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca (Romania)	This study was performed as part of a financed grant from the University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca (Romania), no. 2624/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Cotton SA, 1999, J PATHOL, V189, P273; Crisan D, 2012, INDIAN J DERMATOL VE, V78, DOI 10.4103/0378-6323.98096; DUNN JA, 1989, BIOCHEMISTRY-US, V28, P9464, DOI 10.1021/bi00450a033; DYER DG, 1991, Z ERNAHRUNGSWISS, V30, P29, DOI 10.1007/BF01910730; Giacomoni PU, 2001, BIOGERONTOLOGY, V2, P219, DOI 10.1023/A:1013222629919; Hofmann B, 2013, EXP GERONTOL, V48, P38, DOI 10.1016/j.exger.2012.04.011; Jeanmaire C, 2001, BRIT J DERMATOL, V145, P10, DOI 10.1046/j.1365-2133.2001.04275.x; Kasper M, 2001, ARCH GERONTOL GERIAT, V32, P233, DOI 10.1016/S0167-4943(01)00103-0; Lohwasser C, 2006, J INVEST DERMATOL, V126, P291, DOI 10.1038/sj.jid.5700070; Masaki H, 1999, BBA-GEN SUBJECTS, V1428, P45, DOI 10.1016/S0304-4165(99)00056-2; Okano Y, 2002, J DERMATOL SCI, V29, P171, DOI 10.1016/S0923-1811(02)00021-X; Pageon H, 2008, EXP GERONTOL, V43, P584, DOI 10.1016/j.exger.2008.04.004; Pageon H, 2007, EUR J DERMATOL, V17, P12; PARVER L M, 1991, Eye (London), V5, P181; Schalkwijk CG, 2004, BBA-MOL CELL BIOL L, V1636, P82, DOI 10.1016/j.bbalip.2003.07.002; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; Toyoda M, 2001, J DERMATOL SCI, V27, pS32; Valencia JV, 2004, DIABETOLOGIA, V47, P844, DOI 10.1007/s00125-004-1392-9; Vlassara H, 1996, KIDNEY INT, V49, P1795, DOI 10.1038/ki.1996.270; Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x	23	26	26	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75003	10.1371/journal.pone.0075003	http://dx.doi.org/10.1371/journal.pone.0075003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116020	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300020
J	McDonough, CW; Gillis, NK; Alsultan, A; Chang, SW; Kawaguchi-Suzuki, M; Lang, JE; Shahin, MHA; Buford, TW; El Rouby, NM; Sa, ACC; Langaee, TY; Gums, JG; Chapman, AB; Cooper-DeHoff, RM; Turner, ST; Gong, Y; Johnson, JA				McDonough, Caitrin W.; Gillis, Nancy K.; Alsultan, Abdullah; Chang, Shin-Wen; Kawaguchi-Suzuki, Marina; Lang, Jason E.; Shahin, Mohamed Hossam A.; Buford, Thomas W.; El Rouby, Nihal M.; Sa, Ana C. C.; Langaee, Taimour Y.; Gums, John G.; Chapman, Arlene B.; Cooper-DeHoff, Rhonda M.; Turner, Stephen T.; Gong, Yan; Johnson, Julie A.			Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; GENE-CENTRIC METAANALYSIS; CHOLESTEROL; ASSOCIATION; VISUALIZATION; ANNOTATION; EXPRESSION; HAPLOTYPE; THERAPY; ABCB1	We sought to identify novel pharmacogenomic markers for HDL-C response to atenolol in participants with mild to moderate hypertension. We genotyped 768 hypertensive participants from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study on the Illumina HumanCVD Beadchip. During PEAR, participants were randomized to receive atenolol or hydrochlorothiazide. Blood pressure and cholesterol levels were evaluated at baseline and after treatment. This study focused on participants treated with atenolol monotherapy. Association with atenolol induced HDL-C change was evaluated in 232 whites and 152 African Americans using linear regression. No SNPs achieved a Bonferroni corrected P-value. However, we identified 13 regions with consistent association across whites and African Americans. The most interesting of these regions were seven with prior associations with HDL-C, other metabolic traits, or functional implications in the lipid pathway: GALNT2, FTO, ABCB1, LRP5, STARD3NL, ESR1, and LIPC. Examples are rs2144300 in GALNT2 in whites (P=2.29x10(-4), beta=-1.85 mg/dL) and rs12595985 in FTO in African Americans (P=2.90x10(-4), beta=4.52 mg/dL), both with consistent regional association (P<0.05) in the other race group. Additionally, baseline GALNT2 expression differed by rs2144300 genotype in whites (P=0.0279). In conclusion, we identified multiple gene regions associated with atenolol induced HDL-C change that were consistent across race groups, several with functional implications or prior associations with HDL-C.	[McDonough, Caitrin W.; Gillis, Nancy K.; Alsultan, Abdullah; Chang, Shin-Wen; Kawaguchi-Suzuki, Marina; Shahin, Mohamed Hossam A.; El Rouby, Nihal M.; Sa, Ana C. C.; Langaee, Taimour Y.; Gums, John G.; Cooper-DeHoff, Rhonda M.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [McDonough, Caitrin W.; Gillis, Nancy K.; Alsultan, Abdullah; Chang, Shin-Wen; Kawaguchi-Suzuki, Marina; Shahin, Mohamed Hossam A.; El Rouby, Nihal M.; Sa, Ana C. C.; Langaee, Taimour Y.; Gums, John G.; Cooper-DeHoff, Rhonda M.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Lang, Jason E.] Nemours Childrens Hosp, Div Pulm & Sleep Med, Orlando, FL USA; [Lang, Jason E.] Nemours Childrens Hosp, Ctr Pharmacogen & Translat Res, Orlando, FL USA; [Buford, Thomas W.] Univ Florida, Coll Med, Dept Aging & Geriatr Res, Gainesville, FL USA; [Gums, John G.] Univ Florida, Coll Med, Dept Community Hlth & Family Med, Gainesville, FL USA; [Chapman, Arlene B.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University; State University System of Florida; University of Florida; Mayo Clinic	Johnson, JA (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA.	Johnson@cop.ufl.edu	Buford, Thomas W/B-1111-2011; Gillis, Nancy/N-4860-2017; Shahin, Mohamed/Q-2874-2019; Turner, Stephen/GXM-4654-2022; Alsultan, Abdullah/K-1751-2019	Buford, Thomas W/0000-0002-9541-4358; Gillis, Nancy/0000-0002-7744-8490; Alsultan, Abdullah/0000-0002-7013-8369; McDonough, Caitrin/0000-0001-6393-7288; , Marina/0000-0003-0901-8381	National Institute of Health Pharmacogenetics Research Network grant [U01-GM074492]; National Center for Advancing Translational Sciences [UL1 TR000064, UL1 TR000454, UL1 TR000135]; Mayo Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR000454, UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Institute of Health Pharmacogenetics Research Network grant; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	PEAR was supported by the National Institute of Health Pharmacogenetics Research Network grant U01-GM074492 and the National Center for Advancing Translational Sciences under the award number UL1 TR000064 (University of Florida); UL1 TR000454 (Emory University) and UL1 TR000135 (Mayo Clinic). PEAR efforts at the Mayo Clinic were also supported by funds from the Mayo Foundation. http://www.nih.gov/ http://www.mayoclinic.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2006, BIOCHEM SOC T, V34, P343, DOI 10.1042/BST0340343; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fiegenbaum M, 2005, CLIN PHARMACOL THER, V78, P551, DOI 10.1016/j.clpt.2005.08.003; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Jafri H, 2010, ANN INTERN MED, V153, P800, DOI 10.7326/0003-4819-153-12-201012210-00006; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Kajinami K, 2005, ATHEROSCLEROSIS, V178, P331, DOI 10.1016/j.atherosclerosis.2004.08.034; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Keene KL, 2008, HUM GENET, V123, P333, DOI 10.1007/s00439-008-0482-z; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; LEHTONEN A, 1984, ATHEROSCLEROSIS, V51, P335, DOI 10.1016/0021-9150(84)90181-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Mahungu TW, 2009, CLIN PHARMACOL THER, V86, P204, DOI 10.1038/clpt.2009.78; Messerli FH, 2008, CIRCULATION, V117, P2706, DOI 10.1161/CIRCULATIONAHA.107.695007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Schmitz G, 2009, ARTERIOSCL THROM VAS, V29, P1718, DOI 10.1161/ATVBAHA.108.179507; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	34	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76984	10.1371/journal.pone.0076984	http://dx.doi.org/10.1371/journal.pone.0076984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116192	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300110
J	Geran, L; Travers, S				Geran, Laura; Travers, Susan			Temporal Characteristics of Gustatory Responses in Rat Parabrachial Neurons Vary by Stimulus and Chemosensitive Neuron Type	PLOS ONE			English	Article							SOLITARY TRACT; CORTICAL-NEURONS; TASTE STIMULI; NUCLEUS; CORTEX; TIME; QUALITY; LICKING; VARIABILITY; MODULATION	It has been demonstrated that temporal features of spike trains can increase the amount of information available for gustatory processing. However, the nature of these temporal characteristics and their relationship to different taste qualities and neuron types are not well-defined. The present study analyzed the time course of taste responses from parabrachial (PBN) neurons elicited by multiple applications of "sweet" (sucrose), "salty" (NaCl), "sour" (citric acid), and "bitter" (quinine and cycloheximide) stimuli in an acute preparation. Time course varied significantly by taste stimulus and best-stimulus classification. Across neurons, the ensemble code for the three electrolytes was similar initially but quinine diverged from NaCl and acid during the second 500ms of stimulation and all four qualities became distinct just after 1s. This temporal evolution was reflected in significantly broader tuning during the initial response. Metric space analyses of quality discrimination by individual neurons showed that increases in information (H) afforded by temporal factors was usually explained by differences in rate envelope, which had a greater impact during the initial 2s (22.5% increase in H) compared to the later response (9.5%). Moreover, timing had a differential impact according to cell type, with between-quality discrimination in neurons activated maximally by NaCl or citric acid most affected. Timing was also found to dramatically improve within-quality discrimination (80% increase in H) in neurons that responded optimally to bitter stimuli (B-best). Spikes from B-best neurons were also more likely to occur in bursts. These findings suggest that among PBN taste neurons, time-dependent increases in mutual information can arise from stimulus-and neuron-specific differences in response envelope during the initial dynamic period. A stable rate code predominates in later epochs.	[Geran, Laura; Travers, Susan] Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Travers, S (corresponding author), Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA.	travers.3@osu.edu			NIH [RO1-DC726315, RO3-DC008678]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by NIH RO1-DC726315 (SPT) and RO3-DC008678 (LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIDLER LM, 1953, J NEUROPHYSIOL, V16, P595, DOI 10.1152/jn.1953.16.6.595; BOUDREAU JC, 1987, CHEM SENSES, V12, P437, DOI 10.1093/chemse/12.3.437; Breza JM, 2010, J NEUROPHYSIOL, V103, P1771, DOI 10.1152/jn.00785.2009; BUJAS Z, 1989, PERCEPT PSYCHOPHYS, V45, P385, DOI 10.3758/BF03210710; Chen JY, 2008, J NEUROPHYSIOL, V99, P2144, DOI 10.1152/jn.01020.2007; Chen JY, 2011, J NEUROPHYSIOL, V105, P697, DOI 10.1152/jn.00539.2010; CROSS BA, 1970, J ENDOCRINOL, V48, P475, DOI 10.1677/joe.0.0480475; Cubero-Castillo E, 2001, CHEM SENSES, V26, P419, DOI 10.1093/chemse/26.4.419; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Di Lorenzo PM, 2009, J NEUROSCI, V29, P9227, DOI 10.1523/JNEUROSCI.5995-08.2009; Di Lorenzo PM, 2003, BEHAV NEUROSCI, V117, P1423, DOI 10.1037/0735-7044.117.6.1423; Di Lorenzo PM, 2003, J NEUROPHYSIOL, V90, P1418, DOI 10.1152/jn.00177.2003; FISHMAN IY, 1957, J CELL COMPAR PHYSL, V49, P319, DOI 10.1002/jcp.1030490213; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Frank ME, 2005, BRAIN RES BULL, V66, P70, DOI 10.1016/j.brainresbull.2005.04.004; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Geran LC, 2006, J NEUROPHYSIOL, V96, P2513, DOI 10.1152/jn.00607.2006; Geran LC, 2009, J NEUROPHYSIOL, V101, P1598, DOI 10.1152/jn.91168.2008; Gutierrez R, 2010, J NEUROSCI, V30, P287, DOI 10.1523/JNEUROSCI.0855-09.2010; HALPERN BP, 1971, SCIENCE, V171, P1256, DOI 10.1126/science.171.3977.1256; Halsell CB, 1997, J NEUROPHYSIOL, V78, P920, DOI 10.1152/jn.1997.78.2.920; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Khosravi-Hashemi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040339; Khosravi-Hashemi N, 2011, J NEUROPHYSIOL, V106, P1954, DOI 10.1152/jn.00116.2011; Kim MJ, 2010, NEUROBIOL LEARN MEM, V93, P406, DOI 10.1016/j.nlm.2009.12.007; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; LARSONPOWERS N, 1978, J FOOD SCI, V43, P41, DOI 10.1111/j.1365-2621.1978.tb09732.x; Laviolette SR, 2005, J NEUROSCI, V25, P6066, DOI 10.1523/JNEUROSCI.1168-05.2005; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Lestienne R, 1998, NEUROSCIENCE, V82, P315; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; Lundy RF, 1999, J NEUROPHYSIOL, V82, P2970, DOI 10.1152/jn.1999.82.6.2970; Mistretta CM, 1972, OLFACTION TASTE, P294; NISHIJO H, 1991, J NEUROPHYSIOL, V66, P974, DOI 10.1152/jn.1991.66.3.974; NORGREN R, 1973, J COMP NEUROL, V150, P217, DOI 10.1002/cne.901500208; OGAWA H, 1987, EXP BRAIN RES, V68, P449; OGAWA H, 1969, J PHYSIOL-LONDON, V204, P311, DOI 10.1113/jphysiol.1969.sp008915; Pangborn RM, 1983, J I BREW, V89; Pfaffmann C, 1941, J CELL COMPAR PHYSL, V17, P243, DOI 10.1002/jcp.1030170209; Rosen AM, 2011, J NEUROPHYSIOL, V105, P1889, DOI 10.1152/jn.00836.2010; Roussin AT, 2008, J NEUROPHYSIOL, V99, P644, DOI 10.1152/jn.00920.2007; Roussin AT, 2012, J NEUROSCI, V32, P10494, DOI 10.1523/JNEUROSCI.1856-12.2012; SACHDEV RNS, 1991, BRAIN RES, V549, P194, DOI 10.1016/0006-8993(91)90458-8; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; SCOTT TR, 1974, PHYSIOL BEHAV, V12, P413, DOI 10.1016/0031-9384(74)90118-8; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; SMITH DV, 1979, CHEM SENS FLAV, V4, P215, DOI 10.1093/chemse/4.3.215; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Stapleton JR, 2006, J NEUROSCI, V26, P4126, DOI 10.1523/JNEUROSCI.0092-06.2006; TRAVERS JB, 1987, ANNU REV NEUROSCI, V10, P595, DOI 10.1146/annurev.ne.10.030187.003115; TRAVERS SP, 1989, CHEM SENSES, V14, P55, DOI 10.1093/chemse/14.1.55; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Villars Penelope S, 2004, AANA J, V72, P197; Weiss MS, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00027	59	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76828	10.1371/journal.pone.0076828	http://dx.doi.org/10.1371/journal.pone.0076828			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124597	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100154
J	Jun, DW; Hwang, M; Kim, HJ; Hwang, SK; Kim, S; Lee, CH				Jun, Dong Wha; Hwang, Mihwa; Kim, Hyun Jung; Hwang, Soo Kyung; Kim, Sunshin; Lee, Chang-Hun			Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents	PLOS ONE			English	Article							CANCER CELLS; TUMOR-CELLS; REPAIR; DRUG; RESISTANCE; CISPLATIN; PROTEIN; NA,K-ATPASE; MELPHALAN; ENZYME	Modulation of the DNA repair pathway is an emerging target for the development of anticancer drugs. DNA interstrand cross-links (ICLs), one of the most severe forms of DNA damage caused by anticancer drugs such as cisplatin and mitomycin C (MMC), activates the Fanconi anemia (FA)/BRCA DNA repair pathway. Inhibition of the FA/BRCA pathway can enhance the cytotoxic effects of ICL-inducing anticancer drugs and can reduce anticancer drug resistance. To find FA/BRCA pathway inhibitory small molecules, we established a cell-based high-content screening method for quantitating the activation of the FA/BRCA pathway by measuring FANCD2 foci on DNA lesions and then applied our method to chemical screening. Using commercial LOPAC1280 chemical library screening, ouabain was identified as a competent FA/BRCA pathway inhibitory compound. Ouabain, a member of the cardiac glycoside family, binds to and inhibits Na+/K+-ATPase and has been used to treat heart disease for many years. We observed that ouabain, as well as other cardiac glycoside family members-digitoxin and digoxin-down-regulated FANCD2 and FANCI mRNA levels, reduced monoubiquitination of FANCD2, inhibited FANCD2 foci formation on DNA lesions, and abrogated cell cycle arrest induced by MMC treatment. These inhibitory activities of ouabain required p38 MAPK and were independent of cellular Ca2+ ion increase or the drug uptake-inhibition effect of ouabain. Furthermore, we found that ouabain potentiated the cytotoxic effects of MMC in tumor cells. Taken together, we identified an additional effect of ouabain as a FA/BRCA pathway-inhibiting chemosensitization compound. The results of this study suggest that ouabain may serve as a chemosensitizer to ICL-inducing anticancer drugs.	[Jun, Dong Wha; Hwang, Mihwa; Kim, Hyun Jung; Kim, Sunshin] Natl Canc Ctr, New Expt Therapeut Branch, Div Convergence Technol, Goyang, Gyeonggi, South Korea; [Hwang, Soo Kyung; Lee, Chang-Hun] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Div Canc Biol, Goyang, Gyeonggi, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, S (corresponding author), Natl Canc Ctr, New Expt Therapeut Branch, Div Convergence Technol, Goyang, Gyeonggi, South Korea.	ksunshin@ncc.re.kr; chlee@ncc.re.kr			National Cancer Center [1110031, 1110032]	National Cancer Center	This work was supported by the National Cancer Center Grants 1110031 and 1110032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Surrah AS, 2006, CURR MED CHEM, V13, P1337, DOI 10.2174/092986706776872970; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Brouillard F, 2001, CANCER RES, V61, P1693; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hiyoshi H, 2012, BRIT J CANCER, V106, P1807, DOI 10.1038/bjc.2012.159; Jun DW, 2012, BRIT J PHARMACOL, V167, P141, DOI 10.1111/j.1476-5381.2012.01977.x; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kennedy RD, 2007, J CLIN INVEST, V117, P1440, DOI 10.1172/JCI31245; Kim S, 2011, J BIOMOL SCREEN, V16, P259, DOI 10.1177/1087057110392993; Landais I, 2009, INT J CANCER, V124, P783, DOI 10.1002/ijc.24039; LAWRENCE TS, 1988, INT J RADIAT ONCOL, V15, P953, DOI 10.1016/0360-3016(88)90132-0; Li YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044254; Lord CJ, 2006, CLIN CANCER RES, V12, P4463, DOI 10.1158/1078-0432.CCR-06-1269; Madhusudan S, 2005, TRENDS MOL MED, V11, P503, DOI 10.1016/j.molmed.2005.09.004; McConkey DJ, 2000, CANCER RES, V60, P3807; Mijatovic T, 2006, NEOPLASIA, V8, P402, DOI 10.1593/neo.05850; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Musto P, 2007, EXPERT OPIN INV DRUG, V16, P1467, DOI 10.1517/13543784.16.9.1467; Platz EA, 2011, CANCER DISCOV, V1, P68, DOI 10.1158/2159-8274.CD-10-0020; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Saadatzadeh MR, 2009, BLOOD, V113, P2655, DOI 10.1182/blood-2008-09-181420; SMITH IE, 1992, BRIT J CANCER, V65, P787, DOI 10.1038/bjc.1992.169; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LS, 2012, J CLIN ENDOCR METAB, V97, pE319, DOI 10.1210/jc.2011-2671	38	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75905	10.1371/journal.pone.0075905	http://dx.doi.org/10.1371/journal.pone.0075905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124520	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100077
J	Cordero-Maldonado, ML; Siverio-Mota, D; Vicet-Muro, L; Wilches-Arizabala, IM; Esguerra, CV; de Witte, PAM; Crawford, AD				Lorena Cordero-Maldonado, Maria; Siverio-Mota, Dany; Vicet-Muro, Liliana; Maria Wilches-Arizabala, Isabel; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.			Optimization and Pharmacological Validation of a Leukocyte Migration Assay in Zebrafish Larvae for the Rapid In Vivo Bioactivity Analysis of Anti-Inflammatory Secondary Metabolites	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; CAFFEIC ACID; EXPRESSION ANALYSIS; EARLY MACROPHAGES; CAPRARIA-BIFLORA; GENE-EXPRESSION; ELLAGIC ACID; INFLAMMATION; DISCOVERY	Over the past decade, zebrafish (Danio rerio) have emerged as an attractive model for in vivo drug discovery. In this study, we explore the suitability of zebrafish larvae to rapidly evaluate the anti-inflammatory activity of natural products (NPs) and medicinal plants used in traditional medicine for the treatment of inflammatory disorders. First, we optimized a zebrafish assay for leukocyte migration. Inflammation was induced in four days post-fertilization (dpf) zebrafish larvae by tail transection and co-incubation with bacterial lipopolysaccharides (LPS), resulting in a robust recruitment of leukocytes to the zone of injury. Migrating zebrafish leukocytes were detected in situ by myeloperoxidase (MPO) staining, and anti-inflammatory activity was semi-quantitatively scored using a standardized scale of relative leukocyte migration (RLM). Pharmacological validation of this optimized assay was performed with a panel of anti-inflammatory drugs, demonstrating a concentration-responsive inhibition of leukocyte migration for both steroidal and non-steroidal anti-inflammatory drugs (SAIDs and NSAIDs). Subsequently, we evaluated the bioactivity of structurally diverse NPs with well-documented anti-inflammatory properties. Finally, we further used this zebrafish-based assay to quantify the anti-inflammatory activity in the aqueous and methanolic extracts of several medicinal plants. Our results indicate the suitability of this LPS-enhanced leukocyte migration assay in zebrafish larvae as a front-line screening platform in NP discovery, including for the bioassay-guided isolation of anti-inflammatory secondary metabolites from complex NP extracts.	[Lorena Cordero-Maldonado, Maria; Siverio-Mota, Dany; Vicet-Muro, Liliana; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium; [Lorena Cordero-Maldonado, Maria; Maria Wilches-Arizabala, Isabel] Univ Cuenca, Sch Biochem & Pharm, Fac Chem Sci, Cuenca, Ecuador; [Siverio-Mota, Dany; Vicet-Muro, Liliana] Cent Univ Marta Abreu Las Villas, Fac Chem Pharm, Dept Pharm, Santa Clara, Cuba; [Lorena Cordero-Maldonado, Maria; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	KU Leuven; Universidad de Cuenca; Universidad Central "Marta Abreu" de Las Villas; University of Luxembourg	Crawford, AD (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium.	alexander.crawford@pharm.kuleuven.be	Esguerra, Camila/D-7657-2014; Esguerra, Camila/N-6159-2015	Esguerra, Camila/0000-0001-7891-1427; Esguerra, Camila/0000-0002-2271-8094; de Witte, Peter/0000-0002-9989-9567	Vlaamse Interuniversitaire Raad (VLIR); Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	Vlaamse Interuniversitaire Raad (VLIR); Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	MLCM was funded by a PhD fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador''. DSM and LVM were funded by a PhD fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta Sulay Loy, 2003, Acta Farmaceutica Bonaerense, V22, P53; Bohni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064006; Challal S, 2012, CHIMIA, V66, P229, DOI 10.2533/chimia.2012.229; Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087; Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Collins DO, 2000, J NAT PROD, V63, P1515, DOI 10.1021/np000280w; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Dimitrova P, 2012, CENTRAL EUROPEAN J B, V8, P186; ELIAS JM, 1980, AM J CLIN PATHOL, V73, P797; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Flemming A, 2007, NC3RS, V10, P1; Fonseca AM, 2006, J ESSENT OIL RES, V18, P158, DOI 10.1080/10412905.2006.9699052; Funakoshi-Tago M, 2011, INT IMMUNOPHARMACOL, V11, P1150, DOI 10.1016/j.intimp.2011.03.012; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Gray C, 2011, THROMB HAEMOSTASIS, V105, P811, DOI 10.1160/TH10-08-0525; Gunther M, 2006, PHYTOCHEM ANALYSIS, V17, P1, DOI 10.1002/pca.822; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Jayaraman J, 2012, TOXICOL MECH METHOD, V22, P568, DOI 10.3109/15376516.2012.707255; KAPLOW LS, 1965, BLOOD-J HEMATOL, V26, P215, DOI 10.1182/blood.V26.2.215.215; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kim S, 2011, FOOD CHEM TOXICOL, V49, P2580, DOI 10.1016/j.fct.2011.06.076; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lister JA, 1999, DEVELOPMENT, V126, P3757; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; Marrero-Ponce Y, 2011, EUR J MED CHEM, V46, P5736, DOI 10.1016/j.ejmech.2011.07.053; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; McGregor Gerard, 2005, Phytochemistry Reviews, V4, P47, DOI 10.1007/s11101-004-2374-8; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Orellana-Paucar AM, 2012, EPILEPSY BEHAV, V24, P14, DOI 10.1016/j.yebeh.2012.02.020; Rocha NFM, 2011, N-S ARCH PHARMACOL, V384, P525, DOI 10.1007/s00210-011-0679-x; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Odontuya G, 2005, PHYTOTHER RES, V19, P782, DOI 10.1002/ptr.1723; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Quan LD, 2008, EXPERT OPIN THER PAT, V18, P723, DOI 10.1517/13543776.18.7.723; Rainsford K. D., 2007, V42, P3; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Sarah B, 2006, J ALTERN COMPLEM MED, V12, P981, DOI 10.1089/acm.2006.12.981; Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X; Srivastava JK, 2010, MOL MED REP, V3, P895, DOI 10.3892/mmr.2010.377; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Watzke J, 2007, FISH SHELLFISH IMMUN, V23, P901, DOI 10.1016/j.fsi.2007.03.004; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yazawa R, 2005, MAR BIOTECHNOL, V7, P231, DOI 10.1007/s10126-004-0403-7	60	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75404	10.1371/journal.pone.0075404	http://dx.doi.org/10.1371/journal.pone.0075404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124487	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100044
J	Pizon, V; Rybina, S; Gerbal, F; Delort, F; Vicart, P; Baldacci, G; Karsenti, E				Pizon, Veronique; Rybina, Sofia; Gerbal, Fabien; Delort, Florence; Vicart, Patrick; Baldacci, Giuseppe; Karsenti, Eric			MURF2B, a Novel LC3-Binding Protein, Participates with MURF2A in the Switch between Autophagy and Ubiquitin Proteasome System during Differentiation of C2C12 Muscle Cells	PLOS ONE			English	Article							RING FINGER PROTEINS; MYOFIBRILLAR PROTEINS; DEGRADATION; EXPRESSION; MICROTUBULE; TITIN; INHIBITION; DOMAIN; LC3; IDENTIFICATION	The ubiquitin proteasome system and macroautophagy are proteolytic pathways essential in the maintenance of cellular homeostasis during differentiation and remodelling of skeletal muscle. In both pathways, proteins to be degraded are tagged with polyubiquitin. In skeletal muscles, the MURF2 proteins display E3 ubiquitin ligase structure suggesting that they may covalently attach ubiquitin polypeptides to still unknown target proteins. So far only MURF2A isoforms were studied and shown to interact with p62/SQSTM1, a protein implicated in macroautophagic and ubiquitin proteasome system degradations. Here, we analyzed the MURF2B and MURF2A proteins and show that the ratio of the isoforms changes during differentiation of muscle C2C12 cells and that the shift of the isoforms expression follows the sequential activation of autophagic or proteasomal degradation. We also show that MURF2B has a functional domain needed for its interaction with LC3, a protein needed for autophagic vesicles formation. Using specific MURF2 RNAi cells we observed that MURF2A and MURF2B are both needed for the formation of autophagosomes and that in the absence of MURF2B, the cells expressing MURF2A display an activated ubiquitin proteasome system implicated in the degradation of p62/SQSTM1 by UPS. Altogether, our results indicate that MURF2A and MURF2B proteins could participate in the molecular switch between the two ubiquitin degradative pathways.	[Pizon, Veronique; Delort, Florence; Vicart, Patrick] Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat, CNRS,EAC4413, Paris, France; [Rybina, Sofia; Karsenti, Eric] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Gerbal, Fabien] Univ Paris Diderot, CNRS, UMR 7057, Paris, France; [Baldacci, Giuseppe] Univ Paris Diderot, Inst Jacques Monod, CNRS, Paris, France; [Gerbal, Fabien] Univ Paris 06, Dept Phys, UFR925, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Pizon, V (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat, CNRS,EAC4413, Paris, France.	veronique.pizon@univ-paris-diderot.fr	Pizon, Veronique/M-5590-2018	Pizon, Veronique/0000-0003-3596-8313				Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Faller EM, 2009, MOL CELL NEUROSCI, V41, P85, DOI 10.1016/j.mcn.2009.02.001; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gregorio CC, 2005, J MUSCLE RES CELL M, V26, P389, DOI 10.1007/s10974-005-9021-x; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; IAKOVENKO A, 2000, J MUSCLE RES CELL M, V21, P833; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kachaeva EV, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/493618; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Musa H, 2006, J CELL SCI, V119, P4322, DOI 10.1242/jcs.03198; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perera S, 2012, J MUSCLE RES CELL M, V33, P107, DOI 10.1007/s10974-012-9288-7; Perera S, 2011, DEV BIOL, V351, P46, DOI 10.1016/j.ydbio.2010.12.024; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571; Purintrapiban J, 2003, COMP BIOCHEM PHYS B, V136, P393, DOI 10.1016/S1096-4959(03)00201-X; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Taillandier D, 2004, P NUTR SOC, V63, P357, DOI 10.1079/PAR2004358; TERJE J, 2010, AUTOPHAGY, V7, P279; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	56	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76140	10.1371/journal.pone.0076140	http://dx.doi.org/10.1371/journal.pone.0076140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124537	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100094
J	Venghateri, JB; Gupta, TK; Verma, PJ; Kunwar, A; Panda, D				Venghateri, Jubina B.; Gupta, Tilak Kumar; Verma, Paul J.; Kunwar, Ambarish; Panda, Dulal			Ansamitocin P3 Depolymerizes Microtubules and Induces Apoptosis by Binding to Tubulin at the Vinblastine Site	PLOS ONE			English	Article							PROTEIN-LIGAND COMPLEXES; KINETIC STABILIZATION; TUMOR INHIBITORS; DYNAMIC INSTABILITY; MAYTANSINE-BINDING; SULFHYDRYL-GROUPS; ANTITUMOR AGENTS; MITOTIC ARREST; BLIND DOCKING; HALOGEN BONDS	Maytansinoid conjugates are currently under different phases of clinical trials and have been showing promising activity for various types of cancers. In this study, we have elucidated the mechanism of action of ansamitocin P3, a structural analogue of maytansine for its anticancer activity. Ansamitocin P3 potently inhibited the proliferation of MCF-7, HeLa, EMT-6/AR1 and MDA-MB-231 cells in culture with a half-maximal inhibitory concentration of 20 +/- 3, 50 +/- 0.5, 140 +/- 17, and 150 +/- 1.1 pM, respectively. Ansamitocin P3 strongly depolymerized both interphase and mitotic microtubules and perturbed chromosome segregation at its proliferation inhibitory concentration range. Treatment of ansamitocin P3 activated spindle checkpoint surveillance proteins, Mad2 and BubR1 and blocked the cells in mitotic phase of the cell cycle. Subsequently, cells underwent apoptosis via p53 mediated apoptotic pathway. Further, ansamitocin P3 was found to bind to purified tubulin in vitro with a dissociation constant (K-d) of 1.3 +/- 0.7 mu M. The binding of ansamitocin P3 induced conformational changes in tubulin. A docking analysis suggested that ansamitocin P3 may bind partially to vinblastine binding site on tubulin in two different positions. The analysis indicated that the binding of ansamitocin P3 to tubulin is stabilized by hydrogen bonds. In addition, weak interactions such as halogen-oxygen interactions may also contribute to the binding of ansamitocin P3 to tubulin. The study provided a significant insight in understanding the antiproliferative mechanism of action of ansamitocin P3.	[Venghateri, Jubina B.] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India; [Gupta, Tilak Kumar; Kunwar, Ambarish; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Verma, Paul J.] Monash Univ, Ctr Reprod & Dev, Monash Inst Med Res, Clayton, Vic, Australia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Verma, Paul/AAQ-4657-2021; Venghateri, Jubina Balan/AFX-6954-2022; Kunwar, Ambarish/AAD-3618-2022	Venghateri, Jubina Balan/0000-0001-5158-661X; Kunwar, Ambarish/0000-0002-8671-7816	IITB-Monash Research Academy; DAE-SRC fellowship, Department of Atomic energy; Wadhwani Research Centre in Biosciences and Bioengineering at Indian Institute of Technology Bombay; IITB Monash Research Academy	IITB-Monash Research Academy; DAE-SRC fellowship, Department of Atomic energy; Wadhwani Research Centre in Biosciences and Bioengineering at Indian Institute of Technology Bombay; IITB Monash Research Academy	The work is partly supported by funding from IITB-Monash Research Academy. D.P. is supported by a DAE-SRC fellowship, Department of Atomic energy. A.K. is supported by Wadhwani Research Centre in Biosciences and Bioengineering at Indian Institute of Technology Bombay. P.J.V. is by Monash Institute of Medical Research. J.B.V is supported by fellowship from IITB Monash Research Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P3345, DOI 10.1093/nar/gkg528; BHATTACHARYYA B, 1976, P NATL ACAD SCI USA, V73, P2375, DOI 10.1073/pnas.73.7.2375; BHATTACHARYYA B, 1977, FEBS LETT, V75, P159, DOI 10.1016/0014-5793(77)80075-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cassady JM, 2004, CHEM PHARM BULL, V52, P1, DOI 10.1248/cpb.52.1; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Daly E. M., 2009, CURR CHEM BIOL, V3, P367; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gajula PK, 2013, J MED CHEM, V56, P2235, DOI 10.1021/jm3009629; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HAMEL E, 1992, PHARMACOL THERAPEUT, V55, P31, DOI 10.1016/0163-7258(92)90028-X; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hetenyi C, 2006, FEBS LETT, V580, P1447, DOI 10.1016/j.febslet.2006.01.074; HIGASHIDE E, 1977, NATURE, V270, P721, DOI 10.1038/270721a0; HUANG AB, 1985, BIOCHEM BIOPH RES CO, V128, P1239, DOI 10.1016/0006-291X(85)91073-3; Hubbard S., 1996, NACCESS COMPUTER PRO; IKEYAMA S, 1981, BIOCHEM PHARMACOL, V30, P2421, DOI 10.1016/0006-2952(81)90336-1; Iorga B, 2006, J MOL MODEL, V12, P366, DOI 10.1007/s00894-005-0057-z; ISSELL BF, 1978, CANCER TREAT REV, V5, P199, DOI 10.1016/S0305-7372(78)80014-0; Kaur Harpreet, 2006, In Silico Biology, V6, P111; Kukol A., 2008, MOL MODELING PROTEIN; KUPCHAN SM, 1977, J ORG CHEM, V42, P2349, DOI 10.1021/jo00434a001; KUPCHAN SM, 1978, J MED CHEM, V21, P31, DOI 10.1021/jm00199a006; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P1354, DOI 10.1021/ja00759a054; LI Y, 1992, BIOCHEM BIOPH RES CO, V187, P722, DOI 10.1016/0006-291X(92)91255-O; Liu C, 1997, Expert Opin Investig Drugs, V6, P169, DOI 10.1517/13543784.6.2.169; LOBERT S, 1995, BIOCHEMISTRY-US, V34, P8050, DOI 10.1021/bi00025a011; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; MANDELBAUMSHAVIT F, 1976, BIOCHEM BIOPH RES CO, V72, P47, DOI 10.1016/0006-291X(76)90958-X; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Oroudjev E, 2010, MOL CANCER THER, V9, P2700, DOI 10.1158/1535-7163.MCT-10-0645; Panda D, 2000, BIOCHEMISTRY-US, V39, P14121, DOI 10.1021/bi0010827; Panda D, 1998, P NATL ACAD SCI USA, V95, P9313, DOI 10.1073/pnas.95.16.9313; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rai A, 2013, BIOCHEM PHARMACOL, V86, P378, DOI 10.1016/j.bcp.2013.05.024; Rai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044311; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; REMILLARD S, 1975, SCIENCE, V189, P1002, DOI 10.1126/science.1241159; Riley KE, 2011, CRYST GROWTH DES, V11, P4272, DOI 10.1021/cg200882f; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sertel S, 2011, BIOCHEM PHARMACOL, V81, P723, DOI 10.1016/j.bcp.2010.12.026; Sieber S M, 1975, Bibl Haematol, P495; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Suezawa H, 2004, EUR J ORG CHEM, V2004, P4816, DOI 10.1002/ejoc.20040373; Taft F, 2012, CHEM-EUR J, V18, P880, DOI 10.1002/chem.201101640; TAKAHASHI M, 1987, BIOCHIM BIOPHYS ACTA, V926, P215, DOI 10.1016/0304-4165(87)90206-6; TANIDA S, 1980, J ANTIBIOT, V33, P192, DOI 10.7164/antibiotics.33.192	54	27	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75182	10.1371/journal.pone.0075182	http://dx.doi.org/10.1371/journal.pone.0075182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124473	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100030
J	Zeituni, AE; Miura, K; Diakite, M; Doumbia, S; Moretz, SE; Diouf, A; Tullo, G; Lopera-Mesa, TM; Bess, CD; Mita-Mendoza, NK; Anderson, JM; Fairhurst, RM; Long, CA				Zeituni, Amir E.; Miura, Kazutoyo; Diakite, Mahamadou; Doumbia, Saibou; Moretz, Samuel E.; Diouf, Ababacar; Tullo, Gregory; Lopera-Mesa, Tatiana M.; Bess, Cameron D.; Mita-Mendoza, Neida K.; Anderson, Jennifer M.; Fairhurst, Rick M.; Long, Carole A.			Effects of Age, Hemoglobin Type and Parasite Strain on IgG Recognition of Plasmodium falciparum-Infected Erythrocytes in Malian Children	PLOS ONE			English	Article							VARIANT SURFACE-ANTIGENS; SICKLE-CELL TRAIT; APICAL MEMBRANE ANTIGEN-1; IN-VITRO; FLUORESCENT ANTIBODY; ACQUIRED-IMMUNITY; HUMAN MALARIA; PROTECTIVE ANTIBODIES; HEME OXYGENASE-1; AGGLUTINATION	Background: Naturally-acquired antibody responses to antigens on the surface of Plasmodium falciparum-infected red blood cells (iRBCs) have been implicated in antimalarial immunity. To profile the development of this immunity, we have been studying a cohort of Malian children living in an area with intense seasonal malaria transmission. Methodology/Principal Findings: We collected plasma from a sub-cohort of 176 Malian children aged 3-11 years, before (May) and after (December) the 2009 transmission season. To measure the effect of hemoglobin (Hb) type on antibody responses, we enrolled age-matched HbAA, HbAS and HbAC children. To quantify antibody recognition of iRBCs, we designed a high-throughput flow cytometry assay to rapidly test numerous plasma samples against multiple parasite strains. We evaluated antibody reactivity of each plasma sample to 3 laboratory-adapted parasite lines (FCR3, D10, PC26) and 4 short-term-cultured parasite isolates (2 Malian and 2 Cambodian). 97% of children recognized >= 1 parasite strain and the proportion of IgG responders increased significantly during the transmission season for most parasite strains. Both strain-specific and strain-transcending IgG responses were detected, and varied by age, Hb type and parasite strain. In addition, the breadth of IgG responses to parasite strains increased with age in HbAA, but not in HbAS or HbAC, children. Conclusions/Significance: Our assay detects both strain-specific and strain-transcending IgG responses to iRBCs. The magnitude and breadth of these responses varied not only by age, but also by Hb type and parasite strain used. These findings indicate that studies of acquired humoral immunity should account for Hb type and test large numbers of diverse parasite strains.	[Zeituni, Amir E.; Miura, Kazutoyo; Moretz, Samuel E.; Diouf, Ababacar; Tullo, Gregory; Lopera-Mesa, Tatiana M.; Bess, Cameron D.; Mita-Mendoza, Neida K.; Anderson, Jennifer M.; Fairhurst, Rick M.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Diakite, Mahamadou; Doumbia, Saibou] Univ Bamako, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Mita-Mendoza, Neida K.] Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Long, CA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	clong@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, ZIAAI001062, ZIAAI001000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUIAR JC, 1992, AM J TROP MED HYG, V47, P621; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; ANDERS RF, 1983, P NATL ACAD SCI-BIOL, V80, P6652, DOI 10.1073/pnas.80.21.6652; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BROWN IN, 1968, IMMUNOLOGY, V14, P127; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Cabrera G, 2004, INFECT IMMUN, V72, P284, DOI 10.1128/IAI.72.1.284-294.2004; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; CHULAY JD, 1985, B WORLD HEALTH ORGAN, V63, P317; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COLLINS WE, 1964, AM J TROP MED HYG, V13, P1; COLLINS WE, 1964, AM J TROP MED HYG, V13, P777, DOI 10.4269/ajtmh.1964.13.777; COLLINS WE, 1964, AM J TROP MED HYG, V13, P256, DOI 10.4269/ajtmh.1964.13.256; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Eaton MD, 1938, J EXP MED, V67, P857, DOI 10.1084/jem.67.6.857; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Fairhurst RM, 2012, MICROBES INFECT, V14, P851, DOI 10.1016/j.micinf.2012.05.006; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; FANDEUR T, 1984, J IMMUNOL, V132, P432; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Fu Y, 2010, CYTOM PART A, V77A, P253, DOI 10.1002/cyto.a.20856; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; Giha HA, 1998, AM J TROP MED HYG, V58, P399, DOI 10.4269/ajtmh.1998.58.399; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; GYSIN J, 1982, PARASITE IMMUNOL, V4, P421, DOI 10.1111/j.1365-3024.1982.tb00453.x; GYSIN J, 1987, ANN INST PASTEUR IMM, V138, P829, DOI 10.1016/S0769-2625(87)80003-X; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; JENSEN JB, 1978, AM J TROP MED HYG, V27, P743, DOI 10.4269/ajtmh.1978.27.743; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; MARSH K, 1986, J IMMUNOL METHODS, V91, P107, DOI 10.1016/0022-1759(86)90108-0; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060182; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; OTOO LN, 1988, T ROY SOC TROP MED H, V82, P59, DOI 10.1016/0035-9203(88)90263-5; Piper KP, 1999, EXP PARASITOL, V91, P161, DOI 10.1006/expr.1998.4368; REEDER JC, 1994, AM J TROP MED HYG, V51, P45, DOI 10.4269/ajtmh.1994.51.45; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; SOUTHWELL BR, 1989, T ROY SOC TROP MED H, V83, P464, DOI 10.1016/0035-9203(89)90248-4; Staalso T, 1998, IMMUNOL LETT, V60, P121, DOI 10.1016/S0165-2478(97)00143-0; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Tan XL, 2011, J INFECT DIS, V204, P1750, DOI 10.1093/infdis/jir638; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06; VOLLER A, 1975, BRIT MED J, V1, P659, DOI 10.1136/bmj.1.5959.659; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2006, MOL BIOCHEM PARASIT, V149, P121, DOI 10.1016/j.molbiopara.2006.05.007; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Williams TN, 2003, CYTOM PART A, V56A, P96, DOI 10.1002/cyto.a.10088	77	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76734	10.1371/journal.pone.0076734	http://dx.doi.org/10.1371/journal.pone.0076734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124591	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100148
J	Hernandez, J; Johansson, A; Stedt, J; Bengtsson, S; Porczak, A; Granholm, S; Gonzalez-Acuna, D; Olsen, B; Bonnedahl, J; Drobni, M				Hernandez, Jorge; Johansson, Anders; Stedt, Johan; Bengtsson, Stina; Porczak, Aleksandra; Granholm, Susanne; Gonzalez-Acuna, Daniel; Olsen, Bjorn; Bonnedahl, Jonas; Drobni, Mirva			Characterization and Comparison of Extended-Spectrum beta-Lactamase (ESBL) Resistance Genotypes and Population Structure of Escherichia coli Isolated from Franklin's Gulls (Leucophaeus pipixcan) and Humans in Chile	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; PREVALENCE; SOUTH; CEPHALOSPORINS; DIVERSITY; PLASMIDS; GENES; PCR	We investigated the general level of antibiotic resistance with further analysis of extended-spectrum beta-lactamase (ESBL) prevalence, as well as the population structure of E. coli in fecal flora of humans and Franklin's gulls (Leucophaeus pipixcan) in central parts of Chile. We found a surprisingly high carriage rate of ESBL-producing E. coli among the gulls 112/372 (30.1%) as compared to the human population 6/49 (12.2%.) Several of the E. coli sequence types (STs) identified in birds have previously been reported as Multi Drug Resistant (MDR) human pathogens including the ability to produce ESBLs. This means that not only commensal flora is shared between birds and humans but also STs with pathogenic potential. Given the migratory behavior of Franklin's gulls, they and other migratory species, may be a part of ESBL dissemination in the environment and over great geographic distances. Apart from keeping the antibiotic use low, breaking the transmission chains between the environment and humans must be a priority to hinder the dissemination of resistance.	[Hernandez, Jorge; Olsen, Bjorn; Drobni, Mirva] Uppsala Univ, Sect Clin Microbiol & Infect Dis, Dept Med Sci, Uppsala, Sweden; [Johansson, Anders; Granholm, Susanne] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Stedt, Johan; Bonnedahl, Jonas] Linnaeus Univ, Sch Nat Sci, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden; [Bengtsson, Stina; Porczak, Aleksandra] Cent Hosp Vaxjo, Vaxjo, Sweden; [Gonzalez-Acuna, Daniel] Univ Concepcion, Dept Ciencias Pecuarias, Fac Ciencias Vet, Concepcion, Chile; [Bonnedahl, Jonas] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden	Uppsala University; Umea University; Linnaeus University; Universidad de Concepcion	Bonnedahl, J (corresponding author), Linnaeus Univ, Sch Nat Sci, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden.	jonasb@tkalmar.se	Johansson, Anders/D-2928-2012; Bonnedahl, Jonas/GZG-8435-2022; Johansson, Anders/H-9362-2017	Johansson, Anders/0000-0003-0548-5943; Johansson, Anders/0000-0003-0548-5943; Bonnedahl, Jonas/0000-0002-3182-389X; Olsen, Bjorn/0000-0002-4646-691X	Laboratory for Molecular Infection Medicine Sweden; Swedish Research Council FORMAS [2008-326]; Karin Korsner's Foundation; Olle Engkvist Byggmastare Foundation; Medical Faculty, Uppsala University	Laboratory for Molecular Infection Medicine Sweden; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Karin Korsner's Foundation; Olle Engkvist Byggmastare Foundation; Medical Faculty, Uppsala University	Anders Johansson would like to thank the Laboratory for Molecular Infection Medicine Sweden for supporting him by a Clinical Research Fellowship. This study was funded by the Swedish Research Council FORMAS (2008-326), the Karin Korsner's and Olle Engkvist Byggmastare Foundations and the Medical Faculty, Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUERNFEIND A, 1992, INFECTION, V20, P158, DOI 10.1007/BF01704610; Bengtsson S, 2012, J ANTIMICROB CHEMOTH, V67, P69, DOI 10.1093/jac/dkr421; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bonnedahl J, 2010, J ANTIMICROB CHEMOTH, V65, P1939, DOI 10.1093/jac/dkq222; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bouallegue-Godet O, 2005, J CLIN MICROBIOL, V43, P1037, DOI 10.1128/JCM.43.3.1037-1044.2005; Cabello FC, 2004, REV MED CHILE, V132, P1001; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; DATTA N, 1983, NATURE, V306, P616, DOI 10.1038/306616a0; Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003; Girlich D, 2007, APPL ENVIRON MICROB, V73, P4681, DOI 10.1128/AEM.02491-06; Chagas TPG, 2011, BRAZ J INFECT DIS, V15, P420, DOI [10.1590/S1413-86702011000500002, 10.1016/S1413-8670(11)70222-7]; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Kronvall G, 2003, CLIN MICROBIOL INFEC, V9, P120, DOI 10.1046/j.1469-0691.2003.00546.x; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Millanao A, 2011, REV MED CHILE, V139, P107, DOI /S0034-98872011000100015; Miranda CD, 2001, MAR POLLUT BULL, V42, P1096, DOI 10.1016/S0025-326X(01)00093-5; Moreno MA, 2007, VET MICROBIOL, V120, P363, DOI 10.1016/j.vetmic.2006.10.032; Moura RA, 2009, APPL ENVIRON MICROB, V75, P7399, DOI 10.1128/AEM.00636-09; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Peirano G, 2012, J CLIN MICROBIOL, V50, P294, DOI 10.1128/JCM.06025-11; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Villegas MV, 2008, CLIN MICROBIOL INFEC, V14, P154, DOI 10.1111/j.1469-0691.2007.01869.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	34	58	61	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76150	10.1371/journal.pone.0076150	http://dx.doi.org/10.1371/journal.pone.0076150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098774	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500144
J	Young, A; Wang, Y; Ahmedli, NB; Jiang, MS; Farber, DB				Young, Alejandra; Wang, Ying; Ahmedli, Novruz B.; Jiang, Meisheng; Farber, Debora B.			A Constitutively Active G alpha i3 Protein Corrects the Abnormal Retinal Pigment Epithelium Phenotype of Oa1-/- mice	PLOS ONE			English	Article							OCULAR ALBINISM TYPE-1; HETEROTRIMERIC G-PROTEIN; GOLGI MEMBRANES; ALPHA-SUBUNITS; GENE; CELLS; EXPRESSION; MUTATIONS; TRANSPORT; RECEPTOR	Purpose: Ocular Albinism type 1 (OA1) is a disease caused by mutations in the OA1 gene and characterized by the presence of macromelanosomes in the retinal pigment epithelium (RPE) as well as abnormal crossing of the optic axons at the optic chiasm. We showed in our previous studies in mice that Oa1 activates specifically G alpha i3 in its signaling pathway and thus, hypothesized that a constitutively active G alpha i3 in the RPE of Oa1-/- mice might keep on the Oa1 signaling cascade and prevent the formation of macromelanosomes. To test this hypothesis, we have generated transgenic mice that carry the constitutively active G alpha i3 (Q204L) protein in the RPE of Oa1-/- mice and are now reporting the effects that the transgene produced on the Oa1-/- RPE phenotype. Methods: Transgenic mice carrying RPE-specific expression of the constitutively active G alpha i3 (Q204L) were generated by injecting fertilized eggs of Oa1-/- females with a lentivirus containing the G alpha i3 (Q204L) cDNA. PCR, Southern blots, Western blots and confocal microscopy were used to confirm the presence of the transgene in the RPE of positive transgenic mice. Morphometrical analyses were performed using electron microscopy to compare the size and number of melanosomes per RPE area in putative Oa1-/-, G alpha i3 (Q204L) transgenic mice with those of wild-type NCrl and Oa1-/- mice. Results: We found a correlation between the presence of the constitutively active G alpha i3 (Q204L) transgene and the rescue of the normal phenotype of RPE melanosomes in Oa1-/-, G alpha i3 (Q204L) mice. These mice have higher density of melanosomes per RPE area and a larger number of small melanosomes than Oa1-/- mice, and their RPE phenotype is similar to that of wild-type mice. Conclusions: Our results show that a constitutively active G alpha i3 protein can by-pass the lack of Oa1 protein in Oa1-/- mice and consequently rescue the RPE melanosomal phenotype.	[Young, Alejandra; Ahmedli, Novruz B.; Farber, Debora B.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Young, Alejandra; Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Wang, Ying; Jiang, Meisheng] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jiang, MS (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	jm@ucla.edu; farber@jsei.ucla.edu		Young, Alejandra/0000-0002-1855-0559; Farber, Debora/0000-0002-3207-697X	Vision of Children Foundation; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER	Vision of Children Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial support from the Vision of Children Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi MT, 1996, GENOME RES, V6, P880, DOI 10.1101/gr.6.9.880; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Brand SH, 1996, AM J PHYSIOL-CELL PH, V270, pC1362, DOI 10.1152/ajpcell.1996.270.5.C1362; CREEL DJ, 1990, OPHTHALMIC PAED GEN, V11, P193, DOI 10.3109/13816819009020979; d'Addio M, 2000, HUM MOL GENET, V9, P3011, DOI 10.1093/hmg/9.20.3011; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Gohla A, 2007, AUTOPHAGY, V3, P393, DOI 10.4161/auto.4256; GUILLERY RW, 1975, BRAIN RES, V96, P373, DOI 10.1016/0006-8993(75)90750-7; Hamaguchi I, 2000, J VIROL, V74, P10778, DOI 10.1128/JVI.74.22.10778-10784.2000; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; LANG GE, 1990, OPHTHALMIC PAED GEN, V11, P265, DOI 10.3109/13816819009015712; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Newton JM, 1996, GENOMICS, V37, P219, DOI 10.1006/geno.1996.0545; OgierDenis E, 1997, J BIOL CHEM, V272, P24599, DOI 10.1074/jbc.272.39.24599; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Rachel RA, 2002, PIGM CELL RES, V15, P273, DOI 10.1034/j.1600-0749.2002.02019.x; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; Schnur RE, 1998, AM J HUM GENET, V62, P800, DOI 10.1086/301776; Shen B, 2001, PIGM CELL RES, V14, P243, DOI 10.1034/j.1600-0749.2001.140403.x; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; WILSON BS, 1993, P NATL ACAD SCI USA, V90, P1681, DOI 10.1073/pnas.90.5.1681; Young A, 2008, INVEST OPHTH VIS SCI, V49, P3245, DOI 10.1167/iovs.08-1806; Young A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024376	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76240	10.1371/journal.pone.0076240	http://dx.doi.org/10.1371/journal.pone.0076240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098784	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500155
J	Frick, U; Frick, H; Langguth, B; Landgrebe, M; Hubner-Liebermann, B; Hajak, G				Frick, Ulrich; Frick, Hannah; Langguth, Berthold; Landgrebe, Michael; Huebner-Liebermann, Bettina; Hajak, Goeran			The Revolving Door Phenomenon Revisited: Time to Readmission in 17'415 Patients with 37'697 Hospitalisations at a German Psychiatric Hospital	PLOS ONE			English	Article							SURVIVAL-ANALYSIS; RECURRENT EVENTS; FRAILTY MODELS; UNITED-STATES; EARLY-ONSET; FOLLOW-UP; SCHIZOPHRENIA; DISORDER; STAY; RISK	Objective: Despite the recurring nature of the disease process in many psychiatric patients, individual careers and time to readmission rarely have been analysed by statistical models that incorporate sequence and velocity of recurrent hospitalisations. This study aims at comparing four statistical models specifically designed for recurrent event history analysis and evaluating the potential impact of predictor variables from different sources (patient, treatment process, social environment). Method: The so called Andersen-Gil counting process model, two variants of the conditional models of Prentice, Williams, and Peterson (gap time model, conditional probability model), and the so called frailty model were applied to a dataset of 17'415 patients observed during a 12 years period starting from 1996 and leading to 37'697 psychiatric hospitalisations. Potential prognostic factors stem from a standardized patient documentation form. Results: Estimated regression coefficients over different models were highly similar, but the frailty model best represented the sequentiality of individual treatment careers and differing velocities of disease progression. It also avoided otherwise likely misinterpretations of the impact of gender, partnership, historical time and length of stay. A widespread notion of psychiatric diseases as inevitably chronic and worsening could be rejected. Time in community was found to increase over historical time for all patients. Most important protective factors beyond diagnosis were employment, partnership, and sheltered living situation. Risky conditions were urban living and a concurrent substance use disorder. Conclusion: Prognostic factors for course of diseases should be determined only by statistical models capable of adequately incorporating the recurrent nature of psychiatric illnesses.	[Frick, Ulrich; Langguth, Berthold; Landgrebe, Michael; Huebner-Liebermann, Bettina; Hajak, Goeran] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Frick, Ulrich] Dopfer Univ Appl Sci, Dept Psychol, Cologne, Germany; [Frick, Ulrich] Univ Zurich, Res Inst Publ Hlth & Addict, Zurich, Switzerland; [Frick, Hannah] Univ Innsbruck, Dept Stat, A-6020 Innsbruck, Austria; [Landgrebe, Michael; Hajak, Goeran] Sozialstiftung Bamberg, Dept Psychiat Psychosomat & Psychotherapy, Bamberg, Germany	University of Regensburg; University of Zurich; University of Innsbruck	Langguth, B (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	Berthold.Langguth@medbo.de	Langguth, Berthold/AAP-2638-2021		UIniversity of Regensburg	UIniversity of Regensburg	The study was funded by the UIniversity of Regensburg, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2010, R LANG ENV STAT COMP; Appleby L, 1996, PSYCHIATR SERV, V47, P985; APPLEBY L, 1993, AM J PSYCHIAT, V150, P72; Baethge C, 2004, BIPOLAR DISORD, V6, P115, DOI 10.1111/j.1399-5618.2004.00104.x; Clemmensen L, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-150; Cording C, 1995, SPEKTRUM PSYCHIAT PS, V24, P3; Coryell W, 2012, J AFFECTIVE DISORDER; Doering S, 1998, SCHIZOPHRENIA BULL, V24, P87, DOI 10.1093/oxfordjournals.schbul.a033316; Frank D, 2005, PSYCHIAT SERV, V56, P867, DOI 10.1176/appi.ps.56.7.867; Frick U, 2010, DREHTURE STATIONAREN; Frick U, 2008, BASISDATEN STATIONAR; Frick U, 1999, QUALITAT PSYCHIAT RE, P11; Frick U, 2010, ERGEBNISSE MED STAT; Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599; Hardeveld F, 2013, PSYCHOL MED, V43, P39, DOI 10.1017/S0033291712002395; Heggestad T, 2011, SOC PSYCH PSYCH EPID, V46, P1275, DOI 10.1007/s00127-010-0295-y; HERZ MI, 1979, ARCH GEN PSYCHIAT, V36, P701; Johnstone P, 1999, BRIT MED J, V318, P1387, DOI 10.1136/bmj.318.7195.1387; Kessing Lars Vedel, 2005, Curr Psychiatry Rep, V7, P413, DOI 10.1007/s11920-005-0061-0; Kessing LV, 1999, AM J EPIDEMIOL, V149, P404; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Kim HM, 2011, PSYCHIAT SERV, V62, P1346, DOI 10.1176/ps.62.11.pss6211_1346; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kuehner C, 2012, EUR ARCH PSYCHIAT CL; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lees J, 1999, THERAPEUTIC COMMUNIT; LEWIS T, 1990, ACTA PSYCHIAT SCAND, V82, P130, DOI 10.1111/j.1600-0447.1990.tb01369.x; Lim HJ, 2007, ACCIDENT ANAL PREV, V39, P290, DOI 10.1016/j.aap.2006.07.009; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; MARTIN BA, 1976, CAN MED ASSOC J, V115, P322; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; MODESTIN J, 1988, NERVENARZT, V59, P344; Mojtabai R, 2005, AM J PSYCHIAT, V162, P1291, DOI 10.1176/appi.ajp.162.7.1291; Mojtabai R, 1997, PSYCHIAT QUART, V68, P117, DOI 10.1023/A:1025401621060; MORTENSEN PB, 1994, PSYCHOL MED, V24, P223, DOI 10.1017/S0033291700026982; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Olesen AV, 2006, STAT MED, V25, P1672, DOI 10.1002/sim.2298; Olesen AV, 2002, PSYCHOL MED, V32, P1301, DOI 10.1017/S0033291702005548; Perlis RH, 2004, BIOL PSYCHIAT, V55, P875, DOI 10.1016/j.biopsych.2004.01.022; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Prince JD, 2008, PSYCHIAT SERV, V59, P1038, DOI 10.1176/appi.ps.59.9.1038; Saarento O, 1997, ACTA PSYCHIAT SCAND, V95, P132, DOI 10.1111/j.1600-0447.1997.tb00386.x; Schennach R, 2012, CURR PSYCHIAT REP, V14, P229, DOI 10.1007/s11920-012-0261-3; Schmutte T, 2010, J NERV MENT DIS, V198, P860, DOI 10.1097/NMD.0b013e3181fe726b; Silva NC, 2009, PSYCHIAT SERV, V60, P786, DOI 10.1176/ps.2009.60.6.786; Stahler GJ, 2009, AM J PSYCHIAT, V166, P1258, DOI 10.1176/appi.ajp.2009.08111667; Terry Therneau and original Splus-&GT;R port by Thomas Lumley, 2010, SURVIVAL SURVIVAL AN; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Tulloch AD, 2011, ADM POLICY MENT HLTH, V38, P155, DOI 10.1007/s10488-010-0310-3; Viinamaki H, 1996, ACTA PSYCHIAT SCAND, V94, P365, DOI 10.1111/j.1600-0447.1996.tb09874.x; Viinamaki H, 1998, ACTA PSYCHIAT SCAND, V97, P47, DOI 10.1111/j.1600-0447.1998.tb09962.x; Wienke A, 2003, BIOMETRICS, V59, P1178, DOI 10.1111/j.0006-341X.2003.00135.x; Wieselgren IM, 1996, ACTA PSYCHIAT SCAND, V93, P9, DOI 10.1111/j.1600-0447.1996.tb10613.x; WOOGH CM, 1986, CAN J PSYCHIAT, V31, P214, DOI 10.1177/070674378603100306; WOOGH CM, 1977, CAN MED ASSOC J, V116, P876	57	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75612	10.1371/journal.pone.0075612	http://dx.doi.org/10.1371/journal.pone.0075612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116059	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000325552200029
J	Hou, Y; Mattson, MP; Cheng, AW				Hou, Yan; Mattson, Mark P.; Cheng, Aiwu			Permeability Transition Pore-Mediated Mitochondrial Superoxide Flashes Regulate Cortical Neural Progenitor Differentiation	PLOS ONE			English	Article							CYCLOSPORINE-A; NEURONAL DIFFERENTIATION; NEGATIVE REGULATOR; OXIDATIVE-STRESS; STEM-CELLS; PROLIFERATION; NEUROGENESIS; PRECURSOR; FATE	In the process of neurogenesis, neural progenitor cells (NPCs) cease dividing and differentiate into postmitotic neurons that grow dendrites and an axon, become excitable, and establish synapses with other neurons. Mitochondrial biogenesis and aerobic metabolism provide energy substrates required to support the differentiation, growth and synaptic activity of neurons. Mitochondria may also serve signaling functions and, in this regard, it was recently reported that mitochondria can generate rapid bursts of superoxide (superoxide flashes), the frequency of which changes in response to environmental conditions and signals including oxygen levels and Ca2+ fluxes. Here we show that the frequency of mitochondrial superoxide flashes increases as embryonic cerebral cortical neurons differentiate from NPCs, and provide evidence that the superoxide flashes serve a signaling function that is critical for the differentiation process. The superoxide flashes are mediated by mitochondrial permeability transition pore (mPTP) opening, and pharmacological inhibition of the mPTP suppresses neuronal differentiation. Moreover, superoxide flashes and neuronal differentiation are inhibited by scavenging of mitochondrial superoxide. Conversely, manipulations that increase superoxide flash frequency accelerate neuronal differentiation. Our findings reveal a regulatory role for mitochondrial superoxide flashes, mediated by mPTP opening, in neuronal differentiation.	[Hou, Yan; Mattson, Mark P.; Cheng, Aiwu] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov; chengai@mail.nih.gov			National Institute on Aging	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LW, 2000, J IMMUNOL, V164, P2924, DOI 10.4049/jimmunol.164.6.2924; Candelario KM, 2013, J NEUROCHEM, V125, P420, DOI 10.1111/jnc.12204; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; CORDEAULOSSOUARN L, 1991, BIOL CELL, V71, P57, DOI 10.1016/0248-4900(91)90051-N; Davies WR, 2005, J HEART LUNG TRANSPL, V24, P1868, DOI 10.1016/j.healun.2005.04.004; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Filosto M, 2011, J NEUROL, V258, P1763, DOI 10.1007/s00415-011-6104-z; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hou TT, 2013, J BIOL CHEM, V288, P4602, DOI [10.1074/jbc.M113.527770, 10.1074/jbc.M112.398297]; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; Hunt J, 2010, J NEUROSCI, V30, P2888, DOI 10.1523/JNEUROSCI.5991-09.2010; KOSUGI A, 1991, J IMMUNOL, V146, P1416; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Siggins RW, 2008, INT J CLIN EXP MED, V1, P2; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang B, 2009, NEUROSCI LETT, V461, P252, DOI 10.1016/j.neulet.2009.06.020; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364	36	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76721	10.1371/journal.pone.0076721	http://dx.doi.org/10.1371/journal.pone.0076721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116142	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200063
J	Mandrup, OA; Friis, NA; Lykkemark, S; Just, J; Kristensen, P				Mandrup, Ole Aalund; Friis, Niels Anton; Lykkemark, Simon; Just, Jesper; Kristensen, Peter			A Novel Heavy Domain Antibody Library with Functionally Optimized Complementarity Determining Regions	PLOS ONE			English	Article							PHAGE-DISPLAYED LIBRARIES; VARIABLE DOMAINS; HIGH-AFFINITY; BIOPHYSICAL PROPERTIES; MOLECULAR RECOGNITION; FILAMENTOUS PHAGE; COMBINING SITE; VH DOMAINS; AGGREGATION; SELECTION	Today a number of synthetic antibody libraries of different formats have been created and used for the selection of a large number of recombinant antibodies. One of the determining factors for successful isolation of recombinant antibodies from libraries lies in the quality of the libraries i.e. the number of correctly folded, functional antibodies contained in the library. Here, we describe the construction of a novel, high quality, synthetic single domain antibody library dubbed Predator. The library is based on the HEL4 domain antibody with the addition of recently reported mutations concerning the amino acid composition at positions critical for the folding characteristics and aggregation propensities of domain antibodies. As a unique feature, the CDR3 of the library was designed to mimic the natural human immune response by designating amino acids known to be prevalent in functional antibodies to the diversity in CDR3. CDR randomizations were performed using trinucleotide synthesis to avoid the presence of stop codons. Furthermore a novel cycle free elongation method was used for the conversion of the synthesized single stranded DNA containing the randomized CDRs into double stranded DNA of the library. In addition a modular approach has been adopted for the scaffold in which each CDR region is flanked by unique restrictions sites, allowing easy affinity maturation of selected clones by CDR shuffling. To validate the quality of the library, one round phage display selections were performed on purified antigens and highly complex antigen mixtures such as cultured eukaryotic cells resulting in several specific binders. The further characterization of some of the selected clones, however, indicates a reduction in thermodynamic stability caused by the inclusion the additional mutations to the HEL4 scaffold.	[Mandrup, Ole Aalund; Kristensen, Peter] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Friis, Niels Anton; Just, Jesper] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Lykkemark, Simon] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Lykkemark, Simon] Sino Danish Ctr Educ & Res, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, P (corresponding author), Aarhus Univ, Dept Engn, Aarhus, Denmark.	pk@mb.au.dk	Kristensen, Peter/T-6684-2018	Kristensen, Peter/0000-0001-7205-6853; Just, Jesper/0000-0002-3825-0000; Lykkemark, Simon/0000-0001-8920-6926; Mandrup, Ole Aalund/0000-0002-9700-4328	Danish Council for Independent Research \ Technology and Production Sciences [09-065063, 10-081681]; EU FP6 integrated project PROTEOMAGE [518230]; Bioneer A/S	Danish Council for Independent Research \ Technology and Production Sciences(Det Frie Forskningsrad (DFF)); EU FP6 integrated project PROTEOMAGE; Bioneer A/S	The study has been supported by grants from the The Danish Council for Independent Research vertical bar Technology and Production Sciences, grant number 09-065063 and 10-081681. Furthermore the EU FP6 integrated project PROTEOMAGE, grant number 518230, supported part of the study. OAM was supported by a grant from Bioneer A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 2003, CURRENT PROTOCOLS MO; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bond CJ, 2005, J MOL BIOL, V348, P699, DOI 10.1016/j.jmb.2005.02.063; Brockmann EC, 2011, PROTEIN ENG DES SEL, V24, P691, DOI 10.1093/protein/gzr023; Christ D, 2007, PROTEIN ENG DES SEL, V20, P413, DOI 10.1093/protein/gzm037; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; DAVIES J, 1995, BIO-TECHNOL, V13, P475, DOI 10.1038/nbt0595-475; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Dudgeon K, 2009, PROTEIN ENG DES SEL, V22, P217, DOI 10.1093/protein/gzn059; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hust M, 2004, TRENDS BIOTECHNOL, V22, P8, DOI 10.1016/j.tibtech.2003.10.011; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Marks James D, 2004, Methods Mol Biol, V248, P161; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Ramsland PA, 2001, EXP CLIN IMMUNOGENET, V18, P176, DOI 10.1159/000049197; Rattan SIS, 2005, REJUV RES, V8, P46, DOI 10.1089/rej.2005.8.46; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schultz K, 2005, METABOLISM, V54, P287, DOI 10.1016/j.metabol.2004.09.007; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Thie H, 2008, NEW BIOTECHNOL, V25, P49, DOI 10.1016/j.nbt.2008.01.001; Thomas BR, 1996, ACTA CRYSTALLOGR D, V52, P776, DOI 10.1107/S090744499600279X; WADA KN, 1992, NUCLEIC ACIDS RES, V20, P2111, DOI 10.1093/nar/20.suppl.2111; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	47	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76834	10.1371/journal.pone.0076834	http://dx.doi.org/10.1371/journal.pone.0076834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116173	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200077
J	Martin, ME; Bhatnagar, S; George, MD; Paster, BJ; Canfield, DR; Eisen, JA; Solnick, JV				Martin, Miriam E.; Bhatnagar, Srijak; George, Michael D.; Paster, Bruce J.; Canfield, Don R.; Eisen, Jonathan A.; Solnick, Jay V.			The Impact of Helicobacter pylori Infection on the Gastric Microbiota of the Rhesus Macaque	PLOS ONE			English	Article							RIBOSOMAL-RNA; BACTERIAL MICROBIOTA; MAXIMUM-LIKELIHOOD; SPIRAL BACTERIA; GUT MICROBIOTA; IDENTIFICATION; CONSERVATION; ACQUISITION; HEILMANNII; ORGANISMS	Helicobacter pylori colonization is highly prevalent among humans and causes significant gastric disease in a subset of those infected. When present, this bacterium dominates the gastric microbiota of humans and induces antimicrobial responses in the host. Since the microbial context of H. pylori colonization influences the disease outcome in a mouse model, we sought to assess the impact of H. pylori challenge upon the pre-existing gastric microbial community members in the rhesus macaque model. Deep sequencing of the bacterial 16S rRNA gene identified a community profile of 221 phylotypes that was distinct from that of the rhesus macaque distal gut and mouth, although there were taxa in common. High proportions of both H. pylori and H. suis were observed in the post-challenge libraries, but at a given time, only one Helicobacter species was dominant. However, the relative abundance of non-Helicobacter taxa was not significantly different before and after challenge with H. pylori. These results suggest that while different gastric species may show competitive exclusion in the gastric niche, the rhesus gastric microbial community is largely stable despite immune and physiological changes due to H. pylori infection.	[Martin, Miriam E.; Solnick, Jay V.] Univ Calif Davis, Dept Med, Davis, CA 95616 USA; [Martin, Miriam E.; Bhatnagar, Srijak; George, Michael D.; Eisen, Jonathan A.; Solnick, Jay V.] Univ Calif Davis, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Bhatnagar, Srijak; Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Bhatnagar, Srijak] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Canfield, Don R.; Solnick, Jay V.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Paster, Bruce J.] Forsyth Inst, Cambridge, MA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Forsyth Institute	Solnick, JV (corresponding author), Univ Calif Davis, Dept Med, Davis, CA 95616 USA.	jvsolnick@ucdavis.edu	Eisen, Jonathan A./H-2706-2019; Paster, Bruce J/AAP-8559-2021	Eisen, Jonathan A./0000-0002-0159-2197; Solnick, Jay/0000-0002-7435-8393; Bhatnagar, Srijak/0000-0003-0240-2655; Markum, Miriam/0000-0001-5356-8036	National Institutes of Health [R21 AI080788, R21 DE020025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE020025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by grants from the National Institutes of Health to JVS (R21 AI080788) and to MDG (R21 DE020025). http://www.nih.gov/. The sponsors of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DEBONGNIE JC, 1995, AM J GASTROENTEROL, V90, P411; Debongnie JC, 1998, EUR J GASTROEN HEPAT, V10, P251, DOI 10.1097/00042737-199803000-00011; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; DEWHIRST FE, 1994, INT J SYST BACTERIOL, V44, P553, DOI 10.1099/00207713-44-3-553; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; DRAZEK ES, 1994, J CLIN MICROBIOL, V32, P1799, DOI 10.1128/JCM.32.7.1799-1804.1994; DUBOIS A, 1991, GASTROENTEROLOGY, V100, P884, DOI 10.1016/0016-5085(91)90260-R; DUBOIS A, 1994, GASTROENTEROLOGY, V106, P1405, DOI 10.1016/0016-5085(94)90392-1; FAITH DP, 1992, CLADISTICS, V8, P361, DOI 10.1111/j.1096-0031.1992.tb00078.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hornsby MJ, 2008, GASTROENTEROLOGY, V134, P1049, DOI 10.1053/j.gastro.2008.01.018; Huff JL, 2004, INFECT IMMUN, V72, P5216, DOI 10.1128/IAI.72.9.5216-5226.2004; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007985; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Maldonado-Contreras A, 2011, ISME J, V5, P574, DOI 10.1038/ismej.2010.149; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mattapallil JJ, 2000, GASTROENTEROLOGY, V118, P307, DOI 10.1016/S0016-5085(00)70213-7; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; MORGNER A, 1995, LANCET, V346, P511, DOI 10.1016/S0140-6736(95)91364-5; Muller A, 2011, HELICOBACTER, V16, P26, DOI 10.1111/j.1523-5378.2011.00877.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nawrocki E.P., 2009, STRUCTURAL RNA HOMOL, DOI 10.7936/K78050MP; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Putsep K, 1999, FEBS LETT, V451, P249, DOI 10.1016/S0014-5793(99)00582-7; REED KD, 1988, LAB ANIM SCI, V38, P329; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Sachs G, 2005, PHYSIOLOGY, V20, P429, DOI 10.1152/physiol.00032.2005; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SHAMES B, 1989, J CLIN MICROBIOL, V27, P2849, DOI 10.1128/JCM.27.12.2849-2850.1989; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Smolka AJ, 2012, J GASTROENTEROL, V47, P609, DOI 10.1007/s00535-012-0592-1; Solnick JV, 2006, J CLIN MICROBIOL, V44, P3799, DOI 10.1128/JCM.01482-06; Solnick JV, 2003, J CLIN MICROBIOL, V41, P5511, DOI 10.1128/JCM.41.12.5511-5516.2003; Solnick JV, 1999, LAB ANIM SCI, V49, P197; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Van den Bulck K, 2005, J CLIN MICROBIOL, V43, P2256, DOI 10.1128/JCM.43.5.2256-2260.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wroblewski LE, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-29	54	39	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76375	10.1371/journal.pone.0076375	http://dx.doi.org/10.1371/journal.pone.0076375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116104	Green Published, gold			2022-12-27	WOS:000325552200052
J	Rajender, S; Carlus, SJ; Bansal, SK; Negi, MPS; Sadasivam, N; Sadasivam, MN; Thangaraj, K				Rajender, Singh; Carlus, Silas Justin; Bansal, Sandeep Kumar; Negi, Mahendra Pratap Singh; Sadasivam, Nirmala; Sadasivam, Muthusamy Narayanan; Thangaraj, Kumarasamy			Androgen Receptor CAG Repeats Length Polymorphism and the Risk of Polycystic Ovarian Syndrome (PCOS)	PLOS ONE			English	Article							TRINUCLEOTIDE REPEATS; GENE; WOMEN; INFERTILITY; HETEROGENEITY; ASSOCIATION; TESTOSTERONE	Objective: Polycystic ovarian syndrome (PCOS) refers to an inheritable androgen excess disorder characterized by multiple small follicles located at the ovarian periphery. Hyperandrogenism in PCOS, and inverse correlation between androgen receptor (AR) CAG numbers and AR function, led us to hypothesize that CAG length variations may affect PCOS risk. Methods: CAG repeat region of 169 patients recruited following strictly defined Rotterdam (2003) inclusion criteria and that of 175 ethnically similar control samples, were analyzed. We also conducted a meta-analysis on the data taken from published studies, to generate a pooled estimate on 2194 cases and 2242 controls. Results: CAG bi-allelic mean length was between 8.5 and 24.5 (mean = 17.43, SD = 2.43) repeats in the controls and between 11 and 24 (mean = 17.39, SD = 2.29) repeats in the cases, without any significant difference between the two groups. Further, comparison of bi-allelic mean and its frequency distribution in three categories (short, moderate and long alleles) did not show any significant difference between controls and various case subgroups. Frequency distribution of bi-allelic mean in two categories (extreme and moderate alleles) showed over-representation of extreme sized alleles in the cases with marginally significant value (50.3% vs. 61.5%, chi(2) = 4.41; P = 0.036), which turned insignificant upon applying Bonferroni correction for multiple comparisons. X-chromosome inactivation analysis showed no significant difference in the inactivation pattern of CAG alleles or in the comparison of weighed bi-allelic mean between cases and controls. Meta-analysis also showed no significant correlation between CAG length and PCOS risk, except a minor over-representation of short CAG alleles in the cases. Conclusion: CAG bi-allelic mean length did not differ between controls and cases/case sub-groups nor did the allele distribution. Over-representation of short/extreme-sized alleles in the cases may be a chance finding without any true association with PCOS risk.	[Rajender, Singh; Bansal, Sandeep Kumar; Negi, Mahendra Pratap Singh; Thangaraj, Kumarasamy] Cent Drug Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India; [Carlus, Silas Justin] Taibah Univ, CGID, Al Madinah, Saudi Arabia; [Carlus, Silas Justin] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Sadasivam, Nirmala; Sadasivam, Muthusamy Narayanan] Maaruthi Med Ctr & Hosp, Erode, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Taibah University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rajender, S (corresponding author), Cent Drug Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India.	rajender_singh@cdri.res.in; thangs@ccmb.res.in	Carlus S, Justin/AEJ-6606-2022; Singh, Rajender/ABE-3512-2020	Rajender, Singh/0000-0002-4592-6566; Thangaraj, Kumarasamy/0000-0002-0075-0106	Council of Scientific and Industrial Research, Govt of India [BSC0101]	Council of Scientific and Industrial Research, Govt of India(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by the Council of Scientific and Industrial Research, Govt of India, under PROGRAM(BSC0101) network project. The funders did not have any role in study design, decision to publish or preparation of the manuscript.	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ferk P, 2008, FERTIL STERIL, V90, P860, DOI 10.1016/j.fertnstert.2007.07.1291; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Jaaskelainen J, 2005, FERTIL STERIL, V83, P1724, DOI 10.1016/j.fertnstert.2004.11.080; Kim JJ, 2008, FERTIL STERIL, V90, P2318, DOI 10.1016/j.fertnstert.2007.10.030; Laisk T, 2010, ACTA OBSTET GYN SCAN, V89, P1557, DOI 10.3109/00016349.2010.526182; Liu QR, 2008, ENDOCRINE, V33, P165, DOI 10.1007/s12020-008-9069-7; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Mohlig M, 2006, EUR J ENDOCRINOL, V155, P127, DOI 10.1530/eje.1.02195; Moran C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/317241; Nenonen H, 2010, MOL HUM REPROD, V16, P153, DOI 10.1093/molehr/gap097; Nenonen HA, 2011, INT J ANDROL, V34, P327, DOI 10.1111/j.1365-2605.2010.01084.x; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Radian S, 2010, ENDOCRINE, V22, P498; Rajender S, 2007, ASIAN J ANDROL, V9, P147, DOI 10.1111/j.1745-7262.2007.00250.x; Robeva R, 2010, END ABSTR, V22, P459; Schuring AN, 2012, EXP CLIN ENDOCR DIAB, V120, P73, DOI 10.1055/s-0031-1291343; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Skrgatic L, 2012, J STEROID BIOCHEM, V128, P107, DOI 10.1016/j.jsbmb.2011.11.006; Thangaraj K, 2002, J ANDROL, V23, P815; Tong D, 2010, J ENDOCRINOL INVEST, V33, P559, DOI [10.1007/BF03346648, 10.3275/6871]; Trivax B, 2007, CLIN OBSTET GYNECOL, V50, P168, DOI 10.1097/GRF.0b013e31802f351b; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Wang R, 2012, MOL HUM REPROD, V18, P498, DOI 10.1093/molehr/gas024; Xia YJ, 2012, MOL MED REP, V5, P1330, DOI 10.3892/mmr.2012.789; Xita N, 2008, HUM REPROD, V23, P693, DOI 10.1093/humrep/dem382; Zhang T, 2013, GENE, V524, P161, DOI 10.1016/j.gene.2013.04.040	33	18	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75709	10.1371/journal.pone.0075709	http://dx.doi.org/10.1371/journal.pone.0075709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116069	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200035
J	Spathe, A; Reinecke, A; Haverkamp, A; Hansson, BS; Knaden, M				Spaethe, Anna; Reinecke, Andreas; Haverkamp, Alexander; Hansson, Bill S.; Knaden, Markus			Host Plant Odors Represent Immiscible Information Entities - Blend Composition and Concentration Matter in Hawkmoths	PLOS ONE			English	Article							OVIPOSITION BEHAVIOR; FLORAL CO2; INSECTS; PERCEPTION; VOLATILES; LOCATION; BEETLE	Host plant choice is of vital importance for egg laying herbivorous insects that do not exhibit brood care. Several aspects, including palatability, nutritional quality and predation risk, have been found to modulate host preference. Olfactory cues are thought to enable host location. However, experimental data on odor features that allow choosing among alternative hosts while still in flight are not available. It has previously been shown that M. sexta females prefer Datura wrightii compared to Nicotiana attenuata. The bouquet of the latter is more intense and contains compounds typically emitted by plants after feeding-damage to attract the herbivore's enemies. In this wind tunnel study, we offered female gravid hawkmoths (Manduca sexta) odors from these two ecologically relevant, attractive, non-flowering host species. M. sexta females preferred surrogate leaves scented with vegetative odors form both host species to unscented control leaves. Given a choice between species, females preferred the odor bouquet emitted by D. wrightii to that of N. attenuata. Harmonizing, i.e. adjusting, volatile intensity to similar levels did not abolish but significantly weakened this preference. Superimposing, i.e. mixing, the highly attractive headspaces of both species, however, abolished discrimination between scented and non-scented surrogate leaves. Beyond ascertaining the role of blend composition in host plant choice, our results raise the following hypotheses. (i) The odor of a host species is perceived as a discrete odor 'Gestalt', and its core properties are lost upon mixing two attractive scents (ii). Stimulus intensity is a secondary feature affecting olfactory-based host choice (iii). Constitutively smelling like a plant that is attracting herbivore enemies may be part of a plant's strategy to avoid herbivory where alternative hosts are available to the herbivore.	[Spaethe, Anna; Reinecke, Andreas; Haverkamp, Alexander; Hansson, Bill S.; Knaden, Markus] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Max Planck Society	Hansson, BS (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	hansson@ice.mpg.de; mknaden@ice.mpg.de	Knaden, Markus/E-2151-2015; Hansson, Bill S/G-2774-2013	Knaden, Markus/0000-0002-6710-1071; Hansson, Bill S/0000-0002-4811-1223; Reinecke, Andreas/0000-0002-9336-7324; Haverkamp, Alexander/0000-0003-3512-9659	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrell L, 2005, GLOBAL CHANGE BIOL, V11, P1272, DOI 10.1111/j.1365-2486.2005.00989.x; Adler LS, 2004, ECOLOGY, V85, P1519, DOI 10.1890/03-0409; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Goyret J, 2008, P NATL ACAD SCI USA, V105, P4565, DOI 10.1073/pnas.0708629105; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Guerenstein PG, 2004, J COMP PHYSIOL A, V190, P707, DOI 10.1007/s00359-004-0529-0; Kariyat RR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0020; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler D, 2012, ENTOMOL EXP APPL, V144, P112, DOI 10.1111/j.1570-7458.2012.01270.x; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; Stange G, 1999, NATURWISSENSCHAFTEN, V86, P190, DOI 10.1007/s001140050595; THIERY D, 1987, J CHEM ECOL, V13, P1139, DOI 10.1007/BF01020544; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; YAMAMOTO ROBERT T., 1960, ANN ENT SOC AMER, V53, P503, DOI 10.1093/aesa/53.4.503	29	19	20	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77135	10.1371/journal.pone.0077135	http://dx.doi.org/10.1371/journal.pone.0077135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116211	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200104
J	Zhang, L; Zhang, D; Chen, W; Zou, X; Ling, L				Zhang, Lei; Zhang, Di; Chen, Wen; Zou, Xia; Ling, Li			High Prevalence of HIV, HCV and Tuberculosis and Associated Risk Behaviours among New Entrants of Methadone Maintenance Treatment Clinics in Guangdong Province, China	PLOS ONE			English	Article							INJECTION-DRUG USERS; FEMALE SEX WORKERS; HEPATITIS-C VIRUS; MENTAL-HEALTH; GENDER-DIFFERENCES; INFECTION; EPIDEMIOLOGY; SICHUAN; AIDS; TRANSITION	Background: Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006. This study aims to estimate the prevalence levels of HIV, Hepatitis C (HCV), Tuberculosis (TB) and their co-infections and associated demographic and risk behaviours among MMT entrants. Method: A total of 2296 drug users at the time of their MMT enrolment were recruited from four clinics during 2006-2011. Participants' demographic characteristics, infection status and self-reported high-risk drug-use and sexual behaviours were surveyed. Log-linear contingency analysis was employed to investigate the demographic and behavioural differences between gender and drug-user type, while multivariate regression analysis was used to identify the associated factors of HIV, HCV and TB infections. Results: Female drug users demonstrate significantly higher frequency of daily drug consumption (Log-linear contingency analysis, G(2)=10.86, p=0.013) and higher proportion of having had sex in the past three months (G(2)=30.22, p<0.001) than their male counterparts. Among injecting drug users, females also inject (chi(2)=16.15, p=0.001) and share syringes (chi(2)=13.24, p=0.004) more frequently than males. Prevalence of HIV, HCV and TB among MMT entrants are 6.3%, 78.7% and 4.4% respectively. Co-infections of HIV/HCV, HIV/TB, HCV/TB and HIV/HCV/TB reportedly infect 5.6%, 0.5%, 3.8% and 0.3% of study participants. Infection risks of HIV, HCV and TB are consistently associated with increasing length of drug use, injecting drugs, financial dependence and reduced sexual activities. Conclusion: Injecting drug use is the major contributing factor in prevalence levels of HIV, HCV and TB among MMT entrants. Female drug users are more disadvantaged in their social status and risk-taking in their drug use behaviours than males.	[Zhang, Lei; Zhang, Di; Chen, Wen; Zou, Xia; Ling, Li] Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Di; Chen, Wen; Zou, Xia; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Zhang, Di] Sun Yat Sen Univ, Off Med Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of New South Wales Sydney; Kirby Institute; Sun Yat Sen University	Ling, L (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn	Zou, Xia/U-2205-2019; Zhang, Lei/D-4039-2011	Zhang, Lei/0000-0003-2343-084X	Natural Science Foundation of China [71173245, 30972552]; Globe Fund of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Globe Fund of China	This project supported by Natural Science Foundation of China (number 71173245) (http://www.nsfc.gov.cn/Portal0/default152.htm), Natural Science Foundation of China (number 30972552), Globe Fund of China of 2012 (http://ncaids.chinacdc.cn/gjhz/hdjz8/201208/t20120802_1820489.htm). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; Anderson T.L., 2001, ENCY CRIMINOLOGY DEV, V4, P286; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Barclay D M 3rd, 1995, Arch Fam Med, V4, P541, DOI 10.1001/archfami.4.6.541; Bloor R, 2006, AM J ADDICTION, V15, P201, DOI 10.1080/10550490600625269; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Bruce RD, 2010, INT J DRUG POLICY, V21, P122, DOI 10.1016/j.drugpo.2009.10.004; Chen W, 2012, J ADDICT MED, V6, P212, DOI 10.1097/ADM.0b013e318259b2c4; *CHIN MOHOTPSRO, 2008, CRIT DIAGN TUB; Choi SYP, 2006, SOC SCI MED, V62, P1672, DOI 10.1016/j.socscimed.2005.08.046; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Corsi KF, 2009, J SUBST ABUSE TREAT, V37, P120, DOI 10.1016/j.jsat.2008.11.004; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Dembo R, 2010, J CHILD ADOLES SUBST, V19, P424, DOI 10.1080/1067828X.2010.515886; DESJARLAIS DC, 1992, BRIT J ADDICT, V87, P493; Drobniewski FA, 2005, EUR RESPIR J, V26, P298, DOI 10.1183/09031936.05.00136004; Elifson KW, 2007, AIDS BEHAV, V11, pS45, DOI 10.1007/s10461-007-9306-8; Forsythe L, 2009, TRENDS ISS CRIME CRI, P1; Garfein RS, 2009, INT J TUBERC LUNG D, V13, P626; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Gilchrist G, 2011, AIDS BEHAV, V15, P1834, DOI 10.1007/s10461-011-9991-1; Gu J, 2010, WOMEN HEALTH, V50, P20, DOI 10.1080/03630241003601137; HAAS K, 2004, ANN REV UNDERGRADUAT, V3, P92; Hartel DM, 2006, CLIN INFECT DIS, V43, P525, DOI 10.1086/505978; Irwin KL, 1996, DRUG ALCOHOL DEPEN, V42, P85, DOI 10.1016/0376-8716(96)01262-8; James S, 2013, ADDICT BEHAV, V38, P1804, DOI 10.1016/j.addbeh.2012.09.002; Johnson H, 2006, AUST NZ J CRIMINOL, V39, P190, DOI 10.1375/acri.39.2.190; Jones DL, 2010, AIDS CARE, V22, P152, DOI 10.1080/09540120903039851; KU HH, 1974, AM STAT, V28, P115, DOI 10.2307/2683334; Lau JTF, 2011, AIDS BEHAV, V15, P86, DOI 10.1007/s10461-010-9754-4; Lau JTF, 2009, AIDS CARE, V21, P909, DOI 10.1080/09540120802612790; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; *MIN HLTH CHIN, 2006, NAT GUID COMM BAS ME; *MIN HLTH CHIN, 2011, EST HIV AIDS EP CHIN; Neale J, 2004, BRIT J SOC WORK, V34, P851, DOI 10.1093/bjsw/bch105; NELDER JA, 1974, ROY STAT SOC C-APP, V23, P323; Niveau G, 2006, PUBLIC HEALTH, V120, P33, DOI 10.1016/j.puhe.2005.03.017; Nolte S, 2013, QUAL LIFE RES, V22; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Peng EYC, 2011, J FORMOS MED ASSOC, V110, P446, DOI 10.1016/S0929-6646(11)60066-1; Perlman DC, 1999, SOC SCI MED, V48, P1441, DOI 10.1016/S0277-9536(98)00448-1; Powis B, 1996, SUBST USE MISUSE, V31, P529, DOI 10.3109/10826089609045825; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Roy S, 2011, J NEUROIMMUNE PHARM, V6, P442, DOI 10.1007/s11481-011-9292-5; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Tran TMT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-248; *UN OFF DRUGS CRIN, 2012, WORLD DRUG REP; VANAMEIJDEN EJC, 1994, AM J EPIDEMIOL, V139, P1153, DOI 10.1093/oxfordjournals.aje.a116962; Vega WA, 1998, ADDICTION, V93, P1839, DOI 10.1046/j.1360-0443.1998.931218399.x; VU TTM, 2010, KHAN HOA PROVINCE VI; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; Wang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045632; Wei Z., 2003, TRENDS ISSUES CRIME, V278; *WHO UNICEF, 2011, PROGR REP 2011 GLOB; World Health Organization, 2006, STOP TB STRAT BUILD; Wu F, 2013, J PUBLIC HEALTH-UK, V35, P206, DOI 10.1093/pubmed/fds079; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia YH, 2013, PSYCHOL HEALTH MED, V18, P321, DOI 10.1080/13548506.2012.729845; Xu JJ, 2012, INT J STD AIDS, V23, P670, DOI 10.1258/ijsa.2009.009128; YIN W, 2009, CHIN J INFECT CONTRO, V8, P384; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang, 2010, CHIN J DIS CONTROL P, V14, P300; Zhao L, 2012, AIDS CARE, V24, P195, DOI 10.1080/09540121.2011.596520; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	70	19	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76931	10.1371/journal.pone.0076931	http://dx.doi.org/10.1371/journal.pone.0076931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116185	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200085
J	Farmer, DT; Shariat, N; Park, CY; Liu, HJ; Mavropoulos, A; McManus, MT				Farmer, D'Juan T.; Shariat, Nikki; Park, Chong Yon; Liu, Huey Jiin; Mavropoulos, Anastasia; McManus, Michael T.			Partially Penetrant Postnatal Lethality of an Epithelial Specific MicroRNA in a Mouse Knockout	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; POSTTRANSCRIPTIONAL REGULATION; EXPRESSION; MIR-205; CANCER; P63; MORPHOGENESIS; BIOGENESIS; DISEASE; LIMB	MicroRNAs are small noncoding RNAs thought to have pivotal roles in numerous diseases and developmental processes. However, a growing body of literature indicates that in vivo elimination of these tiny RNAs usually has little to no observable consequence, suggesting functional redundancy with other microRNAs or cellular pathways. We provide an in-depth analysis of miR-205 expression and define miR-205 as an epithelial-specific microRNA, and for the first time show that ablation of this microRNA knockout exhibits partially penetrant lethality in a constitutive mouse knockout model. Given the role of this microRNA in cancer and development, this mouse model will be an incredible reagent to study the function and mechanisms of miR-205 in epithelial tissue development and disease.	[Farmer, D'Juan T.; Shariat, Nikki; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Mavropoulos, Anastasia] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Farmer, D'Juan T.; Shariat, Nikki; Park, Chong Yon; Liu, Huey Jiin; Mavropoulos, Anastasia; McManus, Michael T.] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Farmer, D'Juan T.; Shariat, Nikki; Park, Chong Yon; Liu, Huey Jiin; McManus, Michael T.] Univ Calif San Francisco, WM Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McManus, MT (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	michael.mcmanus@ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Shariat, Nikki/0000-0003-3943-4829	National Institute of General Medical Sciences (NIGMS) IMSD Fellowship; WM Keck Foundation; National Institutes of Health (NIH) [DK063720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810] Funding Source: NIH RePORTER; Direct For Education and Human Resources [1011717] Funding Source: National Science Foundation	National Institute of General Medical Sciences (NIGMS) IMSD Fellowship; WM Keck Foundation(W.M. Keck Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was supported by a National Institute of General Medical Sciences (NIGMS) IMSD Fellowship to DF and the WM Keck Foundation and National Institutes of Health (NIH) DK063720 to MTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fletcher AM, 2008, TRANSL ONCOL, V1, P202, DOI 10.1593/tlo.08163; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Matsushima K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-30; Matsushima K, 2010, DIGESTION, V82, P138, DOI 10.1159/000310918; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Ryan D, 2006, MOL VIS, V12, P1175; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Xie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046990; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	31	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76634	10.1371/journal.pone.0076634	http://dx.doi.org/10.1371/journal.pone.0076634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116130	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300076
J	Haaker, J; Lonsdorf, TB; Thanellou, A; Kalisch, R				Haaker, Jan; Lonsdorf, Tina B.; Thanellou, Alexandra; Kalisch, Raffael			Multimodal Assessment of Long-Term Memory Recall and Reinstatement in a Combined Cue and Context Fear Conditioning and Extinction Paradigm in Humans	PLOS ONE			English	Article							UNPREDICTABLE AVERSIVE EVENTS; SPONTANEOUS-RECOVERY; BASOLATERAL AMYGDALA; POTENTIATED STARTLE; EXTINGUISHED FEAR; RESPONSES; ANXIETY; ACQUISITION; RETURN; HIPPOCAMPUS	Learning to predict danger via associative learning processes is critical for adaptive behaviour. After successful extinction, persisting fear memories often emerge as returning fear. Investigation of return of fear phenomena, e. g. reinstatement, have only recently began and to date, many critical questions with respect to reinstatement in human populations remain unresolved. Few studies have separated experimental phases in time even though increasing evidence shows that allowing for passage of time (and consolidation) between experimental phases has a major impact on the results. In addition, studies have relied on a single psychophysiological dimension only (SCRs/SCL or FPS) which hampers comparability between different studies that showed both differential or generalized return of fear following a reinstatement manipulation. In 93 participants, we used a multimodal approach (fear-potentiated startle, skin conductance responses, fear ratings to asses fear conditioning (day 1), extinction (day 2) as well as delayed memory recall and reinstatement (day 8) in a paradigm that probed contextual and cued fear intra-individually. Our findings show persistence of conditioning and extinction memory over time and demonstrate that reinstated fear responses were qualitatively different between dependent variables (subjective fear ratings, FPS, SCRs) as well as between cued and contextual CSs. While only the arousal-related measurement (SCRs) showed increasing reactions following reinstatement to the cued CSs, no evidence of reinstatement was observed for the subjective ratings and fear-related measurement (FPS). In contrast, for contextual CSs, reinstatement was evident as differential and generalized reinstatement in fear ratings as well as generally elevated physiological fear (FPS) and arousal (SCRs) related measurements to all contextual CSs (generalized non-differential reinstatement). Returning fear after reinstatement likely depends on a variety of variables (experimental design, dependent measurements) and more systematic investigations with respect to critical determinants of reinstatement in humans are required.	[Haaker, Jan; Lonsdorf, Tina B.; Thanellou, Alexandra; Kalisch, Raffael] Univ Med Ctr Hamburg Eppendorf UKE, Inst Syst Neurosci, Hamburg, Germany; [Kalisch, Raffael] Johannes Gutenberg Univ Mainz, Med Ctr, Neuroimaging Ctr Mainz NIC, Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Haaker, J (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Inst Syst Neurosci, Hamburg, Germany.	j.haaker@uke.de	Kalisch, Raffael/H-6624-2016; Lonsdorf, Tina/K-8657-2017; Kalisch, Raffael/A-9863-2018; Haaker, Jan/J-4670-2014	Haaker, Jan/0000-0001-8366-9559; Lonsdorf, Tina/0000-0003-1501-4846	State of Hamburg excellence initiative (neurodapt! consortium) [SFB TRR58]; Deutsche Forschungsgemeinschaft (DFG) [KA 1623/3-1, KA 1623/4-1]	State of Hamburg excellence initiative (neurodapt! consortium); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the SFB TRR58 (subproject B06) State of Hamburg excellence initiative (neurodapt! consortium) and the Deutsche Forschungsgemeinschaft (DFG grants KA 1623/3-1 and KA 1623/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Craske MG, 2008, BEHAV RES THER, V46, P5, DOI 10.1016/j.brat.2007.10.003; Craske MG, 2012, J ABNORM PSYCHOL, V121, P315, DOI 10.1037/a0025738; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dirikx T, 2004, LEARN MEMORY, V11, P549, DOI 10.1101/lm.78004; Dirikx T, 2007, Q J EXP PSYCHOL, V60, P1313, DOI 10.1080/17470210701515785; Dirikx T, 2007, J BEHAV THER EXP PSY, V38, P237, DOI 10.1016/j.jbtep.2006.04.001; Dirikx T, 2009, ACTA PSYCHOL, V130, P175, DOI 10.1016/j.actpsy.2008.12.002; FANSELOW MS, 1980, J EXP PSYCHOL ANIM B, V6, P65, DOI 10.1037/0097-7403.6.1.65; Fonteyne R, 2010, BIOL PSYCHOL, V85, P361, DOI 10.1016/j.biopsycho.2010.08.007; Fonteyne R, 2009, BEHAV RES THER, V47, P830, DOI 10.1016/j.brat.2009.06.011; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; Golkar A, 2012, BIOL PSYCHOL, V91, P292, DOI 10.1016/j.biopsycho.2012.07.007; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; Grillon C, 2006, BIOL PSYCHIAT, V60, P752, DOI 10.1016/j.biopsych.2006.03.072; Harris JA, 2000, J EXP PSYCHOL-ANIM B, V26, P174, DOI 10.1037//0097-7403.26.2.174; Hermans D, 2005, BEHAV RES THER, V43, P533, DOI 10.1016/j.brat.2004.03.013; Huff NC, 2009, BEHAV NEUROSCI, V123, P834, DOI 10.1037/a0016511; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Kull S, 2012, ACTA PSYCHOL, V140, P43, DOI 10.1016/j.actpsy.2012.02.007; LaBar KS, 2005, BEHAV NEUROSCI, V119, P677, DOI 10.1037/0735-7044.119.3.677; Laurent V, 2010, LEARN MEMORY, V17, P86, DOI 10.1101/lm.1655010; Laux L., 1981, STATE TRAIT ANGSTINV; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI [10.1186/2045-5380-2-7, 10.1186/2045-5380-2-3]; Lin HC, 2011, J NEUROSCI, V31, P8851, DOI 10.1523/JNEUROSCI.0979-11.2011; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lommen MJJ, 2013, BEHAV RES THER, V51, P63, DOI 10.1016/j.brat.2012.11.004; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008; Merz CJ, 2010, PSYCHONEUROENDOCRINO, V35, P33, DOI 10.1016/j.psyneuen.2009.07.009; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2006, BEHAV NEUROSCI, V120, P1196, DOI 10.1037/0735-7044.120.5.1196; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Morris RW, 2005, BEHAV NEUROSCI, V119, P1662, DOI 10.1037/0735-7044.119.6.1662; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Norrholm SD, 2008, BEHAV NEUROSCI, V122, P1016, DOI 10.1037/a0012604; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; RACHMAN S, 1989, CLIN PSYCHOL REV, V9, P147, DOI 10.1016/0272-7358(89)90025-1; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Sokol N, 2012, BEHAV RES THER, V50, P313, DOI 10.1016/j.brat.2012.02.005; Spielberger CD, 1985, SO PSYCHOL, V2, P6; Vansteenwegen D, 2008, BIOL PSYCHOL, V77, P39, DOI 10.1016/j.biopsycho.2007.08.012; Venables PH., 1980, TECHNIQUES PSYCHOPHY; Vervliet B, 2013, BIOL PSYCHOL, V92, P51, DOI 10.1016/j.biopsycho.2012.01.006; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Westbrook FR, 2002, J EXP PSYCHOL-ANIM B, V28, P97, DOI 10.1037//0097-7403.28.1.97	57	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76179	10.1371/journal.pone.0076179	http://dx.doi.org/10.1371/journal.pone.0076179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116095	gold, Green Submitted, Green Published			2022-12-27	WOS:000325501300050
J	Kato, K; Ishii, R; Goto, E; Ishitani, R; Tokunaga, F; Nureki, O				Kato, Kazuki; Ishii, Ryohei; Goto, Eiji; Ishitani, Ryuichiro; Tokunaga, Fuminori; Nureki, Osamu			Structural and Functional Analyses of DNA-Sensing and Immune Activation by Human cGAS	PLOS ONE			English	Article							CYCLIC GMP-AMP; CYTOSOLIC DNA; 2ND-MESSENGER; SENSOR; RECOGNITION; UBIQUITINATION; INFLAMMASOME; DINUCLEOTIDE; HELICASE; ADAPTER	The detection of cytosolic DNA, derived from pathogens or host cells, by cytosolic receptors is essential for appropriate host immune responses. Cyclic GMP-AMP synthase (cGAS) is a newly identified cytosolic DNA receptor that produces cyclic GMP-AMP, which activates stimulator of interferon genes (STING), resulting in TBK1-IRF3 pathway activation followed by the production of type I interferons. Here we report the crystal structure of human cGAS. The structure revealed that a cluster of lysine and arginine residues forms the positively charged DNA binding surface of human cGAS, which is important for the STING-dependent immune activation. A structural comparison with other previously determined cGASs and our functional analyses suggested that a conserved zinc finger motif and a leucine residue on the DNA binding surface are crucial for the DNA-specific immune response of human cGAS, consistent with previous work. These structural features properly orient the DNA binding to cGAS, which is critical for DNA-induced cGAS activation and STING-dependent immune activation. Furthermore, we showed that the cGAS-induced activation of STING also involves the activation of the NF-kappa B and IRF3 pathways. Our results indicated that cGAS is a DNA sensor that efficiently activates the host immune system by inducing two distinct pathways.	[Kato, Kazuki; Ishii, Ryohei; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan; [Kato, Kazuki; Ishii, Ryohei; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama, Japan; [Goto, Eiji; Tokunaga, Fuminori] Gunma Univ, Mol Cell Biol Lab, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan	University of Tokyo; RIKEN; Gunma University	Tokunaga, F (corresponding author), Gunma Univ, Mol Cell Biol Lab, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	ftokunaga@gunma-u.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014	Tokunaga, Fuminori/0000-0003-3626-9119; Ishii, Ryohei/0000-0003-2486-1393	Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22117006] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS), through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)", to O.N., by the Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST) to F. T. and O.N., by a grant for the National Project on Protein Structural and Functional Analyses and Platform for Drug Discovery, Informatics, and Structural Life Science, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), to O.N., by a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT to F. T., R. I., and O.N., and by a grant from Takeda Science Foundation to F. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Tokunaga F, 2012, MICROBES INFECT, V14, P563, DOI 10.1016/j.micinf.2012.01.011; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	34	46	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76983	10.1371/journal.pone.0076983	http://dx.doi.org/10.1371/journal.pone.0076983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116191	gold, Green Submitted, Green Published			2022-12-27	WOS:000325501300109
J	Pfeilsticker, JA; Umeda, A; Farrow, B; Hsueh, CL; Deyle, KM; Kim, JT; Lai, BT; Heath, JR				Pfeilsticker, Jessica A.; Umeda, Aiko; Farrow, Blake; Hsueh, Connie L.; Deyle, Kaycie M.; Kim, Jocelyn T.; Lai, Bert T.; Heath, James R.			A Cocktail of Thermally Stable, Chemically Synthesized Capture Agents for the Efficient Detection of Anti-Gp41 Antibodies from Human Sera	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTION; DIAGNOSTICS; PROTEIN; WORLD; GP41	We report on a method to improve in vitro diagnostic assays that detect immune response, with specific application to HIV-1. The inherent polyclonal diversity of the humoral immune response was addressed by using sequential in situ click chemistry to develop a cocktail of peptide-based capture agents, the components of which were raised against different, representative anti-HIV antibodies that bind to a conserved epitope of the HIV-1 envelope protein gp41. The cocktail was used to detect anti-HIV-1 antibodies from a panel of sera collected from HIV-positive patients, with improved signal-to-noise ratio relative to the gold standard commercial recombinant protein antigen. The capture agents were stable when stored as a powder for two months at temperatures close to 60 degrees C.	[Pfeilsticker, Jessica A.; Umeda, Aiko; Hsueh, Connie L.; Deyle, Kaycie M.; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Farrow, Blake] CALTECH, Div Engn & Appl Sci, Div Biol, Pasadena, CA 91125 USA; [Kim, Jocelyn T.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Lai, Bert T.] Indi Mol, Culver City, CA USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Heath, JR (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	heath@caltech.edu		Farrow, Blake/0000-0002-1007-7111; Kim, Jocelyn/0000-0001-7040-5773; Butler, Kaycie/0000-0002-8365-5867	Bill and Melinda Gates Foundation; Institute for Collaborative Biotechnologies through U.S. Army Research Office [W911NF-09-0001]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Institute for Collaborative Biotechnologies through U.S. Army Research Office	This work was funded primarily by a grant from the Bill and Melinda Gates Foundation. Additional funding for the development of screening approaches, and for certain capture agent characterization methods, was provided by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew HD, 2009, ANGEW CHEM INT EDIT, V48, P4944, DOI 10.1002/anie.200900488; Alvarez Marta, 2012, Open Virol J, V6, P135, DOI 10.2174/1874357901206010135; Brachman PS, 1996, MED MICROBIOLOGY; Butto S, 2010, ANN I SUPER SANITA, V46, P24, DOI 10.4415/ANN_10_01_04; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Daskalakis Demetre, 2011, Top Antivir Med, V19, P18; Du APC, 2002, J MOL BIOL, V323, P503, DOI 10.1016/S0022-2836(02)00701-5; Fanales-Belasio E, 2010, ANN I SUPER SANITA, V46, P5, DOI 10.4415/ANN_10_01_02; Finn MG, 2010, CHEM SOC REV, V39, P1231, DOI 10.1039/c003740k; Ginocchio CC, 2011, J CLIN VIROL, V52, pS1, DOI 10.1016/j.jcv.2011.09.025; Huisgen R., 1984, 1 3 DIPOLAR CYCLOADD, V1-2, P1; Iweala OI, 2004, CONTRACEPTION, V70, P141, DOI 10.1016/j.contraception.2004.03.012; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; Lam KS, 1997, CHEM REV, V97, P411, DOI 10.1021/cr9600114; Millward SW, 2011, J AM CHEM SOC, V133, P18280, DOI 10.1021/ja2064389; Tebourski F, 2004, DIAGN MICR INFEC DIS, V48, P59, DOI 10.1016/j.diagmicrobio.2003.08.004; Thirumurugan P., 2013, CHEM REV, DOI org/10.1021/cr200409f; Tiwari RP, 2013, J IMMUNOL METHODS, V387, P157, DOI 10.1016/j.jim.2012.10.009; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991	19	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76224	10.1371/journal.pone.0076224	http://dx.doi.org/10.1371/journal.pone.0076224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116098	Green Accepted, Green Published, gold			2022-12-27	WOS:000325501300053
J	Xiong, J; Zhou, T				Xiong, Jie; Zhou, Tong			A Kalman-Filter Based Approach to Identification of Time-Varying Gene Regulatory Networks	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; RADIATION TOLERANCE; SPINAL-CORD; INFERENCE; SYSTEMS; EXPRESSION; DYNAMICS; MODELS	Motivation: Conventional identification methods for gene regulatory networks (GRNs) have overwhelmingly adopted static topology models, which remains unchanged over time to represent the underlying molecular interactions of a biological system. However, GRNs are dynamic in response to physiological and environmental changes. Although there is a rich literature in modeling static or temporally invariant networks, how to systematically recover these temporally changing networks remains a major and significant pressing challenge. The purpose of this study is to suggest a two-step strategy that recovers time-varying GRNs. Results: It is suggested in this paper to utilize a switching auto-regressive model to describe the dynamics of time-varying GRNs, and a two-step strategy is proposed to recover the structure of time-varying GRNs. In the first step, the change points are detected by a Kalman-filter based method. The observed time series are divided into several segments using these detection results; and each time series segment belonging to two successive demarcating change points is associated with an individual static regulatory network. In the second step, conditional network structure identification methods are used to reconstruct the topology for each time interval. This two-step strategy efficiently decouples the change point detection problem and the topology inference problem. Simulation results show that the proposed strategy can detect the change points precisely and recover each individual topology structure effectively. Moreover, computation results with the developmental data of Drosophila Melanogaster show that the proposed change point detection procedure is also able to work effectively in real world applications and the change point estimation accuracy exceeds other existing approaches, which means the suggested strategy may also be helpful in solving actual GRN reconstruction problem.	[Xiong, Jie] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Xiong, J (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	xiongj08@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program [2012CB316504, 2009CB320602]; National Natural Science Foundation of China [61174122, 61021063, 60721003, 60625305]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported in part by the 973 Program under Grant 2012CB316504 and 2009CB320602, and by the National Natural Science Foundation of China under Grants 61174122, 61021063, 60721003 and 60625305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, P NATL ACAD SCI USA, V106, P11878, DOI 10.1073/pnas.0901910106; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Dondelinger F, 2013, MACH LEARN, V90, P191, DOI 10.1007/s10994-012-5311-x; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Grzegorczyk M, 2011, MACH LEARN, V83, P355, DOI 10.1007/s10994-010-5230-7; Hempel S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.054101; HOMYK T, 1988, GENETICS, V119, P105; Ljung L., 1999, SYSTEM IDENTIFICATIO; Ljung L., 1983, THEORY PRACTICE RECU; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Nongthomba U, 2003, GENETICS, V164, P209; Paoletti S, 2007, EUR J CONTROL, V13, P242, DOI 10.3166/EJC.13.242-260; PARKHURST SM, 1991, GENE DEV, V5, P341, DOI 10.1101/gad.5.3.341; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Robinson JW, 2010, J MACH LEARN RES, V11, P3647; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89; Stafford SL, 2003, INT J RADIAT ONCOL, V55, P1177, DOI 10.1016/S0360-3016(02)04380-8; VANDERKOGEL AJ, 1977, RADIOLOGY, V122, P505, DOI 10.1148/122.2.505; VONESSEN CF, 1969, ACTA RADIOL THER PHY, V8, P311, DOI 10.3109/02841866909134462; WARA WM, 1975, CANCER, V35, P1558, DOI 10.1002/1097-0142(197506)35:6<1558::AID-CNCR2820350613>3.0.CO;2-7; Wu FX, 2010, IEEE ENG MED BIO, P795, DOI 10.1109/IEMBS.2010.5626506; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043819; Yoshida R, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P289, DOI 10.1109/CSB.2005.32; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042306; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	31	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74571	10.1371/journal.pone.0074571	http://dx.doi.org/10.1371/journal.pone.0074571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116005	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300008
J	Carlsson, M; Gustavsson, M; Hu, GZ; Muren, E; Ronne, H				Carlsson, Mattias; Gustavsson, Marie; Hu, Guo-Zhen; Muren, Eva; Ronne, Hans			A Ham1p-Dependent Mechanism and Modulation of the Pyrimidine Biosynthetic Pathway can both Confer Resistance to 5-Fluorouracil in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CARBAMOYL-PHOSPHATE; ARGININE METABOLISM; CANCER-CELLS; EXPRESSION; PROTEINS; ENZYMES; GENOME; MUTANT; GENES	5-Fluorouracil (5-FU) is an anticancer drug and pyrimidine analogue. A problem in 5-FU therapy is acquired resistance to the drug. To find out more about the mechanisms of resistance, we screened a plasmid library in yeast for genes that confer 5-FU resistance when overexpressed. We cloned five genes: CPA1, CPA2, HMS1, YAE1 and YJL055W. CPA1 and CPA2 encode a carbamoyl phosphate synthase involved in arginine biosynthesis and HMS1 a helix-loop-helix transcription factor. Our results suggest that CPA1, CPA2, and HMS1 confer 5-FU resistance by stimulating pyrimidine biosynthesis. Thus, they are unable to confer 5-FU resistance in a ura2 mutant, and inhibit the uptake and incorporation into RNA of both uracil and 5-FU. In contrast, YAE1 and YJL055W confer 5-FU resistance in a ura2 mutant, and selectively inhibit incorporation into RNA of 5-FU but not uracil. YAE1 is the strongest resistance gene, but it partially depends on YJL055W for its function. This suggests that YAE1 and YJL055W function together in a novel mechanism for detoxification of 5-FU and other pyrimidine analogs. Yae1p belongs to a small protein family with only two members, which are conserved in all eukaryotes examined. One of the human homologs, TAOS1, is overexpressed in oral carcinomas.	[Carlsson, Mattias; Hu, Guo-Zhen; Ronne, Hans] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden; [Gustavsson, Marie; Muren, Eva] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Ronne, H (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden.	Hans.Ronne@slu.se		Ronne, Hans/0000-0002-1645-6091	Swedish Cancer Society; Swedish Research School in Genomics and Bioinformatics; Swedish Foundation for Strategic Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research School in Genomics and Bioinformatics; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Cancer Society, the Swedish Research School in Genomics and Bioinformatics and the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI T, 1981, SCIENCE, V212, P463, DOI 10.1126/science.7209543; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Benoist P, 2000, YEAST, V16, P1299, DOI 10.1002/1097-0061(200010)16:14<1299::AID-YEA593>3.0.CO;2-6; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Davies O, 2012, BMB REP, V45, P259, DOI 10.5483/BMBRep.2012.45.4.259; Dengg M, 2006, EMBO REP, V7, P1046, DOI 10.1038/sj.embor.7400782; ELHAJJ HH, 1992, J BACTERIOL, V174, P4450, DOI 10.1128/JB.174.13.4450-4456.1992; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hoskins J, 2007, YEAST, V24, P861, DOI 10.1002/yea.1516; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Jaques S, 1981, PLANT PHYSIOL, V67, P287; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; JENSEN KF, 1982, EMBO J, V1, P69, DOI 10.1002/j.1460-2075.1982.tb01126.x; JUND R, 1970, J BACTERIOL, V102, P607, DOI 10.1128/JB.102.3.607-615.1970; KAMENS J, 1991, NEW BIOL, V3, P1005; Keniry ME, 2004, GENETICS, V166, P1177, DOI 10.1534/genetics.166.3.1177; Ko N, 2008, YEAST, V25, P155, DOI 10.1002/yea.1554; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LACROUTE F, 1965, J GEN MICROBIOL, V40, P127, DOI 10.1099/00221287-40-1-127; Longley DB, 2006, BBA-REV CANCER, V1766, P184, DOI 10.1016/j.bbcan.2006.08.001; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lorenz MC, 1998, GENETICS, V150, P1443; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; PALMER LM, 1975, MOL GEN GENET, V140, P165, DOI 10.1007/BF00329784; PETERS GJ, 1991, ANN ONCOL, V2, P469, DOI 10.1093/oxfordjournals.annonc.a057994; PIERARD A, 1978, J BACTERIOL, V134, P167; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Schmidt WM, 2004, INT J CANCER, V112, P200, DOI 10.1002/ijc.20401; Snoek ISI, 2006, FEMS YEAST RES, V6, P393, DOI 10.1111/j.1567-1364.2005.00007.x; Stepchenkova EI, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-31; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0	41	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e52094	10.1371/journal.pone.0052094	http://dx.doi.org/10.1371/journal.pone.0052094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124444	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100001
J	Larocca, RA; Moraes-Vieira, PM; Bassi, EJ; Semedo, P; de Almeida, DC; da Silva, MB; Thornley, T; Pacheco-Silva, A; Camara, NOS				Larocca, Rafael Assumpcao; Moraes-Vieira, Pedro Manoel; Bassi, Enio Jose; Semedo, Patricia; de Almeida, Danilo Candido; da Silva, Marina Burgos; Thornley, Thomas; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen			Adipose Tissue-Derived Mesenchymal Stem Cells Increase Skin Allograft Survival and Inhibit Th-17 Immune Response	PLOS ONE			English	Article							REGULATORY T-CELLS; MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; IFN-GAMMA; TRANSPLANTATION TOLERANCE; LYMPHOCYTE-PROLIFERATION; INTERFERON-GAMMA; DENDRITIC CELLS; NITRIC-OXIDE; MOUSE MODEL	Adipose tissue-derived mesenchymal stem cells (ADSC) exhibit immunosuppressive capabilities both in vitro and in vivo. Their use for therapy in the transplant field is attractive as they could render the use of immunosuppressive drugs unnecessary. The aim of this study was to investigate the effect of ADSC therapy on prolonging skin allograft survival. Animals that were treated with a single injection of donor allogeneic ADSC one day after transplantation showed an increase in donor skin graft survival by approximately one week. This improvement was associated with preserved histological morphology, an expansion of CD4(+) regulatory T cells (Treg) in draining lymph nodes, as well as heightened IL-10 expression and down-regulated IL-17 expression. In vitro, ADSC inhibit naive CD4(+) T cell proliferation and constrain Th-1 and Th-17 polarization. In summary, infusion of ADSC one day post-transplantation dramatically increases skin allograft survival by inhibiting the Th-17 pathogenic immune response and enhancing the protective Treg immune response. Finally, these data suggest that ADSC therapy will open new opportunities for promoting drug-free allograft survival in clinical transplantation.	[Larocca, Rafael Assumpcao; Moraes-Vieira, Pedro Manoel; Bassi, Enio Jose; da Silva, Marina Burgos; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Lab Transplantat Immunobiol, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil; [Semedo, Patricia; de Almeida, Danilo Candido; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Lab Clin & Expt Immunol, Div Nephrol, Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Albert Einstein Hosp, Inst Israelita Ensino & Pesquisa, Renal Transplantat Div, Sao Paulo, Brazil; [Larocca, Rafael Assumpcao; Thornley, Thomas] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA; [Moraes-Vieira, Pedro Manoel] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Endocrinol, Boston, MA 02215 USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Larocca, RA (corresponding author), Univ Sao Paulo, Lab Transplantat Immunobiol, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil.	rlarocca@bidmc.harvard.edu	Moraes-Vieira, Pedro/C-8701-2014; Assumpcao Larocca, Rafael/H-1655-2015; Semedo-Kuriki, Patricia/D-2429-2010; Bassi, Ênio José/P-9937-2019; camara, niels olsen saraiva/AAX-3269-2020; da Silva, Marina Burgos/C-3026-2012; da Silva, Marina Burgos/AAR-5639-2020; de Almeida, Danilo Candido/R-2646-2019; de Almeida, Danilo/AAK-2399-2021; Bassi, Ênio José/I-3616-2016; Camara, Niels OS/G-8336-2011	Moraes-Vieira, Pedro/0000-0002-8263-786X; Assumpcao Larocca, Rafael/0000-0002-9995-1804; Bassi, Ênio José/0000-0002-7956-5746; camara, niels olsen saraiva/0000-0001-5436-1248; da Silva, Marina Burgos/0000-0001-8630-7211; de Almeida, Danilo Candido/0000-0003-3661-2124; Bassi, Ênio José/0000-0002-7956-5746; Camara, Niels OS/0000-0001-5436-1248; Thornley, Thomas/0000-0001-5296-6825; Semedo-Kuriki, Patricia/0000-0002-2136-3308	State of Sao Paulo Foundation for Research Support (FAPESP) [07/07139-3, 06/55326-4, 10/52180-4, 12/02270-2]; Brazilian Council of Scientific and Technologic Development [470533/2007-2, CNPq/DECIT/MS]; Complex Fluids INCT, Coordination of Improvement of Higher Education Personnel [CAPES Bex-2236/09-5]	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council of Scientific and Technologic Development; Complex Fluids INCT, Coordination of Improvement of Higher Education Personnel	This study was supported by grants 07/07139-3, 06/55326-4, 10/52180-4 and 12/02270-2 from the State of Sao Paulo Foundation for Research Support (FAPESP), Brazilian Council of Scientific and Technologic Development (470533/2007-2, CNPq/DECIT/MS) and Complex Fluids INCT, Coordination of Improvement of Higher Education Personnel (CAPES Bex-2236/09-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asavaroengchai W, 2007, BIOL BLOOD MARROW TR, V13, P46, DOI 10.1016/j.bbmt.2006.09.014; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; BRENNAN DC, 1995, AM J KIDNEY DIS, V26, P701, DOI 10.1016/0272-6386(95)90432-8; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560; Feng G, 2008, EUR J IMMUNOL, V38, P2512, DOI 10.1002/eji.200838411; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Heydarkhan-Hagvall S, 2008, CELLS TISSUES ORGANS, V187, P263, DOI 10.1159/000113407; Hidalgo LG, 2002, CRIT REV IMMUNOL, V22, P317; Hirayama S, 2006, MOL MED, V12, P208, DOI 10.2119/2006-00036.Hirayama; Ivanova-Todorova E, 2009, IMMUNOL LETT, V126, P37, DOI 10.1016/j.imlet.2009.07.010; Kang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Klimczak Aleksandra, 2007, Semin Plast Surg, V21, P226, DOI 10.1055/s-2007-991192; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Larocca R, 2008, INFLAMM RES, V57, P171, DOI 10.1007/s00011-007-7140-0; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Luz-Crawford P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045272; MacLeod M, 2006, J EXP MED, V203, P897, DOI 10.1084/jem.20050711; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Lopez MM, 2006, TRANSPL IMMUNOL, V17, P31, DOI 10.1016/j.trim.2006.09.018; Morita K, 2001, J IMMUNOL, V167, P2979, DOI 10.4049/jimmunol.167.5.2979; MURRAY JE, 1971, PLAST RECONSTR SURG, V47, P425, DOI 10.1097/00006534-197105000-00003; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Renner P, 2009, TRANSPL P, V41, P2607, DOI 10.1016/j.transproceed.2009.06.119; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Surquin Murielle, 2005, Nephrol Ther, V1, P161, DOI 10.1016/j.nephro.2005.05.004; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhang Zhi-gang, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P305; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	63	37	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76396	10.1371/journal.pone.0076396	http://dx.doi.org/10.1371/journal.pone.0076396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124557	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100114
J	Nguyen, TH; Ranwez, V; Berry, V; Scornavacca, C				Thi-Hau Nguyen; Ranwez, Vincent; Berry, Vincent; Scornavacca, Celine			Support Measures to Estimate the Reliability of Evolutionary Events Predicted by Reconciliation Methods	PLOS ONE			English	Article							TREE RECONCILIATION; GENE DUPLICATION; ALGORITHMS; LINEAGE; ERROR	The genome content of extant species is derived from that of ancestral genomes, distorted by evolutionary events such as gene duplications, transfers and losses. Reconciliation methods aim at recovering such events and at localizing them in the species history, by comparing gene family trees to species trees. These methods play an important role in studying genome evolution as well as in inferring orthology relationships. A major issue with reconciliation methods is that the reliability of predicted evolutionary events may be questioned for various reasons: Firstly, there may be multiple equally optimal reconciliations for a given species tree-gene tree pair. Secondly, reconciliation methods can be misled by inaccurate gene or species trees. Thirdly, predicted events may fluctuate with method parameters such as the cost or rate of elementary events. For all of these reasons, confidence values for predicted evolutionary events are sorely needed. It was recently suggested that the frequency of each event in the set of all optimal reconciliations could be used as a support measure. We put this proposition to the test here and also consider a variant where the support measure is obtained by additionally accounting for suboptimal reconciliations. Experiments on simulated data show the relevance of event supports computed by both methods, while resorting to suboptimal sampling was shown to be more effective. Unfortunately, we also show that, unlike the majority-rule consensus tree for phylogenies, there is no guarantee that a single reconciliation can contain all events having above 50% support. In this paper, we detail how to rely on the reconciliation graph to efficiently identify the median reconciliation. Such median reconciliation can be found in polynomial time within the potentially exponential set of most parsimonious reconciliations.	[Thi-Hau Nguyen; Berry, Vincent] Univ Montpellier 2, Ctr Natl Rech Sci, Lab Informat Robot & Microelect Montpellier, Montpellier, France; [Thi-Hau Nguyen; Ranwez, Vincent] Montpellier SupAgro, Unite Mixte Rech AGAP, Montpellier, France; [Scornavacca, Celine] Univ Montpellier 2, Unite Mixte Rech 5554, Inst Sci Evolut Montpellier, Montpellier, France; [Thi-Hau Nguyen; Ranwez, Vincent; Berry, Vincent; Scornavacca, Celine] Inst Biol Computat, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Scornavacca, C (corresponding author), Univ Montpellier 2, Unite Mixte Rech 5554, Inst Sci Evolut Montpellier, Montpellier, France.	celine.scornavacca@univ-montp2.fr	ranwez, vincent/I-5490-2017	ranwez, vincent/0000-0002-9308-7541; Berry, Vincent/0000-0001-7271-4027	Languedoc-Roussillon Chercheur d'Avenir program; French Agence Nationale de la Recherche: Investissements d'avenir/Bioinformatique [ANR-10-BINF-01-02, ANR-09-PEXT- 000]; Institut de Biologie Computationnelle	Languedoc-Roussillon Chercheur d'Avenir program(Region Occitanie); French Agence Nationale de la Recherche: Investissements d'avenir/Bioinformatique(French National Research Agency (ANR)); Institut de Biologie Computationnelle	This work was funded by the Languedoc-Roussillon Chercheur d'Avenir program, by the French Agence Nationale de la Recherche: Investissements d'avenir/Bioinformatique (ANR-10-BINF-01-02, Ancestrome), Programme 6\e'me Extinction (ANR-09-PEXT- 000, Phylospace), and by the Institut de Biologie Computationnelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvestad L, 2009, J ACM, V56, DOI 10.1145/1502793.1502796; Bansal MS, 2012, BIOINFORMATICS, V28, pI283, DOI 10.1093/bioinformatics/bts225; BARTHELEMY JP, 1986, J CLASSIF, V3, P329, DOI 10.1007/BF01894194; Berry V, 1996, MOL BIOL EVOL, V13, P999, DOI 10.1093/molbev/13.7.999; Bryant D., 2003, Bioconsensus. DIMACS Working Group Meetings on Bioconsensus, P163; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chaudhary R, 2011, LECT N BIOINFORMAT, V6674, P227, DOI 10.1007/978-3-642-21260-4_23; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Doyon JP, 2011, BRIEF BIOINFORM, V12, P392, DOI 10.1093/bib/bbr045; Doyon JP, 2010, LECT N BIOINFORMAT, V6398, P93, DOI 10.1007/978-3-642-16181-0_9; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Gorecki P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S14; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Nakhleh L, 2005, J COMPUT BIOL, V12, P796, DOI 10.1089/cmb.2005.12.796; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Park HJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-131; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Scornavacca C, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720012500254; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stolzer M, 2012, BIOINFORMATICS, V28, pI409, DOI 10.1093/bioinformatics/bts386; Szollosi GJ, 2012, METHODS MOL BIOL, V856, P29, DOI 10.1007/978-1-61779-585-5_2; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Than C, 2007, J COMPUT BIOL, V14, P517, DOI 10.1089/cmb.2007.A010; Nguyen TH, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-12; Thi Hau Nguyen, 2012, Algorithms in Bioinformatics. Proceedings of the12th International Workshop, WABI 2012, P123, DOI 10.1007/978-3-642-33122-0_10; Tofigh A., 2009, THESIS KTH SCH COMP; Tofigh A, 2011, IEEE ACM T COMPUT BI, V8, P517, DOI 10.1109/TCBB.2010.14	35	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e73667	10.1371/journal.pone.0073667	http://dx.doi.org/10.1371/journal.pone.0073667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124449	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100006
J	Maynard, ME; Leasure, JL				Maynard, Mark E.; Leasure, J. Leigh			Exercise Enhances Hippocampal Recovery following Binge Ethanol Exposure	PLOS ONE			English	Article							CELL-PROLIFERATION; ALCOHOL DEPENDENCE; PHYSICAL-EXERCISE; MESSENGER-RNA; GROWTH-FACTOR; BRAIN-DAMAGE; ADULT-RATS; NEUROGENESIS; ABSTINENCE; INDUCTION	Binge drinking damages the brain, and although a significant amount of recovery occurs with abstinence, there is a need for effective strategies to maximize neurorestoration. In contrast to binge drinking, exercise promotes brain health, so the present study assessed whether it could counteract ethanol-induced damage by augmenting natural self-repair processes following one or more binge exposures. Adult female rats were exposed to 0 (control), 1 or 2 binges, using an established 4-day model of binge-induced neurodegeneration. Half of the animals in each group remained sedentary, or had running wheel access beginning 7 days after the final binge, and were sacrificed 28 days later. To assess binge-induced hippocampal damage and exercise restoration, we quantified volume of the dentate gyrus and number of granule neurons. We found that a single binge exposure significantly decreased the volume of the dentate gyrus and number of granule neurons. A second binge did not exacerbate the damage. Exercise completely restored baseline volume and granule neuron numbers. To investigate a potential mechanism of this restoration, we administered IdU (a thymidine analog) in order to label cells generated after the first binge. Previous studies have shown that neurogenesis in the dentate gyrus is decreased by binge alcohol exposure, and that the hippocampus responds to this insult by increasing cell genesis during abstinence. We found increased IdU labeling in binge-exposed animals, and a further increase in binged animals that exercised. Our results indicate that exercise reverses long-lasting hippocampal damage by augmenting natural self-repair processes.	[Maynard, Mark E.; Leasure, J. Leigh] Univ Houston, Dept Psychol, Houston, TX USA; [Leasure, J. Leigh] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Leasure, JL (corresponding author), Univ Houston, Dept Psychol, Houston, TX USA.	jlleasure@uh.edu		Leasure, J. Leigh/0000-0002-9014-2525	University of Houston's College of Liberal Arts and Social Sciences; University of Houston's Biology of Behavior Institute	University of Houston's College of Liberal Arts and Social Sciences; University of Houston's Biology of Behavior Institute	This study was supported by a Grant in Aid to J.L.L. from the University of Houston's College of Liberal Arts and Social Sciences, and a summer fellowship awarded to M. M. by the University of Houston's Biology of Behavior Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2003, ALCOHOL ALCOHOLISM, V38, P71, DOI 10.1093/alcalc/agg020; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Berchtold NC, 2001, EUR J NEUROSCI, V14, P1992, DOI 10.1046/j.0953-816x.2001.01825.x; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Cardenas VA, 2007, NEUROIMAGE, V34, P879, DOI 10.1016/j.neuroimage.2006.10.015; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Duka T, 2004, ALCOHOL CLIN EXP RES, V28, P233, DOI 10.1097/01.ALC.0000113780.41701.81; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; Duka T, 2011, BIOL PSYCHIAT, V70, P545, DOI 10.1016/j.biopsych.2011.04.006; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Gomez-Pinilla F, 1998, NEUROSCIENCE, V85, P53, DOI 10.1016/S0306-4522(97)00576-9; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Gupta S, 2008, BRIT J PSYCHIAT, V193, P351, DOI 10.1192/bjp.bp.108.051425; Helfer JL, 2009, BRAIN RES, V1294, P1, DOI 10.1016/j.brainres.2009.07.090; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; HUNT WA, 1993, ALCOHOL, V10, P559, DOI 10.1016/0741-8329(93)90083-Z; Jarvenpaa T, 2005, EPIDEMIOLOGY, V16, P766, DOI 10.1097/01.ede.0000181307.30826.6c; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kelso ML, 2011, NEUROSCIENCE, V197, P381, DOI 10.1016/j.neuroscience.2011.09.019; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Leasure JL, 2010, ALCOHOL CLIN EXP RES, V34, P404, DOI 10.1111/j.1530-0277.2009.01105.x; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penland S, 2001, ALCOHOL, V24, P45, DOI 10.1016/S0741-8329(01)00142-2; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Redila VA, 2006, HIPPOCAMPUS, V16, P305, DOI 10.1002/hipo.20164; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; SCHALLERT T, 1993, J NEURAL TRANSP PLAS, V4, P193, DOI 10.1155/NP.1993.193; Schallert T, 1997, ADV NEUROL, V73, P229; Stephens DN, 2008, PHILOS T R SOC B, V363, P3169, DOI 10.1098/rstb.2008.0097; Sundell L, 2008, STROKE, V39, P3179, DOI 10.1161/STROKEAHA.108.520817; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Thomas JD, 2008, BEHAV NEUROSCI, V122, P1264, DOI 10.1037/a0013271; TIVIS R, 1995, ALCOHOL CLIN EXP RES, V19, P496, DOI 10.1111/j.1530-0277.1995.tb01537.x; Trejo JL, 2002, REV NEUROSCIENCE, V13, P365; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wobrock T, 2009, EUR ARCH PSY CLIN N, V259, P143, DOI 10.1007/s00406-008-0846-3	49	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76644	10.1371/journal.pone.0076644	http://dx.doi.org/10.1371/journal.pone.0076644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098797	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500168
J	Minicucci, MF; dos Santos, PP; Rafacho, BPM; Goncalves, AF; Silva, RAC; Chiuso-Minicucci, F; Azevedo, PS; Polegato, BF; Okoshi, K; Pereira, EJ; Paiva, SAR; Zornoff, LAM				Minicucci, Marcos F.; dos Santos, Priscila P.; Rafacho, Bruna P. M.; Goncalves, Andrea F.; Silva, Renata A. C.; Chiuso-Minicucci, Fernanda; Azevedo, Paula S.; Polegato, Bertha F.; Okoshi, Katashi; Pereira, Elenize J.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.			Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR ANTAGONISTS; VENTRICULAR SYSTOLIC DYSFUNCTION; SUDDEN CARDIAC DEATH; HEART-FAILURE; CLINICAL-IMPLICATIONS; EPLERENONE; MORTALITY; PERIOSTIN; PROLIFERATION; METAANALYSIS	Introduction: Our objective was to analyze the effect of spironolactone on cardiac remodeling after experimental myocardial infarction (MI), assessed by matricellular proteins levels, cardiac collagen amount and distribution, myocardial tissue metalloproteinase inhibitor-1(TIMP-1) concentration, myocyte hypertrophy, left ventricular architecture, and in vitro and in vivo cardiac function. Methods: Wistar rats were assigned to 4 groups: control group, in which animals were submitted to simulated surgery (SHAM group; n=9); group that received spironolactone and in which animals were submitted to simulated surgery (SHAM-S group, n=9); myocardial infarction group, in which animals were submitted to coronary artery ligation (MI group, n=15); and myocardial infarction group with spironolactone supplementation (MI-S group, n=15). The rats were observed for 3 months. Results: The MI group had higher values of left cardiac chambers and mass index and lower relative wall thicknesses compared with the SHAM group. In addition, diastolic and systolic functions were worse in the MI groups. However, spironolactone did not influence any of these variables. The MI-S group had a lower myocardial hydroxyproline concentration and myocyte cross-sectional area compared with the MI group. Myocardial periostin and collagen type III were lower in the MI-S group compared with the MI-group. In addition, TIMP-1 concentration in myocardium was higher in the MI-S group compared with the MI group. Conclusions: The predominant consequence of spironolactone supplementation after MI is related to reductions in collagens, with discrete attenuation of other remodeling variables. Importantly, this effect may be modulated by periostin and TIMP-1 levels.	[Minicucci, Marcos F.; dos Santos, Priscila P.; Rafacho, Bruna P. M.; Goncalves, Andrea F.; Silva, Renata A. C.; Azevedo, Paula S.; Polegato, Bertha F.; Okoshi, Katashi; Pereira, Elenize J.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.] Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Sao Paulo, Brazil; [Chiuso-Minicucci, Fernanda] Univ Estadual, Inst Biosci, Dept Microbiol & Immunol, Sao Paulo, Brazil	Universidade Estadual Paulista	Minicucci, MF (corresponding author), Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Sao Paulo, Brazil.	minicucci@fmb.unesp.br	Rafacho, Bruna Paola Murino/AGW-5794-2022; Azevedo, Paula Schmidt/S-1597-2019; Azevedo, Paula S/F-2701-2012; Minicucci, Fernanda C/A-9220-2015; Zornoff, Leonardo/A-5612-2008; Okoshi, Katashi/A-3955-2011; Minicucci, Marcos F/A-9094-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Polegato, Bertha Furlan/E-8842-2012; Paiva, Sergio AR/A-5101-2008; dos Santos, Priscila Portugal/U-5345-2018	Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Azevedo, Paula Schmidt/0000-0002-5843-6232; Azevedo, Paula S/0000-0002-5843-6232; Minicucci, Fernanda C/0000-0002-4155-6414; Zornoff, Leonardo/0000-0002-9831-8820; Okoshi, Katashi/0000-0001-8980-8839; Minicucci, Marcos F/0000-0002-5980-4367; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Polegato, Bertha Furlan/0000-0002-2875-9532; Paiva, Sergio AR/0000-0003-4412-1990; dos Santos, Priscila Portugal/0000-0003-1159-5030	Botucatu Medical School	Botucatu Medical School	This work was supported by Botucatu Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardisson LP, 2012, INT J CARDIOL, V156, P265, DOI 10.1016/j.ijcard.2010.10.128; Azevedo PS, 2010, CELL PHYSIOL BIOCHEM, V26, P395, DOI 10.1159/000320563; Bapoje SR, 2013, CIRC-HEART FAIL, V6, P166, DOI 10.1161/CIRCHEARTFAILURE.112.000003; Brandimarte F, 2008, CARDIOL CLIN, V26, P91, DOI 10.1016/j.ccl.2007.08.011; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; dos Santos PP, 2012, CELL PHYSIOL BIOCHEM, V30, P1191, DOI 10.1159/000343309; Fraccarollo D, 2008, HYPERTENSION, V51, P905, DOI 10.1161/HYPERTENSIONAHA.107.100941; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li XB, 2013, CIRC-HEART FAIL, V6, P156, DOI 10.1161/CIRCHEARTFAILURE.112.000074; Matsubara LS, 2000, AM J PHYSIOL-HEART C, V279, pH1534, DOI 10.1152/ajpheart.2000.279.4.H1534; Matsui Yutaka, 2010, World J Biol Chem, V1, P69, DOI 10.4331/wjbc.v1.i5.69; Mill JG, 2003, CLIN EXP PHARMACOL P, V30, P739, DOI 10.1046/j.1440-1681.2003.03906.x; Minicucci MF, 2011, INT J CARDIOL, V151, P242, DOI 10.1016/j.ijcard.2011.06.068; Minicucci MF, 2011, CLIN CARDIOL, V34, P410, DOI 10.1002/clc.20922; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Paiva SAR, 2005, J NUTR, V135, P2109, DOI 10.1093/jn/135.9.2109; Pfeffer JM, 2000, CARDIOVASC DRUG THER, V14, P579, DOI 10.1023/A:1007890126061; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Udelson JE, 2010, CIRC-HEART FAIL, V3, P347, DOI 10.1161/CIRCHEARTFAILURE.109.906909; Weir RAP, 2009, AM HEART J, V157, P1088, DOI 10.1016/j.ahj.2009.04.001; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zornoff LAM, 2000, BASIC RES CARDIOL, V95, P208, DOI 10.1007/s003950050183; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76866	10.1371/journal.pone.0076866	http://dx.doi.org/10.1371/journal.pone.0076866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098808	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500179
J	Chang, Q; Miao, XF; Ju, XW; Zhu, LG; Huang, CL; Huang, T; Zuo, XC; Gao, CF				Chang, Qi; Miao, Xinfang; Ju, Xiaowei; Zhu, Lvgang; Huang, Changlin; Huang, Tao; Zuo, Xincheng; Gao, Chunfang			Effects of Pulse Current on Endurance Exercise and Its Anti-Fatigue Properties in the Hepatic Tissue of Trained Rats	PLOS ONE			English	Article							PHYSICAL-EXERCISE; CELL-DEATH; MUSCLE; METABOLISM; EXTRACT; MICE	Fatigue is synonymous with a wide spectrum of familiar physiological conditions, from pathology and general health, to sport and physical exercise. Strenuous, prolonged exercise training causes fatigue. Although several studies have investigated the effects of electrical stimulation frequency on muscle fatigue, the effects of percutaneous pulse current stimulation on fatigue in the hepatic tissue of trained rats is still unclear. In order to find an effective strategy to prevent fatigue or enhance recovery, the effects of pulse current on endurance exercise and its anti-fatigue properties in exercised rats were studied. Rats were subjected to one, three or five weeks of swimming exercise training. After exercise training, rats in the treated group received daily applications of pulse current. All rats were sacrificed after one, three or five weeks of swimming exercise, and the major biochemical indexes were measured in serum and liver. The results demonstrate that pulse current could prolong the exhaustion swimming time, as well as decrease serum ALT, AST and LD levels and liver MDA content. It also elevated serum LDH activity, liver SOD activity and glycogen content. Furthermore, pulse current increased the expression of Bcl-2 and decreased the expression of Bax. Taken together, these results show that pulse current can elevate endurance capacity and facilitate recovery from fatigue.	[Chang, Qi; Ju, Xiaowei; Zhu, Lvgang; Huang, Changlin; Huang, Tao; Zuo, Xincheng] PLA, Hosp 150, Inst Mil Training Related Med Sci, Luoyang, Henan, Peoples R China; [Miao, Xinfang] PLA, Gen Logist Dept, Dept Internal Med, Beijing, Peoples R China; [Gao, Chunfang] PLA, Hosp 150, Inst Anus & Intestine, Luoyang, Henan, Peoples R China		Gao, CF (corresponding author), PLA, Hosp 150, Inst Anus & Intestine, Luoyang, Henan, Peoples R China.	chunfanggaohn@163.com			General program of the General Logistics Department of PLA [13BJZ10]; Scientific Research Plan of the Logistics Department of Jinan Military Region [JN11L035]	General program of the General Logistics Department of PLA; Scientific Research Plan of the Logistics Department of Jinan Military Region	This research was funded by the General program of the General Logistics Department of PLA (grant number: 13BJZ10) and the Scientific Research Plan of the Logistics Department of Jinan Military Region (grant number: JN11L035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament W, 2009, SPORTS MED, V39, P389, DOI 10.2165/00007256-200939050-00005; Anderson FH, 2000, HEPATOL RES, V18, P63, DOI 10.1016/S1386-6346(99)00085-6; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Carvalho JF, 2005, COMP BIOCHEM PHYS A, V140, P409, DOI 10.1016/j.cbpb.2004.12.002; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Drachenberg CB, 1997, ARCH PATHOL LAB MED, V121, P54; Ellemberg D, 2010, PSYCHOL SPORT EXERC, V11, P122, DOI 10.1016/j.psychsport.2009.09.006; Feng ZH, 2011, FREE RADICAL BIO MED, V50, P1437, DOI 10.1016/j.freeradbiomed.2011.03.001; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; Gore RK, 2010, AVIAT SPACE ENVIR MD, V81, P719, DOI 10.3357/ASEM.2755.2010; Hsu CC, 2005, WORLD J GASTROENTERO, V11, P5327, DOI 10.3748/wjg.v11.i34.5327; Iaia FM, 2010, SCAND J MED SCI SPOR, V20, P619, DOI 10.1111/j.1600-0838.2009.00942.x; Kesar T, 2008, J ELECTROMYOGR KINES, V18, P662, DOI 10.1016/j.jelekin.2007.01.001; Kim Hyunjung, 2003, Journal of Medicinal Food, V6, P345; Knochel C, 2012, PROG NEUROBIOL, V96, P46, DOI 10.1016/j.pneurobio.2011.11.007; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Liu LP, 2002, CHINESE J SPOR MED, V2; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Mestre-Alfaro A, 2011, EUR J APPL PHYSIOL, V111, P2281, DOI 10.1007/s00421-011-1862-y; Navas FJ, 1997, MED SCI SPORT EXER, V29, P882, DOI 10.1097/00005768-199707000-00007; Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003; Tan W, 2012, INT J BIOL MACROMOL, V50, P59, DOI 10.1016/j.ijbiomac.2011.09.019; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tomic S, 2012, ARCH MED SCI, V8, P886, DOI 10.5114/aoms.2012.31620; Yan B, 2010, AFR J TRADIT COMPLEM, V7, P291; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	27	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75093	10.1371/journal.pone.0075093	http://dx.doi.org/10.1371/journal.pone.0075093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116026	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200010
J	Gao, W; Baars, JJP; Dolstra, O; Visser, RGF; Sonnenberg, ASM				Gao, Wei; Baars, Johan J. P.; Dolstra, Oene; Visser, Richard G. F.; Sonnenberg, Anton S. M.			Genetic Variation and Combining Ability Analysis of Bruising Sensitivity in Agaricus bisporus	PLOS ONE			English	Article							SCHIZOPHYLLUM-COMMUNE; GROWTH-RATE; INHERITANCE; POPULATIONS; IMPROVEMENT; SELECTION; MUSHROOM; YIELD	Advanced button mushroom cultivars that are less sensitive to mechanical bruising are required by the mushroom industry, where automated harvesting still cannot be used for the fresh mushroom market. The genetic variation in bruising sensitivity (BS) of Agaricus bisporus was studied through an incomplete set of diallel crosses to get insight in the heritability of BS and the combining ability of the parental lines used and, in this way, to estimate their breeding value. To this end nineteen homokaryotic lines recovered from wild strains and cultivars were inter-crossed in a diallel scheme. Fifty-one successful hybrids were grown under controlled conditions, and the BS of these hybrids was assessed. BS was shown to be a trait with a very high heritability. The results also showed that brown hybrids were generally less sensitive to bruising than white hybrids. The diallel scheme allowed to estimate the general combining ability (GCA) for each homokaryotic parental line and to estimate the specific combining ability (SCA) of each hybrid. The line with the lowest GCA is seen as the most attractive donor for improving resistance to bruising. The line gave rise to hybrids sensitive to bruising having the highest GCA value. The highest negative SCA possibly indicates heterosis effects for resistance to bruising. This study provides a foundation for estimating breeding value of parental lines to further study the genetic factors underlying bruising sensitivity and other quality-related traits, and to select potential parental lines for further heterosis breeding. The approach of studying combining ability in a diallel scheme was used for the first time in button mushroom breeding.	[Gao, Wei; Baars, Johan J. P.; Dolstra, Oene; Visser, Richard G. F.; Sonnenberg, Anton S. M.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Gao, Wei] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China	Wageningen University & Research; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Sonnenberg, ASM (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	anton.sonnenberg@wur.nl	Sonnenberg, Anton/GRJ-0442-2022; Visser, Richard GF/B-3423-2012	Sonnenberg, Anton/0000-0002-1699-1481; Visser, Richard GF/0000-0002-0213-4016; Baars, Johan/0000-0002-0692-7371	TTI Green genetics [TTI06201]; Wageningen UR-Plant Breeding; Bromyc; Sylvan; Product Board for Horticulture; Greenery; Banken Champignons; Lutece; WeBe Engineering	TTI Green genetics; Wageningen UR-Plant Breeding; Bromyc; Sylvan; Product Board for Horticulture; Greenery; Banken Champignons; Lutece; WeBe Engineering	This study was funded by TTI Green genetics (TTI06201), Wageningen UR-Plant Breeding, Bromyc, Sylvan, Product Board for Horticulture, Greenery, Banken Champignons, Lutece and WeBe Engineering. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders have no objections to publishing this manuscript.	Acquaah G, 2012, PRINCIPLES PLANT GEN, P139; Adebambo AO, 2011, TROP ANIM HEALTH PRO, V43, P1465, DOI 10.1007/s11250-011-9844-y; [Anonymous], 1966, GENETICS SEXUALITY H; Bahari M, 2012, SCI WORLD J, P1, DOI 10.1100/2012/543158; CALLAC P, 1993, MYCOLOGIA, V85, P835, DOI 10.2307/3760617; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; da Cruz RP, 2010, SCI AGR, V67, P669, DOI 10.1590/S0103-90162010000600008; Deglene L, 1999, PLANT PATHOL, V48, P559, DOI 10.1046/j.1365-3059.1999.00375.x; Elliott T.J., 1972, MUSH SCI, V8, P11; Esquerre C, 2009, J AGR FOOD CHEM, V57, P1903, DOI 10.1021/jf803090c; Foulongne-Oriol M, 2012, APPL MICROBIOL BIOT, V95, P891, DOI 10.1007/s00253-012-4228-4; Foulongne-Oriol M, 2012, APPL ENVIRON MICROB, V78, P2422, DOI 10.1128/AEM.07516-11; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Jolivet S, 1998, MYCOL RES, V102, P1459, DOI 10.1017/S0953756298006248; KARLIN S, 1979, THEOR POPUL BIOL, V16, P81, DOI 10.1016/0040-5809(79)90007-8; KERRIGAN RW, 1993, GENETICS, V133, P225; Kothe E, 2001, APPL MICROBIOL BIOT, V56, P602, DOI 10.1007/s002530100763; Lynch M, 1998, GENETICS ANAL QUANTI, P353; NASPOLINI V, 1981, REV BRAS GENET, V4, P571; Noh A, 2012, SCI WORLD J, DOI 10.1100/2012/792601; Qu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028463; ROJAS BA, 1952, AGRON J, V44, P462, DOI 10.2134/agronj1952.00021962004400090002x; SIMCHEN G, 1964, HEREDITY, V19, P629, DOI 10.1038/hdy.1964.75; SIMCHEN G, 1966, GENETICS, V53, P1151; SIMCHEN G, 1966, HEREDITY, V21, P241, DOI 10.1038/hdy.1966.21; Sonnenberg A. S. M., 2011, Mushroom biology and mushroom products. Proceedings of the 7th International Conference on Mushroom Biology and Mushroom Products, Arcachon, France, 4-7 October, 2011. Volume 1. Oral presentations, P7; Sonnenberg ASM, 1996, APPL ENVIRON MICROB, V62, P4542, DOI 10.1128/AEM.62.12.4542-4547.1996; SONNENBERG ASM, 2005, ACTA EDULIS FUNGI S, V12, P163, DOI DOI 10.1007/978-3-642-36821-9_; SUMMERBELL RC, 1989, GENETICS, V123, P293; Viana JMS, 2003, GENET MOL BIOL, V26, P465, DOI 10.1590/S1415-47572003000400010; WALEJKO RN, 1977, CROP SCI, V17, P647, DOI 10.2135/cropsci1977.0011183X001700040043x; WANG SS, 1972, MYCOLOGIA, V64, P521, DOI 10.2307/3757869; Weijn A, 2013, FUNGAL GENET BIOL, V55, P42, DOI 10.1016/j.fgb.2012.10.004; Weijn A, 2012, LWT-FOOD SCI TECHNOL, V47, P308, DOI 10.1016/j.lwt.2012.01.024; WILLIAMS S, 1976, HEREDITY, V37, P365, DOI 10.1038/hdy.1976.101	35	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76826	10.1371/journal.pone.0076826	http://dx.doi.org/10.1371/journal.pone.0076826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116171	gold, Green Published			2022-12-27	WOS:000325552200075
J	Modvig, S; Degn, M; Horwitz, H; Cramer, SP; Larsson, HBW; Wanscher, B; Sellebjerg, F; Frederiksen, JL				Modvig, Signe; Degn, Matilda; Horwitz, Henrik; Cramer, Stig P.; Larsson, Henrik B. W.; Wanscher, Benedikte; Sellebjerg, Finn; Frederiksen, Jette L.			Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OSTEOPONTIN LEVELS; DISEASE-ACTIVITY; N-ACETYLASPARTATE; CSF; NEUROFILAMENT; MATRIX-METALLOPROTEINASE-9; NATALIZUMAB; CHEMOKINES; CONVERSION	Background: Various inflammatory biomarkers show prognostic potential for multiple sclerosis (MS)-risk after clinically isolated syndromes. However, biomarkers are often examined singly and their interrelation and precise aspects of their associated pathological processes remain unclear. Clarification of these relationships could aid the appropriate implementation of prognostic biomarkers in clinical practice. Objective: To investigate the interrelation between biomarkers of inflammation, demyelination and neurodegeneration in acute optic neuritis and to assess their association to measures of MS risk. Material and Methods: A prospective study at a tertiary referral centre from June 2011 to December 2012 of 56 patients with optic neuritis as a first demyelinating symptom and 27 healthy volunteers. Lumbar puncture was performed within 28 (median 16) days of onset. CSF levels of CXCL13, matrix metalloproteinase (MMP)-9, CXCL10, CCL-2, osteopontin and chitinase-3-like-1, myelin basic protein (MBP) and neurofilament light-chain (NF-L) were determined. MS-risk outcome measures were dissemination in space (DIS) of white matter lesions on cerebral MRI, CSF oligoclonal bands and elevated IgG-index. Results: In the interrelation analysis the biomarkers showed close correlations within two distinct groups: Biomarkers of leukocyte infiltration (CXCL13, MMP-9 and CXCL10) were strongly associated (p<0.0001 for all). Osteopontin and chitinase-3-like-1 were also tightly associated (p<0.0001) and correlated strongly to tissue damage markers (NF-L and MBP). The biomarkers of leukocyte infiltration all associated strongly with MS-risk parameters, whereas CHI3L1 and MBP correlated with MRI DIS, but not with CSF MS-risk parameters and osteopontin and NF-L did not correlate with any MS-risk parameters. Conclusions: Our findings suggest two distinct inflammatory processes: one of leukocyte infiltration, represented by CXCL13, CXCL10 and MMP-9, strongly associated with and potentially predicting MS-risk; the other represented by osteopontin and CHI3L1, suggesting tissue damage-related inflammation, potentially predicting residual disabilities after attack and perhaps cumulative damage over time. These hypotheses should be further addressed in follow-up studies.	[Modvig, Signe; Degn, Matilda; Horwitz, Henrik; Cramer, Stig P.; Frederiksen, Jette L.] Copenhagen Univ Hosp Glostrup, MS Clin, Dept Neurol, Glostrup, Denmark; [Cramer, Stig P.; Larsson, Henrik B. W.] Copenhagen Univ Hosp, Dept Diagnost, Funct Imaging Unit, Glostrup, Denmark; [Wanscher, Benedikte] Copenhagen Univ Hosp Glostrup, Dept Clin Neurophysiol, Glostrup, Denmark; [Sellebjerg, Finn] Copenhagen Univ Hosp Rigshosp, Dept Neurol, Danish MS Res Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Modvig, S (corresponding author), Copenhagen Univ Hosp Glostrup, MS Clin, Dept Neurol, Glostrup, Denmark.	simoni01@regionh.dk	Cramer, Stig P./H-5007-2019	Degn, Matilda/0000-0003-3093-3525; frederiksen, jette/0000-0003-1661-7438; Sellebjerg, Finn/0000-0002-1333-9623; Praestekjaer Cramer, Stig/0000-0003-2959-2161	Danish Council for Strategic Research; Danish Multiple Sclerosis Society; Karen A. Tholstrup foundation; Bdr. Hartmanns foundation; Lykfeldts Legat foundation; Hestehandler Ole Jacobsen Memorial foundation; Danish Research foundation	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Multiple Sclerosis Society; Karen A. Tholstrup foundation; Bdr. Hartmanns foundation; Lykfeldts Legat foundation; Hestehandler Ole Jacobsen Memorial foundation; Danish Research foundation	This research was supported by grants from the Danish Council for Strategic Research (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-strategiske-forskningsrad), the Danish Multiple Sclerosis Society (http://scleroseforeningen.dk/), the Karen A. Tholstrup foundation (http://www.brammeradvokater.dk/fonde/), the Bdr. Hartmanns foundation (http://www.hartmannfonden.dk/), the Lykfeldts Legat foundation (no website), the Hestehandler Ole Jacobsen Memorial foundation (no website) and the Danish Research foundation (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Bornsen L, 2011, MULT SCLER J, V17, P32, DOI 10.1177/1352458510382247; Braitch M, 2008, ARCH NEUROL-CHICAGO, V65, P633, DOI 10.1001/archneur.65.5.633; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chowdhury SA, 2008, ARCH NEUROL-CHICAGO, V65, P232, DOI 10.1001/archneurol.2007.33; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Correale J, 2011, MULT SCLER J, V17, P521, DOI 10.1177/1352458510392619; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Horwitz H, 2012, J NEUROL, V259, P2616, DOI 10.1007/s00415-012-6551-1; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Johansen JS, 2001, SCAND J RHEUMATOL, V30, P297; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Khalil M, 2013, MULT SCLER J, V19, P436, DOI 10.1177/1352458512458010; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lim ET, 2005, MULT SCLER J, V11, P532, DOI 10.1191/1352458505ms1218oa; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Peterson LK, 2007, J NEUROIMMUNOL, V184, P37, DOI 10.1016/j.jneuroim.2006.11.015; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Sellebjerg F, 1998, MULT SCLER, V4, P475, DOI 10.1177/135245859800400603; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Semra YK, 2002, J NEUROIMMUNOL, V122, P132, DOI 10.1016/S0165-5728(01)00455-6; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Soderstrom M, 1998, NEUROLOGY, V50, P708, DOI 10.1212/WNL.50.3.708; Sorensen TL, 2002, J NEUROIMMUNOL, V127, P59, DOI 10.1016/S0165-5728(02)00097-8; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Vogt MHJ, 2004, J NEUROIMMUNOL, V155, P155, DOI 10.1016/j.jneuroim.2004.06.007	37	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77163	10.1371/journal.pone.0077163	http://dx.doi.org/10.1371/journal.pone.0077163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116216	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200108
J	Ueda, K; Ogasawara, S; Akiba, J; Nakayama, M; Todoroki, K; Ueda, K; Sanada, S; Suekane, S; Noguchi, M; Matsuoka, K; Yano, H				Ueda, Kosuke; Ogasawara, Sachiko; Akiba, Jun; Nakayama, Masamichi; Todoroki, Keita; Ueda, Keiko; Sanada, Sakiko; Suekane, Shigetaka; Noguchi, Masanori; Matsuoka, Kei; Yano, Hirohisa			Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line	PLOS ONE			English	Article							SIDE POPULATION CELLS; MARKER; TUMORS; CD133; METASTASIS; EXPRESSION; THERAPY; EFFLUX	Cancer stem cells (CSC) or cancer stem cell-like cells (CSC-LCs) have been identified in many malignant tumors. CSCs are proposed to be related with drug resistance, tumor recurrence, and metastasis and are considered as a new target for cancer treatment; however, there are only a few reports on CSCs or CSC-LCs in renal cell carcinoma (RCC). Different approaches have been reported for CSC identification, but there are no universal markers for CSC. We used two different approaches, the traditional side population (SP) approach, and the enzymatic (aldehyde dehydrogenase 1 (ALDH1)) approach to identify CSC-LC population in two RCC cell lines, ACHN and KRC/Y. We found that ACHN and KRC/Y contain 1.4% and 1.7% SP cells, respectively. ACHN SP cells showed a higher sphere forming ability, drug resistance, and a slightly higher tumorigenic ability in NOD/SCID mice than Non-SP (NSP) cells, suggesting that cells with CSC-LC properties are included in ACHN SP cells. KRC/Y SP and NSP cells showed no difference in such properties. ALDH1 activity analysis revealed that ACHN SP cells expressed a higher level of activity than NSP cells (SP vs. NSP: 32.7% vs 14.6%). Analysis of ALDH1-positive ACHN cells revealed that they have a higher sphere forming ability, self-renewal ability, tumorigenicity and express higher mRNA levels of CSC-LC property-related genes (e. g., ABC transporter genes, self-replication genes, anti-apoptosis genes, and so forth) than ALDH1-negative cells. Drug treatment or exposure to hypoxic condition induced a 2- to 3-fold increase in number of ALDH1-positive cells. In conclusion, the results suggest that the ALDH1-positive cell population rather than SP cells show CSC-LC properties in a RCC cell line, ACHN.	[Ueda, Kosuke; Ogasawara, Sachiko; Akiba, Jun; Nakayama, Masamichi; Todoroki, Keita; Ueda, Keiko; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Ueda, Kosuke; Sanada, Sakiko; Suekane, Shigetaka; Noguchi, Masanori; Matsuoka, Kei] Kurume Univ, Sch Med, Dept Urol, Kurume, Fukuoka 830, Japan; [Noguchi, Masanori] Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; Kurume University	Akiba, J (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.	akiba@med.kurume-u.ac.jp						Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Broadley KWR, 2011, STEM CELLS, V29, P452, DOI 10.1002/stem.582; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Bussolati B, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/286985; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Costa LJ, 2007, ONCOLOGIST, V12, P1404, DOI 10.1634/theoncologist.12-12-1404; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hisaka T, 2004, J HEPATOL, V41, P782, DOI 10.1016/j.jhep.2004.07.012; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Hulspas R, 2000, CYTOMETRY, V40, P245, DOI 10.1002/1097-0320(20000701)40:3<245::AID-CYTO10>3.3.CO;2-X; Ibrahim SF, 2007, EXP CELL RES, V313, P1921, DOI 10.1016/j.yexcr.2007.02.025; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kim K, 2012, HUM PATHOL, V43, P2109, DOI 10.1016/j.humpath.2012.05.006; Kim K, 2011, ONCOL LETT, V2, P1095, DOI 10.3892/ol.2011.368; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kroeger N, 2012, EUR UROL, V61, P888, DOI 10.1016/j.eururo.2012.01.012; Lim YC, 2011, ORAL ONCOL, V47, P83, DOI 10.1016/j.oraloncology.2010.11.011; Loebinger MR, 2008, BRIT J CANCER, V98, P380, DOI 10.1038/sj.bjc.6604185; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ooka H, 2012, ACTA OTO-LARYNGOL, V132, P693, DOI 10.3109/00016489.2012.657358; Ozbek Emin, 2012, Arch Ital Urol Androl, V84, P7; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Resetkova E, 2010, BREAST CANCER RES TR, V123, P97, DOI 10.1007/s10549-009-0619-3; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Smith PJ, 2012, CYTOM PART A, V83, P161; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337; YANO H, 1988, IN VITRO CELL DEV B, V24, P9	52	51	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75463	10.1371/journal.pone.0075463	http://dx.doi.org/10.1371/journal.pone.0075463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116047	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200023
J	Brand, R; Putter, H; van Biezen, A; Niederwieser, D; Martino, R; Mufti, G; Onida, F; Symeonidis, A; Schmid, C; Garderet, L; Robin, M; van Gelder, M; Finke, J; Bornhauser, M; Kobbe, G; Germing, U; de Witte, T; Kroger, N				Brand, Ronald; Putter, Hein; van Biezen, Anja; Niederwieser, Dietger; Martino, Rodrigo; Mufti, Ghulam; Onida, Francesco; Symeonidis, Argiris; Schmid, Christoph; Garderet, Laurent; Robin, Marie; van Gelder, Michel; Finke, Juergen; Bornhaeuser, Martin; Kobbe, Guido; Germing, Ulrich; de Witte, Theo; Kroeger, Nicolaus			Comparison of Allogeneic Stem Cell Transplantation and Non-Transplant Approaches in Elderly Patients with Advanced Myelodysplastic Syndrome: Optimal Statistical Approaches and a Critical Appraisal of Clinical Results Using Non-Randomized Data	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MARROW TRANSPLANTATION; UNRELATED DONORS; FLUDARABINE; BUSULFAN; MODELS; BLOOD	Allogeneic stem cell transplantation (ASCT) from related or unrelated donors may cure patients with myelodysplastic syndromes (MDS), a heterogeneous group of clonal stem cell disorders. We analysed 384 elderly patients (55-69 years) with advanced MDS who received either ASCT (n=247) and were reported to The European Group for Blood and Marrow Transplantation (EBMT) or a non -transplant approach (n=137) reported to the Dusseldorf registry. Besides an attempt to answer the question of "comparison", the purpose of this work is to explain the difficulties in comparing a non-transplant with a transplant cohort, when death before transplant is likely but unknown and the selection of patients for transplant is based on assumptions. It shows which methods are almost always biased and that even the most sophisticated approaches crucially rely on clinical assumptions. Using the most appropriate model for our data, we derive an overall univariate non-significant survival disadvantage for the transplant cohort (HR: 1.29, p=0.11). We show that such an "average" hazard ratio is however misleading due to non-proportionality of the hazards reflecting early treatment related mortality, the occurring of which is logically correlated with the interval between diagnosis and transplant creating a disproportional drop in the (reconstructed) survival curve of the transplanted patients. Also in multivariate analysis (correcting for age > 60 (HR: 1.4, p=0.02) and abnormal cytogenetics (HR: 1.46, p=0.01)), transplantation seems to be worse (HR: 1.39, p=0.05) but only in the (incorrect but commonly applied) model without time varying covariates. The long term (time depending) hazard ratio is shown to be virtually 1 and overall survival is virtually identical in both groups. Nonetheless no conclusion can be reached from a clinical point of view without assumptions which are by their very nature untestable unless all patients would be followed from diagnosis.	[Brand, Ronald; Putter, Hein; van Biezen, Anja] Univ Med Ctr, Dept Stat, Leiden, Netherlands; [Niederwieser, Dietger] Univ Med Ctr, Dept Hematol Oncol, Leipzig, Germany; [Martino, Rodrigo] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Mufti, Ghulam] GKT Sch Med, London, England; [Onida, Francesco] Univ Med Ctr, Fdn IRCCS Osped Maggiore, Milan, Italy; [Symeonidis, Argiris] Univ Med Ctr, Dept Hematol, Patras, Greece; [Schmid, Christoph] Dept Hematol Oncol, Augsburg, Germany; [Garderet, Laurent] Hop St Antoine, Dept Hematol, F-75571 Paris, France; [Robin, Marie] Hop St Louis, Dept BMT, Paris, France; [van Gelder, Michel] Univ Maastricht, Dept Hematol, Maastricht, Netherlands; [Finke, Juergen] Univ Med Ctr, Dept Hematol Oncol, Freiburg, Germany; [Bornhaeuser, Martin] Univ Mediacal Ctr, Dept Hematol Oncol, Dresden, Germany; [Kobbe, Guido; Germing, Ulrich] Univ Hosp, Dept Hematol & Oncol, Dusseldorf, Germany; [de Witte, Theo] Radboud Univ Nijmegen, Nijmegen Ctr Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kroeger, Nicolaus] Univ Med Ctr, Dept Stem Cell Transplantat, Hamburg, Germany	Leipzig University; Hospital of Santa Creu i Sant Pau; University of London; King's College London; IRCCS Ca Granda Ospedale Maggiore Policlinico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Maastricht University; University of Freiburg; Radboud University Nijmegen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kroger, N (corresponding author), Univ Med Ctr, Dept Stem Cell Transplantat, Hamburg, Germany.	nkroeger@uke.uni-hamburg.de	Symeonidis, Argiris/K-2287-2019; Germing, Ulrich/AAX-1036-2021; Kobbe, Guido/ABG-9472-2021; Schmid, Christoph/AAS-6419-2021; Onida, Francesco/K-9585-2019; Putter, Hein/C-2244-2018; de Witte, T.J.M./L-4762-2015	Symeonidis, Argiris/0000-0002-3685-3473; Schmid, Christoph/0000-0001-7070-487X; Putter, Hein/0000-0001-5395-1422; Onida, Francesco/0000-0002-2991-3474; Robin, Marie/0000-0003-1388-9876	Netherlands Organization for Scientific Research [ZONMW-912-07-018]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	HP gratefully acknowledges financial support by the Netherlands Organization for Scientific Research Grant ZONMW-912-07-018, "Prognostic modelling and dynamic prediction for competing risks and multi-state models". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cutler AS, 2004, BLOOD, V104, P579, DOI [10.1182/blood-2004-01-0338, DOI 10.1182/BL00D-2004-01-0338.PUBMED:15039286]; de Witte T, 2000, BRIT J HAEMATOL, V110, P620, DOI 10.1046/j.1365-2141.2000.02200.x; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Deeg HJ, 2002, BLOOD, V100, P1201, DOI 10.1182/blood-2002-02-0527; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Ho AYL, 2004, BLOOD, V104, P1616, DOI 10.1182/blood-2003-12-4207; KEIDING N, 1990, ANN STAT, V18, P582, DOI 10.1214/aos/1176347617; Kroger N, 2006, BONE MARROW TRANSPL, V37, P339, DOI 10.1038/sj.bmt.1705259; Laport GG, 2008, BIOL BLOOD MARROW TR, V14, P246, DOI 10.1016/j.bbmt.2007.11.012; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Lim Y, 2010, J CLIN ONCOL, V28, P405, DOI [10.1200/JCO.2009.21.8073, DOI 10.1200/JC0.2009.21.8073.PUBMED:20008642]; Martino R, 2002, BLOOD, V100, P2243, DOI 10.1182/blood-2002-02-0400; Martino R, 2006, BLOOD, V108, P836, DOI 10.1182/blood-2005-11-4503; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Shimoni A, 2005, LEUKEMIA, V19, P7, DOI 10.1038/sj.leu.2403591; Sierra J, 2002, BLOOD, V100, P1997	17	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74368	10.1371/journal.pone.0074368	http://dx.doi.org/10.1371/journal.pone.0074368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116002	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300005
J	Hemming, K; Pinkney, T; Futaba, K; Pennant, M; Morton, DG; Lilford, RJ				Hemming, Karla; Pinkney, Thomas; Futaba, Kay; Pennant, Mary; Morton, Dion G.; Lilford, Richard J.			A Systematic Review of Systematic Reviews and Panoramic Meta-Analysis: Staples versus Sutures for Surgical Procedures	PLOS ONE			English	Review							V-STAPLES; HAND-SEWN; ESOPHAGOGASTRIC ANASTOMOSES; LAPAROSCOPIC APPENDECTOMY; SITE INFECTIONS; SKIN CLOSURE; SURGERY; ESOPHAGECTOMY; CANCER; STUMP	Objective: To systematically evaluate the evidence across surgical specialties as to whether staples or sutures better improve patient and provider level outcomes. Design: A systematic review of systematic reviews and panoramic meta-analysis of pooled estimates. Results: Eleven systematic reviews, including 13,661 observations, met the inclusion criteria. In orthopaedic surgery sutures were found to be preferable, and for appendicial stump sutures were protective against both surgical site infection and post surgical complications. However, staples were protective against leak in ilecolic anastomosis. For all other surgery types the evidence was inconclusive with wider confidence intervals including the possibly of preferential outcomes for surgical site infection or post surgical complication for either staples or sutures. Whilst reviews showed substantial variation in mean differences in operating time (I-2 94%) there was clear evidence of a reduction in average operating time across all surgery types. Few reviews reported on length of stay, but the three reviews that did (I-2 0%, including 950 observations) showed a non significant reduction in length of stay, but showed evidence of publication bias (P-value for Egger test 0.05). Conclusions: Evidence across surgical specialties indicates that wound closure with staples reduces the mean operating time. Despite including several thousand observations, no clear evidence of superiority emerged for either staples or sutures with respect to surgical site infection, post surgical complications, or length of stay.	[Hemming, Karla; Pennant, Mary; Lilford, Richard J.] Univ Birmingham, Birmingham, W Midlands, England; [Pinkney, Thomas; Futaba, Kay; Morton, Dion G.] NHS Fdn Trust, Sch Canc Sci, Univ Hosp Birmingham, Queen Elizabeth Hosp, Birmingham, W Midlands, England	University of Birmingham; Oxford University Hospitals NHS Foundation Trust; University of Birmingham	Hemming, K (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	k.hemming@bham.ac.uk	Futaba, Kaori/M-1323-2018; Pinkney, Thomas/HGA-4022-2022; Hemming, karla/AAB-3391-2021	Futaba, Kaori/0000-0002-7358-5439; Pinkney, Thomas/0000-0001-7320-6673; Hemming, karla/0000-0002-2226-6550; Lilford, Richard/0000-0002-0634-984X	National Institute of Health Research; Engineering and Physical Sciences Research Council of the UK through the MATCH programme [GR/S29874/01]; MRC methodological research hub; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10008] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI	National Institute of Health Research(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council of the UK through the MATCH programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC methodological research hub(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	K. Hemming and R. J. Lilford were funded in part by a National Institute of Health Research grant for Collaborations for Leadership in Applied Health Research and Care (CLAHRC), for the duration of this work. R. J. Lilford was also funded in part by the Engineering and Physical Sciences Research Council of the UK through the MATCH programme (grant GR/S29874/01) and the MRC methodological research hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astagneau P, 2001, J HOSP INFECT, V48, P267, DOI 10.1053/jhin.2001.1003; Ball TA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2628; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Beitler AL, 1998, AM J SURG, V175, P337, DOI 10.1016/S0002-9610(98)00002-6; Biancari F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008057.pub2; Boesch CE, 2009, J REPROD MED, V54, P139; Bowater RJ, ANN SURG ON IN PRESS; Bowater RJ, 2009, ANN SURG, V249, P551, DOI 10.1097/SLA.0b013e318199f202; Burke M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2634; Choy PYG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004320.pub3; Clay FSH, 2011, AM J OBSTET GYNECOL, V204, P378, DOI 10.1016/j.ajog.2010.11.018; Coello R, 2005, J HOSP INFECT, V60, P93, DOI 10.1016/j.jhin.2004.10.019; Cruse PJ, 1992, INFECT SURG PRACTICE, P1; Dickson MJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2625; EFRON B, 1977, SCI AM, V236, P119, DOI 10.1038/scientificamerican0577-119; Grocott MPW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5173; Hemming K, 2012, STAT MED, V31, P201, DOI 10.1002/sim.4372; Iavazzo C, 2011, AM SURGEON, V77, P1206; Kazemier G, 2006, SURG ENDOSC, V20, P1473, DOI 10.1007/s00464-005-0525-7; Kim RH, 2010, J SURG ONCOL, V101, P527, DOI 10.1002/jso.21510; Korolija D, 2008, MINIM INVASIV THER, V17, P151, DOI 10.1080/13645700802103423; Leung TTW, 2008, J GASTROINTEST SURG, V12, P939, DOI 10.1007/s11605-007-0435-1; Lovegrove RE, 2006, ANN SURG, V244, P18, DOI 10.1097/01.sla.0000225031.15405.a3; Lustosa Suzana Angélica da Silva, 2002, Sao Paulo Med. J., V120, P132, DOI 10.1590/S1516-31802002000500002; Mackeen AD, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003577.pub3, DOI 10.1002/14651858.CD003577]; MacRae HM, 1998, DIS COLON RECTUM, V41, P180, DOI 10.1007/BF02238246; Markar SR, 2011, J GASTROINTEST SURG, V15, P876, DOI 10.1007/s11605-011-1426-9; Matos D, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003144, DOI 10.1002/14651858.CD003144]; Murray BW, 2010, J AM COLL SURGEONS, V211, P812, DOI 10.1016/j.jamcollsurg.2010.07.025; National Institute for Health and Clinical Excellence, 2008, SURG SIT INF; Ockendon M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2630; Office for National Statistics (ONS), 2001, SEL OP NHS HOSP; Pinkney TD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2631; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Sajid MS, 2009, SURG LAPARO ENDO PER, V19, P11, DOI 10.1097/SLE.0b013e31818a66ab; Schluender SJ, 2006, AM SURGEON, V72, P912; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Singh BI, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c403; Smith TO, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1199; Smith TO, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2632; Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15; Tuuli MG, 2011, OBSTET GYNECOL, V117, P682, DOI 10.1097/AOG.0b013e31820ad61e; Urschel JD, 2001, DIS ESOPHAGUS, V14, P212, DOI 10.1046/j.1442-2050.2001.00187.x; Vochteloo AJ, 2010, BMJ-BRIT MED J, V340, P2627	44	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75132	10.1371/journal.pone.0075132	http://dx.doi.org/10.1371/journal.pone.0075132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116028	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300022
J	Jacewicz, A; Trzemecka, A; Guja, KE; Plochocka, D; Yakubovskaya, E; Bebenek, A; Garcia-Diaz, M				Jacewicz, Agata; Trzemecka, Anna; Guja, Kip E.; Plochocka, Danuta; Yakubovskaya, Elena; Bebenek, Anna; Garcia-Diaz, Miguel			A Remote Palm Domain Residue of RB69 DNA Polymerase Is Critical for Enzyme Activity and Influences the Conformation of the Active Site	PLOS ONE			English	Article							MISPAIRED PRIMER TERMINI; MUTATOR MUTANT; BINDING POCKET; HINGE RESIDUE; FIDELITY; BETA; PROTEIN; SUBSTITUTION; ALIGNMENT; KINETICS	Non-conserved amino acids that are far removed from the active site can sometimes have an unexpected effect on enzyme catalysis. We have investigated the effects of alanine replacement of residues distant from the active site of the replicative RB69 DNA polymerase, and identified a substitution in a weakly conserved palm residue (D714A), that renders the enzyme incapable of sustaining phage replication in vivo. D714, located several angstroms away from the active site, does not contact the DNA or the incoming dNTP, and our apoenzyme and ternary crystal structures of the PolD714A mutant demonstrate that D714A does not affect the overall structure of the protein. The structures reveal a conformational change of several amino acid side chains, which cascade out from the site of the substitution towards the catalytic center, substantially perturbing the geometry of the active site. Consistent with these structural observations, the mutant has a significantly reduced kpol for correct incorporation. We propose that the observed structural changes underlie the severe polymerization defect and thus D714 is a remote, non-catalytic residue that is nevertheless critical for maintaining an optimal active site conformation. This represents a striking example of an action-at-a-distance interaction.	[Jacewicz, Agata; Trzemecka, Anna; Bebenek, Anna] Polish Acad Sci, Inst Biochem & Biophys, Dept Mol Biol, Warsaw, Poland; [Plochocka, Danuta] Polish Acad Sci, Inst Biochem & Biophys, Dept Bioinformat, Warsaw, Poland; [Guja, Kip E.; Yakubovskaya, Elena; Garcia-Diaz, Miguel] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bebenek, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Mol Biol, Warsaw, Poland.	aniab@ibb.waw.pl; miguel.garcia-diaz@stonybrook.edu	Guja, Kip/AAU-1039-2020	Guja, Kip/0000-0002-9549-7085; Lada, Agnieszka/0000-0002-5100-7638; Bebenek, Anna/0000-0001-5374-8205	National Institutes of Health [R00 ES015421]; Polish Ministry of Science and Higher Education [N N301 787840]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES022930, R00ES015421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, R01GM100021, T32GM008444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R00 ES015421 to MGD from National Institutes of Health and by grant N N301 787840 to AB from the Polish Ministry of Science and Higher Education. Support for the National Synchrotron Light Source beamline X12C comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and the National Center for Research Resources (P41RR012408) and the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bebenek A, 2002, GENETICS, V162, P1003; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dalal S, 2004, J BIOL CHEM, V279, P577, DOI 10.1074/jbc.M309607200; Dalal S, 2008, BIOCHEMISTRY-US, V47, P12118, DOI 10.1021/bi8011548; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Ghadessy FJ, 2004, NAT BIOTECHNOL, V22, P755, DOI 10.1038/nbt974; Hogg M, 2006, NUCLEIC ACIDS RES, V34, P2528, DOI 10.1093/nar/gkl300; Hogg M, 2010, BIOCHEMISTRY-US, V49, P2317, DOI 10.1021/bi901488d; Jacewicz A, 2007, J MOL BIOL, V368, P18, DOI 10.1016/j.jmb.2007.01.067; Joyce CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1032, DOI 10.1016/j.bbapap.2009.07.021; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karam J. D., 1994, MOL BIOL BACTERIOPHA; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Langkilde A, 2008, ACTA CRYSTALLOGR D, V64, P851, DOI 10.1107/S0907444908017083; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; Maitra M, 2002, J BIOL CHEM, V277, P35550, DOI 10.1074/jbc.M204953200; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrov VM, 2002, J BIOL CHEM, V277, P33041, DOI 10.1074/jbc.M204754200; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Shah AM, 2001, BIOCHEMISTRY-US, V40, P11372, DOI 10.1021/bi010755y; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Starcevic D, 2005, J BIOL CHEM, V280, P28388, DOI 10.1074/jbc.M502178200; Starcevic D, 2005, BIOCHEMISTRY-US, V44, P3775, DOI 10.1021/bi047956x; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Trzemecka A, 2010, J MOL BIOL, V404, P778, DOI 10.1016/j.jmb.2010.09.058; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Xia SL, 2011, BIOCHEMISTRY-US, V50, P9114, DOI 10.1021/bi201260h; Xia SL, 2011, J MOL BIOL, V406, P558, DOI 10.1016/j.jmb.2010.12.033; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p; Zhang H, 2006, BIOCHEMISTRY-US, V45, P2211, DOI 10.1021/bi052099y; Zhang H, 2009, BIOCHEMISTRY-US, V48, P6940, DOI 10.1021/bi900422b	48	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76700	10.1371/journal.pone.0076700	http://dx.doi.org/10.1371/journal.pone.0076700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116139	gold, Green Published			2022-12-27	WOS:000325501300081
J	Vavrova, A; Jansova, H; Mackova, E; Machacek, M; Haskova, P; Tichotova, L; Sterba, M; Simunek, T				Vavrova, Anna; Jansova, Hana; Mackova, Eliska; Machacek, Miloslav; Haskova, Pavlina; Tichotova, Lucie; Sterba, Martin; Simunek, Tomas			Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells	PLOS ONE			English	Article							INDUCED CARDIOTOXICITY; DEXRAZOXANE ICRF-187; OXIDATIVE STRESS; IRON CHELATORS; LABILE IRON; DOXORUBICIN; DRUG; BETA; BIS(2,6-DIOXOPIPERAZINE); CYTOTOXICITY	Anthracyclines (such as doxorubicin or daunorubicin) are among the most effective anticancer drugs, but their usefulness is hampered by the risk of irreversible cardiotoxicity. Dexrazoxane (ICRF-187) is the only clinically approved cardioprotective agent against anthracycline cardiotoxicity. Its activity has traditionally been attributed to the iron-chelating effects of its metabolite with subsequent protection from oxidative stress. However, dexrazoxane is also a catalytic inhibitor of topoisomerase II (TOP2). Therefore, we examined whether dexrazoxane and two other TOP2 catalytic inhibitors, namely sobuzoxane (MST-16) and merbarone, protect cardiomyocytes from anthracycline toxicity and assessed their effects on anthracycline antineoplastic efficacy. Dexrazoxane and two other TOP2 inhibitors protected isolated neonatal rat cardiomyocytes against toxicity induced by both doxorubicin and daunorubicin. However, none of the TOP2 inhibitors significantly protected cardiomyocytes in a model of hydrogen peroxide-induced oxidative injury. In contrast, the catalytic inhibitors did not compromise the antiproliferative effects of the anthracyclines in the HL-60 leukemic cell line; instead, synergistic interactions were mostly observed. Additionally, anthracycline-induced caspase activation was differentially modulated by the TOP2 inhibitors in cardiac and cancer cells. Whereas dexrazoxane was upon hydrolysis able to significantly chelate intracellular labile iron ions, no such effect was noted for either sobuzoxane or merbarone. In conclusion, our data indicate that dexrazoxane may protect cardiomyocytes via its catalytic TOP2 inhibitory activity rather than iron-chelation activity. The differential expression and/or regulation of TOP2 isoforms in cardiac and cancer cells by catalytic inhibitors may be responsible for the selective modulation of anthracycline action observed.	[Vavrova, Anna; Jansova, Hana; Mackova, Eliska; Machacek, Miloslav; Haskova, Pavlina; Tichotova, Lucie; Simunek, Tomas] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Hradec Kralove, Czech Republic; [Sterba, Martin] Charles Univ Prague, Fac Med Hradec Kralove, Dept Pharmacol, Hradec Kralove, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Hradec Kralove	Simunek, T (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Hradec Kralove, Czech Republic.	Tomas.Simunek@faf.cuni.cz	Jansova, Hana/S-5847-2017; Simunek, Tomas/A-3938-2008; Hašková, Pavlína/ABC-6019-2021; Jirkovska, Anna/E-8419-2012; Machacek, Miloslav/T-3378-2017; Sterba, Martin/E-8123-2017	Jansova, Hana/0000-0002-5377-518X; Simunek, Tomas/0000-0001-5464-4176; Jirkovska, Anna/0000-0002-0131-6010; Machacek, Miloslav/0000-0001-7221-5914; Haskova, Pavlina/0000-0002-1179-8885	Czech Science Foundation [13-15008S]; Charles University in Prague [SVV 267 004]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0022]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University in Prague; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This study was supported by the Czech Science Foundation (project 13-15008S; www.gacr.cz), Charles University in Prague (project SVV 267 004; www.cuni.cz) and co-financed by the European Social Fund and the state budget of the Czech Republic (project no. CZ.1.07/2.3.00/30.0022; www.msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcova M, 2007, TOXICOLOGY, V237, P218, DOI 10.1016/j.tox.2007.05.016; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Bendova P, 2010, CHEM RES TOXICOL, V23, P1105, DOI 10.1021/tx100125t; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; COONEY DA, 1985, BIOCHEM PHARMACOL, V34, P3395, DOI 10.1016/0006-2952(85)90368-5; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Fujiwara Y, 1999, J CLIN ONCOL, V17, P3362, DOI 10.1200/JCO.1999.17.10.3362; GALLAGHER R, 1979, BLOOD, V54, P713; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Glickstein H, 2006, BLOOD, V108, P3195, DOI 10.1182/blood-2006-05-020867; Hasinoff BB, 1998, CURR MED CHEM, V5, P1; Hasinoff BB, 2003, MOL PHARMACOL, V64, P670, DOI 10.1124/mol.64.3.670; Hasinoff BB, 1996, ANTI-CANCER DRUG, V7, P558, DOI 10.1097/00001813-199607000-00011; Hasinoff BB, 2007, CARDIOVASC TOXICOL, V7, P140, DOI 10.1007/s12012-007-0023-3; Hasinoff Brian B, 2003, Cardiovasc Toxicol, V3, P89, DOI 10.1385/CT:3:2:89; Inutsuka S, 1998, CANCER CHEMOTH PHARM, V42, P194, DOI 10.1007/s002800050805; KEIZER HG, 1990, PHARMACOL THERAPEUT, V47, P219, DOI 10.1016/0163-7258(90)90088-J; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x; Lu Da Yong, 2005, BMC Pharmacology, V5, P11, DOI 10.1186/1471-2210-5-11; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mackova E, 2012, CHEM-BIOL INTERACT, V197, P69, DOI 10.1016/j.cbi.2012.03.010; MALISZA KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P680, DOI 10.1006/abbi.1995.1091; Martin E, 2009, TOXICOLOGY, V255, P72, DOI 10.1016/j.tox.2008.10.011; MINDERMAN H, 1993, ANTICANCER RES, V13, P1161; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Popelova O, 2009, BRIT J CANCER, V101, P792, DOI 10.1038/sj.bjc.6605192; Sawyer DB, 2013, NEW ENGL J MED, V368, P1154, DOI 10.1056/NEJMcibr1214975; Schroeder PE, 2003, CANCER CHEMOTH PHARM, V52, P167, DOI 10.1007/s00280-003-0619-7; Simunek T, 2009, PHARMACOL REP, V61, P154; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Swain SM, 2004, J CANCER RES CLIN, V130, P1, DOI 10.1007/s00432-003-0498-7; TANABE K, 1991, CANCER RES, V51, P4903; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; van Dalen EC, 2011, COCHRANE DATABASE SY, V71; Vavrova A, 2012, INT J BIOCHEM CELL B, V44, P834, DOI 10.1016/j.biocel.2012.03.005; Vavrova A, 2011, ARCH TOXICOL, V85, P525, DOI 10.1007/s00204-010-0615-8; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	41	50	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76676	10.1371/journal.pone.0076676	http://dx.doi.org/10.1371/journal.pone.0076676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116135	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300077
J	Dumont, BL; Eichler, EE				Dumont, Beth L.; Eichler, Evan E.			Signals of Historical Interlocus Gene Conversion in Human Segmental Duplications	PLOS ONE			English	Article							COPY NUMBER VARIATION; HUMAN GENOME; PRIMATE EVOLUTION; RECOMBINATION RATES; POSITIVE SELECTION; RAPID EVOLUTION; DNA-SEQUENCES; DISEASE RISK; HOT-SPOTS; FAMILY	Standard methods of DNA sequence analysis assume that sequences evolve independently, yet this assumption may not be appropriate for segmental duplications that exchange variants via interlocus gene conversion (IGC). Here, we use high quality multiple sequence alignments from well-annotated segmental duplications to systematically identify IGC signals in the human reference genome. Our analysis combines two complementary methods: (i) a paralog quartet method that uses DNA sequence simulations to identify a statistical excess of sites consistent with inter-paralog exchange, and (ii) the alignment-based method implemented in the GENECONV program. One-quarter (25.4%) of the paralog families in our analysis harbor clear IGC signals by the quartet approach. Using GENECONV, we identify 1477 gene conversion tracks that cumulatively span 1.54 Mb of the genome. Our analyses confirm the previously reported high rates of IGC in subtelomeric regions and Y-chromosome palindromes, and identify multiple novel IGC hotspots, including the pregnancy specific glycoproteins and the neuroblastoma breakpoint gene families. Although the duplication history of a paralog family is described by a single tree, we show that IGC has introduced incredible site-to-site variation in the evolutionary relationships among paralogs in the human genome. Our findings indicate that IGC has left significant footprints in patterns of sequence diversity across segmental duplications in the human genome, out-pacing the contributions of single base mutation by orders of magnitude. Collectively, the IGC signals we report comprise a catalog that will provide a critical reference for interpreting observed patterns of DNA sequence variation across duplicated genomic regions, including targets of recent adaptive evolution in humans.	[Dumont, Beth L.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Dumont, BL (corresponding author), N Carolina State Univ, Initiat Biol Complex, Raleigh, NC 27695 USA.	bldumont@ncsu.edu			NIH [HG002385, 5T32HG000035-17]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, R01HG002385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded, in part, by NIH Grant HG002385 to EEE. BLD was funded by a NIH Training Grant awarded to the Department of Genome Sciences at the University of Washington (5T32HG000035-17). EEE is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beyond the sources of funding listed in the acknowledgements, no external funding was received for this study.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Assis R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002508; Avent ND, 1997, BLOOD, V89, P1779, DOI 10.1182/blood.V89.5.1779.1779_1779_1786; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Benovoy D, 2009, GENOMICS, V93, P27, DOI 10.1016/j.ygeno.2008.09.007; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bromham L, 2000, J MOL EVOL, V50, P296, DOI 10.1007/s002399910034; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Casola C, 2012, GENOME RES, V22, P429, DOI 10.1101/gr.127738.111; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen JM, 2005, HUM MUTAT, V26, P125, DOI 10.1002/humu.20202; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Cole F, 2010, MOL CELL, V39, P700, DOI 10.1016/j.molcel.2010.08.017; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Drouin G, 2002, J MOL EVOL, V55, P14, DOI 10.1007/s00239-001-0085-y; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Ezawa K, 2006, MOL BIOL EVOL, V23, P927, DOI 10.1093/molbev/msj093; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta PK, 2005, BRIT J HAEMATOL, V130, P752, DOI 10.1111/j.1365-2141.2005.05660.x; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hahn MW, 2007, GENETICS, V177, P1941, DOI 10.1534/genetics.107.080077; Hallast P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003666; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Innan H, 2002, GENETICS, V161, P865; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jackson MS, 2005, AM J HUM GENET, V77, P824, DOI 10.1086/497704; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kitano T, 1999, J MOL EVOL, V49, P615, DOI 10.1007/PL00006583; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Lukacsovich T, 1999, GENETICS, V151, P1559; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mansai SP, 2010, GENETICS, V184, P517, DOI 10.1534/genetics.109.111161; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McGrath CL, 2009, GENETICS, V182, P615, DOI 10.1534/genetics.109.101428; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nehrt NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002073; Ohta T, 1997, HEREDITAS, V127, P97, DOI 10.1111/j.1601-5223.1997.00097.x; OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P3251, DOI 10.1073/pnas.79.10.3251; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Shi JH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000327; SIEGEL S., 1956, NONPARAMETRIC STAT B; St Charles J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003434; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; TAJIMA F, 1993, GENETICS, V135, P599; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Talbert PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000326; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang SH, 2012, P NATL ACAD SCI USA, V109, P20992, DOI 10.1073/pnas.1211827110	93	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75949	10.1371/journal.pone.0075949	http://dx.doi.org/10.1371/journal.pone.0075949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124524	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100081
J	Li, ZZ; Xue, J; Yan, SP; Chen, P; Chen, LZ				Li, Zhanzhan; Xue, Jing; Yan, Shipeng; Chen, Peng; Chen, Lizhang			Association between Tumor Necrosis Factor-alpha 308G/A Gene Polymorphism and Silicosis Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							TNF-ALPHA; PUBLICATION BIAS; UNITED-STATES; PROMOTER; TUBERCULOSIS; MORTALITY; RISK; CYTOKINES; RELEASE; DISEASE	Background: Tumor necrosis factor-alpha (TNF-alpha) 308 G/A gene polymorphism has been reported to be associated with susceptibility to silicosis. However, the relevant study results are still inconsistent. Objective and Methods: A meta-analysis was performed in order to drive a more precise estimation of the relationship between TNF-alpha-308 G/A gene polymorphism and susceptibility to silicosis. Electronic databases were searched and nine separate studies were included. The pooled odds ratios (ORs) and the corresponding 95% confidence internal (CI) were calculated by a fixed effect model. Results: A total of 1267 cases and 1214 controls were included. In the overall analysis, significantly increased silicosis risk was found (for GA+AA vs. GG OR=1.45, 95%CI: 1.20-1.760, P=1.58E4; for GA vs. GG: OR=1.53, 95%CI=1.25-1.86, P=3.11E5; for A allele vs. G allele: OR=1.27, 95%CI=1.08-1.50, P=0.004). In the subgroup analysis, significantly increased silicosis risk was also found among Asians (for GA+AA vs. GG: OR=1.63, 95%CI=1.27-2.08, P=1.01E4), for GA vs. GG: OR=1.71, 95%CI=1.33-2.20, P=3.44E5), for A allele vs. G allele: OR=1.45, 95%CI=1.17-1.80, P=0.001). However, no significantly increased risk was found among non-Asians for all genetic models. Conclusions: TNF-alpha-308 G/A polymorphism might lead to an increased risk of silicosis susceptibility, especially for Asians. However, further studies with large sample sizes should be conducted to confirm the association.	[Li, Zhanzhan; Xue, Jing; Yan, Shipeng; Chen, Lizhang] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Chen, Peng] Cent South Univ, Xiangya Med Sch, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chen, LZ (corresponding author), Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China.	liche4005@126.com						Bahcecioglu IH, 2008, INFLAMMATION, V31, P215, DOI 10.1007/s10753-008-9067-1; Bang KM, 2008, AM J IND MED, V51, P633, DOI 10.1002/ajim.20607; BORM PJA, 1988, AM REV RESPIR DIS, V138, P1589, DOI 10.1164/ajrccm/138.6.1589; Brittain EH, 2012, BIOSTATISTICS, V13, P637, DOI 10.1093/biostatistics/kxs006; Chang KC, 2001, INT J TUBERC LUNG D, V5, P177; Charalambous S, 2001, INT J TUBERC LUNG D, V5, P1044; Chaudhury N, 2012, LUNG INDIA, V29, P6, DOI 10.4103/0970-2113.92348; Chen, 1997, Int J Occup Environ Health, V3, P163; Chootrakool H, 2011, STAT MED, V30, P1183, DOI 10.1002/sim.4143; Corbett EL, 2002, AM J RESP CRIT CARE, V165, P690, DOI 10.1164/ajrccm.165.5.2010050; Cui A, 2009, SARCOIDOSIS VASC DIF, V26, P147; DALFONSO S, 1994, IMMUNOGENETICS, V39, P150; Davis Gerald S., 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P81; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Ding B, 2012, INT J GYNECOL CANCER, V22, P213, DOI 10.1097/IGC.0b013e3182375aed; DRISCOLL KE, 1990, AM J RESP CELL MOL, V2, P381, DOI 10.1165/ajrcmb/2.4.381; Girardi E, 2010, EXPERT REV ANTI-INFE, V8, P1105, DOI [10.1586/eri.10.97, 10.1586/ERI.10.97]; Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jiang Zhen-you, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P399; KATSNELSON BA, 1986, ENVIRON HEALTH PERSP, V68, P175, DOI 10.2307/3430262; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Li Lin, 2004, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V22, P323; Li X, 2009, TOXICOL MECH METHOD, V19, P51, DOI 10.1080/15376510802354201; Martinez C, 2010, ARCH BRONCONEUMOL, V46, P97, DOI 10.1016/j.arbres.2009.07.008; Mazurek JM, 2008, AM J IND MED, V51, P568, DOI 10.1002/ajim.20597; Miao Rong-Ming, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P606; Morimoto Y, 2008, EXP MOL PATHOL, V85, P207, DOI 10.1016/j.yexmp.2008.08.003; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; OHTSUKA Y, 1995, AM J RESP CRIT CARE, V152, P2144, DOI 10.1164/ajrccm.152.6.8520788; Qu Ya-bin, 2005, Fudan Xuebao (Yixuekexueban), V32, P637; Rad Isa Abdi, 2012, Maedica (Bucur), V7, P20; Senaldi G, 1998, CYTOKINE, V10, P382, DOI 10.1006/cyto.1997.0303; Slavov E, 2010, TOXICOL IND HEALTH, V26, P479, DOI 10.1177/0748233710373082; Song FJ, 1998, BRIT MED J, V316, P471; Umemura S, 2008, CARCINOGENESIS, V29, P1845, DOI 10.1093/carcin/bgn169; VANDEVENTER SJH, 1993, J INFECT DIS, V167, P461, DOI 10.1093/infdis/167.2.461; Wang De-Jun, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P679; Wang JK, 2012, J GASTROEN HEPATOL, V27, P670, DOI 10.1111/j.1440-1746.2011.06978.x; Wang XT, 2005, AM J IND MED, V48, P24, DOI 10.1002/ajim.20180; Wang YW, 2012, BIOMED ENVIRON SCI, V25, P517, DOI 10.3967/0895-3988.2012.05.004; WHO, 2000, SIL; Wu F, 2008, J OCCUP HEALTH, V50, P445, DOI 10.1539/joh.L8006; Xie C, 2011, CYTOKINE, V56, P550, DOI 10.1016/j.cyto.2011.09.021; Yucesoy B, 2001, TOXICOL APPL PHARM, V172, P75, DOI 10.1006/taap.2001.9124; Zhang XP, 2009, HEPATOB PANCREAT DIS, V8, P351	47	12	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76614	10.1371/journal.pone.0076614	http://dx.doi.org/10.1371/journal.pone.0076614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124578	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100135
J	Yang, XW; He, Y; Xu, J; Xiao, X; Wang, FP				Yang, Xin-Wei; He, Ying; Xu, Jun; Xiao, Xiang; Wang, Feng-Ping			The Regulatory Role of Ferric Uptake Regulator (Fur) during Anaerobic Respiration of Shewanella piezotolerans WP3	PLOS ONE			English	Article							C-TYPE CYTOCHROMES; ESCHERICHIA-COLI; ONEIDENSIS MR-1; IRON-METABOLISM; GENE-EXPRESSION; SMALL RNA; TRANSCRIPTIONAL REGULATION; SALMONELLA-ENTERICA; ELECTRON-ACCEPTORS; HEME-BIOSYNTHESIS	Ferric uptake regulator (Fur) is a global regulator that controls bacterial iron homeostasis. In this study, a fur deletion mutant of the deep-sea bacterium Shewanella piezotolerans WP3 was constructed. Physiological studies revealed that the growth rate of this mutant under aerobic conditions was only slightly lower than that of wild type (WT), but severe growth defects were observed under anaerobic conditions when different electron acceptors (EAs) were provided. Comparative transcriptomic analysis demonstrated that Fur is involved not only in classical iron homeostasis but also in anaerobic respiration. Fur exerted pleiotropic effects on the regulation of anaerobic respiration by controlling anaerobic electron transport, the heme biosynthesis system, and the cytochrome c maturation system. Biochemical assays demonstrated that levels of c-type cytochromes were lower in the fur mutant, consistent with the transcriptional profiling. Transcriptomic analysis and electrophoretic mobility shift assays revealed a primary regulation network for Fur in WP3. These results suggest that Fur may act as a sensor for anoxic conditions to trigger and influence the anaerobic respiratory system.	[Yang, Xin-Wei; He, Ying; Xu, Jun; Xiao, Xiang; Wang, Feng-Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Yang, Xin-Wei; He, Ying; Xu, Jun; Xiao, Xiang; Wang, Feng-Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Ocean Engn, Shanghai 200030, Peoples R China; [Wang, Feng-Ping] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, FP (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	fengpingw@sjtu.edu.cn	xiao, xiang/GWU-6035-2022	Yang, Xinwei/0000-0003-0776-8269	National Science Foundation of China [31290232, 41076078]; National Basic Research Program of China [2011CB808800]; China Ocean Mineral Resources R D Association [DY125-15-T-04]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); China Ocean Mineral Resources R D Association; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation	This work was supported by National Science Foundation of China (Grant No. 31290232, 41076078), National Basic Research Program of China (Grant No. 2011CB808800), China Ocean Mineral Resources R & D Association (Grant No. DY125-15-T-04), "ShuGuang" Project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07; Cavallaro G, 2008, J PROTEOME RES, V7, P4946, DOI 10.1021/pr8004309; Chen S.-Y., 1996, J OCEANOGR, V52, P705; Chen Y, 2011, ISME J, V5, P843, DOI 10.1038/ismej.2010.182; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Craig SA, 2011, J BACTERIOL, V193, P6505, DOI 10.1128/JB.05681-11; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Evans MR, 2011, BMC MICROBIOL, V21, P11; Fennessey CM, 2010, APPL ENVIRON MICROB, V76, P2425, DOI 10.1128/AEM.03066-09; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295; Gonzalez A, 2012, ENVIRON MICROBIOL, V14, P3175, DOI 10.1111/j.1462-2920.2012.02897.x; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Kuehl CJ, 2010, FUTURE MICROBIOL, V5, P1403, DOI 10.2217/FMB.10.90; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Miles S, 2010, J MICROBIOL, V48, P378, DOI 10.1007/s12275-010-0022-0; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Parker D, 2005, J BACTERIOL, V187, P366, DOI 10.1128/JB.187.1.366-375.2005; Paustian ML, 2001, INFECT IMMUN, V69, P4109, DOI 10.1128/IAI.69.6.4109-4115.2001; Pellicer S, 2012, FEBS J, V279, P2231, DOI 10.1111/j.1742-4658.2012.08606.x; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rodionov DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S3; Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Shroff NP, 2010, J BACTERIOL, V192, P3227, DOI 10.1128/JB.01695-09; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Teixido L, 2010, INT MICROBIOL, V13, P33, DOI 10.2436/20.1501.01.109; Thompson DK, 2002, APPL ENVIRON MICROB, V68, P881, DOI 10.1128/AEM.68.2.881-892.2002; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Wang FP, 2004, EXTREMOPHILES, V8, P165, DOI 10.1007/s00792-003-0365-0; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang LY, 1997, J BACTERIOL, V179, P2907, DOI 10.1128/jb.179.9.2907-2914.1997; Wu WF, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001728; Xiao X, 2007, INT J SYST EVOL MICR, V57, P60, DOI 10.1099/ijs.0.64500-0; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Yang YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-131; Yuan J, 2012, PROTEOMICS, V12, P1957, DOI 10.1002/pmic.201100651	70	146	149	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75588	10.1371/journal.pone.0075588	http://dx.doi.org/10.1371/journal.pone.0075588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124499	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100056
J	Armitage, AR; Ho, CK; Quigg, A				Armitage, Anna R.; Ho, Chuan-Kai; Quigg, Antonietta			The Interactive Effects of Pulsed Grazing Disturbance and Patch Size Vary among Wetland Arthropod Guilds	PLOS ONE			English	Article							TROPHIC-LEVEL INTERACTIONS; PLANT COMMUNITY STRUCTURE; BOTTOM-UP FORCES; SALT-MARSH; TOP-DOWN; SPARTINA-ALTERNIFLORA; VERTEBRATE HERBIVORES; INSECT COMMUNITIES; TEMPORAL PATTERNS; BAY	Pulse disturbances and habitat patch size can determine community composition independently or in concert, and may be particularly influential on small spatial scales for organisms with low mobility. In a field experiment, we investigated whether the effects of a pulsed disturbance that simulated a grazing event varied with habitat patch size. We focused on the short-term responses of multiple co-occurring emergent salt marsh arthropods with differing levels of mobility and dispersal potential. As part of a marsh restoration project, two types of emergent marsh structures were created: small circular mounds (0.5 m diameter) separated by several meters of aquatic habitat, and larger, elongated terraces (. 50 m long). Study plots (0.25 m(2)) were established on both structures; in a subset of plots, we simulated a pulsed grazing disturbance event by clipping the aboveground tissue of emergent plants, primarily Spartina alterniflora. At the end of the two-month recovery period, Ischnodemus (Hemiptera: Blissidae) density was over 50% lower in disturbed treatments within both large (terrace) and small (mound) patches. Predatory spider treatment responses were similar to Ischnodemus responses, suggesting a trophic relationship between those two arthropod groups. Alternatively, spiders may have been directly affected by the loss of shelter in the disturbed plots. Prokelisia (Homoptera: Delphacidae), which are generally more mobile than Ischnodemus, were not affected by disturbance treatment or by patch size, suggesting the potential for rapid recolonization following disturbance. Larval stem borers decreased by an order of magnitude in disturbed plots, but only in the large patches. In general, the disturbance effects of vegetation removal on arthropod density and community composition were stronger than patch size effects, and there were few interactions between pulsed disturbance and patch size. Rather, emergent marsh arthropod responses to disturbance and habitat area treatments were linked to the dispersal potential and mobility of each individual taxon.	[Armitage, Anna R.; Ho, Chuan-Kai; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Ho, Chuan-Kai] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Texas A&M University System; National Taiwan University; Texas A&M University System; Texas A&M University College Station	Armitage, AR (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	armitaga@tamug.edu	Armitage, Anna/X-2773-2019	Armitage, Anna/0000-0003-1563-8026; HO, CHUAN-KAI/0000-0002-6437-0073	Texas General Land Office Oil Spill Prevention and Response Division [09-060-000-3396]	Texas General Land Office Oil Spill Prevention and Response Division	This material is based in part upon work supported by the Research and Development program of the Texas General Land Office Oil Spill Prevention and Response Division under Grant No. 09-060-000-3396 (http://www.glo.texas.gov/what-we-do/caring-for-the-coast/oil-spills/research-development.html). While employed under this grant, Amanda Thronson made substantial contributions to the data collection for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PFE, 2008, J EXP MAR BIOL ECOL, V364, P19, DOI 10.1016/j.jembe.2008.06.020; Angelini C, 2012, ECOLOGY, V93, P101, DOI 10.1890/11-0557.1; Brown SC, 1997, ENVIRON ENTOMOL, V26, P1016, DOI 10.1093/ee/26.5.1016; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Denno RF, 1996, ECOL MONOGR, V66, P389, DOI 10.2307/2963487; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Denno RF, 2003, ECOLOGY, V84, P1032, DOI 10.1890/0012-9658(2003)084[1032:PRARSO]2.0.CO;2; DENNO RF, 1979, ECOLOGY, V60, P221, DOI 10.2307/1936482; Denno Robert F., 2000, American Entomologist, V46, P95; Diaz R, 2008, ANN ENTOMOL SOC AM, V101, P604, DOI 10.1603/0013-8746(2008)101[604:TDSAPD]2.0.CO;2; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Evers DE, 1998, ESTUARIES, V21, P1, DOI 10.2307/1352543; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Ford H, 2013, INSECT CONSERV DIVER, V6, P189, DOI 10.1111/j.1752-4598.2012.00202.x; Ford MA, 1998, J ECOL, V86, P974, DOI 10.1046/j.1365-2745.1998.00314.x; FURBISH CE, 1994, ECOLOGY, V75, P1015, DOI 10.2307/1939425; Gough L, 1998, OECOLOGIA, V117, P527, DOI 10.1007/s004420050689; Gratton C, 2003, ECOLOGY, V84, P2692, DOI 10.1890/02-0666; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Halaj J, 2000, ENVIRON ENTOMOL, V29, P383, DOI 10.1603/0046-225X(2000)029[0383:MHREGP]2.0.CO;2; Hartzell D, 2007, WETLANDS, V27, P794, DOI 10.1672/0277-5212(2007)27[794:ACONAC]2.0.CO;2; Ho CK, 2008, ECOLOGY, V89, P1714, DOI 10.1890/07-1069.1; Jefferies RL, 1999, HERBIVORES NUTR TROP; Johnson LA, 1997, AQUAT BOT, V59, P17, DOI 10.1016/S0304-3770(97)00031-4; Kettenring KM, 2010, ESTUAR COAST, V33, P118, DOI 10.1007/s12237-009-9241-1; Kotanen PM, 2013, PLANT ECOL, V214, P409, DOI 10.1007/s11258-013-0178-x; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Laurel BJ, 2003, MAR ECOL PROG SER, V251, P245, DOI 10.3354/meps251245; MacKenzie RA, 2005, AM MIDL NAT, V153, P257, DOI 10.1674/0003-0031(2005)153[0257:SATPII]2.0.CO;2; Martinson HM, 2012, ECOLOGY, V93, P1779, DOI 10.1890/11-1497.1; McFalls TB, 2010, J COASTAL RES, V26, P901, DOI 10.2112/JCOASTRES-D-09-00037.1; Mills VS, 2009, ESTUAR COAST SHELF S, V81, P123, DOI 10.1016/j.ecss.2008.10.005; Moon DC, 2005, ECOL ENTOMOL, V30, P642, DOI 10.1111/j.0307-6946.2005.00733.x; Moon DC, 2004, ECOLOGY, V85, P2709, DOI 10.1890/03-4099; Moon DC, 2002, OECOLOGIA, V133, P243, DOI 10.1007/s00442-002-1013-6; Moon DC, 2002, OIKOS, V98, P480, DOI 10.1034/j.1600-0706.2002.980312.x; Murphy SM, 2012, PLOS ONE, V7; Olofsson J, 2008, OECOLOGIA, V156, P825, DOI 10.1007/s00442-008-1038-6; Olofsson J, 2004, OIKOS, V106, P324, DOI 10.1111/j.0030-1299.2004.13224.x; Rand TA, 2002, OECOLOGIA, V132, P549, DOI 10.1007/s00442-002-0989-2; Randall LAJ, 2005, WETLANDS, V25, P38; Richardson BA, 2010, ECOSYSTEMS, V13, P286, DOI 10.1007/s10021-010-9317-6; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Rose CD, 1999, MAR ECOL PROG SER, V190, P211, DOI 10.3354/meps190211; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Slater JA, 1990, LYGAEIDAE FLORIDA HE; Stagliano DM, 1998, J N AM BENTHOL SOC, V17, P37, DOI 10.2307/1468050; Steinly BA, 2004, P ENTOMOL SOC WASH, V106, P460; Stevenson JC, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P709; STILING P, 1991, FLA ENTOMOL, V74, P88, DOI 10.2307/3495244; STILING PD, 1983, ECOLOGY, V64, P770, DOI 10.2307/1937200; STILING PD, 1984, ECOLOGY, V65, P660, DOI 10.2307/1941431; Stoner KJL, 2004, ECOL APPL, V14, P1306, DOI 10.1890/03-5112; STRONG DR, 1989, J ANIM ECOL, V58, P1065, DOI 10.2307/5142; TURNER MG, 1987, ESTUARIES, V10, P54, DOI 10.2307/1352025; Watts CH, 2006, OECOLOGIA, V148, P61, DOI 10.1007/s00442-005-0344-5; Weyer J, 2012, J INSECT CONSERV, V16, P379, DOI 10.1007/s10841-011-9423-6; White WH, 2005, 46 USDA SYST ENT LAB; With KA, 2011, LANDSCAPE ECOL, V26, P1035, DOI 10.1007/s10980-011-9627-x	62	10	10	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76672	10.1371/journal.pone.0076672	http://dx.doi.org/10.1371/journal.pone.0076672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116133	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200061
J	Majchrzak, K; Lo Re, D; Gajewska, M; Bulkowska, M; Homa, A; Pawlowski, K; Motyl, T; Murphy, PV; Krol, M				Majchrzak, Kinga; Lo Re, Daniele; Gajewska, Malgorzata; Bulkowska, Malgorzata; Homa, Agata; Pawlowski, Karol; Motyl, Tomasz; Murphy, Paul V.; Krol, Magdalena			Migrastatin Analogues Inhibit Canine Mammary Cancer Cell Migration and Invasion	PLOS ONE			English	Article							TUMOR-METASTASIS; BREAST-CANCER; DORRIGOCIN; EXPRESSION; DISCOVERY; CONGENERS; LACTONE; FASCIN; LINES; MODEL	Background: Cancer spread to other organs is the main cause of death of oncological patients. Migration of cancer cells from a primary tumour is the crucial step in the complex process of metastasis, therefore blocking this process is currently the main treatment strategy. Metastasis inhibitors derived from natural products, such as, migrastatin, are very promising anticancer agents. Thus, the aim of our study was to investigate the effect of six migrastatin analogues (MGSTA-1 to 6) on migration and invasion of canine mammary adenocarcinoma cell lines isolated from primary tumours and their metastases to the lungs. Canine mammary tumours constitute a valuable tool for studying multiple aspect of human cancer. Results: Our results showed that two of six fully synthetic analogues of migrastatin: MGSTA-5 and MGSTA-6 were potent inhibitors of canine mammary cancer cells migration and invasion. These data were obtained using the wound healing test, as well as trans-well migration and invasion assays. Furthermore, the treatment of cancer cells with the most effective compound (MGSTA-6) disturbed binding between filamentous F-actin and fascin1. Confocal microscopy analyses revealed that treatment with MGSTA-6 increased the presence of unbound fascin1 and reduced co-localization of F-actin and fascin1 in canine cancer cells. Most likely, actin filaments were not cross-linked by fascin1 and did not generate the typical filopodial architecture of actin filaments in response to the activity of MGSTA-6. Thus, administration of MGSTA-6 results in decreased formation of filopodia protrusions and stress fibres in canine mammary cancer cells, causing inhibition of cancer migration and invasion. Conclusion: Two synthetic migrastatin analogues (MGSTA-5 and MGSTA-6) were shown to be promising compounds for inhibition of cancer metastasis. They may have beneficial therapeutic effects in cancer therapy in dogs, especially in combination with other anticancer drugs. However, further in vivo studies are required to verify this hypothesis.	[Majchrzak, Kinga; Gajewska, Malgorzata; Bulkowska, Malgorzata; Homa, Agata; Motyl, Tomasz; Krol, Magdalena] Warsaw Univ Life Sci, Dept Physiol Sci, Fac Vet Med, Warsaw, Poland; [Majchrzak, Kinga] Warsaw Univ Life Sci, Fac Anim Sci, Dept Anim Environm Biol, Warsaw, Poland; [Lo Re, Daniele; Murphy, Paul V.] Natl Univ Ireland, Sch Chem, Galway, Ireland; [Pawlowski, Karol] Warsaw Univ Life Sci, Dept Large Anim Dis Clin, Fac Vet Med, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Ollscoil na Gaillimhe-University of Galway; Warsaw University of Life Sciences	Krol, M (corresponding author), Warsaw Univ Life Sci, Dept Physiol Sci, Fac Vet Med, Warsaw, Poland.	magdalena_krol@sggw.pl	lo re, Daniele/F-2295-2016; Murphy, Paul V/F-7655-2010; Krol, Magdalena/A-5554-2019	lo re, Daniele/0000-0002-6068-5975; Pawlowski, Karol/0000-0003-4565-2873; Murphy, Paul/0000-0002-1529-6540; Krol, Magdalena/0000-0003-0421-5167; Motyl, Tomasz/0000-0002-3470-3324; Rybicka, Agata/0000-0002-7749-8850; Majchrzak-Kuligowska, Kinga/0000-0002-9504-4588; Gajewska, Malgorzata/0000-0001-7249-8627	Ministry of Sciences and Higher Education of Poland [N N308 574940]; Science Foundation Ireland [07/IN.1/B966]; European Union under REA [PIEF-GA-2011-299042]; COST Action [CM1106]	Ministry of Sciences and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union under REA; COST Action(European Cooperation in Science and Technology (COST))	This work was supported by grant number N N308 574940 from the Ministry of Sciences and Higher Education of Poland and Science Foundation Ireland (grant number 07/IN.1/B966). The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement number PIEF-GA-2011-299042. This work was supported by COST Action CM1106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027339; Anquetin G, 2008, CHEM-EUR J, V14, P1592, DOI 10.1002/chem.200701033; Anquetin G, 2008, EUR J ORG CHEM, V2008, P1953, DOI 10.1002/ejoc.200701192; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Dias LC, 2010, EUR J ORG CHEM, V2010, P6748, DOI 10.1002/ejoc.201001097; Gaul C, 2004, J AM CHEM SOC, V126, P11326, DOI 10.1021/ja048779q; Gaul C, 2003, J AM CHEM SOC, V125, P6042, DOI 10.1021/ja0349103; Ju JH, 2008, BIOORG MED CHEM LETT, V18, P5951, DOI 10.1016/j.bmcl.2008.07.072; Krol M, 2010, J APPL GENET, V51, P37, DOI 10.1007/BF03195709; Krol M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-16; Lecomte N, 2011, P NATL ACAD SCI USA, V108, P15074, DOI 10.1073/pnas.1015247108; Majchrzak K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-170; Manuali E, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-86; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nakae K, 2000, J ANTIBIOT, V53, P1130, DOI 10.7164/antibiotics.53.1130; Nakae K, 2000, J ANTIBIOT, V53, P1228, DOI 10.7164/antibiotics.53.1228; Nakamura H, 2002, J ANTIBIOT, V55, P442, DOI 10.7164/antibiotics.55.442; Njardarson JT, 2004, J AM CHEM SOC, V126, P1038, DOI 10.1021/ja039714a; Oskarsson T, 2010, J AM CHEM SOC, V132, P3224, DOI 10.1021/ja9101503; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Queiroga FL, 2011, IN VIVO, V25, P455; Rao Y, 2009, TETRAHEDRON LETT, V50, P6684, DOI 10.1016/j.tetlet.2009.09.080; Rodriguez Luis G., 2004, V294, P23; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schirmer A, 2006, P NATL ACAD SCI USA, V103, P4234, DOI 10.1073/pnas.0600445103; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Woo EJ, 2002, J ANTIBIOT, V55, P141, DOI 10.7164/antibiotics.55.141; Zhou Y, 2010, TETRAHEDRON LETT, V51, P5262, DOI 10.1016/j.tetlet.2010.07.141	35	16	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76789	10.1371/journal.pone.0076789	http://dx.doi.org/10.1371/journal.pone.0076789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116159	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200069
J	Rothfels, CJ; Larsson, A; Li, FW; Sigel, EM; Huiet, L; Burge, DO; Ruhsam, M; Graham, SW; Stevenson, DW; Wong, GKS; Korall, P; Pryer, KM				Rothfels, Carl J.; Larsson, Anders; Li, Fay-Wei; Sigel, Erin M.; Huiet, Layne; Burge, Dylan O.; Ruhsam, Markus; Graham, Sean W.; Stevenson, Dennis W.; Wong, Gane Ka-Shu; Korall, Petra; Pryer, Kathleen M.			Transcriptome-Mining for Single-Copy Nuclear Markers in Ferns	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC-RELATIONSHIPS; CHLOROPLAST DNA; MOLECULAR PHYLOGENY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; EVOLUTIONARY LINEAGES; MATERNAL INHERITANCE; RETICULATE EVOLUTION; NUCLEOTIDE-SEQUENCES; SOMATIC CYTOKINESIS	Background: Molecular phylogenetic investigations have revolutionized our understanding of the evolutionary history of ferns-the second-most species-rich major group of vascular plants, and the sister clade to seed plants. The general absence of genomic resources available for this important group of plants, however, has resulted in the strong dependence of these studies on plastid data; nuclear or mitochondrial data have been rarely used. In this study, we utilize transcriptome data to design primers for nuclear markers for use in studies of fern evolutionary biology, and demonstrate the utility of these markers across the largest order of ferns, the Polypodiales. Principal Findings: We present 20 novel single-copy nuclear regions, across 10 distinct protein-coding genes: ApPEFP_C, cryptochrome 2, cryptochrome 4, DET1, gapCpSh, IBR3, pgiC, SQD1, TPLATE, and transducin. These loci, individually and in combination, show strong resolving power across the Polypodiales phylogeny, and are readily amplified and sequenced from our genomic DNA test set (from 15 diploid Polypodiales species). For each region, we also present transcriptome alignments of the focal locus and related paralogs-curated broadly across ferns-that will allow researchers to develop their own primer sets for fern taxa outside of the Polypodiales. Analyses of sequence data generated from our genomic DNA test set reveal strong effects of partitioning schemes on support levels and, to a much lesser extent, on topology. A model partitioned by codon position is strongly favored, and analyses of the combined data yield a Polypodiales phylogeny that is well-supported and consistent with earlier studies of this group. Conclusions: The 20 single-copy regions presented here more than triple the single-copy nuclear regions available for use in ferns. They provide a much-needed opportunity to assess plastid-derived hypotheses of relationships within the ferns, and increase our capacity to explore aspects of fern evolution previously unavailable to scientific investigation.	[Rothfels, Carl J.; Li, Fay-Wei; Sigel, Erin M.; Huiet, Layne; Pryer, Kathleen M.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Rothfels, Carl J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Larsson, Anders; Korall, Petra] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Burge, Dylan O.; Graham, Sean W.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Ruhsam, Markus] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Stevenson, Dennis W.] New York Bot Garden, Bronx, NY 10458 USA; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Wong, Gane Ka-Shu] BGI Shenzhen, Shenzhen, Peoples R China	Duke University; University of British Columbia; Uppsala University; University of British Columbia; New York Botanical Garden; University of Alberta; Beijing Genomics Institute (BGI)	Rothfels, CJ (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	crothfels@yahoo.ca	Ruhsam, Markus/B-3608-2010; WONG, Gane Ka-Shu/G-5784-2013; Graham, Sean W/L-3944-2014; Pryer, Kathleen M./ABF-4908-2020; Ruhsam, Markus/N-6820-2019; Pryer, Kathleen/X-4635-2019	WONG, Gane Ka-Shu/0000-0001-6108-5560; Graham, Sean W/0000-0001-8209-5231; Pryer, Kathleen M./0000-0002-9776-6736; Ruhsam, Markus/0000-0002-8457-345X; Rothfels, Carl/0000-0002-6605-1770; Larsson, Anders/0000-0002-2096-8102; Li, Fay-Wei/0000-0002-0076-0152	National Science Foundation [DDIG DEB-1110767, DDIG DEB-1110775, DEB-1145614]; Natural Science and Engineering Research Council (Canada); Discovery grant; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [2006-429, 2010-585]; Alberta Enterprise and Advanced Education; Genome Alberta; Alberta Innovates Technology Futures iCORE; Musea Ventures; BGI-Shenzhen; Division Of Environmental Biology [1110652] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Natural Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Discovery grant; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Alberta Enterprise and Advanced Education; Genome Alberta; Alberta Innovates Technology Futures iCORE; Musea Ventures; BGI-Shenzhen; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funds from the National Science Foundation (www.nsf.gov) DDIG DEB-1110767 to KMP and CJR (co-authors), DDIG DEB-1110775 to KMP and EMS (co-authors), and DEB-1145614 to KMP and LH; a Natural Science and Engineering Research Council (Canada) Postgraduate Scholarship - Doctoral of NSERC (Natural Sciences and Engineering Research Council) to CJR and Discovery grant to SWG; grants from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) to PK (2006-429 and 2010-585); GKSW acknowledges the support of Alberta Enterprise and Advanced Education, Genome Alberta, Alberta Innovates Technology Futures iCORE, Musea Ventures, and BGI-Shenzhen. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjie B, 2007, J PLANT RES, V120, P129, DOI 10.1007/s10265-006-0032-5; Adjie Bayu, 2008, Acta Phytotaxonomica et Geobotanica, V59, P79; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2006, THESIS U TEXAS AUSTI; Barker MS, 2010, BIOSCIENCE, V60, P177, DOI 10.1525/bio.2010.60.3.4; Beck JB, 2010, SYST BOT, V35, P223, DOI 10.1600/036364410791638388; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BRINKMANN H, 1987, J MOL EVOL, V26, P320, DOI 10.1007/BF02101150; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Brown JWS, 1996, PLANT MOL BIOL, V32, P531, DOI 10.1007/BF00019105; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang HM, 2009, AM FERN J, V99, P61, DOI 10.1640/0002-8444-99.2.61; CHANG Y, 2013, TAXON IN PRESS; Chao YS, 2012, INT J MOL SCI, V13, P4523, DOI 10.3390/ijms13044523; Charlesworth D, 1998, HEREDITY, V81, P453, DOI 10.1046/j.1365-2540.1998.00415.x; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; Cranfill R, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P25; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Des Marais DL, 2003, INT J PLANT SCI, V164, P737, DOI 10.1086/376817; Dubuisson JY, 2003, INT J PLANT SCI, V164, P753, DOI 10.1086/377059; Dyer RJ, 2012, ANN BOT-LONDON, V110, P1515, DOI 10.1093/aob/mcs202; Ebihara A, 2005, AM J BOT, V92, P1535, DOI 10.3732/ajb.92.9.1535; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Ford VS, 2006, AM J BOT, V93, P480, DOI 10.3732/ajb.93.3.480; Gao L, 2013, GENOME BIOL EVOL, V5, P1403, DOI 10.1093/gbe/evt099; Gastony Gerald J., 1998, Aliso, V17, P131; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Grusz AL, 2009, AM J BOT, V96, P1636, DOI 10.3732/ajb.0900019; Guillon JM, 2000, CURR GENET, V37, P53, DOI 10.1007/s002940050008; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Haufler CH, 1995, AM FERN J, V85, P361, DOI 10.2307/1547815; He LJ, 2012, MOL PHYLOGENET EVOL, V65, P757, DOI 10.1016/j.ympev.2012.07.021; Hennequin S, 2010, BOT J LINN SOC, V164, P113, DOI 10.1111/j.1095-8339.2010.01076.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Imaizumi T, 2000, PLANT CELL, V12, P81, DOI 10.1105/tpc.12.1.81; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Juslen A, 2011, TAXON, V60, P1284, DOI 10.1002/tax.605005; Kamiya K, 2005, AM J BOT, V92, P775, DOI 10.3732/ajb.92.5.775; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korall P, 2006, MOL PHYLOGENET EVOL, V39, P830, DOI 10.1016/j.ympev.2006.01.001; Kranz HD, 1996, PLANT SYST EVOL, V202, P1, DOI 10.1007/BF00985814; Kreier HP, 2006, AM J BOT, V93, P217, DOI 10.3732/ajb.93.2.217; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Labiak PH, 2010, TAXON, V59, P911, DOI 10.1002/tax.593019; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LARSSON A, 2013, IASSEBLASTE; LARSSON A, 2013, PHYLOGENY WOOD UNPUB; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lee SJ, 2013, BIOCHEM SYST ECOL, V50, P371, DOI 10.1016/j.bse.2013.05.008; Lehtonen S, 2012, BOT J LINN SOC, V170, P489, DOI 10.1111/j.1095-8339.2012.01312.x; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li FW, 2012, SYST BOT, V37, P845, DOI 10.1600/036364412X656626; LI FW, 2013, BLUE DEVIL BLAST UTI; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Liu YC, 2011, TAXON, V60, P824, DOI 10.1002/tax.603014; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maddison WP, 2019, MESQUITE MODULAR SYS; Maggini F, 1998, PLANT SYST EVOL, V213, P199, DOI 10.1007/BF00985200; MARTIN W, 1986, EUR J BIOCHEM, V159, P323, DOI 10.1111/j.1432-1033.1986.tb09871.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McKeown M, 2012, PHYTOKEYS, V14, P43, DOI 10.3897/phytokeys.14.3446; Metzgar JS, 2008, SYST BOT, V33, P31, DOI 10.1600/036364408783887528; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moummou H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-219; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; Nagalingum NS, 2007, SYST BOT, V32, P16, DOI 10.1600/036364407780360256; Nakazato T, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P175, DOI 10.1017/CBO9780511541827.008; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nitta JH, 2011, AM J BOT, V98, P1782, DOI 10.3732/ajb.1000484; Petersen J, 2003, J MOL EVOL, V57, P16, DOI 10.1007/s00239-002-2441-y; Petersen J, 2006, MOL BIOL EVOL, V23, P1109, DOI 10.1093/molbev/msj123; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 2002, TRENDS PLANT SCI, V7, P550, DOI 10.1016/S1360-1385(02)02375-0; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Rai HS, 2010, AM J BOT, V97, P1444, DOI 10.3732/ajb.0900305; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Reid JD, 2006, INT J PLANT SCI, V167, P529, DOI 10.1086/501071; Roper JM, 2007, AM FERN J, V97, P95, DOI 10.1640/0002-8444(2007)97[95:TCPGSO]2.0.CO;2; Rothfels CJ, 2008, TAXON, V57, P712, DOI 10.1002/tax.573005; Rothfels CJ, 2013, SYST BOT, V38, P295, DOI 10.1600/036364413X666787; Rothfels CJ, 2012, TAXON, V61, P515, DOI 10.1002/tax.613003; Rothfels CJ, 2012, SYST BIOL, V61, P490, DOI 10.1093/sysbio/sys001; ROTHFELS CJ, 2013, SYST BIOL IN PRESS; Salmi ML, 2005, PLANT PHYSIOL, V138, P1734, DOI 10.1104/pp.105.062851; Sano R, 2000, MOL PHYLOGENET EVOL, V15, P403, DOI 10.1006/mpev.1999.0708; Sato N, 2004, J PLANT RES, V117, P495, DOI 10.1007/s10265-004-0183-1; Sato N, 2003, DNA RES, V10, P229, DOI 10.1093/dnares/10.6.229; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schneider H, 2004, SYST BOT, V29, P260, DOI 10.1600/036364404774195476; Schneider H, 2013, J SYST EVOL, V51, P142, DOI 10.1111/j.1759-6831.2012.00226.x; Schuettpelz E, 2008, SYST BOT, V33, P621, DOI 10.1600/036364408786500127; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Schuettpelz E, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P395, DOI 10.1017/CBO9780511541827.016; Schuettpelz E, 2009, P NATL ACAD SCI USA, V106, P11200, DOI 10.1073/pnas.0811136106; Sessa EB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-104; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shepherd LD, 2008, MOL PHYLOGENET EVOL, V49, P240, DOI 10.1016/j.ympev.2008.06.015; Sigel EM, 2011, SYST BOT, V36, P554, DOI 10.1600/036364411X583547; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith AR, 2002, AM FERN J, V92, P131, DOI 10.1640/0002-8444(2002)092[0131:IROTTF]2.0.CO;2; STEIN DB, 1990, ANN MO BOT GARD, V77, P334, DOI 10.2307/2399548; Strugnell J, 2005, MOL PHYLOGENET EVOL, V37, P426, DOI 10.1016/j.ympev.2005.03.020; Sundue MA, 2010, BRITTONIA, V62, P357, DOI 10.1007/s12228-009-9108-6; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thiers B., INDEX HERBARIORUM GL; van Damme D, 2006, PLANT CELL, V18, P3502, DOI 10.1105/tpc.106.040923; Van Damme D, 2011, P NATL ACAD SCI USA, V108, P615, DOI 10.1073/pnas.1017890108; Vangerow S, 1999, PLANT BIOLOGY, V1, P235, DOI 10.1055/s-2007-978512; Vogel JC, 1998, BOT ACTA, V111, P247, DOI 10.1111/j.1438-8677.1998.tb00704.x; Wang L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-158; Wang ML, 2002, ACTA PHYTOTAXON SIN, V41, P416; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wikstrom N, 2005, MOL PHYLOGENET EVOL, V36, P484, DOI 10.1016/j.ympev.2005.04.008; Windham MD, 2009, AM FERN J, V99, P128; WITTER MS, 1990, ANN MO BOT GARD, V77, P110, DOI 10.2307/2399630; Wolf P.G., 2012, GENOMICS CHLOROPLAST, P89, DOI DOI 10.1007/978-94-007-2920-9_; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wolf PG, 1997, AM J BOT, V84, P1429, DOI 10.2307/2446141; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044; Wolf PG, 1995, AM FERN J, V85, P306, DOI 10.2307/1547812; WOLF PG, 1996, PTERIDOLOGY PERSPECT, P203; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Yamauchi D, 2005, J PLANT RES, V118, P223, DOI 10.1007/s10265-005-0209-3; Zhang LB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-180; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2	145	56	59	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76957	10.1371/journal.pone.0076957	http://dx.doi.org/10.1371/journal.pone.0076957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116189	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200089
J	Zhang, W; Zhao, F; Hoffmann, AA; Ma, CS				Zhang, Wei; Zhao, Fei; Hoffmann, Ary A.; Ma, Chun-Sen			Single Hot Event That Does Not Affect Survival but Decreases Reproduction in the Diamondback Moth, Plutella xylostella	PLOS ONE			English	Article							HEAT-STRESS; JUVENILE-HORMONE; TEMPERATURE EXTREMES; GENE-EXPRESSION; THERMAL-STRESS; DROSOPHILA; LEPIDOPTERA; EXPOSURE; FECUNDITY; TOLERANCE	Extremely hot events (usually involving a few hours at extreme high temperatures in summer) are expected to increase in frequency in temperate regions under global warming. The impact of these events is generally overlooked in insect population prediction, since they are unlikely to cause widespread mortality, however reproduction may be affected by them. In this study, we examined such stress effects in the diamondback moth, Plutella xylostella. We simulated a single extreme hot day (maximum of 40 degrees C lasting for 3, 4 or 5 h) increasingly experienced under field conditions. This event had no detrimental effects on immediate mortality, copulation duration, mating success, longevity or lifetime fecundity, but stressed females produced 21% (after 3 or 4 h) fewer hatched eggs because of a decline in the number and hatching success of eggs laid on the first two days. These negative effects on reproduction were no longer evident in the following days. Male heat exposure led to a similar but smaller effect on fertile egg production, and exposure extended pre-mating period in both sexes. Our results indicate that a single hot day can have detrimental effects on reproduction, particularly through maternal effects on egg hatching, and thereby influence the population dynamics of diamondback moth.	[Zhang, Wei; Zhao, Fei; Ma, Chun-Sen] Chinese Acad Agr Sci, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Dept Zool, Inst Bio21, Melbourne, Vic 3010, Australia; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Inst Bio21, Melbourne, Vic 3010, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Melbourne; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	csma@ippcaas.cn	Hoffmann, Ary/C-2961-2011; Ma, Chun-Sen/K-5414-2019; Hoffmann, Ary/R-2972-2019; 赵, 飞/AAC-8601-2019	Ma, Chun-Sen/0000-0002-3253-6921; Hoffmann, Ary/0000-0001-9497-7645; Zhao, Fei/0000-0003-4158-3604; Zhang, Wei/0000-0002-9262-0631	Ministry of Agriculture (MOA), PR China [201103021]	Ministry of Agriculture (MOA), PR China	This research was financially supported by a research grant (201103021) from the Ministry of Agriculture (MOA), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; DEBARRO PJ, 1993, AUST J ZOOL, V41, P123, DOI 10.1071/ZO9930123; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P7; Dillon ME, 2007, J EXP BIOL, V210, P2897, DOI 10.1242/jeb.007591; Dong Shuanglin, 2002, Yingyong Shengtai Xuebao, V13, P1633; Ducatez S, 2012, EVOLUTION, V66, P3558, DOI 10.1111/j.1558-5646.2012.01704.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fasolo AG, 2004, BIOL J LINN SOC, V83, P197, DOI 10.1111/j.1095-8312.2004.00380.x; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Friedenberg NA, 2008, ENVIRON ENTOMOL, V37, P650, DOI 10.1603/0046-225X(2008)37[650:TEDDAS]2.0.CO;2; Geister TL, 2009, J COMP PHYSIOL B, V179, P87, DOI 10.1007/s00360-008-0293-5; GIEBULTOWICZ JM, 1992, ENVIRON ENTOMOL, V21, P822, DOI 10.1093/ee/21.4.822; Golizadeh A, 2007, INSECT SCI, V14, P309, DOI 10.1111/j.1744-7917.2007.00157.x; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; Gruntenko NE, 2003, INSECT MOL BIOL, V12, P393, DOI 10.1046/j.1365-2583.2003.00424.x; Gu HN, 2009, ENVIRON ENTOMOL, V38, P524, DOI 10.1603/022.038.0303; Guo JY, 2012, ENVIRON ENTOMOL, V41, P1672, DOI 10.1603/EN12108; Han Guibiao, 1999, Scientia Silvae Sinicae, V35, P75; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; IPCC, 2007, CONTRIBUTION WORKING; Janowitz SA, 2011, J THERM BIOL, V36, P283, DOI 10.1016/j.jtherbio.2011.04.001; Jia FX, 2009, ENVIRON ENTOMOL, V38, P1365, DOI 10.1603/022.038.0503; Krebs RA, 2005, J THERM BIOL, V30, P335, DOI 10.1016/j.jtherbio.2005.02.002; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Lee Song-Tay, 1995, Chinese Journal of Entomology, V15, P81; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; [马春森 Ma Chunsen], 2010, [生态学报, Acta Ecologica Sinica], V21, P3628; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Ma CS., 1993, J JILIN AGR SCI, V3, P44; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; PIVNICK KA, 1990, ENVIRON ENTOMOL, V19, P587, DOI 10.1093/ee/19.3.587; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047413; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; RAUSCHENBACH IY, 1995, J INSECT PHYSIOL, V41, P179, DOI 10.1016/0022-1910(94)00084-T; Rauschenbach IY, 1996, J INSECT PHYSIOL, V42, P735, DOI 10.1016/0022-1910(96)00027-3; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Silbermann R, 2000, EVOLUTION, V54, P2038; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Wakisaka Shigekazu, 1992, P15; Wan FH, 2008, J INSECT SCI, V8, P49; Wang XP, 2005, J APPL ENTOMOL, V129, P39, DOI 10.1111/j.1439-0418.2005.00931.x; YAMADA H, 1983, JPN J APPL ENTOMOL Z, V27, P17, DOI 10.1303/jjaez.27.17; YAMADA H, 1972, Japanese Journal of Applied Entomology and Zoology, V16, P180, DOI 10.1303/jjaez.16.180	59	61	76	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75923	10.1371/journal.pone.0075923	http://dx.doi.org/10.1371/journal.pone.0075923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116081	Green Published, gold			2022-12-27	WOS:000325552200043
J	Duhachek-Muggy, S; Li, H; Qi, Y; Zolkiewska, A				Duhachek-Muggy, Sara; Li, Hui; Qi, Yue; Zolkiewska, Anna			Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MELTRIN-ALPHA; BREAST-CANCER; TUMOR PROGRESSION; SECRETED FORM; REGULATED EXPRESSION; CARDIAC-HYPERTROPHY; CELL-PROLIFERATION; DISINTEGRIN ADAM12; MOLECULAR SWITCH	Human ADAM12, transcript variant 1 (later on referred to as Var-1b), present in publicly available databases contains the sequence 59-GTAATTCTG-3' at the nucleotide positions 340-348 of the coding region, at the 3' end of exon 4. The translation product of this variant, ADAM12-Lb, includes the three amino acid motif (VIL116)-V-114 in the prodomain. This motif is not conserved in ADAM12 from different species and is not present in other human ADAMs. Currently, it is not clear whether a shorter variant, Var-1a, encoding the protein version without the (VIL116)-V-114 motif, ADAM12-La, is expressed in human. In this work, we have established that human mammary epithelial cells and breast cancer cells express both Var-1a and Var-1b transcripts. Importantly, the proteolytic processing and intracellular trafficking of the corresponding ADAM12-La and ADAM12-Lb proteins are different. While ADAM12-La is cleaved and trafficked to the cell surface in a manner similar to ADAM12 in other species, ADAM12-Lb is retained in the ER and is not proteolytically processed. Furthermore, the relative abundance of ADAM12-La and ADAM12-Lb proteins detected in several breast cancer cell lines varies significantly. We conclude that the canonical form of transmembrane ADAM12 is represented by Var-1a/ ADAM12-La, rather than Var-1b/ADAM12-Lb currently featured in major sequence databases.	[Duhachek-Muggy, Sara; Li, Hui; Qi, Yue; Zolkiewska, Anna] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	zolkiea@ksu.edu	LI, HUI/G-1227-2011	LI, HUI/0000-0002-4114-8349	National Institutes of Health [R15CA151065, R01CA172222]; Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE [R15CA151065, R01CA172222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R15CA151065 and R01CA172222, and Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU. This is contribution 13-393-J from Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Barnabas N, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/872743; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Capasso R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031388; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Georges S, 2013, EUR J CANCER, V49, P2253, DOI 10.1016/j.ejca.2013.02.020; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Godde NJ, 2007, GENE, V403, P80, DOI 10.1016/j.gene.2007.07.033; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Hiller M, 2006, AM J HUM GENET, V78, P291, DOI 10.1086/500151; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Ieguchi K, 2013, ONCOGENE, DOI [10.1038/onc.2013.180, DOI 10.1038/0NC.2013.180]; Kleino I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-90; Kleino I, 2009, J CELL BIOCHEM, V108, P877, DOI 10.1002/jcb.22317; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; Kurisaki T, 2002, FEBS LETT, V532, P419, DOI 10.1016/S0014-5793(02)03732-8; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Li H, 2013, BREAST CANCER RES TR, V139, P691, DOI 10.1007/s10549-013-2602-2; Li H, 2012, BREAST CANCER RES TR, V135, P759, DOI 10.1007/s10549-012-2220-4; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Ortiz RM, 2004, GENE CHROMOSOME CANC, V41, P366, DOI 10.1002/gcc.20102; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Powell RM, 2004, AM J RESP CELL MOL, V31, P13, DOI 10.1165/rcmb.2003-0330OC; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rao VH, 2012, ONCOGENE, V31, P2888, DOI 10.1038/onc.2011.460; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Roberts CM, 1999, J BIOL CHEM, V274, P29251, DOI 10.1074/jbc.274.41.29251; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Skubitz KM, 2004, J LAB CLIN MED, V143, P89, DOI 10.1016/j.lab.2003.10.002; Sorensen HP, 2008, J BIOL CHEM, V283, P31920, DOI 10.1074/jbc.M804113200; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Uehara E, 2012, INT J ONCOL, V40, P1414, DOI 10.3892/ijo.2012.1339; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003	64	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75730	10.1371/journal.pone.0075730	http://dx.doi.org/10.1371/journal.pone.0075730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116070	gold, Green Submitted, Green Published			2022-12-27	WOS:000325501300040
J	Watkins, S; Pichler, WJ				Watkins, Stephan; Pichler, Werner J.			Sulfamethoxazole Induces a Switch Mechanism in T Cell Receptors Containing TCRV beta 20-1, Altering pHLA Recognition	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOXIC EPIDERMAL NECROLYSIS; LABIAL SALIVARY-GLANDS; MOLECULAR-DYNAMICS; SJOGRENS-SYNDROME; CROSS-REACTIVITY; CONFORMATIONAL-CHANGES; PEPTIDE-MHC; TCR; SPECIFICITY	T cell receptors (TCR) containing V beta 20-1 have been implicated in a wide range of T cell mediated disease and allergic reactions, making it a target for understanding these. Mechanics of T cell receptors are largely unexplained by static structures available from x-ray crystallographic studies. A small number of molecular dynamic simulations have been conducted on TCR, however are currently lacking either portions of the receptor or explanations for differences between binding and non-binding TCR recognition of respective peptide-HLA. We performed molecular dynamic simulations of a TCR containing variable domain V beta 20-1, sequenced from drug responsive T cells. These were initially from a patient showing maculopapular eruptions in response to the sulfanilamide-antibiotic sulfamethoxazole (SMX). The CDR2 beta domain of this TCR was found to dock SMX with high affinity. Using this compound as a perturbation, overall mechanisms involved in responses mediated by this receptor were explored, showing a chemical action on the TCR free from HLA or peptide interaction. Our simulations show two completely separate modes of binding cognate peptide-HLA complexes, with an increased affinity induced by SMX bound to the V beta 20-1. Overall binding of the TCR is mediated through a primary recognition by either the variable beta or a domain, and a switch in recognition within these across TCR loops contacting the peptide and HLA occurs when SMX is present in the CDR2 beta loop. Large binding affinity differences are induced by summed small amino acid changes primarily by SMX modifying only three critical CDR2 beta loop amino acid positions. These residues, TYR beta 57, ASP beta 64, and LYS beta 65 initially hold hydrogen bonds from the CDR2 beta to adjacent CDR loops. Effects from SMX binding are amplified and traverse longer distances through internal TCR hydrogen bonding networks, controlling the overall TCR conformation. Thus, the CDR2 beta of V beta 20-1 acts as a ligand controlled switch affecting overall TCR binding affinity.	[Watkins, Stephan; Pichler, Werner J.] Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland; [Watkins, Stephan] Univ Bern, Dept Grad Cell Biol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Watkins, S (corresponding author), Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland.	Stephan.lloyd@students.unibe.ch		Pichler, Werner J./0000-0002-8117-359X	Swiss National Science Foundation [SNF 310030_129828/1]; Swiss Center of Human Toxicology (SCAHT)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Center of Human Toxicology (SCAHT)	This study was supported by the Swiss National Science Foundation, supporting grant number SNF 310030_129828/1, and Swiss Center of Human Toxicology (SCAHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerbring EB, 2012, EUR J IMMUNOL, V42, P2990, DOI 10.1002/eji.201242588; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; APOSTOLOV R, 2010, GROMACS USER MANUAL, P352; Arechaga I, 2010, INT IMMUNOL, V22, P897, DOI 10.1093/intimm/dxq443; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Berrie JL, 2012, TRANSPLANTATION, V93, P949, DOI 10.1097/TP.0b013e3182497561; Beyer K, 1999, J IMMUNOL, V162, P1186; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Castrejon JL, 2010, J ALLERGY CLIN IMMUN, V125, P411, DOI 10.1016/j.jaci.2009.10.031; Choudhury N, 2006, J PHYS CHEM B, V110, P8459, DOI 10.1021/jp056909r; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; de Groot BL, 1998, PROTEINS, V31, P116, DOI 10.1002/(SICI)1097-0134(19980501)31:2<116::AID-PROT2>3.0.CO;2-K; Durrant JD, 2009, CHEM BIOL DRUG DES, V73, P168, DOI 10.1111/j.1747-0285.2008.00761.x; Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448; Esposito M, 2011, J PHYS CHEM B, V115, P5144, DOI 10.1021/jp104780z; Fukuda I, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016203; Gagnon SJ, 2006, J MOL BIOL, V363, P228, DOI 10.1016/j.jmb.2006.08.045; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia-Carrasco M, 2006, ARCH MED RES, V37, P921, DOI 10.1016/j.arcmed.2006.08.002; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harr T, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-39; Hausmann Oliver, 2010, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-642-00663-0_2; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Holland CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00629; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; Hub JS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000480; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Ko TM, 2012, EXPERT REV CLIN IMMU, V8, P467, DOI [10.1586/eci.12.31, 10.1586/ECI.12.31]; Kuhns MS, 2012, IMMUNOL REV, V250, P120, DOI 10.1111/imr.12000; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lee MS, 2006, BIOPHYS J, V90, P864, DOI 10.1529/biophysj.105.071589; Lefranc MP, 1998, EXP CLIN IMMUNOGENET, V15, P1, DOI 10.1159/000019049; McArthur CP, 1997, J AUTOIMMUN, V10, P59, DOI 10.1006/jaut.1996.0109; Miah M A, 2008, Mymensingh Med J, V17, pS1; MICHAUDAGRAWAL N, 2011, J COMPUT CHEM, P218; Molina C, 2006, ANN RHEUM DIS, V65, P178, DOI 10.1136/ard.2004.033837; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Osterberg T, 2001, EUR J PHARM SCI, V12, P327, DOI 10.1016/S0928-0987(00)00189-5; Park H, 2006, PROTEINS, V65, P549, DOI 10.1002/prot.21183; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Pichler WJ, 2011, J ALLERGY CLIN IMMUN, V127, pS74, DOI 10.1016/j.jaci.2010.11.048; Pichler WJ, 2003, ANN INTERN MED, V139, P683, DOI 10.7326/0003-4819-139-8-200310210-00012; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Roccatano D, 1999, PROTEIN SCI, V8, P2130, DOI 10.1110/ps.8.10.2130; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schnyder B, 2000, J IMMUNOL, V164, P6647, DOI 10.4049/jimmunol.164.12.6647; Shen Z, 2005, J DERMATOL SCI, V38, P25, DOI 10.1016/j.jdermsci.2005.01.001; Shirts MR, 2007, J PHYS CHEM B, V111, P13052, DOI 10.1021/jp0735987; SUMIDA T, 1994, J RHEUMATOL, V21, P1655; SUMIDA T, 1992, J CLIN INVEST, V89, P681, DOI 10.1172/JCI115635; Sundberg EJ, 2002, J MOL BIOL, V319, P449, DOI 10.1016/S0022-2836(02)00370-4; Thomson CT, 2001, J IMMUNOL, V166, P3994, DOI 10.4049/jimmunol.166.6.3994; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Westen GJP, 2010, PROTEIN SCI, V19, P742, DOI 10.1002/pro.350; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; von Greyerz S, 1999, J IMMUNOL, V162, P595; Wolfson MY, 2011, J PHYS CHEM B, V115, P8317, DOI 10.1021/jp202471d; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544	77	39	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76211	10.1371/journal.pone.0076211	http://dx.doi.org/10.1371/journal.pone.0076211			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116097	gold, Green Published			2022-12-27	WOS:000325501300052
J	Harada, K; Mikuni, S; Beppu, H; Niimi, H; Abe, S; Hano, N; Yamagata, K; Kinjo, M; Kitajima, I				Harada, Kenu; Mikuni, Shintaro; Beppu, Hideyuki; Niimi, Hideki; Abe, Shigeki; Hano, Nobuko; Yamagata, Koichi; Kinjo, Masataka; Kitajima, Isao			A Rapid and High-Throughput Quantitation Assay of the Nuclear Factor kappa B Activity Using Fluorescence Correlation Spectroscopy in the Setting of Clinical Laboratories	PLOS ONE			English	Article							DNA-BINDING PROTEINS; SINGLE-MOLECULE DETECTION; SEPSIS; PROBE	Background: Transcription factor nuclear factor-kappa B (NF-kappa B) plays a key role in the regulation of immune responses to inflammation. However, convenient assay systems to quantitate the NF-kappa B activity level in a timely manner are not available in the setting of clinical laboratories. Therefore, we developed a novel and high-throughput quantitative assay based on fluorescence correlation spectroscopy (FCS) to detect the NF-kappa B activity level in cellular nuclear extracts and evaluated the performance of this method. The basic principle of this assay is to calculate the binding fraction of NF-kappa B to fluorescent-labeled DNA probes, which contain NF-kappa B binding sites. Methods: Non-fluorescent competitive probes are employed to normalize the influence of the viscosity of the nuclear extracts between samples and to eliminate the influence of nonspecific binding of the fluorescent probes. To confirm accurate quantitation, human recombinant NF-kappa B p50 was mixed into U937 cell nuclear extracts, and the binding fraction of the fluorescent probes to NF-kappa B in the mixture was calculated for quantitation. To evaluate whether this method can be applied to measure the NF-kappa B activity in human lymphocytes, the NF-kappa B activity levels of systemic inflammatory response syndrome patients during perioperative periods were measured. Results: The percentage recovery was 88.9%. The coefficients of variation of the intra-assay were approximately 10%. NF-kappa B activity levels during the perioperative period can were successfully measured. The assay time for the FCS measurement was within 20 minutes. Conclusions: This assay system can be used to quantitate NF-kappa B activity levels in a timely manner in the setting of hospital laboratories.	[Harada, Kenu; Beppu, Hideyuki; Niimi, Hideki; Kitajima, Isao] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Lab & Mol Pathol, Toyama 930, Japan; [Mikuni, Shintaro] Hokkaido Univ, Graduated Sch Med, Res Ctr Cooperat Projects, Dept Adv Opt Imaging Res, Sapporo, Hokkaido, Japan; [Mikuni, Shintaro; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan; [Abe, Shigeki; Hano, Nobuko; Yamagata, Koichi] Sysmex Corp BMA Lab, Kobe, Hyogo, Japan	University of Toyama; Hokkaido University; Hokkaido University; Sysmex Corporation	Kitajima, I (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Lab & Mol Pathol, Toyama 930, Japan.	kitajima@med.u-toyama.ac.jp	Yamagata, Koichi/AAV-7222-2021; Kinjo, Masataka/F-5267-2011	Yamagata, Koichi/0000-0003-1277-3468; Kinjo, Masataka/0000-0001-8889-8369	Ministry of Education, Culture, Sports, Science and Technology of Japan [23659294, 25670268]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a Grant-in-Aid for challenging Exploratory Research (#23659294 and #25670268) to I. Kitajima from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altevogt D, 2009, ORG BIOMOL CHEM, V7, P3934, DOI 10.1039/b906447h; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Benotmane AM, 1997, ANAL BIOCHEM, V250, P181, DOI 10.1006/abio.1997.2231; Bhattacharya N, 2010, INT J CANCER, V127, P404, DOI 10.1002/ijc.25054; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen ZZ, 2006, BIOCHEM BIOPH RES CO, V345, P1254, DOI 10.1016/j.bbrc.2006.05.012; Eydeler K, 2009, BIOPHYS J, V96, P3703, DOI 10.1016/j.bpj.2009.01.041; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GUBLER ML, 1995, BIOTECHNIQUES, V18, P1008; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He HJ, 2007, BIOTECHNIQUES, V43, P93, DOI 10.2144/000112475; Jin S, 2005, J BIOCHEM BIOPH METH, V65, P20, DOI 10.1016/j.jbbm.2005.08.006; Kinjo M, 1998, ANAL BIOCHEM, V260, P166, DOI 10.1006/abio.1998.2652; KINJO M, 1995, NUCLEIC ACIDS RES, V23, P1795, DOI 10.1093/nar/23.10.1795; Kobayashi T, 2004, ANAL BIOCHEM, V332, P58, DOI 10.1016/j.ab.2004.05.053; Kobayashi T, 2009, BIOORGAN MED CHEM, V17, P5293, DOI 10.1016/j.bmc.2009.05.030; Korn K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng089; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mikuni S, 2007, FEBS LETT, V581, P389, DOI 10.1016/j.febslet.2006.12.038; Mokart D, 2005, BRIT J ANAESTH, V94, P767, DOI 10.1093/bja/aei143; Nomura Y, 2007, CURR PHARM BIOTECHNO, V8, P286, DOI 10.2174/138920107782109958; Pack CG, 1999, CYTOMETRY, V36, P247, DOI 10.1002/(SICI)1097-0320(19990701)36:3<247::AID-CYTO15>3.0.CO;2-#; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; RIGLER R, 1995, J BIOTECHNOL, V41, P177, DOI 10.1016/0168-1656(95)00054-T; SCHRECK R, 1990, NUCLEIC ACIDS RES, V18, P6497, DOI 10.1093/nar/18.22.6497; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Wang JK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni021; Wolcke J, 2003, J BIOL CHEM, V278, P32587, DOI 10.1074/jbc.M303615200	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75579	10.1371/journal.pone.0075579	http://dx.doi.org/10.1371/journal.pone.0075579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124497	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100054
J	Huang, JH; Zhou, RL; Hu, SQ				Huang Junhong; Zhou Renlai; Hu Senqi			Effects on Automatic Attention Due to Exposure to Pictures of Emotional Faces while Performing Chinese Word Judgment Tasks	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; VISUAL MISMATCH NEGATIVITY; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; SPATIAL ATTENTION; TIME-COURSE; BRAIN; STIMULI; BLINK; HAPPY	Two experiments were conducted to investigate the automatic processing of emotional facial expressions while performing low or high demand cognitive tasks under unattended conditions. In Experiment 1, 35 subjects performed low (judging the structure of Chinese words) and high (judging the tone of Chinese words) cognitive load tasks while exposed to unattended pictures of fearful, neutral, or happy faces. The results revealed that the reaction time was slower and the performance accuracy was higher while performing the low cognitive load task than while performing the high cognitive load task. Exposure to fearful faces resulted in significantly longer reaction times and lower accuracy than exposure to neutral faces on the low cognitive load task. In Experiment 2, 26 subjects performed the same word judgment tasks and their brain event-related potentials (ERPs) were measured for a period of 800 ms after the onset of the task stimulus. The amplitudes of the early component of ERP around 176 ms (P2) elicited by unattended fearful faces over frontal-central-parietal recording sites was significantly larger than those elicited by unattended neutral faces while performing the word structure judgment task. Together, the findings of the two experiments indicated that unattended fearful faces captured significantly more attention resources than unattended neutral faces on a low cognitive load task, but not on a high cognitive load task. It was concluded that fearful faces could automatically capture attention if residues of attention resources were available under the unattended condition.	[Huang Junhong; Zhou Renlai] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Zhou Renlai] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Huang Junhong] China Inst Sport Sci, Competit Sport Res Ctr, Beijing, Peoples R China; [Hu Senqi] Calif State Univ Los Angeles, Dept Psychol, Los Angeles, CA 90032 USA	Beijing Normal University; Beijing Normal University; China Institute of Sport Science; California State University System; California State University Los Angeles	Zhou, RL (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	rlzhou@bnu.edu.cn	Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097	National Basic Research Program of China [2011CB711000]; Fundamental Research Funds for the Central Universities [2009SC3]; National Social Science Fund [11ZD187]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Social Science Fund	This study was Supported by the National Basic Research Program of China (2011CB711000) and the Fundamental Research Funds for the Central Universities (code: 2009SC3). This work were supported by the Major Project of the National Social Science Fund (11&ZD187) and the evaluation and training to the people with drug addiction in Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2003, J NEUROSCI, V23, P5627; Armony J.L., 1999, COGNITIVE NEUROSCIEN, P1067; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Beijing Institute of Linguistic Studies, 1986, MOD CHIN FREQ DICT; Calvo MG, 2010, VIS COGN, V18, P1274, DOI 10.1080/13506285.2010.481867; Carlson JM, 2008, EMOTION, V8, P522, DOI 10.1037/a0012653; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, SOC COGN AFFECT NEUR; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Chen B., 2001, ACTA PSYCHOL SINICA, V33, P1; CHEN BG, 2003, XINLI XUEBAO, V35, P576; Daffner KR, 2000, PSYCHOPHYSIOLOGY, V37, P737, DOI 10.1017/S0048577200990814; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; Ekman P., 1976, PICTURES FACIAL AFFE; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Graham F. K., 1991, HDB COGNITIVE PSYCHO, P251; Harris CR, 2004, PSYCHOL SCI, V15, P171, DOI 10.1111/j.0956-7976.2004.01503005.x; Hodsoll S, 2011, EMOTION, V11, P346, DOI 10.1037/a0022771; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holmes A, 2006, NEUROSCI LETT, V394, P48, DOI 10.1016/j.neulet.2005.10.002; Horstmann G, 2008, PERCEPT PSYCHOPHYS, V70, P1416, DOI 10.3758/PP.70.8.1416; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; KENEMANS JL, 1992, BIOL PSYCHOL, V33, P97, DOI 10.1016/0301-0511(92)90026-Q; KENEMANS JL, 1989, BIOL PSYCHOL, V28, P199, DOI 10.1016/0301-0511(89)90001-X; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Mogg K, 1999, BEHAV RES THER, V37, P595, DOI 10.1016/S0005-7967(98)00158-2; Ogawa T, 2004, JPN PSYCHOL RES, V46, P20, DOI 10.1111/j.1468-5884.2004.00233.x; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Santesso DL, 2008, NEUROPSYCHOLOGIA, V46, P1338, DOI 10.1016/j.neuropsychologia.2007.12.013; Siddle D., 1983, ORIENTING HABITUATIO, P109; Sokolov E.N., 1963, PERCEPTION CONDITION; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Tales A, 1999, NEUROREPORT, V10, P3363, DOI 10.1097/00001756-199911080-00020; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017	48	9	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75386	10.1371/journal.pone.0075386	http://dx.doi.org/10.1371/journal.pone.0075386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124486	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100043
J	Lassale, C; Galan, P; Julia, C; Fezeu, L; Hercberg, S; Kesse-Guyot, E				Lassale, Camille; Galan, Pilar; Julia, Chantal; Fezeu, Leopold; Hercberg, Serge; Kesse-Guyot, Emmanuelle			Association between Adherence to Nutritional Guidelines, the Metabolic Syndrome and Adiposity Markers in a French Adult General Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; CARDIOVASCULAR RISK-FACTORS; MEDITERRANEAN DIET; NATIONAL NUTRITION; WEIGHT CHANGE; BODY-FAT; METAANALYSIS; QUALITY; OBESITY; HEALTH	Introduction: Few studies have focused on the association between diet quality scores and the Metabolic Syndrome (MetS), a multi-component condition predictive of cardiovascular diseases (CVD) and death. The present study aims at investigating, in a cross-sectional design, the association between adherence to the French dietary guidelines through an a priori score - the French Nutrition and Health Program-Guideline Score (PNNS-GS) - and cardiovascular risk factors (CVRF) including the MetS and adiposity markers. Methods: 7902 French adults participating in the NutriNet-Sante study (an on-going web-based cohort study) attended a clinical and biological examination between January 2011 and November 2012: a fasting blood sample was drawn, blood pressure and body composition (bio-impedance) were measured. Multivariate linear and logistic regression models were used to assess the association between PNNS-GS and CVRF or the MetS. Results: An increase of PNNS-GS was significantly negatively associated with waist circumference (WC), systolic and diastolic blood pressure (SBP and DBP) and serum triglycerides concentrations. From bottom to top quartile of PNNS-GS, SBP decreased from 129.9 to 128.8 mm Hg, DBP from 76.7 to 75.9 mm Hg, serum triglycerides concentrations from 110.8 to 104.6 mg/dL and WC from 94.8 to 90.1 cm for men and 81.3 to 78.9 cm for women. All adiposity markers (waist and hip circumference, % body fat, % trunk fat, % leg fat) were markedly reduced across quartiles of PNNS-GS and linearly. Individuals with a better PNNS-GS (quartile 4 vs quartile 1) were less likely to have the MetS (OR=0.71, 95% CI: 0.56-0.89). Conclusion: The negative association between a higher adherence to the French dietary guidelines and a number of CVRF, the MetS prevalence and regional adiposity supports the importance of promoting the PNNS dietary guidelines in the population for the prevention of cardiometabolic abnormalities and hence, cardiovascular diseases.	[Lassale, Camille; Galan, Pilar; Julia, Chantal; Fezeu, Leopold; Hercberg, Serge; Kesse-Guyot, Emmanuelle] Univ Paris 13, Sorbonne Paris Cite, Nutr Epidemiol Res Unit, CNAM,INSERM INRA U1125 U557, Bobigny, France; [Julia, Chantal; Hercberg, Serge] Univ Paris 13, Hop Avicenne, Dept Publ Hlth, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Lassale, C (corresponding author), Univ Paris 13, Sorbonne Paris Cite, Nutr Epidemiol Res Unit, CNAM,INSERM INRA U1125 U557, Bobigny, France.	c.lassale@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; HERCBERG, Serge/B-4429-2008; Kesse-Guyot, Emmanuelle/F-2692-2017; Chantal, Julia/F-2805-2017; Fezeu, Leopold/F-2804-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Serge, Hercberg/F-3038-2017; Lassale, Camille/ABE-7813-2020	Pilar, Galan/0000-0003-1706-3107; HERCBERG, Serge/0000-0002-3168-1350; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Chantal, Julia/0000-0003-2006-5269; Fezeu, Leopold/0000-0002-7589-3179; Serge, Hercberg/0000-0002-3168-1350; Lassale, Camille/0000-0002-9340-2708	Region Ile de France (CORDDIM); Fondation Coeur et Arteres; Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	Region Ile de France (CORDDIM)(Region Ile-de-France); Fondation Coeur et Arteres; Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	This work was supported by grants from the Region Ile de France (CORDDIM) and Fondation Coeur et Arteres. The NutriNet-Sante study is being supported and granted by the following institutions: Ministere de la Sante (DGS), Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Fondation pour la Recherche Medicale (FRM), Institut de Recherche en Sante Publique (IRESP), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM) and Universite Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouRjaili G, 2010, METABOLISM, V59, P1210, DOI 10.1016/j.metabol.2009.11.014; Ahluwalia N, 2013, DIABETES METAB, V39, P99, DOI 10.1016/j.diabet.2012.08.007; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], APPORTS NUTR CONSEIL; Babio N, 2009, PUBLIC HEALTH NUTR, V12, P1607, DOI 10.1017/S1368980009990449; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Boghossian NS, 2013, EUR J CLIN NUTR, V67, P289, DOI 10.1038/ejcn.2013.4; Bozkirli E, 2007, ASIA PAC J CLIN NUTR, V16, P443; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Drewnowski A, 2009, J AM COLL NUTR, V28, P22, DOI 10.1080/07315724.2009.10719757; Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Fogli-Cawley JJ, 2007, AM J CLIN NUTR, V86, P1193, DOI 10.1093/ajcn/86.4.1193; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frisoli TM, 2011, EUR HEART J, V32, P3081, DOI 10.1093/eurheartj/ehr379; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Hosseini-Esfahani F, 2010, METABOLISM, V59, P1833, DOI 10.1016/j.metabol.2010.06.013; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Julia C, 2010, PREV MED, V51, P488, DOI 10.1016/j.ypmed.2010.09.009; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kesse-Guyot E, 2011, J NUTR, V141, P1134, DOI 10.3945/jn.110.136317; Kesse-Guyot E, 2009, AM J EPIDEMIOL, V170, P757, DOI 10.1093/aje/kwp174; Kimokoti RW, 2012, J NUTR, V142, P1720, DOI 10.3945/jn.112.162479; Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Lassale C, 2012, INT J OBESITY, V36, P1455, DOI 10.1038/ijo.2011.264; Le Moullec N, 1996, VALIDATION PHOTO MAN; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Nettleton JA, 2013, AM J EPIDEMIOL, V177, P103, DOI 10.1093/aje/kws297; Nicklas TA, 2012, J NUTR, V142, P2112, DOI 10.3945/jn.112.164889; NutriNet-Sante coordination, 2013, TABL COMP AL; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Siri-Tarino PW, 2011, CURR ATHEROSCLER REP, V13, P453, DOI 10.1007/s11883-011-0207-y; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; Vergnaud AC, 2011, INT J PUBLIC HEALTH, V56, P407, DOI 10.1007/s00038-011-0257-5; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; WHO, 2009, GLOB HLTH RISKS TECH; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528	53	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76349	10.1371/journal.pone.0076349	http://dx.doi.org/10.1371/journal.pone.0076349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124548	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100105
J	Morozumi, Y; Ino, R; Ikawa, S; Mimida, N; Shimizu, T; Toki, S; Ichikawa, H; Shibata, T; Kurumizaka, H				Morozumi, Yuichi; Ino, Ryohei; Ikawa, Shukuko; Mimida, Naozumi; Shimizu, Takeshi; Toki, Seiichi; Ichikawa, Hiroaki; Shibata, Takehiko; Kurumizaka, Hitoshi			Homologous Pairing Activities of Two Rice RAD51 Proteins, RAD51A1 and RAD51A2	PLOS ONE			English	Article							DNA STRAND EXCHANGE; RECOMBINATION PROTEIN; SACCHAROMYCES-CEREVISIAE; RECA PROTEIN; DMC1; GENE; SEQUENCE; DAMAGE; MOUSE; FILAMENT	In higher eukaryotes, RAD51 functions as an essential protein in homologous recombination and recombinational repair of DNA double strand breaks. During these processes, RAD51 catalyzes homologous pairing between single-stranded DNA and double-stranded DNA. Japonica cultivars of rice (Oryza sativa) encode two RAD51 proteins, RAD51A1 and RAD51A2, whereas only one RAD51 exists in yeast and mammals. However, the functional differences between RAD51A1 and RAD51A2 have not been elucidated, because their biochemical properties have not been characterized. In the present study, we purified RAD51A1 and RAD51A2, and found that RAD51A2 robustly promotes homologous pairing in vitro. RAD51A1 also possesses homologous-pairing activity, but it is only about 10% of the RAD51A2 activity. Both RAD51A1 and RAD51A2 bind to ssDNA and dsDNA, and their DNA binding strictly requires ATP, which modulates the polymer formation activities of RAD51A1 and RAD51A2. These findings suggest that although both RAD51A1 and RAD51A2 have the potential to catalyze homologous pairing, RAD51A2 may be the major recombinase in rice.	[Morozumi, Yuichi; Ino, Ryohei; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo, Japan; [Ikawa, Shukuko; Shibata, Takehiko] RIKEN, Wako, Saitama, Japan; [Mimida, Naozumi; Shimizu, Takeshi; Toki, Seiichi; Ichikawa, Hiroaki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Waseda University; RIKEN; National Institute of Agrobiological Sciences - Japan	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo, Japan.	kurumizaka@waseda.jp	Toki, Seiichi/AAR-1889-2021; Ichikawa, Hiroaki/AAB-3127-2019; Shimizu, Takeshi/ABE-6503-2020	Kurumizaka, Hitoshi/0000-0001-7412-3722; Ichikawa, Hiroaki/0000-0002-1898-8235	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Bio-Oriented Technology Research Advancement Institution (BRAIN) in Tokyo; Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [22247002] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Bio-Oriented Technology Research Advancement Institution (BRAIN) in Tokyo; Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and from the Bio-Oriented Technology Research Advancement Institution (BRAIN) in Tokyo to TS and HK, and to HI and ST, respectively. This work was also supported in part by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; BASILE G, 1992, MOL CELL BIOL, V12, P3235, DOI 10.1128/MCB.12.7.3235; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Devisetty Upendra Kumar, 2010, BMC Res Notes, V3, P245, DOI 10.1186/1756-0500-3-245; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; Endo M, 2012, PLANT J, V69, P967, DOI 10.1111/j.1365-313X.2011.04847.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Franklin AE, 2003, CHROMOSOMA, V112, P17, DOI 10.1007/s00412-003-0242-8; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Habu T, 1996, NUCLEIC ACIDS RES, V24, P470, DOI 10.1093/nar/24.3.470; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Ishida T, 2008, GENES CELLS, V13, P91, DOI 10.1111/j.1365-2443.2007.01143.x; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Kurumizaka H, 1999, J MOL BIOL, V291, P537, DOI 10.1006/jmbi.1999.2950; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Maeshima K, 1996, GENES CELLS, V1, P1057, DOI 10.1046/j.1365-2443.1996.d01-224.x; Markmann-Mulisch U, 2002, P NATL ACAD SCI USA, V99, P2959, DOI 10.1073/pnas.032668199; Markmann-Mulisch U, 2007, PLANT CELL, V19, P3080, DOI 10.1105/tpc.107.054049; Matsuo Y, 2006, FEBS J, V273, P3148, DOI 10.1111/j.1742-4658.2006.05323.x; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Pawlowski WP, 2003, PLANT CELL, V15, P1807, DOI 10.1105/tpc.012898; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Rajanikant C, 2008, PLANT MOL BIOL, V68, P479, DOI 10.1007/s11103-008-9385-6; Sakane I, 2008, NUCLEIC ACIDS RES, V36, P4266, DOI 10.1093/nar/gkn405; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WHITAKER SJ, 1992, EUR J CANCER, V28A, P273, DOI 10.1016/0959-8049(92)90432-2; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Yang ZY, 2010, MUTAT RES-FUND MOL M, V691, P55, DOI 10.1016/j.mrfmmm.2010.07.005	50	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75451	10.1371/journal.pone.0075451	http://dx.doi.org/10.1371/journal.pone.0075451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124491	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100048
J	Mukhopadhyay, C; Zhao, XS; Maroni, D; Band, V; Naramura, M				Mukhopadhyay, Chandrani; Zhao, Xiangshan; Maroni, Dulce; Band, Vimla; Naramura, Mayumi			Distinct Effects of EGFR Ligands on Human Mammary Epithelial Cell Differentiation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN-BREAST-CANCER; BASAL-LIKE SUBTYPE; ADULT HUMAN BREAST; GLAND DEVELOPMENT; GENE-EXPRESSION; FACTOR RECEPTOR; FACTOR-ALPHA; STEM-CELLS; SUSTAINED ACTIVATION	Based on gene expression patterns, breast cancers can be divided into subtypes that closely resemble various developmental stages of normal mammary epithelial cells (MECs). Thus, understanding molecular mechanisms of MEC development is expected to provide critical insights into initiation and progression of breast cancer. Epidermal growth factor receptor (EGFR) and its ligands play essential roles in normal and pathological mammary gland. Signals through EGFR is required for normal mammary gland development. Ligands for EGFR are over-expressed in a significant proportion of breast cancers, and elevated expression of EGFR is associated with poorer clinical outcome. In the present study, we examined the effect of signals through EGFR on MEC differentiation using the human telomerase reverse transcriptase (hTERT)-immortalized human stem/progenitor MECs which express cytokeratin 5 but lack cytokeratin 19 (K5(+)K19(-) hMECs). As reported previously, these cells can be induced to differentiate into luminal and myoepithelial cells under appropriate culture conditions. K5(+)K19(-) hMECs acquired distinct cell fates in response to EGFR ligands epidermal growth factor (EGF), amphiregulin (AREG) and transforming growth factor alpha (TGF alpha) in differentiation-promoting MEGM medium. Specifically, presence of EGF during in vitro differentiation supported development into both luminal and myoepithelial lineages, whereas cells differentiated only towards luminal lineage when EGF was replaced with AREG. In contrast, substitution with TGF alpha led to differentiation only into myoepithelial lineage. Chemical inhibition of the MEK-Erk pathway, but not the phosphatidylinositol 3-kinase (PI3K)-AKT pathway, interfered with K5(+)K19(-) hMEC differentiation. The present data validate the utility of the K5(+)K19(-) hMEC cells for modeling key features of human MEC differentiation. This system should be useful in studying molecular/biochemical mechanisms of human MEC differentiation.	[Mukhopadhyay, Chandrani; Maroni, Dulce; Band, Vimla; Naramura, Mayumi] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Zhao, Xiangshan; Band, Vimla; Naramura, Mayumi] Univ Nebraska Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Naramura, M (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	mnaramura@unmc.edu		Naramura, Mayumi/0000-0003-3658-0767	Department of Defense [W81 XWH-10-1-0740, W81XWH-07-1-0351, W81XWH-11-1-0171]; Nebraska Stem Cell Grant [2011-06]; NIH [CA96844, CA144027]; Department of Defense; University of Nebraska; NATIONAL CANCER INSTITUTE [R01CA096844, R01CA144027] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Nebraska Stem Cell Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of Nebraska; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Department of Defense W81 XWH-10-1-0740 and Nebraska Stem Cell Grant 2011-06 to MN and the NIH grants CA96844 and CA144027 and Department of Defense grants W81XWH-07-1-0351 and W81XWH-11-1-0171 to VB. UNMC Core Facilities are in part supported by the NCI Core Support Grant to UNMC-Eppley Cancer Center. C. M. is supported by the Skala Scholarship from University of Nebraska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; Chen CC, 2012, GENE DEV, V26, P2154, DOI 10.1101/gad.197343.112; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DERYNCK R, 1987, CANCER RES, V47, P707; DOTZLAW H, 1990, CANCER RES, V50, P4204; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LEJEUNE S, 1993, CANCER RES, V53, P3597; Li G, 2002, DEVELOPMENT, V129, P4159; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Maroni D, 2011, J CELL SCI, V124, P2501, DOI 10.1242/jcs.084558; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; QI CF, 1994, BRIT J CANCER, V69, P903, DOI 10.1038/bjc.1994.174; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sternlicht MD, 2008, J MAMMARY GLAND BIOL, V13, P181, DOI 10.1007/s10911-008-9084-6; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Venere M, 2013, CANCER CELL, V23, P135, DOI 10.1016/j.ccr.2013.01.020; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	46	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75907	10.1371/journal.pone.0075907	http://dx.doi.org/10.1371/journal.pone.0075907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124521	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100078
J	Schroder, A				Schroeder, Arne			Density- and Size-Dependent Winter Mortality and Growth of Late Chaoborus flavicans Larvae	PLOS ONE			English	Article							FISH PREDATION; BODY-SIZE; INVERTEBRATE PREDATORS; ZOOPLANKTON COMMUNITY; CLIMATE-CHANGE; DYNAMICS; LAKE; ABUNDANCE; SELECTION; DIPTERA	Winter processes such as overwinter survival and growth of individuals can have wide-ranging consequences for population dynamics and communities within and across seasons. In freshwater organisms winter processes have been mainly studied in fish despite that invertebrates also have substantial impacts on lake and pond food webs. One of the major invertebrate consumers in lake and ponds is the planktonic larvae of the dipteran insect Chaoborus spec. However, while much is known about Chaoborus feeding ecology, behaviour and structuring role in food webs, its winter ecology and how it affects its populations are poorly understood. Here size-and density-dependent winter mortality and body growth of late Chaoborus flavicans larvae were quantified over naturally occurring size and density ranges in autumn and under natural winter conditions using two field enclosure experiments. Winter mortality increased with autumn density but decreased with autumn body size while winter growth rates decreased with autumn density and body sizes. There was also a density-and size-independent background mortality component. The proportion of pupae found in spring decreased strongly and exponentially with autumn density. These results may explain the commonly observed univoltine life cycle and multi-annual density fluctuations in northern Chaoborus populations. They further demonstrate the relevance of winter processes and conditions for freshwater invertebrates and ecosystems.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Schroder, A (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	a.schroder@sheffield.ac.uk			European Science Foundation [3873]	European Science Foundation(European Science Foundation (ESF)European Commission)	Part of the research was supported by a Short Visit Grant No 3873 from the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARNOTT SE, 1993, ECOLOGY, V74, P2361, DOI 10.2307/1939588; Balayla D, 2010, HYDROBIOLOGIA, V646, P159, DOI 10.1007/s10750-010-0164-4; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Davison AC, 1997, BOOTSTRAP METHODS TH; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; FEDORENKO AY, 1975, LIMNOL OCEANOGR, V20, P238; Fischer JM, 1997, CAN J FISH AQUAT SCI, V54, P637, DOI 10.1139/cjfas-54-3-637; Foster SE, 2009, LIMNOL OCEANOGR, V54, P757, DOI 10.4319/lo.2009.54.3.0757; Garcia EA, 2008, ECOLOGY, V89, P1703, DOI 10.1890/07-0737.1; Gliwicz ZM, 2000, ARCH HYDROBIOL, V149, P193; HANAZATO T, 1989, OECOLOGIA, V81, P450, DOI 10.1007/BF00378951; HANAZATO T, 1989, ARCH HYDROBIOL, V114, P497; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Huss M, 2008, CAN J FISH AQUAT SCI, V65, P2149, DOI 10.1139/F08-115; Jackson LJ, 2007, FRESHWATER BIOL, V52, P1782, DOI 10.1111/j.1365-2427.2007.01809.x; Jager IS, 2011, INT REV HYDROBIOL, V96, P191, DOI 10.1002/iroh.201011253; Jager IS, 2003, J PLANKTON RES, V25, P255, DOI 10.1093/plankt/25.3.255; Lagergren R, 2008, LIMNOL OCEANOGR, V53, P1083, DOI 10.4319/lo.2008.53.3.1083; Liljendahl-Nurminen A, 2003, ARCH HYDROBIOL, V158, P75, DOI 10.1127/0003-9136/2003/0158-0075; MOORE MV, 1988, FRESHWATER BIOL, V19, P249, DOI 10.1111/j.1365-2427.1988.tb00346.x; Murdoch W.W., 2003, CONSUMER RESOURCE DY; NEILL W E, 1988, P31; Neill W.E., 1988, P236; Neill W.E., 1985, Advances in Limnology, V21, P483; NEILL WE, 1981, OECOLOGIA, V48, P164, DOI 10.1007/BF00347959; Ouimet C, 2001, FRESHWATER BIOL, V46, P1169, DOI 10.1046/j.1365-2427.2001.00738.x; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Persaud AD, 2010, J PLANKTON RES, V32, P57, DOI 10.1093/plankt/fbp099; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; Post JT, 1998, CANADIAN J FISHERIES, V55, P2588; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramcharan C. W., 2001, Ergebnisse der Limnologie, P81; Saether OA, 1997, TAXONOMIC HDB, V2, P149; SARDELLA LC, 1983, HYDROBIOLOGIA, V107, P155, DOI 10.1007/BF00017430; Schroder A, 2012, OIKOS, V121, P417, DOI 10.1111/j.1600-0706.2011.19764.x; Shuter BJ, 2012, AQUAT SCI, V74, P637, DOI 10.1007/s00027-012-0274-3; Skov C, 2011, P ROY SOC B-BIOL SCI, V278, P1414, DOI 10.1098/rspb.2010.2035; Soranno Patricia A., 1993, P103, DOI 10.1017/CBO9780511525513.008; Sutor M, 2001, HYDROBIOLOGIA, V464, P121, DOI 10.1023/A:1013939201391; van de Wolfshaar KE, 2008, ECOLOGY, V89, P259, DOI 10.1890/06-2058.1; VONENDE CN, 1979, ECOLOGY, V60, P119, DOI 10.2307/1936474; Wahlstrom E, 1999, CAN J FISH AQUAT SCI, V56, P1865, DOI 10.1139/cjfas-56-10-1865; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wissel B, 2003, FRESHWATER BIOL, V48, P1421, DOI 10.1046/j.1365-2427.2003.01100.x; WRIGHT RT, 1964, LIMNOL OCEANOGR, V9, P163, DOI 10.4319/lo.1964.9.2.0163; Xie P, 1998, HYDROBIOLOGIA, V368, P83, DOI 10.1023/A:1003217325236; ZARET TM, 1975, ECOLOGY, V56, P232, DOI 10.2307/1935317	50	6	6	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75839	10.1371/journal.pone.0075839	http://dx.doi.org/10.1371/journal.pone.0075839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124517	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100074
J	Rebours, V; Albuquerque, M; Sauvanet, A; Ruszniewski, P; Levy, P; Paradis, V; Bedossa, P; Couvelard, A				Rebours, Vinciane; Albuquerque, Miguel; Sauvanet, Alain; Ruszniewski, Philippe; Levy, Philippe; Paradis, Valerie; Bedossa, Pierre; Couvelard, Anne			Hypoxia Pathways and Cellular Stress Activate Pancreatic Stellate Cells: Development of an Organotypic Culture Model of Thick Slices of Normal Human Pancreas	PLOS ONE			English	Article							IN-VITRO MODEL; LIVER SLICES; DUCTAL ADENOCARCINOMA; INDUCE FIBROSIS; CANCER CELLS; ACINAR; RAT; TRANSDIFFERENTIATION; PROLIFERATION; PLASTICITY	Pancreatic stellate cells (PSC) are involved in fibrogenesis and oncogenesis by modulating the extracellular matrix. Aim: To evaluate the effect of cellular stress on PSC activation using a model of normal human pancreatic tissue slices culture preserving the microenvironment. Methods: Thin sections (300 mu m) of normal human pancreas were cultured under hyperoxia (90% O2) during 72 hours. Viability and morphological analysis were performed at baseline, H24, H48 and H72. Cell differentiation (insulin, trypsin, CA9 and CK7), hypoxia (HIF1-alpha), apoptosis (caspase-3), proliferation (Ki67), TGF-beta expression and PSC activation (smooth muscle actin (SMA), nestin) were assessed using immunostaining, longitudinally. Control experiments were performed under normoxic conditions (21% O2). Results: Thirty sections per specimen (n=10) were cultured. Hypoxia pathways were activated by the higher expression of HIF1-a at H48 and H72. Apoptosis was limited with only rare acinar cells expressing of the caspase-3 at 48 and H72 (NS). Morphological analysis showed gradual appearance of acinoductal metaplasia, proven by CK7 expression and ductal phenotype of dedifferentiated acini. Transdifferentiation of PSC was shown by de novo SMA immunochemistry at H24 and H48. Expression of Ki67 index identified significant proliferation of activated PSC (double immunostaining Ki67-SMA) at H48 and H72 (p=0.02). In vitro culture of normal human pancreas thin sections is feasible with optimized cell viability at 72 hours. This model of culture in hyperoxic conditions provides evidences that cellular stress may rapidly induce transactivation of PSC with ducto-acinar metaplasia.	[Rebours, Vinciane; Ruszniewski, Philippe; Levy, Philippe] Paris Diderot Univ, Beaujon Hosp, AP HP, Pancreatol Dept, Clichy, France; [Rebours, Vinciane; Albuquerque, Miguel; Ruszniewski, Philippe; Paradis, Valerie; Bedossa, Pierre; Couvelard, Anne] Paris Diderot Univ, INSERM, U773, CRB3, Paris, France; [Albuquerque, Miguel; Paradis, Valerie; Bedossa, Pierre] Paris Diderot Univ, Beaujon Hosp, AP HP, Dept Pathol, Clichy, France; [Sauvanet, Alain] Paris Diderot Univ, Beaujon Hosp, AP HP, Pancreat Surg Dept, Clichy, France; [Couvelard, Anne] Paris Diderot Univ, Bichat Hosp, AP HP, Dept Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Rebours, V (corresponding author), Paris Diderot Univ, Beaujon Hosp, AP HP, Pancreatol Dept, Clichy, France.	vinciane.rebours@bjn.aphp.fr	Albuquerque, Miguel/X-9008-2019; Paradis, Valerie/X-9097-2019	Albuquerque, Miguel/0000-0001-7311-1623; Anne, Couvelard/0000-0002-6316-1210; Bedossa, Pierre/0000-0002-8487-7322; Paradis, Valerie/0000-0003-3142-3762; SAUVANET, alain/0000-0002-7436-5999				Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Clouzeau-Girard H, 2006, LAB INVEST, V86, P275, DOI 10.1038/labinvest.3700386; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; Guyot C, 2010, LIVER INT, V30, P1529, DOI 10.1111/j.1478-3231.2010.02342.x; HALL PA, 1992, J PATHOL, V166, P97, DOI 10.1002/path.1711660203; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jaster R, 2005, J CELL MOL MED, V9, P670, DOI 10.1111/j.1582-4934.2005.tb00497.x; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; Lerche-Langrand C, 2000, TOXICOLOGY, V153, P221, DOI 10.1016/S0300-483X(00)00316-4; Lipsett MA, 2007, PANCREAS, V34, P452, DOI 10.1097/MPA.0b013e3180335c80; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Masamune A, 2008, AM J PHYSIOL-GASTR L, V295, pG709, DOI 10.1152/ajpgi.90356.2008; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Olinga P, 2001, J PHARMACOL TOXICOL, V45, P55, DOI 10.1016/S1056-8719(01)00127-7; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Tuchweber B, 1996, LAB INVEST, V74, P265; van Geer MA, 2009, WORLD J GASTROENTERO, V15, P1359, DOI 10.3748/wjg.15.1359; VILA MR, 1994, LAB INVEST, V71, P423; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; WATARI N, 1982, Okajimas Folia Anatomica Japonica, V58, P837	26	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76229	10.1371/journal.pone.0076229	http://dx.doi.org/10.1371/journal.pone.0076229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098783	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500153
J	Tokunaga, M; Shiheido, H; Tabata, N; Sakuma-Yonemura, Y; Takashima, H; Horisawa, K; Doi, N; Yanagawa, H				Tokunaga, Mayuko; Shiheido, Hirokazu; Tabata, Noriko; Sakuma-Yonemura, Yuko; Takashima, Hideaki; Horisawa, Kenichi; Doi, Nobuhide; Yanagawa, Hiroshi			MIP-2A Is a Novel Target of an Anilinoquinazoline Derivative for Inhibition of Tumour Cell Proliferation	PLOS ONE			English	Article							C-MYC; GROWTH-FACTOR; IN-VITRO; PROTEIN; CANCER; VIRUS; EXPRESSION; ADDICTION; ONCOGENES; SELECTION	We recently identified a novel anilinoquinazoline derivative, Q15, as a potent apoptosis inducer in a panel of human cancer cell lines and determined that Q15 targets hCAP-G2, a subunit of condensin II complex, leading to abnormal cell division. However, whether the defect in normal cell division directly results in cell death remains unclear. Here, we used an mRNA display method on a microfluidic chip to search for other Q15-binding proteins. We identified an additional Q15-binding protein, MIP-2A (MBP-1 interacting protein-2A), which has been reported to interact with MBP-1, a repressor of the c-Myc promoter. Our results indicate that Q15 inhibits the interaction between MIP-2A and MBP-1 as well as the expression of c-Myc protein, thereby inducing cell death. This study suggests that the simultaneous targeting of hCAP-G2 and MIP-2A is a promising strategy for the development of antitumor drugs as a treatment for intractable tumours.	[Tokunaga, Mayuko; Shiheido, Hirokazu; Tabata, Noriko; Sakuma-Yonemura, Yuko; Takashima, Hideaki; Horisawa, Kenichi; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Yanagawa, H (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	hyana@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Shiheido, Hirokazu/0000-0002-1415-2019; Doi, Nobuhide/0000-0002-2402-6390	National Institute of Biomedical Innovation (NIBIO), Japan; Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan [22310121, S0801008, S0901009]; grants for a basic research program (CREST) of the Japan Science and Technology Agency	National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); grants for a basic research program (CREST) of the Japan Science and Technology Agency	This work was supported by grants for a basic research program (CREST) of the Japan Science and Technology Agency and a program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan, as well as a Grant-in-Aid for Scientific Research (22310121) and a grant for Strategic Research Foundation Grant-aided Projects for Private Universities (S0801008 and S0901009) from Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao XR, 2004, J VIROL, V78, P11798, DOI 10.1128/JVI.78.21.11798-11806.2004; Ghosh AK, 2003, J BIOL CHEM, V278, P24033, DOI 10.1074/jbc.M211982200; Ghosh AK, 2001, MOL CELL BIOL, V21, P655, DOI 10.1128/MCB.21.2.655-662.2001; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Jeyabalan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010646; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Otsuki T, 1999, INT J ONCOL, V15, P1205; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; Ray RB, 1995, INDUCTION CELL DEATH; Sedoris KC, 2007, BIOCHEMISTRY-US, V46, P8659, DOI 10.1021/bi7003558; Shiheido H, 2012, PLOS ONE, V7; Shiheido H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044889; Tabata N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp184; Weinstein B, 2008, ADV EXP MED BIOL, V617, P3, DOI 10.1007/978-0-387-69080-3_1; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Willis RE, 2012, INT J MOL SCI, V13, P316, DOI 10.3390/ijms13010316	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76774	10.1371/journal.pone.0076774	http://dx.doi.org/10.1371/journal.pone.0076774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098805	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500176
J	Barrett, RD; McLellan, TL; McKinlay, A				Barrett, Robert D.; McLellan, Tracey L.; McKinlay, Audrey			Self versus Family Ratings of the Frontal Systems Behaviour Scale and Measured Executive Functions: Adult Outcomes following Childhood Traumatic Brain Injury	PLOS ONE			English	Article							WORKING-MEMORY; SHORT-TERM; AWARENESS; RELIABILITY; CONCORDANCE; DEFICITS; PREVALENCE; AGREEMENT; CHILDREN; VALIDITY	Traumatic brain injury (TBI) frequently occurs during childhood and adolescence with long-term neuropsychological and behavioral effects. Greater personal awareness of injury is associated with better outcomes. However, personal awareness is often assessed using ratings obtained from family members or significant others. Surprisingly, the accuracy of family-ratings compared with self-ratings has not been well studied in the TBI population. Thus, the purpose of this study was to examine self versus family-ratings of frontal dysfunction and secondly, the association between self/family reported frontal dysfunction and measured executive function outcomes. A total of 60 participants, approximately 10 years post-TBI, comprised 3 groups including; moderate/severe TBI (N=26; mean age 22.9, SD=3.0), mild TBI (N=20; mean age, 21.7, SD=2.7), and control (N=14: mean age, 21.6, SD=3.7). Neuropsychological testing was used to obtain domain scores for executive function and working memory/attention for each participant, and nominated family members and participants with TBI were asked to complete the Frontal Systems Behaviour Scale (FrSBe), consisting of three sub-scales; apathy, disinhibition, and executive dysfunction. Using the FrSBe there was no significant difference between the groups in executive function score, but the moderate/severe and mild groups had significantly lower working memory/attention scores compared with the control group (p<0.05). Repeated measures analysis of variance showed higher self-ratings on all sub-scales compared with family in each group (p<0.05). Scores on executive function and working memory/attention domains correlated with self, but not family reported executive dysfunction. Self-rated executive dysfunction explained 36% of the variance in executive function (p<0.001). While agreement between self-rated and family-rated total FrSBe scores was significant in all groups (p<0.001), our results showed that self-ratings were of higher predictive utility for executive functioning compared with family ratings. Further, at 10 years post-TBI, patients show greater awareness of deficits compared with family who rate consistently closer to the normal functioning range.	[Barrett, Robert D.; McLellan, Tracey L.; McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia	University of Canterbury; Monash University	McKinlay, A (corresponding author), Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand.	Audrey.mckinlay@monash.edu		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council; Accident Compensation Corporation of New Zealand	Health Research Council; Accident Compensation Corporation of New Zealand	Dr. McKinlay was supported by a post-doctoral fellowship from the Health Research Council and the Accident Compensation Corporation of New Zealand (www.hrc.govt.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.acc.co.nz	Amminger GP, 2002, SCHIZOPHR RES, V54, P223, DOI 10.1016/S0920-9964(01)00278-X; Cabaret J, 2009, VET PARASITOL, V164, P21, DOI 10.1016/j.vetpar.2009.04.018; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Jonge JM, 2005, BEHAV COGN PSYCHOTH, V33, P285, DOI 10.1017/S1352465804001948; Delis DC, 2001, DELIS KAPLAN EXECUTI; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Gasquoine, 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grace J.M.P., 2001, FRSBE SELF RATING FO; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Green S. M., 1989, DEV PSYCHOPATHOL, V1, P317, DOI DOI 10.1017/S095457940000050X; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Kixmiller JS, 2000, J CLIN EXP NEUROPSYC, V22, P198, DOI 10.1076/1380-3395(200004)22:2;1-1;FT198; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; MUGNAI L, 1989, MYCOL RES, V92, P199, DOI 10.1016/S0953-7562(89)80012-7; Nelson HE., 1982, NATL ADULT READING T; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHERER M, 1996, J INT NEUROPSYCH SOC, V2, P17; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Werheid K, 2002, ARCH CLIN NEUROPSYCH, V17, P547, DOI 10.1016/S0887-6177(01)00134-2; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	43	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76916	10.1371/journal.pone.0076916	http://dx.doi.org/10.1371/journal.pone.0076916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116182	gold, Green Published			2022-12-27	WOS:000325552200083
J	Guillot, M; Gavrilova, N; Torgasheva, L; Denisenko, M				Guillot, Michel; Gavrilova, Natalia; Torgasheva, Liudmila; Denisenko, Mikhail			Divergent Paths for Adult Mortality in Russia and Central Asia: Evidence from Kyrgyzstan	PLOS ONE			English	Article							HEALTH LIFE-STYLES; ALCOHOL; EXPECTANCY	Adult mortality has been lower in Kyrgyzstan vs. Russia among males since at least 1981 and among females since 1999. Also, Kyrgyzstan's mortality fluctuations have had smaller amplitude. This has occurred in spite of worse macro-economic outcomes in Kyrgyzstan. To understand these surprising patterns, we analyzed cause-specific mortality in Kyrgyzstan vs. Russia for the period 1981-2010, using unpublished official data. We find that, as in Russia, fluctuations in Kyrgyzstan have been primarily due to changes in external causes and circulatory causes, and alcohol appears to play an important role. However, in contrast with Russia, mortality from these causes in Kyrgyzstan has been lower and has increased by a smaller amount. As a result, the mortality gap between the two countries is overwhelmingly attributable to external and cardio-vascular causes, and more generally, to causes that have been shown to be strongly related to alcohol consumption. These cause-specific results, together with the existence of large ethnic differentials in mortality in Kyrgyzstan, highlight the importance of cultural and religious differences, and their impact on patterns of alcohol consumption, in explaining the mortality gap between the two countries. These findings show that explanatory frameworks relying solely on macro-economic factors are not sufficient for understanding differences in mortality levels and trends among former Soviet republics.	[Guillot, Michel] Univ Penn, Philadelphia, PA 19104 USA; [Gavrilova, Natalia] Univ Chicago, Chicago, IL 60637 USA; [Torgasheva, Liudmila] Natl Stat Comm Kyrgyz Republ, Bishkek, Kyrgyzstan; [Denisenko, Mikhail] Natl Res Univ Higher Sch Econ, Moscow, Russia	University of Pennsylvania; University of Chicago; HSE University (National Research University Higher School of Economics)	Guillot, M (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	miguillo@sas.upenn.edu	Gavrilova, Natalia/AAH-2917-2020; Denisenko, Mikhail B./K-3462-2015	Denisenko, Mikhail B./0000-0001-7983-5323	National Institutes of Health [R03HD38752, R01HD045531]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007242] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045531, R03HD038752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institutes of Health (www.nih.gov) grant number R03HD38752 and R01HD045531. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B., 1997, PREMATURE DEATH NEW, P120; [Anonymous], EUR HLTH ALL DAT; Bank World, 2012, WORLD DEV IND; Becker CM, 1998, WORLD DEV, V26, P2057, DOI 10.1016/S0305-750X(98)00093-X; Brainerd E, 1998, WORLD DEV, V26, P2013, DOI 10.1016/S0305-750X(98)00096-5; Cockerham WC, 2000, SOC SCI MED, V51, P1313, DOI 10.1016/S0277-9536(00)00094-0; Cockerham WC, 2004, SOC SCI MED, V59, P1409, DOI 10.1016/j.socscimed.2004.01.023; Cornia GA, 1995, UNICEF INNOCENTI OCC; Guillot M., 2004, NASELENIE KYRGYZSTAN, P53; Guillot M, 2013, POPUL STUD IN PRESS; Guillot M., 2007, ESPACE POPULATIONS S, V1, P113, DOI DOI 10.4000/EPS.2025; Guillot M, 2011, DEMOGRAPHY, V48, P1081, DOI 10.1007/s13524-011-0036-1; Heath Douglas, 1995, INT HDB ALCOHOL CULT; Leon DA, 1998, JAMA-J AM MED ASSOC, V279, P790, DOI 10.1001/jama.279.10.790; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6; MESLE F, 1996, TENDANCES RECENTES M; Notzon FC, 1998, JAMA-J AM MED ASSOC, V279, P793, DOI 10.1001/jama.279.10.793; Shapiro J., 1995, RUSSIAN EC REFORM RI, P149; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov VM, 1998, WORLD DEV, V26, P1995, DOI 10.1016/S0305-750X(98)00102-8; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; University of California Berkeley (USA) and Max Planck Institute for Demographic Research (Germany), HUM MORT DAT; World Health Organization, WHO MORT DAT; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75314	10.1371/journal.pone.0075314	http://dx.doi.org/10.1371/journal.pone.0075314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116034	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200015
J	Mariappan, V; Vellasamy, KM; Thimma, J; Hashim, OH; Vadivelu, J				Mariappan, Vanitha; Vellasamy, Kumutha Malar; Thimma, Jaikumar; Hashim, Onn Haji; Vadivelu, Jamuna			Infection of Burkholderia cepacia Induces Homeostatic Responses in the Host for Their Prolonged Survival: The Microarray Perspective	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PSEUDOMONAS-CEPACIA; EPITHELIAL-CELLS; IN-VITRO; INVASION; INHIBITION; BLOOD; PURIFICATION; MULTIVORANS; CENOCEPACIA	Burkholderia cepacia is an opportunistic human pathogen associated with life-threatening pulmonary infections in immunocompromised individuals. Pathogenesis of B. cepacia infection involves adherence, colonisation, invasion, survival and persistence in the host. In addition, B. cepacia are also known to secrete factors, which are associated with virulence in the pathogenesis of the infection. In this study, the host factor that may be the cause of the infection was elucidated in human epithelial cell line, A549, that was exposed to live B. cepacia (mid-log phase) and its secretory proteins (mid-log and early-stationary phases) using the Illumina Human Ref-8 microarray platform. The non-infection A549 cells were used as a control. Expression of the host genes that are related to apoptosis, inflammation and cell cycle as well as metabolic pathways were differentially regulated during the infection. Apoptosis of the host cells and secretion of pro-inflammatory cytokines were found to be inhibited by both live B. cepacia and its secretory proteins. In contrast, the host cell cycle and metabolic processes, particularly glycolysis/glycogenesis and fatty acid metabolism were transcriptionally up-regulated during the infection. Our microarray analysis provided preliminary insights into mechanisms of B. cepacia pathogenesis. The understanding of host response to an infection would provide novel therapeutic targets both for enhancing the host's defences and repressing detrimental responses induced by the invading pathogen.	[Mariappan, Vanitha; Vellasamy, Kumutha Malar; Thimma, Jaikumar; Vadivelu, Jamuna] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, UMCPR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	jamuna@um.edu.my	Mariappan, Vanitha/I-4769-2013; VADIVELU, JAMUNARANI S/B-8696-2010; Hashim, Onn H/B-9459-2010; Vellasamy, Kumutha Malar/CAF-0007-2022; Vellasamy, Kumutha Malar/A-6592-2017; Mariappan, Vanitha/ABD-4066-2020	Mariappan, Vanitha/0000-0002-2351-1597; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Hashim, Onn H/0000-0002-0196-6793; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Mariappan, Vanitha/0000-0002-2351-1597	Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project [E000013-20001]; Ministry of Science, Innovation and Technology (MOSTI), Malaysia [55-02-03-1002]	Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project; Ministry of Science, Innovation and Technology (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This study was supported by Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project (E000013-20001) and Ministry of Science, Innovation and Technology (MOSTI), Malaysia under the Science Fund (55-02-03-1002). The funders had no role in the study design, data collection and analysis or the decision to publish or preparation of the manuscript.	ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Caraher E, 2007, J CYST FIBROS, V6, P49, DOI 10.1016/j.jcf.2006.05.007; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Chiu CH, 2001, MICROBIOL-SGM, V147, P2651, DOI 10.1099/00221287-147-10-2651; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; DINARELLO CA, 1991, J INFECT DIS, V163, P1177, DOI 10.1093/infdis/163.6.1177; DOMENECH CE, 1992, FEBS LETT, V299, P96, DOI 10.1016/0014-5793(92)80108-S; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Feezor RJ, 2003, INFECT IMMUN, V71, P5803, DOI 10.1128/IAI.71.10.5803-5813.2003; GEOFFROY C, 1991, INFECT IMMUN, V59, P2382, DOI 10.1128/IAI.59.7.2382-2388.1991; Govan JRW, 1998, MICROBIOL-SGM, V144, P2373, DOI 10.1099/00221287-144-9-2373; Govan JRW, 1996, J MED MICROBIOL, V45, P395, DOI 10.1099/00222615-45-6-395; GRANOWITZ EV, 1993, J IMMUNOL, V151, P1637; Holt J., 1994, BERGEYS MANUAL DETER; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; LONON MK, 1988, J CLIN MICROBIOL, V26, P979, DOI 10.1128/JCM.26.5.979-984.1988; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Mariappan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026518; Mariappan V, 2010, VACCINE, V28, P1318, DOI 10.1016/j.vaccine.2009.11.027; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; MCKENNEY D, 1995, J BACTERIOL, V177, P6989, DOI 10.1128/jb.177.23.6989-6992.1995; MCKEVITT AI, 1989, INFECT IMMUN, V57, P771, DOI 10.1128/IAI.57.3.771-778.1989; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; PINE L, 1984, J CLIN MICROBIOL, V19, P286, DOI 10.1128/JCM.19.2.286-290.1984; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walduck A, 2004, FASEB J, V18, P1955, DOI 10.1096/fj.04-2321fje; Wells DB, 2001, INFECT IMMUN, V69, P2718, DOI 10.1128/IAI.69.4.2718-2722.2001; Wongprompitak P, 2008, ASIAN PAC J ALLERGY, V26, P59; Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983	38	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77418	10.1371/journal.pone.0077418	http://dx.doi.org/10.1371/journal.pone.0077418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116227	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325501300119
J	Merler, S; Ajelli, M; Camilloni, B; Puzelli, S; Bella, A; Rota, MC; Tozzi, AE; Muraca, M; Meledandri, M; Iorio, AM; Donatelli, I; Rizzo, C				Merler, Stefano; Ajelli, Marco; Camilloni, Barbara; Puzelli, Simona; Bella, Antonino; Rota, Maria Cristina; Tozzi, Alberto Eugenio; Muraca, Maurizio; Meledandri, Marcello; Iorio, Anna Maria; Donatelli, Isabella; Rizzo, Caterina			Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility	PLOS ONE			English	Article							H1N1 VIRUS; A VIRUS; SEROPREVALENCE; TRANSMISSION; PREVALENCE; ANTIBODIES	Background: A common pattern emerging from several studies evaluating the impact of the 2009 A/H1N1 pandemic influenza (A/H1N1pdm) conducted in countries worldwide is the low attack rate observed in elderly compared to that observed in children and young adults. The biological or social mechanisms responsible for the observed age-specific risk of infection are still to be deeply investigated. Methods: The level of immunity against the A/H1N1pdm in pre and post pandemic sera was determined using left over sera taken for diagnostic purposes or routine ascertainment obtained from clinical laboratories. The antibody titres were measured by the haemagglutination inhibition (HI) assay. To investigate whether certain age groups had higher risk of infection the presence of protective antibody (>= 1: 40), was calculated using exact binomial 95% CI on both pre- and post-pandemic serological data in the age groups considered. To estimate age-specific susceptibility to infection we used an age-structured SEIR model. Results: By comparing pre- and post-pandemic serological data in Italy we found age-specific attack rates similar to those observed in other countries. Cumulative attack rate at the end of the first A/H1N1pdm season in Italy was estimated to be 16.3% (95% CI 9.4%-23.1%). Modeling results allow ruling out the hypothesis that only age-specific characteristics of the contact network and levels of pre-pandemic immunity are responsible for the observed age-specific risk of infection. This means that age-specific susceptibility to infection, suspected to play an important role in the pandemic, was not only determined by pre-pandemic levels of H1N1pdm antibody measured by HI. Conclusions: Our results claim for new studies to better identify the biological mechanisms, which might have determined the observed pattern of susceptibility with age. Moreover, our results highlight the need to obtain early estimates of differential susceptibility with age in any future pandemics to obtain more reliable real time estimates of critical epidemiological parameters.	[Merler, Stefano; Ajelli, Marco] Bruno Kessler Fdn, Trento, Italy; [Puzelli, Simona; Donatelli, Isabella] Natl Inst Hlth, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy; [Camilloni, Barbara; Iorio, Anna Maria] Univ Perugia, Dept Med & Surg Specialties & Publ Hlth, I-06100 Perugia, Italy; [Bella, Antonino; Rota, Maria Cristina; Rizzo, Caterina] Natl Ctr Epidemiol Surveillance & Hlth Promot, Natl Inst Hlth, Rome, Italy; [Tozzi, Alberto Eugenio; Muraca, Maurizio] Bambino Gesu Children Hosp & Res Inst, Rome, Italy; [Meledandri, Marcello] San Filippo Neri Hosp, Rome, Italy	Fondazione Bruno Kessler; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Perugia; Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; San Filippo Neri Hospital	Rizzo, C (corresponding author), Natl Ctr Epidemiol Surveillance & Hlth Promot, Natl Inst Hlth, Rome, Italy.	caterina.rizzo@iss.it	Bella, Antonino/AAB-9943-2019; Camilloni, Barbara/AAU-4394-2020; Muraca, Maurizio/G-3063-2012; Tozzi, Alberto Eugenio/F-9494-2012; Ajelli, Marco/AAX-1113-2020; Rizzo, Caterina/H-4092-2012; merler, stefano/I-3557-2017; Puzelli, Simona/C-2542-2016	Tozzi, Alberto Eugenio/0000-0002-6884-984X; Ajelli, Marco/0000-0003-1753-4749; Rizzo, Caterina/0000-0002-5583-7508; merler, stefano/0000-0002-5117-0611; MURACA, MAURIZIO/0000-0003-1218-097X; Puzelli, Simona/0000-0003-4497-9719; rota, maria cristina/0000-0002-9861-446X	EU FP7 EPIWORK project [231807]; Italian Ministry of Health [1M22]	EU FP7 EPIWORK project; Italian Ministry of Health(Ministry of Health, Italy)	SM and MA thank the EU FP7 EPIWORK project (contract no. 231807) for research funding. CR, MCR, and AB thank the Italian Ministry of Health project "Tuning epidemiological tools for influenza monitoring in Italy'' (Grant n. 1M22) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; Adamson WE, 2011, J CLIN VIROL, V52, P300, DOI 10.1016/j.jcv.2011.08.019; Adamson WE, 2010, EUROSURVEILLANCE, V15; Ajelli M, 2010, EPIDEMIOL INFECT, P1; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2011, EUROSURVEILLANCE, V16, P14; Bone A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033056; Broberg E, 2011, CLIN VACCINE IMMUNOL, V18, P1205, DOI 10.1128/CVI.05072-11; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Delangue J, 2012, CLIN MICROBIOL INFEC, V18, P177, DOI 10.1111/j.1469-0691.2011.03545.x; Dorigatti I, 2012, EPIDEMICS-NETH, V4, P9, DOI 10.1016/j.epidem.2011.11.001; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; EMEA, 1996, 21496 EMEA CPMPBWP; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Harmon M, 1992, INFLUENZA VIRUSES, P515; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Istituto Superiore di Sanita, 2010, INFL SURV SYST; Jacobs JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042328; Lim M, 2010, C P OPT CONTR INFL 7; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Morner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053511; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Reinheimer C, 2012, EUR J CLIN MICROBIOL, V31, P1467, DOI 10.1007/s10096-011-1465-x; Reinheimer C, 2011, INFECTION, V39, P101, DOI 10.1007/s15010-011-0105-9; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Rizzo C., 2010, EURO SURVEILL, V15; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Subelj V, 2012, WIEN KLIN WOCHENSCHR, V124, P177, DOI 10.1007/s00508-012-0126-0; Van K, 2013, INFLUENZA OTHER RESP; von Kries R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023955; Waalen K, 2010, EUROSURVEILLANCE, V15, P2; Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028063; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, 2010, H1N1 POSTP PER; World Health Organization, 2009, INFL LIK ILL US MEX; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Xu C, 2012, ACTA VIROL, V56, P329, DOI 10.4149/av_2012_04_329; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	46	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74785	10.1371/journal.pone.0074785	http://dx.doi.org/10.1371/journal.pone.0074785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116010	gold, Green Submitted, Green Published			2022-12-27	WOS:000325501300013
J	Niemann, H; Linke, P; Knittel, K; MacPherson, E; Boetius, A; Bruckmann, W; Larvik, G; Wallmann, K; Schacht, U; Omoregie, E; Hilton, D; Brown, K; Rehder, G				Niemann, Helge; Linke, Peter; Knittel, Katrin; MacPherson, Enrique; Boetius, Antje; Brueckmann, Warner; Larvik, Gaute; Wallmann, Klaus; Schacht, Ulrike; Omoregie, Enoma; Hilton, David; Brown, Kevin; Rehder, Gregor			Methane-Carbon Flow into the Benthic Food Web at Cold Seeps - A Case Study from the Costa Rica Subduction Zone	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; STABLE-ISOTOPE SIGNATURES; IN-SITU HYBRIDIZATION; MOSBY MUD VOLCANO; DEEP-SEA FAN; HYDROTHERMAL VENT; ANAEROBIC OXIDATION; MICROBIAL COMMUNITIES; EPSILON-PROTEOBACTERIA; SURFACE SEDIMENTS	Cold seep ecosystems can support enormous biomasses of free-living and symbiotic chemoautotrophic organisms that get their energy from the oxidation of methane or sulfide. Most of this biomass derives from animals that are associated with bacterial symbionts, which are able to metabolize the chemical resources provided by the seeping fluids. Often these systems also harbor dense accumulations of non-symbiotic megafauna, which can be relevant in exporting chemosynthetically fixed carbon from seeps to the surrounding deep sea. Here we investigated the carbon sources of lithodid crabs (Paralomis sp.) feeding on thiotrophic bacterial mats at an active mud volcano at the Costa Rica subduction zone. To evaluate the dietary carbon source of the crabs, we compared the microbial community in stomach contents with surface sediments covered by microbial mats. The stomach content analyses revealed a dominance of epsilonproteobacterial 16S rRNA gene sequences related to the free-living and epibiotic sulfur oxidiser Sulfurovum sp. We also found Sulfurovum sp. as well as members of the genera Arcobacter and Sulfurimonas in mat-covered surface sediments where Epsilonproteobacteria were highly abundant constituting 10% of total cells. Furthermore, we detected substantial amounts of bacterial fatty acids such as i-C15:0 and C17:1 omega 6c with stable carbon isotope compositions as low as -53 parts per thousand in the stomach and muscle tissue. These results indicate that the white microbial mats at Mound 12 are comprised of Epsilonproteobacteria and that microbial mat-derived carbon provides an important contribution to the crab's nutrition. In addition, our lipid analyses also suggest that the crabs feed on other C-13-depleted organic matter sources, possibly symbiotic megafauna as well as on photosynthetic carbon sources such as sedimentary detritus.	[Niemann, Helge] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Niemann, Helge; Knittel, Katrin; Boetius, Antje; Larvik, Gaute; Omoregie, Enoma] Max Planck Inst Marine Microbiol, Bremen, Germany; [Linke, Peter; Brueckmann, Warner; Wallmann, Klaus; Schacht, Ulrike; Rehder, Gregor] Univ Kiel, Sonderforsch Bereich 574, Kiel, Germany; [Linke, Peter; Brueckmann, Warner; Wallmann, Klaus] GEOMAR, Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [MacPherson, Enrique] Ctr Estudios Avanzados Blanes CEAB CSIC, Blanes, Spain; [Boetius, Antje] Alfred Wegener Inst Marine & Polar Res, Bremerhaven, Germany; [Omoregie, Enoma] Inst Nacl Tecn Aeroespacial Torrejon de Ardoz, Ctr Astrobiol CSIC INTA, Madrid, Spain; [Hilton, David; Brown, Kevin] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Rehder, Gregor] Leibniz Inst Balt Sea Res Warnemunde IOW, Rostock, Germany	University of Basel; Max Planck Society; University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of California System; University of California San Diego; Scripps Institution of Oceanography; Leibniz Institut fur Ostseeforschung Warnemunde	Niemann, H (corresponding author), Univ Basel, Dept Environm Sci, Basel, Switzerland.	helge.niemann@unibas.ch	Niemann, Helge/C-6630-2014; Wallmann, Klaus/D-4380-2017; Boetius, Antje/D-5459-2013; Linke, Peter/A-4401-2014; Macpherson, Enrique/J-8982-2012	Niemann, Helge/0000-0002-3468-8304; Wallmann, Klaus/0000-0002-1795-376X; Boetius, Antje/0000-0003-2117-4176; Linke, Peter/0000-0001-7373-7335; Macpherson, Enrique/0000-0003-4849-4532; Brueckmann, Warner/0000-0001-6636-8148; Omoregie, Enoma/0000-0002-7701-4182	DFG; NSF [OCE-0242034, OCE-0242091]; Max Planck Society; Helmholtz Association; University of Basel	DFG(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Association(Helmholtz Association); University of Basel	Financial support for the M66-Subflux cruise came through the Collaborative Research Center (SFB) 574 ("Volatiles and Fluids in Subduction Zones'') at Kiel University funded by the DFG. This work was further supported by NSF (OCE-0242034 and OCE-0242091), the Max Planck Society, the Helmholtz Association and the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Berge JP, 2005, ADV BIOCHEM ENG BIOT, V96, P49, DOI 10.1007/b135782; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Blumenberg M, 2004, P NATL ACAD SCI USA, V101, P11111, DOI 10.1073/pnas.0401188101; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borin S, 2009, P NATL ACAD SCI USA, V106, P9151, DOI 10.1073/pnas.0811984106; Bowles MW, 2011, GEOCHIM COSMOCHIM AC, V75, P500, DOI 10.1016/j.gca.2010.09.043; Bruckmann W, 2009, METEOR BERICHTE; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Canfield DE, 2005, ADV MAR BIOL, V48, P313; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124, DOI 10.1128/AEM.63.3.1124-1130.1997; Chevaldonne P, 1996, P BIOL SOC WASH, V109, P286; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Cordes EE, 2010, LIMNOL OCEANOGR, V55, P2537, DOI 10.4319/lo.2010.55.6.2537; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; Decker C, 2012, MAR ECOL-EVOL PERSP, V33, P231, DOI 10.1111/j.1439-0485.2011.00486.x; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elvert M, 2003, GEOMICROBIOL J, V20, P403, DOI 10.1080/01490450303894; Fetzner S, 2010, HDB HYDROCARBON LIPI, P865, DOI [10.1007/978-3-540-77587-4_62, DOI 10.1007/978-3-540-77587-4_62]; Fiedler PC, 2002, DEEP-SEA RES PT I, V49, P321, DOI 10.1016/S0967-0637(01)00057-7; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Girnth AC, 2011, ENVIRON MICROBIOL, V13, P495, DOI 10.1111/j.1462-2920.2010.02353.x; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Grunke S, 2012, BIOGEOSCIENCES, V9, P2947, DOI 10.5194/bg-9-2947-2012; Grunke S, 2011, GEOBIOLOGY, V9, P330, DOI 10.1111/j.1472-4669.2011.00281.x; Hensen C, 2004, GEOLOGY, V32, P201, DOI 10.1130/G20119.1; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Hovland M, 2007, GEO-MAR LETT, V27, P197, DOI 10.1007/s00367-007-0070-6; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Ishii K, 2004, FEMS MICROBIOL ECOL, V50, P203, DOI 10.1016/j.femsec.2004.06.015; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Joye SB, 2009, NAT GEOSCI, V2, P349, DOI 10.1038/NGEO475; KENNICUTT MC, 1985, NATURE, V317, P351, DOI 10.1038/317351a0; Kleindienst S, 2012, ENVIRON MICROBIOL, V14, P2689, DOI 10.1111/j.1462-2920.2012.02832.x; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kopf A, 2000, MAR GEOL, V167, P1, DOI 10.1016/S0025-3227(00)00026-8; Kostanjsek R, 2007, APPL ENVIRON MICROB, V73, P5566, DOI 10.1128/AEM.02468-06; Lanoil BD, 2001, APPL ENVIRON MICROB, V67, P5143, DOI 10.1128/AEM.67.11.5143-5153.2001; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2002, LIMNOL OCEANOGR, V47, P1336, DOI 10.4319/lo.2002.47.5.1336; Linke P, 2005, EARTH PLANET SC LETT, V235, P79, DOI 10.1016/j.epsl.2005.03.009; Losekann T, 2008, ENVIRON MICROBIOL, V10, P3237, DOI 10.1111/j.1462-2920.2008.01712.x; MacAvoy SE, 2005, MAR ECOL PROG SER, V292, P51, DOI 10.3354/meps292051; MacAvoy SE, 2003, CHEM GEOL, V201, P229, DOI 10.1016/S0009-2541(03)00204-3; MacAvoy SE, 2002, MAR ECOL PROG SER, V225, P65, DOI 10.3354/meps225065; MacAvoy SE, 2002, CHEM GEOL, V185, P1, DOI 10.1016/S0009-2541(01)00394-1; MACDONALD IR, 1989, MAR BIOL, V101, P235, DOI 10.1007/BF00391463; Macpherson E, 2010, CRUSTACEANA, V83, P143, DOI 10.1163/001121609X12487811051660; Madigan M. T., 2012, BROCK BIOL MICROORGA; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Mau S, 2006, MAR GEOL, V225, P129, DOI 10.1016/j.margeo.2005.09.007; Meziti A, 2007, RUSS J MAR BIOL+, V33, P84, DOI 10.1134/S1063074007020022; Meziti A, 2010, FEMS MICROBIOL ECOL, V74, P472, DOI 10.1111/j.1574-6941.2010.00964.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moerz T, 2005, NATO SCI S SS IV EAR, V51, P49; Moussard H, 2006, FEMS MICROBIOL ECOL, V58, P449, DOI 10.1111/j.1574-6941.2006.00192.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; Niemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5336, DOI 10.1016/j.gca.2006.08.010; Niemann H, 2005, BIOGEOSCIENCES, V2, P335, DOI 10.5194/bg-2-335-2005; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Niemann H, 2010, HDB HYDROCARBON LIPI, P205, DOI 10.1007/978-3-540-77587-4_13; Niemann H, 2008, ORG GEOCHEM, V39, P1668, DOI 10.1016/j.orggeochem.2007.11.003; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Niggemann J, 2007, GEOCHIM COSMOCHIM AC, V71, P1513, DOI 10.1016/j.gca.2006.12.012; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Omoregie EO, 2009, MAR GEOL, V261, P114, DOI 10.1016/j.margeo.2009.02.001; PAULL CK, 1985, NATURE, V317, P709, DOI 10.1038/317709a0; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Petersen J. E., 2009, P1; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ranero CR, 2000, NATURE, V404, P748, DOI 10.1038/35008046; Rojo F., 2010, HDB HYDROCARBON LIPI, P781, DOI DOI 10.1007/978-3-540-77587-4_59; Sahling H, 2003, DEEP-SEA RES PT I, V50, P1391, DOI 10.1016/j.dsr.2003.08.004; Sahling H, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI [10.1029/2008GC001978mor, DOI 10.1029/2008GC001978M0]; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sommer S, 2010, MAR GEOL, V272, P223, DOI 10.1016/j.margeo.2009.06.003; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Takai K, 2005, APPL ENVIRON MICROB, V71, P7310, DOI 10.1128/AEM.71.11.7310-7320.2005; Thamdrup B, 1996, LIMNOL OCEANOGR, V41, P1629, DOI 10.4319/lo.1996.41.8.1629; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; Thurber AR, 2010, MAR GEOL, V272, P260, DOI 10.1016/j.margeo.2009.06.001; Timmis, 2010, HDB HYDROCARBON LIPI, P187, DOI DOI 10.1007/978-3-540-77587-4_12; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Tsuchida S, 2011, J MAR BIOL ASSOC UK, V91, P23, DOI 10.1017/S0025315410001827; Van Dover CL, 2007, ECOL METHOD CONCEPT, P202, DOI 10.1002/9780470691854.ch8; VANDENOORD A, 1964, COMP BIOCHEM PHYSIOL, V13, P461, DOI 10.1016/0010-406X(64)90038-6; Vanreusel A, 2009, OCEANOGRAPHY, V22, P110, DOI 10.5670/oceanog.2009.12; Wang W, 2011, INT J SYST EVOL MICR, V61, P703, DOI 10.1099/ijs.0.020529-0; WHITCOMB RF, 1981, ANNU REV ENTOMOL, V26, P397, DOI 10.1146/annurev.en.26.010181.002145; Yamamoto M, 2010, ENVIRON MICROBIOL, V12, P1144, DOI 10.1111/j.1462-2920.2010.02155.x	100	46	47	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74894	10.1371/journal.pone.0074894	http://dx.doi.org/10.1371/journal.pone.0074894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116017	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325501300018
J	Sladek, M; Sumova, A				Sladek, Martin; Sumova, Alena			Entrainment of Spontaneously Hypertensive Rat Fibroblasts by Temperature Cycles	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; HEAT-SHOCK FACTOR-1; SUPRACHIASMATIC NUCLEUS; BODY-TEMPERATURE; PERIPHERAL-TISSUES; IN-VITRO; RHYTHMS; LIGHT; MICE; TRANSCRIPTION	The functional state of the circadian system of spontaneously hypertensive rats (SHR) differs in several characteristics from the functional state of normotensive Wistar rats. Some of these changes might be due to the compromised ability of the central pacemaker to entrain the peripheral clocks. Daily body temperature cycles represent one of the important cues responsible for the integrity of the circadian system, because these cycles are driven by the central pacemaker and are able to entrain the peripheral clocks. This study tested the hypothesis that the aberrant peripheral clock entrainment of SHR results from a compromised peripheral clock sensitivity to the daily temperature cycle resetting. Using cultured Wistar rat and SHR fibroblasts transfected with the circadian luminescence reporter Bmal1-dLuc, we demonstrated that two consecutive square-wave temperature cycles with amplitudes of 2.5 degrees C are necessary and sufficient to restart the dampened oscillations and entrain the circadian clocks in both Wistar rat and SHR fibroblasts. We also generated a phase response curve to temperature cycles for fibroblasts of both rat strains. Although some of the data suggested a slight resistance of SHR fibroblasts to temperature entrainment, we concluded that the overall effect it too weak to be responsible for the differences between the SHR and Wistar in vivo circadian phenotype.	[Sladek, Martin; Sumova, Alena] Acad Sci Czech Republic, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Sladek, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic.	sladek@biomed.cas.cz	Sumova, Alena/C-3390-2012; Sládek, Martin/C-3383-2012	Sumova, Alena/0000-0003-4126-5470; Sládek, Martin/0000-0002-9744-9386	Czech Science Foundation [P30510P244, P303110668];  [RVO 67985823]	Czech Science Foundation(Grant Agency of the Czech Republic); 	This work was supported by the Czech Science Foundation grant No. P30510P244, Research Project RVO 67985823 and a minor part of the project was also supported by the Czech Science Foundation grant No. P303110668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; BARRETT RK, 1995, J NEUROSCI, V15, P5681; BERKEY DL, 1990, AM J PHYSIOL, V258, pR743, DOI 10.1152/ajpregu.1990.258.3.R743; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Burgess HJ, 2008, J PHYSIOL-LONDON, V586, P639, DOI 10.1113/jphysiol.2007.143180; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; ERKERT HG, 1981, COMP BIOCHEM PHYS A, V68, P383, DOI 10.1016/0300-9629(81)90065-7; FRANCIS AJP, 1988, PHYSIOL BEHAV, V43, P471, DOI 10.1016/0031-9384(88)90121-7; FRANCIS CD, 1979, PLANT PHYSIOL, V64, P1000, DOI 10.1104/pp.64.6.1000; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; MILLS JN, 1978, J PHYSIOL-LONDON, V285, P455, DOI 10.1113/jphysiol.1978.sp012582; Morf J, 2013, CELL CYCLE, V12, P539, DOI 10.4161/cc.23670; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Nishide S, 2008, EUR J NEUROSCI, V27, P2686, DOI 10.1111/j.1460-9568.2008.06231.x; NJUS D, 1977, J COMP PHYSIOL, V117, P335, DOI 10.1007/BF00691559; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Pohl H, 1998, BIOL RHYTHM RES, V29, P311, DOI 10.1076/brhm.29.3.311.1436; Pravenec M, 2004, PHYSIOL RES, V53, pS15; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Refinetti R, 2010, J BIOL RHYTHM, V25, P247, DOI 10.1177/0748730410372074; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Ruby NF, 1999, J NEUROSCI, V19, P8630; Ruby NF, 2011, J BIOL RHYTHM, V26, P368, DOI 10.1177/0748730411411678; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Sladek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046951; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; Sporl F, 2011, J INVEST DERMATOL, V131, P338, DOI 10.1038/jid.2010.315; SWEENEY BM, 1960, COLD SPRING HARB SYM, V25, P87, DOI 10.1101/SQB.1960.025.01.009; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; TOKURA H, 1983, AM J PHYSIOL, V245, pR800, DOI 10.1152/ajpregu.1983.245.6.R800; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WILKINS MB, 1983, PLANTA, V157, P471, DOI 10.1007/BF00397205; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106; Yoshikawa T, 2013, EUR J NEUROSCI, V37, P491, DOI 10.1111/ejn.12052; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	63	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77010	10.1371/journal.pone.0077010	http://dx.doi.org/10.1371/journal.pone.0077010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116198	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300112
J	Su, LH; Wan, CX; Zhou, JR; Wang, YG; Wang, L; Ai, YL; Zhao, X				Su, Lihong; Wan, Caixia; Zhou, Jianren; Wang, Yiguang; Wang, Liang; Ai, Yanling; Zhao, Xu			Piezochromic Phenomena of Nanometer Voids Formed by Mono-Dispersed Nanometer Powders Compacting Process	PLOS ONE			English	Article							ZINC-OXIDE; HIGH-PRESSURES; COMPLEXES; EMISSION; BEHAVIOR; PHOTOLUMINESCENT; NANOPARTICLES; TRANSITIONS	Piezochromism describes a tendency of certain materials changing colors when they are subjected to various pressure levels. It occurs particularly in some polymers or inorganic materials, such as in palladium complexes. However, piezochromism is generally believed to work at high pressure range of 0.1-10 GPa. This research work focused on unique piezochromism responses of the nanometer voids formed by the 5-20 nm inorganic ISOH nanometer powders. It was discovered that microstructures of the nanometer voids could change color at very low pressures of only 0.002-0.01 GPa; its sensitivity to pressure was increased by tens of times. It is believed that the uniform microstructures of nanometer powders contributed to the material's high sensitivity of piezochromic phenomena. One factor which quantum optical change caused by nanometer voids affected the quantum confinement effect; another is surface Plasmon Resonance of great difference dielectric property between conductive ITO powder and insulation hydroxide.	[Su, Lihong; Wan, Caixia; Wang, Yiguang; Wang, Liang; Ai, Yanling; Zhao, Xu] Northwestern Polytech Univ, Dept Applying Chem, Xian, Shaanxi Provinc, Peoples R China; [Zhou, Jianren] Prairie View A&M Univ, Coll Engn, Prairie View, TX USA	Northwestern Polytechnical University; Texas A&M University System; Prairie View A&M University	Su, LH (corresponding author), Northwestern Polytech Univ, Dept Applying Chem, Xian, Shaanxi Provinc, Peoples R China.	hlshong@nwpu.edu.cn	Wang, Liang/N-8904-2014	Wang, Liang/0000-0001-6223-5962; su, lihong/0000-0001-8889-4624				Bagnall DM, 1998, APPL PHYS LETT, V73, P1038, DOI 10.1063/1.122077; BARNETT JD, 1973, REV SCI INSTRUM, V44, P1, DOI 10.1063/1.1685943; BYLANDER EG, 1978, J APPL PHYS, V49, P1188, DOI 10.1063/1.325059; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; DINGLE R, 1969, PHYS REV LETT, V23, P579, DOI 10.1103/PhysRevLett.23.579; Galloway KW, 2010, CRYSTENGCOMM, V12, P2516, DOI 10.1039/c001376e; Henry PF, 2010, ACTA CRYSTALLOGR B, V66, P412, DOI 10.1107/S0108768110020720; Hideo DT, 2004, PLATIN MET REV, V48, P117; Kim MI, 2011, CHEM-EUR J, V17, P10700, DOI 10.1002/chem.201101191; KOTOWSKI M, 1987, INORG CHIM ACTA, V131, P225, DOI 10.1016/S0020-1693(00)96029-8; Lihong S, 2009, MICRO NANO LETT, V4, P48, DOI 10.1049/mnl:20080055; Linhong S, 2011, PHYS DIFFERENCE BOUN; Muramatsu Y, 2001, POLYMER, V42, P6673, DOI 10.1016/S0032-3861(01)00136-7; Nalwa H. S., 1988, HDB ORGANIC CONDUCTI, V2; Righetti L, 2011, ACS APPL MATER INTER, V3, P1319, DOI 10.1021/am2001218; Sagara Y, 2008, ANGEW CHEM INT EDIT, V47, P5175, DOI 10.1002/anie.200800164; Sagara Y, 2009, NAT CHEM, V1, P605, DOI [10.1038/NCHEM.411, 10.1038/nchem.411]; Sagara Y, 2009, ADV FUNCT MATER, V19, P1869, DOI 10.1002/adfm.200801726; Salaneck MR, 1998, J CHEM PHYS, V89, P4613; Samuelsen EJ, 1999, SYNTHETIC MET, V101, P98, DOI 10.1016/S0379-6779(98)01241-7; Sase M, 2011, J MATER CHEM, V21, P8347, DOI 10.1039/c0jm03950k; SHIROTANI I, 1991, B CHEM SOC JPN, V64, P1607, DOI 10.1246/bcsj.64.1607; SHIROTANI I, 1992, B CHEM SOC JPN, V65, P1078, DOI 10.1246/bcsj.65.1078; Skotheim T.A., 1997, HDB CONDUCTING POLYM; Van de Walle CG, 2000, PHYS REV LETT, V85, P1012, DOI 10.1103/PhysRevLett.85.1012; Zhang ZL, 2011, CHEM COMMUN, V47, P7782, DOI 10.1039/c1cc11882j	26	0	0	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e72964	10.1371/journal.pone.0072964	http://dx.doi.org/10.1371/journal.pone.0072964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24115999	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300002
J	Wang, ZG; Si, XL; Xu, A; Meng, XN; Gao, SL; Qi, YJ; Zhu, L; Li, TJ; Li, WP; Dong, LY				Wang, Zhengguang; Si, Xiulian; Xu, Aman; Meng, Xiangning; Gao, Shile; Qi, Yijun; Zhu, Liang; Li, Tuanjie; Li, Weiping; Dong, Liuyi			Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates with Clinical Implications	PLOS ONE			English	Article							PROGNOSTIC MARKER; MOLECULAR TARGETS; IMMUNE-RESPONSES; EXPRESSION; TRANSDUCER; CARCINOMA; PATHWAY; PROTEIN; GROWTH; IDENTIFICATION	Background: The signal transducers and activators of transcription 3 (STAT3) signaling pathway plays important roles in oncogenesis, angiogenesis, immunity, and tumor cell invasion. In the present study, we investigated the association of interleukin (IL)-6/STAT3 signaling pathway with T lymphocytes and clinical implication in patients with gastric cancer. Methods: Seventy one patients who underwent gastrectomy due to gastric adenocarcinoma were studied. Blood samples were collected before and after surgical gastrectomy to quantify the levels of IL-6, IL-10 and VEGF using an enzyme-linked immunosorbent assay, as well as T lymphocyte subsets (CD3(+), CD4(+), CD8(+), CD4(+)/CD8(+)) and natural killer (NK) cells by a flow cytometry. Furthermore, the expression of IL-6, survivin, STAT3, STAT3 phosphorylation (p-STAT3), and VEGF were determined in human gastric cancer and adjacent normal mucosa through Western blot and immunohistochemistry. Results: Postoperative levels of IL-6, IL-10 and VEGF in serum were significantly lower than preoperative levels. Percentages of T-cell subsets and NK cells in blood were significantly increased after postoperative-week 1 as compared to preoperative group, which was further augmented at 1 month after gastrectomy. In addition, the expression of IL-6, survivin, STAT3, p-STAT3, and VEGF were increased in human gastric cancer tissues as compared to adjacent normal mucosa. Their expression was associated with TNM stage of gastric cancer. The level of STAT3 activation in clinical samples was correlated with IL-6 expression. All gastric tumor samples, which expressed p-STAT3, also expressed IL-6 with weak expression detected in adjacent normal mucosa. Conclusion: Increased IL-6-induced activation of STAT3 was observed in neoplastic gastric tissue, which positively correlated with tumor progression. Moreover, IL-6 and STAT3 downstream signals such as IL-10 and VEGF were reduced in patients after removal of gastric cancer as compared to pre-operation. Therefore, inhibition of the IL-6/STAT3 signaling pathway may provide a new therapeutic strategy against gastric cancer.	[Wang, Zhengguang; Si, Xiulian; Gao, Shile; Li, Weiping; Dong, Liuyi] Anhui Med Univ, Key Lab Antiinflammatory & Immunopharmacol, Key Lab Chinese Med Res & Dev, Dept Pharmacol,Minist Educ,State Adm Tradit Chine, Hefei, Anhui, Peoples R China; [Wang, Zhengguang; Xu, Aman; Meng, Xiangning; Qi, Yijun; Zhu, Liang; Li, Tuanjie] Anhui Med Univ, Affiliated Hosp 1, Dept Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Li, WP (corresponding author), Anhui Med Univ, Key Lab Antiinflammatory & Immunopharmacol, Key Lab Chinese Med Res & Dev, Dept Pharmacol,Minist Educ,State Adm Tradit Chine, Hefei, Anhui, Peoples R China.	weipingli19@hotmail.com; dongly@ahmu.edu.cn	LI, TUANJIE/S-3903-2018; 黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022	LI, TUANJIE/0000-0002-5540-6345; 	Educational Commission of Anhui Province, China [kj2011Z210]	Educational Commission of Anhui Province, China	This study, performed in the authors' laboratory, was supported by grants from Educational Commission of Anhui Province, China (Grant No. kj2011Z210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Amedei A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/690571; Benekli M, 2002, BLOOD, V99, P252, DOI 10.1182/blood.V99.1.252; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burdelya L, 2005, J IMMUNOL, V174, P3925, DOI 10.4049/jimmunol.174.7.3925; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Choi JH, 2006, APMIS, V114, P619, DOI 10.1111/j.1600-0463.2006.apm_401.x; De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Fortis C, 1996, CANCER LETT, V104, P1, DOI 10.1016/0304-3835(96)04213-9; Gamero AM, 2004, CANCER CELL, V5, P111, DOI 10.1016/S1535-6108(04)00028-5; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hirano T, 1998, Int Rev Immunol, V16, P249; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hong Weon-Seon, 1995, Journal of Korean Medical Science, V10, P164; Hsu KW, 2012, CARCINOGENESIS, V33, P1459, DOI 10.1093/carcin/bgs165; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Jackson CB, 2007, J PATHOL, V213, P140, DOI 10.1002/path.2218; Jackson CB, 2009, J GASTROEN HEPATOL, V24, P505, DOI 10.1111/j.1440-1746.2009.05822.x; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kinoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060914; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Lin MT, 2007, INT J CANCER, V120, P2600, DOI 10.1002/ijc.22599; Masuda M, 2002, CANCER RES, V62, P3351; Mocellin S, 2004, GENES IMMUN, V5, P621, DOI 10.1038/sj.gene.6364135; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Sekikawa A, 2008, CARCINOGENESIS, V29, P76, DOI 10.1093/carcin/bgm250; Shahini VM, 2011, ACS MED CHEM LETT, V2, P79, DOI 10.1021/ml100224d; Shin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021492; Szczepanik AM, 2011, WORLD J GASTROENTERO, V17, P343, DOI 10.3748/wjg.v17.i3.343; Szkaradkiewicz A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/901564; TERANISHI T, 1982, J IMMUNOL, V128, P1903; Toyonaga T, 2003, CANCER LETT, V201, P107, DOI 10.1016/S0304-3835(03)00482-8; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xiong H, 2012, J MOL MED, V90, P1037, DOI 10.1007/s00109-012-0869-0; Yakata Y, 2007, INT J ONCOL, V30, P437; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7; Yao XX, 2002, WORLD J GASTROENTERO, V8, P586, DOI 10.3748/wjg.v8.i4.586; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	49	39	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75788	10.1371/journal.pone.0075788	http://dx.doi.org/10.1371/journal.pone.0075788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116074	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300042
J	Brittain, EL; Pugh, ME; Wang, L; Newman, AL; Robbins, IM; Newman, JH; Hemnes, AR				Brittain, Evan L.; Pugh, Meredith E.; Wang, Li; Newman, Alex L.; Robbins, Ivan M.; Newman, John H.; Hemnes, Anna R.			Predictors of Diastolic-To-Wedge Gradient in Patients Evaluated for Pulmonary Hypertension	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; OF-CARDIOLOGY FOUNDATION; PRESSURE-GRADIENT; ASSOCIATION; DIAGNOSIS; ECHOCARDIOGRAPHY; STATEMENT; COUNCIL; SOCIETY; DISEASE	Background: Differentiation of pulmonary arterial hypertension (PAH) and pulmonary venous hypertension (PVH) often requires right heart catheterization (RHC). We sought to determine whether a combination of clinical and echocardiographic variables could predict the pulmonary diastolic to wedge (PAd-PWP) gradient and thus differentiate patients with PAH and PVH. Methods: We prospectively enrolled 108 patients presenting for PH evaluation. We developed a multivariate model to predict PAd-PWP gradient and validated this model using bootstrapping technique. Results: PAH patients had worse hemodynamics and were more likely to have evidence of right ventricular dilation and dysfunction whereas patients with PVH were older and more likely to have features of the metabolic syndrome. PAd-PWP gradient of >= 6mmHg accurately discriminated patients with PAH compared to PVH. Our model including clinical and echocardiographic variables was highly accurate for the prediction of PAd-PWP gradient with a slope 0.89 (slope of 1 represents perfect prediction). Conclusions: In this prospective study of patients referred for PH evaluation, a model of readily available clinical parameters and simple echocardiographic measurements accurately predicted the PAd-PWP gradient, allowing discrimination of patients with PAH and PVH. This model requires validation in a larger cohort, but may afford clinicians more parsimony with referral for invasive testing in the evaluation of PH.	[Brittain, Evan L.] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37212 USA; [Pugh, Meredith E.; Newman, Alex L.; Robbins, Ivan M.; Newman, John H.; Hemnes, Anna R.] Vanderbilt Univ, Med Ctr, Div Pulm & Crit Care Med, Nashville, TN USA; [Wang, Li] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Brittain, EL (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37212 USA.	evan.brittain@vanderbilt.edu		Brittain, Evan/0000-0001-5843-3392	CTSA from the National Center for Advancing Translational Sciences [UL1TR000445]; American College of Cardiology Foundation/Merck Fellowship in Cardiometabolic Disorders (Brittain); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087738, T32HL007411, P01HL108800] Funding Source: NIH RePORTER	CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American College of Cardiology Foundation/Merck Fellowship in Cardiometabolic Disorders (Brittain); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by CTSA award number UL1TR000445 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health; 1 P01 HL 108800-01A1 (Hemnes, Robbins, Pugh). The study was also supported by American College of Cardiology Foundation/Merck Fellowship in Cardiometabolic Disorders (Brittain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ATS, 2012, AM J RESP CRIT CARE, V166, P111; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Bonderman D, 2011, EUR RESPIR J, V37, P1096, DOI 10.1183/09031936.00089610; BUSH CA, 1977, CIRCULATION, V56, P924, DOI 10.1161/01.CIR.56.6.924; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; DELLITALIA LJ, 1984, J AM COLL CARDIOL, V4, P931, DOI 10.1016/S0735-1097(84)80053-4; Fang JC, 2012, J HEART LUNG TRANSPL, V31, P913, DOI 10.1016/j.healun.2012.06.002; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Fujimoto N, 2013, CIRCULATION, V127, P55, DOI 10.1161/CIRCULATIONAHA.112.111302; Gerges C, 2013, CHEST, V143, P758, DOI 10.1378/chest.12-1653; Hancock EW, 2009, CIRCULATION, V119, pE251, DOI 10.1161/CIRCULATIONAHA.108.191097; Hemnes AR, 2011, CHEST, V140, P1267, DOI 10.1378/chest.11-0155; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; NAEIJE R, 1994, AM J RESP CRIT CARE, V149, P881, DOI 10.1164/ajrccm.149.4.8143050; Naeije R, 2013, EUR RESPIR J, V41, P217, DOI 10.1183/09031936.00074312; Opotowsky AR, 2012, CIRC-CARDIOVASC IMAG, V5, P765, DOI 10.1161/CIRCIMAGING.112.976654; PACKER M, 2002, C AM COLL CARD LAT B; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Robbins IM, 2009, CHEST, V136, P31, DOI 10.1378/chest.08-2008; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76461	10.1371/journal.pone.0076461	http://dx.doi.org/10.1371/journal.pone.0076461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124561	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100118
J	Chougule, A; Prabhash, K; Noronha, V; Joshi, A; Thavamani, A; Chandrani, P; Upadhyay, P; Utture, S; Desai, S; Jambhekar, N; Dutt, A				Chougule, Anuradha; Prabhash, Kumar; Noronha, Vanita; Joshi, Amit; Thavamani, Abhishek; Chandrani, Pratik; Upadhyay, Pawan; Utture, Sagarika; Desai, Saral; Jambhekar, Nirmala; Dutt, Amit			Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; FEMALE NEVER-SMOKERS; CANCER PATIENTS; ACTIVATING MUTATIONS; 1ST-LINE TREATMENT; GEFITINIB THERAPY; CLINICAL-RESPONSE; GENE-MUTATIONS; OPEN-LABEL; ERLOTINIB	Background: During the past decade, the incidence of EGFR mutation has been shown to vary across different ethnicities. It occurs at the rate of 10-15% in North Americans and Europeans, 19% in African-Americans, 20-30% in various East Asian series including Chinese, Koreans, and Japanese. Frequency of EGFR mutations in India however remains sparsely explored. Methodology/Principal Findings: We report 23% incidence of Epidermal growth factor receptor (EGFR) mutations in 907 Non small cell lung cancer (NSCLC) patients of Indian ethnicity, in contrast to 10-15% known in Caucasians and 27-62% among East Asians. In this study, EGFR mutations were found to be more common in never-smokers 29.4% as compared to smokers 15.3%. Consistent with other populations, mutation rates among adenocarcinoma-males were predominantly lower than females with 32% incidence. However unlike Caucasians, EGFR mutation rate among adenocarcinoma-never-smoker females were comparable to males suggesting lack of gender bias among never smokers likely to benefit from EGFR targeted therapy. Conclusions/Significance: This study has an overall implication for establishing relevance for routine EGFR mutation diagnostics for NSCLC patients in clinics and emphasizes effectiveness for adoption of EGFR inhibitors as the first line treatment among Indian population. The intermediate frequency of EGFR mutation among Indian population compared to Caucasians and East Asians is reminiscent of an ancestral admixture of genetic influence from Middle Easterners, Central Asians, and Europeans on modern-Indian population that may confer differential susceptibility to somatic mutations in EGFR.	[Chougule, Anuradha; Prabhash, Kumar; Noronha, Vanita; Joshi, Amit] Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Mumbai 400012, Maharashtra, India; [Thavamani, Abhishek; Chandrani, Pratik; Upadhyay, Pawan; Dutt, Amit] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Utture, Sagarika; Desai, Saral; Jambhekar, Nirmala] Tata Mem Hosp, Tata Mem Ctr, Dept Pathol, Mumbai 400012, Maharashtra, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	Prabhash, K (corresponding author), Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Mumbai 400012, Maharashtra, India.	kprabhash1@gmail.com; adutt@actrec.gov.in	Upadhyay, Pawan/AAM-6668-2020; Dutt, Amit/I-1911-2013; Thavamani, Abhishek/I-3207-2018; Chandrani, Pratik/AAV-9081-2021	Upadhyay, Pawan/0000-0003-4945-5375; Dutt, Amit/0000-0002-1119-4774; Thavamani, Abhishek/0000-0001-7187-9188; Chandrani, Pratik/0000-0003-2572-0189	Wellcome Trust/DBT India Alliance [IA/I/11/2500278]; DBT [BT/PR2372/AGR/36/696/2011];  [Seed-In-Air 2897];  [2712];  [IRB 92]	Wellcome Trust/DBT India Alliance(Wellcome Trust); DBT(Department of Biotechnology (DBT) India); ; ; 	A.D. is supported by an Intermediate Fellowship from the Wellcome Trust/DBT India Alliance (IA/I/11/2500278), by a grant from DBT (BT/PR2372/AGR/36/696/2011), and intramural grants (Seed-In-Air 2897, TMH Plan Project 2712 and IRB 92). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes-Funes H, 2005, ANN ONCOL, V16, P1081, DOI 10.1093/annonc/mdi221; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Ferlay J, 2010, IARC CANCERBASE; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Kim HJ, 2013, ONCOL LETT, V5, P271, DOI 10.3892/ol.2012.950; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lee JW, 2005, CLIN CANCER RES, V11, P2879, DOI 10.1158/1078-0432.CCR-04-2029; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Lindeman NI, 2013, J MOL DIAGN; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Noronha V, 2012, INDIAN J CANCER, V49, P74, DOI 10.4103/0019-509X.98925; Noronha V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061561; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan-Chyr Yang YS, 2012, J CLIN ONCOL, V30; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sahoo R, 2011, LUNG CANCER, V73, P316, DOI 10.1016/j.lungcan.2011.01.004; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; ShyamAggarwal S, 2012, J CLIN ONCOL S, V30, P2012; Suda K, 2009, J THORAC ONCOL, V4, P1, DOI 10.1097/JTO.0b013e3181913c9f; Sun Meng-hong, 2011, Chinese Journal of Pathology, V40, P655, DOI 10.3760/cma.j.issn.0529-5807.2011.10.003; Sun YH, 2010, ACTA PHARMACOL SIN, V31, P647, DOI 10.1038/aps.2010.43; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Tomizawa Y, 2005, CLIN CANCER RES, V11, P6816, DOI 10.1158/1078-0432.CCR-05-0441; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	37	64	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76164	10.1371/journal.pone.0076164	http://dx.doi.org/10.1371/journal.pone.0076164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124538	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100095
J	Pavlidou, K; Savvas, I; Moens, YPS; Vasilakos, D; Raptopoulos, D				Pavlidou, Kiriaki; Savvas, Ioannis; Moens, Yves P. S.; Vasilakos, Dimitrios; Raptopoulos, Dimitrios			The Effect of Four Anaesthetic Protocols for Maintenance of Anaesthesia on Trans-Diaphragmatic Pressure in Dogs	PLOS ONE			English	Article							TRANSDIAPHRAGMATIC PRESSURE; INTRAABDOMINAL PRESSURE; RESPIRATORY MUSCLE; BLOOD-FLOW; PROPOFOL; KETAMINE; HALOTHANE; INFUSION; SEVOFLURANE; FENTANYL	The diaphragm is the main inspiratory muscle and the main indicator of diaphragmatic contractility is the transdiaphragmatic pressure (P-di). The aim of this clinical study was to determine the effect of four different anaesthetic protocols on P-di in anaesthetized healthy dogs. Eighty client-owned dogs were recruited in this clinical study. All the animals received dexmedetomidine and morphine as premedication and propofol for induction. Anaesthesia was maintained with one of four protocols: isoflurane (I), isoflurane with CRI of propofol (IP), isoflurane with CRI of fentanyl (IF), and isoflurane with CRI of ketamine (IK). When the surgical plane of anaesthesia was achieved, two balloon catheters were inserted, one into the stomach and one into the mid-third of the oesophagus for P-di measurement. P-di value was the highest in groups I (14.9 +/- 4.7 mmHg) and IK (15.2 +/- 3.5 mmHg) and the lowest in groups IP (12.2 +/- 3.2 mmHg) and IF (12.0 +/- 5.9 mmHg). There was a statistically significant difference (p = 0.029) between groups IK and IF. PE'CO2 was statistically significantly higher (p<0.0005) in group IF (7.7 +/- 0.8 kPa) than in group IK (6.5 +/- 0.7 kPa). Isoflurane alone or isoflurane with ketamine for the maintenance of anaesthesia seem to better preserve the respiratory function and the diaphragmatic contractility than isoflurane with either propofol or fentanyl in dogs. Therefore, the use of isoflurane or isoflurane with ketamine may be of benefit when animals with respiratory problems have to be anaesthetized.	[Pavlidou, Kiriaki; Savvas, Ioannis; Raptopoulos, Dimitrios] Aristotle Univ Thessaloniki, Fac Vet Med, Compan Anim Clin, Anaesthesiol & Intens Care Unit, GR-54006 Thessaloniki, Greece; [Moens, Yves P. S.] Vet Univ Vienna, A-1030 Vienna, Austria; [Vasilakos, Dimitrios] AHEPA Univ Hosp, Anaesthesiol & ICU Dept, Thessaloniki, Greece	Aristotle University of Thessaloniki; University of Veterinary Medicine Vienna; Aristotle University of Thessaloniki; Ahepa University Hospital	Savvas, I (corresponding author), Aristotle Univ Thessaloniki, Fac Vet Med, Compan Anim Clin, Anaesthesiol & Intens Care Unit, GR-54006 Thessaloniki, Greece.	isavas@vet.auth.gr	Savvas, Ioannis/H-9622-2019	Savvas, Ioannis/0000-0001-5575-7244; Pavlidou, Kiriaki/0000-0002-1771-3811	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1988, J APPL PHYSIOL, V64, P2279, DOI 10.1152/jappl.1988.64.6.2279; ANDREWS CJH, 1983, BRIT J ANAESTH, V55, pS211; AUBIER M, 1981, NEW ENGL J MED, V305, P249, DOI 10.1056/NEJM198107303050503; Benditt Joshua O, 2005, Respir Care, V50, P68; Boriek AM, 2006, J APPL PHYSIOL, V101, P794, DOI 10.1152/japplphysiol.00865.2004; Bufalari A, 2012, SCHWEIZ ARCH TIERH, V154, P105, DOI 10.1024/0036-7281/a000308; CLERGUE F, 1986, ANESTHESIOLOGY, V64, P181, DOI 10.1097/00000542-198602000-00009; De Keulenaer BL, 2009, INTENS CARE MED, V35, P969, DOI 10.1007/s00134-009-1445-0; Dorfelt R, 2012, VET ANAESTH ANALG, V39, P390, DOI 10.1111/j.1467-2995.2012.00710.x; Drummond GB, 1996, BRIT J ANAESTH, V76, P663, DOI 10.1093/bja/76.5.663; Drummond GB, 2002, BRIT J ANAESTH, V88, P384, DOI 10.1093/bja/88.3.384; FARKAS G, 1990, CHEST, V97, pS39; GILBERT R, 1979, J APPL PHYSIOL, V47, P628, DOI 10.1152/jappl.1979.47.3.628; HASKINS SC, 1985, AM J VET RES, V46, P1855; HIGGS BD, 1983, ANESTHESIOLOGY, V59, P340, DOI 10.1097/00000542-198310000-00012; HILLMAN DR, 1990, J APPL PHYSIOL, V68, P2296, DOI 10.1152/jappl.1990.68.6.2296; HUBMAYR RD, 1990, J APPL PHYSIOL, V69, P2050, DOI 10.1152/jappl.1990.69.6.2050; HUSSAIN SNA, 1988, J APPL PHYSIOL, V64, P329, DOI 10.1152/jappl.1988.64.1.329; IDE T, 1992, ANESTH ANALG, V74, P739; IDE T, 1991, CAN J ANAESTH, V38, P116, DOI 10.1007/BF03009174; IDE T, 1993, ACTA ANAESTH SCAND, V37, P253, DOI 10.1111/j.1399-6576.1993.tb03710.x; Kagawa T, 1998, ANESTH ANALG, V86, P392, DOI 10.1097/00000539-199802000-00033; KOCHI T, 1990, ANESTH ANALG, V70, P362; KOCHI T, 1992, BRIT J ANAESTH, V68, P562, DOI 10.1093/bja/68.6.562; Kuusela E, 2003, J VET PHARMACOL THER, V26, P199, DOI 10.1046/j.1365-2885.2003.00465.x; Lambert DM, 2005, OBES SURG, V15, P1225, DOI 10.1381/096089205774512546; Lamont LA, 2007, LUMB JONES VET ANEST, P241; LAPORTA D, 1985, J APPL PHYSIOL, V58, P1469, DOI 10.1152/jappl.1985.58.5.1469; Laredo FG, 2004, VET REC, V155, P667, DOI 10.1136/vr.155.21.667; Lumb A.B., 2010, NUNNS APPL RESP PHYS, P327; MAGDER S, 1985, J APPL PHYSIOL, V58, P1148, DOI 10.1152/jappl.1985.58.4.1148; MANKIKIAN B, 1986, ANESTHESIOLOGY, V65, P492, DOI 10.1097/00000542-198611000-00007; Mannarino R, 2012, VET ANAESTH ANALG, V39, P160, DOI 10.1111/j.1467-2995.2011.00679.x; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McDonell W.N., 2007, LUMB JONES VET ANEST, P117; Moore RL, 1927, J EXP MED, V45, P1065, DOI 10.1084/jem.45.6.1065; Nishina K, 2003, ANESTH ANALG, V96, P1674, DOI 10.1213/01.ANE.0000060455.94684.69; Ora J, 2011, J APPL PHYSIOL, V111, P10, DOI 10.1152/japplphysiol.01131.2010; Pavlidou K, 2014, VET ANAESTH ANALG, V41, P278, DOI 10.1111/vaa.12073; POLKEY MI, 1995, THORAX, V50, P1131, DOI 10.1136/thx.50.11.1131; Sano T, 2006, VET ANAESTH ANALG, V33, P266, DOI 10.1111/j.1467-2995.2005.00266.x; SANTIAGO TV, 1979, J APPL PHYSIOL, V47, P112, DOI 10.1152/jappl.1979.47.1.112; SANTIAGO TV, 1985, J APPL PHYSIOL, V59, P1675, DOI 10.1152/jappl.1985.59.6.1675; Seliskar A, 2007, VET REC, V160, P85, DOI 10.1136/vr.160.3.85; SPRUNG J, 1990, J APPL PHYSIOL, V69, P2296, DOI 10.1152/jappl.1990.69.6.2296; Udeshi A, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.12.014; ULKER S, 1991, INT J EXP PATHOL, V72, P527; WANKE T, 1993, CLIN PHYSIOL, V13, P349, DOI 10.1111/j.1475-097X.1993.tb00335.x; WATERMAN AE, 1991, VET REC, V129, P261, DOI 10.1136/vr.129.12.261; Zakynthinos S., 2005, PHYSL BASIS RESP DIS, P289; Zhang XJ, 2009, BRIT J ANAESTH, V102, P61, DOI 10.1093/bja/aen327; Zin W. A., 2005, PHYSL BASIS RESP DIS, P639	52	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75341	10.1371/journal.pone.0075341	http://dx.doi.org/10.1371/journal.pone.0075341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124482	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100039
J	York, PH; Gruber, RK; Hill, R; Ralph, PJ; Booth, DJ; Macreadie, PI				York, Paul H.; Gruber, Renee K.; Hill, Ross; Ralph, Peter J.; Booth, David J.; Macreadie, Peter I.			Physiological and Morphological Responses of the Temperate Seagrass Zostera muelleri to Multiple Stressors: Investigating the Interactive Effects of Light and Temperature	PLOS ONE			English	Article							GREAT-BARRIER-REEF; XANTHOPHYLL-CYCLE; PHOTOSYSTEM-II; HETEROZOSTERA-TASMANICA; FLUORESCENCE TRANSIENT; THALASSIA-TESTUDINUM; POPULATION-DYNAMICS; POSIDONIA-OCEANICA; HALOPHILA-OVALIS; CLIMATE-CHANGE	Understanding how multiple environmental stressors interact to affect seagrass health (measured as morphological and physiological responses) is important for responding to global declines in seagrass populations. We investigated the interactive effects of temperature stress (24, 27, 30 and 32 degrees C) and shading stress (75, 50, 25 and 0% shade treatments) on the seagrass Zostera muelleri over a 3-month period in laboratory mesocosms. Z. muelleri is widely distributed throughout the temperate and tropical waters of south and east coasts of Australia, and is regarded as a regionally significant species. Optimal growth was observed at 27 degrees C, whereas rapid loss of living shoots and leaf mass occurred at 32 degrees C. We found no difference in the concentration of photosynthetic pigments among temperature treatments by the end of the experiment; however, up-regulation of photoprotective pigments was observed at 30 degrees C. Greater levels of shade resulting in high photochemical efficiencies, while elevated irradiance suppressed effective quantum yield (Delta F/F-M'). Chlorophyll fluorescence fast induction curves (FIC) revealed that the J step amplitude was significantly higher in the 0% shade treatment after 8 weeks, indicating a closure of PSII reaction centres, which likely contributed to the decline in Delta F/F-M' and photoinhibition under higher irradiance. Effective quantum yield of PSII (Delta F/F-M') declined steadily in 32 degrees C treatments, indicating thermal damage. Higher temperatures (30 degrees C) resulted in reduced above-ground biomass ratio and smaller leaves, while reduced light led to a reduction in leaf and shoot density, above-ground biomass ratio, shoot biomass and an increase in leaf senescence. Surprisingly, light and temperature had few interactive effects on seagrass health, even though these two stressors had strong effects on seagrass health when tested in isolation. In summary, these results demonstrate that populations of Z. muelleri in southeastern Australia are sensitive to small chronic temperature increases and light decreases that are predicted under future climate change scenarios.	[York, Paul H.; Ralph, Peter J.; Booth, David J.; Macreadie, Peter I.] Univ Technol, Sch Environm, Broadway, NSW, Australia; [York, Paul H.] James Cook Univ, Ctr Trop Water, Cairns, Qld, Australia; [York, Paul H.] James Cook Univ, Environm Res Ctr, Cairns, Qld, Australia; [Gruber, Renee K.] Off Environm & Heritage, Sydney, NSW, Australia; [Gruber, Renee K.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Hill, Ross; Ralph, Peter J.; Macreadie, Peter I.] Univ Technol, Plant Funct Biol & Climate Change Cluster, Broadway, NSW, Australia; [Hill, Ross] Univ New S Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Hill, Ross] Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia	University of Technology Sydney; James Cook University; James Cook University; Office of Environment & Heritage - New South Wales; University of Western Australia; University of Technology Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of New South Wales Sydney	York, PH (corresponding author), Univ Technol, Sch Environm, Broadway, NSW, Australia.	Paul.York@jcu.edu.au	Hill, Ross/E-6075-2013; Ralph, Peter/L-1527-2019; York, Paul H./C-4120-2009; Ralph, Peter J/C-5029-2009	Hill, Ross/0000-0002-4623-1563; Ralph, Peter/0000-0002-3103-7346; York, Paul H./0000-0003-3530-4146; Ralph, Peter J/0000-0002-3103-7346; Gruber, Renee/0000-0002-8788-6910; Booth, David/0000-0002-8256-1412	ARC DECRA Fellowship [DE130101084]; University of Technology, Sydney; NSW Office of Environment and the Heritage; NSW Department of Primary Industries; Hornsby Shire Council; Gosford City Council	ARC DECRA Fellowship(Australian Research Council); University of Technology, Sydney; NSW Office of Environment and the Heritage; NSW Department of Primary Industries; Hornsby Shire Council; Gosford City Council	This work was funded by an ARC DECRA Fellowship (DE130101084, to PM) and a partnership Grant involving the University of Technology, Sydney (http://www.uts.edu.au/), NSW Office of Environment and the Heritage (http://www.environment.nsw.gov.au/), NSW Department of Primary Industries (http://www.dpi.nsw.gov.au/fisheries), Hornsby Shire Council (http://www.hornsby.nsw.gov.au/), and Gosford City Council (http://www.gosford.nsw.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAL EG, 1994, J EXP MAR BIOL ECOL, V178, P113, DOI 10.1016/0022-0981(94)90228-3; Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Brouwer B, 2012, PLANT CELL ENVIRON, V35, P1084, DOI 10.1111/j.1365-3040.2011.02474.x; BULTHUIS DA, 1987, AQUAT BOT, V27, P27, DOI 10.1016/0304-3770(87)90084-2; BULTHUIS DA, 1983, AQUAT BOT, V16, P111, DOI 10.1016/0304-3770(83)90088-8; BULTHUIS DA, 1983, MAR BIOL LETT, V4, P47; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Carr JA, 2012, MAR ECOL PROG SER, V448, P289, DOI 10.3354/meps09556; Collier CJ, 2011, LIMNOL OCEANOGR, V56, P2200, DOI 10.4319/lo.2011.56.6.2200; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; CSIRO & BoM, 2007, CLIM CHANG AUSTR TEC; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Fonseca MS, 2007, J EXP MAR BIOL ECOL, V340, P227, DOI 10.1016/j.jembe.2006.09.015; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Fourqurean JW, 2003, LIMNOL OCEANOGR, V48, P2070; GORDON DM, 1994, AQUAT BOT, V47, P265, DOI 10.1016/0304-3770(94)90057-4; Gordon JDM, 2002, J MAR BIOL ASSOC UK, V82, P339, DOI 10.1017/S0025315402005532; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Green E.P., 2003, WORLD ATLAS SEAGRASS; Haldimann P, 1999, PHOTOSYNTH RES, V62, P67, DOI 10.1023/A:1006321126009; Havaux M, 1996, PLANTA, V198, P324, DOI 10.1007/BF00620047; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hill R, 2004, PHOTOSYNTH RES, V82, P59, DOI 10.1023/B:PRES.0000040444.41179.09; Hoffle H, 2011, ESTUAR COAST SHELF S, V92, P35, DOI 10.1016/j.ecss.2010.12.017; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Ingleton T, 2012, ESTUAR COAST SHELF S, V99, P132, DOI 10.1016/j.ecss.2011.12.024; IPCC, 2000, SPECIAL REPORT EMISS; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; KERR EA, 1985, AQUAT BOT, V23, P177, DOI 10.1016/0304-3770(85)90063-4; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; Lavorel J, 1977, PRIMARY PROCESSES PH, P203; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Lee KS, 1997, J EXP MAR BIOL ECOL, V210, P53, DOI 10.1016/S0022-0981(96)02720-7; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Longstaff BJ, 1999, AQUAT BOT, V65, P105, DOI 10.1016/S0304-3770(99)00035-2; MARSH JA, 1986, J EXP MAR BIOL ECOL, V101, P257, DOI 10.1016/0022-0981(86)90267-4; Moore KA, 2008, J COASTAL RES, P135, DOI 10.2112/SI55-014; Nellemann C., 2009, BLUE CARBON RAPID RE; Olesen B, 2002, MAR ECOL PROG SER, V236, P89, DOI 10.3354/meps236089; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Ralph PJ, 2005, AQUAT BOT, V81, P69, DOI 10.1016/j.aquabot.2004.11.003; Ralph PJ, 2002, J EXP MAR BIOL ECOL, V271, P189, DOI 10.1016/S0022-0981(02)00047-3; Ralph PJ, 1999, AQUAT BOT, V65, P83, DOI 10.1016/S0304-3770(99)00033-9; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Robinson KIM, 1987, WETLANDS, V7, P1, DOI 10.1007/BF03160798.; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; THAYER SS, 1990, PHOTOSYNTH RES, V23, P331, DOI 10.1007/BF00034864; Ulstrup KE, 2005, MAR ECOL PROG SER, V286, P125, DOI 10.3354/meps286125; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; WALKER DI, 1992, MAR POLLUT BULL, V25, P191, DOI 10.1016/0025-326X(92)90224-T; Waycott M, 2005, MAR POLLUT BULL, V51, P343, DOI 10.1016/j.marpolbul.2005.01.017; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zann LP, 2000, MAR POLLUT BULL, V41, P188, DOI 10.1016/S0025-326X(00)00110-7; Zimmerman RC, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P303	68	76	77	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76377	10.1371/journal.pone.0076377	http://dx.doi.org/10.1371/journal.pone.0076377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124551	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000325489100108
J	Xia, J; Luo, M; Ni, N; Chen, JZ; Hu, YM; Deng, Y; Ji, J; Zhou, JB; Fan, XQ; Gu, P				Xia, Jing; Luo, Min; Ni, Ni; Chen, Junzhao; Hu, Yamin; Deng, Yuan; Ji, Jing; Zhou, Jibo; Fan, Xianqun; Gu, Ping			Bone Marrow Mesenchymal Stem Cells Stimulate Proliferation and Neuronal Differentiation of Retinal Progenitor Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSPLANTATION; MULTIPOTENTIALITY; NEUROGENESIS; EXPRESSION; NICHE; ACID; FATE	During retina development, retinal progenitor cell (RPC) proliferation and differentiation are regulated by complex inter-and intracellular interactions. Bone marrow mesenchymal stem cells (BMSCs) are reported to express a variety of cytokines and neurotrophic factors, which have powerful trophic and protective functions for neural tissue-derived cells. Here, we show that the expanded RPC cultures treated with BMSC-derived conditioned medium (CM) which was substantially enriched for bFGF and CNTF, expressed clearly increased levels of nuclear receptor TLX, an essential regulator of neural stem cell (NSC) self-renewal, as well as betacellulin (BTC), an EGF-like protein described as supporting NSC expansion. The BMSC CM- or bFGF-treated RPCs also displayed an obviously enhanced proliferation capability, while BMSC CM-derived bFGF knocked down by anti-bFGF, the effect of BMSC CM on enhancing RPC proliferation was partly reversed. Under differentiation conditions, treatment with BMSC CM or CNTF markedly favoured RPC differentiation towards retinal neurons, including Brn3a-positive retinal ganglion cells (RGCs) and rhodopsin-positive photoreceptors, and clearly diminished retinal glial cell differentiation. These findings demonstrate that BMSCs supported RPC proliferation and neuronal differentiation which may be partly mediated by BMSC CM-derived bFGF and CNTF, reveal potential limitations of RPC culture systems, and suggest a means for optimizing RPC cell fate determination in vitro.	[Xia, Jing; Luo, Min; Ni, Ni; Chen, Junzhao; Hu, Yamin; Deng, Yuan; Ji, Jing; Zhou, Jibo; Fan, Xianqun; Gu, Ping] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Fan, XQ (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	fanxq@sh163.net; guping2009@hotmail.com			National Natural Science Foundations of China [81070737]; Education Commission of Shanghai [11YZ47]; Scientific Research Foundation for the Returned Overseas Chinese Scholars [[2011]1568]; Shanghai Public Health Bureau [2011Y081]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Education Commission of Shanghai; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Shanghai Public Health Bureau	This research was supported by the National Natural Science Foundations of China (81070737), the Education Commission of Shanghai (11YZ47), the Scientific Research Foundation for the Returned Overseas Chinese Scholars ([2011]1568), and the Shanghai Public Health Bureau (2011Y081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gamm DM, 2008, STEM CELLS, V26, P3182, DOI 10.1634/stemcells.2008-0300; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Gu P, 2007, MOL VIS, V13, P1045; Gu P, 2009, MOL VIS, V15, P2111; Hu YM, 2013, NEUROSCI LETT, V534, P90, DOI 10.1016/j.neulet.2012.11.006; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Li QM, 2009, BIOCHEM BIOPH RES CO, V384, P372, DOI 10.1016/j.bbrc.2009.04.147; Liu XY, 2010, BIOMATERIALS, V31, P3063, DOI 10.1016/j.biomaterials.2009.12.054; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Nakanishi C, 2008, BIOCHEM BIOPH RES CO, V374, P11, DOI 10.1016/j.bbrc.2008.06.074; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Sadan O, 2012, EXP NEUROL, V234, P417, DOI 10.1016/j.expneurol.2011.12.045; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59; Wang JM, 2010, MOL VIS, V16, P2850; Xia J, 2012, BRAIN RES, V1433, P38, DOI 10.1016/j.brainres.2011.11.054; Yang J, 2006, STEM CELLS, V24, P2766, DOI 10.1634/stemcells.2006-0103; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314; Zhou HF, 2011, INVEST OPHTH VIS SCI, V52, P1735, DOI 10.1167/iovs.10-5988	28	25	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76157	10.1371/journal.pone.0076157	http://dx.doi.org/10.1371/journal.pone.0076157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098776	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500146
J	Leyton, PA; Beppu, H; Pappas, A; Martyn, TM; Derwall, M; Baron, DM; Galdos, R; Bloch, DB; Bloch, KD				Leyton, Patricio A.; Beppu, Hideyuki; Pappas, Alexandra; Martyn, Trejeeve M.; Derwall, Matthias; Baron, David M.; Galdos, Rita; Bloch, Donald B.; Bloch, Kenneth D.			Deletion of the Sequence Encoding the Tail Domain of the Bone Morphogenetic Protein type 2 Receptor Reveals a Bone Morphogenetic Protein 7-Specific Gain of Function	PLOS ONE			English	Article							PRIMARY PULMONARY-HYPERTENSION; II RECEPTOR; ARTERIAL-HYPERTENSION; INCREASED SUSCEPTIBILITY; SIGNAL-TRANSDUCTION; MICE; BMPR2; MUTATIONS; GENERATION; CLONING	The bone morphogenetic protein (BMP) type II receptor (BMPR2) has a long cytoplasmic tail domain whose function is incompletely elucidated. Mutations in the tail domain of BMPR2 are found in familial cases of pulmonary arterial hypertension. To investigate the role of the tail domain of BMPR2 in BMP signaling, we generated a mouse carrying a Bmpr2 allele encoding a non-sense mediated decay-resistant mutant receptor lacking the tail domain of Bmpr2. We found that homozygous mutant mice died during gastrulation, whereas heterozygous mice grew normally without developing pulmonary arterial hypertension. Using pulmonary artery smooth muscle cells (PaSMC) from heterozygous mice, we determined that the mutant receptor was expressed and retained its ability to transduce BMP signaling. Heterozygous PaSMCs exhibited a BMP7-specific gain of function, which was transduced via the mutant receptor. Using siRNA knockdown and cells from conditional knockout mice to selectively deplete BMP receptors, we observed that the tail domain of Bmpr2 inhibits Alk2-mediated BMP7 signaling. These findings suggest that the tail domain of Bmpr2 is essential for normal embryogenesis and inhibits Alk2-mediated BMP7 signaling in PaSMCs.	[Leyton, Patricio A.; Beppu, Hideyuki; Pappas, Alexandra; Martyn, Trejeeve M.; Derwall, Matthias; Baron, David M.; Bloch, Donald B.; Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA; [Leyton, Patricio A.; Beppu, Hideyuki; Pappas, Alexandra; Martyn, Trejeeve M.; Derwall, Matthias; Baron, David M.; Galdos, Rita; Bloch, Donald B.; Bloch, Kenneth D.] Harvard Univ, Sch Med, Boston, MA USA; [Beppu, Hideyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Clin Lab & Mol Pathol, Toyama 930, Japan; [Derwall, Matthias] Rhein Westfal TH Aachen, Uniklin Aachen, Dept Anesthesiol, Aachen, North Rhine Wes, Germany; [Baron, David M.] Med Univ Vienna, Dept Anesthesia Gen Intens Care & Pain Management, Vienna, Austria; [Galdos, Rita; Bloch, Donald B.] Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toyama; RWTH Aachen University; RWTH Aachen University Hospital; Medical University of Vienna; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Leyton, PA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA.	pleyton@partners.org	Leyton, Patricio/GSM-6747-2022	Bloch, Donald/0000-0002-6828-4754	National Institutes of Health Heart, Lung and Blood Institute [HL074352]; Deutsche Forschungsgemeinschaft [DE-1685-1/1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074352] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from National Institutes of Health Heart, Lung and Blood Institute HL074352, http://www.nhlbi.nih.gov, DE-1685-1/1, Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decisio to publish, or preparation of the manuscript.	Aoki H, 2001, J CELL SCI, V114, P1483; Aramaki T, 2010, DEV CELL, V19, P547, DOI 10.1016/j.devcel.2010.09.001; Austin ED, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-87; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Fessel Joshua P, 2011, Pulm Circ, V1, P305, DOI 10.4103/2045-8932.87293; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Hamid R, 2010, CLIN GENET, V77, P280, DOI 10.1111/j.1399-0004.2009.01311.x; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Nasim MT, 2012, HUM MOL GENET, V21, P2548, DOI 10.1093/hmg/dds073; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76947	10.1371/journal.pone.0076947	http://dx.doi.org/10.1371/journal.pone.0076947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116187	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200087
J	Trefz, P; Koehler, H; Klepik, K; Moebius, P; Reinhold, P; Schubert, JK; Miekisch, W				Trefz, Phillip; Koehler, Heike; Klepik, Klaus; Moebius, Petra; Reinhold, Petra; Schubert, Jochen K.; Miekisch, Wolfram			Volatile Emissions from Mycobacterium avium subsp paratuberculosis Mirror Bacterial Growth and Enable Distinction of Different Strains	PLOS ONE			English	Article							RESTRICTION ENDONUCLEASE ANALYSIS; SHORT-SEQUENCE-REPEAT; IN-VITRO; MYCOLIC ACIDS; MOBILITY SPECTROMETRY; ASPERGILLUS-FUMIGATUS; RADIOMETRIC CULTURE; CYTOKINE RESPONSES; DNA HYBRIDIZATION; ORGANIC-COMPOUNDS	Control of paratuberculosis in livestock is hampered by the low sensitivity of established direct and indirect diagnostic methods. Like other bacteria, Mycobacterium avium subsp. paratuberculosis (MAP) emits volatile organic compounds (VOCs). Differences of VOC patterns in breath and feces of infected and not infected animals were described in first pilot experiments but detailed information on potential marker substances is missing. This study was intended to look for characteristic volatile substances in the headspace of cultures of different MAP strains and to find out how the emission of VOCs was affected by density of bacterial growth. One laboratory adapted and four field strains, three of MAP C-type and one MAP S-type were cultivated on Herrold's egg yolk medium in dilutions of 10(-0), 10(-2), 10(-4) and 10(-6). Volatile substances were pre-concentrated from the headspace over the MAP cultures by means of Solid Phase Micro Extraction (SPME), thermally desorbed from the SPME fibers and separated and identified by means of GC-MS. Out of the large number of compounds found in the headspace over MAP cultures, 34 volatile marker substances could be identified as potential biomarkers for growth and metabolic activity. All five MAP strains could clearly be distinguished from blank culture media by means of emission patterns based on these 34 substances. In addition, patterns of volatiles emitted by the reference strain were significantly different from the field strains. Headspace concentrations of 2-ethylfuran, 2-methylfuran, 3-methylfuran, 2-pentylfuran, ethyl acetate, 1-methyl-1-H-pyrrole and dimethyldisulfide varied with density of bacterial growth. Analysis of VOCs emitted from mycobacterial cultures can be used to identify bacterial growth and, in addition, to differentiate between different bacterial strains. VOC emission patterns may be used to approximate bacterial growth density. In a perspective volatile marker substances could be used to diagnose MAP infections in animals and to identify different bacterial strains and origins.	[Trefz, Phillip; Klepik, Klaus; Schubert, Jochen K.; Miekisch, Wolfram] Univ Rostock, Dept Anaesthesia & Intens Care, D-18055 Rostock, Germany; [Koehler, Heike; Moebius, Petra; Reinhold, Petra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Jena, Germany	University of Rostock; Friedrich Loeffler Institute	Miekisch, W (corresponding author), Univ Rostock, Dept Anaesthesia & Intens Care, D-18055 Rostock, Germany.	wolfram.miekisch@uni-rostock.de	Miekisch, Wolfram/I-1300-2019; Schubert, Jochen/F-4788-2016	Schubert, Jochen/0000-0002-0956-9506; Trefz, Phillip/0000-0001-6138-6515; Mobius, Petra/0000-0002-5574-2998; Miekisch, Wolfram/0000-0003-1619-0315	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [SCHU 1960/4-1, RE 1098/4-1]	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by German Research Foundation (DFG, Deutsche Forschungsgemeinschaft, SCHU 1960/4-1, RE 1098/4-1) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonsin A, 2004, J CLIN MICROBIOL, V42, P1694, DOI 10.1128/JCM.42.4.1694-1702.2004; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Biet F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-264; BORJESSON T, 1992, APPL ENVIRON MICROB, V58, P2599; Borrmann E, 2011, VET MICROBIOL, V152, P101, DOI 10.1016/j.vetmic.2011.04.002; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Bull TJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-11; Chambers ST, 2009, MED MYCOL, V47, P468, DOI 10.1080/13693780802475212; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chiodini RJ, 2012, CRIT REV MICROBIOL, V38, P52, DOI 10.3109/1040841X.2011.638273; COLLINS DM, 1990, J CLIN MICROBIOL, V28, P1591, DOI 10.1128/JCM.28.7.1591-1596.1990; Collins MT, 2005, CLIN DIAGN LAB IMMUN, V12, P685, DOI 10.1128/CDLI.12.6.685-692.2005; Collins MT, 1996, VET CLIN N AM-FOOD A, V12, P357, DOI 10.1016/S0749-0720(15)30411-4; de Juan L, 2006, VET MICROBIOL, V115, P102, DOI 10.1016/j.vetmic.2006.01.008; de Juan L, 2006, APPL ENVIRON MICROB, V72, P5927, DOI 10.1128/AEM.00451-06; DELISLE GW, 1992, ONDERSTEPOORT J VET, V59, P163; Dhiman RK, 2011, J BACTERIOL, V193, P5802, DOI 10.1128/JB.05299-11; Dickschat JS, 2004, CHEMBIOCHEM, V5, P778, DOI 10.1002/cbic.200300813; Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021; Farhana A, 2012, ANTIOXID REDOX SIGN, V17, P1232, DOI 10.1089/ars.2012.4613; Fend R, 2006, J CLIN MICROBIOL, V44, P2039, DOI 10.1128/JCM.01591-05; Gumber S, 2007, VET MICROBIOL, V119, P42, DOI 10.1016/j.vetmic.2006.08.009; Harris NB, 2005, J VET DIAGN INVEST, V17, P554, DOI 10.1177/104063870501700605; Janagama HK, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-268; Janagama HK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-10; Junger M, 2012, APPL MICROBIOL BIOT, V93, P2603, DOI 10.1007/s00253-012-3924-4; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Koehler H, 2008, MAGYAR ALLATORVOSOK, V130, P67; Mobius P, 2008, VET MICROBIOL, V126, P324, DOI 10.1016/j.vetmic.2007.07.016; Pavlou AK, 2004, BIOSENS BIOELECTRON, V20, P538, DOI 10.1016/j.bios.2004.03.002; Peled N, 2012, SENSOR ACTUAT B-CHEM, V171, P588, DOI 10.1016/j.snb.2012.05.038; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Pollak FC, 1996, APPL ENVIRON MICROB, V62, P1295, DOI 10.1128/AEM.62.4.1295-1299.1996; Purkhart R, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027103; Rafidinarivo E, 2009, J LIPID RES, V50, P477, DOI 10.1194/jlr.M800384-JLR200; Reddacliff LA, 2003, APPL ENVIRON MICROB, V69, P3510, DOI 10.1128/AEM.69.6.3510-3516.2003; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Scholler CEG, 2002, J AGR FOOD CHEM, V50, P2615, DOI 10.1021/jf0116754; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Shnayderman M, 2005, ANAL CHEM, V77, P5930, DOI 10.1021/ac050348i; Stich RW, 2004, J MICROBIOL METH, V56, P267, DOI 10.1016/j.mimet.2003.10.013; Svistunenko DA, 2012, BIOCHIMIE, V94, P1274, DOI 10.1016/j.biochi.2012.02.021; Syhre M, 2008, MED MYCOL, V46, P209, DOI 10.1080/13693780701753800; Syhre M, 2008, TUBERCULOSIS, V88, P317, DOI 10.1016/j.tube.2008.01.002; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Thibault VC, 2008, J CLIN MICROBIOL, V46, P4091, DOI 10.1128/JCM.01349-08; Whittington RJ, 1999, J CLIN MICROBIOL, V37, P1077, DOI 10.1128/JCM.37.4.1077-1083.1999; Whittington RJ, 1998, J CLIN MICROBIOL, V36, P701, DOI 10.1128/JCM.36.3.701-707.1998; Yuan Y, 1998, J BIOL CHEM, V273, P21282, DOI 10.1074/jbc.273.33.21282; Zhou LX, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/193963	53	40	41	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76868	10.1371/journal.pone.0076868	http://dx.doi.org/10.1371/journal.pone.0076868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116177	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200081
J	Chen, CR; Yang, SR; Liu, YY; Qu, WM; Urade, Y; Huang, ZL				Chen, Chang-Rui; Yang, Su-Rong; Liu, Yuan-Yuan; Qu, Wei-Min; Urade, Yoshihiro; Huang, Zhi-Li			Roles of Adrenergic alpha(1) and Dopamine D-1 and D-2 Receptors in the Mediation of the Desynchronization Effects of Modafinil in a Mouse EEG Synchronization Model	PLOS ONE			English	Article							MAJOR BIOACTIVE CONSTITUENT; DEEP BRAIN-STIMULATION; EYE-MOVEMENT SLEEP; HISTAMINERGIC SYSTEM; MAGNOLIA-OFFICINALIS; PREFRONTAL CORTEX; IN-VITRO; MICE; RAT; ACTIVATION	Background: Synchronized electroencephalogram (EEG) activity is observed in pathological stages of cognitive impairment and epilepsy. Modafinil, known to increase the release of catecholamines, is a potent wake-promoting agent, and has shown some abilities to desynchronize EEG, but its receptor mechanisms by which modafinil induces desynchoronization remain to be elucidated. Here we used a pharmacological EEG synchronization model to investigate the involvement of adrenergic alpha(1) receptors (R, alpha R-1) and dopamine (DA) D-1 and D-2 receptors (D(1)Rs and D(2)Rs) on modafinil-induced desynchronization in mice. Methodology/Principal Findings: Mice were treated with cholinergic receptor antagonist scopolamine and monoamine depletor reserpine to produce experimental EEG synchronization characterized by continuous large-amplitude synchronized activity, with prominent increased delta and decreased theta, alpha, and beta power density. The results showed that modafinil produced an EEG desynchronization in the model. This was characterized by a general decrease in amplitude of all the frequency bands between 0 and 20 Hz, a prominent reduction in delta power density, and an increase in theta power density. Adrenergic alpha R-1 antagonist terazosin (1 mg/kg, i.p.) completely antagonized the EEG desynchronization effects of modafinil at 90 mg/kg. However, DA D1R and D2R blockers partially attenuated the effects of modafinil. The modafinil-induced decrease in the amplitudes of the delta, theta, alpha, and beta waves and in delta power density were completely abolished by pretreatment with a combination of the D1R antagonist SCH 23390 (30 mu g/kg) and the D2R antagonist raclopride (2 mg/kg, i.p.). Conclusions/Significance: These results suggest that modafinil-mediated desynchronization may be attributed to the activation of adrenergic alpha R-1, and dopaminergic D1R and D2R in a model of EEG synchronization.	[Chen, Chang-Rui; Yang, Su-Rong; Liu, Yuan-Yuan; Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Dept Pharmacol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan; [Huang, Zhi-Li] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Huang, ZL (corresponding author), Fudan Univ, Dept Pharmacol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	huangzl@fudan.edu.cn	liu, yuanyuan/GWZ-5838-2022	Huang, Zhi-Li/0000-0001-9359-1150	National Natural Science Foundation of China [30901797, 31171010, 31121061, 31271164]; Shanghai Committee of Science and Technology [10441901600, 11ZR1402000, 13140903100]; National Basic Research Program of China [2009CB5220004, 2011CB711000]; Shanghai Leading Academic Discipline Project [B119]; Ph.D. Programs Foundation of Ministry of Education of China [20110071110033]; China National Science and Technology Major Project for Drug Discovery [2009ZX09303-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China National Science and Technology Major Project for Drug Discovery	This study was supported in part by grants-in-aid for scientific research from National Natural Science Foundation of China (30901797, 31171010, 31121061, 31271164), Shanghai Committee of Science and Technology (10441901600, 11ZR1402000, 13140903100), National Basic Research Program of China (2009CB5220004, 2011CB711000), Shanghai Leading Academic Discipline Project (B119), Ph.D. Programs Foundation of Ministry of Education of China (20110071110033) and China National Science and Technology Major Project for Drug Discovery (2009ZX09303-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banjo OC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014322; Beck C, 1999, CAN J PSYCHIAT, V44, P680, DOI 10.1177/070674379904400705; Chen CR, 2007, NEUROPHARMACOLOGY, V53, P534, DOI 10.1016/j.neuropharm.2007.06.017; Chen CR, 2011, BRIT J PHARMACOL, V164, P1534, DOI 10.1111/j.1476-5381.2011.01456.x; Chen CR, 2012, NEUROPHARMACOLOGY, V63, P1191, DOI 10.1016/j.neuropharm.2012.06.031; Dringenberg HC, 2002, EUR J PHARMACOL, V447, P43, DOI 10.1016/S0014-2999(02)01829-0; Dringenberg HC, 2000, NEUROBIOL AGING, V21, P135, DOI 10.1016/S0197-4580(00)00108-1; DUTEIL J, 1990, EUR J PHARMACOL, V180, P49, DOI 10.1016/0014-2999(90)90591-S; Echeverria V, 2012, CNS NEUROSCI THER, V18, P517, DOI 10.1111/j.1755-5949.2012.00317.x; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gallopin T, 2004, SLEEP, V27, P19; GESSA GL, 1985, EUR J PHARMACOL, V109, P269, DOI 10.1016/0014-2999(85)90429-7; Ghahremani DG, 2011, NEUROPSYCHOPHARMACOL, V36, P950, DOI 10.1038/npp.2010.233; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; Gozzi A, 2012, NEUROPSYCHOPHARMACOL, V37, P822, DOI 10.1038/npp.2011.260; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; Jasinski DR, 2000, CLIN NEUROPHARMACOL, V23, P149, DOI 10.1097/00002826-200005000-00004; Kelley AM, 2012, AVIAT SPACE ENVIR MD, V83, P685, DOI 10.3357/ASEM.3212.2012; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P11465, DOI 10.1073/pnas.0402028101; KROPF W, 1991, NEUROPHARMACOLOGY, V30, P953, DOI 10.1016/0028-3908(91)90108-N; KROPF W, 1993, NEUROPHARMACOLOGY, V32, P493, DOI 10.1016/0028-3908(93)90175-3; Lazarus M., 2013, CURR OPIN NEUROBIOL; Lazarus M, 2012, TRENDS NEUROSCI, V35, P723, DOI 10.1016/j.tins.2012.07.001; Liu Z, 2012, CNS NEUROSCI THER, V18, P623, DOI 10.1111/j.1755-5949.2012.00334.x; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Manni R, 2005, NEUROL SCI, V26, pS181, DOI 10.1007/s10072-005-0484-8; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; MONTI JM, 1988, PSYCHOPHARMACOLOGY, V95, P395; Nishida N, 2007, EXP NEUROL, V205, P132, DOI 10.1016/j.expneurol.2007.01.021; Oishi Y, 2008, P NATL ACAD SCI USA, V105, P19992, DOI 10.1073/pnas.0810926105; ONGINI E, 1993, J PHARMACOL EXP THER, V266, P726; ONGINI E, 1985, LIFE SCI, V37, P2327, DOI 10.1016/0024-3205(85)90025-6; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sebban C, 1999, BRIT J PHARMACOL, V128, P1045, DOI 10.1038/sj.bjp.0702894; Shi LH, 2006, BRAIN RES, V1090, P202, DOI 10.1016/j.brainres.2006.03.050; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; STERIADE M, 1990, J NEUROSCI, V10, P2541; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STEWART DJ, 1984, BRAIN RES, V322, P219, DOI 10.1016/0006-8993(84)90112-4; Stone EA, 2002, SYNAPSE, V46, P269, DOI 10.1002/syn.10127; Tiligada E, 2011, CNS NEUROSCI THER, V17, P620, DOI 10.1111/j.1755-5949.2010.00212.x; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Velasco M, 2000, ARCH MED RES, V31, P304, DOI 10.1016/S0188-4409(00)00085-0; Wisor JP, 2005, NEUROSCIENCE, V132, P1027, DOI 10.1016/j.neuroscience.2005.02.003	50	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76102	10.1371/journal.pone.0076102	http://dx.doi.org/10.1371/journal.pone.0076102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116090	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300047
J	Dhingra, S; Lind, AL; Lin, HC; Tang, Y; Rokas, A; Calvo, AM				Dhingra, Sourabh; Lind, Abigail L.; Lin, Hsiao-Ching; Tang, Yi; Rokas, Antonis; Calvo, Ana M.			The Fumagillin Gene Cluster, an Example of Hundreds of Genes under veA Control in Aspergillus fumigatus	PLOS ONE			English	Article							FUNGAL METABOLITE GLIOTOXIN; CELL TRANSPLANT RECIPIENTS; VELVET-LIKE COMPLEX; SECONDARY METABOLISM; INVASIVE ASPERGILLOSIS; SCLEROTIAL PRODUCTION; IMPORTIN-ALPHA; BIOSYNTHESIS; NIDULANS; REGULATOR	Aspergillus fumigatus is the causative agent of invasive aspergillosis, leading to infection-related mortality in immunocompromised patients. We previously showed that the conserved and unique-to-fungi veA gene affects different cell processes such as morphological development, gliotoxin biosynthesis and protease activity, suggesting a global regulatory effect on the genome of this medically relevant fungus. In this study, RNA sequencing analysis revealed that veA controls the expression of hundreds of genes in A. fumigatus, including those comprising more than a dozen known secondary metabolite gene clusters. Chemical analysis confirmed that veA controls the synthesis of other secondary metabolites in this organism in addition to gliotoxin. Among the secondary metabolite gene clusters regulated by veA is the elusive but recently identified gene cluster responsible for the biosynthesis of fumagillin, a meroterpenoid known for its anti-angiogenic activity by binding to human methionine aminopeptidase 2. The fumagillin gene cluster contains a veA-dependent regulatory gene, fumR (Afu8g00420), encoding a putative C6 type transcription factor. Deletion of fumR results in silencing of the gene cluster and elimination of fumagillin biosynthesis. We found expression of fumR to also be dependent on laeA, a gene encoding another component of the fungal velvet complex. The results in this study argue that veA is a global regulator of secondary metabolism in A. fumigatus, and that veA may be a conduit via which chemical development is coupled to morphological development and other cellular processes.	[Dhingra, Sourabh; Calvo, Ana M.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Lind, Abigail L.; Rokas, Antonis] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Lin, Hsiao-Ching; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Northern Illinois University; Vanderbilt University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vanderbilt University	Calvo, AM (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	amcalvo@niu.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551	National Institutes of Health (NIH) [R03AI079496]; Northern Illinois University; NLM training grant [2T15LM007450]; Vanderbilt Discovery Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI079496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106413] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007450] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northern Illinois University; NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Vanderbilt Discovery Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by National Institutes of Health (NIH) R03AI079496 and Northern Illinois University to AMC, a NLM training grant 2T15LM007450 to ALL, and a Vanderbilt Discovery Grant to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; AMITANI R, 1995, INFECT IMMUN, V63, P3266, DOI 10.1128/IAI.63.9.3266-3271.1995; Araujo-Bazan L, 2009, FUNGAL GENET BIOL, V46, P506, DOI 10.1016/j.fgb.2009.03.006; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Cary JW, 2007, APPL MICROBIOL BIOT, V76, P1107, DOI 10.1007/s00253-007-1081-y; Comera C, 2007, MICROBES INFECT, V9, P47, DOI 10.1016/j.micinf.2006.10.009; Coyle CM, 2005, APPL ENVIRON MICROB, V71, P3112, DOI 10.1128/AEM.71.6.3112-3118.2005; Cramer RA, 2006, EUKARYOT CELL, V5, P972, DOI 10.1128/EC.00049-06; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Duran R. M., 2009, Open Mycology Journal, V3, P27, DOI 10.2174/1874437000903010027; Duran RM, 2007, APPL MICROBIOL BIOT, V73, P1158, DOI 10.1007/s00253-006-0581-5; EICHNER RD, 1988, J BIOL CHEM, V263, P3772; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; FRAME R, 1988, TOXICOL LETT, V40, P269, DOI 10.1016/0378-4274(88)90050-1; Frisvad JC, 2009, MED MYCOL, V47, pS53, DOI 10.1080/13693780802307720; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Gibbons JG, 2012, CURR BIOL, V22, P1403, DOI 10.1016/j.cub.2012.05.033; Gibbons JG, 2012, EUKARYOT CELL, V11, P68, DOI 10.1128/EC.05102-11; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; KILLOUGH JH, 1952, SCIENCE, V115, P71, DOI 10.1126/science.115.2977.71; Klyasova GA, 2005, TERAPEVT ARKH, V77, P65; Kontoyiannis DP, 2002, EUR J CLIN MICROBIOL, V21, P161, DOI 10.1007/s10096-002-0699-z; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lefkove B, 2007, EXPERT REV ANTI-INFE, V5, P573, DOI 10.1586/14787210.5.4.573; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim FY, 2012, APPL ENVIRON MICROB, V78, P4117, DOI 10.1128/AEM.07710-11; Lin HC, 2013, J AM CHEM SOC, V135, P4616, DOI 10.1021/ja312503y; Lodeiro S, 2009, ORG LETT, V11, P1241, DOI 10.1021/ol802696a; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Molina JM, 2002, NEW ENGL J MED, V346, P1963, DOI 10.1056/NEJMoa012924; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MULLBACHER A, 1984, P NATL ACAD SCI-BIOL, V81, P3835, DOI 10.1073/pnas.81.12.3835; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Myung K, 2009, J AGR FOOD CHEM, V57, P5089, DOI 10.1021/jf900783u; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Oren I, 2002, CURR OPIN PULM MED, V8, P195, DOI 10.1097/00063198-200205000-00008; Pagano L, 2001, HAEMATOLOGICA, V86, P862; Palmer JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003193; Pan XQ, 2007, IN VIVO, V21, P259; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Park HB, 2009, J NAT PROD, V72, P248, DOI 10.1021/np800606e; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; PIVA TJ, 1994, BIOCHEM MOL BIOL INT, V33, P411; Post MJ, 2007, TRANSPL INFECT DIS, V9, P189, DOI 10.1111/j.1399-3062.2007.00219.x; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Richard JL, 1996, MYCOPATHOLOGIA, V134, P167, DOI 10.1007/BF00436725; Rokas A, 2012, ANN NY ACAD SCI, V1273, P25, DOI 10.1111/j.1749-6632.2012.06755.x; Ruchel R, 1999, Contrib Microbiol, V2, P21; Sambrook J., 2001, MOL CLONING LAB MANU; Samson R A, 1999, Contrib Microbiol, V2, P5; SCHMITT HJ, 1990, MYCOSES, V33, P539, DOI 10.1111/myc.1990.33.11-12.539; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherif R, 2010, CURR OPIN PULM MED, V16, P242, DOI 10.1097/MCP.0b013e328337d6de; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Sprote P, 2007, ARCH MICROBIOL, V188, P69, DOI 10.1007/s00203-007-0224-y; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; Suen YK, 2001, FREE RADICAL RES, V35, P1, DOI 10.1080/10715760100300541; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsunawaki S, 2004, INFECT IMMUN, V72, P3373, DOI 10.1128/IAI.72.6.3373-3382.2004; Wallwey C, 2010, ORG BIOMOL CHEM, V8, P3500, DOI 10.1039/c003823g; WARING P, 1990, J BIOL CHEM, V265, P14476; Wiederhold NP, 2003, PHARMACOTHERAPY, V23, P1592, DOI 10.1592/phco.23.15.1592.31965; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Yamada A, 2000, IMMUNOL LETT, V71, P27, DOI 10.1016/S0165-2478(99)00155-8; YAMAZAKI M, 1980, CHEM PHARM BULL, V28, P245, DOI 10.1248/cpb.28.245; Yoshida LS, 2000, BIOCHEM BIOPH RES CO, V268, P716, DOI 10.1006/bbrc.2000.2192; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	89	32	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77147	10.1371/journal.pone.0077147	http://dx.doi.org/10.1371/journal.pone.0077147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116213	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300116
J	Wang, WB; Jiang, T; Gardner, S				Wang, Wei-Bung; Jiang, Tao; Gardner, Shea			Detection of Homologous Recombination Events in Bacterial Genomes	PLOS ONE			English	Article							MULTIPLE ALIGNMENT; SMALLPOX; DIVERSITY; SEQUENCE	We study the detection of mutations, sequencing errors, and homologous recombination events (HREs) in a set of closely related microbial genomes. We base the model on single nucleotide polymorphisms (SNPs) and break the genomes into blocks to handle the rearrangement problem. Then we apply a dynamic programming algorithm to model whether changes within each block are likely a result of mutations, sequencing errors, or HREs. Results from simulation experiments show that we can detect 31%-61% of HREs and the precision of our detection is about 48%-90% depending on the rates of mutation and missing data. The HREfinder software for predicting HREs in a set of whole genomes is available as open source (http://sourceforge.net/projects/hrefinder/).	[Wang, Wei-Bung; Jiang, Tao] Univ Calif Riverside, Dept Comp Sci, Riverside, CA 92521 USA; [Gardner, Shea] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Riverside; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Gardner, S (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	Gardner26@llnl.gov	Jiang, Tao/AGX-8391-2022; jiang, tao/GWC-7108-2022	Jiang, Tao/0000-0003-3833-4498; 	United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; National Institutes of Health [2R01LM008991]; NATIONAL LIBRARY OF MEDICINE [R01LM008991] Funding Source: NIH RePORTER	United States Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344 and was also partially funded by grant National Institutes of Health 2R01LM008991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Cormen Thomas H., 2009, INTRO ALGORITHMS; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dias U, 2010, LECT N BIOINFORMAT, V6398, P240, DOI 10.1007/978-3-642-16181-0_20; Eisen JA, 2000, GENOME BIOL, V1; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; Gardner SN, 2010, J FORENSIC RES, V01, P2, DOI [10.4172/2157-7145.1000107, DOI 10.4172/2157-7145.1000107]; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Hill T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-42; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES NC, 2000, INTRO BIOINFORMATICS; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Osborne JD, 2007, VACCINE, V25, P8807, DOI 10.1016/j.vaccine.2007.10.040; Park H, 2010, P 9 ANN INT C COMP S, P114; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Westesson O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000318	28	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75230	10.1371/journal.pone.0075230	http://dx.doi.org/10.1371/journal.pone.0075230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116030	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300023
J	Zhang, ZH; Meng, HW; Hou, ZY; Ma, J; Feng, L; Lin, XT; Tang, YC; Zhang, XL; Liu, QW; Liu, SW				Zhang, Zhonghe; Meng, Haiwei; Hou, Zhongyu; Ma, Jun; Feng, Lei; Lin, Xiangtao; Tang, Yuchun; Zhang, Xiaoli; Liu, Qingwei; Liu, Shuwei			Fetal Adrenal Gland in the Second Half of Gestation: Morphometrical Assessment with 3.0T Post-Mortem MRI	PLOS ONE			English	Article							2ND TRIMESTER ASSESSMENT; BRAIN	Background: The morphometry of fetal adrenal gland is rarely described with MRI of high magnetic field. The purpose of this study is to assess the normal fetal adrenal gland length (AL), width (AW), height (AH), surface area (AS) and volume (AV) in the second half of gestation with 3.0T post-mortem MRI. Methods and Findings: Fifty-two fetal specimens of 23-40 weeks gestational age (GA) were scanned by 3.0T MRI. Morphological changes and quantitative measurements of the fetal adrenal gland were analyzed. Asymmetry and sexual dimorphism were also obtained. The shape of the fetal adrenal gland did not change substantially from 23 to 40 weeks GA. The bilateral adrenal glands appeared as a 'Y', pyramidal or half-moon shape after reconstruction. There was a highly linear correlation between AL, AW, AH, AS, AV and GA. AW, AH, AS and AV were larger for the left adrenal gland than the right. No sexual dimorphism was found. Conclusions: Our data delineated the normal fetal adrenal gland during the second half of gestation, and can serve as a useful precise reference for anatomy or in vivo fetus.	[Zhang, Zhonghe; Hou, Zhongyu; Liu, Qingwei] Shandong Univ, Dept Med Imaging, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Zhang, Zhonghe; Meng, Haiwei; Hou, Zhongyu; Feng, Lei; Lin, Xiangtao; Tang, Yuchun; Liu, Shuwei] Shandong Univ, Res Ctr Sect & Imaging Anat, Sch Med, Jinan 250100, Shandong, Peoples R China; [Ma, Jun] Guilin Med Coll, Dept Anat, Guilin, Guangxi, Peoples R China; [Zhang, Xiaoli] Shandong Univ, Sch Med, Dept Histol & Embryol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Guilin Medical University; Shandong University	Liu, SW (corresponding author), Shandong Univ, Res Ctr Sect & Imaging Anat, Sch Med, Jinan 250100, Shandong, Peoples R China.	liusw@sdu.edu.cn			National Natural Science Foundation of China [31071050, 81001223, 81300497]; Shandong Province Young and Middle-Aged Scientists Research Awards Fund [BS2010YY042, BS2010YY048, BS2012YY009]; scientific and technological research project of Shandong provincial population and family planning commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Young and Middle-Aged Scientists Research Awards Fund; scientific and technological research project of Shandong provincial population and family planning commission	This work was supported by National Natural Science Foundation of China (NO. 31071050; 81001223; 81300497), Shandong Province Young and Middle-Aged Scientists Research Awards Fund (No. BS2010YY042; BS2010YY048; BS2012YY009), and the scientific and technological research project of Shandong provincial population and family planning commission (The 12th fund in 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger PC, 2006, EUR J RADIOL, V57, P278, DOI 10.1016/j.ejrad.2005.11.030; Chang CH, 2002, ULTRASOUND MED BIOL, V28, P1383, DOI 10.1016/S0301-5629(02)00650-6; Huisman TAGM, 2002, EUR RADIOL, V12, P1941, DOI 10.1007/s00330-001-1209-x; Kinoshita Y, 2001, AM J NEURORADIOL, V22, P382; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Lan LM, 2000, RADIOLOGY, V215, P205, DOI 10.1148/radiology.215.1.r00ap05205; McEwing Rachael, 2003, Australas Radiol, V47, P101, DOI 10.1046/j.0004-8461.2003.01136.x; Meng HW, 2012, NEURORADIOLOGY, V54, P1153, DOI 10.1007/s00234-012-1069-x; Nowak D, 2007, ANN ANAT, V189, P575, DOI 10.1016/j.aanat.2007.03.004; Parazzini C, 2008, NEURORADIOLOGY, V50, P877, DOI 10.1007/s00234-008-0421-7; Saada J, 2004, PRENATAL DIAG, V24, P627, DOI 10.1002/pd.948; Sherer DM, 2008, J ULTRAS MED, V27, P1091, DOI 10.7863/jum.2008.27.7.1091; Shinmoto H, 2003, ABDOM IMAGING, V28, P877, DOI 10.1004/s00261-003-0047-5; Zhang Z, 2013, AM J NEURORADIOL, V34, P1462, DOI 10.3174/ajnr.A3406; Zhang ZH, 2011, EUR J RADIOL, V80, pE432, DOI 10.1016/j.ejrad.2010.11.024; Zhang ZH, 2011, NEURORADIOLOGY, V53, P177, DOI 10.1007/s00234-010-0781-7; Zhang ZH, 2010, INT J DEV NEUROSCI, V28, P537, DOI 10.1016/j.ijdevneu.2010.05.001	17	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75511	10.1371/journal.pone.0075511	http://dx.doi.org/10.1371/journal.pone.0075511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116052	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300032
J	Gritsch, K; Laroche, N; Bonnet, JM; Exbrayat, P; Morgon, L; Rabilloud, M; Grosgogeat, B				Gritsch, Kerstin; Laroche, Norbert; Bonnet, Jeanne-Marie; Exbrayat, Patrick; Morgon, Laurent; Rabilloud, Muriel; Grosgogeat, Brigitte			In Vivo Evaluation of Immediately Loaded Stainless Steel and Titanium Orthodontic Screws in a Growing Bone	PLOS ONE			English	Article							MINISCREW IMPLANTS; MINI-IMPLANTS; HISTOLOGICAL-EVALUATION; SKELETAL ANCHORAGE; MINERAL DENSITY; ORAL IMPLANTS; ALVEOLAR BONE; BEAGLE DOG; PIG; ADOLESCENTS	The present work intends to evaluate the use of immediate loaded orthodontic screws in a growing model, and to study the specific bone response. Thirty-two screws (half of stainless steel and half of titanium) were inserted in the alveolar bone of 8 growing pigs. The devices were immediately loaded with a 100 g orthodontic force. Two loading periods were assessed: 4 and 12 weeks. Both systems of screws were clinically assessed. Histological observations and histomorphometric analysis evaluated the percent of "bone-to-implant contact" and static and dynamic bone parameters in the vicinity of the devices (test zone) and in a bone area located 1.5 cm posterior to the devices (control zone). Both systems exhibit similar responses for the survival rate; 87.5% and 81.3% for stainless steel and titanium respectively (p = 0.64; 4-week period), and 62.5% and 50.0% for stainless steel and titanium respectively (p = 0.09; 12-week period). No significant differences between the devices were found regarding the percent of "bone-to-implant contact" (p = 0.1) or the static and dynamic bone parameters. However, the 5% threshold of "bone-to-implant contact" was obtained after 4 weeks with the stainless steel devices, leading to increased survival rate values. Bone in the vicinity of the miniscrew implants showed evidence of a significant increase in bone trabecular thickness when compared to bone in the control zone (p = 0.05). In our study, it is likely that increased trabecular thickness is a way for low density bone to respond to the stress induced by loading.	[Gritsch, Kerstin; Grosgogeat, Brigitte] Univ Lyon, Fac Odontol Lyon, CNRS, Lab Multimat & Interfaces,UMR 5615, Lyon, France; [Gritsch, Kerstin; Exbrayat, Patrick; Morgon, Laurent; Rabilloud, Muriel; Grosgogeat, Brigitte] Hosp Civils Lyon, Lyon, France; [Laroche, Norbert] Univ St Etienne, Fac Med, INSERM, Lab Biol Integrat Tissu Osseux,U890, St Etienne, France; [Bonnet, Jeanne-Marie] Univ Lyon, Agress Vasc & Reponses Tissulaires INSERM ERI22 E, Lyon, France; [Rabilloud, Muriel] Univ Lyon, CNRS, UMR 5558, Lab Biostat Sante, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Gritsch, K (corresponding author), Univ Lyon, Fac Odontol Lyon, CNRS, Lab Multimat & Interfaces,UMR 5615, Lyon, France.	kerstin.gritsch@univ-lyon1.fr	GROSGOGEAT, Brigitte/AAE-2810-2019; Gritsch, Kerstin/ABF-8626-2020	GROSGOGEAT, Brigitte/0000-0003-2194-7300; Gritsch, Kerstin/0000-0001-7027-3731; Bonnet Garin, Jeanne-Marie/0000-0001-5350-338X				Antoszewska J, 2009, AM J ORTHOD DENTOFAC, V136, DOI [10.1016/j.ajodo.2009.03.031, 10.1016/j.ajodo.2009.03.032]; Bouvier M, 1996, ARCH ORAL BIOL, V41, P941, DOI 10.1016/S0003-9969(96)00047-7; Buchter A, 2006, CLIN ORAL IMPLAN RES, V17, P714, DOI 10.1111/j.1600-0501.2006.01233.x; Carano Aldo, 2005, Prog Orthod, V6, P82; Cha JY, 2010, AM J ORTHOD DENTOFAC, V137, P73, DOI 10.1016/j.ajodo.2008.03.024; CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0; Chen YJ, 2007, CLIN ORAL IMPLAN RES, V18, P768, DOI 10.1111/j.1600-0501.2007.01405.x; Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218; Chung Kyu-Rhim, 2004, J Clin Orthod, V38, P478; Ciochon RL, 1997, J CRAN GENET DEV BIO, V17, P96; Cope J.B., 2005, SEMIN ORTHOD, V11, P3, DOI [10.1053/j.sodo.2004.11.002, DOI 10.1053/J.SODO.2004.11.002]; Cornelis MA, 2008, CLIN ORAL IMPLAN RES, V19, P1054, DOI 10.1111/j.1600-0501.2008.01553.x; Cornelis MA, 2010, ORTHOD CRANIOFAC RES, V13, P21, DOI 10.1111/j.1601-6343.2009.01468.x; Deguchi T, 2003, J DENT RES, V82, P377, DOI 10.1177/154405910308200510; Eliades T, 2009, AM J ORTHOD DENTOFAC, V135, P10, DOI 10.1016/j.ajodo.2008.09.018; Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x; Florvaag B, 2010, J OROFAC ORTHOP, V71, P53, DOI 10.1007/s00056-010-9933-y; Garfinkle JS, 2008, AM J ORTHOD DENTOFAC, V133, P642, DOI 10.1016/j.ajodo.2006.04.053; Giancotti A, 2004, AM J ORTHOD DENTOFAC, V126, P113, DOI 10.1016/j.ajodo.2003.08.025; Kingsmill VJ, 2010, J DENT RES, V89, P510, DOI 10.1177/0022034510362970; Kuboki T, 1997, J DENT RES, V76, P1760, DOI 10.1177/00220345970760110701; Labanauskaite Birute, 2005, Stomatologija, V7, P128; Lin D, 2009, J MECH BEHAV BIOMED, V2, P410, DOI 10.1016/j.jmbbm.2008.11.007; Luzi C, 2009, EUR J ORTHODONT, V31, P21, DOI 10.1093/ejo/cjn087; Mavropoulos A, 2004, BONE, V35, P191, DOI 10.1016/j.bone.2004.03.020; Melsen B, 2000, Clin Orthod Res, V3, P23, DOI 10.1034/j.1600-0544.2000.030105.x; Melsen B, 2001, CLIN ORAL IMPLAN RES, V12, P144, DOI 10.1034/j.1600-0501.2001.012002144.x; Melsen Birte, 2005, J Clin Orthod, V39, P539; MILLAR BG, 1990, BRIT J ORAL MAX SURG, V28, P92, DOI 10.1016/0266-4356(90)90129-9; MOSEKILDE L, 1987, CALCIFIED TISSUE INT, V40, P318, DOI 10.1007/BF02556693; Motoyoshi M, 2007, INT J ORAL MAX SURG, V36, P695, DOI 10.1016/j.ijom.2007.03.009; Ohmae M, 2001, AM J ORTHOD DENTOFAC, V119, P489, DOI 10.1067/mod.2001.114300; Ohnishi H, 2005, ANGLE ORTHOD, V75, P444; Oltramari PVP, 2007, VET J, V173, P399, DOI 10.1016/j.tvjl.2005.11.001; Papadopoulos MA, 2011, J DENT RES, V90, P969, DOI 10.1177/0022034511409236; Papadopoulos MA, 2007, ORAL SURG ORAL MED O, V103, pE6, DOI 10.1016/j.tripleo.2006.11.022; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park H S, 2001, J Clin Orthod, V35, P417; Park HS, 2005, ANGLE ORTHOD, V75, P602; POWELL K, 1973, ARCH ORAL BIOL, V18, P171, DOI 10.1016/0003-9969(73)90136-2; Proffit WR, 1993, CONT ORTHODONTICS; ROBERTS WE, 1989, ANGLE ORTHOD, V59, P247; Roth S, 1997, ARCH ORAL BIOL, V42, P63, DOI 10.1016/S0003-9969(97)83718-1; Sarnat BG, 2007, J CRANIOFAC SURG, V18, P917, DOI 10.1097/scs.0b013e31806843d5; Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010; Traini T, 2009, CLIN IMPLANT DENT R, V11, P41, DOI 10.1111/j.1708-8208.2008.00086.x; Vannet BV, 2007, EUR J ORTHODONT, V29, P437, DOI 10.1093/ejo/cjm078; VONWOWERN N, 1980, SCAND J DENT RES, V88, P134; Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x; Wang ZQ, 2010, AM J ORTHOD DENTOFAC, V137, P100, DOI 10.1016/j.ajodo.2008.01.025; Willems NMBK, 2007, J STRUCT BIOL, V158, P421, DOI 10.1016/j.jsb.2006.12.011; Wu JC, 2007, AM J ORTHOD DENTOFAC, V132, P353, DOI 10.1016/j.ajodo.2006.10.021; Zhang LK, 2010, ANGLE ORTHOD, V80, P354, DOI 10.2319/021909-106.1	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76223	10.1371/journal.pone.0076223	http://dx.doi.org/10.1371/journal.pone.0076223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124540	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100097
J	Jang, BG; Choi, BY; Kim, JH; Kim, MJ; Sohn, M; Suh, SW				Jang, Bong Geom; Choi, Bo Young; Kim, Jin Hee; Kim, Min-Ju; Sohn, Min; Suh, Sang Won			Impairment of Autophagic Flux Promotes Glucose Reperfusion-Induced Neuro2A Cell Death after Glucose Deprivation	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; MEDIATED CLEAVAGE; BRAIN INJURY; HYPOGLYCEMIA; APOPTOSIS; RAT; DEGRADATION; LYSOSOMES; DISEASE	Hypoglycemia-induced brain injury is a common and serious complication of intensive insulin therapy experienced by Type 1 diabetic patients. We previously reported that hypoglycemic neuronal death is triggered by glucose reperfusion after hypoglycemia rather than as a simple result of glucose deprivation. However, the precise mechanism of neuronal death initiated by glucose reperfusion is still unclear. Autophagy is a self-degradation process that acts through a lysosome-mediated trafficking pathway to degrade and recycle intracellular components, thereby regulating metabolism and energy production. Recent studies suggest that autophagic and lysosomal dysfunction leads to abnormal protein degradation and deposition that may contribute to neuronal death. Here, we focused on the relationship between autophagy and lysosomal dysfunction in hypoglycemia-induced neuronal death. In neuronal cells, glucose reperfusion after glucose deprivation resulted in inhibition of autophagy, which may promote cell death. This cell death was accompanied with activation of caspase3 and the lysosomal proteases cathepsin B and D, which indicated impairment of autophagic flux. Taken together, these results suggest that interplay of autophagy, caspase3 activation and lysosomal proteases serve as a basis for neuronal death after hypoglycemia. Thus, we provide the molecular mechanism of neuronal death by glucose reperfusion and suggest some clues for therapeutic strategies to prevent hypoglycemia-induced neuronal death.	[Jang, Bong Geom; Choi, Bo Young; Kim, Jin Hee; Suh, Sang Won] Hallym Univ, Dept Physiol, Coll Med, Chunchon, South Korea; [Kim, Min-Ju] Hallym Univ, Dept Anat & Neurobiol, Coll Med, Chunchon, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea	Hallym University; Hallym University; Inha University	Suh, SW (corresponding author), Hallym Univ, Dept Physiol, Coll Med, Chunchon, South Korea.	swsuh@hallym.ac.kr		SOHN, MIN/0000-0003-4021-2051; Choi, Bo Young/0000-0002-9579-3503	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120202]; Hallym University Specialization Fund [HRF-S-41]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Hallym University Specialization Fund	This work was supported by the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120202) and by a grant from the Hallym University Specialization Fund (HRF-S-41) to S. W. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; CRYER PE, 1989, DIABETES, V38, P1193, DOI 10.2337/diabetes.38.9.1193; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davis EA, 1998, J PEDIATR ENDOCR MET, V11, P177; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; HALLENBECK JM, 1990, ARCH NEUROL-CHICAGO, V47, P1245, DOI 10.1001/archneur.1990.00530110107027; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marambio P, 2010, BBA-MOL BASIS DIS, V1802, P509, DOI 10.1016/j.bbadis.2010.02.002; Martinez-Vicente M, NAT NEUROSCI, V13, P567; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; NIXON RA, 1993, ANN NY ACAD SCI, V679, P87, DOI 10.1111/j.1749-6632.1993.tb18291.x; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sommerfield AJ, 2003, DIABETES CARE, V26, P390, DOI 10.2337/diacare.26.2.390; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2003, J NEUROSCI, V23, P10681; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; WIELOCH T, 1982, PATHOL BIOL, V30, P269; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	53	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76466	10.1371/journal.pone.0076466	http://dx.doi.org/10.1371/journal.pone.0076466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124562	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100119
J	Nangia, V; Jonas, JB; Matin, A; Bhojwani, K; Sinha, A; Kulkarni, M; Gupta, R; Khare, A; Agarwal, S; Bhate, K; Nangia, P; Nangia, P; Panda-Jonas, S				Nangia, Vinay; Jonas, Jost B.; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Kulkarni, Maithili; Gupta, Rajesh; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma; Nangia, Prabhat; Nangia, Purna; Panda-Jonas, Songhomitra			Prevalence and Associated Factors of Glaucoma in Rural Central India. The Central India Eye and Medical Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; POPULATION-BASED SURVEY; CEREBROSPINAL-FLUID PRESSURE; BODY-MASS INDEX; SOUTHERN INDIA; CLOSURE GLAUCOMA; RISK-FACTORS; ISNT RULE; OCULAR HYPERTENSION; CHENNAI GLAUCOMA	Purpose: To assess the prevalence of glaucoma in rural Central India. Methods: The population-based Central India Eye and Medical Study is a population-based study performed in a rural region of Central India. The study included 4711 subjects (aged 30+ years). A detailed ophthalmic and medical examination was performed. Glaucoma was defined by glaucomatous optic disc morphology, and in a second step, by the criteria of the International Society of Geographical and Epidemiological Ophthalmology (ISGEO). Results: Optic disc photographs were available for 4570 (97.0%) subjects. Glaucoma was detected in 122 subjects (51 unilateral) (2.67% (95% CI: 2.20, 3.14). Glaucoma prevalence for the age groups of 30-39yrs, 40-49yrs, 50-59yrs, 60-69yrs, 70-79yrs, and 80+ years was 0.54% (95% CI: 0.11, 0.98), 1.03% (95% CI: 0.49, 1.57), 1.40% (95% CI: 0.58, 2.23), 6.62% (95% CI: 4.92, 8.31), 8.71% (95% CI: 5.55, 11.75), and 14.3% (95% CI: 4.13, 24.4), respectively. In multivariable analysis, glaucoma was associated with higher age (P<0.001), lower body mass index (P = 0.025), lower blood hemoglobin concentration (P = 0.03), higher intraocular pressure (P<0.001), disc hemorrhages (P<0.001), higher prevalence of myopic retinopathy (P<0.001), lower level of education (P = 0.03), longer axial length (P<0.001), thinner retinal nerve fiber layer (P<0.001), higher vertical cup/disc diameter ratio (P<0.001), and narrow anterior chamber angle (P = 0.02). Ratio of open-angle glaucoma to angle-closure glaucoma was 7.7: 1 (1.93% (95% CI: 1.64, 2.22) to 0.24% (95% CI: 0.14, 0.34)). Using the ISGEO criteria, glaucoma prevalence was 2.8% (95% CI: 2.3, 3.3) with a less clear association with older age. Conclusions: Glaucoma prevalence in remote rural Central India is comparable to other regions. Associated factors were older age, lower body mass index, lower blood concentration of hemoglobin, lower level of education, higher intraocular pressure, disc hemorrhage, myopic retinopathy, and longer axial length. The ratio of open-angle glaucoma to angle-closure glaucoma was about 8:1.	[Nangia, Vinay; Jonas, Jost B.; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Kulkarni, Maithili; Gupta, Rajesh; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma; Nangia, Prabhat; Nangia, Purna; Panda-Jonas, Songhomitra] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Suraj Eye Institute; Ruprecht Karls University Heidelberg	Nangia, V (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	nagpursuraj@gmail.com; Jost.Jonas@medma.uni-heidelberg.de	Bhate, Karishma/AAD-8609-2019		Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	This work was supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON B, 1980, ACTA OPHTHALMOL, V58, P726; Bourne RRA, 2003, BRIT J OPHTHALMOL, V87, P1069, DOI 10.1136/bjo.87.9.1069; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Buhrmann RR, 2000, INVEST OPHTH VIS SCI, V41, P40; Chauhan BC, 2008, ARCH OPHTHALMOL-CHIC, V126, P1030, DOI 10.1001/archopht.126.8.1030; Curtin B J, 1977, Trans Am Ophthalmol Soc, V75, P67; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; Dandona L, 2000, OPHTHALMOLOGY, V107, P1702, DOI 10.1016/S0161-6420(00)00275-X; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Ekstrom C, 1996, ACTA OPHTHALMOL SCAN, V74, P107; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; Foster PJ, 2000, BRIT J OPHTHALMOL, V84, P186, DOI 10.1136/bjo.84.2.186; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Garudadri C, 2010, OPHTHALMOLOGY, V117, P1352, DOI 10.1016/j.ophtha.2009.11.006; Grodum K, 2001, ACTA OPHTHALMOL SCAN, V79, P560, DOI 10.1034/j.1600-0420.2001.790603.x; Harizman N, 2006, ARCH OPHTHALMOL-CHIC, V124, P1579, DOI 10.1001/archopht.124.11.1579; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Jacob Aby, 1998, Indian Journal of Ophthalmology, V46, P81; Jonas JB, 1998, BRIT J OPHTHALMOL, V82, P1366, DOI 10.1136/bjo.82.12.1366; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Jonas JB, 1999, SURV OPHTHALMOL, V43, P293, DOI 10.1016/S0039-6257(98)00049-6; JONAS JB, 1989, AM J OPHTHALMOL, V107, P137, DOI 10.1016/0002-9394(89)90212-2; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Jonas JB, 2012, CLIN EXP OPHTHALMOL, V40, pE116, DOI 10.1111/j.1442-9071.2011.02731.x; Jonas JB, 2010, AM J HYPERTENS, V23, P347, DOI 10.1038/ajh.2009.276; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Krishnadas R, 2003, AM J OPHTHALMOL, V135, P830, DOI 10.1016/S0002-9394(02)02271-7; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Morgan JE, 2012, OPHTHALMOLOGY, V119, P723, DOI 10.1016/j.ophtha.2011.10.004; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P4621, DOI 10.1167/iovs.13-11950; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Pogrebniak AE, 2010, INVEST OPHTH VIS SCI, V51, P890, DOI 10.1167/iovs.09-3837; Ramakrishnan R, 2003, OPHTHALMOLOGY, V110, P1484, DOI 10.1016/S0161-6420(03)00564-5; Raychaudhuri A, 2005, BRIT J OPHTHALMOL, V89, P1559, DOI 10.1136/bjo.2005.074948; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Rotchford AP, 2002, ARCH OPHTHALMOL-CHIC, V120, P471, DOI 10.1001/archopht.120.4.471; Shen SY, 2008, INVEST OPHTH VIS SCI, V49, P3846, DOI 10.1167/iovs.08-1759; Sihota R, 2008, EYE, V22, P819, DOI 10.1038/sj.eye.6702798; Steidl SM, 1997, AM J OPHTHALMOL, V123, P181, DOI 10.1016/S0002-9394(14)71034-7; Thomas R, 2007, CLIN EXP OPHTHALMOL, V35, P374, DOI 10.1111/j.1442-9071.2007.01489.x; Thomas R, 2012, INDIAN J OPHTHALMOL, V60, P446, DOI 10.4103/0301-4738.100546; Thomas R, 2011, INDIAN J OPHTHALMOL, V59, pS3, DOI 10.4103/0301-4738.73678; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; Vijaya L, 2008, OPHTHALMOLOGY, V115, P648, DOI 10.1016/j.ophtha.2007.04.062; Vijaya L, 2008, OPHTHALMOLOGY, V115, P655, DOI 10.1016/j.ophtha.2007.05.034; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030104; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470	63	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76434	10.1371/journal.pone.0076434	http://dx.doi.org/10.1371/journal.pone.0076434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098790	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500161
J	Blagitko-Dorfs, N; Jiang, Y; Duque-Afonso, J; Hiller, J; Yalcin, A; Greve, G; Abdelkarim, M; Hackanson, B; Lubbert, M				Blagitko-Dorfs, Nadja; Jiang, Yi; Duque-Afonso, Jesus; Hiller, Jan; Yalcin, Arzu; Greve, Gabriele; Abdelkarim, Mahmoud; Hackanson, Bjoern; Luebbert, Michael			Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; RECEPTOR-BETA; OLDER PATIENTS; VALPROIC ACID; METHYLATION; MS-275; TRIAL; GENE; HYPERMETHYLATION	All-trans retinoic acid (ATRA) has only limited single agent activity in AML without the PML-RAR alpha fusion (non-M3 AML). In search of a sensitizing strategy to overcome this relative ATRA resistance, we investigated the potency of the HDAC class-I selective inhibitor entinostat in AML cell lines Kasumi-1 and HL-60 and primary AML blasts. Entinostat alone induced robust differentiation of both cell lines, which was enhanced by the combination with ATRA. This "priming'' effect on ATRA-induced differentiation was at least equivalent to that achieved with the DNA hypomethylating agent decitabine, and could overall be recapitulated in primary AML blasts treated ex vivo. Moreover, entinostat treatment established the activating chromatin marks acH3, acH3K9, acH4 and H3K4me3 at the promoter of the RAR beta 2 gene, an essential mediator of retinoic acid (RA) signaling in different solid tumor models. Similarly, RAR beta 2 promoter hypermethylation (which in primary blasts from 90 AML/MDS patients was surprisingly infrequent) could be partially reversed by decitabine in the two cell lines. Re-induction of the epigenetically silenced RAR beta 2 gene was achieved only when entinostat or decitabine were given prior to ATRA treatment. Thus in this model, reactivation of RAR beta 2 was not necessarily required for the differentiation effect, and pharmacological RAR beta 2 promoter demethylation may be a bystander phenomenon rather than an essential prerequisite for the cellular effects of decitabine when combined with ATRA. In conclusion, as a "priming'' agent for non-M3 AML blasts to the differentiation-inducing effects of ATRA, entinostat is at least as active as decitabine, and both act in part independently from RAR beta 2. Further investigation of this treatment combination in non-M3 AML patients is therefore warranted, independently of RAR beta 2 gene silencing by DNA methylation.	[Blagitko-Dorfs, Nadja; Jiang, Yi; Duque-Afonso, Jesus; Hiller, Jan; Yalcin, Arzu; Greve, Gabriele; Abdelkarim, Mahmoud; Hackanson, Bjoern; Luebbert, Michael] Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany; [Jiang, Yi] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Shanghai 200030, Peoples R China; [Duque-Afonso, Jesus] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Yalcin, Arzu; Greve, Gabriele] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; Shanghai Jiao Tong University; Stanford University; University of Freiburg	Lubbert, M (corresponding author), Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany.	michael.luebbert@uniklinik-freiburg.de			German Research Council [Lu 429/7-1]; CRC [992]; German Cancer Aid [108397]; German Carreras Leukemia Foundation [DJCLS R10/30f]	German Research Council(German Research Foundation (DFG)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); German Cancer Aid(Deutsche Krebshilfe); German Carreras Leukemia Foundation	This work was supported by the German Research Council Priority Programme 1463 (Lu 429/7-1), CRC 992 (ML), German Cancer Aid (grant 108397 to BH), German Carreras Leukemia Foundation (DJCLS R10/30f). JDA was participant in the Research Fellowship Program at the Department of Hematology and Oncology of the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; Cimino G, 2006, CANCER RES, V66, P8903, DOI 10.1158/0008-5472.CAN-05-2726; Claus R, 2012, EPIGENETICS-US, V7, P772, DOI 10.4161/epi.20299; Claus R, 2012, INT J CANCER, V131, pE138, DOI 10.1002/ijc.26429; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Duque-Afonso J, 2011, ONCOGENE, V30, P3062, DOI 10.1038/onc.2011.32; Ekmekci CG, 2004, AM J HEMATOL, V77, P233, DOI 10.1002/ajh.20186; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; Fazi F, 2007, BLOOD, V109, P4432, DOI 10.1182/blood-2006-09-045781; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; HOFFMANN B, 1990, MOL ENDOCRINOL, V4, P1727, DOI 10.1210/mend-4-11-1727; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Klimek V, 2012, BLOOD, V120, P3815; Kuendgen A, 2005, ANN HEMATOL, V84, P61, DOI 10.1007/s00277-005-0026-8; Lavelle D, 2012, BLOOD, V119, P1240, DOI 10.1182/blood-2011-08-371690; Li C, 1998, CANCER LETT, V124, P205, DOI 10.1016/S0304-3835(97)00475-8; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lubbert M, 2012, HAEMATOL-HEMATOL J, V97, P393, DOI 10.3324/haematol.2011.048231; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; MATOZAKI S, 1995, BRIT J HAEMATOL, V89, P805; Moison C, 2013, FASEB J, V27, P1468, DOI 10.1096/fj.12-210971; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Prebet T, 2010, ASH ANN M, V116, P601; Raffoux E, 2010, ONCOTARGET, V1, P34, DOI 10.18632/oncotarget.106; Rethmeier A, 2006, BRIT J HAEMATOL, V133, P276, DOI 10.1111/j.1365-2141.2006.06014.x; Rosato RR, 2003, CANCER RES, V63, P3637; Schlenk RF, 2009, HAEMATOL-HEMATOL J, V94, P54, DOI 10.3324/haematol.13378; Sirchia SM, 2000, ONCOGENE, V19, P1556, DOI 10.1038/sj.onc.1203456; Sirchia SM, 2002, CANCER RES, V62, P2455; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Tabe Y, 2006, ANN HEMATOL, V85, P689, DOI 10.1007/s00277-006-0148-7; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Wang XF, 2005, CLIN CANCER RES, V11, P3535, DOI 10.1158/1078-0432.CCR-04-1092; Wardley AM, 2010, J CLIN ONCOL S, V28, p15 s; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu XC, 2007, CANCER LETT, V253, P14, DOI 10.1016/j.canlet.2006.11.019	43	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75258	10.1371/journal.pone.0075258	http://dx.doi.org/10.1371/journal.pone.0075258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116031	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200013
J	Carbon, CC; Gruter, M; Gruter, T				Carbon, Claus-Christian; Grueter, Martina; Grueter, Thomas			Age-Dependent Face Detection and Face Categorization Performance	PLOS ONE			English	Article							MACULAR DEGENERATION; RECOGNITION; STIMULI; PERCEPTION; BRAIN	Empirical studies on the development of face processing skills with age show inconsistent patterns concerning qualitative vs. quantitative changes over time or the age range for peak cognitive performance. In the present study, we tested the proficiency in face detection and face categorization with a large sample of participants (N = 312; age range: 2-88 yrs). As test objects, we used so-called Mooney faces, two-tone (black and white) images of faces lacking critical information of a local, featural and relational nature, reflecting difficult real world face processing conditions. We found that performance in the assessment of gender and age from Mooney faces increases up to about age 15, and decreases from 65 years on. The implications of these findings are discussed in the light of classic and recent findings from face development literature.	[Carbon, Claus-Christian; Grueter, Martina; Grueter, Thomas] Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, D-96047 Bamberg, Germany; [Grueter, Martina] Grad Sch Affect & Cognit Sci, Bamberg, Germany	Otto Friedrich University Bamberg	Carbon, CC (corresponding author), Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, D-96047 Bamberg, Germany.	ccc@experimental-psychology.com	Carbon, Claus-Christian/GLQ-6274-2022; Carbon, Claus-Christian/A-7494-2008	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347; Gruter, Martina/0000-0002-2784-0486; Gruter, Thomas/0000-0003-3529-9244	University of Bamberg (FNK); Doktor Robert Pfleger-Stiftung	University of Bamberg (FNK); Doktor Robert Pfleger-Stiftung	This research was supported by a research grant from the University of Bamberg (FNK) and a grant from Doktor Robert Pfleger-Stiftung to CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carbon CC, 2005, COGNITIVE BRAIN RES, V24, P544, DOI 10.1016/j.cogbrainres.2005.03.008; Cattell R. B., 1971, ABILITIES THEIR STRU; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Chaby L, 2003, NEUROSCI LETT, V349, P125, DOI 10.1016/S0304-3940(03)00800-0; Crookes K, 2009, COGNITION, V111, P219, DOI 10.1016/j.cognition.2009.02.004; Doi H, 2009, NEUROSCI RES, V64, P317, DOI 10.1016/j.neures.2009.04.002; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Edelman S, 2001, SCI PSYCH S, P397; FOREMAN N, 1991, J GEN PSYCHOL, V118, P13, DOI 10.1080/00221309.1991.9711129; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; GOREN CC, 1975, PEDIATRICS, V56, P544; Grady CL, 2002, CAN J EXP PSYCHOL, V56, P208, DOI 10.1037/h0087398; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Gruter T, 2009, NEUROSCI LETT, V453, P135, DOI 10.1016/j.neulet.2009.02.021; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Kadosh KC, 2007, TRENDS COGN SCI, V11, P367, DOI 10.1016/j.tics.2007.06.007; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; KINI MM, 1978, AM J OPHTHALMOL, V85, P28, DOI 10.1016/S0002-9394(14)76661-9; Latinus M, 2005, J COGNITIVE NEUROSCI, V17, P1316, DOI 10.1162/0898929055002490; Leder H, 2006, BRIT J PSYCHOL, V97, P19, DOI 10.1348/000712605X54794; Leo I, 2009, INFANCY, V14, P641, DOI 10.1080/15250000903264047; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; McKeeff TJ, 2007, CEREB CORTEX, V17, P669, DOI 10.1093/cercor/bhk015; Mckone E, 2009, COGNITIVE NEUROSCIEN, V4th, P467; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P219, DOI 10.1037/h0083717; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Rakover SS, 2002, BRIT J PSYCHOL, V93, P1, DOI 10.1348/000712602162427; READ DE, 1988, J CLIN EXP NEUROPSYC, V10, P451, DOI 10.1080/01688638808408252; RITCHIE K, 1993, INT J GERIATR PSYCH, V8, P969, DOI 10.1002/gps.930081203; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; SALTHOUSE TA, 1988, AM J PSYCHOL, V101, P217, DOI 10.2307/1422836; Schwaninger A, 2003, DEVELOPMENT OF FACE PROCESSING, P81; Schwarzer G, 2003, DEVELOPMENT OF FACE PROCESSING, P55; Schwarzer G, 2006, AM J PSYCHOL, V119, P329, DOI 10.2307/20445343; Tejeria L, 2002, BRIT J OPHTHALMOL, V86, P1019, DOI 10.1136/bjo.86.9.1019; Tranel D, 1997, DEV NEUROPSYCHOL, V13, P87, DOI 10.1080/87565649709540669; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Webb SJ, 2006, PSYCHOPHYSIOLOGY, V43, pS105; WIBRAL M, 2010, J NEUROSCI, V30, P8342, DOI DOI 10.1523/JNEUR0SCI.5434-09.2010.PUBMED:20554885; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232	45	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e79164	10.1371/journal.pone.0079164	http://dx.doi.org/10.1371/journal.pone.0079164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116236	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200121
J	Khan, F; Vyas, B; Pal, D; Cameotra, SS				Khan, Fazlurrahman; Vyas, Bhawna; Pal, Deepika; Cameotra, Swaranjit Singh			RETRACTED: Aerobic Degradation of N-Methyl-4-Nitroaniline (MNA) by Pseudomonas sp Strain FK357 Isolated from Soil (Retracted article. See vol. 9, pg. e102855, 2014)	PLOS ONE			English	Article; Retracted Publication							P-NITROPHENOL; 5-NITROANTHRANILIC ACID; BIODEGRADATION; PUTIDA; FORMALDEHYDE; ANILINE; NITROBENZENE; PATHWAY; SYSTEM; MINERALIZATION	N-Methyl-4-nitroaniline (MNA) is used as an additive to lower the melting temperature of energetic materials in the synthesis of insensitive explosives. Although the biotransformation of MNA under anaerobic condition has been reported, its aerobic microbial degradation has not been documented yet. A soil microcosms study showed the efficient aerobic degradation of MNA by the inhabitant soil microorganisms. An aerobic bacterium, Pseudomonas sp. strain FK357, able to utilize MNA as the sole carbon, nitrogen, and energy source, was isolated from soil microcosms. HPLC and GC-MS analysis of the samples obtained from growth and resting cell studies showed the formation of 4-nitroaniline (4-NA), 4-aminophenol (4-AP), and 1, 2, 4-benzenetriol (BT) as major metabolic intermediates in the MNA degradation pathway. Enzymatic assay carried out on cell-free lysates of MNA grown cells confirmed N-demethylation reaction is the first step of MNA degradation with the formation of 4-NA and formaldehyde products. Flavin-dependent transformation of 4-NA to 4-AP in cell extracts demonstrated that the second step of MNA degradation is a monooxygenation. Furthermore, conversion of 4-AP to BT by MNA grown cells indicates the involvement of oxidative deamination (release of NH2 substituent) reaction in third step of MNA degradation. Subsequent degradation of BT occurs by the action of benzenetriol 1, 2-dioxygenase as reported for the degradation of 4-nitrophenol. This is the first report on aerobic degradation of MNA by a single bacterium along with elucidation of metabolic pathway.	[Khan, Fazlurrahman; Vyas, Bhawna; Pal, Deepika; Cameotra, Swaranjit Singh] CSIR, Environm Biotechnol & Microbial Biochem Lab, Inst Microbial Technol, Sect 39A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Cameotra, SS (corresponding author), CSIR, Environm Biotechnol & Microbial Biochem Lab, Inst Microbial Technol, Sect 39A, Chandigarh, India.	ssc@imtech.res.in			Research Associateship from the Department of Biotechnology (DBT), India; DST; UGC India	Research Associateship from the Department of Biotechnology (DBT), India; DST(Department of Science & Technology (India)); UGC India(University Grants Commission, India)	FK acknowledges the financial support from the Research Associateship from the Department of Biotechnology (DBT), India. BV and DP acknowledge for their research fellowship awards from DST and UGC India, respectively. This is the IMTECH communication number 50/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROER N, 1990, APPL MICROBIOL BIOT, V33, P217, DOI 10.1007/BF00176528; Agrawal JP, 1998, PROG ENERG COMBUST, V24, P1, DOI 10.1016/S0360-1285(97)00015-4; ALEXANDER M, 1992, SCIENCE, V258, P874, DOI 10.1126/science.258.5084.874; Arnett CM, 2009, MICROBES ENVIRON, V24, P72, DOI 10.1264/jsme2.ME08556; ASANO Y, 1993, BIOSCI BIOTECH BIOCH, V57, P1286, DOI 10.1271/bbb.57.1286; BEUNINK J, 1990, APPL MICROBIOL BIOT, V34, P108, DOI 10.1007/BF00170933; BLECHER R, 1977, H-S Z PHYSIOL CHEM, V358, P807, DOI 10.1515/bchm2.1977.358.2.807; Boyd DR, 2006, ORG BIOMOL CHEM, V4, P181, DOI 10.1039/b513226f; CARTWRIGHT NJ, 1967, BIOCHEM J, V102, P826, DOI 10.1042/bj1020826; Chauhan A, 2010, ENVIRON SCI TECHNOL, V44, P3435, DOI 10.1021/es9024172; Chongcharoen R, 2005, MICROBIOL-SGM, V151, P2615, DOI 10.1099/mic.0.27912-0; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; Fazlurrahman, 2009, LETT APPL MICROBIOL, V49, P721, DOI 10.1111/j.1472-765X.2009.02724.x; Fukumori F, 1997, J BACTERIOL, V179, P399, DOI 10.1128/jb.179.2.399-408.1997; Ghosh A, 2010, ENVIRON SCI TECHNOL, V44, P1069, DOI 10.1021/es9034123; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Hibi M, 2005, FEMS MICROBIOL LETT, V253, P237, DOI 10.1016/j.femsle.2005.09.036; JAIN RK, 1994, APPL ENVIRON MICROB, V60, P3030, DOI 10.1128/AEM.60.8.3030-3032.1994; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; Katsivela E, 1999, APPL ENVIRON MICROB, V65, P1405; Khan F, 2013, J HAZARD MATER, V254, P72, DOI 10.1016/j.jhazmat.2013.03.021; Khan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062178; Lessner DJ, 2002, APPL ENVIRON MICROB, V68, P634, DOI 10.1128/AEM.68.2.634-641.2002; Liang O, 2005, MICROBIOL-SGM, V151, P3435, DOI 10.1099/mic.0.28137-0; Liu Z, 2002, APPL MICROBIOL BIOT, V58, P679, DOI 10.1007/s00253-002-0933-8; LOIDL M, 1990, ARCH MICROBIOL, V155, P56, DOI 10.1007/BF00291275; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; MCCLURE NC, 1986, J GEN MICROBIOL, V132, P2209; NISHINO SF, 1995, APPL ENVIRON MICROB, V61, P2308, DOI 10.1128/AEM.61.6.2308-2313.1995; NISHINO SF, 1993, APPL ENVIRON MICROB, V59, P2520, DOI 10.1128/AEM.59.8.2520-2525.1993; Nolan LC, 2008, BIOTECHNOL LETT, V30, P1879, DOI 10.1007/s10529-008-9791-5; O'Neill C, 2000, APPL MICROBIOL BIOT, V53, P249, DOI 10.1007/s002530050016; Padda RS, 2003, ENVIRON TOXICOL CHEM, V22, P2293, DOI 10.1897/02-220; Perreault NN, 2012, ENVIRON SCI TECHNOL, V46, P6035, DOI 10.1021/es301047d; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; Platten WE, 2010, CHEMOSPHERE, V81, P1131, DOI 10.1016/j.chemosphere.2010.08.044; Providenti MA, 2006, J BACTERIOL, V188, P3862, DOI 10.1128/JB.01675-05; Purohit V, 2000, CHEM RES TOXICOL, V13, P673, DOI 10.1021/tx000002x; Qu Y, 2011, J BACTERIOL, V193, P3057, DOI 10.1128/JB.01188-10; Qu Y, 2010, APPL ENVIRON MICROB, V76, P1417, DOI 10.1128/AEM.02816-09; Robidoux PY, 2000, ENVIRON TOXICOL CHEM, V19, P1764, DOI [10.1002/etc.5620190709, 10.1897/1551-5028(2000)019&lt;1764:CTOECI&gt;2.3.CO;2]; Roca A, 2008, MICROB BIOTECHNOL, V1, P158, DOI 10.1111/j.1751-7915.2007.00014.x; Saupe A, 1999, CHEMOSPHERE, V39, P2325, DOI 10.1016/S0045-6535(99)00141-1; Schafer A, 1996, BIODEGRADATION, V7, P249, DOI 10.1007/BF00058184; Shettigar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051162; Shin KA, 2009, APPL ENVIRON MICROB, V75, P2694, DOI 10.1128/AEM.02198-08; Soccol Carlos R., 2003, Indian Journal of Experimental Biology, V41, P1030; Summers RM, 2012, J BACTERIOL, V194, P2041, DOI 10.1128/JB.06637-11; Summers RM, 2011, MICROBIOL-SGM, V157, P583, DOI 10.1099/mic.0.043612-0; Travkin VM, 2003, J ENVIRON SCI HEAL B, V38, P121, DOI 10.1081/PFC-120018443; Urata M, 2004, BIOSCI BIOTECH BIOCH, V68, P2457, DOI 10.1271/bbb.68.2457; Wei M, 2010, BIODEGRADATION, V21, P915, DOI 10.1007/s10532-010-9351-2; White GF, 1996, APPL ENVIRON MICROB, V62, P637, DOI 10.1128/AEM.62.2.637-642.1996; WOOLFOLK CA, 1975, J BACTERIOL, V123, P1088, DOI 10.1128/JB.123.3.1088-1106.1975; ZEYER J, 1985, APPL ENVIRON MICROB, V50, P447, DOI 10.1128/AEM.50.2.447-453.1985; Zhao JS, 2001, APPL ENVIRON MICROB, V67, P1388, DOI 10.1128/AEM.67.3.1388-1391.2001; Zissi U, 1996, WATER SCI TECHNOL, V34, P495, DOI 10.2166/wst.1996.0588	57	4	4	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75046	10.1371/journal.pone.0075046	http://dx.doi.org/10.1371/journal.pone.0075046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116023	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200007
J	Rua, R; Betsem, E; Gessain, A				Rua, Rejane; Betsem, Edouard; Gessain, Antoine			Viral Latency in Blood and Saliva of Simian Foamy Virus-Infected Humans	PLOS ONE			English	Article							TRANSMISSION; REPLICATION; EPIDEMIOLOGY; PRIMATES	Simian foamy viruses (SFV) are widespread retroviruses among non-human primates (NHP). SFV actively replicate in the oral cavity and can be transmitted to humans through NHP bites, giving rise to a persistent infection. We aimed at studying the natural history of SFV infection in human. We have analyzed viral load and gene expression in 14 hunters from Cameroon previously shown to be infected with a gorilla SFV strain. Viral DNA could be detected by quantitative polymerase chain reaction (q-PCR) targeting the pol-in region, in most samples of peripheral blood mononuclear cells (PBMCs) (7.1 +/- 6.0 SFV DNA copies/105 PBMCs) and saliva (2.4 +/- 4.3 SFV DNA copies/105 cells) derived from the hunters. However, quantitative real-time reverse-transcription polymerase chain reaction (RT)-qPCR revealed the absence of SFV viral gene expression in both PBMCs and saliva, suggesting that SFV was latent in the human samples. Our study demonstrates that a latent infection can occur in humans and persist for years, both in PBMCs and saliva. Such a scenario may contribute to the putative lack of secondary human-to-human transmissions of SFV.	[Rua, Rejane; Betsem, Edouard; Gessain, Antoine] Inst Pasteur, Dept Virol, Unit Epidemiol & Physiopathol Oncogen Viruses, Paris, France; [Rua, Rejane; Betsem, Edouard; Gessain, Antoine] Inst Pasteur, CNRS, Paris, France; [Rua, Rejane] Paris Diderot Univ, Paris, France; [Betsem, Edouard] Univ Yaounde I, Fac Med & Biomed Sci, Dept Microbiol, Yaounde, Cameroon	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Yaounde I	Gessain, A (corresponding author), Inst Pasteur, Dept Virol, Unit Epidemiol & Physiopathol Oncogen Viruses, Paris, France.	antoine.gessain@pasteur.fr	Rua, Rejane/GLQ-7139-2022	Rua, Rejane/0000-0002-4289-3498	"Bourse de l'Ecole Normale Superieure, Faculte Paris Diderot"; "Association Virus Cancer Prevention"; Institut National pour le Cancer; Institut Pasteur in Paris; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	"Bourse de l'Ecole Normale Superieure, Faculte Paris Diderot"; "Association Virus Cancer Prevention"; Institut National pour le Cancer; Institut Pasteur in Paris; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	R. Rua was personally supported by the "Bourse de l'Ecole Normale Superieure, Faculte Paris Diderot". E. Betsem was supported by the "Association Virus Cancer Prevention" and the Institut National pour le Cancer. Financial support was also provided by the Institut Pasteur in Paris. This study has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant no ANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Boneva RS, 2007, AIDS RES HUM RETROV, V23, P1330, DOI 10.1089/aid.2007.0104; Boyer PL, 2007, VIROLOGY, V367, P253, DOI 10.1016/j.virol.2007.05.034; Brooks JI, 2007, TRANSFUSION, V47, P162, DOI 10.1111/j.1537-2995.2007.01079.x; Calattini S, 2006, J MED PRIMATOL, V35, P59, DOI 10.1111/j.1600-0684.2006.00149.x; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Calattini S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-23; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Falcone V, 2003, CURR TOP MICROBIOL, V277, P161; Gessain A, 2013, VIROLOGY, V435, P187, DOI 10.1016/j.virol.2012.09.035; Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Khan AS, 2009, EXPERT REV ANTI-INFE, V7, P569, DOI [10.1586/eri.09.39, 10.1586/ERI.09.39]; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Murray SM, 2008, J VIROL, V82, P5981, DOI 10.1128/JVI.00367-08; Murray SM, 2006, J VIROL, V80, P663, DOI 10.1128/JVI.80.2.663-670.2006; Rethwilm A, 2010, MED MICROBIOL IMMUN, V199, P197, DOI 10.1007/s00430-010-0158-x; Rua R, 2012, J VIROL, V86, P13350, DOI 10.1128/JVI.01715-12; Rua R, 2012, J VIROL, V86, P909, DOI 10.1128/JVI.06235-11; Schweizer M, 1999, J VIROL, V73, P9256, DOI 10.1128/JVI.73.11.9256-9265.1999; Schweizer M, 1997, J VIROL, V71, P4821, DOI 10.1128/JVI.71.6.4821-4824.1997; SCHWEIZER M, 1995, VIROLOGY, V207, P577, DOI 10.1006/viro.1995.1120; Switzer WM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-100; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YU SF, 1993, J VIROL, V67, P6618, DOI 10.1128/JVI.67.11.6618-6624.1993	31	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77072	10.1371/journal.pone.0077072	http://dx.doi.org/10.1371/journal.pone.0077072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116202	gold, Green Submitted, Green Published			2022-12-27	WOS:000325552200098
J	Sanz-Menendez, L; Cruz-Castro, L; Alva, K				Sanz-Menendez, Luis; Cruz-Castro, Laura; Alva, Kenedy			Time to Tenure in Spanish Universities: An Event History Analysis	PLOS ONE			English	Article							SCIENTIFIC CAREERS; ACADEMIC CAREERS; SEX-DIFFERENCES; MOBILITY; PRODUCTIVITY; FACULTY; PROMOTION; SCIENCE; GENDER; PATTERNS	Understanding how institutional incentives and mechanisms for assigning recognition shape access to a permanent job is important. This study, based on data from questionnaire survey responses and publications of 1,257 university science, biomedical and engineering faculty in Spain, attempts to understand the timing of getting a permanent position and the relevant factors that account for this transition, in the context of dilemmas between mobility and permanence faced by organizations. Using event history analysis, the paper looks at the time to promotion and the effects of some relevant covariates associated to academic performance, social embeddedness and mobility. We find that research productivity contributes to career acceleration, but that other variables are also significantly associated to a faster transition. Factors associated to the social elements of academic life also play a role in reducing the time from PhD graduation to tenure. However, mobility significantly increases the duration of the non-tenure stage. In contrast with previous findings, the role of sex is minor. The variations in the length of time to promotion across different scientific domains is confirmed, with faster career advancement for those in the Engineering and Technological Sciences compared with academics in the Biological and Biomedical Sciences. Results show clear effects of seniority, and rewards to loyalty, in addition to some measurements of performance and quality of the university granting the PhD, as key elements speeding up career advancement. Findings suggest the existence of a system based on granting early permanent jobs to those that combine social embeddedness and team integration with some good credentials regarding past and potential future performance, rather than high levels of mobility.	[Sanz-Menendez, Luis; Cruz-Castro, Laura; Alva, Kenedy] CSIC, Inst Publ Goods & Policies IPP, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Politicas y Bienes Publicos (IPP)	Sanz-Menendez, L (corresponding author), CSIC, Inst Publ Goods & Policies IPP, Madrid, Spain.	Luis.Sanz@csic.es	Sanz-Menendez, Luis/AAH-8231-2020; Sanz-Menendez, Luis/F-2320-2013	Cruz-Castro, Laura/0000-0002-9786-6251; Sanz-Menendez, Luis/0000-0002-6869-8105	Ministry of Science and Innovation [CS0-2008-03100]; Ministry of Economy and Competitiveness [CSO2011-29431]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness	This research was funded by the Spanish National R&D Plan (Ministry of Science and Innovation grant CS0-2008-03100 and Ministry of Economy and Competitiveness grant CSO2011-29431) (http://www.mineco.gob.es/portal/site/mineco/idi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARGENS LL, 1969, SOCIOL EDUC, V42, P18; ALLISON PD, 1974, AM SOCIOL REV, V39, P596, DOI 10.2307/2094424; ALLISON PD, 1987, AM SOCIOL REV, V52, P643, DOI 10.2307/2095600; [Anonymous], 1995, PLACES INQUIRY RES A; ARAN L, 1968, J HEALTH SOC BEHAV, V9, P3, DOI 10.2307/2948313; Aziz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059814; Berelson Bernard., 1960, GRADUATE ED US; BLACKBURN RT, 1981, RES HIGH EDUC, V15, P315, DOI 10.1007/BF00973512; Blau PeterM., 1973, ORG ACAD WORK; Blossfeld H., 2007, EVENT HIST ANAL STAT; BOWEN WG, 1991, P NATL ACAD SCI USA, V88, P713, DOI 10.1073/pnas.88.3.713; Box-Steffensmeier JanetM., 2004, EVENT HIST MODELING; Bozeman B, 2001, INT J TECHNOL MANAGE, V22, P716, DOI 10.1504/IJTM.2001.002988; Bozeman B, 2007, ADMIN SOC, V39, P719, DOI 10.1177/0095399707304119; BRUDERL J, 1991, SOC SCI RES, V20, P197, DOI 10.1016/0049-089X(91)90005-N; Canibano C, 2011, SCIENTOMETRICS, V89, P653, DOI 10.1007/s11192-011-0462-2; Caplow Theodore., 1958, ACAD MARKET; CHUBIN DE, 1981, AM SOCIOL REV, V46, P488, DOI 10.2307/2095269; CLEMENTE F, 1973, AM J SOCIOL, V79, P409, DOI 10.1086/225553; Cleves M., 2008, INTRO SURVIVAL ANAL; Cole JR., 1979, FAIR SCI WOMEN SCI C; Cole S, 1992, MAKING SCI NATURE SO; COZZENS SE, 1985, SOC STUD SCI, V15, P127, DOI 10.1177/030631285015001005; COZZENS SE, 1989, SCIENTOMETRICS, V15, P437, DOI 10.1007/BF02017064; Cruz-Castro L, 2010, RES POLICY, V39, P27, DOI 10.1016/j.respol.2009.11.008; Dietz JS, 2000, SCIENTOMETRICS, V49, P419, DOI 10.1023/A:1010537606969; Dietz JS, 2005, RES POLICY, V34, P349, DOI 10.1016/j.respol.2005.01.008; Edler J, 2011, RES POLICY, V40, P791, DOI 10.1016/j.respol.2011.03.003; Ehrenberg RG, 1998, REV ECON STAT, V80, P503, DOI 10.1162/003465398557780; Enders J, 2001, ACAD STAFF EUROPE CH; Estermann T, 2011, U AUTONOMY EUROPELL; Forret ML, 2004, J ORGAN BEHAV, V25, P419, DOI 10.1002/job.253; FOX MF, 1983, SOC STUD SCI, V13, P285, DOI 10.1177/030631283013002005; Garcia CE, 2005, SCIENTOMETRICS, V64, P271, DOI 10.1007/s11192-005-0251-x; Gaughan M, 2004, RES POLICY, V33, P569, DOI 10.1016/j.respol.2004.01.005; Ginther DK, 2003, J HUM RESOUR, V38, P34, DOI 10.2307/1558755; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Haeussler C, 2013, RES POLICY, V42, P688, DOI 10.1016/j.respol.2012.09.009; HARGENS LL, 1982, SOCIOL EDUC, V55, P183, DOI 10.2307/2112671; HARGENS LL, 1967, SOCIOL EDUC, V40, P24, DOI 10.2307/2112185; Hargens LL, 2012, RES HIGH EDUC, V53, P311, DOI 10.1007/s11162-011-9228-1; Hoisl K, 2007, RES POLICY, V36, P619, DOI 10.1016/j.respol.2007.01.009; Horta H, 2010, MANAGE SCI, V56, P414, DOI 10.1287/mnsc.1090.1109; Horta H, 2013, HIGH EDUC, V65, P487, DOI 10.1007/s10734-012-9559-7; Ishida H, 2002, EUR SOCIOL REV, V18, P179, DOI 10.1093/esr/18.2.179; Jonkers K, 2011, RES EVALUAT, V20, P411, DOI 10.3152/095820211X13176484436177; Kaminski D, 2012, SCIENCE, V335, P864, DOI 10.1126/science.1214844; KATZ DA, 1973, AM ECON REV, V63, P469; Lassibille G, 2011, RES HIGH EDUC, V52, P63, DOI 10.1007/s11162-010-9186-z; Leahey E, 2010, RES SOC STRAT MOBIL, V28, P135, DOI 10.1016/j.rssm.2009.12.001; LEVIN SG, 1989, RES HIGH EDUC, V30, P531, DOI 10.1007/BF00992202; Levin SG., 1992, STRIKING MOTHER LODE; Leydesdorff L, 1998, SCIENTOMETRICS, V43, P5, DOI 10.1007/BF02458391; Lissoni F, 2011, IND CORP CHANGE, V20, P253, DOI 10.1093/icc/dtq073; LONG JS, 1993, AM SOCIOL REV, V58, P703, DOI 10.2307/2096282; LONG JS, 1995, ANNU REV SOCIOL, V21, P45, DOI 10.1146/annurev.so.21.080195.000401; LONG JS, 1981, AM SOCIOL REV, V46, P422, DOI 10.2307/2095262; Lopez MJG, 2006, HIGH EDUC, V51, P589, DOI 10.1007/s10734-004-1905-y; Martin-Sempere MJ, 2008, SCIENTOMETRICS, V76, P457, DOI 10.1007/s11192-007-1866-x; Mauleon E, 2008, RES EVALUAT, V17, P213, DOI 10.3152/095820208X331676; Melin G, 2005, RES EVALUAT, V14, P229, DOI 10.3152/147154405781776102; Melkers J, 2010, REV POLICY RES, V27, P389, DOI 10.1111/j.1541-1338.2010.00448.x; Mora JG, 2001, HIGH EDUC, V41, P131, DOI 10.1023/A:1026723014731; Morrison E, 2011, REV HIGH EDUC, V34, P525, DOI 10.1353/rhe.2011.0017; Musselin C, 2004, HIGH EDUC, V48, P55, DOI 10.1023/B:HIGH.0000033770.24848.41; Nakhaie MR, 2007, CAN REV SOC ANTHROP, V44, P361; Neumann A, 2007, J HIGH EDUC-UK, V78, P282, DOI 10.1353/jhe.2007.0018; OECD, 2008, GLOB COMP TAL MOB HI; OECD, 2010, PERF BAS FUND PUBL R; Osuna C, 2011, SCIENTOMETRICS, V86, P575, DOI 10.1007/s11192-010-0312-7; Pelz Donald C., 1966, SCI ORG PRODUCTIVE C; PFEFFER J, 1976, ADMIN SCI QUART, V21, P227, DOI 10.2307/2392044; Rinia EJ, 2001, SCIENTOMETRICS, V51, P293, DOI 10.1023/A:1010589300829; Rogelberg SG, 2007, ORGAN RES METHODS, V10, P195, DOI 10.1177/1094428106294693; Sabatier M, 2010, APPL ECON, V42, P2053, DOI 10.1080/00036840701765338; SALANCIK GR, 1978, US SOC PSYCHOL, V41, P246, DOI 10.2307/3033561; Sanz-Menendez L, 2001, RES EVALUAT, V10, P47, DOI 10.3152/147154401781777123; Sauermann H, 2013, ORGAN SCI, V24, P889, DOI 10.1287/orsc.1120.0769; Schuster J. K., 2006, AM FACULTY RESTRUCTU; Shauman KA, 1996, DEMOGRAPHY, V33, P455, DOI 10.2307/2061780; Siegfried JJ, 2001, J HUM RESOUR, V36, P364, DOI 10.2307/3069663; Siow A, 1998, J LAW ECON ORGAN, V14, P152, DOI 10.1093/oxfordjournals.jleo.a023395; Stewart P, 2009, CAN REV SOCIOL, V46, P59, DOI 10.1111/j.1755-618X.2009.01203.x; Tien FF, 2007, BRIT J SOCIOL EDUC, V28, P105, DOI 10.1080/01425690600996741; Wolfinger NH, 2008, J HIGH EDUC-UK, V79, P388, DOI 10.1353/jhe.0.0015; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; WYER JC, 1984, AM EDUC RES J, V21, P213, DOI 10.3102/00028312021001213; Xie Y., 2003, WOMEN SCI CAREER PRO; Zinovyeva N, 2010, FEDEA DOCUMENTOS TRA	89	26	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77028	10.1371/journal.pone.0077028	http://dx.doi.org/10.1371/journal.pone.0077028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116199	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200095
J	Kim, JSC; Vossel, G; Gamer, M				Kim, Johann Sung-Cheul; Vossel, Gerhard; Gamer, Matthias			Effects of Emotional Context on Memory for Details: The Role of Attention	PLOS ONE			English	Article							COGNITIVE NEUROSCIENCE; AROUSAL	It was repeatedly demonstrated that a negative emotional context enhances memory for central details while impairing memory for peripheral information. This trade-off effect is assumed to result from attentional processes: a negative context seems to narrow attention to central information at the expense of more peripheral details, thus causing the differential effects in memory. However, this explanation has rarely been tested and previous findings were partly inconclusive. For the present experiment 13 negative and 13 neutral naturalistic, thematically driven picture stories were constructed to test the trade-off effect in an ecologically more valid setting as compared to previous studies. During an incidental encoding phase, eye movements were recorded as an index of overt attention. In a subsequent recognition phase, memory for central and peripheral details occurring in the picture stories was tested. Explicit affective ratings and autonomic responses validated the induction of emotion during encoding. Consistent with the emotional trade-off effect on memory, encoding context differentially affected recognition of central and peripheral details. However, contrary to the common assumption, the emotional trade-off effect on memory was not mediated by attentional processes. By contrast, results suggest that the relevance of attentional processing for later recognition memory depends on the centrality of information and the emotional context but not their interaction. Thus, central information was remembered well even when fixated very briefly whereas memory for peripheral information depended more on overt attention at encoding. Moreover, the influence of overt attention on memory for central and peripheral details seems to be much lower for an arousing as compared to a neutral context.	[Kim, Johann Sung-Cheul; Gamer, Matthias] Univ Med Ctr, Dept Syst Neurosci, Hamburg, Germany; [Vossel, Gerhard] Johannes Gutenberg Univ Mainz, Dept Psychol, Interdisciplinary Res Grp Forens Psychophysiol, D-55122 Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Kim, JSC (corresponding author), Univ Med Ctr, Dept Syst Neurosci, Hamburg, Germany.	j.kim@uke.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038	European Science Foundation [09-ECRP-025]; German Research Foundation [GA 1621/1-1]	European Science Foundation(European Science Foundation (ESF)European Commission); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the European Science Foundation (09-ECRP-025, www.esf.org) and the German Research Foundation (GA 1621/1-1, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BATES D, 2009, ME4 LINEAR MIXED EFF; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bernat E, 2006, PSYCHOPHYSIOLOGY, V43, P93, DOI 10.1111/j.1469-8986.2006.00380.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BURKE A, 1992, MEM COGNITION, V20, P277, DOI 10.3758/BF03199665; CACIOPPO JT, 1993, HE PSYCHOPHYSIOLOGY, V2, P173; Chentsova-Dutton YE, 2007, COGNITION EMOTION, V21, P162, DOI 10.1080/02699930600911333; CHRISTIANSON SA, 1991, J EXP PSYCHOL LEARN, V17, P693, DOI 10.1037/0278-7393.17.4.693; CHRISTIANSON SA, 1992, PSYCHOL BULL, V112, P284, DOI 10.1037/0033-2909.112.2.284; CLIFFORD BR, 1978, J APPL PSYCHOL, V63, P352, DOI 10.1037/0021-9010.63.3.352; CLIFFORD BR, 1981, J APPL PSYCHOL, V66, P364, DOI 10.1037/0021-9010.66.3.364; Cohn N, 2012, COGNITIVE PSYCHOL, V65, P1, DOI 10.1016/j.cogpsych.2012.01.003; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Guy SC, 1999, CONSCIOUS COGN, V8, P114, DOI 10.1006/ccog.1998.0379; HEUER F, 1990, MEM COGNITION, V18, P496, DOI 10.3758/BF03198482; Jay T, 2008, AM J PSYCHOL, V121, P83, DOI 10.2307/20445445; KEBECK G, 1986, PERCEPT MOTOR SKILL, V63, P461; Kensinger EA, 2007, J MEM LANG, V56, P575, DOI 10.1016/j.jml.2006.05.004; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Laney C, 2004, MEM COGNITION, V32, P1149, DOI 10.3758/BF03196888; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang PJ, 2008, INT AFFECTIVE PICTUR; LARSEN JT, 2006, HE PSYCHOPHYSIOLOGY, V1, P1; LOFTUS EF, 1982, MEM COGNITION, V10, P318, DOI 10.3758/BF03202423; LOFTUS EF, 1987, LAW HUMAN BEHAV, V11, P55, DOI 10.1007/BF01044839; LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Nobata T, 2010, COGNITION EMOTION, V24, P886, DOI 10.1080/02699930902955954; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PHELPS EA, 2009, EMOTIONAL INFLUENCES, P941; Reisberg D., 2004, MEMORY EMOTION, P3, DOI [10.1093/acprof:oso/9780195158564.003.0001, DOI 10.1093/ACPR0F:0S0/9780195158564.003.0001]; Riggs L, 2011, EMOTION, V11, P776, DOI 10.1037/a0022591; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STEBLAY NM, 1992, LAW HUMAN BEHAV, V16, P413, DOI 10.1007/BF02352267; Steinmetz KRM, 2013, MEM COGNITION, V41, P69, DOI 10.3758/s13421-012-0247-8; Velden M., 1987, J PSYCHOPHYSIOL, V1, P173; Wessel I, 2000, MEMORY, V8, P97; Wright DB, 2009, BRIT J MATH STAT PSY, V62, P439, DOI 10.1348/000711008X327632; Yegiyan NS, 2010, MEDIA PSYCHOL, V13, P77, DOI 10.1080/15213260903563014; Zaki J, 2009, ANN NY ACAD SCI, V1167, P16, DOI 10.1111/j.1749-6632.2009.04601.x	46	15	15	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77405	10.1371/journal.pone.0077405	http://dx.doi.org/10.1371/journal.pone.0077405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116226	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300118
J	Studer, B; Pedroni, A; Rieskamp, J				Studer, Bettina; Pedroni, Andreas; Rieskamp, Joerg			Predicting Risk-Taking Behavior from Prefrontal Resting-State Activity and Personality	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; DECISION-MAKING; INDIVIDUAL-DIFFERENCES; INHIBITION; ACTIVATION; CORTEX; RELIABILITY; SENSITIVITY; PUNISHMENT; REWARD	Risk-taking is subject to considerable individual differences. In the current study, we tested whether resting-state activity in the prefrontal cortex and trait sensitivity to reward and punishment can help predict risk-taking behavior. Prefrontal activity at rest was assessed in seventy healthy volunteers using electroencephalography, and compared to their choice behavior on an economic risk-taking task. The Behavioral Inhibition System/Behavioral Activation System scale was used to measure participants' trait sensitivity to reward and punishment. Our results confirmed both prefrontal resting-state activity and personality traits as sources of individual differences in risk-taking behavior. Right-left asymmetry in prefrontal activity and scores on the Behavioral Inhibition System scale, reflecting trait sensitivity to punishment, were correlated with the level of risk-taking on the task. We further discovered that scores on the Behavioral Inhibition System scale modulated the relationship between asymmetry in prefrontal resting-state activity and risk-taking. The results of this study demonstrate that heterogeneity in risk-taking behavior can be traced back to differences in the basic physiology of decision-makers' brains, and suggest that baseline prefrontal activity and personality traits might interplay in guiding risk-taking behavior.	[Studer, Bettina; Pedroni, Andreas; Rieskamp, Joerg] Univ Basel, Dept Psychol, Basel, Switzerland; [Studer, Bettina] UCL, Inst Cognit Neurosci, London, England	University of Basel; University of London; University College London	Studer, B (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	b.studer@ucl.ac.uk	Studer, Bettina/AAI-8179-2021; Studer, Bettina/AFV-9290-2022; Rieskamp, Joerg/D-4004-2013; Studer, Bettina/E-6177-2017	Studer, Bettina/0000-0002-9483-385X; Studer, Bettina/0000-0002-9483-385X; Rieskamp, Joerg/0000-0003-2632-8015; Studer, Bettina/0000-0002-9483-385X	University of Basel; Swiss National Science Foundation [CRSII1_136227, PBSKP3_138595]	University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the University of Basel (http://www.unibas.ch). AP and JR acknowledge support of the Swiss National Science Foundation (http://www.snf.ch) [grant number CRSII1_136227]. BS is also supported by the Swiss National Science Foundation [grant number PBSKP3_138595]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelt KC, 2011, JUDGM DECIS MAK, V6, P252; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Brand M, 2008, PERS INDIV DIFFER, V45, P226, DOI 10.1016/j.paid.2008.04.003; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Coan JA, 2003, PSYCHOPHYSIOLOGY, V40, P106, DOI 10.1111/1469-8986.00011; Corsi-Cabrera M, 2007, CLIN NEUROPHYSIOL, V118, P9, DOI 10.1016/j.clinph.2006.08.013; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Fox CR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00298; Franken IHA, 2005, PERS INDIV DIFFER, V39, P991, DOI 10.1016/j.paid.2005.04.004; Gianotti LR, 2009, PSYCHOL SCI, V20, P33, DOI 10.1111/j.1467-9280.2008.02260.x; Goudriaan AE, 2006, DRUG ALCOHOL DEPEN, V84, P231, DOI 10.1016/j.drugalcdep.2006.02.007; Gray J. A., 1972, BIOL BASES INDIVIDUA, P182, DOI [10.1016/0005-7967(70)90069-0, DOI 10.1016/B978-0-12-515350-8.50017-X]; Gray J. A., 2003, NEUROPSYCHOLOGY ANXI; Gray J. A., 1981, MODEL PERSONALITY, P246, DOI [10.1007/978-3-642-67783-0_8, DOI 10.1007/978-3-642-67783-0_8]; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hewig J, 2006, BIOL PSYCHOL, V71, P42, DOI 10.1016/j.biopsycho.2005.01.006; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kim DY, 2011, PERS INDIV DIFFER, V50, P1131, DOI 10.1016/j.paid.2011.01.041; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Levin IP, 2002, ORGAN BEHAV HUM DEC, V88, P411, DOI 10.1006/obhd.2001.2983; Logothetis NK, 2009, NEUROIMAGE, V45, P1080, DOI 10.1016/j.neuroimage.2009.01.010; Luchinger R, 2012, NEUROIMAGE, V60, P1426, DOI 10.1016/j.neuroimage.2012.01.031; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Massar SAA, 2012, CLIN NEUROPHYSIOL, V123, P1958, DOI 10.1016/j.clinph.2012.03.005; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Oakes TR, 2004, HUM BRAIN MAPP, V21, P257, DOI 10.1002/hbm.20004; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schutter DJLG, 2005, COGNITIVE BRAIN RES, V24, P685, DOI 10.1016/j.cogbrainres.2005.04.002; Shackman AJ, 2009, PSYCHOL SCI, V20, P1500, DOI 10.1111/j.1467-9280.2009.02476.x; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; Suhr JA, 2007, PERS INDIV DIFFER, V43, P27, DOI 10.1016/j.paid.2006.11.004; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Venkatraman V, 2012, EUR J NEUROSCI, V35, P1075, DOI 10.1111/j.1460-9568.2012.08009.x; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475	47	24	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76861	10.1371/journal.pone.0076861	http://dx.doi.org/10.1371/journal.pone.0076861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116176	Green Published, gold			2022-12-27	WOS:000325501300102
J	Bajic, A; Spasic, M; Andjus, PR; Savic, D; Parabucki, A; Nikolic-Kokic, A; Spasojevic, I				Bajic, Aleksandar; Spasic, Mihajlo; Andjus, Pavle R.; Savic, Danijela; Parabucki, Ana; Nikolic-Kokic, Aleksandra; Spasojevic, Ivan			Fluctuating vs. Continuous Exposure to H2O2: The Effects on Mitochondrial Membrane Potential, Intracellular Calcium, and NF-kappa B in Astroglia	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PERMEABILITY TRANSITION; GENE-EXPRESSION; CELL-CULTURE; REDOX STATE; ASTROCYTES; ACTIVATION; NEURONS; DEATH	The effects of H2O2 are widely studied in cell cultures and other in vitro systems. However, such investigations are performed with the assumption that H2O2 concentration is constant, which may not properly reflect in vivo settings, particularly in redox-turbulent microenvironments such as mitochondria. Here we introduced and tested a novel concept of fluctuating oxidative stress. We treated C6 astroglial cells and primary astrocytes with H2O2, using three regimes of exposure - continuous, as well as fluctuating at low or high rate, and evaluated mitochondrial membrane potential and other parameters of mitochondrial activity - respiration, reducing capacity, and superoxide production, as well as intracellular ATP, intracellular calcium, and NF-kappa B activation. When compared to continuous exposure, fluctuating H2O2 induced a pronounced hyperpolarization in mitochondria, whereas the activity of electron transport chain appears not to be significantly affected. H2O2 provoked a decrease of ATP level and an increase of intracellular calcium concentration, independently of the regime of treatment. However, fluctuating H2O2 induced a specific pattern of large-amplitude fluctuations of calcium concentration. An impact on NF kappa B activation was observed for high rate fluctuations, whereas continuous and low rate fluctuating oxidative stress did not provoke significant effects. Presented results outline the (patho)physiological relevance of redox fluctuations.	[Bajic, Aleksandar; Andjus, Pavle R.] Univ Belgrade, Fac Biol, Ctr Laser Microscopy, Belgrade, Serbia; [Spasic, Mihajlo; Nikolic-Kokic, Aleksandra] Univ Belgrade, Dept Physiol, Inst Biol Res Sinisa Stankov, Belgrade, Serbia; [Savic, Danijela; Parabucki, Ana] Univ Belgrade, Dept Neurobiol, Inst Biol Res Sinisa Stankov, Belgrade, Serbia; [Spasojevic, Ivan] Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Spasojevic, I (corresponding author), Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia.	redoxsci@gmail.com	Nikolic-Kokic, Aleksandra/AAD-5591-2022; Savic, Danijela/I-7471-2019; Spasic, Mihajlo/AAE-9381-2020	Savic, Danijela/0000-0001-7411-4527; Spasojevic, Ivan/0000-0002-3150-3087; Nikolic-Kokic, Aleksandra/0000-0002-1116-2035; Bajic, Aleksandar/0000-0002-1255-9835; Spasic, Mihajlo/0000-0001-9046-0139	Ministry of Education and Science of the Republic of Serbia [III41005, OI173014, III41014]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of the Republic of Serbia grant numbers, III41005, OI173014, and III41014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Boll MC, 2008, NEUROCHEM RES, V33, P1717, DOI 10.1007/s11064-008-9610-3; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Choi JJ, 2007, FREE RADICAL RES, V41, P555, DOI 10.1080/10715760601173010; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Desagher S, 1996, J NEUROSCI, V16, P2553; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dunn JF, 2003, METHODS, V30, P159, DOI 10.1016/S1046-2023(03)00077-X; GILLE JJP, 1992, MUTAT RES, V275, P405, DOI 10.1016/0921-8734(92)90043-O; Grover D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007580; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Li R, 2011, CURR PROTOC CYTOM, V9, P37; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Makino N, 2008, BBA-GEN SUBJECTS, V1780, P927, DOI 10.1016/j.bbagen.2008.03.010; Miljkovic D, 2013, ANTIOXID REDOX SIGN, V19, P2286, DOI 10.1089/ars.2012.5068; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Sani M, 2006, COMP BIOCHEM PHYS B, V145, P331, DOI 10.1016/j.cbpb.2006.08.005; Scorrano L, 1999, J BIOL CHEM, V274, P24657, DOI 10.1074/jbc.274.35.24657; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Spasojevic I, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/596019; Spasojevic I, 2010, REDOX REP, V15, P29, DOI 10.1179/174329210X12650506623087; Spaspjevic I, 2009, CARBOHYD RES, V344, P1676, DOI 10.1016/j.carres.2009.05.023; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; SWARTZ HM, 1994, MAGN RESON MED, V31, P229, DOI 10.1002/mrm.1910310218; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1379, DOI 10.1089/ars.2010.3645; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Xie W, 2008, THESIS IOWA STATE U; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Yoo BK, 2005, NEUROSCI RES, V51, P39, DOI 10.1016/j.neures.2004.09.008; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	46	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76383	10.1371/journal.pone.0076383	http://dx.doi.org/10.1371/journal.pone.0076383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124554	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100111
J	Cornelissen, L; Fabrizi, L; Patten, D; Worley, A; Meek, J; Boyd, S; Slater, R; Fitzgerald, M				Cornelissen, Laura; Fabrizi, Lorenzo; Patten, Deborah; Worley, Alan; Meek, Judith; Boyd, Stewart; Slater, Rebeccah; Fitzgerald, Maria			Postnatal Temporal, Spatial and Modality Tuning of Nociceptive Cutaneous Flexion Reflexes in Human Infants	PLOS ONE			English	Article							SPINAL DORSAL-HORN; SUBSTANTIA-GELATINOSA NEURONS; C-FOS; ELECTRICAL-STIMULATION; CENTRAL SENSITIZATION; WITHDRAWAL REFLEX; RECEPTIVE-FIELDS; EVOKED ALLODYNIA; FLEXOR REFLEX; LOWER-LIMB	Cutaneous flexion reflexes are amongst the first behavioural responses to develop and are essential for the protection and survival of the newborn organism. Despite this, there has been no detailed, quantitative study of their maturation in human neonates. Here we use surface electromyographic (EMG) recording of biceps femoris activity in preterm (<37 weeks gestation, GA) and term (>= 37 weeks GA) human infants, less than 14 days old, in response to tactile, punctate and clinically required skin-breaking lance stimulation of the heel. We show that all infants display a robust and long duration flexion reflex (>4 seconds) to a single noxious skin lance which decreases significantly with gestational age. This reflex is not restricted to the stimulated limb: heel lance evokes equal ipsilateral and contralateral reflexes in preterm and term infants. We further show that infant flexion withdrawal reflexes are not always nociceptive specific: in 29% of preterm infants, tactile stimulation evokes EMG activity that is indistinguishable from noxious stimulation. In 40% of term infants, tactile responses are also present but significantly smaller than nociceptive reflexes. Infant flexion reflexes are also evoked by application of calibrated punctate von Frey hairs (vFh), 0.8-17.2 g, to the heel. Von Frey hair thresholds increase significantly with gestational age and the magnitude of vFh evoked reflexes are significantly greater in preterm than term infants. Furthermore flexion reflexes in both groups are sensitized by repeated vFh stimulation. Thus human infant flexion reflexes differ in temporal, modality and spatial characteristics from those in adults. Reflex magnitude and tactile sensitivity decreases and nociceptive specificity and spatial organisation increases with gestational age. Strong, relatively non-specific, reflex sensitivity in early life may be important for driving postnatal activity dependent maturation of targeted spinal cord sensory circuits.	[Cornelissen, Laura; Fabrizi, Lorenzo; Patten, Deborah; Slater, Rebeccah; Fitzgerald, Maria] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Meek, Judith] Univ Coll Hosp, Elizabeth Garrett Anderson Obstet Wing, London, England; [Worley, Alan; Boyd, Stewart] Great Ormond St Hosp Sick Children, Dept Clin Neurophysiol, London WC1N 3JH, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Fitzgerald, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	m.fitzgerald@ucl.ac.uk	Boyd, Stewart/O-3770-2019; Fabrizi, Lorenzo/H-8135-2019	Boyd, Stewart/0000-0001-7363-2453; Fabrizi, Lorenzo/0000-0002-9582-0727; Slater, Rebeccah/0000-0003-1595-4846; Cornelissen, Laura/0000-0001-8579-0870	Wellcome Trust; Medical Research Council; MRC DTA PhD studentship; Medical Research Council [G0502146] Funding Source: researchfish; MRC [G0502146] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC DTA PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by the Wellcome Trust and Medical Research Council. LC was funded by an MRC DTA PhD studentship. This research was carried out at the National Institute for Health Research (NIHR) UCLH Clinical Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2004, METH MOLEC MED, P11; ANDREWS K, 1994, PAIN, V56, P95, DOI 10.1016/0304-3959(94)90154-6; Andrews K, 1999, DEV MED CHILD NEUROL, V41, P696, DOI 10.1017/S0012162299001425; [Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; Arendt-Nielsen L, 2000, EUR J APPL PHYSIOL, V81, P165, DOI 10.1007/s004210050026; ARENDTNIELSEN L, 1994, EUR J APPL PHYSIOL O, V68, P266, DOI 10.1007/BF00376776; Baccei ML, 2004, J NEUROSCI, V24, P4749, DOI 10.1523/JNEUROSCI.5211-03.2004; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beggs S, 2002, EUR J NEUROSCI, V16, P1249, DOI 10.1046/j.1460-9568.2002.02185.x; Bjerre L, 2011, EUR J PAIN, V15, P816, DOI 10.1016/j.ejpain.2011.01.015; Campbell CM, 2008, PAIN, V134, P91, DOI 10.1016/j.pain.2007.03.035; CHAN CWY, 1989, BRAIN RES, V479, P145, DOI 10.1016/0006-8993(89)91344-9; Daniele CA, 2009, J NEUROSCI, V29, P686, DOI 10.1523/JNEUROSCI.5120-08.2009; Decchi B, 1997, ELECTROMYOGR MOTOR C, V105, P484, DOI 10.1016/S0924-980X(97)00048-9; Ekholm J, 1967, ACTA SOC MED UPS, V1967; Fabrizi L, 2011, CURR BIOL, V21, P1552, DOI 10.1016/j.cub.2011.08.010; Fields HL, 2000, PROG BRAIN RES, V122, P245; Fitzgerald M, 1999, P NATL ACAD SCI USA, V96, P7719, DOI 10.1073/pnas.96.14.7719; FITZGERALD M, 1988, LANCET, V1, P292; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FITZGERALD M, 1984, NEUROSCIENCE, V13, P933, DOI 10.1016/0306-4522(84)90107-6; FITZGERALD M, 1988, DEV MED CHILD NEUROL, V30, P520; FITZGERALD M, 1989, PAIN, V39, P31, DOI 10.1016/0304-3959(89)90172-3; FITZGERALD M, 1985, J PHYSIOL-LONDON, V364, P1; Gaspardo CM, 2008, PAIN, V140, P58, DOI 10.1016/j.pain.2008.07.004; Granmo M, 2008, J NEUROSCI, V28, P5494, DOI 10.1523/JNEUROSCI.0651-08.2008; Hathway GJ, 2009, J PHYSIOL-LONDON, V587, P2927, DOI 10.1113/jphysiol.2008.168013; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hellerud BC, 2002, EARLY HUM DEV, V70, P35, DOI 10.1016/S0378-3782(02)00070-1; Hochman S, 2012, FRONT BIOSCI-LANDMRK, V17, P2158, DOI 10.2741/4043; Jennings E, 1998, J PHYSIOL-LONDON, V509, P859, DOI 10.1111/j.1469-7793.1998.859bm.x; Jennings E, 1996, PAIN, V68, P301, DOI 10.1016/S0304-3959(96)03194-6; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Koch SC, 2013, ANN NY ACAD SCI, V1279, P97, DOI 10.1111/nyas.12033; Koch SC, 2012, P NATL ACAD SCI USA, V109, P12201, DOI 10.1073/pnas.1118960109; KUGELBERG E, 1960, BRAIN, V83, P394, DOI 10.1093/brain/83.3.394; Le Bars D, 2001, PHARMACOL REV, V53, P597; Levinsson A, 1999, J NEUROSCI, V19, P10397; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Miraucourt LS, 2009, J NEUROSCI, V29, P2519, DOI 10.1523/JNEUROSCI.3923-08.2009; Nakatsuka T, 2000, NEUROSCIENCE, V99, P549, DOI 10.1016/S0306-4522(00)00224-4; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Neziri AY, 2010, PAIN, V151, P798, DOI 10.1016/j.pain.2010.09.017; Park JS, 1999, DEV BRAIN RES, V113, P29, DOI 10.1016/S0165-3806(98)00186-2; PRICE DD, 1972, EXP NEUROL, V37, P371, DOI 10.1016/0014-4886(72)90081-7; Rhudy JL, 2011, J PAIN, V12, P782, DOI 10.1016/j.jpain.2011.01.002; Ririe DG, 2008, ANESTHESIOLOGY, V109, P698, DOI 10.1097/ALN.0b013e3181870a32; Roy M, 2012, EUR J PAIN, V16, P870, DOI 10.1002/j.1532-2149.2011.00030.x; Ruscheweyh R, 2011, PAIN, V152, P2662, DOI 10.1016/j.pain.2011.08.016; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67; Sherman SE, 1996, PAIN, V66, P321, DOI 10.1016/0304-3959(96)03063-1; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0; SKOGLUND S, 1960, NATURE, V187, P132, DOI 10.1038/187132a0; TODD AJ, 1990, NEUROSCIENCE, V39, P387, DOI 10.1016/0306-4522(90)90275-9; Waldenstrom A, 2003, J NEUROSCI, V23, P7719; Walker SM, 2007, PAIN, V128, P157, DOI 10.1016/j.pain.2006.09.015; WIESENFELDHALLIN Z, 1984, BRAIN RES, V311, P375, DOI 10.1016/0006-8993(84)90104-5; WILLER JC, 1979, PAIN, V7, P15, DOI 10.1016/0304-3959(79)90103-9; WILLIAMS S, 1990, NEUROSCI LETT, V109, P309, DOI 10.1016/0304-3940(90)90013-Y; Woolf CJ, 2007, ANESTHESIOLOGY, V106, P864, DOI 10.1097/01.anes.0000264769.87038.55; Worley A, 2012, J NEUROSCI METH, V205, P252, DOI 10.1016/j.jneumeth.2012.01.009; Wu J, 2012, BRAIN RES, V1448, P11, DOI 10.1016/j.brainres.2012.02.002; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7	68	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76470	10.1371/journal.pone.0076470	http://dx.doi.org/10.1371/journal.pone.0076470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124564	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100121
J	Jiang, ZH; Zhu, S; Ye, R; Xue, Y; Chen, A; An, LZ; Pei, ZM				Jiang, Zhonghao; Zhu, Shan; Ye, Rui; Xue, Yan; Chen, Amelia; An, Lizhe; Pei, Zhen-Ming			Relationship between NaCl- and H2O2-Induced Cytosolic Ca2+ Increases in Response to Stress in Arabidopsis	PLOS ONE			English	Article							OXIDATIVE STRESS; SALT TOLERANCE; ION CHANNELS; CALCIUM; HOMEOSTASIS; THALIANA; DROUGHT; SIGNALS; NADPH; SOS1	Salinity is among the environmental factors that affect plant growth and development and constrain agricultural productivity. Salinity stress triggers increases in cytosolic free Ca2+ concentration ([Ca2+](i)) via Ca2+ influx across the plasma membrane. Salinity stress, as well as other stresses, induces the production of reactive oxygen species (ROS). It is well established that ROS also triggers increases in [Ca2+](i). However, the relationship and interaction between salinity stress-induced [Ca2+](i) increases and ROS-induced [Ca2+](i) increases remain poorly understood. Using an aequorin-based Ca2+ imaging assay we have analyzed [Ca2+](i) changes in response to NaCl and H2O2 treatments in Arabidopsis thaliana. We found that NaCl and H2O2 together induced larger increases in [Ca2+](i) in Arabidopsis seedlings than either NaCl or H2O2 alone, suggesting an additive effect on [Ca2+](i) increases. Following a pretreatment with either NaCl or H2O2, the subsequent elevation of [Ca2+](i) in response to a second treatment with either NaCl or H2O2 was significantly reduced. Furthermore, the NaCl pre-treatment suppressed the elevation of [Ca2+](i) seen with a second NaCl treatment more than that seen with a second treatment of H2O2. A similar response was seen when the initial treatment was with H2O2; subsequent addition of H2O2 led to less of an increase in [Ca2+](i) than did addition of NaCl. These results imply that NaCl-gated Ca2+ channels and H2O2-gated Ca2+ channels may differ, and also suggest that NaCl-and H2O2-evoked [Ca2+](i) may reduce the potency of both NaCl and H2O2 in triggering [Ca2+](i) increases, highlighting a feedback mechanism. Alternatively, NaCl and H2O2 may activate the same Ca2+ permeable channel, which is expressed in different types of cells and/or activated via different signaling pathways.	[Jiang, Zhonghao; An, Lizhe] Lanzhou Univ, Sch Life Sci, Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Gansu, Peoples R China; [Jiang, Zhonghao; Zhu, Shan; Pei, Zhen-Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Global Change, Ctr Plant Environm Sensing, Hangzhou, Zhejiang, Peoples R China; [Jiang, Zhonghao; Ye, Rui; Xue, Yan; Chen, Amelia; Pei, Zhen-Ming] Duke Univ, Dept Biol, Durham, NC USA	Lanzhou University; Hangzhou Normal University; Duke University	Pei, ZM (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Global Change, Ctr Plant Environm Sensing, Hangzhou, Zhejiang, Peoples R China.	zpei@duke.edu	Yang, Xiaoming/GRJ-9483-2022	Yang, Xiaoming/0000-0002-1792-6921; Jiang, Zhonghao/0000-0002-6675-5997; Pei, Zhen-Ming/0000-0003-1473-696X	China Scholarship Council; Hangzhou Normal University [PD11001008001, PD11002002004002]; Zhejiang NSF [Z3110443]; USDA [CSREES-2006-35100-17304]; NSF [IOS-0848263]	China Scholarship Council(China Scholarship Council); Hangzhou Normal University; Zhejiang NSF; USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	ZJ and SZ were supported by fellowships from China Scholarship Council, Pandeng Project funds (PD11001008001; PD11002002004002) from Hangzhou Normal University, and a grant from Zhejiang NSF (Z3110443). This work is supported by grants from USDA (CSREES-2006-35100-17304) and from NSF (IOS-0848263) to ZMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kwaaitaal M, 2011, BIOCHEM J, V440, P355, DOI 10.1042/BJ20111112; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; MA W, 2011, CA2 CONDUCTION PLANT, DOI DOI 10.1111/J.1469-8137.2010.03577.X.PUBMED:21166809; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; McAinsh MR, 1996, PLANT PHYSIOL, V111, P1031, DOI 10.1104/pp.111.4.1031; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Tracy FE, 2008, PLANT CELL ENVIRON, V31, P1063, DOI 10.1111/j.1365-3040.2008.01817.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vaidyanathan H, 2003, PLANT SCI, V165, P1411, DOI 10.1016/j.plantsci.2003.08.005; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Waring P, 2005, ARCH BIOCHEM BIOPHYS, V434, P33, DOI 10.1016/j.abb.2004.08.001; WISE RR, 1987, PLANT PHYSIOL, V83, P272, DOI 10.1104/pp.83.2.272; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	42	25	29	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76130	10.1371/journal.pone.0076130	http://dx.doi.org/10.1371/journal.pone.0076130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124535	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100092
J	Kolozsvari, BL; Berta, A; Petrovski, G; Mihaltz, K; Gogolak, P; Rajnavolgyi, E; Hassan, Z; Szeles, P; Fodor, M				Kolozsvari, Bence Lajos; Berta, Andras; Petrovski, Goran; Mihaltz, Kata; Gogolak, Peter; Rajnavoelgyi, Eva; Hassan, Ziad; Szeles, Peter; Fodor, Mariann			Alterations of Tear Mediators in Patients with Keratoconus after Corneal Crosslinking Associate with Corneal Changes	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROGRESSIVE KERATOCONUS; INFLAMMATORY MOLECULES; ULTRAVIOLET-A; MATRIX-METALLOPROTEINASES; COLLAGEN; RIBOFLAVIN; ECTASIA; DEGRADATION; EXPRESSION	Keratoconus (KC) is the most common primary corneal ectatic disease which has considerable importance in public health. Corneal collagen crosslinking (CXL) is a procedure to mitigate progression of KC and reduce demand for corneal transplantation. Although studies have proven the efficacy of CXL regarding corneal shape, none have investigated the effects of CXL on tear biomarkers which are useful tools to understand molecular mechanisms behind CXL. Our purpose was to determine the effect of CXL on tear mediators in patients with KC and analyze associations with corneal changes. Tear samples were collected pre-CXL from 26 eyes of 23 patients and during a 12-month follow-up. The mediators' concentration was measured by Cytometric Bead Array technology. Corneal topography parameters measured by Scheimpflug Camera included: Thinnest-corneal-thickness (ThCT), keratometry values (K1, K2), Radii-Minimum (Rmin), Keratoconus-Index (KI), Center-KI (CKI), Index-of-Height Asymmetry (IHA) and Index-of-Surface Variance (ISV). At baseline, KI was correlated negatively with chemokine (C-C motif) ligand 5 (CCL5) (p=0.015) and matrix metalloproteinase (MMP)-13 (p=0.007). At day 4, interleukin (IL)-6 and IL-8 increased, while IL-13, IL-17A, interferon (IFN)-gamma, CCL5, MMP-13, epidermal growth factor (EGF), nerve growth factor (NGF) and plasminogen activator inhibitor (PAI-1) decreased significantly compared to pre-CXL concentrations (p=0.02). At 6 months tissue plasminogen activator (t-PA) increased (p=0.02), while at 12 months Rmin increased (p=0.004), and IL-6 and CXCL8 (p=0.005 and p=0.047) as well as K1, ISV and KI decreased. After 6 months CKI and ISV showed significant associations with IL-17A; CKI with IL-13 and ThCT with IL-13 (p=0.02), while at 12 months there were reverse associations between ThCT and IL-6, IL-13, INF gamma, CCL5 and PAI-1 (p=0.02). Alterations of mediators in tear fluid after CXL associate with topographic changes highlight the fact that many mediators are involved in the complex mechanisms after CXL. Further studies on biomarkers to investigate the efficacy of CXL are needed.	[Kolozsvari, Bence Lajos; Berta, Andras; Hassan, Ziad; Szeles, Peter; Fodor, Mariann] Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Petrovski, Goran] Univ Debrecen, Stem Cells & Eye Res Lab, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Petrovski, Goran] Univ Szeged, Dept Ophthalmol, Fac Med, Szeged, Hungary; [Mihaltz, Kata] Hietzing Hosp, Dept Ophthalmol, Vienna, Austria; [Gogolak, Peter; Rajnavoelgyi, Eva] Univ Debrecen, Dept Immunol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; Szeged University; Hietzing Hospital; University of Debrecen	Fodor, M (corresponding author), Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary.	mfodor@med.unideb.hu		Petrovski, Goran/0000-0003-2905-9252; Gogolak, Peter/0000-0001-9411-9587; Fodor, Mariann/0000-0002-1089-3899	Mecenatura Research Grant, Medical and Health Sciences Centre, Faculty of Medicine, University of Debrecen [DEOEC Mec-4/2011]	Mecenatura Research Grant, Medical and Health Sciences Centre, Faculty of Medicine, University of Debrecen	This work was supported by the Mecenatura Research Grant, Medical and Health Sciences Centre, Faculty of Medicine, University of Debrecen (DEOEC Mec-4/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalain JH, 2000, CORNEA, V19, P474, DOI 10.1097/00003226-200007000-00014; Asri D, 2011, J CATARACT REFR SURG, V37, P2137, DOI 10.1016/j.jcrs.2011.08.026; Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Bhogal R, 2008, INT REV IMMUNOL, V27, P472, DOI 10.1080/08830180802430974; Brooks NO, 2012, J CATARACT REFR SURG, V38, P615, DOI 10.1016/j.jcrs.2011.11.029; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Ebihara N, 2011, INVEST OPHTH VIS SCI, V52, P8549, DOI 10.1167/iovs.11-7956; Fodor M, 2009, J INTERF CYTOK RES, V29, P375, DOI 10.1089/jir.2008.0116; Greenstein SA, 2012, J CATARACT REFR SURG, V38, P292, DOI 10.1016/j.jcrs.2011.08.041; Greenstein SA, 2011, J CATARACT REFR SURG, V37, P1282, DOI 10.1016/j.jcrs.2011.01.029; Hafezi F, 2009, J CATARACT REFR SURG, V35, P621, DOI 10.1016/j.jcrs.2008.10.060; Hersh PS, 2011, J CATARACT REFR SURG, V37, P149, DOI 10.1016/j.jcrs.2010.07.030; Jun AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016437; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Koller T, 2009, CORNEA, V28, P510, DOI 10.1097/ICO.0b013e3181915943; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Kranitz K, 2012, J REFRACT SURG, V28, P645, DOI 10.3928/1081597X-20120823-01; Lambiase A, 2012, CURR OPIN OPHTHALMOL, V23, P296, DOI 10.1097/ICU.0b013e3283543b61; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Lema I, 2008, CORNEA, V27, P758, DOI 10.1097/ICO.0b013e31816a3591; Liu Q, 2009, EYE CONTACT LENS, V35, P232, DOI 10.1097/ICL.0b013e3181b3e87f; Matthews FJ, 2007, EXP EYE RES, V84, P1125, DOI 10.1016/j.exer.2007.02.013; Mazzotta C, 2008, AM J OPHTHALMOL, V146, P527, DOI 10.1016/j.ajo.2008.05.042; Mazzotta C, 2012, ACTA OPHTHALMOL, V90, P259, DOI 10.1111/j.1755-3768.2010.01890.x; McMonnies Charles W, 2007, Eye Contact Lens, V33, P265, DOI 10.1097/ICL.0b013e31814fb64b; Pannebaker C, 2010, MOL VIS, V16, P1949; Qiu Z, 2009, IMMUNOBIOLOGY, V214, P835, DOI 10.1016/j.imbio.2009.06.007; RABINOWITZ YS, 1995, J REFRACT SURG, V11, P371; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Saghizadeh M, 2001, EXP EYE RES, V73, P179, DOI 10.1006/exer.2001.1028; Vinciguerra P, 2009, ARCH OPHTHALMOL-CHIC, V127, P1258, DOI 10.1001/archophthalmol.2009.205; Wilson SE, 1999, INVEST OPHTH VIS SCI, V40, P2185; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2007, CORNEA, V26, P600, DOI 10.1097/ICO.0b013e318041f073; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	37	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76333	10.1371/journal.pone.0076333	http://dx.doi.org/10.1371/journal.pone.0076333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124547	gold, Green Published			2022-12-27	WOS:000325489100104
J	Nanduri, J; Vaddi, DR; Khan, SA; Wang, N; Makerenko, V; Prabhakar, NR				Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makerenko, Vladislav; Prabhakar, Nanduri R.			Xanthine Oxidase Mediates Hypoxia-Inducible Factor-2 alpha Degradation by Intermittent Hypoxia	PLOS ONE			English	Article							OXIDATIVE STRESS; REPERFUSION INJURY; NADPH OXIDASE; SLEEP-APNEA; FACTOR-I; ACTIVATION; RESPONSES; CELLS; RAT; HOMEOSTASIS	Sleep-disordered breathing with recurrent apnea produces chronic intermittent hypoxia (IH). We previously reported that IH leads to down-regulation of HIF-2 alpha protein via a calpain-dependent signaling pathway resulting in oxidative stress. In the present study, we delineated the signaling pathways associated with calpain-dependent HIF-2 alpha degradation in cell cultures and rats subjected to chronic IH. Reactive oxygen species (ROS) scavengers prevented HIF-2 alpha degradation by IH and ROS mimetic decreased HIF-2 alpha protein levels in rat pheochromocytoma PC12 cell cultures, suggesting that ROS mediate IH-induced HIF-2 alpha degradation. IH activated xanthine oxidase (XO) by increased proteolytic conversion of xanthine dehydrogenase to XO. ROS generated by XO activated calpains, which contributed to HIF-2 alpha degradation by IH. Calpain-induced HIF-2 alpha degradation involves C-terminus but not the N-terminus of the HIF-2 alpha protein. Pharmacological blockade as well as genetic knock down of XO prevented IH induced calpain activation and HIF-2 alpha degradation in PC12 cells. Systemic administration of allopurinol to rats prevented IH-induced hypertension, oxidative stress and XO activation in adrenal medulla. These results demonstrate that ROS generated by XO activation mediates IH-induced HIF-2 alpha degradation via activation of calpains.	[Nanduri, Jayasri] Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA; Univ Chicago, Ctr Syst Biol Sensing O2, Div Biol Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Nanduri, J (corresponding author), Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA.	jnanduri@uchicago.edu	Vaddi, Damodara Reddy/AAU-1398-2020	Vaddi, Damodara Reddy/0000-0002-4441-0859	National Heart, Lung, and Blood Institute [HL-76537, HL-90554]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090554, R01HL076537] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute grants HL-76537 and HL-90554. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Grebe M, 2006, AM J RESP CRIT CARE, V173, P897, DOI 10.1164/rccm.200508-1223OC; Han Q, 2013, CELL BIOCHEM BIOPHYS, V66, P431, DOI 10.1007/s12013-012-9491-6; Hoshikawa Y, 2001, J APPL PHYSIOL, V90, P1299, DOI 10.1152/jappl.2001.90.4.1299; Khan SA, 2011, ANTIOXID REDOX SIGN, V14, P533, DOI 10.1089/ars.2010.3213; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Kumar GK, 2006, J PHYSIOL-LONDON, V575, P229, DOI 10.1113/jphysiol.2006.112524; Lavie Lena, 2012, Front Biosci (Elite Ed), V4, P1391; Makarenko VV, 2012, AM J PHYSL CELL PHYS; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; McCord J M, 1985, Adv Myocardiol, V5, P183; MCCORD JM, 1982, CAN J PHYSIOL PHARM, V60, P1346, DOI 10.1139/y82-201; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Nanduri J, 2009, P NATL ACAD SCI USA, V106, P1199, DOI 10.1073/pnas.0811018106; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; NISHINO T, 1994, J BIOCHEM, V116, P1; PARKS DA, 1985, GASTROENTEROLOGY, V89, P6, DOI 10.1016/0016-5085(85)90738-3; Peng YJ, 2003, ADV EXP MED BIOL, V536, P559; Peng YJ, 2003, J APPL PHYSIOL, V94, P2342, DOI 10.1152/japplphysiol.00613.2002; POETS CF, 1994, BIOL NEONATE, V65, P211; Prabhakar NR, 2012, J APPL PHYSIOL, V113, P1304, DOI 10.1152/japplphysiol.00444.2012; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P156, DOI 10.1016/j.resp.2010.08.021; Ramanathan L, 2005, J NEUROCHEM, V93, P47, DOI 10.1111/j.1471-4159.2004.02988.x; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Swei A, 1999, MICROCIRCULATION, V6, P179, DOI 10.1038/sj.mn.7300070; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Yuan GX, 2013, P NATL ACAD SCI USA, V110, pE1788, DOI 10.1073/pnas.1305961110; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Yuan GX, 2004, J PHYSIOL-LONDON, V557, P773, DOI 10.1113/jphysiol.2003.058503	39	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75838	10.1371/journal.pone.0075838	http://dx.doi.org/10.1371/journal.pone.0075838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124516	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100073
J	Pagano, B; Jama, A; Martinez, P; Akanho, E; Bui, TTT; Drake, AF; Fraternali, F; Nikolova, PV				Pagano, Bruno; Jama, Abdullah; Martinez, Pierre; Akanho, Ester; Bui, Tam T. T.; Drake, Alex F.; Fraternali, Franca; Nikolova, Penka V.			Structure and Stability Insights into Tumour Suppressor p53 Evolutionary Related Proteins	PLOS ONE			English	Article							DNA-BINDING DOMAIN; CORE DOMAIN; CRYSTAL-STRUCTURE; THERMODYNAMIC STABILITY; MOLECULAR SIMULATIONS; SECONDARY STRUCTURE; RESPONSE ELEMENTS; RECOGNITION; SEQUENCE; DYNAMICS	The p53 family of genes and their protein products, namely, p53, p63 and p73, have over one billion years of evolutionary history. Advances in computational biology and genomics are enabling studies of the complexities of the molecular evolution of p53 protein family to decipher the underpinnings of key biological conditions spanning from cancer through to various metabolic and developmental disorders and facilitate the design of personalised medicines. However, a complete understanding of the inherent nature of the thermodynamic and structural stability of the p53 protein family is still lacking. This is due, to a degree, to the lack of comprehensive structural information for a large number of homologous proteins and to an incomplete knowledge of the intrinsic factors responsible for their stability and how these might influence function. Here we investigate the thermal stability, secondary structure and folding properties of the DNA-binding domains (DBDs) of a range of proteins from the p53 family using biophysical methods. While the N- and the C-terminal domains of the p53 family show sequence diversity and are normally targets for post-translational modifications and alternative splicing, the central DBD is highly conserved. Together with data obtained from Molecular Dynamics simulations in solution and with structure based homology modelling, our results provide further insights into the molecular properties of evolutionary related p53 proteins. We identify some marked structural differences within the p53 family, which could account for the divergence in biological functions as well as the subtleties manifested in the oligomerization properties of this family.	[Pagano, Bruno; Martinez, Pierre; Fraternali, Franca] Kings Coll London, Sch Biomed Sci, Dept Biochem, London, England; [Pagano, Bruno; Martinez, Pierre; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Pagano, Bruno] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Jama, Abdullah; Akanho, Ester; Bui, Tam T. T.; Drake, Alex F.; Nikolova, Penka V.] Inst Pharmaceut Sci, London, England	University of London; King's College London; University of London; King's College London; University of Naples Federico II	Fraternali, F (corresponding author), Kings Coll London, Sch Biomed Sci, Dept Biochem, New Hunts House, London, England.	franca.fraternali@kcl.ac.uk; penka.nikolova@kcl.ac.uk	Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011; Pagano, Bruno/F-2931-2012	Fraternali, Franca/0000-0002-3143-6574; Pagano, Bruno/0000-0002-7716-9010; Bui, Tam Thu Thi/0000-0002-8074-4928; Martinez, Pierre/0000-0001-7069-4413	Royal Society; University of London	Royal Society(Royal Society of London); University of London	This work was supported in part by funding from the Royal Society and the University of London Central Research Fund Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Canning P, 2012, J MOL BIOL, V423, P515, DOI 10.1016/j.jmb.2012.08.005; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chen C, 2012, J BIOL CHEM, V287, P7477, DOI 10.1074/jbc.M111.315820; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Fernandez A, 2003, BIOPHYS J, V85, P1914, DOI 10.1016/S0006-3495(03)74619-0; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Greiss S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-334; HAYWARD S, 1995, ANNU REV PHYS CHEM, V46, P223, DOI 10.1146/annurev.pc.46.100195.001255; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang Q, 2013, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbapap.2013.04.002, DOI 10.1016/J.BBAPAP.2013.04.002.PUBMED:23583620]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huyen Y, 2004, STRUCTURE, V12, P1237, DOI 10.1016/j.str.2004.05.007; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Khoo KH, 2009, J MOL BIOL, V393, P161, DOI 10.1016/j.jmb.2009.08.013; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Kleinjung J, 2005, NUCLEIC ACIDS RES, V33, pW342, DOI 10.1093/nar/gki369; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lane DP, 2010, CELL CYCLE, V9, P540, DOI 10.4161/cc.9.3.10516; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Lunardi A, 2010, P NATL ACAD SCI USA, V107, P6322, DOI 10.1073/pnas.1002447107; Madhumalar A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S17; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Merabet A, 2010, BIOCHEM J, V427, P225, DOI 10.1042/BJ20091888; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mintseris J, 2003, PROTEINS, V53, P629, DOI 10.1002/prot.10432; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pan YP, 2006, BIOCHEMISTRY-US, V45, P3925, DOI 10.1021/bi052242n; Patel S, 2008, NUCLEIC ACIDS RES, V36, P5139, DOI 10.1093/nar/gkn490; Patel S, 2008, BIOCHEMISTRY-US, V47, P3235, DOI 10.1021/bi7023207; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Shams I, 2013, J MOL BIOL, V425, P1111, DOI 10.1016/j.jmb.2013.01.007; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang Y, 2007, ACTA CRYSTALLOGR D, V63, P276, DOI 10.1107/S0907444906048499; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhao KH, 2001, J BIOL CHEM, V276, P12120, DOI 10.1074/jbc.M011644200	68	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76014	10.1371/journal.pone.0076014	http://dx.doi.org/10.1371/journal.pone.0076014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124530	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100087
J	Price, LC; Caramori, G; Perros, F; Meng, C; Gambaryan, N; Dorfmuller, P; Montani, D; Casolari, P; Zhu, J; Dimopoulos, K; Shao, DM; Girerd, B; Mumby, S; Proudfoot, A; Griffiths, M; Papi, A; Humbert, M; Adcock, IM; Wort, SJ				Price, Laura C.; Caramori, Gaetano; Perros, Frederic; Meng, Chao; Gambaryan, Natalia; Dorfmuller, Peter; Montani, David; Casolari, Paolo; Zhu, Jie; Dimopoulos, Konstantinos; Shao, Dongmin; Girerd, Barbara; Mumby, Sharon; Proudfoot, Alastair; Griffiths, Mark; Papi, Alberto; Humbert, Marc; Adcock, Ian M.; Wort, S. John			Nuclear Factor kappa-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR; PROINFLAMMATORY CYTOKINES; ALVEOLAR MACROPHAGES; INCREASED EXPRESSION; GROWTH-FACTORS; II RECEPTOR; INTERLEUKIN-6; INFLAMMATION; ENDOTHELIN-1	Objectives: To assess activation of the inflammatory transcription factor NF-kappa B (NF-kappa B) in human idiopathic pulmonary arterial hypertension (PAH). Background: Idiopathic PAH is a severe progressive disease characterized by pulmonary vascular remodeling and excessive proliferation of vascular cells. Increasing evidence indicates that inflammation is important in disease pathophysiology. Methods: NF-kappa B-p65 and CD68, CD20 and CD45 were measured by immunohistochemistry and confocal microscopy on lung specimens from patients with idiopathic PAH (n = 12) and controls undergoing lung surgery (n = 14). Clinical data were recorded for all patients including invasive pulmonary hemodynamics for the PAH patients. Immunohistochemical images were analyzed by blinded observers to include standard pulmonary vascular morphometry; absolute macrophage counts/mm 2 and p65-positivity (p65+) using composite images and image-analysis software; and cytoplasmic: nuclear p65+ of individual pulmonary arterial endothelial and smooth muscle cells (PASMC) in 10-20 pulmonary arteries or arterioles per subject. The expression of ET-1 and CCL5 (RANTES) in whole lung was determined by RT-qPCR. Results: Macrophage numbers were increased in idiopathic PAH versus controls (49.0 +/- 4.5 vs. 7.95 +/- 1.9 macrophages/100 mm(2), p<0.0001): these macrophages demonstrated more nuclear p65+ than in macrophages from controls (16.9 +/- 2.49 vs. 3.5 +/- 1.25%, p<0.001). An increase in p65+ was also seen in perivascular lymphocytes in patients with PAH. Furthermore, NF-kappa B activation was increased in pulmonary arterial endothelial cells (62.3 +/- 2.9 vs. 14.4 +/- 3.8, p<0.0001) and PASMC (22.6 +/- 2.3 vs. 11.2 +/- 2.0, p<0.001) in patients with PAH versus controls, with similar findings in arterioles. Gene expression of both ET-1 mRNA ((0.213 +/- 0.069 vs. 1.06 +/- 0.23, p<0.01) and CCL5 (RANTES) (0.16 +/- 0.045 vs. 0.26 +/- 0.039, p<0.05) was increased in whole lung homogenates from patients with PAH. Conclusions: NF-kappa B is activated in pulmonary macrophages, lymphocytes, endothelial and PASMC in patients with end-stage idiopathic PAH. Future research should determine whether NF-kappa B activation is a driver or bystander of pulmonary vascular inflammation and if the former, its potential role as a therapeutic target.	[Price, Laura C.; Meng, Chao; Gambaryan, Natalia; Dimopoulos, Konstantinos; Shao, Dongmin; Mumby, Sharon; Proudfoot, Alastair; Griffiths, Mark; Wort, S. John] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, Unit Crit Care,Fac Med, London, England; [Zhu, Jie] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London, England; [Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Airways Dis Sect, London, England; [Perros, Frederic; Dorfmuller, Peter; Montani, David; Girerd, Barbara; Humbert, Marc] Univ Paris 11, Le Kremlin Bicetre, France; [Perros, Frederic; Dorfmuller, Peter; Montani, David; Girerd, Barbara; Humbert, Marc] Ctr Chirurg Marie Lannelongue, INSERM, LabEx LERMIT, UMR S 999, Le Plessis Robinson, France; [Montani, David; Girerd, Barbara; Humbert, Marc] Hop Bicetre, AP HP, Serv Pneumol, DHU Thorax Innovat, Le Kremlin Bicetre, France; [Dorfmuller, Peter] Ctr Chirurg Marie Lannelongue, Dept Pathol, Le Plessis Robinson, France; [Caramori, Gaetano; Casolari, Paolo; Papi, Alberto] Univ Ferrara, Sect Resp Dis, Ctr Interdipartimentale Studio Malattie Infiammat, I-44100 Ferrara, Italy	Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton Hospital; Imperial College London; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; University of Ferrara	Price, LC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, Unit Crit Care,Fac Med, London, England.	l.price@imperial.ac.uk	Papi, alberto/AAC-1888-2019; Perros, Frédéric/N-6921-2017; Humbert, Marc/ABD-5112-2021; David, Montani/I-6885-2019; Caramori, Gaetano/AAS-8611-2020; Dimopoulos, Konstantinos/AAD-5229-2019; Humbert, Marc/AAC-8459-2019; Adcock, Ian/L-3217-2019; Proudfoot, Alastair/AAG-3235-2021	Perros, Frédéric/0000-0001-7730-2427; David, Montani/0000-0002-9358-6922; Caramori, Gaetano/0000-0002-9807-327X; Dimopoulos, Konstantinos/0000-0003-1300-0504; Humbert, Marc/0000-0003-0703-2892; Griffiths, Mark/0000-0002-1615-1896; Adcock, Ian/0000-0003-2101-8843; PAPI, ALBERTO/0000-0002-6924-4500; Dorfmuller, Peter/0000-0003-2499-6829	British Heart Foundation [F09/043]; Pfizer; Bayer; GSK; Actelion; Wellcome Trust [093080]; Medical Research Council [G0801266]; Department of Health's National Institute Health Research Respiratory Disease Biomedical Research Centre at the Royal Brompton and Harefield National Health Service Foundation Trust; Imperial College London; University of Ferrara; British Heart Foundation [FS/09/043/28040] Funding Source: researchfish; MRC [G0801266] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Pfizer(Pfizer); Bayer(Bayer AG); GSK(GlaxoSmithKline); Actelion; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute Health Research Respiratory Disease Biomedical Research Centre at the Royal Brompton and Harefield National Health Service Foundation Trust; Imperial College London(General Electric); University of Ferrara; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a clinical research fellowship grant from the British Heart Foundation number F09/043 (LCP). SJW receives unrestricted educational grants from Pfizer, Bayer, GSK and Actelion. IMA receives project grants from the Wellcome Trust (093080) and Medical Research Council (G0801266). It was also supported by the Department of Health's National Institute Health Research Respiratory Disease Biomedical Research Centre at the Royal Brompton and Harefield National Health Service Foundation Trust, Imperial College London and University of Ferrara (GC and AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanian K, 2002, AM J RESP CRIT CARE, V165, P1419, DOI 10.1164/rccm.2106007; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bhargava A, 1999, Heart Dis, V1, P126; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Caramori G, 2003, THORAX, V58, P348, DOI 10.1136/thorax.58.4.348; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; Cuhlmann S, 2011, CIRC RES, V108, P950, DOI 10.1161/CIRCRESAHA.110.233841; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Djordjevic T, 2004, ANTIOXID REDOX SIGN, V6, P713, DOI 10.1089/1523086041361703; Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x; Dorfmuller P, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-119; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Dorfmuller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; Eickelberg O, 1999, CIRCULATION, V99, P2276, DOI 10.1161/01.CIR.99.17.2276; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Graham BB, 2013, AM J RESP CELL MOL B; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; HEATH D, 1991, J CLIN PATHOL, V44, P1003, DOI 10.1136/jcp.44.12.1003; Huang J, 2008, AM J PHYSIOL-LUNG C, V294, pL1250, DOI 10.1152/ajplung.00069.2007; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; Itoh T, 2006, RESPIROLOGY, V11, P158, DOI 10.1111/j.1440-1843.2006.00821.x; KALTSCHMIDT C, 1995, BIOL CHEM H-S, V376, P9; Kimura S, 2009, HYPERTENSION, V53, P877, DOI 10.1161/HYPERTENSIONAHA.108.121418; Marok R, 1996, ARTHRITIS RHEUM, V39, P583, DOI 10.1002/art.1780390407; MEYRICK B, 1986, LAB INVEST, V55, P164; MIYATA M, 1995, INT ARCH ALLERGY IMM, V108, P287, DOI 10.1159/000237166; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Ormiston ML, 2012, CIRCULATION, V126, P1099, DOI 10.1161/CIRCULATIONAHA.112.110619; Park JES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030075; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706; Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC; Price LC, 2011, EUR RESPIR J, V37, P813, DOI 10.1183/09031936.00028310; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Quarck R, 2009, J AM COLL CARDIOL, V53, P1211, DOI 10.1016/j.jacc.2008.12.038; Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611; Raychaudhuri B, 2002, CLIN IMMUNOL, V104, P191, DOI 10.1006/clim.2002.5253; Raychaudhuri B, 2002, J BIOL CHEM, V277, P33344, DOI 10.1074/jbc.M203567200; Ritchie NE, 1998, CIRCULATION, V98, P1707, DOI 10.1161/01.CIR.98.17.1707; Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH; Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC; Savai R, 2012, AM J RESP CRIT CARE; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Sawada H, 2007, CHEST, V132, P1265, DOI 10.1378/chest.06-2243; Selimovic N, 2009, EUR RESPIR J, V34, P662, DOI 10.1183/09031936.00174908; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Talati M, 2010, AM J PHYSIOL-LUNG C, V299, pL363, DOI 10.1152/ajplung.00295.2009; TUDER RM, 1994, AM J PATHOL, V144, P275; Wang WY, 2009, J CLIN IMMUNOL, V29, P705, DOI 10.1007/s10875-009-9322-8; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wilson SH, 2002, ATHEROSCLEROSIS, V160, P147, DOI 10.1016/S0021-9150(01)00546-9; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458	63	58	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75415	10.1371/journal.pone.0075415	http://dx.doi.org/10.1371/journal.pone.0075415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124488	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100045
J	Thompson, JP; Serrano-Gomez, A; McDonald, J; Ladak, N; Bowrey, S; Lambert, DG				Thompson, Jonathan P.; Serrano-Gomez, Alcira; McDonald, John; Ladak, Nadia; Bowrey, Sarah; Lambert, David G.			The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; OPIOID RECEPTORS; SEPTIC SHOCK; STATES; MORPHINE; OUTCOMES; EPIDEMIOLOGY; CHEMOTAXIS; INHIBITION; ACTIVATION	Background And Objectives: Nociceptin/Orphanin FQ (N/OFQ) is a non-classical endogenous opioid peptide that modulates immune function in vitro. Its importance in inflammation and human sepsis is unknown. The objectives of this study were to determine the relationship between N/OFQ, transcripts for its precursor (pre-pro-N/OFQ [ppNOC]) and receptor (NOP), inflammatory markers and clinical outcomes in patients undergoing cardiopulmonary bypass and with sepsis. Methods: A prospective observational cohort study of 82 patients admitted to Intensive Care (ICU) with sepsis and 40 patients undergoing cardiac surgery under cardiopulmonary bypass (as a model of systemic inflammation). Sixty three healthy volunteers, matched by age and sex to the patients with sepsis were also studied. Clinical and laboratory details were recorded. Polymorph ppNOC and NOP receptor mRNA were determined using quantitative PCR. Plasma N/OFQ was determined using ELISA and cytokines (TNF-alpha, IL-8, IL-10) measured using radioimmunoassay. Data from patients undergoing cardiac surgery were recorded before, 3 and 24 hours after cardiopulmonary bypass. ICU patients with sepsis were assessed on Days 1 and 2 of ICU admission, and after clinical recovery. Main Results: Plasma N/OFQ concentrations increased (p<0.0001) on Days 1 and 2 of ICU admission with sepsis compared to matched recovery samples. Polymorph ppNOC (p=0.019) and NOP mRNA (p<0.0001) decreased compared to healthy volunteers. TNF-alpha, IL-8 and IL-10 concentrations increased on Day 1 compared to matched recovery samples and volunteers (p<0.0001). Similar changes (increased plasma N/OFQ, [p=0.0058], decreased ppNOC [p<0.0001], increased IL-8 and IL-10 concentrations [both p<0.0001]) occurred after cardiac surgery but these were comparatively lower and of shorter duration. Conclusions: The N/OFQ system is modulated in ICU patients with sepsis with similar but reduced changes after cardiac surgery under cardiopulmonary bypass. Further studies are required to clarify the role of the N/OFQ system in inflammation and sepsis, and the mechanisms involved.	[Thompson, Jonathan P.; Serrano-Gomez, Alcira; McDonald, John; Ladak, Nadia; Bowrey, Sarah; Lambert, David G.] Univ Leicester, Leicester Royal Infirm, Div Anaesthesia Crit Care & Pain Management, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester	Thompson, JP (corresponding author), Univ Leicester, Leicester Royal Infirm, Div Anaesthesia Crit Care & Pain Management, Dept Cardiovasc Sci, Leicester, Leics, England.	jt23@le.ac.uk		Thompson, Jonathan/0000-0002-8595-5943; Lambert, David/0000-0003-4769-8090	Anaesthesia/AAGBI under National Institue of Academic Anaesthesia	Anaesthesia/AAGBI under National Institue of Academic Anaesthesia	This work has been funded by grants from Anaesthesia/AAGBI Small Project Grants 2008 (13,300) pound and the Anaesthesia/AAGBI Small Project Grants 2009 (13,800) pound, both administrated by and under the auspices of the National Institue of Academic Anaesthesia (http://www.niaa.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Al-Hashimi M, 2013, BRIT J ANAESTH, V111, P80, DOI 10.1093/bja/aet153; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Anton B, 2010, J NEUROIMMUNE PHARM, V5, P143, DOI 10.1007/s11481-010-9190-2; Archard C, 1909, B MEM SOC MED HOP P, V28, P958; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brookes ZLS, 2007, AM J PHYSIOL-HEART C, V293, pH2977, DOI 10.1152/ajpheart.00448.2007; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho D, 2008, INTENS CARE MED, V34, P2284, DOI 10.1007/s00134-008-1313-3; Danai Pajman, 2005, Curr Infect Dis Rep, V7, P329, DOI 10.1007/s11908-005-0005-1; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Easten KH, 2009, PEPTIDES, V30, P926, DOI 10.1016/j.peptides.2009.01.021; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Fiset MT, 2003, BIOCHEMISTRY-US, V42, P10498, DOI 10.1021/bi0300635; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Galley HF, 2003, BRIT J ANAESTH, V91, P424, DOI 10.1093/bja/aeg174; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; MANFREDI B, 1993, J NEUROIMMUNOL, V44, P43, DOI 10.1016/0165-5728(93)90266-2; Marshall JC, 2003, CRIT CARE MED, V31, P1560, DOI 10.1097/01.CCM.0000065186.67848.3A; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; McDonald J, 2010, BRIT J ANAESTH, V105, P707; Mellon RD, 1998, J NEUROIMMUNOL, V83, P19, DOI 10.1016/S0165-5728(97)00217-8; Morgan EL, 1996, J NEUROIMMUNOL, V65, P21, DOI 10.1016/0165-5728(95)00171-9; Onorati F, 2010, EUR J CARDIO-THORAC, V37, P897, DOI 10.1016/j.ejcts.2009.11.010; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Peluso J, 1998, J NEUROIMMUNOL, V81, P184, DOI 10.1016/S0165-5728(97)00178-1; Roy S, 2001, SURGERY, V130, P304, DOI 10.1067/msy.2001.116033; Serhan CN, 2001, J IMMUNOL, V166, P3650, DOI 10.4049/jimmunol.166.6.3650; Serrano-Gomez A, 2011, BRIT J ANAESTH, V106, P6, DOI 10.1093/bja/aeq337; Stamer UM, 2011, BRIT J ANAESTH, V106, P566, DOI 10.1093/bja/aer007; Trombella S, 2005, PEPTIDES, V26, P1497, DOI 10.1016/j.peptides.2005.03.015; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Waits PS, 2004, J NEUROIMMUNOL, V149, P110, DOI 10.1016/j.jneuroim.2003.12.018; Wilhelm W, 2002, SHOCK, V17, P354, DOI 10.1097/00024382-200205000-00002; Williams JP, 2008, BRIT J ANAESTH, V100, P810, DOI 10.1093/bja/aen093; Williams JP, 2008, ANESTH ANALG, V106, P865, DOI 10.1213/ane.0b013e3181617646; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Wu ZK, 2008, WORLD J SURG, V32, P2643, DOI 10.1007/s00268-008-9758-7; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Zhao HF, 2012, CRIT CARE MED, V40, P1700, DOI 10.1097/CCM.0b013e318246b83a	51	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76682	10.1371/journal.pone.0076682	http://dx.doi.org/10.1371/journal.pone.0076682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124588	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100145
J	Tobin, ED; Grunbaum, D; Patterson, J; Cattolico, RA				Tobin, Elizabeth D.; Gruenbaum, Daniel; Patterson, Johnathan; Cattolico, Rose Ann			Behavioral and Physiological Changes during Benthic-Pelagic Transition in the Harmful Alga, Heterosigma akashiwo: Potential for Rapid Bloom Formation	PLOS ONE			English	Article							VERTICAL MIGRATION BEHAVIOR; POLYUNSATURATED FATTY-ACIDS; POPULATION-DYNAMICS; SPORE DISPERSAL; NEUTRAL LIPIDS; RED TIDE; RAPHIDOPHYCEAE; GROWTH; BAY; TEMPERATURE	Many species of harmful algae transition between a motile, vegetative stage in the water column and a non-motile, resting stage in the sediments. Physiological and behavioral traits expressed during benthic-pelagic transition potentially regulate the timing, location and persistence of blooms. The roles of key physiological and behavioral traits involved in resting cell emergence and bloom formation were examined in two geographically distinct strains of the harmful alga, Heterosigma akashiwo. Physiological measures of cell viability, division and population growth, and cell fatty acid content were made using flow cytometry and gas chromatography - mass spectrometry techniques as cells transitioned between the benthic resting stage and the vegetative pelagic stage. Video-based tracking was used to quantify cell-level swimming behaviors. Data show increased temperature and light triggered rapid emergence from the resting stage and initiated cell swimming. Algal strains varied in important physiological and behavioral traits, including survivorship during life-stage transitions, population growth rates and swimming velocities. Collectively, these traits function as "population growth strategies" that can influence bloom formation. Many resting cells regained the up-swimming capacity necessary to cross an environmentally relevant halocline and the ability to aggregate in near-surface waters within hours after vegetative growth supporting conditions were restored. Using a heuristic model, we illustrate how strain-specific population growth strategies can govern the timescales over which H. akashiwo blooms form. Our findings highlight the need for identification and quantification of strain-specific physiological and behavioral traits to improve mechanistic understanding of bloom formation and successful bloom prediction.	[Tobin, Elizabeth D.; Gruenbaum, Daniel] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Patterson, Johnathan; Cattolico, Rose Ann] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tobin, ED (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	etobin@u.washington.edu			NOAA Washington Sea Grants [NA10OAR-4170057, NA07OAR-4170007]; United States Department of Energy [DE-EE0003046]; NSF IGERT Program on Ocean Change Fellowship	NOAA Washington Sea Grants; United States Department of Energy(United States Department of Energy (DOE)); NSF IGERT Program on Ocean Change Fellowship	Funding for this research was provided by NOAA Washington Sea Grants (NA10OAR-4170057 to D. Grunbaum); the United States Department of Energy (contract DE-EE0003046) awarded to the National Alliance for Advanced Biofuels and Bioproducts and NOAA Washington Sea Grants (NA07OAR-4170007 to R. A. Cattolico); and the NSF IGERT Program on Ocean Change Fellowship to E. Tobin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2522, DOI 10.1016/j.dsr2.2005.06.014; ANDERSON DM, 2007, BRUUN MEMORIAL LECT; [Anonymous], 2007, FISH KILLS HARMFUL A; Bearon RN, 2008, J THEOR BIOL, V251, P679, DOI 10.1016/j.jtbi.2008.01.007; Bearon RN, 2006, MAR ECOL PROG SER, V306, P153, DOI 10.3354/meps306153; Bearon RN, 2004, LIMNOL OCEANOGR, V49, P607, DOI 10.4319/lo.2004.49.2.0607; BIGELOW N, 2013, ALGAL RES IN PRESS; Bigelow NW, 2011, J AM OIL CHEM SOC, V88, P1329, DOI 10.1007/s11746-011-1799-7; BRZEZINSKI MA, 1993, J PHYCOL, V29, P16, DOI 10.1111/j.1529-8817.1993.tb00275.x; CATTOLICO RA, 1976, PLANT PHYSIOL, V57, P497, DOI 10.1104/pp.57.4.497; Cembella Allan D., 2005, Oceanography, V18, P158; Clough J, 2005, AQUAT MICROB ECOL, V39, P121, DOI 10.3354/ame039121; Cohen Z, 2000, BIOCHEM SOC T, V28, P740, DOI 10.1042/BST0280740; Cullen J.J., 1985, Contributions in Marine Science, V27, P135; Darzynkiewicz Zbigniew, 2010, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0702s52; Donaghay PL, 1997, LIMNOL OCEANOGR, V42, P1283, DOI 10.4319/lo.1997.42.5_part_2.1283; Durham WM, 2012, ANNU REV MAR SCI, V4, P177, DOI 10.1146/annurev-marine-120710-100957; Eltgroth ML, 2005, J PHYCOL, V41, P1000, DOI 10.1111/j.1529-8817.2005.00128.x; Franks PJS, 1997, LIMNOL OCEANOGR, V42, P1297, DOI 10.4319/lo.1997.42.5_part_2.1297; FREDRICKSON KA, 2011, J PHYCOL, V47, P1, DOI DOI 10.1111/J.1529-8817.2011.00970.X; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Gaylord B, 2004, J MARINE SYST, V49, P19, DOI 10.1016/j.jmarsys.2003.05.003; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gurarie E, 2011, B MATH BIOL, V73, P1358, DOI 10.1007/s11538-010-9575-7; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Han MS, 2002, J PHYCOL, V38, P304, DOI 10.1046/j.1529-8817.2002.01087.x; Handy SM, 2005, AQUAT MICROB ECOL, V40, P121, DOI 10.3354/ame040121; Haque SM, 2002, BOT MAR, V45, P356, DOI 10.1515/BOT.2002.036; *HARRNESS, 2005, HARMF ALG RES RESP N, P96; Harvey EL, 2011, LIMNOL OCEANOGR, V56, P371, DOI 10.4319/lo.2011.56.1.0371; He RY, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004602; Herndon J, 2007, HARMFUL ALGAE, V6, P260, DOI 10.1016/j.hal.2006.08.006; Hershberger PK, 1997, CAN J FISH AQUAT SCI, V54, P2228, DOI 10.1139/cjfas-54-10-2228; HONJO J, 1990, HARMFUL RED TIDES HE; Imai I, 1999, MAR BIOL, V133, P755, DOI 10.1007/s002270050517; Ishikawa A, 1996, MAR ECOL PROG SER, V140, P169, DOI 10.3354/meps140169; Itakura S, 2001, PHYCOLOGIA, V40, P263, DOI 10.2216/i0031-8884-40-3-263.1; Jeong HJ, 2003, J EUKARYOT MICROBIOL, V50, P274, DOI 10.1111/j.1550-7408.2003.tb00134.x; Kempton J, 2008, HARMFUL ALGAE, V7, P235, DOI 10.1016/j.hal.2007.08.003; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Lawrence JE, 2002, LIMNOL OCEANOGR, V47, P545, DOI 10.4319/lo.2002.47.2.0545; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Martinez R, 2010, J PLANKTON RES, V32, P529, DOI 10.1093/plankt/fbp135; McKay L, 2006, HARMFUL ALGAE, V5, P623, DOI 10.1016/j.hal.2005.12.001; Okuyama H, 2008, APPL ENVIRON MICROB, V74, P570, DOI 10.1128/AEM.02256-07; Olofsson M, 2012, ENERGIES, V5, P1577, DOI 10.3390/en5051577; Ralston DK, 2007, J PLANKTON RES, V29, P803, DOI 10.1093/plankt/fbm061; Reed DC, 1999, MAR BIOL, V133, P737, DOI 10.1007/s002270050515; Rensel JEJ, 2010, HARMFUL ALGAE, V10, P98, DOI 10.1016/j.hal.2010.07.005; Rosman JH, 2010, LIMNOL OCEANOGR, V55, P1145, DOI 10.4319/lo.2010.55.3.1145; SATOH E, 1987, PLANT CELL PHYSIOL, V28, P1093; Shikata T, 2008, LIMNOL OCEANOGR, V53, P2503, DOI 10.4319/lo.2008.53.6.2503; Shikata T, 2007, HARMFUL ALGAE, V6, P700, DOI 10.1016/j.hal.2007.02.008; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; SMAYDA TJ, 1998, PHYSL ECOLOGY HARMFU, P115; Solovchenko AE, 2011, RUSS J PLANT PHYSL+, V58, P674, DOI 10.1134/S1021443711040157; Taylor F.J., 2002, HARMFUL ALGAL BLOOMS; Taylor F.J.R., 1994, CAN TECH REP FISH AQ, V1948, P175; TAYLOR FJR, 1993, DEV MAR BIOL, V1993; Tobin ED, 2011, HARMFUL ALGAE, V10, P619, DOI 10.1016/j.hal.2011.04.014; TOMAS CR, 1978, J PHYCOL, V14, P309, DOI 10.1111/j.1529-8817.1978.tb00303.x; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; WADA M, 1985, PLANT CELL PHYSIOL, V26, P431, DOI 10.1093/oxfordjournals.pcp.a076926; YAMOCHI S, 1984, MAR BIOL, V83, P255, DOI 10.1007/BF00397457	65	18	19	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76663	10.1371/journal.pone.0076663	http://dx.doi.org/10.1371/journal.pone.0076663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124586	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100143
J	Zhang, XM; Liu, W; Schloter, M; Zhang, GM; Chen, QS; Huang, JH; Li, LH; Elser, JJ; Han, XG				Zhang, Ximei; Liu, Wei; Schloter, Michael; Zhang, Guangming; Chen, Quansheng; Huang, Jianhui; Li, Linghao; Elser, James J.; Han, Xingguo			Response of the Abundance of Key Soil Microbial Nitrogen-Cycling Genes to Multi-Factorial Global Changes	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; DENITRIFYING BACTERIA; TERRESTRIAL ECOSYSTEMS; COMMUNITIES; BIODIVERSITY; DEPOSITION; DIVERSITY; STEPPE; DENITRIFICATION; TRANSFORMATION	Multiple co-occurring environmental changes are affecting soil nitrogen cycling processes, which are mainly mediated by microbes. While it is likely that various nitrogen-cycling functional groups will respond differently to such environmental changes, very little is known about their relative responsiveness. Here we conducted four long-term experiments in a steppe ecosystem by removing plant functional groups, mowing, adding nitrogen, adding phosphorus, watering, warming, and manipulating some of their combinations. We quantified the abundance of seven nitrogen-cycling genes, including those for fixation (nifH), mineralization (chiA), nitrification (amoA of ammonia-oxidizing bacteria (AOB) or archaea (AOA)), and denitrification (nirS, nirK and nosZ). First, for each gene, we compared its sensitivities to different environmental changes and found that the abundances of various genes were sensitive to distinct and different factors. Overall, the abundances of nearly all genes were sensitive to nitrogen enrichment. In addition, the abundances of the chiA and nosZ genes were sensitive to plant functional group removal, the AOB-amoA gene abundance to phosphorus enrichment when nitrogen was added simultaneously, and the nirS and nirK gene abundances responded to watering. Second, for each single-or multifactorial environmental change, we compared the sensitivities of the abundances of different genes and found that different environmental changes primarily affected different gene abundances. Overall, AOB-amoA gene abundance was most responsive, followed by the two denitrifying genes nosZ and nirS, while the other genes were less sensitive. These results provide, for the first time, systematic insights into how the abundance of each type of nitrogen-cycling gene and the equilibrium state of all these nitrogen-cycling gene abundances would shift under each single-or multi-factorial global change.	[Zhang, Ximei; Han, Xingguo] Chinese Acad Sci, State Key Lab Forest & Soil Ecol, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Zhang, Ximei; Zhang, Guangming; Chen, Quansheng; Huang, Jianhui; Li, Linghao; Han, Xingguo] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Liu, Wei] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Schloter, Michael] Helmholtz Ctr Environm Hlth, Oberschleissheim, Germany; [Elser, James J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Arizona State University; Arizona State University-Tempe	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	j.elser@asu.edu; xghan@ibcas.ac.cn	Elser, James J/AAL-6199-2020; Elser, James/A-7082-2008; Chen, Quansheng/AGH-8083-2022; Schloter, 1Michael/H-9151-2013; Han, Xingguo/K-7552-2016	Elser, James J/0000-0002-1460-2155; Elser, James/0000-0002-1460-2155; Chen, Quansheng/0000-0003-2498-3278; Han, Xingguo/0000-0002-1836-975X; Zhang, Ximei/0000-0002-0038-5460	National Natural Science Foundation of China [30830026]; State Key Basic Research Development Program of China (973 Program) [2009CB825103]; Postdoctoral Science Foundation of China [2011M500440, 2012T50158]; US National Science Foundation [DEB-0925017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); US National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Natural Science Foundation of China(30830026) and the State Key Basic Research Development Program of China (973 Program) (2009CB825103), Postdoctoral Science Foundation of China (2011M500440, 2012T50158), and the US National Science Foundation (DEB-0925017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x; Forbes MS, 2009, AUST J SOIL RES, V47, P380, DOI 10.1071/SR08126; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Grogan P, 2003, ECOLOGY, V84, P202, DOI 10.1890/0012-9658(2003)084[0202:COANCI]2.0.CO;2; Hayden HL, 2010, SOIL BIOL BIOCHEM, V42, P1774, DOI 10.1016/j.soilbio.2010.06.015; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Houlton BZ, 2009, P NATL ACAD SCI USA, V106, P21713, DOI 10.1073/pnas.0912111106; Kaiser C, 2011, ECOLOGY, V92, P1036, DOI 10.1890/i0012-9658-92-5-1036; Knops JMH, 2002, ECOL LETT, V5, P454, DOI 10.1046/j.1461-0248.2002.00332.x; Kong DL, 2011, PLANT SOIL, V346, P133, DOI 10.1007/s11104-011-0803-1; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; LI B, 1988, RES GRASSLAND ECOSYS, V3, P84; Lindsay EA, 2010, APPL ENVIRON MICROB, V76, P5547, DOI 10.1128/AEM.03054-09; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; McCrackin ML, 2010, ECOLOGY, V91, P528, DOI 10.1890/08-2210.1; McLaren JR, 2010, GLOBAL CHANGE BIOL, V16, P3075, DOI 10.1111/j.1365-2486.2009.02151.x; McLaren JR, 2010, J ECOL, V98, P459, DOI 10.1111/j.1365-2745.2009.01630.x; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Petersen DG, 2012, ENVIRON MICROBIOL, V14, P993, DOI 10.1111/j.1462-2920.2011.02679.x; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P926, DOI 10.1016/j.soilbio.2010.02.009; Swift MJ, 1998, GLOBAL CHANGE BIOL, V4, P729, DOI 10.1046/j.1365-2486.1998.00207.x; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Towe S, 2010, MICROB ECOL, V60, P762, DOI 10.1007/s00248-010-9695-5; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wakelin SA, 2010, PEDOBIOLOGIA, V53, P391, DOI 10.1016/j.pedobi.2010.08.001; Wall DH, 2010, NAT GEOSCI, V3, P297, DOI 10.1038/ngeo860; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Wallenstein MD, 2005, PEDOBIOLOGIA, V49, P665, DOI 10.1016/j.pedobi.2005.05.005; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wu Jianguo, 1992, P67; Xiao X, 2005, APPL ENVIRON MICROB, V71, P7904, DOI 10.1128/AEM.71.12.7904-7909.2005; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhang LX, 2004, ACTA BOT SIN, V46, P259; Zhang XM, 2012, J ENVIRON SCI-CHINA, V24, P1483, DOI 10.1016/S1001-0742(11)60900-5; Zhang XM, 2011, MOL ECOL, V20, P429, DOI 10.1111/j.1365-294X.2010.04933.x; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zhou LS, 2009, SOIL BIOL BIOCHEM, V41, P796, DOI 10.1016/j.soilbio.2009.01.019	61	40	54	19	326	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76500	10.1371/journal.pone.0076500	http://dx.doi.org/10.1371/journal.pone.0076500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124568	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100125
J	Atek, M; Traissac, P; El Ati, J; Laid, Y; Aounallah-Skhiri, H; Eymard-Duvernay, S; Mezimeche, N; Bougatef, S; Beji, C; Boutekdjiret, L; Martin-Prevel, Y; Lebcir, H; Gartner, A; Kolsteren, P; Delpeuch, F; Ben Romdhane, H; Maire, B				Atek, Madjid; Traissac, Pierre; El Ati, Jalila; Laid, Youcef; Aounallah-Skhiri, Hajer; Eymard-Duvernay, Sabrina; Mezimeche, Nadia; Bougatef, Souha; Beji, Chiraz; Boutekdjiret, Leila; Martin-Prevel, Yves; Lebcir, Hassiba; Gartner, Agnes; Kolsteren, Patrick; Delpeuch, Francis; Ben Romdhane, Habiba; Maire, Bernard			Obesity and Association with Area of Residence, Gender and Socio-Economic Factors in Algerian and Tunisian Adults	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NUTRITION TRANSITION; RISK-FACTORS; WOMEN; UNDERWEIGHT; PREVALENCE; OVERWEIGHT; POSITION; BMI	Introduction: The epidemiological transition has resulted in a major increase in the prevalence of obesity in North Africa. This study investigated differences in obesity and its association with area of residence, gender and socio-economic position among adults in Algeria and Tunisia, two countries with socio-economic and socio-cultural similarities. Methods: Cross-sectional studies used stratified, three-level, clustered samples of 35-70 year old adults in Algeria, (women n = 2741, men n = 2004) and Tunisia (women n = 2964, men n = 2379). Thinness was defined as Body Mass Index (BMI) = weight/height,< 18.5 kg/m(2), obesity as BMI >= 30, and abdominal obesity as waist circumference/height >= 0.6. Associations with area of residence, gender, age, education, profession and household welfare were assessed. Results: Prevalence of thinness was very low except among men in Algeria (7.3% C.I.[5.9-8.7]). Prevalence of obesity among women was high in Algeria (30.1% C.I.[27.8-32.4]) and Tunisia (37.0% C.I.[34.4-39.6]). It was less so among men (9.1% C.I.[7.1-11.0] and 13.3% C.I.[11.2-15.4]). The results were similar for abdominal obesity. In both countries women were much more obesity-prone than men: the women versus men obesity Odds-Ratio was 4.3 C.I.[3.4-5.5] in Algeria and 3.8 C.I.[3.1-4.7] in Tunisia. Obesity was more prevalent in urban versus rural areas in Tunisia, but not in Algeria (e. g. for women, urban versus rural Odds-Ratio was 2.4 C.I.[1.9-3.1] in Tunisia and only 1.2 C.I.[1.0-5.5] in Algeria). Obesity increased with household welfare, but more markedly in Tunisia, especially among women. Nevertheless, in both countries, even in the lowest quintile of welfare, a fifth of the women were obese. Conclusion: The prevention of obesity, especially in women, is a public health issue in both countries, but there were differences in the patterning of obesity according to area of residence and socio-economic position. These specificities must be taken into account in the management of obesity inequalities.	[Atek, Madjid; Laid, Youcef; Mezimeche, Nadia; Boutekdjiret, Leila; Lebcir, Hassiba] INSP, Algiers, Algeria; [Traissac, Pierre; Eymard-Duvernay, Sabrina; Martin-Prevel, Yves; Gartner, Agnes; Delpeuch, Francis; Maire, Bernard] IRD, NUTRIPASS Res Unit, Montpellier, France; [El Ati, Jalila; Beji, Chiraz] INNTA Natl Inst Nutr & Food Technol, Tunis, Tunisia; [El Ati, Jalila; Beji, Chiraz] SURVEN Nutr Surveillance & Epidemiol Tunisia, Res Unit, Tunis, Tunisia; [Aounallah-Skhiri, Hajer; Bougatef, Souha] INSP, Tunis, Tunisia; [Aounallah-Skhiri, Hajer] El Manar Univ, Fac Med, Tunis, Tunisia; [Kolsteren, Patrick] ITM, Antwerp, Belgium; [Ben Romdhane, Habiba] Fac Med, Epidemiol & Prevent Cardiovasc Dis Unit, Tunis, Tunisia	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Tunis-El-Manar; Institut National de Nutrition Technologie Alimentaire; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Institute of Tropical Medicine (ITM); Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Traissac, P (corresponding author), IRD, NUTRIPASS Res Unit, Montpellier, France.	pierre.traissac@ird.fr	Martin-Prevel, Yves/E-7637-2011; ATI, Jalila EL/Y-5467-2018	Martin-Prevel, Yves/0000-0002-4689-7867; Traissac, Pierre/0000-0002-3184-5597; EL ATI, Jalila/0000-0002-8715-455X	European Union [ICA3-CT-2002-10011]; INNTA (National Nutrition and Food Technology Institute of Tunisia); INSP (National Public Health Institute of Tunisia); INSP (Algerian National Public Health Institute); IRD (Institut de Recherche pour le Developpement, France)	European Union(European Commission); INNTA (National Nutrition and Food Technology Institute of Tunisia); INSP (National Public Health Institute of Tunisia); INSP (Algerian National Public Health Institute); IRD (Institut de Recherche pour le Developpement, France)	This research was funded by the European Union (INCO: Med Projects 1998-2002, TAHINA: Epidemiological Transition And Health Impact in North Africa - Contract Number: ICA3-CT-2002-10011), INNTA (National Nutrition and Food Technology Institute of Tunisia), INSP (National Public Health Institute of Tunisia), INSP (Algerian National Public Health Institute), and IRD (Institut de Recherche pour le Developpement, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WORLD URB PROSP 2011; Aounallah-Skhiri H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-38; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI [10.2174/1876823701103010078, DOI 10.2174/1876823701103010078]; Batnitzky A, 2008, SOCIOL HEALTH ILL, V30, P445, DOI 10.1111/j.1467-9566.2007.01067.x; Batnitzky AK, 2011, HEALTH PLACE, V17, P345, DOI 10.1016/j.healthplace.2010.11.012; Beltaifa L, 2009, OBES REV, V10, P145, DOI 10.1111/j.1467-789X.2008.00543.x; Benjelloun S, 2002, PUBLIC HEALTH NUTR, V5, P135, DOI 10.1079/PHN2001285; Central Intelligence Agency, 2012, WORLD FACTBOOK; Charrad M, 2007, WASHINGTON LEE LAW R, V64, P1513; Chebel M, 1995, ENCY AMOUR ISLAM ERO; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Doak CM, 2000, J NUTR, V130, P2965, DOI 10.1093/jn/130.12.2965; El Ati J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048153; El Rhazi K, 2011, PUBLIC HEALTH NUTR, V14, P160, DOI 10.1017/S1368980010001825; Elmadfa I, 2009, FORUM NUTR, V62, P1, DOI [10.1159/000244607, 10.1159/000242367]; Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396; Hassan R, 1995, Plan Parent Chall, P5; Hausmann R., 2010, GLOBAL GENDER GAP RE; Holdsworth M, 2012, HLTH POLICY PLAN, P1; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Janghorbani M, 2008, ARCH IRAN MED, V11, P274, DOI 08113/AIM.008; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Korn EL, 1999, ANAL HLTH SURVEYS; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Levy P, 1999, SAMPLING POPULATIONS; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Lowi M. R., 2004, J N AFR STUD, V9, P83, DOI DOI 10.1080/1362938042000325822; MARSHALL SE, 1981, J MOD AFR STUD, V19, P625, DOI 10.1017/S0022278X0002019X; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Measure DHS, 2012, DEMOGRAPHIC HLTH SUR; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mokhtar N, 2001, J NUTR, V131, p887S, DOI 10.1093/jn/131.3.887S; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Office National de la Famille et de la Population - Ministere de la Sante Publique Macro Systems Inc, 1988, ENQ DEM SANT TUN; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Schooling CM, 2011, INT J EPIDEMIOL, V40, P1556, DOI 10.1093/ije/dyr128; Searle S.R., 1987, LINEAR MODELS UNBALA; StataCorp, 2011, STAT STAT SOFTW REL, P173; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Tessier S, 2010, PUBLIC HEALTH NUTR, V13, P1410, DOI 10.1017/S1368980010000601; Tlili F, 2008, ECOL FOOD NUTR, V47, P399, DOI 10.1080/03670240802003942; Traissac P, 2012, INT J EPIDEMIOL, V41, P1207, DOI 10.1093/ije/dys122; UNDP, 2007, HUMAN DEV REPORT 200; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; World Health Organization, 1995, PHYS STAT US INT ANT	53	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75640	10.1371/journal.pone.0075640	http://dx.doi.org/10.1371/journal.pone.0075640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116063	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200032
J	He, WJ; Chan, LY; Clark, RJ; Tang, J; Zeng, GZ; Franco, OL; Cantacessi, C; Craik, DJ; Daly, NL; Tan, NH				He, Wen-Jun; Chan, Lai Yue; Clark, Richard J.; Tang, Jun; Zeng, Guang-Zhi; Franco, Octavio L.; Cantacessi, Cinzia; Craik, David J.; Daly, Norelle L.; Tan, Ning-Hua			Novel Inhibitor Cystine Knot Peptides from Momordica charantia	PLOS ONE			English	Article							AMINO-ACID-SEQUENCES; TRYPSIN-INHIBITOR; PROTEINASE-INHIBITORS; CYTOTOXIC CYCLOTIDES; FOLDING PATHWAYS; X-RAY; FAMILY; SEEDS; PROGRAM	Two new peptides, MCh-1 and MCh-2, along with three known trypsin inhibitors (MCTI-I, MCTI-II and MCTI-III), were isolated from the seeds of the tropical vine Momordica charantia. The sequences of the peptides were determined using mass spectrometry and NMR spectroscopy. Using a strategy involving partial reduction and stepwise alkylation of the peptides, followed by enzymatic digestion and tandem mass spectrometry sequencing, the disulfide connectivity of MCh-1 was elucidated to be CysI-CysIV, CysII-CysV and CysIII-CysVI. The three-dimensional structures of MCh-1 and MCh-2 were determined using NMR spectroscopy and found to contain the inhibitor cystine knot (ICK) motif. The sequences of the novel peptides differ significantly from peptides previously isolated from this plant. Therefore, this study expands the known peptide diversity in M. charantia and the range of sequences that can be accommodated by the ICK motif. Furthermore, we show that a stable two-disulfide intermediate is involved in the oxidative folding of MCh-1. This disulfide intermediate is structurally homologous to the proposed ancestral fold of ICK peptides, and provides a possible pathway for the evolution of this structural motif, which is highly prevalent in nature.	[He, Wen-Jun; Tang, Jun; Zeng, Guang-Zhi; Tan, Ning-Hua] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Chan, Lai Yue; Clark, Richard J.; Craik, David J.; Daly, Norelle L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Clark, Richard J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Franco, Octavio L.] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Cantacessi, Cinzia; Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Queensland; University of Queensland; Universidade Catolica de Brasilia; James Cook University	Daly, NL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	norelle.daly@jcu.edu.au; nhtan@mail.kib.ac.cn	CHAN, LAI YUE/C-6489-2014; Clark, Richard J/G-8848-2012; Franco, Octavio L/T-3020-2017; Craik, David/B-1695-2010; Daly, Norelle L/D-4302-2013; Cantacessi, Cinzia/B-7356-2014	CHAN, LAI YUE/0000-0002-9346-2487; Clark, Richard J/0000-0002-6807-5426; Craik, David/0000-0003-0007-6796; Daly, Norelle L/0000-0002-4697-6602; Cantacessi, Cinzia/0000-0001-6863-2950; Franco, Octavio/0000-0001-9546-0525	National Basic Research Program of China [2013CB127505, 2009CB522300]; National New Drug Innovation Great Project of China [2011ZX09307-002-02]; National Natural Science Foundation of China [21202174, U1032602, 91013002, 30725048]; foundation of Chinese Academy of Sciences (Hundred Talents Program); Natural Science Foundation of Yunnan Province [2012GA003]; China Scholarship Council; Queensland Smart State Fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Apoio a Pesquisa do Distrito Federal	National Basic Research Program of China(National Basic Research Program of China); National New Drug Innovation Great Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation of Chinese Academy of Sciences (Hundred Talents Program); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); China Scholarship Council(China Scholarship Council); Queensland Smart State Fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the National Basic Research Program of China (2013CB127505, 2009CB522300), the National New Drug Innovation Great Project of China (2011ZX09307-002-02), the National Natural Science Foundation of China (21202174, U1032602, 91013002, 30725048), the foundation of Chinese Academy of Sciences (Hundred Talents Program), and the Natural Science Foundation of Yunnan Province (2012GA003). WJH is a recipient of a fellowship from the China Scholarship Council. NLD was supported by a Queensland Smart State Fellowship and is currently an ARC Future Fellow. DJC is a National Health and Medical Research Council Professorial Research Fellow. OLF is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao de Apoio a Pesquisa do Distrito Federal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arolas JL, 2004, J BIOL CHEM, V279, P37261, DOI 10.1074/jbc.M405565200; ASAHI H, 1994, PARASITOLOGY, V109, P397, DOI 10.1017/S0031182000080641; Begum K, 2003, PARASITOL RES, V90, P221, DOI 10.1007/s00436-003-0830-9; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Cemazar M, 2006, J BIOL CHEM, V281, P8224, DOI 10.1074/jbc.M513399200; Chan LY, 2009, J NAT PROD, V72, P1453, DOI 10.1021/np900174n; Chan LY, 2013, PEPTIDES, V39, P29, DOI 10.1016/j.peptides.2012.09.018; Chen J, 1995, SPERMATOPHYTA; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Foley SF, 2008, ANAL BIOCHEM, V377, P95, DOI 10.1016/j.ab.2008.02.025; Goddard TD, KNELLER DG SPARKY 3; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; HAMATO N, 1995, J BIOCHEM-TOKYO, V117, P432, DOI 10.1093/jb/117.2.432; HARA S, 1989, J BIOCHEM-TOKYO, V105, P88, DOI 10.1093/oxfordjournals.jbchem.a122625; He WJ, 2011, PEPTIDES, V32, P1719, DOI 10.1016/j.peptides.2011.06.016; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kim Hye-Sook, 1998, Parasitology International, V47, P59, DOI 10.1016/S1383-5769(98)00003-8; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LENGUYEN D, 1993, PROTEIN SCI, V2, P165; LING MH, 1993, J BIOL CHEM, V268, P810; Ling MH, 1996, ACTA BIOCH BIOPH SIN, V28, P233; MIURA S, 1995, BIOSCI BIOTECH BIOCH, V59, P469, DOI 10.1271/bbb.59.469; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Otlewski J, 1996, ACTA BIOCHIM POL, V43, P431; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RYLE AP, 1955, BIOCHEM J, V60, P535, DOI 10.1042/bj0600535; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Tang J, 2010, HELV CHIM ACTA, V93, P2287, DOI 10.1002/hlca.201000115; Tang J, 2010, PEPTIDES, V31, P1434, DOI 10.1016/j.peptides.2010.05.004; Telang M, 2003, PHYTOCHEMISTRY, V63, P643, DOI 10.1016/S0031-9422(03)00239-5; van den Hooven HW, 2001, BIOCHEMISTRY-US, V40, P3458, DOI 10.1021/bi0023089; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Wu J, 1998, ANAL BIOCHEM, V258, P268, DOI 10.1006/abio.1998.2596; Wu J, 1997, PROTEIN SCI, V6, P391; Wu J, 1996, ANAL BIOCHEM, V235, P161, DOI 10.1006/abio.1996.0108; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu WY, 2008, CHINESE SCI BULL, V53, P1671, DOI 10.1007/s11434-008-0178-8; Zhou T, 2000, CHINESE SCI BULL, V45, P1825	55	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75334	10.1371/journal.pone.0075334	http://dx.doi.org/10.1371/journal.pone.0075334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116036	Green Accepted, Green Published, gold			2022-12-27	WOS:000325552200016
J	Jiao, YY; Chen, X; Wang, X; Liao, XW; Xiao, L; Miao, AJ; Wu, J; Yang, LY				Jiao, Yiying; Chen, Xu; Wang, Xin; Liao, Xuewei; Xiao, Lin; Miao, Aijun; Wu, Jun; Yang, Liuyan			Identification and Characterization of a Cold-Active Phthalate Esters Hydrolase by Screening a Metagenomic Library Derived from Biofilms of a Wastewater Treatment Plant	PLOS ONE			English	Article							MICROCOCCUS SP YGJ1; N-BUTYL PHTHALATE; CHINA; PURIFICATION; DEGRADATION; CHEMICALS; TOXICITY; ENZYMES; LIPASES; PAES	A cold-active phthalate esters hydrolase gene (designated dphB) was identified through functional screening of a metagenomic library derived from biofilms of a wastewater treatment plant. The enzyme specifically catalyzed the hydrolysis of dipropyl phthalate, dibutyl phthalate, and dipentyl phthalate to the corresponding monoalkyl phthalate esters at low temperatures. The catalytic triad residues of DphB were proposed to be Ser159, Asp251, and His281.	[Jiao, Yiying; Chen, Xu; Wang, Xin; Xiao, Lin; Miao, Aijun; Wu, Jun; Yang, Liuyan] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Dept Environm Biol, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Liao, Xuewei] Nanjing Normal Univ, Ctr Anal & Testing, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Normal University	Wu, J (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Dept Environm Biol, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	wujun2008@nju.edu.cn; yangly@nju.edu.cn	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022		Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07101006]; National Natural Science Foundation [21107047]	Major Science and Technology Program for Water Pollution Control and Treatment; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Science and Technology Program for Water Pollution Control and Treatment (Project no. 2012ZX07101006), and the National Natural Science Foundation (Project no. 21107047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita K, 2001, BIOSCI BIOTECH BIOCH, V65, P1680, DOI 10.1271/bbb.65.1680; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bell PJL, 2002, MICROBIOL-SGM, V148, P2283, DOI 10.1099/00221287-148-8-2283; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Hara H, 2010, APPL ENVIRON MICROB, V76, P1516, DOI 10.1128/AEM.02621-09; Huff J E, 1984, Prog Clin Biol Res, V141, P137; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Jonsson S, 2003, ENVIRON TOXICOL CHEM, V22, P3037, DOI 10.1897/02-548; Ma M, 2007, ENVIRON POLLUT, V147, P331, DOI 10.1016/j.envpol.2006.05.032; Maruyama K, 2005, J BIOCHEM, V137, P27, DOI 10.1093/jb/mvi004; Nishioka T, 2006, APPL ENVIRON MICROB, V72, P2394, DOI 10.1128/AEM.72.4.2394-2399.2006; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Piersma AH, 2000, REPROD TOXICOL, V14, P417, DOI 10.1016/S0890-6238(00)00100-3; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Vamsee-Krishna C, 2008, INDIAN J MICROBIOL, V48, P19, DOI 10.1007/s12088-008-0003-8; Wang F, 2008, J HAZARD MATER, V154, P317, DOI 10.1016/j.jhazmat.2007.10.028; Wang P, 2008, CHEMOSPHERE, V72, P1567, DOI 10.1016/j.chemosphere.2008.04.032; Wu J, 2013, APPL MICROBIOL BIOT, V97, P2483, DOI 10.1007/s00253-012-4232-8; Xu Y, 2003, J BACTERIOL, V185, P2161, DOI 10.1128/JB.185.7.2161-2168.2003; Xu Y, 2003, J BACTERIOL, V185, P5519, DOI 10.1128/JB.185.18.5519-5526.2003; Zeng F, 2008, ENVIRON POLLUT, V156, P425, DOI 10.1016/j.envpol.2008.01.045	27	33	35	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75977	10.1371/journal.pone.0075977	http://dx.doi.org/10.1371/journal.pone.0075977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116085	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200045
J	King, JR; Warren, RJ; Bradford, MA				King, Joshua R.; Warren, Robert J.; Bradford, Mark A.			Social Insects Dominate Eastern US Temperate Hardwood Forest Macroinvertebrate Communities in Warmer Regions	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; SUBTERRANEAN TERMITES; NEST ARCHITECTURE; ANT COMMUNITIES; SOIL FUNCTION; ABUNDANCE; RETICULITERMES; PATTERNS; BIOMASS; EARTHWORMS	Earthworms, termites, and ants are common macroinvertebrates in terrestrial environments, although for most ecosystems data on their abundance and biomass is sparse. Quantifying their areal abundance is a critical first step in understanding their functional importance. We intensively sampled dead wood, litter, and soil in eastern US temperate hardwood forests at four sites, which span much of the latitudinal range of this ecosystem, to estimate the abundance and biomass m(-2) of individuals in macroinvertebrate communities. Macroinvertebrates, other than ants and termites, differed only slightly among sites in total abundance and biomass and they were similar in ordinal composition. Termites and ants were the most abundant macroinvertebrates in dead wood, and ants were the most abundant in litter and soil. Ant abundance and biomass m(-2) in the southernmost site (Florida) were among the highest values recorded for ants in any ecosystem. Ant and termite biomass and abundance varied greatly across the range, from < 1% of the total macroinvertebrate abundance (in the northern sites) to > 95% in the southern sites. Our data reveal a pronounced shift to eusocial insect dominance with decreasing latitude in a temperate ecosystem. The extraordinarily high social insect relative abundance outside of the tropics lends support to existing data suggesting that ants, along with termites, are globally the most abundant soil macroinvertebrates, and surpass the majority of other terrestrial animal (vertebrate and invertebrate) groups in biomass m(-2). Our results provide a foundation for improving our understanding of the functional role of social insects in regulating ecosystem processes in temperate forest.	[King, Joshua R.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Warren, Robert J.] SUNY Buffalo State, Dept Biol, Buffalo, NY USA; [Bradford, Mark A.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA	State University System of Florida; University of Central Florida; State University of New York (SUNY) System; Buffalo State College; Yale University	King, JR (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	joshua.king@ucf.edu	Bradford, Mark A/G-3850-2012	Bradford, Mark A/0000-0002-2022-8331; Warren II, Robert/0000-0001-6765-2351	National Science Foundation (NSF) [DEB 1020415]; University of Central Florida; NSF [DEB-0823293, DEB-0218001]; Division Of Environmental Biology [0823293] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Central Florida; NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	JRK was supported by National Science Foundation (NSF) grant DEB 1020415 and an In-House grant from the University of Central Florida. MAB and RJW were supported by NSF grants DEB-0823293 and DEB-0218001 to the Coweeta LTER Program (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1990, P29; Abe T., 2000, TERMITES EVOLUTION S; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; Baroni-Urbani C, 1978, PRODUCTION ECOLOGY A, P336; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bolstad PV, 2001, FOREST PRODUCTIVITY; Bolton B., 2006, BOLTONS CATALOGUE AN; Brian M. V., 1978, PRODUCTION ECOLOGY A; Brown Jr W.L., 1973, TROPICAL FOREST ECOS, P161, DOI DOI 10.5281/ZENODO.17403; Brussaard L, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P201; BURTON TM, 1975, COPEIA, P541; Callaham MA, 1997, SOIL BIOL BIOCHEM, V29, P317, DOI 10.1016/S0038-0717(96)00095-8; Cammeraat ELH, 2008, J APPL ENTOMOL, V132, P285, DOI 10.1111/j.1439-0418.2008.01281.x; Chojnacky DC, 2004, ENVIRON MANAGE, V33, pS44, DOI 10.1007/s00267-003-9116-3; Clark RE, 2012, ENVIRON ENTOMOL, V41, P1405, DOI 10.1603/EN12131; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; de Bruyn LAL, 1999, AGR ECOSYST ENVIRON, V74, P425, DOI 10.1016/S0167-8809(99)00047-X; DEBRUYN LAL, 1990, AUST J SOIL RES, V28, P55, DOI 10.1071/SR9900055; Deyrup M, 2003, FLA ENTOMOL, V86, P43, DOI 10.1653/0015-4040(2003)086[0043:AULOFA]2.0.CO;2; Edwards C.A, 1998, EARTHWORM ECOLOGY; Elliott KJ, 2011, FOREST ECOL MANAG, V261, P900, DOI 10.1016/j.foreco.2010.03.010; Ellison AM, 2007, ENVIRON ENTOMOL, V36, P766, DOI 10.1603/0046-225X(2007)36[766:RIOTAA]2.0.CO;2; EMERSON ALFRED E., 1936, SCIENCE, V83, P410, DOI 10.1126/science.83.2157.410; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Goodale E, 2009, FOREST ECOL MANAG, V258, P314, DOI 10.1016/j.foreco.2009.04.020; Hendrix Paul F., 1994, Megadrilogica, V5, P73; Holldobler B., 1990, pi; Irland L.C, 1999, NE CHANGING FOREST; Jimenez JJ, 2008, APPL SOIL ECOL, V40, P120, DOI 10.1016/j.apsoil.2008.03.009; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kaspari M, 2012, ECOGRAPHY, V35, P65, DOI 10.1111/j.1600-0587.2011.06971.x; Khattree R, 1999, APPL MULTIVARIATE ST; King JR, 2007, EVOL ECOL RES, V9, P757; King JR, 2010, ECOL ENTOMOL, V35, P287, DOI 10.1111/j.1365-2311.2010.01177.x; King JR, 2005, ENVIRON ENTOMOL, V34, P1566, DOI 10.1603/0046-225X-34.6.1566; Korb J, 2007, CURR BIOL, V17, pR995, DOI 10.1016/j.cub.2007.10.033; Lach L, 2010, ANT ECOLOGY, P1; Lavelle P., 1984, Biology International, P2; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; LAVELLE P, 1992, SSSA SPEC PUBL, V29, P157; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Lavelle P, 1997, ADV ECOL RES, V27, P93, DOI 10.1016/S0065-2504(08)60007-0; Lavelle P., 2001, SOIL ECOLOGY; Lugo AE, 1999, J BIOGEOGR, V26, P1025, DOI 10.1046/j.1365-2699.1999.00329.x; Lugo AE, 1978, DOE S SERIES, P790; Mickler RA, 2002, J AIR WASTE MANAGE, V52, P407, DOI 10.1080/10473289.2002.10470793; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Ollinger SV, 1998, LANDSCAPE ECOL, V13, P323, DOI 10.1023/A:1008004423783; Packard C. E., 1936, Science New York, V83, P575, DOI 10.1126/science.83.2163.575; PETERSEN H, 1982, OIKOS, V39, P287, DOI 10.2307/3544689; Platt W.J., 1990, ECOSYSTEMS FLORIDA, P194; PRINS HHT, 1989, J ANIM ECOL, V58, P851, DOI 10.2307/5128; Rodda GH, 2001, J TROP ECOL, V17, P331, DOI 10.1017/S0266467401001225; SCHALLER G B, 1983, Arquivos de Zoologia (Sao Paulo), V31, P1; Shakir SH, 1997, SOIL BIOL BIOCHEM, V29, P275, DOI 10.1016/S0038-0717(96)00051-X; SRIKOSAMATARA S, 1993, J TROP ECOL, V9, P33, DOI 10.1017/S026646740000691X; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Suarez ER, 2006, ECOL APPL, V16, P154, DOI 10.1890/04-0788; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833; Tobin John E., 1995, P129; TSCHINKEL WR, 1991, INSECT SOC, V38, P77, DOI 10.1007/BF01242715; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; TURNER MG, 1987, ENVIRON MANAGE, V11, P237, DOI 10.1007/BF01867202; Vargo EL, 2013, MOL ECOL, V22, P1447, DOI 10.1111/mec.12166; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Warren RJ, 2010, CASTANEA, V75, P67, DOI 10.2179/08-048.1; Watt AD, 2002, J APPL ECOL, V39, P18, DOI 10.1046/j.1365-2664.2002.00699.x; Wheller WM, 1911, J MORPHOL, V22, P307; Wood T.G., 1978, International Biological Programme, P245	72	47	49	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75843	10.1371/journal.pone.0075843	http://dx.doi.org/10.1371/journal.pone.0075843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116079	Green Published, gold			2022-12-27	WOS:000325552200041
J	Legge, GE; Beckmann, PJ; Tjan, BS; Havey, G; Kramer, K; Rolkosky, D; Gage, R; Chen, MZ; Puchakayala, S; Rangarajan, A				Legge, Gordon E.; Beckmann, Paul J.; Tjan, Bosco S.; Havey, Gary; Kramer, Kevin; Rolkosky, David; Gage, Rachel; Chen, Muzi; Puchakayala, Sravan; Rangarajan, Aravindhan			Indoor Navigation by People with Visual Impairment Using a Digital Sign System	PLOS ONE			English	Article							ELECTRONIC TRAVEL AIDS; USERS	There is a need for adaptive technology to enhance indoor wayfinding by visually-impaired people. To address this need, we have developed and tested a Digital Sign System. The hardware and software consist of digitally-encoded signs widely distributed throughout a building, a handheld sign-reader based on an infrared camera, image-processing software, and a talking digital map running on a mobile device. Four groups of subjects-blind, low vision, blindfolded sighted, and normally sighted controls-were evaluated on three navigation tasks. The results demonstrate that the technology can be used reliably in retrieving information from the signs during active mobility, in finding nearby points of interest, and following routes in a building from a starting location to a destination. The visually impaired subjects accurately and independently completed the navigation tasks, but took substantially longer than normally sighted controls. This fully functional prototype system demonstrates the feasibility of technology enabling independent indoor navigation by people with visual impairment.	[Legge, Gordon E.; Gage, Rachel; Chen, Muzi; Puchakayala, Sravan; Rangarajan, Aravindhan] Univ Minnesota, Minnesota Lab Low Vis Res, St Paul, MN USA; [Beckmann, Paul J.] Univ St Thomas, St Paul, MN USA; [Tjan, Bosco S.] Univ So Calif, Los Angeles, CA USA; [Havey, Gary; Kramer, Kevin; Rolkosky, David] Adv Med Elect Corp AME, Maple Grove, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of St Thomas Minnesota; University of Southern California	Legge, GE (corresponding author), Univ Minnesota, Minnesota Lab Low Vis Res, St Paul, MN USA.	legge@umn.edu		Legge, Gordon/0000-0002-3742-1680	U.S. Department of Education through SenderoGroup LLC [H133A011903]; National Institute on Aging (NIH) [R44AG033522]; NATIONAL EYE INSTITUTE [P30EY011374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG033522] Funding Source: NIH RePORTER	U.S. Department of Education through SenderoGroup LLC; National Institute on Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Early development of DSS was supported by a grant from the U.S. Department of Education (H133A011903) through a subcontract from SenderoGroup LLC to the University of Minnesota. Development of the current version of DSS and the experiments described here were supported by a grant from the National Institute on Aging (NIH) R44AG033522 to Advanced Medical Electronics with subcontract to the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi A, 2013, J VISUAL IMPAIR BLIN, V107, P118, DOI 10.1177/0145482X1310700205; Bahl P., 2000, Proceedings IEEE INFOCOM 2000. Conference on Computer Communications. Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies (Cat. No.00CH37064), P775, DOI 10.1109/INFCOM.2000.832252; Coughlan J., 2006, P IMV 2006; Coughlan J, 2009, INT J ARTIF INTELL T, V18, P379, DOI 10.1142/S0218213009000196; Giudice N.A., 2008, ENGI HDB SMART TECHN, V8, P479, DOI DOI 10.1002/9780470379424.CH25; Giudice NA, 2007, PSYCHOL RES-PSYCH FO, V71, P347, DOI 10.1007/s00426-006-0089-8; Havik EM, 2011, J VISUAL IMPAIR BLIN, V105, P624, DOI 10.1177/0145482X1110501009; Hesch JA, 2007, IEEE INT CONF ROBOT, P3545, DOI 10.1109/ROBOT.2007.364021; Hightower J, 2001, COMPUTER, V34, P57, DOI 10.1109/2.940014; Hub A., 2004, ASSETS 2004. The Sixth International ACM SIGACCESS Conference on Computers and Accessibility, P147; Kalia AA, 2010, J VISUAL IMPAIR BLIN, V104, P135, DOI 10.1177/0145482X1010400303; Kulyukin V, 2004, P 16 INN APPL ART IN; Manduchi R, 2012, COMMUN ACM, V55, P96, DOI 10.1145/2063176.2063200; Mason SJ, 2005, J VISUAL IMPAIR BLIN, V99, P741; Mautz R., 2011, IND POS IND NAV IPIN, P1, DOI DOI 10.1109/IPIN.2011.6071925; Merabet LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044958; Mulloni A, 2009, IEEE PERVAS COMPUT, V8, P22, DOI 10.1109/MPRV.2009.30; Popescu ML, 2012, INVEST OPHTH VIS SCI, V53, P2308, DOI 10.1167/iovs.11-9330; Rajamaki J., 2007, P 6 WSEAS INT C EL H P 6 WSEAS INT C EL H, P96; Ran L, 2004, SECOND IEEE ANNUAL CONFERENCE ON PERVASIVE COMPUTING AND COMMUNICATIONS, PROCEEDINGS, P23, DOI 10.1109/PERCOM.2004.1276842; Roentgen UR, 2011, J VISUAL IMPAIR BLIN, V105, P612, DOI 10.1177/0145482X1110501008; Roentgen UR, 2009, J VISUAL IMPAIR BLIN, V103, P743, DOI 10.1177/0145482X0910301104; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Tjan BS, 2005, COMP VIS PATT REC WO; Willis S, 2004, TR04009120 U FLOR	25	54	54	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76783	10.1371/journal.pone.0076783	http://dx.doi.org/10.1371/journal.pone.0076783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116156	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200067
J	Liu, ZF; Lin, YB; Lu, HF; Ding, MM; Tan, YW; Xu, SJ; Fu, SL				Liu, Zhanfeng; Lin, Yongbiao; Lu, Hongfang; Ding, Mingmao; Tan, Yaowen; Xu, Shejin; Fu, Shenglei			Maintenance of a Living Understory Enhances Soil Carbon Sequestration in Subtropical Orchards	PLOS ONE			English	Article							FLOOR MANAGEMENT; VEGETATION; FERTILITY; IMPACTS; FOREST	Orchard understory represents an important component of the orchards, performing numerous functions related to soil quality, water relations and microclimate, but little attention has been paid on its effect on soil C sequestration. In the face of global climate change, fruit producers also require techniques that increase carbon (C) sequestration in a cost-effective manner. Here we present a case study to compare the effects of understory management (sod culture vs. clean tillage) on soil C sequestration in four subtropical orchards. The results of a 10-year study indicated that the maintenance of sod significantly enhanced the soil C stock in the top 1 m of orchard soils. Relative to clean tillage, sod culture increased annual soil C sequestration by 2.85 t C ha(-1), suggesting that understory management based on sod culture offers promising potential for soil carbon sequestration. Considering that China has the largest area of orchards in the world and that few of these orchards currently have sod understories, the establishment and maintenance of sod in orchards can help China increase C sequestration and greatly contribute to achieving CO2 reduction targets at a regional scale and potentially at a national scale.	[Liu, Zhanfeng; Lin, Yongbiao; Lu, Hongfang; Ding, Mingmao; Fu, Shenglei] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Tan, Yaowen; Xu, Shejin] Guangzhou Fruit Res Inst, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS	Lin, YB (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linyb@scbg.ac.cn; sfu@scbg.ac.cn	Liu, Zhanfeng/ABD-3933-2021; Fu, Shenglei/B-2729-2012	Liu, Zhanfeng/0000-0002-6602-6196; 	National Science Foundation of China [31100384, 30925010, U1131001]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-J-28]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05070301]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Science Foundation of China (31100384, 30925010 and U1131001), the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-J-28), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05070301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2003, AGR ECOSYST ENVIRON, V99, P15, DOI 10.1016/S0167-8809(03)00138-5; Balesdent J, 1996, SOIL BIOL BIOCHEM, V28, P1261, DOI 10.1016/0038-0717(96)00112-5; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Goh KM, 2001, BIOL AGRIC HORTIC, V18, P269, DOI 10.1080/01448765.2001.9754889; Granatstein D, 2009, INT J FRUIT SCI, V9, P257, DOI 10.1080/15538360903245212; He Y., 2005, SUBTROPICAL AGR RES, V1, P45; Hoagland L, 2008, BIOL FERT SOILS, V45, P11, DOI 10.1007/s00374-008-0304-4; Huang ZM, 2011, FRUIT CULTIVATION PE; Ingram JSI, 2001, AGR ECOSYST ENVIRON, V87, P111, DOI 10.1016/S0167-8809(01)00145-1; Itoh M, 1997, J JPN SOC HORTIC SCI, V66, P1, DOI 10.2503/jjshs.66.1; [寇建村 Kou Jiancun], 2010, [草业科学, Pratacultural Science], V27, P154; Kumar BM, 2011, ADV AGROFOR, V8, P1, DOI 10.1007/978-94-007-1630-8; LAL R, 2000, ADV SOIL SCI SER, P3; Liu ZF, 2012, APPL SOIL ECOL, V54, P7, DOI 10.1016/j.apsoil.2011.12.002; Liu ZF, 2012, PEDOBIOLOGIA, V55, P7, DOI 10.1016/j.pedobi.2011.07.014; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Marsh KB, 1996, BIOL AGRIC HORTIC, V13, P161, DOI 10.1080/01448765.1996.9754775; MERWIN IA, 1994, J AM SOC HORTIC SCI, V119, P216, DOI 10.21273/JASHS.119.2.216; Morgan JA, 2010, J SOIL WATER CONSERV, V65, p6A, DOI 10.2489/jswc.65.1.6A; Nieder R, 2003, HANDBOOK OF PROCESSES AND MODELING IN THE SOIL-PLANT SYSTEM, P345; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Shui JG, 2008, PEDOSPHERE, V18, P214, DOI 10.1016/S1002-0160(08)60009-0; SKROCH WA, 1986, HORTSCIENCE, V21, P390; Wang YX, 2010, SUBTROPICAL AGR RES, V6, P189; Wardle DA, 2001, SOIL BIOL BIOCHEM, V33, P893, DOI 10.1016/S0038-0717(00)00235-2; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Winjum JK, 1993, WATER AIR SOIL POLL, V64, P227; Wu JP, 2011, SOIL BIOL BIOCHEM, V43, P2355, DOI 10.1016/j.soilbio.2011.07.011; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057	31	12	18	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76950	10.1371/journal.pone.0076950	http://dx.doi.org/10.1371/journal.pone.0076950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116188	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200088
J	Xu, HD; Zhao, MF; Wan, TH; Song, GZ; He, JL; Chen, Z				Xu, Hang-di; Zhao, Ming-fei; Wan, Tian-hong; Song, Guang-zhong; He, Ji-liang; Chen, Zhi			Association between Mannose-Binding Lectin Gene Polymorphisms and Hepatitis B Virus Infection: A Meta-Analysis	PLOS ONE			English	Article							PROTEIN; SUSCEPTIBILITY; MUTATIONS; POPULATION; TUBERCULOSIS; PROGRESSION; DEFICIENCY; PROMOTER; DISEASE	Objective: The results of studies on the relation between Mannose-binding lectin gene (mbl2) polymorphism and HBV infection were contradictory and inconclusive. In order to shed a light on these inconsistent findings and to clarify the role of mbl2 polymorphisms in susceptibility or progression of chronic hepatitis B (CHB), a meta-analysis was performed. Methods: PubMed and Embase were searched for available articles. A meta-analysis was performed to examine the association between mbl2 polymorphisms and chronicity or progression of hepatitis B infection. Odds ratio (OR) and its 95% confidence interval (CI) served as indexes. Results: A total of 17 eligible studies were involved, including 2151 healthy controls (HC), 1293 spontaneous recovered (SR) patients with acute infection, 2337 cases with chronic hepatitis B (CHB) and 554 cases with progressive hepatitis B. There was no evidence of significant association between mbl2 exon1 polymorphisms and CHB risk in any genetic model or pairwise comparisons when compared with HC group or SR group. In the stratified analysis of ethnic groups, also no obvious relation between mbl2 polymorphism and CHB risk was identified. There was still no significant association between the complete mbl2 genotypic profile (including both the exon1 and the promoter gene) polymorphisms and CHB risk, as compared with SR group. However, it was found that there was an association between the mbl2 AO/OO genotype and severe hepatitis B (SHB) or liver cirrhosis (LC) (LC vs. HC: OR=3.66, 95%CI, 2.38-5.63; SHB vs. HC, OR=3.88, 95%CI, 2.26-6.64), but there was no relationship between the mbl2 AO/OO genotype and hepatocellular carcinoma (HCC) (OR=1.26, 95%CI, 0.82-1.94). Conclusion: The present meta-analysis indicated that mbl2 exon1 polymorphisms might not significantly associate with chronicity of HBV infection, but might be significantly related to the progressive HBV such as SHB and LC.	[Xu, Hang-di; Chen, Zhi] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Ming-fei] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [He, Ji-liang] Zhejiang Univ, Inst Environm Med, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wan, Tian-hong; Song, Guang-zhong; Chen, Zhi] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Chen, Z (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	zju.zhichen@gmail.com			12-5 State S&T Projects of China [2012ZX10002007]	12-5 State S&T Projects of China(Chinese Academy of Sciences)	This work was funded by the 12-5 State S&T Projects of China (2012ZX10002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellamy R, 1998, QJM-INT J MED, V91, P13, DOI 10.1093/qjmed/91.1.13; Chatzidaki V, 2012, EUR J GASTROEN HEPAT, V24, P1185, DOI 10.1097/MEG.0b013e328356440f; Chen DQ, 2010, J MED VIROL, V82, P371, DOI 10.1002/jmv.21716; Cheong JY, 2005, J KOREAN MED SCI, V20, P65, DOI 10.3346/jkms.2005.20.1.65; Chong WP, 2005, HEPATOLOGY, V42, P1037, DOI 10.1002/hep.20891; Denholm JT, 2010, CLIN EXP IMMUNOL, V162, P84, DOI 10.1111/j.1365-2249.2010.04221.x; Fletcher GJ, 2010, INT J IMMUNOGENET, V37, P177, DOI 10.1111/j.1744-313X.2010.00908.x; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; GERLICH WH, 1993, J HEPATOL, V17, pS10, DOI 10.1016/S0168-8278(05)80417-9; Gourraud PA, 2011, GENET EPIDEMIOL, V35, P568, DOI 10.1002/gepi.20592; Hakozaki Y, 2002, LIVER, V22, P29, DOI 10.1046/j.0106-9543.2001.01516.x; Hohler T, 1998, EXP CLIN IMMUNOGENET, V15, P130, DOI 10.1159/000019064; Jack DL, 2001, J INFECT DIS, V184, P1152, DOI 10.1086/323803; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Lee YH, 2005, ARTHRITIS RHEUM-US, V52, P3966, DOI 10.1002/art.21484; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Magalhaes R, 2010, VIRAL IMMUNOL, V23, P449, DOI 10.1089/vim.2009.0105; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Miyaike J, 2002, GUT, V51, P591, DOI 10.1136/gut.51.4.591; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Saifuddin M, 2000, J GEN VIROL, V81, P949, DOI 10.1099/0022-1317-81-4-949; Segat L, 2008, J VIRAL HEPATITIS, V15, P387, DOI [10.1111/j.1365-2893.2008.00965.x, 10.1111/j.1365-2893.2007.00965.x]; Shi H, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P202; Song LH, 2003, MUTAT RES-FUND MOL M, V522, P119, DOI 10.1016/S0027-5107(02)00284-1; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Thomas HC, 1996, LANCET, V348, P1417, DOI 10.1016/S0140-6736(96)05409-8; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; Tong Fu-yi, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P331; Yuen MF, 1999, HEPATOLOGY, V29, P1248, DOI 10.1002/hep.510290417; Zheng Rui-Dan, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P90; Zhong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028839	32	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75371	10.1371/journal.pone.0075371	http://dx.doi.org/10.1371/journal.pone.0075371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116040	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200019
J	Babujee, L; Balakrishnan, V; Kiley, PJ; Glasner, JD; Perna, NT				Babujee, Lavanya; Balakrishnan, Venkatesh; Kiley, Patricia J.; Glasner, Jeremy D.; Perna, Nicole T.			Transcriptome Changes Associated with Anaerobic Growth in Yersinia intermedia (ATCC29909)	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; BORNE TRANSMISSION; ENTEROCOLITICA; EVOLUTION; VIRULENCE; PSEUDOTUBERCULOSIS; RPOS; IDENTIFICATION; METABOLISM	Background: The yersiniae (Enterobacteriaceae) occupy a variety of niches, including some in human and flea hosts. Metabolic adaptations of the yersiniae, which contribute to their success in these specialized environments, remain largely unknown. We report results of an investigation of the transcriptome under aerobic and anaerobic conditions for Y. intermedia, a non-pathogenic member of the genus that has been used as a research surrogate for Y. pestis. Y. intermedia shares characteristics of pathogenic yersiniae, but is not known to cause disease in humans. Oxygen restriction is an important environmental stimulus experienced by many bacteria during their life-cycles and greatly influences their survival in specific environments. How oxygen availability affects physiology in the yersiniae is of importance in their life cycles but has not been extensively characterized. Methodology/Principal Findings: Tiled oligonucleotide arrays based on a draft genome sequence of Y. intermedia were used in transcript profiling experiments to identify genes that change expression in response to oxygen availability during growth in minimal media with glucose. The expression of more than 400 genes, constituting about 10% of the genome, was significantly altered due to oxygen-limitation in early log phase under these conditions. Broad functional categorization indicated that, in addition to genes involved in central metabolism, genes involved in adaptation to stress and genes likely involved with host interactions were affected by oxygen-availability. Notable among these, were genes encoding functions for motility, chemotaxis and biosynthesis of cobalamin, which were up-regulated and those for iron/heme utilization, methionine metabolism and urease, which were down-regulated. Conclusions/Significance: This is the first transcriptome analysis of a non-pathogenic Yersinia spp. and one of few elucidating the global response to oxygen limitation for any of the yersiniae. Thus this study lays the foundation for further experimental characterization of oxygen-responsive genes and pathways in this ecologically diverse genus.	[Babujee, Lavanya; Balakrishnan, Venkatesh; Glasner, Jeremy D.; Perna, Nicole T.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Kiley, Patricia J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Perna, Nicole T.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Perna, NT (corresponding author), Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA.	ntperna@wisc.edu		Kiley, Patricia/0000-0002-8771-1782; Perna, Nicole/0000-0001-8208-0929	"Molecular Evolution of Microbial Pathogen Genomes", NIH [R01-GM62994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062994] Funding Source: NIH RePORTER	"Molecular Evolution of Microbial Pathogen Genomes", NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LB is supported by the "Molecular Evolution of Microbial Pathogen Genomes", NIH R01-GM62994 (P.I. N.T. Perna; Co-P.I.s J.D. Glasner, P.J. Kiley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Babujee L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-110; BAHRANI FK, 1994, J BACTERIOL, V176, P3412, DOI 10.1128/jb.176.11.3412-3419.1994; Bai GC, 2007, ADV EXP MED BIOL, V603, P131; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; BOTTONE EJ, 1977, CRC CR REV MICROBIOL, V5, P211, DOI 10.3109/10408417709102312; Boulette ML, 2007, J BACTERIOL, V189, P6957, DOI 10.1128/JB.00621-07; BRENNER DJ, 1980, CURR MICROBIOL, V4, P207, DOI 10.1007/BF02605858; BUTLER T, 1984, T ROY SOC TROP MED H, V78, P449, DOI 10.1016/0035-9203(84)90057-9; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Carniel E, 1996, J BACTERIOL, V178, P6743, DOI 10.1128/jb.178.23.6743-6751.1996; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Chouikha I, 2012, CURR OPIN MICROBIOL, V15, P239, DOI 10.1016/j.mib.2012.02.003; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, INFECT IMMUN, V77, P501, DOI 10.1128/IAI.00850-08; Douarche C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198101; Dufour YS, 2010, NUCLEIC ACIDS RES, V38, pW321, DOI 10.1093/nar/gkq517; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; FARMER JJ, 1985, J CLIN MICROBIOL, V21, P46, DOI 10.1128/JCM.21.1.46-76.1985; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Forman S, 2007, MICROBIOL-SGM, V153, P2332, DOI 10.1099/mic.0.2006/004275-0; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Foster JW, 1999, NOVART FDN SYMP, V221, P55; Fraser HI, 1999, FEBS LETT, V455, P344, DOI 10.1016/S0014-5793(99)00910-2; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; HEESEMANN J, 1987, FEMS MICROBIOL LETT, V48, P229, DOI 10.1016/0378-1097(87)90167-4; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Hu YB, 2010, FEBS LETT, V584, P2311, DOI 10.1016/j.febslet.2010.03.045; IRIARTE M, 1995, INFECT IMMUN, V63, P1840, DOI 10.1128/IAI.63.5.1840-1847.1995; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lengeler JW, 2009, CONTRIB MICROBIOL, V16, P65, DOI 10.1159/000219373; Leo JC, 2011, ADV EXP MED BIOL, V715, P1, DOI 10.1007/978-94-007-0940-9_1; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Maier RJ, 2005, BIOCHEM SOC T, V33, P83, DOI 10.1042/BST0330083; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Obi IR, 2011, BIOCHEM J, V439, P321, DOI 10.1042/BJ20110767; OLD DC, 1982, J MED MICROBIOL, V15, P551, DOI 10.1099/00222615-15-4-551; OLD DC, 1984, MICROBIOL IMMUNOL, V28, P1303, DOI 10.1111/j.1348-0421.1984.tb00788.x; Pearson MM, 2010, INFECT IMMUN, V78, P2834, DOI 10.1128/IAI.01222-09; PEDERSON KJ, 1995, INFECT IMMUN, V63, P4199, DOI 10.1128/IAI.63.10.4199-4201.1995; Perry R D, 1993, Trends Microbiol, V1, P142, DOI 10.1016/0966-842X(93)90129-F; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; PROVENCE DL, 1992, INFECT IMMUN, V60, P4460, DOI 10.1128/IAI.60.11.4460-4467.1992; PUNSALANG A, 1987, J CLIN MICROBIOL, V25, P859, DOI 10.1128/JCM.25.5.859-862.1987; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Stenkova AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020546; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; STUART SJ, 1986, J BACTERIOL, V166, P1131, DOI 10.1128/jb.166.3.1131-1133.1986; Sulakvelidze A, 2000, MICROBES INFECT, V2, P497, DOI 10.1016/S1286-4579(00)00311-7; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; UNDEN G, 1994, ANTON LEEUW INT J G, V66, P3, DOI 10.1007/BF00871629; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Wang QF, 2006, J BACTERIOL, V188, P7981, DOI 10.1128/JB.00852-06; WARD TFD, 1995, INFECT IMMUN, V63, P3790; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Winans SC, 2002, J BACTERIOL, V184, P873, DOI 10.1128/jb.184.4.873-883.2002; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730	88	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76567	10.1371/journal.pone.0076567	http://dx.doi.org/10.1371/journal.pone.0076567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116118	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300065
J	Bon, I; Lembo, D; Rusnati, M; Clo, A; Morini, S; Miserocchi, A; Bugatti, A; Grigolon, S; Musumeci, G; Landolfo, S; Re, MC; Gibellini, D				Bon, Isabella; Lembo, David; Rusnati, Marco; Clo, Alberto; Morini, Silvia; Miserocchi, Anna; Bugatti, Antonella; Grigolon, Sonia; Musumeci, Giuseppina; Landolfo, Santo; Re, Maria Carla; Gibellini, Davide			Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPARAN-SULFATE PROTEOGLYCANS; ENVELOPE GLYCOPROTEIN GP120; PREEXPOSURE PROPHYLAXIS; ENTRY INHIBITORS; ANTIRETROVIRAL THERAPY; QUANTITATIVE DETECTION; TOPICAL MICROBICIDES; VAGINAL TRANSMISSION; ANTIVIRAL ACTIVITY	Peptide dendrimers are a class of molecules that exhibit a large array of biological effects including antiviral activity. In this report, we analyzed the antiviral activity of the peptide-derivatized SB105-A10 dendrimer, which is a tetra-branched dendrimer synthetized on a lysine core, in activated peripheral blood mononuclear cells (PBMCs) that were challenged with reference and wild-type human immunodeficiency virus type 1 (HIV-1) strains. SB105-A10 inhibited infections by HIV-1 X4 and R5 strains, interfering with the early phases of the viral replication cycle. SB105-A10 targets heparan sulfate proteoglycans (HSPGs) and, importantly, the surface plasmon resonance (SPR) assay revealed that SB105-A10 strongly binds gp41 and gp120, most likely preventing HIV-1 attachment/entry through multiple mechanisms. Interestingly, the antiviral activity of SB105-A10 was also detectable in an organ-like structure of human cervicovaginal tissue, in which SB105-A10 inhibited the HIV-1(ada) R5 strain infection without altering the tissue viability. These results demonstrated the strong antiviral activity of SB105-A10 and suggest a potential microbicide use of this dendrimer to prevent the heterosexual transmission of HIV-1.	[Bon, Isabella; Clo, Alberto; Morini, Silvia; Miserocchi, Anna; Musumeci, Giuseppina; Re, Maria Carla; Gibellini, Davide] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Microbiol Sect, Bologna, Italy; [Lembo, David] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Rusnati, Marco; Bugatti, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Grigolon, Sonia] Spider Biotech Srl, Colleretto Giacosa, Turin, Italy; [Landolfo, Santo] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy; [Re, Maria Carla] INBB, Interuniv Consortium, Rome, Italy	University of Bologna; University of Turin; University of Brescia; University of Turin	Gibellini, D (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Microbiol Sect, Bologna, Italy.	davide.gibellini@unibo.it	Gibellini, Davide/K-8725-2016; BON, ISABELLA/HIK-0216-2022; Rusnati, Marco/F-1168-2010	Gibellini, Davide/0000-0003-3688-1252; BON, ISABELLA/0000-0002-9433-5201; Rusnati, Marco/0000-0001-9968-5908; Lembo, David/0000-0002-0969-100X; Re, Maria Carla/0000-0003-1486-9033; MUSUMECI, GIUSEPPINA/0000-0003-0118-4537	Italian Ministry of Health; University of Bologna; MURST; Spider Biotech grant	Italian Ministry of Health(Ministry of Health, Italy); University of Bologna; MURST(Ministry of Education, Universities and Research (MIUR)); Spider Biotech grant	This work was supported by Italian Ministry of Health (AIDS project), University of Bologna (selected topics) and MURST 60%. The authors acknowledge a grant for the Lagrange Project - Crt Foundation. This study was partially funded by Spider Biotech grant to DG for the purchase of reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Abraham BK, 2012, CURR OPIN HIV AIDS, V7, P600, DOI 10.1097/COH.0b013e328358b9ce; Argyris EG, 2003, J VIROL, V77, P12140, DOI 10.1128/JVI.77.22.12140-12151.2003; Asaftei S, 2012, J MED CHEM, V55, P10405, DOI 10.1021/jm301337y; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; Bekker LG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007435; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Borges A. Rosa, 2005, Current Drug Targets - Infectious Disorders, V5, P247, DOI 10.2174/1568005054880127; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Cai LF, 2010, CHEMMEDCHEM, V5, P1813, DOI 10.1002/cmdc.201000289; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chang DK, 2007, ANTIVIR RES, V74, P51, DOI 10.1016/j.antiviral.2006.12.006; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen Myron S, 2004, Top HIV Med, V12, P104; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Cummins Jr JE, 2007, ANTIMICROB AGENTS CH, V5; Dahl V, 2010, ANTIVIR RES, V85, P286, DOI 10.1016/j.antiviral.2009.09.016; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Donalisio M, 2012, ANTIMICROB AGENTS CH, V56, P5278, DOI 10.1128/AAC.00771-12; Donalisio M, 2010, ANTIMICROB AGENTS CH, V54, P4290, DOI 10.1128/AAC.00471-10; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Foss AM, 2009, SEX TRANSM INFECT, V85, P276, DOI 10.1136/sti.2008.032458; Gartner S, 1990, HIV TECHNIQUES, P53; Gibellini D, 2004, J CLIN VIROL, V29, P282, DOI 10.1016/S1386-6532(03)00169-0; Gibellini D, 2004, J VIROL METHODS, V115, P183, DOI 10.1016/j.jviromet.2003.09.030; Girard MP, 2012, CURR OPIN HIV AIDS, V7, P4, DOI 10.1097/COH.0b013e32834ddc96; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Grobler A, 2012, AIDS, V26, P2261, DOI 10.1097/QAD.0b013e328355ce08; HANSEN JES, 1989, AIDS, V3, P635, DOI 10.1097/00002030-198910000-00003; Heegaard Peter M H, 2006, Recent Pat Antiinfect Drug Discov, V1, P331; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilby JM, 2002, AIDS RES HUM RETROV, V18, P685, DOI 10.1089/088922202760072294; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lalezari JP, 2003, AIDS, V17, P691, DOI 10.1097/00002030-200303280-00007; Lederman MM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-116; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Luganini A, 2010, ANTIVIR RES, V85, P532, DOI 10.1016/j.antiviral.2010.01.003; Maldarelli F, 2011, CURR OPIN HIV AIDS, V6, P49, DOI 10.1097/COH.0b013e32834134ea; Marsden MD, 2009, J ANTIMICROB CHEMOTH, V63, P7, DOI 10.1093/jac/dkn455; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; McCarthy TD, 2005, MOL PHARMACEUT, V2, P312, DOI 10.1021/mp050023q; McEnery Regina, 2011, IAVI Rep, V15, P21; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Ohshiro Y, 1996, MICROBIOL IMMUNOL, V40, P827, DOI 10.1111/j.1348-0421.1996.tb01148.x; Pang W, 2008, VIROLOGY, V377, P80, DOI 10.1016/j.virol.2008.04.013; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Quinn TC, 2008, AIDS, V22, pS7, DOI 10.1097/01.aids.0000327510.68503.e8; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Sarrazin S., 2011, COLD SPRING HARB PER, V3, P7; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Smith RJ, 2005, AIDS, V19, P413, DOI 10.1097/01.aids.0000161771.44276.92; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Svicher V, 2010, NEW MICROBIOL, V33, P195; Telwatte S, 2011, ANTIVIR RES, V90, P195, DOI 10.1016/j.antiviral.2011.03.186; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Tyssen D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012309; Ugolini S, 1999, TRENDS MICROBIOL, V7, P144, DOI 10.1016/S0966-842X(99)01474-2; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Wilson LE, 2009, CLIN INFECT DIS, V48, P214, DOI 10.1086/595701; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995	94	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76482	10.1371/journal.pone.0076482	http://dx.doi.org/10.1371/journal.pone.0076482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116111	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300059
J	Comoglio, F; Fracchia, L; Rinaldi, M				Comoglio, Federico; Fracchia, Letizia; Rinaldi, Maurizio			Bayesian Inference from Count Data Using Discrete Uniform Priors	PLOS ONE			English	Article							UNCERTAINTY	We consider a set of sample counts obtained by sampling arbitrary fractions of a finite volume containing an homogeneously dispersed population of identical objects. We report a Bayesian derivation of the posterior probability distribution of the population size using a binomial likelihood and non-conjugate, discrete uniform priors under sampling with or without replacement. Our derivation yields a computationally feasible formula that can prove useful in a variety of statistical problems involving absolute quantification under uncertainty. We implemented our algorithm in the R package dupiR and compared it with a previously proposed Bayesian method based on a Gamma prior. As a showcase, we demonstrate that our inference framework can be used to estimate bacterial survival curves from measurements characterized by extremely low or zero counts and rather high sampling fractions. All in all, we provide a versatile, general purpose algorithm to infer population sizes from count data, which can find application in a broad spectrum of biological and physical problems.	[Comoglio, Federico] Swiss Fed Inst Technol Zurich, Dept Biosyst Sci & Engn, Basel, Switzerland; [Fracchia, Letizia; Rinaldi, Maurizio] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Farmaco, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro	Rinaldi, M (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Farmaco, Novara, Italy.	maurizio.rinaldi@unipmn.it	Rinaldi, Maurizio/C-7378-2009	Comoglio, Federico/0000-0002-8970-6610; Fracchia, Letizia/0000-0003-3505-1919	Ministry of Education, University and Research (MIUR)	Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Ministry of Education, University and Research (MIUR, http://www.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bates D., 1988, NONLINEAR REGRESSION; Bates DM, 1992, STAT MODELS; Bolstad WM., 2007, INTRO BAYESIAN STAT; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033695; Clough HE, 2005, BIOMETRICS, V61, P610, DOI 10.1111/j.1541-0420.2005.030903.x; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; Fracchia L, 2011, J ENVIRON ENG SCI, V5, P578; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Jaynes E., 2003, PROBABILITY THEORY L, DOI [10.1017/CBO9780511790423, DOI 10.1017/CBO9780511790423]; Jaynes E. T., 1973, Foundations of Physics, V3, P477, DOI 10.1007/BF00709116; JAYNES ET, 1968, IEEE T SYST SCI CYB, VSSC4, P227, DOI 10.1109/TSSC.1968.300117; Keynes Jon Maynard, 1921, TREATISE PROBABILITY; KIRCHMAN D, 1982, APPL ENVIRON MICROB, V44, P376, DOI 10.1128/AEM.44.2.376-382.1982; Koch Arthur L., 1994, P248; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Morita S, 2008, BIOMETRICS, V64, P595, DOI 10.1111/j.1541-0420.2007.00888.x; Morita S, 2010, STAT BIOSCI, V2, P1, DOI 10.1007/s12561-010-9018-x; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Niemela SI, 2003, ACCREDIT QUAL ASSUR, V8, P559, DOI 10.1007/s00769-003-0709-6; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Xiong R, 1999, INT J FOOD MICROBIOL, V46, P45, DOI 10.1016/S0168-1605(98)00172-X; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74388	10.1371/journal.pone.0074388	http://dx.doi.org/10.1371/journal.pone.0074388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116003	gold, Green Submitted, Green Published			2022-12-27	WOS:000325501300006
J	Cueno, ME; Imai, K; Tamura, M; Ochiai, K				Cueno, Marni E.; Imai, Kenichi; Tamura, Muneaki; Ochiai, Kuniyasu			Structural Differences between the Avian and Human H7N9 Hemagglutinin Proteins Are Attributable to Modifications in Salt Bridge Formation: A Computational Study with Implications in Viral Evolution	PLOS ONE			English	Article							INFLUENZA-A VIRUS; RECEPTOR-BINDING; ELECTROSTATIC INTERACTIONS; TRANSMISSION; GLYCOPROTEIN; OUTBREAK; GLYCANS; FUSION; MODELS; SERVER	Influenza A hemagglutinin (HA) is a homotrimeric glycoprotein composed of a fibrous globular stem supporting a globular head containing three sialic acid binding sites responsible for infection. The H7N9 strain has consistently infected an avian host, however, the novel 2013 strain is now capable of infecting a human host which would imply that the HA in both strains structurally differ. A better understanding of the structural differences between the avian and human H7N9 strains may shed light into viral evolution and transmissibility. In this study, we elucidated the structural differences between the avian and human H7N9 strains. Throughout the study, we generated HA homology models, verified the quality of each model, superimposed HA homology models to determine structural differences, and, likewise, elucidated the probable cause for these structural differences. We detected two different types of structural differences between the novel H7N9 human and representative avian strains, wherein, one type (Pattern-1) showed three non-overlapping regions while the other type (Pattern-2) showed only one non-overlapping region. In addition, we found that superimposed HA homology models exhibiting Pattern-1 contain three non-overlapping regions designated as: Region-1 (S157(1)-A160(1)); Region-3 (R262(1)-S265(1)); and Region-4 (S270(1)-D281(1)), whereas, superimposed HA homology models showing Pattern-2 only contain one non-overlapping region designated as Region-2 (S137(1)-S145(1)). We attributed the two patterns we observed to either the presence of salt bridges involving the E114(1) residue or absence of the R141(1):D77(1) salt bridge. Interestingly, comparison between the human H7N7 and H7N9 HA homology models showed high structural similarity. We propose that the putative absence of the R141(1):D77(1) salt bridge coupled with the putative presence of the E114(1):R262(1) and E114(1):K264(1) salt bridges found in the 2013 H7N9 HA homology model is associated to human-type receptor binding. This highlights the possible significance of HA salt bridge formation modifications in viral infectivity, immune escape, transmissibility and evolution.	[Cueno, Marni E.; Imai, Kenichi; Tamura, Muneaki; Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 101, Japan	Nihon University	Cueno, ME (corresponding author), Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 101, Japan.	marni.cueno@nihon-u.ac.jp; ochiai.kuniyasu@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1001024, 2479210]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the following grants: Grants-in-Aid for Scientific Research, Grants-in-Aid for Young Scientist (2479210), Nihon University President's Grant for Multidisciplinary Research, Satoh Fund and Dental Research Center-Nihon University School of Dentistry (Tokyo), "Strategic Research Base Development" Program for Private Universities subsidized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) 2010(S1001024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2006, STRUCTURE, V14, P1211, DOI 10.1016/j.str.2006.06.005; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018664; Cherry JL, 2009, PLOS CURR, V1; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DuBois RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002398; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peiris M, 1999, J CLIN MICROBIOL, V37, P3426, DOI 10.1128/JCM.37.10.3426-3427.1999; Rachakonda PS, 2007, FASEB J, V21, P995, DOI 10.1096/fj.06-7052hyp; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SAHAL D, 1986, BIOCHEMISTRY-US, V25, P6004, DOI 10.1021/bi00368a026; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yassine HM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-258	39	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76764	10.1371/journal.pone.0076764	http://dx.doi.org/10.1371/journal.pone.0076764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116152	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300092
J	Hua, KF; Chou, JC; Lam, YL; Tasi, YL; Chen, A; Ka, SM; Fang, ZX; Liu, ML; Yang, FL; Yang, YL; Chiu, YC; Wu, SH				Hua, Kuo-Feng; Chou, Ju-Ching; Lam, Yulin; Tasi, Yu-Ling; Chen, Ann; Ka, Shuk-Man; Fang, Zhanxiong; Liu, May-Lan; Yang, Feng-Ling; Yang, Yu-Liang; Chiu, Yi-Chich; Wu, Shih-Hsiung			Polyenylpyrrole Derivatives Inhibit NLRP3 Inflammasome Activation and Inflammatory Mediator Expression by Reducing Reactive Oxygen Species Production and Mitogen-Activated Protein Kinase Activation	PLOS ONE			English	Article							NF-KAPPA-B; NALP3 INFLAMMASOME; POLYKETIDES; SECRETION; CYTOKINES; CRYSTALS	Two polyenylpyrroles from a soil ascomycete Gymnoascus reessii were previously identified as hit compounds in screening for cytotoxicity against lung cancer cells. These compounds and various analogs, which have been previously synthesized and tested for anti-lung cancer cell activity, were tested for anti-inflammatory activity. After preliminary screening for cytotoxicity for RAW 264.7 murine macrophage cells, the non-toxic compounds were tested for anti-inflammatory activity using lipopolysaccharide (LPS)-activated RAW 264.7 cells. Compounds 1h, 1i, and 1n reduced LPS-induced nitric oxide (NO) production, with respective ED50 values of 15 +/- 2, 16 +/- 2, and 17 +/- 2 mu M. They also reduced expression of inducible NO synthase and interleukin-6 (IL-6) without affecting cyclooxygenase-2 expression. Compound 1h also reduced secretion of IL-6 and tumor necrosis factor-a by LPS-activated J774A. 1 murine macrophage cells, primary mice peritoneal macrophages, and JAWSII murine bone marrow-derived dendritic cells and reduced NLRP3 inflammasome-mediated interleukin-1 beta (IL-1 beta) secretion by LPS + adenosine triphosphate-activated J774A. 1 and JAWSII cells. The underlying mechanisms for the anti-inflammatory activity of compound 1h were found to be a decrease in LPS-induced reactive oxygen species (ROS) production, mitogen-activated protein kinase phosphorylation, and NF-kappa B activation and a decrease in ATP-induced ROS production and PKC-alpha phosphorylation. These results provide promising insights into the anti-inflammatory activity of these conjugated polyenes and a molecular rationale for future therapeutic intervention in inflammation-related diseases. They also show how compound 1h regulates inflammation and suggest it may be a new source for the development of anti-inflammatory agents to ameliorate inflammation-and NLRP3 inflammasome-related diseases.	[Hua, Kuo-Feng; Chou, Ju-Ching] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Lam, Yulin; Fang, Zhanxiong] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Tasi, Yu-Ling] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Ann] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Liu, May-Lan] Toko Univ, Dept Nutr Sci, Chiayi, Taiwan; [Yang, Feng-Ling; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Yang, Yu-Liang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chiu, Yi-Chich] Natl Ilan Univ, Dept Biomechatron Engn, Ilan, Taiwan	National Ilan University; National University of Singapore; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Ilan University	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.	kfhua@niu.edu.tw			National Science Council, Taiwan [NSC 102-2628-B-197-001-MY3]; Ministry of Education, Singapore (Tier 2) [R-143-000-478-112]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Singapore (Tier 2)(Ministry of Education, Singapore)	The authors wish to thank the National Science Council, Taiwan (contract grant number: NSC 102-2628-B-197-001-MY3) and the Ministry of Education, Singapore (Tier 2 Grant: R-143-000-478-112) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chomcheon P, 2010, CHEM-EUR J, V16, P11178, DOI 10.1002/chem.201000652; Clark BR, 2006, ORG LETT, V8, P701, DOI 10.1021/ol052880y; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fang Z, 2010, J MED CHEM, V53, P7967, DOI 10.1021/jm100619x; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Molina JM, 2002, NEW ENGL J MED, V346, P1963, DOI 10.1056/NEJMoa012924; Moore SF, 2009, J IMMUNOL, V183, P3302, DOI 10.4049/jimmunol.0900394; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Shim SH, 2011, J NAT PROD, V74, P395, DOI 10.1021/np100791b; SLESAREV AI, 1993, NATURE, V364, P735, DOI 10.1038/364735a0; Su SC, 2006, CLIN CHIM ACTA, V374, P106, DOI 10.1016/j.cca.2006.05.045; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Yang YL, 2007, CHEM-EUR J, V13, P6985, DOI 10.1002/chem.200700038; Yang YL, 2009, CHEM-EUR J, V15, P11573, DOI 10.1002/chem.200901556; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76754	10.1371/journal.pone.0076754	http://dx.doi.org/10.1371/journal.pone.0076754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116148	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300090
J	Lee, HS; Jang, MS; Kim, JH; Hong, CP; Lee, EJ; Jeun, EJ; Kim, C; Kim, EK; Ahn, KS; Yang, BG; Ahn, KS; Jang, YP; Ahn, KS; Kim, YM; Jang, MH				Lee, Han-Sung; Jang, Min Seong; Kim, Jung-Hwan; Hong, Chun-Pyo; Lee, Eun-Jung; Jeun, Eun Ji; Kim, Chan; Kim, Eun-Kyung; Ahn, Kwang-Seong; Yang, Bo-Gie; Ahn, Kwang Seok; Jang, Young Pyo; Ahn, Kyoo-Seok; Kim, You-Me; Jang, Myoung Ho			Ulmus davidiana var. japonica Nakai Upregulates Eosinophils and Suppresses Th1 and Th17 Cells in the Small Intestine	PLOS ONE			English	Article							DENDRITIC CELLS; LAMINA-PROPRIA; T-CELLS; IN-VIVO; IMMUNITY; SIGNALS; IL-17	The bark of Ulmus davidiana var. japonica Nakai (Ulmaceae) has been used in traditional Korean medicine for chronic inflammation in the gastrointestinal tract. Here we investigated the frequency and cytokine profile of the major immune cells in the small intestinal lamina propria (SI LP), spleen, and mesenteric lymph nodes (MLNs) of mice treated orally with Ulmus davidiana var. japonica Nakai bark water extract (UDE) to address the immunomodulatory role of this herb in intestinal homeostasis. B6 mice were given 5g/kg UDE once daily for 14 days. They were then sacrificed, and cells were isolated from the spleen, MLNs, and SI LP. The proportion of B versus T lymphocytes, CD4(+) versus CD8(+) T lymphocytes, Th1 and Th17 cells, and Foxp3(+) regulatory T cells in the spleen, MLNs, and SI LP were analyzed. The frequency of antigen-presenting cells (APCs), including dendritic cells, macrophages, and eosinophils in the SI LP and the expression of costimulatory molecules on APCs were also evaluated. The numbers and frequencies of Th1 and Th17 cells in the SI LP were significantly reduced in the UDE-treated mice compared with PBS controls. In addition, the proportion of IL-4-producing eosinophils in the SI LP was significantly elevated in the UDE-treated mice compared with controls. Taken together, these data indicate that UDE up-regulates the number and frequency of SI LP eosinophils, which can down-regulate the Th1 and Th17 responses via IL-4 secretion and contribute to intestinal homeostasis.	[Lee, Han-Sung; Jang, Min Seong; Kim, Jung-Hwan; Hong, Chun-Pyo; Lee, Eun-Jung; Jeun, Eun Ji; Kim, Chan; Yang, Bo-Gie; Kim, You-Me; Jang, Myoung Ho] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Lee, Han-Sung; Ahn, Kwang Seok; Ahn, Kyoo-Seok] Kyung Hee Univ, Coll Korean Med, Dept Pathol, Seoul, South Korea; [Kim, Eun-Kyung; Ahn, Kwang-Seong; Jang, Young Pyo] Kyung Hee Univ, Coll Pharm, Div Pharmacognosy, Seoul, South Korea; [Jang, Myoung Ho] AIM, IBS, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Kyung Hee University; Kyung Hee University; Institute for Basic Science - Korea (IBS)	Jang, MH (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea.	jangmh@ibs.re.kr	Jang, Myoung Ho/D-1714-2009; Kim, You-Me/I-5553-2013; Jang, Young Pyo/AAJ-8782-2020	Jang, Myoung Ho/0000-0001-8909-4725; Kim, You-Me/0000-0001-8780-704X; Jang, Young Pyo/0000-0001-5865-9228; Yang, Bo-Gie/0000-0002-1538-8488	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (MEST) [2013030693]; Institute for Basic Science (IBS); World Class Universities Project, NRF, MEST [R31-10105]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Institute for Basic Science (IBS); World Class Universities Project, NRF, MEST(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology of Korea (MEST) (No. 2013030693), the Institute for Basic Science (IBS) and the World Class Universities Project, NRF, MEST (R31-10105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Choi SY, 2010, J MED FOOD, V13, P1019, DOI 10.1089/jmf.2009.1207; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Guo Z, 2008, INT IMMUNOL, V20, P307, DOI 10.1093/intimm/dxm143; Jacobsen EA, 2007, J ALLERGY CLIN IMMUN, V119, P1313, DOI 10.1016/j.jaci.2007.03.043; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kim YC, 2007, FITOTERAPIA, V78, P196, DOI 10.1016/j.fitote.2006.11.013; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee EH, 2013, J ETHNOPHARMACOL, V146, P608, DOI 10.1016/j.jep.2013.01.035; Lee SJ, 2007, FOOD CHEM TOXICOL, V45, P990, DOI 10.1016/j.fct.2006.12.006; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Park JW, 2011, ORIENTAL PHARM EXP M, V11, P107, DOI 10.1007/s13596-011-0011-9; Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; Song IK, 2007, ENVIRON TOXICOL PHAR, V23, P102, DOI 10.1016/j.etap.2006.07.013; Straumann A, 2004, ALLERGY, V59, P15, DOI 10.1046/j.1398-9995.2003.00382.x; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Stumhofer JS, 2007, SEMIN IMMUNOL, V19, P394, DOI 10.1016/j.smim.2007.11.006; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Svensson-Frej M, 2011, J INNATE IMMUN, V3, P565, DOI 10.1159/000328799; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Wen T, 2012, J IMMUNOL, V188, P1075, DOI 10.4049/jimmunol.1102222; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91	30	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76716	10.1371/journal.pone.0076716	http://dx.doi.org/10.1371/journal.pone.0076716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116141	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300084
J	Marquez, A; Cenit, MC; Cordero-Coma, M; Ortego-Centeno, N; Adan, A; Fonollosa, A; Valle, DD; Pato, E; Blanco, R; Canal, J; Diaz-Llopis, M; de Ramon, E; del Rio, MJ; Serrano, JLG; Artaraz, J; Martin-Villa, JM; Llorenc, V; Gorrono-Echebarria, MB; Martin, J				Marquez, Ana; Carmen Cenit, Maria; Cordero-Coma, Miguel; Ortego-Centeno, Norberto; Adan, Alfredo; Fonollosa, Alejandro; Diaz Valle, David; Pato, Esperanza; Blanco, Ricardo; Canal, Joaquin; Diaz-Llopis, Manuel; de Ramon, Enrique; Jose del Rio, Maria; Garcia Serrano, Jose Luis; Artaraz, Joseba; Manuel Martin-Villa, Jose; Llorenc, Vctor; Begona Gorrono-Echebarria, Marina; Martin, Javier			Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; DISTINCT POPULATIONS; INTERMEDIATE UVEITIS; BEHCETS-DISEASE; GENE; INTERFERON; POLYMORPHISM; RISK; SUSCEPTIBILITY	Objective: Interferon (IFN) signaling plays a crucial role in autoimmunity. Genetic variation in interferon regulatory factor 5 (IRF5), a major regulator of the type I interferon induction, has been associated with risk of developing several autoimmune diseases. In the current study we aimed to evaluate whether three sets of correlated IRF5 genetic variants, independently associated with SLE and with different functional roles, are involved in uveitis susceptibility and its clinical subphenotypes. Methods: Three IRF5 polymorphisms, rs2004640, rs2070197 and rs10954213, representative of each group, were genotyped using TaqMan (R) allelic discrimination assays in a total of 263 non-anterior uveitis patients and 724 healthy controls of Spanish origin. Results: A clear association between two of the three analyzed genetic variants, rs2004640 and rs10954213, and the absence of macular edema was observed in the case/control analysis (P-FDR=5.07E-03, OR= 1.48, CI 95%= 1.14-1.92 and P-FDR= 3.37E-03, OR= 1.54, CI 95%= 1.19-2.01, respectively). Consistently, the subphenotype analysis accordingly with the presence/absence of this clinical condition also reached statistical significance (rs2004640: P= 0.037, OR= 0.69, CI 95%= 0.48-0.98; rs10954213: P= 0.030, OR= 0.67, CI 95%= 0.47-0.96), thus suggesting that both IRF5 genetic variants are specifically associated with the lack of macular edema in uveitis patients. Conclusion: Our results clearly showed for the first time that two functional genetic variants of IRF5 may play a role in the development of macular edema in non-anterior uveitis patients. Identifying genetic markers for macular edema could lead to the possibility of developing novel treatments or preventive therapies.	[Marquez, Ana; Carmen Cenit, Maria; Martin, Javier] CSIC, IPBLN, Granada, Spain; [Cordero-Coma, Miguel] Hosp Leon, Dept Ophthalmol, Leon, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain; [Adan, Alfredo; Llorenc, Vctor] Hosp Clin Barcelona, Dept Ophthalmol, Barcelona, Spain; [Fonollosa, Alejandro; Artaraz, Joseba] Hosp Cruces, Dept Ophthalmol, Bilbao, Spain; [Diaz Valle, David] Hosp Clin San Carlos, Dept Ophthalmol, Madrid, Spain; [Pato, Esperanza] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Blanco, Ricardo] IFIMAV, Hosp Marques de Valdecilla, Dept Rheumatol, Santander, Spain; [Canal, Joaquin] IFIMAV, Hosp Marques de Valdecilla, Dept Ophthalmol, Santander, Spain; [Diaz-Llopis, Manuel] Hosp La Fe, Dept Ophthalmol, E-46009 Valencia, Spain; [de Ramon, Enrique] Hosp Carlos Haya, Dept Internal Med, Malaga, Spain; [Jose del Rio, Maria] Hosp Carlos Haya, Dept Ophthalmol, Malaga, Spain; [Garcia Serrano, Jose Luis] Hosp Clin San Cecilio, Dept Ophthalmol, Granada, Spain; [Manuel Martin-Villa, Jose] Univ Complutense Madrid, Fac Med, Dept Immunol, Madrid, Spain; [Begona Gorrono-Echebarria, Marina] Hosp Principe Asturias, Dept Ophthalmol, Alcala De Henares, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Universidad de Leon; Hospital de Leon; Hospital Universitario San Cecilio; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Cruces; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitari i Politecnic La Fe; Hospital Carlos Haya; Hospital Carlos Haya; Hospital Universitario San Cecilio; Complutense University of Madrid; Prince of Asturias University Hospital	Marquez, A (corresponding author), CSIC, IPBLN, Granada, Spain.	anamaort@ipb.csic.es	Martín, María/HDL-9512-2022; Cenit, Maria Carmen MC/E-9538-2017; Martin-Villa, Jose M. M/F-9234-2013; Llorens Bellés, Víctor/V-3892-2019; blanco, ricardo/AAA-1248-2020; Martin, Javier/B-8141-2008; Martin-Villa, Jose M./K-2522-2019; Fonollosa Calduch, Alejandro/E-5381-2012; Centeno, Norberto Ortego/C-4793-2019	Cenit, Maria Carmen MC/0000-0001-8667-5313; Martin-Villa, Jose M. M/0000-0002-2436-8585; Llorens Bellés, Víctor/0000-0002-7375-1564; blanco, ricardo/0000-0003-2344-2285; Martin, Javier/0000-0002-2202-0622; Martin-Villa, Jose M./0000-0002-2436-8585; Centeno, Norberto Ortego/0000-0003-2325-0937; Marquez, Ana/0000-0001-9913-7688; Gorrono Echebarria, Marina Begona/0000-0003-2805-9664; DIAZ VALLE, DAVID/0000-0003-4450-7471; Adan, Alfredo/0000-0002-0849-8814				BREWERTON DA, 1973, LANCET, V2, P994, DOI 10.1016/S0140-6736(73)91090-8; Caspi Rachel R, 2002, Int Rev Immunol, V21, P197, DOI 10.1080/08830180212063; Commodaro AG, 2011, AUTOIMMUN REV, V10, P205, DOI 10.1016/j.autrev.2010.10.002; Deschenes J, 2008, OCUL IMMUNOL INFLAMM, V16, P1, DOI 10.1080/09273940801899822; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Forooghian F, 2009, ARCH OPHTHALMOL-CHIC, V127, P179, DOI 10.1001/archophthalmol.2008.564; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; LEHOANG P, 1992, AM J OPHTHALMOL, V113, P33, DOI 10.1016/S0002-9394(14)75749-6; Li HJ, 2009, MOL VIS, V15, P2018; Lofgren SE, 2010, J RHEUMATOL, V37, P574, DOI 10.3899/jrheum.090440; Mackensen F, 2013, AM J OPHTHALMOL, V156, P478, DOI 10.1016/j.ajo.2013.05.002; Martin Tammy M., 2005, International Ophthalmology Clinics, V45, P15, DOI 10.1097/01.iio.0000155939.83083.dd; Mattapallil MJ, 2008, J IMMUNOL, V180, P6751, DOI 10.4049/jimmunol.180.10.6751; Miceli-Richard C, 2007, ARTHRITIS RHEUM, V56, P3989, DOI 10.1002/art.23142; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Noma H, 2009, OPHTHALMOLOGY, V116, P87, DOI 10.1016/j.ophtha.2008.09.034; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Pennesi Giuseppina, 2002, Int Rev Immunol, V21, P67, DOI 10.1080/08830180212059; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Valentincic NV, 2011, MOL VIS, V17, P2003; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76777	10.1371/journal.pone.0076777	http://dx.doi.org/10.1371/journal.pone.0076777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116155	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300094
J	Meredith, JE; Sankaranarayanan, S; Guss, V; Lanzetti, AJ; Berisha, F; Neely, RJ; Slemmon, JR; Portelius, E; Zetterberg, H; Blennow, K; Soares, H; Ahlijanian, M; Albright, CF				Meredith, Jere E., Jr.; Sankaranarayanan, Sethu; Guss, Valerie; Lanzetti, Anthony J.; Berisha, Flora; Neely, Robert J.; Slemmon, J. Randall; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Soares, Holly; Ahlijanian, Michael; Albright, Charles F.			Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID TAU; MILD COGNITIVE IMPAIRMENT; PHOSPHORYLATED-TAU; DIFFERENTIAL-DIAGNOSIS; AFFINITY PURIFICATION; AMYLOID DEPOSITION; SANDWICH ELISA; PROTEIN; QUANTIFICATION; SECRETION	Cerebral spinal fluid (CSF) A beta 42, tau and p181tau are widely accepted biomarkers of Alzheimer's disease (AD). Numerous studies show that CSF tau and p181tau levels are elevated in mild-to-moderate AD compared to age-matched controls. In addition, these increases might predict preclinical AD in cognitively normal elderly. Despite their importance as biomarkers, the molecular nature of CSF tau and ptau is not known. In the current study, reverse-phase high performance liquid chromatography was used to enrich and concentrate tau prior to western-blot analysis. Multiple N-terminal and mid-domain fragments of tau were detected in pooled CSF with apparent sizes ranging from <20 kDa to similar to 40 kDa. The pattern of tau fragments in AD and control samples were similar. In contrast, full-length tau and C-terminal-containing fragments were not detected. To quantify levels, five tau ELISAs and three ptau ELISAs were developed to detect different overlapping regions of the protein. The discriminatory potential of each assay was determined using 20 AD and 20 age-matched control CSF samples. Of the tau ELISAs, the two assays specific for tau containing N-terminal sequences, amino acids 9-198 (numbering based on tau 441) and 9-163, exhibited the most significant differences between AD and control samples. In contrast, CSF tau was not detected with an ELISA specific for a more C-terminal region (amino acids 159-335). Significant discrimination was also observed with ptau assays measuring amino acids 159-p181 and 159-p231. Interestingly, the discriminatory potential of p181 was reduced when measured in the context of tau species containing amino acids 9-p181. Taken together, these results demonstrate that tau in CSF occurs as a series of fragments and that discrimination of AD from control is dependent on the subset of tau species measured. These assays provide novel tools to investigate CSF tau and ptau as biomarkers for other neurodegenerative diseases.	[Meredith, Jere E., Jr.; Sankaranarayanan, Sethu; Guss, Valerie; Lanzetti, Anthony J.; Slemmon, J. Randall; Soares, Holly; Ahlijanian, Michael; Albright, Charles F.] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA; [Berisha, Flora; Neely, Robert J.] Bristol Myers Squibb Co, Res & Dev, Lawrenceville, NJ USA; [Portelius, Erik; Blennow, Kaj] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England	Bristol-Myers Squibb; Bristol-Myers Squibb; University of Gothenburg; University of London; University College London	Meredith, JE (corresponding author), Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA.	jere.meredith@bms.com			Bristol-Myers Squibb; Swedish Research Council; Swedish State Support for Clinical Research	Bristol-Myers Squibb(Bristol-Myers Squibb); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State Support for Clinical Research	Funding was provided by Bristol-Myers Squibb and grants to EP, HZ, and KB from the Swedish Research Council and Swedish State Support for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI H, 1995, ANN NEUROL, V38, P649, DOI 10.1002/ana.410380414; Bahl JMC, 2009, NEUROBIOL AGING, V30, P1834, DOI 10.1016/j.neurobiolaging.2008.01.013; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; Borroni B, 2008, NEUROLOGY, V71, P1796, DOI 10.1212/01.wnl.0000335941.68602.39; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Ditto NT, 2009, J NEUROSCI METH, V182, P260, DOI 10.1016/j.jneumeth.2009.05.025; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Hanger DP, 2010, BIOCHEM SOC T, V38, P1016, DOI 10.1042/BST0381016; Hanisch K, 2010, J PROTEOME RES, V9, P1476, DOI 10.1021/pr901002t; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Ishiguro K, 1999, NEUROSCI LETT, V270, P91, DOI 10.1016/S0304-3940(99)00476-0; Itoh N, 2001, ANN NEUROL, V50, P150, DOI 10.1002/ana.1054; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; Kuiperij HB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.011; Luk C, 2012, J NEUROCHEM, V123, P396, DOI 10.1111/j.1471-4159.2012.07911.x; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MERCKEN M, 1992, J NEUROCHEM, V58, P548, DOI 10.1111/j.1471-4159.1992.tb09754.x; MORI H, 1995, NEUROSCI LETT, V186, P181, DOI 10.1016/0304-3940(95)11291-4; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Singer D, 2009, ANAL BIOANAL CHEM, V395, P2263, DOI 10.1007/s00216-009-3208-8; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Slemmon JR, 2012, J NEUROCHEM, V120, P325, DOI 10.1111/j.1471-4159.2011.07553.x; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; VIGOPELFREY C, 1995, NEUROLOGY, V45, P788, DOI 10.1212/WNL.45.4.788; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; WOLOZIN B, 1987, ANN NEUROL, V22, P521, DOI 10.1002/ana.410220412; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2013, J ALZHEIMERS DIS, V33, pS361, DOI 10.3233/JAD-2012-129035	56	71	77	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76523	10.1371/journal.pone.0076523	http://dx.doi.org/10.1371/journal.pone.0076523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116116	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300063
J	Santos, M; Rebelo, S; Van Kleeff, PJM; Kim, CE; Dauer, WT; Fardilha, M; Silva, OADE; Silva, EFDE				Santos, Mariana; Rebelo, Sandra; Van Kleeff, Paula J. M.; Kim, Connie E.; Dauer, William T.; Fardilha, Margarida; da Cruz e Silva, Odete A.; da Cruz e Silva, Edgar F.			The Nuclear Envelope Protein, LAP1B, Is a Novel Protein Phosphatase 1 Substrate	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; B-TYPE LAMINS; SUBCELLULAR-LOCALIZATION; INTERACTING PROTEINS; DOCKING MOTIF; BINDING; TORSINA; IDENTIFICATION; ISOFORMS; RELEVANCE	Protein phosphatase 1 (PP1) binding proteins are quintessential regulators, determining substrate specificity and defining subcellular localization and activity of the latter. Here, we describe a novel PP1 binding protein, the nuclear membrane protein lamina associated polypeptide 1B (LAP1B), which interacts with the DYT1 dystonia protein torsinA. The PP1 binding domain in LAP1B was here identified as the REVRF motif at amino acids 55-59. The LAP1B: PP1 complex can be immunoprecipitated from cells in culture and rat cortex and the complex was further validated by yeast co-transformations and blot overlay assays. PP1, which is enriched in the nucleus, binds to the N-terminal nuclear domain of LAP1B, as shown by immunocolocalization and domain specific binding studies. PP1 dephosphorylates LAP1B, confirming the physiological relevance of this interaction. These findings place PP1 at a key position to participate in the pathogenesis of DYT1 dystonia and related nuclear envelope-based diseases.	[Santos, Mariana; Rebelo, Sandra; da Cruz e Silva, Odete A.] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Neurosci Lab, P-3800 Aveiro, Portugal; [Van Kleeff, Paula J. M.; Fardilha, Margarida; da Cruz e Silva, Edgar F.] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Signal Transduct Lab, P-3800 Aveiro, Portugal; [Kim, Connie E.; Dauer, William T.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Kim, Connie E.; Dauer, William T.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	Universidade de Aveiro; Universidade de Aveiro; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rebelo, S (corresponding author), Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Neurosci Lab, P-3800 Aveiro, Portugal.	srebelo@ua.pt	Santos, Mariana/AAO-2021-2020; da Cruz e Silva, Odete A B/F-4072-2010; Rebelo, S/B-8973-2008; Cruz e Silva, Odete/AAH-5595-2020; Rebelo, Sandra/Q-2215-2019; Fardilha, Margarida/G-3182-2010	Santos, Mariana/0000-0002-2343-2215; da Cruz e Silva, Odete A B/0000-0003-3718-9874; Rebelo, S/0000-0002-5862-5797; Rebelo, Sandra/0000-0002-5862-5797; Fardilha, Margarida/0000-0001-7459-9173; Dauer, William/0000-0003-1775-7504; van Kleeff, Paula/0000-0002-1789-5547	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology; COMPETE program; QREN; European Union (Fundo Europeu de Desenvolvimento Regional); Centre for Cell Biology, University of Aveiro;  [REEQ/1023/BIO/2005];  [PTDC/QUI-BIQ/101317/2008];  [Pest-OE/SAU/UI0482/2011];  [SFRH/BD/65353/2009];  [SFRH/BPD/45611/2008]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077730] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/101317/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology(Portuguese Foundation for Science and Technology); COMPETE program; QREN; European Union (Fundo Europeu de Desenvolvimento Regional); Centre for Cell Biology, University of Aveiro; ; ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fundação para a Ciência e a Tecnologia	This work was supported by the Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology, The COMPETE program, QREN, the European Union (Fundo Europeu de Desenvolvimento Regional), Centre for Cell Biology, University of Aveiro. Funding and scholarships references: REEQ/1023/BIO/2005, PTDC/QUI-BIQ/101317/2008, Pest-OE/SAU/UI0482/2011 and SFRH/BD/65353/2009 and SFRH/BPD/45611/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bordelon JR, 2005, CEREB CORTEX, V15, P1928, DOI 10.1093/cercor/bhi070; BRIDGER JM, 1993, J CELL SCI, V104, P297; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 2002, J CELL SCI, V115, P241; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Esteves SLC, 2012, OMICS, V16, P3, DOI 10.1089/omi.2011.0041; Esteves SL, 2012, J MOL NEUROSCI; Fardilha M, 2004, ANN NY ACAD SCI, V1030, P468, DOI 10.1196/annals.1329.059; Fardilha M, 2010, CURR MED CHEM, V17, P3996, DOI 10.2174/092986710793205363; Fardilha M, 2011, BIOCHEM PHARMACOL, V82, P1403, DOI 10.1016/j.bcp.2011.02.018; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Naismith TV, 2009, J BIOL CHEM; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Rebelo S, 2013, J ALZHEIMERS DIS, V35, P761, DOI 10.3233/JAD-130095; Santos M, 2009, VALIDATION LAP1B NOV; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Silva OABDE, 2004, J MOL NEUROSCI, V23, P123, DOI 10.1385/JMN:23:1-2:123; Steen RL, 2003, J CELL SCI, V116, P2237, DOI 10.1242/jcs.00432; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Steen RL, 2001, J CELL BIOL, V153, P621, DOI 10.1083/jcb.153.3.621; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Tsai KW, 2007, MOL CELL BIOL, V27, P5835, DOI 10.1128/MCB.00363-07; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Watanabe T, 2003, METHOD ENZYMOL, V366, P321	48	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76788	10.1371/journal.pone.0076788	http://dx.doi.org/10.1371/journal.pone.0076788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116158	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300095
J	Sun, YH; Dong, YL; Wang, YT; Zhao, GL; Lu, GJ; Yang, J; Wu, SX; Gu, ZX; Wang, W				Sun, Yong-Hai; Dong, Yu-Lin; Wang, Yu-Tong; Zhao, Guo-Li; Lu, Gui-Jun; Yang, Jing; Wu, Sheng-Xi; Gu, Ze-Xu; Wang, Wen			Synergistic Analgesia of Duloxetine and Celecoxib in the Mouse Formalin Test: A Combination Analysis	PLOS ONE			English	Article							NORADRENERGIC REUPTAKE INHIBITOR; INFLAMMATORY PAIN; RATS; MORPHINE; MODULATION; MANAGEMENT; RECEPTORS; EFFICACY; NEURONS; MODEL	Duloxetine, a serotonin and noradrenaline reuptake inhibitor, and celecoxib, a non-steroidal anti-inflammatory drug, are commonly used analgesics for persistent pain, however with moderate gastrointestinal side effects or analgesia tolerance. One promising analgesic strategy is to give a combined prescription, allowing the maximal or equal efficacy with fewer side effects. In the current study, the efficacy and side effects of combined administration of duloxetine and celecoxib were tested in the mouse formalin pain model. The subcutaneous (s.c.) injection of formalin into the left hindpaw induced significant somatic and emotional pain evaluated by the biphasic spontaneous flinching of the injected hindpaw and interphase ultrasonic vocalizations (USVs) during the 1 h after formalin injection, respectively. Pretreatment with intraperitoneal (i.p.) injection of duloxetine or celecoxib at 1 h before formalin injection induced the dose-dependent inhibition on the second but not first phase pain responses. Combined administration of duloxetine and celecoxib showed significant analgesia for the second phase pain responses. Combination analgesia on the first phase was observed only with higher dose combination. A statistical difference between the theoretical and experimental ED50 for the second phase pain responses was observed, which indicated synergistic interaction of the two drugs. Concerning the emotional pain responses revealed with USVs, we assumed that the antinociceptive effects were almost completely derived from duloxetine, since celecoxib was ineffective when administered alone or reduced the dosage of duloxetine when given in combination. Based on the above findings, acute concomitant administration of duloxetine and celecoxib showed synergism on the somatic pain behavior but not emotional pain behaviors.	[Sun, Yong-Hai; Zhao, Guo-Li; Lu, Gui-Jun; Yang, Jing] Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Dept Anesthesiol, Beijing, Peoples R China; [Dong, Yu-Lin; Wu, Sheng-Xi; Wang, Wen] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Preclin Sch Med, Xian 710032, Peoples R China; [Dong, Yu-Lin; Wu, Sheng-Xi; Wang, Wen] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Preclin Sch Med, Xian 710032, Peoples R China; [Wang, Yu-Tong] Fourth Mil Med Univ, Dept Emergency, Xijing Hosp, Xian 710032, Peoples R China; [Gu, Ze-Xu] Fourth Mil Med Univ, Dept Orthodont, Sch Stomatol, Xian 710032, Peoples R China	Chinese People's Liberation Army General Hospital; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Gu, ZX (corresponding author), Fourth Mil Med Univ, Dept Orthodont, Sch Stomatol, Xian 710032, Peoples R China.	guzexu@fmmu.edu.cn; wangwen@fmmu.edu.cn			Natural Science Foundation of China [81271230, 81171050, 81171052, 30971123, 31010103909]; International Science & Technology Cooperation Program of China [2011DFA32560]; Program for Shaanxi Province Key Research Team of Science and Technology Innovation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Program for Shaanxi Province Key Research Team of Science and Technology Innovation	The study was supported by grants from the Natural Science Foundation of China (Nos 81271230, 81171050, 81171052, 30971123 and 31010103909), International Science & Technology Cooperation Program of China (2011DFA32560) and Program for Shaanxi Province Key Research Team of Science and Technology Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1984, BRAIN RES, V295, P77, DOI 10.1016/0006-8993(84)90817-5; Bai L, 2012, PAIN PHYSICIAN, V15, P311; Bajic D, 1999, J COMP NEUROL, V405, P359; Bardin L, 2010, NEUROSCI RES, V66, P135, DOI 10.1016/j.neures.2009.10.009; Bardin L, 2011, BEHAV PHARMACOL, V22, P390, DOI 10.1097/FBP.0b013e328349aae4; Bovill JG, 1997, EUR J ANAESTH, V14, P9, DOI 10.1097/00003643-199705001-00003; Boyle J, 2012, DIABETES CARE, V35, P2451, DOI 10.2337/dc12-0656; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Buvanendran A, 2009, CURR OPIN ANESTHESIO, V22, P588, DOI 10.1097/ACO.0b013e328330373a; Capuano A, 2009, EUR J PHARMACOL, V605, P57, DOI 10.1016/j.ejphar.2008.12.029; Chen HS, 2003, ANESTHESIOLOGY, V98, P1231, DOI 10.1097/00000542-200305000-00027; CHICHORRO J, 2004, BR J PHARM, V141; DALLEL R, 1995, PAIN, V61, P11, DOI 10.1016/0304-3959(94)00212-W; Deeks JJ, 2002, BRIT MED J, V325, P619, DOI 10.1136/bmj.325.7365.619; Deumens R, 2013, PROG NEUROBIOL, V104, P1, DOI 10.1016/j.pneurobio.2013.01.002; ENGLEMAN EA, 1995, NEUROPSYCHOPHARMACOL, V12, P287, DOI 10.1016/0893-133X(94)00093-F; Fekadu A, 2012, BRIT J PSYCHIAT, V201, P369, DOI 10.1192/bjp.bp.111.102665; Frakes EP, 2011, CURR MED RES OPIN, V27, P2361, DOI 10.1185/03007995.2011.633502; Gregoire S, 2012, PAIN, V153, P1657, DOI 10.1016/j.pain.2012.04.023; Han JS, 2005, J NEUROSCI METH, V141, P261, DOI 10.1016/j.jneumeth.2004.07.005; HAPPICH M, 2012, DEPRESS RES TREAT, P64854; Huang J, 2006, EXP NEUROL, V200, P124, DOI 10.1016/j.expneurol.2006.01.036; Jones CK, 2007, EUR J PAIN, V11, P208, DOI 10.1016/j.ejpain.2006.02.008; Jones CK, 2005, J PHARMACOL EXP THER, V312, P726, DOI 10.1124/jpet.104.075960; Koch S, 2003, NEUROPHARMACOLOGY, V45, P935, DOI 10.1016/S0028-3908(03)00268-5; Liu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007548; Mallen SR, 2011, CURR MED RES OPIN, V27, P1359, DOI 10.1185/03007995.2011.581274; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; McRoberts JA, 2011, NEUROSCIENCE, V172, P474, DOI 10.1016/j.neuroscience.2010.10.045; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Miranda HF, 2012, INFLAMMATION, V35, P1132, DOI 10.1007/s10753-011-9420-7; Mixcoatl-Zecuatl T, 2011, BRIT J PHARMACOL, V164, P159, DOI 10.1111/j.1476-5381.2011.01334.x; MOORE PK, 1991, BRIT J PHARMACOL, V102, P198, DOI 10.1111/j.1476-5381.1991.tb12153.x; Muller Norbert, 2008, Expert Rev Neurother, V8, P527, DOI 10.1586/14737175.8.4.527; Munro G, 2009, EUR J PHARMACOL, V605, P95, DOI 10.1016/j.ejphar.2009.01.004; Niederberger E, 2001, FASEB J, V15, P1622, DOI 10.1096/fj.00-0716fje; Nishiyama T, 2006, ACTA ANAESTH SCAND, V50, P228, DOI 10.1111/j.1399-6576.2006.00921.x; Nuseir K, 2000, NEUROSCIENCE, V96, P773, DOI 10.1016/S0306-4522(99)00603-X; Oliveira AR, 2006, ANESTH ANALG, V102, P832, DOI 10.1213/01.ane.0000196530.72813.d9; Ormseth MJ, 2011, PATIENT PREFER ADHER, V5, P343, DOI 10.2147/PPA.S16358; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; RAHMAN AFMM, 1994, JPN J PHARMACOL, V65, P313, DOI 10.1254/jjp.65.313; Raskin J, 2006, J PALLIAT MED, V9, P29, DOI 10.1089/jpm.2006.9.29; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rezende RM, 2012, PHARMACOLOGY, V89, P127, DOI 10.1159/000336346; Rezende RM, 2010, NEUROPHARMACOLOGY, V59, P551, DOI 10.1016/j.neuropharm.2010.07.022; SAGEN J, 1985, BRAIN RES, V331, P285, DOI 10.1016/0006-8993(85)91554-9; Shi M, 2010, J PAIN, V11, P219, DOI 10.1016/j.jpain.2009.07.002; Shi SJ, 2008, EUR J CLIN PHARMACOL, V64, P233, DOI 10.1007/s00228-007-0400-7; Shibazaki T, 2009, ANGLE ORTHOD, V79, P1169, DOI 10.2319/121108-629R.1; SKAGERBERG G, 1985, NEUROSCIENCE, V15, P445, DOI 10.1016/0306-4522(85)90225-8; Skljarevski V, 2012, PAIN RES TREAT, V2012; Smith T, 2007, VASC HEALTH RISK MAN, V3, P833; Su YL, 2010, NEUROSCI BULL, V26, P429, DOI 10.1007/s12264-010-0932-1; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tamaddonfard E, 2011, PHARMACOL REP, V63, P423, DOI 10.1016/S1734-1140(11)70508-4; Taylor BK, 2000, J PAIN, V1, P218, DOI 10.1054/jpai.2000.7308; Vellani V, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-61; Vos BP, 1998, PAIN, V76, P173, DOI 10.1016/S0304-3959(98)00039-6; VOS BP, 1994, J NEUROSCI, V14, P2708; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Wu LA, 2009, NEUROSCI LETT, V457, P36, DOI 10.1016/j.neulet.2009.03.107	63	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76603	10.1371/journal.pone.0076603	http://dx.doi.org/10.1371/journal.pone.0076603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116126	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300072
J	Juvin, V; Malek, M; Anderson, KE; Dion, C; Chessa, T; Lecureuil, C; Ferguson, GJ; Cosulich, S; Hawkins, PT; Stephens, LR				Juvin, Veronique; Malek, Mouhannad; Anderson, Karen E.; Dion, Carine; Chessa, Tamara; Lecureuil, Charlotte; Ferguson, G. John; Cosulich, Sabina; Hawkins, Phillip T.; Stephens, Len R.			Signaling via Class IA Phosphoinositide 3-Kinases (PI3K) in Human, Breast-Derived Cell Lines	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; PROTEIN-KINASE B; PLECKSTRIN-HOMOLOGY-DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; CANCER-CELLS; BETA P85-ALPHA-P110-BETA; EMBRYONIC LETHALITY; P110-ALPHA ISOFORM; TUMOR-SUPPRESSOR	We have addressed the differential roles of class I Phosphoinositide 3-kinases (PI3K) in human breast-derived MCF10a (and iso-genetic derivatives) and MDA-MB 231 and 468 cells. Class I PI3Ks are heterodimers of p110 catalytic (alpha, beta, delta and gamma) and p50-101 regulatory subunits and make the signaling lipid, phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P-3) that can activate effectors, eg protein kinase B (PKB), and responses, eg migration. The PtdIns(3,4,5) P-3-3-phosphatase and tumour-suppressor, PTEN inhibits this pathway. p110 alpha, but not other p110s, has a number of onco-mutant variants that are commonly found in cancers. mRNA-seq data shows that MCF10a cells express p110 beta>>alpha>delta with undetectable p110 gamma. Despite this, EGF-stimulated phosphorylation of PKB depended upon p110 alpha-, but not beta- or delta- activity. EGF-stimulated chemokinesis, but not chemotaxis, was also dependent upon p110 alpha, but not beta- or delta- activity. In the presence of single, endogenous alleles of onco-mutant p110 alpha (H1047R or E545K), basal, but not EGF-stimulated, phosphorylation of PKB was increased and the effect of EGF was fully reversed by p110 alpha inhibitors. Cells expressing either onco-mutant displayed higher basal motility and EGF-stimulated chemokinesis. This latter effect was, however, only partially-sensitive to PI3K inhibitors. In PTEN-/- cells, basal and EGF-stimulated phosphorylation of PKB was substantially increased, but the p110-dependency was variable between cell types. In MDA-MB 468s phosphorylation of PKB was significantly dependent on p110 beta, but not a-or delta- activity; in PTEN-/- MCF10a it remained, like the parental cells, p110 alpha-dependent. Surprisingly, loss of PTEN suppressed basal motility and EGF-stimulated chemokinesis. These results indicate that; p110a is required for EGF signaling to PKB and chemokinesis, but not chemotaxis; onco-mutant alleles of p110a augment signaling in the absence of EGF and may increase motility, in part, via acutely modulating PI3K-activity-independent mechanisms. Finally, we demonstrate that there is not a universal mechanism that up-regulates p110 beta function in the absence of PTEN.	[Juvin, Veronique; Malek, Mouhannad; Anderson, Karen E.; Dion, Carine; Chessa, Tamara; Lecureuil, Charlotte; Ferguson, G. John; Cosulich, Sabina; Hawkins, Phillip T.; Stephens, Len R.] Babraham Inst, Cambridge, England; [Cosulich, Sabina] Astrazeneca, Macclesfield, Cheshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; AstraZeneca	Stephens, LR (corresponding author), Babraham Inst, Cambridge, England.	len.stephens@babraham.ac.uk	Lécureuil, Charlotte/B-4841-2016	Lécureuil, Charlotte/0000-0002-7339-9185; Anderson, Karen/0000-0002-7394-6660; stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464	BBSRC [BB/I003916]; AstraZeneca; BBSRC [BBS/E/B/000C0413, BBS/E/B/000C0417, BB/I003916/1, BBS/E/B/0000S239] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BBS/E/B/000C0417, BB/I003916/1, BBS/E/B/0000S239] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work presented here was funded by a BBSRC grant (BB/I003916, funding VJ and MM, http://www.bbsrc.ac.uk/) and AstraZeneca (funding CD, http://www.astrazeneca.co.uk/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Anderson KE, 2000, CURR BIOL, V10, P1403, DOI 10.1016/S0960-9822(00)00794-6; Bastian P, 2006, MOL CANCER RES, V4, P411, DOI 10.1158/1541-7786.MCR-06-0030; Benistant C, 2000, ONCOGENE, V19, P5083, DOI 10.1038/sj.onc.1203871; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Burke John E., 2013, Advances in Biological Regulation, V53, P97, DOI 10.1016/j.jbior.2012.09.005; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dbouk HA, 2010, ONCOTARGET, V1, P729; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Fan QW, 2006, CELL CYCLE, V5, P2301, DOI 10.4161/cc.5.20.3362; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hill K, 2000, J BIOL CHEM, V275, P3741, DOI 10.1074/jbc.275.6.3741; Hill KM, 2010, PROSTATE, V70, P755, DOI 10.1002/pros.21108; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hooshmand-Rad R, 2000, J CELL SCI, V113, P207; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Lee JS, 2004, J BIOL CHEM, V279, P9379, DOI 10.1074/jbc.M310638200; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Li HF, 2011, J BIOMOL SCREEN, V16, P383, DOI 10.1177/1087057110397357; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Okkenhaug K, 2002, SCIENCE, V297, P1031; Pang H, 2009, CANCER RES, V69, P8868, DOI 10.1158/0008-5472.CAN-09-1968; Philp AJ, 2001, CANCER RES, V61, P7426; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sawyer C, 2003, CANCER RES, V63, P1667; So L, 2012, J BIOL CHEM; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sturge J, 2002, J CELL SCI, V115, P699; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Voigt P, 2006, J BIOL CHEM; Wallin JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036402; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; Weng LP, 1999, CANCER RES, V59, P5808; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; YANO H, 1993, J BIOL CHEM, V268, P25846; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	94	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75045	10.1371/journal.pone.0075045	http://dx.doi.org/10.1371/journal.pone.0075045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124465	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100022
J	Qiao, T; Ma, RH; Luo, XB; Yang, LQ; Luo, ZL; Zheng, PM				Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Yang, Liu-qing; Luo, Zhen-liang; Zheng, Pei-ming			The Systematic Classification of Gallbladder Stones	PLOS ONE			English	Article							CALCIUM-CARBONATE GALLSTONES; CHOLESTEROL GALLSTONES; INFRARED-SPECTROSCOPY; BETA-GLUCURONIDASE; FT-IR; PATHOGENESIS; DISEASE; EXPRESSION; LIVER	Background: To develop a method for systematic classification of gallbladder stones, analyze the clinical characteristics of each type of stone and provide a theoretical basis for the study of the formation mechanism of different types of gallbladder stones. Methodology: A total of 807 consecutive patients with gallbladder stones were enrolled and their gallstones were studied. The material composition of gallbladder stones was analyzed using Fourier Transform Infrared spectroscopy and the distribution and microstructure of material components was observed with Scanning Electron Microscopy. The composition and distribution of elements were analyzed by an X-ray energy spectrometer. Gallbladder stones were classified accordingly, and then, gender, age, medical history and BMI of patients with each type of stone were analyzed. Principal Findings: Gallbladder stones were classified into 8 types and more than ten subtypes, including cholesterol stones (297), pigment stones (217), calcium carbonate stones (139), phosphate stones (12), calcium stearate stones (9), protein stones (3), cystine stones (1) and mixed stones (129). Mixed stones were those stones with two or more than two kinds of material components and the content of each component was similar. A total of 11 subtypes of mixed stones were found in this study. Patients with cholesterol stones were mainly female between the ages of 30 and 50, with higher BMI and shorter medical history than patients with pigment stones (P<0.05), however, patients with pigment, calcium carbonate, phosphate stones were mainly male between the ages of 40 and 60. Conclusion: The systematic classification of gallbladder stones indicates that different types of stones have different characteristics in terms of the microstructure, elemental composition and distribution, providing an important basis for the mechanistic study of gallbladder stones.	[Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Yang, Liu-qing; Luo, Zhen-liang; Zheng, Pei-ming] Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China; [Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Yang, Liu-qing; Luo, Zhen-liang; Zheng, Pei-ming] Sixth Peoples Hosp Nansha, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China		Qiao, T (corresponding author), Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China.	fqj1958@163.com						AHLBERG J, 1981, J LIPID RES, V22, P404; [Anonymous], [No title captured]; Cao J, 2006, J CHINESE PHYS, V8, P1111; Chen LY, 2012, WORLD J GASTROENTERO, V18, P4215, DOI 10.3748/wjg.v18.i31.4215; Chihara G., 1960, CHEM PHARM BULL, V8, P771; Djessou PS, 2010, ANN BIOL CLIN-PARIS, V68, P39; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; ELEK G, 1982, KLIN WOCHENSCHR, V60, P33, DOI 10.1007/BF01721585; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Fu PB., 1984, CHINESE J SURG, V22, P258; Goto K, 1996, Ryoikibetsu Shokogun Shirizu, P418; Hattori Y, 2000, DIGEST DIS SCI, V45, P1413, DOI 10.1023/A:1005524624411; Jarrar BM, 2011, MALAYS J MED SCI, V18, P47; Jiang ZY, 2008, J LIPID RES, V49, P464, DOI 10.1194/jlr.M700295-JLR200; Jiang ZY, 2009, BIOCHEM BIOPH RES CO, V379, P49, DOI 10.1016/j.bbrc.2008.11.131; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; LEE SP, 1986, GASTROENTEROLOGY, V90, P677, DOI 10.1016/0016-5085(86)91123-6; Liu Gang, 2002, Acta Optica Sinica, V22, P441; MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010; MALET PF, 1988, GASTROENTEROLOGY, V94, P1217, DOI 10.1016/0016-5085(88)90015-7; Mittal B, 2002, J Postgrad Med, V48, P149; Nakeeb A, 2002, ANN SURG, V235, P842, DOI 10.1097/00000658-200206000-00012; Paluszkiewicz C, 1998, CELL MOL BIOL, V44, P65; Qiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042471; Qiao T, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-6; Qiao T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3673472; RAVNBORG L, 1990, SCAND J GASTROENTERO, V25, P720, DOI 10.3109/00365529008997598; Sakorafas GH, 2007, DIGEST DIS SCI, V52, P1313, DOI 10.1007/s10620-006-9107-3; Stewart L, 2000, J GASTROINTEST SURG, V4, P547, DOI 10.1016/S1091-255X(00)80100-6; Stinton LM, 2010, GASTROENTEROL CLIN N, V39, P157, DOI 10.1016/j.gtc.2010.02.003; Stolk MFJ, 2001, DIGEST DIS SCI, V46, P1328, DOI 10.1023/A:1010635901414; Stringer MD, 2007, J PEDIATR SURG, V42, P1677, DOI 10.1016/j.jpedsurg.2007.05.022; TAYLOR DR, 1995, HEPATOLOGY, V22, P488, DOI 10.1016/0270-9139(95)90570-7; Wang HH, 2008, FRONT BIOSCI-LANDMRK, V13, P401, DOI 10.2741/2688; Wang Z, 2006, CHINESE J CLIN GASTR, V18, P325; Wu J, 1984, ACTA SCI NATUR U PEK, V20, P28; Xiao ZL, 1999, AM J PHYSIOL-GASTR L, V276, pG1401, DOI 10.1152/ajpgi.1999.276.6.G1401; Yoo EH, 2008, CLIN CHEM LAB MED, V46, P376, DOI 10.1515/CCLM.2008.074; Yu JK, 2013, ASIAN J SURG, V36, P26, DOI 10.1016/j.asjsur.2012.06.001; Zeng FQ, 2001, SPECTROSC SPECT ANAL, V21, P314; Zhang W., 2011, J SURG CONCEPTS PR, V16, P408; Zhang Z, 2008, WORLD CHINESE J DIGE, V16, P1200	42	50	56	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74887	10.1371/journal.pone.0074887	http://dx.doi.org/10.1371/journal.pone.0074887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124459	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100016
J	Hayashi, Y; Shigenobu, S; Watanabe, D; Toga, K; Saiki, R; Shimada, K; Bourguignon, T; Lo, N; Hojo, M; Maekawa, K; Miura, T				Hayashi, Yoshinobu; Shigenobu, Shuji; Watanabe, Dai; Toga, Kouhei; Saiki, Ryota; Shimada, Keisuke; Bourguignon, Thomas; Lo, Nathan; Hojo, Masaru; Maekawa, Kiyoto; Miura, Toru			Construction and Characterization of Normalized cDNA Libraries by 454 Pyrosequencing and Estimation of DNA Methylation Levels in Three Distantly Related Termite Species	PLOS ONE			English	Article							RETICULITERMES-SPERATUS ISOPTERA; EXPRESSED SEQUENCE TAGS; NASUTITERMES-TAKASAGOENSIS ISOPTERA; JUVENILE-HORMONE ANALOG; DAMP-WOOD TERMITE; SUBTERRANEAN TERMITE; DIFFERENTIATION; GENES; CPG; MORPHOGENESIS	In termites, division of labor among castes, categories of individuals that perform specialized tasks, increases colony-level productivity and is the key to their ecological success. Although molecular studies on caste polymorphism have been performed in termites, we are far from a comprehensive understanding of the molecular basis of this phenomenon. To facilitate future molecular studies, we aimed to construct expressed sequence tag (EST) libraries covering wide ranges of gene repertoires in three representative termite species, Hodotermopsis sjostedti, Reticulitermes speratus and Nasutitermes takasagoensis. We generated normalized cDNA libraries from whole bodies, except for guts containing microbes, of almost all castes, sexes and developmental stages and sequenced them with the 454 GS FLX titanium system. We obtained >1.2 million quality-filtered reads yielding >400 million bases for each of the three species. Isotigs, which are analogous to individual transcripts, and singletons were produced by assembling the reads and annotated using public databases. Genes related to juvenile hormone, which plays crucial roles in caste differentiation of termites, were identified from the EST libraries by BLAST search. To explore the potential for DNA methylation, which plays an important role in caste differentiation of honeybees, tBLASTn searches for DNA methyltransferases (dnmt1, dnmt2 and dnmt3) and methyl-CpG binding domain (mbd) were performed against the EST libraries. All four of these genes were found in the H. sjostedti library, while all except dnmt3 were found in R. speratus and N. takasagoensis. The ratio of the observed to the expected CpG content (CpG O/E), which is a proxy for DNA methylation level, was calculated for the coding sequences predicted from the isotigs and singletons. In all of the three species, the majority of coding sequences showed depletion of CpG O/E (less than 1), and the distributions of CpG O/E were bimodal, suggesting the presence of DNA methylation.	[Hayashi, Yoshinobu; Watanabe, Dai; Bourguignon, Thomas; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Hayashi, Yoshinobu; Lo, Nathan] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Shigenobu, Shuji] Natl Inst Nat Sci, Natl Inst Basic Biol, NIBB Core Res Facil, Okazaki, Aichi 4448585, Japan; [Shigenobu, Shuji] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Watanabe, Dai; Toga, Kouhei; Saiki, Ryota; Shimada, Keisuke; Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan; [Toga, Kouhei] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shimada, Keisuke] Ishikawa Museum Nat Hist, Kanazawa, Ishikawa, Japan; [Bourguignon, Thomas] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Hojo, Masaru] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan	Hokkaido University; University of Sydney; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; University of Toyama; Nagoya University; National University of Singapore; University of the Ryukyus	Miura, T (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	miu@ees.hokudai.ac.jp	Toga, Kouhei/AHC-4090-2022; Miura, Toru/P-2456-2019; Lo, Nathan/E-6115-2010; Shigenobu, Shuji/B-6239-2011	Toga, Kouhei/0000-0001-7244-5920; Miura, Toru/0000-0002-7456-4402; Lo, Nathan/0000-0003-2176-2840; Shigenobu, Shuji/0000-0003-4640-2323; Shimada, Keisuke/0000-0002-8483-7259; Bourguignon, Thomas/0000-0002-4035-8977; Maekawa, Kiyoto/0000-0002-2354-1059	Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; JSPS [23770274, 2469, 12J03468, 249520]; Japan Society for the Promotion of Science [24570022]; Sumitomo Foundation; Australian Research Council; Grants-in-Aid for Scientific Research [25251041] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Australian Research Council(Australian Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Young Scientists (No. 21677001 to TM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/), and by Grant-in-Aid for Young Scientists (No. 23770274 to MH), for JSPS Fellows (Nos. 2469, 12J03468 and 249520 to YH, DW and KT respectively) and for Scientific Research (C) (No. 24570022 to KM) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/). YH was also supported by Grant for Basic Science Research Projects from Sumitomo Foundation (http://www.sumitomo.or.jp/e/). NL was supported by the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1971, INSECT SOC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Dong QF, 2005, METHOD ENZYMOL, V395, P400; Glastad KM, 2013, INSECT MOL BIOL, V22, P143, DOI 10.1111/imb.12010; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Hattori A, 2013, J EXP ZOOL PART B, V320B, P295, DOI 10.1002/jez.b.22501; Hayashi Yoshinobu, 2003, Entomological Science, V6, P253, DOI 10.1046/j.1343-8786.2003.00030.x; Hojo M, 2012, INSECT MOL BIOL, V21, P545, DOI 10.1111/j.1365-2583.2012.01162.x; Hojo MU, 2004, SOCIOBIOLOGY, V44, P433; Holldobler B., 1990, pi; Huang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050383; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Inoue T, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P275; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Jongeneel C V, 2000, Brief Bioinform, V1, P76, DOI 10.1093/bib/1.1.76; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; Kawamura T, 1982, SHIROARI, V49, P44; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lo N, 2012, INSECT SOC, V59, P257, DOI 10.1007/s00040-011-0213-7; Matsuura K, 2012, J CHEM ECOL, V38, P746, DOI 10.1007/s10886-012-0137-3; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Miura T, 2004, INSECT SOC, V51, P247, DOI 10.1007/s00040-003-0736-2; Miura T, 2000, ECOL RES, V15, P83, DOI 10.1046/j.1440-1703.2000.00320.x; Miura T, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P211, DOI 10.1007/978-90-481-3977-4_9; Miyata H, 2004, ENTOMOL SCI, V7, P309, DOI 10.1111/j.1479-8298.2004.00078.x; Moczek AP, 2008, EVOL DEV, V10, P511, DOI 10.1111/j.1525-142X.2008.00264.x; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Nalepa CA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P53; Nambu Y, 2010, SOCIOBIOLOGY, V55, P527; Nijhout H.F., 1994, INSECT HORMONES; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; NOIROT C, 1991, ETHOL ECOL EVOL, P3; OGINO K, 1993, ZOOL SCI, V10, P361; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Oster G.F., 1978, Monographs in Population Biology, pi; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roberts SB, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00116; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; Saiki R, 2011, SOCIOBIOLOGY, V58, P499; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shcheglov Alex S., 2007, P97, DOI 10.1007/978-1-4020-6040-3_5; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Steller MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-463; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; TAKEMATSU Y, 1992, Japanese Journal of Entomology, V60, P67; Toga K, 2012, EVOL DEV, V14, P286, DOI 10.1111/j.1525-142X.2012.00545.x; Toga K, 2009, ZOOL SCI, V26, P382, DOI 10.2108/zsj.26.382; Tsuchiya M, 2008, APPL ENTOMOL ZOOL, V43, P307, DOI 10.1303/aez.2008.307; WATANABE H, 1991, APPL ENTOMOL ZOOL, V26, P418, DOI 10.1303/aez.26.418; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; WILSON EO, 1965, SCIENCE, V149, P1064, DOI 10.1126/science.149.3688.1064; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi SV, 2009, EPIGENETICS-US, V4, P551, DOI 10.4161/epi.4.8.10345; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang D, 2012, INSECT MOL BIOL, V21, P235, DOI 10.1111/j.1365-2583.2011.01130.x	71	9	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76678	10.1371/journal.pone.0076678	http://dx.doi.org/10.1371/journal.pone.0076678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098800	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500171
J	Storm, C; Danne, O; Ueland, PM; Leithner, C; Hasper, D; Schroeder, T				Storm, Christian; Danne, Oliver; Ueland, Per Magne; Leithner, Christoph; Hasper, Dietrich; Schroeder, Tim			Serial Plasma Choline Measurements after Cardiac Arrest in Patients Undergoing Mild Therapeutic Hypothermia: A Prospective Observational Pilot Trial	PLOS ONE			English	Article							PHOSPHOLIPASE-D; RAT-BRAIN; CITICOLINE; HUMANS; MULTICENTER; SURGERY; RELEASE; BETAINE; INJURY	Objective: Choline is related to phospholipid metabolism and is a marker for global ischaemia with a small reference range in healthy volunteers. The aim of our study was to characterize the early kinetics of plasma free choline in patients after cardiac arrest. Additionally, we investigated the potential of plasma free choline to predict neurological outcome. Methods: Twenty patients admitted to our medical intensive care unit were included in this prospective, observational trial. All patients were enrolled between May 2010 and May 2011. They received post cardiac arrest treatment including mild therapeutic hypothermia which was initiated with a combination of cold fluid and a feedback surface cooling device according to current guidelines. Sixteen blood samples per patient were analysed for plasma free choline levels within the first week after resuscitation. Choline was detected by liquid chromatography-tandem mass spectrometry. Results: Most patients showed elevated choline levels on admission (median 14.8 mmol/L; interquartile range; IQR 9.9-20.1) which subsequently decreased. 48 hours after cardiac arrest choline levels in all patients reached subnormal levels at a median of 4.0 mmol/L (IQR 3-4.9; p = 0.001). Subsequently, choline levels normalized within seven days. There was no significant difference in choline levels when groups were analyzed in relation to neurological outcome. Conclusions: Our data indicate a choline deficiency in the early postresucitation phase. This could potentially result in impaired cell membrane recovery. The detailed characterization of the early choline time course may aid in planning of choline supplementation trials. In a limited number of patients, choline was not promising as a biomarker for outcome prediction.	[Storm, Christian; Hasper, Dietrich; Schroeder, Tim] Charite, Campus Virchow Klinikum, Dept Intens Care Med & Nephrol, D-13353 Berlin, Germany; [Danne, Oliver] Charite, Campus Virchow Klinikum, Dept Emergency Med, D-13353 Berlin, Germany; [Ueland, Per Magne] Univ Bergen, Inst Med, Pharmacol Sect, Bergen, Norway; [Ueland, Per Magne] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway; [Leithner, Christoph] Charite, Campus Virchow Klinikum, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bergen; University of Bergen; Haukeland University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Storm, C (corresponding author), Charite, Campus Virchow Klinikum, Dept Intens Care Med & Nephrol, D-13353 Berlin, Germany.	christian.storm@charite.de	Schroeder, Tim/AAD-9114-2022; Ueland, Per M/C-7340-2013	Schroeder, Tim/0000-0002-5399-0576; Ueland, Per Magne/0000-0002-1903-0571; Leithner, Christoph/0000-0002-8277-846X	Medivance Inc. Colorado, USA	Medivance Inc. Colorado, USA	Laboratory work was sponsored by a grant of 5000(sic) by Medivance Inc. Colorado, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwes A, 2012, J NEUROL, V259, P537, DOI 10.1007/s00415-011-6224-5; Bruhl A, 2004, LIFE SCI, V75, P1609, DOI 10.1016/j.lfs.2004.03.019; Buchman AL, 2009, GASTROENTEROLOGY, V137, pS119, DOI 10.1053/j.gastro.2009.08.010; Danne O, 2007, CLIN CHIM ACTA, V383, P103, DOI 10.1016/j.cca.2007.05.001; Danne O, 2010, EXPERT REV MOL DIAGN, V10, P159, DOI 10.1586/ERM.10.2; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Holm PI, 2003, CLIN CHEM, V49, P286, DOI 10.1373/49.2.286; Ilcol YO, 2004, CLIN CHEM LAB MED, V42, P1390, DOI 10.1515/CCLM.2004.259; KLEIN J, 1993, BRAIN RES, V630, P337, DOI 10.1016/0006-8993(93)90674-C; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Korth U, 2003, RESUSCITATION, V58, P209, DOI 10.1016/S0300-9572(03)00119-9; LeLeiko RM, 2009, AM J CARDIOL, V104, P638, DOI 10.1016/j.amjcard.2009.04.047; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Roivainen A, 2000, EUR J NUCL MED, V27, P25, DOI 10.1007/PL00006658; Sahin S, 2010, J CLIN NEUROSCI, V17, P227, DOI 10.1016/j.jocn.2009.05.016; Samaniego EA, 2011, NEUROCRIT CARE, V15, P113, DOI 10.1007/s12028-010-9412-8; Savendahl L, 1997, AM J CLIN NUTR, V66, P622, DOI 10.1093/ajcn/66.3.622; Saver Jeffrey L, 2008, Rev Neurol Dis, V5, P167; Secades JJ, 2006, CEREBROVASC DIS, V21, P380, DOI 10.1159/000091547; Ulus IH, 1998, NEUROCHEM RES, V23, P727, DOI 10.1023/A:1022455325657; Vanek VW, 2012, NUTR CLIN PRACT, V27, P440, DOI 10.1177/0884533612446706; Wu BTF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043448; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; ZEISEL SH, 1985, BIOCHIM BIOPHYS ACTA, V835, P331, DOI 10.1016/0005-2760(85)90289-9	25	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76720	10.1371/journal.pone.0076720	http://dx.doi.org/10.1371/journal.pone.0076720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098804	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500175
J	Jensen, P; Heimberg, M; Ducray, AD; Widmer, HR; Meyer, M				Jensen, Pia; Heimberg, Michel; Ducray, Angelique D.; Widmer, Hans R.; Meyer, Morten			Expression of Trefoil Factor 1 in the Developing and Adult Rat Ventral Mesencephalon	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; DEVELOPMENTAL CELL-DEATH; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; PS2 GENE; REGULATED PROTEIN; MOUSE ASTROCYTES; TEGMENTAL AREA; 2 PARTS	Trefoil factor 1 (TFF1) belongs to a family of secreted peptides with a characteristic tree-looped trefoil structure. TFFs are mainly expressed in the gastrointestinal tract where they play a critical role in the function of the mucosal barrier. TFF1 has been suggested as a neuropeptide, but not much is known about its expression and function in the central nervous system. We investigated the expression of TFF1 in the developing and adult rat midbrain. In the adult ventral mesencephalon, TFF1-immunoreactive (-ir) cells were predominantly found in the substantia nigra pars compacta (SNc), the ventral tegmental area (VTA) and in periaqueductal areas. While around 90% of the TFF1-ir cells in the SNc co-expressed tyrosine hydroxylase (TH), only a subpopulation of the TH-ir neurons expressed TFF1. Some TFF1-ir cells in the SNc co-expressed the calcium-binding proteins calbindin or calretinin and nearly all were NeuN-ir confirming a neuronal phenotype, which was supported by lack of co-localization with the astroglial marker glial fibrillary acidic protein (GFAP). Interestingly, at postnatal (P) day 7 and P14, a significantly higher proportion of TH-ir neurons in the SNc co-expressed TFF1 as compared to P21. In contrast, the proportion of TFF1-ir cells expressing TH remained unchanged during postnatal development. Furthermore, significantly more TH-ir neurons expressed TFF1 in the SNc, compared to the VTA at all four time-points investigated. Injection of the tracer fluorogold into the striatum of adult rats resulted in retrograde labeling of several TFF1 expressing cells in the SNc showing that a significant fraction of the TFF1-ir cells were projection neurons. This was also reflected by unilateral loss of TFF1-ir cells in SNc of 6-hydroxylase-lesioned hemiparkinsonian rats. In conclusion, we show for the first time that distinct subpopulations of midbrain dopaminergic neurons express TFF1, and that this expression pattern is altered in a rat model of Parkinson's disease.	[Jensen, Pia; Meyer, Morten] Univ Southern Denmark, Dept Neurobiol Res, Inst Mol Med, Odense, Denmark; [Jensen, Pia; Heimberg, Michel; Ducray, Angelique D.; Widmer, Hans R.] Univ Bern, Dept Neurosurg, Bern, Switzerland	University of Southern Denmark; University of Bern	Meyer, M (corresponding author), Univ Southern Denmark, Dept Neurobiol Res, Inst Mol Med, Odense, Denmark.	mmeyer@health.sdu.dk	Widmer, Hans Rudolf/O-5172-2017; Widmer, Hans R./AAC-8948-2022	Widmer, Hans Rudolf/0000-0003-3378-8765; 	Danish Parkinson Association; Danish Medical Research Council [271-07-0582]; Danish Centre for Stem Cell Research; Horslev Fonden; IMK Almene Fond; Familien Hede Nielsens Fond; Augustinus Fonden; Fonden til Laegevidenskabens Fremme; Laegeforeningens Forskningsfond; Swiss National Science Foundation [3100A0-112529, 31003A_135565]	Danish Parkinson Association; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Stem Cell Research; Horslev Fonden; IMK Almene Fond; Familien Hede Nielsens Fond; Augustinus Fonden; Fonden til Laegevidenskabens Fremme; Laegeforeningens Forskningsfond; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Danish Parkinson Association, the Danish Medical Research Council (J. No. 271-07-0582), the Danish Centre for Stem Cell Research (www.dasc.dk), Horslev Fonden, IMK Almene Fond, Familien Hede Nielsens Fond, Augustinus Fonden, Fonden til Laegevidenskabens Fremme, Laegeforeningens Forskningsfond and the Swiss National Science Foundation (Contract No. 3100A0-112529 and 31003A_135565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlfahelKakunda A, 1997, DEV BRAIN RES, V103, P9, DOI 10.1016/S0165-3806(97)00101-6; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Baydyuk M, 2013, J NEUROSCI, V33, P3363, DOI 10.1523/JNEUROSCI.3687-12.2013; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Cannon JR, 2009, NEUROSCI LETT, V464, P14, DOI 10.1016/j.neulet.2009.08.023; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; GERFEN CR, 1987, J NEUROSCI, V7, P3915; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; Hinz M, 2004, PEPTIDES, V25, P827, DOI 10.1016/j.peptides.2004.01.020; HIROTA M, 1994, BIOCHEM MOL BIOL INT, V33, P515; HIROTA M, 1994, NEUROSCI LETT, V171, P49, DOI 10.1016/0304-3940(94)90601-7; HIROTA M, 1995, BIOCHEM MOL BIOL INT, V35, P1079; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jackson-Lewis V, 2000, J COMP NEUROL, V424, P476, DOI 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; Kanai M, 1998, P NATL ACAD SCI USA, V95, P178, DOI 10.1073/pnas.95.1.178; Kim BG, 2000, BRAIN RES, V855, P162, DOI 10.1016/S0006-8993(99)02374-4; Kozicz T, 2011, J COMP NEUROL, V519, P1413, DOI 10.1002/cne.22580; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LAUDER JM, 1974, J COMP NEUROL, V155, P469, DOI 10.1002/cne.901550407; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; McRitchie DA, 1996, J COMP NEUROL, V364, P121, DOI 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1; Meyer M, 1999, CELL TRANSPLANT, V8, P25, DOI 10.1177/096368979900800112; Meyer M, 1998, EXP BRAIN RES, V119, P345, DOI 10.1007/s002210050350; MOUATTPRIGENT A, 1994, BRAIN RES, V668, P62, DOI 10.1016/0006-8993(94)90511-8; Oo TF, 1997, DEV BRAIN RES, V98, P191, DOI 10.1016/S0165-3806(96)00173-3; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; ROGERS JH, 1992, BRAIN RES, V587, P203, DOI 10.1016/0006-8993(92)90998-O; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Sautter J, 1997, EXP BRAIN RES, V117, P111, DOI 10.1007/s002210050204; Schein JC, 1998, DEV BIOL, V204, P432, DOI 10.1006/dbio.1998.9076; SCHMUED LC, 1986, BRAIN RES, V377, P147, DOI 10.1016/0006-8993(86)91199-6; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin D, 1999, J CLIN INVEST, V103, pR31, DOI 10.1172/JCI3304; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A	46	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76592	10.1371/journal.pone.0076592	http://dx.doi.org/10.1371/journal.pone.0076592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116124	Green Published, gold			2022-12-27	WOS:000325501300070
J	Friend, SF; Peterson, LK; Treacy, E; Stefanski, AL; Sosinowski, T; Pennock, ND; Berger, AJ; Winn, VD; Dragone, LL				Friend, Samantha F.; Peterson, Lisa K.; Treacy, Eric; Stefanski, Adrianne L.; Sosinowski, Tomasz; Pennock, Nathan D.; Berger, Allison J.; Winn, Virginia D.; Dragone, Leonard L.			The Discovery of a Reciprocal Relationship between Tyrosine-Kinase Signaling and Cullin Neddylation	PLOS ONE			English	Article							UBIQUITIN LIGASE; T-CELLS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; C-CBL; COMPLEX; EXPRESSION; INHIBITOR; NEDD8; TRANSDUCTION	While neddylation is known to activate cullin (CUL)-RING ubiquitin ligases (CRLs), its role in regulating T cell signaling is poorly understood. Using the investigational NEDD8 activating enzyme (NAE) inhibitor, MLN4924, we found that neddylation negatively regulates T cell receptor (TCR) signaling, as its inhibition increases IL-2 production, T cell proliferation and Treg development in vitro. We also discovered that loss of CUL neddylation occurs upon TCR signaling, and CRLs negatively regulate IL-2 production. Additionally, we found that tyrosine kinase signaling leads to CUL deneddylation in multiple cell types. These studies indicate that CUL neddylation is a global regulatory mechanism for tyrosine kinase signaling.	[Friend, Samantha F.; Peterson, Lisa K.; Treacy, Eric; Dragone, Leonard L.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80202 USA; [Friend, Samantha F.; Peterson, Lisa K.; Sosinowski, Tomasz; Pennock, Nathan D.; Dragone, Leonard L.] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO USA; [Friend, Samantha F.; Peterson, Lisa K.; Sosinowski, Tomasz; Pennock, Nathan D.; Dragone, Leonard L.] Natl Jewish Hlth, Denver, CO USA; [Stefanski, Adrianne L.; Winn, Virginia D.] Univ Colorado, Dept Obstet & Gynecol, Sch Med, Aurora, CO USA; [Sosinowski, Tomasz] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Sch Med, Aurora, CO USA; [Berger, Allison J.] Millennium Pharmaceut Inc, Cambridge, MA USA; [Dragone, Leonard L.] Colorado Childrens Hosp, Div Rheumatol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Children's Hospital Colorado	Dragone, LL (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80202 USA.	dragonel@njhealth.org	Pennock, Nathan/G-2464-2017	Pennock, Nathan/0000-0001-5374-7843; Friend, Samantha/0000-0002-2936-5041; Winn, Virginia/0000-0003-1136-2907	National Institutes of Health (NIH) T32 grant [AI07405]; Easton M. Crawford Charitable Lead Unitrust Postdoctoral Fellowship; NIH R21 grant [AI097572]; Rheumatology Research Foundation from the American College of Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007405, R21AI097572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	National Institutes of Health (NIH) T32 grant; Easton M. Crawford Charitable Lead Unitrust Postdoctoral Fellowship; NIH R21 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatology Research Foundation from the American College of Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (NIH) T32 grant AI07405 (S.F.F.), an Easton M. Crawford Charitable Lead Unitrust Postdoctoral Fellowship (L.K.P.), an NIH R21 grant AI097572 (L.L.D, S.F.F, E.T.) and a Rheumatology Research Foundation (http://www.rheumatology.org/foundation/) from the American College of Rheumatology (L.L.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Aubrecht J, 2011, DRUG CHEM TOXICOL, V34, P433, DOI 10.3109/01480545.2010.544316; Balachandran P, 2007, J CLIN INVEST, V117, P419, DOI 10.1172/JCI28792; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Dragone LL, 2006, P NATL ACAD SCI USA, V103, P18202, DOI 10.1073/pnas.0608965103; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; GLIMCHER LH, 1985, J IMMUNOL, V135, P3542; Jin H-S, 2012, P NATL ACAD SCI; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kawaida R, 2005, GENES IMMUN, V6, P194, DOI 10.1038/sj.gene.6364177; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Locke NR, 2009, J IMMUNOL, V183, P975, DOI 10.4049/jimmunol.0803749; MacManus CF, 2011, FASEB J; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mikalsen SO, 1998, J BIOL CHEM, V273, P10036, DOI 10.1074/jbc.273.16.10036; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Peterson LK, 2011, J IMMUNOL, V186, P2273, DOI 10.4049/jimmunol.1003601; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2012, IMMUNOL CELL BIOL, V90, P277, DOI 10.1038/icb.2012.4; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Sykulev Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe50; van der Heijden JW, 2009, CLIN EXP RHEUMATOL, V27, P92; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75200	10.1371/journal.pone.0075200	http://dx.doi.org/10.1371/journal.pone.0075200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124476	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100033
J	Jiang, H; Wang, H; Xu, LQ; Hu, GY; Ma, JY; Xiao, P; Fan, WX; Di, DD; Tian, GZ; Fan, MG; Mi, JC; Yu, RP; Song, LT; Zhao, HY; Piao, DR; Cui, BY				Jiang, Hai; Wang, Heng; Xu, Liqing; Hu, Guiying; Ma, Junying; Xiao, Pei; Fan, Weixing; Di, Dongdong; Tian, Guozhong; Fan, Mengguang; Mi, Jingchuan; Yu, Ruiping; Song, Litao; Zhao, Hongyan; Piao, Dongri; Cui, Buyun			MLVA Genotyping of Brucella melitensis and Brucella abortus Isolates from Different Animal Species and Humans and Identification of Brucella suis Vaccine Strain S2 from Cattle in China	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; REV-1 VACCINE; ASSAY; PCR; POLYMORPHISM; DIVERSITY; INFECTION; GOATS; GENE	In China, brucellosis is an endemic disease and the main sources of brucellosis in animals and humans are infected sheep, cattle and swine. Brucella melitensis (biovars 1 and 3) is the predominant species, associated with sporadic cases and outbreak in humans. Isolates of B. abortus, primarily biovars 1 and 3, and B. suis biovars 1 and 3 are also associated with sporadic human brucellosis. In this study, the genetic profiles of B. melitensis and B. abortus isolates from humans and animals were analyzed and compared by multi-locus variable-number tandem-repeat analysis (MLVA). Among the B. melitensis isolates, the majority (74/82) belonged to MLVA8 genotype 42, clustering in the 'East Mediterranean' group. Two B. melitensis biovar 1 genotype 47 isolates, belonging to the 'Americas' group, were recovered; both were from the Himalayan blue sheep (Pseudois nayaur, a wild animal). The majority of B. abortus isolates (51/70) were biovar 3, genotype 36. Ten B. suis biovar 1 field isolates, including seven outbreak isolates recovered from a cattle farm in Inner Mongolia, were genetically indistinguishable from the vaccine strain S2, based on MLVA cluster analysis. MLVA analysis provided important information for epidemiological trace-back. To the best of our knowledge, this is the first report to associate Brucella cross-infection with the vaccine strain S2 based on molecular comparison of recovered isolates to the vaccine strain. MLVA typing could be an essential assay to improve brucellosis surveillance and control programs.	[Jiang, Hai; Xiao, Pei; Tian, Guozhong; Zhao, Hongyan; Piao, Dongri; Cui, Buyun] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Wang, Heng] Hangzhou Ctr Dis Control & Prevent, Lab Endem & Parasit Dis Control & Prevent, Hangzhou, Peoples R China; [Xu, Liqing; Hu, Guiying; Ma, Junying] Qinghai Inst Endem Dis Prevent & Control, Lab Brucellosis, Xining, Peoples R China; [Fan, Weixing; Di, Dongdong] MOA, China Anim Hlth & Epidemiol Ctr, Lab Zoonoses, Qingdao, Peoples R China; [Fan, Mengguang; Mi, Jingchuan; Yu, Ruiping; Song, Litao] Inner Mongolia Ctr Endem Dis Control & Res, Dept Brucellosis, Hohhot, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; China Animal Health & Epidemiology Center	Cui, BY (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	cuibuyun@icdc.cn		Xiao, Pei/0000-0001-9976-7655	National Nature Science Foundation [81271900]; National Key Program for Infectious Diseases of China [2013ZX10004221, 2014ZX10004003]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This study was funded by the National Nature Science Foundation (81271900), National Key Program for Infectious Diseases of China (2013ZX10004221, 2014ZX10004003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Alton G. G., 1975, Laboratory techniques in brucellosis.; Bardenstein S, 2002, J CLIN MICROBIOL, V40, P1475, DOI 10.1128/JCM.40.2.1475-1480.2002; Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595; Blasco JM, 1997, PREV VET MED, V31, P275, DOI 10.1016/S0167-5877(96)01110-5; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; Bricker BJ, 2003, J VET DIAGN INVEST, V15, P374, DOI 10.1177/104063870301500413; Cloeckaert A, 2002, VACCINE, V20, P2546, DOI 10.1016/S0264-410X(02)00159-7; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; DAVIS DS, 1991, J WILDLIFE DIS, V27, P258, DOI 10.7589/0090-3558-27.2.258; ELBERG SS, 1957, J BACTERIOL, V73, P211, DOI 10.1128/JB.73.2.211-217.1957; Ferreira AC, 2012, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0042514; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garcia-Yoldi D, 2007, VACCINE, V25, P2858, DOI 10.1016/j.vaccine.2006.09.063; Gopaul KK, 2010, J CLIN MICROBIOL, V48, P1461, DOI 10.1128/JCM.02193-09; GRAVES RR, 1943, J AM VET MED ASSOC, V102, P193; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiang H, 2012, VET MICROBIOL, V154, P419, DOI 10.1016/j.vetmic.2011.07.014; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kang SI, 2011, J VET MED SCI, V73, P779, DOI 10.1292/jvms.10-0334; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; Marianelli C, 2008, J HOSP INFECT, V68, P274, DOI 10.1016/j.jhin.2008.01.003; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; THOMAS EL, 1981, VET REC, V108, P90, DOI 10.1136/vr.108.5.90; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Van Metre DC, 1999, J AM VET MED ASSOC, V215, P1491; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Zhang WY, 2010, EMERG INFECT DIS, V16, P2001, DOI 10.3201/eid1612.091081	35	32	43	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76332	10.1371/journal.pone.0076332	http://dx.doi.org/10.1371/journal.pone.0076332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124546	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100103
J	Lan, XZ; Chang, K; Zeng, LJ; Liu, XQ; Qiu, F; Zheng, WL; Quan, H; Liao, ZH; Chen, M; Huang, WL; Liu, WH; Wang, Q				Lan, Xiaozhong; Chang, Kai; Zeng, Lingjiang; Liu, Xiaoqiang; Qiu, Fei; Zheng, Weilie; Quan, Hong; Liao, Zhihua; Chen, Min; Huang, Wenlin; Liu, Wanhong; Wang, Qiang			Engineering Salidroside Biosynthetic Pathway in Hairy Root Cultures of Rhodiola crenulata Based on Metabolic Characterization of Tyrosine Decarboxylase	PLOS ONE			English	Article							ATROPA-BELLADONNA; OVEREXPRESSING PMT; GENE-EXPRESSION; PLANTS; ALKALOIDS; JASMONATE; ROSEA	Tyrosine decarboxylase initializes salidroside biosynthesis. Metabolic characterization of tyrosine decarboxylase gene from Rhodiola crenulata (RcTYDC) revealed that it played an important role in salidroside biosynthesis. Recombinant 53 kDa RcTYDC converted tyrosine into tyramine. RcTYDC gene expression was induced coordinately with the expression of RcUDPGT (the last gene involved in salidroside biosynthesis) in SA/MeJA treatment; the expression of RcTYDC and RcUDPGT was dramatically upregulated by SA, respectively 49 folds and 36 folds compared with control. MeJA also significantly increased the expression of RcTYDC and RcUDPGT in hairy root cultures. The tissue profile of RcTYDC and RcUDPGT was highly similar: highest expression levels found in stems, higher expression levels in leaves than in flowers and roots. The gene expressing levels were consistent with the salidroside accumulation levels. This strongly suggested that RcTYDC played an important role in salidroside biosynthesis in R. crenulata. Finally, RcTYDC was used to engineering salidroside biosynthetic pathway in R. crenulata hairy roots via metabolic engineering strategy of overexpression. All the transgenic lines showed much higher expression levels of RcTYDC than non-transgenic one. The transgenic lines produced tyramine, tyrosol and salidroside at higher levels, which were respectively 3.21-6.84, 1.50-2.19 and 1.27-3.47 folds compared with the corresponding compound in non-transgenic lines. In conclusion, RcTYDC overexpression promoted tyramine biosynthesis that facilitated more metabolic flux flowing toward the downstream pathway and as a result, the intermediate tyrosol was accumulated more that led to the increased production of the end-product salidroside.	[Lan, Xiaozhong; Zheng, Weilie; Quan, Hong] Tibet Univ, Agr & Anim Husb Coll, Nyingchi Of Tibet, Peoples R China; [Lan, Xiaozhong; Chang, Kai; Zeng, Lingjiang; Liu, Xiaoqiang; Qiu, Fei; Liao, Zhihua; Huang, Wenlin] Southwest Univ, Chongqing Engn & Technol Res Ctr Sweetpotato, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China; [Chen, Min] Southwest Univ, Sch Pharmaceut Sci, Chongqing, Peoples R China; [Liu, Wanhong] Chongqing Univ Sci & Technol, Sch Chem & Chem Engn, Chongqing, Peoples R China; [Wang, Qiang] Minist Sci & Technol, China Rural Technol Dev Ctr, Beijing, Peoples R China	Tibet University; Southwest University - China; Southwest University - China; Chongqing University of Science & Technology	Liao, ZH (corresponding author), Southwest Univ, Chongqing Engn & Technol Res Ctr Sweetpotato, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China.	zhliao@swu.edu.cn; mminchen@163.com			Natural Science Foundation Project of Chongqing [2010BB5296]; NSFC Project [31070266]; National Science & Technology Pillar Program [2011BAI13B06]; Tibet Medicinal Resources Investigation Project (State Administration of Chinese Traditional Medicine) [20120716-540000]; Tibet Science and Technology Funding	Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); NSFC Project(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program; Tibet Medicinal Resources Investigation Project (State Administration of Chinese Traditional Medicine); Tibet Science and Technology Funding	The research was financially supported by the Natural Science Foundation Project of Chongqing (2010BB5296), the NSFC Project (31070266), the National Science & Technology Pillar Program (2011BAI13B06), Tibet Medicinal Resources Investigation Project (State Administration of Chinese Traditional Medicine 20120716-540000) and Tibet Science and Technology Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartley GE, 2010, NEW BIOTECHNOL, V27, P308, DOI 10.1016/j.nbt.2010.04.003; Chan SW, 2012, INT J FOOD SCI NUTR, V63, P75, DOI 10.3109/09637486.2011.627840; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; FACCHINI PJ, 1994, J BIOL CHEM, V269, P26684; Gauger KJ, 2010, J MED PLANTS RES, V4, P446; Gyorgy Z, 2009, J PLANT PHYSIOL, V166, P1581, DOI 10.1016/j.jplph.2009.03.016; Imanishi S, 1998, PLANT MOL BIOL, V38, P1101, DOI 10.1023/A:1006058700949; Islas-Flores I, 2002, MOL BIOTECHNOL, V21, P211, DOI 10.1385/MB:21:3:211; Kai GY, 2011, METAB ENG, V13, P319, DOI 10.1016/j.ymben.2011.02.003; Landtag J, 2002, PHYTOCHEMISTRY, V60, P683, DOI 10.1016/S0031-9422(02)00161-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; Liu WH, 2012, PLANTA, V236, P239, DOI 10.1007/s00425-012-1608-z; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Mao Y, 2007, J PHARMACEUT BIOMED, V45, P510, DOI 10.1016/j.jpba.2007.05.031; Memelink J, 2001, TRENDS PLANT SCI, V6, P212, DOI 10.1016/S1360-1385(01)01924-0; Pasquali G, 2006, J BIOSCI BIOENG, V101, P287, DOI 10.1263/jbb.101.287; Qu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029641; SIMONSARKADI L, 1994, J FOOD BIOCHEM, V17, P407, DOI 10.1111/j.1745-4514.1993.tb00483.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang XR, 2011, PHYSIOL PLANTARUM, V143, P309, DOI 10.1111/j.1399-3054.2011.01506.x; Yang CX, 2011, PLANT OMICS, V4, P29; Yang YN, 2012, J AGR FOOD CHEM, V60, P964, DOI 10.1021/jf204660c; Yu HS, 2011, PHYTOCHEMISTRY, V72, P862, DOI 10.1016/j.phytochem.2011.03.020; YUN DJ, 1992, P NATL ACAD SCI USA, V89, P11799, DOI 10.1073/pnas.89.24.11799; Zhao Y, 2012, APPL BIOCHEM BIOTECH, V166, P1480, DOI 10.1007/s12010-012-9542-x; Zhou XF, 2007, BIOL PHARM BULL, V30, P439, DOI 10.1248/bpb.30.439	28	39	48	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75459	10.1371/journal.pone.0075459	http://dx.doi.org/10.1371/journal.pone.0075459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124492	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100049
J	Pereboeva, L; Westin, E; Patel, T; Flaniken, I; Lamb, L; Klingelhutz, A; Goldman, F				Pereboeva, Larisa; Westin, Erik; Patel, Toral; Flaniken, Ian; Lamb, Lawrence; Klingelhutz, Aloysius; Goldman, Frederick			DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; FANCONI-ANEMIA; N-ACETYLCYSTEINE; TELOMERE LENGTH; UNRELATED DONOR; STEM-CELLS; FIBROBLASTS; SENESCENCE; P53; KERATINOCYTES	Dyskeratosis congenita (DC) is an inherited multisystem disorder of premature aging, cancer predisposition, and bone marrow failure caused by selective exhaustion of highly proliferative cell pools. DC patients also have a poor tolerance to chemo/radiotherapy and bone marrow transplantation. Although critically shortened telomeres and defective telomere maintenance contribute to DC pathology, other mechanisms likely exist. We investigate the link between telomere dysfunction and oxidative and DNA damage response pathways and assess the effects of antioxidants. In vitro studies employed T lymphocytes from DC subjects with a hTERC mutation and age-matched controls. Cells were treated with cytotoxic agents, including Paclitaxel, Etoposide, or ionizing radiation. Apoptosis and reactive oxygen species (ROS) were assessed by flow cytometry, and Western blotting was used to measure expression of DNA damage response (DDR) proteins, including total p53, p53S15, and p21(WAF). N-acetyl-cysteine (NAC), an antioxidant, was used to modulate cell growth and ROS. In stimulated culture, DC lymphocytes displayed a stressed phenotype, characterized by elevated levels of ROS, DDR and apoptotic markers as well as a proliferative defect that was more pronounced after exposure to cytotoxic agents. NAC partially ameliorated the growth disadvantage of DC cells and decreased radiation-induced apoptosis and oxidative stress. These findings suggest that oxidative stress may play a role in the pathogenesis of DC and that pharmacologic intervention to correct this pro-oxidant imbalance may prove useful in the clinical setting, potentially alleviating untoward toxicities associated with current cytotoxic treatments.	[Pereboeva, Larisa; Lamb, Lawrence] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; [Westin, Erik; Patel, Toral; Flaniken, Ian; Goldman, Frederick] Childrens Hosp Alabama, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA; [Klingelhutz, Aloysius] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Alabama System; University of Alabama Birmingham; University of Iowa	Goldman, F (corresponding author), Childrens Hosp Alabama, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA.	fgoldman@peds.uab.edu	Klingelhutz, Aloysius/L-9081-2018	Klingelhutz, Aloysius/0000-0003-4258-5046	National Institutes of Health [AG0227388]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially funded by a National Institutes of Health R01 grant (AG0227388 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ayas M, 2013, BONE MARROW TRANSPLA, DOI 10:1038/bmt2013.35; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Buckingham EM, 2012, AGING DIS, V3, P427; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Darbro BW, 2006, ONCOGENE, V25, P7421, DOI 10.1038/sj.onc.1209729; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dietz AC, 2011, BONE MARROW TRANSPL, V46, P98, DOI 10.1038/bmt.2010.65; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; DOKAL I, 1992, BLOOD, V80, P3090; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Gazit R, 2008, SEMIN HEMATOL, V45, P218, DOI 10.1053/j.seminhematol.2008.07.010; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; Goldman FD, 2008, BLOOD, V111, P4523, DOI 10.1182/blood-2007-10-120204; Gourronc FA, 2010, EXP DERMATOL, V19, P279, DOI 10.1111/j.1600-0625.2009.00916.x; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Gu BW, 2009, CELL CYCLE, V8, P6, DOI 10.4161/cc.8.1.7265; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Homma S, 2012, RESPIROLOGY, V17, P467, DOI 10.1111/j.1440-1843.2012.02132.x; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kirwan M, 2011, BRIT J HAEMATOL, V153, P634, DOI 10.1111/j.1365-2141.2011.08679.x; Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673; Kurre P, 2003, J PEDIAT HEMATOL ONC, V25, P581, DOI 10.1097/00043426-200307000-00019; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Pagano G, 2005, EUR J HAEMATOL, V75, P93, DOI 10.1111/j.1600-0609.2005.00507.x; Pagano G., 2011, BIOL CHEM; Pant V, 2012, BLOOD, V120, P5118, DOI 10.1182/blood-2012-05-356014; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thakar MS, 2011, BONE MARROW TRANSPL, V46, P539, DOI 10.1038/bmt.2010.154; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030188	41	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76473	10.1371/journal.pone.0076473	http://dx.doi.org/10.1371/journal.pone.0076473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124565	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100122
J	Baek, KT; Frees, D; Renzoni, A; Barras, C; Rodriguez, N; Manzano, C; Kelley, WL				Baek, Kristoffer T.; Frees, Dorte; Renzoni, Adriana; Barras, Christine; Rodriguez, Natalia; Manzano, Caroline; Kelley, William L.			Genetic Variation in the Staphylococcus aureus 8325 Strain Lineage Revealed by Whole-Genome Sequencing	PLOS ONE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; VIRULENCE-DETERMINANT EXPRESSION; FIBRONECTIN-BINDING; LABORATORY STRAINS; GLOBAL REGULATOR; IN-VITRO; RESISTANCE; SIGMA(B); PROTEIN; SARA	Staphylococcus aureus strains of the 8325 lineage, especially 8325-4 and derivatives lacking prophage, have been used extensively for decades of research. We report herein the results of our deep sequence analysis of strain 8325-4. Assignment of sequence variants compared with the reference strain 8325 (NRS77/PS47) required correction of errors in the 8325 reference genome, and reassessment of variation previously attributed to chemical mutagenesis of the restriction-defective RN4220. Using an extensive strain pedigree analysis, we discovered that 8325-4 contains 16 single nucleotide polymorphisms (SNP) arising prior to the construction of RN4220. We identified 5 indels in 8325-4 compared with 8325. Three indels correspond to expected Phi 11, 12, 13 excisions, one indel is explained by a sequence assembly artifact, and the final indel (Delta 63bp) in the spa-sarS intergenic region is common to only a sub-lineage of 8325-4 strains including SH1000. This deletion was found to significantly decrease (75%) steady state sarS but not spa transcript levels in post-exponential phase. The sub-lineage 8325-4 was also found to harbor 4 additional SNPs. We also found large sequence variation between 8325, 8325-4 and RN4220 in a cluster of repetitive hypothetical proteins (SA0282 homologs) near the Ess secretion cluster. The overall 8325-4 SNP set results in 17 alterations within coding sequences. Remarkably, we discovered that all tested strains of the 8325-4 lineage lack phenol soluble modulin alpha 3 (PSM alpha 3), a virulence determinant implicated in neutrophil chemotaxis, biofilm architecture and surface spreading. Collectively, our results clarify and define the 8325-4 pedigree and reveal clear evidence that mutations existing throughout all branches of this lineage, including the widely used RN6390 and SH1000 strains, could conceivably impact virulence regulation.	[Baek, Kristoffer T.; Frees, Dorte] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Renzoni, Adriana; Barras, Christine; Rodriguez, Natalia; Manzano, Caroline; Kelley, William L.] Univ Hosp, Infect Dis Serv, Geneva, Switzerland; [Renzoni, Adriana; Barras, Christine; Rodriguez, Natalia; Manzano, Caroline; Kelley, William L.] Med Sch Geneva, Geneva, Switzerland	University of Copenhagen; University of Geneva; University of Geneva	Kelley, WL (corresponding author), Univ Hosp, Infect Dis Serv, Geneva, Switzerland.	William.Kelley@unige.ch		Frees, Dorte/0000-0003-4946-2890; Renzoni, Adriana/0000-0002-4897-5208; Baek, Kristoffer Torbjorn/0000-0003-3243-3962	Swiss National Science Foundation [3100A0-120428, 310030-146540]; Danish Council for Independent Research [12-132527]; Nordic Joint Committee for Agricultural Research; Swiss Society for Infectious Diseases; Canton of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Nordic Joint Committee for Agricultural Research; Swiss Society for Infectious Diseases; Canton of Geneva	This work was supported by grants from the Swiss National Science Foundation (3100A0-120428 and 310030-146540 to WLK), the Danish Council for Independent Research (12-132527 to KTB), the Nordic Joint Committee for Agricultural Research (to DF), a fellowship grant from the Swiss Society for Infectious Diseases (to NR), and the Canton of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2011, J BACTERIOL, V193, P1583, DOI 10.1128/JB.01096-10; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Ballal A, 2009, MICROBIOL-SGM, V155, P2342, DOI 10.1099/mic.0.027417-0; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; BERGERBACHI B, 1983, J BACTERIOL, V154, P479; Berscheid A, 2012, INT J MED MICROBIOL, V302, P84, DOI 10.1016/j.ijmm.2012.01.002; Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Frees D, 2005, INFECT IMMUN, V73, P8100, DOI 10.1128/IAI.73.12.8100-8108.2005; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gillaspy A. F., 2006, GRAM POSITIVE PATHOG, P381, DOI DOI 10.1128/; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MAHAIRAS GG, 1989, J BACTERIOL, V171, P3968, DOI 10.1128/jb.171.7.3968-3972.1989; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; Morikawa K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003003; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Paulander W, 2012, MBIO, V3, DOI 10.1128/mBio.00459-12; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Renzoni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021577; Renzoni A, 2009, ANTIMICROB AGENTS CH, V53, P903, DOI 10.1128/AAC.01287-08; SCHAAPER RM, 1987, J MOL BIOL, V198, P187, DOI 10.1016/0022-2836(87)90305-6; Schmidt KA, 2003, INFECT IMMUN, V71, P5139, DOI 10.1128/IAI.71.9.5139-5148.2003; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Susanna KA, 2004, J BACTERIOL, V186, P1120, DOI 10.1128/JB.186.4.1120-1128.2004; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e77122	10.1371/journal.pone.0077122	http://dx.doi.org/10.1371/journal.pone.0077122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098817	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500188
J	Baggio, F; Bozzato, A; Benna, C; Leonardi, E; Romoli, O; Cognolato, M; Tosatto, SCE; Costa, R; Sandrelli, F				Baggio, Francesca; Bozzato, Andrea; Benna, Clara; Leonardi, Emanuela; Romoli, Ottavia; Cognolato, Moira; Tosatto, Silvio C. E.; Costa, Rodolfo; Sandrelli, Federica			2mit, an Intronic Gene of Drosophila melanogaster timeless2, Is Involved in Behavioral Plasticity	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; DEPENDENT PROTEIN-KINASE; MUSHROOM BODIES; NESTED GENES; PREFERENTIAL EXPRESSION; NATURAL-SELECTION; RNA LOCALIZATION; DROSOPHILA; COURTSHIP; MEMORY	Background: Intronic genes represent similar to 6% of the total gene complement in Drosophila melanogaster and similar to 85% of them encode for proteins. We recently characterized the D. melanogaster timeless2 (tim2) gene, showing its active involvement in chromosomal stability and light synchronization of the adult circadian clock. The protein coding gene named 2mit maps on the 11th tim2 intron in the opposite transcriptional orientation. Methodology/Principal Findings: Here we report the molecular and functional characterization of 2mit. The 2mit gene is expressed throughout Drosophila development, localizing mainly in the nervous system during embryogenesis and mostly in the mushroom bodies and ellipsoid body of the central complex in the adult brain. In silico analyses revealed that 2mit encodes a putative leucine-Rich Repeat transmembrane receptor with intrinsically disordered regions, harboring several fully conserved functional interaction motifs in the cytosolic side. Using insertional mutations, tissue-specific over-expression, and down-regulation approaches, it was found that 2mit is implicated in adult short-term memory, assessed by a courtship conditioning assay. In D. melanogaster, tim2 and 2mit do not seem to be functionally related. Bioinformatic analyses identified 2MIT orthologs in 21 Drosophilidae, 4 Lepidoptera and in Apis mellifera. In addition, the tim2-2mit host-nested gene organization was shown to be present in A. mellifera and maintained among Drosophila species. Within the Drosophilidae 2mit-hosting tim2 intron, in silico approaches detected a neuronal specific transcriptional binding site which might have contributed to preserve the specific host-nested gene association across Drosophila species. Conclusions/Significance: Taken together, these results indicate that 2mit, a gene mainly expressed in the nervous system, has a role in the behavioral plasticity of the adult Drosophila. The presence of a putative 2mit regulatory enhancer within the 2mit-hosting tim2 intron could be considered an evolutionary constraint potentially involved in maintaining the tim2-2mit host-nested chromosomal architecture during the evolution of Drosophila species.	[Baggio, Francesca; Bozzato, Andrea; Benna, Clara; Leonardi, Emanuela; Romoli, Ottavia; Cognolato, Moira; Tosatto, Silvio C. E.; Costa, Rodolfo; Sandrelli, Federica] Univ Padua, Dipartimento Biol, Padua, Italy	University of Padua	Sandrelli, F (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	federica.sandrelli@unipd.it	Tosatto, Silvio/B-2840-2009; leonardi, emanuela/AAN-2392-2020; benna, clara/K-1083-2018	Tosatto, Silvio/0000-0003-4525-7793; leonardi, emanuela/0000-0001-8486-8461; BENNA, CLARA/0000-0002-9077-2471; Romoli, Ottavia/0000-0002-7608-2650; SANDRELLI, FEDERICA/0000-0002-5631-7467; Baggio, Francesca/0000-0001-5070-6165	Universita degli Studi di Padova [CPDR042471, CPDR100470, CPDA074398, CPDA098382]; CARIPARO (Progetti di Eccellenza); FIRB Futuro in Ricerca [RBFR08ZSXY]; CARIPLO [2011/0724]; European Community [018741]	Universita degli Studi di Padova; CARIPARO (Progetti di Eccellenza)(Fondazione Cariparo); FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); CARIPLO(Fondazione Cariplo); European Community(European Commission)	AB and CB were supported by postdoctoral fellowships from Universita degli Studi di Padova (CPDR042471 and CPDR100470). This work was funded by grants from Universita degli Studi di Padova (CPDA074398 to FS and CPDA098382 to SCET); CARIPARO (Progetti di Eccellenza, 2011/12) to FS, FIRB Futuro in Ricerca (RBFR08ZSXY) and CARIPLO (2011/0724) to SCET; and European Community (the 6th Framework Project EUCLOCK no. 018741) to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2003, PROTEIN ENG, V16, P459, DOI 10.1093/protein/gzg063; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Assis R, 2008, TRENDS GENET, V24, P475, DOI 10.1016/j.tig.2008.08.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Bhutkar A, 2007, GENOME RES, V17, P1880, DOI 10.1101/gr.7062307; Boden M, 2005, BIOINFORMATICS, V21, P2279, DOI 10.1093/bioinformatics/bti372; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; CHEN MS, 1992, J CELL SCI, V103, P619; CONNOLLY JB, 1998, BEHAVIOUR LEARNING A, V2, P265; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; FELSENSTEIN J, 1985, CONFIDENCE LIMITS ON; GAILEY DA, 1984, GENETICS, V106, P613; Gibson CW, 2005, GENE, V350, P15, DOI 10.1016/j.gene.2004.12.045; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; Grimaldi D. A., 2005, EVOLUTION INSECTS, VXV; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Hudson SG, 2007, GENETICS, V177, P1349, DOI 10.1534/genetics.107.071670; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Kajava AV, 2002, PROTEIN SCI, V11, P1082, DOI 10.1110/ps.4010102; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kobayashi M, 2006, P NATL ACAD SCI USA, V103, P14417, DOI 10.1073/pnas.0606571103; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kondratov RV, 2007, CURR TOP DEV BIOL, V78, P173, DOI 10.1016/S0070-2153(06)78005-X; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumar A, 2009, EUKARYOT CELL, V8, P1321, DOI 10.1128/EC.00143-09; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Marsella L, 2009, BIOINFORMATICS, V25, pI289, DOI 10.1093/bioinformatics/btp232; Martin JR, 2001, J NEUROGENET, V15, P205, DOI 10.3109/01677060109167377; MAUHIN V, 1993, NUCLEIC ACIDS RES, V21, P3951, DOI 10.1093/nar/21.17.3951; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; MISRA S, 2002, GENOME BIOL RES, V83; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Salzberg A, 1997, GENETICS, V147, P1723; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Saxena AK, 2008, SAR QSAR ENVIRON RES, V19, P11, DOI 10.1080/10629360701844126; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Siwicki KK, 2003, BEHAV PROCESS, V64, P225, DOI 10.1016/S0376-6357(03)00137-2; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tolino M, 2012, EUR J NEUROSCI, V35, P1818, DOI 10.1111/j.1460-9568.2012.08160.x; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316; Tsang WH, 2009, GENOMICS, V94, P177, DOI 10.1016/j.ygeno.2009.05.009; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; WILLMUND R, 1982, ANIM BEHAV, V30, P209, DOI 10.1016/S0003-3472(82)80256-X; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	80	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76351	10.1371/journal.pone.0076351	http://dx.doi.org/10.1371/journal.pone.0076351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098788	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500159
J	Bronstein, O; Loya, Y				Bronstein, Omri; Loya, Yossi			The Taxonomy and Phylogeny of Echinometra (Camarodonta: Echinometridae) from the Red Sea and Western Indian Ocean	PLOS ONE			English	Article							GAMETE RECOGNITION; GENUS ECHINOMETRA; SPECIATION; URCHINS; PACIFIC; SPERM; BIOGEOGRAPHY; MORPHOLOGY; EVOLUTION; GENETICS	The number of valid species in the genus Echinometra (Echinodermata, Echinoidea) and their associated identification keys have been debated in the scientific literature for more than 180 years. As the phylogeny and dispersal patterns of these species have been widely used as a prominent model for marine speciation, new insights into their taxonomy have the potential to deepen our understanding of marine speciation processes. In this study we examine Echinometra taxonomy, combining morphology and molecular tools. We present the taxonomy and phylogeny of Red Sea and Western Indian Ocean Echinometra. The currently available morphological keys were found to be limited in their ability to delineate all species within this genus. Nonetheless, morphological similarities between the Red Sea and Western Indian Ocean populations were high, and delimited them from the other species. These latter populations together formed a monophyletic clade, genetically distant from any of the other Echinometra species by more than 3%. Combining both traditional taxonomy and molecular evidence, we found that these populations were neither Echinometra mathaei nor E. oblonga, as previously considered. The morphological discrepancies of these populations, and their genetic divergence from the other Echinometra species, suggest that they should be considered as a new Echinometra species.	[Bronstein, Omri; Loya, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel	Tel Aviv University	Bronstein, O (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	omribronstein@gmail.com	Loya, Joseph/AAJ-9014-2020; Loya, Yossi/J-3039-2012	Loya, Yossi/0000-0001-6870-9444; Bronstein, Omri/0000-0003-2620-3976	Israel Science Foundation (ISF); Raynor Chair for Environmental Conservation Research	Israel Science Foundation (ISF)(Israel Science Foundation); Raynor Chair for Environmental Conservation Research	This research was supported by the Israel Science Foundation (ISF) and the Raynor Chair for Environmental Conservation Research (to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AMY RL, 1983, B MAR SCI, V33, P173; Arakaki Y, 1999, ZOOL SCI, V16, P551, DOI 10.2108/zsj.16.551; Arakaki Y, 1998, ZOOL SCI, V15, P159, DOI 10.2108/zsj.15.159; Berlocher SH, 1998, ENDLESS FORMS, P99; BERMINGHAM E, 1993, P NATL ACAD SCI USA, V90, P2734, DOI 10.1073/pnas.90.7.2734; Blainville H, 1825, DICT SCI NATURELLES; CHIA FS, 1975, AM ZOOL, V15, P553; CLARK AM, 1971, MONOGRAPH SHALLOW WA, P690; FISHELSON L, 1971, MAR BIOL, V10, P113, DOI 10.1007/BF00354828; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Geyer LB, 2003, EVOLUTION, V57, P1049; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KELSO DP, 1970, COMP MORPHOLOGICAL E, P112; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Landry C, 2003, P ROY SOC B-BIOL SCI, V270, P1839, DOI 10.1098/rspb.2003.2395; Lawrence J.M., 1983, Bulletin of the Institute of Oceanography and Fisheries, V9, P141; Lessios HA, 1998, P ROY SOC B-BIOL SCI, V265, P583, DOI 10.1098/rspb.1998.0334; MATSUOKA N, 1991, ZOOL SCI, V8, P121; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; MAYR E, 1954, EVOLUTION, V8, P1, DOI 10.2307/2405661; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; MCCLANAHAN T, 2001, EDIBLE SEA URCHINS B, P297; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; MICHEL C, 1974, NOTES MARINE BIOL ST, P77230; Mortensen T., 1943, MONOGRAPH ECHINOIDEA; Motokawa T., 1991, BIOL ECHINODERMATA, P89; Palumbi SR, 2005, P NATL ACAD SCI USA, V102, P6566, DOI 10.1073/pnas.0501806102; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; PALUMBI SR, 1991, MOL BIOL EVOL, V8, P227; Palumbi SR, 1997, EVOLUTION, V51, P1506, DOI 10.1111/j.1558-5646.1997.tb01474.x; Pochon X, 2001, MAR BIOL, V139, P1069; RAFF RA, 1990, DEV GROWTH DIFFER, V32, P283; Rahman SM, 2004, COMP BIOCHEM PHYS A, V139, P469, DOI 10.1016/j.cbpb.2004.10.005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSO AR, 1977, AUST J MAR FRESH RES, V28, P693; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	40	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77374	10.1371/journal.pone.0077374	http://dx.doi.org/10.1371/journal.pone.0077374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116225	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200116
J	Ganpule-Rao, A; Joglekar, C; Patkar, D; Chinchwadkar, M; Bhat, D; Lubree, H; Rege, S; Uradey, B; Yajnik, C; Yudkin, J				Ganpule-Rao, Anjali; Joglekar, Charudatta; Patkar, Deepak; Chinchwadkar, Manoj; Bhat, Dattatreya; Lubree, Himangi; Rege, Sonali; Uradey, Bhagyashree; Yajnik, Chittaranjan; Yudkin, John			Associations of Trunk Fat Depots with Insulin Resistance, beta Cell Function and Glycaemia - A Multiple Technique Study	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; ABDOMINAL ADIPOSITY; COMPUTED-TOMOGRAPHY; REGIONAL ADIPOSITY; INDIAN MEN; SENSITIVITY; OBESITY; TISSUE; HYPERGLYCEMIA; LIPOTOXICITY	Objective: Central (truncal) adiposity is associated strongly with insulin resistance and diabetes. There are very few reports comparing methods of trunk fat measurement in their ability to predict glycaemia and insulin resistance. We report a comparative analysis of different trunk fat measurements in predicting glycaemia and insulin resistance in middle aged Indian men. Materials and Methods: Trunk fat measurements were performed using anthropometry, magnetic resonance imaging (MRI), dual-energy X-ray absorptiometry (DXA) and computed tomography (CT) on 128 men. Additional measurements were taken to characterise insulin resistance (Matsuda index) and beta cell function (Insulinogenic Index), glycaemia (fasting and 120 min glucose concentrations). Using residual approach we compared the ability of different trunk fat measurement techniques to predict insulin resistance, beta cell function and glycaemia. Results: There was a strong association between trunk fat measures from each technique with glycaemia and insulin resistance indices but not with the Insulinogenic Index. Insulin resistance and glycaemia, were best predicted using anthropometric measurements, notably by waist circumference and subscapular skinfold thickness. Neither MRI measures of trunk or visceral fat nor DXA trunk fat added significantly. CT liver density contributed to some extent to predict insulin resistance and 120 min glucose after anthropometric measurements. Conclusions: Our results suggest that, in Indian men, anthropometric measurements are good predictors of glycaemia and insulin resistance. Other complex measurements such as MRI, DXA and CT make only a small addition to the prediction. This finding supports the application of anthropometry for determining trunk fat in clinical and epidemiological settings.	[Ganpule-Rao, Anjali; Joglekar, Charudatta; Chinchwadkar, Manoj; Bhat, Dattatreya; Lubree, Himangi; Rege, Sonali; Uradey, Bhagyashree; Yajnik, Chittaranjan] KEM Hosp, Diabet Unit, Pune, Maharashtra, India; [Patkar, Deepak] Dr Balabhai Nanavati Hosp, Bombay, Maharashtra, India; [Yudkin, John] UCL, Dept Med, London, England	University of London; University College London	Yajnik, C (corresponding author), KEM Hosp, Diabet Unit, Pune, Maharashtra, India.	diabetes@vsnl.com	Yudkin, John S/C-1988-2008		Nestle Foundation, Lausanne, Switzerland; International Atomic Energy Agency, Vienna, Austria	Nestle Foundation, Lausanne, Switzerland; International Atomic Energy Agency, Vienna, Austria(International Atomic Energy Agency)	The authors thank the Nestle Foundation, Lausanne, Switzerland and the International Atomic Energy Agency, Vienna, Austria for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; ABATE N, 1995, J CLIN INVEST, V96, P88, DOI DOI 10.1172/JCI118083; Abd El Dayem SM, 2012, ANATOL J CARDIOL, V12, P60, DOI 10.5152/akd.2012.014; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALPHA B, 1992, EUR J CLIN CHEM CLIN, V30, P27; Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; [Anonymous], 1999, DPX IQ OP MAN; Banerji MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE425, DOI 10.1152/ajpendo.1997.273.2.E425; Bhat DS, 2005, INT J OBESITY, V29, P842, DOI 10.1038/sj.ijo.0802953; BORKAN GA, 1982, AM J PHYS ANTHROPOL, V58, P307, DOI 10.1002/ajpa.1330580309; Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; dos Santos LC, 2008, SAO PAULO MED J, V126, P82, DOI 10.1590/S1516-31802008000200004; DWYER A, 1983, J COMPUT ASSIST TOMO, V7, P70, DOI 10.1097/00004728-198302000-00012; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Gradmark AMI, 2010, BRIT J NUTR, V104, P582, DOI 10.1017/S0007114510000796; Henderson M, 2011, DIABETES METAB, V37, P72, DOI 10.1016/j.diabet.2010.06.008; Lee CC, 2005, J GERONTOL A-BIOL, V60, P872, DOI 10.1093/gerona/60.7.872; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Racette SB, 2006, DIABETES CARE, V29, P673, DOI 10.2337/diacare.29.03.06.dc05-1605; SHELGIKAR KM, 1991, DIABETIC MED, V8, P712, DOI 10.1111/j.1464-5491.1991.tb01689.x; Snijder MB, 2004, OBES RES, V12, P1370, DOI 10.1038/oby.2004.173; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Stewart Kerry J, 2003, J Cardiopulm Rehabil, V23, P109, DOI 10.1097/00008483-200303000-00008; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Yajnik CS, 2008, DIABETOLOGIA, V51, P39, DOI 10.1007/s00125-007-0847-1; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75391	10.1371/journal.pone.0075391	http://dx.doi.org/10.1371/journal.pone.0075391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116041	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200020
J	Gregory, TM; Sankey, A; Augereau, B; Vandenbussche, E; Amis, A; Emery, R; Hansen, U				Gregory, Thomas M.; Sankey, Andrew; Augereau, Bernard; Vandenbussche, Eric; Amis, Andrew; Emery, Roger; Hansen, Ulrich			Accuracy of Glenoid Component Placement in Total Shoulder Arthroplasty and Its Effect on Clinical and Radiological Outcome in a Retrospective, Longitudinal, Monocentric Open Study	PLOS ONE			English	Article							VERSION; INCLINATION; TOMOGRAPHY	Background: The success of Total Shoulder Arthroplasty (TSA) is believed to depend on the restoration of the natural anatomy of the joint and a key development has been the introduction of modular humeral components to more accurately restore the patient's anatomy. However, there are no peer-reviewed studies that have reported the degree of glenoid component mal-position achieved in clinical practice and the clinical outcome of such mal-position. The main purpose of this study was to assess the accuracy of glenoid implant positioning during TSA and to relate it to the radiological (occurrence of radiolucent lines and osteolysis on CT) and clinical outcomes. Methods: 68 TSAs were assessed with a mean follow-up of 38+/-227 months. The clinical evaluation consisted of measuring the mobility as well as of the Constant Score. The radiological evaluation was performed on CT-scans in which metal artefacts had been eliminated. From the CT-scans radiolucent lines and osteolysis were assessed. The positions of the glenoid and humeral components were also measured from the CT scans. Results: Four position glenoid component parameters were calculated The posterior version (6 degrees +/- 12 degrees; mean +/- SD), the superior tilt (12 degrees +/- 17 degrees), the rotation of the implant relative to the scapular plane (3 degrees +/- 14 degrees) and the off-set distance of the centre of the glenoid implant from the scapular plane (6 +/- 4 mm). An inferiorly inclined implant was found to be associated with higher levels of radiolucent lines while retroversion and non-neutral rotation were associated with a reduced range of motion. Conclusion: this study demonstrates that glenoid implants of anatomic TSA are poorly positioned and that this malposition has a direct effect on the clinical and radiological outcome. Thus, further developments in glenoid implantation techniques are required to enable the surgeon to achieve a desired implant position and outcome.	[Gregory, Thomas M.; Augereau, Bernard; Vandenbussche, Eric] Hop Europeen Georges Pompidou, APHP, Dept Orthopaed Surg, Paris, France; [Gregory, Thomas M.; Amis, Andrew; Emery, Roger; Hansen, Ulrich] Univ London Imperial Coll Sci Technol & Med, London, England; [Sankey, Andrew; Emery, Roger] St Marys Hosp, Dept Orthopaed Surg, London, England; [Emery, Roger] Univ London Imperial Coll Sci Technol & Med, Div Surg, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Imperial College London; Imperial College London	Gregory, TM (corresponding author), Hop Europeen Georges Pompidou, APHP, Dept Orthopaed Surg, Paris, France.	tms.gregory@gmail.com	Hansen, Ulrich/K-3255-2014		Arthritis and Rheumatism Campaign [16326]	Arthritis and Rheumatism Campaign	The authors would like to thank the Arthritis and Rheumatism Campaign, who funded this study (grant reference 16326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi HO, 2008, J BIOMECH, V41, P2144, DOI 10.1016/j.jbiomech.2008.04.028; Bohsali KI, 2006, J BONE JOINT SURG AM, V88A, P2279, DOI 10.2106/JBJS.F.00125; Churchill RS, 2001, J SHOULDER ELB SURG, V10, P327, DOI 10.1067/mse.2001.115269; Favre P, 2008, CLIN BIOMECH, V23, P175, DOI 10.1016/j.clinbiomech.2007.09.009; Franklin J L, 1988, J Arthroplasty, V3, P39, DOI 10.1016/S0883-5403(88)80051-2; Franta AK, 2007, J SHOULDER ELB SURG, V16, P555, DOI 10.1016/j.jse.2006.11.004; FRIEDMAN RJ, 1992, J BONE JOINT SURG AM, V74A, P1032, DOI 10.2106/00004623-199274070-00009; Gregory T, 2007, P I MECH ENG H, V221, P87, DOI 10.1243/09544119JEIM167; Gregory T, 2009, J ORTHOP RES; Gregory T, 2007, 10 INT C SHOULD SURG; Gregory T, 2012, ACTA ORTHOP, V83, P529, DOI 10.3109/17453674.2012.733916; Hempfing A, 2001, J SHOULDER ELB SURG, V10, P460, DOI 10.1067/mse.2001.117127; Hopkins AR, 2004, J SHOULDER ELB SURG, V13, P668, DOI 10.1016/j.jse.2004.04.008; Iannotti JP, 2005, J SHOULDER ELBOW SUR, V12; Kircher J, 2009, J SHOULDER ELB SURG, V18, P515, DOI 10.1016/j.jse.2009.03.014; Konrad GG, 2006, CLIN BIOMECH, V21, P942, DOI 10.1016/j.clinbiomech.2006.04.013; Mole D., 1999, SHOULDER ARTHROPLAST, P163, DOI DOI 10.1007/978-3-642-58365-0_16; Moska MJ, 1998, 7 INT C SHOULD SURG, P5; Nyffeler RW, 2006, J SHOULDER ELB SURG, V15, P625, DOI 10.1016/j.jse.2005.09.016; Nyffeler RW, 2003, J SHOULDER ELB SURG, V12, P493, DOI 10.1016/S1058-2746(03)00181-2; Oosterom R, 2004, CLIN BIOMECH, V19, P1000, DOI 10.1016/j.clinbiomech.2004.07.001; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Rosset C, 2005, J DIGIT IMAGING, V18, P270, DOI 10.1007/s10278-005-6703-2; Terrier A, 2009, J SHOULDER ELB SURG, V18, P515	24	38	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75791	10.1371/journal.pone.0075791	http://dx.doi.org/10.1371/journal.pone.0075791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116075	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200038
J	Sukowati, CHC; Anfuso, B; Torre, G; Francalanci, P; Croce, LS; Tiribelli, C				Sukowati, Caecilia Hapsari Ceriapuri; Anfuso, Beatrice; Torre, Giuliano; Francalanci, Paola; Croce, Lory Saveria; Tiribelli, Claudio			The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study	PLOS ONE			English	Article							CANCER STEM-CELLS; PROGENITOR CELLS; DOWN-REGULATION; LIVER; TRANSPORTER; QUANTIFICATION; POPULATION; INHIBITION; THY-1	Although the CD90 (Thy-1) was proposed as biomarker of several tumors and cancer stem cells, the involvement of this molecule in the progression of hepatocellular carcinoma (HCC) and other less frequent hepatic neoplasms is still undefined. The distribution of CD90 was investigated both in in vivo (human tissues samples) and in vitro (human HCC cell line JHH-6). A total of 67 liver tumors were analyzed: 51 HCC, 6 cholangiocarcinoma and 10 hepatoblastoma. In all cases, paired tissue sample of both the tumor and cirrhotic liver was available. Hepatic tissue obtained in 12 healthy livers was used as control. CD90 gene expression was studied by RT-qPCR, protein expression was assessed by quantitative Western Blot, immunofluorescence and flow cytometry. The CD90 expression analysis showed a significant increment in tumor compared to both its paired cirrhotic tissue and normal liver (p<0.05 and p<0.001, respectively). This increase was accompanied by the up-regulation of stromal component in the cancer, as demonstrated by alpha smooth muscle actin staining. In vitro analysis of JHH-6 cell line showed a higher proliferation capacity of CD90(+) compared to CD90-cells (p<0.001), also noticed in 3D clonogenic assay (p<0.05), associated by a significant higher expression of the promoting factors (hepatocyte growth factor, fibroblast associated protein and alpha smooth muscle actin 2). A higher expression of the breast cancer resistance protein was found in CD90+ subpopulation while the multidrug resistance protein 1 showed an opposite behavior. Collectively, these results point to the importance of CD90 in the HCC.	[Sukowati, Caecilia Hapsari Ceriapuri; Anfuso, Beatrice; Croce, Lory Saveria; Tiribelli, Claudio] Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy; [Torre, Giuliano] Osped Pediat Bambino Gesu, Dept Surg & Transplantat, Hepatol Unit, Rome, Italy; [Francalanci, Paola] Osped Pediat Bambino Gesu, Dept Labs, Rome, Italy; [Sukowati, Caecilia Hapsari Ceriapuri; Croce, Lory Saveria; Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Trieste	Sukowati, CHC (corresponding author), Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy.	caecilia.sukowati@csf.units.it	croce', lory saveria l/E-2565-2011; Francalanci, Paola/AAA-4908-2020; Tiribelli, Claudio/A-4716-2014	croce', lory saveria l/0000-0001-9890-7011; Sukowati, Caecilia/0000-0001-9699-7578; Anfuso, Beatrice/0000-0001-7819-6830; Tiribelli, Claudio/0000-0001-6596-7595	Italian Ministry of Foreign Affairs of the Istituto Italiano di Cultura, Jakarta, Indonesia; Fondazione Umberto Veronesi, Milan, Italy; Fondazione Aldo Duca of the University of Trieste, Italy; grant PORFESR [2000/ISTR/2011]; Italian Liver Foundation	Italian Ministry of Foreign Affairs of the Istituto Italiano di Cultura, Jakarta, Indonesia; Fondazione Umberto Veronesi, Milan, Italy(Fondazione Umberto Veronesi); Fondazione Aldo Duca of the University of Trieste, Italy; grant PORFESR; Italian Liver Foundation	CHCS was supported by fellowships of the Italian Ministry of Foreign Affairs of the Istituto Italiano di Cultura, Jakarta, Indonesia, Fondazione Umberto Veronesi, Milan, Italy, and Fondazione Aldo Duca of the University of Trieste, Italy; BA fellowship was partially supported by grant PORFESR 2007/2013 (2000/ISTR/2011); This work was supported by a grant from the Italian Liver Foundation. The funders had nor role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts. No additional external funding received for this study.	[Anonymous], 2013, OCTOBER, V8; Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cesselli D, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/120925; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Dudas J, 2009, HISTOCHEM CELL BIOL, V131, P115, DOI 10.1007/s00418-008-0503-y; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Ho DWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037159; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Lingala S, 2010, EXP MOL PATHOL, V89, P27, DOI 10.1016/j.yexmp.2010.05.005; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lu JW, 2011, ACTA HISTOCHEM, V113, P833, DOI 10.1016/j.acthis.2011.01.001; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Murakami Koji, 1999, Neoplasia (New York), V1, P424, DOI 10.1038/sj.neo.7900046; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-317; Paulusma CC, 1999, BIOCHEM J, V338, P393, DOI 10.1042/0264-6021:3380393; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SIMONETTI RG, 1991, DIGEST DIS SCI, V36, P962, DOI 10.1007/BF01297149; Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001; True LD, 2010, MODERN PATHOL, V23, P1346, DOI 10.1038/modpathol.2010.122; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu XH, 2011, DIGEST DIS SCI, V56, P252, DOI 10.1007/s10620-010-1256-8; Zen Y, 2007, AM J PATHOL, V170, P1750, DOI 10.2353/ajpath.2007.060798; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946	34	66	75	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76830	10.1371/journal.pone.0076830	http://dx.doi.org/10.1371/journal.pone.0076830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116172	gold, Green Submitted, Green Published			2022-12-27	WOS:000325552200076
J	Crewe, C; Kinter, M; Szweda, LI				Crewe, Clair; Kinter, Michael; Szweda, Luke I.			Rapid Inhibition of Pyruvate Dehydrogenase: An Initiating Event in High Dietary Fat-Induced Loss of Metabolic Flexibility in the Heart	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-OXIDATION; ACID-METABOLISM; EXPRESSION; KINASE-4; STARVATION; ALPHA; CYCLE; DYSFUNCTION; MECHANISMS	Cardiac function depends on the ability to switch between fatty acid and glucose oxidation for energy production in response to changes in substrate availability and energetic stress. In obese and diabetic individuals, increased reliance on fatty acids and reduced metabolic flexibility are thought to contribute to the development of cardiovascular disease. Mechanisms by which cardiac mitochondria contribute to diet-induced metabolic inflexibility were investigated. Mice were fed a high fat or low fat diet for 1 d, 1 wk, and 20 wk. Cardiac mitochondria isolated from mice fed a high fat diet displayed a diminished ability to utilize the glycolytically derived substrate pyruvate. This response was rapid, occurring within the first day on the diet, and persisted for up to 20 wk. A selective increase in the expression of pyruvate dehydrogenase kinase 4 and inhibition of pyruvate dehydrogenase are responsible for the rapid suppression of pyruvate utilization. An important consequence is that pyruvate dehydrogenase is sensitized to inhibition when mitochondria respire in the presence of fatty acids. Additionally, increased expression of pyruvate dehydrogenase kinase 4 preceded any observed diet-induced reductions in the levels of glucose transporter type 4 and glycolytic enzymes and, as judged by Akt phosphorylation, insulin signaling. Importantly, diminished insulin signaling evident at 1 wk on the high fat diet did not occur in pyruvate dehydrogenase kinase 4 knockout mice. Dietary intervention leads to a rapid decline in pyruvate dehydrogenase kinase 4 levels and recovery of pyruvate dehydrogenase activity indicating an additional form of regulation. Finally, an overnight fast elicits a metabolic response similar to that induced by high dietary fat obscuring diet-induced metabolic changes. Thus, our data indicate that diet-induced inhibition of pyruvate dehydrogenase may be an initiating event in decreased oxidation of glucose and increased reliance of the heart on fatty acids for energy production.	[Crewe, Clair; Kinter, Michael; Szweda, Luke I.] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; [Crewe, Clair; Szweda, Luke I.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Kinter, Michael; Szweda, Luke I.] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Reynolds Ctr Aging, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Szweda, LI (corresponding author), Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Luke-Szweda@omrf.org		Kinter, Michael/0000-0001-7409-8918	NIA [R01AG016339]; Oklahoma Medical Research Foundation (OMRF.org); Hille Family Foundation (hillefoundation.org); NATIONAL INSTITUTE ON AGING [R01AG016339] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oklahoma Medical Research Foundation (OMRF.org); Hille Family Foundation (hillefoundation.org); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by a Grant (R01AG016339) from the NIA with additional support from the Oklahoma Medical Research Foundation (OMRF.org) and the Hille Family Foundation (hillefoundation.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIA or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Holness MJ, 2002, BIOCHEM J, V364, P687, DOI 10.1042/bj20011841; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kinter CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050016; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; ORFALI KA, 1993, FEBS LETT, V336, P501, DOI 10.1016/0014-5793(93)80864-Q; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; RANDLE PJ, 1963, LANCET, V1, P785; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Rindler PM, 2013, J BIOL CHEM, V288, P1979, DOI 10.1074/jbc.M112.412890; Rinnankoski-Tuikka R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-53; Rosiers CD, 2011, CARDIOVASC RES, V90, P210, DOI 10.1093/cvr/cvr055; RUSSELL RR, 1991, AM J PHYSIOL, V261, pH1756, DOI 10.1152/ajpheart.1991.261.6.H1756; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Ussher JR, 2009, DIABETES, V58, P1766, DOI 10.2337/db09-0011; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Zhang LY, 2012, FEBS LETT, V586, P996, DOI 10.1016/j.febslet.2012.02.027; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	41	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77280	10.1371/journal.pone.0077280	http://dx.doi.org/10.1371/journal.pone.0077280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116221	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300117
J	Hughes, AD; Bathula, R; Park, C; Tillin, T; Wit, N; Thom, SM; Chaturvedi, N				Hughes, Alun D.; Bathula, Raj; Park, Chloe; Tillin, Therese; Wit, Nicholas; Thom, Simon McG; Chaturvedi, Nish			Microcirculatory Rarefaction in South Asians - A Potential Mechanism for Increased Cardiovascular Risk and Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RETINAL MICROVASCULAR STRUCTURE; CAPILLARY RAREFACTION; ARTERIAL STIFFNESS; VASCULAR CALIBER; WHITE EUROPEANS; VESSEL DIAMETER; BLOOD-PRESSURE; INDIAN ASIANS; ATHEROSCLEROSIS	People of South Asian descent have an increased risk of cardiovascular disease (CVD) and diabetes, but little is known about the microcirculation in South Asian people despite evidence that this plays an important role in the aetiology of CVD. We compared the retinal microcirculation in a population-based sample of 287 middle-aged adults (144 European 143 South Asian) matched for age and sex. Retinal photographs were taken and analysed using a validated semi-automated program and microvascular measures were compared. Blood pressure, anthropometry and fasting bloods were also measured. South Asians had significantly fewer arteriolar and venular vessels and bifurcations. Arterioles and venules were longer and venules were also more tortuous in South Asians. These differences were not explained by adjustment for traditional risk factors including blood pressure, body mass index, diabetes or measures of insulin resistance. People of South Asian descent have rarefaction of the retinal microcirculation compared to age-sex matched individuals of European descent. Reduced microvascular density could contribute to the elevated risk of CVD and impaired glucose tolerance in South Asian people.	[Hughes, Alun D.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, NHLI Div, London, England; Imperial Coll Healthcare NHS Trust, London, England	Imperial College London; Imperial College London	Hughes, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, NHLI Div, London, England.	a.hughes@imperial.ac.uk	Hughes, Alun David/N-3781-2013	Hughes, Alun David/0000-0001-5432-5271; Tillin, Therese/0000-0003-1590-9826; Thom, Simon/0000-0002-3020-1351; Park, Chloe/0000-0001-8302-7484	British Heart Foundation NIHR Biomedical Research Centre Scheme; British Heart Foundation [PG/12/29/29497] Funding Source: researchfish	British Heart Foundation NIHR Biomedical Research Centre Scheme; British Heart Foundation(British Heart Foundation)	Funding came from the British Heart Foundation NIHR Biomedical Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathula R, 2010, DIABETOLOGIA; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Chambers JC, 1999, HEART, V81, P501, DOI 10.1136/hrt.81.5.501; Chapman N, 2001, BRIT J OPHTHALMOL, V85, P74, DOI 10.1136/bjo.85.1.74; Cheung N, 2007, J AM COLL CARDIOL, V50, P48, DOI 10.1016/j.jacc.2007.03.029; Cheung N, 2007, INVEST OPHTH VIS SCI, V48, P1018, DOI 10.1167/iovs.06-0978; Dixon Anthony N, 2006, Diab Vasc Dis Res, V3, P22, DOI 10.3132/dvdr.2006.002; Fischbacher CM, 2003, DIABETIC MED, V20, P31, DOI 10.1046/j.1464-5491.2003.00822.x; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Gunarathne A, 2008, J HYPERTENS, V26, P1420, DOI 10.1097/HJH.0b013e3282ffb42a; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; He FJ, 2010, HYPERTENSION, V56, P253, DOI 10.1161/HYPERTENSIONAHA.110.155747; Hughes A, 2009, MICROCIRCULATION, V16, P159, DOI 10.1080/10739680802353868; Jarrett R J, 1979, Diabetes Care, V2, P175, DOI 10.2337/diacare.2.2.175; Jeganathan VSE, 2009, HYPERTENS RES, V32, P975, DOI 10.1038/hr.2009.130; Jeganathan VSE, 2009, MICROCIRCULATION, V16, P534, DOI 10.1080/10739680902975222; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mahal S, 2009, CLIN SCI, V117, P229, DOI 10.1042/CS20080538; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MEYER LC, 1994, DIABETIC MED, V11, P670; Nama V, 2011, J HUM HYPERTENS, V25, P465, DOI 10.1038/jhh.2011.1; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; O'Brien, 1996, Blood Press Monit, V1, P55; Owen CG, 2011, ARTERIOSCL THROM VAS, V31, P1933, DOI 10.1161/ATVBAHA.111.225219; Park C, 2012, ATHEROSCLEROSIS, V221, P503, DOI 10.1016/j.atherosclerosis.2011.11.025; Patel SR, 2011, BRIT J OPHTHALMOL, V95, P1573, DOI 10.1136/bjo.2010.201665; Pradeepa R, 2008, DIABETIC MED, V25, P536, DOI 10.1111/j.1464-5491.2008.02423.x; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; Serne EH, 2001, CARDIOVASC RES, V49, P161, DOI 10.1016/S0008-6363(00)00198-X; Stolk RP, 2008, DIABETES CARE, V31, P708, DOI 10.2337/dc07-1657; Tapp RJ, 2007, PEDIATRICS, V120, pE1225, DOI 10.1542/peds.2006-2951; Tapp RJ, 2013, MICROCIRCULATION, V20, P609, DOI 10.1111/micc.12060; Taylor B, 2007, INT J OBESITY, V31, P1527, DOI 10.1038/sj.ijo.0803674; Tillin T, 2008, DIABETOLOGIA, V51, P1719, DOI 10.1007/s00125-008-1096-7; Tillin T, 2005, J AM SOC NEPHROL, V16, P3702, DOI 10.1681/ASN.2005060584; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Tillin T, 2013, DIABETES CARE, V36, P383, DOI 10.2337/dc12-0544; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wang L, 2008, HYPERTENSION, V51, P119, DOI 10.1161/HYPERTENSIONAHA.107.098343; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wong TY, 2008, AM J EPIDEMIOL, V167, P51, DOI 10.1093/aje/kwm256; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P301, DOI 10.1136/bjo.2005.084400; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153	44	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76680	10.1371/journal.pone.0076680	http://dx.doi.org/10.1371/journal.pone.0076680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116136	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300078
J	Middlebrooks, JC; Nick, HS; Subramony, SH; Advincula, J; Rosales, RL; Lee, LV; Ashizawa, T; Waters, MF				Middlebrooks, John C.; Nick, Harry S.; Subramony, S. H.; Advincula, Joel; Rosales, Raymond L.; Lee, Lillian V.; Ashizawa, Tetsuo; Waters, Michael F.			Mutation in the Kv3.3 Voltage-Gated Potassium Channel Causing Spinocerebellar Ataxia 13 Disrupts Sound-Localization Mechanisms	PLOS ONE			English	Article							NEURONAL EXCITABILITY; INTERAURAL PHASE; SUPERIOR OLIVE; MEDIAL NUCLEUS; TRAPEZOID BODY; MOUSE-BRAIN; EXPRESSION; SUBUNITS; SYSTEM; CUES	Normal sound localization requires precise comparisons of sound timing and pressure levels between the two ears. The primary localization cues are interaural time differences, ITD, and interaural level differences, ILD. Voltage-gated potassium channels, including Kv3.3, are highly expressed in the auditory brainstem and are thought to underlie the exquisite temporal precision and rapid spike rates that characterize brainstem binaural pathways. An autosomal dominant mutation in the gene encoding Kv3.3 has been demonstrated in a large Filipino kindred manifesting as spinocerebellar ataxia type 13 (SCA13). This kindred provides a rare opportunity to test in vivo the importance of a specific channel subunit for human hearing. Here, we demonstrate psychophysically that individuals with the mutant allele exhibit profound deficits in both ITD and ILD sensitivity, despite showing no obvious impairment in pure-tone sensitivity with either ear. Surprisingly, several individuals exhibited the auditory deficits even though they were pre-symptomatic for SCA13. We would expect that impairments of binaural processing as great as those observed in this family would result in prominent deficits in localization of sound sources and in loss of the "spatial release from masking" that aids in understanding speech in the presence of competing sounds.	[Middlebrooks, John C.] Univ Calif Irvine, Dept Otolaryngol, Irvine, CA USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Middlebrooks, John C.] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA; [Nick, Harry S.; Subramony, S. H.; Ashizawa, Tetsuo; Waters, Michael F.] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Subramony, S. H.] Univ Florida, Coll Med, Dept Neurol, McKnight Brain Inst, Gainesville, FL 32611 USA; [Advincula, Joel] Western Visayas State Univ Med Ctr, Iloilo, Philippines; [Rosales, Raymond L.] Univ Santo Tomas, Dept Neurol & Psychiat, Manila, Philippines; [Lee, Lillian V.] Philippine Childrens Med Ctr, Child Neurosci Ctr, Quezon City, Philippines	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Santo Tomas	Waters, MF (corresponding author), Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA.	mwaters@neurology.ufl.edu			NIH NIDCD [RO1 DC000420]; NIH NINDS [K23 NS054715]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS054715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000420] Funding Source: NIH RePORTER	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH NIDCD RO1 DC000420 (to JCM), NIH NINDS K23 NS054715 (to MFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059815; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Cherry CE, 1953, J ACOUST SOC AM, V25, P975, DOI [10.1121/1.1907229, DOI 10.1121/1.1907229]; Grigg JJ, 2000, HEARING RES, V140, P77, DOI 10.1016/S0378-5955(99)00187-2; GUINAN JJ, 1972, INT J NEUROSCI, V4, P147, DOI 10.3109/00207457209164756; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kidd G, 2008, J ACOUST SOC AM, V124, P3793, DOI 10.1121/1.2998980; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li W, 2001, J COMP NEUROL, V437, P196, DOI 10.1002/cne.1279; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Middlebrooks JC, 2012, J ACOUST SOC AM, V132, P3896, DOI 10.1121/1.4764879; MILLS AW, 1960, J ACOUST SOC AM, V32, P132, DOI 10.1121/1.1907864; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Strutt JW, 1907, PHILOS MAG, V13, P214, DOI DOI 10.1080/14786440709463595; Subramony SH, 2013, CEREBELLUM; Tollin DJ, 2005, J NEUROSCI, V25, P10648, DOI 10.1523/JNEUROSCI.1609-05.2005; Tong HX, 2010, J PHYSIOL-LONDON, V588, P1451, DOI 10.1113/jphysiol.2009.186676; Tsuchitani C, 1997, HEARING RES, V105, P211, DOI 10.1016/S0378-5955(96)00212-2; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498; YOST WA, 1974, J ACOUST SOC AM, V55, P1299, DOI 10.1121/1.1914701; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	28	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76749	10.1371/journal.pone.0076749	http://dx.doi.org/10.1371/journal.pone.0076749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116147	Green Published, gold			2022-12-27	WOS:000325501300089
J	Rodriguez-Perez, MA; Adeleke, MA; Burkett-Cadena, ND; Garza-Hernandez, JA; Reyes-Villanueva, F; Cupp, EW; Toe, L; Salinas-Carmona, MC; Rodriguez-Ramirez, AD; Katholi, CR; Unnasch, TR				Rodriguez-Perez, Mario A.; Adeleke, Monsuru A.; Burkett-Cadena, Nathan D.; Garza-Hernandez, Javier A.; Reyes-Villanueva, Filiberto; Cupp, Eddie W.; Toe, Laurent; Salinas-Carmona, Mario C.; Rodriguez-Ramirez, Americo D.; Katholi, Charles R.; Unnasch, Thomas R.			Development of a Novel Trap for the Collection of Black Flies of the Simulium ochraceum Complex	PLOS ONE			English	Article							ONCHOCERCA-VOLVULUS TRANSMISSION; DAMNOSUM SL; IVERMECTIN TREATMENT; DIPTERA-SIMULIIDAE; BITING ACTIVITY; ENDEMIC FOCI; 1ST EVIDENCE; ELIMINATION; DISEASE; ATTRACTION	Background: Human landing collections are currently the standard method for collecting onchocerciasis vectors in Africa and Latin America. As part of the efforts to develop a trap to replace human landing collections for the monitoring and surveillance of onchocerciasis transmission, comprehensive evaluations of several trap types were conducted to assess their ability to collect Simulium ochraceum sensu lato, one of the principal vectors of Onchocerca volvulus in Latin America. Methodology/Principal Findings: Diverse trap designs with numerous modifications and bait variations were evaluated for their abilities to collect S. Ochraceum s.l. females. These traps targeted mostly host seeking flies. A novel trap dubbed the "Esperanza window trap" showed particular promise over other designs. When baited with CO2 and BG-lure (a synthetic blend of human odor components) a pair of Esperanza window traps collected numbers of S. Ochraceum s.l. females similar to those collected by a team of vector collectors. Conclusions/Significance: The Esperanza window trap, when baited with chemical lures and CO2 can be used to collect epidemiologically significant numbers of Simulium ochraceum s.l., potentially serving as a replacement for human landing collections for evaluation of the transmission of O. volvulus.	[Rodriguez-Perez, Mario A.; Garza-Hernandez, Javier A.; Reyes-Villanueva, Filiberto] Inst Politecn Nacl, Ctr Biotecnol Genom, Reynosa, Tamaulipas, Mexico; [Rodriguez-Perez, Mario A.; Salinas-Carmona, Mario C.] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Nuevo Leon, Mexico; [Adeleke, Monsuru A.] Osun State Univ, Dept Biol Sci, Osogbo, Nigeria; [Burkett-Cadena, Nathan D.; Unnasch, Thomas R.] Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA; [Cupp, Eddie W.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Toe, Laurent] World Hlth Org, Multidis Surveillance Ctr, Ouagadougou, Burkina Faso; [Rodriguez-Ramirez, Americo D.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Katholi, Charles R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Nuevo Leon; State University System of Florida; University of South Florida; Auburn University System; Auburn University; World Health Organization; Instituto Nacional de Salud Publica; University of Alabama System; University of Alabama Birmingham	Unnasch, TR (corresponding author), Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA.	tunnasch@health.usf.edu	Salinas-Carmona, Mario C/Y-2456-2019; Perez, Mario A. Rodriguez/AAH-3572-2020; Rodriguez-Perez, Mario A./P-8814-2014; Garza-Hernandez, Javier A./AAQ-6167-2021	Salinas-Carmona, Mario C/0000-0002-4239-7363; Perez, Mario A. Rodriguez/0000-0002-0905-6073; Rodriguez-Perez, Mario A./0000-0002-0905-6073; Garza-Hernandez, Javier A./0000-0001-9580-2126; Adeleke, Monsuru/0000-0001-7447-3220; Burkett-Cadena, Nathan/0000-0001-6168-1637	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Financial support for this work was provided by The Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basanez MG, 2007, T ROY SOC TROP MED H, V101, P256, DOI 10.1016/j.trstmh.2006.08.009; Basanez MG, 1998, J MED ENTOMOL, V35, P745, DOI 10.1093/jmedent/35.5.745; BELLEC C, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P209; Bellec C, 1974, METHODES ECHANTILLON; Biogents, 2013, BG LUR MOSQ LUR PROF; Biogents, 2008, MAT SAF DAT SHEET BG; BRADBURY WC, 1974, CAN J ZOOL, V52, P251, DOI 10.1139/z74-030; BRIGHTWELL R, 1991, MED VET ENTOMOL, V5, P153, DOI 10.1111/j.1365-2915.1991.tb00536.x; COLLINS RC, 1981, AM J TROP MED HYG, V30, P728, DOI 10.4269/ajtmh.1981.30.728; Crosskey R.W., 1990, NATURAL HIST BLACKFL; Cupp EW, 2011, ACTA TROP, V120, pS100, DOI 10.1016/j.actatropica.2010.08.009; CUPP EW, 1979, AM J TROP MED HYG, V28, P422, DOI 10.4269/ajtmh.1979.28.422; Dar SC, 1984, MOSQ NEWS, V44, P79; DAVIES JB, 1981, TROPENMED PARASITOL, V32, P17; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DISLICH H, 1979, ANGEW CHEM INT EDIT, V18, P49, DOI 10.1002/anie.197900491; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; GREEN CH, 1988, B ENTOMOL RES, V78, P591, DOI 10.1017/S0007485300015443; GUERENSTEIN PG, 1995, EXPERIENTIA, V51, P834, DOI 10.1007/BF01922439; HRIBAR LJ, 1991, J MED ENTOMOL, V28, P874, DOI 10.1093/jmedent/28.6.874; Jacobi CA, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-53; JONSSON E, 1986, FRESHWATER BIOL, V16, P711, DOI 10.1111/j.1365-2427.1986.tb01012.x; Katabarwa Moses N, 2012, J Parasitol Res, V2012, P748540, DOI 10.1155/2012/748540; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Lindblade KA, 2007, AM J TROP MED HYG, V77, P334, DOI 10.4269/ajtmh.2007.77.334; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; PORTER CH, 1988, AM J TROP MED HYG, V39, P567, DOI 10.4269/ajtmh.1988.39.567; PORTER CH, 1988, AM J TROP MED HYG, V38, P153, DOI 10.4269/ajtmh.1988.38.153; PORTER CH, 1988, AM J TROP MED HYG, V38, P142, DOI 10.4269/ajtmh.1988.38.142; Program Coordinating Comm OEPA Sta, 2012, RES REP TROP MED, V3, P21, DOI 10.2147/RRTM.S30482; PROST A, 1986, T ROY SOC TROP MED H, V80, P525, DOI 10.1016/0035-9203(86)90129-X; Rodriguez-Perez M, 2013, DROSOPHILA INF SERV, V7, pe2133; Rodriguez-Perez MA, 2008, AM J TROP MED HYG, V79, P239, DOI 10.4269/ajtmh.2008.79.239; Rodriguez-Perez MA, 2008, AM J TROP MED HYG, V78, P147, DOI 10.4269/ajtmh.2008.78.147; Sauerbrey M, 2008, ANN TROP MED PARASIT, V102, P25, DOI 10.1179/136485908X337454; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; THOMPSON BH, 1977, TROPENMED PARASITOL, V28, P83; THOMPSON BH, 1977, TROPENMED PARASITOL, V28, P226; THOMPSON BH, 1976, TROPENMED PARASITOL, V27, P455; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; WALSH JF, 1980, TROPENMED PARASITOL, V31, P479; WALSH JF, 1978, T ROY SOC TROP MED H, V72, P675, DOI 10.1016/0035-9203(78)90039-1; World Health Organization, 1995, 852 WHO EXP COMM; World Health Organization, 2001, WHOCDSCPECEE200118A, P64	46	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76814	10.1371/journal.pone.0076814	http://dx.doi.org/10.1371/journal.pone.0076814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116169	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300100
J	Boggavarapu, R; Jeckelmann, JM; Harder, D; Schneider, P; Ucurum, Z; Hediger, M; Fotiadis, D				Boggavarapu, Rajendra; Jeckelmann, Jean-Marc; Harder, Daniel; Schneider, Philipp; Ucurum, Zoehre; Hediger, Matthias; Fotiadis, Dimitrios			Expression, Purification and Low-Resolution Structure of Human Vitamin C Transporter SVCT1 (SLC23A1)	PLOS ONE			English	Article							FAMILY	Expression and purification of human membrane proteins for structural studies represent a great challenge. This is because micro-to milligram amounts of pure isolated protein are required. To this aim, we successfully expressed the human vitamin C transporter-1 (hSVCT1; SLC23A1) in Xenopus laevis oocytes and isolated highly pure protein in microgram amounts. Recombinant hSVCT1 was functional when expressed in oocytes and glycosylated. Structural analysis of purified hSVCT1 by transmission electron microscopy and single particle analysis unveiled its shape, dimensions and low-resolution structure as well as the existence of a major monomeric and minor dimeric population. Chemical crosslinking of isolated oocyte membranes containing expressed hSVCT1 indicated similar oligomeric states of hSVCT1 in lipid bilayers. This work reports the first purification and structural analysis of a human SVCT protein and opens the way for future functional and structural studies using purified hSVCT1.	[Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; Univ Bern, Swiss Natl Ctr Competence Res NCCR TransCure, Bern, Switzerland	University of Bern; University of Bern	Fotiadis, D (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	dimitrios.fotiadis@ibmm.unibe.ch		Harder, Daniel/0000-0003-4226-9748; Jeckelmann, Jean-Marc/0000-0001-9973-2700; Hediger, Matthias/0000-0003-1946-027X; Boggavarapu, Venkata/0000-0001-6312-5722	University of Bern; Swiss National Science Foundation [31003A_125150, 31003A_144168]; European Science Foundation [09-EuroSYNBIO-FP-012 NANOCELL]; National Centre of Competence in Research (NCCR) TransCure	University of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); National Centre of Competence in Research (NCCR) TransCure(Swiss National Science Foundation (SNSF))	This research has been supported by the University of Bern, the Swiss National Science Foundation (Grants 31003A_125150 and 31003A_144168 to DF), the European Science Foundation (Grant 09-EuroSYNBIO-FP-012 NANOCELL to DF), and the National Centre of Competence in Research (NCCR) TransCure (to DF and MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021901; BLOCK G, 1991, AM J CLIN NUTR, V53, pS270, DOI 10.1093/ajcn/53.1.270S; Burzle M, 2013, MOL ASPECTS MED, V34, P436, DOI 10.1016/j.mam.2012.12.002; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Erichsen HC, 2006, AM J EPIDEMIOL, V163, P245, DOI 10.1093/aje/kwj035; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Hong SW, 2013, ONCOGENE, V32, P1508, DOI 10.1038/onc.2012.176; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo SH, 2011, INT J PHARMACEUT, V414, P77, DOI 10.1016/j.ijpharm.2011.05.001; Mackenzie B, 2008, AM J PHYSIOL-CELL PH, V294, pC451, DOI 10.1152/ajpcell.00439.2007; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Patak P, 2004, ENDOCR RES, V30, P871, DOI 10.1081/ERC-200044126; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Velho AM, 2009, EXP CELL RES, V315, P2312, DOI 10.1016/j.yexcr.2009.04.007; Verrax J, 2008, BIOCHEM PHARMACOL, V76, P1644, DOI 10.1016/j.bcp.2008.09.024; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929	20	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76427	10.1371/journal.pone.0076427	http://dx.doi.org/10.1371/journal.pone.0076427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124560	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100117
J	Chatterjee, R; Halder, PK; Datta, S				Chatterjee, Rakesh; Halder, Pranab Kumar; Datta, Saumen			Identification and Molecular Characterization of YsaL (Ye3555): A Novel Negative Regulator of YsaN ATPase in Type Three Secretion System of Enteropathogenic Bacteria Yersinia enterocolitica	PLOS ONE			English	Article							III SECRETION; FLAGELLAR EXPORT; OUTER PROTEINS; SALMONELLA; VIRULENCE; FLIH; COMPONENT; CHAPERONE; COMPLEX; LOCUS	Type Three Secretion (T3S) ATPases are involved in delivery of virulent factors from bacteria to their hosts (through injectisome) in an energy (ATP) dependent manner during pathogenesis. The activities of these ATPases are tightly controlled by their specific regulators. In Yersinia enterocolitica, YsaN was predicted as a putative ATPase of the Ysa-Ysp Type Three Secretion System (T3SS) based on sequence similarity with other T3S ATPases. However detailed study and characterization of YsaN and its regulation remains largely obscure. Here, in this study, we have successfully cloned, over-expressed, purified and characterized the molecular properties of YsaN from Yersinia enterocolitica. YsaN acts as a Mg2+ dependent ATPase and exists in solution as higher order oligomer (dodecamer). The ATPase activity of oligomeric YsaN is several fold higher than the monomeric form. Furthermore, by employing in silico studies we have identified the existence of a negative regulator of YsaN- a hypothetical protein YE3555 (termed 'YsaL'). To verify the functionality of YsaL, we have evaluated the biochemical and biophysical properties of YsaL. Purified YsaL is dimeric in solution and strongly associates with YsaN to form a stable heterotrimeric YsaL-YsaN complex (stoichiometry-2:1). The N terminal 6-20 residues of YsaN are invariably required for stable YsaL-YsaN complex formation. YsaL inhibited the ATPase activity of YsaN with a maximum inhibition at the molar ratio 2:1 (YsaL:YsaN). In short, our studies provide an insight into the presence of YsaN ATPase in Yersinia enterocolitica and its regulator YsaL. Our studies also correlate the functionality of one of the existing protein interaction networks that possibly is indispensable for the energy dependent process of Ysa-Ysp T3SS in pathogenic Yersinia enterocolitica.	[Chatterjee, Rakesh; Halder, Pranab Kumar; Datta, Saumen] Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Datta, S (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India.	saumen_datta@iicb.res.in		Chatterjee, Rakesh/0000-0003-0501-4252; Chatterjee, Rakesh/0000-0003-4430-9491	Department of Science and Technology (DST), Government of India; CSIR; UGC	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India)	This project was funded by Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are also thankful to the Council of scientific and Industrial Research (CSIR), Government of India. The authors also are grateful to Prof. Siddhartha Roy, Director, CSIR-Indian Institute of Chemical Biology (CSIR-IICB). CSIR fellowship to Rakesh Chatterjee and UGC fellowship to Pranab Kumar Halder.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Biemans-Oldehinkel E, 2011, J BACTERIOL, V193, P5514, DOI 10.1128/JB.05235-11; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Foultier B, 2003, INFECT IMMUN, V71, P242, DOI 10.1128/IAI.71.1.242-253.2003; Foultier B, 2002, J MOL EVOL, V55, P37, DOI 10.1007/s00239-001-0089-7; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; HUANG HC, 1995, MOL PLANT MICROBE IN, V8, P733, DOI 10.1094/MPMI-8-0733; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Iwobi A, 2003, INFECT IMMUN, V71, P1872, DOI 10.1128/IAI.71.4.1872-1879.2003; Jenks PJ, 1997, FEMS MICROBIOL LETT, V152, P205, DOI 10.1016/S0378-1097(97)00170-5; Kosarewicz A, 2012, PHILOS T R SOC B, V367, P1140, DOI 10.1098/rstb.2011.0205; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; Laukkanen R, 2010, J APPL MICROBIOL, V108, P956, DOI 10.1111/j.1365-2672.2009.04494.x; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Okabe M, 2009, FEBS LETT, V583, P743, DOI 10.1016/j.febslet.2009.01.026; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Pastor A, 2005, FEMS MICROBIOL LETT, V253, P95, DOI 10.1016/j.femsle.2005.09.028; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; Snellings NJ, 2001, INFECT IMMUN, V69, P4627, DOI 10.1128/IAI.69.7.4627-4638.2001; Stone CB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00021; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trost B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-72; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75028	10.1371/journal.pone.0075028	http://dx.doi.org/10.1371/journal.pone.0075028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124464	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100021
J	Egeland, J; Aarlien, AK; Saunes, BK				Egeland, Jens; Aarlien, Anne Kristine; Saunes, Brit-Kari			Few Effects of Far Transfer of Working Memory Training in ADHD: A Randomized Controlled Trial	PLOS ONE			English	Article							CHILDREN; ATTENTION; METHYLPHENIDATE; STRENGTHS	Objective: Studies have shown that children with ADHD profit from working memory training, although few studies have investigated transfer effects comprehensively. The current Randomized Controlled Trial analyzes transfer to other neuropsychological (NP) domains, academic performance and everyday functioning at home and school. Method: Sixty-seven children with ADHD were randomized into a control group or a training group. The training group underwent Cogmed's RoboMemo program. All participants were assessed pre-training, immediately after and eight months later with a battery of NP tests, measures of mathematical and reading skills, as well as rating scales filled out by parents and teachers. Results: There was a significant training effect in psychomotor speed, but not to any other NP measures. Reading and mathematics were improved. There were no training induced changes in symptom rating scales either at home or at school. The increased reading scores remained significant eight months later. Conclusion: The study is the most comprehensive study of transfer effects to date, and with mixed results compared to previous research. More research is needed regarding how to improve the training program and the conditions and thresholds for successful training.	[Egeland, Jens; Aarlien, Anne Kristine] Vestfold Hosp Trust, Div Mental Hlth & Addict, Tonsberg, Norway; [Egeland, Jens] Univ Oslo, Dept Psychol, Oslo, Norway; [Saunes, Brit-Kari] Telemark Hosp Trust, Div Adolescent & Child, Skien, Norway	University of Oslo; Telemark Hospital Trust	Egeland, J (corresponding author), Vestfold Hosp Trust, Div Mental Hlth & Addict, Tonsberg, Norway.	jens.egeland@siv.no			Centre for child and Adolescent Mental Health, Eastern & Southern Norway; Norwegian Resource Center for ADHD, Tourette and Narcolepsy	Centre for child and Adolescent Mental Health, Eastern & Southern Norway; Norwegian Resource Center for ADHD, Tourette and Narcolepsy	The study has been funded with grants from the Centre for child and Adolescent Mental Health, Eastern & Southern Norway and from The Norwegian Resource Center for ADHD, Tourette and Narcolepsy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway TP, 2011, COGNITIVE DEVELOPMENT AND WORKING MEMORY: A DIALOGUE BETWEEN NEO-PIAGETIAN THEORIES AND COGNITIVE APPROACHES, P233; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beck SJ, 2010, J CLIN CHILD ADOLESC, V39, P825, DOI 10.1080/15374416.2010.517162; Blum NJ, 2011, DEV MED CHILD NEUROL, V53, P843, DOI 10.1111/j.1469-8749.2011.03944.x; Conners C., 2002, CPT 2 CONTINUOUS PER; Connolly AJ, 1998, KEY MATH 1998 DIAGNO; Dahlin KIE, 2011, READ WRIT, V24, P479, DOI 10.1007/s11145-010-9238-y; Delis DC, 2001, DELIS KAPLAN EXECUTI; DuPaul G. J., 1998, ADHD RATING SCALE 4; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; Egeland J, 2011, CONT TRENDS ADHD RES, P69; Egeland J, 2010, J ATTEN DISORD, V13, P347, DOI 10.1177/1087054709332477; Egeland J, 2009, SCAND J PSYCHOL, V50, P347, DOI 10.1111/j.1467-9450.2009.00717.x; Egeland J, 2010, J ATTEN DISORD, V13, P339, DOI 10.1177/1087054708323019; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Fallmyr O., 2011, TIDSSKRIFT NORSK PSY, V48, P339; Gioya GA, 2000, BRIEF BEHAV RATING I; Golden C.J., 1978, STROOP COLOR WORD TE; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hoien T., 2005, LOGOS; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF2; Holmes J, 2010, APPL COGNITIVE PSYCH, V24, P827, DOI 10.1002/acp.1589; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2012, J APPL RES MEM COGN, V1, P194, DOI 10.1016/j.jarmac.2012.07.004; Logie RH, 2012, J APPL RES MEM COGN, V1, P206, DOI 10.1016/j.jarmac.2012.07.006; Lohaugen GCC, 2011, J PEDIATR-US, V158, P555, DOI 10.1016/j.jpeds.2010.09.060; Loosli SV, 2012, CHILD NEUROPSYCHOL, V18, P62, DOI 10.1080/09297049.2011.575772; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Miyake A., 1999, MODELS WORKING MEMOR; Novais P, 2009, COGMED ARBETSMINNETR; Pietrzak RH, 2006, NEUROSCI BIOBEHAV R, V30, P1225, DOI 10.1016/j.neubiorev.2006.10.002; Reitan RM, 1992, TRAIL MAKING TEST MA; Rhodes SM, 2006, J CHILD PSYCHOL PSYC, V47, P1184, DOI 10.1111/j.1469-7610.2006.01633.x; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Sivan A.B., 1992, BENTON VISUAL RETENT; Talley JL, 1993, CAVLT 2 CHILDRENS AU; Wechsler D., 2011, WASI 2 WECHSLER ABBR; World Health Organization, 1992, ICD 10 CLASSIFICATIO	42	62	66	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75660	10.1371/journal.pone.0075660	http://dx.doi.org/10.1371/journal.pone.0075660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124503	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100060
J	Fruzangohar, M; Kroeger, TA; Adelson, DL				Fruzangohar, Mario; Kroeger, Trent A.; Adelson, David L.			Improved Part-of-Speech Prediction in Suffix Analysis	PLOS ONE			English	Article								Motivation: Predicting the part of speech (POS) tag of an unknown word in a sentence is a significant challenge. This is particularly difficult in biomedicine, where POS tags serve as an input to training sophisticated literature summarization techniques, such as those based on Hidden Markov Models (HMM). Different approaches have been taken to deal with the POS tagger challenge, but with one exception - the TnT POS tagger - previous publications on POS tagging have omitted details of the suffix analysis used for handling unknown words. The suffix of an English word is a strong predictor of a POS tag for that word. As a pre-requisite for an accurate HMM POS tagger for biomedical publications, we present an efficient suffix prediction method for integration into a POS tagger. Results: We have implemented a fully functional HMM POS tagger using experimentally optimised suffix based prediction. Our simple suffix analysis method, significantly outperformed the probability interpolation based TnT method. We have also shown how important suffix analysis can be for probability estimation of a known word (in the training corpus) with an unseen POS tag; a common scenario with a small training corpus. We then integrated this simple method in our POS tagger and determined an optimised parameter set for both methods, which can help developers to optimise their current algorithm, based on our results. We also introduce the concept of counting methods in maximum likelihood estimation for the first time and show how counting methods can affect the prediction result. Finally, we describe how machine-learning techniques were applied to identify words, for which prediction of POS tags were always incorrect and propose a method to handle words of this type. Availability and Implementation: Java source code, binaries and setup instructions are freely available at http://genomes.sapac.edu.au/text_mining/pos_tagger.zip.	[Fruzangohar, Mario; Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Kroeger, Trent A.] Univ Adelaide, Sch Comp Sci, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Adelson, DL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011	Adelson, David L/0000-0003-2404-5636				Brants T, 2000, 6TH APPLIED NATURAL LANGUAGE PROCESSING CONFERENCE/1ST MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE AND PROCEEDINGS OF THE ANLP-NAACL 2000 STUDENT RESEARCH WORKSHOP, P224; BRILL E, 1992, THIRD CONFERENCE ON APPLIED NATURAL LANGUAGE PROCESSING, P152, DOI 10.3115/974499.974526; Chen SF, 1999, COMPUT SPEECH LANG, V13, P359, DOI 10.1006/csla.1999.0128; CUTTING D, 1992, THIRD CONFERENCE ON APPLIED NATURAL LANGUAGE PROCESSING, P133; Dimitris G, 2004, LECT NOTES COMPUT SC, V3025, P371; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Hahn U, 2004, LECT NOTES ARTIF INT, V3157, P852; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Merialdo B., 1994, Computational Linguistics, V20, P155; NCBI, 2011, PUBMED J; Padro M, 2004, LECT NOTES ARTIF INT, V3230, P127; Ratnaparkhi Adwait, 1996, C EMP METH NAT LANG; Smith L. H., 2006, Natural Language Engineering, V12, P335, DOI 10.1017/S13513249050039671; Sutton C, 2004, DYNAMIC CONDITIONAL, P99; Toutanova K, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P252, DOI 10.3115/1073445.1073478	15	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76042	10.1371/journal.pone.0076042	http://dx.doi.org/10.1371/journal.pone.0076042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124532	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100089
J	Li, XL; Cao, J; Wang, SP; Geng, ZR; Song, XL; Hu, X; Wang, ZL				Li, Xiangli; Cao, Jing; Wang, Shuping; Geng, Zhirong; Song, Xiaoli; Hu, Xin; Wang, Zhilin			Residues in Human Arsenic (+3 Oxidation State) Methyltransferase Forming Potential Hydrogen Bond Network around S-adenosylmethionine	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SITE-DIRECTED MUTAGENESIS; CIRCULAR-DICHROISM; DIMETHYLARSINOUS ACID; CYSTEINE RESIDUES; INFRARED-SPECTRA; METHYLATION; RAT; BINDING; HAS3MT	Residues Tyr59, Gly78, Ser79, Met103, Gln107, Ile136 and Glu137 in human arsenic (+3 oxidation state) methyltransferase (hAS3MT) were deduced to form a potential hydrogen bond network around S-adenosylmethionine (SAM) from the sequence alignment between Cyanidioschyzon merolae arsenite S-adenosylmethyltransferase (CmArsM) and hAS3MT. Herein, seven mutants Y59A, G78A, S79A, M103A, Q107A, I136A and E137A were obtained. Their catalytic activities and conformations were characterized and models were built. Y59A and G78A were completely inactive. Only 7.0%, 10.6% and 13.8% inorganic arsenic (iAs) was transformed to monomethylated arsenicals (MMA) when M103A, Q107A and I136A were used as the enzyme. The V-max (the maximal velocity of the reaction) values of M103A, Q107A, I136A and E137A were decreased to 8%, 22%, 15% and 50% of that of WT-hAS3MT, respectively. The K-M(SAM) (the Michaelis constant for SAM) values of mutants M103A, I136A and E137A were 15.7, 8.9 and 5.1 fold higher than that of WT-hAS3MT, respectively, indicating that their affinities for SAM were weakened. The altered microenvironment of SAM and the reduced capacity of binding arsenic deduced from K-M(As) (the Michaelis constant for iAs) value probably synergetically reduced the catalytic activity of Q107A. The catalytic activity of S79A was higher than that of WT despite of the higher K-M(SAM), suggesting that Ser79 did not impact the catalytic activity of hAS3MT. In short, residues Tyr59 and Gly78 significantly influenced the catalytic activity of hAS3MT as well as Met103, Ile136 and Glu137 because they were closely associated with SAM-binding, while residue Gln107 did not affect SAM-binding regardless of affecting the catalytic activity of hAS3MT. Modeling and our experimental results suggest that the adenine ring of SAM is sandwiched between Ile136 and Met103, the amide group of SAM is hydrogen bonded to Gly78 in hAS3MT and SAM is bonded to Tyr59 with van der Waals, cation-pi and hydrogen bonding contacts.	[Li, Xiangli; Cao, Jing; Wang, Shuping; Geng, Zhirong; Wang, Zhilin] Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China; [Song, Xiaoli] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou, Peoples R China; [Hu, Xin] Nanjing Univ, Modern Anal Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Yangzhou University; Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Hu, Xin/B-1792-2009; Geng, Zhirong/HGC-1447-2022	Hu, Xin/0000-0003-3400-554X; Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21075064, 21027013, 21021062, 21275072, 21201101]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Basic Research Program of China (2013CB922102) and the National Natural Science Foundation of China (21075064, 21027013, 21021062, 21275072 and 21201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Aposhian HV, 1997, ANNU REV PHARMACOL, V37, P397, DOI 10.1146/annurev.pharmtox.37.1.397; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHALLENGER F, 1945, CHEM REV, V36, P315, DOI 10.1021/cr60115a003; Chen YC, 2003, J OCCUP ENVIRON MED, V45, P241, DOI 10.1097/01.jom.0000058336.05741.e8; Cleland W. W, 1970, ENZYMES, V2, P1; Delano W. L., 2004, PYMOL USERS GUIDE; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; DONG A, 1992, BIOCHEMISTRY-US, V31, P182, DOI 10.1021/bi00116a027; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Francesconi KA, 2004, ANALYST, V129, P373, DOI 10.1039/b401321m; Gailer J, 1999, APPL ORGANOMET CHEM, V13, P837, DOI 10.1002/(SICI)1099-0739(199911)13:11<837::AID-AOC924>3.0.CO;2-Z; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Hamahata A, 1996, BIOCHEM J, V317, P141, DOI 10.1042/bj3170141; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kedderis GL, 2006, CHEM-BIOL INTERACT, V161, P139, DOI 10.1016/j.cbi.2006.04.001; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kuhn B, 2000, J AM CHEM SOC, V122, P2586, DOI 10.1021/ja992218v; KUROKI T, 1987, MUTAGENESIS, V2, P33, DOI 10.1093/mutage/2.1.33; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Li XL, 2013, FEBS LETT, V587, P2232, DOI 10.1016/j.febslet.2013.05.052; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Lu XF, 2003, ANAL CHEM, V75, P6463, DOI 10.1021/ac034868u; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; MCCURDY A, 1992, J AM CHEM SOC, V114, P10314, DOI 10.1021/ja00052a031; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y; Saxena D, 1998, APPL ENVIRON MICROB, V64, P2831; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Sun GF, 2007, ENVIRON HEALTH PERSP, V115, P648, DOI 10.1289/ehp.9271; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Thomas DJ, 2004, TOXICOL APPL PHARM, V198, P319, DOI 10.1016/j.taap.2003.10.020; Tseng CH, 2005, TOXICOL APPL PHARM, V206, P299, DOI 10.1016/j.taap.2004.11.022; Waddell TG, 2000, ORIGINS LIFE EVOL B, V30, P539, DOI 10.1023/A:1026523222285; Walton FS, 2003, CHEM RES TOXICOL, V16, P261, DOI 10.1021/tx025649r; Wang SP, 2012, J BIOL CHEM, V287, P38790, DOI 10.1074/jbc.M112.368050; Waters SB, 2004, CHEM RES TOXICOL, V17, P404, DOI 10.1021/tx0342161; WUOSMAA AM, 1990, SCIENCE, V249, P160, DOI 10.1126/science.2371563; Xu YY, 2008, TOXICOL APPL PHARM, V232, P142, DOI 10.1016/j.taap.2008.06.010; YANG JT, 1986, METHOD ENZYMOL, V130, P208	52	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76709	10.1371/journal.pone.0076709	http://dx.doi.org/10.1371/journal.pone.0076709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124590	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100147
J	Preuss, S; Stein, W				Preuss, Stephanie; Stein, Wolfgang			Comparison of Two Voltage-Sensitive Dyes and Their Suitability for Long-Term Imaging of Neuronal Activity	PLOS ONE			English	Article							OPTICAL MEASUREMENT; FUNCTIONAL-ORGANIZATION; STOMATOGASTRIC GANGLION; PYLORIC PATTERN; NEURAL ACTIVITY; NERVOUS-SYSTEM; LOBSTER; RESOLUTION; SIGNALS; NETWORK	One of the key approaches for studying neural network function is the simultaneous measurement of the activity of many neurons. Voltage-sensitive dyes (VSDs) simultaneously report the membrane potential of multiple neurons, but often have pharmacological and phototoxic effects on neuronal cells. Yet, to study the homeostatic processes that regulate neural network function long-term recordings of neuronal activities are required. This study aims to test the suitability of the VSDs RH795 and Di-4-ANEPPS for optically recording pattern generating neurons in the stomatogastric nervous system of crustaceans with an emphasis on long-term recordings of the pyloric central pattern generator. We demonstrate that both dyes stain pyloric neurons and determined an optimal concentration and light intensity for optical imaging. Although both dyes provided sufficient signal-to-noise ratio for measuring membrane potentials, Di-4-ANEPPS displayed a higher signal quality indicating an advantage of this dye over RH795 when small neuronal signals need to be recorded. For Di-4-ANEPPS, higher dye concentrations resulted in faster and brighter staining. Signal quality, however, only depended on excitation light strength, but not on dye concentration. RH795 showed weak and slowly developing phototoxic effects on the pyloric motor pattern as well as slow bleaching of the staining and is thus the better choice for long-term experiments. Low concentrations and low excitation intensities can be used as, in contrast to Di-4-ANEPPS, the signal-to-noise ratio was independent of excitation light strength. In summary, RH795 and Di-4-ANEPPS are suitable for optical imaging in the stomatogastric nervous system of crustaceans. They allow simultaneous recording of the membrane potential of multiple neurons with high signal quality. While Di-4-ANEPPS is better suited for short-term experiments that require high signal quality, RH795 is a better candidate for long-term experiments since it has only minor effects on the motor pattern.	[Preuss, Stephanie] Univ Ulm, Inst Neurobiol, D-89069 Ulm, Germany; [Stein, Wolfgang] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	Ulm University; Illinois State University	Stein, W (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	wstein@neurobiologie.de		Preuss, Stephanie/0000-0003-3318-8284	Illinois State University; DFG [STE 937/8-1]	Illinois State University; DFG(German Research Foundation (DFG))	This work was supported by a startup grant from Illinois State University and DFG grant STE 937/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.005.2009; ANTIC S, 1995, J NEUROSCI, V15, P1392; Antic S, 1999, FASEB J, V13, pS271, DOI 10.1096/fasebj.13.9002.S271; Briggman KL, 2006, J NEUROSCI, V26, P10925, DOI 10.1523/JNEUROSCI.3265-06.2006; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Chemla S, 2010, J PHYSIOL-PARIS, V104, P40, DOI 10.1016/j.jphysparis.2009.11.009; COHEN LB, 1978, ANNU REV NEUROSCI, V1, P171, DOI 10.1146/annurev.ne.01.030178.001131; COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968; COHEN LB, 1978, REV PHYSIOL BIOCH P, V83, P35, DOI 10.1007/3-540-08907-1_2; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dumas JH, 2005, ANN BIOMED ENG, V33, P1802, DOI 10.1007/s10439-005-8466-9; EBNER TJ, 1995, PROG NEUROBIOL, V46, P463, DOI 10.1016/0301-0082(95)00010-S; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; Galizia CG, 2000, J INSECT PHYSIOL, V46, P877, DOI 10.1016/S0022-1910(99)00194-8; Galizia CG, 2000, CURR OPIN NEUROBIOL, V10, P504, DOI 10.1016/S0959-4388(00)00109-4; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; GRINVALD A, 1987, BIOPHYS J, V51, P643, DOI 10.1016/S0006-3495(87)83389-1; GRINVALD A, 1985, ANNU REV NEUROSCI, V8, P263; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; GUPTA RK, 1981, J MEMBRANE BIOL, V58, P123, DOI 10.1007/BF01870975; Gutierrez Gabrielle J, 2009, J Vis Exp, DOI 10.3791/1207; Harris-Warrick RM, 1992, DYNAMIC BIOIL NETWOR; HEINZEL HG, 1988, J NEUROPHYSIOL, V59, P566, DOI 10.1152/jn.1988.59.2.566; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P191, DOI 10.1023/A:1008822218061; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P207, DOI 10.1023/A:1008867702131; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Karlson P, 1980, KURZES LEHRBUCH BIOC; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; LOEW LM, 1981, BIOPHYS J, V34, P353, DOI 10.1016/S0006-3495(81)84854-0; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder Eve, 1992, Pergamon Studies in Neuroscience, V4, P3; Mennerick S, 2010, J NEUROSCI, V30, P2871, DOI 10.1523/JNEUROSCI.5607-09.2010; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Obaid AL, 1999, J NEUROSCI, V19, P3073; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; ORBACH HS, 1983, J NEUROSCI, V3, P2251; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; POOLER J, 1972, J GEN PHYSIOL, V60, P367, DOI 10.1085/jgp.60.4.367; Rodgers EW, 2011, J NEUROSCI, V31, P16387, DOI 10.1523/JNEUROSCI.3770-11.2011; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; ROSS WN, 1977, J MEMBRANE BIOL, V33, P141, DOI 10.1007/BF01869514; ROSS WN, 1989, P NATL ACAD SCI USA, V86, P1679, DOI 10.1073/pnas.86.5.1679; ROSS WN, 1979, J MEMBRANE BIOL, V48, P343, DOI 10.1007/BF01869445; Sacconi L, 2006, P NATL ACAD SCI USA, V103, P3124, DOI 10.1073/pnas.0511338103; SALZBERG BM, 1993, JPN J PHYSIOL, V43, pS37; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; SCHAFFER P, 1994, PFLUG ARCH EUR J PHY, V426, P548, DOI 10.1007/BF00378533; SENSEMAN DM, 1980, SCIENCE, V208, P1269, DOI 10.1126/science.7375937; Soofi W, 2012, J COMPUT NEUROSCI, V33, P77, DOI 10.1007/s10827-011-0375-3; Stadele C, 2012, J NEUROSCI METH, V203, P78, DOI 10.1016/j.jneumeth.2011.09.015; Stein W, 2007, EUR J NEUROSCI, V26, P1148, DOI 10.1111/j.1460-9568.2007.05744.x; Stein W, 2010, J NEUROSCI METH, V188, P290, DOI 10.1016/j.jneumeth.2010.03.003; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stuart GJ, 2006, PFLUG ARCH EUR J PHY, V453, P403, DOI 10.1007/s00424-006-0149-3; Swensen AM, 2000, J EXP BIOL, V203, P2075; Tabor R, 2008, EUR J NEUROSCI, V28, P117, DOI 10.1111/j.1460-9568.2008.06316.x; Tsau Y, 1996, J NEUROSCI METH, V70, P121, DOI 10.1016/S0165-0270(96)00109-4; Tsytsarev Vassiliy, 2009, Front Neuroeng, V2, P2, DOI 10.3389/neuro.16.002.2009; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	68	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75678	10.1371/journal.pone.0075678	http://dx.doi.org/10.1371/journal.pone.0075678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124505	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100062
J	Knutsen, E; Fiskaa, T; Ursvik, A; Jorgensen, TE; Perander, M; Lund, E; Seternes, OM; Johansen, SD; Andreassen, M				Knutsen, Erik; Fiskaa, Tonje; Ursvik, Anita; Jorgensen, Tor Erik; Perander, Maria; Lund, Eiliv; Seternes, Ole Morten; Johansen, Steinar D.; Andreassen, Morten			Performance Comparison of Digital microRNA Profiling Technologies Applied on Human Breast Cancer Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; MICROARRAY; MIRBASE; TARGETS; ISOMIRS; MIRNAS; GROWTH; QPCR; PCR	MicroRNA profiling represents an important first-step in deducting individual RNA-based regulatory function in a cell, tissue, or at a specific developmental stage. Currently there are several different platforms to choose from in order to make the initial miRNA profiles. In this study we investigate recently developed digital microRNA high-throughput technologies. Four different platforms were compared including next generation SOLiD ligation sequencing and Illumina HiSeq sequencing, hybridization-based NanoString nCounter, and miRCURY locked nucleic acid RT-qPCR. For all four technologies, full microRNA profiles were generated from human cell lines that represent noninvasive and invasive tumorigenic breast cancer. This study reports the correlation between platforms, as well as a more extensive analysis of the accuracy and sensitivity of data generated when using different platforms and important consideration when verifying results by the use of additional technologies. We found all the platforms to be highly capable for microRNA analysis. Furthermore, the two NGS platforms and RT-qPCR all have equally high sensitivity, and the fold change accuracy is independent of individual miRNA concentration for NGS and RT-qPCR. Based on these findings we propose new guidelines and considerations when performing microRNA profiling.	[Knutsen, Erik; Ursvik, Anita; Perander, Maria; Johansen, Steinar D.; Andreassen, Morten] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Tromso, Norway; [Fiskaa, Tonje; Seternes, Ole Morten] Univ Tromso, Fac Hlth Sci, Dept Pharm, Tromso, Norway; [Jorgensen, Tor Erik; Johansen, Steinar D.] Univ Nordland, Marine Genom Grp, Fac Biosci & Aquaculture, Bodo, Norway; [Lund, Eiliv] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Nord University; UiT The Arctic University of Tromso	Johansen, SD (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Med Biol, Tromso, Norway.	steinar.johansen@uit.no; morten.andreassen@uit.no	Seternes, Ole Morten/M-9520-2019; Knutsen, Erik/ABH-6287-2020	Seternes, Ole Morten/0000-0001-8537-3612; Knutsen, Erik/0000-0002-4903-0150; Perander, Maria/0000-0002-1177-2407; Lund, Eiliv/0000-0002-8071-8711; Jorgensen, Tor Erik/0000-0002-6401-0713	University of Tromso (Small RNA Initiative project); SpareBank1 Nord-Norge medical research foundation	University of Tromso (Small RNA Initiative project); SpareBank1 Nord-Norge medical research foundation	This work was supported by grants from the University of Tromso (Small RNA Initiative project, SDJ and OMS) and the SpareBank1 Nord-Norge medical research foundation (SDJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Jacobsen N, 2011, METHODS MOL BIOL, V732, P39, DOI 10.1007/978-1-61779-083-6_4; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; KLEVECZ RR, 1984, INT REV CYTOL, V86, P97, DOI 10.1016/S0074-7696(08)60178-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kolbert CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052517; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-371; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Palmero EI, 2011, GENET MOL BIOL, V34, P363, DOI 10.1590/S1415-47572011000300001; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	51	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75813	10.1371/journal.pone.0075813	http://dx.doi.org/10.1371/journal.pone.0075813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116077	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000325552200040
J	McGrath, J; Mortensen, PB; Pedersen, CB; Ehrenstein, V; Petersen, L				McGrath, John; Mortensen, Preben Bo; Pedersen, Carsten Bocker; Ehrenstein, Vera; Petersen, Liselotte			Paternal Age and General Cognitive Ability-A Cross Sectional Study of Danish Male Conscripts	PLOS ONE			English	Article							DE-NOVO MUTATIONS; BIRTH-ORDER; MATERNAL AGE; PARENTAL AGE; RISK-FACTORS; INTELLIGENCE; OVERADJUSTMENT; SCHIZOPHRENIA; ASSOCIATION; OUTCOMES	Objectives: Offspring of older men have impaired cognitive ability as children, but it is unclear if this impairment persists into adulthood. The main objective of this study was to explore the association between paternal age at offspring birth and general cognitive ability as young adults. Design: Population-based cross-sectional study with prospectively collected data on obstetric factors and parental education. Setting: Nationwide Danish sample. Participants: Male conscripts (n = 169,009). Primary and secondary outcome measures: General cognitive ability as assessed by the Borge Priens test score, an intelligence test with components related to logical, verbal, numerical and spatial reasoning. Results: We observed an inverse U-shaped association between paternal age and general cognitive ability (slightly lower test scores in the offspring of fathers aged less than 25 years and older than 40 years, compared with fathers aged 25 to 29 years). However, after adjustment for maternal age, parental education and birth order the shape of the association changed. Offspring of fathers younger than 20 still showed slightly lower cognitive ability (-1.11 (95% CI -1.68 to -0.54)), but no significant impairments were identified in the men whose fathers were older than 29 years at the time of their birth (e. g. the mean difference in test score in the offspring of fathers aged 40 to 44 years were -0.03 [95% CI (-0.27 to 0.20)] compared with fathers aged 25 to 29 years). Conclusions: We did not find that the offspring of older fathers had impaired cognitive ability as young adults. Whereas, we found a tendency that the offspring of teen fathers have lower cognitive ability. Thus, our results suggest that any potentially deleterious effects of older fathers on general cognitive ability as young adults may be counter-balanced by other potentially beneficial factors.	[McGrath, John] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [McGrath, John] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Australia; [Mortensen, Preben Bo; Pedersen, Carsten Bocker; Petersen, Liselotte] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Mortensen, Preben Bo; Pedersen, Carsten Bocker; Petersen, Liselotte] Lundbeck Fdn Initiat Integrat Psychiat Res, IPSYCH, Aarhus, Denmark; [Mortensen, Preben Bo; Pedersen, Carsten Bocker] Aarhus Univ, CIRRAU, Aarhus, Denmark; [Ehrenstein, Vera] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	University of Queensland; Queensland Centre for Mental Health Research; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University	Petersen, L (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark.	llp@ncrr.dk	McGrath, John Joseph/G-5493-2010; Mortensen, Preben B/D-2358-2015; Pedersen, Carsten Bøcker/B-8441-2013	McGrath, John Joseph/0000-0002-4792-6068; Mortensen, Preben B/0000-0002-5230-9865; Pedersen, Carsten Bøcker/0000-0003-2077-8533; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Ehrenstein, Vera/0000-0002-3415-3254	Lundbeck Foundation, Denmark: The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark	Lundbeck Foundation, Denmark: The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark	This study was funded by the Lundbeck Foundation, Denmark: The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark. This funder had no involvement in any aspect of the study.	Byrne M, 2003, ARCH GEN PSYCHIAT, V60, P673, DOI 10.1001/archpsyc.60.7.673; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; Crow JF, 2003, SCIENCE, V301, P606, DOI 10.1126/science.1088552; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; El-Saadi O, 2004, SCHIZOPHR RES, V67, P227, DOI 10.1016/S0920-9964(03)00100-2; Fergusson D M, 1993, Paediatr Perinat Epidemiol, V7, P77, DOI 10.1111/j.1365-3016.1993.tb00604.x; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Green A, 1996, DAN MED BULL, V43, P464; Hamlyn J, 2013, NEUROBIOL DIS, V53, P3, DOI 10.1016/j.nbd.2012.10.023; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Malaspina Dolores, 2002, CNS Spectr, V7, P26; Miller B, 2011, SCHIZOPHRENIA BULL, V37, P1039, DOI 10.1093/schbul/sbq011; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Myrskyla M, 2013, AM J EPIDEMIOL, V177, P649, DOI 10.1093/aje/kws237; Nahum GG, 2003, J REPROD MED, V48, P963; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Osler M, 2007, SCHIZOPHR RES, V92, P132, DOI 10.1016/j.schres.2007.01.009; Pedersen CB, 2014, MOL PSYCHIATR, V19, P530, DOI 10.1038/mp.2013.69; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen L, 2011, AM J PSYCHIAT, V168, P82, DOI 10.1176/appi.ajp.2010.10020252; Rodgers JL, 2000, AM PSYCHOL, V55, P599, DOI 10.1037//0003-066X.55.6.599; Rose G., 2008, ROSES STRATEGY PREVE; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; *STAT DANM, 1991, IDA INT DAT ARB; Sulloway FJ, 2007, SCIENCE, V316, P1711, DOI 10.1126/science.1144749; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Svensson AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024771; Teasdale TW, 2008, INTELLIGENCE, V36, P121, DOI 10.1016/j.intell.2007.01.007; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P496, DOI 10.1097/EDE.0b013e3181a82f12; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241	43	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77444	10.1371/journal.pone.0077444	http://dx.doi.org/10.1371/journal.pone.0077444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116230	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200117
J	Raborn, J; Fu, T; Wu, X; Xiu, ZL; Li, GH; Luo, BH				Raborn, Joel; Fu, Ting; Wu, Xue; Xiu, Zhilong; Li, Guohui; Luo, Bing-Hao			Variation in One Residue Associated with the Metal Ion-Dependent Adhesion Site Regulates alpha IIb beta 3 Integrin Ligand Binding Affinity	PLOS ONE			English	Article							I-LIKE DOMAIN; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; BETA(3) INTEGRIN; FIRM ADHESION; OUTSIDE-IN; ALPHA-I; X-RAY; SUBUNIT	The Asp of the RGD motif of the ligand coordinates with the beta I domain metal ion dependent adhesion site (MIDAS) divalent cation, emphasizing the importance of the MIDAS in ligand binding. There appears to be two distinct groups of integrins that differ in their ligand binding affinity and adhesion ability. These differences may be due to a specific residue associated with the MIDAS, particularly the beta 3 residue Ala(252) and corresponding Ala in the beta 1 integrin compared to the analogous Asp residue in the beta 2 and beta 7 integrins. Interestingly, mutations in the adjacent to MIDAS (ADMIDAS) of integrins alpha 4 beta 7 and alpha L beta 2 increased the binding and adhesion abilities compared to the wild-type, while the same mutations in the alpha 2 beta 1, alpha 5 beta 1, alpha V beta 3, and alpha IIb beta 3 integrins demonstrated decreased ligand binding and adhesion. We introduced a mutation in the alpha IIb beta 3 to convert this MIDAS associated Ala252 to Asp. By combination of this mutant with mutations of one or two ADMIDAS residues, we studied the effects of this residue on ligand binding and adhesion. Then, we performed molecular dynamics simulations on the wild-type and mutant alpha IIb beta 3 integrin beta I domains, and investigated the dynamics of metal ion binding sites in different integrin-RGD complexes. We found that the tendency of calculated binding free energies was in excellent agreement with the experimental results, suggesting that the variation in this MIDAS associated residue accounts for the differences in ligand binding and adhesion among different integrins, and it accounts for the conflicting results of ADMIDAS mutations within different integrins. This study sheds more light on the role of the MIDAS associated residue pertaining to ligand binding and adhesion and suggests that this residue may play a pivotal role in integrin-mediated cell rolling and firm adhesion.	[Raborn, Joel; Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Fu, Ting; Wu, Xue; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Peoples R China; [Fu, Ting; Wu, Xue; Xiu, Zhilong] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian, Peoples R China; [Fu, Ting] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Raborn, Joel] Univ Alabama Birmingham, Med Sch Birmingham, Birmingham, AL USA	Louisiana State University System; Louisiana State University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Alabama System; University of Alabama Birmingham	Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Peoples R China.	ghli@dicp.ac.cn; luo@lsu.edu			American Heart Association [10GRNT3960011]; Louisiana Board of Regents [LEQSF(2009-12)-RD-A07]	American Heart Association(American Heart Association); Louisiana Board of Regents	The research is supported by the American Heart Association (#10GRNT3960011) and the Louisiana Board of Regents (LEQSF(2009-12)-RD-A07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; Case D.A., 2008, AMBER10; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen JS, 2006, AM J RESP CRIT CARE, V174, P103; Cierniewska-Cieslak A, 2002, J BIOL CHEM, V277, P11126, DOI 10.1074/jbc.M112388200; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Goodman TG, 1996, J BIOL CHEM, V271, P23729, DOI 10.1074/jbc.271.39.23729; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamata T, 2002, J IMMUNOL, V168, P2296, DOI 10.4049/jimmunol.168.5.2296; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lin ECK, 1997, J BIOL CHEM, V272, P14236, DOI 10.1074/jbc.272.22.14236; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Raborn J, 2012, J CELL BIOCHEM, V113, P1190, DOI 10.1002/jcb.23448; Raborn J, 2011, BIOCHEMISTRY-US, V50, P2084, DOI 10.1021/bi2000092; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Wang JN, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624401; Wang W, 2010, BIOCHEMISTRY-US, V49, P10158, DOI 10.1021/bi101462h; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wu J, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651626; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052460; Xu BS, 2011, J COMPUT CHEM, V32, P3188, DOI 10.1002/jcc.21900; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Zhang YX, 2013, J PHYS CHEM B, V117, P982, DOI 10.1021/jp309682t; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	51	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76793	10.1371/journal.pone.0076793	http://dx.doi.org/10.1371/journal.pone.0076793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116162	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200071
J	Shekhawat, UKS; Ganapathi, TR				Shekhawat, Upendra K. S.; Ganapathi, Thumballi R.			MusaWRKY71 Overexpression in Banana Plants Leads to Altered Abiotic and Biotic Stress Responses	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; DISEASE RESISTANCE; SALICYLIC-ACID; ABSCISIC-ACID; GENE; ARABIDOPSIS; TOLERANCE; DEFENSE; RECOGNIZES; EXPRESSION	WRKY transcription factors are specifically involved in the transcriptional reprogramming following incidence of abiotic or biotic stress on plants. We have previously documented a novel WRKY gene from banana, MusaWRKY71, which was inducible in response to a wide array of abiotic or biotic stress stimuli. The present work details the effects of MusaWRKY71 overexpression in transgenic banana plants. Stable integration and overexpression of MusaWRKY71 in transgenic banana plants was proved by Southern blot analysis and quantitative real time PCR. Transgenic banana plants overexpressing MusaWRKY71 displayed enhanced tolerance towards oxidative and salt stress as indicated by better photosynthesis efficiency (Fv/Fm) and lower membrane damage of the assayed leaves. Further, differential regulation of putative downstream genes of MusaWRKY71 was investigated using real-time RT-PCR expression analysis. Out of a total of 122 genes belonging to WRKY, pathogenesis-related (PR) protein genes, non-expressor of pathogenesis-related genes 1 (NPR1) and chitinase families analyzed, 10 genes (six belonging to WRKY family, three belonging to PR proteins family and one belonging to chitinase family) showed significant differential regulation in MusaWRKY71 overexpressing lines. These results indicate that MusaWRKY71 is an important constituent in the transcriptional reprogramming involved in diverse stress responses in banana.	[Shekhawat, Upendra K. S.; Ganapathi, Thumballi R.] Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Ganapathi, TR (corresponding author), Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	trgana@barc.gov.in		Shekhawat, Upendra/0000-0002-4012-2614				Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Eulgem T, 2006, PLOS PATHOG, V2, P1028, DOI 10.1371/journal.ppat.0020126; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Li H, 2013, PLANT GROWTH REGUL, V70, P207, DOI 10.1007/s10725-013-9792-9; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Marchive C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054185; Mzid R, 2007, PHYSIOL PLANTARUM, V131, P434, DOI 10.1111/j.1399-3054.2007.00975.x; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Oh SK, 2008, NEW PHYTOL, V177, P977, DOI 10.1111/j.1469-8137.2007.02310.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Shekhawat UKS, 2011, MOL BIOL REP, V38, P4023, DOI 10.1007/s11033-010-0521-4; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Sreedharan S, 2012, PLANT MOL BIOL, V80, P503, DOI 10.1007/s11103-012-9964-4; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144	30	37	41	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75506	10.1371/journal.pone.0075506	http://dx.doi.org/10.1371/journal.pone.0075506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116051	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200025
J	Yoon, JH; Kim, SK; Choi, HJ; Choi, SI; Cha, SY; Koh, SB; Kang, HT; Ahn, SV				Yoon, Jin-Ha; Kim, Sung-Kyung; Choi, Ho-June; Choi, Soo-In; Cha, So-Youn; Koh, Sang-Baek; Kang, Hee-Taik; Ahn, Song Vogue			Adiponectin Provides Additional Information to Conventional Cardiovascular Risk Factors for Assessing the Risk of Atherosclerosis in Both Genders	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HOMEOSTASIS MODEL ASSESSMENT; METABOLIC SYNDROME; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; ARTERY ATHEROSCLEROSIS; SERUM ADIPONECTIN; ENDOCRINE ORGAN; ADIPOSE-TISSUE	Background: This study evaluated the relation between adiponectin and atherosclerosis in both genders, and investigated whether adiponectin provides useful additional information for assessing the risk of atherosclerosis. Methods: We measured serum adiponectin levels and other cardiovascular risk factors in 1033 subjects (454 men, 579 women) from the Korean Genomic Rural Cohort study. Carotid intima-media-thickness (CIMT) was used as measure of atherosclerosis. Odds ratios (ORs) with 95% confidence intervals (95% CI) were calculated using multiple logistic regression, and receiver operating characteristic curves (ROC), the category-free net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated. Results: After adjustment for conventional cardiovascular risk factors, such as age, waist circumference, smoking history, low-density and high-density lipoprotein cholesterol, triglycerides, systolic blood pressure and insulin resistance, the ORs (95% CI) of the third tertile adiponectin group were 0.42 (0.25-0.72) in men and 0.47 (0.29-0.75) in women. The area under the curve (AUC) on the ROC analysis increased significantly by 0.025 in men and 0.022 in women when adiponectin was added to the logistic model of conventional cardiovascular risk factors (AUC in men: 0.655 to 0.680, p = 0.038; AUC in women: 0.654 to 0.676, p = 0.041). The NRI was 0.32 (95% CI: 0.13-0.50, p < 0.001), and the IDI was 0.03 (95% CI: 0.01-0.04, p < 0.001) for men. For women, the category-free NRI was 0.18 (95% CI: 0.02-0.34, p = 0.031) and the IDI was 0.003 (95% CI: -0.002-0.008, p = 0.189). Conclusion: Adiponectin and atherosclerosis were significantly related in both genders, and these relationships were independent of conventional cardiovascular risk factors. Furthermore, adiponectin provided additional information to conventional cardiovascular risk factors regarding the risk of atherosclerosis.	[Yoon, Jin-Ha; Kim, Sung-Kyung; Choi, Ho-June; Choi, Soo-In; Cha, So-Youn] Yonsei Univ, Wonju Coll Med, Inst Occupat & Environm Med, Seoul 120749, South Korea; [Yoon, Jin-Ha; Kim, Sung-Kyung; Koh, Sang-Baek; Ahn, Song Vogue] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Seoul 120749, South Korea; [Ahn, Song Vogue] Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Seoul 120749, South Korea; [Yoon, Jin-Ha] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Kang, Hee-Taik] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea; [Yoon, Jin-Ha; Kang, Hee-Taik] Yonsei Univ, Grad Sch, Dept Med, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Kang, HT (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea.	KANGHT@yuhs.ac; dodge@yonsei.ac.kr	Ahn, Song Vogue/AAK-2900-2021	Kim, Sung-Kyung/0000-0002-2742-6410; Kang, Hee-Taik/0000-0001-8048-6247	Korea Centers for Disease Control and Prevention [2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00]	Korea Centers for Disease Control and Prevention	This study was supported in part by a grant from the Korea Centers for Disease Control and Prevention (2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahn MS, 2011, MOL CELL TOXICOL, V7, P33, DOI 10.1007/s13273-011-0005-1; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Dullaart RPF, 2010, ATHEROSCLEROSIS, V211, P393, DOI 10.1016/j.atherosclerosis.2010.03.024; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fortuno A, 2003, J PHYSIOL BIOCHEM, V59, P51, DOI 10.1007/BF03179868; Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Iglseder B, 2005, STROKE, V36, P2577, DOI 10.1161/01.STR.0000190834.00284.fd; Karakas M, 2010, ATHEROSCLEROSIS, V209, P220, DOI 10.1016/j.atherosclerosis.2009.08.020; Kotani K, 2008, STROKE, V39, pE32, DOI 10.1161/STROKEAHA.107.505669; Lakoski SG, 2005, AM HEART J, V150, P907, DOI 10.1016/j.ahj.2004.11.025; Lindberg S, 2013, AM J CARDIOL, V111, P1139, DOI 10.1016/j.amjcard.2012.12.043; Mahadev K, 2008, CARDIOVASC RES, V78, P376, DOI 10.1093/cvr/cvn034; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Nilsson PM, 2006, ARTERIOSCL THROM VAS, V26, P2758, DOI 10.1161/01.ATV.0000249638.01416.4b; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Seftel Allen D, 2005, J Urol, V174, P1045; Seino Y, 2009, METABOLISM, V58, P355, DOI 10.1016/j.metabol.2008.10.008; Shibata R, 2012, CURR MED CHEM, V19, P5459, DOI 10.2174/092986712803833164; Shimabukuro M, 2003, J CLIN ENDOCR METAB, V88, P3236, DOI 10.1210/jc.2002-021883; Wang JH, 2010, INTERNAL MED, V49, P739, DOI 10.2169/internalmedicine.49.3093; Yoon JH, 2011, CLIN CHIM ACTA, V412, P2199, DOI 10.1016/j.cca.2011.08.003; Yoon JH, 2011, ANN HUM BIOL, V38, P640, DOI 10.3109/03014460.2011.598188	28	15	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75535	10.1371/journal.pone.0075535	http://dx.doi.org/10.1371/journal.pone.0075535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116054	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200027
J	Crooks, N; Babey, L; Haddon, WJ; Love, AC; Waring, CP				Crooks, Neil; Babey, Lucy; Haddon, William J.; Love, Adrian C.; Waring, Colin P.			Sexual Dimorphisms in the Dermal Denticles of the Lesser-Spotted Catshark, Scyliorhinus canicula (Linnaeus, 1758)	PLOS ONE			English	Article							MATING-BEHAVIOR; REPRODUCTIVE-BIOLOGY; SHARK SKIN; SIMULTANEOUS HERMAPHRODITE; NURSE SHARK; BLUE SHARK; BODY-SIZE; STRATEGIES; COURTSHIP; STINGRAY	The dermal layers of several elasmobranch species have been shown to be sexually dimorphic. Generally, when this occurs the females have thicker dermal layers compared to those of males. This sexual dimorphism has been suggested to occur as a response to male biting during mating. Although male biting as a copulatory behaviour in Scyliorhinus canicula has been widely speculated to occur, only relatively recently has this behaviour been observed. Male S. canicula use their mouths to bite the female's pectoral and caudal fins as part of their pre-copulatory behaviour and to grasp females during copulation. Previous work has shown that female S. canicula have a thicker epidermis compared to that of males. The structure of the dermal denticles in females may also differ from that of males in order to protect against male biting or to provide a greater degree of friction in order to allow the male more purchase. This study reveals that the length, width and density of the dermal denticles of mature male and female S. canicula are sexually dimorphic across the integument in areas where males have been observed to bite and wrap themselves around females (pectoral fin, area posterior to the pectoral fin, caudal fin, and pelvic girdle). No significant differences in the dermal denticle dimensions were found in other body areas examined (head, dorsal skin and caudal peduncle). Sexually dimorphic dermal denticles in mature S. canicula could be a response to male biting/wrapping as part of the copulatory process.	[Crooks, Neil; Babey, Lucy; Haddon, William J.; Love, Adrian C.] Sparsholt Coll, Winchester, Hants, England; [Waring, Colin P.] Univ Portsmouth, Inst Marine Sci, Portsmouth, Hants, England	University of Portsmouth	Crooks, N (corresponding author), Sparsholt Coll, Winchester, Hants, England.	neil.crooks@sparsholt.ac.uk		Crooks, Neil/0000-0003-3904-3879				Angeloni L, 2003, ANIM BEHAV, V66, P417, DOI 10.1006/anbe.2003.2255; Arnqvist Goran, 2005, pUnpaginated; Ball P, 1999, NATURE, V400, P507, DOI 10.1038/22883; Bechert D.W., 1986, ICAS, P1044; Bolau H, 1881, Z WISS ZOOL, V35, P321; Bone Q., 1975, P493; Brunnschweiler J.M., 2008, OPEN FISH SCI J, V1, P23; Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854; CARRIER JC, 1994, COPEIA, P646; Carrier JC, 2004, CRC MAR BIOL SER, P269; CASTRO JI, 1988, COPEIA, P740; Chapman DD, 2003, ENVIRON BIOL FISH, V68, P241, DOI 10.1023/A:1027332113894; Chapman T, 2006, CURR BIOL, V16, pR744, DOI 10.1016/j.cub.2006.08.020; CLARK E, 1975, NATL GEOGR, V148, P338; Compagno L.J.V., 1984, CARCHARHINIFORMES; Crooks N, 2013, ACTA ZOOL-STOCKHOLM, V94, P331, DOI 10.1111/j.1463-6395.2012.00560.x; DEMPSTER ROBERT P., 1961, OCCAS PAPERS CALIFORNIA ACAD SCI, V33, P1; DODD JM, 1983, FISH PHYSIOL, V9, P31; Domi N, 2000, 3RD MEETING OF THE EUROPEAN ELASMOBRANCH ASSOCIATION, PROCEEDINGS, P67; ELLIS JR, 1995, J FISH BIOL, V47, P155, DOI 10.1111/j.1095-8649.1995.tb01881.x; Ellis JR, 1997, J FISH BIOL, V51, P361; Gianguzza P, 2004, FUNCT ECOL, V18, P899, DOI 10.1111/j.0269-8463.2004.00911.x; Griffiths AM, 2012, J HERED, V103, P166, DOI 10.1093/jhered/esr112; Houziaux Jean-Sebastien, 1997, Revue Francaise d'Aquariologie Herpetologie, V24, P15; Ivory P, 2004, J NORTHWEST ATL FISH, V35, P89, DOI [10.2960/J.v35.m504, DOI 10.2960/J.V35.M504]; Kajiura SM, 1996, J EXP BIOL, V199, P2297; Kajiura SM, 2000, ENVIRON BIOL FISH, V58, P23, DOI 10.1023/A:1007667108362; Kapoor B.G., 2004, ICHTHYOLOGY HDB; KLIMLEY AP, 1980, COPEIA, P878; Lang A., 2012, ENCY NANOTECHNOLOGY, P2394, DOI DOI 10.1007/978-90-481-9751-4_266; McCauley DJ, 2010, PAC SCI, V64, P349, DOI 10.2984/64.2.349; MCCOURT RM, 1980, COPEIA, P900, DOI 10.2307/1444479; Mello WC, 2011, ACTA ZOOLOGICA, V94, P147; Mok EYM, 1997, J NAT HIST, V31, P739, DOI 10.1080/00222939700770371; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Motta P, 2012, J MORPHOL, V273, P1096, DOI 10.1002/jmor.20047; NORDELL SE, 1994, ENVIRON BIOL FISH, V39, P219, DOI 10.1007/BF00005124; Oeffner J, 2012, J EXP BIOL, V215, P785, DOI 10.1242/jeb.063040; Orvig T., 1977, Linnean Soc Symp Ser, VNo. 4, P53; Pierce SJ, 2009, J FISH BIOL, V74, P1291, DOI 10.1111/j.1095-8649.2009.02202.x; Powter DM, 2008, J FISH BIOL, V72, P2615, DOI 10.1111/j.1095-8649.2008.01878.x; Pratt Harold L. Jr, 1995, National Geographic Magazine, V187, P44; PRATT HL, 1979, FISH B-NOAA, V77, P445; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; RASCHI W, 1992, AUST J MAR FRESH RES, V43, P123, DOI 10.1071/MF9920123; Raschi WG, 1986, 3963 JASA, P1; Reif W.-E., 1985, Courier Forschungsinstitut Senckenberg, V78, P1; Reif W.-E., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V157, P133; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P172; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P184; Rodriguez-Cabello C, 2007, J FISH BIOL, V70, P1568, DOI 10.1111/j.1095-8649.2007.01444.x; Rodriguez-Cabello C, 2004, FISH RES, V69, P57, DOI 10.1016/j.fishres.2004.04.002; Schensky F, 1914, TIER UND PFLANZENLEB; Schlegel H, 1869, VISSCHEN; Schumacher JF, 2007, BIOFOULING, V23, P307, DOI 10.1080/08927010701393276; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; Southall EJ, 2003, P ROY SOC B-BIOL SCI, V270, pS47, DOI 10.1098/rsbl.2003.0006; STEVENS JD, 1974, J MAR BIOL ASSOC UK, V54, P373, DOI 10.1017/S0025315400058604; Sullivan T, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046001; TRICAS TC, 1980, COPEIA, P553, DOI 10.2307/1444540; TRICAS TC, 1985, MAR BIOL, V84, P233, DOI 10.1007/BF00392492; UCHIDA S, 1990, NOAA Technical Report NMFS, P211; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Whitney NM, 2004, ANIM BEHAV, V68, P1435, DOI 10.1016/j.anbehav.2004.02.018; Yano K, 1999, ICHTHYOL RES, V46, P289, DOI 10.1007/BF02678515	66	21	21	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76887	10.1371/journal.pone.0076887	http://dx.doi.org/10.1371/journal.pone.0076887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116179	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300103
J	del Amo, EM; Ghemtio, L; Xhaard, H; Yliperttula, M; Urtti, A; Kidron, H				del Amo, Eva M.; Ghemtio, Leo; Xhaard, Henri; Yliperttula, Marjo; Urtti, Arto; Kidron, Heidi			Applying Linear and Non-Linear Methods for Parallel Prediction of Volume of Distribution and Fraction of Unbound Drug	PLOS ONE			English	Article							PHARMACOKINETIC PARAMETERS; ORAL BIOAVAILABILITY; MODELS; HUMANS	Volume of distribution and fraction unbound are two key parameters in pharmacokinetics. The fraction unbound describes the portion of free drug in plasma that may extravasate, while volume of distribution describes the tissue access and binding of a drug. Reliable in silico predictions of these pharmacokinetic parameters would benefit the early stages of drug discovery, as experimental measuring is not feasible for screening purposes. We have applied linear and nonlinear multivariate approaches to predict these parameters: linear partial least square regression and non-linear recursive partitioning classification. The volume of distribution and fraction of unbound drug in plasma are predicted in parallel within the model, since the two are expected to be affected by similar physicochemical drug properties. Predictive models for both parameters were built and the performance of the linear models compared to models included in the commercial software Volsurf+. Our models performed better in predicting the unbound fraction (Q(2) 0.54 for test set compared to 0.38 with Volsurf+ model), but prediction accuracy of the volume of distribution was comparable to the Volsurf+ model (Q(2) of 0.70 for test set compared to 0.71 with Volsurf+ model). The nonlinear classification models were able to identify compounds with a high or low volume of distribution (sensitivity 0.81 and 0.71, respectively, for test set), while classification of fraction unbound was less successful. The interrelationship between the volume of distribution and fraction unbound is investigated and described in terms of physicochemical descriptors. Lipophilicity and solubility descriptors were found to have a high influence on both volume of distribution and fraction unbound, but with an inverse relationship.	[del Amo, Eva M.; Ghemtio, Leo; Xhaard, Henri; Urtti, Arto; Kidron, Heidi] Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland; [Yliperttula, Marjo] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland	University of Helsinki; University of Helsinki	Kidron, H (corresponding author), Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland.	heidi.kidron@helsinki.fi	Kidron, Heidi/A-5826-2015; del Amo, Eva María/AAX-1089-2020	Kidron, Heidi/0000-0001-6427-8042; del Amo, Eva María/0000-0002-5705-4515; ghemtio, leo/0000-0003-3591-5676	Graduate School in Pharmaceutical Research; Academy of Finland; Finnish Cultural Foundation; OrionPharma Ltd.; Biocenter Finland	Graduate School in Pharmaceutical Research; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); OrionPharma Ltd.; Biocenter Finland	This work has been supported by the Graduate School in Pharmaceutical Research, the Academy of Finland, Biocenter Finland, the Finnish Cultural Foundation, and OrionPharma Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ACDLABS SOFTW; [Anonymous], SYBYL 8 0; [Anonymous], 2012, SUIT 2012 MAESTR 201; [Anonymous], ACD DICT; Balakin Konstantin V, 2005, Curr Drug Discov Technol, V2, P99, DOI 10.2174/1570163054064666; Berellini G, 2009, J MED CHEM, V52, P4488, DOI 10.1021/jm9004658; Chen C, 2004, 666 U BERK DEP STAT; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7; Demir-Kavuk O, 2011, J COMPUT AID MOL DES, V25, P1121, DOI 10.1007/s10822-011-9496-z; Fatemi MH, 2011, J SERB CHEM SOC, V76, P1003, DOI 10.2298/JSC101104091F; Gleeson MP, 2007, J MED CHEM, V50, P101, DOI 10.1021/jm060981b; Gleeson MP, 2006, J MED CHEM, V49, P1953, DOI 10.1021/jm0510070; Gombar VK, 2013, J CHEM INF MODEL; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HIRONO S, 1994, BIOL PHARM BULL, V17, P686; Karalis V, 2003, EUR J PHARM SCI, V20, P115, DOI 10.1016/S0928-0987(03)00177-5; Karalis V, 2002, PHARM RES-DORDR, V19, P1827, DOI 10.1023/A:1021489323828; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; LIM VS, 1991, AM J KIDNEY DIS, V18, P34; Lombardo F, 2006, J MED CHEM, V49, P2262, DOI 10.1021/jm050200r; Lullmann H, 2005, COLOR ATLAS PHARM, P402; Ma CY, 2008, J PHARMACEUT BIOMED, V47, P677, DOI 10.1016/j.jpba.2008.03.023; Moda TL, 2007, BIOORGAN MED CHEM, V15, P7738, DOI 10.1016/j.bmc.2007.08.060; MOE, 2008, MOE MOL OP ENV; Ng C, 2004, J PHARM SCI-US, V93, P2535, DOI 10.1002/jps.20117; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Paul Y, 2010, ASIAN J CHEM, V22, P4880; Rowland M, 2011, CLIN PHARMACOKINET, P864; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; TETT SE, 1988, BRIT J CLIN PHARMACO, V26, P303, DOI 10.1111/j.1365-2125.1988.tb05281.x; Thompson AJ, 2011, MOL PHARMACOL, V80, P183, DOI 10.1124/mol.111.071415; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; Turner JV, 2004, INT J PHARMACEUT, V270, P209, DOI 10.1016/j.ijpharm.2003.10.011; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; WHITE NJ, 1994, T ROY SOC TROP MED H, V88, P41, DOI 10.1016/0035-9203(94)90471-5; Zhang SX, 2006, J CHEM INF MODEL, V46, P1984, DOI 10.1021/ci060132x; Zhivkova Z, 2012, J PHARM SCI-US, V101, P1253, DOI 10.1002/jps.22819	37	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74758	10.1371/journal.pone.0074758	http://dx.doi.org/10.1371/journal.pone.0074758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116008	Green Published, gold			2022-12-27	WOS:000325501300011
J	Bostanci, N; Thurnheer, T; Aduse-Opoku, J; Curtis, MA; Zinkernagel, AS; Belibasakis, GN				Bostanci, Nagihan; Thurnheer, Thomas; Aduse-Opoku, Joseph; Curtis, Michael A.; Zinkernagel, Annelies S.; Belibasakis, Georgios N.			Porphyromonas gingivalis Regulates TREM-1 in Human Polymorphonuclear Neutrophils via Its Gingipains	PLOS ONE			English	Article							MYELOID CELLS-1; INFLAMMATORY RESPONSES; PERIODONTAL-DISEASE; IN-VITRO; EPITHELIAL-CELLS; APOPTOTIC CELLS; RECEPTOR; LIPOPOLYSACCHARIDE; PATHOGEN; ACTIVATION	The Triggering Receptor Expressed on Myeloid cells 1 (TREM-1) is a cell surface receptor of the immunoglobulin superfamily, with the capacity to amplify pro-inflammatory cytokine production and regulate apoptosis. Polymorphonuclear neutrophils (PMNs) are the first line of defence against infection, and a major source of TREM-1. Porphyromonas gingivalis is a Gram-negative anaerobe highly implicated in the inflammatory processes governing periodontal disease, which is characterized by the destruction of the tooth-supporting tissues. It expresses a number of virulence factors, including the cysteine proteinases (or gingipains). The aim of this in vitro study was to investigate the effect of P. gingivalis on TREM-1 expression and production by primary human PMNs, and to evaluate the role of its gingipains in this process. After 4 h of challenge, P. gingivalis enhanced TREM-1 expression as identified by quantitative real-time PCR. This was followed by an increase in soluble (s)TREM-1 secretion over a period of 18 h, as determined by ELISA. At this time-point, the P. gingivalis-challenged PMNs exhibited diminished TREM-1 cell-membrane staining, as identified by flow cytometry and confocal laser scanning microscopy. Furthermore engagement of TREM-1, by means of anti-TREM-1 antibodies, enhanced the capacity of P. gingivalis to stimulate interleukin (IL)-8 production. Conversely, antagonism of TREM-1 using a synthetic peptide resulted in reduction of IL-8 secretion. Using isogenic P. gingivalis mutant strains, we identified the Arg-gingipain to be responsible for shedding of sTREM-1 from the PMN surface, whereas the Lys-gingipain had the capacity to degrade TREM-1. In conclusion, the differential regulation of TREM-1 by the P. gingivalis gingipains may present a novel mechanism by which P. gingivalis manipulates the host innate immune response helping to establish chronic periodontal inflammation.	[Bostanci, Nagihan; Thurnheer, Thomas; Belibasakis, Georgios N.] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Aduse-Opoku, Joseph; Curtis, Michael A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Immunol & Infect Dis, London, England; [Zinkernagel, Annelies S.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; University of London; Queen Mary University London; University of Zurich; University Zurich Hospital	Bostanci, N (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	nagihan.bostanci@zzm.uzh.ch	Zinkernagel, Annelies S/F-1780-2017; Bostanci, Nagihan/ABD-5524-2020; Belibasakis, Georgios/AAL-3159-2020; Aduse-Opoku, Joseph/CAF-0056-2022	Zinkernagel, Annelies S/0000-0003-4700-1118; Bostanci, Nagihan/0000-0002-6742-3556; Belibasakis, Georgios/0000-0002-8164-0653; opoku, anita/0000-0001-7243-8157; Thurnheer, Thomas/0000-0002-8615-8209; Curtis, Mike A/0000-0002-1563-9953				Aduse-Opoku J, 2000, MICROBIOL-UK, V146, P1933, DOI 10.1099/00221287-146-8-1933; Belibasakis GN, 2013, INT ENDOD J, V46, P99, DOI 10.1111/j.1365-2591.2012.02105.x; Belibasakis GN, 2007, MICROB PATHOGENESIS, V43, P46, DOI 10.1016/j.micpath.2007.03.001; Berker E, 2005, J PERIODONTOL, V76, P964, DOI 10.1902/jop.2005.76.6.964; Bisson C, 2012, J CLIN PERIODONTOL, V39, P1141, DOI 10.1111/jcpe.12008; Bondy-Carey JL, 2013, MOL ORAL MICROBIOL, V28, P102, DOI 10.1111/omi.12008; Bostanci N, 2013, J DENT RES, V92, P161, DOI 10.1177/0022034512470691; Bostanci N, 2009, ORAL MICROBIOL IMMUN, V24, P146, DOI 10.1111/j.1399-302X.2008.00488.x; Bostanci N, 2012, FEMS IMMUNOL MED MIC, V66, P37, DOI 10.1111/j.1574-695X.2012.00982.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bostanci N, 2011, MOL IMMUNOL, V49, P387, DOI 10.1016/j.molimm.2011.09.012; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cai MT, 2013, ANESTHESIOLOGY, V118, P1140, DOI 10.1097/ALN.0b013e31828744a5; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Curtis MA, 2001, CRIT REV ORAL BIOL M, V12, P192, DOI 10.1177/10454411010120030101; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; DeCarlo AA, 1997, J DENT RES, V76, P1260, DOI 10.1177/00220345970760060501; Galicia JC, 2009, J LEUKOCYTE BIOL, V86, P181, DOI [10.1189/JLB.0109003, 10.1189/jlb.0109003]; Gamonal J, 2003, J CLIN PERIODONTOL, V30, P616, DOI 10.1034/j.1600-051X.2003.00350.x; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot Sebastien, 2004, Clin Med Res, V2, P181; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Guzik K, 2007, CELL DEATH DIFFER, V14, P171, DOI 10.1038/sj.cdd.4401927; Guzik K, 2008, BIOCHIMIE, V90, P405, DOI 10.1016/j.biochi.2007.09.008; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hajishengallis G, 2009, MICROBES INFECT, V11, P637, DOI 10.1016/j.micinf.2009.03.009; Hiroi M, 1998, ANTICANCER RES, V18, P3475; Jagels MA, 1996, ADV EXP MED BIOL, V389, P155; Kantarci A, 2003, J PERIODONTOL, V74, P66, DOI 10.1902/jop.2003.74.1.66; Kantarci Alpdogan, 2002, J Int Acad Periodontol, V4, P119; Kishimoto M, 2006, MICROBIOL IMMUNOL, V50, P315, DOI 10.1111/j.1348-0421.2006.tb03799.x; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; Murray DA, 2003, INFECT IMMUN, V71, P7232, DOI 10.1128/IAI.71.12.7232-7235.2003; Preshaw PM, 1999, J PERIODONTAL RES, V34, P197, DOI 10.1111/j.1600-0765.1999.tb02242.x; Radsak MP, 2004, J IMMUNOL, V172, P4956, DOI 10.4049/jimmunol.172.8.4956; Scott DA, 2012, FRONT ORAL BIOL, V15, P56; Su LX, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-157; van Zandbergen G, 2004, J IMMUNOL, V172, P1768, DOI 10.4049/jimmunol.172.3.1768; Zaric S, 2010, INFECT IMMUN, V78, P4151, DOI 10.1128/IAI.00600-10	51	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75784	10.1371/journal.pone.0075784	http://dx.doi.org/10.1371/journal.pone.0075784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124513	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000325489100070
J	Guo, ZG; Wang, XR; Li, HH; Gao, YH				Guo, Zhengguang; Wang, Xiaorong; Li, Huihua; Gao, Youhe			Screening E3 Substrates Using a Live Phage Display Library	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; MDM2 PROMOTES; NEGATIVE REGULATOR; PROTEIN; DEGRADATION; UBIQUITINATION; P53; IDENTIFICATION; SPECIFICITY; GENE	Ubiquitin ligases (E3s) determine specificity of ubiquitination by recognizing target substrates. However, most of their substrates are unknown. Most known substrates have been identified using distinct approaches in different laboratories. We developed a high-throughput strategy using a live phage display library as E3 substrates in in vitro screening. His-ubiquitinated phage, enriched with Ni-beads, could effectively infect E. coli for amplification. Sixteen natural potential substrates and many unnatural potential substrates of E3 MDM2 were identified through 4 independent screenings. Some substrates were identified in different independent experiments. Additionally, 10 of 12 selected candidates were ubiquitinated by MDM2 in vitro, and 3 novel substrates, DDX42, TP53RK and RPL36a were confirmed ex vivo. The whole strategy is rather simple and efficient. Non-degradation substrates can be discovered. This strategy can be extended to any E3s as long as the E3 does not ubiquitinate the empty phage.	[Guo, Zhengguang; Wang, Xiaorong; Gao, Youhe] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Sch Basic Med, Dept Physiol & Pathophysiol,Peking Union Med Coll, Beijing 100730, Peoples R China; [Guo, Zhengguang] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Core Instrument Facil,Peking Union Med Coll, Beijing 100730, Peoples R China; [Li, Huihua] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Pathol,Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Gao, YH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Sch Basic Med, Dept Physiol & Pathophysiol,Peking Union Med Coll, Beijing 100730, Peoples R China.	gaoyouhe@pumc.edu.cn			National Basic Research Program of China [2012CB517606, 2013CB530805, 2011CB964901]; National High Technology Research and Development Program of China [2011AA020116]; Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT [IRT0909]; 111 Project [B08007]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (2012CB517606, 2013CB530805, 2011CB964901), the National High Technology Research and Development Program of China (2011AA020116), Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT (IRT0909), and 111 Project (B08007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Abu Shadat NM, 2010, CANCER INVEST, V28, P806, DOI 10.3109/07357907.2010.494323; Andrews PS, 2010, ASSAY DRUG DEV TECHN, V8, P471, DOI 10.1089/adt.2009.0264; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Benhar I, 2001, BIOTECHNOL ADV, V19, P1, DOI 10.1016/S0734-9750(00)00054-9; Burande CF, 2009, MOL CELL PROTEOMICS, V8, P1719, DOI 10.1074/mcp.M800410-MCP200; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Busso CS, 2009, ONCOGENE, V28, P1616, DOI 10.1038/onc.2009.5; Buyse IM, 1997, J VIROL, V71, P6200, DOI 10.1128/JVI.71.8.6200-6203.1997; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; CORDONCARDO C, 1994, CANCER RES, V54, P794; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Crawford NPS, 2009, J BIOL CHEM, V284, P28660, DOI 10.1074/jbc.M109.023457; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hitomi K, 2009, AMINO ACIDS, V36, P619, DOI 10.1007/s00726-008-0126-6; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Hwang YC, 2009, AM J PATHOL, V175, P342, DOI 10.2353/ajpath.2009.080931; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANDERS JE, 1994, ONCOGENE, V9, P2745; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Miwa S, 2006, BIOCHEM BIOPH RES CO, V340, P54, DOI 10.1016/j.bbrc.2005.11.148; Miyake S, 2000, MOL CELL BIOL, V20, P8889, DOI 10.1128/MCB.20.23.8889-8902.2000; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; *RIZ, P NATL ACAD SCI USA, V92, P4467, DOI DOI 10.1073/PNAS.92.10.4467.PUBMED:7538672; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Shu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027346; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wyszomierski SL, 2005, CANCER CELL, V8, P437, DOI 10.1016/j.ccr.2005.11.006; Xu HX, 2010, J BIOL CHEM, V285, P18407, DOI 10.1074/jbc.M109.059568; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	76	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76622	10.1371/journal.pone.0076622	http://dx.doi.org/10.1371/journal.pone.0076622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124579	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100136
J	Koreissi-Dembele, Y; Fanou-Fogny, N; Moretti, D; Schuth, S; Dossa, RAM; Egli, I; Zimmermann, MB; Brouwer, ID				Koreissi-Dembele, Yara; Fanou-Fogny, Nadia; Moretti, Diego; Schuth, Stephan; Dossa, Romain A. M.; Egli, Ines; Zimmermann, Michael B.; Brouwer, Inge D.			Dephytinisation with Intrinsic Wheat Phytase and Iron Fortification Significantly Increase Iron Absorption from Fonio (Digitaria exilis) Meals in West African Women	PLOS ONE			English	Article							PHYTIC ACID; INOSITOL PHOSPHATES; HUMANS; BIOAVAILABILITY; ZINC; FOODS; PURIFICATION; DEGRADATION; CEREALS; PROTEIN	Low iron and high phytic acid content make fonio based meals a poor source of bioavailable iron. Phytic acid degradation in fonio porridge using whole grain cereals as phytase source and effect on iron bioavailability when added to iron fortified fonio meals were investigated. Grains, nuts and seeds collected in Mali markets were screened for phytic acid and phytase activity. We performed an iron absorption study in Beninese women (n = 16), using non-dephytinised fonio porridge (FFP) and dephytinised fonio porridge (FWFP; 75% fonio-25% wheat), each fortified with Fe-57 or Fe-58 labeled FeSO4. Iron absorption was quantified by measuring the erythrocyte incorporation of stable iron isotopes. Phytic acid varied from 0.39 (bambara nut) to 4.26 g/100 g DM (pumpkin seed), with oilseeds values higher than grains and nuts. Phytase activity ranged from 0.17 +/- 1.61 (fonio) to 2.9 +/- 1.3 phytase unit (PU) per g (whole wheat). Phytic acid was almost completely degraded in FWFP after 60 min of incubation (pH approximate to 5.0, 50 degrees C). Phytate: iron molar ratios decreased from 23.7:1 in FFP to 2.7:1 in FWFP. Iron fortification further reduced phytate: iron molar ratio to 1.9:1 in FFP and 0.3:1 in FWFP, respectively. Geometric mean (95% CI) iron absorption significantly increased from 2.6% (0.8-7.8) in FFP to 8.3% (3.8-17.9) in FWFP (P<0.0001). Dephytinisation of fonio porridge with intrinsic wheat phytase increased fractional iron absorption 3.2 times, suggesting it could be a possible strategy to decrease PA in cereal-based porridges.	[Koreissi-Dembele, Yara; Fanou-Fogny, Nadia; Zimmermann, Michael B.; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Dept Food Sci, NL-6700 AP Wageningen, Netherlands; [Koreissi-Dembele, Yara; Fanou-Fogny, Nadia; Zimmermann, Michael B.; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Nutr Grp, NL-6700 AP Wageningen, Netherlands; [Moretti, Diego; Egli, Ines; Zimmermann, Michael B.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [Koreissi-Dembele, Yara] Reg Agron Res Ctr CRRA Sotuba, Inst Rural Econ IER, Food Technol Lab LTA, Bamako, Mali; [Fanou-Fogny, Nadia; Dossa, Romain A. M.] Univ Abomey Calavi, FSA, Dept Nutr & Food Sci, Cotonou, Benin; [Schuth, Stephan] Univ Bonn, Steinmann Inst Geol Mineral & Petrol, Bonn, Germany	Wageningen University & Research; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Abomey Calavi; University of Bonn	Koreissi-Dembele, Y (corresponding author), Wageningen Univ, Div Human Nutr, Dept Food Sci, NL-6700 AP Wageningen, Netherlands.	ykoreissidemb@gmail.com; nadiafanou.fogny@gmail.com	Moretti, Diego/AAC-9028-2019; Moretti, Diego/G-5212-2013; Zimmermann, Michael B/C-3062-2016; Brouwer, Inge D/K-8455-2013	Moretti, Diego/0000-0002-7366-2182; Moretti, Diego/0000-0002-7366-2182; Brouwer, Inge/0000-0002-2554-7227	Netherlands Fellowships Program NUFFIC; International Foundation for Science, (IFS Stockholm, Sweden) [IFS-E-4491]; European Union [INCO CT-2005-015403]	Netherlands Fellowships Program NUFFIC; International Foundation for Science, (IFS Stockholm, Sweden)(International Foundation for Science); European Union(European Commission)	Financial support was provided by the Netherlands Fellowships Program NUFFIC. Part of fieldwork activities and equipment purchase was funded by the International Foundation for Science, (IFS Stockholm, Sweden), under the project reference IFS-E-4491. Another part of the field work such as the fonio treatement and porridge degradation test was funded by the European Union funded project FP6/EU/INCO FONIO project No. INCO CT-2005-015403 through a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adubiaro H. O., 2011, Advance Journal of Food Science & Technology, V3, P228; Allen L, 2006, GUIDELINES FOOD FORT; BROWN E, 1962, J CLIN INVEST, V41, P2182, DOI 10.1172/JCI104677; COOK JD, 1991, AM J CLIN NUTR, V54, P717, DOI 10.1093/ajcn/54.4.717; Cook JD, 1997, AM J CLIN NUTR, V65, P964, DOI 10.1093/ajcn/65.4.964; Coulibaly A., 2011, American Journal of Plant Nutrition and Fertilization Technology, V1, P1, DOI 10.3923/ajpnft.2011.1.22; Drame D., 2011, FONIO AFRICAN CEREAL, DOI DOI 10.1186/s12864-015-2255-0; Egli I, 2004, J NUTR, V134, P1077, DOI 10.1093/jn/134.5.1077; Egli I, 2003, J FOOD SCI, V68, P1855, DOI 10.1111/j.1365-2621.2003.tb12342.x; Egli I, 2002, J FOOD SCI, V67, P3484, DOI 10.1111/j.1365-2621.2002.tb09609.x; Egli I, 2001, THESIS SWISS FEDERAL; Elemo G. N., 2011, African Journal of Plant Science, V5, P291; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; FAO/WHO, 1998, VIT MIN REQ HUM NUTR; Fogny-Fanou N., 2009, African Journal of Food, Agriculture, Nutrition and Development, V9, P1927; GIBSON DM, 1988, ARCH BIOCHEM BIOPHYS, V260, P503, DOI 10.1016/0003-9861(88)90475-4; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; GILLOOLY M, 1984, BRIT J NUTR, V51, P37, DOI 10.1079/BJN19840007; Greiner R, 1999, J SCI FOOD AGR, V79, P1453, DOI [10.1002/(SICI)1097-0010(199908)79:11<1453::AID-JSFA386>3.0.CO;2-R, 10.1002/(SICI)1097-0010(199908)79:11&lt;1453::AID-JSFA386&gt;3.0.CO;2-R]; Greiner R, 2006, FOOD TECHNOL BIOTECH, V44, P125; HALLBERG L, 1989, AM J CLIN NUTR, V49, P140, DOI 10.1093/ajcn/49.1.140; HOSAIN F, 1967, J CLIN INVEST, V46, P1, DOI 10.1172/JCI105501; Hurrell RF, 2003, AM J CLIN NUTR, V77, P1213, DOI 10.1093/ajcn/77.5.1213; Hurrell RF, 1997, EUR J CLIN NUTR, V51, pS4; HURRELL RF, 1992, AM J CLIN NUTR, V56, P573, DOI 10.1093/ajcn/56.3.573; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Ip H, 2007, EUR J CLIN NUTR, V63, P165; KASTENMAYER P, 1994, BRIT J NUTR, V71, P411, DOI 10.1079/BJN19940148; Kayode APP, 2006, J AGR FOOD CHEM, V54, P256, DOI 10.1021/jf0521404; Koreissi-Dembele Y, 2013, J FOOD COMPOS ANAL, V29, P134, DOI 10.1016/j.jfca.2012.07.010; Lei XG, 2000, J APPL ANIM RES, V17, P97, DOI 10.1080/09712119.2000.9706294; MAKOWER RU, 1970, CEREAL CHEM, V47, P288; Mansfeldt T, 2012, J SOIL SEDIMENT, V12, P97, DOI 10.1007/s11368-011-0402-z; Moretti D, 2006, AM J CLIN NUTR, V83, P632, DOI 10.1093/ajcn.83.3.632; Porres JM, 2001, J FOOD SCI, V66, P614, DOI 10.1111/j.1365-2621.2001.tb04610.x; Ravindran V., 1995, Poultry and Avian Biology Reviews, V6, P125; RICKARD ES, 1997, ANTINUTRIENTS PHYTOC; Sandberg AS, 1999, AM J CLIN NUTR, V70, P240; Sandberg AS, 1996, J NUTR, V126, P476, DOI 10.1093/jn/126.2.476; SANDSTROM B, 1992, J TRACE ELEM ELECT H, V6, P99; Schoenberg R, 2005, INT J MASS SPECTROM, V242, P257, DOI 10.1016/j.ijms.2004.11.025; Teutsch N, 2009, EARTH PLANET SC LETT, V285, P52, DOI 10.1016/j.epsl.2009.05.044; Troesch B, AM J CLIN NUTR, V89, P539; Vall E, 2011, CAH AGRIC, V20, P294, DOI 10.1684/agr.2011.0499; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Vietmeyer N., 1996, LOST CROPS AFRICA, V1, P59, DOI DOI 10.17226/2305; Walczyk T, 1997, FRESEN J ANAL CHEM, V359, P445, DOI 10.1007/s002160050608; Weyer S, 2003, INT J MASS SPECTROM, V226, P355, DOI 10.1016/S1387-3806(03)00078-2; World Health Organization, 2001, IR DEF AN ASS PREV C; World Health Organization, 2008, METH MAN PROD TEST M; World Health Organization, 1995, PHYS STAT US INT ANT; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	52	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e70613	10.1371/journal.pone.0070613	http://dx.doi.org/10.1371/journal.pone.0070613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124445	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100002
J	Milano, G; Abruzzo, PM; Bolotta, A; Marini, M; Terraneo, L; Ravara, B; Gorza, L; Vitadello, M; Burattini, S; Curzi, D; Falcieri, E; von Segesser, LK; Samaja, M				Milano, Giuseppina; Abruzzo, Provvidenza Maria; Bolotta, Alessandra; Marini, Marina; Terraneo, Laura; Ravara, Barbara; Gorza, Luisa; Vitadello, Maurizio; Burattini, Sabrina; Curzi, Davide; Falcieri, Elisabetta; von Segesser, Ludwig K.; Samaja, Michele			Impact of the Phosphatidylinositide 3-Kinase Signaling Pathway on the Cardioprotection Induced by Intermittent Hypoxia	PLOS ONE			English	Article							IMPROVES POSTISCHEMIC RECOVERY; RAT CAROTID-BODY; UP-REGULATION; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; MYOCARDIAL INJURY; ACTIVATION; KINASE; AKT; SURVIVAL	Background: Exposure to intermittent hypoxia (IH) may enhance cardiac function and protects heart against ischemia-reperfusion (I/R) injury. To elucidate the underlying mechanisms, we developed a cardioprotective IH model that was characterized at hemodynamic, biochemical and molecular levels. Methods: Mice were exposed to 4 daily IH cycles (each composed of 2-min at 6-8% O-2 followed by 3-min reoxygenation for 5 times) for 14 days, with normoxic mice as controls. Mice were then anesthetized and subdivided in various subgroups for analysis of contractility (pressure-volume loop), morphology, biochemistry or resistance to I/R (30-min occlusion of the left anterior descending coronary artery (LAD) followed by reperfusion and measurement of the area at risk and infarct size). In some mice, the phosphatidylinositide 3-kinase (PI3K) inhibitor wortmannin was administered (24 mu g/kg ip) 15 min before LAD. Results: We found that IH did not induce myocardial hypertrophy; rather both contractility and cardiac function improved with greater number of capillaries per unit volume and greater expression of VEGF-R2, but not of VEGF. Besides increasing the phosphorylation of protein kinase B (Akt) and the endothelial isoform of NO synthase with respect to control, IH reduced the infarct size and post-LAD proteins carbonylation, index of oxidative damage. Administration of wortmannin reduced the level of Akt phosphorylation and worsened the infarct size. Conclusion: We conclude that the PI3K/Akt pathway is crucial for IH-induced cardioprotection and may represent a viable target to reduce myocardial I/R injury.	[Milano, Giuseppina; von Segesser, Ludwig K.] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Milano, Giuseppina] IRCSS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Regenerat, Milan, Italy; [Abruzzo, Provvidenza Maria; Bolotta, Alessandra; Marini, Marina] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Terraneo, Laura; Samaja, Michele] Univ Milan, Dept Hlth Sci, Milan, Italy; [Ravara, Barbara; Gorza, Luisa] Univ Padua, Dipartimento Sci Biomed, Padua, Italy; [Vitadello, Maurizio] CNR, Inst Neurosci, Padova Sect, Padua, Italy; [Burattini, Sabrina; Curzi, Davide; Falcieri, Elisabetta] Univ Urbino Carlo Bo, DiSTeVA, Urbino, Italy	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Centro Cardiologico Monzino; University of Bologna; University of Milan; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Urbino	Milano, G (corresponding author), CHU Vaudois, CH-1011 Lausanne, Switzerland.	giuseppina.milano@chuv.ch	Samaja, Michele/N-3499-2013; Abruzzo, Provvidenza Maria/G-7009-2015; Marini, Marina/B-1490-2012; Marini, Marina/Y-6191-2019	Samaja, Michele/0000-0002-0705-340X; Abruzzo, Provvidenza Maria/0000-0001-5242-9448; Marini, Marina/0000-0003-1932-7380; Marini, Marina/0000-0003-1932-7380; Terraneo, Laura/0000-0003-2991-1898; GORZA, LUISA/0000-0003-4897-400X; Milano, Giuseppina/0000-0002-5560-4667; Falcieri, Elisabetta/0000-0002-0006-9871	Italian Ministry of Education (MIUR-PRIN); Lausanne CardioMet Foundation	Italian Ministry of Education (MIUR-PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Lausanne CardioMet Foundation	This study was supported by grants from The Italian Ministry of Education (MIUR-PRIN) and from Lausanne CardioMet Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi S, 2001, ENDOCRINOLOGY, V142, P498, DOI 10.1210/en.142.1.498; AHLUWALIA A, 2013, BIOCH BIOPHYS RES CO; Beguin PC, 2007, J MOL CELL CARDIOL, V42, P343, DOI 10.1016/j.yjmcc.2006.11.008; Belaidi E, 2008, AM J PHYSIOL-HEART C, V294, pH901, DOI 10.1152/ajpheart.00715.2007; Belaidi E, 2012, FUND CLIN PHARMACOL, V26, P454, DOI 10.1111/j.1472-8206.2011.00940.x; Bianciardi P, 2006, BIOCHEM BIOPH RES CO, V342, P875, DOI 10.1016/j.bbrc.2006.02.042; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Burri PH, 2004, DEV DYNAM, V231, P474, DOI 10.1002/dvdy.20184; Burtscher M, 2004, INT J CARDIOL, V96, P247, DOI 10.1016/j.ijcard.2003.07.021; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Caretti A, 2008, EXP BIOL MED, V233, P1222, DOI 10.3181/0802-RM-73; Chong KY, 2013, BIOCHEM BIOPH RES CO, V430, P774, DOI 10.1016/j.bbrc.2012.11.072; Dalla Libera L, 2009, J APPL PHYSIOL, V107, P549, DOI 10.1152/japplphysiol.00280.2009; Del Rio R, 2011, BRAIN RES, V1395, P74, DOI 10.1016/j.brainres.2011.04.028; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Esposito F, 2011, EUR J APPL PHYSIOL, V111, P859, DOI 10.1007/s00421-010-1707-0; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Huang CY, 2012, J APPL PHYSIOL, V112, P883, DOI 10.1152/japplphysiol.00605.2011; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kolar F, 2007, AM J PHYSIOL-HEART C, V292, pH224, DOI 10.1152/ajpheart.00689.2006; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee SD, 2007, INT J CARDIOL, V116, P348, DOI 10.1016/j.ijcard.2006.03.064; Maeda H, 2013, BBA-MOL BASIS DIS, V1832, P1159, DOI 10.1016/j.bbadis.2013.02.014; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Manukhina EB, 2011, EXP BIOL MED, V236, P867, DOI 10.1258/ebm.2011.011023; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marini M, 2008, HISTOCHEM CELL BIOL, V129, P479, DOI 10.1007/s00418-007-0373-8; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Milano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027910; Milano G, 2010, EUR J CARDIO-THORAC, V37, P942, DOI 10.1016/j.ejcts.2009.10.030; Milano G, 2010, EXP BIOL MED, V235, P401, DOI 10.1258/ebm.2009.009153; Naghshin J, 2012, J APPL PHYSIOL, V113, P791, DOI 10.1152/japplphysiol.00185.2012; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Natarajan R, 2009, VASC PHARMACOL, V51, P110, DOI 10.1016/j.vph.2009.05.007; Paris S, 2005, FEBS LETT, V579, P105, DOI 10.1016/j.febslet.2004.11.055; Park AM, 2007, ANTIOXID REDOX SIGN, V9, P723, DOI 10.1089/ars.2007.1460; Park AM, 2007, AM J PHYSIOL-HEART C, V292, pH751, DOI 10.1152/ajpheart.01016.2006; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Qian YZ, 1999, AM J PHYSIOL-HEART C, V276, pH224, DOI 10.1152/ajpheart.1999.276.1.H224; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; REIMER KA, 1990, CIRCULATION, V82, P2266, DOI 10.1161/01.CIR.82.6.2266; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Seng S, 2010, J BIOL CHEM, V285, P26190, DOI 10.1074/jbc.M109.095786; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tagliavacca L, 2012, BBA-GEN SUBJECTS, V1820, P900, DOI 10.1016/j.bbagen.2012.02.016; Tarricone E, 2008, CELL STRESS CHAPERON, V13, P483, DOI 10.1007/s12192-008-0048-y; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Valle MD, 2006, J NUCL CARDIOL, V13, P69, DOI 10.1016/j.nuclcard.2005.11.008; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wang ZH, 2012, EXP PHYSIOL, V97, P1105, DOI 10.1113/expphysiol.2012.065102; Wang ZH, 2011, AM J PHYSIOL-HEART C, V301, pH1695, DOI 10.1152/ajpheart.00276.2011; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Yang CH, 2013, J ATHEROSCLER THROMB, V20, P9, DOI 10.5551/jat.14316; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200	65	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76659	10.1371/journal.pone.0076659	http://dx.doi.org/10.1371/journal.pone.0076659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124584	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100141
J	O'Shea, RP; Kornmeier, J; Roeber, U				O'Shea, Robert P.; Kornmeier, Juergen; Roeber, Urte			Predicting Visual Consciousness Electrophysiologically from Intermittent Binocular Rivalry	PLOS ONE			English	Article							AMBIGUOUS FIGURES; STOCHASTIC PROPERTIES; EVOKED-POTENTIALS; NEURAL MODEL; NECKER-CUBE; PERCEPTION; BRAIN; CORTEX; DISTRIBUTIONS; TIME	Purpose: We sought brain activity that predicts visual consciousness. Methods: We used electroencephalography (EEG) to measure brain activity to a 1000-ms display of sine-wave gratings, oriented vertically in one eye and horizontally in the other. This display yields binocular rivalry: irregular alternations in visual consciousness between the images viewed by the eyes. We replaced both gratings with 200 ms of darkness, the gap, before showing a second display of the same rival gratings for another 1000 ms. We followed this by a 1000-ms mask then a 2000-ms inter-trial interval (ITI). Eleven participants pressed keys after the second display in numerous trials to say whether the orientation of the visible grating changed from before to after the gap or not. Each participant also responded to numerous non-rivalry trials in which the gratings had identical orientations for the two eyes and for which the orientation of both either changed physically after the gap or did not. Results: We found that greater activity from lateral occipital-parietal-temporal areas about 180 ms after initial onset of rival stimuli predicted a change in visual consciousness more than 1000 ms later, on re-presentation of the rival stimuli. We also found that less activity from parietal, central, and frontal electrodes about 400 ms after initial onset of rival stimuli predicted a change in visual consciousness about 800 ms later, on re-presentation of the rival stimuli. There was no such predictive activity when the change in visual consciousness occurred because the stimuli changed physically. Conclusion: We found early EEG activity that predicted later visual consciousness. Predictive activity 180 ms after onset of the first display may reflect adaption of the neurons mediating visual consciousness in our displays. Predictive activity 400 ms after onset of the first display may reflect a less-reliable brain state mediating visual consciousness.	[O'Shea, Robert P.; Roeber, Urte] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [O'Shea, Robert P.; Roeber, Urte] So Cross Univ, Sch Hlth & Human Sci, Discipline Psychol, Coffs Harbour, Australia; [O'Shea, Robert P.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [O'Shea, Robert P.] So Cross Univ, Sch Hlth & Human Sci, Cognit Neurosci Res Cluster, Coffs Harbour, Australia; [Kornmeier, Juergen] Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany; [Kornmeier, Juergen] Univ Eye Hosp, Dept Ophthalmol, Freiburg, Germany; [Roeber, Urte] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia	Leipzig University; Southern Cross University; University of Otago; Southern Cross University; University of Freiburg; University of Sydney	O'Shea, RP (corresponding author), Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany.	robert.oshea@scu.edu.au	O'Shea, Robert P./C-5723-2008	O'Shea, Robert P./0000-0003-3132-7199; Roeber, Urte/0000-0002-6631-5828	German Research Foundation (DFG) [RO 3061/1-2, BA 877/16-2]; German Research Foundation (DFG) [RO 3061/1-2, BA 877/16-2]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support came from the German Research Foundation (DFG grant no. RO 3061/1-2 awarded to Urte Roeber, and DFG grant no. BA 877/16-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R., 2009, ENCY NEUROSCIENCE, V2, P179; Bode S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021612; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Brascamp JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001497; Brascamp JW, 2012, PSYCHOL SCI, V23, P1159, DOI 10.1177/0956797612440100; Brascamp JW, 2005, J VISION, V5, P287, DOI 10.1167/5.4.1; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; Britz J, 2011, PSYCHOPHYSIOLOGY, V48, P1489, DOI 10.1111/j.1469-8986.2011.01222.x; Britz J, 2011, HUM BRAIN MAPP, V32, P1432, DOI 10.1002/hbm.21117; Britz J, 2009, CEREB CORTEX, V19, P55, DOI 10.1093/cercor/bhn056; Calabrese A, 2008, SCHOLARPEDIA, V4, P2668; COGAN AI, 1987, VISION RES, V27, P2125, DOI 10.1016/0042-6989(87)90127-1; COGAN R, 1973, J GEN PSYCHOL, V89, P297, DOI 10.1080/00221309.1973.9710832; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Deutsche Gesellschaft fur Psychologie, 2004, REV FROSCH BEZ ETH R; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Durrant E-L, 2011, THESIS; Ehm W, 2011, PSYCHOPHYSIOLOGY, V48, P547, DOI 10.1111/j.1469-8986.2010.01087.x; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fahrenfort JJ, 2008, J VISION, V8, DOI 10.1167/8.1.12; FOX R, 1967, PERCEPT PSYCHOPHYS, V2, P432, DOI 10.3758/BF03208783; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Genc E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00161; Grossberg S, 2008, VISION RES, V48, P2232, DOI 10.1016/j.visres.2008.06.024; Hawes ML, 2011, THESIS; Hayashi R, 2004, VISION RES, V44, P2367, DOI 10.1016/j.visres.2004.04.017; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Hsieh PJ, 2012, NEUROPSYCHOLOGIA, V50, P522, DOI 10.1016/j.neuropsychologia.2011.09.019; JASKOWSKI P, 1983, ACTA NEUROBIOL EXP, V43, P221; Kaernbach C, 1999, NEUROREPORT, V10, P713, DOI 10.1097/00001756-199903170-00010; Kalarickal GJ, 2000, NEUROCOMPUTING, V32, P843, DOI 10.1016/S0925-2312(00)00252-6; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Kornmeier J, 2005, VISION RES, V45, P955, DOI 10.1016/j.visres.2004.10.006; Kornmeier J, 2004, PSYCHOPHYSIOLOGY, V41, P1, DOI 10.1046/j.1469-8986.2003.00126.x; Kornmeier J, 2007, PSYCHOPHYSIOLOGY, V44, P552, DOI 10.1111/j.1469-8986.2007.00525.x; Kornmeier J, 2006, INT J PSYCHOPHYSIOL, V62, P345, DOI 10.1016/j.ijpsycho.2006.04.007; Kornmeier J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00051; Kornmeier J, 2009, J VISION, V9, DOI 10.1167/9.1.7; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Lamme VAF, 2010, COGN NEUROSCI-UK, V1, P204, DOI 10.1080/17588921003731586; Lankheet MJM, 2006, J VISION, V6, P304, DOI 10.1167/6.4.1; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LEVELT WJM, 1967, BRIT J PSYCHOL, V58, P143, DOI 10.1111/j.2044-8295.1967.tb01068.x; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MATSUOKA K, 1984, BIOL CYBERN, V49, P201, DOI 10.1007/BF00334466; McDougall W., 1901, BRAIN, V24, P579, DOI DOI 10.1093/BRAIN/24.4.579; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; Muller TJ, 1999, NEUROREPORT, V10, P3423; Murata T, 2003, NEUROREPORT, V14, P1347, DOI 10.1097/01.wnr.0000077553.91466.41; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Necker L.A, 1832, LONDON EDINBURGH PHI, V1, P329, DOI 10.1080/14786443208647909; Niedeggen M, 2001, EUR J NEUROSCI, V14, P1719, DOI 10.1046/j.0953-816x.2001.01785.x; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; O'Shea RP, 2009, PERCEPTION, V38, P110; O'Shea R. P., 2005, BINOCULAR RIVALRY, P301; O'Shea R. P., 2010, ENCY PERCEPTION, P399; O'Shea RP, 2005, VISION RES, V45, P247, DOI 10.1016/j.visres.2004.08.009; O'Shea RP, 2003, J VISION, V3, P610, DOI 10.1167/3.10.3; O'Shea RP, 2010, CLIN EEG NEUROSCI, V41, P114; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; ODONNELL BF, 1988, PSYCHOPHYSIOLOGY, V25, P137, DOI 10.1111/j.1469-8986.1988.tb00976.x; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; ORBACH J, 1963, Percept Mot Skills, V17, P439; OSHEA RP, 1984, PERCEPT PSYCHOPHYS, V36, P266, DOI 10.3758/BF03206368; Paffen C. L, 2011, FRONTIERS HUMAN NEUR, V5, P1, DOI DOI 10.HTTPS://D0I.0RG/10; Paffen CLE, 2006, PSYCHOL SCI, V17, P752, DOI 10.1111/j.1467-9280.2006.01777.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; Pizzagalli DA, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P56, DOI 10.1017/CBO9780511546396.003; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Porta, 1593, REFRACTIONE OPTICES; Railo H, 2011, CONSCIOUS COGN, V20, P972, DOI 10.1016/j.concog.2011.03.019; REISBERG D, 1984, PERCEPTION, V13, P461, DOI 10.1068/p130461; Roeber U, 2004, NEUROSCI LETT, V371, P51, DOI 10.1016/j.neulet.2004.08.038; Roeber U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022612; Roeber U, 2008, J VISION, V8, DOI 10.1167/8.3.21; Schiller P., 1933, PSYCHOL FORSCH, V17, P179, DOI DOI 10.1007/BF02411959; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Stollenwerk L, 2003, NEURAL COMPUT, V15, P2863, DOI 10.1162/089976603322518777; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Van Boxtel JJA, 2007, J VISION, V7, DOI 10.1167/7.14.3; van Ee R, 2006, VISION RES, V46, P3129, DOI 10.1016/j.visres.2006.03.017; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; Veser S, 2008, VISION RES, V48, P2359, DOI 10.1016/j.visres.2008.07.024; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilcke JC, 2009, BRAIN RES, V1305, P96, DOI 10.1016/j.brainres.2009.09.080; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447; Wong EMY, 2010, J VISION, V10, DOI 10.1167/10.1.14; World Medical Association, 2004, DECL HELS ETH PRINC; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554; Zeki S, 1999, CONSCIOUS COGN, V8, P225, DOI 10.1006/ccog.1999.0390; Zhang P, 2011, NEURON, V71, P362, DOI 10.1016/j.neuron.2011.05.035; Zhang WW, 2009, NAT NEUROSCI, V12, P24, DOI 10.1038/nn.2223; Zhou YH, 2004, BIOL CYBERN, V90, P256, DOI 10.1007/s00422-004-0472-8	117	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76134	10.1371/journal.pone.0076134	http://dx.doi.org/10.1371/journal.pone.0076134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124536	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100093
J	Li, YX; Cao, GS; Zheng, XD; Wang, J; Wei, HM; Tian, ZG; Sun, R				Li, Yangxi; Cao, Guoshuai; Zheng, Xiaodong; Wang, Jun; Wei, Haiming; Tian, Zhigang; Sun, Rui			CRACC-CRACC Interaction between Kupffer and NK Cells Contributes to Poly I:C/D-GalN Induced Hepatitis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SLAM FAMILY RECEPTORS; T-CELLS; SAP; INJURY; INVOLVEMENT; ACTIVATION; EXPRESSION; RESPONSES; MOLECULE	CD2-like receptor activating cytotoxic cells (CRACC) is known as a critical activating receptor of natural killer (NK) cells. We have previously reported that NK cells contribute to Poly I:C/D-galactosamine (D-GalN)-induced fulminant hepatitis. Since natural killer group 2, member D (NKG2D) is considered critical but not the only activating receptor for NK cells, we investigated the role of CRACC in this model. We found that CRACC was abundant on hepatic NK cells but with low expression levels on Kupffer cells under normal conditions. Expression of CRACC on NK cells and Kupffer cells was remarkably upregulated after poly I:C injection. Hepatic CRACC mRNA levels were also upregulated in Poly I:C/D-GalN-treated mice, and correlated positively with the serum alanine aminotransferase (ALT) levels. CRACC expression on Kupffer cells was specifically silenced by nano-particle encapsulated siRNA in vivo, which significantly reduced Poly I:C/D-GalN-induced liver injury. In co-culture experiments, it was further verified that silencing CRACC expression or blockade of CRACC activation by mAb reduced the production of interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. Collectively, our findings suggest that CRACC-CRACC interaction between NK cells and resident Kupffer cells contributes to Poly I:C/D-GalN-induced fulminant hepatitis.	[Li, Yangxi; Cao, Guoshuai; Zheng, Xiaodong; Wang, Jun; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei, Anhui, Peoples R China; [Wang, Jun; Wei, Haiming; Tian, Zhigang; Sun, Rui] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, R (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei, Anhui, Peoples R China.	sunr@ustc.edu.cn	Zheng, Xiaodong/N-2830-2013; Li, Yangxi/AFZ-9382-2022; Wang, Jun/F-9033-2011; Tian, Zhigang/J-3512-2013	Li, Yangxi/0000-0003-4579-1080; Wang, Jun/0000-0001-9957-9208; 	Ministry of Science & Technology of China (973 Basic Science Project) [2013CB530506, 2010CB911901]; Natural Science Foundation of China [91029303, 31021061, 30911120480]	Ministry of Science & Technology of China (973 Basic Science Project); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science & Technology of China (973 Basic Science Project 2013CB530506, 2010CB911901), Natural Science Foundation of China (91029303, 31021061, 30911120480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chen M, 2005, J IMMUNOL, V175, P1047, DOI 10.4049/jimmunol.175.2.1047; Choi HG, 2012, INT IMMUNOPHARMACOL, V13, P271, DOI 10.1016/j.intimp.2012.04.016; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Fasth AER, 2010, EUR J IMMUNOL, V40, P378, DOI 10.1002/eji.200939399; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; Hsi ED, 2008, CLIN CANCER RES, V14, P2775, DOI 10.1158/1078-0432.CCR-07-4246; Ishikawa E, 2005, J VIROL, V79, P7658, DOI 10.1128/JVI.79.12.7658-7663.2005; Kim JR, 2010, CLIN EXP IMMUNOL, V160, P348, DOI 10.1111/j.1365-2249.2010.04116.x; Kramer B, 2013, INFECT IMMUN, V81, P690, DOI [10.1128/IAI.00895-12, 10.1128/IAI.00895]; Li FA, 2012, J VIROL, V86, P2251, DOI 10.1128/JVI.06209-11; Miyazawa Y, 1998, HEPATOLOGY, V27, P497, DOI 10.1002/hep.510270225; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rethi B, 2006, BLOOD, V107, P2821, DOI 10.1182/blood-2005-06-2265; Schroeder A, 2010, J INTERN MED, V267, P9, DOI 10.1111/j.1365-2796.2009.02189.x; SEGLEN PO, 1976, METHOD CELL BIOL, V13, P2, DOI DOI 10.1016/S0091-679X(08)61797-5.PUBMED:177845; Shi B, 2011, J HISTOCHEM CYTOCHEM, V59, P727, DOI 10.1369/0022155411410885; Sintes J, 2010, J LEUKOCYTE BIOL, V88, P687, DOI 10.1189/jlb.1109756; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Waggoner SN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00377; Wang J, 2006, J HEPATOL, V44, P446, DOI 10.1016/j.jhep.2005.08.015; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wu Y, 2013, HEPATOLOGY, V57, P1107, DOI 10.1002/hep.26192; Yang XZ, 2011, J CONTROL RELEASE, V156, P203, DOI 10.1016/j.jconrel.2011.07.035; Zhou Z, 2012, IEEE ICC, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0036928.PUBMED:22629344	34	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76681	10.1371/journal.pone.0076681	http://dx.doi.org/10.1371/journal.pone.0076681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098802	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500173
J	Alves, AC; Bruhn, S; Ramasamy, A; Wang, H; Holloway, JW; Hartikainen, AL; Jarvelin, MR; Benson, M; Balding, DJ; Coin, LJM				Alves, Alexessander Couto; Bruhn, Soren; Ramasamy, Adaikalavan; Wang, Hui; Holloway, John W.; Hartikainen, Anna-Liisa; Jarvelin, Marjo-Riitta; Benson, Mikael; Balding, David J.; Coin, Lachlan J. M.			Dysregulation of Complement System and CD4+T Cell Activation Pathways Implicated in Allergic Response	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SET ENRICHMENT ANALYSIS; NETWORK-BASED ANALYSIS; T-CELLS; MICROARRAY EXPERIMENTS; IMMUNE-RESPONSES; GENE-EXPRESSION; NASAL-MUCOSA; RHINITIS; ASTHMA	Allergy is a complex disease that is likely to involve dysregulated CD4+ T cell activation. Here we propose a novel methodology to gain insight into how coordinated behaviour emerges between disease-dysregulated pathways in response to pathophysiological stimuli. Using peripheral blood mononuclear cells of allergic rhinitis patients and controls cultured with and without pollen allergens, we integrate CD4+ T cell gene expression from microarray data and genetic markers of allergic sensitisation from GWAS data at the pathway level using enrichment analysis; implicating the complement system in both cellular and systemic response to pollen allergens. We delineate a novel disease network linking T cell activation to the complement system that is significantly enriched for genes exhibiting correlated gene expression and protein-protein interactions, suggesting a tight biological coordination that is dysregulated in the disease state in response to pollen allergen but not to diluent. This novel disease network has high predictive power for the gene and protein expression of the Th2 cytokine profile (IL-4, IL-5, IL-10, IL-13) and of the Th2 master regulator (GATA3), suggesting its involvement in the early stages of CD4+ T cell differentiation. Dissection of the complement system gene expression identifies 7 genes specifically associated with atopic response to pollen, including C1QR1, CFD, CFP, ITGB2, ITGAX and confirms the role of C3AR1 and C5AR1. Two of these genes (ITGB2 and C3AR1) are also implicated in the network linking complement system to T cell activation, which comprises 6 differentially expressed genes. C3AR1 is also significantly associated with allergic sensitisation in GWAS data.	[Alves, Alexessander Couto; Ramasamy, Adaikalavan; Jarvelin, Marjo-Riitta; Balding, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Ramasamy, Adaikalavan] Kings Coll London, Dept Med & Mol Genet, London, England; [Balding, David J.] UCL, Genet Inst, London WC1E 6BT, England; [Bruhn, Soren; Wang, Hui; Benson, Mikael] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Holloway, John W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Wang, Hui] Gothenburg Univ, Dept Paediat, Gothenburg, Sweden; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Hosp Oulu, Unit Gen Practice, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Coin, Lachlan J. M.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Coin, Lachlan J. M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Imperial College London; University of London; King's College London; University of London; University College London; Linkoping University; University of Southampton; University of Gothenburg; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Imperial College London; University of Queensland	Alves, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England.	acoutoal@imperial.ac.uk; l.coin@imperial.ac.uk	Balding, David/G-9898-2011; Ramasamy, Adaikalavan/G-2632-2010; Coin, Lachlan JM/A-9001-2014; Coin, Lachlan/O-4976-2019; Holloway, John W/B-5424-2009	Balding, David/0000-0002-1480-6115; Ramasamy, Adaikalavan/0000-0002-7598-2892; Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Holloway, John W/0000-0001-9998-0464; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Couto Alves, Alex/0000-0001-8519-7356	European Commission [223367]; Academy of Finland (Centre of Excellence in Complex Disease Genetics and SALVE) [104781, 120315, 129269, 1114194, 139900/24300796]; University Hospital Oulu; Biocenter; University of Oulu [75617]; NHLBI through STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project [HEALTH-F4-2007-201413]; Medical Research Council, UK (PrevMetSyn/SALVE); Academy of Finland; Biocentrum Helsinki; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland (Centre of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu; Biocenter; University of Oulu; NHLBI through STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK (PrevMetSyn/SALVE)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Biocentrum Helsinki; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	ACA, LC, DB, SB, JH, and MB acknowledge funding from European Commission, Framework 7, grant number 223367 (MultiMod). NFBC1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, 139900/24300796, Centre of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu (75617), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706:02), ENGAGE project HEALTH-F4-2007-201413, the Medical Research Council, UK (PrevMetSyn/SALVE). The DNA extractions, sample quality controls, biobank upkeep and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz M, 1970, PEDIATRICS, V46; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Alves A, 2005, P ECML PKDD DISC CHA, P60; ANDERSSON M, 1994, ALLERGY, V49, P242, DOI 10.1111/j.1398-9995.1994.tb02656.x; Barrenas F, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r46; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson M, 2006, GENES IMMUN, V7, P514, DOI 10.1038/sj.gene.6364322; Benson M, 2006, J ALLERGY CLIN IMMUN, V118, P220, DOI 10.1016/j.jaci.2006.03.006; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CHEN A, 1994, J IMMUNOL, V153, P1430; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Colak R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013348; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Deng J, 2002, INT IMMUNOL, V14, P513, DOI 10.1093/intimm/14.5.513; Fang C, 2011, BLOOD; Gandibleux X., 2002, MULTIPLE CRITERIA OP; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hansel NN, 2008, ALLERGY, V63, P366, DOI 10.1111/j.1398-9995.2007.01540.x; Hawlisch H, 2004, MOL IMMUNOL, V41, P123, DOI 10.1016/j.molimm.2004.03.019; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hu PZ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunninghake GM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-17; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Johnson T, 2010, QUICKTEST QUICK TEST; Jun SW, 2008, J ALLERGY CLIN IMMUN, V122, P119, DOI 10.1016/j.jaci.2008.04.028; Kawamoto S, 2004, J CLIN INVEST, V114, P399, DOI 10.1172/jci200419082; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kemp KL, 2010, J IMMUNOL, V184, P4178, DOI 10.4049/jimmunol.0901282; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kneidinger M, 2008, BLOOD, V111, P3097, DOI 10.1182/blood-2007-08-104372; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Lalli PN, 2007, J IMMUNOL, V179, P5793, DOI 10.4049/jimmunol.179.9.5793; Lambrecht BN, 2006, J CLIN INVEST, V116, P628, DOI 10.1172/JCI27876; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Lumley T, 2009, RMETA METAANALYSIS R; Mak TW, 1998, GENE KNOCKOUT FACTSB; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pekkarinen PT, 2011, IMMUNOBIOLOGY, V216, P737, DOI 10.1016/j.imbio.2010.10.004; Ramasamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044008; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; SCHWAEBLE W, 1993, J IMMUNOL, V151, P2521; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szczepankiewicz A, 2008, INT ARCH ALLERGY IMM, V145, P43, DOI 10.1159/000107465; Takeda K, 2011, J IMMUNOLOGY; Tamura T, 2001, J IMMUNOL, V167, P1962, DOI 10.4049/jimmunol.167.4.1962; VARNEY VA, 1992, AM REV RESPIR DIS, V146, P170, DOI 10.1164/ajrccm/146.1.170; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wambre E, 2011, CLIN EXP ALLERGY, V41, P192, DOI 10.1111/j.1365-2222.2010.03641.x; Wang H, 2011, ALLERGY, V66, P132, DOI 10.1111/j.1398-9995.2010.02444.x; Wang H, 2010, CLIN EXP ALLERGY, V40, P1194, DOI 10.1111/j.1365-2222.2010.03542.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang X, 2011, BIOINFORMATICS, V27, P879, DOI 10.1093/bioinformatics/btr028; Wills-Karp Marsha, 2007, Proc Am Thorac Soc, V4, P247, DOI 10.1513/pats.200704-046AW; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xiong Q, 2012, GENOME RES, V22, P386, DOI 10.1101/gr.124370.111; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84; Zhao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039016	73	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e74821	10.1371/journal.pone.0074821	http://dx.doi.org/10.1371/journal.pone.0074821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116013	Green Published, Green Accepted, gold			2022-12-27	WOS:000325552200004
J	Chaves-Kirsten, GP; Mazucanti, CHY; Real, CC; Souza, BM; Britto, LRG; Torrao, AS				Chaves-Kirsten, Gabriela P.; Mazucanti, Caio H. Y.; Real, Caroline C.; Souza, Bruna M.; Britto, Luiz R. G.; Torrao, Andrea S.			Temporal Changes of CB1 Cannabinoid Receptor in the Basal Ganglia as a Possible Structure-Specific Plasticity Process in 6-OHDA Lesioned Rats	PLOS ONE			English	Article							NIGROSTRIATAL DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; ENDOCANNABINOID SYSTEM; MESSENGER-RNA; ENDOGENOUS CANNABINOIDS; GLOBUS-PALLIDUS; IN-VIVO; MODEL; EXPRESSION; MPTP	The endocannabinoid system has been implicated in several neurobiological processes, including neurodegeneration, neuroprotection and neuronal plasticity. The CB1 cannabinoid receptors are abundantly expressed in the basal ganglia, the circuitry that is mostly affected in Parkinson's Disease (PD). Some studies show variation of CB1 expression in basal ganglia in different animal models of PD, however the results are quite controversial, due to the differences in the procedures employed to induce the parkinsonism and the periods analyzed after the lesion. The present study evaluated the CB1 expression in four basal ganglia structures, namely striatum, external globus pallidus (EGP), internal globus pallidus (IGP) and substantia nigra pars reticulata (SNpr) of rats 1, 5, 10, 20, and 60 days after unilateral intrastriatal 6-hydroxydopamine injections, that causes retrograde dopaminergic degeneration. We also investigated tyrosine hydroxylase (TH), parvalbumin, calbindin and glutamic acid decarboxylase (GAD) expression to verify the status of dopaminergic and GABAergic systems. We observed a structure-specific modulation of CB1 expression at different periods after lesions. In general, there were no changes in the striatum, decreased CB1 in IGP and SNpr and increased CB1 in EGP, but this increase was not sustained over time. No changes in GAD and parvalbumin expression were observed in basal ganglia, whereas TH levels were decreased and the calbindin increased in striatum in short periods after lesion. We believe that the structure-specific variation of CB1 in basal ganglia in the 6-hydroxydopamine PD model could be related to a compensatory process involving the GABAergic transmission, which is impaired due to the lack of dopamine. Our data, therefore, suggest that the changes of CB1 and calbindin expression may represent a plasticity process in this PD model.	[Chaves-Kirsten, Gabriela P.; Souza, Bruna M.; Torrao, Andrea S.] Univ Sao Paulo, Dept Physiol & Biophys, Lab Neuronal Commun, Sao Paulo, Brazil; [Mazucanti, Caio H. Y.] Univ Sao Paulo, Dept Pharmacol, Lab Mol Neuropharmacol, Sao Paulo, Brazil; [Real, Caroline C.; Britto, Luiz R. G.] Univ Sao Paulo, Dept Physiol & Biophys, Lab Cellular Neurobiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Chaves-Kirsten, GP (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Lab Neuronal Commun, Sao Paulo, Brazil.	gabipc@icb.usp.br	Mazucanti, Caio/AAI-4704-2021; Torrao, Andrea S/C-2353-2012; Real, Caroline C/N-1674-2013	Mazucanti, Caio/0000-0001-9144-4886; Torrao, Andrea S/0000-0001-6301-3448; Real, Caroline C/0000-0001-6096-3341	FAPESP CNPq University of Sao Paulo - NAPNA	FAPESP CNPq University of Sao Paulo - NAPNA	FAPESP CNPq University of Sao Paulo - NAPNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, EUR J NEUROSCI, V9, P120, DOI 10.1111/j.1460-9568.1997.tb01360.x; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Allen KL, 2009, J CHEM NEUROANAT, V37, P266, DOI 10.1016/j.jchemneu.2009.02.001; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Baek JH, 2011, NEUROSCI LETT, V487, P330, DOI 10.1016/j.neulet.2010.10.050; Benarroch E, 2007, NEUROLOGY, V69, P306, DOI 10.1212/01.wnl.0000267407.79757.75; Blandini F, 2007, EUR J NEUROSCI, V25, P397, DOI 10.1111/j.1460-9568.2006.05285.x; Blandini Fabio, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS124, DOI 10.1016/j.parkreldis.2008.04.015; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brotchie JM, 2003, CURR OPIN PHARMACOL, V3, P54, DOI 10.1016/S1471-4892(02)00011-5; Cabranes A, 2005, NEUROBIOL DIS, V20, P207, DOI 10.1016/j.nbd.2005.03.002; Casteels C, 2011, EXP NEUROL, V229, P440, DOI 10.1016/j.expneurol.2011.03.014; Casteels C, 2010, BRAIN RES, V1316, P153, DOI 10.1016/j.brainres.2009.12.026; Chaves GP, 2008, J NEUROSCI RES, V86, P1626, DOI 10.1002/jnr.21613; Chung YC, 2011, J IMMUNOL, V187, P6508, DOI 10.4049/jimmunol.1102435; de Lago Eva, 2007, CNS & Neurological Disorders-Drug Targets, V6, P377; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Dowie MJ, 2009, NEUROSCIENCE, V163, P456, DOI 10.1016/j.neuroscience.2009.06.014; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Fernandez-Ruiz J, 2009, BRIT J PHARMACOL, V156, P1029, DOI 10.1111/j.1476-5381.2008.00088.x; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Garcia-Arencibia M, 2007, BRAIN RES, V1134, P162, DOI 10.1016/j.brainres.2006.11.063; Garcia-Arencibia M, 2009, J NEURAL TRANSM-SUPP, P269, DOI 10.1007/978-3-211-92660-4_22; Garcia-Arencibia M, 2009, CNS NEUROL DISORD-DR, V8, P432, DOI 10.2174/187152709789824642; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gonzalez S, 2006, BRAIN RES, V1073, P209, DOI 10.1016/j.brainres.2005.12.014; Gubellini P, 2002, J NEUROSCI, V22, P6900; HERKENHAM M, 1991, BRAIN RES, V547, P267, DOI 10.1016/0006-8993(91)90970-7; Hontanilla B, 1998, BRAIN RES BULL, V47, P107, DOI 10.1016/S0361-9230(98)00035-5; Hu H, 2012, NEUROSCIENCE, V227, P211, DOI 10.1016/j.neuroscience.2012.09.067; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Hurley MJ, 2003, J NEURAL TRANSM, V110, P1279, DOI 10.1007/s00702-003-0033-7; Karlocai MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027196; KITA H, 1994, BRAIN RES, V657, P31, DOI 10.1016/0006-8993(94)90950-4; Lastres-Becker I, 2005, NEUROBIOL DIS, V19, P96, DOI 10.1016/j.nbd.2004.11.009; Lastres-Becker I, 2001, EUR J NEUROSCI, V14, P1827, DOI 10.1046/j.0953-816x.2001.01812.x; Leonelli M, 2005, DEV BRAIN RES, V156, P176, DOI 10.1016/j.devbrainres.2005.02.009; Matyas F, 2006, NEUROSCIENCE, V137, P337, DOI 10.1016/j.neuroscience.2005.09.005; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Morera-Herreras T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00110; Ng MC, 1996, MOL BRAIN RES, V36, P329, DOI 10.1016/0169-328X(95)00266-U; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; Papa SM, 2008, EXP NEUROL, V211, P334, DOI 10.1016/j.expneurol.2008.03.009; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; Romero J, 2000, LIFE SCI, V66, P485, DOI 10.1016/S0024-3205(99)00618-9; Sanchez AJ, 2012, CLIN IMMUNOL, V142, P57, DOI 10.1016/j.clim.2011.02.010; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Silverdale MA, 2001, EXP NEUROL, V169, P400, DOI 10.1006/exnr.2001.7649; Tanaka KI, 2006, NEUROSCI LETT, V410, P85, DOI 10.1016/j.neulet.2006.08.021; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Van Laere K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.009; Van Waes V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00021; Venderova K, 2005, EXP NEUROL, V194, P284, DOI 10.1016/j.expneurol.2005.02.012; Walsh S, 2010, BRAIN RES BULL, V81, P543, DOI 10.1016/j.brainresbull.2010.01.009; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Xia RP, 2012, NEUROSCI BULL, V28, P39, DOI 10.1007/s12264-012-1050-z	60	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76874	10.1371/journal.pone.0076874	http://dx.doi.org/10.1371/journal.pone.0076874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116178	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200082
J	Feroz, SR; Mohamad, SB; Bakri, ZSD; Malek, SNA; Tayyab, S				Feroz, Shevin R.; Mohamad, Saharuddin B.; Bakri, Zarith S. D.; Malek, Sri N. A.; Tayyab, Saad			Probing the Interaction of a Therapeutic Flavonoid, Pinostrobin with Human Serum Albumin: Multiple Spectroscopic and Molecular Modeling Investigations	PLOS ONE			English	Article							LIGAND-BINDING; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; SUBDOMAIN IIA; PROTEIN; THERMODYNAMICS; DENATURATION; STABILITY; BILIRUBIN; SITES	Interaction of a pharmacologically important flavonoid, pinostrobin (PS) with the major transport protein of human blood circulation, human serum albumin (HSA) has been examined using a multitude of spectroscopic techniques and molecular docking studies. Analysis of the fluorescence quenching data showed a moderate binding affinity (1.03 x 10(5) M-1 at 25 degrees C) between PS and HSA with a 1: 1 stoichiometry. Thermodynamic analysis of the binding data (Delta S = +44.06 J mol(-1) K-1 and Delta H = -15.48 kJ mol(-1)) and molecular simulation results suggested the involvement of hydrophobic and van der Waals forces, as well as hydrogen bonding in the complex formation. Both secondary and tertiary structural perturbations in HSA were observed upon PS binding, as revealed by intrinsic, synchronous, and three-dimensional fluorescence results. Far-UV circular dichroism data revealed increased thermal stability of the protein upon complexation with PS. Competitive drug displacement results suggested the binding site of PS on HSA as Sudlow's site I, located at subdomain IIA, and was well supported by the molecular modelling data.	[Feroz, Shevin R.; Bakri, Zarith S. D.; Malek, Sri N. A.; Tayyab, Saad] Univ Malaya, Fac Sci, Inst Biol Sci, Biomol Res Grp,Biochem Programme, Kuala Lumpur, Malaysia; [Mohamad, Saharuddin B.] Univ Malaya, Fac Sci, Inst Biol Sci, Bioinformat Programme, Kuala Lumpur, Malaysia; [Mohamad, Saharuddin B.; Tayyab, Saad] Univ Malaya, Fac Sci, Inst Biol Sci, Ctr Res Computat Sci & Informat Biol Bioind Envir, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Tayyab, S (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Biomol Res Grp,Biochem Programme, Kuala Lumpur, Malaysia.	saadtayyab2004@yahoo.com	TAYYAB, SAAD/B-5490-2010; Malek, Sri Nurestri/W-8556-2019; MOHAMAD, SAHARUDDIN/B-9665-2010; Malek, Sri Nurestri Abd/B-9834-2010; Feroz, Shevin Rizal/AAZ-9913-2020	TAYYAB, SAAD/0000-0003-1826-3098; Malek, Sri Nurestri/0000-0001-6278-8559; Malek, Sri Nurestri Abd/0000-0001-6278-8559; Feroz, Shevin Rizal/0000-0002-9426-2911	HIR Grant by the Ministry of Higer Education, Government of Malaysia [F000002-21001]	HIR Grant by the Ministry of Higer Education, Government of Malaysia	This work was financially supported by an HIR Grant (F000002-21001) sanctioned by the Ministry of Higer Education, Government of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zied OK, 2008, J AM CHEM SOC, V130, P10793, DOI 10.1021/ja8031289; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003; Dangles O., 2006, Flavonoids: chemistry, biochemistry and applications, P443; Demchenko A.P., 2009, INTRO FLUORESCENCE S; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Fahey JF, 2002, J AGR FOOD CHEM, V50, P7472, DOI 10.1021/jf025692k; Faizul FM, 2008, J PHOTOCH PHOTOBIO B, V90, P1, DOI 10.1016/j.jphotobiol.2007.10.002; Feroz SR, 2012, J AGR FOOD CHEM, V60, P5899, DOI 10.1021/jf301139h; Freitas PG, 2012, J LUMIN, V132, P3027, DOI 10.1016/j.jlumin.2012.06.020; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; JACOBSEN J, 1974, CLIN CHEM, V20, P783; Kalanur SS, 2010, J PHARMACEUT BIOMED, V53, P660, DOI 10.1016/j.jpba.2010.05.025; KHANNA NC, 1986, J BIOL CHEM, V261, P8883; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Le Bail JC, 2000, CANCER LETT, V156, P37, DOI 10.1016/S0304-3835(00)00435-3; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Ross PD, 1996, BIOPHYS J, V71, P2144, DOI 10.1016/S0006-3495(96)79415-8; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Saquib Q, 2011, FOOD CHEM TOXICOL, V49, P1787, DOI 10.1016/j.fct.2011.04.028; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Trnkova L, 2011, J MOL STRUCT, V985, P243, DOI 10.1016/j.molstruc.2010.11.001; Trynda-Lemiesz L, 2004, BIOORGAN MED CHEM, V12, P3269, DOI 10.1016/j.bmc.2004.03.073; Twine SM, 2003, ARCH BIOCHEM BIOPHYS, V414, P83, DOI 10.1016/S0003-9861(03)00173-5; van de Weert M, 2011, J MOL STRUCT, V998, P144, DOI 10.1016/j.molstruc.2011.05.023; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; WALLEVIK K, 1973, J BIOL CHEM, V248, P2650; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Wu D, 2002, J AGR FOOD CHEM, V50, P701, DOI 10.1021/jf010963x; Wu N, 2011, PHYTOMEDICINE, V18, P110, DOI 10.1016/j.phymed.2010.07.001; Zaroog MS, 2012, PROCESS BIOCHEM, V47, P775, DOI 10.1016/j.procbio.2012.02.008	42	75	79	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76067	10.1371/journal.pone.0076067	http://dx.doi.org/10.1371/journal.pone.0076067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116089	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200048
J	Woody, S; Stall, R; Ramos, J; Patel, YM				Woody, Shelly; Stall, Richard; Ramos, Joseph; Patel, Yashomati M.			Regulation of Myosin Light Chain Kinase during Insulin-Stimulated Glucose Uptake in 3T3-L1 Adipocytes	PLOS ONE			English	Article							GLUT4 VESICLE TRANSLOCATION; DEPENDENT PROTEIN-KINASE; ADIPOSE CELL; MUSCLE-CELLS; PHOSPHORYLATION; TRANSPORT; MEMBRANE; EXOCYTOSIS; FUSION; MYO1C	Myosin II (MyoII) is required for insulin-responsive glucose transporter 4 (GLUT4)-mediated glucose uptake in 3T3-L1 adipocytes. Our previous studies have shown that insulin signaling stimulates phosphorylation of the regulatory light chain (RLC) of MyoIIA via myosin light chain kinase (MLCK). The experiments described here delineate upstream regulators of MLCK during insulin-stimulated glucose uptake. Since 3T3-L1 adipocytes express two MyoII isoforms, we wanted to determine which isoform was required for insulin-stimulated glucose uptake. Using a siRNA approach, we demonstrate that a 60% decrease in MyoIIA protein expression resulted in a 40% inhibition of insulin-stimulated glucose uptake. We also show that insulin signaling stimulates the phosphorylation of MLCK. We further show that MLCK can be activated by calcium as well as signaling pathways. We demonstrate that adipocytes treated with the calcium chelating agent, 1,2-b (iso-aminophenoxy) ethane-N,N,N',N'-tetra acetic acid, (BAPTA) (in the presence of insulin) impaired the insulin-induced phosphorylation of MLCK by 52% and the RLC of MyoIIA by 45% as well as impairing the recruitment of MyoIIA to the plasma membrane when compared to cells treated with insulin alone. We further show that the calcium ionophore, A23187 alone stimulated the phosphorylation of MLCK and the RLC associated with MyoIIA to the same extent as insulin. To identify signaling pathways that might regulate MLCK, we examined ERK and CaMKII. Inhibition of ERK2 impaired phosphorylation of MLCK and insulin-stimulated glucose uptake. In contrast, while inhibition of CaMKII did inhibit phosphorylation of the RLC associated with MyoIIA, inhibition of CAMKIId did not impair MLCK phosphorylation or translocation to the plasma membrane or glucose uptake. Collectively, our results are the first to delineate a role for calcium and ERK in the activation of MLCK and thus MyoIIA during insulin-stimulated glucose uptake in 3T3-L1 adipocytes.	[Woody, Shelly; Stall, Richard; Ramos, Joseph; Patel, Yashomati M.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro	Patel, YM (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	ympatel@uncg.edu			National Institutes of Health [2R15DK073180-02A1]; National Science Foundation [DBI-0319021]; North Carolina Biotechnology Center [003-IDG-1011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK073180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); North Carolina Biotechnology Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an National Institutes of Health grant to Y.M.P. (2R15DK073180-02A1). Microscopy studies were supported in part by grants from the National Science Foundation (DBI-0319021) and the North Carolina Biotechnology Center (003-IDG-1011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti L, 1999, MOL CELL ENDOCRINOL, V157, P121, DOI 10.1016/S0303-7207(99)00154-9; Bessard A, 2006, HEPATOLOGY, V44, P152, DOI 10.1002/hep.21222; Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Brozinick JT, 1999, BIOCHEM J, V339, P533, DOI 10.1042/0264-6021:3390533; Choi YO, 2006, EXP MOL MED, V38, P180, DOI 10.1038/emm.2006.22; Chung LTK, 2010, BIOCHEM BIOPH RES CO, V391, P995, DOI 10.1016/j.bbrc.2009.12.004; CONTI MA, 1981, J BIOL CHEM, V256, P3178; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Fulcher FK, 2008, EXP CELL RES, V314, P3264, DOI 10.1016/j.yexcr.2008.08.007; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Harmon AW, 2004, AM J PHYSIOL-ENDOC M, V287, pE758, DOI 10.1152/ajpendo.00581.2003; Hartshorne DJ, 1998, ACTA PHYSIOL SCAND, V164, P483; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; IKEBE M, 1990, J BIOL CHEM, V265, P8975; Illario M, 2009, CELL SIGNAL, V21, P786, DOI 10.1016/j.cellsig.2009.01.022; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Konstantopoulos N, 2007, ENDOCRINOLOGY, V148, P374, DOI 10.1210/en.2006-0446; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mitra P, 2004, J BIOL CHEM, V279, P37431, DOI 10.1074/jbc.C400180200; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Steimle PA, 2005, BIOCHEM BIOPH RES CO, V331, P1560, DOI 10.1016/j.bbrc.2005.04.082; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Toyoda T, 2011, J BIOL CHEM, V286, P4133, DOI 10.1074/jbc.M110.174938; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Worrall DS, 2002, MOL ENDOCRINOL, V16, P378, DOI 10.1210/me.16.2.378; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810; Zhang JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045976	47	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77248	10.1371/journal.pone.0077248	http://dx.doi.org/10.1371/journal.pone.0077248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116218	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200110
J	Nagai, K; Tahara-Hanaoka, S; Morishima, Y; Tokunaga, T; Imoto, Y; Noguchi, E; Kanemaru, K; Imai, M; Shibayama, S; Hizawa, N; Fujieda, S; Yamagata, K; Shibuya, A				Nagai, Kei; Tahara-Hanaoka, Satoko; Morishima, Yuko; Tokunaga, Takahiro; Imoto, Yoshimasa; Noguchi, Emiko; Kanemaru, Kazumasa; Imai, Masamichi; Shibayama, Shiro; Hizawa, Nobuyuki; Fujieda, Shigeharu; Yamagata, Kunihiro; Shibuya, Akira			Expression and Function of Allergin-1 on Human Primary Mast Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; BRONCHOALVEOLAR LAVAGE; IMMUNE-RESPONSES; ACTIVATION; IMMUNORECEPTOR; IDENTIFICATION; BASOPHILS; CYTOKINES; ANTIGENS; INNATE	Mast cells (MC) play an important role in allergic and non-allergic immune responses. Activation of human MC is modulated by several cell surface inhibitory receptors, including recently identified Allergin-1 expressed on both human and mouse MC. Although Allergin-1 suppresses IgE-mediated, mast cell-dependent anaphylaxis in mice, the expression profile and function of Allergin-1 on human primary MC remains undetermined. Here, we established a seven-color flow cytometry method for assessing expression and function of a very small number of human primary MC. We show that Allergin-1S1, a splicing isoform of Allergin-1, is predominantly expressed on human primary MC in both bronchoalveolar lavage (BAL) fluid and nasal scratching specimens. Moreover, Allergin-1S1 inhibits IgE-mediated activation from human primary MC in BAL fluid. These results indicate that Allergin-1 on human primary MC exhibits similar characteristics as mouse Allergin-1 in the expression profile and function.	[Nagai, Kei; Tahara-Hanaoka, Satoko; Kanemaru, Kazumasa; Shibuya, Akira] Univ Tsukuba, Dept Immunol, Fac Med, Tsukuba, Ibaraki, Japan; [Nagai, Kei; Yamagata, Kunihiro] Univ Tsukuba, Dept Nephrol, Fac Med, Tsukuba, Ibaraki, Japan; [Morishima, Yuko; Hizawa, Nobuyuki] Univ Tsukuba, Dept Pulm Med, Fac Med, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Fac Med, Tsukuba, Ibaraki, Japan; [Nagai, Kei; Tahara-Hanaoka, Satoko; Noguchi, Emiko; Kanemaru, Kazumasa; Shibuya, Akira] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Tokunaga, Takahiro; Imoto, Yoshimasa; Fujieda, Shigeharu] Univ Fukui, Dept Otorhinolaryngol & Head & Neck Surg, Fukui 910, Japan; [Imai, Masamichi; Shibayama, Shiro] Ono Pharmaceut Co Ltd, Tsukuba Res Inst, Exploratory Res Labs, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Fukui; Novartis; Ono Pharmaceutical Co Ltd	Shibuya, A (corresponding author), Univ Tsukuba, Dept Immunol, Fac Med, Tsukuba, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp		Nagai, Kei/0000-0001-5050-5291	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This research was supported in part by grants provided by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; CASALE TB, 1987, J CLIN INVEST, V79, P1197, DOI 10.1172/JCI112937; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Chlap Z, 1998, Pneumonol Alergol Pol, V66, P321; Florian S, 2006, ALLERGY, V61, P1054, DOI 10.1111/j.1398-9995.2006.01171.x; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gekara NO, 2008, CELL MICROBIOL, V10, P225, DOI 10.1111/j.1462-5822.2007.01033.x; Grutzkau A, 2004, CYTOM PART A, V61A, P62, DOI 10.1002/cyto.a.20068; HASLAM PL, 1987, AM REV RESPIR DIS, V135, P35; Hauswirth Alexander W, 2006, Methods Mol Biol, V315, P77; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; HUNT LW, 1992, MAYO CLIN PROC, V67, P941, DOI 10.1016/S0025-6196(12)60924-0; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lienard H, 1999, J BIOL CHEM, V274, P32493, DOI 10.1074/jbc.274.45.32493; Malbec O, 1998, J IMMUNOL, V160, P1647; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Oskeritzian CA, 2010, J EXP MED, V207, P465, DOI 10.1084/jem.20091513; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Schildge J, 2003, Pneumologie, V57, P202, DOI 10.1055/s-2003-38569; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; SOLER P, 1987, THORAX, V42, P565, DOI 10.1136/thx.42.8.565; Valent F, 2001, IMMUNOL REV, V179, P74, DOI 10.1034/j.1600-065X.2001.790108.x; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76160	10.1371/journal.pone.0076160	http://dx.doi.org/10.1371/journal.pone.0076160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116093	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300048
J	Allan, G; Ouadid-Ahidouch, H; Sanchez-Fernandez, EM; Risquez-Cuadro, R; Fernandez, JMG; Ortiz-Mellet, C; Ahidouch, A				Allan, Ghada; Ouadid-Ahidouch, Halima; Sanchez-Fernandez, Elena M.; Risquez-Cuadro, Rocio; Garcia Fernandez, Jose M.; Ortiz-Mellet, Carmen; Ahidouch, Ahmed			New Castanospermine Glycoside Analogues Inhibit Breast Cancer Cell Proliferation and Induce Apoptosis without Affecting Normal Cells	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; HUMAN HEPATOCELLULAR-CARCINOMA; N-LINKED OLIGOSACCHARIDES; CYCLIN-DEPENDENT KINASES; ENDOPLASMIC-RETICULUM; PROGNOSTIC MARKER; IN-VITRO; PHARMACOLOGICAL CHAPERONES; GM(1) GANGLIOSIDOSIS; TUMOR-GROWTH	sp(2)-Iminosugar-type castanospermine analogues have been shown to exhibit anti-tumor activity. However, their effects on cell proliferation and apoptosis and the molecular mechanism at play are not fully understood. Here, we investigated the effect of two representatives, namely the pseudo-S-and C-octyl glycoside 2-oxa-3-oxocastanospermine derivatives SO-OCS and CO-OCS, on MCF-7 and MDA-MB-231 breast cancer and MCF-10A mammary normal cell lines. We found that SO-OCS and CO-OCS inhibited breast cancer cell viability in a concentration-and time-dependent manner. This effect is specific to breast cancer cells as both molecules had no impact on normal MCF-10A cell proliferation. Both drugs induced a cell cycle arrest. CO-OCS arrested cell cycle at G1 and G2/M in MCF-7 and MDA-MB-231cells respectively. In MCF-7 cells, the G1 arrest is associated with a reduction of CDK4 (cyclin-dependent kinase 4), cyclin D1 and cyclin E expression, pRb phosphorylation, and an overexpression of p21(Waf1/Cip1). In MDA-MB-231 cells, CO-OCS reduced CDK1 but not cyclin B1 expression. SO-OCS accumulated cells in G2/M in both cell lines and this blockade was accompanied by a decrease of CDK1, but not cyclin B1 expression. Furthermore, both drugs induced apoptosis as demonstrated by the increased percentage of annexin V positive cells and Bax/Bcl-2 ratio. Interestingly, in normal MCF-10A cells the two drugs failed to modify cell proliferation, cell cycle progression, cyclins, or CDKs expression. These results demonstrate that the effect of CO-OCS and SO-OCS is triggered by both cell cycle arrest and apoptosis, suggesting that these castanospermine analogues may constitute potential anti-cancer agents against breast cancer.	[Allan, Ghada; Ouadid-Ahidouch, Halima; Ahidouch, Ahmed] UPJV, Lab Cellular & Mol Physiol EA 4667, SFR CAP SANTE FED 4132, UFR Sci, Amiens, France; [Sanchez-Fernandez, Elena M.; Risquez-Cuadro, Rocio; Ortiz-Mellet, Carmen] Univ Seville, Fac Quim, Dept Quim Organ, E-41071 Seville, Spain; [Garcia Fernandez, Jose M.] Univ Seville, CSIC, IIQ, Seville, Spain; [Ahidouch, Ahmed] Univ Ibn Zohr, Dept Biol, Fac Sci, Agadir, Morocco	Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Ibn Zohr University of Agadir	Ouadid-Ahidouch, H (corresponding author), UPJV, Lab Cellular & Mol Physiol EA 4667, SFR CAP SANTE FED 4132, UFR Sci, Amiens, France.	ha-sciences@u-picardie.fr; aa-lbv@u-picardie.fr	Cuadro, Rísquez/M-3977-2013; Mellet, Carmen Ortiz/C-7993-2011; Sánchez-Fernández, Elena/C-4594-2013; Fernandez, Jose M Garcia/D-8105-2011	Mellet, Carmen Ortiz/0000-0002-7676-7721; Sánchez-Fernández, Elena/0000-0002-8617-8234; Fernandez, Jose M Garcia/0000-0002-6827-0387	"Region Picardie"; "Ministere de la Recherche et de l'Enseignement Superieur"; Syrian Ministry of Higher Education; Ministry of Health; Spanish Ministerio de Economia y Competitividad [SAF2010-15670, CTQ2010-15848]; European Comission; Fondo Europeo de Desarrollo Regional (FEDER); Fondo Social Europeo (FSE); Fundacion Ramon Areces; Junta de Andalucia; FPU; Marie Curie Career Integration Grant	"Region Picardie"(Region Hauts-de-France); "Ministere de la Recherche et de l'Enseignement Superieur"; Syrian Ministry of Higher Education; Ministry of Health; Spanish Ministerio de Economia y Competitividad(Spanish Government); European Comission(European CommissionEuropean Commission Joint Research Centre); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Fondo Social Europeo (FSE)(European Social Fund (ESF)European Commission); Fundacion Ramon Areces; Junta de Andalucia(Junta de Andalucia); FPU(Spanish Government); Marie Curie Career Integration Grant	This work was supported by the "Region Picardie", and the "Ministere de la Recherche et de l'Enseignement Superieur". The authors greatly acknowledge the Syrian Ministry of Higher Education and Ministry of Health for funding the PhD thesis of GA. The Spanish Ministerio de Economia y Competitividad (contract numbers SAF2010-15670 and CTQ2010-15848), the European Comission, the Fondo Europeo de Desarrollo Regional (FEDER), the Fondo Social Europeo (FSE), the Fundacion Ramon Areces and the Junta de Andalucia are gratefully acknowledged for funding. RRC is recipient of a FPU grant. EMSF is recipient of a Marie Curie Career Integration Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Aguilar-Moncayo M, 2012, CHEM COMMUN, V48, P6514, DOI 10.1039/c2cc32065g; Aguilar-Moncayo M, 2009, ORG BIOMOL CHEM, V7, P2738, DOI 10.1039/b906968b; Alfonso P, 2013, CHEMBIOCHEM, V14, P943, DOI 10.1002/cbic.201200708; Alle KM, 1998, CLIN CANCER RES, V4, P847; Bobrovnikova-Marjon E, 2007, DEV CELL, V13, P322, DOI 10.1016/j.devcel.2007.08.006; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; CARLBERG M, 1993, ANTICANCER RES, V13, P167; Chiang PC, 2008, N-S ARCH PHARMACOL, V377, P167, DOI 10.1007/s00210-007-0249-4; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Faouzi M, 2013, BBA-MOL CELL RES, V1833, P752, DOI 10.1016/j.bbamcr.2012.12.009; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; HADWIGER A, 1986, EMBO J, V5, P689, DOI 10.1002/j.1460-2075.1986.tb04268.x; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Home G, 2011, DRUG DISCOV TODAY, V16, P107, DOI 10.1016/j.drudis.2010.08.017; Hsu JL, 2009, N-S ARCH PHARMACOL, V380, P373, DOI 10.1007/s00210-009-0453-5; HUMPHRIES MJ, 1986, CANCER RES, V46, P5215; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jimenez JB, 1997, REV CLIN ESP, V197, P299; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kaufman R. J., 1999, BIOCHIM BIOPHYS ACTA, V1423, P13; KEYOMARSI K, 1994, CANCER RES, V54, P380; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Li ZC, 2012, J BIOSCIENCES, V37, P1005, DOI 10.1007/s12038-012-9265-8; Malumbres M, 2000, BIOL CHEM, V381, P827, DOI 10.1515/BC.2000.105; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MELERO JA, 1978, J CELL PHYSIOL, V95, P295, DOI 10.1002/jcp.1040950307; Nadler Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1998; NGUYEN M, 1992, J BIOL CHEM, V267, P26157; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OSTRANDER GK, 1988, CANCER RES, V48, P1091; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; PILI R, 1995, CANCER RES, V55, P2920; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rudolph P, 2003, INT J CANCER, V105, P674, DOI 10.1002/ijc.11132; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Russo A, 2006, ANN ONCOLOGY OFFI S7, V17; Sanchez-Fernandez EM, 2010, CHEM COMMUN, V46, P5328, DOI 10.1039/c0cc00446d; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skelding KA, 2011, CELL CYCLE, V10, P631, DOI 10.4161/cc.10.4.14798; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; Sun JY, 2007, PHYTOMEDICINE, V14, P353, DOI 10.1016/j.phymed.2006.08.003; Sun JY, 2009, PHYTOMEDICINE, V16, P1070, DOI 10.1016/j.phymed.2009.02.012; Takai T, 2013, MOL THER, V21, P526, DOI 10.1038/mt.2012.263; Tiscornia G, 2013, HUM MOL GENET, V22, P633, DOI 10.1093/hmg/dds471; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; Tsai Yien Che, 2010, Genes Cancer, V1, P764; vanSlooten HJ, 1996, BRIT J CANCER, V74, P78, DOI 10.1038/bjc.1996.319; Veronese S, 1998, INT J CANCER, V79, P13, DOI 10.1002/(SICI)1097-0215(19980220)79:1<13::AID-IJC3>3.0.CO;2-Z; Wang L, 2006, CANCER INVEST, V24, P581, DOI 10.1080/07357900600894799; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wrodnigg TM, 2008, ANTI-CANCER AGENT ME, V8, P77, DOI 10.2174/187152008783330851; Zhao YX, 2008, BIOORGAN MED CHEM, V16, P6333, DOI 10.1016/j.bmc.2008.05.012; Zhao YX, 2010, CHEM BIOL DRUG DES, V75, P570, DOI 10.1111/j.1747-0285.2010.00968.x; ZUKERBERG LR, 1995, MODERN PATHOL, V8, P560	72	40	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76411	10.1371/journal.pone.0076411	http://dx.doi.org/10.1371/journal.pone.0076411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124558	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100115
J	Arya, T; Kishor, C; Saddanapu, V; Reddi, R; Addlagatta, A				Arya, Tarun; Kishor, Chandan; Saddanapu, Venkateshwarlu; Reddi, Ravikumar; Addlagatta, Anthony			Discovery of a New Genetic Variant of Methionine Aminopeptidase from Streptococci with Possible Post-Translational Modifications: Biochemical and Structural Characterization	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; RIBOSOME; ALIGNMENT	Protein N-terminal methionine excision is an essential co-translational process that occurs in the cytoplasm of all organisms. About 60-70% of the newly synthesized proteins undergo this modification. Enzyme responsible for the removal of initiator methionine is methionine aminopeptidase (MetAP), which is a dinuclear metalloprotease. This protein is conserved through all forms of life from bacteria to human except viruses. MetAP is classified into two isoforms, Type I and II. Removal of the map gene or chemical inhibition is lethal to bacteria and to human cell lines, suggesting that MetAP could be a good drug target. In the present study we describe the discovery of a new genetic variant of the Type I MetAP that is present predominantly in the streptococci bacteria. There are two inserts (insert one: 27 amino acids and insert two: four residues) within the catalytic domain. Possible glycosylation and phosphorylation posttranslational modification sites are identified in the 'insert one'. Biochemical characterization suggests that this enzyme behaves similar to other MetAPs in terms of substrate specificity. Crystal structure Type Ia MetAP from Streptococcus pneumoniae (SpMetAP1a) revealed that it contains two molecules in the asymmetric unit and well ordered inserts with structural features that corroborate the possible posttranslational modification. Both the new inserts found in the SpMetAP1a structurally align with the P-X-X-P motif found in the M. tuberculosis and human Type I MetAPs as well as the 60 amino acid insert in the human Type II enzyme suggesting possible common function. In addition, one of the beta-hairpins within in the catalytic domain undergoes a flip placing a residue which is essential for enzyme activity away from the active site and the beta-hairpin loop of this secondary structure in the active site obstructing substrate binding. This is the first example of a MetAP crystallizing in the inactive form.	[Arya, Tarun; Kishor, Chandan; Saddanapu, Venkateshwarlu; Reddi, Ravikumar; Addlagatta, Anthony] CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Addlagatta, A (corresponding author), CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India.	anthony@iict.res.in	Reddi, Ravikumar/AAM-6814-2021; Addlagatta, Anthony/B-1101-2010; Addlagatta, Anthony/AAW-2675-2020	Reddi, Ravikumar/0000-0002-7657-4727; Kishor, Chandan/0000-0002-6328-1116	University Grants commission (UGC); Council of Scientific and Industrial Research (CSIR), New Delhi	University Grants commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Thanks to University Grants commission (UGC), Council of Scientific and Industrial Research (CSIR), New Delhi, for research fellowships to CK and TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addlagatta A, 2005, BIOCHEMISTRY-US, V44, P14741, DOI 10.1021/bi051691k; Addlagatta A, 2005, BIOCHEMISTRY-US, V44, P7166, DOI 10.1021/bi0501176; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; CHANG SYP, 1989, J BACTERIOL, V171, P4071, DOI 10.1128/jb.171.7.4071-4072.1989; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano WL, 2002, HE PYMOL MOL GRAPHIC; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Imperiali B, 1997, ACCOUNTS CHEM RES, V30, P452, DOI 10.1021/ar950226k; Kishor C, 2012, MEDCHEMCOMM, V3, P1406, DOI 10.1039/c2md20096a; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Sandikci A, 2013, NAT STRUCT MOL BIOL, V20, P843, DOI 10.1038/nsmb.2615; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100	21	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75207	10.1371/journal.pone.0075207	http://dx.doi.org/10.1371/journal.pone.0075207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124477	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100034
J	Hou, YL; Wang, YC; Lu, XM; Zhang, X; Zhao, Q; Todhunter, RJ; Zhang, ZW				Hou, Yali; Wang, Yachun; Lu, Xuemei; Zhang, Xu; Zhao, Qian; Todhunter, Rory J.; Zhang, Zhiwu			Monitoring Hip and Elbow Dysplasia Achieved Modest Genetic Improvement of 74 Dog Breeds over 40 Years in USA	PLOS ONE			English	Article							UK LABRADOR RETRIEVERS; CANINE HIP; DORSOLATERAL SUBLUXATION; SELECTION; PEDIGREE; TRAITS; SCORES; TRENDS	Hip (HD) and Elbow Dysplasia (ED) are two common complex developmental disorders of dogs. In order to decrease their prevalence and severity, the Orthopedic Foundation for Animals (OFA) has a voluntary registry of canine hip and elbow conformation certified by boarded radiologists. However, the voluntarily reports have been severely biased against exposing dogs with problems, especially at beginning period. Fluctuated by additional influential factors such as age, the published raw scores barely showed trends of improvement. In this study, we used multiple-trait mixed model to simultaneously adjust these factors and incorporate pedigree to derive Estimated Breeding Values (EBV). A total of 1,264,422 dogs from 74 breeds were evaluated for EBVs from 760,455 hip scores and 135,409 elbow scores. These EBVs have substantially recovered the reporting bias and the other influences. Clear and steady trends of genetic improvement were observed over the 40 years since 1970. The total genetic improvements were 16.4% and 1.1% of the phenotypic standard deviation for HD and ED, respectively. The incidences of dysplasia were 0.83% and 2.08%, and the heritabilities were estimated as 0.22 and 0.17 for hip and elbow scores, respectively. The genetic correlation between them was 0.12. We conclude that EBV is more effective than reporting raw phenotype. The weak genetic correlation suggested that selection based on hip scores would also slightly improve elbow scores but it is necessary to allocate effort toward improvement of elbow scores alone.	[Hou, Yali; Wang, Yachun; Zhang, Xu] China Agr Univ, Key Lab Agr Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Hou, Yali; Lu, Xuemei] Chinese Acad Sci, Lab Dis Genom & Individualized Med, Beijing Inst Genom, Beijing, Peoples R China; [Zhao, Qian; Zhang, Zhiwu] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Northeast Agricultural University - China; Cornell University; Cornell University	Todhunter, RJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.	rjt2@cornell.edu; zz19@cornell.edu	Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016	Zhang, Zhiwu/0000-0002-5784-9684	National Institutes of Health [1R21AR055228-01A1]; National Science Foundation [0606461]; Chinese National Key Technologies RD Program [2011BAD28B02]; China Agriculture Research System [CARS-37]; National Natural Science Foundation of China [31172191]; Department of Clinical Sciences in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chinese National Key Technologies RD Program(National Key Technology R&D Program); China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Clinical Sciences in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health (1R21AR055228-01A1), National Science Foundation (#0606461), Chinese National Key Technologies R&D Program (No. 2011BAD28B02), China Agriculture Research System (CARS-37), National Natural Science Foundation of China (No. 31172191), and the Department of Clinical Sciences in the College of Veterinary Medicine, Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Farese JP, 1999, AM J VET RES, V60, P1571; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Gibbs C, 1997, VET REC, V141, P275; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Guo G, 2011, OSTEOARTHR CARTILAGE, V19, P420, DOI 10.1016/j.joca.2010.12.011; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hedhammar AA, 2011, VET J, V189, P141, DOI [10.1016/j.tvjl.2011.06.011, 10.1016/j.tvjl.2011.06.018]; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Keller GG, 2011, VET J, V189, P197, DOI 10.1016/j.tvjl.2011.06.019; Lavrijsen ICM, 2012, VET J, V193, P486, DOI 10.1016/j.tvjl.2012.01.001; Lewis TW, 2011, VET J, V189, P227, DOI 10.1016/j.tvjl.2011.06.024; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012797; Lust G, 2001, AM J VET RES, V62, P1711, DOI 10.2460/ajvr.2001.62.1711; Madsen P, 2006, P 8 WORLD C GEN APPL, P13; Madsen P, 2007, USERS GUIDE DMU VERS; Maki K, 2000, J ANIM SCI, V78, P1141; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Murdoch BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026819; Ogden DM, 2011, VET SURG, V00, P1; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; Samoy Y, 2006, VET COMP ORTHOPAED, V19, P1; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Sorensen DA., 2002, STAT BIOL HEALTH; Sun C, 2010, J ANIM SCI, V88, P871, DOI 10.2527/jas.2009-1912; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Todhunter RJ, 2003, J HERED, V94, P39, DOI 10.1093/jhered/esg006; Todhunter RJ, 2012, GENETICS ORTHOPEDIC; Vernau KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057195; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Woolliams JA, 2011, VET J, V189, P169, DOI 10.1016/j.tvjl.2011.06.015; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	36	26	26	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76390	10.1371/journal.pone.0076390	http://dx.doi.org/10.1371/journal.pone.0076390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124555	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100112
J	Zhang, M; Liu, JY; Li, K; Yu, DY				Zhang, Man; Liu, Jianyu; Li, Kai; Yu, Deyue			Identification and Characterization of a Novel Monoterpene Synthase from Soybean Restricted to Neryl Diphosphate Precursor	PLOS ONE			English	Article							TERPENE SYNTHASES; (E)-BETA-OCIMENE SYNTHASE; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; GENE-EXPRESSION; FLORAL SCENT; PLANTS; PYROPHOSPHATE; METABOLISM	Terpenes are important defensive compounds against herbivores and pathogens. Here, we report the identification of a new monoterpene synthase gene, GmNES, from soybean. The transcription of GmNES was up-regulated in soybean plants that were infested with cotton leafworm (Prodenia litura), mechanically wounded or treated with salicylic acid (SA). Gas chromatography-mass spectrometry (GC-MS) analysis revealed that recombinant GmNES enzyme exclusively produced nerol, generated from a newly identified substrate for monoterpene synthase: neryl diphosphate (NPP). This finding indicates that GmNES is a nerol synthase gene in soybean. Subcellular localization using GFP fusions showed that GmNES localized to the chloroplasts. Transgenic tobacco overexpressing GmNES was generated. In dual-choice assays, the GmNES-expressing tobacco lines significantly repelled cotton leafworm. In feeding tests with transgenic plants, the growth and development of cotton leafworm were significantly retarded. This study confirms the ecological role of terpenoids and provides new insights into their metabolic engineering in transgenic plants.	[Zhang, Man; Liu, Jianyu; Li, Kai; Yu, Deyue] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zhang, Man] Jiangsu Acad Agr Sci, Inst Vegetable Crops, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Yu, DY (corresponding author), Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	dyyu@njau.edu.cn			National Basic Research Program of China (973 Program) [2010CB125906, 2009CB118400]; National Natural Science Foundation of China [30800692, 31000718]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China (973 Program) (2010CB125906, 2009CB118400) and National Natural Science Foundation of China (30800692, 31000718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Arimura G, 2004, PLANT PHYSIOL, V135, P1976, DOI 10.1104/pp.104.042929; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bohlmann J, 2009, P NATL ACAD SCI USA, V106, P10402, DOI 10.1073/pnas.0905226106; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chorianopoulos N, 2004, J AGR FOOD CHEM, V52, P8261, DOI 10.1021/jf049113i; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; CROTEAU R, 1976, ARCH BIOCHEM BIOPHYS, V176, P734, DOI 10.1016/0003-9861(76)90217-4; CROTEAU R, 1981, ARCH BIOCHEM BIOPHYS, V207, P460, DOI 10.1016/0003-9861(81)90054-0; Davis EM, 2000, TOP CURR CHEM, V209, P53; Degenhardt J, 2003, CURR OPIN BIOTECH, V14, P169, DOI 10.1016/S0958-1669(03)00025-9; Demissie ZA, 2011, PLANTA, V233, P685, DOI 10.1007/s00425-010-1332-5; Dobson H, 2006, RELATIONSHIP FLORAL; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Gomez SK, 2005, ARCH INSECT BIOCHEM, V58, P114, DOI 10.1002/arch.20037; Hori M, 1998, J CHEM ECOL, V24, P1425, DOI 10.1023/A:1020947414051; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Navia-Gine WG, 2009, PLANT PHYSIOL BIOCH, V47, P416, DOI 10.1016/j.plaphy.2009.01.008; Nieuwenhuizen NJ, 2009, J EXP BOT, V60, P3203, DOI 10.1093/jxb/erp162; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; RAFFA KF, 1985, ENVIRON ENTOMOL, V14, P552, DOI 10.1093/ee/14.5.552; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Terzi V, 2007, LETT APPL MICROBIOL, V44, P613, DOI 10.1111/j.1472-765X.2007.02128.x; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Zhang M, 2012, PLANT BIOTECHNOL REP, V6, P363, DOI 10.1007/s11816-012-0233-4; Zhang M, 2009, MOL BIOL REP, V36, P879, DOI 10.1007/s11033-008-9258-8	35	22	24	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75972	10.1371/journal.pone.0075972	http://dx.doi.org/10.1371/journal.pone.0075972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124526	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100083
J	Beazley, KE; Lima, F; Borras, T; Nurminskaya, M				Beazley, Kelly E.; Lima, Florence; Borras, Teresa; Nurminskaya, Maria			Attenuation of Chondrogenic Transformation in Vascular Smooth Muscle by Dietary Quercetin in the MGP-Deficient Mouse Model	PLOS ONE			English	Article							TRANSGLUTAMINASE 2-MEDIATED ACTIVATION; CELL PHENOTYPIC PLASTICITY; BETA-CATENIN; GROWTH-FACTOR; CHONDROCYTE DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CARTILAGE FORMATION; GENE-EXPRESSION; FACTOR-5 GDF-5; BLOOD-PRESSURE	Rationale: Cartilaginous metaplasia of vascular smooth muscle (VSM) is characteristic for arterial calcification in diabetes and uremia and in the background of genetic alterations in matrix Gla protein (MGP). A better understanding of the molecular details of this process is critical for the development of novel therapeutic approaches to VSM transformation and arterial calcification. Objective: This study aimed to identify the effects of bioflavonoid quercetin on chondrogenic transformation and calcification of VSM in the MGP-null mouse model and upon TGF-beta 3 stimulation in vitro, and to characterize the associated alterations in cell signaling. Methods and Results: Molecular analysis revealed activation of beta-catenin signaling in cartilaginous metaplasia in Mgp-/- aortae in vivo and during chondrogenic transformation of VSMCs in vitro. Quercetin intercepted chondrogenic transformation of VSM and blocked activation of beta-catenin both in vivo and in vitro. Although dietary quercetin drastically attenuated calcifying cartilaginous metaplasia in Mgp-/- animals, approximately one-half of total vascular calcium mineral remained as depositions along elastic lamellae. Conclusion: Quercetin is potent in preventing VSM chondrogenic transformation caused by diverse stimuli. Combined with the demonstrated efficiency of dietary quercetin in preventing ectopic chondrogenesis in the MGP-null vasculature, these findings indicate a potentially broad therapeutic applicability of this safe for human consumption bioflavonoid in the therapy of cardiovascular conditions linked to cartilaginous metaplasia of VSM. Elastocalcinosis is a major component of MGP-null vascular disease and is controlled by a mechanism different from chondrogenic transformation of VSM and not sensitive to quercetin.	[Beazley, Kelly E.; Lima, Florence; Nurminskaya, Maria] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Borras, Teresa] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC USA	University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Nurminskaya, M (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	mnurminskaya@som.umaryland.edu	Nurminskaya, Maria/GQH-4607-2022		National Institutes of Health (NIH) [R01HL099305, EY13126, T32AR007592]; NATIONAL EYE INSTITUTE [R01EY013126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (NIH) grants R01HL099305 (to M.N.), EY13126 (to T. B.) and T32AR007592 (to K. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Agrotis A, 2004, J BIOL CHEM, V279, P42221, DOI 10.1074/jbc.M408121200; Aitkenhead M, 2002, MICROVASC RES, V63, P159, DOI 10.1006/mvre.2001.2380; Amano O, 1999, ARCH ORAL BIOL, V44, P935, DOI 10.1016/S0003-9969(99)00086-2; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; BEAZLEY KE, 2012, ARTERIOSCLER THROMB; Beazley KE, 2013, J BIOL CHEM, V288, P2632, DOI 10.1074/jbc.M112.368639; Beazley KE, 2012, J HEART LUNG TRANSPL, V31, P1009, DOI 10.1016/j.healun.2012.04.009; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; Bhaskar S, 2013, NUTRITION, V29, P219, DOI 10.1016/j.nut.2012.01.019; Bostrom KI, 2011, CIRC RES, V109, P564, DOI 10.1161/CIRCRESAHA.110.234278; Bostrom KI, 2011, CIRC RES, V108, P446, DOI 10.1161/CIRCRESAHA.110.236596; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P59, DOI 10.3177/jnsv.55.59; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127; El-Maadawy S, 2003, CONNECT TISSUE RES, V44, P272, DOI 10.1080/03008200390181762; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Essalihi R, 2003, AM J HYPERTENS, V16, P103, DOI 10.1016/S0895-7061(02)03204-1; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Furlan F, 2007, J BONE MINER RES, V22, P1387, DOI 10.1359/JBMR.070516; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Gonzalez-Fernandez R, 2010, FERTIL STERIL, V94, P99, DOI 10.1016/j.fertnstert.2009.02.074; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Herrmann SM, 2000, ARTERIOSCL THROM VAS, V20, P2386, DOI 10.1161/01.ATV.20.11.2386; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Ishizeki K, 1999, J ANAT, V194, P265, DOI 10.1046/j.1469-7580.1999.19420265.x; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Johnstone SR, 2012, CIRC RES, V111, P201, DOI 10.1161/CIRCRESAHA.112.272302; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Liao YB, 2007, ARTERIOSCL THROM VAS, V27, P1037, DOI 10.1161/ATVBAHA.106.137182; Liu YW, 2011, ATHEROSCLEROSIS, V219, P440, DOI 10.1016/j.atherosclerosis.2011.08.033; Loiselle AE, 2013, BONE, V54, P205, DOI 10.1016/j.bone.2012.08.132; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mason DP, 1999, CIRC RES, V85, P1179; Miceli-Libby L, 2008, J VASC RES, V45, P1, DOI 10.1159/000109072; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Naik V, 2012, CARDIOVASC RES, V94, P545, DOI 10.1093/cvr/cvs126; Nemenoff RA, 2011, ARTERIOSCL THROM VAS, V31, P1300, DOI 10.1161/ATVBAHA.111.223701; Ng K, 2011, AM J PHYSIOL-RENAL, V300, pF1431, DOI 10.1152/ajprenal.00079.2011; Nguyen AT, 2013, CIRC RES, V112, P17, DOI 10.1161/CIRCRESAHA.112.281048; Nurminsky D, 2011, MECH DEVELOP, V128, P234, DOI 10.1016/j.mod.2010.11.007; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Reis M, 2013, EXP CELL RES, V319, P1317, DOI 10.1016/j.yexcr.2012.12.023; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Sharma B, 2013, MICROVASC RES, V85, P24, DOI 10.1016/j.mvr.2012.10.005; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Spin JM, 2012, CARDIOVASC RES, V95, P147, DOI 10.1093/cvr/cvs098; Tchetina E, 2003, J BONE MINER RES, V18, P844, DOI 10.1359/jbmr.2003.18.5.844; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Gijn ME, 2002, CARDIOVASC RES, V55, P16, DOI 10.1016/S0008-6363(02)00221-3; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Wang XH, 2004, AM J PHYSIOL-HEART C, V287, pH2376, DOI 10.1152/ajpheart.01173.2003; Wong SCC, 2005, APPL IMMUNOHISTO M M, V13, P248, DOI 10.1097/01.pai.0000142845.91862.c8; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022	81	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76210	10.1371/journal.pone.0076210	http://dx.doi.org/10.1371/journal.pone.0076210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098781	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500151
J	Dafforn, KA; Kelaher, BP; Simpson, SL; Coleman, MA; Hutchings, PA; Clark, GF; Knott, NA; Doblin, MA; Johnston, EL				Dafforn, Katherine A.; Kelaher, Brendan P.; Simpson, Stuart L.; Coleman, Melinda A.; Hutchings, Pat A.; Clark, Graeme F.; Knott, Nathan A.; Doblin, Martina A.; Johnston, Emma L.			Polychaete Richness and Abundance Enhanced in Anthropogenically Modified Estuaries Despite High Concentrations of Toxic Contaminants	PLOS ONE			English	Article							METAL CONTAMINATION; MULTIPLE STRESSORS; MARINE-ENVIRONMENT; SPECIES RICHNESS; HARBOR SEDIMENTS; SOFT SEDIMENTS; HEAVY-METALS; IMPACTS; COMMUNITIES; POLLUTION	Ecological communities are increasingly exposed to multiple chemical and physical stressors, but distinguishing anthropogenic impacts from other environmental drivers remains challenging. Rarely are multiple stressors investigated in replicated studies over large spatial scales (>1000 kms) or supported with manipulations that are necessary to interpret ecological patterns. We measured the composition of sediment infaunal communities in relation to anthropogenic and natural stressors at multiple sites within seven estuaries. We observed increases in the richness and abundance of polychaete worms in heavily modified estuaries with severe metal contamination, but no changes in the diversity or abundance of other taxa. Estuaries in which toxic contaminants were elevated also showed evidence of organic enrichment. We hypothesised that the observed response of polychaetes was not a 'positive' response to toxic contamination or a reduction in biotic competition, but due to high levels of nutrients in heavily modified estuaries driving productivity in the water column and enriching the sediment over large spatial scales. We deployed defaunated field-collected sediments from the surveyed estuaries in a small scale experiment, but observed no effects of sediment characteristics (toxic or enriching). Furthermore, invertebrate recruitment instead reflected the low diversity and abundance observed during field surveys of this relatively 'pristine' estuary. This suggests that differences observed in the survey are not a direct consequence of sediment characteristics (even severe metal contamination) but are related to parameters that covary with estuary modification such as enhanced productivity from nutrient inputs and the diversity of the local species pool. This has implications for the interpretation of diversity measures in large-scale monitoring studies in which the observed patterns may be strongly influenced by many factors that covary with anthropogenic modification.	[Dafforn, Katherine A.; Clark, Graeme F.; Johnston, Emma L.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Dafforn, Katherine A.; Clark, Graeme F.; Doblin, Martina A.; Johnston, Emma L.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Kelaher, Brendan P.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Simpson, Stuart L.] Commonwealth Sci & Ind Res Org, Land & Water, Kirrawee, NSW, Australia; [Coleman, Melinda A.; Knott, Nathan A.] New South Wales Dept Primary Ind, Nelson Bay, NSW, Australia; [Hutchings, Pat A.] Australian Museum, Sydney, NSW 2000, Australia; [Doblin, Martina A.] Univ Technol Sydney, Broadway, NSW, Australia	University of New South Wales Sydney; Sydney Institute of Marine Science; Southern Cross University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); NSW Department of Primary Industries; Australian Museum; University of Technology Sydney	Dafforn, KA (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	k.dafforn@unsw.edu.au	Johnston, Emma L/B-7210-2009; Kelaher, Brendan/P-3647-2017; Coleman, Melinda A/R-5563-2016; Johnston, Emma/AAC-2878-2022; Simpson, Stuart L/A-6044-2011; Doblin, Martina A/E-8719-2013; Knott, Nathan/AAA-8888-2019; Doblin, Martina/L-1804-2019; Dafforn, Katherine/J-9647-2013	Johnston, Emma L/0000-0002-2117-366X; Kelaher, Brendan/0000-0002-7505-4412; Coleman, Melinda A/0000-0003-2623-633X; Johnston, Emma/0000-0002-2117-366X; Simpson, Stuart L/0000-0003-1759-0564; Doblin, Martina A/0000-0001-8750-3433; Knott, Nathan/0000-0002-7873-0412; Doblin, Martina/0000-0001-8750-3433; Dafforn, Katherine/0000-0001-8848-377X	Australian Research Council [DP0990640, LP0990640]	Australian Research Council(Australian Research Council)	This research was primarily supported by the Australian Research Council through an Australian Research Fellowship (DP0990640) awarded to Johnston and a Linkage Grant (LP0990640) awarded to Johnston, Kelaher and Coleman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUAISHA KM, 1995, WATER AIR SOIL POLL, V83, P285, DOI 10.1007/BF00477358; Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Alquezar R, 2006, ENVIRON POLLUT, V142, P116, DOI 10.1016/j.envpol.2005.09.009; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANSARI ZA, 1986, INDIAN J MAR SCI, V15, P223; ANZECC, 1999, STRAT PLAN ACT NAT R; [ARMCANZ ANZECC], 2000, AUSTR NZ GUID FRESHW; Birch GF, 1996, ENVIRON GEOL, V28, P169, DOI 10.1007/s002540050090; Birch GF, 2000, INT J ENVIRON POLLUT, V13, P573, DOI 10.1504/IJEP.2000.002334; Borja A, 2008, MAR POLLUT BULL, V56, P1519, DOI 10.1016/j.marpolbul.2008.07.005; Borja A, 2011, MAR POLLUT BULL, V62, P499, DOI 10.1016/j.marpolbul.2010.12.009; BRYAN GW, 1992, ENVIRON POLLUT, V76, P89, DOI 10.1016/0269-7491(92)90099-V; Burton GA, 2010, ENVIRON TOXICOL CHEM, V29, P2625, DOI 10.1002/etc.332; CCME, 1999, PROT DER CAN SED QUA; Chapman PM, 2002, MAR POLLUT BULL, V44, P7, DOI 10.1016/S0025-326X(01)00253-3; CHAPMAN PM, 1989, ENVIRON TOXICOL CHEM, V8, P589, DOI 10.1002/etc.5620080706; Chapman PM, 2001, ENVIRON TOXICOL CHEM, V20, P3, DOI [10.1002/etc.5620200102, 10.1897/1551-5028(2001)020&lt;0003:ASCIE&gt;2.0.CO;2]; Chariton AA, 2010, MAR FRESHWATER RES, V61, P1109, DOI 10.1071/MF09263; Cheung KC, 2003, CHEMOSPHERE, V52, P1431, DOI 10.1016/S0045-6535(03)00479-X; Cole VJ, 2005, MAR ENVIRON RES, V60, P195, DOI 10.1016/j.marenvres.2004.10.004; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Dafforn KA, 2012, ENVIRON POLLUT, V163, P207, DOI 10.1016/j.envpol.2011.12.029; Dafforn KA, 2009, DIVERS DISTRIB, V15, P807, DOI 10.1111/j.1472-4642.2009.00587.x; Dauvin JC, 2007, MAR POLLUT BULL, V55, P271, DOI 10.1016/j.marpolbul.2006.08.017; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elliott M, 2002, HYDROBIOLOGIA, V475, P513, DOI 10.1023/A:1020372316420; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; GA, 2012, OZ COASTS AUSTR ONL; GAPPA JL, 1993, ENVIRON POLLUT, V82, P157, DOI 10.1016/0269-7491(93)90113-3; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; He ZJ, 2001, MAR POLLUT BULL, V42, P193, DOI 10.1016/S0025-326X(00)00142-9; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Hewitt JE, 2005, ECOL APPL, V15, P942, DOI 10.1890/04-0732; Hill NA, 2011, CHEMOSPHERE, V83, P400, DOI 10.1016/j.chemosphere.2010.12.089; Irvine I, 1998, AUST J EARTH SCI, V45, P297, DOI 10.1080/08120099808728388; Johnston EL, 2002, MAR ECOL PROG SER, V226, P103, DOI 10.3354/meps226103; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Keeley NB, 2013, AQUACULT ENV INTERAC, V3, P275, DOI 10.3354/aei00068; Keeley NB, 2013, MAR POLLUT BULL, V66, P105, DOI 10.1016/j.marpolbul.2012.10.024; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; KEOUGH MJ, 1991, AUST J MAR FRESH RES, V42, P539; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mac Nally R, 1997, ECOL MODEL, V99, P229; MacDonald D.D., 1992, DEV CANADIAN MARINE; Martinez-Llado X, 2007, ENVIRON POLLUT, V149, P104, DOI 10.1016/j.envpol.2006.11.020; McKinley A, 2010, MAR ECOL PROG SER, V420, P175, DOI 10.3354/meps08856; McKinley AC, 2011, ENVIRON POLLUT, V159, P1499, DOI 10.1016/j.envpol.2011.03.008; MORAN PJ, 1989, MAR ECOL-P S Z N I, V10, P231, DOI 10.1111/j.1439-0485.1989.tb00475.x; O'Brien AL, 2013, ENVIRON POLLUT, V175, P45, DOI 10.1016/j.envpol.2012.11.038; Olsgard F, 1999, MAR POLLUT BULL, V38, P448, DOI 10.1016/S0025-326X(98)90202-8; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; RAJAGOPAL S, 1995, J THERM BIOL, V20, P461, DOI 10.1016/0306-4565(95)00006-I; Roberts DA, 2010, WATER RES, V44, P5117, DOI 10.1016/j.watres.2010.04.036; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; SANTOS SL, 1980, MAR ECOL PROG SER, V2, P235, DOI 10.3354/meps002235; Scanes P, 2010, NSW ESTUARINE CATCHM; Scanes P, 2007, ESTUAR COAST SHELF S, V74, P306, DOI 10.1016/j.ecss.2007.04.021; Simpson SL, 2011, ENVIRON TOXICOL CHEM, V30, P2326, DOI 10.1002/etc.633; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Stark JS, 1998, ECOTOXICOLOGY, V7, P161, DOI 10.1023/A:1014356327595; Statham PJ, 2012, SCI TOTAL ENV; Strom D, 2011, ENV TOXICOLOGY CHEM; Thrush SF, 1996, ECOLOGY, V77, P2472, DOI 10.2307/2265747; Trannum HC, 2004, J EXP MAR BIOL ECOL, V310, P87, DOI 10.1016/j.jembe.2004.04.003; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; UNDERWOOD AJ, 1991, J MAR BIOL ASSOC UK, V71, P841, DOI 10.1017/S0025315400053509; US EPA, 2007, 3051ASW846 USEPA; *USEPA, 1996, 8260B USEPA; USEPA, 1992, 823R92006 USEPA OFF; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Wilkie EM, 2010, ENVIRON POLLUT, V158, P1261, DOI 10.1016/j.envpol.2010.01.027; Zhang WG, 2009, ENVIRON POLLUT, V157, P1533, DOI 10.1016/j.envpol.2009.01.007	74	39	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e77018	10.1371/journal.pone.0077018	http://dx.doi.org/10.1371/journal.pone.0077018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098816	Green Published, gold			2022-12-27	WOS:000325423500187
J	Duffy, M; Bolton, D; Gillespie, K; Ehlers, A; Clark, DM				Duffy, Michael; Bolton, David; Gillespie, Kate; Ehlers, Anke; Clark, David M.			A Community Study of the Psychological Effects of the Omagh Car Bomb on Adults	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; SYMPTOMS; PREDICTORS; DEPRESSION; ASSAULT; CITY; SURVIVORS; MEMORIES; PHOBIA	Background: The main aims of the study were to assess psychological morbidity among adults nine months after a car bomb explosion in the town of Omagh, Northern Ireland and to identify predictors of chronic posttraumatic stress disorder symptoms. Method: A questionnaire was sent to all adults in households in The Omagh District Council area. The questionnaire comprised established predictors of PTSD (such as pre-trauma personal characteristics, type of exposure, initial emotional response and long-term adverse physical or financial problems), predictors derived from the Ehlers and Clark (2000) cognitive model, a measure of PTSD symptoms and the General Health Questionnaire. Results: Among respondents (n = 3131) the highest rates of PTSD symptoms and probable casesness (58.5%) were observed among people who were present in the street when the bomb exploded but elevated rates were also observed in people who subsequently attended the scene (21.8% probable caseness) and among people for whom someone close died (11.9%). People with a near miss (left the scene before the explosion) did not show elevated rates. Exposure to the bombing increased PTSD symptoms to a greater extent than general psychiatric symptoms. Previously established predictors accounted for 42% of the variance in PTSD symptoms among people directly exposed to the bombing. Predictors derived from the cognitive model accounted for 63%. Conclusions: High rates of chronic PTSD were observed in individuals exposed to the bombing. Psychological variables that are in principle amenable to treatment were the best predictors of PTSD symptoms. Teams planning treatment interventions for victims of future bombings and other traumas may wish to take these results into account.	[Duffy, Michael] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Bolton, David] Inst Conflict Related Trauma, Enniskillen, North Ireland; [Gillespie, Kate] Cognit Therapy Training, Dublin, Ireland; [Ehlers, Anke; Clark, David M.] Univ Oxford, Oxford, England	Queens University Belfast; University of Oxford	Duffy, M (corresponding author), Queens Univ Belfast, Belfast, Antrim, North Ireland.	michael.duffy@qub.ac.uk	Ehlers, Anke/G-8713-2014	Ehlers, Anke/0000-0002-8742-0192; Clark, David/0000-0002-8173-6022; Bolton, David/0000-0001-9818-9590; Duffy, MIchael/0000-0003-2194-2411	Wellcome Trust; National Institute for Health Research [NF-SI-0512-10132] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Professors Clark and Ehlers held Wellcome Principal Fellowships at the time of the study. The Wellcome Trust funded Professor Clark's and Professor Ehlers' salary during the duration of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2002, PSYCHIATRY, V65, P289, DOI 10.1521/psyc.65.4.289.20240; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bunting BP, 2013, J TRAUMA STRESS, V26, P134, DOI 10.1002/jts.21766; Clohessy S, 1999, BRIT J CLIN PSYCHOL, V38, P251, DOI 10.1348/014466599162836; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; DUFFY M, 2007, BMJ-BRIT MED J, V334, P147, DOI DOI 10.1136/BMJ.39043.685775.F7; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; EHLERS A, BEHAV RES T IN PRESS; Ehring T, 2008, J CONSULT CLIN PSYCH, V76, P219, DOI 10.1037/0022-006X.76.2.219; Ehring T, 2007, J NERV MENT DIS, V195, P1004, DOI 10.1097/NMD.0b013e31815c1999; Ehring T, 2006, BEHAV RES THER, V44, P1699, DOI 10.1016/j.brat.2005.11.013; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Freh FM, 2013, J PSYCHIATR RES, V47, P215, DOI 10.1016/j.jpsychires.2012.10.008; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Gillespie K, 2002, BEHAV RES THER, V40, P345, DOI 10.1016/S0005-7967(02)00004-9; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; GREEN BL, 1990, J APPL SOC PSYCHOL, V20, P1033, DOI 10.1111/j.1559-1816.1990.tb00388.x; Grieger TA, 2005, PSYCHIAT SERV, V56, P1374, DOI 10.1176/appi.ps.56.11.1374; Halligan SL, 2003, J CONSULT CLIN PSYCH, V71, P419, DOI 10.1037/0022-006X.71.3.419; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kleim B, 2007, PSYCHOL MED, V37, P1457, DOI 10.1017/S0033291707001006; Kleim B, 2012, PSYCHOL TRAUMA-US, V4, P527, DOI 10.1037/a0027006; Lommen MJJ, 2009, BEHAV RES THER, V47, P60, DOI 10.1016/j.brat.2008.10.009; Michael T, 2005, BEHAV RES THER, V43, P613, DOI 10.1016/j.brat.2004.04.006; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; NICE, 2005, MAN PTSD AD CHILDR P; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Norwood AE, 2000, PSYCHIAT QUART, V71, P207, DOI 10.1023/A:1004678010161; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; [No title captured]	40	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76618	10.1371/journal.pone.0076618	http://dx.doi.org/10.1371/journal.pone.0076618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098795	Green Published, gold			2022-12-27	WOS:000325423500166
J	Gianotti, TF; Burgueno, A; Mansilla, NG; Pirola, CJ; Sookoian, S				Fernandez Gianotti, Tomas; Burgueno, Adriana; Gonzales Mansilla, Noelia; Jose Pirola, Carlos; Sookoian, Silvia			Fatty Liver Is Associated with Transcriptional Downregulation of Stearoyl-CoA Desaturase and Impaired Protein Dimerization	PLOS ONE			English	Article							INSULIN-RESISTANCE; MESSENGER-RNA; GENE; OBESITY; DEFICIENCY; EXPRESSION; DIET; ACCUMULATION; STEATOSIS; STABILITY	Aims and Methods: We evaluated the modulation of liver stearoyl-CoA desaturase-1 (Scd1) by dietary factors and insulin resistance (IR) in two experimental models of high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). The first model included Sprague Dawley (SD) rats that developed NAFLD without IR, and the second one included a rat model of genetic IR and cardiovascular disease, the spontaneously hypertensive rats (SHR) and its normotensive, insulin-sensitive control Wistar-Kyoto (WKY). The adult rats were given standard chow diet (CD) or HFD for 10 weeks. In all the animals, we explored the hepatic Scd1 transcriptional activity and protein levels. Results: HFD-fed rats of both strains developed severe NAFLD. Liver abundance of Scd1 mRNA was significantly decreased in HFD-fed rats regardless of the strain; SD-CD: 235 +/- 195 vs. SD-HFD 4.5 +/- 2.9, p<0.0004, and SHR-CD: 75.6 +/- 10.8 vs. SHR-HFD: 4.48 +/- 17.4, and WKY-CD: 168.7 +/- 17.4 vs. WKY-HFD: 12.9 +/- 17.4, p<0.000001 (mean +/- SE, ANCOVA adjusted by HOMA). Analysis of liver Scd1 protein expression showed a particular pattern in the HFD groups, characterized by the presence of high levels of a monomeric protein band (32.2-36.6 Kda, p<0.003) and decreased levels of a dimeric protein band (61.9-66.1 Kda, p<0.02) regardless of the rat strain. Pharmacologic intervention with the peroxisome proliferator-activated receptor a agonist clofibrate reverted the liver phenotype and significantly modified the hepatic Scd1 transcriptional activity and protein expression. Conclusion: Diet-induced fatty liver is associated with the downregulation of hepatic Scd1 transcript and de-dimerization of the protein, and these changes were not much affected by the status of peripheral IR.	[Fernandez Gianotti, Tomas; Burgueno, Adriana; Gonzales Mansilla, Noelia; Jose Pirola, Carlos] Univ Buenos Aires, Dept Mol Genet & Biol Complex Dis, Inst Med Res A Lanari IDIM, Natl Council Sci & Technol Res CONICET, Buenos Aires, DF, Argentina; [Sookoian, Silvia] Univ Buenos Aires, Dept Clin & Mol Hepatol, Inst Med Res A Lanari IDIM, Natl Council Sci & Technol Res CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pirola, CJ (corresponding author), Univ Buenos Aires, Dept Mol Genet & Biol Complex Dis, Inst Med Res A Lanari IDIM, Natl Council Sci & Technol Res CONICET, Buenos Aires, DF, Argentina.	pirola.carlos@lanari.fmed.uba.ar; sookoian.silvia@lanari.fmed.uba.ar		Burgueno, Adriana L./0000-0001-7584-7044; Fernandez Gianotti, Tomas/0000-0003-2569-9156	Universidad de Buenos Aires [UBACYT CM04]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2008-1521, 2010-0441]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This study was supported in part by Grants UBACYT CM04 (Universidad de Buenos Aires), and PICT 2008-1521 and 2010-0441 (Agencia Nacional de Promocion Cientifica y Tecnologica). All authors are affiliated with National Scientific and Technical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cohen Paul, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P271, DOI 10.2174/1568008033340117; Dobrzyn A, 2004, TRENDS CARDIOVAS MED, V14, P77, DOI 10.1016/j.tcm.2003.12.005; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Hu CC, 2004, OBES RES, V12, P1264, DOI 10.1038/oby.2004.160; Jones BH, 1996, AM J PHYSIOL-ENDOC M, V271, pE44, DOI 10.1152/ajpendo.1996.271.1.E44; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Landa MS, 2007, AM J PHYSIOL-ENDOC M, V292, pE1388, DOI 10.1152/ajpendo.00234.2006; LANDSCHULZ KT, 1994, BIOCHEM BIOPH RES CO, V200, P763, DOI 10.1006/bbrc.1994.1516; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McNamara RK, 2012, PHARMACOL RES, V66, P283, DOI 10.1016/j.phrs.2012.06.010; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Ntambi JM, 1996, BIOCHEM BIOPH RES CO, V220, P990, DOI 10.1006/bbrc.1996.0520; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; Rahman SM, 2005, AM J PHYSIOL-ENDOC M, V288, pE381, DOI 10.1152/ajpendo.00314.2004; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Sessler AM, 1996, J BIOL CHEM, V271, P29854, DOI 10.1074/jbc.271.47.29854; Silbernagel G, 2012, J CLIN ENDOCR METAB, V97, pE2288, DOI 10.1210/jc.2012-2152; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Stefan N, 2008, DIABETOLOGIA, V51, P648, DOI 10.1007/s00125-008-0938-7; Tanaka S, 2012, BIOL PHARM BULL, V35, P184, DOI 10.1248/bpb.35.184; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Zhang SB, 2005, BIOCHEM J, V388, P135, DOI 10.1042/BJ20041554	34	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76912	10.1371/journal.pone.0076912	http://dx.doi.org/10.1371/journal.pone.0076912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098813	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500184
J	Silva, MA; Prieto, R; Jonsen, I; Baumgartner, MF; Santos, RS				Silva, Monica A.; Prieto, Rui; Jonsen, Ian; Baumgartner, Mark F.; Santos, Ricardo S.			North Atlantic Blue and Fin Whales Suspend Their Spring Migration to Forage in Middle Latitudes: Building up Energy Reserves for the Journey?	PLOS ONE			English	Article							VERTICAL MIGRATION; BALEEN WHALES; SATELLITE; MOVEMENTS; ZOOPLANKTON; BEHAVIOR; AZORES; RIDGE; TEMPERATURE; ENERGETICS	The need to balance energy reserves during migration is a critical factor for most long-distance migrants and an important determinant of migratory strategies in birds, insects and land mammals. Large baleen whales migrate annually between foraging and breeding sites, crossing vast ocean areas where food is seldom abundant. How whales respond to the demands and constraints of such long migrations remains unknown. We applied a behaviour discriminating hierarchical state-space model to the satellite tracking data of 12 fin whales and 3 blue whales tagged off the Azores, to investigate their movements, behaviour (transiting and area-restricted search, ARS) and daily activity cycles during the spring migration. Fin and blue whales remained at middle latitudes for prolonged periods, spending most of their time there in ARS behaviour. While near the Azores, fin whale ARS behaviour occurred within a restricted area, with a high degree of overlap among whales. There were noticeable behavioural differences along the migratory pathway of fin whales tracked to higher latitudes: ARS occurred only in the Azores and north of 56 degrees N, whereas in between these areas whales travelled at higher overall speeds while maintaining a nearly direct trajectory. This suggests fin whales may alternate periods of active migration with periods of extended use of specific habitats along the migratory route. ARS behaviour in blue whales occurred over a much wider area as whales slowly progressed northwards. The tracks of these whales terminated still at middle latitudes, before any behavioural switch was detected. Fin whales exhibited behavioural-specific diel rhythms in swimming speed but these varied significantly between geographic areas, possibly due to differences in the day-night cycle across areas. Finally, we show a link between fin whales seen in the Azores and those summering in eastern Greenland-western Iceland along a migratory corridor located in central Atlantic waters.	[Silva, Monica A.; Prieto, Rui; Santos, Ricardo S.] Univ Azores, Ctr Inst Marine Res IMAR, Horta, Azores, Portugal; [Silva, Monica A.; Prieto, Rui; Santos, Ricardo S.] Univ Azores, Dept Oceanog & Fisheries, Horta, Azores, Portugal; [Silva, Monica A.; Prieto, Rui; Santos, Ricardo S.] Lab Robot & Syst Engn & Sci LARSyS, Lisbon, Portugal; [Silva, Monica A.; Baumgartner, Mark F.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jonsen, Ian] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Universidade dos Acores; Universidade dos Acores; Woods Hole Oceanographic Institution; Dalhousie University	Silva, MA (corresponding author), Univ Azores, Ctr Inst Marine Res IMAR, Horta, Azores, Portugal.	monica@uac.pt	Santos, Ricardo/B-3960-2008; Silva, Mónica/D-1893-2012; Prieto, Rui/G-8286-2011	Santos, Ricardo/0000-0002-2536-1369; Silva, Mónica/0000-0002-2683-309X; Prieto, Rui/0000-0002-0354-2572; Jonsen, Ian/0000-0001-5423-6076	Fundacao para a Ciencia e a Tecnologia (FCT); Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCTC); FEDER; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores Program [PTDC/MAR/74071/2006, M2.1.2/F/012/2011]; FCT; DRCTC -Government of the Azores pluriannual funding; LARSyS Associated Laboratory through FCT/MCE project [PEst-OE/EEI/LA0009/2011-2013]; FCT [SFRH/BPD/29841/2006, SFRH/BD/41192/2007]; Azores Regional Fund for Science and Technology [M3.1.5/F/115/2012]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCTC); FEDER(European Commission); Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores Program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); DRCTC -Government of the Azores pluriannual funding; LARSyS Associated Laboratory through FCT/MCE project; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Azores Regional Fund for Science and Technology	This research was funded by Fundacao para a Ciencia e a Tecnologia (FCT), Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCTC), FEDER, the Competitiveness Factors Operational (COMPETE), QREN European Social Fund, and Proconvergencia Acores Program through research projects PTDC/MAR/74071/2006 and M2.1.2/F/012/2011. The authors acknowledge funds provided by FCT to LARSyS Associated Laboratory & IMAR-University of the Azores/the Thematic Area E of the Strategic Project (OE & Compete) and by the DRCTC -Government of the Azores pluriannual funding. Publication fees for this open access publication were supported by LARSyS Associated Laboratory through FCT/MCE project PEst-OE/EEI/LA0009/2011-2013. MAS was supported by an FCT postdoctoral grant (SFRH/BPD/29841/2006) and RP was supported by an FCT doctoral grant (SFRH/BD/41192/2007) and by the research grant from the Azores Regional Fund for Science and Technology (M3.1.5/F/115/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2012, MAR BIOL, V159, P2441, DOI 10.1007/s00227-012-1947-0; Acevedo-Gutierrez A, 2002, J EXP BIOL, V205, P1747; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Anonymous, 2009, Journal of Cetacean Research and Management, V11, P425; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Baumgartner Mark F., 2007, P138; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; BRODIE PF, 1975, ECOLOGY, V56, P152, DOI 10.2307/1935307; Burtenshaw JC, 2004, DEEP-SEA RES PT II, V51, P967, DOI 10.1016/j.dsr2.2004.06.020; Clapham P, 2001, MAR MAMMAL SCI, V17, P432, DOI 10.1111/j.1748-7692.2001.tb01289.x; Clark DR, 2001, J PLANKTON RES, V23, P365, DOI 10.1093/plankt/23.4.365; Cohen EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041818; Connor RC, 2001, MAR MAMMAL SCI, V17, P436, DOI 10.1111/j.1748-7692.2001.tb01290.x; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Dale T, 2000, ICES J MAR SCI, V57, P1800, DOI 10.1006/jmsc.2000.0961; De Robertis A, 2003, ICES J MAR SCI, V60, P885, DOI 10.1016/S1054-3139(03)00070-5; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Doniol-Valcroze T, 2011, BEHAV ECOL, V22, P880, DOI 10.1093/beheco/arr038; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FASHAM MJR, 1985, PROG OCEANOGR, V14, P129, DOI 10.1016/0079-6611(85)90009-6; Gales N, 2011, 61 M SCI COMM INT WH, P1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gelman A., 2003, BAYESIAN DATA ANAL; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Gordon J, 1995, LIFE MARINE SCI A, V13A, P79; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Heger A, 2008, DEEP-SEA RES PT II, V55, P126, DOI 10.1016/j.dsr2.2007.09.014; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Huskin I, 2001, J PLANKTON RES, V23, P671, DOI 10.1093/plankt/23.7.671; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kaartvedt S, 2010, ADV MAR BIOL, V57, P255, DOI 10.1016/S0065-2881(10)57009-3; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Klevjer TA, 2011, LIMNOL OCEANOGR, V56, P765, DOI 10.4319/lo.2011.56.3.0765; Letessier TB, 2011, J PLANKTON RES, V33, P1510, DOI 10.1093/plankt/fbr056; Lockyer C., 1984, Reports of the International Whaling Commission Special Issue, P27; Lockyer C.H., 1981, Society for Experimental Biology Seminar Series, P105; Lockyer C.H., 1987, APPROACHES MARINE MA, P183; Lopez R., 2011, CLSDTMEMO1165; Machin F, 2009, DEEP-SEA RES PT II, V56, P2606, DOI 10.1016/j.dsr2.2008.12.038; Martins A, 2011, ESA SOLAS EGU JOINT; Mate BR, 1999, MAR MAMMAL SCI, V15, P1246, DOI 10.1111/j.1748-7692.1999.tb00888.x; Mauritzen C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001114; Opdal A.F., 2009, Journal of Northwest Atlantic Fishery Science, V41, P13; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; Saenko OA, 2005, J PHYS OCEANOGR, V35, P826, DOI 10.1175/JPO2722.1; Sigurjonsson J, 1995, WHALES SEALS FISH MA, P720; Silva IF, 2011, 63 M SCI COMM INT WH, P1; Silva MA, MARINE BIOL IN PRESS; TINBERGEN N, 1967, BEHAVIOUR, V28, P307, DOI 10.1163/156853967X00064; TURCHIN P, 1991, ECOLOGY, V72, P1253, DOI 10.2307/1941099; van Wijk RE, 2012, OIKOS, V121, P655, DOI 10.1111/j.1600-0706.2011.20083.x; Villa E, 2011, 25 ANN C EUR CET SOC; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Visser F, 2011, MAR ECOL PROG SER, V440, P267, DOI 10.3354/meps09349; Wall Dave, 2009, Marine Biodiversity Records, V2, pe128, DOI 10.1017/S1755267209990443; Wallace MI, 2010, LIMNOL OCEANOGR, V55, P831, DOI 10.4319/lo.2009.55.2.0831; Waring Gordon T., 2008, Journal of Cetacean Research and Management, V10, P137; WATKINS W A, 1984, Rit Fiskideildar, V8, P1; Watkins WA, 1996, MAR MAMMAL SCI, V12, P564; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; White M., 2007, BLACKWELL FISHERIES, V12, P65; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Zerbini A.N., 2011, INT WHAL COMM M SCI, P1; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295	74	111	119	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76507	10.1371/journal.pone.0076507	http://dx.doi.org/10.1371/journal.pone.0076507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116112	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200057
J	Hammerle, B; Yanez, Y; Palanca, S; Canete, A; Burks, DJ; Castel, V; de Mora, JF				Haemmerle, Barbara; Yanez, Yania; Palanca, Sarai; Canete, Adela; Burks, Deborah J.; Castel, Victoria; Font de Mora, Jaime			Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; FACTOR-KAPPA-B; MYELOID-LEUKEMIA CELLS; INDUCED DIFFERENTIATION; BORTEZOMIB STABILIZES; 13-CIS-RETINOIC ACID; COLORECTAL-CARCINOMA; MULTIPLE-MYELOMA; CANCER-CELLS; APOPTOSIS	Background: Neuroblastma cell lines contain a side-population of cells which express stemness markers. These stem-like cells may represent the potential underlying mechanism for resistance to conventional therapy and recurrence of neuroblastoma in patients. Methodology/Principal Findings: To develop novel strategies for targeting the side-population of neurobastomas, we analyzed the effects of 13-cis-retinoic acid (RA) combined with the proteasome inhibitor MG132. The short-term action of the treatment was compared with effects after a 5-day recovery period during which both chemicals were withdrawn. RA induced growth arrest and differentiation of SH-SY5Y and SK-N-BE(2) neuroblastoma cell lines. Inhibition of the proteasome caused apoptosis in both cell lines, thus, revealing the critical role of this pathway in the regulated degradation of proteins involved in neuroblastoma proliferation and survival. The combination of RA with MG132 induced apoptosis in a dose-dependent manner, in addition to promoting G2/M arrest in treated cultures. Interestingly, expression of stem cell markers such as Nestin, Sox2, and Oct4 were reduced after the recovery period of combined treatment as compared with untreated cells or treated cells with either compound alone. Consistent with this, neurosphere formation was significantly impaired by the combined treatment of RA and MG132. Conclusions: Given that stem-like cells are associated with resistant to conventional therapy and are thought to be responsible for relapse, our results suggest that dual therapy of RA and proteasome inhibitor might be beneficial for targeting the side-population of cells associated residual disease in high-risk neuroblastoma.	[Haemmerle, Barbara; Burks, Deborah J.] Ctr Invest Principe Felipe, Mol Endocrinol Lab, Valencia, Spain; [Yanez, Yania; Canete, Adela; Castel, Victoria] Hosp La Fe, Paediat Oncol Unit, E-46009 Valencia, Spain; [Palanca, Sarai] Hosp La Fe, Mol Biol Lab, E-46009 Valencia, Spain; [Burks, Deborah J.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Font de Mora, Jaime] Univ Catolica Valencia San Vicente Martir, Fac Med, Inst Valenciano Patol, Valencia, Spain; [Font de Mora, Jaime] Hosp La Fe, Fdn Invest, Lab Cellular & Mol Biol, E-46009 Valencia, Spain	Prince Felipe Research Center; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Universidad Catolica de Valencia San Vicente Martir; Hospital Universitari i Politecnic La Fe	de Mora, JF (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Med, Inst Valenciano Patol, Valencia, Spain.	jaime.fontdemora@gmail.com	de Mora, Jaime Font/H-6304-2015; Yañez, Yania/ABH-2960-2020; canete, adela/G-5903-2016; de Mora, Jaime Font/AAK-7591-2021; Cañete, Adela/ABG-7558-2020	de Mora, Jaime Font/0000-0002-6816-2095; Yañez, Yania/0000-0001-8392-4978; canete, adela/0000-0002-5669-5097; de Mora, Jaime Font/0000-0002-6816-2095; Castel, Victoria/0000-0002-3792-0615	Spanish Ministry of Economy and Competitivity [SAF2009-08334, SAF2012-37330]; NeuroblastoVal from Gent per Gent; Regenerative Medicine program of the Valencian Community (ISCIII); Bancaixa Foundation	Spanish Ministry of Economy and Competitivity(Spanish Government); NeuroblastoVal from Gent per Gent; Regenerative Medicine program of the Valencian Community (ISCIII); Bancaixa Foundation	This work was supported by SAF2009-08334 and SAF2012-37330 grants from Spanish Ministry of Economy and Competitivity and NeuroblastoVal from Gent per Gent. A part of this work was also funded by the Regenerative Medicine program of the Valencian Community (ISCIII). BH was supported by a post-doctoral fellowship from Bancaixa Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Bavi P, 2011, AM J PATHOL, V178, P2109, DOI 10.1016/j.ajpath.2011.01.034; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Brown RE, 2007, ANN CLIN LAB SCI, V37, P141; Canete A, 2009, J CLIN ONCOL, V27, P1014, DOI 10.1200/JCO.2007.14.5839; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Combaret V, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-50; Cusack JC, 2001, CANCER RES, V61, P3535; Dong QG, 2002, ONCOGENE, V21, P6510, DOI 10.1038/sj.onc.1205848; Fang YF, 2011, MOL CARCINOGEN, V50, P24, DOI 10.1002/mc.20687; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Hutter G, 2012, ANN HEMATOL, V91, P847, DOI 10.1007/s00277-011-1377-y; Kim OH, 2004, INT J ONCOL, V24, P935; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lavelin I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008503; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; London WB, 2011, J CLIN ONCOL, V29, P3286, DOI 10.1200/JCO.2010.34.3392; Lorenzi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046928; Luo PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027298; MacLaren AP, 2001, CELL DEATH DIFFER, V8, P210, DOI 10.1038/sj.cdd.4400801; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Moon Ki-Young, 2007, Cancer Res Treat, V39, P82, DOI 10.4143/crt.2007.39.2.82; Nakaso K, 2004, NEUROSCI LETT, V354, P213, DOI 10.1016/j.neulet.2003.10.048; Newton TC, 2010, TRANSL ONCOL, V3, P246, DOI 10.1593/tlo.09301; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Pagnan G, 2009, CLIN CANCER RES, V15, P1199, DOI 10.1158/1078-0432.CCR-08-2477; Pickering BM, 2007, ONCOGENE, V26, P1166, DOI 10.1038/sj.onc.1209897; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Reynolds CP, 2000, MED PEDIATR ONCOL, V35, P597, DOI 10.1002/1096-911X(20001201)35:6<597::AID-MPO23>3.0.CO;2-B; Richardson Paul G, 2003, Cancer Control, V10, P361; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Suzuki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027996; Tanturli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017008; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Tweddle DA, 2001, CANCER RES, V61, P8; Uttenweiler-Joseph S, 2013, PROTEOMICS, V13, P37, DOI 10.1002/pmic.201200233; Veal GJ, 2007, BRIT J CANCER, V96, P424, DOI 10.1038/sj.bjc.6603554; Wang XL, 2012, BIOCHEM J, V443, P821, DOI 10.1042/BJ20111491; Williams SA, 2003, CANCER RES, V63, P7338; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Ying MD, 2013, MOL CANCER THER, V12, P195, DOI 10.1158/1535-7163.MCT-12-0433	51	45	46	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76761	10.1371/journal.pone.0076761	http://dx.doi.org/10.1371/journal.pone.0076761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116151	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300091
J	Locatelli, A; Spor, A; Jolivet, C; Piveteau, P; Hartmann, A				Locatelli, Aude; Spor, Ayme; Jolivet, Claudy; Piveteau, Pascal; Hartmann, Alain			Biotic and Abiotic Soil Properties Influence Survival of Listeria monocytogenes in Soil	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; VBNC STATE; OUTBREAK; DIVERSITY; CONTAMINATION; SALMONELLA; PREVALENCE; INNOCUA; STORAGE	Listeria monocytogenes is a food-borne pathogen responsible for the potentially fatal disease listeriosis and terrestrial ecosystems have been hypothesized to be its natural reservoir. Therefore, identifying the key edaphic factors that influence its survival in soil is critical. We measured the survival of L. monocytogenes in a set of 100 soil samples belonging to the French Soil Quality Monitoring Network. This soil collection is meant to be representative of the pedology and land use of the whole French territory. The population of L. monocytogenes in inoculated microcosms was enumerated by plate count after 7, 14 and 84 days of incubation. Analysis of survival profiles showed that L. monocytogenes was able to survive up to 84 days in 71% of the soils tested, in the other soils (29%) only a short-term survival (up to 7 to 14 days) was observed. Using variance partitioning techniques, we showed that about 65% of the short-term survival ratio of L. monocytogenes in soils was explained by the soil chemical properties, amongst which the basic cation saturation ratio seems to be the main driver. On the other hand, while explaining a lower amount of survival ratio variance (11%), soil texture and especially clay content was the main driver of long-term survival of L. monocytogenes in soils. In order to assess the effect of the endogenous soils microbiota on L. monocytogenes survival, sterilized versus non-sterilized soils microcosms were compared in a subset of 9 soils. We found that the endogenous soil microbiota could limit L. monocytogenes survival especially when soil pH was greater than 7, whereas in acidic soils, survival ratios in sterilized and unsterilized microcosms were not statistically different. These results point out the critical role played by both the endogenous microbiota and the soil physic-chemical properties in determining the survival of L. monocytogenes in soils.	[Locatelli, Aude; Spor, Ayme; Piveteau, Pascal; Hartmann, Alain] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Jolivet, Claudy; Piveteau, Pascal] INRA, US InfoSol 1106, Orleans, France; [Piveteau, Pascal] Univ Bourgogne, Agroecol UMR1347, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Hartmann, A (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	alain.hartmann@dijon.inra.fr	Hartmann, Alain/B-7862-2018; Spor, Aymé/A-6271-2012	Hartmann, Alain/0000-0001-6034-5068; Spor, Aymé/0000-0002-4707-9559; Jolivet, Claudy/0000-0001-5871-6413	French Agency for Environment and Energy Management (ADEME); INRA (Environnement Agronomie Department); Conseil Regional de Bourgogne; 'Agence Nationale de la Recherche' (ANR) [07 SEST, 018-01, 05 SEST, 009-01]	French Agency for Environment and Energy Management (ADEME)(French National Research Agency (ANR)); INRA (Environnement Agronomie Department); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); 'Agence Nationale de la Recherche' (ANR)(French National Research Agency (ANR))	Ph.D. grant of Aude Locatelli was funded by the French Agency for Environment and Energy Management (ADEME) and INRA (Environnement Agronomie Department). Part of this work was funded by the Conseil Regional de Bourgogne. This work was also funded by the 'Agence Nationale de la Recherche' (ANR) (programs 07 SEST project 018-01, 05 SEST project 009-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGHAZALI MR, 1990, J APPL BACTERIOL, V69, P642, DOI 10.1111/j.1365-2672.1990.tb01557.x; [Anonymous], 2009, NFISO103816; [Anonymous], 2002, ISO103811; Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Aytac SA, 2010, J FOOD AGRIC ENVIRON, V8, P275; Besnard V, 2000, LETT APPL MICROBIOL, V31, P77, DOI 10.1046/j.1472-765X.2000.00771.x; Besnard V, 2002, VET RES, V33, P359, DOI 10.1051/vetres:2002022; Beuchat LR, 1996, FOOD CONTROL, V7, P223, DOI 10.1016/S0956-7135(96)00039-4; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borucki MK, 2005, APPL ENVIRON MICROB, V71, P5893, DOI 10.1128/AEM.71.10.5893-5899.2005; BOTZLER R G, 1974, Journal of Wildlife Diseases, V10, P204; COLBURN KG, 1990, APPL ENVIRON MICROB, V56, P2007, DOI 10.1128/AEM.56.7.2007-2011.1990; Cook R.D., 1999, RESPONSE TRANSFORMAT, DOI DOI 10.1002/9780470316948; Cunningham E, 2009, FOOD CONTROL, V20, P1141, DOI 10.1016/j.foodcont.2009.03.005; Dowe MJ, 1997, J FOOD PROTECT, V60, P1201, DOI 10.4315/0362-028X-60.10.1201; El Marrakchi A, 2005, LETT APPL MICROBIOL, V40, P87, DOI 10.1111/j.1472-765X.2004.01651.x; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fenlon DR, 2000, J APPL MICROBIOL, V88, p149S, DOI 10.1111/j.1365-2672.2000.tb05343.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franz E, 2008, ENVIRON MICROBIOL, V10, P313, DOI 10.1111/j.1462-2920.2007.01453.x; Gaul LK, 2013, CLIN INFECT DIS, V56, P20, DOI 10.1093/cid/cis817; Girardin H, 2005, FEMS MICROBIOL ECOL, V54, P287, DOI 10.1016/j.femsec.2005.04.003; GRAY ML, 1966, BACTERIOL REV, V30, P309, DOI 10.1128/MMBR.30.2.309-382.1966; Grif K, 2003, EUR J CLIN MICROBIOL, V22, P16, DOI 10.1007/s10096-002-0835-9; Grolleau E., 2004, ETUDE GESTION SOLS, V11, P255; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Hutchison ML, 2005, APPL ENVIRON MICROB, V71, P1231, DOI 10.1128/AEM.71.3.1231-1236.2005; Jablasone J, 2005, INT J FOOD MICROBIOL, V99, P7, DOI 10.1016/j.ijfoodmicro.2004.06.011; JACQUET C, 1995, APPL ENVIRON MICROB, V61, P2242, DOI 10.1128/AEM.61.6.2242-2246.1995; Jeyaletchumi P., 2011, Journal of Tropical Agriculture and Food Science, V39, P255; Jolivet C., 2006, ETUDE ET GESTION DES, V13, P149; Jones DL, 1999, SOIL USE MANAGE, V15, P76, DOI 10.1111/j.1475-2743.1999.tb00069.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lemunier M, 2005, APPL ENVIRON MICROB, V71, P5779, DOI 10.1128/AEM.71.10.5779-5786.2005; Lindback T, 2010, VET RES, V41, DOI 10.1051/vetres/2009056; Low JC, 1997, VET J, V153, P9, DOI 10.1016/S1090-0233(97)80005-6; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; McLaughlin HP, 2011, ARCH MICROBIOL, V193, P775, DOI 10.1007/s00203-011-0716-7; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Mubiru DN, 2000, J ENVIRON QUAL, V29, P1821, DOI 10.2134/jeq2000.00472425002900060012x; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Ranjard L, 2010, AGRON SUSTAIN DEV, V30, P359, DOI 10.1051/agro/2009033; Rocourt J, 2000, INT J FOOD MICROBIOL, V62, P197, DOI 10.1016/S0168-1605(00)00336-6; Siegman-Igra Y, 2002, EMERG INFECT DIS, V8, P305; Sim J, 2002, LETT APPL MICROBIOL, V35, P409, DOI 10.1046/j.1472-765X.2002.01207.x; Slutsker L., 1999, Listeria, listeriosis and food safety., P75; VANRENTERGHEM B, 1991, J APPL BACTERIOL, V71, P211; WEIS J, 1975, APPL MICROBIOL, V30, P29, DOI 10.1128/AEM.30.1.29-32.1975; WELSHIME.HJ, 1968, J BACTERIOL, V95, P300, DOI 10.1128/JB.95.2.300-303.1968; Welshimer H. J., 1975, Problems of listeriosis,, P59; WELSHIMER HJ, 1960, J BACTERIOL, V80, P316, DOI 10.1128/JB.80.3.316-320.1960; Wesley I. V., 1999, Listeria, listeriosis and food safety., P39; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465	57	69	68	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75969	10.1371/journal.pone.0075969	http://dx.doi.org/10.1371/journal.pone.0075969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116083	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300044
J	Wu, JK; Li, MF; Li, TZ				Wu, Junkai; Li, Maofu; Li, Tianzhong			Genetic Features of the Spontaneous Self-Compatible Mutant, 'Jin Zhui' (Pyrus bretschneideri Rehd.)	PLOS ONE			English	Article							F-BOX GENE; INCOMPATIBILITY S-LOCUS; SKP1-LIKE PROTEIN; NICOTIANA-ALATA; PRUNUS-AVIUM; POLLEN; RNASE; IDENTIFICATION; MULTIPLE; RECOGNITION	'Jin Zhui' is a spontaneous self-compatible mutant of 'Ya Li' (Pyrus bretschneideri Rehd. S21S34), the latter displaying a typical S-RNase-based gametophytic self-incompatibility (GSI). The pollen-part mutation (PPM) of 'Jin Zhui' might be due to a natural mutation in the pollen-S gene (S-34 haplotype). However, the molecular mechanisms behind these phenotypic changes are still unclear. In this study, we identified five SLF (S-Locus F-box) genes in 'Ya Li', while no nucleotide differences were found in the SLF genes of 'Jin Zhui'. Further genetic analysis by S-RNase PCR-typing of selfed progeny of 'Jin Zhui' and 'Ya Li' x 'Jin Zhui' progeny showed three progeny classes (S21S21, S21S34 and S34S34) as opposed to the two classes reported previously (S21S34 and S34S34), indicating that the pollen gametes of 'Jin Zhui', bearing either the S-21- or S-34-haplotype, were able to overcome self-incompatibility (SI) barriers. Moreover, no evidence of pollen-S duplication was found. These findings support the hypothesis that loss of function of S-locus unlinked PPM expressed in pollen leads to SI breakdown in 'Jin Zhui', rather than natural mutation in the pollen-S gene (S-34 haplotype). Furthermore, abnormal meiosis was observed in a number of pollen mother cells (PMCs) in 'Jin Zhui', but not in 'Ya Li'. These and other interesting findings are discussed.	[Wu, Junkai; Li, Tianzhong] China Agr Univ, Lab Fruit Tree Cell & Mol Breeding, Beijing 100094, Peoples R China; [Li, Maofu] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS	Li, MF (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	maofuli@ibcas.ac.cn; litianzhong1535@163.com			Beijing Natural Science Foundation [6102017]; National Science Foundation for Young Scholars of China [31201606]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Natural Science Foundation (6102017) and National Science Foundation for Young Scholars of China (31201606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2009, J JPN SOC HORTIC SCI, V78, P402, DOI 10.2503/jjshs1.78.402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON MA, 1986, NATURE, V321, P38, DOI 10.1038/321038a0; Chen G, 2012, J GENET GENOMICS, V39, P93, DOI 10.1016/j.jgg.2012.01.001; Chen G, 2010, J EXP BOT, V61, P2027, DOI 10.1093/jxb/erp381; Cheng JianHong, 2006, Acta Horticulturae Sinica, V33, P470; Crane MB, 1942, J GENET, V43, P31, DOI 10.1007/BF02982745; De Franceschi P, 2011, TREE GENET GENOMES, V7, P231, DOI 10.1007/s11295-010-0327-5; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Doyle J. J., 1987, PHYTOCHEM B, P11; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Entani T, 1999, THEOR APPL GENET, V99, P391, DOI 10.1007/s001220051249; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Golz JF, 2001, P NATL ACAD SCI USA, V98, P15372, DOI 10.1073/pnas.261571598; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; Kakui H, 2011, PLANT J, V68, P1028, DOI 10.1111/j.1365-313X.2011.04752.x; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; Li MF, 2009, PLANT BIOLOGY, V11, P774, DOI 10.1111/j.1438-8677.2008.00180.x; Matsumoto D, 2012, PLANT PHYSIOL, V159, P1252, DOI 10.1104/pp.112.197343; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; Okada K, 2008, PLANT MOL BIOL, V66, P389, DOI 10.1007/s11103-007-9277-1; Qi YJ, 2011, TREE GENET GENOMES, V7, P685, DOI 10.1007/s11295-011-0366-6; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Sanzol J, 2009, PLANT CELL REP, V28, P457, DOI 10.1007/s00299-008-0645-3; SASSA H, 1992, PLANT CELL PHYSIOL, V33, P811; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsukamoto T, 2006, PLANT MOL BIOL, V62, P371, DOI 10.1007/s11103-006-9026-x; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Wu J, 2011, SEX PLANT REPROD, V24, P23, DOI 10.1007/s00497-010-0148-6; Xu C, 2013, PLANT MOL BIOL, V81, P245, DOI 10.1007/s11103-012-9995-x; Xue YB, 1996, PLANT CELL, V8, P805, DOI 10.1105/tpc.8.5.805; Yamane H, 2003, PLANT CELL PHYSIOL, V44, P764, DOI 10.1093/pcp/pcg088; Yang M, 1999, P NATL ACAD SCI USA, V96, P11416, DOI 10.1073/pnas.96.20.11416; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zuriaga E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053947; Zuriaga E, 2012, PLANT MOL BIOL, V79, P229, DOI 10.1007/s11103-012-9908-z	45	12	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76509	10.1371/journal.pone.0076509	http://dx.doi.org/10.1371/journal.pone.0076509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116113	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300060
J	Beyene, T; Woldeamanuel, Y; Asrat, D; Ayana, G; Boulware, DR				Beyene, Tafese; Woldeamanuel, Yimtubezinash; Asrat, Daniel; Ayana, Gonfa; Boulware, David R.			Comparison of Cryptococcal Antigenemia between Antiretroviral Naive and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia	PLOS ONE			English	Article							PRIMARY PROPHYLAXIS; INFECTED PATIENTS; MENINGITIS; SERUM; THERAPY; PREVALENCE; MORTALITY; UGANDA; ADULTS; DIAGNOSIS	Background: Cryptococcal meningitis is a major cause of HIV/AIDS-related deaths in Africa. Cryptococcosis is a neglected killer. However, meningitis can be prevented by early cryptococcal antigen (CrAg) screening and preemptive antifungal treatment during a prolonged period of detectable, subclinical infection. We determined the prevalence of cryptococcal antigenemia in comparison to CD4 count and clinical symptoms. Methods: We surveyed 254 consenting HIV-infected participants to obtain demographic information and clinical history. Serum CrAg was measured by latex agglutination at two sites in the Oromia region of Ethiopia among all persons receiving a CD4 count. Results: Of the 254 participants, 127(50.0%) were ART-naive, 121(47.6%) were ART-experienced, and 6(2.4%) were ART-defaulters. The prevalence of cryptococcal antigenemia was 10.2% overall being 14.2% among ART-naive, 4.1% among ART-experienced, and 50% (3/6) among ART-defaulters, irrespective of CD4 count. Cryptococcal antigenemia was more frequently detected from ART-naive patients (p = 0.012) and ART-defaulters (p = 0.001) compared with ART-experienced. Serum CrAg positivity was 20.9% in persons with CD4 <= 150 cells/mu L, 12.2% in 151-200 cells/mu L, 5.8% among 201-350 CD4/mu L, and none above 350 cells/mu L. Potential meningitis symptoms were common in the outpatient cohort irrespective of CrAg-status, with only fever and altered mental status statistically more common in CrAg-positive compared to CrAg-negative persons (P<0.05), yet no symptom had a positive predictive value >33%. Conclusion: We report a 20.9% cryptococcal antigenemia prevalence among those with CD4+ T cells count <= 150 cells/mu L, irrespective of ART status, with even higher CrAg prevalence in ART-naives and ART-defaulters. These groups are target populations for CrAg screening at entry into HIV care.	[Beyene, Tafese] Adama Sci & Technol Univ, Asella Sch Hlth Sci, Dept Biomed Sci, Asella, Ethiopia; [Woldeamanuel, Yimtubezinash; Asrat, Daniel] Univ Addis Ababa, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Ayana, Gonfa] EHNRI, Reg Labs Capac Bldg Directorate, Addis Ababa, Ethiopia; [Boulware, David R.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA	Adama Science & Technology University; Addis Ababa University; Ethiopian Health & Nutrition Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Beyene, T (corresponding author), Adama Sci & Technol Univ, Asella Sch Hlth Sci, Dept Biomed Sci, Asella, Ethiopia.	tafeseb.tufa@yahoo.com	Boulware, David R/AAF-7124-2021; Woldeamanuel, YImtubezinash/AAX-9402-2020; Boulware, David R/GRS-0999-2022	Woldeamanuel, YImtubezinash/0000-0001-6606-8903; Boulware, David R/0000-0002-4715-0060	Addis Ababa University; Oromia Health bureau	Addis Ababa University; Oromia Health bureau	Addis Ababa University has supported stationary's fee, Oromia Health bureau has supported some laboratory reagents, and Pharma share and Oxiod company donated Remal Cryptococcal antigen Test kit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; Alemu AW, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5398; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Cachay ER, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-29; Chariyalertsak S, 2002, CLIN INFECT DIS, V34, P277, DOI 10.1086/338154; Cohen DB, 2010, TROP MED INT HEALTH, V15, P910, DOI 10.1111/j.1365-3156.2010.02565.x; DESMET P, 1989, AIDS, V3, P77, DOI 10.1097/00002030-198902000-00004; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Hakim JG, 2000, AIDS, V14, P1401, DOI 10.1097/00002030-200007070-00013; Harris JR, 2012, CLIN INFECT DIS, V54, pe43, DOI 10.1093/cid/cir903; Jarvis J, 2011, SAMJ S AFR MED J, V101, P244, DOI 10.7196/SAMJ.4795; Jarvis Joseph N, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P374, DOI 10.1177/1545109712459077; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2011, SAMJ S AFR MED J, V101, P232, DOI 10.7196/SAMJ.4752; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Katwere M, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-21; Kisenge PR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-39; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Mamoojee Y, 2011, TROP MED INT HEALTH, V16, P53, DOI 10.1111/j.1365-3156.2010.02683.x; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Osazuwa Oghomwen Favour, 2012, Acta Med Iran, V50, P344; Oyella J, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-15; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parkes-Ratanshi R, 2011, LANCET INFECT DIS, V11, P933, DOI 10.1016/S1473-3099(11)70245-6; PEPFAR, 2013, PRES EM PLAN AIDS RE; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajasingham R, 2012, CLIN INFECT DIS, V55, P1742, DOI 10.1093/cid/cis725; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Rolfes MAR, 2012, CROI SEATTL; Ryan KJ, 2004, SHERIS MED MICROBIOL, P669; Seboxa Teshale, 2010, Ethiop Med J, V48, P237; Smith RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062213; Tassie JM, 2003, JAIDS-J ACQ IMM DEF, V33, P411, DOI 10.1097/00126334-200307010-00019; Trachtenberg JD, 2007, INT J INFECT DIS, V11, P524, DOI 10.1016/j.ijid.2007.01.014; Wajanga BMK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-48; Woldemanuel Y, 2001, Ethiop Med J, V39, P185; World Health Organization, 2011, RAP ADV DIAGN PREV M	47	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75585	10.1371/journal.pone.0075585	http://dx.doi.org/10.1371/journal.pone.0075585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124498	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100055
J	Lan, MY; Liu, CP; Huang, HH; Lee, SW				Lan, Ming-Ying; Liu, Chia-Pei; Huang, Her-Hsiung; Lee, Sheng-Wei			Both Enhanced Biocompatibility and Antibacterial Activity in Ag-Decorated TiO2 Nanotubes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SILVER NANOPARTICLES; ESCHERICHIA-COLI; SURFACE; TITANIUM; ADSORPTION; ATTACHMENT; COATINGS; FACES	In this study, Ag is electron-beam evaporated to modify the topography of anodic TiO2 nanotubes of different diameters to obtain an implant with enhanced antibacterial activity and biocompatibility. We found that highly hydrophilic as-grown TiO2 nanotubes became poorly hydrophilic with Ag incorporation; however they could effectively recover their wettability to some extent under ultraviolet light irradiation. The results obtained from antibacterial tests suggested that the Ag-decorated TiO2 nanotubes could greatly inhibit the growth of Staphylococcus aureus. In vitro biocompatibility evaluation indicated that fibroblast cells exhibited an obvious diameter-dependent behavior on both as-grown and Ag-decorated TiO2 nanotubes. Most importantly, of all samples, the smallest diameter (25-nm-diameter) Ag-decorated nanotubes exhibited the most obvious biological activity in promoting adhesion and proliferation of human fibroblasts, and this activity could be attributed to the highly irregular topography on a nanometric scale of the Ag-decorated nanotube surface. These experimental results demonstrate that by properly controlling the structural parameters of Ag-decorated TiO2 nanotubes, an implant surface can be produced that enhances biocompatibility and simultaneously boosts antibacterial activity.	[Lan, Ming-Ying] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lan, Ming-Ying] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Liu, Chia-Pei; Lee, Sheng-Wei] Natl Cent Univ, Inst Mat Sci & Engn, Jhongli, Taiwan; [Huang, Her-Hsiung] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; National Yang Ming Chiao Tung University	Lee, SW (corresponding author), Natl Cent Univ, Inst Mat Sci & Engn, Jhongli, Taiwan.	swlee@ncu.edu.tw			Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST101-G4-3-1, VGHUST101-G4-3-2]; National Science Council of Taiwan [NSC-100-2221-E-008-016-MY3]	Veterans General Hospitals University System of Taiwan Joint Research Program; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The research is supported by the Veterans General Hospitals University System of Taiwan Joint Research Program under Contract nos. VGHUST101-G4-3-1 and VGHUST101-G4-3-2 and by the National Science Council of Taiwan under Contract no. NSC-100-2221-E-008-016-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092; Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004; Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h; Cabal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042393; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186; Chun AL, 2005, BIOMATERIALS, V26, P7304, DOI 10.1016/j.biomaterials.2005.05.080; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1; Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125; Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003; de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8; Dong W, 2007, CHEM MATER, V19, P4454, DOI 10.1021/cm070845a; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gibbins B., 2005, MED DEVICE DIAGN IND, V8, P2; Hatchett DW, 1996, J PHYS CHEM-US, V100, P9854, DOI 10.1021/jp953757z; Hiramatsu H, 2004, CHEM MATER, V16, P2509, DOI 10.1021/cm049532v; Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031; Jin M, 2007, J PHYS CHEM C, V111, P658, DOI 10.1021/jp065590n; KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1; Lan MY, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-150; Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034388; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012; Meng FM, 2009, APPL SURF SCI, V255, P6715, DOI 10.1016/j.apsusc.2009.02.076; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020; Rottman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052883; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; VITANOV T, 1983, J ELECTROANAL CHEM, V159, P437, DOI 10.1016/S0022-0728(83)80639-1; Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394; Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098; Yang WE, 2009, J ALLOY COMPD, V479, P642, DOI 10.1016/j.jallcom.2009.01.021; Yang WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085102; Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s; Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040	44	49	50	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75364	10.1371/journal.pone.0075364	http://dx.doi.org/10.1371/journal.pone.0075364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124484	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100041
J	Ling, ZX; Liu, X; Luo, YQ; Wu, XX; Yuan, L; Tong, XJ; Li, LJ; Xiang, C				Ling, Zongxin; Liu, Xia; Luo, Yueqiu; Wu, Xiaoxing; Yuan, Li; Tong, Xiaojuan; Li, Lanjuan; Xiang, Charlie			Associations between Vaginal Pathogenic Community and Bacterial Vaginosis in Chinese Reproductive-Age Women	PLOS ONE			English	Article							PYROSEQUENCING ANALYSIS; ATOPOBIUM-VAGINAE; MICROBIOTA; PH; METRONIDAZOLE; LACTOBACILLI; DIVERSITY; HEALTH	Background: Bacterial vaginosis (BV) is one of the most common urogenital infections among women of reproductive age that represents shifts in microbiota from Lactobacillus spp. to diverse anaerobes. The aim of our study was to evalute the diagnostic values of Gardnerella, Atopobium, Eggerthella, Megasphaera typeI, Leptotrichia/Sneathia and Prevotella, defined as a vaginal pathogenic community for BV and their associations with vaginal pH and Nugent scores. Methods and Findings: We investigated the vaginal pathogenic bacteria and Lactobacillus spp. with species-specific real-time quantitative PCR (qPCR) in 50 BV-positive and 50 BV-negative Chinese women of reproductive age. Relative to BV-negative subjects, a siginificant decline in Lactobacillus and an obvious increase in bacteria in the vaginal pathogenic community were observed in BV-postive subjects (P<0.05). With the exception of Megasphaera typeI, other vaginal pathogenic bacteria were highly predictable for BV with a better sensitivity and specificity. The vaginal pathogenic community was positively associated with vaginal pH and Nugent scores, while Lactobacillus spp., such as L. iners and L. crispatus was negatively associated with them (P<0.05). Conclusions: Our data implied that the prevalance of vaginal pathogenic bacteria as well as the depletion of Lactobacillus was highly accurate for BV diagnosis. Vaginal microbiota shifts, especially the overgrowth of the vaginal pathogenic community, showed well diagnostic values in predicting BV. Postive correlations between those vaginal pathogenic bacteria and vaginal pH, Nugent score indicated the vaginal pathogenic community rather than a single vaginal microorganism, was participated in the onset of BV directly.	[Ling, Zongxin; Luo, Yueqiu; Wu, Xiaoxing; Yuan, Li; Tong, Xiaojuan; Li, Lanjuan; Xiang, Charlie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Ling, Zongxin; Luo, Yueqiu; Wu, Xiaoxing; Yuan, Li; Tong, Xiaojuan; Li, Lanjuan; Xiang, Charlie] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Liu, Xia] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Intens Care Unit, Hangzhou 310003, Zhejiang, Peoples R China; [Xiang, Charlie] J Craig Venter Inst, Rockville, MD USA	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; J. Craig Venter Institute	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; cxiang@zju.edu.cn	Ling, Zongxin/AAM-4059-2021; Ling, Zongxin/M-1657-2018	Ling, Zongxin/0000-0001-9662-099X; Liu, Xia/0000-0002-9987-3332	National Basic Research Program of China (973 program) [2013CB531404]; Zhejiang University	National Basic Research Program of China (973 program)(National Basic Research Program of China); Zhejiang University	This present work was funded by the grants of the National Basic Research Program of China (973 program) Grant 2013CB531404 and partly supported by a Qiu-Shi Scholarship from Zhejiang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Amsel R., 1983, AM J MED, V14, P74, DOI DOI 10.1016/0002-9343(83)91112-9.PUBMED:6600371; Caillouette JC, 1997, AM J OBSTET GYNECOL, V176, P1270, DOI 10.1016/S0002-9378(97)70345-4; Clarke MA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-33; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Garcia-Closas M, 1999, AM J OBSTET GYNECOL, V180, P1060, DOI 10.1016/S0002-9378(99)70595-8; Graver MA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-8; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Kalra Apoorv, 2007, Curr Infect Dis Rep, V9, P485, DOI 10.1007/s11908-007-0074-4; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Ling ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-390; Ling ZX, 2013, MICROB ECOL, V65, P773, DOI 10.1007/s00248-012-0154-3; Ling ZX, 2013, MICROB ECOL, V65, P487, DOI 10.1007/s00248-012-0123-x; Ling ZX, 2011, MICROB ECOL, V61, P704, DOI 10.1007/s00248-011-9813-z; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pavlova SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/j.1365-2672.2002.01547.x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Zhang R, 2012, J MED MICROBIOL, V61, P729, DOI 10.1099/jmm.0.038687-0	28	20	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76589	10.1371/journal.pone.0076589	http://dx.doi.org/10.1371/journal.pone.0076589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124575	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100132
J	Piazza, R; Magistroni, V; Pirola, A; Redaelli, S; Spinelli, R; Redaelli, S; Galbiati, M; Valletta, S; Giudici, G; Cazzaniga, G; Gambacorti-Passerini, C				Piazza, Rocco; Magistroni, Vera; Pirola, Alessandra; Redaelli, Sara; Spinelli, Roberta; Redaelli, Serena; Galbiati, Marta; Valletta, Simona; Giudici, Giovanni; Cazzaniga, Giovanni; Gambacorti-Passerini, Carlo			CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data	PLOS ONE			English	Article							CANCER	Copy number alterations (CNA) are common events occurring in leukaemias and solid tumors. Comparative Genome Hybridization (CGH) is actually the gold standard technique to analyze CNAs; however, CGH analysis requires dedicated instruments and is able to perform only low resolution Loss of Heterozygosity (LOH) analyses. Here we present CEQer (Comparative Exome Quantification analyzer), a new graphical, event-driven tool for CNA/allelic-imbalance (AI) coupled analysis of exome sequencing data. By using case-control matched exome data, CEQer performs a comparative digital exonic quantification to generate CNA data and couples this information with exome-wide LOH and allelic imbalance detection. This data is used to build mixed statistical/heuristic models allowing the identification of CNA/AI events. To test our tool, we initially used in silico generated data, then we performed whole-exome sequencing from 20 leukemic specimens and corresponding matched controls and we analyzed the results using CEQer. Taken globally, these analyses showed that the combined use of comparative digital exon quantification and LOH/AI allows generating very accurate CNA data. Therefore, we propose CEQer as an efficient, robust and user-friendly graphical tool for the identification of CNA/AI in the context of whole-exome sequencing data.	[Piazza, Rocco; Magistroni, Vera; Pirola, Alessandra; Redaelli, Sara; Spinelli, Roberta; Valletta, Simona; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Redaelli, Serena] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy; [Galbiati, Marta; Giudici, Giovanni; Cazzaniga, Giovanni] Univ Milano Bicocca, San Gerardo Hosp, Tettamanti Res Ctr, Monza, Italy	University of Milano-Bicocca; University of Milano-Bicocca; San Gerardo Hospital; University of Milano-Bicocca	Piazza, R (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	rocco.piazza@unimib.it	Magistroni, Vera/AAA-5582-2020; redaelli, sara/I-5146-2012; Cazzaniga, Giovanni/K-6338-2016	Magistroni, Vera/0000-0002-7334-9401; redaelli, sara/0000-0003-0166-1188; Rocco, Piazza/0000-0003-4198-9620; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Valletta, Simona/0000-0002-3524-4991; Cazzaniga, Giovanni/0000-0003-2955-4528	Progetti di Ricerca di Interesse Nazionale [20084XBENM_004]; Italian Ministry of Health [RFPS-2006-333974]; Italian Association for Cancer Research (AIRC) [IG-10092]; CARIPLO Foundation [2009-2667]; Regione Lombardia [ID-16871, ID-14546A]; Regione Lombardia -Dote Ricercatori FSE - 16-AR	Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); CARIPLO Foundation(Fondazione Cariplo); Regione Lombardia(Regione Lombardia); Regione Lombardia -Dote Ricercatori FSE - 16-AR(Regione Lombardia)	This work was supported by the Progetti di Ricerca di Interesse Nazionale (PRIN: http://prin.miur.it/) (20084XBENM_004); Italian Ministry of Health (RFPS-2006-333974); the Italian Association for Cancer Research (AIRC: http://www.airc.it/) (IG-10092); CARIPLO Foundation (http://www.fondazionecariplo.it/) (2009-2667); Regione Lombardia (ID-16871 and ID-14546A); Regione Lombardia -Dote Ricercatori FSE - 16-AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS F; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Haimovich Adrian D., 2011, Yale Journal of Biology and Medicine, V84, P439; Johansson B, 2002, ACTA HAEMATOL-BASEL, V107, P76, DOI 10.1159/000046636; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Love MI, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1732; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Piazza R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks394; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Popp HD, 2010, GENE CHROMOSOME CANC, V49, P1071, DOI 10.1002/gcc.20823; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308	16	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74825	10.1371/journal.pone.0074825	http://dx.doi.org/10.1371/journal.pone.0074825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124457	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100014
J	Warner, D; Ferreira, LMM; Breuer, MJH; Dijkstra, J; Pellikaan, WF				Warner, Daniel; Ferreira, Luis M. M.; Breuer, Michel J. H.; Dijkstra, Jan; Pellikaan, Wilbert F.			Stable Isotope Labeled n-Alkanes to Assess Digesta Passage Kinetics through the Digestive Tract of Ruminants	PLOS ONE			English	Article							MARKER EXCRETION PATTERNS; ENRICHMENTS DELTA-C-13; BOTANICAL COMPOSITION; DAIRY-COWS; IN-VIVO; CARBON; RUMEN; METABOLISM; CATTLE; SHEEP	We describe the use of carbon stable isotope (C-13) labeled n-alkanes as a potential internal tracer to assess passage kinetics of ingested nutrients in ruminants. Plant cuticular n-alkanes originating from intrinsically v labeled ryegrass plants were pulse dosed intraruminally in four rumen-cannulated lactating dairy cows receiving four contrasting ryegrass silage treatments that differed in nitrogen fertilization level (45 or 90 kg nitrogen ha(-1)) and maturity (early or late). Passage kinetics through the gastrointestinal tract were derived from the delta C-13 (i.e. the ratio C-13:C-12) in apparently undigested fecal material. Isotopic enrichment was observed in a wide range of long-chain n-alkanes (C-27-C-36) and passage kinetics were determined for the most abundant C-29, C-31 and C-33 n-alkanes, for which a sufficiently high response signal was detected by combustion isotope ratio mass spectrometry. Basal diet treatment and carbon chain length of n-alkanes did not affect fractional passage rates from the rumen (K-1) among individual n-alkanes (3.71-3.95%/h). Peak concentration time and transit time showed a quantitatively small, significant (p <= 0.002) increase with carbon chain length. K-1 estimates were comparable to those of the C-13 labeled digestible dry matter fraction (3.38%/h; r = 0.61 to 0.71; p <= 0.012). A literature review has shown that n-alkanes are not fermented by microorganisms in the rumen and affirms no preferential depletion of C-13 versus C-12. Our results suggest that C-13 labeled n-alkanes can be used as nutrient passage tracers and support the reliability of the delta C-13 signature of digestible feed nutrients as a tool to measure nutrient-specific passage kinetics.	[Warner, Daniel; Breuer, Michel J. H.; Dijkstra, Jan; Pellikaan, Wilbert F.] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands; [Ferreira, Luis M. M.] Univ Tras Os Montes & Alto Douro, Ctr Ciencia Anim & Vet, Vila Real, Portugal	Wageningen University & Research; University of Tras-os-Montes & Alto Douro	Warner, D (corresponding author), Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands.	daniel.warner@wur.nl	Ferreira, Luis M.M./C-6868-2009; DIJKSTRA, Jan/G-7680-2011	Ferreira, Luis M.M./0000-0002-3341-861X; DIJKSTRA, Jan/0000-0003-3728-6885	Product Board Animal Feed (Den Haag, The Netherlands)	Product Board Animal Feed (Den Haag, The Netherlands)	This work was co-financed by the Product Board Animal Feed (Den Haag, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrahamse PA, 2008, J DAIRY SCI, V91, P2033, DOI 10.3168/jds.2007-0579; Abrahamse PA, 2008, J DAIRY SCI, V91, P4778, DOI 10.3168/jds.2008-1350; ALEXANDER CL, 1969, J ANIM SCI, V29, P948, DOI 10.2527/jas1969.296948x; Ali HAM, 2005, J AGR SCI-CAMBRIDGE, V143, P85, DOI 10.1017/S0021859605004958; BARTLEY EE, 1971, J ANIM SCI, V33, P1351; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; Bezabih M, 2011, LIVEST SCI, V142, P298, DOI 10.1016/j.livsci.2011.08.009; Bezabih M, 2011, ANIMAL, V5, P57, DOI 10.1017/S1751731110001515; Bibby J., 1977, PREDICTION IMPROVED; BOSCH MW, 1995, BRIT J NUTR, V73, P41, DOI 10.1079/BJN19950007; BRUINING M, 1992, ANIM FEED SCI TECH, V37, P193, DOI 10.1016/0377-8401(92)90003-O; Bulang M, 2008, LIVEST SCI, V115, P42, DOI 10.1016/j.livsci.2007.06.007; Cannas A., 2000, Modelling nutrient utilization in farm animals, P49, DOI 10.1079/9780851994499.0049; Clauss M, 2001, OECOLOGIA, V129, P321, DOI 10.1007/s004420100735; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; COLUCCI PE, 1990, J DAIRY SCI, V73, P2143, DOI 10.3168/jds.S0022-0302(90)78895-9; DHANOA MS, 1985, BRIT J NUTR, V53, P663, DOI 10.1079/BJN19850076; Dijkstra J, 2007, ANIMAL, V1, P99, DOI 10.1017/S1751731107657760; Dijkstra J., 2000, Modelling nutrient utilization in farm animals, P25, DOI 10.1079/9780851994499.0025; DOVE H, 1991, AUST J AGR RES, V42, P913, DOI 10.1071/AR9910913; Dove H, 1996, AUST J AGR RES, V47, P1333, DOI 10.1071/AR9961333; Dove H, 2006, NAT PROTOC, V1, P1680, DOI 10.1038/nprot.2006.225; EHLE FR, 1984, J DAIRY SCI, V67, P2910, DOI 10.3168/jds.S0022-0302(84)81654-9; Ferreira LMM, 2009, J ANIM SCI, V87, P2732, DOI 10.2527/jas.2008-1718; Ferreira LMM, 2009, ANIM FEED SCI TECH, V151, P128, DOI 10.1016/j.anifeedsci.2008.11.003; Firkins JL, 1998, J DAIRY SCI, V81, P3350, DOI 10.3168/jds.S0022-0302(98)75901-6; FRANCE J, 1993, BRIT J NUTR, V70, P369, DOI 10.1079/BJN19930129; Giraldez FJ, 2006, LIVEST SCI, V100, P195, DOI 10.1016/j.livprodsci.2005.08.009; Gorissen A, 1996, PLANT SOIL, V179, P81, DOI 10.1007/BF00011645; Hatt JM, 1998, ZOO BIOL, V17, P295, DOI 10.1002/(SICI)1098-2361(1998)17:4&lt;295::AID-ZOO4&gt;3.0.CO;2-4; Huhtanen P, 2001, ANIM FEED SCI TECH, V94, P29, DOI 10.1016/S0377-8401(01)00297-8; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Ippel JH, 2004, PROTEOMICS, V4, P226, DOI 10.1002/pmic.200300506; Kebreab E, 2004, ANIM FEED SCI TECH, V112, P131, DOI 10.1016/j.anifeedsci.2003.10.009; Keli A, 2008, ANIMAL, V2, P1748, DOI 10.1017/S1751731108003108; LECHNERDOLL M, 1989, J ANIM PHYSIOL AN N, V61, P120, DOI 10.1111/j.1439-0396.1989.tb00091.x; Mayes R. W., 1988, Proceedings of the 12th General Meeting of the European Grassland Federation, Dublin, Ireland, July 4-7, 1988., P159; Mayes R. W., 1997, Proceedings of the Nutrition Society, V56, p187A; MAYES RW, 1986, J AGR SCI, V107, P161, DOI 10.1017/S0021859600066910; MCCARTHY RD, 1964, BIOCHIM BIOPHYS ACTA, V84, P74, DOI 10.1016/0926-6542(64)90102-7; OHAJURUKA OA, 1991, J ANIM SCI, V69, P1726; Olivan M, 1999, J AGR SCI, V132, P305, DOI 10.1017/S0021859699006358; Owens F. N., 1986, CONTROL DIGESTION ME, P196; OWENS FN, 1992, J DAIRY SCI, V75, P2605, DOI 10.3168/jds.S0022-0302(92)78023-0; Pellikaan WF, 2013, ANIMAL, V7, P754, DOI 10.1017/S1751731112002303; POPPI DP, 1980, J AGR SCI-CAMBRIDGE, V94, P275, DOI 10.1017/S0021859600028859; Scott MP, 1999, PHYTOCHEMISTRY, V52, P555, DOI 10.1016/S0031-9422(99)00271-X; SICILIANOJONES J, 1986, J DAIRY SCI, V69, P2304, DOI 10.3168/jds.S0022-0302(86)80669-5; Sponheimer M, 2003, SMALL RUMINANT RES, V48, P149, DOI 10.1016/S0921-4488(03)00002-6; Sudekum KH, 1995, ISOT ENVIRON HEALT S, V31, P219, DOI 10.1080/10256019508234020; Sutherland T. M., 1988, Aspects of digestive physiology in ruminants. Proceedings of a Satellite Symposium of the 30th International Congress of the International Union of Physiological Sciences, July 21-23, 1986. Ithaca, New York, P43; UDEN P, 1980, J SCI FOOD AGR, V31, P625, DOI 10.1002/jsfa.2740310702; Warner D, 2013, J DAIRY SCI, V96, P5844, DOI 10.3168/jds.2013-6694; [No title captured]	54	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75496	10.1371/journal.pone.0075496	http://dx.doi.org/10.1371/journal.pone.0075496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124493	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100050
J	Jonas, JB; Nangia, V; Khare, A; Kulkarni, M; Matin, A; Sinha, A; Bhojwani, K; Nangia, P; Panda-Jonas, S				Jonas, Jost B.; Nangia, Vinay; Khare, Anshu; Kulkarni, Maithili; Matin, Arshia; Sinha, Ajit; Bhojwani, Krishna; Nangia, Prabhat; Panda-Jonas, Songhomitra			Prevalence of Optic Disc Hemorrhages in Rural Central India. The Central India Eye and Medical Study	PLOS ONE			English	Article							GLAUCOMA; POPULATION; ASSOCIATIONS; PROGRESSION	Purpose: To determine the frequency of optic disc hemorrhages in a rural Indian population. Methods: The population-based Central Indian Eye and Medical Study included 4711 subjects. Mean age was 48.5 +/- 12.9 years (range:30-100 years). Color optic disc photographs were examined. Results: Optic disc photographs were available for 4570 (97.0%) subjects. Prevalence of disc hemorrhages was 17/8869 (0.19%; 95%CI:0.10,0.28) per eye and 16/4570 (0.35 +/- 0.09%; 95%CI:0.18,0.52) per subject. Prevalence of disc hemorrhages increased from 0.05% (95%CI:0.00,0.13) in the age group of 30-39 years to 0.25% (95CI: 0.00,0.49) in the age group of 60-69 years and to 0.91% (95%CI:0.24,1.58) in the age group of 70+ years. After adjusting for older age, higher systolic blood pressure, diabetes mellitus, myopic refractive error, smaller neuroretinal rim area and thinner retinal nerve fiber layer, occurrence of disc hemorrhages was associated only with glaucomatous optic nerve damage (P<0.001; Odds ratio:87; 95%CI:32,239). Eleven of the 17 (65%; 95%CI:39,90) disc hemorrhages were found in glaucomatous eyes. Out of 193 glaucomatous eyes, 11 eyes (5.7%; 95%CI:2.4,9.0) showed a disc hemorrhage. Out of the 8676 non-glaucomatous eyes, 6 eyes (0.07%; 95% CI:0.01,0.12) had an optic disc hemorrhage. Conclusions: Prevalence of disc hemorrhages (0.2% per eye; 0.4% per subject) in Indians aged 30+ years was strongly associated with glaucoma after adjustment for age, blood pressure and diabetes mellitus. A disc hemorrhage suggested glaucomatous optic nerve damage with a positive predictive value of 65%. About 6% of glaucomatous eyes showed a disc hemorrhage at the time of clinical examination highlighting the importance of optic disc hemorrhages for the diagnosis of glaucoma.	[Jonas, Jost B.; Nangia, Vinay; Khare, Anshu; Kulkarni, Maithili; Matin, Arshia; Sinha, Ajit; Bhojwani, Krishna; Nangia, Prabhat; Panda-Jonas, Songhomitra] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Suraj Eye Institute; Ruprecht Karls University Heidelberg	Jonas, JB (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	Jost.Jonas@augen.ma.uni-heidelberg.de; nagpursuraj@gmail.com			Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1981, ARCH OPHTHALMOL-CHIC, V99, P1795, DOI 10.1001/archopht.1981.03930020669009; Bengtsson B, 2005, J GLAUCOMA, V14, P135, DOI 10.1097/01.ijg.0000151683.04410.f3; BENGTSSON B, 1981, ACTA OPHTHALMOL, V59, P1; Bourne RRA, 2003, BRIT J OPHTHALMOL, V87, P1069, DOI 10.1136/bjo.87.9.1069; DIEHL DLC, 1990, ARCH OPHTHALMOL-CHIC, V108, P545, DOI 10.1001/archopht.1990.01070060093056; DRANCE SM, 1977, ARCH OPHTHALMOL-CHIC, V95, P226; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Grodum K, 2002, J GLAUCOMA, V11, P226, DOI 10.1097/01.IJG.0000013483.08219.F0; Healey PR, 1998, OPHTHALMOLOGY, V105, P216, DOI 10.1016/S0161-6420(98)92704-X; HEIJL A, 1986, ACTA OPHTHALMOL, V64, P274; JONAS JB, 1994, AM J OPHTHALMOL, V118, P1; JONAS JB, 1997, INVEST OPHTH VIS SCI, V43, P2956; Jonas JB, 2013, DIABETES CARE, V36, pE69, DOI 10.2337/dc12-2377; Jonas JB, 2012, CLIN EXP OPHTHALMOL, V40, pE116, DOI 10.1111/j.1442-9071.2011.02731.x; Jonas JB, 2010, EPIDEMIOLOGY, V21, P754, DOI 10.1097/EDE.0b013e3181e66201; Jonasson F, 2003, EYE, V17, P747, DOI 10.1038/sj.eye.6700374; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Siegner SW, 1996, OPHTHALMOLOGY, V103, P1014, DOI 10.1016/S0161-6420(96)30572-1; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Thomas R, 2007, CLIN EXP OPHTHALMOL, V35, P374, DOI 10.1111/j.1442-9071.2007.01489.x; Thomas R, 2012, INDIAN J OPHTHALMOL, V60, P446, DOI 10.4103/0301-4738.100546; Wang Y, 2006, AM J OPHTHALMOL, V142, P241, DOI 10.1016/j.ajo.2006.02.032; Xu L, 2008, ARCH OPHTHALMOL-CHIC, V126, P435, DOI 10.1001/archopht.126.3.435; Yamamoto T, 2004, J GLAUCOMA, V13, P356, DOI 10.1097/01.ijg.0000137436.68060.d2	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76154	10.1371/journal.pone.0076154	http://dx.doi.org/10.1371/journal.pone.0076154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098775	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500145
J	Charbonneau, DM; Beauregard, M				Charbonneau, David M.; Beauregard, Marc			Role of Key Salt Bridges in Thermostability of G. thermodenitrificans EstGtA2: Distinctive Patterns within the New Bacterial Lipolytic Enzyme Family XV	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; MONOACYLGLYCEROL LIPASE; PROTEIN STABILITY; CRYSTAL-STRUCTURE; FOLDING PATHWAY; CARBOXYLESTERASE; SURFACE; CLASSIFICATION; STABILIZATION; EXPRESSION	Bacterial lipolytic enzymes were originally classified into eight different families defined by Arpigny and Jaeger (families I-VIII). Recently, the discovery of new lipolytic enzymes allowed for extending the original classification to fourteen families (I-XIV). We previously reported that G. thermodenitrificans EstGtA2 (access no. AEN92268) belonged to a novel group of bacterial lipolytic enzymes. Here we propose a 15th family (family XV) and suggest criteria for the assignation of protein sequences to the N' subfamily. Five selected salt bridges, hallmarks of the N' subfamily (E3/R54, E12/R37, E66/R140, D124/K178 and D205/R220) were disrupted in EstGtA2 using a combinatorial alanine-scanning approach. A set of 14 (R/K -> A) mutants was produced, including five single, three double, three triple and three quadruple mutants. Despite a high tolerance to non-conservative mutations for folding, all the alanine substitutions were destabilizing (decreasing T-m by 5 to 14 degrees C). A particular combination of four substitutions exceeded this tolerance and prevents the correct folding of EstGtA2, leading to enzyme inactivation. Although other mutants remain active at low temperatures, the accumulation of more than two mutations had a dramatic impact on EstGtA2 activity at high temperatures suggesting an important role of these conserved salt bridge-forming residues in thermostability of lipolytic enzymes from the N' subfamily. We also identified a particular interloop salt bridge in EstGtA2 (D194/H222), located at position i-2 and i-4 residues from the catalytic Asp and His respectively which is conserved in other related bacterial lipolytic enzymes (families IV and XIII) with high tolerance to mutations and charge reversal. We investigated the role of residue identity at position 222 in controlling stability-pH dependence in EstGtA2. The introduction of a His to Arg mutation led to increase thermostability under alkaline pH. Our results suggest primary targets for optimization of EstGtA2 for specific biotechnological purposes.	[Charbonneau, David M.; Beauregard, Marc] Univ Quebec Trois Rivieres, Dept Chim Phys, Ctr Rech Mat Lignocellulos, Trois Rivieres, PQ GA9 5H7, Canada; [Charbonneau, David M.; Beauregard, Marc] Univ Laval, PROTEO Quebec Network Res Prot Struct Funct & Eng, Quebec City, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; Laval University	Beauregard, M (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Phys, Ctr Rech Mat Lignocellulos, Trois Rivieres, PQ GA9 5H7, Canada.	marc.beauregard@uqtr.ca			National Sciences and Engineering Research Council of Canada (NSERC); NSERC [138654]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	DMC was supported by a fellowship from the National Sciences and Engineering Research Council of Canada (NSERC) and a NSERC grant 138654 award to MB (www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; BENSON AD, 2013, ENBANK, P41, DOI DOI 10.1093/NAR/GKS1195; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Brown BM, 1999, P NATL ACAD SCI USA, V96, P1983, DOI 10.1073/pnas.96.5.1983; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Charbonneau DM, 2010, J BIOCHEM, V148, P299, DOI 10.1093/jb/mvq064; Chow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047665; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Dadarlat VM, 2008, J PHYS CHEM B, V112, P6159, DOI 10.1021/jp077024d; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Imamura S, 2000, J BIOCHEM-TOKYO, V127, P419, DOI 10.1093/oxfordjournals.jbchem.a022623; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kitaura S, 2001, J BIOCHEM-TOKYO, V129, P397, DOI 10.1093/oxfordjournals.jbchem.a002870; Knochel T, 2002, J BIOL CHEM, V277, P8626, DOI 10.1074/jbc.M109517200; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; Montoro-Garcia S, 2009, J BACTERIOL, V191, P3076, DOI 10.1128/JB.01060-08; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; MULKERRIN MG, 1989, BIOCHEMISTRY-US, V28, P6556, DOI 10.1021/bi00442a005; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Oliveberg M, 1996, BIOCHEMISTRY-US, V35, P6795, DOI 10.1021/bi9529317; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; Rao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060645; Rengachari S, 2012, BBA-MOL CELL BIOL L, V1821, P1012, DOI 10.1016/j.bbalip.2012.04.006; Reyes-Duarte D, 2005, ANGEW CHEM INT EDIT, V44, P7553, DOI 10.1002/anie.200502461; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer RT, 1996, FASEB J, V10, P42, DOI 10.1096/fasebj.10.1.8566546; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yennamalli RM, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-10	56	36	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76675	10.1371/journal.pone.0076675	http://dx.doi.org/10.1371/journal.pone.0076675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116134	gold, Green Published			2022-12-27	WOS:000325552200062
J	Selva, L; Benmessaoud, R; Lanaspa, M; Jroundi, I; Moraleda, C; Acacio, S; Inigo, M; Bastiani, A; Monsonis, M; Pallares, R; Bassat, Q; Munoz-Almagro, C				Selva, Laura; Benmessaoud, Rachid; Lanaspa, Miguel; Jroundi, Imane; Moraleda, Cinta; Acacio, Sozinho; Inigo, Melania; Bastiani, Alien; Monsonis, Manuel; Pallares, Roman; Bassat, Quique; Munoz-Almagro, Carmen			Detection of Streptococcus pneumoniae and Haemophilus influenzae Type B by Real-Time PCR from Dried Blood Spot Samples among Children with Pneumonia: A Useful Approach for Developing Countries	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; CONJUGATE VACCINE; STRAINS; DISEASE; IMPACT	Background: Dried blood spot (DBS) is a reliable blood collection method for storing samples at room temperature and easily transporting them. We have previously validated a Real-Time PCR for detection of Streptococcus pneumoniae in DBS. The objective of this study was to apply this methodology for the diagnosis of S. pneumoniae and Haemophilus influenzae b (Hib) in DBS samples of children with pneumonia admitted to two hospitals in Mozambique and Morocco. Methods: Ply and wzg genes of S. pneumoniae and bexA gene of Hib, were used as targets of Real-Time PCR. 329 DBS samples of children hospitalized with clinical diagnosis of pneumonia were tested. Results: Real-Time PCR in DBS allowed for a significant increase in microbiological diagnosis of S. pneumoniae and Hib. When performing blood bacterial culture, only ten isolates of S. pneumoniae and none of Hib were detected (3.0% positivity rate, IC95% 1.4-5.5%). Real-Time PCR from DBS samples increased the detection yield by 4x fold, as 30 S. pneumoniae and 11 Hib cases were detected (12.4% positivity rate, IC95% 9.0-16.5%; P< 0.001). Conclusion: Real-Time PCR applied in DBS may be a valuable tool for improving diagnosis and surveillance of pneumonia caused by S. pneumoniae or Hib in developing countries.	[Selva, Laura; Inigo, Melania; Bastiani, Alien; Monsonis, Manuel; Munoz-Almagro, Carmen] Univ Hosp St Joan de Deu, Barcelona, Spain; [Benmessaoud, Rachid; Lanaspa, Miguel; Jroundi, Imane; Moraleda, Cinta; Bassat, Quique] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Lanaspa, Miguel; Acacio, Sozinho; Bassat, Quique] CISM, Maputo, Mozambique; [Benmessaoud, Rachid; Moraleda, Cinta] Fdn Clin Recerca Biomed, Rabat, Morocco; [Jroundi, Imane] Minist Sante, INAS, Rabat, Morocco; [Pallares, Roman] Bellvitge Hosp, Idibell, Ciberes, Barcelona, Spain; [Pallares, Roman] Univ Barcelona, Barcelona, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Munoz-Almagro, C (corresponding author), Univ Hosp St Joan de Deu, Barcelona, Spain.	cma@hsjdbcn.org	PALLARES, Roman/B-5710-2008; Munoz-Almagro, Carmen/B-4308-2015; Bassat, Quique/P-2341-2016; Lanaspa, Miguel/AAO-4971-2020; Muñoz-Almagro, Carmen/N-7248-2015	PALLARES, Roman/0000-0003-3262-8508; Munoz-Almagro, Carmen/0000-0001-5586-404X; Bassat, Quique/0000-0003-0875-7596; Muñoz-Almagro, Carmen/0000-0001-5586-404X; Moraleda, Cinta/0000-0002-8335-903X; Lanaspa, Miguel/0000-0002-9310-177X	Fondo de Investigaciones Sanitarias [PI10/02058]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR00136, FI-ICIP 2012]; Fundacio Sant Joan de Deu	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Fundacio Sant Joan de Deu	This work was supported in part by Fondo de Investigaciones Sanitarias [PI10/02058 and a Research Grant to QB], Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR00136 and FI-ICIP 2012 to LS] and Fundacio Sant Joan de Deu [Research Grant to LS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydogan H, 2006, MICROBIOL RES, V161, P55, DOI 10.1016/j.micres.2005.06.004; Benninger MS, 2010, CURR ALLERGY ASTHM R, V10, P411, DOI 10.1007/s11882-010-0139-6; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Boppana SB, 2010, JAMA-J AM MED ASSOC, V303, P1375, DOI 10.1001/jama.2010.423; Braikat M, 2012, VACCINE, V30, P2594, DOI 10.1016/j.vaccine.2012.01.041; Carrol ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021042; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; de Almeida AECC, 2005, BRAZ J MED BIOL RES, V38, P777, DOI 10.1590/S0100-879X2005000500016; De Crignis E, 2010, J VIROL METHODS, V165, P51, DOI 10.1016/j.jviromet.2009.12.017; Diez-Padrisa N, 2012, TROP MED INT HEALTH, V17, P1100, DOI 10.1111/j.1365-3156.2012.03035.x; El Mdaghri N., 2012, Eastern Mediterranean Health Journal, V18, P1097; Gessner BD, 2009, EXPERT REV VACCINES, V8, P91, DOI 10.1586/14760584.8.1.91; Hernandez-Bou S, 2009, PEDIATR PULM, V44, P1192, DOI 10.1002/ppul.21114; Ladhani SN, 2012, CLIN THER, V34, P385, DOI 10.1016/j.clinthera.2011.11.027; Lakshmi V, 2011, INDIAN J MICROBIOL, V51, P147, DOI 10.1007/s12088-011-0135-0; Munoz-Almagro C, 2011, EUR J CLIN MICROBIOL, V30, P327, DOI 10.1007/s10096-010-1086-9; Roca A, 2008, TROP MED INT HEALTH, V13, P818, DOI 10.1111/j.1365-3156.2008.02061.x; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Santos C, 2012, J VIROL METHODS, V179, P17, DOI 10.1016/j.jviromet.2011.06.012; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Selva L, 2011, EMERG INFECT DIS, V17, P1125, DOI [10.3201/eid1706.100997, 10.3201/eid/1706.100997]; Siberry G, 2001, B WORLD HEALTH ORGAN, V79, P43; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; UNICEF/WHO, 2006, NEUM FORG KILL CHILD; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; Wasas AD, 1999, J CLIN MICROBIOL, V37, P2045, DOI 10.1128/JCM.37.6.2045-2046.1999; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; World Health Organization (WHO), 1991, LANCET, V338, P1453, DOI [10.1016/0140-6736(91)92751-M, DOI 10.1016/0140-6736(91)92751-M.PUBMED:1683434]; Xu QF, 2012, PEDIATR INFECT DIS J, V31, P638, DOI 10.1097/INF.0b013e31824ba6f7	29	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76970	10.1371/journal.pone.0076970	http://dx.doi.org/10.1371/journal.pone.0076970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116190	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200090
J	Gelaye, E; Lamien, CE; Silber, R; Tuppurainen, ESM; Grabherr, R; Diallo, A				Gelaye, Esayas; Lamien, Charles Euloge; Silber, Roland; Tuppurainen, Eeva S. M.; Grabherr, Reingard; Diallo, Adama			Development of a Cost-Effective Method for Capripoxvirus Genotyping Using Snapback Primer and dsDNA Intercalating Dye	PLOS ONE			English	Article							LUMPY SKIN-DISEASE; PHYLOGENETIC ANALYSIS; MELTING ANALYSIS; SHEEP POX; VIRUS; IDENTIFICATION; THREAT; CATTLE; GENOME; GENE	Sheep pox virus (SPPV), goat pox virus (GTPV) and lumpy skin disease virus (LSDV) are very closely related viruses of the Capripoxvirus (CaPV) genus of the Poxviridae family. They are responsible for sheep pox, goat pox and lumpy skin disease which affect sheep, goat and cattle, respectively. The epidemiology of capripox diseases is complex, as some CaPVs are not strictly host-specific. Additionally, the three forms of the disease co-exist in many sub-Saharan countries which complicates the identification of the virus responsible for an outbreak. Genotyping of CaPVs using a low-cost, rapid, highly specific, and easy to perform method allows a swift and accurate identification of the causative agent and significantly assists in selecting appropriate control and eradication measures, such as the most suitable vaccine against the virus during the outbreaks. The objective of this paper is to describe the design and analytical performances of a new molecular assay for CaPV genotyping using unlabelled snapback primers in the presence of dsDNA intercalating EvaGreen dye. This assay was able to simultaneously detect and genotype CaPVs in 63 samples with a sensitivity and specificity of 100%. The genotyping was achieved by observing the melting temperature of snapback stems of the hairpins and those of the full-length amplicons, respectively. Fourteen CaPVs were genotyped as SPPVs, 25 as GTPVs and 24 as LSDVs. The method is highly pathogen specific and cross platform compatible. It is also cost effective as it does not use fluorescently labelled probes, nor require high-resolution melting curve analysis software. Thus it can be easily performed in diagnostic and research laboratories with limited resources. This genotyping method will contribute significantly to the early detection and genotyping of CaPV infection and to epidemiological studies.	[Gelaye, Esayas; Lamien, Charles Euloge; Diallo, Adama] IAEA, Anim Prod & Hlth Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Dept Nucl Sci & Applicat, A-1400 Vienna, Austria; [Silber, Roland] Austrian Agcy Hlth & Food Safety, Inst Vet Dis Control, Modling, Austria; [Tuppurainen, Eeva S. M.] Pirbright Inst, Capripoxvirus Reference Lab, Woking, Surrey, England; [Grabherr, Reingard] Univ Nat Resources & Life Sci, Inst Appl Microbiol, Vienna, Austria; [Gelaye, Esayas] Univ Nat Resources & Life Sci, Inst Appl Genet & Cell Biol, Vienna, Austria; [Gelaye, Esayas] Natl Vet Inst, Res & Diagnost Labs, Debre Zeit, Ethiopia	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Lamien, CE (corresponding author), IAEA, Anim Prod & Hlth Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Dept Nucl Sci & Applicat, A-1400 Vienna, Austria.	C.Lamien@iaea.org		LAMIEN, Charles Euloge/0000-0003-1899-7614; Grabherr, Reingard/0000-0002-4501-927X	IAEA Peaceful Uses Initiatives (PUI) project; United States Department of State; tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program	IAEA Peaceful Uses Initiatives (PUI) project; United States Department of State; tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program(United States Agency for International Development (USAID))	This work was supported by the IAEA Peaceful Uses Initiatives (PUI) project funded by the United States Department of State and the tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiuk S, 2008, TRANSBOUND EMERG DIS, V55, P263, DOI 10.1111/j.1865-1682.2008.01043.x; Bhanuprakash V, 2006, COMP IMMUNOL MICROB, V29, P27, DOI 10.1016/j.cimid.2005.12.001; Dames S, 2007, CLIN CHEM, V53, P1847, DOI 10.1373/clinchem.2007.090761; Farrar JS, 2011, CLIN CHEM, V57, P1303, DOI 10.1373/clinchem.2011.166306; Hosamani M, 2004, VIRUS GENES, V29, P73, DOI 10.1023/B:VIRU.0000032790.16751.13; KITCHING RP, 1989, EPIDEMIOL INFECT, V102, P335, DOI 10.1017/S0950268800030016; Lamien CE, 2011, VET MICROBIOL, V149, P30, DOI 10.1016/j.vetmic.2010.09.038; Lamien CE, 2011, J VIROL METHODS, V171, P134, DOI 10.1016/j.jviromet.2010.10.014; Le Goff C, 2009, J GEN VIROL, V90, P1967, DOI 10.1099/vir.0.010686-0; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; NAWATHE DR, 1982, ZBL VET MED B, V29, P31; Oguzoglu TC, 2006, VET RES COMMUN, V30, P965, DOI 10.1007/s11259-006-3259-7; PROZESKY L, 1982, ONDERSTEPOORT J VET, V49, P167; Stram Y, 2008, J VIROL METHODS, V151, P225, DOI 10.1016/j.jviromet.2008.05.003; TANTAWI HH, 1979, TROP ANIM HEALTH PRO, V11, P208, DOI 10.1007/BF02237803; Tulman ER, 2002, J VIROL, V76, P6054, DOI 10.1128/JVI.76.12.6054-6061.2002; Tulman ER, 2001, J VIROL, V75, P7122, DOI 10.1128/JVI.75.15.7122-7130.2001; Tuppurainen ESM, 2012, TRANSBOUND EMERG DIS, V59, P40, DOI 10.1111/j.1865-1682.2011.01242.x; Verma S, 2011, TRANSBOUND EMERG DIS, V58, P79, DOI 10.1111/j.1865-1682.2010.01172.x; Weber O, 2007, POXVIRUSES, P167; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; World Organisation for Animal Health (OIE), 2012, MANUAL DIAGNOSTIC TE, V6th; Wu ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026534; YERUHAM I, 1995, VET REC, V137, P91, DOI 10.1136/vr.137.4.91; Zhou LM, 2008, CLIN CHEM, V54, P1648, DOI 10.1373/clinchem.2008.107615; Zhou LM, 2010, CLIN CHEM, V56, P814, DOI 10.1373/clinchem.2009.142034; Zhou T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-25; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75971	10.1371/journal.pone.0075971	http://dx.doi.org/10.1371/journal.pone.0075971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116084	Green Published, gold			2022-12-27	WOS:000325501300045
J	Huang, X; Liu, WJ; Feng, B; Tan, QR; Ji, JL				Huang, Xiao; Liu, Wenjuan; Feng, Bin; Tan, Qingrong; Ji, Jianlin			Applicability of the Chinese Version of the Hypomania Symptom Checklist (HCL-32) Scale for Outpatients of Psychiatric Departments in General Hospitals	PLOS ONE			English	Article							BIPOLAR DISORDER; PREVALENCE; SPECTRUM; ILLNESS; DISEASE	Objectives: This study aimed to determine the suitability of the Chinese version of the Hypomania Symptom Checklist (HCL-32) scale for psychiatric department outpatients with mood disorders in Chinese general hospitals, and provide a theoretical basis for the application of the HCL-32 scale. Methods: Outpatients with mood disorders receiving continuous treatment in the psychiatric medicine department of three top-ranking general hospitals in three cities completed scoring the HCL-32 scale. Results: A total of 1010 patients were recruited. 417 were diagnosed with bipolar disorder (236 for type I and 181 for type II) and 593 were depression. Four factors with eigenvalues >1 were considered. Factor 1 with an eigenvalue of 5.5 was labeled "active/cheerful''. Factor 2 with an eigenvalue of 2.7 was labeled "adventurous/irritable.'' The coefficient of internal consistency reliability of the HCL-32 total scale was 0.84, and the coefficients for factors 1 and 2 were 0.84 and 0.88, respectively. With the total score of HCL-32 >= 14 as positive standard, the sensitivity of HCL-32 was calculated at 69.30% and the specificity was 97.81%. Conclusions: Results showed that HCL-32 had a preferable reliability and validity and was suitable as auxiliary means for bipolar disorder screening in general hospitals.	[Huang, Xiao; Liu, Wenjuan; Ji, Jianlin] Fudan Univ, Dept Psychol Med, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Feng, Bin] Tongde Hosp Zhejiang Prov, Dept Psychiat, Hangzhou, Zhejiang, Peoples R China; [Tan, Qingrong] Xijing Hosp, Dept Psychiat, Xian, Shanxi, Peoples R China	Fudan University; Air Force Military Medical University	Ji, JL (corresponding author), Fudan Univ, Dept Psychol Med, Zhongshan Hosp, Shanghai 200433, Peoples R China.	ji_jian_lin@126.com						Akiskal HS, 2000, J AFFECT DISORDERS, V59, pS5, DOI 10.1016/S0165-0327(00)00203-2; American Psychiatric A, 2002, AM J PSYCHIAT, V159, P1; Angst J, 2005, J AFFECT DISORDERS, V88, P217, DOI 10.1016/j.jad.2005.05.011; Angst J, 2005, EPIDEMIOL PSICHIAT S, V14, P68, DOI 10.1017/S1121189X00006278; Angst J GA, 2002, UPDATE MAINTENANCE T; Ghaemi SN, 2002, CAN J PSYCHIAT, V47, P125, DOI 10.1177/070674370204700202; Hantouche EG, 1998, J AFFECT DISORDERS, V50, P163, DOI 10.1016/S0165-0327(98)00112-8; Harpole LH, 2005, GEN HOSP PSYCHIAT, V27, P4, DOI 10.1016/j.genhosppsych.2004.09.004; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P53, DOI 10.4088/JCP.v64n0111; [杨海晨 YANG Haichen], 2008, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V17, P950; LISH JD, 1994, J AFFECT DISORDERS, V31, P281, DOI 10.1016/0165-0327(94)90104-X; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; [司天梅 SI Tian-Mei], 2009, [中国心理卫生杂志, Chinese Mental Health Journal], V23, P493; Suppes T, 2001, J AFFECT DISORDERS, V67, P45, DOI 10.1016/S0165-0327(01)00432-3; Yang HC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-84; [张红霞 Zhang Hongxia], 2002, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V11, P270	18	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75631	10.1371/journal.pone.0075631	http://dx.doi.org/10.1371/journal.pone.0075631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116062	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300036
J	Ko, JY; Kim, YD; Hong, YJ; Lee, HJ; Hur, J; Choi, BW; Heo, JH; Kim, YJ				Ko, Ji Young; Kim, Young Dae; Hong, Yoo Jin; Lee, Hye-Jeong; Hur, Jin; Choi, Byoung Wook; Heo, Ji Hoe; Kim, Young Jin			Lack of Association between Stroke and Left Atrial Out-Pouching Structures: Results of a Case-Control Study	PLOS ONE			English	Article							CORONARY CT ANGIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; RADIOFREQUENCY ABLATION; ACCESSORY APPENDAGES; MULTIDETECTOR CT; CARDIAC CT; DIVERTICULUM; FIBRILLATION; THROMBUS	Background and Purpose: Clinical significance of out-pouching structures of the left atrium (LA) as potential embolic sources remains unclear. We sought to evaluate the association between stroke and LA out-pouching structures. Methods: A case-control study was conducted to assess the prevalence of LA out-pouching structures in subjects with and without stroke. Case subjects were 270 stroke patients who had undergone cardiac CT. Control subjects were 270 age-and sex-matched patients without a history of stroke and who had undergone cardiac CT. Presence of LA out-pouching structures was determined by ECG-gated cardiac CT. The location of out-pouching structures was categorized as near Bachmann bundle, anterior, inferoseptal, inferior, and lateral. The prevalence, number and location of out-pouching structures and clinical characteristics were compared between the two groups. Results: One hundred sixty eight out-pouching structures were identified in 139 stroke patients (51%), while a total of 169 out-pouching structures were found in 155 control patients (57%) (p=0.1949). The prevalence of LA out-pouching structures with different locations was not significantly different between the stroke group and control group. In the stroke group, the prevalence of out-pouching structures was not significantly different by subtypes of ischemic stroke and the prevalence of LA out-pouching structures was not different between patients with atrial fibrillation (AF) and without AF. Conclusion: The left atrial out-pouching structures are commonly seen in a population with and without stroke with similar prevalence. Our study suggests that LA out-pouching structures are not significant risk factors of stroke.	[Ko, Ji Young; Hong, Yoo Jin; Lee, Hye-Jeong; Hur, Jin; Choi, Byoung Wook; Kim, Young Jin] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea; [Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ, Coll Med, Dept Neurol, Severance Hosp, Seoul, South Korea; [Choi, Byoung Wook] Yonsei Univ, Coll Med, Div Cardiovasc Radiol, Severance Cardiovasc Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, YJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea.	dryj@yuhs.ac		Choi, Byoung Wook/0000-0002-8873-5444; Hur, Jin/0000-0002-8651-6571; Heo, Ji Hoe/0000-0001-9898-3321; Kim, Young Jin/0000-0002-6235-6550; Lee, Hye-Jeong/0000-0003-4349-9174; Hong, Yoojin/0000-0002-7276-0944; Kim, Young Dae/0000-0001-5750-2616				Abbara S, 2009, AM J ROENTGENOL, V193, P807, DOI 10.2214/AJR.08.2229; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Balli O, 2012, EUR J RADIOL, V81, pE37, DOI 10.1016/j.ejrad.2010.11.017; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Duerinckx AJ, 2008, INT J CARDIOVAS IMAG, V24, P215, DOI 10.1007/s10554-007-9240-x; Hur J, 2011, STROKE, V42, P2471, DOI 10.1161/STROKEAHA.110.611293; Hur J, 2009, STROKE, V40, P2073, DOI 10.1161/STROKEAHA.108.537928; Killeen RP, 2010, INT J CARDIOVAS IMAG, V26, P241, DOI 10.1007/s10554-009-9511-9; Killeen RP, 2009, CIRCULATION, V120, pE60, DOI 10.1161/CIRCULATIONAHA.109.855569; Kim HY, 2012, INT J CARDIOVAS IMAG, V28, P101, DOI 10.1007/s10554-012-0142-1; Kim YJ, 2009, RADIOLOGY, V250, P61, DOI 10.1148/radiol.2501080559; Lazoura O, 2012, J CARDIOVASC COMPUT, V6, P268, DOI 10.1016/j.jcct.2012.02.004; Lee BI, 2001, CEREBROVASC DIS, V12, P145, DOI 10.1159/000047697; Lee WJ, 2008, CIRCULATION, V117, P1351, DOI 10.1161/CIRCULATIONAHA.107.744706; McGuinness J, 2007, J THORAC CARDIOV SUR, V133, P820, DOI 10.1016/j.jtcvs.2006.09.084; Nagai T, 2011, CIRCULATION, V124, P1086, DOI 10.1161/CIRCULATIONAHA.110.000315; Naqvi TZ, 2004, J AM SOC ECHOCARDIOG, V17, P1077, DOI 10.1016/j.echo.2004.05.008; Peng LQ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P345, DOI 10.1161/CIRCEP.111.965665; SRINIVASAN V, 1980, CARDIOVASC DIS, V7, P405; Troupis J, 2012, INT J CARDIOVAS IMAG, V28, P375, DOI 10.1007/s10554-011-9815-4; Wan YD, 2009, SURG RADIOL ANAT, V31, P191, DOI 10.1007/s00276-008-0427-1	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76617	10.1371/journal.pone.0076617	http://dx.doi.org/10.1371/journal.pone.0076617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116128	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300074
J	O'Neill, PK; Or, M; Erill, I				O'Neill, Patrick K.; Or, Mindy; Erill, Ivan			scnRCA: A Novel Method to Detect Consistent Patterns of Translational Selection in Mutationally-Biased Genomes	PLOS ONE			English	Article							CODON USAGE BIAS; TRANSFER-RNA GENES; ESCHERICHIA-COLI; ADAPTATION INDEX; EXPRESSION; PREDICTION; ORGANIZATION; EFFICIENCY; EVOLUTION; ABUNDANCE	Codon usage bias (CUB) results from the complex interplay between translational selection and mutational biases. Current methods for CUB analysis apply heuristics to integrate both components, limiting the depth and scope of CUB analysis as a technique to probe into the evolution and optimization of protein-coding genes. Here we introduce a self-consistent CUB index (scnRCA) that incorporates implicit correction for mutational biases, facilitating exploration of the translational selection component of CUB. We validate this technique using gene expression data and we apply it to a detailed analysis of CUB in the Pseudomonadales. Our results illustrate how the selective enrichment of specific codons among highly expressed genes is preserved in the context of genome-wide shifts in codon frequencies, and how the balance between mutational and translational biases leads to varying definitions of codon optimality. We extend this analysis to other moderate and fast growing bacteria and we provide unified support for the hypothesis that C- and A-ending codons of two-box amino acids, and the U-ending codons of four-box amino acids, are systematically enriched among highly expressed genes across bacteria. The use of an unbiased estimator of CUB allows us to report for the first time that the signature of translational selection is strongly conserved in the Pseudomonadales in spite of drastic changes in genome composition, and extends well beyond the core set of highly optimized genes in each genome. We generalize these results to other moderate and fast growing bacteria, hinting at selection for a universal pattern of gene expression that is conserved and detectable in conserved patterns of codon usage bias.	[O'Neill, Patrick K.; Or, Mindy; Erill, Ivan] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Erill, I (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	erill@umbc.edu	Erill, Ivan/H-9405-2015	Erill, Ivan/0000-0002-7280-7191	UMBC Office of Research through a Special Research Assistantship/Initiative Support (SRAIS) award; UMBC; NSF [MCB-1158056]; Div Of Molecular and Cellular Bioscience [1158056] Funding Source: National Science Foundation	UMBC Office of Research through a Special Research Assistantship/Initiative Support (SRAIS) award; UMBC; NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the UMBC Office of Research through a Special Research Assistantship/Initiative Support (SRAIS) award, by UMBC start-up funds and by NSF grant MCB-1158056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BULMER M, 1991, GENETICS, V129, P897; Carbone A, 2005, MOL BIOL EVOL, V22, P547, DOI 10.1093/molbev/msi040; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Carbone A, 2006, J MOL EVOL, V63, P733, DOI 10.1007/s00239-005-0250-9; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Davis JJ, 2011, MOL BIOL EVOL, V28, P211, DOI 10.1093/molbev/msq185; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; EyreWalker A, 1996, MOL BIOL EVOL, V13, P864, DOI 10.1093/oxfordjournals.molbev.a025646; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fox JM, 2010, DNA RES, V17, P185, DOI 10.1093/dnares/dsq012; Fuchsman CA, 2006, APPL ENVIRON MICROB, V72, P6841, DOI 10.1128/AEM.00429-06; Gilchrist MA, 2009, GENETICS, V183, P1493, DOI 10.1534/genetics.109.108209; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Grocock RJ, 2002, GENE, V289, P131, DOI 10.1016/S0378-1119(02)00503-6; Guo FB, 2012, DNA RES, V19, P477, DOI 10.1093/dnares/dss027; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hershberg R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049060; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Higgs PG, 2008, MOL BIOL EVOL, V25, P2279, DOI 10.1093/molbev/msn173; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; KURLAND CG, 1991, FEBS LETT, V285, P165, DOI 10.1016/0014-5793(91)80797-7; Lafay B, 2000, MICROBIOL-UK, V146, P851, DOI 10.1099/00221287-146-4-851; Lobry JR, 2002, GENOME BIOL, V3; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MORTON BR, 1993, J MOL EVOL, V37, P273, DOI 10.1007/BF00175504; Mrazek J, 2006, ENVIRON MICROBIOL, V8, P273, DOI 10.1111/j.1462-2920.2005.00894.x; Percudani R, 1999, MOL BIOL EVOL, V16, P1752, DOI 10.1093/oxfordjournals.molbev.a026087; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Raiford DW, 2010, IEEE ACM T COMPUT BI, V7, P238, DOI 10.1109/TCBB.2008.65; Ran WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051652; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Supek F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-182; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; von Mandach C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-617; Wald N, 2012, NUCLEIC ACIDS RES, V40, P7074, DOI 10.1093/nar/gks348; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105; Zhang Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-43	60	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76177	10.1371/journal.pone.0076177	http://dx.doi.org/10.1371/journal.pone.0076177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116094	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300049
J	Zeng, T; Jiang, XY; Li, JJ; Wang, DQ; Li, GQ; Lu, LZ; Wang, GL				Zeng, Tao; Jiang, Xueyuan; Li, Jinjun; Wang, Deqian; Li, Guoqin; Lu, Lizhi; Wang, Genlin			Comparative Proteomic Analysis of the Hepatic Response to Heat Stress in Muscovy and Pekin Ducks: Insight into Thermal Tolerance Related to Energy Metabolism	PLOS ONE			English	Article							OXIDATIVE STRESS; ALPHA-ENOLASE; HYDROGEN-PEROXIDE; 14-3-3 PROTEINS; SHOCK PROTEINS; CALRETICULIN; PROHIBITIN; CHAPERONE; REVEALS; PEROXIREDOXINS	The Pekin duck, bred from the mallard (Anas platyrhynchos) in china, is one of the most famous meat duck species in the world. However, it is more sensitive to heat stress than Muscovy duck, which is believed to have originated in South America. With temperature raising, mortality, laying performance, and meat quality of the Pekin duck are severely affected. This study aims to uncover the temperature-dependent proteins of two duck species using comparative proteomic approach. Duck was cultured under 39 degrees C +/- 0.5 degrees C for 1 h, and then immediately returned to 20 degrees C for a 3 h recovery period, the liver proteins were extracted and electrophoresed in two-dimensional mode. After analysis of gel images, 61 differentially expressed proteins were detected, 54 were clearly identified by MALDI TOF/TOF MS. Of the 54 differentially expressed protein spots identified, 7 were found in both species, whereas 47 were species specific (25 in Muscovy duck and 22 in Pekin duck). As is well known, chaperone proteins, such as heat shock protein (HSP) 70 and HSP10, were abundantly up-regulated in both species in response to heat stress. However, we also found that several proteins, such as a-enolase, and S-adenosylmethionine synthetase, showed different expression patterns in the 2 duck species. The enriched biological processes were grouped into 3 main categories according to gene ontology analysis: cell death and apoptosis (20.93%), amino acid metabolism (13.95%) and oxidation reduction (20.93%). The mRNA levels of several differentially expressed protein were investigated by real-time RT-PCR. To our knowledge, this study is the first to provide insights into the differential expression of proteins following heat stress in ducks and enables better understanding of possible heat stress response mechanisms in animals.	[Zeng, Tao; Jiang, Xueyuan; Wang, Genlin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zeng, Tao; Li, Jinjun; Wang, Deqian; Li, Guoqin; Lu, Lizhi] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Med, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences	Lu, LZ (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Med, Hangzhou, Zhejiang, Peoples R China.	lulizhibox@163.com; glwang@njau.edu.cn		zeng, tao/0000-0002-3349-0291	earmarked fund for National Waterfowl-industry Technology Research System [CARS-43-2]; National Supporting Projects for Science and Techniques [2012BAD12B10]	earmarked fund for National Waterfowl-industry Technology Research System; National Supporting Projects for Science and Techniques	This work was sponsored by the earmarked fund for National Waterfowl-industry Technology Research System (CARS-43-2) and National Supporting Projects for Science and Techniques (2012BAD12B10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bax ML, 2012, POULTRY SCI, V91, P112, DOI 10.3382/ps.2011-01663; Bernstein L., 2007, CLIMATE CHANGE SYNTH; Brinkmann C, 2013, J PHYSIOL SCI, V63, P1, DOI 10.1007/s12576-012-0237-4; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen FG, 2011, J PROTEOME RES, V10, P3944, DOI 10.1021/pr200535r; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Chen J, 2012, VET J, V193, P514, DOI 10.1016/j.tvjl.2012.01.034; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Clapp C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.90; Dalal SN, 2004, CELL CYCLE, V3, P672; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; Durand TC, 2011, J PROTEOMICS, V74, P1396, DOI 10.1016/j.jprot.2011.03.013; Fan LF, 2013, J PROTEOMICS, V80, P196, DOI 10.1016/j.jprot.2012.12.017; Fella K, 2005, PROTEOMICS, V5, P1914, DOI 10.1002/pmic.200401067; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; Guo GF, 2012, J PROTEOMICS, V75, P1867, DOI 10.1016/j.jprot.2011.12.032; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ibarz A, 2010, PROTEOMICS, V10, P963, DOI 10.1002/pmic.200900528; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jianzhen H, 2007, J VET MED A, V54, P464, DOI 10.1111/j.1439-0442.2007.00990.x; Kang GZ, 2012, J PROTEOME RES, V11, P6066, DOI 10.1021/pr300728y; Kathiria AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031231; Katz E, 2007, PLANTA, V226, P989, DOI 10.1007/s00425-007-0545-8; Kim J, 2007, J MICROBIOL BIOTECHN, V17, P146; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Liu W, 2001, ACTA CRYSTALLOGR D, V57, P1646, DOI 10.1107/S0907444901011106; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Luo Q, 2011, FREE RADICAL RES, V45, P1355, DOI 10.3109/10715762.2011.627330; Magrys A, 2007, J CLIN IMMUNOL, V27, P181, DOI 10.1007/s10875-006-9065-8; Maheshwari R, 2009, PLANT GROWTH REGUL, V59, P37, DOI 10.1007/s10725-009-9386-8; Mao H, 2012, MOL BIOL REP, V39, P7031, DOI 10.1007/s11033-012-1534-y; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Ryu SY, 2012, CELL SIGNAL, V24, P60, DOI 10.1016/j.cellsig.2011.07.011; Srivastava S, 2011, PLANT GROWTH REGUL, V64, P1, DOI 10.1007/s10725-010-9526-1; Stillman JH, 2009, MOL ECOL, V18, P4206, DOI 10.1111/j.1365-294X.2009.04354.x; Sule A, 2004, PHYTOCHEMISTRY, V65, P1853, DOI 10.1016/j.phytochem.2004.03.030; Tan GY, 2010, POULTRY SCI, V89, P115, DOI 10.3382/ps.2009-00318; THEOLOGIS A, 1992, CELL, V70, P181, DOI 10.1016/0092-8674(92)90093-R; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; Tsutsumi T, 2009, HEPATOLOGY, V50, P378, DOI 10.1002/hep.22998; Turk R, 2012, J PROTEOMICS, V75, P4412, DOI 10.1016/j.jprot.2012.05.021; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046463; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan Q, 2011, BIOCHEMISTRY-US, V50, P566, DOI 10.1021/bi101639y; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Zheng AJ, 2012, J PROTEOMICS, V75, P5396, DOI 10.1016/j.jprot.2012.06.019	68	30	31	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76917	10.1371/journal.pone.0076917	http://dx.doi.org/10.1371/journal.pone.0076917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116183	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300107
J	Lennon, JT; Hamilton, SK; Muscarella, ME; Grandy, AS; Wickings, K; Jones, SE				Lennon, Jay T.; Hamilton, Stephen K.; Muscarella, Mario E.; Grandy, A. Stuart; Wickings, Kyle; Jones, Stuart E.			A Source of Terrestrial Organic Carbon to Investigate the Browning of Aquatic Ecosystems	PLOS ONE			English	Article							LAKE FOOD WEBS; FLUORESCENCE SPECTROSCOPY; HUMIC MATERIALS; MATTER; WATER; POTASSIUM; PHOSPHORUS; SUBSIDIES; DAPHNIA; GROWTH	There is growing evidence that terrestrial ecosystems are exporting more dissolved organic carbon (DOC) to aquatic ecosystems than they did just a few decades ago. This "browning" phenomenon will alter the chemistry, physics, and biology of inland water bodies in complex and difficult-to-predict ways. Experiments provide an opportunity to elucidate how browning will affect the stability and functioning of aquatic ecosystems. However, it is challenging to obtain sources of DOC that can be used for manipulations at ecologically relevant scales. In this study, we evaluated a commercially available source of humic substances ("Super Hume") as an analog for natural sources of terrestrial DOC. Based on chemical characterizations, comparative surveys, and whole-ecosystem manipulations, we found that the physical and chemical properties of Super Hume are similar to those of natural DOC in aquatic and terrestrial ecosystems. For example, Super Hume attenuated solar radiation in ways that will not only influence the physiology of aquatic taxa but also the metabolism of entire ecosystems. Based on its chemical properties (high lignin content, high quinone content, and low C:N and C: P ratios), Super Hume is a fairly recalcitrant, low-quality resource for aquatic consumers. Nevertheless, we demonstrate that Super Hume can subsidize aquatic food webs through 1) the uptake of dissolved organic constituents by microorganisms, and 2) the consumption of particulate fractions by larger organisms (i.e., Daphnia). After discussing some of the caveats of Super Hume, we conclude that commercial sources of humic substances can be used to help address pressing ecological questions concerning the increased export of terrestrial DOC to aquatic ecosystems.	[Lennon, Jay T.; Muscarella, Mario E.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Hamilton, Stephen K.] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Hamilton, Stephen K.] Michigan State Univ, Dept Zool, Hickory Corners, MI USA; [Grandy, A. Stuart] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Wickings, Kyle] Cornell Univ, Dept Entomol, Geneva, NY USA; [Jones, Stuart E.] Univ Notre Dame, Dept Biol Sci, South Bend, IN USA	Indiana University System; Indiana University Bloomington; Michigan State University; Michigan State University; University System Of New Hampshire; University of New Hampshire; Cornell University; University of Notre Dame	Lennon, JT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lennonj@indiana.edu	Hamilton, Stephen K/N-2979-2014; Jones, Stuart/ABD-5264-2021; Muscarella, Mario E/G-7595-2017; Lennon, Jay T./ABE-6120-2020	Hamilton, Stephen K/0000-0002-4702-9017; Jones, Stuart/0000-0003-4740-6721; Muscarella, Mario E/0000-0001-6183-6037; Lennon, Jay T./0000-0003-3126-6111	National Science Foundation [DEB-0842441, DEB-0743402]; Center for Water Sciences at Michigan State University; Huron Mountains Wildlife Foundation	National Science Foundation(National Science Foundation (NSF)); Center for Water Sciences at Michigan State University; Huron Mountains Wildlife Foundation	This research was supported with funding from the National Science Foundation (DEB-0842441 to JTL an SEJ and DEB-0743402 to SKH and JTL), the Center for Water Sciences at Michigan State University, and the Huron Mountains Wildlife Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; APHA, 2012, 3120 APHA, V22nd; Arvola L, 1996, CAN J FISH AQUAT SCI, V53, P1646, DOI 10.1139/cjfas-53-7-1646; Ask J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003951; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Berggren M, 2010, ECOL LETT, V13, P870, DOI 10.1111/j.1461-0248.2010.01483.x; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Briand E, 2004, LIMNOL OCEANOGR-METH, V2, P406, DOI 10.4319/lom.2004.2.406; Caraco N, 2010, ECOLOGY, V91, P2385, DOI 10.1890/09-0330.1; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; CARPENTER SR, 1990, ECOLOGY, V71, P2038, DOI 10.2307/1938617; CHIOU CT, 1987, ENVIRON SCI TECHNOL, V21, P1231, DOI 10.1021/es00165a012; Christensen DL, 1996, LIMNOL OCEANOGR, V41, P553, DOI 10.4319/lo.1996.41.3.0553; Civitello DJ, 2013, ECOLOGY, V94, P380, DOI 10.1890/12-0883.1; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 2006, ECOL LETT, V9, P558, DOI 10.1111/j.1461-0248.2006.00898.x; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Cory RM, 2010, LIMNOL OCEANOGR-METH, V8, P67; Curtis PJ, 1997, BIOGEOCHEMISTRY, V36, P125, DOI 10.1023/A:1005787913638; CUTHBERT ID, 1992, LIMNOL OCEANOGR, V37, P1319, DOI 10.4319/lo.1992.37.6.1319; Evans C, 2008, BIOGEOCHEMISTRY, V91, P13, DOI 10.1007/s10533-008-9256-x; Fellman JB, 2009, ENVIRON SCI TECHNOL, V43, P6228, DOI 10.1021/es900143g; Findlay SEG, 2005, FRONT ECOL ENVIRON, V3, P133, DOI 10.1890/1540-9295(2005)003[0133:ICTITH]2.0.CO;2; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Geddes P, 2009, HYDROBIOLOGIA, V628, P47, DOI 10.1007/s10750-009-9745-5; Grandy AS, 2009, GEODERMA, V150, P278, DOI 10.1016/j.geoderma.2009.02.007; GRASSO D, 1990, CHEMOSPHERE, V21, P1181, DOI 10.1016/0045-6535(90)90139-K; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hamilton SK, 2001, BIOGEOCHEMISTRY, V54, P297, DOI 10.1023/A:1010635524108; Hamilton SK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002738; Hamilton SK, 2009, CAN J FISH AQUAT SCI, V66, P343, DOI 10.1139/F09-003; Hanson PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021884; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Hood E, 2005, BIOGEOCHEMISTRY, V74, P231, DOI 10.1007/s10533-004-4322-5; Jaworski GHM, 2003, FRESHWATER BIOL, V48, P833, DOI 10.1046/j.1365-2427.2003.01051.x; JONES RI, 1988, FRESHWATER BIOL, V19, P357, DOI 10.1111/j.1365-2427.1988.tb00357.x; Jones SE, TIPPING POI IN PRESS; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; JURGENS K, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P295; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; KASPRZAK P, 1993, PROC INT ASSOC THEOR, V25, P652; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kirchman D. L., 1993, HDB METHODS AQUATIC, P509, DOI [10.1201/9780203752746, DOI 10.1201/9780203752746]; Klug JL, 2005, CAN J FISH AQUAT SCI, V62, P472, DOI 10.1139/F04-229; LEHMAN JT, 1976, LIMNOL OCEANOGR, V21, P646, DOI 10.4319/lo.1976.21.5.0646; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Lennon JT, 2008, ECOLOGY, V89, P1001, DOI 10.1890/07-1380.1; Lennon JT, 2006, LIMNOL OCEANOGR, V51, P1602, DOI 10.4319/lo.2006.51.4.1602; Lennon JT, 2004, OECOLOGIA, V138, P584, DOI 10.1007/s00442-003-1459-1; Lennon JT, 2001, J PLANKTON RES, V23, P425, DOI 10.1093/plankt/23.4.425; MALCOLM RL, 1986, ENVIRON SCI TECHNOL, V20, P904, DOI 10.1021/es00151a009; Maranger RJ, 2003, AQUATIC ECOSYSTEMS I, P26; McCallister SL, 2004, LIMNOL OCEANOGR, V49, P1687, DOI 10.4319/lo.2004.49.5.1687; McKnight DM, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000269; McKnight DM., 2003, AQUATIC ECOSYSTEMS, P71, DOI 10.1016/B978-012256371-3/50004-4; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Mulholland PJ, 2003, AQUATIC ECOSYSTEMS I, P26; Neter J., 1996, APPL LINEAR STAT MOD; NIELSEN MV, 1989, LIMNOL OCEANOGR, V34, P1311, DOI 10.4319/lo.1989.34.7.1311; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ozdoba DM, 2001, ROY SOC CH, P309, DOI 10.1039/9781847551085-00309; Pace ML, 2002, LIMNOL OCEANOGR, V47, P333, DOI 10.4319/lo.2002.47.2.0333; Parn J, 2012, BIOGEOCHEMISTRY, V108, P351, DOI 10.1007/s10533-011-9604-0; Parker DL, 1997, APPL ENVIRON MICROB, V63, P2324, DOI 10.1128/AEM.63.6.2324-2329.1997; Quilty JR, 2011, SOIL RES, V49, P1, DOI 10.1071/SR10059; RICHEY JE, 1978, SCIENCE, V202, P1183, DOI 10.1126/science.202.4373.1183; Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591; Sandgren C.D., 1988, P9; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stanley EH, 2012, FRESHWATER BIOL, V57, P26, DOI 10.1111/j.1365-2427.2011.02613.x; Steiner CF, 2003, ECOLOGY, V84, P982, DOI 10.1890/0012-9658(2003)084[0982:VDIPCA]2.0.CO;2; STEMBERGER RS, 1981, CAN J FISH AQUAT SCI, V38, P721, DOI 10.1139/f81-095; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Stomp M, 2007, ISME J, V1, P271, DOI 10.1038/ismej.2007.59; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Talling J. F., 2010, Freshwater Reviews, V3, P97, DOI 10.1608/FRJ-3.2.1; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tranvik LJ, 2009, ENCY INLAND WATERS, P754; Vinebrooke RD, 1998, LIMNOL OCEANOGR, V43, P1065, DOI 10.4319/lo.1998.43.6.1065; von Wachenfeldt E, 2009, LIMNOL OCEANOGR, V54, P1811, DOI 10.4319/lo.2009.54.5.1811; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Wetzel R.G., 2000, LIMNOLOGICAL ANAL	88	27	27	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75771	10.1371/journal.pone.0075771	http://dx.doi.org/10.1371/journal.pone.0075771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124511	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100068
J	Markosyan, RM; Cohen, FS				Markosyan, Ruben M.; Cohen, Fredric S.			The Transmembrane Domain and Acidic Lipid Flip-Flop Regulates Voltage-Dependent Fusion Mediated by Class II and III Viral Proteins	PLOS ONE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; MEMBRANE-FUSION; CELL-LINE; CYTOPLASMIC DOMAINS; HEMIFUSION; ENTRY; ACTIVATION; RECEPTOR; SUPPORT; PEPTIDE	Voltage dependence of fusion induced by class II and class III viral fusion proteins was investigated. Class II proteins from Ross River and Sindbus virus and a mutant class III protein from Epstein Barr virus were found to induce cell-cell fusion that is voltage dependent. Combined with previous studies, in all, four class II and two class III protein have now been shown to exhibit voltage-dependent fusion, demonstrating that this is probably a general phenomenon for these two classes of viral fusion proteins. In the present study, monitoring fusion of pseudovirus expressing Vesicular Stomatitis virus (VSV) G within endosomes shows that here, too, fusion is voltage dependent. This supports the claim that voltage dependence of fusion is biologically relevant and that cell-cell fusion reliably models the voltage dependence. Fusion induced by class I viral proteins is independent of voltage; chimeras expressing the ectodomain of a class I fusion protein and the transmembrane domain of VSV G could therefore be used to explore the location within the protein responsible for voltage dependence. Results showed that the transmembrane domain is the region associated with voltage dependence. Experiments in which cells were enriched with acidic lipids led to the conclusion that it is the flip-flop of acidic lipids that carries the charge responsible for the observed voltage dependence of fusion. This flip-flop occurred downstream of hemifusion, in accord with previous findings that the voltage dependent steps of fusion occur at a stage subsequent to hemifusion.	[Markosyan, Ruben M.; Cohen, Fredric S.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Rush University	Cohen, FS (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.	Fredric_Cohen@rush.edu			National Institutes of Health [R01 GM066837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101539, R01GM066837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding by: National Institutes of Health R01 GM066837. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; DeMartini JC, 2001, J VIROL, V75, P4239, DOI 10.1128/JVI.75.9.4239-4246.2001; DOMS RW, 1985, J BIOL CHEM, V260, P2973; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Gibbons DL, 2004, J VIROL, V78, P3312, DOI 10.1128/JVI.78.7.3312-3318.2004; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; JONAK ZL, 1993, AIDS RES HUM RETROV, V9, P23, DOI 10.1089/aid.1993.9.23; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; Kunzelmann K, 2013, PFLUGERS ARCH; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Leikina E, 2000, MOL BIOL CELL, V11, P2359, DOI 10.1091/mbc.11.7.2359; Lin G, 2003, J VIROL, V77, P931, DOI 10.1128/JVI.77.2.931-942.2003; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Markosyan RM, 2007, J VIROL, V81, P11218, DOI 10.1128/JVI.01256-07; Markosyan RM, 2010, MOL BIOL CELL, V21, P2001, DOI 10.1091/mbc.E09-10-0904; Markovic I, 2001, J CELL BIOL, V155, P833, DOI 10.1083/jcb.200103005; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Odell D, 1997, J VIROL, V71, P7996, DOI 10.1128/JVI.71.10.7996-8000.1997; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Roth SL, 2011, FEBS LETT, V585, P865, DOI 10.1016/j.febslet.2011.02.015; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; SchrothDiez B, 1998, J VIROL, V72, P133, DOI 10.1128/JVI.72.1.133-141.1998; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wilk T, 1996, VIROLOGY, V218, P269, DOI 10.1006/viro.1996.0190; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	45	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76174	10.1371/journal.pone.0076174	http://dx.doi.org/10.1371/journal.pone.0076174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124539	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100096
J	Sung, KE; Su, XJ; Berthier, E; Pehlke, C; Friedl, A; Beebe, DJ				Sung, Kyung Eun; Su, Xiaojing; Berthier, Erwin; Pehlke, Carolyn; Friedl, Andreas; Beebe, David J.			Understanding the Impact of 2D and 3D Fibroblast Cultures on In Vitro Breast Cancer Models	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MICROFLUIDIC DEVICES; TUMOR-GROWTH; CELL-INTERACTIONS; MAMMARY-GLAND; MATRIX; COLLAGEN; MICROENVIRONMENTS; PROGRESSION; BIOLOGY	The utilization of 3D, physiologically relevant in vitro cancer models to investigate complex interactions between tumor and stroma has been increasing. Prior work has generally focused on the cancer cells and, the role of fibroblast culture conditions on tumor-stromal cell interactions is still largely unknown. Here, we focus on the stroma by comparing functional behaviors of human mammary fibroblasts (HMFs) cultured in 2D and 3D and their effects on the invasive progression of breast cancer cells (MCF10DCIS.com). We identified increased levels of several paracrine factors from HMFs cultured in 3D conditions that drive the invasive transition. Using a microscale co-culture model with improved compartmentalization and sensitivity, we demonstrated that HMFs cultured in 3D intensify the promotion of the invasive progression through the HGF/c-Met interaction. This study highlights the importance of the 3D stromal microenvironment in the development of multiple cell type in vitro cancer models.	[Sung, Kyung Eun; Su, Xiaojing; Pehlke, Carolyn; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA; [Berthier, Erwin] Univ Wisconsin, Dept Med Microbiol, Madison, WI USA; [Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Sung, Kyung Eun; Su, Xiaojing; Pehlke, Carolyn; Friedl, Andreas; Beebe, David J.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI USA; [Sung, Kyung Eun; Pehlke, Carolyn; Friedl, Andreas; Beebe, David J.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Beebe, DJ (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA.	djbeebe@wisc.edu		Sung, Kyung/0000-0001-9664-6399; Berthier, Erwin/0000-0002-4421-9034	National Institutes of Health [K25-CA104162, R01CA107012, 1R33CA137673-01, R01EB010039BRG]; National Science Foundation [EFRI-1136903]; Wisconsin Partnership Program; DARPA Micro/nano Fluidics Fundamentals Focus Center; Department of Defense breast cancer research grant [DOD BCRP W81XWH-10-BCRP-CA]; Korea Research Foundation [KRF-2008-220-D00133]; NLM training grant [NLM 5T15LM007359]; NATIONAL CANCER INSTITUTE [R33CA137673, K25CA104162, R01CA107012] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Wisconsin Partnership Program; DARPA Micro/nano Fluidics Fundamentals Focus Center; Department of Defense breast cancer research grant(United States Department of Defense); Korea Research Foundation(National Research Foundation of Korea); NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by National Institutes of Health grants (K25-CA104162, R01CA107012, 1R33CA137673-01, and R01EB010039BRG), National Science Foundation award (EFRI-1136903), the Wisconsin Partnership Program, the DARPA Micro/nano Fluidics Fundamentals Focus Center, the Department of Defense breast cancer research grant (DOD BCRP W81XWH-10-BCRP-CA), the Korea Research Foundation grant (KRF-2008-220-D00133), and NLM training grant (NLM 5T15LM007359). D.J. Beebe has equity in Bellbrook Labs which has licensed technology reported in this manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Berthier E, 2008, LAB CHIP, V8, P860, DOI 10.1039/b717423c; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blobel CP, 2010, BLOOD, V115, P5128, DOI 10.1182/blood-2010-03-275271; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dawson PJ, 1996, AM J PATHOL, V148, P313; Domenech M, 2009, INTEGR BIOL-UK, V1, P267, DOI 10.1039/b823059e; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Elliott BE, 2002, CAN J PHYSIOL PHARM, V80, P91, DOI 10.1139/y02-010; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Espina V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010240; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Gao CF, 2009, MOL CANCER THER, V8, P2803, DOI 10.1158/1535-7163.MCT-09-0125; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Goda S, 2006, AM J PATHOL, V169, P445, DOI 10.2353/ajpath.2006.050676; Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Grinnell F, 2008, J BODYW MOV THER, V12, P191, DOI 10.1016/j.jbmt.2008.03.005; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Han X, 2008, OPT EXPRESS, V16, P1846, DOI 10.1364/OE.16.001846; Haslam SZ, 2003, BREAST CANCER RES, V5, P208, DOI 10.1186/bcr615; Hompland T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2983664; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Montanez-Sauri SI, 2013, INTEGR BIOL-UK, V5, P631, DOI 10.1039/c3ib20225a; Montanez-Sauri SI, 2011, JALA-J LAB AUTOM, V16, P171, DOI 10.1016/j.jala.2011.02.003; Morales J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-462; Nakamura T, 1997, CANCER RES, V57, P3305; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Puccinelli JP, 2010, JALA-J LAB AUTOM, V15, P25, DOI 10.1016/j.jala.2009.10.002; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Sharma M, 2010, BREAST CANCER RES TR, V123, P397, DOI 10.1007/s10549-009-0654-0; Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043; Syed ZA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-180; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e; Wong AP, 2008, BIOMATERIALS, V29, P1853, DOI 10.1016/j.biomaterials.2007.12.044; Yang WT, 2010, BREAST CANCER RES TR, V119, P305, DOI 10.1007/s10549-009-0350-0; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zhao XS, 2008, CANCER RES, V68, P467, DOI 10.1158/0008-5472.CAN-07-0782; Zhuo SM, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088029	62	110	113	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76373	10.1371/journal.pone.0076373	http://dx.doi.org/10.1371/journal.pone.0076373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124550	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100107
J	Wang, J; Xiong, XJ; Liu, W				Wang, Jie; Xiong, Xingjiang; Liu, Wei			Yoga for Essential Hypertension: A Systematic Review	PLOS ONE			English	Review							BLOOD-PRESSURE; RISK-FACTORS; MEDICINE; HEALTH; COMPLEMENTARY; PREVENTION; DISEASE	Background: Yoga is thought to be effective for health conditions. The article aims to assess the current clinical evidence of yoga for Essential hypertension (EH). Strategy: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library were searched until June, 2013. We included randomized clinical trials testing yoga against conventional therapy, yoga versus no treatment, yoga combined with conventional therapy versus conventional therapy or conventional therapy combined with breath awareness. Study selection, data extraction, quality assessment, and data analyses were conducted according to the Cochrane standards. Results: A total of 6 studies (involving 386 patients) were included. The methodological quality of the included trials was evaluated as generally low. A total of 6 RCTs met all the inclusion criteria. 4 of them compared yoga plus conventional therapy with conventional therapy. 1 RCT described yoga combined with conventional therapy versus conventional therapy combined with breath awareness. 2 RCT tested the effect of yoga versus conventional therapy alone. 1 RCT described yoga compared to no treatment. Only one trial reported adverse events without details, the safety of yoga is still uncertain. Conclusions: There is some encouraging evidence of yoga for lowering SBP and DBP. However, due to low methodological quality of these identified trials, a definite conclusion about the efficacy and safety of yoga on EH cannot be drawn from this review. Therefore, further thorough investigation, large-scale, proper study designed, randomized trials of yoga for hypertension will be required to justify the effects reported here.	[Wang, Jie; Xiong, Xingjiang; Liu, Wei] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Cardiol, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS	Liu, W (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Dept Cardiol, Beijing, Peoples R China.	lvzyxxg@163.com	Xiong, Xingjiang/Q-8626-2019		National Basic Research Program of China (973 Program) [2003CB517103]; National Natural Science Foundation Project of China [90209011]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC))	The current work was partially supported by the National Basic Research Program of China (973 Program, No. 2003CB517103) and the National Natural Science Foundation Project of China (No. 90209011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijlani RL, 2005, J ALTERN COMPLEM MED, V11, P267, DOI 10.1089/acm.2005.11.267; Birdee GS, 2008, J GEN INTERN MED, V23, P1653, DOI 10.1007/s11606-008-0735-5; Calhoun DA, 2002, CURR HYPERTENS REP, V4, P221, DOI 10.1007/s11906-002-0011-8; Chaudhary A K, 1988, J Assoc Physicians India, V36, P721; Ching SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-148; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleophas TJ, 2002, CIRCULATION, V105, P1669, DOI 10.1161/01.CIR.0000012745.50229.AC; Cohen DL, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep130; Deepa T, 2012, J CLIN DIAGN RES, V6, P21; Dhameja K, 2012, J ALTERN COMPLEM MED, V18, P1, DOI [10.1089/acm.2011.0961., DOI 10.1089/ACM.2011.0961.PUBMED:22268965]; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ernst E, 2005, WIEN MED WOCHENSCHR, V155, P386, DOI 10.1007/s10354-005-0205-1; Ferreira AS, 2011, CHIN J INTEGR MED, V17, P818, DOI 10.1007/s11655-011-0892-y; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; Hawk C, 2012, PREV MED, V54, P18, DOI 10.1016/j.ypmed.2011.07.002; Jayasinghe SR, 2004, EUR J CARDIOV PREV R, V11, P369, DOI 10.1097/00149831-200410000-00002; Lee MS, 2004, J ALTERN COMPLEM MED, V10, P675; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McCaffrey Ruth, 2005, Holist Nurs Pract, V19, P173; Mizuno J, 2013, J BODYW MOV THER, V17, P35, DOI 10.1016/j.jbmt.2012.10.007; Mogra AL, 1986, J AVIAT MED, V30, P68; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Murugesan R., 2000, Indian Journal of Physiology and Pharmacology, V44, P207; Okonta NR, 2012, HOLIST NURS PRACT, V26, P137, DOI 10.1097/HNP.0b013e31824ef647; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Raub JA, 2002, J ALTERN COMPLEM MED, V8, P797, DOI 10.1089/10755530260511810; Ravinder Mamtani, 2005, CARDIOL REV, V13, P156; Slama M, 2002, CURR OPIN CARDIOL, V17, P531, DOI 10.1097/00001573-200209000-00014; Su DJ, 2011, J HEALTH CARE POOR U, V22, P296, DOI 10.1353/hpu.2011.0002; Telles S, 2013, MED SCI MONITOR, V19, P61, DOI 10.12659/MSM.883743; Wang J, 2012, EVID-BASED COMPL ALT, V2012; Wang J., 2012, INTERNAL MED, V2, P1, DOI [10.4172/2165-8048.1000113, DOI 10.4172/2165-8048.1000113]; Wang J, 2012, EVID-BASED COMPL ALT, V2012; Wolff RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018798; Woo KS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/132912; Xiong XJ, 2013, HYPERTENS RES, V36, P570, DOI 10.1038/hr.2013.18; Xu H, 2008, J ALTERN COMPLEM MED, V14, P3, DOI 10.1089/acm.2006.6329; Xu H, 2012, CHIN J INTEGR MED, V18, P403, DOI 10.1007/s11655-012-1126-7; Xu H, 2011, CHIN J INTEGR MED, V17, P83, DOI 10.1007/s11655-011-0641-2; Yang K, 2007, EVID-BASED COMPL ALT, V4, P487, DOI 10.1093/ecam/nem154	41	13	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76357	10.1371/journal.pone.0076357	http://dx.doi.org/10.1371/journal.pone.0076357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124549	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100106
J	Biondi, A; Zappala, L; Stark, JD; Desneux, N				Biondi, Antonio; Zappala, Lucia; Stark, John D.; Desneux, Nicolas			Do Biopesticides Affect the Demographic Traits of a Parasitoid Wasp and Its Biocontrol Services through Sublethal Effects?	PLOS ONE			English	Article							ABSOLUTA LEPIDOPTERA-GELECHIIDAE; PHYTOSEIULUS-PERSIMILIS ACARI; APHIDIUS-COLEMANI HYMENOPTERA; ORIUS-INSIDIOSUS HEMIPTERA; TUTA-ABSOLUTA; NATURAL ENEMIES; DEVELOPMENTAL STRATEGIES; BENEFICIAL ARTHROPODS; MULTISTEP BIOASSAY; AZADIRACHTA-INDICA	Pesticide risk assessments are usually based on short-term acute toxicity tests, while longer-term population dynamic related traits, critical to the success of biological control and Integrated Pest Management (IPM) programs, are often overlooked. This is increasingly important with respect to new biopesticides that frequently cause no short-term acute effects, but that can induce multiple physiological and behavioral sublethal effects, leading to a decrease in population growth and ecosystem services. In this study we assessed the lethal and sublethal effects of six biopesticides [abamectin, azadirachtin, Bacillus thuringiensis, borax plus citrus oil (Prev-AmH), emamectin benzoate, and spinosad], used in tomato crops to control the invasive pest Tuta absoluta (Lepidoptera: Gelechiidae), on adults and pupae of the parasitoid Bracon nigricans (Hymenoptera: Braconidae). Data on female survival and production of female offspring were used to calculate population growth indexes as a measure of population recovery after pesticide exposure. Spinosad caused 100% and 80% mortality in exposed adults (even 10 d after the treatment) and pupae, respectively. Although most of the biopesticides had low levels of acute toxicity, multiple sublethal effects were observed. The biocontrol activity of both females that survived 1h and 10-d old residues, and females that emerged from topically treated pupae was significantly affected by the application of the neurotoxic insecticides emamectin benzoate and abamectin. Furthermore, very low B. nigricans demographic growth indices were estimated for these two insecticides, indicating potential local extinction of the wasp populations. Among the tested products, Bt proved to be the safest for B. nigricans adults and pupae. Our findings emphasize that acute toxicity assessment alone cannot fully predict the actual impact of pesticides on non-target parasitoids. Thus, sublethal effects related to the species specific life-history variables must be carefully considered in order to assess pesticide risks and to incorporate new pesticides, including biopesticides, into IPM programmes.	[Biondi, Antonio; Zappala, Lucia] Univ Catania, Dept Agri Food & Environm Syst Management, Catania, Italy; [Biondi, Antonio; Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France; [Stark, John D.] Washington State Univ, Puyallup Res & Extens Ctr, Dept Entomol, Puyallup, WA 98371 USA	University of Catania; INRAE; Washington State University	Biondi, A (corresponding author), Univ Catania, Dept Agri Food & Environm Syst Management, Catania, Italy.	antonio.biondi@unict.it	Zappalà, Lucia/B-9740-2014; Desneux, Nicolas/J-6262-2013; BIONDI, Antonio/I-6381-2012	Zappalà, Lucia/0000-0002-2804-3980; BIONDI, Antonio/0000-0002-1982-7716	Italian Ministry of Education, University and Research (PRIN project) [2010CXXHJE_004]; French Ministry of Agriculture (CASDAR project) [10063]; University of Catania	Italian Ministry of Education, University and Research (PRIN project)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); French Ministry of Agriculture (CASDAR project); University of Catania	This research was partially funded by the Italian Ministry of Education, University and Research (PRIN project 2010CXXHJE_004) and the French Ministry of Agriculture (CASDAR project 10063). Antonio Biondi received a PhD grant from the University of Catania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2012, J PEST SCI, V85, P359, DOI 10.1007/s10340-012-0426-1; Arno J, 2011, J PEST SCI, V84, P513, DOI 10.1007/s10340-011-0384-z; ASCHER KRS, 1993, ARCH INSECT BIOCHEM, V22, P433, DOI 10.1002/arch.940220311; Banks HT, 2007, B MATH BIOL, V69, P2139, DOI 10.1007/s11538-007-9207-z; Banks JE, 2011, BIOL CONTROL, V59, P336, DOI 10.1016/j.biocontrol.2011.09.005; Beltra A, 2013, J PEST SCI, V86, P253, DOI 10.1007/s10340-012-0475-5; Bengochea P, 2013, CHEMOSPHERE, V91, P1189, DOI 10.1016/j.chemosphere.2013.01.034; Biondi A, 2013, J ECON ENTOMOL, V106, P1638, DOI 10.1603/EC12518; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Bostanian NJ, 2006, PEST MANAG SCI, V62, P334, DOI 10.1002/ps.1171; Bostanian NJ, 2004, PEST MANAG SCI, V60, P1231, DOI 10.1002/ps.938; Cabral S, 2011, J PEST SCI, V84, P373, DOI 10.1007/s10340-011-0373-2; Campos MR, 2011, CROP PROT, V30, P1535, DOI 10.1016/j.cropro.2011.08.013; Canale A, 2012, J PEST SCI, V85, P65, DOI 10.1007/s10340-011-0382-1; Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Croft B. A., 1990, ARTHROPOD BIOL CONTR; Desneux N, 2004, PEST MANAG SCI, V60, P381, DOI 10.1002/ps.822; Desneux N, 2004, CHEMOSPHERE, V54, P619, DOI 10.1016/j.chemosphere.2003.09.007; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, CHEMOSPHERE, V65, P1697, DOI 10.1016/j.chemosphere.2006.04.082; Desneux N, 2006, ENVIRON TOXICOL CHEM, V25, P2675, DOI 10.1897/05-562R.1; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Duso C, 2008, BIOCONTROL SCI TECHN, V18, P1027, DOI 10.1080/09583150802521251; El-Zahi ES, 2012, EGYPT J BIOL PEST CO, V22, P211; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; Gontijo PC, 2013, ANN APPL BIOL, V162, P50, DOI 10.1111/aab.12000; Gonzalez-Cabrera J, 2011, BIOCONTROL, V56, P71, DOI 10.1007/s10526-010-9310-1; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Haseeb M, 2002, J APPL ENTOMOL, V126, P8, DOI 10.1046/j.1439-0418.2002.00596.x; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hewa-Kapuge S, 2003, J ECON ENTOMOL, V96, P1083, DOI 10.1603/0022-0493-96.4.1083; Iqbal M, 1996, ENTOMOPHAGA, V41, P117, DOI 10.1007/BF02893298; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Kawazu K, 2011, J APPL ENTOMOL, V135, P647, DOI 10.1111/j.1439-0418.2010.01596.x; Kim DS, 2006, BIOCONTROL, V51, P465, DOI 10.1007/s10526-005-1028-0; Kobori Y, 2004, APPL ENTOMOL ZOOL, V39, P255, DOI 10.1303/aez.2004.255; Mansour R, 2011, PHYTOPARASITICA, V39, P369, DOI 10.1007/s12600-011-0170-8; Marcic D, 2012, J PEST SCI, V85, P395, DOI 10.1007/s10340-012-0442-1; Molla O, 2011, BIOCONTROL, V56, P883, DOI 10.1007/s10526-011-9353-y; Nannini M, 2011, ACTA HORTIC, P47, DOI 10.17660/ActaHortic.2011.917.5; Nukenine EN, 2011, J PEST SCI, V84, P479, DOI 10.1007/s10340-011-0371-4; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pizzol J, 2012, J PEST SCI, V85, P489, DOI 10.1007/s10340-012-0434-1; Planes L, 2013, J PEST SCI, V86, P321, DOI 10.1007/s10340-012-0440-3; Rahman T, 2011, PEST MANAG SCI, V67, P993, DOI 10.1002/ps.2144; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Stara J, 2011, J PEST SCI, V84, P25, DOI 10.1007/s10340-010-0322-5; STARK JD, 1992, J ECON ENTOMOL, V85, P1125, DOI 10.1093/jee/85.4.1125; Stark JD, 2004, P NATL ACAD SCI USA, V101, P732, DOI 10.1073/pnas.0304903101; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Stark JD, 2007, J ECON ENTOMOL, V100, P1027, DOI 10.1603/0022-0493(2007)100[1027:IERMOP]2.0.CO;2; Sterk G, 1999, BIOCONTROL, V44, P99, DOI 10.1023/A:1009959009802; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Tena A, 2013, ECOL ENTOMOL, V38, P278, DOI 10.1111/een.12018; Tome HVV, 2013, CROP PROT, V46, P63, DOI 10.1016/j.cropro.2012.12.021; Tropea Garzia G., 2012, Bulletin OEPP, V42, P205, DOI 10.1111/epp.2556; VAN ACTHERBERG C., 2010, SPECIES 2000 IT IS C; Vanaclocha P, 2013, J PEST SCI, V86, P329, DOI 10.1007/s10340-012-0448-8; Warton RA, 1993, ANNU REV ENTOMOL, V38, P121; Wu G, 2005, PESTIC BIOCHEM PHYS, V82, P79, DOI 10.1016/j.pestbp.2005.01.001; Zappala L, 2012, J APPL ENTOMOL, V136, P401, DOI 10.1111/j.1439-0418.2011.01662.x; Zappala L, 2012, EUR J ENTOMOL, V109, P561, DOI 10.14411/eje.2012.070; Zappala L, 2012, B INSECTOL, V65, P51	69	242	250	4	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76548	10.1371/journal.pone.0076548	http://dx.doi.org/10.1371/journal.pone.0076548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098793	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500164
J	Guo, Y; Qiu, LJ				Guo, Yong; Qiu, Li-Juan			RETRACTED: Genome-Wide Analysis of the Dof Transcription Factor Gene Family Reveals Soybean-Specific Duplicable and Functional Characteristics (Retracted article. See vol. 11, e0167019, 2016)	PLOS ONE			English	Article; Retracted Publication							DOMAIN PROTEINS; ARABIDOPSIS; EXPRESSION; SEQUENCE; DNA; EVOLUTIONARY; RICE; OBP3; OVEREXPRESSION; IDENTIFICATION	The Dof domain protein family is a classic plant-specific zinc-finger transcription factor family involved in a variety of biological processes. There is great diversity in the number of Dof genes in different plants. However, there are only very limited reports on the characterization of Dof transcription factors in soybean (Glycine max). In the present study, 78 putative Dof genes were identified from the whole-genome sequence of soybean. The predicted GmDof genes were non-randomly distributed within and across 19 out of 20 chromosomes and 97.4% (38 pairs) were preferentially retained duplicate paralogous genes located in duplicated regions of the genome. Soybean-specific segmental duplications contributed significantly to the expansion of the soybean Dof gene family. These Dof proteins were phylogenetically clustered into nine distinct subgroups among which the gene structure and motif compositions were considerably conserved. Comparative phylogenetic analysis of these Dof proteins revealed four major groups, similar to those reported for Arabidopsis and rice. Most of the GmDofs showed specific expression patterns based on RNA-seq data analyses. The expression patterns of some duplicate genes were partially redundant while others showed functional diversity, suggesting the occurrence of sub-functionalization during subsequent evolution. Comprehensive expression profile analysis also provided insights into the soybean-specific functional divergence among members of the Dof gene family. Cis-regulatory element analysis of these GmDof genes suggested diverse functions associated with different processes. Taken together, our results provide useful information for the functional characterization of soybean Dof genes by combining phylogenetic analysis with global gene-expression profiling.	[Guo, Yong; Qiu, Li-Juan] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	qiulijuan@caas.cn			National Natural Science Foundation of China [31071446, 31271753]; Fundamental Research Funds for ICS-CAAS; State High-tech Research and Development Program [2013AA102602]; National Transgenic Major Program [2013ZX08004-001, 2013ZX08004-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for ICS-CAAS; State High-tech Research and Development Program(National High Technology Research and Development Program of China); National Transgenic Major Program	This work was supported by the National Natural Science Foundation of China (31071446 and 31271753), the Fundamental Research Funds for ICS-CAAS (Grant to Y. G.), the State High-tech Research and Development Program (2013AA102602) and the National Transgenic Major Program (2013ZX08004-001 and 2013ZX08004-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Cai XF, 2013, J INTEGR PLANT BIOL, V55, P552, DOI 10.1111/jipb.12043; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Cannon SB, 2011, BREEDING SCI, V61, P437, DOI 10.1270/jsbbs.61.437; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Do JH, 2008, MOL CELLS, V25, P279; Dong GQ, 2007, PLANT MOL BIOL, V63, P73, DOI 10.1007/s11103-006-9073-3; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gualberti G, 2002, PLANT CELL, V14, P1253, DOI 10.1105/tpc.010491; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; Guo Y, 2009, PLANT CELL, V21, P3518, DOI 10.1105/tpc.108.064139; Hernando-Amado S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-202; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Kang HG, 2003, PLANT J, V35, P362, DOI 10.1046/j.1365-313X.2003.01812.x; Kang HG, 2000, PLANT J, V21, P329, DOI 10.1046/j.1365-313x.2000.00678.x; Kim HS, 2010, PLANT J, V64, P524, DOI 10.1111/j.1365-313X.2010.04346.x; Konishi M, 2007, PLANT PHYSIOL BIOCH, V45, P623, DOI 10.1016/j.plaphy.2007.05.001; Krohn NM, 2002, J BIOL CHEM, V277, P32438, DOI 10.1074/jbc.M203814200; Kushwaha H, 2011, MOL BIOL REP, V38, P5037, DOI 10.1007/s11033-010-0650-9; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Liu Y, 2011, PLANT GROWTH REGUL, V63, P225, DOI 10.1007/s10725-010-9519-0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mochida K, 2010, BIOINFORMATICS, V26, P290, DOI 10.1093/bioinformatics/btp645; Moreno-Risueno MA, 2007, MOL GENET GENOMICS, V277, P379, DOI 10.1007/s00438-006-0186-9; Negi J, 2013, CURR BIOL, V23, P479, DOI 10.1016/j.cub.2013.02.001; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papi M, 2000, GENE DEV, V14, P28; Park DH, 2003, PLANT J, V34, P161, DOI 10.1046/j.1365-313X.2003.01710.x; Plesch G, 2001, PLANT J, V28, P455, DOI 10.1046/j.1365-313X.2001.01166.x; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shaw LM, 2009, FUNCT INTEGR GENOMIC, V9, P485, DOI 10.1007/s10142-009-0130-2; Skirycz A, 2008, PLANT J, V56, P779, DOI 10.1111/j.1365-313X.2008.03641.x; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian AG, 2004, THEOR APPL GENET, V108, P903, DOI 10.1007/s00122-003-1499-2; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wang HW, 2007, PLANT J, V52, P716, DOI 10.1111/j.1365-313X.2007.03268.x; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Washio K, 2003, PLANT PHYSIOL, V133, P850, DOI 10.1104/pp.103.027334; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wei PC, 2010, PLANT PHYSIOL, V153, P1031, DOI 10.1104/pp.110.153247; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yanagisawa S, 1997, EUR J BIOCHEM, V250, P403, DOI 10.1111/j.1432-1033.1997.0403a.x; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141	65	55	73	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76809	10.1371/journal.pone.0076809	http://dx.doi.org/10.1371/journal.pone.0076809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098807	Green Published, gold			2022-12-27	WOS:000325423500178
J	Ricketson, LJ; Nettel-Aguirre, A; Vanderkooi, OG; Laupland, KB; Kellner, JD				Ricketson, Leah J.; Nettel-Aguirre, Alberto; Vanderkooi, Otto G.; Laupland, Kevin B.; Kellner, James D.			Factors Influencing Early and Late Mortality in Adults with Invasive Pneumococcal Disease in Calgary, Canada: A Prospective Surveillance Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; ASSOCIATION; DEATH; RISK	Background: Invasive pneumococcal disease continues to be an important cause of mortality. In Calgary, 60% of deaths occur within 5 days of presenting to hospital. This proportion has not changed since before the era of penicillin. The purpose of this study was to investigate what factors may influence death within 5 days of presentation with pneumococcal disease. Methods and Findings: Demographic and clinical data from the CASPER (Calgary Area Streptococcus pneumoniae Epidemiology Research) study on 1065 episodes of invasive pneumococcal disease in adults (>= 18 years) from 2000 to 2010 were analyzed. Adjusted multinomial regression was performed to analyze 3 outcomes: early mortality (<5 days post - presentation), late mortality (5 - 30 days post - presentation), and survival, generating relative risk ratios (RRR). Patients with severe disease had increased risk of early and late death. In multinomial regression with survivors as baseline, the risk of early death increased in those with a Charlson index >= 2 (RRR: 6.3, 95% CI: 1.8-21.9); the risk of late death increased in those with less severe disease and a Charlson >= 2 (RRR: 6.1, 95% CI: 1.4-27.7). Patients who never received appropriate antibiotics had 5.6X (95% CI: 2.4 - 13.1) the risk of early death. Risk of both early and late death increased by a RRR of 1.3 (95% CI: 1.2 - 1.4) per 5 - year increase in age. In multinomial regression, there were no significant differences in the effects of the factors tested between early and late mortality. Conclusions: Presenting with severe invasive pneumococcal disease, multiple comorbidities, and older age increases the risk of both early and late death. Patients who died early often presented too late for effective antibiotic therapy, highlighting the need for an effective vaccine.	[Ricketson, Leah J.; Nettel-Aguirre, Alberto; Vanderkooi, Otto G.; Kellner, James D.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Ricketson, Leah J.; Nettel-Aguirre, Alberto; Laupland, Kevin B.; Kellner, James D.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Nettel-Aguirre, Alberto; Kellner, James D.] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB T2N 1N4, Canada; [Vanderkooi, Otto G.; Kellner, James D.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Vanderkooi, Otto G.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 1N4, Canada; [Laupland, Kevin B.] Univ Calgary, Dept Crit Care Med, Calgary, AB T2N 1N4, Canada; [Laupland, Kevin B.] Univ Calgary, Dept Med, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kellner, JD (corresponding author), Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada.	Jim.Kellner@albertahealthservices.ca	Nettel-Aguirre, Alberto/ABB-9412-2021; Laupland, kevin/AAJ-6339-2020; Laupland, Kevin/AAG-3656-2020; Kellner, James Duncan/D-6358-2011	Laupland, kevin/0000-0002-1205-5354; Kellner, James Duncan/0000-0002-9083-2980; Ricketson, Leah/0000-0003-1369-8391; Nettel-Aguirre, Alberto/0000-0001-6604-0652	Pfizer Canada; Alberta Children's Hospital Foundation	Pfizer Canada(Pfizer); Alberta Children's Hospital Foundation	This work and the CASPER project are supported in part by an unrestricted grant from Pfizer Canada (www.pfizer.ca) and the Alberta Children's Hospital Foundation (www.childrenshospital.ab.ca) to Otto Vanderkooi and James Kellner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanee SRJ, 2007, CLIN INFECT DIS, V45, P46, DOI 10.1086/518538; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Balakrishnan I, 2000, J INFECTION, V40, P256, DOI 10.1053/jinf.2000.0653; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benin AL, 2003, J INFECT DIS, V188, P81, DOI 10.1086/375782; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BURMAN LA, 1985, REV INFECT DIS, V7, P133; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *CLINICALLABORATOR, 2011, 20 PERF STAND ANT S, P96; Feldman C, 2011, DRUGS, V71, P131, DOI 10.2165/11585310-000000000-00000; Garau J, 2008, CLIN MICROBIOL INFEC, V14, P322, DOI 10.1111/j.1469-0691.2007.01915.x; Garcia-Vidal C, 2008, EUR RESPIR J, V32, P733, DOI 10.1183/09031936.00128107; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Johnstone J, 2010, CLIN INFECT DIS, V51, P15, DOI 10.1086/653114; Macias WL, 2004, CRIT CARE MED, V32, pS223, DOI 10.1097/01.CCM.0000126120.49367.AC; Marrie TJ, 2011, MEDICINE, V90, P171, DOI 10.1097/MD.0b013e31821a5a76; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Sleeman K, 2001, J INFECT DIS, V183, P239, DOI 10.1086/317924; Valles X, 2006, CHEST, V130, P800, DOI 10.1378/chest.130.3.800; Vanderkooi OG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028547; Vila-Corcoles A, 2009, VACCINE, V27, P1504, DOI 10.1016/j.vaccine.2009.01.013; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	24	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e71924	10.1371/journal.pone.0071924	http://dx.doi.org/10.1371/journal.pone.0071924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24115997	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200002
J	Kawalec, P; Kryst, J; Mikrut, A; Pilc, A				Kawalec, Pawel; Kryst, Joanna; Mikrut, Alicja; Pilc, Andrzej			Nevirapine-Based Regimens in HIV-Infected Antiretroviral-Naive Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							REVERSE-TRANSCRIPTASE INHIBITORS; INITIAL THERAPY; OPEN-LABEL; EFAVIRENZ; EFFICACY; COMBINATION; STAVUDINE; ADULTS; DIDANOSINE; LAMIVUDINE	Background: Nevirapine belongs to the group of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and is commonly administered in first-line treatment of HIV infection. Objective: Systematic review and meta-analysis was undertaken to compare effectiveness of nevirapine-based regimens with other antiretroviral schedules used as an initial treatment of HIV-infected antiretroviral-naive subjects. Methods: Electronic databases (PubMed, EMBASE, the Cochrane Library, Trip Database) were searched up to 28 December 2012 for randomized controlled trials (RCTs) published as a full text and regarding nevirapine-based regimens used as a initial treatment for HIV infection. Meta-analysis was performed with RevMan (R) V 5.2 software. Results: Twelve RCTs were included in the systematic review and all of them were suitable for meta-analysis. Results of the meta-analysis have shown that nevirapine, efavirenz, and ritonavir-boosted protease inhibitor, added to the background regimens, were equally effective in terms of reaching undetectable plasma HIV RNA level as well as risk of disease progression or death. Compared with ritonavir-boosted protease inhibitor-based regimens, nevirapine-based regimens statistically significantly increased the risk of discontinuation of assigned treatment (RR=3.10; 95% CI: 1.14-8.41; p<0.05). Conclusions: Despite limited RCTs data available for particular comparisons, our results suggest that nevirapine-based regimens may be considered for first-line treatment of HIV-infected adults, due to their comparable efficacy to the other currently recommended initial antiretroviral therapies.	[Kawalec, Pawel; Pilc, Andrzej] Jagiellonian Univ, Drug Management Dept, Inst Publ Hlth, Fac Hlth Sci, Krakow, Poland; [Kawalec, Pawel; Kryst, Joanna; Mikrut, Alicja] Ctr HTA Sp Zoo Sp Komandytowa, Krakow, Poland; [Pilc, Andrzej] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences	Kawalec, P (corresponding author), Jagiellonian Univ, Drug Management Dept, Inst Publ Hlth, Fac Hlth Sci, Krakow, Poland.	pawel.kawalec@uj.edu.pl	Pilc, Andrzej/A-3948-2008	Pilc, Andrzej/0000-0002-4045-0597; Kryst, Joanna/0000-0003-4516-8723	Institute of Pharmacology of Polish Academy of Sciences	Institute of Pharmacology of Polish Academy of Sciences	The payment for the article will be covered by sources of Institute of Pharmacology of Polish Academy of Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No private or commercial resources will be used to cover publication fees.	Albert JM, 1998, STAT MED, V17, P2435, DOI 10.1002/(SICI)1097-0258(19981115)17:21&lt;2435::AID-SIM994&gt;3.3.CO;2-7; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Ayala Gaytan JJ, 2004, MED INT MEX, V20, P29; Bartlett JA, 2007, HIV CLIN TRIALS, V8, P221, DOI 10.1310/hct0804-221; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Chou R, 2006, LANCET, V368, P1503, DOI 10.1016/S0140-6736(06)69638-4; Coster LO, 2012, AIDS REV, V14, P132; de Beaudrap P, 2008, AIDS RES HUM RETROV, V24, P753, DOI 10.1089/aid.2007.0295; DeJesus E, 2011, INT J CLIN PRACT, V65, P1240, DOI 10.1111/j.1742-1241.2011.02807.x; Harris M, 2009, JAIDS-J ACQ IMM DEF, V50, P335, DOI 10.1097/QAI.0b013e3181938fc9; *HIV CAUSAL COLL, 2012, AIDS, V26; Ioannidis JPA, 2006, LANCET, V368, P1470, DOI 10.1016/S0140-6736(06)69615-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Lapadula G, 2008, CLIN INFECT DIS, V46, P1127, DOI 10.1086/529394; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Lockman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001236; Lowe SH, 2005, HIV CLIN TRIALS, V6, P235, DOI 10.1310/A686-M37Y-J2PT-E9GJ; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MBUAGBAW LC, 2010, COCHRANE DB SYST REV, V12; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; NUNEZ M, 2002, CLIN TRIALS, V3, P186, DOI DOI 10.1310/0CJ5-2ABQ-CB00-6MR6; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Parienti JJ, 2011, EXPERT OPIN DRUG MET, V7, P495, DOI 10.1517/17425255.2011.565331; Patel A K, 2006, J Assoc Physicians India, V54, P915; Raboud JM, 2000, J ACQ IMMUN DEF SYND, V24, P433, DOI 10.1097/00126334-200008150-00006; Raboud JM, 1999, J ACQ IMMUN DEF SYND, V22, P260; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Reekie J, 2011, HIV MED, V12, P259, DOI 10.1111/j.1468-1293.2010.00877.x; Reynolds C, 2012, CHEM SOC REV, V41, P4657, DOI 10.1039/c2cs35058k; Sanne I, 2000, AIDS, V14, pS12; Siegfried NL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004535; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Soriano V, 2011, ANTIVIR THER, V16, P339, DOI 10.3851/IMP1745; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; TEVA N, 2013, SUMMARY PRODUCT CHAR; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; van den Berg-Wolf M, 2008, HIV CLIN TRIALS, V9, P324, DOI 10.1310/hct0905-324; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wester CW, 2010, AIDS, V24, pS27, DOI 10.1097/01.aids.0000366080.91192.55; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; World Health Organization, 2010, ANT THER HIV INF AD; Zhou ML, 2006, JAIDS-J ACQ IMM DEF, V43, P501	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76587	10.1371/journal.pone.0076587	http://dx.doi.org/10.1371/journal.pone.0076587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116123	Green Published, gold			2022-12-27	WOS:000325501300069
J	Kohli, S; Chhabra, A; Jaiswal, A; Rustagi, Y; Sharma, M; Rani, V				Kohli, Shrey; Chhabra, Aastha; Jaiswal, Astha; Rustagi, Yashika; Sharma, Manish; Rani, Vibha			Curcumin Suppresses Gelatinase B Mediated Norepinephrine Induced Stress in H9c2 Cardiomyocytes	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MYOCARDIAL EXTRACELLULAR-MATRIX; GENE-EXPRESSION; HEART-FAILURE; TRANSGENIC MOUSE; DISEASE; CARDIOTOXICITY; NORADRENALINE; PROTEINASES; HYPERTROPHY	Background: Extracellular matrix (ECM) remodeling facilitates biomechanical signals in response to abnormal physiological conditions. This process is witnessed as one of the major effects of the stress imposed by catecholamines, such as epinephrine and norepinephrine (NE), on cardiac muscle cells. Matrix metalloproteinases (MMPs) are the key proteases involved in degradation of the ECM in heart. Objectives: The present study focuses on studying the effect of curcumin on Gelatinase B (MMP-9), an ECM remodeling regulatory enzyme, in NE-induced cardiac stress. Curcumin, a bioactive polyphenol found in the spice turmeric, has been studied for its multi-fold beneficial properties. This study focuses on investigating the role of curcumin as a cardio-protectant. Methods: H9c2 cardiomyocytes were subjected to NE and curcumin treatments to study the response in stress conditions. Effect on total collagen content was studied using Picrosirus red staining. Gelatinase B activity was assessed through Gel-Diffusion Assay and Zymographic techniques. RT-PCR, Western Blotting and Immunocytochemistry were performed to study effect on expression of gelatinase B. Further, the effect of curcumin on the localization of NF-kappa B, known to regulate gelatinase B, was also examined. Results: Curcumin suppressed the increase in the total collagen content under hypertrophic stress and was found to inhibit the in-gel and in-situ gelatinolytic activity of gelatinase B. Moreover, it was found to suppress the mRNA and protein expression of gelatinase B. Conclusions: The study provides an evidence for an overall inhibitory effect of curcumin on Gelatinase B in NE-induced hypertrophic stress in H9c2 cardiomyocytes which may contribute in the prevention of ECM remodeling.	[Kohli, Shrey; Chhabra, Aastha; Jaiswal, Astha; Rustagi, Yashika; Rani, Vibha] Jaypee Inst Informat Technol, Dept Biotechnol, Noida, Uttar Pradesh, India; [Sharma, Manish] DRDO, DIPAS, Peptide & Prote Div, Delhi, India	Jaypee Institute of Information Technology (JIIT); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Rani, V (corresponding author), Jaypee Inst Informat Technol, Dept Biotechnol, Noida, Uttar Pradesh, India.	vibha.rani@jiit.ac.in		RUSTAGI, YASHIKA/0000-0003-1122-941X	Department of Biotechnology, Government of India [BT/PR3978/17/766/2011]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the research grant awarded to Dr. Vibha Rani by the Department of Biotechnology, Government of India (BT/PR3978/17/766/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2011, J PHARM PHARMACOL, V63, P1604, DOI 10.1111/j.2042-7158.2011.01363.x; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BISHOP JE, 1994, CARDIOVASC RES, V28, P1581, DOI 10.1093/cvr/28.10.1581; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Brown PD, 2000, EXPERT OPIN INV DRUG, V9, P2167, DOI 10.1517/13543784.9.9.2167; Carvalho RF, 2006, INT J EXP PATHOL, V87, P437, DOI 10.1111/j.1365-2613.2006.00497.x; CAWSTON TE, 1995, BRIT MED BULL, V51, P385, DOI 10.1093/oxfordjournals.bmb.a072968; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Deschamps AM, 2006, CARDIOVASC RES, V69, P666, DOI 10.1016/j.cardiores.2005.10.004; Epstein JA, 2008, J CLIN INVEST, V118, P850, DOI 10.1172/JCI34650; Hong DS, 2010, PHARMACOL RES, V61, P142, DOI 10.1016/j.phrs.2009.08.009; Jaiswal A, 2011, BIOINFORMATION, V6, P23, DOI 10.6026/97320630006023; Jugdutt Bodh I., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P1, DOI 10.2174/1568006033337276; Kang YJ, 2001, ENVIRON HEALTH PERSP, V109, P27, DOI 10.2307/3434844; Kassiri Z, 2005, THROMB HAEMOSTASIS, V93, P212, DOI 10.1160/TH04-08-0522; Kizaki K, 2006, PHARMACOL RES, V53, P341, DOI 10.1016/j.phrs.2006.01.001; Li YY, 2002, AM J PHYSIOL-HEART C, V282, pH983, DOI 10.1152/ajpheart.00233.2001; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lindsey ML, 2010, J MOL CELL CARDIOL, V48, P431, DOI 10.1016/j.yjmcc.2009.09.007; Liu P, 2006, CAN J CARDIOL, V22, p25B, DOI 10.1016/S0828-282X(06)70983-7; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Menon B, 2005, AM J PHYSIOL-CELL PH, V289, pC168, DOI 10.1152/ajpcell.00606.2004; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Rump AFE, 2002, ARZNEIMITTEL-FORSCH, V52, P543; Sang QXA, 2006, CURR TOP MED CHEM, V6, P289, DOI 10.2174/156802606776287045; Sikora E, 2010, Immun Ageing, V7, P1, DOI 10.1186/1742-4933-7-1; Spinale FG, 2000, CARDIOVASC RES, V46, P225, DOI 10.1016/S0008-6363(99)00431-9; Tyagi SC, 1997, MOL CELL BIOCHEM, V168, P1, DOI 10.1023/A:1006850903242; Vanden Berghe W, 2012, PHARMACOL RES, V65, P565, DOI 10.1016/j.phrs.2012.03.007; Wang NP, 2012, BRIT J PHARMACOL, V167, P1550, DOI 10.1111/j.1476-5381.2012.02109.x; Wang XY, 2010, J CELL COMMUN SIGNAL, V4, P15, DOI 10.1007/s12079-009-0083-1; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	36	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76519	10.1371/journal.pone.0076519	http://dx.doi.org/10.1371/journal.pone.0076519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116115	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300062
J	Oliveira, TA; Koakoski, G; Kreutz, LC; Ferreira, D; da Rosa, JGS; de Abreu, MS; Giacomini, ACV; Oliveira, RP; Fagundes, M; Piato, AL; Barreto, RE; Barcellos, LJG				Oliveira, Thiago Acosta; Koakoski, Gessi; Kreutz, Luiz Carlos; Ferreira, Daiane; Santos da Rosa, Joao Gabriel; de Abreu, Murilo Sander; Vendrametto Giacomini, Ana Cristina; Oliveira, Ricardo Pimentel; Fagundes, Michele; Piato, Angelo Luis; Barreto, Rodrigo Egydio; Gil Barcellos, Leonardo Jose			Alcohol Impairs Predation Risk Response and Communication in Zebrafish	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; WHOLE-BODY CORTISOL; DANIO-RERIO; ADULT ZEBRAFISH; FAMILY-HISTORY; ETHANOL; STRESS; ALARM; RECOGNITION; BEHAVIOR	The effects of ethanol exposure on Danio rerio have been studied from the perspectives of developmental biology and behavior. However, little is known about the effects of ethanol on the prey-predator relationship and chemical communication of predation risk. Here, we showed that visual contact with a predator triggers stress axis activation in zebrafish. We also observed a typical stress response in zebrafish receiving water from these conspecifics, indicating that these fish chemically communicate predation risk. Our work is the first to demonstrate how alcohol effects this prey-predator interaction. We showed for the first time that alcohol exposure completely blocks stress axis activation in both fish seeing the predator and in fish that come in indirect contact with a predator by receiving water from these conspecifics. Together with other research results and with the translational relevance of this fish species, our data points to zebrafish as a promising animal model to study human alcoholism.	[Oliveira, Thiago Acosta; Koakoski, Gessi; Ferreira, Daiane; Santos da Rosa, Joao Gabriel; de Abreu, Murilo Sander; Vendrametto Giacomini, Ana Cristina] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97119900 Santa Maria, RS, Brazil; [Kreutz, Luiz Carlos; Vendrametto Giacomini, Ana Cristina; Oliveira, Ricardo Pimentel; Fagundes, Michele; Gil Barcellos, Leonardo Jose] Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil; [Piato, Angelo Luis] Univ Comunitaria Regiao Chapeco, Programa Posgrad Ciencias Ambientais, Chapeco, SC, Brazil; [Barreto, Rodrigo Egydio] UNESP, Caunesp, Biosci Inst, Dept Physiol, Botucau, SP, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade de Passo Fundo; Universidade Comunitaria Regional de Chapeco; Universidade Estadual Paulista	Barcellos, LJG (corresponding author), Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil.	lbarcellos@upf.br	PIATO, ANGELO/K-3444-2012; Kreutz, Luiz C/A-3729-2015; Sander de Abreu, Murilo/J-9756-2015; Barreto, Rodrigo E/A-3440-2013; Fagundes, Michele/AAY-6703-2020	PIATO, ANGELO/0000-0001-5109-7306; Kreutz, Luiz C/0000-0002-7685-7401; Sander de Abreu, Murilo/0000-0001-5562-0715; Barreto, Rodrigo E/0000-0002-4611-0059; Fagundes, Michele/0000-0002-7880-8961	CNPq [302073/2011-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	There are no funders. L.J.G.B. has a CNPq research fellowship (302073/2011-6). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos LJG, 2010, J FISH BIOL, V76, P1032, DOI 10.1111/j.1095-8649.2010.02542.x; Barcellos LJG, 2007, AQUACULTURE, V272, P774, DOI 10.1016/j.aquaculture.2007.09.002; Barreto RE, 2003, BEHAV PROCESS, V60, P235, DOI 10.1016/S0376-6357(02)00127-4; Bell AM, 2007, PHYSIOL BEHAV, V91, P15, DOI 10.1016/j.physbeh.2007.01.012; Bryer PJ, 2001, J CHEM ECOL, V27, P533, DOI 10.1023/A:1010332820944; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Croissant B, 2008, BIOL PSYCHOL, V79, P268, DOI 10.1016/j.biopsycho.2008.07.001; Dai X, 2007, PSYCHONEUROENDOCRINO, V32, P293, DOI 10.1016/j.psyneuen.2007.01.004; Eskay RL, 1993, NATL I ALCOHOL ABUSE, V23; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Barcellos LJG, 2011, PHYSIOL BEHAV, V103, P372, DOI 10.1016/j.physbeh.2011.03.009; Gilman JM, 2008, J NEUROSCI, V28, P4583, DOI 10.1523/JNEUROSCI.0086-08.2008; Jordao LC, 2000, BEHAVIOUR, V137, P681, DOI 10.1163/156853900502286; KALANT H, 1990, CRIT REV BIOTECHNOL, V9, P265; Koakoski G, 2013, ZEBRAFISH CHEM UNPUB; Korpi NL, 2001, ENVIRON BIOL FISH, V61, P205, DOI 10.1023/A:1011091426030; Kottelat M., 1993, FRESHWATER FISHES W; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Li J, 2011, ADDICT BIOL, V16, P600, DOI 10.1111/j.1369-1600.2011.00344.x; Luca MR, 2012, BEHAV BRAIN RES, V229, P194; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; Sink TD, 2008, FISH PHYSIOL BIOCHEM, V34, P95, DOI 10.1007/s10695-007-9150-9; Smith N. J., 1981, MAN FISHES AMAZON; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632; Sripada CS, 2011, NEUROIMAGE, V55, P371, DOI 10.1016/j.neuroimage.2010.11.062; WALTMAN C, 1993, J CLIN ENDOCR METAB, V77, P518, DOI 10.1210/jc.77.2.518; WAND GS, 1991, J CLIN ENDOCR METAB, V72, P1290, DOI 10.1210/jcem-72-6-1290; WISENDEN BD, 1995, ANIM BEHAV, V49, P623	32	47	47	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75780	10.1371/journal.pone.0075780	http://dx.doi.org/10.1371/journal.pone.0075780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116073	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300041
J	Chiapponi, C; Piras, F; Piras, F; Fagioli, S; Caltagirone, C; Spalletta, G				Chiapponi, Chiara; Piras, Fabrizio; Piras, Federica; Fagioli, Sabrina; Caltagirone, Carlo; Spalletta, Gianfranco			Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; FOLLOW-UP MRI; 1ST-EPISODE SCHIZOPHRENIA; ALZHEIMERS-DISEASE; VOXELWISE ANALYSIS; CORPUS-CALLOSUM; CEREBRAL-CORTEX; AREA VOLUMES; INTEGRITY; ABNORMALITIES	It is still unknown whether the structural brain impairments that characterize schizophrenia (SZ) worsen during the lifetime. Here, we aimed to describe age-related microstructural brain changes in cortical grey matter and subcortical white matter of patients affected by SZ. In this diffusion tensor imaging study, we included 69 patients diagnosed with SZ and 69 healthy control (HC) subjects, age and gender matched. We carried out analyses of covariance, with diagnosis as fixed factor and brain diffusion-related parameters as dependent variables, and controlled for the effect of education. White matter fractional anisotropy decreased in the entire age range spanned (18-65 years) in both SZ and HC and was significantly lower in younger patients with SZ, with no interaction (age by diagnosis) effect in fiber tracts including corpus callosum, corona radiata, thalamic radiations and external capsule. Also, grey matter mean diffusivity increased in the entire age range in both SZ and HC and was significantly higher in younger patients, with no age by diagnosis interaction in the left frontal operculum cortex, left insula and left planum polare and in the right temporal pole and right intracalcarine cortex. In individuals with SZ we found that localized brain cortical and white matter subcortical microstructural impairments appear early in life but do not worsen in the 18-65 year age range.	[Chiapponi, Chiara; Piras, Fabrizio; Piras, Federica; Fagioli, Sabrina; Caltagirone, Carlo; Spalletta, Gianfranco] IRCCS Santa Lucia Fdn, Lab Clin & Behav Neurol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata	Spalletta, G (corresponding author), IRCCS Santa Lucia Fdn, Lab Clin & Behav Neurol, Rome, Italy.	g.spalletta@hsantalucia.it	Piras, Federica/AAC-4768-2022; Piras, Fabrizio/M-7902-2016; Fagioli, Sabrina/I-4512-2017; Spalletta, Gianfranco/K-3828-2018	Piras, Federica/0000-0002-9546-7038; Piras, Fabrizio/0000-0003-3566-5494; Fagioli, Sabrina/0000-0002-6381-0989; Spalletta, Gianfranco/0000-0002-7432-4249; Chiapponi, Chiara/0000-0002-5264-492X	Italian Ministry of Health [RC07-08-09-10-11-12/A]; ERANET NEUCONNECT grant from the European Community	Italian Ministry of Health(Ministry of Health, Italy); ERANET NEUCONNECT grant from the European Community	This work was supported by RC07-08-09-10-11-12/A grants from the Italian Ministry of Health and by the ERANET NEUCONNECT grant from the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; ANDREASEN NC, 1986, SCHIZOPHRENIA BULL, V12, P348, DOI 10.1093/schbul/12.3.348; APA, 2000, DIAGN STAT MAN MENT; Ashtari M, 2007, NEUROIMAGE, V35, P501, DOI 10.1016/j.neuroimage.2006.10.047; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bersani G, 2010, PSYCHIAT RES-NEUROIM, V183, P119, DOI 10.1016/j.pscychresns.2010.04.011; Bose SK, 2009, SCHIZOPHR RES, V112, P7, DOI 10.1016/j.schres.2009.04.023; Brickman AM, 2012, NEUROBIOL AGING, V33, P1699, DOI 10.1016/j.neurobiolaging.2011.06.001; Bronge L, 2002, DEMENT GERIATR COGN, V13, P205, DOI 10.1159/000057698; Cacciari C, 2010, J ALZHEIMERS DIS, V20, P501, DOI 10.3233/JAD-2010-1384; Carlesimo GA, 2012, NEUROLOGY, V78, P1939, DOI 10.1212/WNL.0b013e318259e1c5; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Cherubini A, 2010, J ALZHEIMERS DIS, V19, P1273, DOI 10.3233/JAD-2010-091186; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Chew LJ, 2013, DEV NEUROSCI-BASEL, V35, P102, DOI 10.1159/000346157; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Coleman MJ, 2009, SCHIZOPHRENIA BULL, V35, P1108, DOI 10.1093/schbul/sbp090; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Covington MA, 2005, SCHIZOPHR RES, V77, P85, DOI 10.1016/j.schres.2005.01.016; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman JI, 2008, AM J PSYCHIAT, V165, P1024, DOI 10.1176/appi.ajp.2008.07101640; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gogtay N, 2011, SCHIZOPHRENIA BULL, V37, P504, DOI 10.1093/schbul/sbr030; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2012, CURR OPIN NEUROL, V25, P727, DOI 10.1097/WCO.0b013e32835a26b3; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griego JA, 2008, BRAIN LANG, V107, P158, DOI 10.1016/j.bandl.2008.04.001; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; Hoffman RE, 2008, BRIT J PSYCHIAT, V193, P424, DOI 10.1192/bjp.bp.107.040501; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Hulshoff HE, 2002, AM J PSYCHIAT, V159, P244, DOI 10.1176/appi.ajp.159.2.244; Ikram MA, 2011, EUR J EPIDEMIOL, V26, P811, DOI 10.1007/s10654-011-9624-z; Jang DP, 2006, NEUROIMAGE, V32, P220, DOI 10.1016/j.neuroimage.2006.01.032; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jeon T, 2012, NEUROIMAGE, V62, P1705, DOI 10.1016/j.neuroimage.2012.05.082; John JP, 2009, SCHIZOPHR RES, V109, P148, DOI 10.1016/j.schres.2008.12.019; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kantrowitz JT, 2009, SCHIZOPHRENIA BULL, V35, P1085, DOI 10.1093/schbul/sbp100; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kochunov P, 2013, BIOL PSYCHIAT, V73, P482, DOI 10.1016/j.biopsych.2012.10.002; Konrad A, 2012, J COGNITIVE NEUROSCI, V24, P888, DOI 10.1162/jocn_a_00187; Koo MS, 2008, ARCH GEN PSYCHIAT, V65, P746, DOI 10.1001/archpsyc.65.7.746; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kubota M, 2011, SCHIZOPHR RES, V125, P21, DOI 10.1016/j.schres.2010.10.004; Lam M, 2012, SCHIZOPHR RES, V134, P125, DOI 10.1016/j.schres.2011.10.020; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; Mason O, 2013, INT PSYCHOGERIATR, V25, P320, DOI 10.1017/S1041610212001731; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x; Mitelman SA, 2005, NEUROIMAGE, V27, P753, DOI 10.1016/j.neuroimage.2005.05.024; Mitelman SA, 2005, SCHIZOPHR RES, V76, P207, DOI 10.1016/j.schres.2005.01.010; Mitelman SA, 2009, SCHIZOPHR RES, V113, P241, DOI 10.1016/j.schres.2009.06.022; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mori T, 2007, PSYCHIAT RES-NEUROIM, V154, P133, DOI 10.1016/j.pscychresns.2006.09.004; Nakamura M, 2007, BIOL PSYCHIAT, V62, P773, DOI 10.1016/j.biopsych.2007.03.030; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oquendo MA, 2003, J CLIN PSYCHIAT, V64, P825, DOI 10.4088/JCP.v64n0714; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Peran P, 2009, HUM BRAIN MAPP, V30, P2667, DOI 10.1002/hbm.20698; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pfefferbaum A, 2010, NEUROBIOL AGING, V31, P482, DOI 10.1016/j.neurobiolaging.2008.04.013; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Piras F, 2011, HUM BRAIN MAPP, V32, P282, DOI 10.1002/hbm.21018; Puri BK, 2010, EXPERT REV NEUROTHER, V10, P33, DOI [10.1586/ern.09.142, 10.1586/ERN.09.142]; Rosenberger G, 2008, SCHIZOPHR RES, V102, P181, DOI 10.1016/j.schres.2008.04.019; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schneiderman JS, 2011, SCHIZOPHR RES, V130, P57, DOI 10.1016/j.schres.2011.04.027; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shergill SS, 2001, J NEUROL NEUROSUR PS, V71, P688, DOI 10.1136/jnnp.71.5.688; Shi YD, 2013, CEREB CORTEX, V23, P36, DOI 10.1093/cercor/bhr372; Simon TJ, 2005, NEUROIMAGE, V25, P169, DOI 10.1016/j.neuroimage.2004.11.018; Simons JS, 2006, NEUROIMAGE, V32, P696, DOI 10.1016/j.neuroimage.2006.04.209; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Spalletta G, 2003, SCHIZOPHR RES, V64, P15, DOI 10.1016/S0920-9964(03)00010-0; Spalletta G, 2010, PSYCHIAT RES-NEUROIM, V182, P77, DOI 10.1016/j.pscychresns.2009.11.001; Spoletini I, 2009, SCHIZOPHR RES, V108, P57, DOI 10.1016/j.schres.2008.11.011; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Takahashi T, 2011, PROG NEURO-PSYCHOPH, V35, P1957, DOI 10.1016/j.pnpbp.2011.07.009; Takahashi T, 2010, SCHIZOPHR RES, V119, P65, DOI 10.1016/j.schres.2009.12.006; Tseng BY, 2013, NEUROIMAGE, V82, P510, DOI 10.1016/j.neuroimage.2013.06.011; Ture U, 1999, J NEUROSURG, V90, P720, DOI 10.3171/jns.1999.90.4.0720; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Voineskos AN, 2010, BRAIN, V133, P1494, DOI 10.1093/brain/awq040; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Weiss EM, 2004, SCHIZOPHR RES, V70, P287, DOI 10.1016/j.schres.2004.01.010; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yoshida T, 2009, SCHIZOPHR RES, V113, P84, DOI 10.1016/j.schres.2009.05.004; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	124	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75115	10.1371/journal.pone.0075115	http://dx.doi.org/10.1371/journal.pone.0075115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124469	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100026
J	Cooper, P; Walker, AW; Reyes, J; Chico, M; Salter, SJ; Vaca, M; Parkhill, J				Cooper, Philip; Walker, Alan W.; Reyes, Jorge; Chico, Martha; Salter, Susannah J.; Vaca, Maritza; Parkhill, Julian			Patent Human Infections with the Whipworm, Trichuris trichiura, Are Not Associated with Alterations in the Faecal Microbiota	PLOS ONE			English	Article							HELMINTH INFECTIONS; GUT MICROBIOME; SUIS THERAPY; ASCARIASIS; MICROFLORA; CHILDREN; IMPACT; TRACT; COLON	Background: The soil-transmitted helminth (STH), Trichuris trichiura colonises the human large intestine where it may modify inflammatory responses, an effect possibly mediated through alterations in the intestinal microbiota. We hypothesised that patent T. trichiura infections would be associated with altered faecal microbiota and that anthelmintic treatment would induce a microbiota resembling more closely that observed in uninfected individuals. Materials and Methods: School children in Ecuador were screened for STH infections and allocated to 3 groups: uninfected, T. trichiura only, and mixed infections with T. trichiura and Ascaris lumbricoides. A sample of uninfected children and those with T. trichiura infections only were given anthelmintic treatment. Bacterial community profiles in faecal samples were studied by 454 pyrosequencing of 16 S rRNA genes. Results: Microbiota analyses of faeces were done for 97 children: 30 were uninfected, 17 were infected with T. trichiura, and 50 with T. trichiura and A. lumbricoides. Post-treatment samples were analyzed for 14 children initially infected with T. trichiura alone and for 21 uninfected children. Treatment resulted in 100% cure of STH infections. Comparisons of the microbiota at different taxonomic levels showed no statistically significant differences in composition between uninfected children and those with T. trichiura infections. We observed a decreased proportional abundance of a few bacterial genera from the Clostridia class of Firmicutes and a reduced bacterial diversity among children with mixed infections compared to the other two groups, indicating a possible specific effect of A. lumbricoides infection. Anthelmintic treatment of children with T. trichiura did not alter faecal microbiota composition. Discussion: Our data indicate that patent human infections with T. trichiura may have no effect on faecal microbiota but that A. lumbricoides colonisation might be associated with a disturbed microbiota. Our results also catalogue the microbiota of rural Ecuadorians and indicate differences with individuals from more urban industrialised societies.	[Cooper, Philip; Chico, Martha; Vaca, Maritza] Fdn Ecuatoriana Invest Salud, Quito, Ecuador; [Cooper, Philip; Reyes, Jorge] Univ San Francisco Quito, Quito, Ecuador; [Cooper, Philip] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Walker, Alan W.; Salter, Susannah J.; Parkhill, Julian] Wellcome Trust Sanger Inst, Hinxton, England	Liverpool School of Tropical Medicine; University of Liverpool; Wellcome Trust Sanger Institute	Cooper, P (corresponding author), Fdn Ecuatoriana Invest Salud, Quito, Ecuador.	P.J.Cooper@liv.ac.uk	Parkhill, Julian/G-4703-2011; Walker, Alan W./AAE-8102-2019	Parkhill, Julian/0000-0002-7069-5958; Walker, Alan W./0000-0001-5099-8495; Cooper, Philip/0000-0002-6770-6871; Reyes, Jorge A/0000-0002-5215-164X; Salter, Susannah/0000-0003-3898-8504	Wellcome Trust [088862/Z/09/Z, WT076964]	Wellcome Trust(Wellcome Trust)	The collection of samples in Ecuador was supported by the Wellcome Trust (grant number, 088862/Z/09/Z) and the Foundation for the National Institutes of Health (Grand Challenges in Global Health). Funding for AWW, SJS, JP and sequencing was provided by the Wellcome Trust (grant number, WT076964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Bancroft AJ, 2012, TRENDS PARASITOL, V28, P93, DOI 10.1016/j.pt.2011.12.001; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; BRYANT MP, 1956, J BACTERIOL, V72, P22, DOI 10.1128/JB.72.1.22-26.1956; BUNDY DAP, 1987, EPIDEMIOL INFECT, V98, P65, DOI 10.1017/S0950268800061719; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; CROWTHER JS, 1971, J MED MICROBIOL, V4, P343, DOI 10.1099/00222615-4-3-343; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Moncayo AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000293; MACDONALD TT, 1991, J CLIN PATHOL, V44, P194, DOI 10.1136/jcp.44.3.194; Mansfield LS, 2003, AM J TROP MED HYG, V68, P70; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; Montresor A, 1988, GUIDELINES EVALUATIO; Olsen A, 2007, T ROY SOC TROP MED H, V101, P747, DOI 10.1016/j.trstmh.2007.03.006; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ortiz MR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001157; Rodrigues LC, 2008, CLIN EXP ALLERGY, V38, P1769, DOI 10.1111/j.1365-2222.2008.03027.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shin JL, 2004, CAN J GASTROENTEROL, V18, P175, DOI 10.1155/2004/298064; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Suputtamongkol Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001044; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; WHO, 1985, DIAGN TECHN INT PAR; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	43	120	124	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76573	10.1371/journal.pone.0076573	http://dx.doi.org/10.1371/journal.pone.0076573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124574	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100131
J	Harbour, VL; Weigl, Y; Robinson, B; Amir, S				Harbour, Valerie L.; Weigl, Yuval; Robinson, Barry; Amir, Shimon			Comprehensive Mapping of Regional Expression of the Clock Protein PERIOD2 in Rat Forebrain across the 24-h Day	PLOS ONE			English	Article							AGRANULAR INSULAR CORTEX; CA1 AXONAL PROJECTIONS; STRIA TERMINALIS; BED NUCLEUS; SUPRACHIASMATIC NUCLEUS; HIPPOCAMPAL-FORMATION; CIRCADIAN-RHYTHM; CORTICAL AFFERENTS; EXTENDED AMYGDALA; LIMBIC FOREBRAIN	In mammals, a light-entrainable clock located in the suprachiasmatic nucleus (SCN) regulates circadian rhythms by synchronizing oscillators throughout the brain and body. Notably, the nature of the relation between the SCN clock and subordinate oscillators in the rest of the brain is not well defined. We performed a high temporal resolution analysis of the expression of the circadian clock protein PERIOD2 (PER2) in the rat forebrain to characterize the distribution, amplitude and phase of PER2 rhythms across different regions. Eighty-four LEW/Crl male rats were entrained to a 12-h: 12-h light/dark cycle, and subsequently perfused every 30 min across the 24-h day for a total of 48 time-points. PER2 expression was assessed with immunohistochemistry and analyzed using automated cell counts. We report the presence of PER2 expression in 20 forebrain areas important for a wide range of motivated and appetitive behaviors including the SCN, bed nucleus, and several regions of the amygdala, hippocampus, striatum, and cortex. Eighteen areas displayed significant PER2 rhythms, which peaked at different times of day. Our data demonstrate a previously uncharacterized regional distribution of rhythms of a clock protein expression in the brain that provides a sound basis for future studies of circadian clock function in animal models of disease.	[Harbour, Valerie L.; Weigl, Yuval; Robinson, Barry; Amir, Shimon] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada.	shimon.amir@concordia.ca	Amir, Shimon/AAE-4635-2022		Canadian Institutes of Health Research [MOP 13625]; Fonds de la recherche en sante Quebec; Concordia University Research Chair Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante Quebec(Fonds de la Recherche en Sante du Quebec); Concordia University Research Chair Program	Supported by grants from the Canadian Institutes of Health Research (Grant # MOP 13625), le Fonds de la recherche en sante Quebec, and the Concordia University Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Alheid GF, 2003, ANN NY ACAD SCI, V985, P185; Amir S, 2006, NEUROSCI LETT, V399, P147, DOI 10.1016/j.neulet.2006.01.041; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Amir S, 2009, PROG NEURO-PSYCHOPH, V33, P1321, DOI 10.1016/j.pnpbp.2009.04.003; Amir S, 2009, BIOL PSYCHIAT, V65, P829, DOI 10.1016/j.biopsych.2008.12.019; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; [Anonymous], 1993, NEUROBIOLOGY CINGULA; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Beaule C, 2003, J MOL NEUROSCIENCE; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; Bunney JN, 2008, BRIT MED BULL, V86, P23, DOI 10.1093/bmb/ldn019; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CASSONE VM, 1993, J BIOL RHYTHM, V8, pS73; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Cenquizca LA, 2006, J COMP NEUROL, V497, P101, DOI 10.1002/cne.20985; D'Agostino RB, 1986, GOODNESS OF FIT TECH; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Day HEW, 1999, J COMP NEUROL, V413, P113; Day HEW, 2001, J NEUROSCI, V21, P732, DOI 10.1523/JNEUROSCI.21-02-00732.2001; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Erb S, 2001, PSYCHOPHARMACOLOGY, V158, P360, DOI 10.1007/s002130000642; Erb S, 2001, Stress, V4, P289; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Guillery RW, 2002, J COMP NEUROL, V447, P1, DOI 10.1002/cne.10221; Haberly LB, 1990, SYNAPTIC ORG BRAIN, P317; Harbour VL, 2011, J MOL NEUROSCI, V45, P154, DOI 10.1007/s12031-010-9469-z; Hood S, 2010, THESIS CONCORDIA U M; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Kobayashi M, 2011, INT REV NEUROBIOL, V97, P285, DOI 10.1016/B978-0-12-385198-7.00011-4; KOHLER C, 1988, J COMP NEUROL, V271, P208, DOI 10.1002/cne.902710204; Kowianski P, 1999, Folia Morphol (Warsz), V58, P9; KRUSHEL LA, 1988, J COMP NEUROL, V270, P39, DOI 10.1002/cne.902700105; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lee YL, 1997, J NEUROSCI, V17, P6434; Loscher W, 1996, PROG NEUROBIOL, V50, P427, DOI 10.1016/S0301-0082(96)00036-6; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Pantazopoulos H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020658; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perrin JS, 2006, P NATL ACAD SCI USA, V103, P5591, DOI 10.1073/pnas.0601310103; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Petrovich GD, 2003, ANN NY ACAD SCI, V985, P251; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ramanathan C, 2010, NEUROSCI LETT, V473, P220, DOI 10.1016/j.neulet.2010.02.051; REEP RL, 1982, NEUROSCIENCE, V7, P1265, DOI 10.1016/0306-4522(82)91133-2; REEP RL, 1982, NEUROSCIENCE, V7, P2609, DOI 10.1016/0306-4522(82)90087-2; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Sewards TV, 2003, BRAIN RES REV, V42, P243, DOI 10.1016/S0165-0173(03)00175-9; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Willuhn I, 2003, EUR J NEUROSCI, V17, P1053, DOI 10.1046/j.1460-9568.2003.02525.x; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398; WYSS JM, 1992, HIPPOCAMPUS, V2, P1; Yamamoto S, 2001, J COMP NEUROL, V430, P518; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	91	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76391	10.1371/journal.pone.0076391	http://dx.doi.org/10.1371/journal.pone.0076391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124556	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000325489100113
J	Jia, B; Xuan, LM; Cai, KY; Hu, ZQ; Ma, LX; Wei, CC				Jia, Ben; Xuan, Liming; Cai, Kaiye; Hu, Zhiqiang; Ma, Liangxiao; Wei, Chaochun			NeSSM: A Next-Generation Sequencing Simulator for Metagenomics	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ALIGNMENT; READS; MICROBIOME; GENOMES; FORMAT; VELVET; GENE; TOOL	Background: Metagenomics can reveal the vast majority of microbes that have been missed by traditional cultivation-based methods. Due to its extremely wide range of application areas, fast metagenome sequencing simulation systems with high fidelity are in great demand to facilitate the development and comparison of metagenomics analysis tools. Results: We present here a customizable metagenome simulation system: NeSSM (Next-generation Sequencing Simulator for Metagenomics). Combining complete genomes currently available, a community composition table, and sequencing parameters, it can simulate metagenome sequencing better than existing systems. Sequencing error models based on the explicit distribution of errors at each base and sequencing coverage bias are incorporated in the simulation. In order to improve the fidelity of simulation, tools are provided by NeSSM to estimate the sequencing error models, sequencing coverage bias and the community composition directly from existing metagenome sequencing data. Currently, NeSSM supports single-end and pair-end sequencing for both 454 and Illumina platforms. In addition, a GPU (graphics processing units) version of NeSSM is also developed to accelerate the simulation. By comparing the simulated sequencing data from NeSSM with experimental metagenome sequencing data, we have demonstrated that NeSSM performs better in many aspects than existing popular metagenome simulators, such as MetaSim, GemSIM and Grinder. The GPU version of NeSSM is more than one-order of magnitude faster than MetaSim. Conclusions: NeSSM is a fast simulation system for high-throughput metagenome sequencing. It can be helpful to develop tools and evaluate strategies for metagenomics analysis and it's freely available for academic users at http://cbb.sjtu.edu.cn/similar to ccwei/pub/software/NeSSM.php.	[Jia, Ben] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Hu, Zhiqiang; Wei, Chaochun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Dept Bioinformat & Biostat, Shanghai 200030, Peoples R China; [Xuan, Liming] E China Univ Sci & Technol, Sch Bioengn, Shanghai 200237, Peoples R China; [Xuan, Liming; Cai, Kaiye; Hu, Zhiqiang; Ma, Liangxiao; Wei, Chaochun] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China University of Science & Technology; Chinese Academy of Sciences	Wei, CC (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Dept Bioinformat & Biostat, Shanghai 200030, Peoples R China.	ccwei@sjtu.edu.cn	Hu, Zhiqiang/P-5083-2019; Hu, ZHiqiang/K-5041-2017; wei, chaochun/AAW-2846-2020	Hu, Zhiqiang/0000-0001-8854-3410; Hu, ZHiqiang/0000-0001-8854-3410; Wei, Chaochun/0000-0002-1031-034X	National Natural Science Foundation of China [61272250]; National Basic Research Program of China [2012AA101601, 2012CB316501]; National High-Tech RD Program (863) [2012AA101601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High-Tech RD Program (863)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (61272250), the National Basic Research Program of China (2012AA101601, 2012CB316501), and the National High-Tech R&D Program (863) (2012AA101601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferrer Manuel, 2007, Biotechnology Journal, V2, P207, DOI 10.1002/biot.200600183; Furrie E, 2006, GUT, V55, P141, DOI 10.1136/gut.2005.081695; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Jia P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025353; Kowalchuk GA, 2007, MICROB ECOL, V53, P475, DOI 10.1007/s00248-006-9201-2; Legendre P., 2012, NUMERICAL ECOLOGY; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu CM, 2012, BIOINFORMATICS, V28, P878, DOI 10.1093/bioinformatics/bts061; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Su XQ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S16; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Willerth SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013564; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yun J, 2004, APPL ENVIRON MICROB, V70, P7229, DOI 10.1128/AEM.70.12.7229-7235.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	38	40	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75448	10.1371/journal.pone.0075448	http://dx.doi.org/10.1371/journal.pone.0075448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124490	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100047
J	Ma, NN; Wang, Y; Qiu, SC; Kang, ZH; Che, SG; Wang, GX; Huang, JL				Ma, Nana; Wang, Ying; Qiu, Shichun; Kang, Zhenhui; Che, Shugang; Wang, Guixue; Huang, Junli			Overexpression of OsEXPA8, a Root-Specific Gene, Improves Rice Growth and Root System Architecture by Facilitating Cell Extension	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; FT-IR SPECTROSCOPY; MECHANICAL-PROPERTIES; WALL POLYSACCHARIDES; ARABIDOPSIS-THALIANA; HAIR DEVELOPMENT; PETUNIA-HYBRIDA; PLANT-GROWTH; EXPRESSION; WOOD	Expansins are unique plant cell wall proteins that are involved in cell wall modifications underlying many plant developmental processes. In this work, we investigated the possible biological role of the root-specific a-expansin gene OsEXPA8 in rice growth and development by generating transgenic plants. Overexpression of OsEXPA8 in rice plants yielded pleiotropic phenotypes of improved root system architecture (longer primary roots, more lateral roots and root hairs), increased plant height, enhanced leaf number and enlarged leaf size. Further study indicated that the average cell length in both leaf and root vascular bundles was enhanced, and the cell growth in suspension cultures was increased, which revealed the cellular basis for OsEXPA8-mediated rice plant growth acceleration. Expansins are thought to be a key factor required for cell enlargement and wall loosening. Atomic force microscopy (AFM) technology revealed that average wall stiffness values for 35S::OsEXPA8 transgenic suspension-cultured cells decreased over six-fold compared to wild-type counterparts during different growth phases. Moreover, a prominent change in the wall polymer composition of suspension cells was observed, and Fourier-transform infrared (FTIR) spectra revealed a relative increase in the ratios of the polysaccharide/lignin content in cell wall compositions of OsEXPA8 overexpressors. These results support a role for expansins in cell expansion and plant growth.	[Ma, Nana; Wang, Ying; Qiu, Shichun; Kang, Zhenhui; Che, Shugang; Wang, Guixue; Huang, Junli] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China	Chongqing University	Huang, JL (corresponding author), Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China.	huangjunli@cqu.edu.cn	Kang, Zhenhui/CAE-9105-2022	Wang, Guixue/0000-0002-9192-8757	National Natural Science Foundation of China [31271685]; Fundamental Research Funds for the Central Universities [CQDXWL-2012-114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant no. 31271685) and Fundamental Research Funds for the Central Universities (grant no. CQDXWL-2012-114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerholm M, 2001, POLYMER, V42, P963, DOI 10.1016/S0032-3861(00)00434-1; Bibikova TN, 1998, DEVELOPMENT, V125, P2925; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Casuso I, 2011, J MOL RECOGNIT, V24, P406, DOI 10.1002/jmr.1081; Chen MH, 2000, PHYTOCHEM ANALYSIS, V11, P153, DOI 10.1002/(SICI)1099-1565(200005/06)11:3&lt;153::AID-PCA502&gt;3.0.CO;2-Z; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Choi D, 2006, PHYSIOL PLANTARUM, V126, P511, DOI 10.1111/j.1399-3054.2005.00612.x; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; COSGROVE DJ, 1993, NEW PHYTOL, V124, P1, DOI 10.1111/j.1469-8137.1993.tb03795.x; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Damanik RI, 2012, PLANT GROWTH REGUL, V67, P83, DOI 10.1007/s10725-012-9668-4; Ding WN, 2009, CELL RES, V19, P1309, DOI 10.1038/cr.2009.109; FAIX O, 1991, HOLZFORSCHUNG, V45, P21, DOI 10.1515/hfsg.1991.45.s1.21; Gray-Mitsumune M, 2008, PLANT BIOTECHNOL J, V6, P62, DOI 10.1111/j.1467-7652.2007.00295.x; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Hepworth DG, 1998, ANN BOT-LONDON, V81, P729, DOI 10.1006/anbo.1998.0619; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kalamaki MS, 2003, J AGR FOOD CHEM, V51, P7456, DOI 10.1021/jf034164l; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Kohler L, 2002, PLANTA, V215, P33, DOI 10.1007/s00425-001-0718-9; LEPPARD GG, 1971, J CELL BIOL, V50, P63, DOI 10.1083/jcb.50.1.63; Lesniewska E, 2004, ULTRAMICROSCOPY, V100, P171, DOI 10.1016/j.ultramic.2003.11.004; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; Rodrigues J, 1998, HOLZFORSCHUNG, V52, P46, DOI 10.1515/hfsg.1998.52.1.46; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; Shin JH, 2005, MOL CELLS, V20, P210; Smart LB, 1998, PLANT PHYSIOL, V116, P1539, DOI 10.1104/pp.116.4.1539; STRACK D, 1989, PHYTOCHEMISTRY, V28, P2071, DOI 10.1016/S0031-9422(00)97922-6; TAKEUCHI Y, 1978, PHYSIOL PLANTARUM, V42, P21, DOI 10.1111/j.1399-3054.1978.tb01532.x; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Wang CX, 2004, ANN BOT-LONDON, V93, P443, DOI 10.1093/aob/mch062; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Wilson RH, 2000, PLANT PHYSIOL, V124, P397, DOI 10.1104/pp.124.1.397; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zenoni S, 2004, PLANT CELL, V16, P295, DOI 10.1105/tpc.018705; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x; Zhang XQ, 2011, PLANT CELL REP, V30, P27, DOI 10.1007/s00299-010-0937-2	46	76	83	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75997	10.1371/journal.pone.0075997	http://dx.doi.org/10.1371/journal.pone.0075997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124527	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100084
J	Sahu, SN; Anriany, Y; Grim, CJ; Kim, S; Chang, Z; Joseph, SW; Cinar, HN				Sahu, Surasri N.; Anriany, Yuda; Grim, Christopher J.; Kim, Sungji; Chang, Zenas; Joseph, Sam W.; Cinar, Hediye N.			Identification of Virulence Properties in Salmonella Typhimurium DT104 Using Caenorhabditis elegans	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MULTIDRUG-RESISTANCE REGION; UNFOLDED PROTEIN RESPONSE; INNATE IMMUNE-RESPONSE; C-ELEGANS; ANTIMICROBIAL PEPTIDES; MODEL HOST; INTESTINE; PATHOGEN; PATHWAY	Salmonella enterica serover Typhimurium definitive phage type DT104, resistant to multiple antibiotics, is one of the most widespread Salmonella species in human infection worldwide. Although several cohort studies indicate that DT104 carrying the multidrug resistance (MDR) locus on salmonella genomic island 1 is a possible hyper-virulent strain compared to DT104 strains without MDR, or other Salmonella enterica serotypes, existing experimental evidence regarding virulence properties associated with the MDR region is controversial. To address this question, we constructed an isogenic MDR deletion (Delta MDR) mutant strain of DT104, SNS12, by allelic exchange and used Caenorhabditis elegans as a host model to assess differences in virulence between these two strains. SNS12 exhibited decreased virulence in C. elegans, and we observed increased colonization and proliferation of the intestine of C. elegans by DT104. The immune response against MDR-carrying DT104 appears to function through a non-canonical Unfolded Protein Response (UPR) pathway, namely prion-like-(QN-rich)-domain-bearing protein pathway (PQN), in a ced-1 dependent manner in C. elegans. Further, we also demonstrate that genes of the PQN pathway and antimicrobial peptide gene abf-2, are expressed at higher transcriptional levels in worms immediately following exposure to DT104, in comparison with worms exposed to SNS12. Altogether, our results suggest that the MDR region of Salmonella Typhimurium DT104 has a direct role in virulence against Caenorhabditis elegans.	[Sahu, Surasri N.; Grim, Christopher J.; Cinar, Hediye N.] US FDA, Div Virulence Assessment, Laurel, MD USA; [Sahu, Surasri N.; Grim, Christopher J.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Anriany, Yuda] Prince Georges Community Coll, Dept Biol Sci, Laurel, MD USA; [Kim, Sungji; Joseph, Sam W.] Kyungpook Natl Univ KNU, Taegu, South Korea; [Chang, Zenas] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	US Food & Drug Administration (FDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kyungpook National University; University System of Maryland; University of Maryland College Park	Sahu, SN (corresponding author), US FDA, Div Virulence Assessment, Laurel, MD USA.	surasri.sahu@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This study was funded by Food and Drug Administration intramural funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alegado RA, 2003, CELL MICROBIOL, V5, P435, DOI 10.1046/j.1462-5822.2003.00287.x; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Allen CA, 2001, INFECT IMMUN, V69, P4673, DOI 10.1128/IAI.69.7.4673-4677.2001; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Arcangioli MA, 1999, FEMS MICROBIOL LETT, V174, P327, DOI 10.1016/S0378-1097(99)00161-5; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Ayabe T, 2004, TRENDS MICROBIOL, V12, P394, DOI 10.1016/j.tim.2004.06.007; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Bailey AM, 2010, J BACTERIOL, V192, P1607, DOI 10.1128/JB.01517-09; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Briggs CE, 1999, ANTIMICROB AGENTS CH, V43, P846, DOI 10.1128/AAC.43.4.846; Carlson SA, 2000, MICROB PATHOGENESIS, V28, P373, DOI 10.1006/mpat.2000.0355; Carlson SA, 2005, MICROB PATHOGENESIS, V38, P181, DOI 10.1016/j.micpath.2005.01.004; Carlson SA, 2000, MICROB PATHOGENESIS, V28, P37, DOI 10.1006/mpat.1999.0322; Davies A, 1996, Commun Dis Rep CDR Rev, V6, pR159; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gomez Thomas M., 1997, World Health Statistics Quarterly, V50, P81; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Randall LP, 2001, J MED MICROBIOL, V50, P770, DOI 10.1099/0022-1317-50-9-770; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Slutsker L, 1998, INFECT DIS CLIN N AM, V12, P199, DOI 10.1016/S0891-5520(05)70418-9; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Villar RG, 1999, JAMA-J AM MED ASSOC, V281, P1811, DOI 10.1001/jama.281.19.1811; Wu MT, 2002, MICROB PATHOGENESIS, V33, P279, DOI 10.1006/mpat.2002.0535; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	44	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76673	10.1371/journal.pone.0076673	http://dx.doi.org/10.1371/journal.pone.0076673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124587	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100144
J	Santha, P; Pakaski, M; Fodor, EK; Fazekas, OC; Kalman, S; Kalman, J; Janka, Z; Szabo, G; Kalman, J				Santha, Petra; Pakaski, Magdolna; Fodor, Eszter K.; Fazekas, Orsike Cs; Kalman, Sara; Kalman, Janos, Jr.; Janka, Zoltan; Szabo, Gyula; Kalman, Janos			Cytoskeletal Protein Translation and Expression in the Rat Brain Are Stressor-Dependent and Region-Specific	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; SYNAPTIC PLASTICITY; ACTIN CYTOSKELETON; RESTRAINT STRESS; CELL-PROLIFERATION; FOOTSHOCK STRESS; HIPPOCAMPUS; RECEPTORS; ADF/COFILIN; DISORDERS	Stress is an integral component of life that can sometimes cause a critical overload, depending on the qualitative and quantitative natures of the stressors. The involvement of actin, the predominant component of dendritic integrity, is a plausible candidate factor in stress-induced neuronal cytoskeletal changes. The major aim of this study was to compare the effects of three different stress conditions on the transcription and translation of actin-related cytoskeletal genes in the rat brain. Male Wistar rats were exposed to one or other of the frequently used models of physical stress, i.e. electric foot shock stress (EFSS), forced swimming stress (FSS), or psychosocial stress (PSS) for periods of 3, 7, 14, or 21 days. The relative mRNA and protein expressions of beta-actin, cofilin and mitogen-activated protein kinase 1 (MAPK-1) were determined by qRT-PCR and western blotting from hippocampus and frontal cortex samples. Stressor-specific alterations in both beta-actin and cofilin expression levels were seen after stress. These alterations were most pronounced in response to EFSS, and exhibited a U-shaped time course. FSS led to a significant beta-actin mRNA expression elevation in the hippocampus and the frontal cortex after 3 and 7 days, respectively, without any subsequent change. PSS did not cause any change in beta-actin or cofilin mRNA or protein expression in the examined brain regions. EFSS, FSS and PSS had no effect on the expression of MAPK-1 mRNA at any tested time point. These findings indicate a very delicate, stress type-dependent regulation of neuronal cytoskeletal components in the rat hippocampus and frontal cortex.	[Santha, Petra; Pakaski, Magdolna; Fodor, Eszter K.; Fazekas, Orsike Cs; Kalman, Sara; Kalman, Janos, Jr.; Kalman, Janos] Univ Szeged, Dept Psychiat, Alzheimers Dis Res Ctr, Szeged, Hungary; [Janka, Zoltan] Univ Szeged, Dept Psychiat, Szeged, Hungary; [Szabo, Gyula] Univ Szeged, Dept Pathophysiol, Szeged, Hungary	Szeged University; Szeged University; Szeged University	Santha, P (corresponding author), Univ Szeged, Dept Psychiat, Alzheimers Dis Res Ctr, Szeged, Hungary.	santha.petra@gmail.com	Szabó, Gyula/E-3602-2012	Szabó, Gyula/0000-0002-3409-5357; Kalman, Janos/0000-0003-0930-4214	OTKA [83667]; Hungarian Ministry of Education and Culture [TAMOP 4.2.2.A-11/16KONV-2012-0052, 4.2.2/B, TAMOP-4.2.2.A-11/1/KONV-2012-0052]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Education and Culture	This study was supported by OTKA (grant no. 83667) and by The Hungarian Ministry of Education and Culture (grant nos. TAMOP 4.2.2.A-11/16KONV-2012-0052, 4.2.2/B and TAMOP-4.2.2.A-11/1/KONV-2012-0052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleisa AM, 2006, NEUROBIOL DIS, V22, P453, DOI 10.1016/j.nbd.2005.12.005; Alkadhi KA, 2005, NEUROBIOL DIS, V20, P849, DOI 10.1016/j.nbd.2005.05.020; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bianchi M, 2003, SYNAPSE, V49, P188, DOI 10.1002/syn.10230; Bremner J. Douglas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P503; Carboni L, 2006, EUR NEUROPSYCHOPHARM, V16, P521, DOI 10.1016/j.euroneuro.2006.01.007; Carvalho-Netto EF, 2011, PHYSIOL BEHAV, V104, P242, DOI 10.1016/j.physbeh.2011.01.024; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; Fuchs E, 1998, NEUROSCI BIOBEHAV R, V23, P295, DOI 10.1016/S0149-7634(98)00031-1; Gerges NZ, 2001, BRAIN RES, V922, P250, DOI 10.1016/S0006-8993(01)03181-X; Huang HC, 2009, J ALZHEIMERS DIS, V16, P15, DOI 10.3233/JAD-2009-0960; Jafari M, 2012, MOL NEUROBIOL, V46, P304, DOI 10.1007/s12035-012-8288-3; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003; Lahmame A, 1997, BRAIN RES, V750, P285, DOI 10.1016/S0006-8993(96)01368-6; Lamprecht R, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Munsie Lise N, 2012, Bioarchitecture, V2, P204, DOI 10.4161/bioa.22549; Piubelli C, 2011, NEUROSCIENCE, V176, P349, DOI 10.1016/j.neuroscience.2010.12.043; Piubelli C, 2011, EUR NEUROPSYCHOPHARM, V21, P545, DOI 10.1016/j.euroneuro.2010.11.003; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Robbins MT, 2008, J PAIN, V9, P991, DOI 10.1016/j.jpain.2008.05.006; Rosenbrock H, 2005, BRAIN RES, V1040, P55, DOI 10.1016/j.brainres.2005.01.065; Santha P, 2012, NEUROCHEM RES, V37, P958, DOI 10.1007/s11064-011-0688-7; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sousa N, 2012, TRENDS NEUROSCI, V35, P742, DOI 10.1016/j.tins.2012.08.006; Szucs Szabina, 2010, Neuropsychopharmacol Hung, V12, P301; Takao K, 1995, EUR J PHARMACOL, V294, P721, DOI 10.1016/0014-2999(95)00620-6; Trentani A, 2003, NEUROBIOL DIS, V14, P602, DOI 10.1016/j.nbd.2003.08.006; Tsukada F, 2003, BIOL PHARM BULL, V26, P368; Vialou V, 2010, J NEUROSCI, V30, P14585, DOI 10.1523/JNEUROSCI.2496-10.2010	43	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e73504	10.1371/journal.pone.0073504	http://dx.doi.org/10.1371/journal.pone.0073504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124448	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100005
J	Santin, JR; Machado, ID; Rodrigues, SFP; Teixeira, S; Muscara, MN; Galdino, SL; Pitta, ID; Farsky, SHP				Santin, Jose Roberto; Machado, Isabel Daufenback; Rodrigues, Stephen F. P.; Teixeira, Simone; Muscara, Marcelo N.; Galdino, Suely Lins; Pitta, Ivan da Rocha; Farsky, Sandra H. P.			Role of an Indole-Thiazolidine Molecule PPAR Pan-Agonist and COX Inhibitor on Inflammation and Microcirculatory Damage in Acute Gastric Lesions	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION; PROLIFERATOR; PIOGLITAZONE; EXPRESSION; CELLS; ROSIGLITAZONE; NEUTROPHILS; ULCERS	The present study aimed to show the in vivo mechanisms of action of an indole-thiazolidine molecule peroxisome-proliferator activated receptor pan-agonist (PPAR pan) and cyclooxygenase (COX) inhibitor, LYSO-7, in an ethanol/HCl-induced (Et/HCl) gastric lesion model. Swiss male mice were treated with vehicle, LYSO-7 or Bezafibrate (p.o.) 1 hour before oral administration of Et/HCl (60%/0.03M). In another set of assays, animals were injected i.p. with an anti-granulocyte antibody, GW9962 or L-NG-nitroarginine methyl ester (L-NAME) before treatment. One hour after Et/HCl administration, neutrophils were quantified in the blood and bone marrow and the gastric microcirculatory network was studied in situ. The gastric tissue was used to quantify the percentage of damaged area, as well as myeloperoxidase (MPO), inducible nitric oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS) protein and PPAR. protein and gene expression. Acid secretion was evaluated by the pylorus ligation model. LYSO-7 or Bezafibrate treatment reduced the necrotic area. LYSO-7 treatment enhanced PPAR. gene and protein expression in the stomach, and impaired local neutrophil influx and stasis of the microcirculatory network caused by Et/HCl administration. The effect seemed to be due to PPAR. agonist activity, as the LYSO-7 effect was abolished in GW9962 pre-treated mice. The reversal of microcirculatory stasis, but not neutrophil influx, was mediated by nitric oxide (NO), as L-NAME pre-treatment abolished the LYSO-7-mediated reestablishment of microcirculatory blood flow. This effect may depend on enhanced eNOS protein expression in injured gastric tissue. The pH and concentration of H+ in the stomach were not modified by LYSO-7 treatment. In addition, LYSO-7 may induce less toxicity, as 28 days of oral treatment did not induce weight loss, as detected in pioglitazone treated mice. Thus, we show that LYSO-7 may be an effective treatment for gastric lesions by controlling neutrophil influx and microcirculatory blood flow mediated by NO.	[Santin, Jose Roberto; Machado, Isabel Daufenback; Rodrigues, Stephen F. P.; Farsky, Sandra H. P.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Expt Toxicol, Sao Paulo, Brazil; [Teixeira, Simone; Muscara, Marcelo N.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil; [Galdino, Suely Lins; Pitta, Ivan da Rocha] Univ Fed Pernambuco, Dept Chem, Recife, PE, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Pernambuco	Farsky, SHP (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Expt Toxicol, Sao Paulo, Brazil.	sfarsky@usp.br	Machado, Isabel D/B-8913-2014; Rodrigues, Stephen Fernandes/F-7073-2012; Farsky, Sandra HP/C-4044-2012; Muscará, Marcelo N/F-3250-2012; Pitta, Ivan/C-9265-2014; Machado, Isabel/AAE-3418-2020; Santin, José Roberto/E-6951-2013; Teixeira, Simone/K-3991-2016	Rodrigues, Stephen Fernandes/0000-0002-6818-0365; Muscará, Marcelo N/0000-0002-8342-5586; Pitta, Ivan/0000-0002-2899-4049; Machado, Isabel/0000-0003-0724-5150; Santin, José Roberto/0000-0002-8805-8818; Teixeira, Simone/0000-0002-8515-5030	FAPESP [2010/17175-0, 2011/01848-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank FAPESP for financial support (Grants No. 2010/17175-0 and 2011/01848-8). MN Muscara, SL Galdino, IR Pitta and SHP Farsky are fellow of the Conselho Nacional de Pesquisa e Tecnologia (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878; Bayir Y, 2006, PHYTOMEDICINE, V13, P584, DOI 10.1016/j.phymed.2005.07.002; Betz B, 2012, PPAR RES, V2012, DOI 10.1155/2012/219319; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brzozowski Tomasz, 2005, Inflammopharmacology, V13, P317, DOI 10.1163/156856005774423908; Celinski K, 2011, J PHYSIOL PHARMACOL, V62, P347; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dembinski A, 2011, GASTROENTEROLOGY, V140, pS; Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08; El-Demerdash E, 2010, DRUG DISCOV THER, V4, P276; Fajas L, 2001, NUTR METAB CARDIOVAS, V11, P64; Farnesi-de-Assuncao TS, 2012, CELL IMMUNOL, V273, P23, DOI 10.1016/j.cellimm.2011.11.010; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; Friedland SN, 2012, AM J MED, V125, P126, DOI 10.1016/j.amjmed.2011.08.025; Goso Y, 2007, ALCOHOL CLIN EXP RES, V31, P390, DOI 10.1111/j.1530-0277.2006.00319.x; Guha P, 2010, BRIT J PHARMACOL, V159, P726, DOI 10.1111/j.1476-5381.2009.00572.x; Guha P, 2009, J PHARMACOL EXP THER, V328, P829, DOI 10.1124/jpet.108.145334; Guo JS, 2006, EUR J PHARMACOL, V536, P301, DOI 10.1016/j.ejphar.2005.12.088; GUSLANDI M, 1987, Digestive Diseases, V5, P21, DOI 10.1159/000171159; Imamoto E, 2004, BIOFACTORS, V20, P37, DOI 10.1002/biof.5520200104; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Kato S, 2009, J PHYSIOL PHARMACOL, V60, P147; Konturek PC, 2010, J PHYSIOL PHARMACOL, V61, P429; Konturek PC, 2003, EUR J PHARMACOL, V472, P213, DOI 10.1016/S0014-2999(03)01932-0; Krznaric Z, 2011, DIGEST DIS, V29, P469, DOI 10.1159/000331515; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lahiri S, 2009, EUR J PHARMACOL, V609, P118, DOI 10.1016/j.ejphar.2009.03.005; Lakshmi V, 2010, PHYTOMEDICINE, V17, P569, DOI 10.1016/j.phymed.2009.10.016; Lee JH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-34; Lemos M, 2011, J ETHNOPHARMACOL, V138, P503, DOI 10.1016/j.jep.2011.09.046; Li CY, 2008, ALCOHOL, V42, P683, DOI 10.1016/j.alcohol.2008.08.009; Liang C, 2009, BRIT J PHARMACOL, V158, P1865, DOI 10.1111/j.1476-5381.2009.00450.x; Liang YJ, 2010, DIABETES-METAB RES, V26, P406, DOI 10.1002/dmrr.1100; Lim HA, 2012, BIOGERONTOLOGY, V13, P133, DOI 10.1007/s10522-011-9361-4; Long EM, 2011, P NATL ACAD SCI USA, V108, P16357, DOI 10.1073/pnas.1100702108; Ma L, 2000, AM J PHYSIOL-GASTR L, V279, pG341, DOI 10.1152/ajpgi.2000.279.2.G341; Martin HL, 2012, EXP NEUROL, V235, P528, DOI 10.1016/j.expneurol.2012.02.017; Medeiros JVR, 2008, BRIT J PHARMACOL, V153, P721, DOI 10.1038/sj.bjp.0707605; Meissner M, 2010, J BIOL CHEM, V285, P33797, DOI 10.1074/jbc.M110.137943; Meyer S, 2010, PPAR RES, V2010, DOI 10.1155/2010/848645; MIZUI T, 1983, JPN J PHARMACOL, V33, P939, DOI 10.1254/jjp.33.939; Morsy MA, 2010, CLIN EXP PHARMACOL P, V37, P173, DOI 10.1111/j.1440-1681.2009.05250.x; Rocha NFM, 2011, EUR J PHARM SCI, V44, P455, DOI 10.1016/j.ejps.2011.08.020; Muscara MN, 1999, AM J PHYSIOL-GASTR L, V276, pG1313, DOI 10.1152/ajpgi.1999.276.6.G1313; Naito Yuji, 2010, Nihon Rinsho, V68, P341; Ning JW, 2012, WORLD J GASTROENTERO, V18, P2262, DOI 10.3748/wjg.v18.i18.2262; OHNO T, 1995, J GASTROENTEROL, V30, P557, DOI 10.1007/BF02367779; Pancione M, 2009, HUM PATHOL, V40, P714, DOI 10.1016/j.humpath.2008.08.019; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Reilly CM, 2000, J IMMUNOL, V164, P1498, DOI 10.4049/jimmunol.164.3.1498; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sadaghiani MS, 2011, BEHAV BRAIN RES, V224, P336, DOI 10.1016/j.bbr.2011.06.011; Santin JR, 2013, EUR J PHARM SCI, V48, P689, DOI 10.1016/j.ejps.2012.12.029; Beserra AMSES, 2011, J AGR FOOD CHEM, V59, P6957, DOI 10.1021/jf2003267; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Sung NY, 2007, BRIT J CANCER, V97, P700, DOI 10.1038/sj.bjc.6603893; SZABO S, 1990, GASTROENTEROL CLIN N, V19, P67; Takagi T, 2004, REDOX REP, V9, P376, DOI 10.1179/135100004225006911; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Villegas I, 2004, EUR J PHARMACOL, V505, P195, DOI 10.1016/j.ejphar.2004.10.020; WALLACE JL, 1995, AM J PHYSIOL-GASTR L, V268, pG134, DOI 10.1152/ajpgi.1995.268.1.G134; Wang ACC, 2001, AM J RESP CELL MOL, V24, P688, DOI 10.1165/ajrcmb.24.6.4376; Wu L, 2012, BLOOD, V119, P115, DOI 10.1182/blood-2011-06-363093; YANG X, 2011, PLOS ONE, V6, P1516, DOI DOI 10.1371/J0URNAL.P0NE.0025271.PUBMED:21966476; Yuen CY, 2011, CARDIOVASC RES, V90, P122, DOI 10.1093/cvr/cvq392; Zhang LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048453	67	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76894	10.1371/journal.pone.0076894	http://dx.doi.org/10.1371/journal.pone.0076894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124600	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100157
J	Wang, XQ; Huang, GH; Yu, DY; Ge, BS; Wang, JQ; Xu, FX; Huang, F; Xu, H; Lu, JR				Wang, Xiaoqiang; Huang, Guihong; Yu, Daoyong; Ge, Baosheng; Wang, Jiqian; Xu, Fengxi; Huang, Fang; Xu, Hai; Lu, Jian R.			Solubilization and Stabilization of Isolated Photosystem I Complex with Lipopeptide Detergents	PLOS ONE			English	Article							MEMBRANE-PROTEIN; PEPTIDE SURFACTANTS; KINETICS	It is difficult to maintain a target membrane protein in a soluble and functional form in aqueous solution without biological membranes. Use of surfactants can improve solubility, but it remains challenging to identify adequate surfactants that can improve solubility without damaging their native structures and biological functions. Here we report the use of a new class of lipopeptides to solubilize photosystem I (PS-I), a well known membrane protein complex. Changes in the molecular structure of these surfactants affected their amphiphilicity and the goal of this work was to exploit a delicate balance between detergency and biomimetic performance in PS-I solubilization via their binding capacity. Meanwhile, the effects of these surfactants on the thermal and structural stability and functionality of PS-I in aqueous solution were investigated by circular dichroism, fluorescence spectroscopy, SDS-PAGE analysis and O-2 uptake measurements, respectively. Our studies showed that the solubility of PS-I depended on both the polarity and charge in the hydrophilic head of the lipopeptides and the length of its hydrophobic tail. The best performing lipopeptides in favour of PS-I solubility turned out to be C14DK and C16DK, which were comparable to the optimal amphiphilicity of the conventional chemical surfactants tested. Lipopeptides showed obvious advantages in enhancing PS-I thermostability over sugar surfactant DDM and some full peptide amphiphiles reported previously. Fluorescence spectroscopy along with SDS-PAGE analysis demonstrated that lipopeptides did not undermine the polypeptide composition and conformation of PS-I after solubilization; instead they showed better performance in improving the structural stability and integrity of this multi-subunit membrane protein than conventional detergents. Furthermore, O-2 uptake measurements indicated that PS-I solubilized with lipopeptides maintained its functionality. The underlying mechanism for the favorable actions of lipopeptide in PS-I solubilization and stabilization is discussed.	[Wang, Xiaoqiang; Huang, Guihong; Yu, Daoyong; Ge, Baosheng; Wang, Jiqian; Xu, Fengxi; Huang, Fang; Xu, Hai] China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China; [Wang, Xiaoqiang; Huang, Guihong; Yu, Daoyong; Ge, Baosheng; Wang, Jiqian; Xu, Fengxi; Huang, Fang; Xu, Hai] China Univ Petr East China, Ctr Bioengn & Biotechnol, Qingdao, Shandong, Peoples R China; [Lu, Jian R.] Univ Manchester, Sch Phys & Astron, Phys Biol Lab, Manchester, Lancs, England	China University of Petroleum; China University of Petroleum; University of Manchester	Huang, F (corresponding author), China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China.	fhuang@upc.edu.cn; xuh@upc.edu.cn	Ge, Baosheng/AAT-4788-2020; Wang, Jiqian/H-4213-2014; Yu, Daoyong/E-5269-2013; Lu, Jian/GRY-4556-2022	Ge, Baosheng/0000-0001-9906-2081; Yu, Daoyong/0000-0002-3380-1897; Yu, Hai/0000-0002-6386-9761; Wang, Jiqian/0000-0002-7525-5943	National Key Basic Research Program of China [2012CB518000]; Fundamental Research Funds for the Central Universities; Project of Science and Technology Program for Basic Research of Qingdao [13-1-4-237-jch]; National Natural Science Foundation of China [31000377, 20906105, 21033005]; Shandong Province Natural Science Foundation [ZR2010BL008]; program for New Century Excellent Talents in University of Ministry of Education of China [NCET-10-0815]; Natural Science Foundation for Distinguished Young Scholar of Shandong Province [JQ201008]	National Key Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Project of Science and Technology Program for Basic Research of Qingdao; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation for Distinguished Young Scholar of Shandong Province	This work was financially supported in part by the National Key Basic Research Program of China (2012CB518000), the Fundamental Research Funds for the Central Universities, the Project of Science and Technology Program for Basic Research of Qingdao (13-1-4-237-jch), the National Natural Science Foundation of China (No. 31000377, 20906105, 21033005), Shandong Province Natural Science Foundation (No. ZR2010BL008), the program for New Century Excellent Talents in University of Ministry of Education of China (NCET-10-0815) and the Natural Science Foundation for Distinguished Young Scholar of Shandong Province (No. JQ201008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2010, MOL BIOSYST, V6, P677, DOI 10.1039/b925791h; Alkhalfioui F, 2009, CURR OPIN PHARMACOL, V9, P629, DOI 10.1016/j.coph.2009.04.002; Allen SJ, 2004, J MOL BIOL, V342, P1279, DOI 10.1016/j.jmb.2004.07.040; Arnold T., 2008, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0408s53, DOI 10.1002/0471140864.PS0408S53]; BRUCE BD, 1988, J BIOL CHEM, V263, P7302; Columbus L, 2009, J AM CHEM SOC, V131, P7320, DOI 10.1021/ja808776j; Cometta A, 2000, BIOPHYS J, V79, P3235, DOI 10.1016/S0006-3495(00)76556-8; Compton ELR, 2006, J MOL BIOL, V357, P325, DOI 10.1016/j.jmb.2005.12.042; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; COOPER DG, 1981, APPL ENVIRON MICROB, V42, P408, DOI 10.1128/AEM.42.3.408-412.1981; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Engelmann E, 2001, FEBS LETT, V499, P112, DOI 10.1016/S0014-5793(01)02533-9; FERSHT A, STRUCTURE MECH PROTE, P510; FORD RC, 1988, EMBO J, V7, P2287, DOI 10.1002/j.1460-2075.1988.tb03071.x; Ge BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010233; Gutmann DAP, 2007, PROTEIN SCI, V16, P1422, DOI 10.1110/ps.072759907; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; HILL BC, 1988, BIOCHEMISTRY-US, V27, P4741, DOI 10.1021/bi00413a024; Iwuchukwu IJ, 2010, NAT NANOTECHNOL, V5, P73, DOI [10.1038/nnano.2009.315, 10.1038/NNANO.2009.315]; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jia DH, 2011, SOFT MATTER, V7, P1777, DOI 10.1039/c0sm00581a; Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230; Kruip J, 1999, J BIOL CHEM, V274, P18181, DOI 10.1074/jbc.274.26.18181; LAM E, 1984, FEBS LETT, V168, P10, DOI 10.1016/0014-5793(84)80197-0; Li DH, 2004, ACTA BOT SIN, V46, P423; LU RJ, 2007, CURR OPIN COLLOID IN, V12, P60, DOI DOI 10.1016/J.C0CIS.2007.05.004; Matsumoto K, 2009, J PHYS CHEM B, V113, P75, DOI 10.1021/jp8021425; McGregor CL, 2003, NAT BIOTECHNOL, V21, P171, DOI 10.1038/nbt776; Muh F, 2005, BBA-BIOENERGETICS, V1708, P219, DOI 10.1016/j.bbabio.2005.03.005; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; PETER NC, 2010, ADV FUNCT MAT F, V20, P4048; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; Tjus SE, 1998, PLANT PHYSIOL, V116, P755, DOI 10.1104/pp.116.2.755; WANG X, PLOS ONE, V6; Wang XQ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00102; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; YANG F, 2009, SEPARATION CHARACTER, P22; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Zhao BB, 2008, PLANT SCI, V175, P556, DOI 10.1016/j.plantsci.2008.06.003; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103	43	5	5	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76256	10.1371/journal.pone.0076256	http://dx.doi.org/10.1371/journal.pone.0076256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098786	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500157
J	Maudet, C; Sourisce, A; Dragin, L; Lahouassa, H; Rain, JC; Bouaziz, S; Ramirez, BC; Margottin-Goguet, F				Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Rain, Jean-Christophe; Bouaziz, Serge; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence			HIV-1 Vpr Induces the Degradation of ZIP and sZIP, Adaptors of the NuRD Chromatin Remodeling Complex, by Hijacking DCAF1/VprBP	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; CUL4-DDB1 UBIQUITIN LIGASE; VIRAL PROTEIN-R; NF-KAPPA-B; MACROPHAGE INFECTION; MI-2/NURD COMPLEX; ENZYME APOBEC3G; IN-VIVO; TRANSCRIPTION	The Vpr protein from type 1 and type 2 Human Immunodeficiency Viruses (HIV-1 and HIV-2) is thought to inactivate several host proteins through the hijacking of the DCAF1 adaptor of the Cul4A ubiquitin ligase. Here, we identified two transcriptional regulators, ZIP and sZIP, as Vpr-binding proteins degraded in the presence of Vpr. ZIP and sZIP have been shown to act through the recruitment of the NuRD chromatin remodeling complex. Strikingly, chromatin is the only cellular fraction where Vpr is present together with Cul4A ubiquitin ligase subunits. Components of the NuRD complex and exogenous ZIP and sZIP were also associated with this fraction. Several lines of evidence indicate that Vpr induces ZIP and sZIP degradation by hijacking DCAF1: (i) Vpr induced a drastic decrease of exogenously expressed ZIP and sZIP in a dose-dependent manner, (ii) this decrease relied on the proteasome activity, (iii) ZIP or sZIP degradation was impaired in the presence of a DCAF1-binding deficient Vpr mutant or when DCAF1 expression was silenced. Vpr-mediated ZIP and sZIP degradation did not correlate with the growth-related Vpr activities, namely G2 arrest and G2 arrest-independent cytotoxicity. Nonetheless, infection with HIV-1 viruses expressing Vpr led to the degradation of the two proteins. Altogether our results highlight the existence of two host transcription factors inactivated by Vpr. The role of Vpr-mediated ZIP and sZIP degradation in the HIV-1 replication cycle remains to be deciphered.	[Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence] Inst Cochin, INSERM, U1016, Paris, France; [Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence] CNRS, UMR8104, Paris, France; [Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Bouaziz, Serge; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence] Univ Paris 05, Paris, France; [Maudet, Claire] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Rain, Jean-Christophe] HYBRIGEN Serv SAS, Paris, France; [Bouaziz, Serge] CNRS, UMR8015, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Margottin-Goguet, F (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.	florence.margottin-goguet@inserm.fr	Margottin-Goguet, Florence/F-9272-2013; Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Maudet, Claire/AAH-1728-2019; RAMIREZ, Cecilia/O-6100-2017	Margottin-Goguet, Florence/0000-0002-3124-6690; Bouaziz, Serge/0000-0001-7792-8307; Maudet, Claire/0000-0001-8856-0819; RAMIREZ, Cecilia/0000-0002-6670-9827; RAIN, Jean-Christophe/0000-0001-8110-0641	"Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS); "Sidaction"; "Fondation de France"; University Paris Diderot; University Paris Descartes; ANRS	"Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS)(ANRSFrench National Research Agency (ANR)); "Sidaction"; "Fondation de France"(Fondation de France); University Paris Diderot; University Paris Descartes; ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by grants from the "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS), "Sidaction" and "Fondation de France". CM and LD received support from the University Paris Diderot and University Paris Descartes respectively; AS and LH received support from "Sidaction" and ANRS respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 1996, J MOL BIOL, V261, P599, DOI 10.1006/jmbi.1996.0485; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Amini S, 2004, DNA CELL BIOL, V23, P249, DOI 10.1089/104454904773819833; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cui JQ, 2006, CELL CYCLE, V5, P2626, DOI 10.4161/cc.5.22.3442; de Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035385; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Deshmane SL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-477; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033657; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Janket ML, 2004, BIOCHEM BIOPH RES CO, V314, P1126, DOI 10.1016/j.bbrc.2004.01.008; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P621, DOI 10.1038/ni0612-621c; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Li G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011371; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Maudet C, 2011, J BIOL CHEM, V286, P23742, DOI 10.1074/jbc.M111.220780; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Pestov DG, 1999, BIOTECHNIQUES, V26, P102, DOI 10.2144/99261st04; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Planelles V, 2010, MOL ASPECTS MED, V31, P398, DOI 10.1016/j.mam.2010.05.002; Precious BL, 2007, VIROLOGY, V368, P114, DOI 10.1016/j.virol.2007.06.024; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Roux P, 2000, J VIROL, V74, P4658, DOI 10.1128/JVI.74.10.4658-4665.2000; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Sharp PM, 2001, PHILOS T R SOC B, V356, P867, DOI 10.1098/rstb.2001.0863; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Taneichi D, 2011, J NEUROIMMUNE PHARM, V6, P177, DOI 10.1007/s11481-011-9276-5; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varin A, 2005, J BIOL CHEM, V280, P42557, DOI 10.1074/jbc.M502211200; WANG LL, 1995, J BIOL CHEM, V270, P25564, DOI 10.1074/jbc.270.43.25564; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yu WH, 2010, J BIOL CHEM, V285, P14301, DOI 10.1074/jbc.M110.107508; Zhu Y, 2003, APOPTOSIS, V8, P71, DOI 10.1023/A:1021653119934; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	63	18	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77320	10.1371/journal.pone.0077320	http://dx.doi.org/10.1371/journal.pone.0077320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116224	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200115
J	Tuohimaa, P; Wang, JH; Khan, S; Kuuslahti, M; Qian, K; Manninen, T; Auvinen, P; Vihinen, M; Lou, YR				Tuohimaa, Pentti; Wang, Jing-Huan; Khan, Sofia; Kuuslahti, Marianne; Qian, Kui; Manninen, Tommi; Auvinen, Petri; Vihinen, Mauno; Lou, Yan-Ru			Gene Expression Profiles in Human and Mouse Primary Cells Provide New Insights into the Differential Actions of Vitamin D-3 Metabolites	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; 1-ALPHA,25 DIHYDROXYVITAMIN D3; FRIZZLED-RELATED PROTEIN-1; KAPPA-B LIGAND; 25-HYDROXYVITAMIN D-3; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; KOREAN POPULATION; INHIBITORY FACTOR; EPITHELIAL-CELLS	1 alpha,25-Dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3) had earlier been regarded as the only active hormone. The newly identified actions of 25-hydroxyvitamin D-3 (25(OH)D-3) and 24R,25-dihydroxyvitamin D-3 (24R,25(OH)(2)D-3) broadened the vitamin D-3 endocrine system, however, the current data are fragmented and a systematic understanding is lacking. Here we performed the first systematic study of global gene expression to clarify their similarities and differences. Three metabolites at physiologically comparable levels were utilized to treat human and mouse fibroblasts prior to DNA microarray analyses. Human primary prostate stromal P29SN cells (hP29SN), which convert 25(OH)D-3 into 1 alpha,25(OH)(2)D-3 by 1 alpha-hydroxylase (encoded by the gene CYP27B1), displayed regulation of 164, 171, and 175 genes by treatment with 1 alpha,25(OH)(2)D-3, 25(OH)D-3, and 24R,25(OH)(2)D-3, respectively. Mouse primary Cyp27b1 knockout fibroblasts (mCyp27b1(-/-)), which lack 1 alpha-hydroxylation, displayed regulation of 619, 469, and 66 genes using the same respective treatments. The number of shared genes regulated by two metabolites is much lower in hP29SN than in mCyp27b1(-/-). By using DAVID Functional Annotation Bioinformatics Microarray Analysis tools and Ingenuity Pathways Analysis, we identified the agonistic regulation of calcium homeostasis and bone remodeling between 1 alpha,25(OH)(2)D-3 and 25(OH)D-3 and unique non-classical actions of each metabolite in physiological and pathological processes, including cell cycle, keratinocyte differentiation, amyotrophic lateral sclerosis signaling, gene transcription, immunomodulation, epigenetics, cell differentiation, and membrane protein expression. In conclusion, there are three distinct vitamin D-3 hormones with clearly different biological activities. This study presents a new conceptual insight into the vitamin D-3 endocrine system, which may guide the strategic use of vitamin D-3 in disease prevention and treatment.	[Tuohimaa, Pentti; Wang, Jing-Huan; Kuuslahti, Marianne] Univ Tampere, Dept Anat, Sch Med, FIN-33101 Tampere, Finland; [Tuohimaa, Pentti] Univ Tampere, Tampere Univ Hosp, Dept Clin Chem, FIN-33101 Tampere, Finland; [Wang, Jing-Huan] Univ Tampere, Tampere Grad Sch Biomed & Biotechnol, FIN-33101 Tampere, Finland; [Wang, Jing-Huan] Univ Turku, Drug Discovery Grad Sch, Turku, Finland; [Khan, Sofia; Vihinen, Mauno] Univ Tampere, Inst Biomed Technol & BioMediTech, FIN-33101 Tampere, Finland; [Khan, Sofia] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Khan, Sofia] Helsinki Univ Cent Hosp, Helsinki, Finland; [Qian, Kui; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Manninen, Tommi] Univ Tampere, Sch Med, Dept Cell Biol, FIN-33101 Tampere, Finland; [Vihinen, Mauno] Lund Univ, Inst Expt Med Sci, Lund, Sweden; [Vihinen, Mauno] Tampere Univ Hosp, Tampere, Finland; [Lou, Yan-Ru] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; Tampere University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Lund University; Tampere University; Tampere University Hospital; University of Helsinki	Lou, YR (corresponding author), Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland.	yan-ru.lou@helsinki.fi	Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Vihinen, Mauno/A-8452-2012; Lou, Yan-Ru/AAX-4008-2020; Lou, Yan-Ru/K-4348-2012; Qian, Kui/J-1942-2014	Auvinen, Petri/0000-0002-3947-4778; Vihinen, Mauno/0000-0002-9614-7976; Lou, Yan-Ru/0000-0001-7717-6010; Lou, Yan-Ru/0000-0001-7717-6010; Qian, Kui/0000-0001-7170-533X; Khan, Sofia/0000-0003-4185-8882	Tampere University Hospital; Drug Discovery Graduate School (University of Turku); Academy of Finland; Finnish Cancer Foundation; Sigrid Juselius Foundation; Medical Research Fund of Tampere University Hospital [EVO-9G143, EVO-9H160]; Medical Research Fund of Tampere University Hospital (Viikki Doctoral Program in Molecular Biosciences)	Tampere University Hospital; Drug Discovery Graduate School (University of Turku); Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Fund of Tampere University Hospital; Medical Research Fund of Tampere University Hospital (Viikki Doctoral Program in Molecular Biosciences)	This work was supported by grants from Tampere University Hospital, Drug Discovery Graduate School (University of Turku), the Academy of Finland, the Finnish Cancer Foundation, Sigrid Juselius Foundation, the Medical Research Fund of Tampere University Hospital (EVO-9G143 and EVO-9H160) and Viikki Doctoral Program in Molecular Biosciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2005, CELL, V122, P647, DOI 10.1016/j.cell.2005.08.024; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Ajibade DV, 2010, ENDOCRINOLOGY, V151, P2974, DOI 10.1210/en.2010-0033; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Azoitei N, 2007, ONCOGENE, V26, P6536, DOI 10.1038/sj.onc.1210476; Barreto AM, 2000, CANCER EPIDEM BIOMAR, V9, P265; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bell TD, 2010, J CELL BIOCHEM, V111, P7, DOI 10.1002/jcb.22661; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; Bikle DD, 2010, J BONE MINER METAB, V28, P117, DOI 10.1007/s00774-009-0153-8; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Campbell MJ, 2000, ONCOGENE, V19, P5091, DOI 10.1038/sj.onc.1203888; Campos LT, 2013, J STEROID BIOCHEM, V133, P12, DOI 10.1016/j.jsbmb.2012.08.002; Chae SC, 2004, HUM IMMUNOL, V65, P1427, DOI 10.1016/j.humimm.2004.07.002; Chae SC, 2004, IMMUNOL LETT, V95, P91, DOI 10.1016/j.imlet.2004.06.008; Chen FF, 2002, BIOCHEM J, V364, P571, DOI 10.1042/BJ20011703; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Diesel B, 2005, CLIN CANCER RES, V11, P5370, DOI 10.1158/1078-0432.CCR-04-1968; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Eyles D.W., 2012, FRONT NEUROENDOCRINO; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; Grgurevic L, 2011, BIOCHEM BIOPH RES CO, V408, P26, DOI 10.1016/j.bbrc.2011.03.109; Ha BG, 2008, PROTEOMICS, V8, P2625, DOI 10.1002/pmic.200701192; Hausler KD, 2004, J BONE MINER RES, V19, P1873, DOI 10.1359/JBMR.040807; Hibino T, 2004, J DERMATOL SCI, V35, P9, DOI 10.1016/j.jdermsci.2003.12.003; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Karam C, 2011, MED HYPOTHESES, V76, P643, DOI 10.1016/j.mehy.2011.01.021; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kriebitzsch C, 2009, ANTICANCER RES, V29, P3471; Krishnan AV, 2004, PROSTATE, V59, P243, DOI 10.1002/pros.20006; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Li J, 2008, J STEROID BIOCHEM, V112, P122, DOI 10.1016/j.jsbmb.2008.09.006; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Lou YR, 2006, J STEROID BIOCHEM, V99, P44, DOI 10.1016/j.jsbmb.2005.11.006; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Lou YR, 2003, FASEB J, V17, P332, DOI 10.1096/fj.03-0140fje; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Morishima N, 2011, J BIOL CHEM, V286, P35227, DOI 10.1074/jbc.M111.233502; Munetsuna E, 2011, J MOL ENDOCRINOL, V47, P209, DOI 10.1530/JME-11-0008; Nanba D, 2003, ANAT REC PART A, V270A, P97, DOI 10.1002/ar.a.10012; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Park DY, 2007, AM J PATHOL, V171, P1509, DOI 10.2353/ajpath.2007.070331; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Peng XJ, 2009, BREAST CANCER RES TR, V113, P31, DOI 10.1007/s10549-008-9900-0; Pham L, 2007, GENE EXPR PATTERNS, V7, P846, DOI 10.1016/j.modgep.2007.07.002; Porojnicu A, 2007, J STEROID BIOCHEM, V103, P675, DOI 10.1016/j.jsbmb.2006.12.031; Rauch T, 2005, CELL CYCLE, V4, P1078; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Ritter CS, 2006, KIDNEY INT, V70, P654, DOI 10.1038/sj.ki.5000394; Ritter CS, 2011, J MOL ENDOCRINOL, V46, P63, DOI 10.1677/JME-10-0128; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Ruohola JP, 2006, J BONE MINER RES, V21, P1483, DOI 10.1359/JBMR.060607; Sato Y, 1997, EUR NEUROL, V37, P225, DOI 10.1159/000117447; SEAMARK DA, 1980, CLIN CHIM ACTA, V106, P51, DOI 10.1016/0009-8981(80)90374-5; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Shalhoub V, 2010, J CELL BIOCHEM, V111, P911, DOI 10.1002/jcb.22779; Shen L, 2011, MED HYPOTHESES, V77, P698, DOI 10.1016/j.mehy.2011.07.057; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; St-Arnaud R, 2011, MOL CELL ENDOCRINOL, V347, P48, DOI 10.1016/j.mce.2011.05.018; Tarroni P, 2012, J CELL BIOCHEM, V113, P640, DOI 10.1002/jcb.23392; Tashiro K, 2004, MOL CELL ENDOCRINOL, V226, P27, DOI 10.1016/j.mce.2004.07.012; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tuohimaa P, 2012, ANTICANCER RES, V32, P373; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; Vieth R, 2002, LANCET, V359, P672, DOI 10.1016/S0140-6736(02)07814-5; Wang JH, 2006, BIOCHEM BIOPH RES CO, V345, P720, DOI 10.1016/j.bbrc.2006.04.156; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Wang XN, 2007, EXP CELL RES, V313, P3034, DOI 10.1016/j.yexcr.2007.05.021; Wu W, 2005, CANCER RES, V65, P7509, DOI 10.1158/0008-5472.CAN-04-3350; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415	89	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75338	10.1371/journal.pone.0075338	http://dx.doi.org/10.1371/journal.pone.0075338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116037	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200017
J	Avtar, R; Suzuki, R; Takeuchi, W; Sawada, H				Avtar, Ram; Suzuki, Rikie; Takeuchi, Wataru; Sawada, Haruo			PALSAR 50 m Mosaic Data Based National Level Biomass Estimation in Cambodia for Implementation of REDD plus Mechanism	PLOS ONE			English	Article							TROPICAL FOREST BIOMASS; LANDSAT TM DATA; ABOVEGROUND BIOMASS; RADAR BACKSCATTER; CARBON STOCKS; BAND SAR; DENSITY; DEFORESTATION; ALOS/PALSAR; SENSITIVITY	Tropical countries like Cambodia require information about forest biomass for successful implementation of climate change mitigation mechanism related to Reducing Emissions from Deforestation and forest Degradation (REDD+). This study investigated the potential of Phased Array-type L-band Synthetic Aperture Radar Fine Beam Dual (PALSAR FBD) 50 m mosaic data to estimate Above Ground Biomass (AGB) in Cambodia. AGB was estimated using a bottom-up approach based on field measured biomass and backscattering (sigma(o)) properties of PALSAR data. The relationship between the PALSAR sigma(o) HV and HH/HV with field measured biomass was strong with R-2 = 0.67 and 0.56, respectively. PALSAR estimated AGB show good results in deciduous forests because of less saturation as compared to dense evergreen forests. The validation results showed a high coefficient of determination R-2 = 0.61 with RMSE = 21 Mg/ha using values up to 200 Mg/ha biomass. There were some uncertainties because of the uncertainty in the field based measurement and saturation of PALSAR data. AGB map of Cambodian forests could be useful for the implementation of forest management practices for REDD+ assessment and policies implementation at the national level.	[Avtar, Ram; Takeuchi, Wataru; Sawada, Haruo] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan; [Avtar, Ram; Suzuki, Rikie] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Avtar, Ram] UNU ISP, Tokyo, Japan	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); United Nations University	Avtar, R (corresponding author), Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan.	ram.envjnu@gmail.com	Avtar, Ram/C-7394-2012	Avtar, Ram/0000-0003-3653-5771; Takeuchi, Wataru/0000-0002-9138-6601	Ministry of Environment, Japan [F-1101]	Ministry of Environment, Japan(Ministry of the Environment, Japan)	This study was supported by the Environmental Research and Technology Development Fund (F-1101) of the Ministry of Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka S, 2009, 30 AS C REM SENS ACR; Angelsen A, 2008, VINNV PROGR REN MOV; Austin JM, 2003, FOREST ECOL MANAG, V176, P575, DOI 10.1016/S0378-1127(02)00314-6; Avtar R., 2013, ENVIRON MONIT ASSESS, V185, P2013; Avtar Ram, 2013, Environment Development and Sustainability, V15, P1593, DOI 10.1007/s10668-013-9448-y; Avtar R, 2013, ARAB J GEOSCI, V6, P4859, DOI 10.1007/s12517-012-0768-2; Avtar R, 2012, GEOCARTO INT, V27, P119, DOI 10.1080/10106049.2011.626081; Avtar R, 2013, INT J DIGIT EARTH, V6, P255, DOI 10.1080/17538947.2011.620639; Beaudoin A, 1994, INT J REMOTE SENS, V15, P414; Brown S, 1995, ENVIRON MONIT ASSESS, V38, P157, DOI 10.1007/BF00546760; Brown S., 1997, ESTIMATING BIOMASS B, P5; Carreiras JMB, 2012, REMOTE SENS ENVIRON, V121, P426, DOI 10.1016/j.rse.2012.02.012; Cartus O, 2012, REMOTE SENS ENVIRON, V124, P466, DOI 10.1016/j.rse.2012.05.029; Castro KL, 2003, INT J REMOTE SENS, V24, P1853, DOI 10.1080/01431160210154056; Collins JN, 2009, INT J REMOTE SENS, V30, P1141, DOI 10.1080/01431160802448935; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Djomo AN, 2011, FOREST ECOL MANAG, V261, P1448, DOI 10.1016/j.foreco.2011.01.031; DOBSON MC, 1992, IEEE T GEOSCI REMOTE, V30, P412, DOI 10.1109/36.134090; Englhart S, 2011, REMOTE SENS ENVIRON, V115, P1260, DOI 10.1016/j.rse.2011.01.008; Foody GM, 2003, REMOTE SENS ENVIRON, V85, P463, DOI 10.1016/S0034-4257(03)00039-7; FRA, 2010, GLOB FOR RES ASS; Gama FF, 2010, REMOTE SENS-BASEL, V2, P939, DOI 10.3390/rs2040939; Gaughan AE, 2009, APPL GEOGR, V29, P212, DOI 10.1016/j.apgeog.2008.09.007; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Hajnsek I, 2009, IEEE T GEOSCI REMOTE, V47, P481, DOI 10.1109/TGRS.2008.2009437; Hame T, 2013, IEEE J-STARS, V6, P92, DOI 10.1109/JSTARS.2013.2241020; Harrell PA, 1997, REMOTE SENS ENVIRON, V59, P223, DOI 10.1016/S0034-4257(96)00155-1; Harrell PA, 1995, REMOTE SENS ENVIRON, V54, P247, DOI 10.1016/0034-4257(95)00127-1; IMHOFF ML, 1995, IEEE T GEOSCI REMOTE, V33, P511, DOI 10.1109/36.377953; Kasischke ES, 1997, REMOTE SENS ENVIRON, V59, P141, DOI 10.1016/S0034-4257(96)00148-4; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kenzo T, 2009, J FOREST RES-JPN, V14, P365, DOI 10.1007/s10310-009-0149-1; Kiyono Y, 2010, JARQ-JPN AGR RES Q, V44, P81, DOI 10.6090/jarq.44.81; Kuplich TM, 2005, INT J REMOTE SENS, V26, P4829, DOI 10.1080/01431160500239107; Le Toan T, 2011, REMOTE SENS ENVIRON, V115, P2850, DOI 10.1016/j.rse.2011.03.020; LETOAN T, 1992, IEEE T GEOSCI REMOTE, V30, P403, DOI 10.1109/36.134089; Lu D, 2005, INT J REMOTE SENS, V26, P2509, DOI 10.1080/01431160500142145; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Lucas RM, 2007, AQUAT CONSERV, V17, P245, DOI 10.1002/aqc.833; Luckman A, 1998, REMOTE SENS ENVIRON, V63, P126, DOI 10.1016/S0034-4257(97)00133-8; Luckman A, 1997, REMOTE SENS ENVIRON, V60, P1, DOI 10.1016/S0034-4257(96)00121-6; Maniatis D, 2010, CARBON BALANCE MANAG, V5, DOI [10.1186/1750-0680-5-9, DOI 10.1186/1750-0680-5-9)]; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchard ETA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040692; Mutanga O, 2012, INT J APPL EARTH OBS, V18, P399, DOI 10.1016/j.jag.2012.03.012; Muukkonen P, 2007, REMOTE SENS ENVIRON, V107, P617, DOI 10.1016/j.rse.2006.10.011; Page Susan, 2009, P263, DOI 10.1007/978-3-540-77381-8_9; RANSON KJ, 1994, IEEE T GEOSCI REMOTE, V32, P388, DOI 10.1109/36.295053; RAUSTE Y, 1994, INT J REMOTE SENS, V15, P2797, DOI 10.1080/01431169408954285; Ravindranath NH, 2008, CARBON INVENTORY MET, P113; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SADER SA, 1989, REMOTE SENS ENVIRON, V28, P143, DOI 10.1016/0034-4257(89)90112-0; Sales MH, 2007, ECOL MODEL, V205, P221, DOI 10.1016/j.ecolmodel.2007.02.033; Sandberg G, 2011, REMOTE SENS ENVIRON, DOI [10.1016/j.rse.2011.03.018, DOI 10.1016/J.RSE.2011.03.018]; Santos JR, 2003, REMOTE SENS ENVIRON, V87, P482, DOI 10.1016/j.rse.2002.12.001; Sato T, 2011, INT TECHN SEM REDD K; Schulze ED, 2006, BIOGEOSCIENCES, V3, P147, DOI 10.5194/bg-3-147-2006; Shimada M, 2010, IEEE J-STARS, V3, P657, DOI 10.1109/JSTARS.2010.2072984; Shimada M, 2009, IEEE T GEOSCI REMOTE, V47, P3915, DOI 10.1109/TGRS.2009.2023909; Sivanpillai R, 2006, FOREST ECOL MANAG, V223, P247, DOI 10.1016/j.foreco.2005.11.013; Skutsch M, 2007, ENVIRON SCI POLICY, V10, P322, DOI 10.1016/j.envsci.2006.08.009; Steininger MK, 2000, INT J REMOTE SENS, V21, P1139, DOI 10.1080/014311600210119; Sun GQ, 2011, REMOTE SENS ENVIRON, V115, P2906, DOI 10.1016/j.rse.2011.03.021; Suzuki R, 2013, POLAR SCI, V7, P100, DOI 10.1016/j.polar.2013.03.001; UNEP, 2009, CAMB ENV OUTL; VANZYL JJ, 1993, IEEE T GEOSCI REMOTE, V31, P153, DOI 10.1109/36.210456; Visseren-Hamakers IJ, 2012, CURR OPIN ENV SUST, V4, P646, DOI 10.1016/j.cosust.2012.10.005; Wang GX, 2011, SCAND J FOREST RES, V26, P360, DOI 10.1080/02827581.2011.564204; Watanabe M, 2006, IEEE T GEOSCI REMOTE, V44, P3154, DOI 10.1109/TGRS.2006.880632	70	34	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74807	10.1371/journal.pone.0074807	http://dx.doi.org/10.1371/journal.pone.0074807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116012	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300014
J	Maldonado, MB; Lomascolo, SB; Vazquez, DP				Belen Maldonado, Maria; Beatriz Lomascolo, Silvia; Pedro Vazquez, Diego			The Importance of Pollinator Generalization and Abundance for the Reproductive Success of a Generalist Plant	PLOS ONE			English	Article							SPECIALIST; POPULATION; VISITORS; DESERT	Previous studies have examined separately how pollinator generalization and abundance influence plant reproductive success, but none so far has evaluated simultaneously the relative importance of these pollinator attributes. Here we evaluated the extent to which pollinator generalization and abundance influence plant reproductive success per visit and at the population level on a generalist plant, Opuntia sulphurea (Cactaceae). We used field experiments and path analysis to evaluate whether the per-visit effect is determined by the pollinator's degree of generalization, and whether the population level effect (pollinator impact) is determined by the pollinator's degree of generalization and abundance. Based on the models we tested, we concluded that the per-visit effect of a pollinator on plant reproduction was not determined by the pollinators' degree of generalization, while the population-level impact of a pollinator on plant reproduction was mainly determined by the pollinators' degree of generalization. Thus, generalist pollinators have the greatest species impact on pollination and reproductive success of O. sulphurea. According to our analysis this greatest impact of generalist pollinators may be partly explained by pollinator abundance. However, as abundance does not suffice as an explanation of pollinator impact, we suggest that vagility, need for resource consumption, and energetic efficiency of generalist pollinators may also contribute to determine a pollinator's impact on plant reproduction.	[Belen Maldonado, Maria; Beatriz Lomascolo, Silvia; Pedro Vazquez, Diego] Consejo Nacl Invest Cient & Tecn, Inst Argentino Invest Zonas Aridas, CC 507, Mendoza, Argentina; [Belen Maldonado, Maria; Beatriz Lomascolo, Silvia; Pedro Vazquez, Diego] Univ Nacl Cuyo, Inst Ciencias Basicas, Ctr Univ, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Maldonado, MB (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Argentino Invest Zonas Aridas, CC 507, Mendoza, Argentina.	mmaldonado@mendoza-conicet.gob.ar		Vazquez, Diego P./0000-0002-3449-5748; Lomascolo, Silvia/0000-0002-4422-7851	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 6564, 2781]; Fondo para la Investigacion Cientifica y Tecnologica [PICT 20805, 1471, 2010-2779]; BBVA Foundation [BIOCON03-162]; BBVA bank; Universidad Nacional de Cuyo; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas)	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica; BBVA Foundation(BBVA Foundation); BBVA bank(BBVA Foundation); Universidad Nacional de Cuyo; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding came from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) (PIP 6564 and 2781), Fondo para la Investigacion Cientifica y Tecnologica (PICT 20805, 1471 and 2010-2779) and BBVA Foundation ("BBVA is the official name of the foundation funded by BBVA bank, and there is no full name for it'')(BIOCON03-162). M.B. Maldonado was supported by an undergraduate fellowship from the Universidad Nacional de Cuyo, and S. B. Lomascolo by a CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen Marcelo A, 2007, Ecol. austral, V17, P7; Bascompte J, 2007, ANNU REV ECOL SYST, V38, P367; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Burnham K.P., 2010, MODEL SELECTION MULT; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; DALMASSO AD, 1999, MULTEQUINA, V8, P11; Darwin C., 1877, VARIOUS CONTRIVANCES; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; FOX J, 2010, SEM STRUCTURAL EQUAT; Gomez JM, 2000, OECOLOGIA, V122, P90, DOI 10.1007/PL00008840; Gomez JM, 2009, ECOL EVOL INTERACCIO, P61; Gruter Christoph, 2011, Communicative & Integrative Biology, V4, P633; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kiesling R., 2005, 100 CACTUS ARGENTINO; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; Mitchell R.J., 2001, DESIGN ANAL ECOLOGIC, P217; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; MOTTEN AF, 1981, ECOLOGY, V62, P1278, DOI 10.2307/1937292; Olsen KM, 1997, OECOLOGIA, V109, P114, DOI [10.1007/s004420050065, 10.1007/PL00008811]; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; R Development Core Team, 2010, R A LANGUAGE AND ENV; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Shipley B., 2000, CAUSE CORRELATIONS B; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Thostesen AM, 1996, OIKOS, V77, P77, DOI 10.2307/3545587; Vazquez DP, 2012, ECOLOGY, V93, P719, DOI 10.1890/11-1356.1; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vazquez DP, 2003, ECOLOGY, V84, P2493, DOI 10.1890/02-0587; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; ZIMMERMAN M, 1990, PLANT REPRODUCTIVE E, P157	34	13	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75482	10.1371/journal.pone.0075482	http://dx.doi.org/10.1371/journal.pone.0075482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116049	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300031
J	Engelmann, JB; Maciuba, B; Vaughan, C; Paulus, MP; Dunlop, BW				Engelmann, Jan B.; Maciuba, Britta; Vaughan, Christopher; Paulus, Martin P.; Dunlop, Boadie W.			Posttraumatic Stress Disorder Increases Sensitivity to Long Term Losses among Patients with Major Depressive Disorder	PLOS ONE			English	Article							DECISION-MAKING; INTERTEMPORAL CHOICE; SELF-CONTROL; PREFRONTAL CORTEX; DSM-IV; REWARD; DELAY; TIME; UNCERTAINTY; FUTURE	Background: Decisions under risk and with outcomes that are delayed in time are ubiquitous in real life and can have a significant impact on the health and wealth of the decision-maker. Despite its potential relevance for real-world choices, the degree of aberrant risky and intertemporal decision-making in patients suffering from major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) has received little attention to date. Method: We used a case-control design to compare decision-making in healthy control subjects (N=16) versus untreated depressed subjects in a current major depressive episode (N=20). In order to examine how major depressive disorder (MDD) may impact decision-making, subjects made decisions over (1) risky outcomes and (2) delayed outcomes in the domain of gains and losses using choice paradigms from neuroeconomics. In a pre-planned analysis, depressed subjects were subdivided into those with primary PTSD along with comorbid MDD (MDD+PTSD) versus those with primary MDD without PTSD (MDD-only). Choice behavior was modeled via a standard econometric model of intertemporal choice, a quasi-hyperbolic temporal discounting function, which was estimated for each subject group separately. Results: Under conditions of potential gain, depressed subjects demonstrated greater discounting for gains across all time frames compared to controls. In the realm of losses, both subgroups of depressed subjects discounted more steeply than controls for short time frames. However, for delayed losses ranging from >1-10 years, MDD+PTSD subjects showed shallower discounting rates relative to MDD-only subjects, who continued to discount future losses steeply. Risk attitudes did not contribute to differences in intertemporal choice. Conclusions: Depressed patients make choices that minimize current pain and maximize current reward, despite severe later consequences or lost opportunities. Anxiety associated with PTSD may serve as a partially protective factor in decision-making about long-term potential losses compared to MDD patients without PTSD.	[Engelmann, Jan B.] Univ Zurich, Dept Econ, Zurich, Switzerland; [Maciuba, Britta] Scott & White Hosp, Texas A&M Hlth Ctr, Dept Family Med, Temple, TX USA; [Vaughan, Christopher; Dunlop, Boadie W.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Mood & Anxiety Disorders Program, Atlanta, GA 30322 USA; [Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of Zurich; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Emory University; University of California System; University of California San Diego	Dunlop, BW (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Mood & Anxiety Disorders Program, Atlanta, GA 30322 USA.	bdunlop@emory.edu	Dunlop, Boadie/N-3362-2017; Engelmann, Jan B./H-8429-2014	Dunlop, Boadie/0000-0002-4653-0483; Engelmann, Jan B./0000-0001-6493-8792; Paulus, Martin/0000-0002-0825-3606	National Institutes of Mental Health grant [K23 MH086690]; Mercator Foundation Switzerland; NCCR Affective Sciences; Neurochoice project of SystemsX; University of Zurich 'Foundations of Human Social Behavior'; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH086690] Funding Source: NIH RePORTER	National Institutes of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mercator Foundation Switzerland; NCCR Affective Sciences; Neurochoice project of SystemsX; University of Zurich 'Foundations of Human Social Behavior'; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a National Institutes of Mental Health grant, K23 MH086690 (BWD). JBE gratefully acknowledges support from the Mercator Foundation Switzerland, the NCCR Affective Sciences, the Neurochoice project of SystemsX and the research priority program at the University of Zurich 'Foundations of Human Social Behavior'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Burghart DR, J RISK UNCE IN PRESS; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Cella M, 2010, J AFFECT DISORDERS, V124, P207, DOI 10.1016/j.jad.2009.11.013; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Destoop M, 2012, J AFFECT DISORDERS, V137, P98, DOI 10.1016/j.jad.2011.12.010; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; Elman I, 2009, BIOL PSYCHIAT, V66, P1083, DOI 10.1016/j.biopsych.2009.06.006; Engelmann JB, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00118; Engelmann JB, 2012, SOC COGN AFFECT NEUR, V7, P557, DOI 10.1093/scan/nss050; Engelmann JB, 2009, BRAIN RES, V1290, P28, DOI 10.1016/j.brainres.2009.06.078; Engelmann JB, 2009, J NEUROSCI, V29, P6055, DOI 10.1523/JNEUROSCI.1037-09.2009; Epper T, 2011, J RISK UNCERTAINTY, V43, P169, DOI 10.1007/s11166-011-9129-x; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; First M. B., 1995, STRUCTURED CLIN INTE; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Grant DM, 2008, J ABNORM PSYCHOL, V117, P662, DOI 10.1037/a0012591; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hamilton KR, 2012, AM J DRUG ALCOHOL AB, V38, P30, DOI 10.3109/00952990.2011.643978; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hasler G, 2012, NEUROSCI BIOBEHAV R, V36, P64, DOI 10.1016/j.neubiorev.2011.04.011; Henriques JB, 2000, COGNITION EMOTION, V14, P711, DOI 10.1080/02699930050117684; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kovacs M, 2009, PSYCHOL MED, V39, P1841, DOI 10.1017/S0033291709005789; Kroes MCW, 2011, J PSYCHIATR NEUROSCI, V36, P256, DOI 10.1503/jpn.100077; Kuhberger A, 2002, ORGAN BEHAV HUM DEC, V89, P1162, DOI 10.1016/S0749-5978(02)00021-3; Kuhn S, 2012, BIOL PSYCHIAT; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Lempert KM, 2010, J BEHAV THER EXP PSY, V41, P258, DOI 10.1016/j.jbtep.2010.02.003; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Madden GJ, 2003, EXP CLIN PSYCHOPHARM, V11, P139, DOI 10.1037/1064-1297.11.2.139; Mann L, 1997, J BEHAV DECIS MAKING, V10, P1, DOI 10.1002/(SICI)1099-0771(199703)10:1<1::AID-BDM242>3.0.CO;2-X; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Must A, 2007, J AFFECT DISORDERS, V103, P273, DOI 10.1016/j.jad.2007.02.001; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; PRELEC D, 1991, MANAGE SCI, V37, P770, DOI 10.1287/mnsc.37.7.770; Read D., 2004, BLACKWELL HDB JUDGME, P424, DOI DOI 10.1002/9780470752937.CH21; Salerian AJ, 2012, PSYCHIAT RES-NEUROIM, V204, P1, DOI 10.1016/j.pscychresns.2012.04.019; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; Shin LM, 2006, ANN NY ACAD SCI, V107, P167; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Slade T, 2006, PSYCHOL MED, V36, P1593, DOI 10.1017/S0033291706008452; Takahashi T, 2008, NEUROENDOCRINOL LETT, V29, P351; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y	70	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e78292	10.1371/journal.pone.0078292	http://dx.doi.org/10.1371/journal.pone.0078292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116235	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000325501300123
J	Cai, H; Cong, WN; Daimon, CM; Wang, R; Tschop, MH; Sevigny, J; Martin, B; Maudsley, S				Cai, Huan; Cong, Wei-na; Daimon, Caitlin M.; Wang, Rui; Tschoep, Matthias H.; Sevigny, Jean; Martin, Bronwen; Maudsley, Stuart			Altered Lipid and Salt Taste Responsivity in Ghrelin and GOAT Null Mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; EPITHELIAL NA+ CHANNEL; CHAIN FATTY-ACIDS; INSULIN SENSITIVITY; DIETARY LIPIDS; MOLECULAR-MECHANISMS; ALPHA-GUSTDUCIN; KNOCKOUT MICE; FOOD-INTAKE; CELLS	Taste perception plays an important role in regulating food preference, eating behavior and energy homeostasis. Taste perception is modulated by a variety of factors, including gastric hormones such as ghrelin. Ghrelin can regulate growth hormone release, food intake, adiposity, and energy metabolism. Octanoylation of ghrelin by ghrelin O-acyltransferase (GOAT) is a specific post-translational modification which is essential for many biological activities of ghrelin. Ghrelin and GOAT are both widely expressed in many organs including the gustatory system. In the current study, overall metabolic profiles were assessed in wild-type (WT), ghrelin knockout (ghrelin(-/-)), and GOAT knockout (GOAT(-/-)) mice. Ghrelin(-/-) mice exhibited decreased food intake, increased plasma triglycerides and increased ketone bodies compared to WT mice while demonstrating WT-like body weight, fat composition and glucose control. In contrast GOAT(-/-) mice exhibited reduced body weight, adiposity, resting glucose and insulin levels compared to WT mice. Brief access taste behavioral tests were performed to determine taste responsivity in WT, ghrelin(-/-) and GOAT(-/-) mice. Ghrelin and GOAT null mice possessed reduced lipid taste responsivity. Furthermore, we found that salty taste responsivity was attenuated in ghrelin(-/-) mice, yet potentiated in GOAT(-/-) mice compared to WT mice. Expression of the potential lipid taste regulators Cd36 and Gpr120 were reduced in the taste buds of ghrelin and GOAT null mice, while the salt-sensitive ENaC subunit was increased in GOAT(-/-) mice compared with WT mice. The altered expression of Cd36, Gpr120 and ENaC may be responsible for the altered lipid and salt taste perception in ghrelin(-/-) and GOAT(-/-) mice. The data presented in the current study potentially implicates ghrelin signaling activity in the modulation of both lipid and salt taste modalities.	[Cai, Huan; Cong, Wei-na; Daimon, Caitlin M.; Wang, Rui; Martin, Bronwen] NIA, Metab Unit, Lab Clin Invest, NIH, Baltimore, MD 21224 USA; [Tschoep, Matthias H.] Helmholtz Ctr Munich, Inst Diabet & Obes, Munich, Germany; [Sevigny, Jean] Ctr Rech CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada; [Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Lab Neurosci, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Laval University; Laval University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Metab Unit, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Sévigny, Jean/AGH-9323-2022; Sevigny, Jean/E-8039-2012; Tschoep, Matthias H/I-5443-2014; Wang, Rui/I-5643-2019; Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Cai, Huan/B-6578-2016	Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; Wang, Rui/0000-0001-7015-0272; Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Tschoep, Matthias/0000-0002-4744-371X; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institute on Aging, National Institutes of Health	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Massadi O, 2011, PEPTIDES, V32, P2301, DOI 10.1016/j.peptides.2011.08.020; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Bigiani A, 2001, J NEUROPHYSIOL, V85, P1552, DOI 10.1152/jn.2001.85.4.1552; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Cong WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047240; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Degrace-Passilly P, 2012, CURR OPIN CLIN NUTR, V15, P107, DOI 10.1097/MCO.0b013e32834ff19c; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; DESIMONE JA, 1985, AM J PHYSIOL, V249, pR52, DOI 10.1152/ajpregu.1985.249.1.R52; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; DREWNOWSKI A, 1985, PHYSIOL BEHAV, V35, P617, DOI 10.1016/0031-9384(85)90150-7; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; FARBMAN AI, 1965, J ULTRA MOL STRUCT R, V12, P328, DOI 10.1016/S0022-5320(65)80103-4; Gaillard D, 2008, ANN NY ACAD SCI, V1141, P163, DOI 10.1196/annals.1441.028; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Granata R, 2012, FASEB J, V26, P3393, DOI 10.1096/fj.11-201343; Groschl M, 2005, CLIN CHEM, V51, P997, DOI 10.1373/clinchem.2004.040667; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; HAMILTON CL, 1964, J COMP PHYSIOL PSYCH, V58, P459, DOI 10.1037/h0047142; Hashimoto H, 2007, ENDOCRINOLOGY, V148, P1638, DOI 10.1210/en.2006-0993; Hashimoto H, 2011, CURR PROTEIN PEPT SC, V12, P280, DOI 10.2174/138920311795906727; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Heppner KM, 2012, METHOD ENZYMOL, V514, P249, DOI 10.1016/B978-0-12-381272-8.00015-5; Hiraoka T, 2003, PHYSIOL BEHAV, V79, P713, DOI 10.1016/S0031-9384(03)00201-4; Hummler E, 2000, J AM SOC NEPHROL, V11, pS129; Kang K, 2011, PEPTIDES, V32, P2236, DOI 10.1016/j.peptides.2011.04.028; Khan NA, 2009, BBA-MOL CELL BIOL L, V1791, P149, DOI 10.1016/j.bbalip.2009.01.001; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Laugerette F, 2007, BIOCHIMIE, V89, P265, DOI 10.1016/j.biochi.2006.10.011; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Liu P, 2011, J NEUROSCI, V31, P8634, DOI 10.1523/JNEUROSCI.6273-10.2011; Ma XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016391; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Martin B, 2012, J BIOL CHEM, V287, P31766, DOI 10.1074/jbc.M112.387316; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Matsumura S, 2007, BIOMED RES-TOKYO, V28, P49, DOI 10.2220/biomedres.28.49; MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Rice HB, 2000, PHYSIOL BEHAV, V68, P755, DOI 10.1016/S0031-9384(99)00255-3; Romero A, 2010, EUR J ENDOCRINOL, V163, P1, DOI 10.1530/EJE-10-0099; Sclafani A, 2007, AM J PHYSIOL-REG I, V292, pR1828, DOI 10.1152/ajpregu.00826.2006; Scribner KB, 2008, AM J PHYSIOL-ENDOC M, V295, pE1126, DOI 10.1152/ajpendo.90487.2008; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; St-Pierre DH, 2007, J CLIN ENDOCR METAB, V92, P264, DOI 10.1210/jc.2006-1603; Stranahan AM, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/732975; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Takeda M, 2001, NUTRITION, V17, P117, DOI 10.1016/S0899-9007(00)00513-X; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; Tsuruta M, 1999, PHYSIOL BEHAV, V66, P285, DOI 10.1016/S0031-9384(98)00299-6; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Verhulst PJ, 2012, WORLD J GASTROENTERO, V18, P3183, DOI 10.3748/wjg.v18.i25.3183; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052	81	42	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76553	10.1371/journal.pone.0076553	http://dx.doi.org/10.1371/journal.pone.0076553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124572	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100129
J	Horikiri, Y; Shimo, T; Kurio, N; Okui, T; Matsumoto, K; Iwamoto, M; Sasaki, A				Horikiri, Yuu; Shimo, Tsuyoshi; Kurio, Naito; Okui, Tatsuo; Matsumoto, Kenichi; Iwamoto, Masahiro; Sasaki, Akira			Sonic Hedgehog Regulates Osteoblast Function by Focal Adhesion Kinase Signaling in the Process of Fracture Healing	PLOS ONE			English	Article							KAPPA-B LIGAND; BREAST-CANCER CELLS; RECEPTOR ACTIVATOR; BONE-FORMATION; STEM-CELLS; OSTEOGENIC DIFFERENTIATION; TYROSINE PHOSPHORYLATION; INDIAN HEDGEHOG; EXPRESSION; PATHWAY	Several biological studies have indicated that hedgehog signaling plays an important role in osteoblast proliferation and differentiation, and sonic hedgehog (SHH) expression is positively correlated with phosphorylated focal adhesion kinase (FAK) Tyr(397). However, the relationship between them and their role in the process of normal fracture repair has not been clarified yet. Immunohistochemical analysis revealed that SHH and pFAK Tyr(397) were expressed in bone marrow cells and that pFAK Tyr(397) was also detected in ALP-positive osteoblasts near the TRAP-positive osteoclasts in the fracture site in the ribs of mice on day 5 after fracture. SHH and pFAK Tyr(397) were detectable in osteoblasts near the hypertrophic chondrocytes on day 14. In vitro analysis showed that SHH up-regulated the expression of FAK mRNA and pFAK Tyr(397) time dependently in osteoblastic MC3T3-E1 cells. Functional analysis revealed that 5 lentivirus encoding short hairpin FAK RNAs (shFAK)-infected MC3T3-E1 cell groups displayed a round morphology and decreased proliferation, adhesion, migration, and differentiation. SHH stimulated the proliferation and differentiation of MC3T3-E1 cells, but had no effect on the shFAK-infected cells. SHH also stimulated osteoclast formation in a co-culture system containing MC3T3-E1 and murine CD11b(+) bone marrow cells, but did not affect the shFAK-infected MC3T3-E1 co-culture group. These data suggest that SHH signaling was activated in osteoblasts at the dynamic remodeling site of a bone fracture and regulated their proliferation and differentiation, as well as osteoclast formation, via FAK signaling.	[Horikiri, Yuu; Shimo, Tsuyoshi; Kurio, Naito; Okui, Tatsuo; Matsumoto, Kenichi; Sasaki, Akira] Okayama Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Iwamoto, Masahiro] Childrens Hosp Philadelphia, Res Inst, Div Orthoped Surg, Philadelphia, PA 19104 USA	Okayama University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shimo, T (corresponding author), Okayama Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	shimotsu@md.okayama-u.ac.jp	Shimo, Tsuyoshi/AAT-8358-2020	Shimo, Tsuyoshi/0000-0002-7811-2366	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by the programs Grants-in-Aid for Young Scientists (A) [to T. S.] and Grants-in-Aid for Exploratory Research (to T. S. and A. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Blaess S, 2004, J NEUROSCI, V24, P3402, DOI 10.1523/JNEUROSCI.5241-03.2004; Chen JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/carcin/bgs274; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Edwards PC, 2005, GENE THER, V12, P75, DOI 10.1038/sj.gt.3302386; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Fournier-Thibault C, 2009, J NEUROSCI, V29, P12506, DOI 10.1523/JNEUROSCI.2003-09.2009; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Honami T, 2012, ORAL ONCOL, V48, P49, DOI 10.1016/j.oraloncology.2011.08.026; Huang CH, 2009, J CELL BIOCHEM, V108, P1263, DOI 10.1002/jcb.22356; ILLC D, 1995, NATURE, V377, P539; Ito H, 1999, BIOCHEM BIOPH RES CO, V262, P443, DOI 10.1006/bbrc.1999.1197; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; Kimura H, 2008, CANCER CELL, V13, P249, DOI 10.1016/j.ccr.2008.01.027; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Koukouritaki SB, 1999, MOL MED, V5, P731, DOI 10.1007/BF03402097; Kurio N, 2011, EXP CELL RES, V317, P1134, DOI 10.1016/j.yexcr.2011.02.008; Lee HL, 2011, BONE, V49, P242, DOI 10.1016/j.bone.2011.04.006; Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Martin TJ, 2005, J CLIN INVEST, V115, P2322, DOI 10.1172/JCI26239; Miyaji T, 2003, HISTOCHEM CELL BIOL, V119, P233, DOI 10.1007/s00418-003-0501-z; Mundy GR, 2008, DEV CELL, V14, P637, DOI 10.1016/j.devcel.2008.04.010; Nakamura M, 2010, J BIOMED MATER RES A, V92A, P783, DOI 10.1002/jbm.a.32404; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Plaisant M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016798; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Tian Y, 2012, CELL BIOCHEM BIOPHYS, V64, P169, DOI 10.1007/s12013-012-9369-7; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wary KK, 2012, MICROVASC RES, V83, P64, DOI 10.1016/j.mvr.2011.05.002; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811	45	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76785	10.1371/journal.pone.0076785	http://dx.doi.org/10.1371/journal.pone.0076785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124594	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100151
J	Lin, G; Field, JJ; Yu, JC; Ken, R; Neuberg, D; Nathan, DG; Linden, J				Lin, Gene; Field, Joshua J.; Yu, Jennifer C.; Ken, Ruey; Neuberg, Donna; Nathan, David G.; Linden, Joel			NF-kappa B Is Activated in CD4(+) iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A(2A) Receptors	PLOS ONE			English	Article							KILLER T-CELLS; ISCHEMIA-REPERFUSION INJURY; IFN-GAMMA PRODUCTION; NKT CELLS; INVARIANT NKT; VASCULAR INFLAMMATION; MURINE; MICE; VASOOCCLUSION; LOCALIZATION	Reperfusion injury following tissue ischemia occurs as a consequence of vaso-occlusion that is initiated by activation of invariant natural killer T (iNKT) cells. Sickle cell disease (SDC) results in widely disseminated microvascular ischemia and reperfusion injury as a result of vaso-occlusion by rigid and adhesive sickle red blood cells. In mice, iNKT cell activation requires NF-kappa B signaling and can be inhibited by the activation of anti-inflammatory adenosine A(2A) receptors (A(2A)Rs). Human iNKT cells are divided into subsets of CD4+ and CD4- cells. In this study we found that human CD4+ iNKT cells, but not CD4- cells undergo rapid NF-kappa B activation (phosphorylation of NF-kappa B on p65) and induction of A(2A)Rs (detected with a monoclonal antibody 7F6-G5-A2) during SCD painful vaso-occlusive crises. These findings indicate that SCD primarily activates the CD4+ subset of iNKT cells. Activation of NF-kappa B and induction of A(2A)Rs is concordant, i.e. only CD4+ iNKT cells with activated NF-kappa B expressed high levels of A(2A)Rs. iNKT cells that are not activated during pVOC express low levels of A(2A)R immunoreactivity. These finding suggest that A(2A)R transcription may be induced in CD4+ iNKT cells as a result of NFkB activation in SCD. In order to test this hypothesis further we examined cultured human iNKT cells. In cultured cells, blockade of NF-kappa B with Bay 11-7082 or IKK inhibitor VII prevented rapid induction of A(2A)R mRNA and protein upon iNKT activation. In conclusion, NF-kappa B-mediated induction of A(2A)Rs in iNKT cells may serve as a counter-regulatory mechanism to limit the extent and duration of inflammatory immune responses. As activated iNKT cells express high levels of A(2A)Rs following their activation, they may become highly sensitive to inhibition by A(2A)R agonists.	[Lin, Gene; Yu, Jennifer C.; Ken, Ruey; Linden, Joel] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Field, Joshua J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Neuberg, Donna; Nathan, David G.] Dana Farber Canc Inst, Boston, MA 02115 USA	La Jolla Institute for Immunology; Medical College of Wisconsin; Harvard University; Dana-Farber Cancer Institute	Linden, J (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA.	jlinden@liai.org	Linden, Joel/AAH-5690-2020; Linden, Joel/J-9259-2014	Linden, Joel/0000-0002-0689-1647	National Institutes of Health [RC2 HL101367, R34 HL108757, R01HL095704]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111969, RC2HL101367, R34HL108757, R01HL095704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants RC2 HL101367, R34 HL108757 and R01HL095704 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Bessoles S, 2008, J LEUKOCYTE BIOL, V84, P224, DOI 10.1189/jlb.1007669; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brittain JE, 2004, J BIOL CHEM, V279, P42393, DOI 10.1074/jbc.M407631200; Cao ZX, 2009, AM J PHYSIOL-GASTR L, V297, pG249, DOI 10.1152/ajpgi.00041.2009; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Field JJ, 2013, BLOOD; Field JJ, 2011, CHEST, V139, P563, DOI 10.1378/chest.10-1243; Glover DK, 2007, AM J PHYSIOL-HEART C, V292, pH3164, DOI 10.1152/ajpheart.00743.2005; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HEBBEL RP, 1981, BLOOD, V58, P947; Hettinger BD, 2001, J COMP NEUROL, V431, P331, DOI 10.1002/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W; Knight-Madden JM, 2005, THORAX, V60, P206, DOI 10.1136/thx.2004.029165; Kollander R, 2010, TRANSL RES, V155, P170, DOI 10.1016/j.trsl.2009.10.004; Koshiba M, 1999, MOL PHARMACOL, V55, P614; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Lappas CM, 2006, J EXP MED, V203, P2639, DOI 10.1084/jem.20061097; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Li L, 2007, J IMMUNOL, V178, P5899, DOI 10.4049/jimmunol.178.9.5899; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P843, DOI 10.1161/ATVBAHA.112.247874; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; O'Reilly V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028648; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Polanowska-Grabowska R, 2010, ARTERIOSCL THROM VAS, V30, P2392, DOI 10.1161/ATVBAHA.110.211615; Pritchard KA, 2012, AM J RESP CELL MOL, V46, P389, DOI 10.1165/rcmb.2011-0097OC; Rosin DL, 1998, J COMP NEUROL, V401, P163; Shryock JC, 1998, CIRCULATION, V98, P711, DOI 10.1161/01.CIR.98.7.711; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Thedrez A, 2007, BLOOD, V110, P251, DOI 10.1182/blood-2007-01-066217; Wallace K.L., 2010, BLOOD; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Wang XH, 2012, J EXP MED, V209, P987, DOI 10.1084/jem.20111024; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646	43	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74664	10.1371/journal.pone.0074664	http://dx.doi.org/10.1371/journal.pone.0074664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124453	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100010
J	Matsuzaki, S; Darcha, C				Matsuzaki, Sachiko; Darcha, Claude			Involvement of the Wnt/beta-Catenin Signaling Pathway in the Cellular and Molecular Mechanisms of Fibrosis in Endometriosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-CELLS; PERITONEAL ENDOMETRIOSIS; MESENCHYMAL TRANSITION; RNA INTEGRITY; BETA; ACTIVATION; EXPRESSION; DISEASE; NODULES	Background: During the development and progression of endometriotic lesions, excess fibrosis may lead to scarring, chronic pain, and altered tissue function. However, the cellular and molecular mechanisms of fibrosis in endometriosis remain to be clarified. Objectives: The objective of the present study was to investigate whether the Wnt/beta-catenin signaling pathway was involved in regulating the cellular and molecular mechanisms of fibrosis in endometriosis in vitro and to evaluate whether fibrosis could be prevented by targeting the Wnt/beta-catenin pathway in a xenograft model of endometriosis in immunodeficient nude mice. Methods: Seventy patients (40 with and 30 without endometriosis) with normal menstrual cycles were recruited. In vitro effects of small-molecule antagonists of the Tcf/beta-catenin complex (PKF 115-584 and CGP049090) on fibrotic markers (alpha smooth muscle actin, type I collagen, connective tissue growth factor, fibronectin) and collagen gel contraction were evaluated in endometrial and endometriotic stromal cells from patients with endometriosis. In vitro effects of activation of the Wnt/beta-catenin signaling pathway by treatment with recombinant Wnt3a on profibrotic responses were evaluated in endometrial stromal cells of patients without endometriosis. The effects of CGP049090 treatment on the fibrosis of endometriotic implants were evaluated in a xenograft model of endometriosis in immunodeficient nude mice. Results: Treatment with PKF 115-584 and CGP049090 significantly decreased the expression of alpha smooth muscle actin, type I collagen, connective tissue growth factor and fibronectin mRNAs in both endometriotic and endometrial stromal cells with or without transforming growth factor-beta 1 stimulation. Both endometriotic and endometrial stromal cell-mediated contraction of collagen gels was significantly decreased by treatment with PKF 115-584 and CGP049090 as compared to that of untreated cells. The animal experiments showed that CGP049090 prevented the progression of fibrosis and reversed established fibrosis in endometriosis. Conclusion: Aberrant activation of the Wnt/beta-catenin pathway may be involved in mediating fibrogenesis in endometriosis.	[Matsuzaki, Sachiko] CHU Clermont Ferrand, CHU Estaing, Clermont Ferrand, France; [Matsuzaki, Sachiko] Univ Auvergne, Clermont Univ, ISIT UMR6284, Clermont Ferrand, France; [Matsuzaki, Sachiko] Univ Clermont Ferrand, Photochim Mol & Macromol Lab, CNRS, ISIT UMR6284, F-63177 Clermont Ferrand, France; [Darcha, Claude] CHU Clermont Ferrand, Serv Anat & Cytol Pathol, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Matsuzaki, S (corresponding author), CHU Clermont Ferrand, CHU Estaing, Clermont Ferrand, France.	sachikoma@aol.com			Karl Storz Endoscopy; GmbH (Tuttlingen, Germany)	Karl Storz Endoscopy; GmbH (Tuttlingen, Germany)	This study was supported in part by Karl Storz Endoscopy & GmbH (Tuttlingen, Germany). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Anaf V, 2000, HUM REPROD, V15, P1744, DOI 10.1093/humrep/15.8.1744; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ewan KBR, 2008, CURR DRUG TARGETS, V9, P532, DOI 10.2174/138945008784911787; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hull ML, 2012, AM J PATHOL, V180, P880, DOI 10.1016/j.ajpath.2011.11.013; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Koninckx PR, 2012, FERTIL STERIL, V98, P564, DOI 10.1016/j.fertnstert.2012.07.1061; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Matsuzaki S, 1999, GYNECOL OBSTET INVES, V47, P197, DOI 10.1159/000010094; Matsuzaki S, 2013, PLOS ONE, V28; Matsuzaki S, 2012, HUM REPROD, V27, P712, DOI 10.1093/humrep/der442; Matsuzaki S, 2010, J CLIN ENDOCR METAB, V95, P3437, DOI 10.1210/jc.2009-2713; Nisolle M, 1997, FERTIL STERIL, V68, P585, DOI 10.1016/S0015-0282(97)00191-X; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Solovyan VT, 2006, J CELL PHYSIOL, V207, P445, DOI 10.1002/jcp.20607; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	29	86	103	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76808	10.1371/journal.pone.0076808	http://dx.doi.org/10.1371/journal.pone.0076808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124596	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100153
J	Santana, S; Sastre, I; Recuero, M; Bullido, MJ; Aldudo, J				Santana, Soraya; Sastre, Isabel; Recuero, Maria; Bullido, Maria J.; Aldudo, Jesus			Oxidative Stress Enhances Neurodegeneration Markers Induced by Herpes Simplex Virus Type 1 Infection in Human Neuroblastoma Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TAU PHOSPHORYLATION; VIRAL-INFECTIONS; APOLIPOPROTEIN-E; PROTEIN; ACCUMULATION; INVOLVEMENT; PATHOGENESIS; DEGRADATION; GLUTATHIONE	Mounting evidence suggests that Herpes simplex virus type 1 (HSV-1) is involved in the pathogenesis of Alzheimer's disease (AD). Previous work from our laboratory has shown HSV-1 infection to induce the most important pathological hallmarks of AD brains. Oxidative damage is one of the earliest events of AD and is thought to play a crucial role in the onset and development of the disease. Indeed, many studies show the biomarkers of oxidative stress to be elevated in AD brains. In the present work the combined effects of HSV-1 infection and oxidative stress on Ab levels and autophagy (neurodegeneration markers characteristic of AD) were investigated. Oxidative stress significantly potentiated the accumulation of intracellular Ab mediated by HSV-1 infection, and further inhibited its secretion to the extracellular medium. It also triggered the accumulation of autophagic compartments without increasing the degradation of long-lived proteins, and enhanced the inhibition of the autophagic flux induced by HSV-1. These effects of oxidative stress were not due to enhanced virus replication. Together, these results suggest that HSV-1 infection and oxidative damage interact to promote the neurodegeneration events seen in AD.	[Santana, Soraya; Sastre, Isabel; Recuero, Maria; Bullido, Maria J.; Aldudo, Jesus] UAM, CSIC, CBMSO, Madrid, Spain; [Sastre, Isabel; Recuero, Maria; Bullido, Maria J.; Aldudo, Jesus] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Bullido, MJ (corresponding author), UAM, CSIC, CBMSO, Madrid, Spain.	mjbullido@cbm.uam.es; jaldudo@cbm.uam.es	Bullido, maria j/C-8509-2014	Bullido, maria j/0000-0002-6477-1117; Aldudo, Jesus/0000-0002-7098-4709	Ministerio de Economia y Competitividad [SAF2010-15558]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas CIBERNED [PI2010/09-8]	Ministerio de Economia y Competitividad(Spanish Government); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas CIBERNED	This work was supported by grants from the Ministerio de Economia y Competitividad (SAF2010-15558; URL: http://www.mineco.gob.es/portal/site/mineco) and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas CIBERNED (PI2010/09-8; URL: http://www.ciberned.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez G, 2012, J NEUROSCI RES, V90, P1020, DOI 10.1002/jnr.23003; Arimoto E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-62; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Burgos JS, 2006, J VIROL, V80, P5383, DOI 10.1128/JVI.00006-06; Burgos JS, 2002, J VIROL, V76, P12394, DOI 10.1128/JVI.76.23.12394-12398.2002; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Clausen A, 2012, J ALZHEIMERS DIS, V30, P183, DOI 10.3233/JAD-2012-111298; De Chiara G, 2012, MOL NEUROBIOL, V46, P614, DOI 10.1007/s12035-012-8320-7; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; Fatokun AA, 2007, NEUROSCI LETT, V416, P34, DOI 10.1016/j.neulet.2007.01.078; Ferrer I, 2004, NEUROTOX RES, V6, P469, DOI 10.1007/BF03033283; Gobeil PAM, 2012, MBIO, V3, DOI 10.1128/mBio.00267-12; GRONOSTAJSKI RM, 1984, J CELL PHYSIOL, V119, P127, DOI 10.1002/jcp.1041190120; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lerchundi R, 2011, J ALZHEIMERS DIS, V23, P513, DOI 10.3233/JAD-2010-101386; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Lussignol M, 2013, J VIROL, V87, P859, DOI 10.1128/JVI.01158-12; Mathew SS, 2010, FREE RADICAL BIO MED, V49, P383, DOI 10.1016/j.freeradbiomed.2010.04.026; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Newcomb WW, 2012, J VIROL, V86, P11931, DOI 10.1128/JVI.01349-12; Nucci C, 2000, EXP EYE RES, V70, P215, DOI 10.1006/exer.1999.0782; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paola D, 2000, BIOCHEM BIOPH RES CO, V268, P642, DOI 10.1006/bbrc.2000.2164; Piacentini R, 2010, NEUROBIOL AGING; Porcellini Elisa, 2010, Immun Ageing, V7, P16, DOI 10.1186/1742-4933-7-16; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Recuero M, 2004, FEBS LETT, V570, P114, DOI 10.1016/j.febslet.2004.06.025; Recuero M, 2013, J ALZHEIMERS DIS, V34, P637, DOI 10.3233/JAD-121510; Recuero M, 2010, FEBS LETT, V584, P4611, DOI 10.1016/j.febslet.2010.10.028; Recuero M, 2009, AGING CELL, V8, P128, DOI 10.1111/j.1474-9726.2009.00457.x; Santana S, 2012, J ALZHEIMERS DIS, V30, P815, DOI 10.3233/JAD-2012-112000; Santana S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.010; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; van den Pol AN, 2006, TRENDS NEUROSCI, V29, P398, DOI 10.1016/j.tins.2006.06.002; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak MA, 2009, J ALZHEIMERS DIS, V16, P341, DOI 10.3233/JAD-2009-0963; Zambrano A, 2008, J ALZHEIMERS DIS, V14, P259	46	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75842	10.1371/journal.pone.0075842	http://dx.doi.org/10.1371/journal.pone.0075842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124518	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100075
J	Deng, JJ; He, MX; Chen, LZ; Chen, C; Zheng, JM; Cai, ZL				Deng, Jingjing; He, Miaoxia; Chen, Lizao; Chen, Chao; Zheng, Jianming; Cai, Zailong			The Loss of miR-26a-Mediated Post-Transcriptional Regulation of Cyclin E2 in Pancreatic Cancer Cell Proliferation and Decreased Patient Survival	PLOS ONE			English	Article							MICRORNA EXPRESSION; BREAST-CANCER; STATISTICS; MIR-26A; EZH2; CARCINOGENESIS; CARCINOMA; GROWTH	Background: miR-26a plays a critical role in tumorigenesis, either as a tumor suppressor or as an oncogenic miRNA, depending on different tumor types. However, the function of miR-26a in pancreatic cancer has not been clearly elucidated. The present study was designed to determine the roles of miR-26a in pancreatic cancer and its association with the survival of patients with pancreatic cancer. Methods: The expression of miR-26a was examined in 15 pairs of pancreatic duct adenocarcinoma (PDAC) and their adjacent benign pancreatic tissues (ABPT), by qRT-PCR. The results were confirmed by in situ hybridization using two panels of 106 PDACs and their ABPT microarray. The association of miR-26a expression with overall survival was determined. The proliferation and cell cycle distribution of Capan-2, SW-1990, and Panc-1 cells, transfected with miR-26a mimics or a miR-26a inhibitor, were assessed using the Cell Counting Kit-8 assay and flow cytometry, respectively. The cell tumorigenicity was evaluated via murine xenograft experiments. Cyclin D2, E2, EZH2, and PCNA levels were analyzed by Western blot and immunohistochemistry. Results: miR-26a was expressed in the cytoplasm of pancreatic ductal epithelial cells, whereas its expression was significantly downregulated in PDAC tissues compared with that of ABPT. Patients with low miR-26a expression had a significantly shorter survival than those with high miR-26a expression. The in vitro and in vivo assays showed that overexpression of miR-26a resulted in cell cycle arrest, inhibited cell proliferation, and decreased tumor growth, which was associated with cyclin E2 downregulation. Conclusions: miR-26a is an important suppressor of pancreatic ductal carcinoma, and can prove to be a novel prognostic factor and therapeutic target for pancreatic cancer treatment.	[Deng, Jingjing; He, Miaoxia; Zheng, Jianming; Cai, Zailong] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Chen, Lizao; Chen, Chao] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Zheng, JM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China.	jmzheng1962@163.com; czl8003@163.com			National Natural Science Foundation of China [81172077]; Shanghai biobank network of common human tumor tissue fund [12DZ2295102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai biobank network of common human tumor tissue fund	This study was supported by National Natural Science Foundation of China (Project No. 81172077) and Shanghai biobank network of common human tumor tissue fund (Project No. 12DZ2295102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avan A, 2012, MOL CANCER THER, V11, P1735, DOI 10.1158/1535-7163.MCT-12-0037; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Chen S, 2010, J HEPATOL, V52, P864, DOI 10.1016/j.jhep.2009.12.040; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ikenaga N, 2010, ANN SURG ONCOL, V17, P3120, DOI 10.1245/s10434-010-1188-8; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kota J, 2009, CELL, V137, P1065; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Moelans CB, 2011, CELL ONCOL, V34, P89, DOI 10.1007/s13402-011-0021-0; Rachagani S, 2010, CANCER LETT, V292, P8, DOI 10.1016/j.canlet.2009.11.010; Ryu JK, 2011, PANCREATOLOGY, V11, P343, DOI 10.1159/000329183; Sahin F, 2003, MODERN PATHOL, V16, P686, DOI 10.1097/01.MP.0000075645.97329.86; Sander S, 2009, CELL CYCLE, V8, P556, DOI 10.4161/cc.8.4.7599; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Wang J, 2011, J BIOSCIENCES, V36, P481, DOI 10.1007/s12038-011-9083-4; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhou J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033577	33	45	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76450	10.1371/journal.pone.0076450	http://dx.doi.org/10.1371/journal.pone.0076450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116110	gold, Green Submitted, Green Published			2022-12-27	WOS:000325552200056
J	Golden, BDO; Wuebben, EL; Rizzino, A				Golden, Briana D. Ormsbee; Wuebben, Erin L.; Rizzino, Angie			Sox2 Expression Is Regulated by a Negative Feedback Loop in Embryonic Stem Cells That Involves AKT Signaling and FoxO1	PLOS ONE			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN-KINASE; SELF-RENEWAL; NANOG AUTOREPRESSION; GENE-EXPRESSION; OCT-3/4 GENE; ES CELLS; PHOSPHORYLATION; DIFFERENTIATION; PLURIPOTENCY; MOUSE	The self-renewal and pluripotency of embryonic stem cells (ESC) is regulated by a highly integrated network of essential transcription factors, which includes Sox2. Previous studies have shown that elevating Sox2 on its own in mouse ESC induces differentiation and inhibits the expression of endogenous Sox2 at the protein and mRNA level. These findings led us to hypothesize that increases in Sox2 activate a negative feedback loop that inhibits the transcription of the endogenous Sox2 gene. To test this hypothesis, we used i-OSKM-ESC, which elevate Sox2 in conjunction with Oct4, Klf4, and c-Myc when treated with doxycycline (Dox). Elevating the expression of these four transcription factors in i-OSKM-ESC does not induce differentiation, but it represses expression of endogenous Sox2. We determined that increases of Sox2 in i-OSKM-ESC lead to increases in activated AKT and inactivation of FoxO1 (an activator of Sox2), as well as decreases in binding of FoxO1 to the 5'flanking region of Sox2. Importantly, we determined that inhibition of AKT in Dox-treated i-OSKM-ESC leads to re-expression of endogenous Sox2 at the mRNA and protein level and reactivation of FoxO1. These findings argue that AKT signaling is part of the negative feedback loop that helps carefully control the transcription of Sox2 in ESC by modulating the binding of FoxO1 to the Sox2 gene. Collectively, our findings provide new insights into the mechanisms that enable ESC to carefully regulate the levels of Sox2 and retain their stem cell properties.	[Golden, Briana D. Ormsbee; Wuebben, Erin L.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Rizzino, A (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu			National Institutes of Health [GM080751]; National Cancer Institute [CA74771, CA009476]; NATIONAL CANCER INSTITUTE [R01CA074771, T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health (GM080751). Core facilities of the UNMC Eppley Cancer Center were supported in part by a grant from the National Cancer Institute (CA74771). ELW was supported in part by a Cancer Biology Training Grant from the National Cancer Institute (CA009476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Gao ZH, 2012, J BIOL CHEM, V287, P11384, DOI 10.1074/jbc.M111.320143; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lin Y, 2012, MOL CELL; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mallanna SK, 2008, MOL REPROD DEV, V75, P1247, DOI 10.1002/mrd.20871; Nakamura T, 2008, GENES CELLS, V13, P1269, DOI 10.1111/j.1365-2443.2008.01243.x; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Polajeva J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-378; Rizzino A, 2013, STEM CELLS; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shanmugasundaram K, 2012, ONCOGENE; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu Y, 2013, STEM CELLS; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	44	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76345	10.1371/journal.pone.0076345	http://dx.doi.org/10.1371/journal.pone.0076345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116102	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200050
J	Lai, JS; Yang, B; Lin, DM; Kerkhoff, AJ; Ma, KP				Lai, Jiangshan; Yang, Bo; Lin, Dunmei; Kerkhoff, Andrew J.; Ma, Keping			The Allometry of Coarse Root Biomass: Log-Transformed Linear Regression or Nonlinear Regression?	PLOS ONE			English	Article							BREAST-HEIGHT DIAMETERS; NET PRIMARY PRODUCTION; PREDICTING BODY-MASS; FAGUS-SYLVATICA L.; LOGARITHMIC TRANSFORMATIONS; ABOVEGROUND BIOMASS; FOREST ECOSYSTEMS; TROPICAL FORESTS; METABOLIC-RATES; SYSTEM BIOMASS	Precise estimation of root biomass is important for understanding carbon stocks and dynamics in forests. Traditionally, biomass estimates are based on allometric scaling relationships between stem diameter and coarse root biomass calculated using linear regression (LR) on log-transformed data. Recently, it has been suggested that nonlinear regression (NLR) is a preferable fitting method for scaling relationships. But while this claim has been contested on both theoretical and empirical grounds, and statistical methods have been developed to aid in choosing between the two methods in particular cases, few studies have examined the ramifications of erroneously applying NLR. Here, we use direct measurements of 159 trees belonging to three locally dominant species in east China to compare the LR and NLR models of diameter-root biomass allometry. We then contrast model predictions by estimating stand coarse root biomass based on census data from the nearby 24-ha Gutianshan forest plot and by testing the ability of the models to predict known root biomass values measured on multiple tropical species at the Pasoh Forest Reserve in Malaysia. Based on likelihood estimates for model error distributions, as well as the accuracy of extrapolative predictions, we find that LR on log-transformed data is superior to NLR for fitting diameter-root biomass scaling models. More importantly, inappropriately using NLR leads to grossly inaccurate stand biomass estimates, especially for stands dominated by smaller trees.	[Lai, Jiangshan; Yang, Bo; Lin, Dunmei; Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yang, Bo; Lin, Dunmei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Math & Stat, Gambier, OH 43022 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kenyon College; Kenyon College	Ma, KP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn		Lin, Dunmei/0000-0001-6112-7783; Yang, Bo/0000-0002-6288-445X; Kerkhoff, Andrew/0000-0001-9617-8687	National Natural Science Foundation of China [31200403, 31270496]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05050204]; Kenyon College; NSF Research Opportunity Award [EF-1214332, EF-1065861]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Kenyon College; NSF Research Opportunity Award(National Science Foundation (NSF))	This work was financially supported by the National Natural Science Foundation of China (31200403 and 31270496) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05050204). AJK was supported by sabbatical funding from Kenyon College and by NSF Research Opportunity Award EF-1214332 supplemental to NSF grant EF-1065861. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne F, 2013, J THEOR BIOL, V317, P418, DOI 10.1016/j.jtbi.2012.09.035; BASKERVILLE G L, 1972, Canadian Journal of Forest Research, V2, P49, DOI 10.1139/x72-009; Bolte A, 2004, PLANT SOIL, V264, P1, DOI 10.1023/B:PLSO.0000047777.23344.a3; Brassard BW, 2011, BIOMASS BIOENERG, V35, P4189, DOI 10.1016/j.biombioe.2011.06.045; Brassard BW, 2009, CRIT REV PLANT SCI, V28, P179, DOI 10.1080/07352680902776572; BROWN S, 1989, FOREST SCI, V35, P881; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Cawley GC, 2010, J ZOOL, V280, P355, DOI 10.1111/j.1469-7998.2009.00665.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Condit R, 1998, TROPICAL FOREST CENS; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Drexhage M, 1999, SCAND J FOREST RES, V14, P328, DOI 10.1080/02827589950152647; Drexhage M, 2001, FORESTRY, V74, P491, DOI 10.1093/forestry/74.5.491; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; Glass NR, 1969, J FISH RES BOARD CAN, V26, P2543; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Helmisaari HS, 2002, FOREST ECOL MANAG, V165, P317, DOI 10.1016/S0378-1127(01)00648-X; Hui DF, 2007, J THEOR BIOL, V249, P168, DOI 10.1016/j.jtbi.2007.07.003; JANSSON M, 1985, GEOGR ANN A, V67, P61, DOI 10.2307/520466; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Le Goff N, 2001, ANN FOREST SCI, V58, P1, DOI 10.1051/forest:2001104; Lin DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048244; Litton CM, 2008, BIOTROPICA, V40, P313, DOI 10.1111/j.1744-7429.2007.00383.x; Litton CM, 2006, FOREST ECOL MANAG, V231, P105, DOI 10.1016/j.foreco.2006.05.008; Lubowski RN, 2013, REV ENV ECON POLICY, V7, P67, DOI 10.1093/reep/res024; Mascaro J, 2011, BIOTROPICA, V43, P649, DOI 10.1111/j.1744-7429.2011.00798.x; MCCUEN RH, 1990, J HYDRAUL ENG-ASCE, V116, P414, DOI 10.1061/(ASCE)0733-9429(1990)116:3(414); Miller AT, 2006, CAN J FOREST RES, V36, P12, DOI 10.1139/X05-229; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Lima AJN, 2012, FOREST ECOL MANAG, V277, P163, DOI 10.1016/j.foreco.2012.04.028; Packard GC, 2010, J ZOOL, V282, P221, DOI 10.1111/j.1469-7998.2010.00737.x; Packard GC, 2008, J EXP BIOL, V211, P3581, DOI 10.1242/jeb.023317; Packard GC, 2011, BIOL REV, V86, P549, DOI 10.1111/j.1469-185X.2010.00160.x; Packard GC, 2011, COMP BIOCHEM PHYS A, V159, P392, DOI 10.1016/j.cbpa.2011.04.005; Packard GC, 2009, J THEOR BIOL, V257, P515, DOI 10.1016/j.jtbi.2008.10.016; Packard G, 2009, J COMP PHYSIOL B, V179, P175, DOI 10.1007/s00360-008-0300-x; Pandey GR, 1999, J HYDROL, V225, P92, DOI 10.1016/S0022-1694(99)00135-3; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2013, LANG ENV STAT COMP; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Wang CK, 2001, GLOBAL CHANGE BIOL, V7, P719, DOI 10.1046/j.1354-1013.2001.00441.x; Wang XK, 2001, FOREST ECOL MANAG, V148, P117, DOI 10.1016/S0378-1127(00)00482-5; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Yang YH, 2011, J ECOL, V99, P431, DOI 10.1111/j.1365-2745.2010.01774.x; ZAR JH, 1968, BIOSCIENCE, V18, P1118, DOI 10.2307/1294589	57	33	42	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77007	10.1371/journal.pone.0077007	http://dx.doi.org/10.1371/journal.pone.0077007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116197	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200094
J	Liang, B; Xiong, F; Wu, HP; Wang, Y; Dong, XJ; Cheng, SF; Feng, GS; Zhou, GF; Xiong, B; Liang, HM; Xia, XW; Zheng, CS				Liang, Bin; Xiong, Fu; Wu, Hanping; Wang, Yong; Dong, Xiangjun; Cheng, Shaofeng; Feng, Gansheng; Zhou, Guofeng; Xiong, Bin; Liang, Huimin; Xia, Xiangwen; Zheng, Chuansheng			Effect of Transcatheter Intraarterial Therapies on the Distribution of Doxorubicin in Liver Cancer in a Rabbit Model	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; HEPATIC ARTERIAL EMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; DRUG-ELUTING BEADS; SOLID TUMORS; TRANSARTERIAL CHEMOEMBOLIZATION; LYMPHOGRAPHIC AGENT; CHEMOTHERAPY; DELIVERY; MALIGNANCY	Background and Aims: Transcatheter intraarterial techniques can effectively deliver chemotherapeutic agents to tumor and improve the efficacy of chemotherapy. The present study is designed to evaluate the effect of transcatheter intraarterial techniques on the distribution of doxorubicin in relation to blood vessels in liver cancer. Methods: VX2 tumors were implanted in the livers of 32 rabbits. The animals were divided into 4 groups of 8 animals each. Group 1 (doxo iv) animals received doxorubicin intravenous injection; group 2 (doxo ia) received doxorubicin hepatic intraarterial infusion; group 3 (doxo ia + E) received doxorubicin hepatic intraarterial infusion followed by embolization; group 4 (doxo + L ia + E) received hepatic intraarterial infusion of doxorubicin mixed with Lipiodol followed by embolization. Ten minutes or 4 hours after treatment, the animals were sacrificed and tumors were sampled. Immunofluorescence techniques were used to evaluate the distribution of doxorubicin in relation to blood vessels. Results: Doxorubicin fluorescence was distributed around tumor blood vessels and decreased with distance from the blood vessels. Tumor cells in avascular and adjacent regions were not exposed to detectable concentrations of doxorubicin. Tumors in the group 2, 3 and 4 had a significant increase in doxorubicin penetration compared with the group 1 tumors (P<0.05). Among the three groups of transcatheter therapies, doxorubicin penetration distance in group 3 was significantly larger than that in group 2 and 4 (P<0.05), and no significant difference was found between group 2 and 4 tumors (P>0.05) at 10 minutes. In contrast, at 4 hours and in total, both group 3 and 4 tumors had significant increases in drug penetration compared with group 2 (P<0.05), and no significant difference was noted between group 3 and 4 tumors (P>0.05). Conclusion: Transcatheter intraarterial therapies improve doxorubicin penetration in liver cancer; nevertheless their effect on drug distribution is somewhat limited.	[Liang, Bin; Xiong, Fu; Wang, Yong; Dong, Xiangjun; Cheng, Shaofeng; Feng, Gansheng; Zhou, Guofeng; Xiong, Bin; Liang, Huimin; Xia, Xiangwen; Zheng, Chuansheng] Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wu, Hanping] Case Western Reserve Univ, Dept Radiol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Case Western Reserve University; Case Western Reserve University Hospital	Zheng, CS (corresponding author), Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	hqzcsxh@mails.tjmu.edu.cn	Xiong, Bin/AGX-8289-2022; Wang, Yong/B-6207-2015	Wang, Yong/0000-0003-4707-5280	National Natural Sciences Foundation of China [81101134]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grant from National Natural Sciences Foundation of China (No. 81101134). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREEDIS C, 1954, AM J PATHOL, V30, P969; Brown DB, 2007, J VASC INTERV RADIOL, V18, P1469, DOI 10.1016/j.jvir.2007.08.027; Brown DB, 2006, J VASC INTERV RADIOL, V17, P225, DOI 10.1097/01.RVI.0000195330.47954.48; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; CADY B, 1974, SURG GYNECOL OBSTET, V138, P381; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; FURUTA T, 1988, J SURG ONCOL, V39, P229, DOI 10.1002/jso.2930390404; Geschwind JFH, 2002, J VASC INTERV RADIOL, V13, P991, DOI 10.1016/S1051-0443(07)61862-4; HIGUCHI T, 1994, CANCER, V73, P2259, DOI 10.1002/1097-0142(19940501)73:9<2259::AID-CNCR2820730905>3.0.CO;2-P; Hong K, 2005, J VASC INTERV RADIOL, V16, P1711, DOI 10.1097/01.RVI.0000184535.26360.5A; Huxham LA, 2004, CANCER RES, V64, P6537, DOI 10.1158/0008-5472.CAN-04-0986; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; KANEMATSU T, 1989, HEPATOLOGY, V10, P98, DOI 10.1002/hep.1840100119; KONNO T, 1983, EUR J CANCER CLIN ON, V19, P1053, DOI 10.1016/0277-5379(83)90028-7; Lankelma J, 1999, CLIN CANCER RES, V5, P1703; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P1335, DOI 10.1097/01.RVI.0000228416.21560.7F; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Maeda S, 2002, HEPATOL RES, V23, P202, DOI 10.1016/S1386-6346(01)00174-7; Moreira PL, 2003, CARDIOVASC INTER RAD, V26, P100, DOI 10.1007/s00270-003-2632-y; Namur J, 2011, J HEPATOL, V55, P1332, DOI 10.1016/j.jhep.2011.03.024; Namur J, 2010, J VASC INTERV RADIOL, V21, P259, DOI 10.1016/j.jvir.2009.10.026; Patel KJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-356; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; SHIBATA J, 1989, CANCER, V64, P1586, DOI 10.1002/1097-0142(19891015)64:8<1586::AID-CNCR2820640805>3.0.CO;2-E; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	29	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76388	10.1371/journal.pone.0076388	http://dx.doi.org/10.1371/journal.pone.0076388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116106	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200054
J	Moriel, DG; Beatson, SA; Wurpel, DJ; Lipman, J; Nimmo, GR; Paterson, DL; Schembri, MA				Moriel, Danilo G.; Beatson, Scott A.; Wurpel, Daniel J.; Lipman, Jeffrey; Nimmo, Graeme R.; Paterson, David L.; Schembri, Mark A.			Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; TRIMERIC AUTOTRANSPORTER; NEISSERIA-MENINGITIDIS; BIOFILM FORMATION; ABIOTIC SURFACES; SIGNAL PEPTIDES; PREDICTION; INFECTION; PROTECTION; RESPONSES	Acinetobacter baumannii is an emerging opportunistic bacterium associated with nosocomial infections in intensive care units. The alarming increase in infections caused by A. baumannii is strongly associated with enhanced resistance to antibiotics, in particular carbapenems. This, together with the lack of a licensed vaccine, has translated into significant economic, logistic and health impacts to health care facilities. In this study, we combined reverse vaccinology and proteomics to identify surface-exposed and secreted antigens from A. baumannii. Using in silico prediction tools and comparative genome analysis in combination with in vitro proteomic approaches, we identified 42 antigens that could be used as potential vaccine targets. Considering the paucity of effective antibiotics available to treat multidrug-resistant A. baumannii infections, these vaccine targets may serve as a framework for the development of a broadly protective multi-component vaccine, an outcome that would have a major impact on the burden of A. baumannii infections in intensive care units across the globe.	[Moriel, Danilo G.; Beatson, Scott A.; Wurpel, Daniel J.; Lipman, Jeffrey; Nimmo, Graeme R.; Paterson, David L.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Moriel, Danilo G.; Beatson, Scott A.; Wurpel, Daniel J.; Lipman, Jeffrey; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Lipman, Jeffrey] Univ Queensland, Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia; [Lipman, Jeffrey] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Nimmo, Graeme R.] Pathol Queensland Cent Lab, Brisbane, Qld, Australia; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp Campus, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland	Schembri, MA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	m.schembri@uq.edu.au	Nimmo, Graeme/AAG-5426-2019; Beatson, Scott/B-6985-2013; Schembri, Mark A/C-7262-2009; Moriel, Danilo G/I-2885-2013	Beatson, Scott/0000-0002-1806-3283; Schembri, Mark A/0000-0003-4863-9260; Moriel, Danilo G/0000-0002-1421-8129; Lipman, Jeffrey/0000-0002-5965-9876; Paterson, David/0000-0003-2079-4437	Australian National Health and Medical Research Council; University of Queensland; Royal Brisbane and Women's Hospital; Royal Brisbane and Women's Hospital Foundation; Australian Research Council (ARC) Future Fellowship [FT100100662]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); Royal Brisbane and Women's Hospital; Royal Brisbane and Women's Hospital Foundation; Australian Research Council (ARC) Future Fellowship(Australian Research Council)	This work was supported by grants from the Australian National Health and Medical Research Council, The University of Queensland, the Royal Brisbane and Women's Hospital, and the Royal Brisbane and Women's Hospital Foundation. MAS is supported by an Australian Research Council (ARC) Future Fellowship (FT100100662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; DiTommaso A, 1997, VACCINE, V15, P1218, DOI 10.1016/S0264-410X(97)00023-6; Donati C, 2013, ANN NY ACAD SCI, V1285, P115, DOI 10.1111/nyas.12046; Fattahian Y, 2011, MICROB PATHOGENESIS, V51, P402, DOI 10.1016/j.micpath.2011.09.004; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Ishikawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048830; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King LB, 2013, J INFECT DIS, V207, P1128, DOI 10.1093/infdis/jis939; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; Mihara K, 2004, MICROBIOL-SGM, V150, P2587, DOI 10.1099/mic.0.27141-0; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; MURPHY TF, 1989, MICROB PATHOGENESIS, V6, P159, DOI 10.1016/0882-4010(89)90066-1; O'Shea MK, 2012, INT J ANTIMICROB AG, V39, P363, DOI 10.1016/j.ijantimicag.2012.01.018; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Poirel L, 2003, J CLIN MICROBIOL, V41, P3542, DOI 10.1128/JCM.41.8.3542-3547.2003; Roberts JA, 2004, J UROLOGY, V171, P1682, DOI 10.1097/01.ju.0000116123.05160.43; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	48	65	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77631	10.1371/journal.pone.0077631	http://dx.doi.org/10.1371/journal.pone.0077631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116234	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200120
J	Zhao, F; Li, M; Qian, Y; Tsien, JZ				Zhao, Fang; Li, Meng; Qian, Yi; Tsien, Joe Z.			Remote Measurements of Heart and Respiration Rates for Telemedicine	PLOS ONE			English	Article							NONCONTACT; DYNAMICS; CAMERA	Non-contact and low-cost measurements of heart and respiration rates are highly desirable for telemedicine. Here, we describe a novel technique to extract blood volume pulse and respiratory wave from a single channel images captured by a video camera for both day and night conditions. The principle of our technique is to uncover the temporal dynamics of heart beat and breathing rate through delay-coordinate transformation and independent component analysis-based deconstruction of the single channel images. Our method further achieves robust elimination of false positives via applying ratio-variation probability distributions filtering approaches. Moreover, it enables a much needed low-cost means for preventing sudden infant death syndrome in new born infants and detecting stroke and heart attack in elderly population in home environments. This noncontact-based method can also be applied to a variety of animal model organisms for biomedical research.	[Zhao, Fang; Li, Meng; Tsien, Joe Z.] Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Zhao, Fang; Li, Meng; Tsien, Joe Z.] Georgia Regents Univ, Dept Neurol, Augusta, GA USA; [Zhao, Fang; Qian, Yi] Yunnan Banna Primate Model Res Ctr, BanNa Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Tsien, JZ (corresponding author), Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	jtsien@gru.edu			Georgia Research Alliance; Yunnan Department of Science and Technology [2012BA009]	Georgia Research Alliance; Yunnan Department of Science and Technology	This work is supported in part by Georgia Research Alliance (JZT) and Yunnan Department of Science and Technology grant number 2012BA009 (FZ and YQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; CHIALVO DR, 1987, NATURE, V330, P749, DOI 10.1038/330749a0; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; de Chazal P, 2008, IEEE ENG MED BIO, P514, DOI 10.1109/IEMBS.2008.4649203; Diraco G, 2010, DES AUT TEST EUROPE, P1536; Eedy DJ, 2001, BRIT J DERMATOL, V144, P696, DOI 10.1046/j.1365-2133.2001.04124.x; Garbey M, 2007, IEEE T BIO-MED ENG, V54, P1418, DOI 10.1109/TBME.2007.891930; Greneker EF, 1997, IEE CONF PUBL, P150, DOI 10.1049/cp:19971650; Higashikaturagi K, 2008, HANN BEITR NACHRICHT, V1, P101, DOI 10.1109/ICUWB.2008.4653294; Hu SJ, 2008, INT CONF BIOMED, P72, DOI 10.1109/BMEI.2008.365; Humphreys K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2724789; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 1999, NEURAL PROCESS LETT, V10, P1, DOI 10.1023/A:1018647011077; James CJ, 2003, ARTIF INTELL MED, V28, P89, DOI 10.1016/S0933-3657(03)00037-X; Krupinski EA, 1999, TELEMED J, V5, P257, DOI 10.1089/107830299312005; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lazaro A, 2010, PROG ELECTROMAGN RES, V100, P265, DOI 10.2528/PIER09120302; Ledwidge M, 1998, ARCH DIS CHILD, V78, P481, DOI 10.1136/adc.78.5.481; Lienhart R, 2002, IEEE IMAGE PROC, P900; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063590; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matthews G, 2000, CRIT REV BIOMED ENG, V28, P173, DOI 10.1615/CritRevBiomedEng.v28.i12.290; McSharry PE, 2004, P SOC PHOTO-OPT INS, V5467, P1; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Poh MZ, 2010, OPT EXPRESS, V18, P10762, DOI 10.1364/OE.18.010762; STEINSCHNEIDER A, 1972, PEDIATRICS, V50, P646; Stiedl O, 2004, AUTON NEUROSCI-BASIC, V115, P15, DOI 10.1016/j.autneu.2004.07.006; Stiedl O, 1997, BEHAV NEUROSCI, V111, P703, DOI 10.1037/0735-7044.111.4.703; Stiedl O, 2009, NEUROSCI BIOBEHAV R, V33, P181, DOI 10.1016/j.neubiorev.2008.08.015; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; ULYANOV SS, 1993, P SOC PHOTO-OPT INS, V1884, P160, DOI 10.1117/12.148363; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Wieringa FP, 2005, ANN BIOMED ENG, V33, P1034, DOI 10.1007/s10439-005-5763-2; Williams A, 2007, P 15 INT C MULT, P892; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046686	42	111	123	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e71384	10.1371/journal.pone.0071384	http://dx.doi.org/10.1371/journal.pone.0071384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24115996	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200001
J	Cerna, L; Munzbergova, Z				Cerna, Lucie; Muenzbergova, Zuzana			Comparative Population Dynamics of Two Closely Related Species Differing in Ploidy Level	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; PLANT DEMOGRAPHY; PERENNIAL HERB; ENDEMIC PLANT; GROWTH RATES; CONTACT ZONE; RARE; BIOLOGY; LIFE; DIFFERENTIATION	Background: Many studies compare the population dynamics of single species within multiple habitat types, while much less is known about the differences in population dynamics in closely related species in the same habitat. Additionally, comparisons of the effect of habitat types and species are largely missing. Methodology and Principal Findings: We estimated the importance of the habitat type and species for population dynamics of plants. Specifically, we compared the dynamics of two closely related species, the allotetraploid species Anthericum liliago and the diploid species Anthericum ramosum, occurring in the same habitat type. We also compared the dynamics of A. ramosum in two contrasting habitats. We examined three populations per species and habitat type. The results showed that single life history traits as well as the mean population dynamics of A. liliago and A. ramosum from the same habitat type were more similar than the population dynamics of A. ramosum from the two contrasting habitats. Conclusions: Our findings suggest that when transferring knowledge regarding population dynamics between populations, we need to take habitat conditions into account, as these conditions appear to be more important than the species involved (ploidy level). However, the two species differ significantly in their overall population growth rates, indicating that the ploidy level has an effect on species performance. In contrast to what has been suggested by previous studies, we observed a higher population growth rate in the diploid species. This is in agreement with the wider range of habitats occupied by the diploid species.	[Cerna, Lucie; Muenzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Munzbergova, Z (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Černá, Lucie/GSJ-0030-2022	Münzbergová, Zuzana/0000-0002-4026-6220; 	project GACR [P504/10/0456]; institutional research project RVO [67985939]; institutional research project MSMT	project GACR; institutional research project RVO; institutional research project MSMT	The study was supported by project GACR P504/10/0456 and partly also by institutional research projects RVO 67985939 and MSMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2008, ECOLOGY, V89, P1155, DOI 10.1890/06-2009.1; ALVAREZBUYLLA ER, 1994, ECOLOGY, V75, P255, DOI 10.2307/1939401; Baack EJ, 2005, EVOLUTION, V59, P1936; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BIERZYCHUDEK P, 1982, NEW PHYTOL, V90, P757, DOI 10.1111/j.1469-8137.1982.tb03285.x; BLAISE S, 1991, EVOL TREND PLANT, V5, P137; Bretagnolle F, 1996, J ECOL, V84, P343, DOI 10.2307/2261197; Bucharova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045855; Bucharova A, 2012, BIOL CONSERV, V145, P39, DOI 10.1016/j.biocon.2011.09.016; Bucharova A, 2010, AM J BOT, V97, P1260, DOI 10.3732/ajb.0900351; Buggs RJA, 2007, EVOLUTION, V61, P125, DOI 10.1111/j.1558-5646.2007.00010.x; Caswell, 2000, MATRIX POPULATION MO; Dahlgren JP, 2009, J ECOL, V97, P666, DOI 10.1111/j.1365-2745.2009.01504.x; de Kroon H, 2000, ECOLOGY, V81, P607, DOI 10.1890/0012-9658(2000)081[0607:EAROMA]2.0.CO;2; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Dostalek T, 2013, FOLIA GEOBOT, V48, P75, DOI 10.1007/s12224-012-9132-2; Efron B., 1994, INTRO BOOTSTRAP; Ehrlen J, 2003, AM NAT, V162, P796, DOI 10.1086/379350; Ellis MM, 2013, J ECOL, V101, P734, DOI 10.1111/1365-2745.12069; Flegrova M, 1999, FOLIA GEOBOT, V34, P19, DOI 10.1007/BF02803074; Francis B., 1993, STAT SYSTEM GEN LINE; Freville H, 2004, ECOLOGY, V85, P694, DOI 10.1890/03-0119; GARBUTT K, 1983, NEW PHYTOL, V93, P129, DOI 10.1111/j.1469-8137.1983.tb02698.x; Garcia D, 2000, J ECOL, V88, P436, DOI 10.1046/j.1365-2745.2000.00459.x; GORNALL RJ, 1993, NEW PHYTOL, V123, P383, DOI 10.1111/j.1469-8137.1993.tb03749.x; Heinken-Smidova A, 2012, FOLIA GEOBOT, V47, P193, DOI 10.1007/s12224-011-9116-7; Hodgson JG, 1987, FUNCT ECOL, V1, P243, DOI 10.2307/2389427; Husband BC, 1998, AM J BOT, V85, P1688, DOI 10.2307/2446502; Jacquemyn H, 2008, ECOLOGY, V89, P3480, DOI 10.1890/07-1908.1; Jakalaniemi A, 2006, CONSERV BIOL, V20, P844, DOI 10.1111/j.1523-1739.2006.00348.x; Jakalaniemi A, 2009, OECOLOGIA, V159, P505, DOI 10.1007/s00442-008-1235-3; Jakalaniemi A, 2013, CONSERV BIOL, V27, P552, DOI 10.1111/cobi.12027; Jongejans E, 2005, J ECOL, V93, P681, DOI 10.1111/j.1365-2745.2005.01003.x; Jongejans E, 2010, J ECOL, V98, P279, DOI 10.1111/j.1365-2745.2009.01612.x; Kanno H, 2004, PLANT ECOL, V170, P43, DOI 10.1023/B:VEGE.0000019027.88318.54; Kubat K., 2002, KLIC KE KVETENE CESK; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Lammi A, 1999, CONSERV BIOL, V13, P1069, DOI 10.1046/j.1523-1739.1999.98278.x; Lehouck V, 2009, BIOL CONSERV, V142, P518, DOI 10.1016/j.biocon.2008.11.007; Lennartsson T, 2001, J ECOL, V89, P451, DOI 10.1046/j.1365-2745.2001.00566.x; Luijten SH, 2002, J ECOL, V90, P593, DOI 10.1046/j.1365-2745.2002.00703.x; Munzbergova Z, 2007, ANN BOT-LONDON, V100, P1259, DOI 10.1093/aob/mcm204; Manton I, 1934, VERGLEICHENDE CHOROL; Menges ES, 2004, ECOL MONOGR, V74, P79, DOI 10.1890/03-4029; MITCHELL WW, 1992, CAN J BOT, V70, P80, DOI 10.1139/b92-010; Munzbergova Z, 2007, BIOL J LINN SOC, V92, P211, DOI 10.1111/j.1095-8312.2007.00820.x; Munzbergova Z, 2006, FOLIA GEOBOT, V41, P137, DOI 10.1007/BF02806475; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Munzbergova Z, 2005, J APPL ECOL, V42, P1115, DOI 10.1111/j.1365-2664.2005.01099.x; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Munzbergova Z, 2013, PLOS ONE, P8; Munzbergova Z, PLANT BIOL IN PRESS; Nicole F, 2011, J ECOL, V99, P1211, DOI 10.1111/j.1365-2745.2011.01852.x; Oostermeijer JGB, 2003, BIOL CONSERV, V113, P389, DOI 10.1016/S0006-3207(03)00127-7; Oostermeijer JGB, 1996, J ECOL, V84, P153, DOI 10.2307/2261351; Pegtel Dick M., 1999, Plant Species Biology, V14, P201, DOI 10.1046/j.1442-1984.1999.00019.x; Petit C, 1997, HEREDITY, V79, P31, DOI 10.1038/hdy.1997.120; Petit C, 1999, EVOL ECOL, V13, P45, DOI 10.1023/A:1006534130327; Pico FX, 2003, OIKOS, V103, P69, DOI 10.1034/j.1600-0706.2003.12553.x; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Raabova J, 2011, BASIC APPL ECOL, V12, P152, DOI 10.1016/j.baae.2011.01.001; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rosquist G, 2002, PLANT SYST EVOL, V236, P55, DOI 10.1007/s00606-002-0238-5; Rosquist G, 2001, CAN J BOT, V79, P850, DOI 10.1139/b01-064; Rydgren K, 2007, ECOLOGY, V88, P2320, DOI 10.1890/06-1634.1; Schleuning M, 2009, CONSERV BIOL, V23, P174, DOI 10.1111/j.1523-1739.2008.01054.x; Schleuning M, 2008, J ECOL, V96, P1045, DOI 10.1111/j.1365-2745.2008.01416.x; Scobie AR, 2009, ANN BOT-LONDON, V103, P835, DOI 10.1093/aob/mcp007; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Skalicky V, 1959, ACTA U CAROLINAE BIO, V2, P117; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; STEBBINS GL, 1985, ANN MO BOT GARD, V72, P824, DOI 10.2307/2399224; Tanaka H, 2008, J VEG SCI, V19, P127, DOI 10.3170/2007-8-18342; Tsaliki M, 2009, ACTA OECOL, V35, P415, DOI 10.1016/j.actao.2009.01.008; Vega E, 2004, PLANT ECOL, V175, P107, DOI 10.1023/B:VEGE.0000048094.21994.74; Willems JH, 1996, FLORA, V191, P41; Winter C, 2008, BIOL CONSERV, V141, P1095, DOI 10.1016/j.biocon.2008.02.002; Yates CJ, 2005, CONSERV BIOL, V19, P239, DOI 10.1111/j.1523-1739.2005.00286.x; Zietsman J, 2008, BIOL CONSERV, V141, P1475, DOI 10.1016/j.biocon.2008.03.017; Zuidema PA, 2001, J ECOL, V89, P995, DOI 10.1111/j.1365-2745.2001.00621.x	81	20	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75563	10.1371/journal.pone.0075563	http://dx.doi.org/10.1371/journal.pone.0075563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116057	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300034
J	Jones, AMP; Saxena, PK				Jones, Andrew Maxwell Phineas; Saxena, Praveen Kumar			Inhibition of Phenylpropanoid Biosynthesis in Artemisia annua L.: A Novel Approach to Reduce Oxidative Browning in Plant Tissue Culture	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; UV-B TOLERANCE; 2-AMINOINDAN-2-PHOSPHONIC ACID; SECONDARY METABOLISM; SALICYLIC-ACID; DISEASE RESISTANCE; ACTIVATED-CHARCOAL; CELL-DEATH; REGENERATION; SEEDLINGS	Oxidative browning is a common and often severe problem in plant tissue culture systems caused by the accumulation and oxidation of phenolic compounds. The current study was conducted to investigate a novel preventative approach to address this problem by inhibiting the activity of the phenylalanine ammonia lyase enzyme (PAL), thereby reducing the biosynthesis of phenolic compounds. This was accomplished by incorporating 2-aminoindane-2- phosphonic acid (AIP), a competitive PAL inhibitor, into culture media of Artemisia annua as a model system. Addition of AIP into culture media resulted in significant reductions in visual tissue browning, a reduction in total phenol content, as well as absorbance and autoflourescence of tissue extracts. Reduced tissue browning was accompanied with a significant increase in growth on cytokinin based medium. Microscopic observations demonstrated that phenolic compounds accumulated in discrete cells and that these cells were more prevalent in brown tissue. These cells were highly plasmolyzed and often ruptured during examination, demonstrating a mechanism in which phenolics are released into media in this system. These data indicate that inhibiting phenylpropanoid biosynthesis with AIP is an effective approach to reduce tissue browning in A. annua. Additional experiments with Ulmus americana and Acer saccharum indicate this approach is effective in many species and it could have a wide application in systems where oxidative browning restricts the development of biotechnologies.	[Jones, Andrew Maxwell Phineas; Saxena, Praveen Kumar] Univ Guelph, Gosling Res Inst Plant Preservat, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph	Saxena, PK (corresponding author), Univ Guelph, Gosling Res Inst Plant Preservat, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	psaxena@uoguelph.ca			National Science and Engineering Research Council of Canada; Gosling Foundation	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gosling Foundation	This work was funded by the National Science and Engineering Research Council of Canada and the Gosling Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Aliyu OM, 2005, AFR J BIOTECHNOL, V4, P1485; Appert C, 2003, PHYTOCHEMISTRY, V62, P415, DOI 10.1016/S0031-9422(02)00561-7; Bagheri A, 2011, PLANTS TISSUE CULTUR, V21; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; BHAT SR, 1991, PLANT CELL REP, V10, P358, DOI 10.1007/BF00193159; BROWN GD, 1994, J NAT PROD, V57, P975, DOI 10.1021/np50109a015; Chen MH, 2000, PHYTOCHEMISTRY, V53, P365, DOI 10.1016/S0031-9422(99)00531-2; Cvikrova M, 2003, PLANT PHYSIOL BIOCH, V41, P251, DOI 10.1016/S0981-9428(03)00016-0; DALAL MA, 1992, SCI HORTIC-AMSTERDAM, V51, P35, DOI 10.1016/0304-4238(92)90101-H; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Durner J, 1997, TRENDS PLANT SCI, V2, P266, DOI 10.1016/S1360-1385(97)86349-2; Folin O, 1927, J BIOL CHEM, V73, P627; FULZELE DP, 1991, PHYTOTHER RES, V5, P149, DOI 10.1002/ptr.2650050402; Gitz DC, 1998, PHYTOCHEMISTRY, V49, P377, DOI 10.1016/S0031-9422(98)00011-9; Gitz DC, 2004, J EXP BOT, V55, P919, DOI 10.1093/jxb/erh092; GRABBER JH, 1995, PHYTOCHEMISTRY, V40, P1077, DOI 10.1016/0031-9422(95)00413-2; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; Hu W-J, 1999, REPRESSION LIGNIN BI; Janas KM, 1998, J PLANT GROWTH REGUL, V17, P169, DOI 10.1007/PL00007031; Jones AMP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-75; Krishna H, 2008, SCI HORTIC-AMSTERDAM, V118, P132, DOI 10.1016/j.scienta.2008.05.040; LAINE E, 1994, PLANT CELL REP, V13, P473, DOI 10.1007/BF00231970; Laukkanen H, 2000, TREE PHYSIOL, V20, P467; Lester GE, 2012, J FOOD COMPOSIT ANAL; Madhusudhanan K, 2000, BIOL PLANTARUM, V43, P297, DOI 10.1023/A:1002729032527; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; Medina MB, 2011, J AGR FOOD CHEM, V59, P1565, DOI 10.1021/jf103711c; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAIR MSR, 1986, J NAT PROD, V49, P504, DOI 10.1021/np50045a021; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Nybakken L, 2007, TREES-STRUCT FUNCT, V21, P273, DOI 10.1007/s00468-006-0120-0; Ochoa-Alejo N, 2001, IN VITRO CELL DEV-PL, V37, P701; Oh MM, 2009, J PLANT PHYSIOL, V166, P180, DOI 10.1016/j.jplph.2008.04.015; Panaia M, 2000, PLANT CELL TISS ORG, V63, P23, DOI 10.1023/A:1006457624282; PANIEGO NB, 1994, PLANT CELL TISS ORG, V36, P163, DOI 10.1007/BF00037715; Parthasarathy V. A., 2007, Recent trends in horticultural biotechnology, Vol. I and II. ICAE national symposium on biotechnological interventions for improvement of horticultural crops: issues and strategies, Vellanikkara, Kerala, India, 10-12 January, 2005, P85; Peiser G, 1998, POSTHARVEST BIOL TEC, V14, P171, DOI 10.1016/S0925-5214(98)00048-9; Shukla MR, 2012, CAN J FOREST RES, V42, P686, DOI [10.1139/X2012-022, 10.1139/x2012-022]; Solecka D, 2003, PHYSIOL PLANTARUM, V119, P253, DOI 10.1034/j.1399-3054.2003.00181.x; Tabiyeh DT, 2006, ACTA HORTIC, P201, DOI 10.17660/ActaHortic.2006.726.31; Tamagnone L, 1998, PLANT CELL, V10, P1801, DOI 10.1105/tpc.10.11.1801; Tang W, 2004, PHYSIOL PLANTARUM, V122, P386, DOI 10.1111/j.1399-3054.2004.00406.x; Tang W, 2004, PLANT CELL REP, V22, P871, DOI 10.1007/s00299-004-0781-3; Teklemariam TA, 2004, PHYSIOL PLANTARUM, V122, P244, DOI 10.1111/j.0031-9317.2004.00396.x; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; TOTH K, 1994, BIOL PLANTARUM, V36, P511, DOI 10.1007/BF02921170; Uchendu EE, 2011, IN VITRO CELL DEV-PL, V47, P710, DOI 10.1007/s11627-011-9379-y; WOERDENBAG HJ, 1993, PLANT CELL TISS ORG, V32, P247, DOI 10.1007/BF00029850; ZON J, 1992, LIEBIGS ANN CHEM, P625, DOI 10.1002/jlac.1992199201107	50	83	91	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76802	10.1371/journal.pone.0076802	http://dx.doi.org/10.1371/journal.pone.0076802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116165	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300097
J	Lee, SH; Choi, BH; Lim, D; Gondro, C; Cho, YM; Dang, CG; Sharma, A; Jang, GW; Lee, KT; Yoon, D; Lee, HK; Yeon, SH; Yang, BS; Kang, HS; Hong, SK				Lee, Seung Hwan; Choi, Bong Hwan; Lim, Dajeong; Gondro, Cedric; Cho, Young Min; Dang, Chang Gwon; Sharma, Aditi; Jang, Gul Won; Lee, Kyung Tai; Yoon, Duhak; Lee, Hak Kyo; Yeon, Seong Heum; Yang, Boh Suk; Kang, Hee Seol; Hong, Seong Koo			Genome-Wide Association Study Identifies Major Loci for Carcass Weight on BTA14 in Hanwoo (Korean Cattle)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE DISEQUILIBRIUM; POPULATION; SCAN; QTL; EXPRESSION; VARIANTS; STATURE; IMPACT; GROWTH	This genome-wide association study (GWAS) was conducted to identify major loci that are significantly associated with carcass weight, and their effects, in order to provide increased understanding of the genetic architecture of carcass weight in Hanwoo. This genome-wide association study identified one major chromosome region ranging from 23 Mb to 25 Mb on chromosome 14 as being associated with carcass weight in Hanwoo. Significant Bonferroni-corrected genome-wide associations (P<1.52x10(-6)) were detected for 6 Single Nucleotide Polymorphic (SNP) loci for carcass weight on chromosome 14. The most significant SNP was BTB-01280026 (P=4.02x10(-11)), located in the 25 Mb region on Bos taurus autosome 14 (BTA14). The other 5 significant SNPs were Hapmap27934-BTC-065223 (P=4.04x10(-11)) in 25.2 Mb, BTB-01143580 (P=6.35x10(-11)) in 24.3 Mb, Hapmap30932-BTC-011225 (P=5.92x10(-10)) in 24.8 Mb, Hapmap27112-BTC-063342 (P=5.18x10(-9)) in 25.4 Mb, and Hapmap24414-BTC-073009 (P=7.38x10(-8)) in 25.4 Mb, all on BTA 14. One SNP (BTB-01143580; P=6.35x10(-11)) lies independently from the other 5 SNPs. The 5 SNPs that lie together showed a large Linkage disequilibrium (LD) block (block size of 553 kb) with LD coefficients ranging from 0.53 to 0.89 within the block. The most significant SNPs accounted for 6.73% to 10.55% of additive genetic variance, which is quite a large proportion of the total additive genetic variance. The most significant SNP (BTB-01280026; P=4.02x10(-11)) had 16.96 kg of allele substitution effect, and the second most significant SNP (Hapmap27934-BTC-065223; P=4.04x10(-11)) had 18.06 kg of effect on carcass weight, which correspond to 44% and 47%, respectively, of the phenotypic standard deviation for carcass weight in Hanwoo cattle. Our results demonstrated that carcass weight was affected by a major Quantitative Trait Locus (QTL) with a large effect and by many SNPs with small effects that are normally distributed.	[Lee, Seung Hwan; Dang, Chang Gwon; Sharma, Aditi; Yeon, Seong Heum; Yang, Boh Suk; Kang, Hee Seol; Hong, Seong Koo] RDA, Natl Inst Anim Sci, Hanwoo Expt Stn, Pyeongchang, South Korea; [Choi, Bong Hwan; Lim, Dajeong; Cho, Young Min; Jang, Gul Won; Lee, Kyung Tai; Hong, Seong Koo] RDA, Natl Inst Anim Sci, Anim Genome & Bioinformat Div, Suwon, South Korea; [Gondro, Cedric] Univ New England, Sch Rural & Environm Sci, Armidale, NSW, Australia; [Yoon, Duhak] Kyungpook Natl Univ, Dept Anim Sci, Sangju, South Korea; [Lee, Hak Kyo] Hankyong Natl Univ, Dept Anim Sci, Anseong, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; University of New England; Kyungpook National University; Hankyong National University	Lee, SH (corresponding author), RDA, Natl Inst Anim Sci, Hanwoo Expt Stn, Pyeongchang, South Korea.	slee46@korea.kr	gondro, cedric/B-4362-2010	gondro, cedric/0000-0003-0666-656X; Lee, Seung Hwan/0000-0003-1508-4887	AGENDA project [PJ907008062012]; Molecular Breeding program of Next Generation BIOGREEN21 project in the National Institute of Animal Science, RDA [PJ0081882012]	AGENDA project; Molecular Breeding program of Next Generation BIOGREEN21 project in the National Institute of Animal Science, RDA	This study was supported by awards from the AGENDA project (grant no. PJ907008062012) and Molecular Breeding program (PJ0081882012) of Next Generation BIOGREEN21 project in the National Institute of Animal Science, RDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APGS, 1995, REP BUS AN PROD GRAD; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Choi GS, 1978, J ANIMSCI TECH KOR, V20, P177; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Gilmour A., 2006, ASREML USER GUIDE RE; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hulett D. L., 2007, Genetic improvement: making it happen. Proceedings of the Seventeenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Armidale, New South Wales, Australia, 23rd - 26th September 2007, P384; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kim ES, 2009, ANIM GENET, V40, P300, DOI 10.1111/j.1365-2052.2008.01832.x; Kim GS, 1985, J ANIM SCI TECH KOR, V27, P193; Kneeland J, 2004, J ANIM SCI, V82, P3405; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Koshkoih A E, 2006, P 8 WORLD C GEN APPL, P13; Lee SH, 2011, ASIAN AUSTRAL J ANIM, V24, P1660, DOI 10.5713/ajas.2011.11165; Lee SH, 2011, MAMM GENOME, V22, P589, DOI 10.1007/s00335-011-9331-9; MacLeod IM, 2006, 8 WORLD C GEN APPL L; Maltecca C, 2009, ANIM GENET, V40, P27, DOI 10.1111/j.1365-2052.2008.01793.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mizoshita K, 2004, J ANIM SCI, V82, P3415; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Pritchard JK, 2000, GENETICS, V155, P945; Rolf MM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-24; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	31	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74677	10.1371/journal.pone.0074677	http://dx.doi.org/10.1371/journal.pone.0074677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116007	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300010
J	Ouldamer, L; Caille, A; Body, G				Ouldamer, Lobna; Caille, Agnes; Body, Gilles			Fallopian Tube Prolapse after Hysterectomy: A Systematic Review	PLOS ONE			English	Review							SEROUS CARCINOMA; INTRAEPITHELIAL CARCINOMA; MANAGEMENT; ADENOCARCINOMA; MIMICKING; FISTULA; VAULT	Background: Prolapse of the fallopian tube into the vaginal vault is a rarely reported complication that may occur after hysterectomy. Clinicians can miss the diagnosis of this disregarded complication when dealing with post-hysterectomy vaginal bleeding. Objectives: We performed a systematic review in order to describe the clinical presentation, therapeutic management and outcome of fallopian tube prolapse occurring after hysterectomy. Search Strategy: A systematic search of MEDLINE and EMBASE references from January 1980 to December 2010 was performed. We included articles that reported cases of fallopian tube prolapse after hysterectomy. Data from eligible studies were independently extracted onto standardized forms by two reviewers. Results: Twenty-eight articles including 51 cases of fallopian tube prolapse after hysterectomy were included in this systematic review. Clinical presentations included abdominal pain, dyspareunia, post-coital bleeding, and/or vaginal discharge. Two cases were asymptomatic and diagnosed at routine checkup. The surgical management reported comprised partial or total salpingectomy, with vaginal repair in some cases combined with oophorectomy using different approaches (vaginal approach, combined vaginal-laparoscopic approach, laparoscopic approach, or laparotomy). Six patients were initially treated by silver nitrate application without success. Conclusions: This systematic review provided a precise summary of the clinical characteristics and treatment of patients presenting with fallopian tube prolapse following hysterectomy published in the past 30 years. We anticipate that these results will help inform current investigations and treatment.	[Ouldamer, Lobna; Body, Gilles] Univ Hosp Tours, Dept Gynecol, Tours, France; [Ouldamer, Lobna] INSERM, U1069, Tours, France; [Caille, Agnes] INSERM, CIC 202, Tours, France; [Caille, Agnes; Body, Gilles] Univ Tours, Tours, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Ouldamer, L (corresponding author), Univ Hosp Tours, Dept Gynecol, Tours, France.	l.ouldamer@chu-tours.fr	Ouldamer, Lobna/I-2062-2016; caille, agnes/L-9011-2015	Caille, Agnes/0000-0003-4715-6144				Alarab M, 2003, EUR J GYNAECOL ONCOL, V24, P91; Basu D, 2007, J OBSTET GYNAECOL, V27, P324, DOI 10.1080/01443610701269143; BATTY LH, 1980, J REPROD MED, V24, P244; BYRNE DL, 1989, J ROY SOC MED, V82, P764, DOI 10.1177/014107688908201221; Caceres A, 2008, OBSTET GYNECOL, V112, P494, DOI 10.1097/AOG.0b013e3181802782; Candiani GB, 1996, J REPROD MED, V41, P915; Carlson JW, 2008, J CLIN ONCOL, V26, P4160, DOI 10.1200/JCO.2008.16.4814; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; De Clippel K, 2001, AUST NZ J OBSTET GYN, V41, P106; de Kroon CD, 2003, BJOG-INT J OBSTET GY, V110, P333, DOI 10.1016/S1470-0328(02)02652-6; EHLEN T, 1989, GYNECOL ONCOL, V33, P382, DOI 10.1016/0090-8258(89)90533-7; Fan Qing-bo, 2006, Chinese Medical Sciences Journal, V21, P20; Fox R, 2008, J OBSTET GYNAECOL, V28, P456, DOI 10.1080/01443610802164409; Garry R, 2005, BEST PRACT RES CL OB, V19, P451, DOI 10.1016/j.bpobgyn.2005.01.010; HELLEN EA, 1993, CYTOPATHOLOGY, V4, P181, DOI 10.1111/j.1365-2303.1993.tb00084.x; Hernandez CR, 1998, J AM ASSOC GYN LAP, V5, P59, DOI 10.1016/S1074-3804(98)80013-3; Ingber MS, 2010, CAN J UROL, V17, P5117; Jashnani K D, 2002, J Postgrad Med, V48, P241; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; KOKS CAM, 1994, J GYNECOL SURG, V10, P271, DOI 10.1089/gyn.1994.10.271; Kucuk Mustafa, 2002, BMC Womens Health, V2, P2, DOI 10.1186/1472-6874-2-2; Langebrekke A, 2008, GYNECOL SURG, V5, P303, DOI 10.1007/s10397-008-0373-2; Lefrancq T, 1999, HISTOPATHOLOGY, V34, P548, DOI 10.1111/j.1365-2559.1999.00644.x; Lenglet Y, 2005, Gynecol Obstet Fertil, V33, P768, DOI 10.1016/j.gyobfe.2005.08.012; Lo KWK, 2007, SURG INNOV, V14, P24, DOI 10.1177/1553350606298970; MASSAD LS, 1989, INT J GYNECOL OBSTET, V29, P257, DOI 10.1016/0020-7292(89)90265-8; Michal M, 2000, VIRCHOWS ARCH, V437, P436, DOI 10.1007/s004280000257; Moreno A., 2007, FEMALE PATIENT, V32, P51; MUNTZ HG, 1992, OBSTET GYNECOL, V79, P853; MURRAY RC, 1966, OBSTET GYNECOL, V27, P271; Oates Sharon, 1996, Journal of Obstetrics and Gynaecology (Abingdon), V16, P126, DOI 10.3109/01443619609007761; Piacenza JM, 2001, EUR J OBSTET GYN R B, V98, P253, DOI 10.1016/S0301-2115(01)00332-3; Pozzi M, 1902, COMPT REUD SOC OBSTE, V4, P255; Przybycin CG, 2010, AM J SURG PATHOL, V34, P1407, DOI 10.1097/PAS.0b013e3181ef7b16; Ramin SM, 1999, SOUTHERN MED J, V92, P963, DOI 10.1097/00007611-199910000-00004; Rivlin ME, 2006, J PELVIC MED SURG, V12, P53, DOI [10.1097/01.spv.0000200405.27871.64, DOI 10.1097/01.SPV.0000200405.27871.64]; Rosenthal DM, 2005, OBSTET GYNECOL, V105, P808, DOI 10.1097/01.AOG.0000141571.71513.87; Salvador S, 2008, GYNECOL ONCOL, V110, P408, DOI 10.1016/j.ygyno.2008.05.010; SILVERBERG SG, 1974, ARCH PATHOL, V97, P100; Song YS, 2005, PATHOL RES PRACT, V201, P819, DOI 10.1016/j.prp.2005.09.001; THOMSON JD, 1980, AUST NZ J OBSTET GYN, V20, P187, DOI 10.1111/j.1479-828X.1980.tb02906.x; Tjalma WAA, 2003, INT J GYNECOL OBSTET, V83, P207, DOI 10.1016/S0020-7292(03)00255-8; Uqaili S, 2006, J Obstet Gynaecol, V26, P176; Varnholt H, 2005, INT J GYNECOL PATHOL, V24, P292, DOI 10.1097/01.pgp.0000159324.44913.b8; Warshal DP, 1999, OBSTET GYNECOL, V94, P834, DOI 10.1016/S0029-7844(99)00241-0; WETCHLER SJ, 1986, OBSTET GYNECOL, V67, P747, DOI 10.1097/00006250-198605000-00027; WHEELOCK JB, 1985, GYNECOL ONCOL, V21, P369, DOI 10.1016/0090-8258(85)90277-X; Whiteman MK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.039; Zutshi V, 2008, J TURK-GER GYNECOL A, V9, P117	49	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76543	10.1371/journal.pone.0076543	http://dx.doi.org/10.1371/journal.pone.0076543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116117	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300064
J	Yan, X; Que, YW; Wang, H; Wang, CC; Li, Y; Yue, XF; Ma, ZH; Talbot, NJ; Wang, ZY				Yan, Xia; Que, Yawei; Wang, Hong; Wang, Congcong; Li, Ya; Yue, Xiaofeng; Ma, Zhonghua; Talbot, Nicholas J.; Wang, Zhengyi			The MET13 Methylenetetrahydrofolate Reductase Gene Is Essential for Infection-Related Morphogenesis in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							PLANT INFECTION; PATHOGENICITY; IDENTIFICATION; BIOSYNTHESIS; PENETRATION; EXPRESSION; VIRULENCE; INVASION; SYNTHASE; BIOLOGY	Methylenetetrahydrofolate reductases (MTHFRs) play a key role in the biosynthesis of methionine in both prokaryotic and eukaryotic organisms. In this study, we report the identification of a novel T-DNA-tagged mutant WH672 in the rice blast fungus Magnaporthe oryzae, which was defective in vegetative growth, conidiation and pathogenicity. Analysis of the mutation confirmed a single T-DNA insertion upstream of MET13, which encodes a 626-amino-acid protein encoding a MTHFR. Targeted gene deletion of MET13 resulted in mutants that were non-pathogenic and significantly impaired in aerial growth and melanin pigmentation. All phenotypes associated with Delta met13 mutants could be overcome by addition of exogenous methionine. The M. oryzae genome contains a second predicted MTHFR-encoding gene, MET12. The deduced amino acid sequences of Met13 and Met12 share 32% identity. Interestingly, Delta met12 mutants produced significantly less conidia compared with the isogenic wild-type strain and grew very poorly in the absence of methionine, but were fully pathogenic. Deletion of both genes resulted in Delta met13 Delta met12 mutants that showed similar phenotypes to single Delta met13 mutants. Taken together, we conclude that the MTHFR gene, MET13, is essential for infection-related morphogenesis by the rice blast fungus M. oryzae.	[Yan, Xia; Que, Yawei; Wang, Hong; Wang, Congcong; Li, Ya; Yue, Xiaofeng; Ma, Zhonghua; Wang, Zhengyi] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Zhejiang University; University of Exeter	Wang, ZY (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	zhywang@zju.edu.cn	Ma, Zhonghua/J-6972-2014; Talbot, Nicholas J/I-9584-2014; Talbot, Nicholas J/I-5618-2019	Ma, Zhonghua/0000-0002-5426-0997; Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757	National Key Basic Research and Development Program of China [2012CB114002]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; Natural Science Foundation of China [31071648]; Doctoral Fund of Ministry of Education of China [20100101110097]	National Key Basic Research and Development Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Key Basic Research and Development Program of China (2012CB114002), by Program for Changjiang Scholars and Innovative Research Team in University (IRT0943), by the Natural Science Foundation of China (Grant No. 31071648) and the Doctoral Fund of Ministry of Education of China (20100101110097) to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balhadere PV, 1999, MOL PLANT MICROBE IN, V12, P129, DOI 10.1094/MPMI.1999.12.2.129; Caracuel-Rios Z, 2007, CURR OPIN MICROBIOL, V10, P339, DOI 10.1016/j.mib.2007.05.019; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chen JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000202; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Ding SL, 2010, PLANT CELL, V22, P2495, DOI 10.1105/tpc.110.074302; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Frandsen RJN, 2010, EUKARYOT CELL, V9, P1225, DOI 10.1128/EC.00031-10; Fu J, 2013, FUNGAL BIOL-UK, V117, P13, DOI 10.1016/j.funbio.2012.11.001; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; LEUNG H, 1988, PHYTOPATHOLOGY, V78, P1227, DOI 10.1094/Phyto-78-1227; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Li Y, 2010, MOL PLANT MICROBE IN, V23, P1260, DOI 10.1094/MPMI-03-10-0052; Li Y, 2010, MOL PLANT MICROBE IN, V23, P317, DOI 10.1094/MPMI-23-3-0317; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SCC, 2002, EUKARYOT CELL, V1, P311, DOI 10.1128/EC.1.2.311-314.2002; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Naula N, 2002, YEAST, V19, P841, DOI 10.1002/yea.877; Ou SH, 1985, RICE DIS; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Roje S, 1999, J BIOL CHEM, V274, P36089, DOI 10.1074/jbc.274.51.36089; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Shan XY, 1999, J BIOL CHEM, V274, P32613, DOI 10.1074/jbc.274.46.32613; Sheppard CA, 1999, J BACTERIOL, V181, P718, DOI 10.1128/JB.181.3.718-725.1999; Sienko M, 2007, FUNGAL GENET BIOL, V44, P691, DOI 10.1016/j.fgb.2006.12.002; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot Nicholas J., 1995, Trends in Microbiology, V3, P9, DOI 10.1016/S0966-842X(00)88862-9; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; VALENT B, 1990, PHYTOPATHOLOGY, V80, P33, DOI 10.1094/Phyto-80-33; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Vickers TJ, 2006, J BIOL CHEM, V281, P38150, DOI 10.1074/jbc.M608387200; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yan X, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002385; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988	48	29	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76914	10.1371/journal.pone.0076914	http://dx.doi.org/10.1371/journal.pone.0076914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116181	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300106
J	Yang, SW; Cheng, JH; Sun, J; Hu, YY; Liang, XY				Yang, Shewei; Cheng, Jianhua; Sun, Jian; Hu, Yongyou; Liang, Xiaoyan			Defluorination of Aqueous Perfluorooctanesulfonate by Activated Persulfate Oxidation	PLOS ONE			English	Article							EFFICIENT DECOMPOSITION; PERFLUOROCARBOXYLIC ACIDS; SULFONATE PFOS; WATER; SURFACTANTS; 1,1,1-TRICHLOROETHANE; FLUOROCHEMICALS; KINETICS; REMOVAL; IRON	Activated persulfate oxidation technologies based on sulfate radicals were first evaluated for defluorination of aqueous perfluorooctanesulfonate (PFOS). The influences of catalytic method, time, pH and K2S2O8 amounts on PFOS defluorination were investigated. The intermediate products during PFOS defluorination were detected by using LC/MS/MS. The results showed that the S2O82- had weak effect on the defluorination of PFOS, while the PFOS was oxidatively defluorinated by sulfate radicals in water. The defluorination efficiency of PFOS under various treatment was followed the order: HT (hydrothermal)/K2S2O8. UV (ultraviolet)/K2S2O8. Fe2+/K2S2O8. US (ultrasound)/K2S2O8. Low pH was favorable for the PFOS defluorination with sulfate radicals. Increase in the amount of S2O82- had positive effect on PFOS defluorination. However, further increase in amounts of S2O82- caused insignificant improvement in PFOS defluorination due to elimination of sulfate radicals under high concentration of S2O82-. CF3(CF2)(n)COOH (n = 0-6) were detected as intermediates during PFOS defluorination. Sulfate radicals oxidation and hydrolysis were the main mechanisms involved in defluorination process of PFOS.	[Yang, Shewei; Cheng, Jianhua; Sun, Jian; Hu, Yongyou; Liang, Xiaoyan] S China Univ Technol, Coll Environm & Energy, Minist Educ, Key Lab Pollut Control & Ecol Remediat Ind Agglom, Guangzhou, Guangdong, Peoples R China; [Cheng, Jianhua; Hu, Yongyou] S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Cheng, JH (corresponding author), S China Univ Technol, Coll Environm & Energy, Minist Educ, Key Lab Pollut Control & Ecol Remediat Ind Agglom, Guangzhou, Guangdong, Peoples R China.	jhcheng@scut.edu.cn	liang, xiaoyan/GYJ-5006-2022		Project of Science and Technology Excellent Scholar of Zhu Jiang [0501-64]; Fundamental research funds for the National Central Universities [2116520]	Project of Science and Technology Excellent Scholar of Zhu Jiang; Fundamental research funds for the National Central Universities	The authors wish to gratefully acknowledge the Project of Science and Technology Excellent Scholar of Zhu Jiang (No. 0501-64) and Fundamental research funds for the National Central Universities (No. 2116520) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anipsitakis GP, 2006, ENVIRON SCI TECHNOL, V40, P1000, DOI 10.1021/es050634b; Carter KE, 2008, ENVIRON SCI TECHNOL, V42, P6111, DOI 10.1021/es703273s; Cheng J, 2008, ENVIRON SCI TECHNOL, V42, P8057, DOI 10.1021/es8013858; Cheng J, 2010, ENVIRON SCI TECHNOL, V44, P445, DOI 10.1021/es902651g; Hollingsworth J, 2005, CHEMOSPHERE, V59, P1219, DOI 10.1016/j.chemosphere.2004.11.067; Hori H, 2006, ENVIRON SCI TECHNOL, V40, P1049, DOI 10.1021/es0517419; Hori H, 2005, ENVIRON SCI TECHNOL, V39, P2383, DOI 10.1021/es0484754; Hori H, 2008, ENVIRON SCI TECHNOL, V42, P7438, DOI 10.1021/es800832p; Huang KC, 2002, CHEMOSPHERE, V49, P413, DOI 10.1016/S0045-6535(02)00330-2; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Key BD, 1998, ENVIRON SCI TECHNOL, V32, P2283, DOI 10.1021/es9800129; Lee YC, 2012, CHEM ENG J, V198, P27, DOI 10.1016/j.cej.2012.05.073; Lee YC, 2010, WATER RES, V44, P886, DOI 10.1016/j.watres.2009.09.055; Lee YC, 2009, WATER RES, V43, P2811, DOI 10.1016/j.watres.2009.03.052; Li BZ, 2013, ULTRASON SONOCHEM, V20, P855, DOI 10.1016/j.ultsonch.2012.11.014; Liang CJ, 2007, CHEMOSPHERE, V66, P106, DOI 10.1016/j.chemosphere.2006.05.026; Liang CJ, 2003, SOIL SEDIMENT CONTAM, V12, P207, DOI 10.1080/713610970; Lin AYC, 2012, J HAZARD MATER, V243, P272, DOI 10.1016/j.jhazmat.2012.10.029; Liu CS, 2012, SEP PURIF TECHNOL, V87, P95, DOI 10.1016/j.seppur.2011.11.027; Moriwaki H, 2005, ENVIRON SCI TECHNOL, V39, P3388, DOI 10.1021/es040342v; Ochoa-Herrera V, 2008, ENVIRON SCI TECHNOL, V42, P3260, DOI 10.1021/es702842q; Park H, 2010, REV ROUM CHIM, V55, P611; Park H, 2009, J PHYS CHEM A, V113, P690, DOI 10.1021/jp807116q; Schroder HF, 2005, J CHROMATOGR A, V1082, P110, DOI 10.1016/j.chroma.2005.02.070; Schultz MM, 2006, ENVIRON SCI TECHNOL, V40, P7350, DOI 10.1021/es061025m; Sinclair E, 2006, ENVIRON SCI TECHNOL, V40, P1408, DOI 10.1021/es051798v; Vecitis CD, 2008, J PHYS CHEM C, V112, P16850, DOI 10.1021/jp804050p; Vecitis CD, 2008, J PHYS CHEM A, V112, P4261, DOI 10.1021/jp801081y; Vecitis CD, 2010, ENVIRON SCI TECHNOL, V44, P432, DOI 10.1021/es902444r; Waldemer RH, 2007, ENVIRON SCI TECHNOL, V41, P1010, DOI 10.1021/es062237m; Yamamoto T, 2007, ENVIRON SCI TECHNOL, V41, P5660, DOI 10.1021/es0706504	31	48	51	16	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74877	10.1371/journal.pone.0074877	http://dx.doi.org/10.1371/journal.pone.0074877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116016	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300017
J	Choi, Y; Dienes, HP; Krawczynski, K				Choi, Youkyung; Dienes, Hans-Peter; Krawczynski, Kris			Kinetics of miR-122 Expression in the Liver during Acute HCV Infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RT-PCR; MICRORNA MIR-122; RNA; IDENTIFICATION; NORMALIZATION; TRANSLATION; INTERFERON; CANCER; STABILIZATION	The relationships among micro RNA-122 (miR-122) expression in the liver, hepatitis C virus (HCV) replication and hepatic damage were analyzed in three chimpanzees observed for 180 days after inoculation with HCV genotype 1a. Levels of miR-122 in the liver and serum were measured by real-time RT PCR in serial liver biopsies and serum samples. Hepatic miR-122 levels were normalized separately for each of three chimpanzees with small RNAs and microRNAs that are endogenous to the liver and are stably expressed. Two-to 4-fold rise in hepatic miR-122 levels was observed at the onset of HCV infection (the first 4 weeks) when HCV titers in the liver and serum increased rapidly in all three chimpanzees in concordance with in vitro data indicating the miR-122 significance for HCV replication. Between 10 to 14 weeks after inoculation, when hepatic and serum HCV RNA titers exceeded 3 logs and alanine aminotransferase (ALT) activity was elevated, hepatic miR-122 levels were in decline. Cumulative data derived from all three chimpanzees from 180 days of observation documented an inverse (negative) correlation between hepatic miR-122 and HCV RNA in the liver and serum and positive correlation between level of serum miR-122 and HCV replication. Subsequent rise of miR-122 level during HCV clearance and ALT normalization suggested a tri-phasic occurrence of the relationship among hepatic miR-122 expression, HCV replication and hepatic destruction, which was the most apparent in one chimpanzee but less evident in two other animals. In vivo kinetics of hepatic and serum miR-122, HCV replication and hepatic destruction reflects complexities of the virus-host interaction during the acute phase of HCV infection.	[Choi, Youkyung; Krawczynski, Kris] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA; [Dienes, Hans-Peter] Univ Cologne, Inst Pathol, Cologne, Germany	Centers for Disease Control & Prevention - USA; University of Cologne	Krawczynski, K (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA.	kzk1@cdc.gov			Centers for Disease Control budget	Centers for Disease Control budget	The study was funded from Centers for Disease Control budget. Financial Management Office of CDC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; He YP, 2002, VIRAL IMMUNOL, V15, P95, DOI 10.1089/088282402317340260; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Houghton M, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01925.x; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Li Y, 2012, P NATL ACAD SCI US; Major ME, 1999, J VIROL, V73, P3317, DOI 10.1128/JVI.73.4.3317-3325.1999; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Morita K, 2011, LIVER INT, V31, P474, DOI 10.1111/j.1478-3231.2010.02433.x; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Niepmann M, 2009, CELL CYCLE, V8, P1473, DOI 10.4161/cc.8.10.8349; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Shan Y, 2007, GASTROENTEROLOGY, V133, P1166, DOI 10.1053/j.gastro.2007.08.002; Shimakami T, 2012, J VIROL, V86, P7372, DOI 10.1128/JVI.00513-12; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Villanueva RA, 2010, ANTIVIR RES, V88, P119, DOI 10.1016/j.antiviral.2010.07.004; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	32	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76501	10.1371/journal.pone.0076501	http://dx.doi.org/10.1371/journal.pone.0076501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124569	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100126
J	Free, CL; Baxter, GS; Dickman, CR; Leung, LKP				Free, Carissa L.; Baxter, Greg S.; Dickman, Christopher R.; Leung, Luke K. P.			Resource Pulses in Desert River Habitats: Productivity-Biodiversity Hotspots, or Mirages?	PLOS ONE			English	Article							DASYURID MARSUPIALS; ARID AUSTRALIA; AGAMID LIZARDS; SIMPSON DESERT; VEGETATION; RAINFALL; DYNAMICS; ECOLOGY; WATER; STRATEGIES	Resource pulses in the world's hot deserts are driven largely by rainfall and are highly variable in both time and space. However, run-on areas and drainage lines in arid regions receive more water more often than adjacent habitats, and frequently sustain relatively high levels of primary productivity. These landscape features therefore may support higher biotic diversity than other habitats, and potentially act as refuges for desert vertebrates and other biota during droughts. We used the ephemeral Field River in the Simpson Desert, central Australia, as a case study to quantify how resources and habitat characteristics vary spatially and temporally along the riparian corridor. Levels of moisture and nutrients were greater in the clay-dominated soils of the riverine corridor than in the surrounding sand dunes, as were cover values of trees, annual grasses, other annual plants and litter; these resources and habitat features were also greater near the main catchment area than in the distal reaches where the river channel runs out into extensive dune fields. These observations confirm that the riverine corridor is more productive than the surrounding desert, and support the idea that it may act as a refuge or as a channel for the ingress of peri-desert species. However, the work also demonstrates that species diversity of invertebrates and plants is not higher within the river corridor; rather, it is driven by rainfall and the accompanying increase in annual plants following a rain event. Further research is required to identify the biota that depend upon these resource pulses.	[Free, Carissa L.; Leung, Luke K. P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia; [Baxter, Greg S.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Sydney	Free, CL (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia.	carissa.free@uqconnect.edu.au	Baxter, Greg/AAQ-5364-2021; Dickman, Christopher/Q-4662-2019	Baxter, Greg/0000-0003-1816-4970; Dickman, Christopher/0000-0002-1067-3730; Leung, Luke/0000-0002-8829-4925				ABENSPERGTRAUN M, 1993, AUST J ECOL, V18, P317, DOI 10.1111/j.1442-9993.1993.tb00459.x; Arthington A.H, 2012, ENV FLOWS SAVING RIV; BRAITHWAITE RW, 1988, AUST J ECOL, V13, P375, DOI 10.1111/j.1442-9993.1988.tb00986.x; BUCKLEY RC, 1982, AUST J ECOL, V7, P187, DOI 10.1111/j.1442-9993.1982.tb01592.x; Charley J.L., 1968, P ECOL SOC AUST, V3, P28; Cole GA., 1968, DESERT BIOL, P423; Collins N. M., 1983, Nitrogen as an ecological factor, P381; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Daly BG, 2007, AUSTRAL ECOL, V32, P825, DOI 10.1111/j.1442-9993.2007.01768.x; Datry T, 2011, AQUAT SCI, V73, P453, DOI 10.1007/s00027-011-0236-1; Department of Environment and Water Resources, 2007, AUSTR BIOG REG; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Dubbin W, 2001, SOILS; Duguid A, 2002, WETLANDS ARID NO TER; Esteban J, 2006, ECOL COMPLEX, V3, P109, DOI 10.1016/j.ecocom.2005.10.001; Fensham RJ, 2010, ECOLOGY, V91, P681, DOI 10.1890/08-2356.1; FRANK A. S. K., 2010, THESIS U SYDNEY SYDN; Frank ASK, 2012, RANGELAND J, V34, P319, DOI 10.1071/RJ12032; Gibson D. F., 1992, AUST MAMMAL, V15, P105; Gordon CE, 2010, AUSTRAL ECOL, V35, P41, DOI 10.1111/j.1442-9993.2009.02010.x; Graf W. L., 1988, FLUVIAL PROCESSES DR; Greenaway P., 1984, P145; Greenville AC, 2009, INT J WILDLAND FIRE, V18, P631, DOI 10.1071/WF08093; Greenville AC, 2009, BIOL J LINN SOC, V97, P531, DOI 10.1111/j.1095-8312.2009.01241.x; GUTIERREZ JR, 1987, ECOLOGY, V68, P2032, DOI 10.2307/1939894; Gynther I, 2009, CRAVENS PEAK SCI STU, P199; Hamilton SK, 2005, LIMNOL OCEANOGR, V50, P743, DOI 10.4319/lo.2005.50.3.0743; Haythornthwaite AS, 2006, ECOGRAPHY, V29, P285, DOI 10.1111/j.2006.0906-7590.04307.x; Haythornthwaite AS, 2000, AUSTRAL ECOL, V25, P193; Jacobson PJ, 2000, J ARID ENVIRON, V45, P21, DOI 10.1006/jare.1999.0619; Jones H. A., 2007, P132; Kingsford R, 2006, ECOLOGY OF DESERT RIVERS, pXI; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2003, WILDLIFE RES, V30, P547, DOI 10.1071/WR02093; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Loik ME, 2004, OECOLOGIA, V141, P269, DOI 10.1007/s00442-004-1570-y; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; LUNDIEJENKINS G, 1993, WILDLIFE RES, V20, P495, DOI 10.1071/WR9930495; Mahon PS, 1999, THESIS U SYDNEY SYDN; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; McDonald R.I.R., 1998, AUSTR SOIL LAND SURV; McIntyre RES, 2009, J ARID ENVIRON, V73, P48, DOI 10.1016/j.jaridenv.2008.09.011; Moore P., 2005, GUIDE PLANTS INLAND; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Morton S.R., 1995, REFUGIA BIOL DIVERSI; MORTON SR, 1985, ECOLOGY, V66, P1859, DOI 10.2307/2937381; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Murrell B, 1984, ARID AUSTR, P327; Noy-Mein I., 1974, Annual Rev Ecol Syst, V5, P195, DOI 10.1146/annurev.es.05.110174.001211; Predavec M, 1997, J ARID ENVIRON, V36, P327, DOI 10.1006/jare.1996.0156; PRIMER-E, 2007, PRIMER 6 6 1 10; Prinsloo GL, 1990, NAMIB ECOLOGY 25 YEA, P67; Purdie R., 1984, LAND SYSTEMS SIMPSON; R Development Core Team, 2005, R LANG ENV STAT COMP; RICE BL, 1994, AUST J BOT, V42, P687, DOI 10.1071/BT9940687; SAS Institute Inc, 2003, SAS VERS 9 1; Sharma R.C., 2005, P149; Sheldon F., 2004, The Darling, P280; Shephard M., 1992, SIMPSON DESERT NATUR; Ponder Winston, 2007, P1; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; Steward AL, 2012, FRONT ECOL ENVIRON, V10, P202, DOI 10.1890/110136; Stromberg JC, 2009, BIODIVERS CONSERV, V18, P663, DOI 10.1007/s10531-008-9532-z; Tongway D.J., 2001, BANDED VEGETATION PA; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Unmack PJ, 2001, J ARID ENVIRON, V49, P653, DOI 10.1006/jare.2001.0813; Urban A, 1990, Wildflowers and plants of inland Australia; Van Etten EJB, 2009, AUST GEOGR, V40, P109, DOI 10.1080/00049180802657075; Webster R, 1988, EUROP J SOIL SCI, V40, P493; Whitford W., 2002, ECOLOGY DESERT SYSTE; Williams O.B., 1985, P269	72	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e72690	10.1371/journal.pone.0072690	http://dx.doi.org/10.1371/journal.pone.0072690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124446	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100003
J	Sheridan, H; Reingold, EM				Sheridan, Heather; Reingold, Eyal M.			The Mechanisms and Boundary Conditions of the Einstellung Effect in Chess: Evidence from Eye Movements	PLOS ONE			English	Article							SATISFACTION; SEARCH; SET; EXPERTISE; PLAYERS	In a wide range of problem-solving settings, the presence of a familiar solution can block the discovery of better solutions (i.e., the Einstellung effect). To investigate this effect, we monitored the eye movements of expert and novice chess players while they solved chess problems that contained a familiar move (i.e., the Einstellung move), as well as an optimal move that was located in a different region of the board. When the Einstellung move was an advantageous (but suboptimal) move, both the expert and novice chess players who chose the Einstellung move continued to look at this move throughout the trial, whereas the subset of expert players who chose the optimal move were able to gradually disengage their attention from the Einstellung move. However, when the Einstellung move was a blunder, all of the experts and the majority of the novices were able to avoid selecting the Einstellung move, and both the experts and novices gradually disengaged their attention from the Einstellung move. These findings shed light on the boundary conditions of the Einstellung effect, and provide convergent evidence for Bilalic, McLeod, & Gobet (2008)'s conclusion that the Einstellung effect operates by biasing attention towards problem features that are associated with the familiar solution rather than the optimal solution.	[Sheridan, Heather] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Reingold, Eyal M.] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Southampton; University of Toronto; University Toronto Mississauga	Sheridan, H (corresponding author), Univ Southampton, Sch Psychol, Southampton, Hants, England.	H.Sheridan@soton.ca.uk			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grant by an NSERC Grant to Eyal Reingold. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; [Anonymous], 1996, PERCEPTION MEMORY CH; Berbaum K.S., 2010, HDB MED IMAGE PERCEP, P107; Berbaum KS, 2000, ACAD RADIOL, V7, P945, DOI 10.1016/S1076-6332(00)80176-2; BERBAUM KS, 1990, INVEST RADIOL, V25, P133, DOI 10.1097/00004424-199002000-00006; Berbaum KS, 1996, ACAD RADIOL, V3, P815, DOI 10.1016/S1076-6332(96)80271-6; Bilalic M, 2008, COGNITION, V108, P652, DOI 10.1016/j.cognition.2008.05.005; Bilalic M, 2008, COGNITIVE PSYCHOL, V56, P73, DOI 10.1016/j.cogpsych.2007.02.001; Bilalic M, 2010, CURR DIR PSYCHOL SCI, V19, P111, DOI 10.1177/0963721410363571; BROWN J, 1968, PSYCHON SCI, V10, P41; Charness N, 2001, MEM COGNITION, V29, P1146, DOI 10.3758/BF03206384; Chesney DL, 2013, MEM COGNITION, V41, P1079, DOI 10.3758/s13421-013-0315-8; Elo A., 1986, RATING CHESSPLAYERS; ELO AE, 1965, J GERONTOL, V20, P289; Frensch Peter A., 1989, ADV PSYCHOL HUMAN IN, V5, P157; Gould Stephen J., 1996, MISMEASURE MAN REVIS; Greenberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036206; HECHT H, 1995, PSYCHOL SCI, V6, P90, DOI 10.1111/j.1467-9280.1995.tb00312.x; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Luchins A. S., 1942, PSYCHOL MONOGRAPHS, V54, P248; Piaget J., 1956, CHILDS CONCEPTION SP; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Reingold EM, 2001, PSYCHON B REV, V8, P504, DOI 10.3758/BF03196185; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; Reingold EM, 2005, COGNITIVE PROCESS, P325, DOI DOI 10.1093/ACPR0F:0S0/9780198566816.003.0014; Saariluoma P., 1990, LINES THOUGHT REFLEC, V2, P41; SAMUEL S, 1995, RADIOLOGY, V194, P895, DOI 10.1148/radiology.194.3.7862998; Schultz PW, 2002, GENET SOC GEN PSYCH, V128, P165; SIMON HA, 1973, AM SCI, V61, P394; SWELLER J, 1978, J EXP PSYCHOL-HUM L, V4, P513, DOI 10.1037/0278-7393.4.5.513; Tetlock PE, 2005, EXPERT POLITICAL JUDGMENT: HOW GOOD IS IT, HOW CAN WE KNOW, P1; Vallee-Tourangeau F, 2011, Q J EXP PSYCHOL, V64, P1889, DOI 10.1080/17470218.2011.605151; Wiley J, 1998, MEM COGNITION, V26, P716, DOI 10.3758/BF03211392	34	17	18	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75796	10.1371/journal.pone.0075796	http://dx.doi.org/10.1371/journal.pone.0075796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124515	Green Published, Green Accepted, gold			2022-12-27	WOS:000325489100072
J	Umschweif, G; Alexandrovich, AG; Trembovler, V; Horowitz, M; Shohami, E				Umschweif, Gali; Alexandrovich, Alexander G.; Trembovler, Victoria; Horowitz, Michal; Shohami, Esther			The Role and Dynamics of beta-Catenin in Precondition Induced Neuroprotection after Traumatic Brain Injury	PLOS ONE			English	Article							CLOSED-HEAD INJURY; GLYCOGEN-SYNTHASE KINASE-3; ACCLIMATION-INDUCED NEUROPROTECTION; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CELL-DEATH; CADHERIN; PATHWAY; MICE; ACTIVATION; INCREASES	Preconditioning via heat acclimation (34 degrees C 30 d) results in neuroprotection from traumatic brain injury due to constitutive as well as dynamic changes triggered by the trauma. Among these changes is Akt phosphorylation, which decreases apoptosis and induces HIF1 alpha. In the present study we investigated the Akt downstream GSK3 beta/beta -catenin pathway and focused on post injury alternations of beta catenin and its impact on the cellular response in preconditioned heat acclimated mice. We found that the reduction in motor disability is accompanied with attenuation of depressive like behavior in heat acclimated mice that correlates with the GSK3 beta phosphorylation state. Concomitantly, a robust beta catenin phosphorylation is not followed by its degradation, or by reduced nuclear accumulation. Enhanced tyrosine phosphorylation of beta catenin in the injured area weakens the beta catenin-N cadherin complex. Membrane beta catenin is transiently reduced in heat acclimated mice and its recovery 7 days post TBI is accompanied by induction of the synaptic marker synaptophysin. We suggest a set of cellular events following traumatic brain injury in heat acclimated mice that causes beta catenin to participate in cell-cell adhesion alternations rather than in Wnt signaling. These events may contribute to synaptogenesis and the improved motor and cognitive abilities seen heat acclimated mice after traumatic brain injury.	[Umschweif, Gali; Alexandrovich, Alexander G.; Trembovler, Victoria] Hebrew Univ Jerusalem, Dept Pharmacol, Jerusalem, Israel; [Umschweif, Gali; Horowitz, Michal; Shohami, Esther] Hebrew Univ Jerusalem, Environm Physiol Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Horowitz, M (corresponding author), Hebrew Univ Jerusalem, Environm Physiol Lab, Jerusalem, Israel.	m.horowitz@mail.huji.ac.il; esty@cc.huji.ac.il			Yissum Research Development Company of the Hebrew University of Jerusalem [0334185]	Yissum Research Development Company of the Hebrew University of Jerusalem	This study was supported by Yissum Research Development Company of the Hebrew University of Jerusalem, budget number 0334185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Aikin R, 2004, ENDOCRINOLOGY, V145, P4522, DOI 10.1210/en.2004-0488; Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bhuiyan MIH, 2011, ARCH PHARM RES, V34, P1023, DOI 10.1007/s12272-011-0620-3; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Eynan M, 2012, J APPL PHYSIOL, V113, P595, DOI 10.1152/japplphysiol.00228.2012; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hillion JA, 2006, J CEREBR BLOOD F MET, V26, P1323, DOI 10.1038/sj.jcbfm.9600286; Horowitz M, 2007, PROG BRAIN RES, V162, P373, DOI 10.1016/S0079-6123(06)62018-9; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI 10.1089/neu.2008-0743; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; LEVI E, 1993, J APPL PHYSIOL, V75, P833, DOI 10.1152/jappl.1993.75.2.833; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; Maloyan A, 1999, AM J PHYSIOL-REG I, V276, pR1506, DOI 10.1152/ajpregu.1999.276.5.R1506; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Neary JT, 2006, J NEUROSCI RES, V84, P515, DOI 10.1002/jnr.20969; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schwimmer H, 2004, MOL BRAIN RES, V130, P95, DOI 10.1016/j.molbrainres.2004.07.011; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	51	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76129	10.1371/journal.pone.0076129	http://dx.doi.org/10.1371/journal.pone.0076129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124534	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100091
J	Pekkonen, M; Ketola, T; Laakso, JT				Pekkonen, Minna; Ketola, Tarmo; Laakso, Jouni T.			Resource Availability and Competition Shape the Evolution of Survival and Growth Ability in a Bacterial Community	PLOS ONE			English	Article							SPECIES INTERACTIONS; STABLE COEXISTENCE; BIOFILM FORMATION; TRADE-OFFS; DIVERSITY; ENVIRONMENT; MAINTENANCE; POPULATIONS; MECHANISMS; SELECTION	Resource availability is one of the main factors determining the ecological dynamics of populations or species. Fluctuations in resource availability can increase or decrease the intensity of resource competition. Resource availability and competition can also cause evolutionary changes in life-history traits. We studied how community structure and resource fluctuations affect the evolution of fitness related traits using a two-species bacterial model system. Replicated populations of Serratia marcescens (copiotroph) and Novosophingobium capsulatum (oligotroph) were reared alone or together in environments with intergenerational, pulsed resource renewal. The comparison of ancestral and evolved bacterial clones with 1 or 13 weeks history in pulsed resource environment revealed species-specific changes in life-history traits. Co-evolution with S. marcescens caused N. capsulatum clones to grow faster. The evolved S. marcescens clones had higher survival and slower growth rate then their ancestor. The survival increased in all treatments after one week, and thereafter continued to increase only in the S. marcescens monocultures that experienced large resource pulses. Though adaptive radiation is often reported in evolution studies with bacteria, clonal variation increased only in N. capsulatum growth rate. Our results suggest that S. marcescens adapted to the resource renewal cycle whereas N. capsulatum was more affected by the interspecific competition. Our results exemplify species-specific evolutionary response to both competition and environmental variation.	[Pekkonen, Minna; Laakso, Jouni T.] Univ Helsinki, Dept Biosci, Integrat Ecol Unit, Ctr Excellence Biol Interact, Helsinki, Finland; [Ketola, Tarmo; Laakso, Jouni T.] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla	Pekkonen, M (corresponding author), Univ Helsinki, Dept Biosci, Integrat Ecol Unit, Ctr Excellence Biol Interact, Helsinki, Finland.	minna.pekkonen@helsinki.fi	Ketola, Tarmo/AAD-2609-2019; Laakso, Jouni/I-7794-2013	Ketola, Tarmo/0000-0001-5151-7980; Laakso, Jouni/0000-0001-8245-9912	Academy of Finland [106993, 1106312, 1255572, 128888]; Ella and Georg Ehrnrooth Foundation; Alfred Kordelin Foundation; Finnish Concordia foundation for Pekkonen	Academy of Finland(Academy of Finland); Ella and Georg Ehrnrooth Foundation; Alfred Kordelin Foundation; Finnish Concordia foundation for Pekkonen	This study was supported by the Academy of Finland (http://www.aka.fi/) projects 106993, 1106312, 1255572 for Laakso, and project 128888 for Ketola; Ella and Georg Ehrnrooth Foundation (www.ellageorg.fi/), Alfred Kordelin Foundation (http://www.kordelin.fi/), and Finnish Concordia foundation (http://www.konkordia-liitto.com/) for Pekkonen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY Z, 1982, ECOLOGY, V63, P1242, DOI 10.2307/1938850; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Andersson S, 2008, FEMS MICROBIOL LETT, V283, P83, DOI 10.1111/j.1574-6968.2008.01149.x; [Anonymous], 1988, AM ANTHROPOL; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; Begon M., 1996, ECOLOGY; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Collins S, 2007, GENETICS, V176, P1089, DOI 10.1534/genetics.107.072926; Collins S, 2011, P ROY SOC B-BIOL SCI, V278, P247, DOI 10.1098/rspb.2010.1173; Darwin C, 1859, ORIGIN SPECIES MEANS; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Descamps-Julien B, 2005, ECOLOGY, V86, P2815, DOI 10.1890/04-1700; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Gause G. F., 1934, STRUGGLE EXISTENCE; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; GOTTSCHAL JC, 1993, ANTON LEEUW INT J G, V63, P299, DOI 10.1007/BF00871225; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Grover J. P., 1997, RESOURCE COMPETITION; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; HELLING RB, 1987, GENETICS, V116, P349; Hiltunen T, 2008, ACTA OECOL, V33, P291, DOI 10.1016/j.actao.2007.12.002; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jasmin JN, 2007, ECOL LETT, V10, P272, DOI 10.1111/j.1461-0248.2007.01021.x; Kirk KL, 2002, FRESHWATER BIOL, V47, P1089, DOI 10.1046/j.1365-2427.2002.00841.x; Krieg NR, 1984, BERGEYS MANUAL SYSTE, V1, P964; Lankau RA, 2011, ANNU REV ECOL EVOL S, V42, P335, DOI 10.1146/annurev-ecolsys-102710-145100; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; LEIFSON E, 1962, INT B BACT NOMENCL T, V12, P161, DOI 10.1099/0096266X-12-4-161; LEVINS RICHARD, 1968; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; LUCKINBILL LS, 1978, SCIENCE, V202, P1201, DOI 10.1126/science.202.4373.1201; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Osmond MM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0085; Paerl HW, 1996, MICROB ECOL, V31, P225; Pekkonen M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-18; Pekkonen M, 2011, EVOL ECOL RES, V13, P1; Poisot T, 2011, BIOL LETTERS, V7, P201, DOI 10.1098/rsbl.2010.0774; RANTA E, 2002, TILASTOTIEDETTA EKOL; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Rozen DE, 2009, ECOL LETT, V12, P34, DOI 10.1111/j.1461-0248.2008.01257.x; Spencer CC, 2007, EVOL ECOL RES, V9, P775; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Tilman D., 1982, Monographs in Population Biology, pi; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Velicer GJ, 1999, ECOLOGY, V80, P1168, DOI 10.2307/177064; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1	66	29	29	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76471	10.1371/journal.pone.0076471	http://dx.doi.org/10.1371/journal.pone.0076471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098791	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500162
J	Tian, ZX; Li, SS; Zhang, JL; Guo, YM				Tian, Zhaoxing; Li, Shanshan; Zhang, Jinliang; Guo, Yuming			The Characteristic of Heat Wave Effects on Coronary Heart Disease Mortality in Beijing, China: A Time Series Study	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; CASE-CROSSOVER; COLD SPELLS; SAO-PAULO; IMPACT; RISK; CITY	Background: There is limited evidence for the impacts of heat waves on coronary heart disease (CHD) mortality in Beijing, capital city of China. Objectives: We aimed to find a best heat wave definition for CHD mortality; and explore the characteristic of heat wave effects on CHD in Beijing, China. Methods: We obtained daily data on weather and CHD mortality in Beijing for years 2000-2011. A quasi-Poisson regression model was used to assess the short-term impact of heat waves on CHD mortality in hot season (May-September), while controlling for relative humidity, day of the week, long-term trend and season. We compared 18 heat wave definitions by combining heat wave thresholds (87.5th, 90.0th, 92.5th, 95th, 97.5th, and 99th percentile of daily mean temperature) with different duration days (>= 2 to >= 4 days), using Akaike information criterion for quasi-Poisson. We examined whether heat wave effects on CHD mortality were modified by heat wave duration and timing. Results: Heat wave definition using 97.5th percentile of daily mean temperature (30.5 degrees C) and duration >= 2 days produced the best model fit. Based on this heat wave definition, we found that men and elderly were sensitive to the first heat waves of the season, while women and young were sensitive to the second heat waves. In general, the longer duration of heat waves increased the risks of CHD mortality more than shorter duration for elderly. The first two days of heat waves had the highest impact on CHD mortality. Women and elderly were at higher risks than men and young when exposed to heat waves, but the effect differences were not statistically significant. Conclusions: Heat waves had significant impact on CHD mortality. This finding may have implications for policy making towards protecting human health from heat waves.	[Tian, Zhaoxing] Peking Univ, Emergency Dept, Hosp 3, Beijing 100871, Peoples R China; [Li, Shanshan; Guo, Yuming] Univ Queensland, Dept Epidemiol & Biostat, Sch Populat Hlth, Brisbane, Qld, Australia; [Zhang, Jinliang] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Zhang, Jinliang] Chinese Res Inst Environm Sci, Environm Stand Inst, Beijing, Peoples R China	Peking University; University of Queensland; Chinese Research Academy of Environmental Sciences; Chinese Research Academy of Environmental Sciences	Guo, YM (corresponding author), Univ Queensland, Dept Epidemiol & Biostat, Sch Populat Hlth, Brisbane, Qld, Australia.	y.guo1@uq.edu.au	Guo, Yuming/I-8353-2018	Guo, Yuming/0000-0002-1766-6592; Li, Shanshan/0000-0002-9021-8470	National Nature Science Foundation of China [81172745]; Shanghai Science and Technology Committee [11DZ2260900]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	The study was supported by National Nature Science Foundation of China (#81172745) and Shanghai Science and Technology Committee (#11DZ2260900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG WHO, 2008, WHO GLOB REP FALLS P; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006; Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; COLLINS KJ, 1987, BRIT J HOSP MED, V38, P506; Conti S, 2005, ENVIRON RES, V98, P390, DOI 10.1016/j.envres.2004.10.009; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; Ding T, 2010, INT J CLIMATOL, V30, P1452, DOI 10.1002/joc.1989; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Fouillet A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-114; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; GUO Y, 2012, ENVIRON RES, DOI DOI 10.1016/J.ENVRES.2012.1009.1001; Guo YM, 2013, EPIDEMIOLOGY, V24, P471, DOI 10.1097/EDE.0b013e31828c4a5d; Guo YM, 2013, HEART, V99, P195, DOI 10.1136/heartjnl-2012-302518; Guo YM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00830; Guo YM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-36; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Johnson Helen, 2005, Health Stat Q, P6; Kaiser Reinhard, 2007, Am J Public Health, V97 Suppl 1, pS158, DOI 10.2105/AJPH.2006.100081; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Michelozzi P, 2006, J EPIDEMIOL COMMUN H, V60, P417, DOI 10.1136/jech.2005.040857; Revich B, 2008, OCCUP ENVIRON MED, V65, P691, DOI 10.1136/oem.2007.033944; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Schaffer A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-3; Son JY, 2012, ENVIRON HEALTH PERSP, V120, P566, DOI 10.1289/ehp.1103759; Stafoggia M, 2009, EPIDEMIOLOGY, V20, P575, DOI 10.1097/EDE.0b013e31819ecdf0; Tian ZX, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-56; Tong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037500; Tong SL, 2011, MATURITAS, V69, P5, DOI 10.1016/j.maturitas.2011.01.009; Wang XY, 2012, OCCUP ENVIRON MED, V69, P163, DOI 10.1136/oem.2010.062141; Wilkinson P, 2010, LANCET, V375, P804, DOI 10.1016/S0140-6736(10)60343-1; Wu ZS, 2001, CIRCULATION, V103, P462; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423	43	33	37	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e77321	10.1371/journal.pone.0077321	http://dx.doi.org/10.1371/journal.pone.0077321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098818	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500189
J	Alves, L; Azevedo, A; Barros, H; Paccaud, F; Marques-Vidal, P				Alves, Luis; Azevedo, Ana; Barros, Henrique; Paccaud, Fred; Marques-Vidal, Pedro			Portuguese Migrants in Switzerland: Healthcare and Health Status Compared to Portuguese Residents	PLOS ONE			English	Article							SELF-RATED HEALTH; CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; PREVALENCE; TRENDS; OVERWEIGHT; OBESITY; RELIABILITY; POPULATION; MIGRATION	Background: Most migrant studies have compared health characteristics between migrants and nationals of the host country. We aimed at comparing health characteristics of migrants with nationals from their home country. Methods: Portuguese national health survey (2005-6; 30,173 participants aged 18-75 years) and four national health surveys conducted in Switzerland (2002, 2004, 2007 and 2011, totalling 1,170 Portuguese migrants of the same age range). Self-reported data on length of stay, cardiovascular risk factors, healthcare use and health status were collected. Results: Resident Portuguese were significantly older and more educated than migrants. Resident Portuguese had a higher mean BMI and prevalence of obesity than migrants. Resident Portuguese also reported more frequently being hypertensive and having their blood pressure screened within the last year. On the contrary, migrant Portuguese were more frequently smokers, had a medical visit in the previous year more frequently and self-rated their health higher than resident Portuguese. After adjustment for age, gender, marital status and education, migrants had a higher likelihood of smoking, of having a medical visit the previous year, and of self-rating their current health as good or very good than resident Portuguese. Compared to Portuguese residents, cholesterol screening in the previous year was more common only among migrants living in Switzerland for more than 17 years. Conclusion: Portuguese migrants in Switzerland do not differ substantially from resident Portuguese regarding most cardiovascular risk factors. Migrants consider themselves healthier than Portuguese residents and more often had a recent medical visit.	[Alves, Luis; Azevedo, Ana; Barros, Henrique] Univ Porto, Inst Saude Publ, P-4100 Oporto, Portugal; [Alves, Luis; Azevedo, Ana; Barros, Henrique] Dept Epidemiol Clin Med Predit & Saude Publ, Oporto, Portugal; [Alves, Luis] Unidade Saude Familiar St Andre de Canidelo, Vila Nova De Gaia, Portugal; [Alves, Luis] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Paccaud, Fred; Marques-Vidal, Pedro] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland	Universidade do Porto; Universidade do Porto; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marques-Vidal, P (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Pedro-Manuel.Marques-Vidal@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; Azevedo, Ana/AAA-2287-2020; paccaud, fred/M-7516-2019; Alves, Luís Andrés Amorim/C-1618-2018; Barros, Henrique/Q-8609-2019; Barros, Henrique/A-5488-2008	Marques-Vidal, Pedro M/0000-0002-4548-8500; Azevedo, Ana/0000-0002-7368-9609; Alves, Luís Andrés Amorim/0000-0001-5855-2754; Barros, Henrique/0000-0003-4699-6571; 				[Anonymous], 2006, ETRANGERS ETRANGERES, P1; Baron-Epel O, 2001, ISRAEL MED ASSOC J, V3, P940; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Bjerregaard P, 2002, J EPIDEMIOL COMMUN H, V56, P279, DOI 10.1136/jech.56.4.279; Brodov Y, 2002, ISR MED ASSOC J, V4, P326; Calmonte R, 2005, GESUNDHEIT GESUNDHEI; Carreira H, 2012, PUBLIC HEALTH NUTR, V15, P972, DOI 10.1017/S1368980012000559; Damian J, 2012, AM J EPIDEMIOL, V175, P857, DOI 10.1093/aje/kws030; Fibbi R, 2010, PORTUGAIS SUISSE; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Freyer-Adam J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-659; Guggisberg J, 2011, GESUNDHEITSMONITORIN, P1; KourisBlazos A, 1996, AGE AGEING, V25, P177, DOI 10.1093/ageing/25.3.177; Kurokawa N, 2011, OBES RES CLIN PRACT, V5, pE1, DOI 10.1016/j.orcp.2010.11.002; Marques-Vidal P, 2005, OBES RES, V13, P1141, DOI 10.1038/oby.2005.135; Marques-Vidal P, 2012, INT J PUBLIC HEALTH, V57, P63, DOI 10.1007/s00038-011-0297-x; Marques-Vidal P, 2011, PUBLIC HEALTH NUTR, V14, P1148, DOI 10.1017/S1368980011000103; McKay L., 2003, MIGRATION HLTH REV I; Norredam M, 2010, EUR J PUBLIC HEALTH, V20, P555, DOI 10.1093/eurpub/ckp195; Padez C, 2011, AM J HUM BIOL, V23, P271; Parrino C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034551; PAWSON IG, 1982, SOC SCI MED, V16, P183, DOI 10.1016/0277-9536(82)90021-1; Pereira M, 2012, BLOOD PRESSURE, V21, P220, DOI 10.3109/08037051.2012.666380; Precioso J, 2009, ACTA MEDICA PORT, V22, P335; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Rohrer JE, 2007, J EVAL CLIN PRACT, V13, P150, DOI 10.1111/j.1365-2753.2006.00692.x; SALMOND CE, 1985, AM J EPIDEMIOL, V122, P291, DOI 10.1093/oxfordjournals.aje.a114101; Silveira E, 2002, SOC PSYCH PSYCH EPID, V37, P13, DOI 10.1007/s127-002-8209-5; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204	29	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77066	10.1371/journal.pone.0077066	http://dx.doi.org/10.1371/journal.pone.0077066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116201	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200097
J	Cuenca, J; Aleza, P; Vicent, A; Brunel, D; Ollitrault, P; Navarro, L				Cuenca, Jose; Aleza, Pablo; Vicent, Antonio; Brunel, Dominique; Ollitrault, Patrick; Navarro, Luis			Genetically Based Location from Triploid Populations and Gene Ontology of a 3.3-Mb Genome Region Linked to Alternaria Brown Spot Resistance in Citrus Reveal Clusters of Resistance Genes	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; HALF-TETRAD ANALYSIS; POWDERY MILDEW RESISTANCE; HOST-SPECIFIC TOXINS; ALLELIC CONFIGURATION; PONCIRUS-TRIFOLIATA; TANGERINE PATHOTYPE; BREEDING PARENTS; MINNEOLA TANGELO; FORTUNE MANDARIN	Genetic analysis of phenotypical traits and marker-trait association in polyploid species is generally considered as a challenge. In the present work, different approaches were combined taking advantage of the particular genetic structures of 2n gametes resulting from second division restitution (SDR) to map a genome region linked to Alternaria brown spot (ABS) resistance in triploid citrus progeny. ABS in citrus is a serious disease caused by the tangerine pathotype of the fungus Alternaria alternata. This pathogen produces ACT-toxin, which induces necrotic lesions on fruit and young leaves, defoliation and fruit drop in susceptible genotypes. It is a strong concern for triploid breeding programs aiming to produce seedless mandarin cultivars. The monolocus dominant inheritance of susceptibility, proposed on the basis of diploid population studies, was corroborated in triploid progeny. Bulk segregant analysis coupled with genome scan using a large set of genetically mapped SNP markers and targeted genetic mapping by half tetrad analysis, using SSR and SNP markers, allowed locating a 3.3 Mb genomic region linked to ABS resistance near the centromere of chromosome III. Clusters of resistance genes were identified by gene ontology analysis of this genomic region. Some of these genes are good candidates to control the dominant susceptibility to the ACT-toxin. SSR and SNP markers were developed for efficient early marker-assisted selection of ABS resistant hybrids.	[Cuenca, Jose; Aleza, Pablo; Vicent, Antonio; Ollitrault, Patrick; Navarro, Luis] Inst Valenciano Invest Agr Moncada, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain; [Brunel, Dominique; Ollitrault, Patrick] INRA, Etud Polymorphisme Genomes Vegetaux, Evry, France; [Ollitrault, Patrick] Coopeerat Int Rech Agron Dev, Ameliorat Genet Especes Multiplicat Vegetat Ctr, BIOS Dept, Montpellier, France	INRAE; CIRAD	Ollitrault, P (corresponding author), Inst Valenciano Invest Agr Moncada, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain.	ollitrault@cirad.fr; lnavarro@ivia.es	Antonio, Vicent/W-6375-2019; Aleza, Pablo/ABF-4339-2020; Cuenca, Jose/N-7047-2014; Vicent, Antonio/D-1306-2014; Navarro, Luis/D-1001-2012; Aleza, Pablo/M-3710-2014	Antonio, Vicent/0000-0002-3848-0631; Aleza, Pablo/0000-0003-3554-5337; Vicent, Antonio/0000-0002-3848-0631; Navarro, Luis/0000-0001-5163-5960; Aleza, Pablo/0000-0002-8936-1448; Ollitrault, Patrick/0000-0002-9456-5517; CUENCA, JOSE/0000-0002-3094-9933	Ministry of "Economia y Competividad"-Fondo Europeo de Desarrollo Regional (FEDER) [AGL2011-26490]; INIA [RTA2010-00105-00-00]; DOC-INIA	Ministry of "Economia y Competividad"-Fondo Europeo de Desarrollo Regional (FEDER); INIA(Instituto de Investigacion Agropecuaria (INIA)); DOC-INIA	This research was jointly financed by the grant AGL2011-26490-Ministry of "Economia y Competividad"-Fondo Europeo de Desarrollo Regional (FEDER) and INIA RTA2010-00105-00-00 and DOC-INIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero J, 2013, MOL PLANT PATHOL, V14, P610, DOI 10.1111/mpp.12031; Ajiro N, 2010, PHYTOPATHOLOGY, V100, P120, DOI 10.1094/PHYTO-100-2-0120; AKHUNOV E, 2009, THEOR APPL GENET, V119, P507, DOI DOI 10.1007/s00122-009-1059-5; Akimitsu KA, 2003, MOL PLANT PATHOL, V4, P435, DOI 10.1046/j.1364-3703.2003.00189.X; Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Aleza P, 2012, TREE GENET GENOMES, V8, P1293, DOI 10.1007/s11295-012-0515-6; Aleza P, 2012, PLANT CELL REP, V31, P1723, DOI 10.1007/s00299-012-1286-0; Aleza P, 2012, 12 INT CITR C 19 23; Aleza P, 2011, ANN BOT-LONDON, V108, P37, DOI 10.1093/aob/mcr099; Aleza P, 2010, HORTSCIENCE, V45, P139, DOI 10.21273/HORTSCI.45.1.139; Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Bhatia A, 2003, PLANT DIS, V87, P1089, DOI 10.1094/PDIS.2003.87.9.1089; Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Canihos Y, 1999, PLANT DIS, V83, P429, DOI 10.1094/PDIS.1999.83.5.429; Cervera M, 2005, METH MOL B, V286, P177; Chen CX, 2008, PLANT SCI, V174, P1, DOI 10.1016/j.plantsci.2007.08.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuenca J, 2011, HEREDITY, V107, P462, DOI 10.1038/hdy.2011.33; Cuenca J, 2013, ANN BOT-LONDON, V111, P731, DOI 10.1093/aob/mct032; Cuenca J, 2010, HORTSCIENCE, V45, P977, DOI 10.21273/HORTSCI.45.6.977; Cuppen Edwin, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4841; Dalkilic Z, 2005, J AM SOC HORTIC SCI, V130, P191, DOI 10.21273/JASHS.130.2.191; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DASILVA JAG, 1996, METHODS GENOME ANAL, P211; de Souza MC, 2009, SCI HORTIC-AMSTERDAM, V123, P1, DOI 10.1016/j.scienta.2009.07.005; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; DOUCHES DS, 1988, EUPHYTICA, V38, P247, DOI 10.1007/BF00023528; DOUCHES DS, 1987, GENOME, V29, P519, DOI 10.1139/g87-089; Elena K, 2006, EUR J PLANT PATHOL, V115, P259, DOI 10.1007/s10658-006-9005-8; ESEN A, 1973, J HERED, V64, P147, DOI 10.1093/oxfordjournals.jhered.a108373; ESEN A, 1971, J HERED, V62, P329, DOI 10.1093/oxfordjournals.jhered.a108186; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Everts KL, 1996, PLANT DIS, V80, P276, DOI 10.1094/PD-80-0276; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fang DQ, 1998, GENETICS, V150, P883; Folimonov AS, 2007, VIROLOGY, V368, P205, DOI 10.1016/j.virol.2007.06.038; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Froelicher Y, 2012, 12 INT CITR C; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; Gmitter FG, 2012, 12 INT CITR C 19 23; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; GOES A, 2001, FITOPATOL BRAS, V26, P386; Golmohammadi M, 2006, PLANT PATHOL, V55, P578, DOI 10.1111/j.1365-3059.2006.01427.x; Grosser JW, 2010, HORTSCIENCE, V45, P1160, DOI 10.21273/HORTSCI.45.8.1160; Guest D, 1997, PLANT PATHOGENS PLAN, P242; Gulsen O, 2010, EUPHYTICA, V173, P265, DOI 10.1007/s10681-010-0146-7; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Guo M, 1996, GENETICS, V142, P1349; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; HUTTON D G, 1988, Australasian Plant Pathology, V17, P69, DOI 10.1071/APP9880069; Hyten DL, 2009, CROP SCI, V49, P265, DOI 10.2135/cropsci2008.08.0511; JOHNSON SL, 1995, GENETICS, V139, P1727; JORGENSEN JH, 1977, EUPHYTICA, V26, P55, DOI 10.1007/BF00032068; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; Kamiri M, 2011, PLANT CELL REP, V30, P1415, DOI 10.1007/s00299-011-1050-x; KOHMOTO K, 1993, PHYTOPATHOLOGY, V83, P495, DOI 10.1094/Phyto-83-495; KOHMOTO K, 1991, PHYTOPATHOLOGY, V81, P719, DOI 10.1094/Phyto-81-719; Lindner KR, 2000, GENOME, V43, P538, DOI 10.1139/gen-43-3-538; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Luro F, 2004, ACTA HORTIC, P841, DOI 10.17660/ActaHortic.2004.663.152; MARSDEN JE, 1987, GENETICS, V116, P299; Mccollum TG, 2007, PROC FL STATE HORTIC, V120, P285; MENDIBURU AO, 1979, THEOR APPL GENET, V54, P177, DOI 10.1007/BF00263048; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Ming R, 2001, GENOME RES, V11, P2075, DOI 10.1101/gr.198801; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Mourao FAA, 1996, FRUIT VARIETIES J, V50, P76; Nagy ED, 2007, THEOR APPL GENET, V114, P961, DOI 10.1007/s00122-006-0481-1; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Navarro L., 2005, PHYTOMA, V170, P36; Navarro L, 2012, 12 INT CITR C 19 23; Ollitrault P, 2008, PL BRED RE, V30, P323; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; OTANI H, 1995, CAN J BOT, V73, pS453, DOI 10.1139/b95-282; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Peever TL, 1999, PHYTOPATHOLOGY, V89, P851, DOI 10.1094/PHYTO.1999.89.10.851; PEGG K. G., 1966, QUEENSLAND J AGR ANM SCI, V23, P15; Peres NA, 2006, CROP PROT, V25, P454, DOI 10.1016/j.cropro.2005.07.010; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; REINISCH AJ, 1994, GENETICS, V138, P829; Reis RF, 2007, SCI HORTIC-AMSTERDAM, V113, P336, DOI 10.1016/j.scienta.2007.04.005; Ricci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016912; SOLEL Z, 1991, PLANT PATHOL, V40, P145, DOI 10.1111/j.1365-3059.1991.tb02303.x; Solel Z, 1997, J PHYTOPATHOL, V145, P389, DOI 10.1111/j.1439-0434.1997.tb00420.x; Starrantino A., 1992, P INT SOC CITRIC, V1, P117; Stukenbrock EH, 2009, MOL PLANT MICROBE IN, V22, P371, DOI 10.1094/MPMI-22-4-0371; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Szelinger S, 2011, METHODS MOL BIOL, V700, P49, DOI 10.1007/978-1-61737-954-3_4; Tavoletti S, 1996, P NATL ACAD SCI USA, V93, P10918, DOI 10.1073/pnas.93.20.10918; Terol J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-31; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; Timmer Lavern W., 2003, Phytopathologia Mediterranea, V42, P99; Toyoda K, 2002, TRANSGENIC RES, V11, P567, DOI 10.1023/A:1021182111770; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Vicent A, 2009, CROP PROT, V28, P1, DOI 10.1016/j.cropro.2008.07.004; Vicent A, 2007, PLANT DIS, V91, P393, DOI 10.1094/PDIS-91-4-0393; Vicent A, 2004, EUR J PLANT PATHOL, V110, P245, DOI 10.1023/B:EJPP.0000019794.00000.02; Vicent A., 2000, Plant Disease, V84, P1044, DOI 10.1094/PDIS.2000.84.9.1044B; Wang XF, 2010, PLANT DIS, V94, P375, DOI 10.1094/PDIS-94-3-0375C; XU WW, 1995, THEOR APPL GENET, V91, P947, DOI 10.1007/BF00223905; Yan WY, 2010, J GENET GENOMICS, V37, P47, DOI 10.1016/S1673-8527(09)60024-2; Yang SL, 2012, MOL PLANT PATHOL, V13, P900, DOI 10.1111/j.1364-3703.2012.00799.x; Yang ZN, 2003, PLANT PHYSIOL, V131, P482, DOI 10.1104/pp.011262; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Zhao HY, 1998, GENETICS, V150, P473	116	22	28	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e767553	10.1371/journal.pone.0076755	http://dx.doi.org/10.1371/journal.pone.0076755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116149	Green Published, gold			2022-12-27	WOS:000325552200064
J	Kauwe, JSK; Ridge, PG; Foster, NL; Cannon-Albright, LA				Kauwe, John S. K.; Ridge, Perry G.; Foster, Norman L.; Cannon-Albright, Lisa A.			Strong Evidence for a Genetic Contribution to Late-Onset Alzheimer's Disease Mortality: A Population-Based Study	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY GENE; GENOME-WIDE ASSOCIATION; INHERITED PREDISPOSITION; HERITABLE PREDISPOSITION; IDENTIFIES VARIANTS; DEATH CERTIFICATES; VASCULAR DEMENTIA; COMMON VARIANTS; UTAH MORMONS; RISK	Background: Alzheimer's disease (AD) is an international health concern that has a devastating effect on patients and families. While several genetic risk factors for AD have been identified much of the genetic variance in AD remains unexplained. There are limited published assessments of the familiality of Alzheimer's disease. Here we present the largest genealogy-based analysis of AD to date. Methods: We assessed the familiality of AD in The Utah Population Database (UPDB), a population-based resource linking electronic health data repositories for the state with the computerized genealogy of the Utah settlers and their descendants. We searched UPDB for significant familial clustering of AD to evaluate the genetic contribution to disease. We compared the Genealogical Index of Familiality (GIF) between AD individuals and randomly selected controls and estimated the Relative Risk (RR) for a range of family relationships. Finally, we identified pedigrees with a significant excess of AD deaths. Results: The GIF analysis showed that pairs of individuals dying from AD were significantly more related than expected. This excess of relatedness was observed for both close and distant relationships. RRs for death from AD among relatives of individuals dying from AD were significantly increased for both close and more distant relatives. Multiple pedigrees had a significant excess of AD deaths. Conclusions: These data strongly support a genetic contribution to the observed clustering of individuals dying from AD. This report is the first large population-based assessment of the familiality of AD mortality and provides the only reported estimates of relative risk of AD mortality in extended relatives to date. The high-risk pedigrees identified show a true excess of AD mortality (not just multiple cases) and are greater in depth and width than published AD pedigrees. The presence of these high-risk pedigrees strongly supports the possibility of rare predisposition variants not yet identified.	[Kauwe, John S. K.; Ridge, Perry G.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Foster, Norman L.] Univ Utah, Dept Neurol, Ctr Alzheimers Care Imaging & Res, Salt Lake City, UT USA; [Cannon-Albright, Lisa A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Cannon-Albright, Lisa A.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA	Brigham Young University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Kauwe, JSK (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	Kauwe@byu.edu	Kauwe, John/AAC-6646-2021	Kauwe, John/0000-0001-8641-2468; albright, lisa/0000-0003-2602-3668	Huntsman Cancer Foundation; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NIH [R01AG042611]; Alzheimer's Association [MNIRG-11-205386]; Charleston Conference on Alzheimer's Disease; BYU Gerontology Program; Huntsman Cancer Institute's Cancer Center Support grant from National Cancer Institute [P30 CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042611] Funding Source: NIH RePORTER	Huntsman Cancer Foundation; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Charleston Conference on Alzheimer's Disease; BYU Gerontology Program; Huntsman Cancer Institute's Cancer Center Support grant from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	LACA acknowledges support from the Huntsman Cancer Foundation; and the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. JSKK acknowledges support from NIH (R01AG042611), the Alzheimer's Association (MNIRG-11-205386), the Charleston Conference on Alzheimer's Disease and the BYU Gerontology Program. Partial support for all data sets within the Utah Population Database (UPDB) was provided by Huntsman Cancer Institute, University of Utah and the Huntsman Cancer Institute's Cancer Center Support grant, P30 CA42014 from National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; CAMERON HM, 1981, J PATHOL, V133, P273, DOI 10.1002/path.1711330402; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DOLLEAR W, 1992, NEUROEPIDEMIOLOGY, V11, P53, DOI 10.1159/000110912; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; FARRER LA, 1989, ANN NEUROL, V25, P485, DOI 10.1002/ana.410250511; Frecker MF, 1995, NEUROLOGY, V45, P2298, DOI 10.1212/WNL.45.12.2298; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Gatz M, 2001, J Gerontol B Psychol Sci Soc Sci, V56, pP292; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hoyert D L, 1996, Vital Health Stat 20, P1; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; JORDE LB, 1989, ANN HUM GENET, V53, P339, DOI 10.1111/j.1469-1809.1989.tb01803.x; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; MARTYN CN, 1988, J EPIDEMIOL COMMUN H, V42, P134, DOI 10.1136/jech.42.2.134; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; NEWENS AJ, 1993, J EPIDEMIOL COMMUN H, V47, P293, DOI 10.1136/jech.47.4.293; Norton MC, 2011, AM J GERIAT PSYCHIAT, V19, P814, DOI 10.1097/JGP.0b013e3182011b38; Ostbye T, 2008, HEALTH SERV RES, V43, P313, DOI 10.1111/j.1475-6773.2007.00748.x; Patel AA, 2011, J BONE JOINT SURG AM, V93A, P225, DOI 10.2106/JBJS.J.00276; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; RAIFORD K, 1994, NEUROLOGY, V44, P2208, DOI 10.1212/WNL.44.11.2208-a; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Shirts BH, 2010, CLIN GASTROENTEROL H, V8, P812, DOI 10.1016/j.cgh.2010.05.012; Tashjian RZ, 2009, J BONE JOINT SURG AM, V91A, P1136, DOI 10.2106/JBJS.H.00831; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Teerlink CC, 2007, AM J RESP CRIT CARE, V176, P865, DOI 10.1164/rccm.200703-448OC; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1948, MATH HEREDITE; 1990, CATEGORICAL DATA ANA	49	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77087	10.1371/journal.pone.0077087	http://dx.doi.org/10.1371/journal.pone.0077087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116205	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200100
J	Singh, AP; Prabha, V; Rishi, P				Singh, Aman Preet; Prabha, Vijay; Rishi, Praveen			Value Addition in the Efficacy of Conventional Antibiotics by Nisin against Salmonella	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; DRUG-RESISTANT SALMONELLA; ESCHERICHIA-COLI O157-H7; GRAM-NEGATIVE BACTERIA; CELL-FREE-EXTRACT; ANTIMICROBIAL PEPTIDES; REFRIGERATED STORAGE; POSSIBLE ADJUNCT; ESSENTIAL OIL; L. PLANTARUM	Frequent and indiscriminate use of existing battery of antibiotics has led to the development of multi drug resistant (MDR) strains of pathogens. As decreasing the concentration of the antibiotic required to treat Salmonellosis might help in combating the development of resistant strains, the present study was designed to assess the synergistic effects, if any, of nisin, in combination with conventional anti-Salmonella antibiotics against Salmonella enterica serovar Typhimurium. Minimum inhibitory concentrations (MICs) of the selected antimicrobial agents were determined by micro and macro broth dilution assays. In-vitro synergy between the agents was evaluated by radial diffusion assay, fractional inhibitory concentration (FIC) index (checkerboard test) and time-kill assay. Scanning electron microscopy (SEM) was also performed to substantiate the effect of the combinations. In-vivo synergistic efficacy of the combinations selected on the basis of in-vitro results was also evaluated in the murine model, in terms of reduction in the number of Salmonellae in liver, spleen and intestine. Nisin-ampicillin and nisin-EDTA combinations were observed to have additive effects, whereas the combinations of nisin-ceftriaxone and nisin-cefotaxime were found to be highly synergistic against serovar Typhimurium as evident by checkerboard test and time-kill assay. SEM results revealed marked changes on the outer membrane of the bacterial cells treated with various combinations. In-vivo synergy was evident from the larger log unit decreases in all the target organs of mice treated with the combinations than in those treated with drugs alone. This study thus highlights that nisin has the potential to act in conjunction with conventional antibiotics at much lower MICs. These observations seem to be significant, as reducing the therapeutic concentrations of antibiotics may be a valuable strategy for avoiding/reducing the development of emerging antibiotic resistance. Value added potential of nisin in the efficacy of conventional antibiotics may thus be exploited not only against Salmonella but against other Gram-negative infections as well.	[Singh, Aman Preet; Prabha, Vijay; Rishi, Praveen] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Rishi, P (corresponding author), Panjab Univ, Dept Microbiol, Basic Med Sci Block, Chandigarh 160014, India.	rishipraveen@yahoo.com		Rishi, Praveen/0000-0001-5425-8064; Prabha, Vijay/0000-0002-7654-2215; Singh, Aman Preet/0000-0002-0261-2428	CSIR [09/135(0584)/2009-EMR-I]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Financial support to carry out this study was provided by CSIR funded Junior Research Fellowship, under the fellowship grant no. 09/135(0584)/2009-EMR-I to Mr. Aman Preet Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birosova L, 2009, J MED MICROBIOL, V58, P436, DOI 10.1099/jmm.0.003657-0; Boziaris IS, 1999, INT J FOOD MICROBIOL, V53, P105, DOI 10.1016/S0168-1605(99)00139-7; Chalon MC, 2012, FOOD RES INT, V45, P735, DOI 10.1016/j.foodres.2011.08.024; Chaudhary U, 2004, Indian J Med Microbiol, V22, P75; Clinical and Laboratory Standards Institute, 2010, PERF STAND ANT SUS S; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; CUTTER CN, 1995, J FOOD PROTECT, V58, P977, DOI 10.4315/0362-028X-58.9.977; De Melo AMSC, 1998, J FOOD PROTECT, V61, P839, DOI 10.4315/0362-028X-61.7.839; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Govaris A, 2010, INT J FOOD MICROBIOL, V137, P175, DOI 10.1016/j.ijfoodmicro.2009.12.017; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Jay J M, 2000, MODERN FOOD MICROBIO, V2nd; Ji HF, 2005, BIOCHEM BIOPH RES CO, V333, P661, DOI 10.1016/j.bbrc.2005.05.014; Joerger RD, 2003, POULTRY SCI, V82, P640, DOI 10.1093/ps/82.4.640; Kalita A, 2004, J INFECT DIS, V190, P1476, DOI 10.1086/424463; KITANO K, 1979, ANTIMICROB AGENTS CH, V16, P838, DOI 10.1128/AAC.16.6.838; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Lin CH, 2012, PEPTIDES, V36, P114, DOI 10.1016/j.peptides.2012.03.002; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Molbak K, 2005, CLIN INFECT DIS, V41, P1613, DOI 10.1086/497599; Murdock CA, 2007, LETT APPL MICROBIOL, V44, P255, DOI 10.1111/j.1472-765X.2006.02076.x; Paul D, 2013, NAT REV MICROBIOL, V11, P95; Preet S, 2010, J ANTIMICROB CHEMOTH, V65, P991, DOI 10.1093/jac/dkq066; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rishi P, 2011, ANTIMICROB AGENTS CH, V55, P4176, DOI 10.1128/AAC.00273-11; Rishi P, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-9; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; Rybak JM, 1996, DRUGS, V52, P390; SERRA P, 1977, ARCH INTERN MED, V137, P1562, DOI 10.1001/archinte.137.11.1562; Singh AP, 2011, J ANTIBIOT, V64, P795, DOI 10.1038/ja.2011.92; Solomakos N, 2008, MEAT SCI, V80, P159, DOI 10.1016/j.meatsci.2007.11.014; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; STEVENS KA, 1991, APPL ENVIRON MICROB, V57, P3613, DOI 10.1128/AEM.57.12.3613-3615.1991; Ulvatne H, 2001, J ANTIMICROB CHEMOTH, V48, P203, DOI 10.1093/jac/48.2.203; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Yenugu S, 2010, J PEPT SCI, V16, P337, DOI 10.1002/psc.1246	38	34	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76844	10.1371/journal.pone.0076844	http://dx.doi.org/10.1371/journal.pone.0076844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116175	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200079
J	Wang, JS; Wang, XM; Yuan, BH; Qiang, S				Wang, Jianshu; Wang, Xuemin; Yuan, Bohua; Qiang, Sheng			Differential Gene Expression for Curvularia eragrostidis Pathogenic Incidence in Crabgrass (Digitaria sanguinalis) Revealed by cDNA-AFLP Analysis	PLOS ONE			English	Article							ABSCISIC-ACID; ALDEHYDE OXIDASE; SENSITIVITY; DROUGHT; STEP; DNA	Gene expression profiles of Digitaria sanguinalis infected by Curvularia eragrostidis strain QZ-2000 at two concentrations of conidia and two dew durations were analyzed by cDNA amplified fragment length polymorphisms (cDNA-AFLP). Inoculum strength was more determinant of gene expression than dew duration. A total of 256 primer combinations were used for selective amplification and 1214 transcript-derived fragments (TDFs) were selected for their differential expression. Of these, 518 up-regulated differentially expressed TDFs were identified. Forty-six differential cDNA fragments were chosen to be cloned and 35 of them were successfully cloned and sequenced, of which 25 were homologous to genes of known function according to the GenBank database. Only 6 genes were up-regulated in Curvularia eragrostidis-inoculated D. sanguinalis, with functions involved in signal transduction, energy metabolism, cell growth and development, stress responses, abscisic acid biosynthesis and response. It appears that a few pathways may be important parts of the pathogenic strategy of C. eragrostidis strain QZ-2000 on D. sanguinalis. Our study provides the fundamentals to further study the pathogenic mechanism, screen for optimal C. eragrostidis strains as potential mycoherbicide and apply this product to control D. sanguinalis.	[Wang, Jianshu; Qiang, Sheng] Nanjing Agr Univ, Weed Res Lab, Nanjing, Jiangsu, Peoples R China; [Wang, Jianshu; Wang, Xuemin; Yuan, Bohua] Hebei Univ Engn, Coll Agr, Handan, Peoples R China	Nanjing Agricultural University; Hebei University of Engineering	Qiang, S (corresponding author), Nanjing Agr Univ, Weed Res Lab, Nanjing, Jiangsu, Peoples R China.	wrl@njau.edu.cn	Qiang, Sheng/A-6161-2012		National 863 Hi-tech Research Program [2011AA10A206]	National 863 Hi-tech Research Program(National High Technology Research and Development Program of China)	The National 863 Hi-tech Research Program (2011AA10A206) provided financial support for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Chandramohan S, 2001, BIOL CONTROL, V22, P246, DOI 10.1006/bcon.2001.0974; Guo J, 2006, FUNGAL GENET BIOL, V43, P111, DOI 10.1016/j.fgb.2005.11.001; Holm L. G., 1977, WORLDS WORST WEEDS D; Holm LG, 1979, GEOGRAPHICAL ATLAW; Johnson DA, 1997, BIOL CONTROL, V10, P92, DOI 10.1006/bcon.1997.0555; Kim T. J, 1997, WEED SCI SOC AM ABST, V37, P112; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Li XY, 2011, AFR J BIOTECHNOL, V10, P17907, DOI 10.5897/AJB10.2523; Lu D., 1995, ACTA PHYTOECCOL SIN, V1, P55; Malc E, 2009, MUTAT RES-FUND MOL M, V669, P95, DOI 10.1016/j.mrfmmm.2009.05.008; Martin A, 2009, MOL PLANT, V2, P1359, DOI 10.1093/mp/ssp076; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Seo PJ, 2011, PLANTA, V233, P189, DOI 10.1007/s00425-010-1293-8; Tilley AM, 2002, BIOL CONTROL, V25, P12, DOI 10.1016/S1049-9644(02)00035-X; Gonzalez CV, 2012, PLANT CELL ENVIRON, V35, P1958, DOI 10.1111/j.1365-3040.2012.02529.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker Robert H., 1998, Weed Technology, V12, P707; WIEDERHOLT RJ, 1995, WEED TECHNOL, V9, P518; Wiederholt RJ, 1993, P N CENTRAL WEED SCI, V48, P20; Yesbergenova Z, 2005, PLANT J, V42, P862, DOI 10.1111/j.1365-313X.2005.02422.x; Zhu Y, 2003, ACTA PHYTOPATHOLOGIC, V33, P524; Zhu YZ, 2004, BIOCONTROL SCI TECHN, V14, P769, DOI 10.1080/09583150410001720699	26	4	4	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75430	10.1371/journal.pone.0075430	http://dx.doi.org/10.1371/journal.pone.0075430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116044	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200022
J	Chia, JH; Lai, HC; Su, LH; Kuo, AJ; Wu, TL				Chia, Ju-Hsin; Lai, Hsin-Chih; Su, Lin-Hui; Kuo, An-Jing; Wu, Tsu-Lan			Molecular Epidemiology of Clostridium difficile at a Medical Center in Taiwan: Persistence of Genetically Clustering of A(-)B(+) Isolates and Increase of A(+)B(+) Isolates	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; TANDEM-REPEAT ANALYSIS; TOXIN-A; BINARY TOXIN; INFECTION; DISEASE; STRAINS; DIAGNOSIS; PCR; TOXINOTYPES	Introduction: We investigated the changing trend of various toxigenic Clostridium difficile isolates at a 3 500-bed hospital in Taiwan. Genetic relatedness and antimicrobial susceptibility of toxigenic C. difficile isolates were also examined. Methods: A total of 110 non-repeat toxigenic C. difficile isolates from different patients were collected between 2002 and 2007. Characterization of the 110 toxigenic isolates was performed using agar dilution method, multilocus variable-number tandem-repeat analysis (MLVA) genotyping, tcdC genotyping, and toxinotyping. Results: Among the 110 toxigenic isolates studied, 70 isolates harbored tcdA and tcdB (A(+)B(+)) and 40 isolates harbored tcdB only (A(-)B(+)). The annual number of A(+)B(+) isolates considerably increased over the 6-year study (P = 0.055). A total of 109 different MLVA genotypes were identified, in which A(+)B(+) isolates and A(-)B(+) isolates were differentiated into two genetic clusters with similarity of 17.6%. Twenty-four (60%) of the 40 A(-)B(+) isolates formed a major cluster, MLVA-group 1, with a similarity of 85%. Seven (6.4%) resistant isolates were identified, including two metronidazole-resistant and five vancomycin-resistant isolates. Conclusions: This study indicated a persistence of a MLVA group 1 A(-)B(+) isolates and an increase of A(+)B(+) isolates with diverse MLVA types. Moreover, C. difficile isolates with antimicrobial resistance to metronidazole or vancomycin were found to have emerged. Continuous surveillance is warranted to understand the recent situation and control the further spread of the toxigenic C. difficile isolates, especially among hospitalized patients.	[Chia, Ju-Hsin; Su, Lin-Hui; Kuo, An-Jing; Wu, Tsu-Lan] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Chia, Ju-Hsin; Lai, Hsin-Chih; Su, Lin-Hui; Kuo, An-Jing; Wu, Tsu-Lan] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Chia, Ju-Hsin] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wu, TL (corresponding author), Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan.	wutsulan@cgmh.org.tw		LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council, Taiwan [NSC 98-2320-B-182A-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants NSC 98-2320-B-182A-003-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al-Barrak A, 1999, Can Commun Dis Rep, V25, P65; Bakker D, 2010, J CLIN MICROBIOL, V48, P3744, DOI 10.1128/JCM.01171-10; Clinical and Laboratory Standards Institute, 2007, METH ANT SUSC TEST A; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; Elliott B, 2009, ANAEROBE, V15, P249, DOI 10.1016/j.anaerobe.2009.08.006; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Geric B, 2006, J INFECT DIS, V193, P1143, DOI 10.1086/501368; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kim H, 2008, J CLIN MICROBIOL, V46, P1116, DOI 10.1128/JCM.01188-07; KNOOP FC, 1993, CLIN MICROBIOL REV, V6, P251, DOI 10.1128/CMR.6.3.251-265.1993; Koh TH, 2007, PATHOLOGY, V39, P438, DOI 10.1080/00313020701444507; Komatsu M, 2003, EUR J CLIN MICROBIOL, V22, P525, DOI 10.1007/s10096-003-0992-5; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Larson AM, 2010, J CLIN MICROBIOL, V48, P124, DOI 10.1128/JCM.00734-09; Lee YC, 2011, J MICROBIOL IMMUNOL; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Peterson LR, 2007, CLIN INFECT DIS, V45, P1152, DOI 10.1086/522185; Pituch H, 2001, CLIN MICROBIOL INFEC, V7, P442, DOI 10.1046/j.1198-743x.2001.00312.x; Pupaibool Jakrapan, 2008, Journal of the Medical Association of Thailand, V91, P37; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Sawabe E, 2007, EUR J CLIN MICROBIOL, V26, P695, DOI 10.1007/s10096-007-0355-8; Shah D, 2010, EXPERT REV ANTI-INFE, V8, P555, DOI [10.1586/eri.10.28, 10.1586/ERI.10.28]; Shin BM, 2008, J MED MICROBIOL, V57, P697, DOI 10.1099/jmm.0.47771-0; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Sundriyal A, 2010, PROTEIN EXPR PURIF; Terhes G, 2004, J CLIN MICROBIOL, V42, P4316, DOI 10.1128/JCM.42.9.4316-4318.2004; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003; Wroblewski D, 2009, J CLIN MICROBIOL, V47, P2142, DOI 10.1128/JCM.02498-08	42	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75471	10.1371/journal.pone.0075471	http://dx.doi.org/10.1371/journal.pone.0075471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116048	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300030
J	Kwekel, JC; Desai, VG; Moland, CL; Vijay, V; Fuscoe, JC				Kwekel, Joshua C.; Desai, Varsha G.; Moland, Carrie L.; Vijay, Vikrant; Fuscoe, James C.			Life Cycle Analysis of Kidney Gene Expression in Male F344 Rats	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; INCREASED SUSCEPTIBILITY; NEPHROTOXICITY; INJURY; ASSOCIATION; BIOMARKERS; INFANTS; FDA	Age is a predisposing condition for susceptibility to chronic kidney disease and progression as well as acute kidney injury that may arise due to the adverse effects of some drugs. Age-related differences in kidney biology, therefore, are a key concern in understanding drug safety and disease progression. We hypothesize that the underlying suite of genes expressed in the kidney at various life cycle stages will impact susceptibility to adverse drug reactions. Therefore, establishing changes in baseline expression data between these life stages is the first and necessary step in evaluating this hypothesis. Untreated male F344 rats were sacrificed at 2, 5, 6, 8, 15, 21, 78, and 104 weeks of age. Kidneys were collected for histology and gene expression analysis. Agilent whole-genome rat microarrays were used to query global expression profiles. An ANOVA (p<0.01) coupled with a fold-change>1.5 in relative mRNA expression, was used to identify 3,724 unique differentially expressed genes (DEGs). Principal component analyses of these DEGs revealed three major divisions in life-cycle renal gene expression. K-means cluster analysis identified several groups of genes that shared age-specific patterns of expression. Pathway analysis of these gene groups revealed age-specific gene networks and functions related to renal function and aging, including extracellular matrix turnover, immune cell response, and renal tubular injury. Large age-related changes in expression were also demonstrated for the genes that code for qualified renal injury biomarkers KIM-1, Clu, and Tff3. These results suggest specific groups of genes that may underlie age-specific susceptibilities to adverse drug reactions and disease. This analysis of the basal gene expression patterns of renal genes throughout the life cycle of the rat will improve the use of current and future renal biomarkers and inform our assessments of kidney injury and disease.	[Kwekel, Joshua C.; Desai, Varsha G.; Moland, Carrie L.; Vijay, Vikrant; Fuscoe, James C.] US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Kwekel, JC (corresponding author), US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	Joshua.Kwekel@fda.hhs.gov; James.Fuscoe@fda.hhs.gov	Vijay, Vikrant/E-7651-2010	Vijay, Vikrant/0000-0001-8425-1285	U.S. Food and Drug Administration; FDA Office of Women's Health	U.S. Food and Drug Administration; FDA Office of Women's Health	This work was funded by the U.S. Food and Drug Administration. The research was supported in part by an appointment to the Research Participation Program at the National Center for Toxicological Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U. S. Food and Drug Administration. The authors thank the FDA Office of Women's Health for support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn J, 2002, CLIN PHARMACOKINET, V41, P959, DOI 10.2165/00003088-200241120-00003; BEIERSCHMITT WP, 1986, LIFE SCI, V39, P2335, DOI 10.1016/0024-3205(86)90664-8; Chen G, 2007, AM J PHYSIOL-RENAL, V293, pF1272, DOI 10.1152/ajprenal.00138.2007; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; Espandiari P, 2010, J APPL TOXICOL, V30, P172, DOI 10.1002/jat.1484; Espandiari P, 2007, TOXICOL SCI, V99, P637, DOI 10.1093/toxsci/kfm184; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Hewitt NJ, 2007, XENOBIOTICA, V37, P1196, DOI 10.1080/00498250701534893; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kwekel JC, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-14; Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675; LAFAYETTE RA, 1993, J AM SOC NEPHROL, V3, P1892; Mei CL, 2009, SEMIN NEPHROL, V29, P555, DOI 10.1016/j.semnephrol.2009.07.002; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Mendrick DL, 2011, PHARMACOGENOMICS, V12, P235, DOI 10.2217/PGS.10.184; MIURA K, 1987, TOXICOL APPL PHARM, V87, P284, DOI 10.1016/0041-008X(87)90290-0; Musso CG, 2011, NEPHRON PHYSIOL, V119, P1, DOI 10.1159/000328010; Ozer JS, 2010, NAT BIOTECHNOL, V28, P486, DOI 10.1038/nbt.1627; Pannu N, 2011, AM J KIDNEY DIS, V58, P206, DOI 10.1053/j.ajkd.2011.01.028; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Surendran K, 2004, KIDNEY INT, V65, P2212, DOI 10.1111/j.1523-1755.2004.00641.x; Travis L B, 1991, Tex Med, V87, P50; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Zoetis T, 2003, BIRTH DEFECTS RES B, V68, P111, DOI 10.1002/bdrb.10013	28	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75305	10.1371/journal.pone.0075305	http://dx.doi.org/10.1371/journal.pone.0075305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116033	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300024
J	Vinn, O				Vinn, Olev			Occurrence, Formation and Function of Organic Sheets in the Mineral Tube Structures of Serpulidae (Polychaeta, Annelida)	PLOS ONE			English	Article							ULTRASTRUCTURE	A scanning electron microscopy study of organic sheets in serpulid tube mineral structures was carried out to discern their function, formation and evolution. The organic sheets may have some taxonomic value in distinguishing the two major clades of serpulids previously identified. The organic sheets in the mineral tube structure occur only in certain taxa belonging to clade A, but not all species in clade A have them. Organic sheets are best developed in genus Spirobranchus. One could speculate that organic sheets have evolved as an adaption to further strengthen the mechanical properties of the tubes in clade A, which contains serpulids with the most advanced mineral tube microstructures. The organic sheets are presumably secreted with at least some mineral phase.	Univ Tartu, Dept Geol, EE-50090 Tartu, Estonia	University of Tartu	Vinn, O (corresponding author), Univ Tartu, Dept Geol, Ulikooli 18, EE-50090 Tartu, Estonia.	olev.vinn@ut.ee	Vinn, Olev/AAG-6806-2020	Vinn, Olev/0000-0002-2889-2544	Estonian Science Foundation [ETF9064]; Estonian Ministry of Education and Science [SF0180051s08]	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia)	The author is indebted to a Sepkoski Grant (Paleontological Society), Estonian Science Foundation grant ETF9064 and the target-financed project (from the Estonian Ministry of Education and Science) SF0180051s08 for financial support. SYNTHESYS support under the European Commission's FPVI European-funded Integrated Infrastructure Initiative to the projects NL-TAF-111 and SE-TAF-113 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Chan VBS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042718; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P149, DOI 10.1016/j.palaeo.2005.03.054; Smith AM, 2013, MAR BIOL IN PRESS; Tanur AE, 2010, J STRUCT BIOL, V169, P145, DOI 10.1016/j.jsb.2009.09.008; Ten Hove HA, 2009, ZOOTAXA, P1; TENHOVE HA, 1993, GEOL MIJNBOUW, V72, P23; Vinn O, 2011, ROLE INTERNAL ORGANI, V2011; Vinn O, 2011, EVOLUTION DENSE OUTE, V201; Vinn O, 2008, NEUES JAHRB GEOL P-A, V248, P79, DOI 10.1127/0077-7749/2008/0248-0079; Vinn O, 2011, ZOOMORPHOLOGY, V130, P181, DOI 10.1007/s00435-011-0133-0; Vinn O, 2009, EST J EARTH SCI, V58, P286, DOI 10.3176/earth.2009.4.07; Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x	13	15	17	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75330	10.1371/journal.pone.0075330	http://dx.doi.org/10.1371/journal.pone.0075330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116035	Green Submitted, gold, Green Published			2022-12-27	WOS:000325501300025
J	Zhang, XL; Zhang, YM; Gu, DY; Cao, CX; Zhang, Q; Xu, Z; Gong, YL; Chen, JF; Tang, CJ				Zhang, Xunlei; Zhang, Yangmei; Gu, Dongying; Cao, Chunxiang; Zhang, Qi; Xu, Zhi; Gong, Yongling; Chen, Jinfei; Tang, Cuiju			Increased Risk of Developing Digestive Tract Cancer in Subjects Carrying the PLCE1 rs2274223 A > G Polymorphism: Evidence from a Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PHOSPHOLIPASE-C-EPSILON; UPPER GASTROINTESTINAL CANCERS; GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; GASTRIC-CANCER; CHINESE POPULATION; GENETIC ASSOCIATION; SUSCEPTIBILITY; 10Q23	Background: To date, the association between phospholipase C epsilon 1 (PLCE1) rs2274223 A>G and risk of digestive tract cancer (DTC) remains inconclusive. To derive a more precise estimation of the association, we conducted a meta-analysis on all eligible case-control studies involving 8281 cases and 10,532 controls. Methods: A comprehensive search was conducted to identify all eligible studies of PLCE1 rs2274223 polymorphism and digestive tract cancer risk. The pooled odds ratio (OR) and the 95% confidence interval (95% CI) were calculated using a fixed or random effect model. Heterogeneity, publication bias, and sensitivity analysis were also explored. Results: Overall, the PLCE1 rs2274223 A>G polymorphism was associated with risk of DTC in all genetic models (GA vs. AA: OR = 1.21, 95% CI = 1.14-1.29, P<0.001; GG vs. AA: OR = 1.30, 95% CI = 1.06-1.60, P = 0.012; GG/GA vs. AA: OR = 1.20, 95% CI = 1.10-1.32, P<0.001; GG vs. GA/AA: OR = 1.21, 95% CI = 1.01-1.46, P = 0.040). The recessive model did not reach statistically significance when the P values were Bonferroni corrected to 0.0125. In the stratified analysis by cancer type, ethnicity, and source of controls, significantly increased risk was observed for esophagus cancer, Asians in three genetic models (heterozygote comparison, homozygote comparison and dominant model), population-based studies in all genetic models, and for gastric cancer in the heterozygote comparison and dominant model after Bonferroni correction. However, in the subsite of gastric cancer, no significant association was found either in cardia or non-cardia gastric cancer. Conclusion: Our study indicated that PLCE1 rs2274223 A>G polymorphism was significantly associated with increased risk of DTC, especially among Asian populations. Due to some minor limitations, our findings should be confirmed in further studies.	[Zhang, Xunlei; Gu, Dongying; Cao, Chunxiang; Zhang, Qi; Xu, Zhi; Gong, Yongling; Chen, Jinfei; Tang, Cuiju] Nanjing Med Univ, Dept Oncol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Yangmei] Southeast Univ, Dept Oncol, Xuzhou Hosp, Coll Med, Xuzhou, Peoples R China; [Zhang, Yangmei] Xuzhou Cent Hosp, Xuzhou, Peoples R China	Nanjing Medical University; Southeast University - China	Tang, CJ (corresponding author), Nanjing Med Univ, Dept Oncol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	tangcuiju@tom.com	Zhang, Xun/HHM-9059-2022	Zhang, Xun/0000-0001-5411-2727	Ministry of Health and Welfare of Nanjing, China [YKK10097]	Ministry of Health and Welfare of Nanjing, China	The work was supported by a grant from the Ministry of Health and Welfare of Nanjing, China; Grant number: YKK10097; Website: http://www.njh.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Bye H, 2012, CARCINOGENESIS, V33, P2155, DOI 10.1093/carcin/bgs262; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dura P, 2012, EUR J CANC PREV; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028971; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hu HC, 2012, ANN SURG ONCOL, V19, P2403, DOI 10.1245/s10434-011-2160-y; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Lao-Sirieix P, 2010, CURR OPIN GENET DEV, V20, P210, DOI 10.1016/j.gde.2010.03.002; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li FX, 2012, MOL BIOL REP, V39, P9557, DOI 10.1007/s11033-012-1820-8; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Luo DW, 2011, J GASTROENTEROL, V46, P1260, DOI 10.1007/s00535-011-0445-3; Ma HX, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-258; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ou LP, 2010, CANCER GENET CYTOGEN, V200, P110, DOI 10.1016/j.cancergencyto.2010.01.021; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pelucchi C, 2006, ALCOHOL RES HEALTH, V29, P193; Saito H, 2012, GASTRIC CANC; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Tsugane S, 2007, GASTRIC CANCER, V10, P75, DOI 10.1007/s10120-007-0420-0; Wang J, 2012, INT J CANCER, V130, P1898, DOI 10.1002/ijc.26199; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wang XL, 2012, MED ONCOL, V29, P1051, DOI 10.1007/s12032-011-9981-1; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Wong SCH, 2003, ANTICANCER RES, V23, P465; Yuan Z, 2012, ORAL ONCOL; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051; Zhou RM, 2012, ARCH MED RES, V43, P578, DOI 10.1016/j.arcmed.2012.09.006	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76425	10.1371/journal.pone.0076425	http://dx.doi.org/10.1371/journal.pone.0076425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116107	gold, Green Submitted, Green Published			2022-12-27	WOS:000325501300057
J	Danielsen, EM; Hansen, GH				Danielsen, E. Michael; Hansen, Gert H.			Generation of Stable Lipid Raft Microdomains in the Enterocyte Brush Border by Selective Endocytic Removal of Non-Raft Membrane	PLOS ONE			English	Article							EPITHELIAL-CELLS; MICROVILLAR ENZYMES; ABSORPTIVE CELLS; PROTEINS; TRANSPORT; ORGANIZATION; TRAFFICKING; POLARITY; BIOSYNTHESIS; MECHANISM	The small intestinal brush border has an unusually high proportion of glycolipids which promote the formation of lipid raft microdomains, stabilized by various cross-linking lectins. This unique membrane organization acts to provide physical and chemical stability to the membrane that faces multiple deleterious agents present in the gut lumen, such as bile salts, digestive enzymes of the pancreas, and a plethora of pathogens. In the present work, we studied the constitutive endocytosis from the brush border of cultured jejunal explants of the pig, and the results indicate that this process functions to enrich the contents of lipid raft components in the brush border. The lipophilic fluorescent marker FM, taken up into early endosomes in the terminal web region (TWEEs), was absent from detergent resistant membranes (DRMs), implying an association with non-raft membrane. Furthermore, neither major lipid raft-associated brush border enzymes nor glycolipids were detected by immunofluorescence microscopy in subapical punctae resembling TWEEs. Finally, two model raft lipids, BODIPY-lactosylceramide and BODIPY-GM(1), were not endocytosed except when cholera toxin subunit B (CTB) was present. In conclusion, we propose that constitutive, selective endocytic removal of non-raft membrane acts as a sorting mechanism to enrich the brush border contents of lipid raft components, such as glycolipids and the major digestive enzymes. This sorting may be energetically driven by changes in membrane curvature when molecules move from a microvillar surface to an endocytic invagination.	[Danielsen, E. Michael; Hansen, Gert H.] Univ Copenhagen, Dept Cellular & Mol Med, Panum Inst, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	University of Copenhagen	Danielsen, EM (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Panum Inst, Fac Hlth Sci, DK-1168 Copenhagen, Denmark.	midan@sund.ku.dk			Augustinus Fonden; Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond; Fonden til Laegevidenskabens Fremme; Horslev Fonden	Augustinus Fonden; Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond; Fonden til Laegevidenskabens Fremme; Horslev Fonden	The study was supported by grants from Augustinus Fonden, Aase og Ejnar Danielsens Fond, Brodrene Hartmanns Fond, Fonden til Laegevidenskabens Fremme, and Horslev Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2012, NAT CELL BIOL, V14, P1235, DOI 10.1038/ncb2635; BLOK J, 1981, CELL TISSUE RES, V216, P1; Booth A G, 1974, Biochem J, V142, P575; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Carmosino M, 2010, BIOL CELL, V102, P75, DOI 10.1042/BC20090134; CHRISTIANSEN K, 1981, BIOCHIM BIOPHYS ACTA, V647, P188, DOI 10.1016/0005-2736(81)90245-5; Coskun U, 2010, FEBS LETT, V584, P1685, DOI 10.1016/j.febslet.2009.12.043; Danielsen EM, 2012, BBA-BIOMEMBRANES, V1818, P530, DOI 10.1016/j.bbamem.2011.11.011; Danielsen EM, 2006, MOL MEMBR BIOL, V23, P71, DOI 10.1080/09687860500445604; DANIELSEN EM, 1995, BIOCHEMISTRY-US, V34, P1596, DOI 10.1021/bi00005a016; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; DANIELSEN EM, 1993, J CELL BIOL, V120, P1347, DOI 10.1083/jcb.120.6.1347; DANIELSEN EM, 1982, BIOCHEM J, V202, P647, DOI 10.1042/bj2020647; Ewers H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004721; Fujita M, 2007, MED MOL MORPHOL, V40, P1, DOI 10.1007/s00795-006-0346-3; Glenn GM, 2009, INFECT IMMUN, V77, P5206, DOI 10.1128/IAI.00712-09; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Hagerstrand H, 2006, MOL MEMBR BIOL, V23, P277, DOI 10.1080/09687860600682536; Hanani M, 2012, J CELL MOL MED, V16, P22, DOI 10.1111/j.1582-4934.2011.01378.x; Hansen GH, 2009, AM J PHYSIOL-GASTR L, V297, pG708, DOI 10.1152/ajpgi.00192.2009; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hansen GH, 2003, BIOCHEM J, V373, P125, DOI 10.1042/BJ20030235; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Kraehenbuhl J P, 1992, Trends Cell Biol, V2, P170, DOI 10.1016/0962-8924(92)90036-M; Kunding AH, 2010, MOL MEMBR BIOL, V27, P170, DOI 10.3109/09687688.2010.494625; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; MAROUX S, 1988, BIOCHIMIE, V70, P1297, DOI 10.1016/0300-9084(88)90198-8; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; MOOSEKER MS, 1983, CIBA F SYMP, V95, P195; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; PALAY SL, 1959, J BIOPHYS BIOCHEM CY, V5, P363, DOI 10.1083/jcb.5.3.363; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SJOSTROM H, 1983, CIBA F SYMP, V95, P50; SKOVBJERG H, 1978, SCAND J CLIN LAB INV, V38, P723, DOI 10.3109/00365517809104879; SKOVBJERG H, 1982, BIOCHIM BIOPHYS ACTA, V707, P89, DOI 10.1016/0167-4838(82)90400-9; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615	53	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76661	10.1371/journal.pone.0076661	http://dx.doi.org/10.1371/journal.pone.0076661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124585	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100142
J	Dasgupta, N; Xu, YH; Oh, S; Sun, Y; Jia, L; Keddache, M; Grabowski, GA				Dasgupta, Nupur; Xu, You-Hai; Oh, Sunghee; Sun, Ying; Jia, Li; Keddache, Mehdi; Grabowski, Gregory A.			Gaucher Disease: Transcriptome Analyses Using Microarray or mRNA Sequencing in a Gba1 Mutant Mouse Model Treated with Velaglucerase alfa or Imiglucerase	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; LINKED SIDEROBLASTIC ANEMIA; ENZYME REPLACEMENT THERAPY; GLOBAL GENE-EXPRESSION; ACID-BETA-GLUCOSIDASE; MEGAKARYOCYTIC DIFFERENTIATION; MITOCHONDRIAL DYSFUNCTION; PARKINSONS-DISEASE; FACTOR GATA-1; GLUCOCEREBROSIDASE	Gaucher disease type 1, an inherited lysosomal storage disorder, is caused by mutations in GBA1 leading to defective glucocerebrosidase (GCase) function and consequent excess accumulation of glucosylceramide/glucosylsphingosine in visceral organs. Enzyme replacement therapy (ERT) with the biosimilars, imiglucerase (imig) or velaglucerase alfa (vela) improves/reverses the visceral disease. Comparative transcriptomic effects (microarray and mRNA-Seq) of no ERT and ERT (imig or vela) were done with liver, lung, and spleen from mice having Gba1 mutant alleles, termed D409V/null. Disease-related molecular effects, dynamic ranges, and sensitivities were compared between mRNA-Seq and microarrays and their respective analytic tools, i.e. Mixed Model ANOVA (microarray), and DESeq and edgeR (mRNA-Seq). While similar gene expression patterns were observed with both platforms, mRNA-Seq identified more differentially expressed genes (DEGs) (similar to 3-fold) than the microarrays. Among the three analytic tools, DESeq identified the maximum number of DEGs for all tissues and treatments. DESeq and edgeR comparisons revealed differences in DEGs identified. In 9V/null liver, spleen and lung, post-therapy transcriptomes approximated WT, were partially reverted, and had little change, respectively, and were concordant with the corresponding histological and biochemical findings. DEG overlaps were only 8-20% between mRNA-Seq and microarray, but the biological pathways were similar. Cell growth and proliferation, cell cycle, heme metabolism, and mitochondrial dysfunction were most altered with the Gaucher disease process. Imig and vela differentially affected specific disease pathways. Differential molecular responses were observed in direct transcriptome comparisons from imig- and vela-treated tissues. These results provide cross-validation for the mRNA-Seq and microarray platforms, and show differences between the molecular effects of two highly structurally similar ERT biopharmaceuticals.	[Dasgupta, Nupur; Xu, You-Hai; Oh, Sunghee; Sun, Ying; Keddache, Mehdi; Grabowski, Gregory A.] Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH USA; [Xu, You-Hai; Oh, Sunghee; Sun, Ying; Keddache, Mehdi; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Jia, Li] NIH, CCR Bioinformat Core, Adv Biomed Comp Ctr, Frederick Natl Lab Canc Res, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA	Grabowski, GA (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH USA.	greg.grabowski@cchmc.org			National Institutes of Health [DK 36729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is supported by a grant by from the National Institutes of Health (DK 36729).	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Barak V, 1999, EUR CYTOKINE NETW, V10, P205; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cardoso SM, 2010, EXP NEUROL, V223, P294, DOI 10.1016/j.expneurol.2009.06.008; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; CHIBA T, 1993, P NATL ACAD SCI USA, V90, P11593, DOI 10.1073/pnas.90.24.11593; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Friedman BA, 1999, BLOOD, V93, P2807; Grabowski G. A., 2010, METABOLIC MOL BASES; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Guggenbuhl P, 2008, JOINT BONE SPINE, V75, P116, DOI 10.1016/j.jbspin.2007.06.006; Gutierrez L, 2004, DEVELOPMENT, V131, P3183, DOI 10.1242/dev.01198; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hollak CEM, 1997, BLOOD CELL MOL DIS, V23, P201, DOI 10.1006/bcmd.1997.0137; Hong YB, 2004, J HUM GENET, V49, P349, DOI 10.1007/s10038-004-0155-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Lahiry P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025400; Lalle M, 2011, J BIOL CHEM, V286, P1227, DOI 10.1074/jbc.M110.194613; Liew CW, 2006, J BIOL CHEM, V281, P28296, DOI 10.1074/jbc.M602830200; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; McEachern KA, 2006, J GENE MED, V8, P719, DOI 10.1002/jgm.901; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Michelakakis H, 1996, BBA-MOL BASIS DIS, V1317, P219, DOI 10.1016/S0925-4439(96)00056-7; Morceau F, 2004, ANN NY ACAD SCI, V1030, P537, DOI 10.1196/annals.1329.064; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myerowitz R, 2004, MOL GENET METAB, V83, P288, DOI 10.1016/j.ymgme.2004.06.020; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; PASTORES GM, 1993, BLOOD, V82, P408; Patel-Hett S, 2011, BLOOD, V118, P1641, DOI 10.1182/blood-2011-01-330688; PEVNY L, 1995, DEVELOPMENT, V121, P163; Ponka P, 1997, BLOOD, V89, P1; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roukos DH, 2010, EXPERT REV MED DEVIC, V7, P723, DOI [10.1586/erd.10.68, 10.1586/ERD.10.68]; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRITSCHLER HJ, 1994, BIOCHEM MOL BIOL INT, V34, P169; Tsuji S, 2010, HUM MOL GENET, V19, pR65, DOI 10.1093/hmg/ddq162; van den Akker E, 2004, BLOOD, V103, P4457, DOI 10.1182/blood-2003-08-2713; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; Vazquez MC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/205713; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-20; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Yamaguchi Y, 1998, BLOOD, V91, P3447, DOI 10.1182/blood.V91.9.3447.3447_3447_3458	84	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74912	10.1371/journal.pone.0074912	http://dx.doi.org/10.1371/journal.pone.0074912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124461	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100018
J	Hauke, J; Schild, A; Neugebauer, A; Lappa, A; Fricke, J; Fauser, S; Rosler, S; Pannes, A; Zarrinnam, D; Altmuller, J; Motameny, S; Nurnberg, G; Nurnberg, P; Hahnen, E; Beck, BB				Hauke, Jan; Schild, Andrea; Neugebauer, Antje; Lappa, Alexandra; Fricke, Julia; Fauser, Sascha; Roesler, Stefanie; Pannes, Andrea; Zarrinnam, Dirk; Altmueller, Janine; Motameny, Susanne; Nuernberg, Gudrun; Nuernberg, Peter; Hahnen, Eric; Beck, Bodo B.			A Novel Large In-Frame Deletion within the CACNA1F Gene Associates with a Cone-Rod Dystrophy 3-Like Phenotype	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; LINKED RETINAL DISORDER; PROGRESSIVE CONE; CALCIUM-CHANNEL; CLINICAL-FEATURES; RIBBON SYNAPSES; EYE DISEASE; HIGH MYOPIA; MUTATIONS; FAMILIES	Cone-rod dystrophies (CORDs) represent a heterogeneous group of monogenic diseases leading to early impairment of vision. The majority of CORD entities show autosomal modes of inheritance and X-linked traits are comparably rare. So far, three X-chromosomal entities were reported (CORDX1, -X2 and -X3). In this study, we analysed a large family of German origin with solely affected males over three generations showing a CORDX-like phenotype. Due to the heterogeneity of cone-rod dystrophies, we performed a combined linkage and X-exome sequencing approach and identified a novel large intragenic in-frame deletion encompassing exons 18 to 26 within the CACNA1F gene. CACNA1F is described causative for CORDX3 in a single family originating from Finland and alterations in this gene have not yet been reported in other CORDX pedigrees. Our data independently confirm CACNA1F as the causative gene for CORDX3-like phenotypes and detailed clinical characterization of the family expands the knowledge about the phenotypic spectrum of deleterious CACNA1F alterations.	[Hauke, Jan; Roesler, Stefanie; Pannes, Andrea; Beck, Bodo B.] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Hauke, Jan; Roesler, Stefanie; Nuernberg, Peter; Hahnen, Eric] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Hauke, Jan; Hahnen, Eric] Univ Cologne, Ctr Familial Breast & Ovarian Canc, D-50931 Cologne, Germany; [Schild, Andrea; Neugebauer, Antje; Lappa, Alexandra; Fricke, Julia; Fauser, Sascha] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Altmueller, Janine; Motameny, Susanne; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Hahnen, E (corresponding author), Univ Cologne, CMMC, D-50931 Cologne, Germany.	eric.hahnen@uk-koeln.de		Hauke, Jan/0000-0001-8236-4075; Altmuller, Janine/0000-0003-4372-1521	'Gertrud Kusen-Stiftung'; 'Ernst und Berta Grimmke-Stiftung' [5/10]; 'Koln Fortune Programm' [46/2010]; 'Imhoff Stiftung'	'Gertrud Kusen-Stiftung'; 'Ernst und Berta Grimmke-Stiftung'; 'Koln Fortune Programm'; 'Imhoff Stiftung'	This study was kindly supported by the 'Gertrud Kusen-Stiftung' (to EH, BB, AS, and AN). JH was supported by the 'Ernst und Berta Grimmke-Stiftung' (grant 5/10), the 'Koln Fortune Programm' (grant 46/2010) and the 'Imhoff Stiftung'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Allen LE, 2003, BRIT J OPHTHALMOL, V87, P1413, DOI 10.1136/bjo.87.11.1413; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bergen AAB, 1996, J MED GENET, V33, P869, DOI 10.1136/jmg.33.10.869; Bergen AAB, 1997, AM J HUM GENET, V60, P1468, DOI 10.1086/515458; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Doering CJ, 2007, CHANNELS, V1; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1667; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Ebenezer ND, 2005, INVEST OPHTH VIS SCI, V46, P1891, DOI 10.1167/iovs.04-1482; FORSIUS H, 1964, Klin Monbl Augenheilkd, V144, P447; Goldschmidt E, 2011, ACTA OPHTHALMOL, V89, P97, DOI 10.1111/j.1755-3768.2010.02104.x; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Hope CI, 2005, CLIN EXP OPHTHALMOL, V33, P129, DOI 10.1111/j.1442-9071.2005.00987.x; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Jalkanen R, 2003, J MED GENET, V40, P418, DOI 10.1136/jmg.40.6.418; Jalkanen R, 2007, INVEST OPHTH VIS SCI, V48, P2498, DOI 10.1167/iovs.06-1103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lodha N, 2010, ADV EXP MED BIOL, V664, P549, DOI 10.1007/978-1-4419-1399-9_63; Lorenz B, 1996, Ther Umsch, V53, P7; MANTYJARVI M, 1989, ACTA OPHTHALMOL, V67, P234; Mantyjarvi M, 2001, ACTA OPHTHALMOL SCAN, V79, P359, DOI 10.1034/j.1600-0420.2001.079004359.x; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2000, IMMUNOL CELL BIOL, V78, P442, DOI 10.1046/j.1440-1711.2000.00923.x; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Morgans CW, 2000, MICROSC RES TECHNIQ, V50, P141, DOI 10.1002/1097-0029(20000715)50:2<141::AID-JEMT6>3.0.CO;2-B; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PEARCE WG, 1990, CAN J OPHTHALMOL, V25, P3; RABB M F, 1981, International Ophthalmology Clinics, V21, P51, DOI 10.1097/00004397-198102130-00006; Ruether K, 1993, Ger J Ophthalmol, V2, P429; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; VANDORP DB, 1985, CLIN GENET, V28, P526; Vincent A, 2011, MOL VIS, V17, P3262; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zito I, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9106	50	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76414	10.1371/journal.pone.0076414	http://dx.doi.org/10.1371/journal.pone.0076414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124559	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100116
J	Park, B; Park, J; Jun, JK; Choi, KS; Suh, M				Park, Boyoung; Park, Jonghan; Jun, Jae Kwan; Choi, Kui Son; Suh, Mina			Gender Differences in the Association of Smoking and Drinking with the Development of Cognitive Impairment	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; ALCOHOL-CONSUMPTION; LUNG-CANCER; RISK-FACTOR; NONWESTERN SOCIETY; ALZHEIMERS-DISEASE; OLDER-ADULTS; DEMENTIA; NICOTINE; DECLINE	Modifiable lifestyle-related factors such as smoking and alcohol drinking are associated with cognitive impairment in the elderly population but the relationships have shown various results. To evaluate the relationship of alcohol drinking and smoking in the early 60 s with the risk of developing incident cognitive impairment. In 1999, we evaluated cognitive function, smoking, and drinking status in 3,174 inhabitants aged 60-64 years in a rural area of Korea, with a follow-up assessment of cognitive function 7 years later. A total of 1,810 individuals who did not show cognitive impairment at baseline were included. A stratified analysis was applied to evaluate how smoking and alcohol drinking affected the risk of developing cognitive impairment based on gender. Current smokers showed a higher risk for developing cognitive impairment than did never smokers (odds ratio [OR], 1.53; 95% confidence interval [CI], 1.09-2.15). The OR for female current smokers compared with never smokers was 1.62 (95% CI, 1.05-2.52), and smokers with higher pack-years were more likely to develop cognitive impairment than never smokers, showing a dose-response relationship (P for trend = 0.004). Frequent alcohol consumption increased the risk of developing cognitive impairment (OR, 1.68; 95% CI, 1.01-2.78), and a dose-response relationship was observed among male subjects (P for trend = 0.044). Infrequent drinking in females decreased the odds of developing cognitive impairment (OR, 0.67; 95% CI, 0.42-1.00), whereas frequent drinking tended to increase the odds, although this trend was not significant, suggesting a U-shaped relationship. Although the sample was small for some analyses, especially in female, our data suggest that smoking and drinking in the early 60 s are associated with a risk of developing cognitive impairment, and this relationship is characterized by gender differences.	[Park, Boyoung; Jun, Jae Kwan; Choi, Kui Son; Suh, Mina] Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea; [Park, Jonghan] Catholic Univ Daegu, Dept Psychiat, Taegu, South Korea	National Cancer Center - Korea (NCC); Catholic University of Daegu	Park, B (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea.	hayejine@ncc.re.kr			National Cancer Center of Korea [1310230]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1310230). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2002, ADDICTION, V97, P15, DOI 10.1046/j.1360-0443.2002.00016.x; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Anttila T, 2004, BMJ-BRIT MED J, V329, P539, DOI 10.1136/bmj.38181.418958.BE; Arab L, 2011, J ALZHEIMERS DIS, V27, P553, DOI 10.3233/JAD-2011-110431; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Chan KKK, 2010, INT J GERIATR PSYCH, V25, P1272, DOI 10.1002/gps.2470; Chen JH, 2009, J FORMOS MED ASSOC, V108, P754, DOI 10.1016/S0929-6646(09)60402-2; Cho M. J., 1999, J KOREAN NEUROPSYCHI, V38, P48; Cho MJ, 2011, J KOREAN MED SCI, V26, P1, DOI 10.3346/jkms.2011.26.1.1; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405, DOI 10.1093/oxfordjournals.aje.a009293; ELROD K, 1988, LIFE SCI, V43, P277, DOI 10.1016/0024-3205(88)90318-9; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; Graham K, 1998, ADDICTION, V93, P1137, DOI 10.1046/j.1360-0443.1998.93811372.x; Hartung DM, 2009, AM J HEALTH-SYST PH, V66, P398, DOI 10.2146/ajhp080300; Haugen A, 2002, CARCINOGENESIS, V23, P227, DOI 10.1093/carcin/23.2.227; Kelada SN, 2002, NEUROTOXICOLOGY, V23, P515, DOI 10.1016/S0161-813X(02)00061-X; KYEREMATEN GA, 1988, DRUG METAB DISPOS, V16, P823; LEE PN, 1994, NEUROEPIDEMIOLOGY, V13, P131, DOI 10.1159/000110372; Lee Y, 2013, PREV MED, V56, P124, DOI 10.1016/j.ypmed.2012.12.002; Panza F, 2012, INT J GERIATR PSYCH, V27, P1218, DOI 10.1002/gps.3772; Panza F, 2009, J ALZHEIMERS DIS, V17, P7, DOI 10.3233/JAD-2009-1009; PARK JH, 1990, INT J GERIATR PSYCH, V5, P381, DOI 10.1002/gps.930050606; PARK JH, 1991, INT J GERIATR PSYCH, V6, P875, DOI 10.1002/gps.930061208; Patel JD, 2004, JAMA-J AM MED ASSOC, V291, P1763, DOI 10.1001/jama.291.14.1763; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; Salomon AR, 1996, BIOCHEMISTRY-US, V35, P13568, DOI 10.1021/bi9617264; YAMAMOTO J, 1994, COMMUNITY MENT HLT J, V30, P17, DOI 10.1007/BF02188872; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	32	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75095	10.1371/journal.pone.0075095	http://dx.doi.org/10.1371/journal.pone.0075095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124468	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100025
J	Luo, ZR; Zhuang, XJ; Kumar, D; Wu, XR; Yue, C; Han, CK; Lv, JC				Luo, Zhuren; Zhuang, Xiongjie; Kumar, Dushyant; Wu, Xiurong; Yue, Cen; Han, Chengkun; Lv, Jiancheng			The Correlation of Hippocampal T-2-Mapping with Neuropsychology Test in Patients with Alzheimer's Disease	PLOS ONE			English	Article							TRANSVERSE RELAXATION RATES; NEUROFIBRILLARY TANGLES; REGIONAL-DISTRIBUTION; T-2 RELAXATION; SENILE PLAQUES; BRAIN-REGIONS; IRON; MYELIN; PROLONGATION; PARKINSONS	Objectives: 1) To deduce T-2, the inverse of the transverse relaxation rate (R-2), in the hippocampus of healthy adults; 2) to investigate the brain iron deposition in Alzheimer's disease (AD) patients and age-matched healthy controls using T-2-values. Methods: T-2-weighted data from the bilateral-hippocampi of ten AD patients and sixty healthy controls were collected at six echo time points using multi-slice multi-echo turbo spin echo (MSME-TSE) imaging on a 3.0 T MR-scanner, followed by the neuropsychological testing. The correlations between T-2-values and Mini-Mental State Examination (MMSE) scores were investigated on group-wise basis (covariates in the group-wise analyses: gender, age, side and healthy/AD). Results: There were no significant differences in hippocampal T-2-values on intra-gender and inter-gender basis (P > 0.05). Hippocampal T-2-values of both sides were similar (right: 85.2 +/- 2.4 milliseconds; left: 85.3 +/- 2.5 milliseconds). The bilateral hippocampal T-2 values correlated moderately with age (right: r = -0.59; left: -0.58; P < 0.001). The AD-group had significantly lower T-2-values in the hippocampus when compared to normal controls (P < 0.001) and such low T-2-values had a strong positive correlation with the MMSE score (R2 = 0.97; P < 0.05). Conclusion: Patients with AD showed significantly lower T-2 values, which can be attributed to the increased iron depositions in the hippocampus. A positive correlation between T-2-values and cognition scores suggests that quantitative T-2 can be used in the early diagnosis of AD and in the monitoring of the treatment response.	[Luo, Zhuren; Zhuang, Xiongjie; Wu, Xiurong; Han, Chengkun; Lv, Jiancheng] Xiamen Univ, Dept Radiol, Affiliated Hosp 1, Xiamen, Peoples R China; [Kumar, Dushyant] Univ Med Ctr Hamburg Eppendorf UKE, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Kumar, Dushyant] Univ Med Ctr Hamburg Eppendorf UKE, Multiple Sclerosis Imaging Sect, Hamburg, Germany; [Yue, Cen] Xiamen Univ, Dept Neurol, Affiliated Hosp 1, Xiamen, Peoples R China	Xiamen University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Xiamen University	Zhuang, XJ (corresponding author), Xiamen Univ, Dept Radiol, Affiliated Hosp 1, Xiamen, Peoples R China.	xiongjiezhuang@gmail.com			Youth Foundation of Health Department of Fujian Province of China [2012-2-75]	Youth Foundation of Health Department of Fujian Province of China	This work was financially supported by the Youth Foundation of Health Department of Fujian Province of China (No. 2012-2-75) (http://www.fjphb.gov.cn/show.aspx?ctlgid=448882&id=77384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; BESSON JAO, 1992, BRIT J PSYCHIAT, V160, P187, DOI 10.1192/bjp.160.2.187; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BREGER RK, 1989, RADIOLOGY, V171, P273, DOI 10.1148/radiology.171.1.2928538; Brittenham GM, 2003, BLOOD, V101, P15, DOI 10.1182/blood-2002-06-1723; BROWNSTEIN KR, 1977, J MAGN RESON, V26, P17, DOI 10.1016/0022-2364(77)90230-X; Campeau NG, 1997, RADIOLOGY, V205, P197, DOI 10.1148/radiology.205.1.9314985; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Collingwood JF, 2005, J ALZHEIMERS DIS, V7, P267; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; DEDMAN DJ, 1992, BIOCHEM J, V287, P509, DOI 10.1042/bj2870509; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Doraiswamy PM, 2004, LANCET NEUROL, V3, P431, DOI 10.1016/S1474-4422(04)00809-9; EHMANN WD, 1986, NEUROTOXICOLOGY, V7, P197; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Englund E, 1987, Alzheimer Dis Assoc Disord, V1, P156; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; GIANNAKOPOULOS P, 1995, ARCH NEUROL-CHICAGO, V52, P1150, DOI 10.1001/archneur.1995.00540360028012; Haley AP, 2004, NEUROSCI LETT, V362, P167, DOI 10.1016/j.neulet.2004.01.031; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hasan KM, 2012, MAGN RESON MED, V67, P731, DOI 10.1002/mrm.23054; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; House MJ, 2007, MAGN RESON MED, V57, P172, DOI 10.1002/mrm.21118; House MJ, 2006, AM J NEURORADIOL, V27, P430; HUESGEN CT, 1993, NEUROLOGY, V43, P145, DOI 10.1212/WNL.43.1_Part_1.145; KIRSCH SJ, 1992, NEUROSCI LETT, V134, P187, DOI 10.1016/0304-3940(92)90513-7; Kolind SH, 2009, MAGN RESON MED, V62, P106, DOI 10.1002/mrm.21966; Laakso MP, 1996, NEUROBIOL AGING, V17, P535, DOI 10.1016/0197-4580(96)00036-X; LeVine SM, 1997, BRAIN RES, V760, P298, DOI 10.1016/S0006-8993(97)00470-8; Liu G, 2005, BBA-MOL BASIS DIS, V1741, P246, DOI 10.1016/j.bbadis.2005.06.006; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Novellino F, 2013, MOVEMENT DISORD, V28, P196, DOI 10.1002/mds.25263; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pitkanen A, 1996, NEUROLOGY, V46, P1724, DOI 10.1212/WNL.46.6.1724; REINIKAINEN KJ, 1989, NEUROSCI LETT, V106, P229, DOI 10.1016/0304-3940(89)90230-9; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; Schenck John F, 2006, Top Magn Reson Imaging, V17, P41, DOI 10.1097/01.rmr.0000245455.59912.40; Sjobeck M, 2003, NEUROPATH APPL NEURO, V29, P159, DOI 10.1046/j.1365-2990.2003.00456.x; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; THOMAS LO, 1993, AM J NEURORADIOL, V14, P1043; THOMPSON CM, 1988, NEUROTOXICOLOGY, V9, P1; [王东 Wang Dong], 2010, [中华神经科杂志, Chinese Journal of Neurology], V43, P626; Wang HL, 2004, NEUROSCI LETT, V363, P150, DOI 10.1016/j.neulet.2004.03.061; Zheng HL, 2005, BIOORGAN MED CHEM, V13, P773, DOI 10.1016/j.bmc.2004.10.037	49	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76203	10.1371/journal.pone.0076203	http://dx.doi.org/10.1371/journal.pone.0076203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098779	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500149
J	Corona, ED; Jacquelin, D; Gatica, L; Rosa, AL				Daniel Corona, Edgardo; Jacquelin, Daniela; Gatica, Laura; Luis Rosa, Alberto			Multiple Protein Domains Contribute to Nuclear Import and Cell Toxicity of DUX4, a Candidate Pathogenic Protein for Facioscapulohumeral Muscular Dystrophy	PLOS ONE			English	Article							LOCALIZATION SIGNALS; DNA-BINDING; HOMEODOMAIN; D4Z4; GENE; SEQUENCE; REPEAT; LOCUS; CONSERVATION; EXPRESSION	DUX4 (Double Homeobox Protein 4) is a nuclear transcription factor encoded at each D4Z4 unit of a tandem-repeat array at human chromosome 4q35. DUX4 constitutes a major candidate pathogenic protein for facioscapulohumeral muscular dystrophy (FSHD), the third most common form of inherited myopathy. A low-level expression of DUX4 compromises cell differentiation in myoblasts and its overexpression induces apoptosis in cultured cells and living organisms. In this work we explore potential molecular determinants of DUX4 mediating nuclear import and cell toxicity. Deletion of the hypothetical monopartite nuclear localization sequences RRRR23, RRKR98 and RRAR(148) (i.e. NLS1, NLS2 and NLS3, respectively) only partially delocalizes DUX4 from the cell nuclei. Nuclear entrance guided by NLS1, NLS2 and NLS3 does not follow the classical nuclear import pathway mediated by alpha/beta importins. NLS and homeodomain mutants from DUX4 are dramatically less cell-toxic than the wild type molecule, independently of their subcellular localization. A triple Delta NLS1-2-3 deletion mutant is still partially localized in the nuclei, indicating that additional sequences in DUX4 contribute to nuclear import. Deletion of >= 111 amino acids from the C-terminal of DUX4, on a Delta NLS1-2-3 background, almost completely re-localizes DUX4 to the cytoplasm, indicating that the C-ter tail contributes to subcellular trafficking of DUX4. Also, C-terminal deletion mutants of DUX4 on a NLS wild type background are less toxic than wild type DUX4. Results reported here indicate that DUX4 possesses redundant mechanisms to assure nuclear entrance and that its various transcription-factor associated domains play an essential role in cell toxicity.	[Daniel Corona, Edgardo; Jacquelin, Daniela; Gatica, Laura; Luis Rosa, Alberto] Fdn Allende, Lab Biol Celular & Mol, Cordoba, Argentina; [Luis Rosa, Alberto] Sanatorio Allende, Cordoba, Argentina		Rosa, AL (corresponding author), Fdn Allende, Lab Biol Celular & Mol, Cordoba, Argentina.	alberto_l_rosa@yahoo.com.ar			CONICET (Argentina); FONCYT (Argentina)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT (Argentina)(FONCyT)	We thank R. Defago for English editing, H.J.F. Maccioni for critical reading of the manuscript and H. Lujan and his team at UCC for their generous sharing of microscope facilities. EDC and DJ held fellowships from CONICET (Argentina). LG held a fellowship from FONCYT (Argentina). ALR is Medical Investigator from the National Research Council from Argentina (CONICET)	ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796; Christophe-Hobertus C, 1999, EUR J BIOCHEM, V265, P491, DOI 10.1046/j.1432-1327.1999.00796.x; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Ostlund C, 2005, BIOCHEMISTRY-US, V44, P2378, DOI 10.1021/bi047992w; Padberg GW, 1998, NEUROMUSCULAR DISORD; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105; QIAN YQ, 1994, J MOL BIOL, V238, P333, DOI 10.1006/jmbi.1994.1296; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; TSAO DHH, 1995, J MOL BIOL, V251, P297, DOI 10.1006/jmbi.1995.0435; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386	44	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75614	10.1371/journal.pone.0075614	http://dx.doi.org/10.1371/journal.pone.0075614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116060	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200030
J	Malleret, B; Xu, FG; Mohandas, N; Suwanarusk, R; Chu, C; Leite, JA; Low, K; Turner, C; Sriprawat, K; Zhang, R; Bertrand, O; Colin, Y; Costa, FTM; Ong, CN; Ng, ML; Lim, CT; Nosten, F; Renia, L; Russell, B				Malleret, Benoit; Xu, Fenggao; Mohandas, Narla; Suwanarusk, Rossarin; Chu, Cindy; Leite, Juliana A.; Low, Kayen; Turner, Claudia; Sriprawat, Kanlaya; Zhang, Rou; Bertrand, Olivier; Colin, Yves; Costa, Fabio T. M.; Ong, Choon Nam; Ng, Mah Lee; Lim, Chwee Teck; Nosten, Francois; Renia, Laurent; Russell, Bruce			Significant Biochemical, Biophysical and Metabolic Diversity in Circulating Human Cord Blood Reticulocytes	PLOS ONE			English	Article							FLOW CYTOMETRIC ANALYSIS; MEMBRANE DEFORMABILITY; TRANSFERRIN RECEPTOR; SHEEP RETICULOCYTES; PLASMODIUM-VIVAX; THIAZOLE ORANGE; MATURITY INDEX; CELL MEMBRANE; ERYTHROCYTES; MATURATION	Background: The transition from enucleated reticulocytes to mature normocytes is marked by substantial remodeling of the erythrocytic cytoplasm and membrane. Despite conspicuous changes, most studies describe the maturing reticulocyte as a homogenous erythropoietic cell type. While reticulocyte staging based on fluorescent RNA stains such as thiazole orange have been useful in a clinical setting; these 'sub-vital' stains may confound delicate studies on reticulocyte biology and may preclude their use in heamoparasite invasion studies. Design and Methods: Here we use highly purified populations of reticulocytes isolated from cord blood, sorted by flow cytometry into four sequential subpopulations based on transferrin receptor (CD71) expression: CD71high, CD71medium, CD71low and CD71negative. Each of these subgroups was phenotyped in terms of their, morphology, membrane antigens, biomechanical properties and metabolomic profile. Results: Superficially CD71high and CD71medium reticulocytes share a similar gross morphology (large and multilobular) when compared to the smaller, smooth and increasingly concave reticulocytes as seen in the in the CD71low and CD71negativesamples. However, between each of the four sample sets we observe significant decreases in shear modulus, cytoadhesive capacity, erythroid receptor expression (CD44, CD55, CD147, CD235R, and CD242) and metabolite concentrations. Interestingly increasing amounts of boric acid was found in the mature reticulocytes. Conclusions: Reticulocyte maturation is a dynamic and continuous process, confounding efforts to rigidly classify them. Certainly this study does not offer an alternative classification strategy; instead we used a nondestructive sampling method to examine key phenotypic changes of in reticulocytes. Our study emphasizes a need to focus greater attention on reticulocyte biology.	[Malleret, Benoit; Suwanarusk, Rossarin; Leite, Juliana A.; Renia, Laurent] ASTAR, Biopolis, Lab Malaria Immunobiol, Singapore Immunol Network SIgN, Singapore, Singapore; [Xu, Fenggao; Ong, Choon Nam] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA; [Chu, Cindy; Turner, Claudia; Sriprawat, Kanlaya] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Leite, Juliana A.; Costa, Fabio T. M.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Low, Kayen] JEOL Asia Pte Ltd, Singapore, Singapore; [Zhang, Rou; Lim, Chwee Teck] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore; [Bertrand, Olivier; Colin, Yves] INSERM, UMR S Unite Mixte Rech 665, Paris, France; [Bertrand, Olivier; Colin, Yves] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Bertrand, Olivier; Colin, Yves] Univ Paris 07, Paris, France; [Ng, Mah Lee; Russell, Bruce] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Nosten, Francois] Mahidol Oxford Univ, Res Unit, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford, England	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; New York Blood Center; Mahidol University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Jeol Ltd; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National University of Singapore; National University of Singapore; National University of Singapore; Mahidol University; University of Oxford	Renia, L (corresponding author), ASTAR, Biopolis, Lab Malaria Immunobiol, Singapore Immunol Network SIgN, Singapore, Singapore.	renia_laurent@immunol.a-star.edu.sg; micbmr@nus.edu.sg	Nosten, Francois/AAC-5509-2019; Renia, Laurent/E-2117-2011; Lim, chwee Teck/B-3307-2011; Leite, Juliana/G-2563-2013; Malleret, Benoit/E-9159-2011; Costa, Fabio/E-1181-2012; Chu, Cindy S/E-3135-2014; colin, yves/O-1910-2017; Russell, Bruce/A-9240-2011; Suwanarusk, Rossarin/E-2115-2013; Ng, Mei Li/Q-3704-2016	Nosten, Francois/0000-0002-7951-0745; Renia, Laurent/0000-0003-0349-1557; Lim, chwee Teck/0000-0003-4019-9782; Malleret, Benoit/0000-0001-9658-7528; Costa, Fabio/0000-0001-9969-7300; Chu, Cindy S/0000-0001-9465-8214; colin, yves/0000-0001-5196-4254; Russell, Bruce/0000-0003-2333-4348; Suwanarusk, Rossarin/0000-0002-7310-245X; Ong, Choon Nam/0000-0002-4002-1725; Ng, Mei Li/0000-0001-9917-4534	Singapore Ministry of Health NMRC [CBRG12nov036]; SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore); Wellcome Trust of Great Britain; Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/52013-3]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); National University of Singapore; National University Health System, Singapore 'Start Up' Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263] Funding Source: NIH RePORTER	Singapore Ministry of Health NMRC(Ministry of Health-SingaporeNational Medical Research Council, Singapore); SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust of Great Britain(Wellcome Trust); Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); National University of Singapore(National University of Singapore); National University Health System, Singapore 'Start Up' Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study received funding from Singapore Ministry of Health NMRC (CBRG12nov036) grant, SIgN and from the Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore). SMRU is sponsored by The Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. JAL was supported by a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Process no. 2009/52013-3), and FTMC is enrolled at the Programa Estrategico de Ciencia, Tecnologia & Inovacao nas Fundacoes Estaduais de Saude (PECTI/AM Saude) from Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM). BR also received financial support from the National University of Singapore and National University Health System, Singapore 'Start Up' Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTLES JF, 1962, J BIOL CHEM, V237, P3770; Bessis M., 1973, LIVING BLOOD CELLS T; BRECHER G, 1950, AM J CLIN PATHOL, V20, P1079, DOI 10.1093/ajcp/20.11_ts.1079; BRUN A, 1990, BLOOD, V76, P2397; CABANTCHIK ZI, 1974, J MEMBRANE BIOL, V15, P227, DOI 10.1007/BF01870089; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; CHAMBERLAIN JK, 1978, BLOOD, V52, P959; CHASIS JA, 1989, BLOOD, V74, P2562; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Colella GM, 1991, BLOOD, V78; Coste I, 2001, BLOOD, V97, P3984, DOI 10.1182/blood.V97.12.3984; DAVIS BH, 1995, CYTOMETRY, V22, P35, DOI 10.1002/cyto.990220107; DAVIS BH, 1989, ARCH PATHOL LAB MED, V113, P684; Dertinger SD, 2002, MUTAT RES-GEN TOX EN, V515, P3, DOI 10.1016/S1383-5718(02)00009-8; Ehrlich P, 1881, BERL KLIN WSCHR, V18, P43; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Goel MS, 2002, BLOOD, V100, P3797, DOI 10.1182/blood-2002-03-0712; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; Heilmeyer L., 1932, ZTSCHR KLIN MED, V121, P361; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; Key JA, 1921, ARCH INTERN MED, V28, P511, DOI 10.1001/archinte.1921.00100170012002; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; Kono M, 2009, CLIN CHIM ACTA, V404, P105, DOI 10.1016/j.cca.2009.03.017; KOSENOW W, 1952, Z Kinderheilkd, V70, P552; LACELLE PL, 1970, SEMIN HEMATOL, V7, P355; LEBLOND PF, 1971, BLOOD-J HEMATOL, V37, P40, DOI 10.1182/blood.V37.1.40.40; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603; LEWIS M, 1977, AM J HUM GENET, V29, P101; LOWENSTEIN LM, 1959, INT REV CYTOL, V8, P135, DOI 10.1016/S0074-7696(08)62730-8; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; MEL HC, 1977, BLOOD, V49, P1001; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; NOBES PR, 1990, J CLIN PATHOL, V43, P675, DOI 10.1136/jcp.43.8.675; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; PAPAYANNOPOULOU T, 1975, BLOOD CELLS, V1, P535; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; PATERAKIS GS, 1993, ACTA HAEMATOL-BASEL, V90, P182; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Riley RS, 2001, J CLIN LAB ANAL, V15, P267, DOI 10.1002/jcla.1039; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; SAGE BH, 1983, CYTOMETRY, V4, P222, DOI 10.1002/cyto.990040306; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sathyanarayana P, 2007, BLOOD, V110, P509, DOI 10.1182/blood-2006-11-056465; Seip M, 1953, ACTA MED SCANDINAVIC, V146; Southcott MJG, 1999, BLOOD, V93, P4425, DOI 10.1182/blood.V93.12.4425.412k22_4425_4435; Turkez H, 2012, CYTOTECHNOLOGY; Xu FG, 2009, RAPID COMMUN MASS SP, V23, P3243, DOI 10.1002/rcm.4246	51	89	89	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76062	10.1371/journal.pone.0076062	http://dx.doi.org/10.1371/journal.pone.0076062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116088	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200047
J	Shi, H; Li, Y; Wang, XZ; Lu, C; Yang, LL; Gu, CM; Xiong, JQ; Huang, YX; Wang, SX; Lu, MX				Shi, Hao; Li, Ya; Wang, Xiaozhong; Lu, Cheng; Yang, Lilan; Gu, Changmei; Xiong, Jiaqiang; Huang, Yangxin; Wang, Shixuan; Lu, Meixia			Association between RASSF1A Promoter Methylation and Ovarian Cancer: A Meta-Analysis	PLOS ONE			English	Article							FREQUENT EPIGENETIC INACTIVATION; TUMOR-SUPPRESSOR GENES; CHROMOSOME 3P; CPG ISLAND; HYPERMETHYLATION; DIAGNOSIS; PATTERNS; SERUM; BIAS	Background: The RAS association domain family protein 1a gene (RASSF1A) is one of the tumor suppressor genes (TSG). Inactivation of RASSF1A is critical to the pathogenesis of cancer. Aberrant TSG methylation was considered an important epigenetic silencing mechanism in the progression of ovarian cancer. A number of studies have discussed association between RASSF1A promoter methylation and ovarian cancer. However, they were mostly based on a small number of samples and showed inconsist results, Therefore, we conducted a meta-analysis to better identify the association. Methods: Eligible studies were identified by searching the PubMed, EMBASE, Web of Science, and CNKI databases using a systematic searching strategy. We pooled the odds ratio (ORs) from individual studies using a fixed-effects model. We performed heterogeneity and publication bias analysis simultaneously. Results: Thirteen studies, with 763 ovarian cancer patients and 438 controls were included in the meta-analysis. The frequencies of RASSF1A promoter methylation ranged from 30% to 58% (median is 48%) in the cancer group and 0 to 21% (median is 0) in the control group. The frequencies of RASSF1A promoter methylation in the cancer group were significantly higher than those in the control group. The pooled odds ratio was 11.17 (95% CI = 7.51-16.61) in the cancer group versus the corresponding control group under the fixed-effects model. Conclusion: The results suggested that RASSF1A promoter methylation had a strong association with ovarian cancer.	[Shi, Hao; Gu, Changmei; Lu, Meixia] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Shi, Hao; Gu, Changmei; Lu, Meixia] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Li, Ya; Xiong, Jiaqiang; Wang, Shixuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Wang, Xiaozhong] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China; [Lu, Cheng] Nanchang Univ, Coll Med, Dept Anat, Nanchang, Jiangxi, Peoples R China; [Yang, Lilan] Nanchang Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China; [Huang, Yangxin] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Nanchang University; Nanchang University; Nanchang University; State University System of Florida; University of South Florida	Lu, MX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.	mlu@hust.edu.cn						Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Barnholtz-Sloan JS, 2003, AM J OBSTET GYNECOL, V189, P1120, DOI 10.1067/S0002-9378(03)00579-9; Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhagat R, 2012, CELL ONCOL, V35, P473, DOI 10.1007/s13402-012-0106-4; BonDurant AE, 2011, GYNECOL ONCOL, V123, P581, DOI 10.1016/j.ygyno.2011.08.029; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Byun DS, 2001, CANCER RES, V61, P7034; Choi YL, 2006, VIRCHOWS ARCH, V448, P331, DOI 10.1007/s00428-005-0091-3; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Hall M, 2013, BRIT J CANCER, V108, P250, DOI 10.1038/bjc.2012.541; He Y, 2011, J BENGBU MED COLL, V36, p[35, 41]; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho CM, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-53; Ibanez de Caceres I, 2004, CANCER RES, V64, P6476; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; [蒋文瀚 Jiang Wenhan], 2011, [循证医学, The Journal of Evidence-Based Medicine], V11, P305; Kuroki T, 2003, CANCER RES, V63, P3724; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061658; Lee MG, 2001, CANCER RES, V61, P6688; Li QR, 2007, J SHANDONG U MED SCI, P1046; Ma Lin, 2005, Zhonghua Zhongliu Zazhi, V27, P657; Makarla PB, 2005, CLIN CANCER RES, V11, P5365, DOI 10.1158/1078-0432.CCR-04-2455; Montavon C, 2012, GYNECOL ONCOL, V124, P582, DOI 10.1016/j.ygyno.2011.11.026; Ozdemir F, 2012, EXP THER MED, V4, P1092, DOI 10.3892/etm.2012.715; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pfeifer GP, 2005, BIOCHEMISTRY-MOSCOW+, V70, P576, DOI 10.1007/s10541-005-0151-y; Rathi A, 2002, CLIN CANCER RES, V8, P3324; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Shen WJ, 2008, CHIN J CANC PREV TRE, V15, P530; Teodoridis JM, 2005, CANCER RES, V65, P8961, DOI 10.1158/0008-5472.CAN-05-1187; Wong N, 2002, J HEPATOL, V37, P633, DOI 10.1016/S0168-8278(02)00269-6; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Yoon JH, 2001, INT J CANCER, V94, P212, DOI 10.1002/ijc.1466; 陈冬丽, 2010, [中国癌症杂志, China Oncology], V20, P712	38	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76787	10.1371/journal.pone.0076787	http://dx.doi.org/10.1371/journal.pone.0076787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116157	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200068
J	Gupta, P; Zheng, YF; Ting, TW; Lamoureux, EL; Cheng, CY; Wong, TY				Gupta, Preeti; Zheng, Yingfeng; Ting, Tay Wan; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Wong, Tien-Yin			Prevalence of Cataract Surgery and Visual Outcomes in Indian Immigrants in Singapore: The Singapore Indian Eye Study	PLOS ONE			English	Article							RISK-FACTORS; POPULATION; BLINDNESS; BARRIERS; CHINESE; IMPAIRMENT; EXTRACTION; VISION; ACUITY	Objective: To determine the prevalence of cataract surgery and factors associated with post-surgical visual outcomes in migrant Indians living in Singapore. Research Design and Methods: We conducted a population-based study in 3,400 Indian immigrants residing in Singapore-the Singapore Indian Eye Study (SINDI). All participants underwent comprehensive medical eye examination and a standardized interview. Post-operative visual impairment (VI) was defined as best-corrected or presenting visual acuity (BCVA or PVA) of 20/60 or worse. Results: The age-and gender-standardized prevalence of cataract surgery was 9.7% (95% confidence interval [CI]: 8.9%, 10.7%) in Singapore resident Indians. Post-operative VI defined by BCVA occurred in 10.9% eyes (87/795). The main causes of post-operative VI were diabetic retinopathy (20.7%), posterior capsular opacification (18.4%), and age-related macular degeneration (12.6%). Undercorrected refractive error doubled the prevalence of post-operative VI when PVA was used. Conclusions: The rate of cataract surgery is about 10% in Indian residents in Singapore. Socioeconomic variables and migration had no significant impact on the prevalence of cataract surgery. Diabetic retinopathy was a major cause of postoperative VI in migrant Indians living in Singapore. Uncorrected postoperative refractive error remains an efficient way to improve vision.	[Gupta, Preeti; Zheng, Yingfeng; Ting, Tay Wan; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Wong, Tien-Yin] Singapore Eye Res Inst, Singapore, Singapore; [Gupta, Preeti; Zheng, Yingfeng; Ting, Tay Wan; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Wong, Tien-Yin] Singapore Natl Eye Ctr, Singapore, Singapore; [Lamoureux, Ecosse L.; Wong, Tien-Yin] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3010, Australia; [Cheng, Ching-Yu; Wong, Tien-Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Cheng, Ching-Yu] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Cheng, Ching-Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; National University of Singapore; National University of Singapore; National University of Singapore	Cheng, CY (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	ching-yu_cheng@nuhs.edu.sg	Zheng, Yingfeng/CAE-9225-2022; Cheng, Ching-Yu/Y-2229-2019; Lamoureux, Ecosse/Z-5482-2019; Wong, Tien Yin/AAC-9724-2020; Zheng, Yingfeng/AAE-2983-2022	Zheng, Yingfeng/0000-0002-0914-7864; Cheng, Ching-Yu/0000-0003-0655-885X; Wong, Tien Yin/0000-0002-8448-1264; 	Biomedical Research Council (BMRC) [08/1/35/19/550]; National Medical Research Council (NMRC), Singapore [StaR/0003/2008]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study was funded by Biomedical Research Council (BMRC), 08/1/35/19/550 and National Medical Research Council (NMRC), StaR/0003/2008, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Baranano AE, 2008, OPHTHALMOLOGY, V115, P815, DOI 10.1016/j.ophtha.2007.05.052; Broman AT, 2005, ARCH OPHTHALMOL-CHIC, V123, P1231, DOI 10.1001/archopht.123.9.1231; Chiang PPC, 2011, INVEST OPHTH VIS SCI, V52, P7586, DOI 10.1167/iovs.11-7698; Congdon NG, 2007, ARCH OPHTHALMOL-CHIC, V125, P1546, DOI 10.1001/archopht.125.11.eeb70014; Dandona L, 1999, AM J OPHTHALMOL, V127, P650, DOI 10.1016/S0002-9394(99)00044-6; Desai P, 1996, BRIT J OPHTHALMOL, V80, P868, DOI 10.1136/bjo.80.10.868; Foster PJ, 2003, BRIT J OPHTHALMOL, V87, P1112, DOI 10.1136/bjo.87.9.1112; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; KHOO D H C, 1990, Annals Academy of Medicine Singapore, V19, P484; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Lau J, 2002, BRIT J OPHTHALMOL, V86, P12, DOI 10.1136/bjo.86.1.12; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Liu B, 2009, OPHTHALMOLOGY, V116, P1322, DOI 10.1016/j.ophtha.2009.01.030; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Nangia V, 2011, J CATARACT REFR SURG, V37, P1932, DOI 10.1016/j.jcrs.2011.08.020; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Singapore Department of Statistics, 2009, SING FIG 2010 ETHN D; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; United Nations Development Programme, 2009, HUM DEV REP 2009 OV; United States Census Bureau, SEL POP PROF US POP; Vaidyanathan K, 1999, B WORLD HEALTH ORGAN, V77, P104; Vijaya L, 2010, INDIAN J OPHTHALMOL, V58, P223, DOI 10.4103/0301-4738.62648; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2001, ARCH OPHTHALMOL-CHIC, V119, P727, DOI 10.1001/archopht.119.5.727; World Health Organization International Agency for the Prevention of Blindness, 2002, REP WORLD VIS 2002 S; Yin QX, 2009, INVEST OPHTH VIS SCI, V50, P1069, DOI 10.1167/iovs.08-2783; Yorston D, 2005, EYE, V19, P1083, DOI 10.1038/sj.eye.6701966; Zhao JL, 2010, OPHTHALMOLOGY, V117, P2120, DOI 10.1016/j.ophtha.2010.03.005; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75584	10.1371/journal.pone.0075584	http://dx.doi.org/10.1371/journal.pone.0075584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116058	Green Published, gold			2022-12-27	WOS:000325501300035
J	Osmundson, J; Dewell, S; Darst, SA				Osmundson, Joseph; Dewell, Scott; Darst, Seth A.			RNA-Seq Reveals Differential Gene Expression in Staphylococcus aureus with Single-Nucleotide Resolution	PLOS ONE			English	Article							LABORATORY STRAINS; CELL-WALL; TRANSCRIPTION; AGR; REGULATOR; GENOMES; SARA; IDENTIFICATION; RESISTANCE; INHIBITION	Staphylococcus aureus is a gram-positive cocci and an important human commensal bacteria and pathogen. S. aureus infections are increasingly difficult to treat because of the emergence of highly resistant MRSA (methicillin-resistant S. aureus) strains. Here we present a method to study differential gene expression in S. aureus using high-throughput RNA-sequencing (RNA-seq). We used RNA-seq to examine gene expression in S. aureus RN4220 cells containing an exogenously expressed transcription factor and between two S. aureus strains (RN4220 and NCTC8325-4). We investigated the sequence and gene expression differences between RN4220 and NCTC8325-4 and used the RNA-seq data to identify S. aureus promoters suitable for in vitro analysis. We used RNA-seq to describe, on a genome wide scale, genes positively and negatively regulated by the phage encoded transcription factor gp67. RNA-seq offers the ability to study differential gene expression with single-nucleotide resolution, and is a considerable improvement over the predominant genome-wide transcriptome technologies used in S. aureus.	[Osmundson, Joseph; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Osmundson, J (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	josmundson@rockefeller.edu			National Institutes of Health [RO1 GM053759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This was supported by the National Institutes of Health Grant RO1 GM053759 to S. A. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; Berscheid A, 2012, INT J MED MICROBIOL, V302, P84, DOI 10.1016/j.ijmm.2012.01.002; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Dehbi M, 2009, J BACTERIOL, V191, P3763, DOI 10.1128/JB.00241-09; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hubscher J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-307; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; MENDOZAVARGAS A, 2009, PLOS ONE, V4, pNI158; Montero-Diez C, 2013, J BACTERIOL; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nordmann P, 2007, CURR OPIN MICROBIOL, V10, P436, DOI 10.1016/j.mib.2007.07.004; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; O'Neill AJ, 2009, ANTIMICROB AGENTS CH, V53, P1701, DOI 10.1128/AAC.01309-08; Ohta T, 2004, DNA RES, V11, P51, DOI 10.1093/dnares/11.1.51; Osmundson J., 2013, BACTERIOPHAGE, V3, pe24767, DOI 10.4161/bact.24767; Osmundson J, 2012, CELL, V151, P1005, DOI 10.1016/j.cell.2012.10.034; Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Reynolds J, 2011, J MOL BIOL, V412, P862, DOI 10.1016/j.jmb.2011.06.018; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Soon WW, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.61; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truong-Bolduc QC, 2011, J BACTERIOL, V193, P6207, DOI 10.1128/JB.05847-11; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Vvedenskaya IO, 2012, GENE DEV, V26, P1498, DOI 10.1101/gad.192732.112; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10	50	11	11	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76572	10.1371/journal.pone.0076572	http://dx.doi.org/10.1371/journal.pone.0076572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116120	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300067
J	Pang, PF; Wu, C; Shen, M; Gong, FM; Zhu, KS; Jiang, ZB; Guan, SH; Shan, H; Shuai, XT				Pang, Pengfei; Wu, Chun; Shen, Min; Gong, Faming; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong; Shuai, Xintao			An MRI-Visible Non-Viral Vector Bearing GD2 Single Chain Antibody for Targeted Gene Delivery to Human Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							NEURAL GANGLIOSIDE GD2; STROMAL CELLS; UMBILICAL-CORD; DNA; CYTOTOXICITY; EXPRESS; DISEASE; CULTURE; TRAIL; PEI	The neural ganglioside GD2 has recently been reported to be a novel surface marker that is only expressed on human bone marrow mesenchymal stem cells within normal marrow. In this study, an MRI-visible, targeted, non-viral vector for effective gene delivery to human bone marrow mesenchymal stem cells was first synthesized by attaching a targeting ligand, the GD2 single chain antibody (scAb(GD2)), to the distal ends of PEG-g-PEI-SPION. The targeted vector was then used to condense plasmid DNA to form nanoparticles showing stable small size, low cytotoxicity, and good biocompatibility. Based on a reporter gene assay, the transfection efficiency of targeting complex reached the highest value at 59.6% +/- 4.5% in human bone marrow mesenchymal stem cells, which was higher than those obtained using nontargeting complex and lipofectamine/pDNA (17.7% +/- 2.9% and 34.9% +/- 3.6%, respectively) (P<0.01). Consequently, compared with the nontargeting group, more in vivo gene expression was observed in the fibrotic rat livers of the targeting group. Furthermore, the targeting capacity of scAb(GD2)-PEG-g-PEI-SPION was successfully verified in vitro by confocal laser scanning microscopy, Prussian blue staining, and magnetic resonance imaging. Our results indicate that scAb(GD2)-PEG-g-PEI-SPION is a promising MRI-visible non-viral vector for targeted gene delivery to human bone marrow mesenchymal stem cells.	[Pang, Pengfei; Wu, Chun; Shen, Min; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong] Sun Yat Sen Univ, Mol Imaging Lab, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Gong, Faming; Shuai, Xintao] Sun Yat Sen Univ, PCFM Lab, Minist Educ, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China; [Pang, Pengfei; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong] Sun Yat Sen Univ, Intervent Radiol Inst, Guangzhou 510275, Guangdong, Peoples R China; [Pang, Pengfei; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Radiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Shan, H (corresponding author), Sun Yat Sen Univ, Mol Imaging Lab, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	Shanhong@mail.sysu.edu.cn; shuaixt@mail.sysu.edu.cn	Shuai, Xintao/C-5819-2008	Shuai, Xintao/0000-0003-4271-0310; Jiang, Zaibo/0000-0003-0523-6488	NSFC-Guangdong Joint Foundation Key Project [U1032002]; National Natural Science Foundation of China [81071206, 81172193, 81201090, 81070349, 50830107]; Ministry of Public Health of China [164]; Science and Technology Plannig Project of Guangdong Province [2008A 030201004]; National Science Foundation for Distinguished Young Scholars of China [51225305]	NSFC-Guangdong Joint Foundation Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Public Health of China; Science and Technology Plannig Project of Guangdong Province; National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the NSFC-Guangdong Joint Foundation Key Project (Grant No. U1032002), the National Natural Science Foundation of China (Grant Nos. 81071206, 81172193, 81201090, 81070349, and 50830107), the 2010-2012 Clinical Key Program of Ministry of Public Health of China (Grant No. 164), the Science and Technology Plannig Project of Guangdong Province (Grant No. 2008A 030201004), and the National Science Foundation for Distinguished Young Scholars of China (Grant No. 51225305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HH, 2008, BIOMATERIALS, V29, P2415, DOI 10.1016/j.biomaterials.2008.02.006; Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Bosch P, 2006, MOL REPROD DEV, V73, P1393, DOI 10.1002/mrd.20593; Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026; Chen GH, 2009, BIOMATERIALS, V30, P1962, DOI 10.1016/j.biomaterials.2008.12.043; Dai LJ, 2009, STEM CELL RES, V2, P16, DOI 10.1016/j.scr.2008.07.005; Dutta T, 2010, NANOMED-NANOTECHNOL, V6, P25, DOI 10.1016/j.nano.2009.05.005; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Farrell LL, 2007, EUR J PHARM BIOPHARM, V65, P388, DOI 10.1016/j.ejpb.2006.11.026; Fischer D, 2002, BIOCONJUGATE CHEM, V13, P1124, DOI 10.1021/bc025550w; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kim SW, 2004, J BIOMED MATER RES A, V71A, P308, DOI 10.1002/jbm.a.30160; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Merceron C, 2012, STEM CELLS, V30, P471, DOI 10.1002/stem.1686; Meyerrose TE, 2008, STEM CELLS, V26, P1713, DOI 10.1634/stemcells.2008-0008; Nemeth K, 2012, STEM CELLS, V30, P222, DOI 10.1002/stem.771; Pandita D, 2011, BIOMACROMOLECULES, V12, P472, DOI 10.1021/bm1012647; Ricks DM, 2008, STEM CELLS DEV, V17, P441, DOI 10.1089/scd.2007.0194; Shan YB, 2012, BIOMATERIALS, V33, P3025, DOI 10.1016/j.biomaterials.2011.12.045; Shen M, 2012, INT J NANOMED, V7, P3319, DOI 10.2147/IJN.S32900; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xu J, 2009, CELL PHYSIOL BIOCHEM, V23, P415, DOI 10.1159/000218188; Zhou B, 2010, MAGN RESON IMAGING, V28, P394, DOI 10.1016/j.mri.2009.12.005	27	15	17	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76612	10.1371/journal.pone.0076612	http://dx.doi.org/10.1371/journal.pone.0076612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116127	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300073
J	Bellay, S; de Oliveira, EF; Almeida-Neto, M; Lima, DP; Takemoto, RM; Luque, JL				Bellay, Sybelle; de Oliveira, Edson Fontes; Almeida-Neto, Mario; Lima Junior, Dilermando Pereira; Takemoto, Ricardo Massato; Luque, Jose Luis			Developmental Stage of Parasites Influences the Structure of Fish-Parasite Networks	PLOS ONE			English	Article							HOST-SPECIFICITY; NESTEDNESS; CARTOGRAPHY; MODULARITY; EVOLUTION	Specialized interactions tend to be more common in systems that require strong reciprocal adaptation between species, such as those observed between parasites and hosts. Parasites exhibit a high diversity of species and life history strategies, presenting host specificity which increases the complexity of these antagonistic systems. However, most studies are limited to the description of interactions between a few parasite and host species, which restricts our understanding of these systems as a whole. We investigated the effect of the developmental stage of the parasite on the structure of 30 metazoan fish-parasite networks, with an emphasis on the specificity of the interactions, connectance and modularity. We assessed the functional role of each species in modular networks and its interactions within and among the modules according to the developmental stage (larval and adult) and taxonomic group of the parasites. We observed that most parasite and host species perform a few interactions but that parasites at the larval stage tended to be generalists, increasing the network connectivity within and among modules. The parasite groups did not differ among each other in the number of interactions within and among the modules when considering only species at the larval stage. However, the same groups of adult individuals differed from each other in their interaction patterns, which were related to variations in the degree of host specificity at this stage. Our results show that the interaction pattern of fishes with parasites, such as acanthocephalans, cestodes, digeneans and nematodes, is more closely associated with their developmental stage than their phylogenetic history. This finding corroborates the hypothesis that the life history of parasites results in adaptations that cross phylogenetic boundaries.	[Bellay, Sybelle; Takemoto, Ricardo Massato] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura, Programa Posgrad Ecol Ambientes Aquat Continentai, Dept Ciencias Biol, Maringa, Parana, Brazil; [Bellay, Sybelle] Univ Estadual Norte Parana, Ctr Ciencias Humanas & Educ, Grp Estudos & Pesquisa Recursos Hidr & Ecol Aplic, Jacarezinho, Parana, Brazil; [de Oliveira, Edson Fontes] Univ Tecnol Fed Parana, Dept Engn Ambiental, Programa Posgrad Engn Ambiental, Londrina, Parana, Brazil; [Almeida-Neto, Mario] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Goiania, Go, Brazil; [Lima Junior, Dilermando Pereira] Univ Fed Mato Grosso, Dept Ciencias Biol & Saude, Pontal Do Araguaia, MG, Brazil; [Luque, Jose Luis] Univ Fed Rio de Janeiro, Dept Parasitol Anim, Rio De Janeiro, Brazil	Universidade Estadual de Maringa; Universidade Estadual do Norte do Parana (UENP); Pontificia Universidade Catolica do Parana; Universidade Tecnologica Federal do Parana; Universidade Federal de Goias; Universidade Federal de Mato Grosso; Universidade Federal do Rio de Janeiro	Bellay, S (corresponding author), Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura, Programa Posgrad Ecol Ambientes Aquat Continentai, Dept Ciencias Biol, Maringa, Parana, Brazil.	sybellebellay@yahoo.com.br	Luque, Jose L/C-9767-2014; de Oliveira, Edson Fontes/AAO-2107-2020; Almeida-Neto, M./A-6389-2009; de Oliveira, Edson Fontes/AGY-4950-2022; Takemoto, Ricardo M/F-7010-2012; Lima-Junior, Dilermando/AAT-6144-2020	de Oliveira, Edson Fontes/0000-0002-4224-6565; Almeida-Neto, M./0000-0002-2161-2968; de Oliveira, Edson Fontes/0000-0002-4224-6565; Takemoto, Ricardo M/0000-0001-7592-2083; Lima-Junior, Dilermando/0000-0001-5071-3314; Bellay, Sybelle/0000-0002-2242-9735; Luque, Jose/0000-0003-3515-1127	PEA/CAPES/PROEX; DIRPPG/UTFPR- Campus Londrina; CNPq	PEA/CAPES/PROEX; DIRPPG/UTFPR- Campus Londrina; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Manuscript funded by PEA/CAPES/PROEX, DIRPPG/UTFPR- Campus Londrina and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BARKER SC, 1991, INT J PARASITOL, V21, P497, DOI 10.1016/0020-7519(91)90053-A; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bellay S, 2011, PARASITOLOGY, V138, P1945, DOI 10.1017/S0031182011001314; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bozza AN, 2010, BIOTA NEOTROP, V10, P217, DOI 10.1590/S1676-06032010000300025; Choisy M, 2003, AM NAT, V162, P172, DOI 10.1086/375681; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Fernandez J.C, 1993, FUNCTIONAL BIOL PARA; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Jordano P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P173; Khan R A, 2012, J Parasitol Res, V2012, P237280, DOI 10.1155/2012/237280; Krasnov BR, 2012, AM NAT, V179, P501, DOI 10.1086/664612; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lima DP, 2012, J ANIM ECOL, V81, P905, DOI 10.1111/j.1365-2656.2012.01967.x; Luque JL, 2004, ACTA PARASITOL, V49, P353; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Mouillot D, 2008, ECOGRAPHY, V31, P16, DOI 10.1111/j.2007.0906-7590.05231.x; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Palm HW, 2008, INT J PARASITOL, V38, P381, DOI 10.1016/j.ijpara.2007.08.011; PIMM SL, 1982, FOOD WEBS; Podani J, 2012, ECOGRAPHY, V35, P889, DOI 10.1111/j.1600-0587.2011.07319.x; POULIN R, 1992, INT J PARASITOL, V22, P753, DOI 10.1016/0020-7519(92)90124-4; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; POULIN R, 1998, EVOLUTIONARY ECOLOGY; Poulin R, 2013, J ANIM ECOL, V82, P1265, DOI 10.1111/1365-2656.12101; Poulin R, 2010, TRENDS PARASITOL, V26, P492, DOI 10.1016/j.pt.2010.05.008; Price P. W., 1980, EVOLUTIONARY BIOL PA; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; R Core Team, 2016, R FDN STAT COMP; StatSoft Inc., 2005, STAT DAT AN SOFTW SY; Thatcher V. E., 2006, AQUATIC BIODIVERSITY, V1; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; Whittington ID, 2011, INTEGR COMP BIOL, V51, P91, DOI 10.1093/icb/icr003; Woo P. T. K., 2006, FISH DIS DISORDERS P, V1	42	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75710	10.1371/journal.pone.0075710	http://dx.doi.org/10.1371/journal.pone.0075710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124506	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100063
J	Bluml, V; Kapusta, ND; Doering, S; Brahler, E; Wagner, B; Kersting, A				Blueml, Victor; Kapusta, Nestor D.; Doering, Stephan; Braehler, Elmar; Wagner, Birgit; Kersting, Anette			Personality Factors and Suicide Risk in a Representative Sample of the German General Population	PLOS ONE			English	Article							ADULTS 50 YEARS; MAJOR DEPRESSION; 5-FACTOR MODEL; GENDER-DIFFERENCES; ANXIETY DISORDERS; PRIMARY-CARE; IDEATION; TRAITS; AGE; NEUROTICISM	Objective: Previous research has shown an association between certain personality characteristics and suicidality. Methodological differences including small sample sizes and missing adjustment for possible confounding factors could explain the varying results. The aim of this study was to assess the impact of the Big Five personality dimensions on suicidality in a representative population based sample of adults. Method: Interviews were conducted in a representative German population-based sample (n=2555) in 2011. Personality characteristics were assessed using the Big Five Inventory-10 (BFI-10) and suicide risk was assessed with the Suicidal Behaviors Questionnaire-Revised (SBQ-R). Multivariate logistic regression models were calculated adjusting for depression, anxiety, and various sociodemographic variables. Results: Neuroticism and openness were significantly associated with suicide risk, while extraversion and conscientiousness were found to be protective. Significant sex differences were observed. For males, extraversion and conscientiousness were protective factors. Neuroticism and openness were found to be associated with suicide risk only in females. These associations remained significant after adjusting for covariates. Conclusion: The results highlight the role of personality dimensions as risk factors for suicide-related behaviors. Different personality dimensions are significantly associated with suicide-related behaviors even when adjusting for other known risk factors of suicidality.	[Blueml, Victor; Kapusta, Nestor D.; Doering, Stephan] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Braehler, Elmar; Wagner, Birgit; Kersting, Anette] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Wagner, Birgit; Kersting, Anette] Univ Leipzig, Dept Psychosomat Med & Psychotherapy, D-04109 Leipzig, Germany	Medical University of Vienna; Leipzig University; Leipzig University; Leipzig University	Bluml, V (corresponding author), Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria.	victor.blueml@meduniwien.ac.at	Kapusta, Nestor D/C-9368-2009; Doering, Stephan/I-2383-2013; Braehler, Elmar/C-6535-2009	Kapusta, Nestor D/0000-0002-0970-4341; Doering, Stephan/0000-0001-7455-1380; Braehler, Elmar/0000-0002-2648-2728; Bluml, Victor/0000-0003-0226-0837				Bernal M, 2007, J AFFECT DISORDERS, V101, P27, DOI 10.1016/j.jad.2006.09.018; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Chioqueta AP, 2005, PERS INDIV DIFFER, V38, P1283, DOI 10.1016/j.paid.2004.08.010; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [https://doi.org/10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, 10.1037/1040-3590.4.1.5]; Cougle JR, 2009, J PSYCHIATR RES, V43, P825, DOI 10.1016/j.jpsychires.2008.12.004; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Duberstein PR, 2001, J PERS ASSESS, V77, P380, DOI 10.1207/S15327752JPA7702_16; Fang L, 2012, J NERV MENT DIS, V200, P598, DOI 10.1097/NMD.0b013e31825bfb53; Forkmann T, 2012, J NERV MENT DIS, V200, P401, DOI 10.1097/NMD.0b013e31825322cf; Gunthert KC, 1999, J PERS SOC PSYCHOL, V77, P1087, DOI 10.1037/0022-3514.77.5.1087; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hayward RD, 2013, AM J GERIAT PSYCHIAT, V21, P88, DOI 10.1016/j.jagp.2012.11.012; Heisel MJ, 2006, J AFFECT DISORDERS, V90, P175, DOI 10.1016/j.jad.2005.11.005; Jang KL, 1996, J PERS, V64, P577, DOI 10.1111/j.1467-6494.1996.tb00522.x; John O, 1991, BIG 5 INVENTORY VERS; Johnson WB, 1999, SUICIDE LIFE-THREAT, V29, P165; KAPLAN ML, 1994, J CLIN PSYCHOL, V50, P294, DOI 10.1002/1097-4679(199403)50:2<294::AID-JCLP2270500224>3.0.CO;2-R; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Kerby DS, 2003, PERS INDIV DIFFER, V35, P249, DOI 10.1016/S0191-8869(02)00174-5; KOOREVAAR AML, 2013, J AFFECT DISORDERS, DOI DOI 10.1016/J.JAD.2013.05.075.PUBMED:23820093; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; L/we B., 2002, GESUNDHEITSFRAGEBOGE; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Manuck SB, 1998, NEUROPSYCHOPHARMACOL, V19, P287, DOI 10.1038/sj.npp.1395199; McCann SJH, 2010, ARCH SUICIDE RES, V14, P368, DOI 10.1080/13811118.2010.524070; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Piedmont RL, 2012, J PERS, V80, P1641, DOI 10.1111/j.1467-6494.2012.00777.x; Piedmont RL, 2009, J PERS SOC PSYCHOL, V96, P1245, DOI 10.1037/a0015368; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rozanov VA, 2011, SPAN J PSYCHOL, V14, P693, DOI 10.5209/rev_SJOP.2011.v14.n2.17; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Useda JD, 2004, COMPR PSYCHIAT, V45, P353, DOI 10.1016/j.comppsych.2004.06.002; Velting DM, 1999, PERS INDIV DIFFER, V27, P943, DOI 10.1016/S0191-8869(99)00046-X; Voracek M, 2009, PERCEPT MOTOR SKILL, V109, P208, DOI 10.2466/PMS.109.1.208-212; WAGNER B, 2013, DEPRESS ANXIETY, DOI DOI 10.1002/DA.2210532.PUBMED:23576272;; Watson D, 1996, J PERS, V64, P737, DOI 10.1111/j.1467-6494.1996.tb00943.x; Weber K, 2012, AGING MENT HEALTH, V16, P472, DOI 10.1080/13607863.2011.630375; Wilson CM, 2012, CRISIS, V33, P54, DOI 10.1027/0227-5910/a000110	52	62	65	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76646	10.1371/journal.pone.0076646	http://dx.doi.org/10.1371/journal.pone.0076646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124582	gold, Green Published			2022-12-27	WOS:000325489100139
J	Camilli, R; Daprai, L; Cavrini, F; Lombardo, D; D'Ambrosio, F; Del Grosso, M; Vescio, MF; Landini, MP; Pascucci, MG; Torresani, E; Garlaschi, ML; Sambri, V; Pantosti, A				Camilli, Romina; Daprai, Laura; Cavrini, Francesca; Lombardo, Donatella; D'Ambrosio, Fabio; Del Grosso, Maria; Vescio, Maria Fenicia; Landini, Maria Paola; Pascucci, Maria Grazia; Torresani, Erminio; Garlaschi, Maria Laura; Sambri, Vittorio; Pantosti, Annalisa			Pneumococcal Carriage in Young Children One Year after Introduction of the 13-Valent Conjugate Vaccine in Italy	PLOS ONE			English	Article							PNEUMONIAE NASOPHARYNGEAL CARRIAGE; STREPTOCOCCUS-PNEUMONIAE; SEROTYPE 19A; GENETIC-STRUCTURE; HEALTHY-CHILDREN; UNITED-STATES; DISEASE; PREVALENCE; ERA; 6C	Background: In mid 2010, the 7-valent pneumococcal conjugate vaccine (PCV7) was replaced by the 13-valent conjugate vaccine (PCV13) for childhood immunization in Italy. Our objective in this study was to obtain a snapshot of pneumococcal carriage frequency, colonizing serotypes, and antibiotic resistance in healthy children in two Italian cities one year after PCV13 was introduced. Methods: Nasopharyngeal swabs were obtained from 571 children aged 0-5 years from November 2011-April 2012. Pneumococcal isolates were serotyped and tested for antimicrobial susceptibility. Penicillin and/or erythromycin nonsusceptible isolates were analyzed by Multi Locus Sequence Typing (MLST). Results: Among the children examined, 81.2% had received at least one dose of PCV7 or PCV13 and 74.9% had completed the recommended vaccination schedule for their age. Among the latter, 57.3% of children had received PCV7, 27.1% PCV13, and 15.6% a combination of the two vaccines. The overall carriage rate was 32.9%, with children aged 6-35 months the most prone to pneumococcal colonization (6-23 months OR: 3.75; 95% CI: 2.19-6.43 and 24-35 months OR: 3.15, 95% CI: 2.36-4.22). A total of 184 pneumococcal isolates were serotyped and divided into PCV7 (5.4%), PCV13 (18.0%), and non-PCV13 (82.0%) serotypes. Serotypes 6C, 24F, and 19A were the most prevalent (10.3%, 8.6%, and 8.1%, respectively). The proportion of penicillin non-susceptible (MIC >0.6 mg/L) isolates was 30.9%, while 42.3% were erythromycin resistant. Non-PCV13 serotypes accounted for 75.4% and 70.8% of the penicillin and erythromycin non-susceptible isolates, respectively. Conclusions: Our results revealed low rates of PCV7 and PCV13 serotypes in Italian children, potentially due to the effects of vaccination. As the use of PCV13 continues, its potential impact on vaccine serotypes such as 19A and cross-reactive serotypes such as 6C will be assessed, with this study providing a baseline for further analysis of surveillance isolates.	[Camilli, Romina; D'Ambrosio, Fabio; Del Grosso, Maria; Vescio, Maria Fenicia; Pantosti, Annalisa] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Daprai, Laura; Torresani, Erminio; Garlaschi, Maria Laura] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Microbiol Unit, Milan, Italy; [Cavrini, Francesca; Lombardo, Donatella; Landini, Maria Paola; Sambri, Vittorio] Univ Bologna, S Orsola M Malpighi Hosp, Microbiol Unit, Bologna, Italy; [Pascucci, Maria Grazia] Direz Gen Sanita & Polit Sociali, Serv Sanita Pubbl, Bologna, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Pantosti, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	annalisa.pantosti@iss.it	Pantosti, Annalisa/A-7291-2013; CAMILLI, ROMINA/C-8811-2016; Sambri, Vittorio/H-5372-2019; Del Grosso, Maria/C-8815-2016; Lombardo, Donatella/GZL-5851-2022; Vescio, Fenicia/N-5776-2017	Pantosti, Annalisa/0000-0002-8409-4731; CAMILLI, ROMINA/0000-0003-1309-5670; Sambri, Vittorio/0000-0002-5012-7355; Del Grosso, Maria/0000-0002-2663-9764; Lombardo, Donatella/0000-0003-0730-742X; Vescio, Fenicia/0000-0002-3285-919X; D'Ambrosio, Fabio/0000-0003-4101-7186	Italian Ministry of Health, Centro Nazionale per la prevenzione e il controllo delle malattie (CCM)	Italian Ministry of Health, Centro Nazionale per la prevenzione e il controllo delle malattie (CCM)	This study was supported by the Italian Ministry of Health, Centro Nazionale per la prevenzione e il controllo delle malattie (CCM, http://www.ccm-network.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Alfonsi V, 2011, HEALTH POLICY, V103, P176, DOI 10.1016/j.healthpol.2011.10.002; Ansaldi F, 2012, VACCINE, V30, P2288, DOI 10.1016/j.vaccine.2012.01.067; Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Boccalini S, 2011, VACCINE, V29, P9521, DOI 10.1016/j.vaccine.2011.10.013; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Campos LC, 2009, DIAGN MICR INFEC DIS, V65, P112, DOI 10.1016/j.diagmicrobio.2009.06.020; Cardozo DM, 2008, J MED MICROBIOL, V57, P185, DOI 10.1099/jmm.0.47470-0; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Del Grosso M, 2013, J MED MICROBIOL, V62, P1220, DOI 10.1099/jmm.0.061242-0; Dunais B, 2011, EUR J CLIN MICROBIOL, V30, P837, DOI 10.1007/s10096-011-1154-9; European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in europe, 2012, ANN REP EUR ANT RES; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gherardi G, 2012, ANTIMICROB AGENTS CH, V56, P4965, DOI 10.1128/AAC.00830-12; Green MC, 2011, J CLIN MICROBIOL, V49, P2097, DOI 10.1128/JCM.02207-10; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Grivea IN, 2011, VACCINE, V29, P8882, DOI 10.1016/j.vaccine.2011.09.074; Hermans PWM, 2008, VACCINE, V26, P449, DOI 10.1016/j.vaccine.2007.11.026; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; ICONA Working Group, 2009, 0929 ISTISAN; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Marchisio P, 2002, EMERG INFECT DIS, V8, P479; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moschioni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061003; Nahm MH, 2009, J INFECT DIS, V199, P320, DOI 10.1086/596064; Nunes S, 2009, J CLIN MICROBIOL, V47, P472, DOI 10.1128/JCM.01984-08; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pantosti A, 2002, CLIN INFECT DIS, V35, P205, DOI 10.1086/341250; Petrosillo N, 2002, EUR J CLIN MICROBIOL, V21, P181, DOI 10.1007/s10096-001-0689-6; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Rodrigues F, 2009, MICROB DRUG RESIST, V15, P269, DOI 10.1089/mdr.2009.0043; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Valente C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030235; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Weil-Olivier C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-207; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac	51	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76309	10.1371/journal.pone.0076309	http://dx.doi.org/10.1371/journal.pone.0076309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124543	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100100
J	Dunne, MR; Elliott, L; Hussey, S; Mahmud, N; Kelly, J; Doherty, DG; Feighery, CF				Dunne, Margaret R.; Elliott, Louise; Hussey, Seamus; Mahmud, Nasir; Kelly, Jacinta; Doherty, Derek G.; Feighery, Conleth F.			Persistent Changes in Circulating and Intestinal gamma delta T Cell Subsets, Invariant Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Children and Adults with Coeliac Disease	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; PERIPHERAL-BLOOD; INTRAEPITHELIAL LYMPHOCYTES; AUTOIMMUNE DISORDERS; CYTOKINE SECRETION; GENE-EXPRESSION; ALPHA-BETA; NKT CELLS; TCR; INFECTION	Coeliac disease is a chronic small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed individuals. The only current therapy is a lifelong gluten free diet. While much work has focused on the gliadin-specific adaptive immune response in coeliac disease, little is understood about the involvement of the innate immune system. Here we used multi-colour flow cytometry to determine the number and frequency of gamma delta T cells (V delta 1, V delta 2 and V delta 3 subsets), natural killer cells, CD56(+) T cells, invariant NKT cells, and mucosal associated invariant T cells, in blood and duodenum from adults and children with coeliac disease and healthy matched controls. All circulating innate lymphocyte populations were significantly decreased in adult, but not paediatric coeliac donors, when compared with healthy controls. Within the normal small intestine, we noted that V delta 3 cells were the most abundant gamma delta T cell type in the adult epithelium and lamina propria, and in the paediatric lamina propria. In contrast, patients with coeliac disease showed skewing toward a predominant V delta 1 profile, observed for both adult and paediatric coeliac disease cohorts, particularly within the gut epithelium. This was concurrent with decreases in all other gut lymphocyte subsets, suggesting a specific involvement of V delta 1 cells in coeliac disease pathogenesis. Further analysis showed that gamma delta T cells isolated from the coeliac gut display an activated, effector memory phenotype, and retain the ability to rapidly respond to in vitro stimulation. A profound loss of CD56 expression in all lymphocyte populations was noted in the coeliac gut. These findings demonstrate a sustained aberrant innate lymphocyte profile in coeliac disease patients of all ages, persisting even after elimination of gluten from the diet. This may lead to impaired immunity, and could potentially account for the increased incidence of autoimmune co-morbidity.	[Dunne, Margaret R.; Elliott, Louise; Mahmud, Nasir; Doherty, Derek G.; Feighery, Conleth F.] St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland; [Dunne, Margaret R.; Elliott, Louise; Mahmud, Nasir; Doherty, Derek G.; Feighery, Conleth F.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Dunne, Margaret R.; Hussey, Seamus; Kelly, Jacinta] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Hussey, Seamus] Our Ladys Childrens Hosp, Natl Ctr Paediat Gastroenterol Hepatol & Nutr, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	Dunne, MR (corresponding author), St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland.	dunnem12@tcd.ie	Hussey, Séamus/F-8810-2015; Dunne, Margaret/AAE-9152-2020	Hussey, Séamus/0000-0002-9362-0465; Dunne, Margaret/0000-0002-2816-5064; Doherty, Derek/0000-0002-4394-658X	Children's Medical Research Foundation; Our Lady's Children's Hospital Crumlin; St. James's Hospital	Children's Medical Research Foundation; Our Lady's Children's Hospital Crumlin; St. James's Hospital	Sources of funding: The Children's Medical Research Foundation, Our Lady's Children's Hospital Crumlin and St. James's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2012, EUR J IMMUNOL, V42, P2505, DOI 10.1002/eji.201242531; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; BUCHT A, 1995, CLIN EXP IMMUNOL, V99, P57; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Calleja S, 2011, DIGEST DIS SCI, V56, P2042, DOI 10.1007/s10620-010-1534-5; Cervantes JL, 2012, CELL MOL IMMUNOL, V9, P434, DOI 10.1038/cmi.2012.38; Cianci R, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.22; Cohavy O, 2007, J IMMUNOL, V178, P5524, DOI 10.4049/jimmunol.178.9.5524; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; De Rosa SC, 2001, J LEUKOCYTE BIOL, V70, P518; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; DELIBERO G, 1993, EUR J IMMUNOL, V23, P499, DOI 10.1002/eji.1830230230; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Ellis HJ, 2003, GUT, V52, P212, DOI 10.1136/gut.52.2.212; FALK MC, 1994, CLIN EXP IMMUNOL, V98, P78; FARSTAD IN, 1993, SCAND J IMMUNOL, V38, P451, DOI 10.1111/j.1365-3083.1993.tb02587.x; Fasano A, 2006, CURR OPIN GASTROEN, V22, P674, DOI 10.1097/01.mog.0000245543.72537.9e; FERGUSON A, 1971, GUT, V12, P988, DOI 10.1136/gut.12.12.988; GIACOMELLI R, 1994, CLIN EXP IMMUNOL, V98, P83; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Grose RH, 2007, GUT, V56, P790, DOI 10.1136/gut.2006.095307; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; HALSTENSEN TS, 1995, ADV EXP MED BIOL, V371, P1333; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kerttula TO, 1998, CLIN EXP IMMUNOL, V111, P536; KERTTULA TO, 1995, IMMUNOLOGY, V86, P104; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kress E, 2006, MOL IMMUNOL, V43, P2002, DOI 10.1016/j.molimm.2005.11.011; Kuhl AA, 2009, IMMUNOLOGY, V128, P580, DOI 10.1111/j.1365-2567.2009.03162.x; KUTLU T, 1993, GUT, V34, P208, DOI 10.1136/gut.34.2.208; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Li JQ, 2005, CELL MOL IMMUNOL, V2, P253; Lopez RD, 2002, IMMUNOL RES, V26, P207, DOI 10.1385/IR:26:1-3:207; Mangan BA, 2013, J IMMUNOL, V191, P30, DOI 10.4049/jimmunol.1300121; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; PEYRAT MA, 1995, J IMMUNOL, V155, P3060; RUST C, 1992, SCAND J IMMUNOL, V35, P459, DOI 10.1111/j.1365-3083.1992.tb02881.x; SAVILAHTI E, 1990, PEDIATR RES, V28, P579, DOI 10.1203/00006450-199012000-00005; Soderstrom K, 1996, J IMMUNOL, V156, P2331; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; TREJDOSIEWICZ LK, 1991, CLIN EXP IMMUNOL, V84, P440; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Verbeek WHM, 2008, AM J GASTROENTEROL, V103, P3152, DOI 10.1111/j.1572-0241.2008.02213.x; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358; Zeissig S, 2007, AM J PHYSIOL-GASTR L, V293, pG1101, DOI 10.1152/ajpgi.00342.2007	53	83	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76008	10.1371/journal.pone.0076008	http://dx.doi.org/10.1371/journal.pone.0076008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124528	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100085
J	Sehr, P; Rubio, I; Seitz, H; Putzker, K; Ribeiro-Muller, L; Pawlita, M; Muller, M				Sehr, Peter; Rubio, Ivonne; Seitz, Hanna; Putzker, Kerstin; Ribeiro-Mueller, Lis; Pawlita, Michael; Mueller, Martin			High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CERVICAL INTRAEPITHELIAL NEOPLASIA; POPULATION-BASED COHORT; VIRUS-LIKE PARTICLES; SENSITIVE MEASURE; COSTA-RICA; HPV; L1; CANCER; WOMEN	A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assay (HT-PBNA) with excellent repeatability and run-to-run reproducibility was developed for human papillomavirus types (HPV) 16, 18, 31, 45, 52, 58 and bovine papillomavirus type 1. Preparation of 384 well assay plates with serially diluted sera and the actual cell-based assay are separated in time, therefore batches of up to one hundred assay plates can be processed sequentially. A mean coefficient of variation (CV) of 13% was obtained for anti-HPV 16 and HPV 18 titers for a standard serum tested in a total of 58 repeats on individual plates in seven independent runs. Natural antibody response was analyzed in 35 sera from patients with HPV 16 DNA positive cervical intraepithelial neoplasia grade 2+ lesions. The new HT-PBNA is based on Gaussia luciferase with increased sensitivity compared to the previously described manual PBNA (manPBNA) based on secreted alkaline phosphatase as reporter. Titers obtained with HT-PBNA were generally higher than titers obtained with the manPBNA. A good linear correlation (R-2 = 0.7) was found between HT-PBNA titers and anti-HPV 16 L1 antibody-levels determined by a Luminex bead-based GST-capture assay for these 35 sera and a Kappa-value of 0.72, with only 3 discordant sera in the low titer range. In addition to natural low titer antibody responses the high sensitivity of the HT-PBNA also allows detection of cross-neutralizing antibodies induced by commercial HPV L1-vaccines and experimental L2-vaccines. When analyzing the WHO international standards for HPV 16 and 18 we determined an analytical sensitivity of 0.864 and 1.105 mIU, respectively.	[Sehr, Peter; Putzker, Kerstin] European Mol Biol Lab, EMBL DKFZ Chem Biol Core Facil, D-69012 Heidelberg, Germany; [Rubio, Ivonne; Seitz, Hanna; Ribeiro-Mueller, Lis; Pawlita, Michael; Mueller, Martin] German Canc Res Ctr, Infect & Canc Program, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Muller, M (corresponding author), German Canc Res Ctr, Infect & Canc Program, Heidelberg, Germany.	Martin.mueller@dkfz.de	Waterboer, Tim/G-1252-2010	Putzker, Kerstin/0000-0001-8375-5908; Sehr, Peter/0000-0002-4348-5066; Pawlita, Michael/0000-0002-4720-8306	German Cancer Research Center	German Cancer Research Center(Helmholtz Association)	Funding from the German Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2007, CURR PROTOC CELL BIO; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; CHRISTENSEN ND, 1990, J VIROL, V64, P3151, DOI 10.1128/JVI.64.7.3151-3156.1990; Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Dianna E., 2012, COLLABORATIVE STUDY, V18; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Ferguson M, 2011, VACCINE, V29, P6520, DOI 10.1016/j.vaccine.2011.07.007; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Gissmann L, 2009, ARCH MED RES, V40, P466, DOI 10.1016/j.arcmed.2009.07.002; IARC Biological Agents, 2011, IARC MON EV CARC RIS, V100B, P255; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kaufmann AM, 2007, INT J CANCER, V121, P2794, DOI 10.1002/ijc.23022; Kawana K, 1998, J VIROL, V72, P10298, DOI 10.1128/JVI.72.12.10298-10300.1998; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nieto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039741; Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; RODEN RBS, 1995, J VIROL, V69, P5147, DOI 10.1128/JVI.69.8.5147-5151.1995; RODEN RBS, 1994, J VIROL, V68, P7570, DOI 10.1128/JVI.68.11.7570-7574.1994; Rodriguez AC, 2007, SEX TRANSM DIS, V34, P494, DOI 10.1097/01.olq.0000251241.03088.a0; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Schiller JT, 2010, ANNU REV MICROBIOL, V64, P23, DOI 10.1146/annurev.micro.112408.134019; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; Wang Qing-yong, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P584; Wang SS, 2004, BRIT J CANCER, V91, P1269, DOI 10.1038/sj.bjc.6602088; Wang SS, 2003, BRIT J CANCER, V89, P1248, DOI 10.1038/sj.bjc.6601272; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Wentzensen N, 2011, J INFECT DIS, V204, P94, DOI 10.1093/infdis/jir209; Yeager MD, 2000, VIROLOGY, V278, P570, DOI 10.1006/viro.2000.0674; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	42	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75677	10.1371/journal.pone.0075677	http://dx.doi.org/10.1371/journal.pone.0075677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124504	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100061
J	Sun, ZJ; Zhang, L; Zhang, W; Hall, B; Bian, YS; Kulkarni, AB				Sun, Zhi-jun; Zhang, Lu; Zhang, Wei; Hall, Bradford; Bian, Yansong; Kulkarni, Ashok B.			Inhibition of mTOR Reduces Anal Carcinogenesis in Transgenic Mouse Model	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TGF-BETA; CANCER; HEAD; NECK; GROWTH; PATHWAY; PTEN; INFLAMMATION; ACTIVATION	The molecular mechanism of human anal squamous cell carcinoma (ASCC) is unclear, and the accumulating evidence indicate association of ASCC with the activation of the Akt/mTOR pathway. Here we describe a mouse model with spontaneous anal squamous cell cancer, wherein a combined deletion of Tgfbr1 and Pten in stratified squamous epithelia was induced using inducible K14-Cre. Histopathologic analyses confirmed that 33.3% of the mice showed increased susceptibility to ASCC and precancerous lesions. Biomarker analyses demonstrated that the activation of the Akt pathway in ASCC of the Tgfbr1 and Pten double knockout (2cKO) mouse was similar to that observed in human anal cancer. Chemopreventive experiments using mTOR inhibitor-rapamycin treatment significantly delayed the onset of the ASCC tumors and reduced the tumor burden in 2cKO mice by decreasing the phosphorylation of Akt and S6. This is the first conditional knockout mouse model used for investigating the contributions of viral and cellular factors in anal carcinogenesis without carcinogen-mediated induction, and it would provide a platform for assessing new therapeutic modalities for treating and/or preventing this type of cancer.	[Sun, Zhi-jun; Zhang, Lu; Zhang, Wei] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Sun, Zhi-jun; Zhang, Lu; Zhang, Wei] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Sun, Zhi-jun; Zhang, Lu; Hall, Bradford; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Bian, Yansong] Natl Inst Deafness & Other Commun Disorders, Head & Neck Surg Branch, NIH, Bethesda, MD USA	Wuhan University; Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Sun, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China.	zhijundejia@163.com; ak40m@nih.gov	Sun, Zhi-Jun/AAD-8791-2022	Sun, Zhi-Jun/0000-0003-0932-8013	National Institute of Dental and Craniofacial Research, NIH [ZIA-DE-000698]; National Natural Science Foundation of China [81072203, 81272963, 81371106]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000723, ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000698] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Intramural Research Programs ZIA-DE-000698 (ABK) of the National Institute of Dental and Craniofacial Research, NIH, and National Natural Science Foundation of China 81072203, 81272963 (ZJS) and 81371106 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornphimoltham P, 2005, CANCER RES, V65, P9953, DOI 10.1158/0008-5472.CAN-05-0921; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Cress RD, 2003, PREV MED, V36, P555, DOI 10.1016/S0091-7435(03)00013-6; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Diaz-Chavez J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-3; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Honjo Y, 2007, CELL CYCLE, V6, P1360, DOI 10.4161/cc.6.11.4268; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Lee JH, 2012, EUR J IMMUNOL, V42, P2683, DOI 10.1002/eji.201142317; Liang CH, 2012, CANCER RES, V72, P5004, DOI 10.1158/0008-5472.CAN-11-3277; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mitsuishi T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-118; Patel H, 2007, INT J CANCER, V121, P2668, DOI 10.1002/ijc.23028; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; Snietura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033396; Stelzer MK, 2010, CANCER PREV RES, V3, P1542, DOI 10.1158/1940-6207.CAPR-10-0228; Stelzer MK, 2010, CANCER PREV RES, V3, P1534, DOI 10.1158/1940-6207.CAPR-10-0086; Sun ZJ, 2012, CLIN CANCER RES, V18, P5304, DOI 10.1158/1078-0432.CCR-12-1371; Szmulowicz UM, 2012, SEX HEALTH, V9, P593, DOI 10.1071/SH12010; Thomas MK, 2011, VIROLOGY, V421, P114, DOI 10.1016/j.virol.2011.09.018; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74888	10.1371/journal.pone.0074888	http://dx.doi.org/10.1371/journal.pone.0074888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124460	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100017
J	Wang, JJ; Xia, X; Tang, SD; Wang, J; Deng, XZ; Zhang, Y; Yue, M				Wang, Jia-Jia; Xia, Xian; Tang, Shai-Di; Wang, Jie; Deng, Xiao-Zhao; Zhang, Yun; Yue, Ming			Meta-Analysis on the Associations of TLR2 Gene Polymorphisms with Pulmonary Tuberculosis Susceptibility among Asian Populations	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; MYCOBACTERIUM-TUBERCULOSIS; ACTIVATION; INFECTION; DISEASE; MACROPHAGES	Background: Publications regarding the associations of toll-like receptor 2 (TLR2) G2258A and T597C polymorphisms with pulmonary tuberculosis (PTB) susceptibility are inconsistent. A meta-analysis was conducted to investigate the relationship between TLR2 G2258A and T597C polymorphisms with PTB susceptibility. Methods: A systematic search was performed for published studies on the relationship between TLR2 polymorphisms and PTB susceptibility. Information was gathered from each eligible study, and statistically analyzed. Results: 6 eligible studies, totaling 1301 cases and 1217 controls on G2258A genotypes, and 8 studies, totaling 2175 cases and 2069 controls on T597C genotypes, were included in the analysis. TLR2 2258G allele and 2258GG genotype were found to be associated with decreased PTB susceptibility (A vs. G: OR = 3.02, 95% CI: 2.22-4.12, P<0.001, GA+AA vs. GG: OR = 2.69, 95% CI = 1.49-4.87, P = 0.001). In the subgroup analyses, the 2258G allele and 2258GG genotype also exhibited a protective effect of PTB risk in Asians (A vs. G: OR = 2.95, 95% CI: 1.91-4.55, P<0.001; GA+AA vs. GG: OR = 3.59, 95% CI: 2.23-5.78, P, 0.001), while no associations were observed in Caucasians. No significant associations between T597C polymorphism and PTB were found in the allele model (C vs. T: OR = 0.95, 95% CI: 0.86-1.04, P = 0.28), co-dominant model (CC vs. TT: OR = 0.88, 95% CI = 0.92-1.40, P = 0.25; CT vs. TT: OR = 0.92, 95% CI = 0.80-1.06, P = 0.28), recessive model (CC vs. TT+TC: OR = 0.96, 95% CI: 0.80-1.16, P = 0.69), or dominant model (TC+CC vs. TT: OR = 0.93, 95% CI = 0.76-1.15, P = 0.51). The associations of T597C polymorphism with PTB susceptibility, in the ethnic-specific analyses, were still not significant. Conclusion: TLR2 2258G allele may provide protective effects against PTB susceptibility, particularly among Asians, whereas TLR2 T597C polymorphism might not be associated with PTB susceptibility.	[Wang, Jia-Jia; Tang, Shai-Di] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Xia, Xian] Gen Hosp Beijing Mil Reg, Dept Nosocomial Infect Control, Beijing, Peoples R China; [Wang, Jie] Nanjing Med Univ, Kangda Coll, Dept Gen Practice, Nanjing, Jiangsu, Peoples R China; [Deng, Xiao-Zhao] Huadong Res Inst Med & Biotech, Inst Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhang, Yun; Yue, Ming] Huadong Res Inst Med & Biotech, Inst Epidemiol & Microbiol, Nanjing, Jiangsu, Peoples R China; [Yue, Ming] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Seventh Medical Center of Chinese PLA General Hospital; Nanjing Medical University; China Pharmaceutical University	Yue, M (corresponding author), Huadong Res Inst Med & Biotech, Inst Epidemiol & Microbiol, Nanjing, Jiangsu, Peoples R China.	njym08@163.com	岳, 明/AAX-5776-2021	岳, 明/0000-0002-7677-0832	National Natural Science Foundation of China [81273146, 81102165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (numbers 81273146, 81102165) (http://isisn.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Ben-Selma W, 2012, MOL BIOL REP, V39, P51, DOI 10.1007/s11033-011-0709-2; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; BLACKWELL JM, 1995, MOL MED, V1, P194, DOI 10.1007/BF03401567; Bloom BR, 1998, NEW ENGL J MED, V338, P677, DOI 10.1056/NEJM199803053381008; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Che N, 2011, J CHINESE ANTITUBERC, V33, P204; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; Dalgic N, 2011, DIS MARKERS, V31, P33, DOI [10.1155/2011/545972, 10.3233/DMA-2011-0800]; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; [金蕾 Lei Jin], 2007, [细胞生物学杂志, Chinese Journal of Cell Biology], V29, P229; Li S, 2011, THESIS JINLIN AGR U; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Magira EE, 2012, HUM IMMUNOL, V73, P641, DOI 10.1016/j.humimm.2012.03.008; Mahasirimongkol S, 2009, GENES IMMUN, V10, P77, DOI 10.1038/gene.2008.81; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Means TK, 1999, J IMMUNOL, V163, P3920; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Sanchez D, 2012, INT J IMMUNOGENET, V39, P216, DOI 10.1111/j.1744-313X.2011.01077.x; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Shi YanJie, 2012, Journal of Xinxiang Medical College, V29, P253; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Stein CM, 2005, HUM HERED, V60, P109, DOI 10.1159/000088913; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Xue Y, 2010, INT J IMMUNOGENET, V37, P135, DOI 10.1111/j.1744-313X.2009.00892.x; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	34	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75090	10.1371/journal.pone.0075090	http://dx.doi.org/10.1371/journal.pone.0075090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124467	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100024
J	Narendran, R; Himes, M; Mason, NS				Narendran, Rajesh; Himes, Michael; Mason, N. Scott			Reproducibility of Post-Amphetamine [C-11]FLB 457 Binding to Cortical D-2/3 Receptors	PLOS ONE			English	Article							INDUCED DOPAMINE RELEASE; POSITRON-EMISSION-TOMOGRAPHY; SPECT MEASUREMENT; HUMAN CORTEX; TRANSMISSION; DEPENDENCE; QUANTIFICATION; RADIOTRACERS; COCAINE; BRAIN	In a recent positron emission tomography (PET) study, we demonstrated the ability to measure amphetamine-induced dopamine (DA) release in the human cortex with the relatively high affinity dopamine D-2/3 radioligand [C-11]FLB 457. Herein we report on reproducibility and reliability of [C-11]FLB 457 binding potential relative to non-displaceable uptake (BPND) following an acute amphetamine challenge. Ten healthy human subjects were studied twice with [C-11]FLB 457 following an acute amphetamine (oral, 0.5 mg kg(-1) dose) challenge on two-separate days approximately one week apart. D-2/3 receptor binding parameters were estimated using a two-tissue compartment kinetic analysis in the cortical regions of interest and cerebellum (reference region). The test-retest variability and intraclass correlation coefficient were assessed for distribution volume (V-T), binding potential relative to plasma concentration (BPP), and BPND of [C-11]FLB 457. The test-retest variability of [C-11]FLB 457 V-T, BPP and BPND were <= 17%, 22% and 11% respectively. These results, which are consistent with the published test-retest variability for this ligand measured under baseline conditions demonstrate that the post-amphetamine [C-11]FLB 457 BPND is reproducible. These data further support the use [C-11]FLB 457 and amphetamine to characterize cortical dopamine transmission in neuropsychiatric disorders.	[Narendran, Rajesh; Himes, Michael; Mason, N. Scott] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narendran, R (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	narendranr@upmc.edu			National Institute on Drug Abuse [RO1 DA026472]; National Institute on Alcohol Abuse and Alcoholism [RO1 AA018330]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026472] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Awards from the National Institute on Drug Abuse (RO1 DA026472) and National Institute on Alcohol Abuse and Alcoholism (RO1 AA018330) supported this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABI-DARGHAM A, 1994, J NUCL MED, V35, P228; Bailer UF, 2012, INT J EAT DISORDER, V45, P263, DOI 10.1002/eat.20937; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Carson RE, 1997, J CEREBR BLOOD F MET, V17, P437, DOI 10.1097/00004647-199704000-00009; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; DEUITCH L, 2012, IMAGING PREFRONTAL C; Endres CJ, 1997, J CEREBR BLOOD F MET, V17, P932, DOI 10.1097/00004647-199709000-00002; GANDELMAN MS, 1994, J PHARM SCI, V83, P1014, DOI 10.1002/jps.2600830718; Gunn RN, 1998, NEUROIMAGE, V8, P426, DOI 10.1006/nimg.1998.0379; HALLDIN C, 1995, J NUCL MED, V36, P1275; HILL AV, 1910, PHYS MED BIOL, V1991, P749; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kegeles LS, 1999, SYNAPSE, V31, P302; Kirk Roger, 1982, EXPT DESIGN PROCEDUR, V2nd; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Laruelle M, 1997, SYNAPSE, V25, P1, DOI 10.1002/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H; LARUELLE M, 1995, J NUCL MED, V36, P1182; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Martinez D, 2012, BIOL PSYCHIAT, V71, P192, DOI 10.1016/j.biopsych.2011.08.024; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; NARENDRAN R, 2010, J PHARMACOL EXP THER, V63, P574; NARENDRAN R, 2013, MOL PSYCHIA IN PRESS; Narendran R, 2011, SYNAPSE, V65, P991, DOI 10.1002/syn.20926; Narendran R, 2011, SYNAPSE, V65, P35, DOI 10.1002/syn.20813; Narendran R, 2010, J PHARMACOL EXP THER, V333, P533, DOI 10.1124/jpet.109.163501; Narendran R, 2009, SYNAPSE, V63, P574, DOI 10.1002/syn.20633; Narendran R, 2009, SYNAPSE, V63, P447, DOI 10.1002/syn.20628; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; REIMER MLJ, 1993, BIOL MASS SPECTROM, V22, P235, DOI 10.1002/bms.1200220404; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sudo Y, 2001, NUCL MED COMMUN, V22, P1215, DOI 10.1097/00006231-200111000-00008; Vilkman H, 2000, EUR J NUCL MED, V27, P1666, DOI 10.1007/s002590000342; Villemagne VL, 1999, SYNAPSE, V33, P268, DOI 10.1002/(SICI)1098-2396(19990915)33:4<268::AID-SYN3>3.3.CO;2-N; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76905	10.1371/journal.pone.0076905	http://dx.doi.org/10.1371/journal.pone.0076905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098812	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500183
J	Baksi, S; Jana, NR; Bhattacharyya, NP; Mukhopadhyay, D				Baksi, Shounak; Jana, Nihar R.; Bhattacharyya, Nitai Pada; Mukhopadhyay, Debashis			Grb2 Is Regulated by Foxd3 and Has Roles in Preventing Accumulation and Aggregation of Mutant Huntingtin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN STRIATAL CELLS; CAG REPEAT; DISEASE; PROTEIN; TRANSCRIPTION; DOMAIN; MICE; GENE; EXPRESSION	Growth factor receptor protein binding protein 2 (Grb2) is known to be associated with intracellular growth and proliferation related signaling cascades. Huntingtin (Htt), a ubiquitously expressed protein, when mutated, forms toxic intracellular aggregates - the hallmark of Huntington's disease (HD). We observed an elevated expression of Grb2 in neuronal cells in animal and cell models of HD. Grb2 overexpression was predominantly regulated by the transcription factor Forkhead Box D3 (Foxd3). Exogenous expression of Grb2 also reduced aggregation of mutant Htt in Neuro2A cells. Grb2 is also known to interact with Htt, depending on epidermal growth factor receptor (EGFR) activation. Grb2- mutant Htt interaction in the contrary, took place in vesicular structures, independent of EGFR activation that eventually merged with autophagosomes and activated the autophagy machinery helping in autophagosome and lysosome fusion. Grb2, with its emerging dual role, holds promise for a survival mechanism for HD.	[Baksi, Shounak; Mukhopadhyay, Debashis] Saha Inst Nucl Phys, Struct Genom Div, Kolkata, India; [Jana, Nihar R.] Natl Brain Res Ctr, Div Cellular & Mol Neurosci, Manesar, Haryana, India; [Bhattacharyya, Nitai Pada] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Saha Institute of Nuclear Physics	Mukhopadhyay, D (corresponding author), Saha Inst Nucl Phys, Struct Genom Div, Kolkata, India.	debashis.mukhopadhyay@saha.ac.in		Baksi, Shounak/0000-0001-7225-5377; Jana, Nihar/0000-0002-6549-4211	IBOP, DAE, Govt. of India	IBOP, DAE, Govt. of India	This work is funded by IBOP, DAE, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Banerjee M, 2010, NUCLEIC ACIDS RES, V38, P878, DOI 10.1093/nar/gkp1011; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bhattacharyya M, 2004, J BIOL CHEM, V279, P55080, DOI 10.1074/jbc.M406418200; Choudhury KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051415; Datta M, 2011, J BIOL CHEM, V286, P33759, DOI 10.1074/jbc.M111.265173; Ghose J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023837; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Harper PS, 1996, J ROY COLL PHYS LOND, V30, P221; Heng MY, 2010, AUTOPHAGY, V6, P1206, DOI 10.4161/auto.6.8.13617; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Maheshwari M, 2012, J BIOL CHEM, V287, P29949, DOI 10.1074/jbc.M112.371724; Majumder P, 2007, CELL MOL NEUROBIOL, V27, P1127, DOI 10.1007/s10571-007-9220-7; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Raychaudhuri M, 2010, J ALZHEIMERS DIS, V20, P275, DOI 10.3233/JAD-2010-1371; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Sinha M, 2011, RNA BIOL, V8, P1005, DOI 10.4161/rna.8.6.16035; Sinha M, 2010, BIOCHEM BIOPH RES CO, V396, P742, DOI 10.1016/j.bbrc.2010.05.007; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tari AM, 2001, SEMIN ONCOL, V28, P142, DOI 10.1053/sonc.2001.28555; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Xifro X, 2008, J NEUROCHEM, V105, P1596, DOI 10.1111/j.1471-4159.2008.05252.x	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76792	10.1371/journal.pone.0076792	http://dx.doi.org/10.1371/journal.pone.0076792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116161	gold, Green Published, Green Submitted			2022-12-27	WOS:000325552200070
J	Bol, K; Haeck, JC; Groen, HC; Niessen, WJ; Bernsen, MR; de Jong, M; Veenland, JF				Bol, Karin; Haeck, Joost C.; Groen, Harald C.; Niessen, Wiro J.; Bernsen, Monique R.; de Jong, Marion; Veenland, Jifke F.			Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?	PLOS ONE			English	Article							RECEPTOR RADIONUCLIDE THERAPY; RADIOLABELED SOMATOSTATIN ANALOG; INDIUM-111-PENTETREOTIDE; PARAMETERS; PERFUSION; TRACER	Although efficient delivery and distribution of treatment agents over the whole tumor is essential for successful tumor treatment, the distribution of most of these agents cannot be visualized. However, with single-photon emission computed tomography (SPECT), both delivery and uptake of radiolabeled peptides can be visualized in a neuroendocrine tumor model overexpressing somatostatin receptors. A heterogeneous peptide uptake is often observed in these tumors. We hypothesized that peptide distribution in the tumor is spatially related to tumor perfusion, vessel density and permeability, as imaged and quantified by DCE-MRI in a neuroendocrine tumor model. Four subcutaneous CA20948 tumor-bearing Lewis rats were injected with the somatostatin-analog In-111-DTPA-Octreotide (50 MBq). SPECT-CT and MRI scans were acquired and MRI was spatially registered to SPECT-CT. DCE-MRI was analyzed using semi-quantitative and quantitative methods. Correlation between SPECT and DCE-MRI was investigated with 1) Spearman's rank correlation coefficient; 2) SPECT uptake values grouped into deciles with corresponding median DCE-MRI parametric values and vice versa; and 3) linear regression analysis for median parameter values in combined datasets. In all tumors, areas with low peptide uptake correlated with low perfusion/density//permeability for all DCE-MRI-derived parameters. Combining all datasets, highest linear regression was found between peptide uptake and semi-quantitative parameters (R-2>0.7). The average correlation coefficient between SPECT and DCE-MRI-derived parameters ranged from 0.52-0.56 (p<0.05) for parameters primarily associated with exchange between blood and extracellular extravascular space. For these parameters a linear relation with peptide uptake was observed. In conclusion, the 'exchange-related' DCE-MRI-derived parameters seemed to predict peptide uptake better than the 'contrast amount-related' parameters. Consequently, fast and efficient diffusion through the vessel wall into tissue is an important factor for peptide delivery. DCE-MRI helps to elucidate the relation between vascular characteristics, peptide delivery and treatment efficacy, and may form a basis to predict targeting efficiency.	[Bol, Karin; Haeck, Joost C.; Niessen, Wiro J.; Veenland, Jifke F.] Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands; [Bol, Karin; Haeck, Joost C.; Niessen, Wiro J.; Veenland, Jifke F.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Bol, Karin; Haeck, Joost C.; Groen, Harald C.; Niessen, Wiro J.; Bernsen, Monique R.; de Jong, Marion; Veenland, Jifke F.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Bol, Karin; Haeck, Joost C.; Groen, Harald C.; Bernsen, Monique R.; de Jong, Marion] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Bol, K (corresponding author), Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands.	k.bol@erasmusmc.nl		Niessen, Wiro/0000-0002-5822-1995; Veenland, Jifke/0000-0003-0456-6143; Bernsen, Monique/0000-0002-5203-5083	Dutch Cancer Society - KWF [2008-4037]	Dutch Cancer Society - KWF(KWF Kankerbestrijding)	This work was funded by the Dutch Cancer Society - KWF (grant no. 2008-4037) - http://www.kwfkankerbestrijding.nl/Pages/Home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PHYS MED BIOL, V56, P1601, DOI 10.1088/0031-9155/56/6/006; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Bodei L, 2010, EUR REV MED PHARMACO, V14, P347; BREEMAN WAP, 1995, J NUCL MED, V36, P623; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; Capello A, 2005, EUR J NUCL MED MOL I, V32, P1288, DOI 10.1007/s00259-005-1877-x; de Herder Wouter W, 2006, Pituitary, V9, P243, DOI 10.1007/s11102-006-0270-5; de Jong M, 1999, EUR J NUCL MED, V26, P693, DOI 10.1007/s002590050439; Delaunoit T, 2005, MAYO CLIN PROC, V80, P502, DOI 10.4065/80.4.502; Fesinmeyer MD, 2005, CANCER EPIDEM BIOMAR, V14, P1766, DOI 10.1158/1055-9965.EPI-05-0120; Forrer F, 2007, BEST PRACT RES CL EN, V21, P111, DOI 10.1016/j.beem.2007.01.007; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Hansen AE, 2012, RADIOTHER ONCOL, V102, P424, DOI 10.1016/j.radonc.2011.10.021; Heisen M, 2010, MAGN RESON MED, V63, P811, DOI 10.1002/mrm.22171; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Jong M, 2003, EUR J NUCL MED MOL I, V30, P463, DOI 10.1007/s00259-002-1107-8; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; KRENNING EP, 1993, EUR J NUCL MED, V20, P716, DOI 10.1007/BF00181765; Kwekkeboom DJ, 2008, J CLIN ONCOL, V26, P2124, DOI 10.1200/JCO.2007.15.2553; Kwekkeboom DJ, 2005, J NUCL MED, V46, p62S; LEE JD, 1995, J NUCL MED, V36, P537; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; Melancon MP, 2011, J CONTROL RELEASE, V156, P265, DOI 10.1016/j.jconrel.2011.06.030; Metz S, 2010, J NUCL MED, V51, P1691, DOI 10.2967/jnumed.110.077719; Miyazaki K, 2012, RADIOLOGY, V263, P139, DOI 10.1148/radiol.12110770; O'Connor JPB, 2011, BRIT J CANCER, V105, P139, DOI 10.1038/bjc.2011.191; Parker GJM, 1997, JMRI-J MAGN RESON IM, V7, P564, DOI 10.1002/jmri.1880070318; PATEL YC, 1990, NEW ENGL J MED, V323, P1274, DOI 10.1056/NEJM199011013231811; Reubi JC, 2005, J NUCL MED, V46, p67S; Rufini V, 2006, SEMIN NUCL MED, V36, P228, DOI 10.1053/j.semnuclmed.2006.03.007; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Van Essen M, 2007, ACTA ONCOL, V46, P723, DOI 10.1080/02841860701441848	32	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77076	10.1371/journal.pone.0077076	http://dx.doi.org/10.1371/journal.pone.0077076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116203	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200099
J	Chang, YN; Guo, HL; Li, J; Song, Y; Zhang, MY; Jin, JJ; Xing, GM; Zhao, YL				Chang, Ya-Nan; Guo, Haili; Li, Juan; Song, Yan; Zhang, Mingyi; Jin, Junjiang; Xing, Gengmei; Zhao, Yuliang			Adjusting the Balance between Effective Loading and Vector Migration of Macrophage Vehicles to Deliver Nanoparticles	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IRON-OXIDE NANOPARTICLES; CELL-MIGRATION; DRUG-DELIVERY; TUMOR; ADHESION; NANOTECHNOLOGY; RECOGNITION; METASTASIS; PARTICLES	The nature of macrophage allows the possibility that this cell type could be used as drug delivery system to track therapeutic drug nanoparticles (NPs) in cancer. However, there is no existing research on the regulation between effective loading of NPs and targeted delivery of macrophages. Here, we investigated the important parameters of intracellular NP quantity and the vector migration rate. Macrophage loading capacity was obtained by comparing the uptake quantity of varisized NPs, and the delivery ability of loaded cells was determined by measuring vector migration rates. We observed a positive correlation between the size of NPs and directed macrophage migration. Our findings suggest that the molecular mechanism of migration vector rate regulation involved increased expression levels of colony-stimulating factor-1 (CSF-1) receptor and integrin induced by 100-nm and 500-nm particles. The ability of macrophages uptake to varisized NPs showed the opposite trend, with the increased vector rate of cell migration influenced by NPs. We are able to demonstrate the important balance between effective macrophage loading and targeted delivery. By adjusting the balance parameters, it will be possible to utilize NPs in macrophage-mediated disease diagnosis and therapy.	[Chang, Ya-Nan; Guo, Haili; Li, Juan; Song, Yan; Zhang, Mingyi; Jin, Junjiang; Xing, Gengmei; Zhao, Yuliang] Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Zhao, Yuliang] Chinese Acad Sci, Natl Ctr Nanosci & Technol China, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Xing, GM (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China.	xinggm@ihep.ac.cn; zhaoyuliang@ihep.ac.cn		Chang, Yanan/0000-0003-4745-6876; Li, Juan/0000-0003-4110-3295	National Basic Research Program of China (973 Program) [2013CB932703, 2012CB932601]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The authors are grateful for the support of the National Basic Research Program of China (973 Program) (2013CB932703 and 2012CB932601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Chellat F, 2005, BIOMATERIALS, V26, P7260, DOI 10.1016/j.biomaterials.2005.05.044; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cui ZG, 2004, PHARM RES-DORDR, V21, P1018, DOI 10.1023/B:PHAM.0000029292.66792.4f; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gendelman HE, 2009, J NEUROIMMUNE PHARM, V4, P47, DOI 10.1007/s11481-008-9135-1; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Ikehara Y, 2006, CANCER RES, V66, P8740, DOI 10.1158/0008-5472.CAN-06-0470; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kindwall-Keller TL, 2008, CYTOKINE, V43, P114, DOI 10.1016/j.cyto.2008.04.015; Kingsley JD, 2006, J NEUROIMMUNE PHARM, V1, P340, DOI 10.1007/s11481-006-9032-4; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; KOLBBACHOFEN V, 1991, CARBOHYD RES, V213, P201, DOI 10.1016/S0008-6215(00)90609-8; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee JY, 2008, N-S ARCH PHARMACOL, V377, P111, DOI 10.1007/s00210-008-0266-y; McCarthy JR, 2006, SMALL, V2, P983, DOI 10.1002/smll.200600139; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Settles M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025197; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Valois CRA, 2010, BIOMATERIALS, V31, P366, DOI 10.1016/j.biomaterials.2009.09.053; Wang L, 2008, CANCER RES, V68, P5639, DOI 10.1158/0008-5472.CAN-07-5804; Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c; Zahr AS, 2005, LANGMUIR, V21, P403, DOI 10.1021/la0478595; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhang MY, 2011, ARCH TOXICOL, V85, P1575, DOI 10.1007/s00204-011-0725-y; Zhao YL, 2011, NANOMEDICINE-UK, V6, P25, DOI [10.2217/nnm.10.129, 10.2217/NNM.10.129]	39	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76024	10.1371/journal.pone.0076024	http://dx.doi.org/10.1371/journal.pone.0076024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116086	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200046
J	Chinnaswamy, S; Chatterjee, S; Boopathi, R; Mukherjee, S; Bhattacharjee, S; Kundu, TK				Chinnaswamy, Sreedhar; Chatterjee, Snehajyoti; Boopathi, Ramachandran; Mukherjee, Shuvolina; Bhattacharjee, Samsiddhi; Kundu, Tapas K.			A Single Nucleotide Polymorphism Associated with Hepatitis C Virus Infections Located in the Distal Region of the IL28B Promoter Influences NF-kappa B-Mediated Gene Transcription	PLOS ONE			English	Article							NECROSIS FACTOR-ALPHA; INTERFERON-ALPHA; RIBAVIRIN THERAPY; INNATE IMMUNITY; PLUS RIBAVIRIN; EXPRESSION; LAMBDA; RECOGNITION; CLEARANCE; GENOTYPE	Persistence of hepatitis C virus (HCV) infection is observed only in a subset of infected individuals and among them only some respond to treatment. Genome-wide association studies (GWAS) carried out around the world identified single nucleotide polymorphisms (SNPs) in the IL28B locus that are strongly associated with both HCV clearance and treatment response. The functional significance of these associations however, is not clear. In this report we show that an SNP rs28416813 in the distal promoter region of IL28B that is in close proximity to a non-consensus NF-kappa B-binding site affects downstream reporter gene expression. The effect is likely due to differential binding of NF-kappa B at the non-consensus site. The non-protective allele showed a reduction in luciferase reporter gene expression compared to the protective allele in HEK293T cells under different experimental conditions including treatment with tumor necrosis factor alpha (TNF-alpha) and 5' triphosphorylated dsRNA. Furthermore, the HCV RNA polymerase was able to induce transcription from the IL28B promoter in a RIG-I-dependent manner. This induction was influenced by the alleles present at rs28416813. We also demonstrate strong linkage disequilibrium between rs28416813 and another important SNP rs12979860 in two ethnic populations. These results suggest possible mechanisms by which SNPs at the IL28B locus influence spontaneous clearance and treatment response in chronic HCV infections.	[Chinnaswamy, Sreedhar; Mukherjee, Shuvolina; Bhattacharjee, Samsiddhi] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Chatterjee, Snehajyoti; Boopathi, Ramachandran; Kundu, Tapas K.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Chinnaswamy, S (corresponding author), Natl Inst Biomed Genom, PO NSS, Kalyani, W Bengal, India.	sc2@nibmg.ac.in	Chatterjee, Snehajyoti/AAV-3919-2021; Chinnaswamy, Sreedhar/GMX-0166-2022	Chatterjee, Snehajyoti/0000-0002-4873-9416; Mukherjee, Shuvolina/0000-0002-2005-5274; Kundu, Tapas/0000-0001-7790-214X; Bhattacharjee, Samsiddhi/0000-0002-8549-1130; Chinnaswamy, Sreedhar/0000-0003-0095-3453	Science and Engineering Research Board (SERB), Department of Science and Technology, Ministry of Science and Technology, Government of India, [SR/FT/LS-26/2011]; National Institute of Biomedical Genomics, Kalyani	Science and Engineering Research Board (SERB), Department of Science and Technology, Ministry of Science and Technology, Government of India,; National Institute of Biomedical Genomics, Kalyani	The funding for this work was provided to SC1 by the Science and Engineering Research Board (SERB), Department of Science and Technology, Ministry of Science and Technology, Government of India, under the SERB young scientist project #SR/FT/LS-26/2011 and by the National Institute of Biomedical Genomics, Kalyani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chen JY, 2011, GENES IMMUN, V12, P300, DOI 10.1038/gene.2011.1; Clark PJ, 2012, J GASTROEN HEPATOL, V27, P212, DOI 10.1111/j.1440-1746.2011.06918.x; de Castellarnau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031016; Diegelmann J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015200; Ding Q, 2012, EUR J IMMUNOL, V42, P2374, DOI 10.1002/eji.201242388; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hayes CN, 2012, NAT REV GASTRO HEPAT, V9, P406, DOI 10.1038/nrgastro.2012.101; Hohler T, 1998, J Med Virol, V54, P173, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;173::AID-JMV5&gt;3.0.CO;2-2; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Li W, 2012, ANTIVIR RES, V94, P54, DOI 10.1016/j.antiviral.2012.02.007; Liu HM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/548390; Lyoo K, 2011, J CLIN VIROL, V52, P363, DOI 10.1016/j.jcv.2011.08.006; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Murata K, 2014, J GASTROENTEROL, V49, P126, DOI 10.1007/s00535-013-0814-1; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; R Core Team, 2021, R LANGUAGE ENV STAT; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Reynolds JM, 2012, PLOS ONE, V7, P271, DOI 10.1371/journal.pone.0029983; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; Shin JH, 2006, J STAT SOFT, P16; Shindo H, 2013, J VIRAL HEPATITIS, V20, P281, DOI 10.1111/j.1365-2893.2012.01649.x; Simonin Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003234; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Smith KR, 2011, GENOME MED, V3, DOI 10.1186/gm273; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Sugiyama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026620; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Venegas M, 2011, WORLD J GASTROENTERO, V17, P3636, DOI 10.3748/wjg.v17.i31.3636; Yu GY, 2012, MOL CELL, V48, P313, DOI 10.1016/j.molcel.2012.07.032	51	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75495	10.1371/journal.pone.0075495	http://dx.doi.org/10.1371/journal.pone.0075495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116050	gold, Green Submitted, Green Published			2022-12-27	WOS:000325552200024
J	Hofman, J; Kucera, R; Cihalova, D; Klimes, J; Ceckova, M; Staud, F				Hofman, Jakub; Kucera, Radim; Cihalova, Daniela; Klimes, Jiri; Ceckova, Martina; Staud, Frantisek			Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITORS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; IN-VITRO; AFFINITY-CHROMATOGRAPHY; CAMPTOTHECIN ANALOGS; CELLS; IDENTIFICATION; ROSCOVITINE; SELICICLIB	Purine cyclin-dependent kinase inhibitors have been recognized as promising candidates for the treatment of various cancers; nevertheless, data regarding interaction of these substances with drug efflux transporters is still lacking. Recently, we have demonstrated inhibition of breast cancer resistance protein (ABCG2) by olomoucine II and purvalanol A and shown that these compounds are able to synergistically potentiate the antiproliferative effect of mitoxantrone, an ABCG2 substrate. In this follow up study, we investigated whether olomoucine II and purvalanol A are transported by ABCG2 and ABCB1 (P-glycoprotein). Using monolayers of MDCKII cells stably expressing human ABCB1 or ABCG2, we demonstrated that olomoucine II, but not purvalanol A, is a dual substrate of both ABCG2 and ABCB1. We, therefore, assume that pharmacokinetics of olomoucine II will be affected by both ABCB1 and ABCG2 transport proteins, which might potentially result in limited accumulation of the compound in tumor tissues or lead to drug-drug interactions. Pharmacokinetic behavior of purvalanol A, on the other hand, does not seem to be affected by either ABCG2 or ABCB1, theoretically favoring this drug in the potential treatment of efflux transporter-based multidrug resistant tumors. In addition, we observed intensive sulfatation of olomoucine II in MDCKII cell lines with subsequent active efflux of the metabolite out of the cells. Therefore, care should be taken when performing pharmacokinetic studies in MDCKII cells, especially if radiolabeled substrates are used; the generated sulfated conjugate may largely contaminate pharmacokinetic analysis and result in misleading interpretation. With regard to chemical structures of olomoucine II and purvalanol A, our data emphasize that even drugs with remarkable structure similarity may show different pharmacokinetic behavior such as interactions with ABC transporters or biotransformation enzymes.	[Hofman, Jakub; Cihalova, Daniela; Ceckova, Martina; Staud, Frantisek] Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic; [Kucera, Radim; Klimes, Jiri] Charles Univ Prague, Fac Pharm, Dept Pharmaceut Chem & Drug Anal, Hradec Kralove, Czech Republic	Charles University Prague; Charles University Prague	Staud, F (corresponding author), Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic.	frantisek.staud@faf.cuni.cz	Ceckova, Martina/M-1849-2018; Staud, Frantisek/F-4596-2010; Klimes, Jiri/T-7803-2017; Kučera, Radim/AAD-7444-2019; Kučera, Radim/S-6366-2017; Hofman, Jakub/T-6461-2017	Ceckova, Martina/0000-0003-2936-7212; Staud, Frantisek/0000-0001-6712-097X; Klimes, Jiri/0000-0002-0708-1435; Kučera, Radim/0000-0003-3052-7965; Kučera, Radim/0000-0003-3052-7965; Hofman, Jakub/0000-0002-4285-7681	Grant Agency of Charles University [700912/C/2012, SVV/2013/267-003]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0061]	Grant Agency of Charles University; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This work was supported by Grant Agency of Charles University 700912/C/2012 and SVV/2013/267-003. The publication is co-financed by the European Social Fund and the state budget of the Czech Republic, Project no. CZ.1.07/2.3.00/30.0061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Allen JD, 2002, MOL CANCER THER, V1, P427; An R, 2009, PHARM RES-DORDR, V26, P449, DOI 10.1007/s11095-008-9738-5; Bachmeier CJ, 2005, PHARM RES-DORDR, V22, P113, DOI 10.1007/s11095-004-9016-0; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Dantzig AH, 1996, CANCER RES, V56, P4171; DIAZPADILLA I, 2009, INVEST NEW DRUGS; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Goh LB, 2002, BIOCHEM PHARMACOL, V64, P1569, DOI 10.1016/S0006-2952(02)01355-2; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Han B., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P31, DOI 10.2174/1568011043482205; Hikita T, 2010, GENES CELLS, V15, P1051, DOI 10.1111/j.1365-2443.2010.01439.x; Hofman J, 2012, PHARMACOL RES, V65, P312, DOI 10.1016/j.phrs.2011.11.017; Holcapek M, 2008, ANAL BIOANAL CHEM, V391, P59, DOI 10.1007/s00216-008-1962-7; Ishikawa T, 2006, CURR PHARM DESIGN, V12, P313, DOI 10.2174/138161206775201992; Knockaert M, 2002, BIOCHEM PHARMACOL, V64, P819, DOI 10.1016/S0006-2952(02)01144-9; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Krystof V, 2005, CELL MOL LIFE SCI, V62, P1763, DOI 10.1007/s00018-005-5185-1; Krystof V, 2002, BIOORG MED CHEM LETT, V12, P3283, DOI 10.1016/S0960-894X(02)00693-5; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; Kuteykin-Teplyakov K, 2010, BRIT J PHARMACOL, V160, P1453, DOI 10.1111/j.1476-5381.2010.00801.x; Monaco EA, 2004, BIOCHEM PHARMACOL, V67, P1947, DOI 10.1016/j.bcp.2004.02.007; Nakagawa H, 2006, CANCER LETT, V234, P81, DOI 10.1016/j.canlet.2005.05.052; Ng KH, 2003, KIDNEY INT, V63, P976, DOI 10.1046/j.1523-1755.2003.00818.x; Rabindran SK, 2000, CANCER RES, V60, P47; Rajnai Z, 2010, DRUG METAB DISPOS, V38, P2000, DOI 10.1124/dmd.110.032805; Seamon JA, 2006, MOL CANCER THER, V5, P2459, DOI 10.1158/1535-7163.MCT-06-0339; Shepard RL, 2003, INT J CANCER, V103, P121, DOI 10.1002/ijc.10792; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Staud F, 2010, METHODS MOL BIOL, V596, P199, DOI 10.1007/978-1-60761-416-6_10; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Yang KH, 2008, BIOSCI TRENDS, V2, P137	35	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75520	10.1371/journal.pone.0075520	http://dx.doi.org/10.1371/journal.pone.0075520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116053	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200026
J	Qiu, MT; Xu, L; Yang, X; Ding, XX; Hu, JW; Jiang, F; Xu, L; Yin, R				Qiu, Mantang; Xu, Lei; Yang, Xin; Ding, Xiangxiang; Hu, Jingwen; Jiang, Feng; Xu, Lin; Yin, Rong			XRCC3 Thr241Met Is Associated with Response to Platinum-Based Chemotherapy but Not Survival in Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DNA-REPAIR GENES; SINGLE-NUCLEOTIDE POLYMORPHISMS; XPD; EFFICACY; ERCC1; RISK; SNP	Background: A lot of studies have investigated the correlation between x-ray repair cross-complementing group 3 (XRCC3) Thr241Met polymorphism and clinical outcomes in non-small cell cancer (NSCLC), while the conclusion is still conflicting. Materials and Methods: We conducted this meta-analysis to evaluate the predictive value of XRCC3 Thr241Met polymorphism on response and overall survival of patients with NSCLC. Pooled odds ratios (ORs) and hazard ratios (HRs) and corresponding 95% confidence intervals (95% CIs) were used to estimate the association strength. Results: A total of 14 eligible studies with 2828 patients were identified according to our inclusion criteria. Meta-analysis results showed that carriers of the variant 241Met allele were significantly associated with good response, compared with those harboring the wild 241Thr allele (Met vs. Thr, OR = 1.453, 95% CI: 1.116-1.892, Pheterogeneity = 0.968 and ThrMet+MetMet vs. ThrThr, OR = 1.476, 95% CI: 1.087-2.004, Pheterogeneity = 0.696). This significant association was observed in Caucasian population but not in Asian population. On the other hand, there was no significant association of XRCC3 Thr241Met polymorphism with survival (ThrMet+MetMet vs. ThrThr, HR = 1.082, 95% CI: 0.929-1.261, Pheterogeneity = 0.564), and there was no difference between Asian and Caucasian population. Conclusions: These findings suggest a predictive role of XRCC3 Thr241Met polymorphism on response to platinum-based chemotherapy in patients with advanced NSCLC. Additionally, we first report that the XRCC3 Thr241Met polymorphism is associated with response to platinum-based chemotherapy and highlights the prognostic value of the XRCC3 Thr241Met polymorphism.	[Qiu, Mantang; Xu, Lei; Yang, Xin; Ding, Xiangxiang; Hu, Jingwen; Jiang, Feng; Xu, Lin; Yin, Rong] Nanjing Med Univ, Affiliated Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Qiu, Mantang] Nanjing Med Univ, Clin Coll 4, Nanjing, Jiangsu, Peoples R China; [Xu, Lei; Yang, Xin; Ding, Xiangxiang; Hu, Jingwen] Nanjing Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Xu, L (corresponding author), Nanjing Med Univ, Affiliated Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China.	xulin83cn@gmail.com; yinhero001@126.com	Qiu, Mantang/L-8937-2019		National Natural Science Foundation of China [81201830]; Natural Science Key Research Foundation of Jiangsu Province [BK2011036]; Natural Science Foundation of Jiangsu Province, China [BK2010589, BK2011857]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Key Research Foundation of Jiangsu Province; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (81201830), Natural Science Key Research Foundation of Jiangsu Province (BK2011036) and Natural Science Foundation of Jiangsu Province (BK2010589, BK2011857), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI W, 1995, BRIT MED J, V311, P899; Bosken CH, 2002, JNCI-J NATL CANCER I, V94, P1091; Bunn PA, 1998, CLIN CANCER RES, V4, P1087; Butkiewicz D, 2012, INT J CANCER, V131, pE1100, DOI 10.1002/ijc.27596; Chen XX, 2012, CLIN TRANSL ONCOL, V14, P207, DOI 10.1007/s12094-012-0785-3; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; de las Penas R, 2006, ANN ONCOL, V17, P668, DOI 10.1093/annonc/mdj135; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford BN, 2000, CARCINOGENESIS, V21, P1977, DOI 10.1093/carcin/21.11.1977; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Joerger M, 2012, CANCER-AM CANCER SOC, V118, P2466, DOI 10.1002/cncr.26562; Ke HG, 2012, ASIAN PAC J CANCER P, V13, P4413, DOI 10.7314/APJCP.2012.13.9.4413; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liao WY, 2012, J THORAC ONCOL, V7, P973, DOI 10.1097/JTO.0b013e31824fe98c; Ludovini V, 2011, J THORAC ONCOL, V6, P2018, DOI 10.1097/JTO.0b013e3182307e1f; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Osawa K, 2012, INT J MOL SCI, V13, P16658, DOI 10.3390/ijms131216658; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Provencio M, 2012, CANCER CHEMOTH PHARM, V70, P883, DOI 10.1007/s00280-012-1985-9; Ren SX, 2012, LUNG CANCER, V75, P102, DOI 10.1016/j.lungcan.2011.05.023; Ren SX, 2009, J ONCOL, V15, P706; Rodriguez J, 2011, EUR J CANCER, V47, P839, DOI 10.1016/j.ejca.2010.11.032; Ryk C, 2006, LUNG CANCER, V54, P285, DOI 10.1016/j.lungcan.2006.08.004; Tahara Eiichi, 2010, Jpn J Clin Oncol, V40, P702, DOI 10.1093/jjco/hyq031; Tibaldi C, 2008, CLIN CANCER RES, V14, P1797, DOI 10.1158/1078-0432.CCR-07-1364; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; van de Vaart PJM, 2000, INT J CANCER, V89, P160, DOI 10.1002/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J; Wu JJ, 2012, CLIN CANCER RES, V18, P3972, DOI 10.1158/1078-0432.CCR-11-1531; Xu Chong'an, 2011, Zhongguo Fei Ai Za Zhi, V14, P912, DOI 10.3779/j.issn.1009-3419.2011.12.03; Yin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020055; Zhou CC, 2010, JPN J CLIN ONCOL, V40, P954, DOI 10.1093/jjco/hyq071	34	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77005	10.1371/journal.pone.0077005	http://dx.doi.org/10.1371/journal.pone.0077005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116196	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200093
J	Rougeron, V; Woods, CM; Tiedje, KE; Bodeau-Livinec, F; Migot-Nabias, F; Deloron, P; Luty, AJF; Fowkes, FJI; Day, KP				Rougeron, Virginie; Woods, Caira M.; Tiedje, Kathryn E.; Bodeau-Livinec, Florence; Migot-Nabias, Florence; Deloron, Philippe; Luty, Adrian J. F.; Fowkes, Freya J. I.; Day, Karen P.			Epistatic Interactions between Apolipoprotein E and Hemoglobin S Genes in Regulation of Malaria Parasitemia	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; ALZHEIMERS-DISEASE; HAPTOGLOBIN GENOTYPE; CLINICAL MALARIA; E POLYMORPHISM; ENDEMIC AREA; RECEPTOR; ALLELE	Apolipoprotein E is a monomeric protein secreted by the liver and responsible for the transport of plasma cholesterol and triglycerides. The APOE gene encodes 3 isoforms epsilon 4, epsilon 3 and epsilon 2 with APOE epsilon 4 associated with higher plasma cholesterol levels and increased pathogenesis in several infectious diseases (HIV, HSV). Given that cholesterol is an important nutrient for malaria parasites, we examined whether APOE epsilon 4 was a risk factor for Plasmodium infection, in terms of prevalence or parasite density. A cross sectional survey was performed in 508 children aged 1 to 12 years in Gabon during the wet season. Children were screened for Plasmodium spp. infection, APOE and hemoglobin S (HbS) polymorphisms. Median parasite densities were significantly higher in APOE epsilon 4 children for Plasmodium spp. densities compared to non-APOE epsilon 4 children. When stratified for HbS polymorphisms, median Plasmodium spp. densities were significantly higher in HbAA children if they had an APOE epsilon 4 allele compared to those without an APOE epsilon 4 allele. When considering non-APOE epsilon 4 children, there was no quantitative reduction of Plasmodium spp. parasite densities for HbAS compared to HbAA phenotypes. No influence of APOE epsilon 4 on successful Plasmodium liver cell invasion was detected by multiplicity of infection. These results show that the APOE epsilon 4 allele is associated with higher median malaria parasite densities in children likely due to the importance of cholesterol availability to parasite growth and replication. Results suggest an epistatic interaction between APOE and HbS genes such that sickle cell trait only had an effect on parasite density in APOE epsilon 4 children. This suggests a linked pathway of regulation of parasite density involving expression of these genes. These findings have significance for understanding host determinants of regulation of malaria parasite density, the design of clinical trials as well as studies of co-infection with Plasmodium and other pathogens.	[Rougeron, Virginie; Woods, Caira M.; Tiedje, Kathryn E.; Bodeau-Livinec, Florence; Fowkes, Freya J. I.; Day, Karen P.] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Bodeau-Livinec, Florence; Migot-Nabias, Florence; Deloron, Philippe; Luty, Adrian J. F.] Inst Rech Dev, UMR216, Paris, France; [Deloron, Philippe] Univ Paris 05, Paris Sorbonne Cite, PRES, Paris, France; [Fowkes, Freya J. I.] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Populat Hlth, Melbourne, Vic, Australia	New York University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Burnet Institute	Day, KP (corresponding author), NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA.	karen.day@nyumc.org	Rougeron, Virginie/AAH-7447-2020; Deloron, Philippe/G-6305-2010; Day, Karen/F-3697-2015; Luty, Adrian/CAH-2547-2022; Bodeau-Livinec, Florence/U-9053-2017	Deloron, Philippe/0000-0003-4705-2484; Day, Karen/0000-0002-6115-6135; Bodeau-Livinec, Florence/0000-0002-4266-6287; Fowkes, Freya/0000-0001-5832-9464; Migot-Nabias, Florence/0000-0001-9982-594X; Luty, Adrian John Frederick/0000-0001-8830-3425; Rougeron, Virginie/0000-0001-5873-5681; Tiedje, Kathryn E/0000-0003-3305-0533	Wellcome Trust Programme [041354]; European Union INCO Programme [IC18-CT98-0359]; NIH/National Institute of Allergy and Infectious Disease [R01-AI-084156]; NIH Ruth L. Kirschstein National Research Service Award Individual Fellowship [F31-GM-86134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086134] Funding Source: NIH RePORTER	Wellcome Trust Programme(Wellcome Trust); European Union INCO Programme; NIH/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Ruth L. Kirschstein National Research Service Award Individual Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FJIF and KPD received financial support from the Wellcome Trust Programme (grant No. 041354) and FMN, PD, AJFL and KPD received support from the European Union INCO Programme (contract no. IC18-CT98-0359). VR, KET and KPD were supported by a grant from NIH/National Institute of Allergy and Infectious Disease grant (R01-AI-084156). CMW was a recipient of a NIH Ruth L. Kirschstein National Research Service Award Individual Fellowship (F31-GM-86134). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucan C, 2004, J MED GENET, V41, P21, DOI 10.1136/jmg.2003.011981; Bansal Devendra, 2005, Lipids Health Dis, V4, P10, DOI 10.1186/1476-511X-4-10; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corder EH, 2008, REJUV RES, V11, P667, DOI 10.1089/rej.2008.0742; Corder EH, 2008, P NATL ACAD SCI USA, V105, pE87, DOI 10.1073/pnas.0808164105; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; CROOK R, 1994, J NEUROSCI METH, V53, P125, DOI 10.1016/0165-0270(94)90168-6; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Fairhurst RM, 2006, CURR OPIN HEMATOL, V13, P124, DOI 10.1097/01.moh.0000219655.73162.42; Falk N, 2006, AM J TROP MED HYG, V74, P944, DOI 10.4269/ajtmh.2006.74.944; Fowkes FJI, 2006, AM J TROP MED HYG, V74, P26, DOI 10.4269/ajtmh.2006.74.26; Fowkes FJI, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-1; Frankland S, 2006, EUKARYOT CELL, V5, P849, DOI 10.1128/EC.5.5.849-860.2006; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2002, STAT APROGRAM ESTIMA; Gregg R E, 1986, Methods Enzymol, V129, P482; GREGG RE, 1988, CLIN CHEM, V34, pB28; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; Jayabalasingham B, 2010, BIOL REPROD, V2; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Katzman Robert, 1994, Current Opinion in Neurobiology, V4, P703, DOI 10.1016/0959-4388(94)90013-2; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Labaied M, 2011, CELL MICROBIOL, V13, P569, DOI 10.1111/j.1462-5822.2010.01555.x; Lucotte G, 1997, HUM BIOL, V69, P253; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mamotte CDS, 1999, AM J PHYSIOL-ENDOC M, V276, pE553, DOI 10.1152/ajpendo.1999.276.3.E553; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Migot-Nabias F, 2000, GENES IMMUN, V1, P435, DOI 10.1038/sj.gene.6363703; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; Parquet V, 2009, ANTIMICROB AGENTS CH, V53, P2248, DOI 10.1128/AAC.01462-08; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rathore D, 2001, MOL BIOCHEM PARASIT, V118, P75, DOI 10.1016/S0166-6851(01)00369-3; Ribalta J, 2003, CURR OPIN CLIN NUTR, V6, P177, DOI 10.1097/00075197-200303000-00006; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 2000, Bull Mem Acad R Med Belg, V155, P218; Shakibaei M, 1996, J EXP MED, V184, P1699, DOI 10.1084/jem.184.5.1699; SIEST G, 1995, CLIN CHEM, V41, P1068; Sinnis P, 1996, J EXP MED, V184, P945, DOI 10.1084/jem.184.3.945; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Taoufiq Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-52; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; UTERMANN G, 1984, HUM GENET, V65, P232, DOI 10.1007/BF00286508; Vignali M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-211; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wozniak MA, 2003, J MED GENET, V40, P348, DOI 10.1136/jmg.40.5.348; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	60	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76924	10.1371/journal.pone.0076924	http://dx.doi.org/10.1371/journal.pone.0076924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116184	Green Submitted, gold, Green Published			2022-12-27	WOS:000325552200084
J	Stames, EM; O'Toole, JF				Stames, Erine M.; O'Toole, John F.			Mitochondrial Aminopeptidase Deletion Increases Chronological Lifespan and Oxidative Stress Resistance while Decreasing Respiratory Metabolism in S. cerevisiae	PLOS ONE			English	Article							MAMMALIAN TARGET; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; GLOBAL ANALYSIS; YEAST; PROTEIN; RAPAMYCIN; MTOR; ACTIVATION; PATHWAY	Recessive mutations in XPNPEP3, encoding a mitochondrial x-prolyl aminopeptidase, have been identified in families with a rare hereditary tubulointerstitial kidney disease. The yeast ortholog of XPNPEP3, Icp55p, participates in the proteolytic processing and stabilization of mitochondrial proteins and its deletion accelerates the degradation of its protein targets. We used icp55 deletion strains of S. cerevisiae to model loss of XPNPEP3 enzymatic function and study its phenotypic consequences on mitochondrial function. We found that Icp55p is not required for respiratory competence; however, compared to controls deletion strains had reduced mitochondrial oxygen consumption when grown in glucose containing media. The reduced mitochondrial respiration of icp55 deletion strains in glucose media requires the mitochondrial peptide transporter, Mdl1p, and was corrected by Tor1p inhibition with rapamycin. Under similar growth conditions the abundance of the mitochondrial ATP synthase complex was decreased in the icp55 deletion strain and was corrected by concurrent deletion of tor1. The icp55 deletion strain demonstrated an increased chronological lifespan and decreased reactive oxygen species. These changes were additive to similar changes known to occur in tor1 deletion strains suggesting independent mechanisms. Together, these results demonstrate that loss of Icp55p function reduces mitochondrial oxygen consumption and ATP synthase complex assembly in glucose media, while also promoting stress resistance, decreasing reactive oxygen species and increasing chronological lifespan through mechanisms that are distinct from decreased Tor1p activity.	[O'Toole, John F.] MetroHealth Med Syst, Div Nephrol, Dept Med, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA	MetroHealth System; Case Western Reserve University	O'Toole, JF (corresponding author), MetroHealth Med Syst, Div Nephrol, Dept Med, Cleveland, OH USA.	jxo69@case.edu			National Institutes of Health [K08DK071108, RO1DK091597]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071108, R01DK091597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JFO has received support through the National Institutes of Health (K08DK071108 and RO1DK091597) and this publication was made possible by the Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF180, DOI 10.1152/ajprenal.00015.2012; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF1, DOI 10.1152/ajprenal.00014.2012; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204; Pan Y, 2009, AGING-US, V1, P131, DOI 10.18632/aging.100016; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Tenreiro S, 2010, FEMS YEAST RES, V10, P970, DOI 10.1111/j.1567-1364.2010.00649.x; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Varshavsky A, 2011, PROTEIN SCI, V10; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; YOSHIMOTO T, 1988, J BIOCHEM, V104, P93, DOI 10.1093/oxfordjournals.jbchem.a122430; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77234	10.1371/journal.pone.0077234	http://dx.doi.org/10.1371/journal.pone.0077234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116217	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200109
J	van Seeters, T; Biessels, GJ; Niesten, JM; van der Schaaf, IC; Dankbaar, JW; Horsch, AD; Mali, WPTM; Kappelle, LJ; van der Graaf, Y; Velthuis, BK				van Seeters, Tom; Biessels, Geert Jan; Niesten, Joris M.; van der Schaaf, Irene C.; Dankbaar, Jan Willem; Horsch, Alexander D.; Mali, Willem P. T. M.; Kappelle, L. Jaap; van der Graaf, Yolanda; Velthuis, Birgitta K.		Dust Investigators	Reliability of Visual Assessment of Non-Contrast CT, CT Angiography Source Images and CT Perfusion in Patients with Suspected Ischemic Stroke	PLOS ONE			English	Article							FINAL INFARCT EXTENT; ALBERTA STROKE; THROMBOLYTIC THERAPY; COMPUTED-TOMOGRAPHY; NONCONTRAST CT; SCORE ASPECTS; AGREEMENT; PREDICTION; MISMATCH; VALIDITY	Background and Purpose: Good reliability of methods to assess the extent of ischemia in acute stroke is important for implementation in clinical practice, especially between observers with varying experience. Our aim was to determine inter- and intra-observer reliability of the 1/3 middle cerebral artery (MCA) rule and the Alberta Stroke Program Early CT Score (ASPECTS) for different CT modalities in patients suspected of acute ischemic stroke. Methods: We prospectively included 105 patients with acute neurological deficit due to suspected acute ischemic stroke within 9 hours after symptom onset. All patients underwent non-contrast CT, CT perfusion and CT angiography on admission. All images were evaluated twice for presence of ischemia, ischemia with >1/3 MCA involvement, and ASPECTS. Four observers evaluated twenty scans twice for intra-observer agreement. We used kappa statistics and intraclass correlation coefficient to calculate agreement. Results: Inter-observer agreement for the 1/3 MCA rule and ASPECTS was fair to good for non-contrast CT, poor to good for CT angiography source images, but excellent for all CT perfusion maps (cerebral blood volume, mean transit time, and predicted penumbra and infarct maps). Intra-observer agreement for the 1/3 MCA rule and ASPECTS was poor to good for non-contrast CT, fair to moderate for CT angiography source images, and good to excellent for all CT perfusion maps. Conclusion: Between observers with a different level of experience, agreement on the radiological diagnosis of cerebral ischemia is much better for CT perfusion than for non-contrast CT and CT angiography source images, and therefore CT perfusion is a very reliable addition to standard stroke imaging.	[van Seeters, Tom; Niesten, Joris M.; van der Schaaf, Irene C.; Dankbaar, Jan Willem; Horsch, Alexander D.; Mali, Willem P. T. M.; Velthuis, Birgitta K.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Biessels, Geert Jan; Kappelle, L. Jaap] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht Stroke Ctr, Utrecht, Netherlands; [Horsch, Alexander D.] Rijnstate Hosp, Dept Radiol, Arnhem, Netherlands; [van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Rijnstate Hospital; Utrecht University; Utrecht University Medical Center	van Seeters, T (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	T.vanSeeters@umcutrecht.nl	Meijer, Frederick J.A./L-4516-2015; Horsch, Alexander D./U-3330-2019; van Dijk, Ewoud J/J-7951-2012; Mali, Willem PThM/I-1123-2014	Meijer, Frederick J.A./0000-0001-5921-639X; Mali, Willem PThM/0000-0003-4391-0904; Horsch, Alexander/0000-0001-8213-2784; Dippel, Diederik/0000-0002-9234-3515	Dutch Heart Foundation [2008T034]; NutsOhra Foundation [0903-012]	Dutch Heart Foundation(Netherlands Heart Foundation); NutsOhra Foundation	This study was supported by a grant from the Dutch Heart Foundation (grant 2008T034; http://www.hartstichting.nl) and the NutsOhra Foundation (grant 0903-012; http://www.stichtingnutsohra.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv RI, 2007, AM J NEURORADIOL, V28, P1975, DOI 10.3174/ajnr.A0689; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Camargo ECS, 2007, RADIOLOGY, V244, P541, DOI 10.1148/radiol.2442061028; Coutts SB, 2004, STROKE, V35, P2472, DOI 10.1161/01.STR.0000145330.14928.2a; Coutts SB, 2004, STROKE, V35, pE103, DOI 10.1161/01.STR.0000127082.19473.45; Dippel DWJ, 2000, NEURORADIOLOGY, V42, P629, DOI 10.1007/s002340000369; Eckert B, 2011, NEURORADIOLOGY, V53, P79, DOI 10.1007/s00234-010-0702-9; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Finlayson O, 2013, STROKE, V44, P234, DOI 10.1161/STROKEAHA.112.665208; Gamer M, 2010, IRR VARIOUS COEFFICI; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Kloska SP, 2007, EUR RADIOL, V17, P2491, DOI 10.1007/s00330-007-0696-9; Lev MH, 1999, RADIOLOGY, V213, P150, DOI 10.1148/radiology.213.1.r99oc10150; Lin K, 2008, AM J NEURORADIOL, V29, P931, DOI 10.3174/ajnr.A0975; Lin K, 2007, AM J NEURORADIOL, V28, P1292, DOI 10.3174/ajnr.A0539; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Mak HKF, 2003, STROKE, V34, P1194, DOI 10.1161/01.STR.0000069162.64966.71; Marks MP, 1999, STROKE, V30, P389, DOI 10.1161/01.STR.30.2.389; Muir KW, 2006, J NEUROL NEUROSUR PS, V77, P334, DOI 10.1136/jnnp.2005.074179; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Puetz V, 2009, INT J STROKE, V4, P354, DOI 10.1111/j.1747-4949.2009.00337.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Sharma M, 2011, AM J NEURORADIOL, V32, P359, DOI 10.3174/ajnr.A2282; Tan JC, 2007, ANN NEUROL, V61, P533, DOI 10.1002/ana.21130; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Wintermark M, 2007, NEUROLOGY, V68, P694, DOI 10.1212/01.wnl.0000255959.30107.08; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39	30	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75615	10.1371/journal.pone.0075615	http://dx.doi.org/10.1371/journal.pone.0075615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116061	gold, Green Submitted, Green Published			2022-12-27	WOS:000325552200031
J	Wang, HX; Wu, XR; Yang, H; Yin, CL; Shi, LJ; Wang, XJ				Wang, Hong-Xia; Wu, Xin-Rui; Yang, Hui; Yin, Chun-Lin; Shi, Li-Jin; Wang, Xue-Jiang			Urotensin II Inhibits Skeletal Muscle Glucose Transport Signaling Pathways via the NADPH Oxidase Pathway	PLOS ONE			English	Article							INSULIN-RESISTANCE; EXPRESSION; MOUSE; PROLIFERATION; ACTIVATION; MODEL; GENE	Our previous studies have demonstrated that the urotensin (UII) and its receptor are up-regulated in the skeletal muscle of mice with type II diabetes mellitus (T2DM), but the significance of UII in skeletal muscle insulin resistance remains unknown. The purpose of this study was to investigate the effect of UII on NADPH oxidase and glucose transport signaling pathways in the skeletal muscle of mice with T2DM and in C2C12 mouse myotube cells. KK/upj-AY/J mice (KK) mice were divided into the following groups: KK group, with saline treatment for 2 weeks; KK+urantide group, with daily 30 mu g/kg body weight injections over the same time period of urantide, a potent urotensin II antagonist peptide; Non-diabetic C57BL/6J mice were used as normal controls. After urantide treatment, mice were subjected to an intraperitoneal glucose tolerance test, in addition to measurements of the levels of ROS, NADPH oxidase and the phosphorylated AKT, PKC and ERK. C2C12 cells were incubated with serum-free DMEM for 24 hours before conducting the experiments, and then administrated with 100 nM UII for 2 hours or 24 hours. Urantide treatment improved glucose tolerance, decreased the translocation of the NADPH subunits p40-phox and p47-phox, and increased levels of the phosphorylated PKC, AKT and ERK. In contrast, UII treatment increased ROS production and p47-phox and p67-phox translocation, and decreased the phosphorylated AKT, ERK1/2 and p38MAPK; Apocynin abrogated this effect. In conclusion, UII increased ROS production by NADPH oxidase, leading to the inhibition of signaling pathways involving glucose transport, such as AKT/PKC/ERK. Our data imply a role for UII at the molecular level in glucose homeostasis, and possibly in skeletal muscle insulin resistance in T2DM.	[Wang, Hong-Xia; Wu, Xin-Rui; Yang, Hui; Wang, Xue-Jiang] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Yin, Chun-Lin] Capital Med Univ, Xuan Wu Hosp, Dept Cardiol, Beijing, Peoples R China; [Shi, Li-Jin] Xinxiang Med Coll, Affiliated Hosp 1, Dept Neurol, Xinxiang, Peoples R China	Capital Medical University; Capital Medical University; Xinxiang Medical University	Wang, XJ (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	whxdy@sina.com			National Natural Science Foundation of China [81000343]; Beijing Natural Science Foundation [7112013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (no. 81000343, http://www.nsfc.gov.cn/Portal0/default152.htm) and Beijing Natural Science Foundation (no. 7112013, http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Barrette Pierre-Olivier, 2012, Front Endocrinol (Lausanne), V3, P165, DOI 10.3389/fendo.2012.00165; Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533; CASTLE CK, 1993, ARTERIOSCLER THROMB, V13, P302, DOI 10.1161/01.ATV.13.2.302; Chen YL, 2008, EUR J PHARMACOL, V593, P24, DOI 10.1016/j.ejphar.2008.07.025; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Diebold I, 2011, MOL BIOL CELL, V22, P4424, DOI 10.1091/mbc.E10-12-0971; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Elshourbagy NA, 2002, BRIT J PHARMACOL, V136, P9, DOI 10.1038/sj.bjp.0704671; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Ishikawa Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/702948; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; Samocha-Bonet D, 2010, TRENDS ENDOCRIN MET, V21, P83, DOI 10.1016/j.tem.2009.09.008; Sullivan-Gunn MJ, 2011, J CACHEXIA SARCOPENI, V2, P181, DOI 10.1007/s13539-011-0037-3; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Wang HX, 2009, REGUL PEPTIDES, V154, P85, DOI 10.1016/j.regpep.2009.01.004; Wang HX, 2012, CYTOKINE, V60, P360, DOI 10.1016/j.cyto.2012.04.029; Wang XW, 2012, TOXICOL APPL PHARM, V259, P346, DOI 10.1016/j.taap.2012.01.013; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015; Watson AMD, 2013, DIABETOLOGIA, V56, P1155, DOI 10.1007/s00125-013-2837-9; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Woods Yvonne L., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P187	24	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76796	10.1371/journal.pone.0076796	http://dx.doi.org/10.1371/journal.pone.0076796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116164	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200073
J	Wong, G; Barlow, CK; Weir, JM; Jowett, JBM; Magliano, DJ; Zimmet, P; Shaw, J; Meikle, PJ				Wong, Gerard; Barlow, Christopher K.; Weir, Jacquelyn M.; Jowett, Jeremy B. M.; Magliano, Dianna J.; Zimmet, Paul; Shaw, Jonathan; Meikle, Peter J.			Inclusion of Plasma Lipid Species Improves Classification of Individuals at Risk of Type 2 Diabetes	PLOS ONE			English	Article							INFLAMMATION; CERAMIDES; OBESITY	Background: A significant proportion of individuals with diabetes or impaired glucose tolerance have fasting plasma glucose less than 6.1 mmol/L and so are not identified with fasting plasma glucose measurements. In this study, we sought to evaluate the utility of plasma lipids to improve on fasting plasma glucose and other standard risk factors for the identification of type 2 diabetes or those at increased risk (impaired glucose tolerance). Methods and Findings: Our diabetes risk classification model was trained and cross-validated on a cohort 76 individuals with undiagnosed diabetes or impaired glucose tolerance and 170 gender and body mass index matched individuals with normal glucose tolerance, all with fasting plasma glucose less than 6.1 mmol/L. The inclusion of 21 individual plasma lipid species to triglycerides and HbA1c as predictors in the diabetes risk classification model resulted in a statistically significant gain in area under the receiver operator characteristic curve of 0.049 (p<0.001) and a net reclassification improvement of 10.5% (p<0.001). The gain in area under the curve and net reclassification improvement were subsequently validated on a separate cohort of 485 subjects. Conclusions: Plasma lipid species can improve the performance of classification models based on standard lipid and non-lipid risk factors.	[Wong, Gerard; Barlow, Christopher K.; Weir, Jacquelyn M.; Jowett, Jeremy B. M.; Magliano, Dianna J.; Zimmet, Paul; Shaw, Jonathan; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Meikle, PJ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	peter.meikle@bakeridi.edu.au	Shaw, Jonathan/E-7388-2010; Zimmet, Paul/O-8486-2019; Meikle, Peter J/B-4023-2009	Shaw, Jonathan/0000-0002-6187-2203; Zimmet, Paul/0000-0003-0627-0776; Barlow, Christopher/0000-0001-9309-2829; Meikle, Peter/0000-0002-2593-4665; Magliano, Dianna/0000-0002-9507-6096	NHMRC; Victorian Cancer Agency Public Health Fellowship; Dairy Health and Nutrition Consortium, Australia; National Health and Medical Research Council of Australia; OIS Program of the Victorian Government, Australia; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA [1R01DK088972-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088972] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency Public Health Fellowship; Dairy Health and Nutrition Consortium, Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); OIS Program of the Victorian Government, Australia; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PJM and JS are supported by an NHMRC senior research fellowship. DJM is supported by a Victorian Cancer Agency Public Health Fellowship. This work was supported by funding from the Dairy Health and Nutrition Consortium, Australia, The National Health and Medical Research Council of Australia, the OIS Program of the Victorian Government, Australia and by Award Number 1R01DK088972-01 from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the aforementioned funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Barr ELM., 2006, AUSDIAB 2005 AUSTR D; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Cefalu WT, 2009, DIABETES, V58, P307, DOI 10.2337/db08-1656; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Magliano DJ, 2008, DIABETOLOGIA, V51, P2179, DOI 10.1007/s00125-008-1150-5; Magliano DJ, 2009, AUST NZ J PUBL HEAL, V33, P540, DOI 10.1111/j.1753-6405.2009.00450.x; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Noble Douglas, 2011, BMJ, V343, pd7163, DOI 10.1136/bmj.d7163; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rizza S, 2012, ATHEROSCLEROSIS; Rizza S, 2010, ATHEROSCLEROSIS, V212, P316, DOI 10.1016/j.atherosclerosis.2010.05.017; Shaw J., 2012, DIABETES SILENT PAND; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stahlman M, 2012, DIABETOLOGIA, V55, P1156, DOI 10.1007/s00125-011-2444-6; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	31	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76577	10.1371/journal.pone.0076577	http://dx.doi.org/10.1371/journal.pone.0076577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116121	gold, Green Published			2022-12-27	WOS:000325552200058
J	Mills, KT; Hamm, LL; Alper, AB; Miller, C; Hudaihed, A; Balamuthusamy, S; Chen, CS; Liu, YX; Tarsia, J; Rifai, N; Kleinpeter, M; He, J; Chen, J				Mills, Katherine T.; Hamm, L. Lee; Alper, A. Brent; Miller, Chad; Hudaihed, Alhakam; Balamuthusamy, Saravanan; Chen, Chung-Shiuan; Liu, Yanxi; Tarsia, Joseph; Rifai, Nader; Kleinpeter, Myra; He, Jiang; Chen, Jing			Circulating Adipocytokines and Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; PLASMA-PROTEIN; ADIPONECTIN; LEPTIN; ASSOCIATION; ALBUMINURIA; PROGRESSION; POPULATION	Background: Adipokines have been associated with atherosclerotic heart disease, which shares many common risk factors with chronic kidney disease (CKD), but their relationship with CKD has not been well characterized. Methods: We investigated the association of plasma leptin, resistin and adiponectin with CKD in 201 patients with CKD and 201 controls without. CKD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2) or presence of albuminuria. Quantile regression and logistic regression models were used to examine the association between adipokines and CKD adjusting for multiple confounding factors. Results: Compared to controls, adjusted median leptin (38.2 vs. 17.2 ng/mL, p<0.0001) and adjusted mean resistin (16.2 vs 9.0 ng/mL, p<0.0001) were significantly higher in CKD cases. The multiple-adjusted odds ratio (95% confidence interval) of CKD comparing the highest tertile to the lower two tertiles was 2.3 (1.1, 4.9) for leptin and 12.7 (6.5, 24.6) for resistin. Median adiponectin was not significantly different in cases and controls, but the odds ratio comparing the highest tertile to the lower two tertiles was significant (1.9; 95% CI, 1.1, 3.6). In addition, higher leptin, resistin, and adiponectin were independently associated with lower eGFR and higher urinary albumin levels. Conclusions: These findings suggest that adipocytokines are independently and significantly associated with the risk and severity of CKD. Longitudinal studies are warranted to evaluate the prospective relationship of adipocytokines to the development and progression of CKD.	[Mills, Katherine T.; Chen, Chung-Shiuan; Liu, Yanxi; He, Jiang; Chen, Jing] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Hamm, L. Lee; Alper, A. Brent; Miller, Chad; Hudaihed, Alhakam; Balamuthusamy, Saravanan; Tarsia, Joseph; Kleinpeter, Myra; He, Jiang; Chen, Jing] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Hamm, L. Lee; Alper, A. Brent; Kleinpeter, Myra; Chen, Jing] Tulane Univ, Sch Med, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Rifai, Nader] Children Hosp, Dept Lab Med, Boston, MA USA; [Rifai, Nader] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Tulane University; Tulane University; Tulane University; Harvard University; Boston Children's Hospital; King Abdulaziz University	Chen, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	jchen@tulane.edu	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652	National Center for Research Resources, National Institutes of Health, Bethesda, Maryland [P20-RR017659, P30-GM103337]; Clinical and Translational Clinical Research Center grant from the Louisiana Board of Regents RC/EEP Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P30GM103337] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Clinical Research Center grant from the Louisiana Board of Regents RC/EEP Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants (P20-RR017659 and P30-GM103337) from the National Center for Research Resources, National Institutes of Health, Bethesda, Maryland (http://www.nih.gov/about/almanac/organization/NCRR.htm) and partially supported by a Clinical and Translational Clinical Research Center grant from the Louisiana Board of Regents RC/EEP Fund (http://web.laregents.org/programs/rceep/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J, 2006, KIDNEY INT, V69, P596, DOI 10.1038/sj.ki.5000089; Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Vinuesa SG, 2006, J AM SOC NEPHROL, V17, pS206, DOI 10.1681/ASN.2006080916; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fruehwald-Schultes B, 1999, METABOLISM, V48, P1290, DOI 10.1016/S0026-0495(99)90270-6; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh568; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsieh C C, 1991, Epidemiology, V2, P137, DOI 10.1097/00001648-199103000-00008; Kawamura R, 2010, NEPHROL DIAL TRANSPL, V25, P3236, DOI 10.1093/ndt/gfq155; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Nanayakkara PWB, 2009, CLIN NEPHROL, V72, P21; Norata GD, 2010, NUTR METAB CARDIOVAS, V20, P56, DOI 10.1016/j.numecd.2009.01.011; Nordfors L, 1998, KIDNEY INT, V54, P1267, DOI 10.1046/j.1523-1755.1998.00088.x; Ntaios G, 2013, ATHEROSCLEROSIS, V227, P216, DOI 10.1016/j.atherosclerosis.2012.12.029; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Sarnak MJ, 2002, KIDNEY INT, V62, P2208, DOI 10.1046/j.1523-1755.2002.00677.x; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Shankar A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/269532; Sharma K, 1997, KIDNEY INT, V51, P1980, DOI 10.1038/ki.1997.269; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yaturu S, 2007, CYTOKINE, V37, P1, DOI 10.1016/j.cyto.2007.02.003; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	31	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76902	10.1371/journal.pone.0076902	http://dx.doi.org/10.1371/journal.pone.0076902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116180	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300104
J	Park, E; Nebenfuhr, A				Park, Eunsook; Nebenfuehr, Andreas			Myosin XIK of Arabidopsis thaliana Accumulates at the Root Hair Tip and Is Required for Fast Root Hair Growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MOTILITY; EXPRESSED SEQUENCE TAGS; F-ACTIN ORGANIZATION; PLANT-CELLS; PHYSCOMITRELLA-PATENS; POLARIZED GROWTH; GTPASE CONTROLS; TAIL FUSIONS; GENE FAMILY; ROP2 GTPASE	Myosin motor proteins are thought to carry out important functions in the establishment and maintenance of cell polarity by moving cellular components such as organelles, vesicles, or protein complexes along the actin cytoskeleton. In Arabidopsis thaliana, disruption of the myosin XIK gene leads to reduced elongation of the highly polar root hairs, suggesting that the encoded motor protein is involved in this cell growth. Detailed live-cell observations in this study revealed that xik root hairs elongated more slowly and stopped growth sooner than those in wild type. Overall cellular organization including the actin cytoskeleton appeared normal, but actin filament dynamics were reduced in the mutant. Accumulation of RabA4b-containing vesicles, on the other hand, was not significantly different from wild type. A functional YFP-XIK fusion protein that could complement the mutant phenotype accumulated at the tip of growing root hairs in an actin-dependent manner. The distribution of YFP-XIK at the tip, however, did not match that of the ER or several tip-enriched markers including CFP-RabA4b. We conclude that the myosin XIK is required for normal actin dynamics and plays a role in the subapical region of growing root hairs to facilitate optimal growth.	[Park, Eunsook; Nebenfuehr, Andreas] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Nebenfuhr, A (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	nebenfuehr@utk.edu		Nebenfuhr, Andreas/0000-0002-4997-2180; Park, Eunsook/0000-0003-2984-3039	National Science Foundation [MCB-0822111]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation (grant MCB-0822111 to AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asamizu E, 2000, DNA RES, V7, P175, DOI 10.1093/dnares/7.3.175; Avisar D, 2012, J EXP BOT, V63, P241, DOI 10.1093/jxb/err265; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Era A, 2009, PLANT CELL PHYSIOL, V50, P1041, DOI 10.1093/pcp/pcp055; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Furt F, 2013, PLANT J, V73, P417, DOI 10.1111/tpj.12039; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Grierson CS, 2002, ARABIODPSIS BOOK; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Hoffmann A, 2004, PROTOPLASMA, V224, P201, DOI 10.1007/s00709-004-0068-0; Houtman D, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/18001; Jiang SY, 2007, DEV BIOL, V304, P579, DOI 10.1016/j.ydbio.2007.01.008; Jiang SY, 2004, PLANT CELL PHYSIOL, V45, P590, DOI 10.1093/pcp/pch061; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Kang BH, 2011, TRAFFIC, V12, P313, DOI 10.1111/j.1600-0854.2010.01146.x; Kawamura E, 2006, PLANT PHYSIOL, V140, P102, DOI 10.1104/pp.105.069989; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; KINKEMA M, 1994, J MOL BIOL, V239, P591, DOI 10.1006/jmbi.1994.1400; Kost B, 2008, TRENDS CELL BIOL, V18, P119, DOI 10.1016/j.tcb.2008.01.003; Lee YJ, 2008, J CELL BIOL, V181, P1155, DOI 10.1083/jcb.200801086; Lee YJ, 2008, CURR OPIN PLANT BIOL, V11, P662, DOI 10.1016/j.pbi.2008.10.002; Li JF, 2007, J BIOL CHEM, V282, P20593, DOI 10.1074/jbc.M700645200; Lo Presti L, 2012, MOL BIOL CELL, V23, P4579, DOI 10.1091/mbc.E12-07-0499; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Natesan SKA, 2009, MOL PLANT, V2, P1262, DOI 10.1093/mp/ssp078; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; Ojangu EL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-81; Park E, 2011, ADVAN PL BIO, V2, P259, DOI 10.1007/978-1-4419-0987-9_12; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Peremyslov VV, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00184; Peremyslov V, 2011, PLANT PHYSIOL, V155, P1191, DOI 10.1104/pp.110.170720; Peremyslov VV, 2010, PLANT CELL, V22, P1883, DOI 10.1105/tpc.110.076315; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; Sparkes IA, 2008, J EXP BOT, V59, P2499, DOI 10.1093/jxb/ern114; Sparkes IA, 2010, BIOCHEM SOC T, V38, P833, DOI 10.1042/BST0380833; Staiger CJ, 2009, J CELL BIOL, V184, P269, DOI 10.1083/jcb.200806185; Sun C, 2009, J MICROSC-OXFORD, V234, P147, DOI 10.1111/j.1365-2818.2009.03156.x; Szumlanski AL, 2009, PLANT CELL, V21, P526, DOI 10.1105/tpc.108.060277; Thole JM, 2008, PLANT CELL, V20, P381, DOI 10.1105/tpc.107.054304; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Vermeer JEM, 2009, PLANT J, V57, P356, DOI 10.1111/j.1365-313X.2008.03679.x; Vidali L, 2010, PLANT CELL, V22, P1868, DOI 10.1105/tpc.109.073288; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Wang GF, 2012, PLANT CELL, V24, P3447, DOI 10.1105/tpc.112.101360; Weigel D., 2002, ARABIDOPSIS LAB MANU; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	64	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76745	10.1371/journal.pone.0076745	http://dx.doi.org/10.1371/journal.pone.0076745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116145	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300087
J	Williams, S; Bateman, A; O'Kelly, I				Williams, Sarah; Bateman, Andrew; O'Kelly, Ita			Altered Expression of Two-Pore Domain Potassium (K-2P) Channels in Cancer	PLOS ONE			English	Article							ION CHANNELS; K+ CHANNELS; CELL-PROLIFERATION; UP-REGULATION; DIFFERENTIAL EXPRESSION; ABERRANT EXPRESSION; GENE PROMOTER; MIGRATION; PROTEIN; ETHER	Potassium channels have become a focus in cancer biology as they play roles in cell behaviours associated with cancer progression, including proliferation, migration and apoptosis. Two-pore domain (K-2P) potassium channels are background channels which enable the leak of potassium ions from cells. As these channels are open at rest they have a profound effect on cellular membrane potential and subsequently the electrical activity and behaviour of cells in which they are expressed. The K-2P family of channels has 15 mammalian members and already 4 members of this family (K(2P)2.1, K(2P)3.1, K(2P)9.1, K(2P)5.1) have been implicated in cancer. Here we examine the expression of all 15 members of the K-2P family of channels in a range of cancer types. This was achieved using the online cancer microarray database, Oncomine (www.oncomine.org). Each gene was examined across 20 cancer types, comparing mRNA expression in cancer to normal tissue. This analysis revealed all but 3 K-2P family members (K(2P)4.1, K(2P)16.1, K(2P)18.1) show altered expression in cancer. Overexpression of K-2P channels was observed in a range of cancers including breast, leukaemia and lung while more cancers (brain, colorectal, gastrointestinal, kidney, lung, melanoma, oesophageal) showed underexpression of one or more channels. K(2P)1.1, K(2P)3.1, K(2P)12.1, were overexpressed in a range of cancers. While K(2P)1.1, K(2P)3.1, K(2P)5.1, K(2P)6.1, K(2P)7.1 and K(2P)10.1 showed significant underexpression across the cancer types examined. This analysis supports the view that specific K-2P channels may play a role in cancer biology. Their altered expression together with their ability to impact the function of other ion channels and their sensitivity to environmental stimuli (pO2, pH, glucose, stretch) makes understanding the role these channels play in cancer of key importance.	[Williams, Sarah; O'Kelly, Ita] Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England; [Bateman, Andrew] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	O'Kelly, I (corresponding author), Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England.	I.M.O'Kelly@southampton.ac.uk			Gerald Kerkut Charitable Trust	Gerald Kerkut Charitable Trust	Work funded by the Gerald Kerkut Charitable Trust (http://www.southampton.ac.uk/similar to gktrust/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul M, 2006, J MEMBRANE BIOL, V214, P99, DOI 10.1007/s00232-006-0065-7; Rodriguez-Rasgado JA, 2012, SENSORS-BASEL, V12, P5986, DOI 10.3390/s120505986; Afrasiabi E, 2010, CELL SIGNAL, V22, P57, DOI 10.1016/j.cellsig.2009.09.010; Agarwal JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-18; Alvarez-Baron CP, 2011, MOL ENDOCRINOL, V25, P1326, DOI 10.1210/me.2011-0045; Arcangeli A, 1995, J PHYSIOL-LONDON, V489, P455, DOI 10.1113/jphysiol.1995.sp021065; Arvind S, 2012, BRIT J NEUROSURG, V26, P16, DOI 10.3109/02688697.2011.583365; Asher V, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-6; Banderali U, 2011, CELL PHYSIOL BIOCHEM, V28, P1169, DOI 10.1159/000335850; Bittner S, 2010, BRAIN PATHOL, V20, P999, DOI 10.1111/j.1750-3639.2010.00407.x; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Brevet M, 2009, PANCREAS, V38, P649, DOI 10.1097/MPA.0b013e3181a56ebf; Brevet M, 2009, CELL PHYSIOL BIOCHEM, V24, P25, DOI 10.1159/000227810; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Campanucci VA, 2005, NEUROSCIENCE, V135, P1087, DOI 10.1016/j.neuroscience.2005.07.009; Catacuzzeno L, 2011, J CELL PHYSIOL, V226, P1926, DOI 10.1002/jcp.22523; Chantome A, 2009, EXP CELL RES, V315, P3620, DOI 10.1016/j.yexcr.2009.07.021; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; D'Amico M, 2013, RECENT PAT ANTI-CANC, V8, P53; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Ding XW, 2008, DIGEST DIS SCI, V53, P2039, DOI 10.1007/s10620-007-0116-7; Ding XW, 2008, J SURG ONCOL, V97, P57, DOI 10.1002/jso.20891; Ding XW, 2007, WORLD J GASTROENTERO, V13, P1257, DOI 10.3748/wjg.v13.i8.1257; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; Duprat F, 2007, TRENDS NEUROSCI, V30, P573, DOI 10.1016/j.tins.2007.08.003; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Faouzi M, 2010, J MEMBRANE BIOL, V234, P47, DOI 10.1007/s00232-010-9238-5; Felipe A, 2006, CANCER DETECT PREV, V30, P375, DOI 10.1016/j.cdp.2006.06.002; Ferlay J, 2010, IARC CANCERBASE; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Fortunato P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-504; Fraser SP, 2008, EMBO REP, V9, P512, DOI 10.1038/embor.2008.75; Glassmeier G, 2012, PFLUG ARCH EUR J PHY, V463, P365, DOI 10.1007/s00424-011-1045-z; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hammadi M, 2012, J CELL PHYSIOL, V227, P3837, DOI 10.1002/jcp.24095; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang LY, 2009, CARCINOGENESIS, V30, P737, DOI 10.1093/carcin/bgp034; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Jang SH, 2009, BMB REP, V42, P535, DOI 10.5483/BMBRep.2009.42.8.535; Jang SH, 2009, BIOCHEM BIOPH RES CO, V384, P180, DOI 10.1016/j.bbrc.2009.04.108; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kim CJ, 2004, APMIS, V112, P588, DOI 10.1111/j.1600-0463.2004.apm1120905.x; Kim HJ, 2010, BIOL PHARM BULL, V33, P1754, DOI 10.1248/bpb.33.1754; Kosztka L, 2011, MELANOMA RES, V21, P308, DOI 10.1097/CMR.0b013e3283462713; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lai W, 2011, ONCOL REP, V26, P909, DOI 10.3892/or.2011.1366; Lallet-Daher H, 2009, ONCOGENE, V28, P1792, DOI 10.1038/onc.2009.25; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Lastraioli E, 2004, CANCER RES, V64, P606, DOI 10.1158/0008-5472.CAN-03-2360; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lee GW, 2012, ACTA PHYSIOL, V204, P513, DOI 10.1111/j.1748-1716.2011.02359.x; Lee I, 2010, MOL CANCER THER, V9, P2951, DOI 10.1158/1535-7163.MCT-10-0511; Ma YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037451; Mant A, 2012, J BIOL CHEM; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nogueira EF, 2010, CLIN ENDOCRINOL, V73, P22, DOI 10.1111/j.1365-2265.2009.03738.x; Nunez M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-6; O'Kelly I, 1999, AM J PHYSIOL-LUNG C, V276, pL96, DOI 10.1152/ajplung.1999.276.1.L96; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Park SH, 2008, GYNECOL ENDOCRINOL, V24, P250, DOI 10.1080/09513590801893315; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Plummer HK, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-104; Pocsai K, 2006, CELL MOL LIFE SCI, V63, P2364, DOI 10.1007/s00018-006-6166-8; Potier M, 2006, MOL CANCER THER, V5, P2946, DOI 10.1158/1535-7163.MCT-06-0194; Potier M, 2010, BIOCHEM BIOPH RES CO, V397, P42, DOI 10.1016/j.bbrc.2010.05.046; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Shao XD, 2008, CANCER BIOL THER, V7, P45, DOI 10.4161/cbt.7.1.5126; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Steinle M, 2011, RADIOTHER ONCOL, V101, P122, DOI 10.1016/j.radonc.2011.05.069; Stringer BK, 2001, CANCER RES, V61, P582; Suzuki Y, 2012, INT J ONCOL, V41, P465, DOI 10.3892/ijo.2012.1483; Tan G, 2008, BIOCHEM BIOPH RES CO, V367, P743, DOI 10.1016/j.bbrc.2008.01.014; Menendez ST, 2012, J MOL MED, V90, P1173, DOI 10.1007/s00109-012-0893-0; Menendez ST, 2010, J PATHOL, V221, P402, DOI 10.1002/path.2722; Veeravalli KK, 2012, CELL SIGNAL, V24, P272, DOI 10.1016/j.cellsig.2011.09.011; Voloshyna I, 2008, CANCER RES, V68, P1197, DOI 10.1158/0008-5472.CAN-07-5163; Wadhwa S, 2009, INT UROL NEPHROL, V41, P251, DOI 10.1007/s11255-008-9459-z; Wang LH, 2012, BBA-MOL CELL RES, V1823, P505, DOI 10.1016/j.bbamcr.2011.11.012; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Wu J, 2012, NEOPLASMA, V59, P207, DOI 10.4149/neo_2012_027; Zheng YA, 2011, CLIN BIOCHEM, V44, P1405, DOI 10.1016/j.clinbiochem.2011.09.006	96	43	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74589	10.1371/journal.pone.0074589	http://dx.doi.org/10.1371/journal.pone.0074589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116006	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000325501300009
J	Chirino, B; Strahsburger, E; Agullo, L; Gonzalez, M; Seeger, M				Chirino, Bernardita; Strahsburger, Erwin; Agullo, Loreine; Gonzalez, Myriam; Seeger, Michael			Genomic and Functional Analyses of the 2-Aminophenol Catabolic Pathway and Partial Conversion of Its Substrate into Picolinic Acid in Burkholderia xenovorans LB400	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; PSEUDOMONAS-PUTIDA; DEGRADATION; SEQUENCE; NITROBENZENE; METABOLITES; BIPHENYL; 1,6-DIOXYGENASE; BIODEGRADATION; PROTOANEMONIN	2-aminophenol (2-AP) is a toxic nitrogen-containing aromatic pollutant. Burkholderia xenovorans LB400 possess an amn gene cluster that encodes the 2-AP catabolic pathway. In this report, the functionality of the 2-aminophenol pathway of B. xenovorans strain LB400 was analyzed. The amnRJBACDFEHG cluster located at chromosome 1 encodes the enzymes for the degradation of 2-aminophenol. The absence of habA and habB genes in LB400 genome correlates with its no growth on nitrobenzene. RT-PCR analyses in strain LB400 showed the co-expression of amnJB, amnBAC, amnACD, amnDFE and amnEHG genes, suggesting that the amn cluster is an operon. RT-qPCR showed that the amnB gene expression was highly induced by 2-AP, whereas a basal constitutive expression was observed in glucose, indicating that these amn genes are regulated. We propose that the predicted MarR-type transcriptional regulator encoded by the amnR gene acts as repressor of the amn gene cluster using a MarR-type regulatory binding sequence. This report showed that LB400 resting cells degrade completely 2-AP. The amn gene cluster from strain LB400 is highly identical to the amn gene cluster from P. knackmussi strain B13, which could not grow on 2-AP. However, we demonstrate that B. xenovorans LB400 is able to grow using 2-AP as sole nitrogen source and glucose as sole carbon source. An amnBA 2 mutant of strain LB400 was unable to grow with 2-AP as nitrogen source and glucose as carbon source and to degrade 2-AP. This study showed that during LB400 growth on 2-AP this substrate was partially converted into picolinic acid (PA), a well-known antibiotic. The addition of PA at lag or mid-exponential phase inhibited LB400 growth. The MIC of PA for strain LB400 is 2 mM. Overall, these results demonstrate that B. xenovorans strain LB400 posses a functional 2-AP catabolic central pathway, which could lead to the production of picolinic acid.	[Seeger, Michael] Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile; Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria	Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile.	michael.seeger@usm.cl	Agullo, Loreine/AAH-2424-2019; Seeger, Michael/AFK-3436-2022	Strahsburger, Erwin/0000-0001-8829-5859; Agullo Carvajal, Loreine Joselyn/0000-0003-4789-2686	FONDECYT [1020221, 1070507]; Center for Nanotechnology and Systems Biology; USM [131109, 130948]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center for Nanotechnology and Systems Biology; USM	M.S. gratefully acknowledges financial support from FONDECYT (1020221 and 1070507) (http://www.fondecyt.cl), Center for Nanotechnology and Systems Biology (http://www.usm.cl) and USM (131109, 130948) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aoki K, 1997, MICROBIOL RES, V152, P33; Beltrametti F, 2001, MICROBIOL-SGM, V147, P2169, DOI 10.1099/00221287-147-8-2169; BLASCO R, 1995, J BIOL CHEM, V270, P29229, DOI 10.1074/jbc.270.49.29229; Blasco R, 1997, APPL ENVIRON MICROB, V63, P427, DOI 10.1128/AEM.63.2.427-434.1997; Borawska Maria H., 2008, Polish Journal of Food and Nutrition Sciences, V58, P415; Brennan RJ, 1997, MUTAGENESIS, V12, P215, DOI 10.1093/mutage/12.4.215; BRUHN C, 1987, APPL ENVIRON MICROB, V53, P208, DOI 10.1128/AEM.53.1.208-210.1987; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Cai S, 2006, J ANTIMICROB CHEMOTH, V57, P85, DOI 10.1093/jac/dki418; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Clinical and Laboratory Standards Institute, 2008, METH DIL ANT SUSC TE; Davis JK, 1999, ARCH MICROBIOL, V172, P330, DOI 10.1007/s002030050787; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; FERNANDEZPOL JA, 1977, P NATL ACAD SCI USA, V74, P2889, DOI 10.1073/pnas.74.7.2889; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; He Z, 2000, J IND MICROBIOL BIOT, V25, P25, DOI 10.1038/sj.jim.7000018; Romero-Silva MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056038; Lai QL, 2012, J BACTERIOL, V194, P6674, DOI 10.1128/JB.01813-12; Le Roes-Hill M, 2009, TRENDS BIOTECHNOL, V27, P248, DOI 10.1016/j.tibtech.2009.01.001; Lendenmann U, 1996, J BACTERIOL, V178, P6227, DOI 10.1128/jb.178.21.6227-6232.1996; MELILLO G, 1994, J BIOL CHEM, V269, P8128; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; Musk DJ, 2008, J APPL MICROBIOL, V105, P380, DOI 10.1111/j.1365-2672.2008.03751.x; NISHINO SF, 1993, APPL ENVIRON MICROB, V59, P2520, DOI 10.1128/AEM.59.8.2520-2525.1993; Ohkuma Y, 2001, ARCH BIOCHEM BIOPHYS, V389, P49, DOI 10.1006/abbi.2001.2302; Park HS, 1999, APPL ENVIRON MICROB, V65, P1083; Park HS, 2000, J BACTERIOL, V182, P573, DOI 10.1128/JB.182.3.573-580.2000; Park HS, 2001, J BACTERIOL, V183, P5074, DOI 10.1128/JB.183.17.5074-5081.2001; Perera IC, 2011, PROTEIN SCI, V20, P621, DOI 10.1002/pro.588; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; Seeger M, 2009, MICROBIOLOGY HYDROCA, P1179; Spain JC, 2003, APPL ENVIRON MICROB, V69, P4037, DOI 10.1128/AEM.69.7.4037-4042.2003; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; Takenaka S, 2005, BIOSCI BIOTECH BIOCH, V69, P1033, DOI 10.1271/bbb.69.1033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vincent JB, 2003, SPORTS MED, V33, P213, DOI 10.2165/00007256-200333030-00004; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Ye J, 2004, WORLD J MICROB BIOT, V20, P117, DOI 10.1023/B:WIBI.0000021720.03712.12	44	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75746	10.1371/journal.pone.0075746	http://dx.doi.org/10.1371/journal.pone.0075746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124510	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100067
J	He, YX; Du, M; Gao, Y; Liu, HS; Wang, HW; Wu, XJ; Wang, ZT				He, Yixin; Du, Min; Gao, Yan; Liu, Hongshuai; Wang, Hongwei; Wu, Xiaojun; Wang, Zhengtao			Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EMERGING THERAPIES; CELL-DEATH; IN-VITRO; SCLEROSIS; INHIBITION; ACID; TAU; BAX; P53	Multiple sclerosis (MS) is a chronic autoimmune neuroinflammatory disease found mostly in young adults in the western world. Oxidative stress induced neuronal apoptosis plays an important role in the pathogenesis of MS. In current study, astragaloside IV (ASI), a natural saponin molecule isolated from Astragalus membranceus, given at 20 mg/kg daily attenuated the severity of experimental autoimmune encephalomyelitis (EAE) in mice significantly. Further studies disclosed that ASI treatment inhibited the increase of ROS and pro-inflammatory cytokine levels, down-regulation of SOD and GSH-Px activities, and elevation of iNOS, p53 and phosphorylated tau in central nervous system (CNS) as well as the leakage of BBB of EAE mice. Meanwhile, the decreased ratio of Bcl-2/Bax was reversed by ASI. Moreover, ASI regulated T-cell differentiation and infiltration into CNS. In neuroblast SH-SY5Y cells, ASI dose-dependently reduced cellular ROS level and phosphorylation of tau in response to hydrogen peroxide challenge by modulation of Bcl-2/Bax ratio. ASI also inhibited activation of microglia both in vivo and in vitro. iNOS up-regulation induced by IFN gamma stimulation was abolished by ASI dose-dependently in BV-2 cells. In summary, ASI prevented the severity of EAE progression possibly by counterbalancing oxidative stress and its effects via reduction of cellular ROS level, enhancement of antioxidant defense system, increase of anti-apoptotic and anti-inflammatory pathways, as well as modulation of T-cell differentiation and infiltration into CNS. The study suggested ASI may be effective for clinical therapy/prevention of MS.	[He, Yixin; Gao, Yan; Liu, Hongshuai; Wang, Hongwei; Wu, Xiaojun; Wang, Zhengtao] Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai, Peoples R China; [He, Yixin] China Pharmaceut Univ, Dept Pharmacognosy, Nanjing, Jiangsu, Peoples R China; [Du, Min] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Immune Signaling & Regulat, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; China Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wu, XJ (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai, Peoples R China.	xiaojunwu320@126.com; wangzht@hotmail.com	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	Program of Shanghai Pujiang Talent Plan [11PJ1408800]; National Natural Science Foundation of China [31270917]; Program of Shanghai Talent Developmental Plan [2010009, 2011012]; Key Research Innovation Project [13ZZ099]; Key Project from Department of Education of China [20123107130002]	Program of Shanghai Pujiang Talent Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Talent Developmental Plan; Key Research Innovation Project; Key Project from Department of Education of China	This work was supported by Program of Shanghai Pujiang Talent Plan (11PJ1408800), National Natural Science Foundation of China (31270917), Program of Shanghai Talent Developmental Plan (2010009, 2011012), Key Research Innovation Project (13ZZ099) and Key Project from Department of Education of China (20123107130002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar A, 2012, ACTA NEUROL BELG, V112, P275, DOI 10.1007/s13760-012-0059-4; Almolda B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027473; Amorini AM, 2009, CLIN BIOCHEM, V42, P1001, DOI 10.1016/j.clinbiochem.2009.03.020; Anderson JM, 2008, BRAIN, V131, P1736, DOI 10.1093/brain/awn119; Castro-Borrero W, 2012, THER ADV NEUROL DISO, V5, P205, DOI 10.1177/1756285612450936; Chan W, 2006, NEUROCHEM INT, V55, P414; Chen LQ, 2005, ANAT REC PART A, V287A, P1236, DOI 10.1002/ar.a.20241; Cheng CY, 2006, J BIOMED MATER RES A, V76A, P463, DOI 10.1002/jbm.a.30249; Cohen JA, 2009, ARCH NEUROL-CHICAGO, V66, P821, DOI 10.1001/archneurol.2009.104; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Frigo M, 2012, CURR MED CHEM, V19, P1295, DOI 10.2174/092986712799462559; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Huang LF, 2012, FITOTERAPIA, V83, P1514, DOI 10.1016/j.fitote.2012.08.019; Ko JKS, 2005, WORLD J GASTROENTERO, V11, P5787, DOI 10.3748/wjg.v11.i37.5787; Koch M, 2006, J NEUROL, V253, P483, DOI 10.1007/s00415-005-0037-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Lagrange P, 1999, FREE RADICAL BIO MED, V27, P667, DOI 10.1016/S0891-5849(99)00112-4; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Li ZP, 2002, ACTA PHARMACOL SIN, V23, P898; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; MESSMER UK, 1994, FEBS LETT, V355, P23; Miller SA, 2009, IMMUNOLOGY, V126, P306, DOI 10.1111/j.1365-2567.2008.03040.x; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Oliveira SR, 2012, J NEUROL SCI, V321, P49, DOI 10.1016/j.jns.2012.07.045; Peiris M, 2007, J NEUROSCI METH, V163, P245, DOI 10.1016/j.jneumeth.2007.03.013; Qiu LH, 2010, BIOL PHARM BULL, V33, P641, DOI 10.1248/bpb.33.641; Schneider A, 2004, J BIOL CHEM, V279, P55833, DOI 10.1074/jbc.M409954200; Schreibelt G, 2008, FREE RADICAL BIO MED, V45, P256, DOI 10.1016/j.freeradbiomed.2008.03.024; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Shaw PH, 1996, PATHOL RES PRACT, V192, P669, DOI 10.1016/S0344-0338(96)80088-4; Spencer JPE, 2012, MOL ASPECTS MED, V33, P83, DOI 10.1016/j.mam.2011.10.016; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tanaka K, 2004, NEUROCHEM RES, V29, P1529, DOI 10.1023/B:NERE.0000029565.92587.25; Tasset I, 2012, CLIN BIOCHEM, V45, P440, DOI 10.1016/j.clinbiochem.2012.01.023; Uzar E, 2006, MOL CELL BIOCHEM, V291, P63, DOI 10.1007/s11010-006-9196-5; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Wang Shi-bo, 2011, Chinese Pharmacological Bulletin, V27, P1603, DOI 10.3969/j.issn.1001-1978.2011.11.031; Wang Yuan-yuan, 2011, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V27, P363; Witherick J, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/164608; Wu XJ, 2010, J NEUROIMMUNOL, V223, P65, DOI 10.1016/j.jneuroim.2010.04.001; Xiang H, 1998, J NEUROSCI, V18, P1363; Zargari M, 2007, NEUROSCI LETT, V412, P24, DOI 10.1016/j.neulet.2006.08.033; Zhang WD, 2006, PLANTA MED, V72, P621, DOI 10.1055/s-2006-931572; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhang ZG, 2012, MOL CELL BIOCHEM, V364, P209, DOI 10.1007/s11010-011-1219-1; Zhu SQ, 2008, ACTA PHARMACOL SIN, V29, P57, DOI 10.1111/j.1745-7254.2008.00712.x; 江清林, 2003, [中国老年学杂志, Chinese Journal of Gerontology], V23, P52	59	117	124	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76495	10.1371/journal.pone.0076495	http://dx.doi.org/10.1371/journal.pone.0076495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124567	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100124
J	Hellen, EH; Dana, SK; Kurths, J; Kehler, E; Sinha, S				Hellen, Edward H.; Dana, Syamal K.; Kurths, Juergen; Kehler, Elizabeth; Sinha, Sudeshna			Noise-Aided Logic in an Electronic Analog of Synthetic Genetic Networks	PLOS ONE			English	Article							STOCHASTIC RESONANCE; TOGGLE SWITCH; GATES; SYSTEMS	We report the experimental verification of noise-enhanced logic behaviour in an electronic analog of a synthetic genetic network, composed of two repressors and two constitutive promoters. We observe good agreement between circuit measurements and numerical prediction, with the circuit allowing for robust logic operations in an optimal window of noise. Namely, the input-output characteristics of a logic gate is reproduced faithfully under moderate noise, which is a manifestation of the phenomenon known as Logical Stochastic Resonance. The two dynamical variables in the system yield complementary logic behaviour simultaneously. The system is easily morphed from AND/NAND to OR/NOR logic.	[Hellen, Edward H.; Kehler, Elizabeth] Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA; [Dana, Syamal K.] Indian Inst Chem Biol, CSIR, Kolkata, India; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Sinha, Sudeshna] Indian Inst Sci Educ & Res Mohali, Mohali, Punjab, India	University of North Carolina; University of North Carolina Greensboro; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Potsdam Institut fur Klimafolgenforschung; Indian Institute of Science Education & Research (IISER) - Mohali	Hellen, EH (corresponding author), Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA.	ehhellen@uncg.edu	Hellen, Edward/AAN-7714-2021	Hellen, Edward/0000-0001-5060-7220; Sinha, Sudeshna/0000-0002-1364-5276	Council of Scientific and Industrial Research (CSIR) Network project GENESIS [BC0123]; CSIR Emeritus Scientist scheme	Council of Scientific and Industrial Research (CSIR) Network project GENESIS; CSIR Emeritus Scientist scheme	SKD acknowledges support by the Council of Scientific and Industrial Research (CSIR) Network project GENESIS (BC0123) and the CSIR Emeritus Scientist scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/50001; Bartee T, 1991, COMPUTER SCI SERIES; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; BULSARA A, 1991, J THEOR BIOL, V152, P531, DOI 10.1016/S0022-5193(05)80396-0; Dari A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041909; Dari A, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/18001; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Fierens PI, 2010, PHYS LETT A, V374, P2207, DOI 10.1016/j.physleta.2010.03.026; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guerra DN, 2010, NANO LETT, V10, P1168, DOI 10.1021/nl9034175; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Hellen EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062997; Hellen EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023286; Mano MM, 1993, COMPUTER SYSTEM ARCH, P1; Murali K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3245318; Murali K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.104101; Perrone S, 2012, OPT EXPRESS, V20, P22692, DOI 10.1364/OE.20.022692; Sharma PR, 2013, PHYS LETT A, V377, P367, DOI 10.1016/j.physleta.2012.12.002; Singh KP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046219; Sinha S, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/60003; Wang JW, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-50; Worschech L, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3302457	26	30	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76032	10.1371/journal.pone.0076032	http://dx.doi.org/10.1371/journal.pone.0076032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124531	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100088
J	Li, SQ; Cheuk, AT; Shern, JF; Song, YK; Hurd, L; Liao, HL; Wei, JS; Khan, J				Li, Samuel Q.; Cheuk, Adam T.; Shern, Jack F.; Song, Young K.; Hurd, Laura; Liao, Hongling; Wei, Jun S.; Khan, Javed			Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534)	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; EMBRYONAL RHABDOMYOSARCOMA; IN-VIVO; ALVEOLAR RHABDOMYOSARCOMA; MYELOID-LEUKEMIA; CANCER MODELS; POTENT; IDENTIFICATION; GENE; NEUROBLASTOMA	Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. Despite advances in modern therapy, patients with relapsed or metastatic disease have a very poor clinical prognosis. Fibroblast Growth Factor Receptor 4 (FGFR4) is a cell surface tyrosine kinase receptor that is involved in normal myogenesis and muscle regeneration, but not commonly expressed in differentiated muscle tissues. Amplification and mutational activation of FGFR4 has been reported in RMS and promotes tumor progression. Therefore, FGFR4 is a tractable therapeutic target for patients with RMS. In this study, we used a chimeric Ba/F3 TEL-FGFR4 construct to test five tyrosine kinase inhibitors reported to specifically inhibit FGFRs in the nanomolar range. We found ponatinib (AP24534) to be the most potent FGFR4 inhibitor with an IC50 in the nanomolar range. Ponatinib inhibited the growth of RMS cells expressing wild-type or mutated FGFR4 through increased apoptosis. Phosphorylation of wild-type and mutated FGFR4 as well as its downstream target STAT3 was also suppressed by ponatinib. Finally, ponatinib treatment inhibited tumor growth in a RMS mouse model expressing mutated FGFR4. Therefore, our data suggests that ponatinib is a potentially effective therapeutic agent for RMS tumors that are driven by a dysregulated FGFR4 signaling pathway.	[Li, Samuel Q.; Cheuk, Adam T.; Shern, Jack F.; Song, Young K.; Hurd, Laura; Liao, Hongling; Wei, Jun S.; Khan, Javed] NCI, Oncogen Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khan, J (corresponding author), NCI, Oncogen Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	khanjav@mail.nih.gov	Shern, Jack/V-4002-2019; Khan, Javed/P-9157-2014		Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010806, ZIABC010999, ZIABC010998] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Cao L, CANC RES, V70, P6497; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Christensen JG, 2003, CANCER RES, V63, P7345; Crose LES, 2012, CLIN CANCER RES, V18, P3780, DOI 10.1158/1078-0432.CCR-10-3063; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Gozgit JM, 2011, MOL CANCER THER, V10, P1028, DOI 10.1158/1535-7163.MCT-10-1044; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Hu KJ, 2009, MOL CANCER THER, V8, P3024, DOI 10.1158/1535-7163.MCT-09-0365; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Klint Peter, 1999, Frontiers in Bioscience, V4, pD165, DOI 10.2741/Klint; Lee SH, 2005, CLIN CANCER RES, V11, P3633, DOI 10.1158/1078-0432.CCR-04-2129; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Marics I, 2002, DEVELOPMENT, V129, P4559; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ognjanovic S, 2009, CANCER-AM CANCER SOC, V115, P4218, DOI 10.1002/cncr.24465; Paulson V, 2011, GENE CHROMOSOME CANC, V50, P397, DOI 10.1002/gcc.20864; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stauffer JK, 2012, CANCER INVEST, V30, P343, DOI 10.3109/07357907.2012.664670; STRATTON MR, 1989, CANCER RES, V49, P6324; Taylor AC, 2000, MED PEDIATR ONCOL, V35, P96, DOI 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Thuault S, 2012, ONCOGENE; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	32	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76551	10.1371/journal.pone.0076551	http://dx.doi.org/10.1371/journal.pone.0076551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124571	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100128
J	Park, MK; Ngo, V; Kwon, YM; Lee, YT; Yoo, S; Cho, YH; Hong, SM; Hwang, HS; Ko, EJ; Jung, YJ; Moon, DW; Jeong, EJ; Kim, MC; Lee, YN; Jang, JH; Oh, JS; Kim, CH; Kang, SM				Park, Min-Kyung; Vu Ngo; Kwon, Young-Man; Lee, Young-Tae; Yoo, Sieun; Cho, Young-Hee; Hong, Sung-Moon; Hwang, Hye Suk; Ko, Eun-Ju; Jung, Yu-Jin; Moon, Dae-Won; Jeong, Eun-Ji; Kim, Min-Chul; Lee, Yu-Na; Jang, Ji-Hun; Oh, Joon-Suk; Kim, Cheol-Hyun; Kang, Sang-Moo			Lactobacillus plantarum DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate Immunity	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SSP BULGARICUS OLL1073R-1; IMPROVED CROSS-PROTECTION; CASEI STRAIN SHIROTA; DENDRITIC CELLS; ALVEOLAR MACROPHAGES; HUMAN HEALTH; MICE; INFECTION; RESPONSES	Lactobacillus plantarum DK119 (DK119) isolated from the fermented Korean cabbage food was used as a probiotic to determine its antiviral effects on influenza virus. DK119 intranasal or oral administration conferred 100% protection against subsequent lethal infection with influenza A viruses, prevented significant weight loss, and lowered lung viral loads in a mouse model. The antiviral protective efficacy was observed in a dose and route dependent manner of DK119 administration. Mice that were treated with DK119 showed high levels of cytokines IL-12 and IFN-gamma in bronchoalveolar lavage fluids, and a low degree of inflammation upon infection with influenza virus. Depletion of alveolar macrophage cells in lungs and bronchoalveolar lavages completely abrogated the DK119-mediated protection. Modulating host innate immunity of dendritic and macrophage cells, and cytokine production pattern appeared to be possible mechanisms by which DK119 exhibited antiviral effects on influenza virus infection. These results indicate that DK119 can be developed as a beneficial antiviral probiotic microorganism.	[Park, Min-Kyung] Chungwoon Univ, Dept Human Nutr & Food Sci, Hongsung Kun, Chungnam, South Korea; [Park, Min-Kyung; Vu Ngo; Kwon, Young-Man; Lee, Young-Tae; Yoo, Sieun; Hwang, Hye Suk; Ko, Eun-Ju; Jung, Yu-Jin; Kim, Min-Chul; Lee, Yu-Na; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Park, Min-Kyung; Vu Ngo; Kwon, Young-Man; Lee, Young-Tae; Yoo, Sieun; Hwang, Hye Suk; Ko, Eun-Ju; Jung, Yu-Jin; Kim, Min-Chul; Lee, Yu-Na; Kang, Sang-Moo] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Cho, Young-Hee; Hong, Sung-Moon; Kim, Cheol-Hyun] Dankook Univ, Dept Anim Resource Sci, Cheonan Si, Chungnam, South Korea; [Moon, Dae-Won; Jeong, Eun-Ji; Jang, Ji-Hun; Oh, Joon-Suk] Tobico Inc, Cheonan Si, Chungnam, South Korea; [Kim, Min-Chul] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Dankook University; Emory University	Kang, SM (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	skang24@gsu.edu	Ngo, Vu/GON-5915-2022	Ngo, Vu L./0000-0002-9820-0443	Tobico Inc.; NIH/NIAID [AI093772, AI087782, AI105170]; faculty sabbatical training grant from Chungwoon University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105170, R56AI087782, R01AI093772] Funding Source: NIH RePORTER	Tobico Inc.; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); faculty sabbatical training grant from Chungwoon University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the research grant from Tobico Inc. (SMK), and NIH/NIAID grants AI093772 (SMK), AI087782 (SMK), and AI105170 (SMK). MKP was a recipient of the faculty sabbatical training grant from Chungwoon University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Cho YH, 2013, KOREAN J FOOD SCI AN, V33, P75, DOI 10.5851/kosfa.2013.33.1.75; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Drouault S, 2001, VET RES, V32, P101, DOI 10.1051/vetres:2001115; Dunne C, 2001, AM J CLIN NUTR, V73, p386S, DOI 10.1093/ajcn/73.2.386s; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; GORBACH SL, 1990, ANN MED, V22, P37, DOI 10.3109/07853899009147239; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanniffy S, 2004, ADV APPL MICROBIOL, V56, P1, DOI 10.1016/S0065-2164(04)56001-X; Harata G, 2010, LETT APPL MICROBIOL, V50, P597, DOI 10.1111/j.1472-765X.2010.02844.x; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; Hori T, 2001, CLIN DIAGN LAB IMMUN, V8, P593, DOI 10.1128/CDLI.8.3.593-597.2001; Ishida Y, 2005, J DAIRY SCI, V88, P527, DOI 10.3168/jds.S0022-0302(05)72714-4; Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012; Jones M, 2006, EXPERT OPIN DRUG SAF, V5, P603, DOI 10.1517/14740338.5.5.603; Joo Hong-Gu, 2003, J Vet Sci, V4, P229; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kawashima T, 2011, INT IMMUNOPHARMACOL, V11, P2017, DOI 10.1016/j.intimp.2011.08.013; Kim MH, 2008, IMMUNOL LETT, V115, P138, DOI 10.1016/j.imlet.2007.10.016; Kim MH, 2009, KOREAN J PHYSIOL PHA, V13, P169, DOI 10.4196/kjpp.2009.13.3.169; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019; Long JK, 2000, CLEV CLIN J MED, V67, P92; Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015; Makino S, 2010, BRIT J NUTR, V104, P998, DOI 10.1017/S000711451000173X; Masuda S, 2008, INT J FOOD MICROBIOL, V121, P245, DOI 10.1016/j.ijfoodmicro.2007.10.011; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Mok H, 2007, J VIROL, V81, P13710, DOI 10.1128/JVI.01351-07; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Murawski MR, 2010, J VIROL, V84, P1110, DOI 10.1128/JVI.01709-09; Nagai T, 2011, INT IMMUNOPHARMACOL, V11, P2246, DOI 10.1016/j.intimp.2011.09.012; Nagao F, 2000, BIOSCI BIOTECH BIOCH, V64, P2706, DOI 10.1271/bbb.64.2706; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Oxford JS, 2007, INFLUENZA OTHER RESP, V1, P27, DOI 10.1111/j.1750-2659.2006.00006.x; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; THEPEN T, 1991, EUR J IMMUNOL, V21, P2845, DOI 10.1002/eji.1830211128; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; WEN HS, 1959, J INFECT DIS, V105, P9, DOI 10.1093/infdis/105.1.9; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004; Youn HN, 2012, POULTRY SCI, V91, P2517, DOI 10.3382/ps.2012-02334; Youn HN, 2012, ANTIVIR RES, V93, P138, DOI 10.1016/j.antiviral.2011.11.004	54	93	98	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75368	10.1371/journal.pone.0075368	http://dx.doi.org/10.1371/journal.pone.0075368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124485	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100042
J	Sutcliffe, B; Forero, MG; Zhu, BF; Robinson, IM; Hidalgo, A				Sutcliffe, Ben; Forero, Manuel G.; Zhu, Bangfu; Robinson, Iain M.; Hidalgo, Alicia			Neuron-Type Specific Functions of DNT1, DNT2 and Spz at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							CYSTINE-KNOT PROTEIN; SYNAPTIC DEVELOPMENT; GENETIC DISSECTION; RETROGRADE SIGNAL; SPATZLE PROTEIN; NERVOUS-SYSTEM; GROWTH CONE; TOLL GENE; NEUROTROPHIN; RECEPTOR	Retrograde growth factors regulating synaptic plasticity at the neuromuscular junction (NMJ) in Drosophila have long been predicted but their discovery has been scarce. In vertebrates, such retrograde factors produced by the muscle include GDNF and the neurotrophins (NT: NGF, BDNF, NT3 and NT4). NT superfamily members have been identified throughout the invertebrates, but so far no functional in vivo analysis has been carried out at the NMJ in invertebrates. The NT family of proteins in Drosophila is formed of DNT1, DNT2 and Spatzle (Spz), with sequence, structural and functional conservation relative to mammalian NTs. Here, we investigate the functions of Drosophila NTs (DNTs) at the larval NMJ. All three DNTs are expressed in larval body wall muscles, targets for motor-neurons. Over-expression of DNTs in neurons, or the activated form of the Spz receptor, Toll(10b), in neurons only, rescued the semi-lethality of spz(2) and DNT1(41), DNT2(e03444) double mutants, indicating retrograde functions in neurons. In spz2 mutants, DNT1(41), DNT2(e03444) double mutants, and upon over-expression of the DNTs, NMJ size and bouton number increased. Boutons were morphologically abnormal. Mutations in spz and DNT1, DNT2 resulted in decreased number of active zones per bouton and decreased active zone density per terminal. Alterations in DNT function induced ghost boutons and synaptic debris. Evoked junction potentials were normal in spz(2) mutants and DNT1(41), DNT2(e03444) double mutants, but frequency and amplitude of spontaneous events were reduced in spz(2) mutants suggesting defective neurotransmission. Our data indicate that DNTs are produced in muscle and are required in neurons for synaptogenesis. Most likely alterations in DNT function and synapse formation induce NMJ plasticity leading to homeostatic adjustments that increase terminal size restoring overall synaptic transmission. Data suggest that Spz functions with neuron-type specificity at the muscle 4 NMJ, and DNT1 and DNT2 function together at the muscles 6,7 NMJ.	[Sutcliffe, Ben; Forero, Manuel G.; Zhu, Bangfu; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Sutcliffe, Ben; Robinson, Iain M.] Univ Plymouth, Peninsula Coll Med & Dent, Plymouth PL4 8AA, Devon, England	University of Birmingham; University of Plymouth	Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Sutcliffe, Ben/R-3655-2019; Hidalgo, Alicia/F-5930-2015	Sutcliffe, Ben/0000-0003-3264-1649; Hidalgo, Alicia/0000-0001-8041-5764; Forero, Manuel/0000-0001-9972-8621	MRC [G0200140, G0802208]; Wellcome Trust Equipment [073228, 088583]; MRC PhD studentship; Medical Research Council [G0802208, G0200140] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Equipment(Wellcome Trust); MRC PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by MRC Career Establishment Grant G0200140, Wellcome Trust Equipment 073228 and Project 088583 Grants to A. H., MRC Project Grant G0802208 to I. R. and MRC PhD studentship to B. S. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ARNOT CJ, 2010, J BIOL CHEM; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GERTTULA S, 1988, GENETICS, V119, P123; Halfon MS, 1998, DEV BIOL, V199, P164, DOI 10.1006/dbio.1998.8915; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; Hallbook F, 2006, BRAIN BEHAV EVOLUT, V68, P133, DOI 10.1159/000094083; Hoffmann A, 2008, J BIOL CHEM, V283, P32598, DOI 10.1074/jbc.M801815200; Hoffmann A, 2008, ACTA CRYSTALLOGR F, V64, P707, DOI 10.1107/S1744309108018812; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kassabov SR, 2013, CELL REP, V3, P1213, DOI 10.1016/j.celrep.2013.03.008; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Morisato D, 2001, DEVELOPMENT, V128, P2309; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Rohrbough J, 2010, DEVELOPMENT, V137, P3523, DOI 10.1242/dev.047878; Rose D, 1999, J NEUROSCI, V19, P4899; Rose D, 1997, DEVELOPMENT, V124, P1561; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schwenkert I, 2008, MECH DEVELOP, V125, P700, DOI 10.1016/j.mod.2008.04.004; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Wilson KHS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-243; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	44	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75902	10.1371/journal.pone.0075902	http://dx.doi.org/10.1371/journal.pone.0075902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124519	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100076
J	Taniguchi, M; Kajioka, S; Shozib, HB; Sawamura, K; Nakayama, S				Taniguchi, Mizuki; Kajioka, Shunichi; Shozib, Habibul B.; Sawamura, Kenta; Nakayama, Shinsuke			Spatial Analysis of Slowly Oscillating Electric Activity in the Gut of Mice Using Low Impedance Arrayed Microelectrodes	PLOS ONE			English	Article							MOUSE SMALL-INTESTINE; GUINEA-PIG STOMACH; INTERSTITIAL-CELLS; PACEMAKER ACTIVITY; SMOOTH-MUSCLE; GASTROINTESTINAL-TRACT; WAVE PROPAGATION; GASTRIC ANTRUM; CAJAL; MECHANISMS	Smooth and elaborate gut motility is based on cellular cooperation, including smooth muscle, enteric neurons and special interstitial cells acting as pacemaker cells. Therefore, spatial characterization of electric activity in tissues containing these electric excitable cells is required for a precise understanding of gut motility. Furthermore, tools to evaluate spatial electric activity in a small area would be useful for the investigation of model animals. We thus employed a microelectrode array (MEA) system to simultaneously measure a set of 8x8 field potentials in a square area of similar to 1 mm(2). The size of each recording electrode was 50650 mm(2), however the surface area was increased by fixing platinum black particles. The impedance of microelectrode was sufficiently low to apply a high-pass filter of 0.1 Hz. Mapping of spectral power, and auto-correlation and cross-correlation parameters characterized the spatial properties of spontaneous electric activity in the ileum of wild-type (WT) and W/W-v mice, the latter serving as a model of impaired network of pacemaking interstitial cells. Namely, electric activities measured varied in both size and cooperativity in W/W-v mice, despite the small area. In the ileum of WT mice, procedures suppressing the excitability of smooth muscle and neurons altered the propagation of spontaneous electric activity, but had little change in the period of oscillations. In conclusion, MEA with low impedance electrodes enables to measure slowly oscillating electric activity, and is useful to evaluate both histological and functional changes in the spatio-temporal property of gut electric activity.	[Taniguchi, Mizuki; Shozib, Habibul B.; Sawamura, Kenta; Nakayama, Shinsuke] Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kajioka, Shunichi] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan	Nagoya University; Kyushu University	Nakayama, S (corresponding author), Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	h44673a@nucc.cc.nagoya-u.ac.jp			Japan Society for the Promotion Science; Japan Gut Club	Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Gut Club	This work was partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion Science, and the Japan Gut Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarali HI, 2010, NEUROGASTROENT MOTIL, V22, P1045, DOI 10.1111/j.1365-2982.2010.01560.x; Bayguinov O, 2011, NEUROGASTROENT MOTIL, V23, P1029, DOI 10.1111/j.1365-2982.2011.01784.x; Brading AF, 2005, NAT CLIN PRACT UROL, V2, P546, DOI 10.1038/ncpuro0340; Bramich NJ, 1996, J PHYSIOL-LONDON, V492, P185, DOI 10.1113/jphysiol.1996.sp021300; Buist ML, 2010, ANN BIOMED ENG, V38, P3022, DOI 10.1007/s10439-010-0051-1; Camilleri Michael, 2002, Rev Gastroenterol Disord, V2, P47; Dickens EJ, 1999, J PHYSIOL-LONDON, V514, P515, DOI 10.1111/j.1469-7793.1999.515ae.x; Du P, 2009, ANN BIOMED ENG, V37, P839, DOI 10.1007/s10439-009-9654-9; Faussone-Pellegrini MS, 1999, MICROSC RES TECHNIQ, V47, P248, DOI 10.1002/(SICI)1097-0029(19991115)47:4<248::AID-JEMT4>3.0.CO;2-W; Faville RA, 2009, BIOPHYS J, V96, P4834, DOI 10.1016/j.bpj.2009.03.058; Furness JB, 2006, ENTERIC NERVOUS SYSTEM, P1; Harhun MI, 2005, J CELL MOL MED, V9, P232, DOI 10.1111/j.1582-4934.2005.tb00352.x; Hirst GDS, 2006, J PHYSIOL-LONDON, V571, P165, DOI 10.1113/jphysiol.2005.100735; Hotta Aya, 2005, Journal of Smooth Muscle Research, V41, P207, DOI 10.1540/jsmr.41.207; Huang SM, 1999, AM J PHYSIOL-GASTR L, V276, pG518, DOI 10.1152/ajpgi.1999.276.2.G518; Huizinga JD, 1998, J PHYSIOL-LONDON, V506, P843, DOI 10.1111/j.1469-7793.1998.843bv.x; Huizinga JD, 2005, J CELL MOL MED, V9, P468, DOI 10.1111/j.1582-4934.2005.tb00372.x; Iino S, 2007, ARCH HISTOL CYTOL, V70, P163, DOI 10.1679/aohc.70.163; Imtiaz MS, 2006, BIOPHYS J, V90, P1, DOI 10.1529/biophysj.104.058743; Ishikawa T, 2004, AM J PHYSIOL-CELL PH, V286, pC1344, DOI 10.1152/ajpcell.00392.2003; Kinoshita K, 2007, HISTOCHEM CELL BIOL, V127, P41, DOI 10.1007/s00418-006-0223-0; Kito Y, 2005, AM J PHYSIOL-CELL PH, V288, pC710, DOI 10.1152/ajpcell.00361.2004; Lammers WJEP, 2008, GASTROENTEROLOGY, V135, P1601, DOI 10.1053/j.gastro.2008.07.020; Lang RJ, 2006, J PHYSIOL-LONDON, V576, P695, DOI 10.1113/jphysiol.2006.116855; MAEDA H, 1992, DEVELOPMENT, V116, P369; Means SA, 2010, J THEOR BIOL, V267, P137, DOI 10.1016/j.jtbi.2010.08.008; Nakayama S, 2012, NEUROGASTROENT MOTIL, V24, P397, DOI 10.1111/j.1365-2982.2012.01882.x; Nakayama S, 2006, J PHYSIOL-LONDON, V576, P727, DOI 10.1113/jphysiol.2006.118893; Nakayama S, 2011, BIOSENS BIOELECTRON, V27, P34, DOI 10.1016/j.bios.2011.05.041; Nakayama S, 2009, BIOSENS BIOELECTRON, V25, P61, DOI 10.1016/j.bios.2009.06.006; O'Grady G, 2012, NEUROGASTROENT MOTIL, V24, pe299, DOI 10.1111/j.1365-2982.2012.01932.x; O'Grady G, 2012, NEUROGASTROENT MOTIL, V24, P1, DOI 10.1111/j.1365-2982.2011.01815.x; O'Grady G, 2012, J PHYSIOL-LONDON, V590, P1299, DOI 10.1113/jphysiol.2011.224014; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Rhee PL, 2011, J PHYSIOL-LONDON, V589, P6105, DOI 10.1113/jphysiol.2011.217497; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Sanders KM, 1999, NEUROGASTROENT MOTIL, V11, P311; Seerden TC, 2005, AM J PHYSIOL-GASTR L, V289, pG1043, DOI 10.1152/ajpgi.00205.2005; Szurszewski JH, 1987, PHYSL GASTROINTESTIN, P383; Takaki M, 2010, PROG BIOPHYS MOL BIO, V102, P129, DOI 10.1016/j.pbiomolbio.2010.05.007; TOMITA T, 1981, SMOOTH MUSCLE ASSESS, P127; Tsutsui H, 2010, J PHYSIOL-LONDON, V588, P2017, DOI 10.1113/jphysiol.2010.189126; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; van Helden DF, 2010, CLIN EXP PHARMACOL P, V37, P516, DOI 10.1111/j.1440-1681.2009.05331.x; Vittal H, 2007, NAT CLIN PRACT GASTR, V4, P336, DOI 10.1038/ncpgasthep0838; Vogt KE, 2011, J PHYSIOL-LONDON, V589, P489, DOI 10.1113/jphysiol.2010.200220; Wang XY, 2002, AM J PATHOL, V160, P1529, DOI 10.1016/S0002-9440(10)62579-5; Wood JD, 2006, PHYSL GASTROINTESTIN, V2, P665; Yagati AK, 2009, BIOSENS BIOELECTRON, V24, P1503, DOI 10.1016/j.bios.2008.07.080; Youm JB, 2006, PHILOS T R SOC A, V364, P1135, DOI 10.1098/rsta.2006.1759	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75235	10.1371/journal.pone.0075235	http://dx.doi.org/10.1371/journal.pone.0075235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124480	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100037
J	Wang, ZQ; Keita, M; Bachvarova, M; Gobeil, S; Morin, C; Plante, M; Gregoire, J; Renaud, MC; Sebastianelli, A; Trinh, XB; Bachvarov, D				Wang, Zhi-Qiang; Keita, Mamadou; Bachvarova, Magdalena; Gobeil, Stephane; Morin, Chantale; Plante, Marie; Gregoire, Jean; Renaud, Marie-Claude; Sebastianelli, Alexandra; Trinh, Xuan Bich; Bachvarov, Dimcho			Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; TUMOR-SUPPRESSOR GENE; BREAST-CANCER; DOWN-REGULATION; EXPRESSION; TARGET; APOPTOSIS; BETA; HEMATOPOIESIS; METHYLATION	Previously, we have identified the RUNX2 gene as hypomethylated and overexpressed in post-chemotherapy (CT) primary cultures derived from serous epithelial ovarian cancer (EOC) patients, when compared to primary cultures derived from matched primary (prior to CT) tumors. However, we found no differences in the RUNX2 methylation in primary EOC tumors and EOC omental metastases, suggesting that DNA methylation-based epigenetic mechanisms have no impact on RUNX2 expression in advanced (metastatic) stage of the disease. Moreover, RUNX2 displayed significantly higher expression not only in metastatic tissue, but also in high-grade primary tumors and even in low malignant potential tumors. Knockdown of the RUNX2 expression in EOC cells led to a sharp decrease of cell proliferation and significantly inhibited EOC cell migration and invasion. Gene expression profiling and consecutive network and pathway analyses confirmed these findings, as various genes and pathways known previously to be implicated in ovarian tumorigenesis, including EOC tumor invasion and metastasis, were found to be downregulated upon RUNX2 suppression, while a number of pro-apoptotic genes and some EOC tumor suppressor genes were induced. Taken together, our data are indicative for a strong oncogenic potential of the RUNX2 gene in serous EOC progression and suggest that RUNX2 might be a novel EOC therapeutic target. Further studies are needed to more completely elucidate the functional implications of RUNX2 and other members of the RUNX gene family in ovarian tumorigenesis.	[Wang, Zhi-Qiang; Keita, Mamadou; Gobeil, Stephane; Bachvarov, Dimcho] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Wang, Zhi-Qiang; Keita, Mamadou; Bachvarova, Magdalena; Morin, Chantale; Plante, Marie; Gregoire, Jean; Renaud, Marie-Claude; Sebastianelli, Alexandra; Trinh, Xuan Bich; Bachvarov, Dimcho] Hop Hotel Dieu, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Gobeil, Stephane] CHUL, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Plante, Marie; Gregoire, Jean; Renaud, Marie-Claude; Sebastianelli, Alexandra] Univ Laval, Dept Obstet & Gynecol, Quebec City, PQ, Canada; [Trinh, Xuan Bich] Univ Antwerp Hosp, Dept Gynecol Oncol, Antwerp, Belgium	Laval University; Laval University; Laval University; University of Antwerp	Bachvarov, D (corresponding author), Univ Laval, Dept Mol Med, Quebec City, PQ, Canada.	dimtcho.batchvarov@crhdq.ulaval.ca		Bachvarov, Dimcho/0000-0001-6509-9599	Cancer Research Society of Canada	Cancer Research Society of Canada	This study was sustained by a grant to D. B. from the Cancer Research Society of Canada. Clinical specimens were provided by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de recherche du Quebec - Sante which is affiliated with the Canadian Tumor Repository Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Alouini S, 2012, GYNECOL ONCOL, V126, P313, DOI 10.1016/j.ygyno.2012.04.044; Alper O, 2001, MOL CELL BIOCHEM, V218, P55, DOI 10.1023/A:1007205205131; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; Barnholtz-Sloan JS, 2003, AM J OBSTET GYNECOL, V189, P1120, DOI 10.1067/S0002-9378(03)00579-9; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Blyth K, 2010, BLOOD CELL MOL DIS, V45, P117, DOI 10.1016/j.bcmd.2010.05.007; Bock AJ, 2010, INT J GYNECOL CANCER, V20, P1448, DOI 10.1111/IGC.0b013e3181f7d6be; Brard L, 2011, GYNECOL ONCOL, V123, P370, DOI 10.1016/j.ygyno.2011.07.002; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Casaburi I, 2012, CELL CYCLE, V11, P2699, DOI 10.4161/cc.21029; Daikoku T, 2005, CANCER RES, V65, P3735, DOI 10.1158/0008-5472.CAN-04-3814; Daikoku T, 2007, CANCER RES, V67, P5285, DOI 10.1158/0008-5472.CAN-07-0828; Duprez E, 2004, CELL CYCLE, V3, P389; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fridman JS, 1998, ONCOGENE, V17, P2981, DOI 10.1038/sj.onc.1202224; Hantke B, 2003, BIOL CHEM, V384, P1247, DOI 10.1515/BC.2003.137; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Huang XM, 1999, NAT STRUCT BIOL, V6, P624; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanamori Y, 1999, CANCER RES, V59, P4225; Karnezis T, 2012, ONCOTARGET, V3, P893, DOI 10.18632/oncotarget.593; Kayed H, 2007, BRIT J CANCER, V97, P1106, DOI 10.1038/sj.bjc.6603984; Keita M, 2013, CELL CYCLE, V12, P972, DOI 10.4161/cc.23963; Keita M, 2013, GYNECOL ONCOL, V128, P356, DOI 10.1016/j.ygyno.2012.11.036; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Lecomte C, 2005, CELL CYCLE, V4, P1862, DOI 10.4161/cc.4.12.2300; Lee CWL, 2011, GYNECOL ONCOL, V122, P410, DOI 10.1016/j.ygyno.2011.04.044; Lehtinen L, 2013, ONCOTARGET, V4, P48, DOI 10.18632/oncotarget.756; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li H, 2013, TUMOUR BIOL; Li H, 2012, CANCER PREV RES, V5, P484, DOI 10.1158/1940-6207.CAPR-11-0414; Li W, 2010, CELL CYCLE, V9, P4433, DOI 10.4161/cc.9.22.13838; Li WP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/456534; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Madsen CV, 2012, ANTICANCER RES, V32, P3817; Maier S, 2005, AM J PHARMACOGENOMIC, V5, P223, DOI 10.2165/00129785-200505040-00003; Mann AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013050; Mansour M, 2011, J VIROL, V85, P6015, DOI 10.1128/JVI.01537-10; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Morrow KA, 2011, J BIOL CHEM, V286, P40376, DOI 10.1074/jbc.M111.250035; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Okada-Ban M, 1999, ONCOGENE, V18, P6719, DOI 10.1038/sj.onc.1203092; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Papacleovoulou G, 2011, J ENDOCRINOL, V211, P273, DOI 10.1530/JOE-11-0081; Planaguma J, 2011, HUM PATHOL, V42, P57, DOI 10.1016/j.humpath.2010.01.025; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Purcell DJ, 2012, J CELL BIOCHEM, V113, P2406, DOI 10.1002/jcb.24114; Robinson HM, 2003, LEUKEMIA, V17, P2249, DOI 10.1038/sj.leu.2403140; Sandi MJ, 2011, J CELL PHYSIOL, V226, P3442, DOI 10.1002/jcp.22702; Sasaki H, 2000, CANCER RES, V60, P5659; Scheitz CJ, 2012, J CELL BIOCH; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stone B, 2003, INT J CANCER, V104, P73, DOI 10.1002/ijc.10900; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Taraboletti G, 2010, ONCOTARGET, V1, P662; Tetu B, 2008, MODERN PATHOL, V21, P1002, DOI 10.1038/modpathol.2008.80; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Vergote I, 2000, J NATL CANCER I, V92, P1534, DOI 10.1093/jnci/92.18.1534; Wang CQ, 2010, BLOOD CELL MOL DIS, V44, P275, DOI 10.1016/j.bcmd.2010.01.006; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wotton S, 2002, CANCER RES, V62, P7181; Yamaoka T, 2011, J DERMATOL SCI, V64, P99, DOI 10.1016/j.jdermsci.2011.07.005; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yang MH, 2012, ONCOGENE, V31, P2401, DOI 10.1038/onc.2011.423; Zhang SQ, 2009, OMICS, V13, P307, DOI 10.1089/omi.2009.0030; Zhao HX, 2012, EXP MOL MED, V44, P633, DOI 10.3858/emm.2012.44.11.072	82	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74384	10.1371/journal.pone.0074384	http://dx.doi.org/10.1371/journal.pone.0074384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124450	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100007
J	Xu, Y; Ma, LL; Zhou, C; Zhang, FJ; Kong, FJ; Wang, WN; Qian, LB; Wang, CC; Liu, XB; Yan, M; Wang, JA				Xu, Yong; Ma, Lei-Lei; Zhou, Chen; Zhang, Fei-Jiang; Kong, Fei-Juan; Wang, Wen-Na; Qian, Ling-Bo; Wang, Can-Can; Liu, Xian-Bao; Yan, Min; Wang, Jian-An			Hypercholesterolemic Myocardium Is Vulnerable to Ischemia-Reperfusion Injury and Refractory to Sevoflurane-Induced Protection	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; INFARCT SIZE; DIETARY-CHOLESTEROL; CARDIOPROTECTION; RAT; APOPTOSIS; HYPERLIPIDEMIA; SIMVASTATIN; INHIBITION; BCL-2	Recent studies have demonstrated that volatile anesthetic postconditioning confers myocardial protection against ischemia-reperfusion (IR) injury through activation of the reperfusion injury salvage kinase (RISK) pathway. As RISK has been shown to be impaired in hypercholesterolemia. Therefore, we investigate whether anesthetic-induced cardiac protection was maintained in hypercholesterolemic rats. In the present study, normocholesteolemic or hypercholesterolemic rat hearts were subjected to 30 min of ischemia and 2 h of reperfusion. Animals received 2.4% sevoflurane for 5 min or 3 cycles of 10-s ischemia/10-s reperfusion. The hemodynamic parameters, including left ventricular developed pressure, left ventricular end-diastolic pressure and heart rate, were continuously monitored. The infarct size, apoptosis, p-Akt, p-ERK1/2, p-GSK3 beta were determined. We found that both sevoflurane and ischemic postconditioning significantly improved heart pump function, reduced infarct size and increased the phosphorylation of Akt, ERK1/2 and their downstream target of GSK3 beta in the healthy rats. In the hypercholesterolemic rats, neither sevoflurane nor ischemic postconditioning improved left ventricular hemodynamics, reduced infarct size and increased the phosphorylated Akt, ERK1/2 and GSK3 beta. In contrast, GSK inhibitor SB216763 conferred cardioprotection against IR injury in healthy and hypercholesterolemic hearts. In conclusions, hyperchoesterolemia abrogated sevoflurane-induced cardioprotection against IR injury by alteration of upstream signaling of GSK3 beta and acute GSK inhibition may provide a novel therapeutic strategy to protect hypercholesterolemic hearts against IR injury.	[Xu, Yong; Ma, Lei-Lei; Zhou, Chen; Zhang, Fei-Jiang; Wang, Wen-Na; Yan, Min] Zhejiang Univ, Dept Anesthesiol, Affiliated Hosp 2, Sch Med, Hangzhou 310027, Zhejaing, Peoples R China; [Kong, Fei-Juan] Nanjing Med Univ, Dept Anesthesiol, Hangzhou Peoples Hosp 1, Hangzhou, Zhejaing, Peoples R China; [Qian, Ling-Bo; Wang, Can-Can] Zhejiang Med Coll, Dept Physiol, Hangzhou, Zhejaing, Peoples R China; [Liu, Xian-Bao; Wang, Jian-An] Zhejiang Univ, Dept Cardiol, Affiliated Hosp 2, Sch Med, Hangzhou 310027, Zhejaing, Peoples R China	Zhejiang University; Nanjing Medical University; Zhejiang University	Yan, M (corresponding author), Zhejiang Univ, Dept Anesthesiol, Affiliated Hosp 2, Sch Med, Hangzhou 310027, Zhejaing, Peoples R China.	yanminnia@hotmail.com; wang_jian_an@tom.com			Natural Science Foundation of China [81170118, 81201496]; Natural Science Foundation of Zhejiang Province [R2090259]; Medicine Administration Bureau of Zhejiang Province [2011ZZ009]; Foundation from Science and Technology Department of Zhejiang Province [2009C13G2010218, 2012C33088]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medicine Administration Bureau of Zhejiang Province; Foundation from Science and Technology Department of Zhejiang Province	This work was supported by the Natural Science Foundation of China (numbers 81170118 and 81201496), the Natural Science Foundation of Zhejiang Province (number R2090259), Medicine Administration Bureau of Zhejiang Province (number 2011ZZ009), and the Foundation from Science and Technology Department of Zhejiang Province (numbers 2009C13G2010218 and 2012C33088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne CM, 2001, CIRCULATION, V104, P3046, DOI 10.1161/hc5001.100624; Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Corti R, 2001, ANN NY ACAD SCI, V947, P181; Drenger B, 2011, ANESTHESIOLOGY, V114, P1364, DOI 10.1097/ALN.0b013e31820efafd; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Gorbe A, 2011, AM J PHYSIOL-HEART C, V300, pH1907, DOI 10.1152/ajpheart.01242.2010; Gross ER, 2004, CIRC RES, V94, P960, DOI 10.1161/01.RES.0000122392.33172.09; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; HORTON JD, 1995, J BIOL CHEM, V270, P5381, DOI 10.1074/jbc.270.10.5381; Iliodromitis EK, 2006, ATHEROSCLEROSIS, V188, P356, DOI 10.1016/j.atherosclerosis.2005.11.023; Iliodromitis EK, 2010, BASIC RES CARDIOL, V105, P193, DOI 10.1007/s00395-009-0078-3; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kupai K, 2009, AM J PHYSIOL-HEART C, V297, pH1729, DOI 10.1152/ajpheart.00484.2009; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Mykytenko J, 2007, BASIC RES CARDIOL, V102, P90, DOI 10.1007/s00395-006-0625-0; Okamura T, 2000, CARDIOVASC RES, V45, P642, DOI 10.1016/S0008-6363(99)00271-0; Osipov RM, 2009, CIRCULATION, V120, pS22, DOI 10.1161/CIRCULATIONAHA.108.842724; Pagel PS, 2008, J CARDIOTHOR VASC AN, V22, P753, DOI 10.1053/j.jvca.2008.03.005; Penumathsa SV, 2007, J MOL CELL CARDIOL, V42, P508, DOI 10.1016/j.yjmcc.2006.10.018; ROACH PD, 1993, BIOCHIM BIOPHYS ACTA, V1170, P165, DOI 10.1016/0005-2760(93)90067-J; Sack MN, 2011, J CARDIOVASC PHARM T, V16, P267, DOI 10.1177/1074248411408313; Wang TD, 2002, LIPIDS, V37, P385, DOI 10.1007/s1145-002-0906-2; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Yu CK, 2007, BRIT J ANAESTH, V99, P632, DOI 10.1093/bja/aem261; Zhang SZ, 2006, ANESTHESIOLOGY, V105, P550, DOI 10.1097/00000542-200609000-00019; Zhang Y, 2011, CARDIOVASC RES, V91, P108, DOI 10.1093/cvr/cvr029; Zhao HX, 2010, BASIC RES CARDIOL, V105, P109, DOI 10.1007/s00395-009-0044-0; Zhao HX, 2009, ACTA BIOCH BIOPH SIN, V41, P745, DOI 10.1093/abbs/gmp063; Zheng ZP, 2011, J SURG RES, V170, pE3, DOI 10.1016/j.jss.2011.04.035	30	21	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76652	10.1371/journal.pone.0076652	http://dx.doi.org/10.1371/journal.pone.0076652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124583	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100140
J	Hwang, HJ; Jung, TW; Hong, HC; Choi, HY; Seo, JA; Kim, SG; Kim, NH; Choi, KM; Choi, DS; Baik, SH; Yoo, HJ				Hwang, Hwan-Jin; Jung, Tae Woo; Hong, Ho Cheol; Choi, Hae Yoon; Seo, Ji-A; Kim, Sin Gon; Kim, Nan Hee; Choi, Kyung Mook; Choi, Dong Seop; Baik, Sei Hyun; Yoo, Hye Jin			Progranulin Protects Vascular Endothelium against Atherosclerotic Inflammatory Reaction via Akt/eNOS and Nuclear Factor-kappa B Pathways	PLOS ONE			English	Article							GROWTH-FACTOR; SERUM PROGRANULIN; HOST-DEFENSE; CELLS; EXPRESSION; CONVERSION; ELASTASE; LIGAND; BINDS	Objective: Atherosclerosis is considered a chronic inflammatory disease, initiated by activation and dysfunction of the endothelium. Recently, progranulin has been regarded as an important modulator of inflammatory processes; however, the role for prgranulin in regulating inflammation in vascular endothelial cells has not been described. Method and Results: Signaling pathways mediated by progranulin were analyzed in human umbilical vein endothelial cells (HUVECs) treated with progranulin. Progranulin significantly induced Akt and endothelial nitric oxide synthase (eNOS) phosphorylation in HUVECs, an effect that was blocked with Akt inhibitor. Furthermore, nitric oxide (NO) level, the end product of Akt/eNOS pathway, was significantly upregulated after progranulin treatment. Next, we showed that progranulin efficiently inhibited lipopolysaccharide (LPS)-mediated pro-inflammatory signaling. LPS-induced phosphorylation of I kappa B and nuclear factor-kappa B (NF-kappa B) levels decreased after progranulin treatment. Also, progranulin blocked translocation of NF-kappa B from the cytosol to the nucleus. In addition, progranulin significantly reduced the expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) by inhibiting binding of NF-kappa B to their promoter regions and blocked attachment of monocytes to HUVECs. Progranulin also significantly reduced the expression of tumor necrosis factor receptor-alpha (TNF-alpha) and monocyte chemo-attractant protein-1 (MCP-1), the crucial inflammatory molecules known to aggravate atherosclerosis. Conclusion: Progranulin efficiently inhibited LPS-mediated pro-inflammatory signaling in endothelial cells through activation of the Akt/eNOS pathway and attenuation of the NF-kappa B pathway, suggesting its protective roles in vascular endothelium against inflammatory reaction underlying atherosclerosis.	[Hwang, Hwan-Jin; Jung, Tae Woo; Hong, Ho Cheol; Choi, Hae Yoon; Seo, Ji-A; Kim, Sin Gon; Kim, Nan Hee; Choi, Kyung Mook; Choi, Dong Seop; Baik, Sei Hyun; Yoo, Hye Jin] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Yoo, HJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	deisy21@naver.com	Choi, Kyung Mook/C-4195-2018; Kim, Nan Hee/T-8627-2019; SEO, JI A/AAU-7968-2020	Choi, Kyung Mook/0000-0001-6175-0225; SEO, JI A/0000-0002-1927-2618; Kim, Sin Gon/0000-0002-7430-3675; Kim, Nan Hee/0000-0003-4378-520X	National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A1A1005257]; Korea University Grant [K1325151]; Korean Diabetes Association; Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea [HI10V-0007-010013]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea University Grant; Korean Diabetes Association; Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A1005257), Korea University Grant (K1325151) and a grant (HJY, 2013) from Korean Diabetes Association (HJY) and by the Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea (HI10V-0007-010013) (KMC and SHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Diamant Michaela, 2006, Curr Diab Rep, V6, P279, DOI 10.1007/s11892-006-0061-4; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Huang PL, 2003, CURR HYPERTENS REP, V5, P473, DOI 10.1007/s11906-003-0055-4; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kojima Y, 2009, ATHEROSCLEROSIS, V206, P102, DOI 10.1016/j.atherosclerosis.2009.02.017; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Lu RQ, 2001, P NATL ACAD SCI USA, V98, P142, DOI 10.1073/pnas.011525198; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Pickford F, 2011, AM J PATHOL, V178, P284, DOI 10.1016/j.ajpath.2010.11.002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tung SY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-91; Yilmaz Y, 2011, DIS MARKERS, V31, P205, DOI [10.1155/2011/126240, 10.3233/DMA-2011-0815]; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	27	44	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76679	10.1371/journal.pone.0076679	http://dx.doi.org/10.1371/journal.pone.0076679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098801	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500172
J	Girard, PM; Graindorge, D; Smirnova, V; Rigolet, P; Francesconi, S; Scanlon, S; Sage, E				Girard, Pierre-Marie; Graindorge, Dany; Smirnova, Violetta; Rigolet, Pascal; Francesconi, Stefania; Scanlon, Susan; Sage, Evelyne			Oxidative Stress in Mammalian Cells Impinges on the Cysteines Redox State of Human XRCC3 Protein and on Its Cellular Localization	PLOS ONE			English	Article							STRAND BREAK REPAIR; SINGLET OXYGEN; MOLECULAR-MECHANISMS; S-GLUTATHIONYLATION; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; N-ACETYLCYSTEINE; UVA RADIATION; DIETHYL ESTER; HUMAN RAD51C	In vertebrates, XRCC3 is one of the five Rad51 paralogs that plays a central role in homologous recombination (HR), a key pathway for maintaining genomic stability. While investigating the potential role of human XRCC3 (hXRCC3) in the inhibition of DNA replication induced by UVA radiation, we discovered that hXRCC3 cysteine residues are oxidized following photosensitization by UVA. Our in silico prediction of the hXRCC3 structure suggests that 6 out of 8 cysteines are potentially accessible to the solvent and therefore potentially exposed to ROS attack. By non-reducing SDS-PAGE we show that many different oxidants induce hXRCC3 oxidation that is monitored in Chinese hamster ovarian (CHO) cells by increased electrophoretic mobility of the protein and in human cells by a slight decrease of its immunodetection. In both cell types, hXRCC3 oxidation was reversed in few minutes by cellular reducing systems. Depletion of intracellular glutathione prevents hXRCC3 oxidation only after UVA exposure though depending on the type of photosensitizer. In addition, we show that hXRCC3 expressed in CHO cells localizes both in the cytoplasm and in the nucleus. Mutating all hXRCC3 cysteines to serines (XR3/S protein) does not affect the subcellular localization of the protein even after exposure to camptothecin (CPT), which typically induces DNA damages that require HR to be repaired. However, cells expressing mutated XR3/S protein are sensitive to CPT, thus highlighting a defect of the mutant protein in HR. In marked contrast to CPT treatment, oxidative stress induces relocalization at the chromatin fraction of both wild-type and mutated protein, even though survival is not affected. Collectively, our results demonstrate that the DNA repair protein hXRCC3 is a target of ROS induced by environmental factors and raise the possibility that the redox environment might participate in regulating the HR pathway.	[Girard, Pierre-Marie; Graindorge, Dany; Smirnova, Violetta; Rigolet, Pascal; Francesconi, Stefania; Scanlon, Susan; Sage, Evelyne] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Girard, Pierre-Marie; Graindorge, Dany; Smirnova, Violetta; Rigolet, Pascal; Francesconi, Stefania; Scanlon, Susan; Sage, Evelyne] CNRS, UMR3348, F-91405 Orsay, France; [Rigolet, Pascal] Univ Paris 11, Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Girard, PM (corresponding author), Inst Curie, Ctr Rech, F-91405 Orsay, France.	pierre-marie.girard@curie.fr	Rigolet, Pascal/S-8602-2018; Francesconi, Stefania/J-7910-2016	Rigolet, Pascal/0000-0001-6868-4953; francesconi, stefania/0000-0002-9665-349X; girard, pierre-marie/0000-0001-9703-4407; Gueble, Susan/0000-0002-8043-1147	La Region Ile de France on DIM SenT program; La Ligue Contre le Cancer; Centre National de la Recherche Scientifique; Institut Curie	La Region Ile de France on DIM SenT program(Region Ile-de-France); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Curie	D.G. was the recipient of a doctoral fellowship from La Region Ile de France on DIM SenT program and La Ligue Contre le Cancer. This work was funded by the Centre National de la Recherche Scientifique and Institut Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bae SI, 2008, BIOCHEM PHARMACOL, V76, P1653, DOI 10.1016/j.bcp.2008.09.003; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; BELLOMO G, 1990, METHOD ENZYMOL, V186, P627; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Biverstal A, 2008, MUTAT RES-FUND MOL M, V648, P32, DOI 10.1016/j.mrfmmm.2008.09.011; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bracchitta G, 2013, PHOTOCH PHOTOBIO SCI, V12, P911, DOI 10.1039/c3pp25326k; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Bravard A, 2009, CANCER RES, V69, P3642, DOI 10.1158/0008-5472.CAN-08-3943; BUETTNER GR, 1987, BIOCHIM BIOPHYS ACTA, V923, P501, DOI 10.1016/0304-4165(87)90060-2; CATALFO A, 2005, PHOTOCH PHOTOBIO SCI, V4, P304, DOI DOI 10.1039/B406908K; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Czaplewski C, 2004, PROTEIN ENG DES SEL, V17, P29, DOI 10.1093/protein/gzh003; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dardalhon D, 2008, CELL CYCLE, V7, P611, DOI 10.4161/cc.7.5.5400; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; DEVASAGAYAM TPA, 1991, J PHOTOCH PHOTOBIO B, V9, P105, DOI 10.1016/1011-1344(91)80008-6; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Gildemeister OS, 2009, J BIOL CHEM, V284, P31945, DOI 10.1074/jbc.M109.024646; Girard PM, 2008, DNA REPAIR, V7, P1500, DOI 10.1016/j.dnarep.2008.05.004; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hinz JM, 2003, CARCINOGENESIS, V24, P249, DOI 10.1093/carcin/24.2.249; Kanofsky JR, 2011, PHOTOCHEM PHOTOBIOL, V87, P14, DOI 10.1111/j.1751-1097.2010.00855.x; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Kozmin S, 2005, P NATL ACAD SCI USA, V102, P13538, DOI 10.1073/pnas.0504497102; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Lambert S, 2000, EMBO J, V19, P3090, DOI 10.1093/emboj/19.12.3090; Lambert S, 2002, ONCOGENE, V21, P4065, DOI 10.1038/sj.onc.1205535; Lee AJ, 2005, CANCER EPIDEM BIOMAR, V14, P497, DOI 10.1158/1055-9965.EPI-04-0295; LEVY EJ, 1993, P NATL ACAD SCI USA, V90, P9171, DOI 10.1073/pnas.90.19.9171; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lio YC, 2004, J BIOL CHEM, V279, P42313, DOI 10.1074/jbc.M405212200; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Maresca V, 2006, J INVEST DERMATOL, V126, P182, DOI 10.1038/sj.jid.5700021; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; MINHAS HS, 1995, BIOCHEM PHARMACOL, V49, P1475, DOI 10.1016/0006-2952(94)00518-Q; Montaner B, 2007, EMBO REP, V8, P1074, DOI 10.1038/sj.embor.7401084; Noda T, 2001, FASEB J, V15, P2131, DOI 10.1096/fj.01-0131com; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Sage E, 2012, PHOTOCH PHOTOBIO SCI, V11, P74, DOI 10.1039/c1pp05219e; Schweitzer C, 2003, CHEM REV, V103, P1685, DOI 10.1021/cr010371d; Shackelford RE, 2005, ANTIOXID REDOX SIGN, V7, P940, DOI 10.1089/ars.2005.7.940; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Soeur J, 2011, MUTAT RES-GEN TOX EN, V718, P24, DOI 10.1016/j.mrgentox.2010.10.009; Somyajit K, 2013, MOL CELL BIOL, V33, P1830, DOI 10.1128/MCB.01521-12; Sonoda E, 2007, DNA REPAIR, V6, P280, DOI 10.1016/j.dnarep.2006.10.025; Stefani M, 2008, INT J MOL SCI, V9, P2515, DOI 10.3390/ijms9122515; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TYRRELL RM, 1989, PHOTOCHEM PHOTOBIOL, V49, P407, DOI 10.1111/j.1751-1097.1989.tb09187.x; von Montfort C, 2006, BIOL CHEM, V387, P1399, DOI 10.1515/BC.2006.175; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Watanabe N, 2004, METHOD ENZYMOL, V378, P319; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yamada NA, 2004, J BIOL CHEM, V279, P23250, DOI 10.1074/jbc.M402247200; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	79	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75751	10.1371/journal.pone.0075751	http://dx.doi.org/10.1371/journal.pone.0075751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116071	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200036
J	Kupfer, SS; Maranville, JC; Baxter, SS; Huang, Y; Di Rienzo, A				Kupfer, Sonia S.; Maranville, Joseph C.; Baxter, Shaneen S.; Huang, Yong; Di Rienzo, Anna			Comparison of Cellular and Transcriptional Responses to 1,25-Dihydroxyvitamin D3 and Glucocorticoids in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							VITAMIN-D; RESISTANT ASTHMA; 25-HYDROXYVITAMIN D; SERUM-LEVELS; BONE MASS; IN-VITRO; AFRICAN; METHYLPREDNISOLONE; DEXAMETHASONE; PROLIFERATION	Glucocorticoids (GC) and 1,25-dihydroxyvitamin D3 (1,25(OH)(2) D3) are steroid hormones with anti-inflammatory properties with enhanced effects when combined. We previously showed that transcriptional response to GCs was correlated with inter-individual and inter-ethnic cellular response. Here, we profiled cellular and transcriptional responses to 1,25(OH)(2) D3 from the same donors. We studied cellular response to combined treatment with GCs and 1,25(OH)(2) D3 in a subset of individuals least responsive to GCs. We found that combination treatment had significantly greater inhibition of proliferation than with either steroid hormone alone. Overlapping differentially expressed (DE) genes between the two hormones were enriched for adaptive and innate immune processes. Non-overlapping differentially expressed genes with 1,25(OH)(2) D3 treatment were enriched for pathways involving the electron transport chain, while with GC treatment, non-overlapping genes were enriched for RNA-related processes. These results suggest that 1,25(OH)(2) D3 enhances GC anti-inflammatory properties through a number of shared and non-shared transcriptionally-mediated pathways.	[Kupfer, Sonia S.; Huang, Yong] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Maranville, Joseph C.; Baxter, Shaneen S.; Di Rienzo, Anna] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	dirienzo@bsd.uchicago.edu	Kupfer, Sonia S/ABD-9416-2021	Di Rienzo, Anna/0000-0002-8982-9098; Maranville, Joseph/0000-0002-1688-1573	Digestive Disease Research Core Center [P30 DK42086]; Clinical Therapeutics training grant to the University of Chicago [T32GM007019];  [K08 CA142892];  [R01 GM101682]; NATIONAL CANCER INSTITUTE [K08CA142892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007019, R01GM101682] Funding Source: NIH RePORTER	Digestive Disease Research Core Center; Clinical Therapeutics training grant to the University of Chicago; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants K08 CA142892 (to S. S. K.), R01 GM101682 (to A. D.) and Digestive Disease Research Core Center pilot and feasibility funding P30 DK42086 (to S. S. K.). JCM was supported by a Clinical Therapeutics training grant to the University of Chicago (T32GM007019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ J, 1992, J ALLERGY CLIN IMMUN, V89, P714, DOI 10.1016/0091-6749(92)90379-G; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Bikle DD, 1999, MINER ELECTROL METAB, V25, P178, DOI 10.1159/000057442; Brodell RT, 2011, J DRUGS DERMATOL, V10, P158; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; Corrigan CJ, 1996, EUR RESPIR J, V9, P2077, DOI 10.1183/09031936.96.09102077; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1026, DOI 10.1164/ajrccm/144.5.page; Daniels ED, 1997, OSTEOPOROSIS INT, V7, P105, DOI 10.1007/BF01623684; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Ferreira GB, 2012, J PROTEOME RES, V11, P941, DOI 10.1021/pr200724e; Grant WB, 2006, PROG BIOPHYS MOL BIO, V92, P65, DOI 10.1016/j.pbiomolbio.2006.02.013; Grant WB, 2012, DERM-ENDOCRINOL, V4, P85, DOI 10.4161/derm.19667; Grant WB, 2010, J AM MED DIR ASSOC, V11, P617, DOI 10.1016/j.jamda.2010.03.013; HACZKU A, 1994, J ALLERGY CLIN IMMUN, V93, P510, DOI 10.1016/0091-6749(94)90361-1; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; KIRKHAM BW, 1991, J RHEUMATOL, V18, P821; Kreindler JL, 2012, AM J RESP CRIT CARE, V186, P470, DOI 10.1164/rccm.201207-1295ED; LANGHOFF E, 1986, LANCET, V1, P1296; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; MANOLAGAS SC, 1985, MOL CELL ENDOCRINOL, V43, P113, DOI 10.1016/0303-7207(85)90074-7; MARANVILLE JC, 2013, PHARMACOGENOMICS J, V3, P56; Martinesi M, 2008, INFLAMM BOWEL DIS, V14, P597, DOI 10.1002/ibd.20354; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Parisien M, 1997, J BONE MINER RES, V12, P948, DOI 10.1359/jbmr.1997.12.6.948; POZNANSKY MC, 1984, CLIN SCI, V67, P639, DOI 10.1042/cs0670639; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Seki M, 1998, ARTHRITIS RHEUM, V41, P823, DOI 10.1002/1529-0131(199805)41:5<823::AID-ART8>3.0.CO;2-#; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOLOMON DH, 1988, P NATL ACAD SCI USA, V85, P6904, DOI 10.1073/pnas.85.18.6904; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z; Wjst M, 2007, J STEROID BIOCHEM, V103, P799, DOI 10.1016/j.jsbmb.2006.12.053; Wu AC, 2012, AM J RESP CRIT CARE, V186, P508, DOI 10.1164/rccm.201202-0351OC; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; ZARRABEITIA MT, 1987, BLUT, V54, P343, DOI 10.1007/BF00626015; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76643	10.1371/journal.pone.0076643	http://dx.doi.org/10.1371/journal.pone.0076643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116131	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200059
J	Dueholm, MS; Otzen, D; Nielsen, PH				Dueholm, Morten S.; Otzen, Daniel; Nielsen, Per Halkjaer			Evolutionary Insight into the Functional Amyloids of the Pseudomonads	PLOS ONE			English	Article							BIOFILM FORMATION; BACTERIA; BURKHOLDERIA; AGGREGATION; AERUGINOSA; PATHOGENS; ADHESINS	Functional bacterial amyloids (FuBA) are important components in many environmental biofilms where they provide structural integrity to the biofilm, mediate bacterial aggregation and may function as virulence factor by binding specifically to host cell molecules. A novel FuBA system, the Fap system, was previously characterized in the genus Pseudomonas, however, very little is known about the phylogenetic diversity of bacteria with the genetic capacity to apply this system. Studies of genomes and public metagenomes from a diverse range of habitats showed that the Fap system is restricted to only three classes in the phylum Proteobacteria, the Beta-, Gamma- and Deltaproteobacteria. The structural organization of the fap genes into a single fapABCDEF operon is well conserved with minor variations such as a frequent deletion of fapA. A high degree of variation was seen within the primary structure of the major Fap fibril monomers, FapC, whereas the minor monomers, FapB, showed less sequence variation. Comparison of phylogenetic trees based on Fap proteins and the 16S rRNA gene of the corresponding bacteria showed remarkably similar overall topology. This indicates, that horizontal gene transfer is an infrequent event in the evolution of the Fap system.	[Dueholm, Morten S.; Nielsen, Per Halkjaer] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aarhus, Denmark; [Otzen, Daniel] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Prot Struct inSPIN, Dept Mol Biol & Genet, Aarhus, Denmark	Aalborg University; Aarhus University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aarhus, Denmark.	phn@bio.aau.dk	Dueholm, Morten Simonsen/T-6718-2018; Nielsen, Per Halkjær/T-6796-2018	Dueholm, Morten Simonsen/0000-0003-4135-2670; Nielsen, Per Halkjær/0000-0002-6402-1877; Otzen, Daniel/0000-0002-2918-8989	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation; Aalborg University	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation(Lundbeckfonden); Aalborg University	The authors are grateful to funding from the Villum Kann Rasmussen Foundation (BioNET), the Lundbeck Foundation and Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attaway HH, 2002, CURR MICROBIOL, V45, P30, DOI 10.1007/s00284-001-0053-1; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Beatson SA, 2011, J BACTERIOL, V193, P1286, DOI 10.1128/JB.01337-10; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kalastavadi Tejas, 2008, BMC Biochemistry, V9, P7, DOI 10.1186/1471-2091-9-7; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; LiPuma JJ, 2003, SEMIN RESP CRIT CARE, V24, P681, DOI 10.1055/s-2004-815664; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Nielsen PH, 2011, SPRINGER SER BIOFILM, V5, P41, DOI 10.1007/978-3-642-19940-0_3; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; Rudrappa T, 2008, FEMS MICROBIOL ECOL, V64, P153, DOI 10.1111/j.1574-6941.2008.00465.x; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Segonds C, 2009, J CLIN MICROBIOL, V47, P1510, DOI 10.1128/JCM.02489-08; SENEVIRATNE G, 2011, MICROBIOLOGY MONOGRA, P81; Shankar M, 2013, J BACTERIOL, V195, P39, DOI 10.1128/JB.01236-12; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; Wiehlmann L, 2007, INT J MED MICROBIOL, V297, P615, DOI 10.1016/j.ijmm.2007.03.014; Woo PCY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000416; Yang CH, 2011, J CHIN MED ASSOC, V74, P435, DOI 10.1016/j.jcma.2011.08.013	37	43	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76630	10.1371/journal.pone.0076630	http://dx.doi.org/10.1371/journal.pone.0076630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116129	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300075
J	Hayashi, Y; Asuzu, DT; Gibbons, SJ; Aarsvold, KH; Bardsley, MR; Lomberk, GA; Mathison, AJ; Kendrick, ML; Shen, KR; Taguchi, T; Gupta, A; Rubin, BP; Fletcher, JA; Farrugia, G; Urrutia, RA; Ordog, T				Hayashi, Yujiro; Asuzu, David T.; Gibbons, Simon J.; Aarsvold, Kirsten H.; Bardsley, Michael R.; Lomberk, Gwen A.; Mathison, Angela J.; Kendrick, Michael L.; Shen, K. Robert; Taguchi, Takahiro; Gupta, Anu; Rubin, Brian P.; Fletcher, Jonathan A.; Farrugia, Gianrico; Urrutia, Raul A.; Ordog, Tamas			Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1-and Stem Cell Factor-Activated Pathways	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; OF-FUNCTION MUTATIONS; SMOOTH-MUSCLE-CELLS; INTERSTITIAL-CELLS; KIT-LIGAND; C-KIT; INHIBITOR; IDENTIFICATION; EXPRESSION; CHROMATIN	Stem cell factor (mouse: Kitl, human: KITLG) and insulin-like growth factor-1 (IGF1), acting via KIT and IGF1 receptor (IGF1R), respectively, are critical for the development and integrity of several tissues. Autocrine/paracrine KITLG-KIT and IGF1-IGF1R signaling are also activated in several cancers including gastrointestinal stromal tumors (GIST), the most common sarcoma. In murine gastric muscles, IGF1 promotes Kitl-dependent development of interstitial cells of Cajal (ICC), the non-neoplastic counterpart of GIST, suggesting cooperation between these pathways. Here, we report a novel mechanism linking IGF1-IGF1R and KITLG-KIT signaling in both normal and neoplastic cells. In murine gastric muscles, the microenvironment for ICC and GIST, human hepatic stellate cells (LX-2), a model for cancer niches, and GIST cells, IGF1 stimulated Kitl/KITLG protein and mRNA expression and promoter activity by activating several signaling pathways including AKT-mediated glycogen synthase kinase-3 beta inhibition (GSK3i). GSK3i alone also stimulated Kitl/KITLG expression without activating mitogenic pathways. Both IGF1 and GSK3i induced chromatin-level changes favoring transcriptional activation at the Kitl promoter including increased histone H3/H4 acetylation and H3 lysine (K) 4 methylation, reduced H3K9 and H3K27 methylation and reduced occupancy by the H3K27 methyltransferase EZH2. By pharmacological or RNA interference-mediated inhibition of chromatin modifiers we demonstrated that these changes have the predicted impact on KITLG expression. KITLG knock-down and immunoneutralization inhibited the proliferation of GIST cells expressing wild-type KIT, signifying oncogenic autocrine/paracrine KITLG-KIT signaling. We conclude that membrane-to-nucleus signaling involving GSK3i establishes a previously unrecognized link between the IGF1-IGF1R and KITLG-KIT pathways, which is active in both physiologic and oncogenic contexts and can be exploited for therapeutic purposes.	[Hayashi, Yujiro; Asuzu, David T.; Gibbons, Simon J.; Aarsvold, Kirsten H.; Bardsley, Michael R.; Farrugia, Gianrico; Ordog, Tamas] Mayo Clin, Enter Neurosci Program, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Hayashi, Yujiro; Asuzu, David T.; Aarsvold, Kirsten H.; Bardsley, Michael R.; Lomberk, Gwen A.; Mathison, Angela J.; Urrutia, Raul A.; Ordog, Tamas] Mayo Clin, Gastroenterol Res Unit, Div Gastroenterol & Hepatol, Rochester, MN USA; [Kendrick, Michael L.; Shen, K. Robert] Mayo Clin, Dept Surg, Rochester, MN USA; [Taguchi, Takahiro] Kochi Univ, Div Human Hlth & Med Sci, Grad Sch Kuroshio Sci, Nanko Ku, Kochi 780, Japan; [Gupta, Anu; Rubin, Brian P.] Cleveland Clin, Dept Anat Pathol, Lerner Res Inst, Cleveland, OH 44106 USA; [Gupta, Anu; Rubin, Brian P.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44106 USA; [Gupta, Anu; Rubin, Brian P.] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Fletcher, Jonathan A.] Harvard Univ, Sch Med, Boston, MA USA; [Farrugia, Gianrico; Urrutia, Raul A.; Ordog, Tamas] Mayo Clin, Ctr Individualized Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Kochi University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Mayo Clinic	Ordog, T (corresponding author), Mayo Clin, Enter Neurosci Program, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	ordog.tamas@mayo.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X; Gibbons, Simon/0000-0001-5311-5993; Mathison, Angela/0000-0002-6763-2710; Harrington, Jon/0000-0003-1293-5201	National Institutes of Health [R01 DK058185, P01 DK068055, P30 DK084567, P30 CA015083, P50 CA127003]; GIST Cancer Research Fund; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE [P50CA127003, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058185, P30DK084567, P01DK068055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GIST Cancer Research Fund; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institutes of Health (http://www.nih.gov/) grants R01 DK058185, P01 DK068055 (Project 2), P30 DK084567, P30 CA015083, P50 CA127003, as well as by the GIST Cancer Research Fund (http://www.gistinfo.org/) and the Mayo Clinic Center for Individualized Medicine http://mayoresearch.mayo.edu/center-for-individualized-medicine/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonescu CR, 2011, J PATHOL, V223, P251, DOI 10.1002/path.2798; Asuzu DT, 2011, NEUROGASTROENT MOTIL, V23, pE309, DOI 10.1111/j.1365-2982.2011.01730.x; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Baumann U, 1999, HEPATOLOGY, V30, P112, DOI 10.1002/hep.510300140; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bono P, 2004, BLOOD, V103, P2929, DOI 10.1182/blood-2003-10-3443; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Edris B, 2013, P NATL ACAD SCI USA, V110, P3501, DOI 10.1073/pnas.1222893110; Flynn RS, 2009, AM J PHYSIOL-GASTR L, V297, pG1232, DOI 10.1152/ajpgi.00323.2009; Gaca MDA, 1999, J HEPATOL, V30, P850, DOI 10.1016/S0168-8278(99)80139-1; Gomez-Pinilla PJ, 2011, NEUROGASTROENT MOTIL, V23, P36, DOI 10.1111/j.1365-2982.2010.01590.x; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Grover M, 2011, GASTROENTEROLOGY, V140, P1575, DOI 10.1053/j.gastro.2011.01.046; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirano K, 2008, PATHOL RES PRACT, V204, P799, DOI 10.1016/j.prp.2008.05.002; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Izbeki F, 2010, J PHYSIOL-LONDON, V588, P3101, DOI 10.1113/jphysiol.2010.191023; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Janeway KA, 2010, INT J CANCER, V127, P2718, DOI 10.1002/ijc.25247; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuemmerle JF, 2005, AM J PHYSIOL-GASTR L, V288, pG101, DOI 10.1152/ajpgi.00032.2004; Kuemmerle JF, 1998, AM J PHYSIOL-GASTR L, V275, pG151, DOI 10.1152/ajpgi.1998.275.1.G151; Kuemmerle JF, 2003, AM J PHYSIOL-GASTR L, V284, pG411, DOI 10.1152/ajpgi.00310.2002; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; MAJUMDAR MK, 1994, J BIOL CHEM, V269, P1237; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Muhlenberg T, 2009, CANCER RES, V69, P6941, DOI 10.1158/0008-5472.CAN-08-4004; Negri T, 2009, J PATHOL, V217, P103, DOI 10.1002/path.2450; ORDBG T, 2004, AM J PHYSIOL-GASTR L, V286, pG351, DOI DOI 10.1152/AJPGI.00281.2003.PUBMED:14563669; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Sokolovic A, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-3; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Theou-Anton N, 2006, BRIT J CANCER, V94, P1180, DOI 10.1038/sj.bjc.6603063; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Williams KL, 2002, AM J PHYSIOL-GASTR L, V283, pG875, DOI 10.1152/ajpgi.00089.2002; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yakar S, 2012, ENDOCRIN METAB CLIN, V41, P231, DOI 10.1016/j.ecl.2012.04.008; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhou Y, 2008, LEUKEMIA LYMPHOMA, V49, P1945, DOI 10.1080/10428190802304966	63	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76822	10.1371/journal.pone.0076822	http://dx.doi.org/10.1371/journal.pone.0076822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116170	Green Published, gold			2022-12-27	WOS:000325501300101
J	Kelmo, F; Bell, JJ; Attrill, MJ				Kelmo, Francisco; Bell, James J.; Attrill, Martin J.			Tolerance of Sponge Assemblages to Temperature Anomalies: Resilience and Proliferation of Sponges following the 1997-8 El-Nino Southern Oscillation	PLOS ONE			English	Article							CORAL-REEF SPONGES; GREAT-BARRIER-REEF; NORTHERN BAHIA; CLIMATE-CHANGE; CNIDARIAN COMMUNITY; CARIBBEAN REEFS; MARINE SPONGES; BRAZIL; PATTERNS; PACIFIC	Coral reefs across the world are under threat from a range of stressors, and while there has been considerable focus on the impacts of these stressors on corals, far less is known about their effect on other reef organisms. The 1997-8 El-Nino Southern Oscillation (ENSO) had notable and severe impacts on coral reefs worldwide, but not all reef organisms were negatively impacted by this large-scale event. Here we describe how the sponge fauna at Bahia, Brazil was influenced by the 1997-8 ENSO event. Sponge assemblages from three contrasting reef habitats (reef tops, walls and shallow banks) at four sites were assessed annually from 1995 to 2011. The within-habitat sponge diversity did not vary significantly across the study period; however, there was a significant increase in density in all habitats. Multivariate analyses revealed no significant difference in sponge assemblage composition (ANOSIM) between pre- and post-ENSO years for any of the habitats, suggesting that neither the 1997-8 nor any subsequent smaller ENSO events have had any measurable impact on the reef sponge assemblage. Importantly, this is in marked contrast to the results previously reported for a suite of other taxa (including corals, echinoderms, bryozoans, and ascidians), which all suffered mass mortalities as a result of the ENSO event. Our results suggest that of all reef taxa, sponges have the potential to be resilient to large-scale thermal stress events and we hypothesize that sponges might be less affected by projected increases in sea surface temperature compared to other major groups of reef organisms.	[Kelmo, Francisco] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Attrill, Martin J.] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England	Universidade Federal da Bahia; Victoria University Wellington; University of Plymouth	Kelmo, F (corresponding author), Univ Fed Bahia, Inst Biol, Campus Univ Ondina, Salvador, BA, Brazil.	kelmo@ufba.br		Attrill, Martin/0000-0002-4039-031X; Bell, James/0000-0001-9996-945X	Plymouth University Marine Institute	Plymouth University Marine Institute	This work is funded by the corresponding author, Francisco Kelmo, with additional support from the Plymouth University Marine Institute to FK. The funder coordinated the overall research objectives and organised the sampling, identification of organisms and data collation throughout the survey, developed sampling methodology, input information on species biology and wrote the paper.	Aerts LAM, 2000, MAR ECOL-P S Z N I, V21, P191, DOI 10.1046/j.1439-0485.2000.00685.x; Alcolado Pedro M., 2007, V28, P3; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Antonius A, 1998, REV BIOL TROP, V46, P145; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Attrill MJ, 2007, ESTUAR COAST SHELF S, V73, P243, DOI 10.1016/j.ecss.2007.01.007; Attrill MJ, 2004, CLIM RES, V26, P151, DOI 10.3354/cr026151; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; Bell JJ, 2008, MAR BIOL, V155, P563, DOI 10.1007/s00227-008-1036-6; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bell JJ, 2004, J MAR BIOL ASSOC UK, V84, P581, DOI 10.1017/S0025315404009580h; Bittencourt ACDP, 2000, AN ACAD BRAS CIENC, V72, P271, DOI 10.1590/S0001-37652000000200012; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bruno JF, 2001, CORAL REEFS, V20, P127, DOI 10.1007/s003380100151; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Carballo JL, 2006, ECOSCIENCE, V13, P119, DOI 10.2980/1195-6860(2006)13[119:EONSOT]2.0.CO;2; Carballo JL, 2008, MAR ECOL-EVOL PERSP, V29, P216, DOI 10.1111/j.1439-0485.2008.00228.x; Carballo JL, 2007, ECOSCIENCE, V14, P92, DOI 10.2980/1195-6860(2007)14[92:ACOSAP]2.0.CO;2; Cebrian E, 2006, MAR ECOL PROG SER, V323, P83, DOI 10.3354/meps323083; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cleary DFR, 2007, J MAR BIOL ASSOC UK, V87, P1669, DOI 10.1017/S0025315407052770; CORTES J, 1984, REV BIOL TROP, V32, P227; Cuet P., 1988, P 6 INT COR REEF S T, V2, P207; Custodio MR, 2007, MUSEU NACL SERIE LIV, V28; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Diaz MC, 2001, B MAR SCI, V69, P535; Duckworth AR, 2013, MAR BIOL, V160, P27, DOI 10.1007/s00227-012-2053-z; Duckworth AR, 2012, MAR ECOL PROG SER, V462, P67, DOI 10.3354/meps09853; Dunlap M, 1998, MAR ECOL-P S Z N I, V19, P325, DOI 10.1111/j.1439-0485.1998.tb00471.x; Dunlap M, 1996, MAR BIOL, V126, P117, DOI 10.1007/BF00571383; Eakin CM, 2001, B MAR SCI, V69, P171; Feingold JS, 2001, B MAR SCI, V69, P61; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Hajdu E., 2011, MUSEU NACL SERIE LIV; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 1996, ECOLOGY, V77, P2256, DOI 10.2307/2265718; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jimenez CE, 2003, MAR ECOL-P S Z N I, V24, P179, DOI 10.1046/j.1439-0485.2003.03814.x; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Kelmo F, 2006, HYDROBIOLOGIA, V555, P231, DOI 10.1007/s10750-005-1119-z; Kelmo F, 2003, CORAL REEFS, V22, P541, DOI 10.1007/s00338-003-0343-0; Kelmo F, 2004, BIOL CONSERV, V118, P609, DOI 10.1016/j.biocon.2003.10.010; Kelmo F, 2001, B MAR SCI, V69, P547; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065073; Kelmo F, 2013, ECOL INDIC, V30, P148, DOI 10.1016/j.ecolind.2013.02.009; Knapp ISS, 2013, MAR POLLUT BULL, V66, P209, DOI 10.1016/j.marpolbul.2012.08.017; Kumar A, 2001, J CLIMATE, V14, P345, DOI 10.1175/1520-0442(2001)014<0345:TSNAWO>2.0.CO;2; Leao Z.M.A.N., 1997, P583; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Lopez-Victoria M, 2005, MAR ECOL-EVOL PERSP, V26, P33, DOI 10.1111/j.1439-0485.2005.00036.x; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; McPhaden MJ, 1999, NATURE, V398, P559, DOI 10.1038/19193; Mo KC, 2001, GEOPHYS RES LETT, V28, P2065, DOI 10.1029/2000GL012448; Moraes FC, 2011, MUSEU NACL SERIE LIV, V44; MURICY G, 1991, Vie et Milieu, V41, P205; Muricy G, 2006, MUSEU NACL SERIE LIV, V17, P104; Muricy G, 2011, MUSEU NACL SERIE LIV, V46; Nolasco MC, 1986, QUATERNARY S AM ANTA, P159; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Peso-Aguiar M.C., 2000, Aquatic Ecosystem Health & Management, V3, P459, DOI 10.1016/S1463-4988(00)00051-8; Pile A.J., 1997, P1403; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Roberts DE, 2006, MAR ECOL PROG SER, V321, P19, DOI 10.3354/meps321019; Rodrigues RR, 2011, J CLIMATE, V24, P3402, DOI 10.1175/2011JCLI3983.1; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; Schils T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046639; Schoenberg Christine H. L., 2007, V28, P569; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; Ward-Paige CA, 2005, MAR POLLUT BULL, V51, P570, DOI 10.1016/j.marpolbul.2005.04.006; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Wilkinson C, 1999, NATURE RESOUR, V35, P16; Wilkinson C, 1999, AMBIO, V28, P188; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268; Wulff JL, 2006, FUNCT ECOL, V20, P699, DOI 10.1111/j.1365-2435.2006.01143.x; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007	85	29	29	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76441	10.1371/journal.pone.0076441	http://dx.doi.org/10.1371/journal.pone.0076441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116109	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300058
J	Wickstrum, J; Sammons, LR; Restivo, KN; Hefty, PS				Wickstrum, Jason; Sammons, Lindsay R.; Restivo, Keasha N.; Hefty, P. Scott			Conditional Gene Expression in Chlamydia trachomatis Using the Tet System	PLOS ONE			English	Article							TETRACYCLINE ANALOGS; REGULATORY ELEMENTS; ESCHERICHIA-COLI; REPRESSOR; ASSAY; MECHANISMS; PROMOTER; VECTOR	Chlamydia trachomatis is maintained through a complex bi-phasic developmental cycle that incorporates numerous processes that are poorly understood. This is reflective of the previous paucity of genetic tools available. The recent advent of a method for transforming Chlamydia has enabled the development of essential molecular tools to better study these medically important bacteria. Critical for the study of Chlamydia biology and pathogenesis, is a system for tightly controlled inducible gene expression. To accomplish this, a new shuttle vector was generated with gene expression controlled by the Tetracycline repressor and anhydryotetracycline. Evaluation of GFP expression by this system demonstrated tightly controlled gene regulation with rapid protein expression upon induction and restoration of transcription repression following inducer removal. Additionally, induction of expression could be detected relatively early during the developmental cycle and concomitant with conversion into the metabolically active form of Chlamydia. Uniform and strong GFP induction was observed during middle stages of the developmental cycle. Interestingly, variable induced GFP expression by individual organisms within shared inclusions during later stages of development suggesting metabolic diversity is affecting induction and/or expression. These observations support the strong potential of this molecular tool to enable numerous experimental analyses for a better understanding of the biology and pathogenesis of Chlamydia.	[Wickstrum, Jason; Sammons, Lindsay R.; Restivo, Keasha N.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Hefty, PS (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	pshefty@ku.edu			National Institutes of Health NIH [AI103711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103711] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from National Institutes of Health NIH AI103711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; DEGENKOLB J, 1991, ANTIMICROB AGENTS CH, V35, P1591, DOI 10.1128/AAC.35.8.1591; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Kamionka A, 2004, NUCLEIC ACIDS RES, V32, P842, DOI 10.1093/nar/gkh200; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; OLIVA B, 1992, ANTIMICROB AGENTS CH, V36, P913, DOI 10.1128/AAC.36.5.913; Osaka I, 2013, ANTIMICROB AGENTS CH, V57, P2838, DOI 10.1128/AAC.00056-13; Osaka I, 2012, ANTIMICROB AGENTS CH, V56, P4184, DOI 10.1128/AAC.00427-12; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaumburg CS, 2003, NUCLEIC ACIDS RES, V31, P551, DOI 10.1093/nar/gkg150; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; SKERRA A, 1994, GENE, V141, P79, DOI 10.1016/0378-1119(94)90131-7; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Wang YB, 2013, PATHOG DIS, V67, P100, DOI 10.1111/2049-632X.12024; Wang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059195; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Whetstine CR, 2009, APPL ENVIRON MICROB, V75, P6553, DOI 10.1128/AEM.02825-08; Wilson DP, 2004, B MATH BIOL, V66, P523, DOI 10.1016/j.bulm.2003.09.001	33	64	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76743	10.1371/journal.pone.0076743	http://dx.doi.org/10.1371/journal.pone.0076743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116144	Green Submitted, Green Published, gold			2022-12-27	WOS:000325501300086
J	Arakawa, T; Kamiya, N; Nakamura, H; Fukuda, I				Arakawa, Takamasa; Kamiya, Narutoshi; Nakamura, Haruki; Fukuda, Ikuo			Molecular Dynamics Simulations of Double-Stranded DNA in an Explicit Solvent Model with the Zero-Dipole Summation Method	PLOS ONE			English	Article							PARTICLE-MESH EWALD; RANGE ELECTROSTATIC INTERACTIONS; NUCLEIC-ACIDS; B-DNA; ENERGY FUNCTION; REACTION FIELD; LIMITING LAWS; A-DNA; WATER; TRANSITION	Molecular dynamics MD) simulations of a double-stranded DNA with explicit water and small ions were performed with the zero-dipole summation (ZD) method, which was recently developed as one of the non-Ewald methods. Double-stranded DNA is highly charged and polar, with phosphate groups in its backbone and their counterions, and thus precise treatment for the long-range electrostatic interactions is always required to maintain the stable and native double-stranded form. A simple truncation method deforms it profoundly. On the contrary, the ZD method, which considers the neutralities of charges and dipoles in a truncated subset, well reproduced the electrostatic energies of the DNA system calculated by the Ewald method. The MD simulations using the ZD method provided a stable DNA system, with similar structures and dynamic properties to those produced by the conventional Particle mesh Ewald method.	[Arakawa, Takamasa; Kamiya, Narutoshi; Nakamura, Haruki; Fukuda, Ikuo] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kamiya, N (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	nkamiya@protein.osaka-u.ac.jp	Kamiya, Narutoshi/C-4548-2016	Kamiya, Narutoshi/0000-0002-0527-6968	JSPS KAKENHI [23370071, 24118008]; JSPS [25440070, 25390156]; Grants-in-Aid for Scientific Research [25440070] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers 23370071 and 24118008. NK and IF are grateful for a Grant-in-Aid for Scientific Research (C) (25440070 and 25390156, respectively) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER JA, 1973, MOL PHYS, V26, P789, DOI 10.1080/00268977300102101; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; BROOKS CL, 1985, J CHEM PHYS, V83, P5897, DOI 10.1063/1.449621; Cheatham TE, 1996, J MOL BIOL, V259, P434; Cheatham TE, 2000, ANNU REV PHYS CHEM, V51, P435, DOI 10.1146/annurev.physchem.51.1.435; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Fennell CJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206581; Fukuda Ikuo, 2012, Biophys Rev, V4, P161, DOI 10.1007/s12551-012-0089-4; Fukuda I, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739789; Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; Fukuda I, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114301; Fukunishi Y, 2003, J PHYS CHEM B, V107, P13201, DOI 10.1021/jp035478e; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; Heddi B, 2008, J MOL BIOL, V382, P956, DOI 10.1016/j.jmb.2008.07.047; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamiya N, 2013, CHEM PHYS LETT, V568, P26, DOI 10.1016/j.cplett.2013.03.014; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; MacKerell AD, 1997, J PHYS CHEM B, V101, P646, DOI 10.1021/jp9622795; MacKerell AD, 2008, CURR OPIN STRUC BIOL, V18, P194, DOI 10.1016/j.sbi.2007.12.012; MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157; MANNING GS, 1972, BIOPOLYMERS, V11, P937, DOI 10.1002/bip.1972.360110502; Mashimo T, 2013, HIGH PERF COMP S 201, P70; MIASKIEWICZ K, 1993, J AM CHEM SOC, V115, P1526, DOI 10.1021/ja00057a045; Nakamura H, 1996, Q REV BIOPHYS, V29, P1, DOI 10.1017/S0033583500005746; Ni B, 2011, J MOL MODEL, V17, P2883, DOI 10.1007/s00894-011-0975-x; Nina M, 2002, J PHYS CHEM B, V106, P3696, DOI 10.1021/jp013855m; Norberg J, 2002, ACCOUNTS CHEM RES, V35, P465, DOI 10.1021/ar010026a; Noy A, 2007, NUCLEIC ACIDS RES, V35, P3330, DOI 10.1093/nar/gkl1135; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; Pan YP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000448; Pande V, 2008, NUCLEIC ACIDS RES, V36, P1508, DOI 10.1093/nar/gkm1182; Pastor N, 2005, BIOPHYS J, V88, P3262, DOI 10.1529/biophysj.104.058339; Patra M, 2004, J PHYS CHEM B, V108, P4485, DOI 10.1021/jp031281a; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Roy S, 2010, J BIOMOL STRUCT DYN, V27, P443, DOI 10.1080/07391102.2010.10507329; Saenger W., 1984, PRINCIPLES NUCL ACID; SAITO M, 1994, J CHEM PHYS, V101, P4055, DOI 10.1063/1.468411; Sen S, 2001, J AM CHEM SOC, V123, P7414, DOI 10.1021/ja0032632; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Wang YL, 2007, BIOPHYS J, V92, P3063, DOI 10.1529/biophysj.106.092106; Wang ZL, 2011, J NANOSCI NANOTECHNO, V11, P8457, DOI 10.1166/jnn.2011.4994; Wolf D, 1999, J CHEM PHYS, V110, P8254, DOI 10.1063/1.478738; YORK DM, 1995, J AM CHEM SOC, V117, P5001, DOI 10.1021/ja00122a034	52	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76606	10.1371/journal.pone.0076606	http://dx.doi.org/10.1371/journal.pone.0076606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124577	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100134
J	Evans, C; Cook, SJ; Coleman, MP; Gilley, J				Evans, Catherine; Cook, Simon J.; Coleman, Michael P.; Gilley, Jonathan			MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK-ERK Signaling	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; NEURONAL SURVIVAL; SELF-DESTRUCTION; IN-VIVO; PATHWAY; WLD(S); IDENTIFICATION; ERK5/BMK1; SYNAPSES; REVEALS	Wallerian degeneration is delayed when sufficient levels of proteins with NMNAT activity are maintained within axons after injury. This has been proposed to form the basis of 'slow Wallerian degeneration' (Wld(S)), a neuroprotective phenotype conferred by an aberrant fusion protein, Wld(S). Proteasome inhibition also delays Wallerian degeneration, although much less robustly, with stabilization of NMNAT2 likely to play a key role in this mechanism. The pan-MEK inhibitor U0126 has previously been shown to reverse the axon-protective effects of proteasome inhibition, suggesting that MEK-ERK signaling plays a role in delayed Wallerian degeneration, in addition to its established role in promoting neuronal survival. Here we show that whilst U0126 can also reverse Wld(S)-mediated axon protection, more specific inhibitors of MEK1/2 and MEK5, PD184352 and BIX02189, have no significant effect on the delay to Wallerian degeneration in either situation, whether used alone or in combination. This suggests that an off-target effect of U0126 is responsible for reversion of the axon protective effects of Wld(S) expression or proteasome inhibition, rather than inhibition of MEK1/2-ERK1/2 or MEK5-ERK5 signaling. Importantly, this off-target effect does not appear to result in alterations in the stabilities of either Wld(S) or NMNAT2.	[Evans, Catherine; Cook, Simon J.; Coleman, Michael P.; Gilley, Jonathan] Babraham Inst, Signalling Programme, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Gilley, J (corresponding author), Babraham Inst, Signalling Programme, Cambridge, England.	jon.gilley@babraham.ac.uk		Cook, Simon/0000-0001-9087-1616	Synergy grant; Science Policy Committee of the Babraham Institute; BBSRC [BBS/E/B/000C0417, BBS/E/B/000C0419] Funding Source: UKRI; MRC [G1000702] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0417, BBS/E/B/0000C199, BBS/E/B/000C0419] Funding Source: researchfish; Medical Research Council [G1000702] Funding Source: researchfish	Synergy grant; Science Policy Committee of the Babraham Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Synergy grant awarded by the Science Policy Committee of the Babraham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Babetto E, 2010, J NEUROSCI, V30, P13291, DOI 10.1523/JNEUROSCI.1189-10.2010; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Bhattacharya MRC, 2012, J NEUROSCI, V32, P5054, DOI 10.1523/JNEUROSCI.4951-11.2012; Choi K, 2008, MOL PHARMACOL, V74, P527, DOI 10.1124/mol.107.044628; Cohen MS, 2012, CHEM BIOL, V19, P179, DOI 10.1016/j.chembiol.2012.01.012; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Gerdts J, 2011, J BIOL CHEM, V286, P28011, DOI 10.1074/jbc.M111.250472; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gilley R, 2012, CELL SIGNAL, V24, P170, DOI 10.1016/j.cellsig.2011.08.018; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Ikegami K, 2004, BRAIN RES, V1030, P81, DOI 10.1016/j.brainres.2004.09.050; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kitay BM, 2013, HUM MOL GENET, V22, P1601, DOI 10.1093/hmg/ddt009; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McCaw BJ, 2005, GENE, V345, P183, DOI 10.1016/j.gene.2004.11.011; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Xiong X, 2012, PLOS BIOL IN PRESS; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yung HW, 2004, BIOCHEM PHARMACOL, V68, P351, DOI 10.1016/j.bcp.2004.03.030; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76505	10.1371/journal.pone.0076505	http://dx.doi.org/10.1371/journal.pone.0076505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124570	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100127
J	Jamison, RA; Samarage, CR; Bryson-Richardson, RJ; Fouras, A				Jamison, R. Aidan; Samarage, Chaminda R.; Bryson-Richardson, Robert J.; Fouras, Andreas			In Vivo Wall Shear Measurements within the Developing Zebrafish Heart	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; BLOOD-FLOW; VERTEBRATE HEART; CHICKEN EMBRYOS; VELOCITY-FIELD; STRESS; PIV; ACCURACY	Physical forces can influence the embryonic development of many tissues. Within the cardiovascular system shear forces resulting from blood flow are known to be one of the regulatory signals that shape the developing heart. A key challenge in investigating the role of shear forces in cardiac development is the ability to obtain shear force measurements in vivo. Utilising the zebrafish model system we have developed a methodology that allows the shear force within the developing embryonic heart to be determined. Accurate wall shear measurement requires two essential pieces of information; high-resolution velocity measurements near the heart wall and the location and orientation of the heart wall itself. We have applied high-speed brightfield imaging to capture time-lapse series of blood flow within the beating heart between 3 and 6 days post-fertilization. Cardiac-phase filtering is applied to these time-lapse images to remove the heart wall and other slow moving structures leaving only the red blood cell movement. Using particle image velocimetry to calculate the velocity of red blood cells in different regions within the heart, and using the signal-to-noise ratio of the cardiac-phase filtered images to determine the boundary of blood flow, and therefore the position of the heart wall, we have been able to generate the necessary information to measure wall shear in vivo. We describe the methodology required to measure shear in vivo and the application of this technique to the developing zebrafish heart. We identify a reduction in shear at the ventricular-bulbar valve between 3 and 6 days post-fertilization and demonstrate that the shear environment of the ventricle during systole is constantly developing towards a more uniform level.	[Jamison, R. Aidan; Samarage, Chaminda R.; Fouras, Andreas] Monash Univ, Lab Dynam Imaging, Melbourne, Vic 3004, Australia; [Jamison, R. Aidan; Samarage, Chaminda R.; Fouras, Andreas] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Jamison, RA (corresponding author), Monash Univ, Lab Dynam Imaging, Melbourne, Vic 3004, Australia.	aidan.jamison@monash.edu	Fouras, Andreas/A-9410-2008; Bryson-Richardson, Robert/B-7556-2008	Fouras, Andreas/0000-0002-8933-1759; Bryson-Richardson, Robert/0000-0002-9501-8208	Australian Research Council Discovery Project [130100294]; NHMRC Career Development Fellowship [1022721]	Australian Research Council Discovery Project(Australian Research Council); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported under Australian Research Council Discovery Project number 130100294. A. F. is supported by NHMRC Career Development Fellowship (1022721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Bulwer B, 2009, ECHOCARDIOGRAPHY POC, P45; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Fouras A, 1998, EXP FLUIDS, V25, P409, DOI 10.1007/s003480050248; Fouras A, 2008, EXP FLUIDS, V44, P317, DOI 10.1007/s00348-007-0404-1; Fouras A, 2007, EXP FLUIDS, V42, P799, DOI 10.1007/s00348-007-0293-3; Fouras A, 2009, EXP FLUIDS, V47, P569, DOI 10.1007/s00348-009-0616-7; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Jamison RA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.036007; Ku JP, 2002, ANN BIOMED ENG, V30, P743, DOI 10.1114/1.1496086; Lee JY, 2007, PHYSIOL MEAS, V28, P1149, DOI 10.1088/0967-3334/28/10/002; Lu J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2830824; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Poelma C, 2008, EXP FLUIDS, V45, P703, DOI 10.1007/s00348-008-0476-6; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; Rosencranz R., 2006, PATHOL PATTERNS REV, V125, pS78; Sugii Y, 2002, PHYSIOL MEAS, V23, P403, DOI 10.1088/0967-3334/23/2/315; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246	23	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75722	10.1371/journal.pone.0075722	http://dx.doi.org/10.1371/journal.pone.0075722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124507	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100064
J	Zhang, WL; Muck-Hausl, M; Wang, JC; Sun, CB; Gebbing, M; Miskey, C; Ivics, Z; Izsvak, Z; Ehrhardt, A				Zhang, Wenli; Muck-Hausl, Martin; Wang, Jichang; Sun, Chuanbo; Gebbing, Maren; Miskey, Csaba; Ivics, Zoltan; Izsvak, Zsuzsanna; Ehrhardt, Anja			Integration Profile and Safety of an Adenovirus Hybrid-Vector Utilizing Hyperactive Sleeping Beauty Transposase for Somatic Integration	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; GENOMES IN-VITRO; GENE-THERAPY; HUMAN-CELLS; TRANSGENE EXPRESSION; MOUSE-LIVER; CHROMOSOMAL INTEGRATION; PHENOTYPIC CORRECTION; STABLE CORRECTION; MAMMALIAN-CELLS	We recently developed adenovirus/transposase hybrid-vectors utilizing the previously described hyperactive Sleeping Beauty (SB) transposase HSB5 for somatic integration and we could show stabilized transgene expression in mice and a canine model for hemophilia B. However, the safety profile of these hybrid-vectors with respect to vector dose and genotoxicity remains to be investigated. Herein, we evaluated this hybrid-vector system in C57Bl/6 mice with escalating vector dose settings. We found that in all mice which received the hyperactive SB transposase, transgene expression levels were stabilized in a dose-dependent manner and that the highest vector dose was accompanied by fatalities in mice. To analyze potential genotoxic side-effects due to somatic integration into host chromosomes, we performed a genome-wide integration site analysis using linker-mediated PCR (LM-PCR) and linear amplification-mediated PCR (LAM-PCR). Analysis of genomic DNA samples obtained from HSB5 treated female and male mice revealed a total of 1327 unique transposition events. Overall the chromosomal distribution pattern was close-to-random and we observed a random integration profile with respect to integration into gene and non-gene areas. Notably, when using the LM-PCR protocol, 27 extra-chromosomal integration events were identified, most likely caused by transposon excision and subsequent transposition into the delivered adenoviral vector genome. In total, this study provides a careful evaluation of the safety profile of adenovirus/Sleeping Beauty transposase hybrid-vectors. The obtained information will be useful when designing future preclinical studies utilizing hybrid-vectors in small and large animal models.	[Zhang, Wenli; Muck-Hausl, Martin; Ehrhardt, Anja] Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany; [Zhang, Wenli] Northwest Agr & Forestry Univ, Yangling, Peoples R China; [Wang, Jichang; Sun, Chuanbo; Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, Berlin, Germany; [Gebbing, Maren] Ruhr Univ Bochum, Bochum, Germany; [Miskey, Csaba; Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany; [Ehrhardt, Anja] Univ Witten Herdecke, Fac Hlth, Dept Human Med, Inst Virol & Microbiol,Ctr Biomed Educ & Res, Witten, Germany	University of Munich; Northwest A&F University - China; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruhr University Bochum; Paul Ehrlich Institute; Witten Herdecke University	Ehrhardt, A (corresponding author), Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany.	anja.ehrhardt@uni-wh.de	Miskey, Csaba/U-3473-2017	Izsvak, Zsuzsanna/0000-0002-2053-2384; Wang, Jichang/0000-0002-7027-0298; Schiwon, Maren/0000-0001-6570-1105; zhang, wenli/0000-0002-6243-6286	DFG [SPP 1230]; Wilhelm Sander-Foundation; EU Framework Programme 7 (Persistent Transgenesis); Friedrich-Baur-Foundation; Chinese Scholarship Council (CSC); Northwest A&F University, Yangling, China	DFG(German Research Foundation (DFG)); Wilhelm Sander-Foundation; EU Framework Programme 7 (Persistent Transgenesis); Friedrich-Baur-Foundation; Chinese Scholarship Council (CSC)(China Scholarship Council); Northwest A&F University, Yangling, China	This work was supported in part by DFG grant SPP 1230, the Wilhelm Sander-Foundation, EU Framework Programme 7 (Persistent Transgenesis), and the Friedrich-Baur-Foundation (A.E.). W.Z. was supported by a fellowship from the Chinese Scholarship Council (CSC) in cooperation with Northwest A&F University, Yangling, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Brunetti-Pierri N, 2008, GENE THER, V15, P553, DOI 10.1038/gt.2008.14; Brunetti-Pierri N, 2005, HUM GENE THER, V16, P811, DOI 10.1089/hum.2005.16.811; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Chuah MKL, 2004, SEMIN THROMB HEMOST, V30, P249, DOI 10.1055/s-2004-825638; Das RK, 2007, J APPL TOXICOL, V27, P527, DOI 10.1002/jat.1230; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; Ehrhardt A, 2007, MOL THER, V15, P146, DOI 10.1038/sj.mt.6300011; Galla M, 2011, NUCLEIC ACIDS RES, V39, P7147, DOI 10.1093/nar/gkr384; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hausl M, 2011, CURR GENE THER, V11, P363; Hausl MA, 2010, MOL THER, V18, P1896, DOI 10.1038/mt.2010.169; Hillgenberg M, 2001, J VIROL, V75, P9896, DOI 10.1128/JVI.75.20.9896-9908.2001; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huang X, 2010, HUM GENE THER, V21, P1577, DOI 10.1089/hum.2009.138; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jager L, 2007, CURR GENE THER, V7, P272; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Jager L, 2009, HUM GENE THER, V20, P883, DOI 10.1089/hum.2009.020; Jiang ZL, 2004, MOL THER, V10, P688, DOI 10.1016/j.ymthe.2004.07.020; Kato K, 2005, NUCLEIC ACIDS RES, V33, pD533; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kubo S, 2011, MOL THER, V19, P76, DOI 10.1038/mt.2010.182; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Nakai H, 2005, J VIROL, V79, P3606, DOI 10.1128/JVI.79.6.3606-3614.2005; Oka K, 2001, CIRCULATION, V103, P1274; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Puntel M, 2006, HUM GENE THER, V17, P531, DOI 10.1089/hum.2006.17.531; Recchia A, 2004, MOL THER, V10, P660, DOI 10.1016/j.ymthe.2004.07.003; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Schiedner G, 2003, HUM GENE THER, V14, P1631, DOI 10.1089/104303403322542275; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Soifer H, 2002, MOL THER, V5, P599, DOI 10.1006/mthe.2002.0586; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Stephen SL, 2008, J GENE MED, V10, P1176, DOI 10.1002/jgm.1246; Toietta G, 2003, MOL THER, V7, P649, DOI 10.1016/S1525-0016(03)00059-5; Vink CA, 2009, MOL THER, V17, P1197, DOI 10.1038/mt.2009.94; Wang HJ, 2006, J VIROL, V80, P11699, DOI 10.1128/JVI.00779-06; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2004, MOL CELL BIOL, V24, P9239, DOI 10.1128/MCB.24.20.9239-9247.2004; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yant SR, 2003, MOL CELL BIOL, V23, P8505, DOI 10.1128/MCB.23.23.8505-8518.2003; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089	53	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75344	10.1371/journal.pone.0075344	http://dx.doi.org/10.1371/journal.pone.0075344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124483	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000325489100040
J	Zhao, JF; Chen, HH; Ojcius, DM; Zhao, X; Sun, D; Ge, YM; Zheng, LL; Lin, XA; Li, LJ; Yan, J				Zhao, Jing-Fang; Chen, Hong-Hu; Ojcius, David M.; Zhao, Xin; Sun, Dexter; Ge, Yu-Mei; Zheng, Lin-Li; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie			Identification of Leptospira interrogans Phospholipase C as a Novel Virulence Factor Responsible for Intracellular Free Calcium Ion Elevation during Macrophage Death	PLOS ONE			English	Article							CELL-DEATH; APOPTOSIS; ACTIVATION; INFECTION; PROTEIN; ENTRY; PATHOGENESIS; EXPRESSION; IMMUNITY; SUBTYPES	Background: Leptospira-induced macrophage death has been confirmed to play a crucial role in pathogenesis of leptospirosis, a worldwide zoonotic infectious disease. Intracellular free Ca2+ concentration ([Ca2+](i)) elevation induced by infection can cause cell death, but [Ca2+](i) changes and high [Ca2+](i)-induced death of macrophages due to infection of Leptospira have not been previously reported. Methodology/Principal Findings: We first used a Ca2+-specific fluorescence probe to confirm that the infection of L. interrogans strain Lai triggered a significant increase of [Ca2+](i) in mouse J774A.1 or human THP-1 macrophages. Laser confocal microscopic examination showed that the [Ca2+](i) elevation was caused by both extracellular Ca2+ influx through the purinergic receptor, P2X7, and Ca2+ release from the endoplasmic reticulum, as seen by suppression of [Ca2+](i) elevation when receptor-gated calcium channels were blocked or P2X7 was depleted. The LB361 gene product of the spirochete exhibited phosphatidylinositol phospholipase C (L-PI-PLC) activity to hydrolyze phosphatidylinositol-4,5-bisphosphate (PIP2) into inositol-1,4,5-trisphosphate (IP3), which in turn induces intracellular Ca2+ release from endoplasmic reticulum, with the Km of 199 mu M and Kcat of 8.566E-5 S-1. Secretion of L-PI-PLC from the spirochete into supernatants of leptospire-macrophage co-cultures and cytosol of infected macrophages was also observed by Western Blot assay. Lower [Ca2+](i) elevation was induced by infection with a LB361-deficient leptospiral mutant, whereas transfection of the LB361 gene caused a mild increase in [Ca2+](i). Moreover, PI-PLCs (PI-PLC-beta 3 and PI-PLC-gamma 1) of the two macrophages were activated by phosphorylation during infection. Flow cytometric detection demonstrated that high [Ca2+](i) increases induced apoptosis and necrosis of macrophages, while mild [Ca2+](i) elevation only caused apoptosis. Conclusions/Significance: This study demonstrated that L. interrogans infection induced [Ca2+](i) elevation through extracellular Ca2+ influx and intracellular Ca2+ release cause macrophage apoptosis and necrosis, and the LB361 gene product was shown to be a novel PI-PLC of L. interrogans responsible for the [Ca2+](i) elevation.	[Zhao, Jing-Fang; Ge, Yu-Mei; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Jing-Fang; Chen, Hong-Hu; Zhao, Xin; Ge, Yu-Mei; Zheng, Lin-Li; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Jing-Fang] Zhejiang Prov Hosp Tradit Chinese Med, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Dept Mol Cell Biol, Merced, CA USA; [Sun, Dexter] Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Neurol, New York, NY 10021 USA; [Sun, Dexter] Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Neurosci, New York, NY 10021 USA; [Sun, Dexter] Cornell Univ, Weill Med Coll, Hosp Special Surg, New York, NY 10021 USA	Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; University of California System; University of California Merced; University of California System; University of California Merced; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [81171534, 81261160321]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China [2010ZZ09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China	This work was supported by grants (81171534 and 81261160321) from the National Natural Science Foundation of China and a grant (2010ZZ09) from the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Carrillo-Casas EM, 2008, CURR MICROBIOL, V56, P539, DOI 10.1007/s00284-008-9096-x; Cerella Claudia, 2010, Int J Cell Biol, V2010, P546163, DOI 10.1155/2010/546163; Chen W, 2009, BIOCHEMISTRY-US, V48, P3578, DOI 10.1021/bi802312d; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Dong HY, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-223; Durban MA, 2007, EUR J LIPID SCI TECH, V109, P469, DOI 10.1002/ejlt.200700027; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hotez PJ, 2011, INT J INFECT DIS, V15, pE611, DOI 10.1016/j.ijid.2011.05.006; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Hu WL, 2013, CELL MICROBIOL, V15, P1624, DOI 10.1111/cmi.12141; Jin DD, 2009, INFECT IMMUN, V77, P799, DOI 10.1128/IAI.00914-08; Kim DH, 2012, J INFECT DIS, V205, P445, DOI 10.1093/infdis/jir765; Lemos JR, 2012, CELL CALCIUM, V51, P284, DOI 10.1016/j.ceca.2012.01.008; Lennartz MR, 1999, INT J BIOCHEM CELL B, V31, P415, DOI 10.1016/S1357-2725(98)00108-3; Li SJ, 2010, INNATE IMMUN-LONDON, V16, P80, DOI 10.1177/1753425909105580; Liu YY, 2007, MED MICROBIOL IMMUN, V196, P233, DOI 10.1007/s00430-007-0047-0; Lo YC, 2011, EMERG INFECT DIS, V17, P1145, DOI [10.3201/eid1706.100980, 10.3201/eid/1706.100980]; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; Meites E, 2004, EMERG INFECT DIS, V10, P406, DOI 10.3201/eid1003.030431; Meng HW, 2007, INT J DEV NEUROSCI, V25, P509, DOI 10.1016/j.ijdevneu.2007.09.010; Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997; Nakano T, 2006, CARDIOVASC RES, V69, P908, DOI 10.1016/j.cardiores.2005.11.023; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Nomikos M, 2011, J CELL SCI, V124, P2582, DOI 10.1242/jcs.083485; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Putney JW, 2001, J CELL SCI, V114, P2223; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002; Saha S, 2005, TOXICON, V45, P361, DOI 10.1016/j.toxicon.2004.11.007; Schreier S, 2009, BIOL RES, V42, P5, DOI [10.4067/S0716-97602009000100001, /S0716-97602009000100001]; Smaili SS, 2000, J BIOENERG BIOMEMBR, V32, P35, DOI 10.1023/A:1005508311495; Strege PR, 2005, AM J PHYSIOL-GASTR L, V289, pG249, DOI 10.1152/ajpgi.00022.2005; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025432; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Vijayachari P, 2008, J BIOSCIENCES, V33, P557, DOI 10.1007/s12038-008-0074-z; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; WANG B, 1984, INFECT IMMUN, V46, P809, DOI 10.1128/IAI.46.3.809-813.1984; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042266; Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Yang T, 2007, J BIOL CHEM, V282, P37471, DOI 10.1074/jbc.M701379200; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang CL, 2012, MICROBES INFECT, V14, P317, DOI 10.1016/j.micinf.2011.11.007; Zhang L, 2012, MOL MICROBIOL, V83, P1006, DOI 10.1111/j.1365-2958.2012.07985.x	63	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75652	10.1371/journal.pone.0075652	http://dx.doi.org/10.1371/journal.pone.0075652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124502	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100059
J	Nelder, MP; Russell, C; Williams, D; Johnson, K; Li, L; Baker, SL; Marshall, S; Bhanich-Supapol, W; Pillai, DR; Ralevski, F				Nelder, Mark P.; Russell, Curtis; Williams, Dawn; Johnson, Karen; Li, Lennon; Baker, Stacey L.; Marshall, Sean; Bhanich-Supapol, Wendy; Pillai, Dylan R.; Ralevski, Filip			Spatiotemporal Dynamics and Demographic Profiles of Imported Plasmodium falciparum and Plasmodium vivax Infections in Ontario, Canada (1990-2009)	PLOS ONE			English	Article							UNITED-STATES; RISK GROUPS; MALARIA; SURVEILLANCE; PATTERNS; CHEMOPROPHYLAXIS; TRANSMISSION	We examined malaria cases reported to Ontario's public health surveillance systems from 1990 through 2009 to determine how temporal scale (longitudinal, seasonal), spatial scale (provincial, health unit), and demography (gender, age) contribute to Plasmodium infection in Ontario travellers. Our retrospective study included 4,551 confirmed cases of imported malaria reported throughout Ontario, with additional analysis at the local health unit level (i.e., Ottawa, Peel, and Toronto). During the 20-year period, Plasmodium vivax accounted for 50.6% of all cases, P. falciparum (38.6%), Plasmodium sp. (6.0%), P. ovale (3.1%), and P. malariae (1.8%). During the first ten years of the study (1990-1999), P. vivax (64% of all cases) was the dominant agent, followed by P. falciparum (28%); however, during the second ten years (2000-2009) the situation reversed and P. falciparum (55%) dominated, followed by P. vivax (30%). The prevalence of P. falciparum and P. vivax cases varied spatially (e.g., P. falciparum more prevalent in Toronto, P. vivax more prevalent in Peel), temporally (e.g. P. falciparum incidence increased during the 20-year study), and demographically (e.g. preponderance of male cases). Infection rates per 100,000 international travellers were estimated: rates of infection were 2x higher in males compared to females; rates associated with travel to Africa were 37x higher compared to travel to Asia and 126x higher compared to travel to the Americas; rates of infection were 2.3-3.5x higher in June and July compared to October through March; and rates of infection were highest in those 65-69 years old. Where exposure country was reported, 71% of P. falciparum cases reported exposure in Ghana or Nigeria and 63% of P. vivax cases reported exposure in India. Our study provides insights toward improving pre-travel programs for Ontarians visiting malaria-endemic regions and underscores the changing epidemiology of imported malaria in the province.	[Nelder, Mark P.; Russell, Curtis] Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis, Communicable Dis Prevent & Control, Toronto, ON, Canada; [Williams, Dawn; Johnson, Karen] Publ Hlth Ontario, Surveillance Serv, Communicable Dis Prevent & Control, Toronto, ON, Canada; [Li, Lennon; Marshall, Sean] Publ Hlth Ontario, Analyt Serv, Knowledge Serv, Toronto, ON, Canada; [Baker, Stacey L.] Minist Environm, Toronto, ON, Canada; [Bhanich-Supapol, Wendy] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Pillai, Dylan R.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Ralevski, Filip] Publ Hlth Ontario, Parasitol, Publ Hlth Ontario Lab Toronto, Toronto, ON, Canada	McMaster University; University of Calgary	Nelder, MP (corresponding author), Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis, Communicable Dis Prevent & Control, Toronto, ON, Canada.	mark.nelder@oahpp.ca						Al-Tawfiq JA, 2006, SAUDI MED J, V27, P86; [Anonymous], 2012, STRATEGIC ACTION PLA; Baas MC, 2006, J TRAVEL MED, V13, P2, DOI 10.1111/j.1708-8305.2006.00003.x; Berang-Ford L, 2009, INTERDISC PERSPECT I; Casalino E, 2002, ARCH INTERN MED, V162, P1625, DOI 10.1001/archinte.162.14.1625; Chadee DD, 1999, AM J TROP MED HYG, V61, P513, DOI 10.4269/ajtmh.1999.61.513; Charles DM, 2005, MED J AUSTRALIA, V182, P164, DOI 10.5694/j.1326-5377.2005.tb06646.x; Committee to Advise on Tropical Medicine and Travel (CATMAT), 2009, Can Commun Dis Rep, V35 Suppl 1, P1; Eckhardt R, 2012, EMERG INFECT DIS, V18, P775, DOI 10.3201/eid1805.110602; European Centre for Disease Prevention and Control, 2011, RAP RISK ASS AUT PLA; Garcia LS, 2007, DIAGNOSTIC MED PARAS, V5th; Khairnar K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-284; Lee CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060751; Legros F, 1998, Euro Surveill, V3, P45; Legros F, 2007, EMERG INFECT DIS, V13, P883, DOI 10.3201/eid1305.060955; MacLean JD, 2004, EMERG INFECT DIS, V10, P1195; Mali Sonja, 2011, Morbidity and Mortality Weekly Report, V60, P1; Ministry of Health and Long-Term Care, 2012, CAN COMM HLTH SURV 2; Ministry of Health and Long-term Care, 2013, INF DIS PROT; Miura T, 2005, AM J TROP MED HYG, V73, P599, DOI 10.4269/ajtmh.2005.73.599; Muentener P, 1999, B WORLD HEALTH ORGAN, V77, P560; Millet JP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-56; Rahman S, 1995, SOC SCI MED, V42, P1433; REUBEN R, 1993, SOC SCI MED, V37, P473, DOI 10.1016/0277-9536(93)90282-9; Romi R, 2001, Euro Surveill, V6, P143; Schlagenhauf P, 2008, CLIN MICROBIOL REV, V21, P466, DOI 10.1128/CMR.00059-07; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Statistics Canada, 2007, 006 CENS REL TOP; Statistics Canada, 2013, INT TRAV CHRON IND; Statistics Canada, 2013, NUMB INT TRAV ENT RE; Statistics Canada, 2013, NUMB NONP RES AG GRO; Statistics Canada, 2013, NUMB NONR TRAV ENT C; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2012, INT TRAV HLTH 2012 C; World Health Organization, 2007, A6012 WHO; World Trade Organization, 2011, TOUR HIGHL; Wylie WNT, 1983, LABOUR-TRAVAIL, V11, P7, DOI [10.2307/25140199, DOI 10.2307/25140199]; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zucker JR, 1996, EMERG INFECT DIS, V2, P37, DOI 10.3201/eid0201.960104	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76208	10.1371/journal.pone.0076208	http://dx.doi.org/10.1371/journal.pone.0076208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098780	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500150
J	Belkin, DA; Chen, J; Mo, JL; Rosoff, JS; Goldenberg, S; Poppas, DP; Krueger, JG; Herschman, M; Mitsui, H; Felsen, D; Carucci, JA				Belkin, Daniel A.; Chen, Jie; Mo, Jonathan L.; Rosoff, James S.; Goldenberg, Sagit; Poppas, Dix P.; Krueger, James G.; Herschman, Miriam; Mitsui, Hiroshi; Felsen, Diane; Carucci, John A.			An Animal Explant Model for the Study of Human Cutaneous Squamous Cell Carcinoma	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL; NUDE RATS; CANCER; TRANSFORMATION; METASTASIS; APOPTOSIS; MIGRATION; INVASION	We established a human tissue explant model to facilitate study of cutaneous squamous cell carcinoma. We accomplished this by implanting debulked SCC, from surgical discard, into nude rats. Human SCC remained viable and continued to proliferate for at least 4 weeks and showed evidence of neovascularization. At 4 weeks, SCC implants showed a trend toward increased PCNA positive cells compared to fresh SCC cells/mm(2) tissue) supporting continued proliferation throughout engraftment. Von Willebrand's Factor (VWF) positive cells were found within implants and likely represented rat vessel neovascularization. Human Langerhans' (Langerin+) cells, but no T cells (CD3+, CD8+, FoxP3+), macrophages (CD163), or NK cells (NKp46), were present in SCC implants at 4 weeks. These findings support the possibility that LCs fail to migrate from cutaneous SCC and thus contribute to lack of effective antitumor response. Our findings also provide a novel model system for further study of primary cutaneous SCC.	[Belkin, Daniel A.] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [Chen, Jie; Mo, Jonathan L.; Rosoff, James S.; Goldenberg, Sagit; Poppas, Dix P.; Felsen, Diane] Weill Cornell Med Coll, Dept Urol, Inst Pediat Urol, New York, NY USA; [Krueger, James G.; Mitsui, Hiroshi] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Herschman, Miriam; Carucci, John A.] NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA	Cornell University; Cornell University; Rockefeller University; New York University; NYU Langone Medical Center	Carucci, JA (corresponding author), NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA.	john.carucci@nyumc.org		carucci, john/0000-0001-6817-9439	Dana Foundation Human Immunology Consortium Grant	Dana Foundation Human Immunology Consortium Grant	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were funded in part by the Dana Foundation Human Immunology Consortium Grant.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bao A, 2006, OTOLARYNG HEAD NECK, V135, P853, DOI 10.1016/j.otohns.2006.06.1257; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Billings SD, 2003, AM J PATHOL, V163, P2451, DOI 10.1016/S0002-9440(10)63600-0; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FIEBIG HH, 1989, STRAHLENTHER ONKOL, V165, P522; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fujita H, 2012, J INVEST DERMATOL, V132, P1645, DOI 10.1038/jid.2012.34; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Karia PS, 2013, J AM ACAD DERMATOL; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kriehuber E, 2005, BLOOD, V106, P175, DOI 10.1182/blood-2004-08-3072; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Moussai D, 2011, J INVEST DERMATOL, V131, P229, DOI 10.1038/jid.2010.266; Park YW, 2005, CLIN CANCER RES, V11, P1963, DOI 10.1158/1078-0432.CCR-04-1665; Petratos PB, 2003, PLAST RECONSTR SURG, V111, P1988, DOI 10.1097/01.PRS.0000056831.87062.4B; Pettersen JS, 2011, J INVEST DERMATOL; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Smith LP, 2006, INT J CANCER, V118, P2111, DOI 10.1002/ijc.21694; Vishwanath M, 2006, J INVEST DERMATOL, V126, P2452, DOI 10.1038/sj.jid.5700448; Weinberg AS, 2007, DERMATOL SURG, V33, P885, DOI 10.1111/j.1524-4725.2007.33190.x; Weinberg RA, 2008, NAT GENET, V40, P494, DOI 10.1038/ng0508-494; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76156	10.1371/journal.pone.0076156	http://dx.doi.org/10.1371/journal.pone.0076156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116092	Green Submitted, Green Published, gold			2022-12-27	WOS:000325552200049
J	Bernhard, W; Barreto, K; Raithatha, S; Sadowski, I				Bernhard, Wendy; Barreto, Kris; Raithatha, Sheetal; Sadowski, Ivan			An Upstream YY1 Binding Site on the HIV-1 LTR Contributes to Latent Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; TRANSCRIPTION FACTOR YY1; CD4(+) T-CELLS; INTEGRATED HIV-1; REGULATES INDUCTION; FOLLOW-UP; TFII-I; PROMOTER; ESTABLISHMENT	During HIV-1 infection a population of latently infected cells is established. This population is the major obstacle preventing total eradication of the virus from AIDS patients. HIV-1 latency is thought to arise by various mechanisms including repressive chromatin modifications. Transcription factors such as YY1 have been shown to facilitate repressive chromatin modifications by the recruitment of histone deacetylases. In this study, we identified a novel binding site for YY1 on the HIV-1 LTR, 120 nucleotides upstream of the transcription start site. We show that YY1 can bind to this site in vitro and in vivo and that binding to the LTR is dissociated upon T cell activation. Overexpression of YY1 causes an increase in the proportion of cells that produce latent infections. These observations, in combination with previous results, demonstrate that YY1 plays a prominent role in controlling the establishment and maintenance of latent HIV-1 provirus in unstimulated cells.	[Bernhard, Wendy; Barreto, Kris; Raithatha, Sheetal; Sadowski, Ivan] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Sadowski, I (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	ijs.ubc@gmail.com			Canadian Institutes for Health Research Operating Grant [HOP-120237]	Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institutes for Health Research Operating Grant HOP-120237 (to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; BAUKNECHT T, 1992, EMBO J, V11, P4607, DOI 10.1002/j.1460-2075.1992.tb05563.x; Bell B, 1996, ONCOGENE, V13, P2687; Bernhard W, 2011, FEBS LETT, V585, P3549, DOI 10.1016/j.febslet.2011.10.018; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Dahabieh MS, 2011, VIROLOGY, V418, P57, DOI 10.1016/j.virol.2011.07.002; Donahue DA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-11; Donahue DA, 2012, J VIROL, V86, P3253, DOI 10.1128/JVI.06648-11; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Guerrero MLF, 2005, CLIN INFECT DIS, V41, P390, DOI 10.1086/431487; HAHN S, 1992, Current Biology, V2, P152, DOI 10.1016/0960-9822(92)90268-F; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; Kolesnitchenko V, 1997, J VIROL, V71, P9753, DOI 10.1128/JVI.71.12.9753-9763.1997; Li XD, 1996, VIROLOGY, V225, P196, DOI 10.1006/viro.1996.0588; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; LIU R, 1994, NUCLEIC ACIDS RES, V22, P2453, DOI 10.1093/nar/22.13.2453; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Malcolm T, 2007, VIRUS GENES, V35, P215, DOI 10.1007/s11262-007-0109-9; Malcolm T, 2008, FEBS LETT, V582, P3903, DOI 10.1016/j.febslet.2008.10.032; MARGOLIS DM, 1994, J VIROL, V68, P905, DOI 10.1128/JVI.68.2.905-910.1994; Matalon S, 2011, MOL MED, V17, P466, DOI 10.2119/molmed.2011.00076; MOMOEDA M, 1994, J VIROL, V68, P7159, DOI 10.1128/JVI.68.11.7159-7168.1994; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Romerio F, 1997, J VIROL, V71, P9375, DOI 10.1128/JVI.71.12.9375-9382.1997; Sadowski I, 2008, CURR HIV RES, V6, P286, DOI 10.2174/157016208785132563; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shishido T, 2012, J VIROL, V86, P9055, DOI 10.1128/JVI.00793-12; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Song SK, 1996, VIROLOGY, V225, P377, DOI 10.1006/viro.1996.0612; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zalani S, 1997, J VIROL, V71, P3268, DOI 10.1128/JVI.71.4.3268-3274.1997	46	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77052	10.1371/journal.pone.0077052	http://dx.doi.org/10.1371/journal.pone.0077052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116200	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200096
J	Jiang, WD; Huang, RC; Duan, CH; Fu, LW; Xi, Y; Yang, YB; Yang, WM; Yang, DZ; Yang, DH; Huang, RP				Jiang, Weidong; Huang, Ruochun; Duan, Chaohui; Fu, Liwu; Xi, Yun; Yang, Yuebo; Yang, Wei-Min; Yang, Dongzi; Yang, Dong-Hua; Huang, Ruo-Pan			Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; BREAST-CANCER; OSTEOPROTEGERIN OPG; EXPRESSION; GROWTH; CELLS; BETA; BIOMARKERS; RECEPTOR; TUMOR	Background: Protein and antibody arrays have emerged as a promising technology to study protein expression and protein function in a high-throughput manner. These arrays also represent a new opportunity to profile protein expression levels in cancer patients' samples and to identify useful biosignatures for clinical diagnosis, disease classification, prediction, drug development and patient care. We applied antibody arrays to discover a panel of proteins which may serve as biomarkers to distinguish between patients with ovarian cancer and normal controls. Methodology/Principal Findings: Using a case-control study design of 34 ovarian cancer patients and 53 age-matched healthy controls, we profiled the expression levels of 174 proteins using antibody array technology and determined the CA125 level using ELISA. The expression levels of those proteins were analyzed using 3 discriminant methods, including artificial neural network, classification tree and split-point score analysis. A panel of 5 serum protein markers (MSP-alpha, TIMP-4, PDGF-R alpha, and OPG and CA125) was identified, which could effectively detect ovarian cancer with high specificity (95%) and high sensitivity (100%), with AUC = 0.98, while CA125 alone had an AUC of 0.87. Conclusions/Significance: Our pilot study has shown the promising set of 5 serum markers for ovarian cancer detection.	[Jiang, Weidong; Huang, Ruochun; Huang, Ruo-Pan] RayBiotech Inc, Norcross, GA USA; [Huang, Ruochun; Huang, Ruo-Pan] RayBiotech Inc, Guangzhou, Guangdong, Peoples R China; [Duan, Chaohui] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China; [Fu, Liwu] Sun Yat Sen Univ, Affiliated Canc Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Xi, Yun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yuebo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Wei-Min] Wuxi Maternal & Child Hlth Hosp, Dept Gynecol, Wuxi, Peoples R China; [Yang, Dongzi] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Dong-Hua] Fox Chase Canc Ctr, Biosample Repository, Philadelphia, PA 19111 USA; [Huang, Ruo-Pan] South China Biochip Res Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Fox Chase Cancer Center	Huang, RP (corresponding author), RayBiotech Inc, Norcross, GA USA.	rhuang@raybiotech.com	Yang, Wei/GWV-4107-2022; Fu, Liwu/AAE-8835-2020; Yang, Wei/HIA-0360-2022		RayBiotech Biomarker Discovery Pilot Grant; leading scientist project for Guangzhou economic development district [2009L-P180]; Program of hundred leading innovators and entrepreneurs [LCY201111]; Guangdong innovative research team program [201001s0104659419]; Guangzhou economic development district [2010Q-P450]	RayBiotech Biomarker Discovery Pilot Grant; leading scientist project for Guangzhou economic development district; Program of hundred leading innovators and entrepreneurs; Guangdong innovative research team program; Guangzhou economic development district	The work was in part supported by RayBiotech Biomarker Discovery Pilot Grant. The authors would like to express their thanks for the support of the leading scientist project for Guangzhou economic development district (2009L-P180); Program of hundred leading innovators and entrepreneurs (LCY201111); Guangdong innovative research team program (201001s0104659419), and research grants from the Guangzhou economic development district (2010Q-P450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Apte SM, 2004, GYNECOL ONCOL, V93, P78, DOI 10.1016/j.ygyno.2003.12.041; Badgwell D, 2007, DIS MARKERS, V23, P397, DOI 10.1155/2007/309382; Bandera CA, 2003, CURR OPIN OBSTET GYN, V15, P51, DOI 10.1097/00001703-200302000-00008; CARLSON KJ, 1994, ANN INTERN MED, V121, P124, DOI 10.7326/0003-4819-121-2-199407150-00009; Chen L, 2011, INT J BIOL MARKER, V26, P108, DOI 10.5301/JBM.2011.8322; Corey E, 2005, CANCER RES, V65, P1710, DOI 10.1158/0008-5472.CAN-04-2033; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Fisher JL, 2006, CANCER RES, V66, P3620, DOI 10.1158/0008-5472.CAN-05-3119; Fjallskog ML, 2007, ACTA ONCOL, V46, P741, DOI 10.1080/02841860601048388; Fu OY, 2009, ANTICANCER RES, V29, P3131; Gentry-Maharaj A, 2012, BEST PRACT RES CL OB, V26, P243, DOI 10.1016/j.bpobgyn.2011.11.006; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Holen I, 2002, CANCER RES, V62, P1619; Huang RP, 2001, J IMMUNOL METHODS, V255, P1, DOI 10.1016/S0022-1759(01)00394-5; Huang RP, 2003, COMB CHEM HIGH T SCR, V6, P769; Huang Ruochun, 2010, Cancer Genomics & Proteomics, V7, P129; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Kobayashi E, 2012, CANCER EPIDEM BIOMAR, V21, P1902, DOI 10.1158/1055-9965.EPI-12-0646; Lane D, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-34; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Madsen Christine Vestergaard, 2012, Patholog Res Int, V2012, P851432, DOI 10.1155/2012/851432; MARKOWSKA J, 1992, European Journal of Gynaecological Oncology, V13, P360; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Neville-Webbe HL, 2004, BREAST CANCER RES TR, V86, P269; Ripley D, 2006, INT J GYNECOL CANCER, V16, P1794, DOI 10.1111/j.1525-1438.2006.00714.x; SCHWARTZ PE, 1995, ANN MED, V27, P519, DOI 10.3109/07853899509002463; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	30	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76795	10.1371/journal.pone.0076795	http://dx.doi.org/10.1371/journal.pone.0076795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116163	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200072
J	Kimura, Y; Fujita, Y; Shibata, K; Mori, M; Yamashita, T				Kimura, Yuriko; Fujita, Yuki; Shibata, Kumi; Mori, Megumi; Yamashita, Toshihide			Sigma-1 Receptor Enhances Neurite Elongation of Cerebellar Granule Neurons via TrkB Signaling	PLOS ONE			English	Article							BRAIN; NEUROTROPHINS; ACTIVATION; CHAPERONES; OUTGROWTH	Sigma-1 receptor (Sig-1R) is an integral membrane protein predominantly expressed in the endoplasmic reticulum. Sig-1R demonstrates a high affinity to various synthetic compounds including well-known psychotherapeutic drugs in the central nervous system (CNS). For that, it is considered as an alternative target for psychotherapeutic drugs. On the cellular level, when Sig-1R is activated, it is known to play a role in neuroprotection and neurite elongation. These effects are suggested to be mediated by its ligand-operated molecular chaperone activity, and/or upregulation of various Ca2+ signaling. In addition, recent studies show that Sig-1R activation induces neurite outgrowth via neurotrophin signaling. Here, we tested the hypothesis that Sig-1R activation promotes neurite elongation through activation of tropomyosin receptor kinase (Trk), a family of neurotrophin receptors. We found that 2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate (PRE-084), a selective Sig-1R agonist, significantly promoted neurite outgrowth, and K252a, a Trk inhibitor, attenuated Sig-1R-mediated neurite elongation in cerebellar granule neurons (CGNs). Moreover, we revealed that Sig-1R interacts with TrkB, and PRE-084 treatment enhances phosphorylation of Y515, but not Y706. Thus, our results indicate that Sig-1R activation promotes neurite outgrowth in CGNs through Y515 phosphorylation of TrkB.	[Kimura, Yuriko; Fujita, Yuki; Shibata, Kumi; Mori, Megumi; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Kimura, Yuriko; Fujita, Yuki; Yamashita, Toshihide] CREST, JST, Chiyoda Ku, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018; Mori, Megumi/0000-0002-4810-5480	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant for Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Fobian K, 2010, J NEUROSCI RES, V88, P1170, DOI 10.1002/jnr.22285; Fujita Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.85; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Guzman-Lenis MS, 2009, NEUROSCIENCE, V162, P31, DOI 10.1016/j.neuroscience.2009.03.067; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hayashi T, 2010, J PHARMACOL EXP THER, V332, P1054, DOI 10.1124/jpet.109.159244; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ishikawa M, 2007, BIOL PSYCHIAT, V62, P878, DOI 10.1016/j.biopsych.2007.04.001; Ishikawa M, 2010, J RECEPT LIGAND CH R, V3, P25; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kim HW, 2008, BRIT J PHARMACOL, V154, P1125, DOI 10.1038/bjp.2008.159; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; Martin WR, 1967, J PHARMACOL EXP THER, V197, P517; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; Yagasaki Y, 2006, J BIOL CHEM, V281, P12941, DOI 10.1074/jbc.M508157200; Zamanillo D, 2000, NEUROSCI LETT, V282, P169, DOI 10.1016/S0304-3940(00)00884-3	28	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75760	10.1371/journal.pone.0075760	http://dx.doi.org/10.1371/journal.pone.0075760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116072	Green Published, gold, Green Submitted			2022-12-27	WOS:000325552200037
J	Ou, CQ; Song, YF; Yang, J; Chau, PYK; Yang, L; Chen, PY; Wong, CM				Ou, Chun-Quan; Song, Yun-Feng; Yang, Jun; Chau, Patsy Yuen-Kwan; Yang, Lin; Chen, Ping-Yan; Wong, Chit-Ming			Excess Winter Mortality and Cold Temperatures in a Subtropical City, Guangzhou, China	PLOS ONE			English	Article							HEART-DISEASE MORTALITY; AMBIENT-TEMPERATURE; SEASONAL-VARIATIONS; RISK; DEATHS; CITIES; DEPRIVATION; POPULATION; WEATHER; BRITAIN	Background: A significant increase in mortality was observed during cold winters in many temperate regions. However, there is a lack of evidence from tropical and subtropical regions, and the influence of ambient temperatures on seasonal variation of mortality was not well documented. Methods: This study included 213,737 registered deaths from January 2003 to December 2011 in Guangzhou, a subtropical city in Southern China. Excess winter mortality was calculated by the excess percentage of monthly mortality in winters over that of non-winter months. A generalized linear model with a quasi-Poisson distribution was applied to analyze the association between monthly mean temperature and mortality, after controlling for other meteorological measures and air pollution. Results: The mortality rate in the winter was 26% higher than the average rate in other seasons. On average, there were 1,848 excess winter deaths annually, with around half (52%) from cardiovascular diseases and a quarter (24%) from respiratory diseases. Excess winter mortality was higher in the elderly, females and those with low education level than the young, males and those with high education level, respectively. A much larger winter increase was observed in out-of-hospital mortality compared to in-hospital mortality (45% vs. 17%). We found a significant negative correlation of annual excess winter mortality with average winter temperature (r(s)=-0.738, P=0.037), but not with air pollution levels. A 1 C decrease in monthly mean temperature was associated with an increase of 1.38% (95% CI: 0.34%-2.40%) and 0.88% (95% CI: 0.11%-1.64%) in monthly mortality at lags of 0-1 month, respectively. Conclusion: Similar to temperate regions, a subtropical city Guangzhou showed a clear seasonal pattern in mortality, with a sharper spike in winter. Our results highlight the role of cold temperature on the winter mortality even in warm climate. Precautionary measures should be strengthened to mitigate cold-related mortality for people living in warm climate.	[Ou, Chun-Quan; Yang, Jun; Chen, Ping-Yan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Song, Yun-Feng] Guangdong 2 Prov Peoples Hosp, Intens Care Unit, Guangzhou, Guangdong, Peoples R China; [Chau, Patsy Yuen-Kwan; Yang, Lin; Wong, Chit-Ming] Univ Hong Kong, Dept Community Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chau, Patsy Yuen-Kwan] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Hlth Syst Policy & Management, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; University of Hong Kong; Chinese University of Hong Kong	Chen, PY (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China.	chenpy99@smu.edu.cn	YANG, Lin/F-9601-2014; Yang, Jun/Q-3037-2019	YANG, Lin/0000-0002-5964-3233; Ou, Chun-Quan/0000-0001-6866-7213	National Nature Science Foundation of China [81102207]; Guangdong Nature Science Foundation [S2011040005355]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Nature Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by National Nature Science Foundation of China [81102207] and Guangdong Nature Science Foundation [S2011040005355]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Aylin P, 2001, INT J EPIDEMIOL, V30, P1100, DOI 10.1093/ije/30.5.1100; Barnett AG, 2008, AUST NZ J PUBL HEAL, V32, P408, DOI 10.1111/j.1753-6405.2008.00270.x; Barnett AG, 2007, EPIDEMIOLOGY, V18, P369, DOI 10.1097/01.ede.0000257515.34445.a0; Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Blagojevic LM, 2012, CENT EUR J PUBL HEAL, V20, P135, DOI 10.21101/cejph.a3711; Chang CL, 2004, J CLIN EPIDEMIOL, V57, P749, DOI 10.1016/j.jclinepi.2003.10.016; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davie GS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-263; De Lorenzo F, 1999, QJM-INT J MED, V92, P747, DOI 10.1093/qjmed/92.12.747; De Lorenzo F, 1999, ARCH INTERN MED, V159, P1954, DOI 10.1001/archinte.159.16.1954; Egondi T, 2012, GLOBAL HEALTH ACTION, V5, P23, DOI 10.3402/gha.v5i0.19065; Eng H, 1998, J Cardiovasc Risk, V5, P89, DOI 10.1097/00043798-199804000-00004; Guangzhou Statistic Bureau, 2011, GUANGHZ STAT B; Guo YM, 2013, HEART, V99, P195, DOI 10.1136/heartjnl-2012-302518; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Iniguez C, 2010, INT J ENV RES PUB HE, V7, P3196, DOI 10.3390/ijerph7083196; Kalkstein LS, 1997, ENVIRON HEALTH PERSP, V105, P84, DOI 10.1289/ehp.9710584; Keatinge W R, 2000, Int J Circumpolar Health, V59, P154; Keatinge W R, 2002, Int J Circumpolar Health, V61, P292; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Kynast-Wolf G, 2010, TROP MED INT HLTH; Maheswaran R, 2004, PUBLIC HEALTH, V118, P167, DOI 10.1016/j.puhe.2003.09.004; Marmot M, 2011, HLTH IMPACTS COLD HO; McCormack GR, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.092841; Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9; Mrema S, 2012, GLOBAL HEALTH ACTION, V5, P33, DOI 10.3402/gha.v5i0.19068; Nayha Simo, 2002, Int J Circumpolar Health, V61, P373; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Ockene IS, 2004, ARCH INTERN MED, V164, P863, DOI 10.1001/archinte.164.8.863; Peachey M, 2010, EXCESS WINTER DEATHS; Pin SP, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.005; Rau R, 2004, BRIT MED J, V329, P976, DOI 10.1136/bmj.329.7472.976-b; Rivrud IM, 2010, J ANIM ECOL, V79, P1280, DOI 10.1111/j.1365-2656.2010.01731.x; Shahar DR, 1999, EUR J CLIN NUTR, V53, P395, DOI 10.1038/sj.ejcn.1600761; Shahar DR, 2001, EUR J EPIDEMIOL, V17, P129, DOI 10.1023/A:1017542928978; Smolkova B, 2004, MUTAT RES-FUND MOL M, V551, P135, DOI 10.1016/j.mrfmmm.2004.02.021; Tian ZX, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-56; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Yang J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-63	43	43	45	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77150	10.1371/journal.pone.0077150	http://dx.doi.org/10.1371/journal.pone.0077150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116214	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200106
J	Borowiec, AS; Delcourt, P; Dewailly, E; Bidaux, G				Borowiec, Anne-Sophie; Delcourt, Philippe; Dewailly, Etienne; Bidaux, Gabriel			Optimal Differentiation of In Vitro Keratinocytes Requires Multifactorial External Control	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; EXTRACELLULAR CALCIUM; TERMINAL DIFFERENTIATION; CELL-CYCLE; GROWTH; CULTURE; SERUM; EXPRESSION; PROTEIN; RECEPTORS	For almost 30 years, keratinocyte differentiation has been studied in numerous cell models including keratinocyte primary culture with various supplemented culture media. In this respect, it has become quite difficult to draw comparisons between studies using such a variety of culture conditions. Serum-free condition with low calcium has been used to culture basal proliferating cells, though differentiation is induced by various procedures. These latter include the addition of calcium at mM concentration and a concomitant addition of serum and calcium. Lowering the incubation temperature of cells has also been reported to induce a premature differentiation of keratinocytes in organotypic skin culture. This effect of temperature on keratinocyte differentiation has been poorly depicted, although average human skin temperature has been shown to be about 32 degrees C. However, studying differentiation and quantifying shifts in the differentiation rate of a cell population implies to precisely know i) the proportion of differentiated cells in the whole population, and ii) to which extent and to which level of expression, the induction of a gene or a protein might be considered as a marker of differentiation. This lack has rarely been taken into consideration and has surely led to over-interpretations of single protein induction and to consequent extrapolations to real differentiation processes. By means of paralleled analyses with immunocytofluorescence, flow cytometry, and with multiple differentiation markers quantify by qPCR and western-blot, we studied the paradoxical connection between calcium, serum, multilayer culture and incubation temperature on the differentiation of in vitro keratinocytes. Conversely to previous reports, we have shown that calcium switch is indeed a potent model for inducing calcium-dependent genes, but is not an efficient procedure when one wishes to assess the keratinocyte differentiation rate. Moreover, we have demonstrated that a synergic stimulation by calcium, serum, confluence and lower incubation temperature amplified the differentiation rate.	[Borowiec, Anne-Sophie; Delcourt, Philippe; Dewailly, Etienne; Bidaux, Gabriel] Univ Lille 1, INSERM, U1003, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France; [Borowiec, Anne-Sophie; Delcourt, Philippe; Dewailly, Etienne; Bidaux, Gabriel] Univ Lille 1, Lab Excellence Ion Channels Sci & Therapeut, F-59655 Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Bidaux, G (corresponding author), CNRS, Lab Biophoton Cellulaire Fonct, Inst Rech Interdisciplinaire, USR3078, Parc Sci Haute Borne, Villeneuve Dascq, France.	gabriel.bidaux@gmail.com	Bidaux, Gabriel/F-1294-2016	Bidaux, Gabriel/0000-0002-6162-3223	INSERM (France)	INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was funded by INSERM (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; BERGHARD A, 1990, J BIOL CHEM, V265, P21086; BERTOLERO F, 1986, IN VITRO CELL DEV B, V22, P423; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; FUCHS E, 1981, CELL, V25, P617, DOI 10.1016/0092-8674(81)90169-0; Gackiere F, 2006, CELL CALCIUM, V39, P357, DOI 10.1016/j.ceca.2005.12.003; Gibbs S, 1997, ARCH DERMATOL RES, V289, P585, DOI 10.1007/s004030050244; Gifford JR, 2012, J PHYSIOL-LONDON, V590, P6403, DOI 10.1113/jphysiol.2012.240523; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Hennings H, 1980, Curr Probl Dermatol, V10, P3; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; JONES JCR, 1985, J CELL BIOL, V101, P506, DOI 10.1083/jcb.101.2.506; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052494; Leinonen PT, 2009, J INVEST DERMATOL, V129, P1379, DOI 10.1038/jid.2008.381; Li LW, 1996, J INVEST DERMATOL, V106, P254, DOI 10.1111/1523-1747.ep12340654; MALMQVIST KG, 1983, SCAN ELECTRON MICROS, P1815; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; MOORE EW, 1970, J CLIN INVEST, V49, pA67; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; PILLAI S, 1988, J CELL PHYSIOL, V134, P229, DOI 10.1002/jcp.1041340208; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; PITTELKOW MR, 1986, MAYO CLIN PROC, V61, P771, DOI 10.1016/S0025-6196(12)64815-0; Ponec M, 1997, ARCH DERMATOL RES, V289, P317, DOI 10.1007/s004030050198; Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; SMITH EL, 1986, J INVEST DERMATOL, V86, P709, DOI 10.1111/1523-1747.ep12276343; STEWART CA, 1992, IN VITRO CELL DEV-AN, V28A, P211, DOI 10.1007/BF02631094; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Takagi R, 2011, BIOCHEM BIOPH RES CO, V412, P226, DOI 10.1016/j.bbrc.2011.07.069; Thiele JJ, 1999, J INVEST DERMATOL, V113, P335, DOI 10.1046/j.1523-1747.1999.00693.x; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	40	64	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77507	10.1371/journal.pone.0077507	http://dx.doi.org/10.1371/journal.pone.0077507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116231	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300122
J	Csukly, G; Stefanics, G; Komlosi, S; Czigler, I; Czobor, P				Csukly, Gabor; Stefanics, Gabor; Komlosi, Sarolta; Czigler, Istvan; Czobor, Pal			Emotion-Related Visual Mismatch Responses in Schizophrenia: Impairments and Correlations with Emotion Recognition	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEMORY-BASED DETECTION; NEGATIVITY GENERATION; FACIAL EXPRESSIONS; IRRELEVANT CHANGES; SENSORY MEMORY; HUMAN BRAIN; MMN; LOCALIZATION; PERCEPTION	Background and Objectives: Mismatch negativity (MMN) is an event-related potential (ERP) measure of preattentional sensory processing. While deficits in the auditory MMN are robust electrophysiological findings in schizophrenia, little is known about visual mismatch response and its association with social cognitive functions such as emotion recognition in schizophrenia. Our aim was to study the potential deficit in the visual mismatch response to unexpected facial emotions in schizophrenia and its association with emotion recognition impairments, and to localize the sources of the mismatch signals. Experimental Design: The sample comprised 24 patients with schizophrenia and 24 healthy control subjects. Controls were matched individually to patients by gender, age, and education. ERPs were recorded using a high-density 128-channel BioSemi amplifier. Mismatch responses to happy and fearful faces were determined in 2 time windows over six regions of interest (ROIs). Emotion recognition performance and its association with the mismatch response were also investigated. Principal Observations: Mismatch signals to both emotional conditions were significantly attenuated in patients compared to controls in central and temporal ROIs. Controls recognized emotions significantly better than patients. The association between overall emotion recognition performance and mismatch response to the happy condition was significant in the 250-360 ms time window in the central ROI. The estimated sources of the mismatch responses for both emotional conditions were localized in frontal regions, where patients showed significantly lower activity. Conclusions: Impaired generation of mismatch signals indicate insufficient automatic processing of emotions in patients with schizophrenia, which correlates strongly with decreased emotion recognition.	[Csukly, Gabor; Komlosi, Sarolta; Czobor, Pal] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary; [Stefanics, Gabor] Univ Zurich, Inst Biomed Engn, TNU, Zurich, Switzerland; [Stefanics, Gabor] ETH, Zurich, Switzerland; [Stefanics, Gabor] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Stefanics, Gabor; Czigler, Istvan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Czobor, Pal] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	Semmelweis University; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Nathan Kline Institute for Psychiatric Research	Csukly, G (corresponding author), Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary.	csukly.gabor@med.semmelweis-univ.hu	Stefanics, Gabor/M-9955-2019; Csukly, Gabor/J-8244-2017	Stefanics, Gabor/0000-0002-0324-0996; Csukly, Gabor/0000-0002-5006-9407; Czigler, Istvan/0000-0003-1661-3808	"Ambient Assisted Living Joint Programme - Call 2'' grant [AAL_08-1-2011-0005 M3W]; National Research Fund of Hungary (OTKA) [71600]	"Ambient Assisted Living Joint Programme - Call 2'' grant; National Research Fund of Hungary (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was partially supported by the "Ambient Assisted Living Joint Programme - Call 2'' grant (Project Identifier: AAL_08-1-2011-0005 M3W). (http://www.aal-europe.eu). The additional part of the study was supported by the National Research Fund of Hungary (OTKA, 71600; http://www.otka.hu/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2006, BRIT J PSYCHIAT, V189, P373, DOI 10.1192/bjp.bp.105.021022; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Astikainen P, 2004, NEUROSCI LETT, V368, P231, DOI 10.1016/j.neulet.2004.07.025; Astikainen P, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-30; Astikainen P, 2008, EUR J NEUROSCI, V28, P2319, DOI 10.1111/j.1460-9568.2008.06510.x; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Calvo MG, 2008, COGN AFFECT BEHAV NE, V8, P41, DOI 10.3758/CABN.8.1.41; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Calvo MG, 2006, COGNITION EMOTION, V20, P1049, DOI 10.1080/02699930500298351; Cohen J.E., 1988, STAT POWER ANAL BEHA; Czigler I, 2002, PSYCHOPHYSIOLOGY, V39, P869, DOI 10.1111/1469-8986.3960869; Czigler I, 2007, PSYCHOPHYSIOLOGY, V44, P610, DOI 10.1111/j.1469-8986.2007.00530.x; Czigler I, 2010, NEUROPSYCHOLOGIA, V48, P1277, DOI 10.1016/j.neuropsychologia.2009.12.029; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Derogatis LR., 1994, SCL 90 R SYMPTOM CHE; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Heekeren K, 2008, PSYCHOPHARMACOLOGY, V199, P77, DOI 10.1007/s00213-008-1129-4; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Jung HT, 2012, SCHIZOPHR RES, V136, P150, DOI 10.1016/j.schres.2011.10.023; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Kimura M, 2012, CEREB CORTEX, V22, P1774, DOI 10.1093/cercor/bhr244; Kimura M, 2012, INT J PSYCHOPHYSIOL, V83, P144, DOI 10.1016/j.ijpsycho.2011.11.010; Kimura M, 2009, PSYCHOPHYSIOLOGY, V46, P402, DOI 10.1111/j.1469-8986.2008.00767.x; Kohler Christian G, 2010, Schizophr Bull, V36, P1009, DOI 10.1093/schbul/sbn192; Korostenskaja M, 2005, PROG NEURO-PSYCHOPH, V29, P543, DOI 10.1016/j.pnpbp.2005.01.019; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Maekawa T, 2012, CURR PSYCHIATRY REV, V8, P97, DOI 10.2174/1573400511208020097; Mancuso F, 2011, SCHIZOPHR RES, V125, P143, DOI 10.1016/j.schres.2010.11.007; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pazo-Alvarez P, 2004, NEUROSCI LETT, V371, P111, DOI 10.1016/j.neulet.2004.08.073; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Schmidt A, 2013, CEREB CORTEX, V23, P2394, DOI 10.1093/cercor/bhs238; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; Stagg C, 2004, NEUROREPORT, V15, P659, DOI 10.1097/00001756-200403220-00017; Stefanics G, 2012, NEUROIMAGE, V63, P253, DOI 10.1016/j.neuroimage.2012.06.068; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Stefanics G, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00046; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Sulykos I, 2011, BRAIN RES, V1398, P64, DOI 10.1016/j.brainres.2011.05.009; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Unoka Z., 2004, PSYCHIAT HUNG, V19, P235; Urban A, 2008, SCHIZOPHR RES, V102, P320, DOI 10.1016/j.schres.2008.03.014; VANRIJN ACM, 1990, MED BIOL ENG COMPUT, V28, P389, DOI 10.1007/BF02441961; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Yao J, 2005, NEUROIMAGE, V25, P369, DOI 10.1016/j.neuroimage.2004.11.036; Zhao L, 2006, NEUROSCI LETT, V410, P126, DOI 10.1016/j.neulet.2006.09.081	65	40	43	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75444	10.1371/journal.pone.0075444	http://dx.doi.org/10.1371/journal.pone.0075444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116046	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325501300029
J	Dalrymple, SA; Ko, J; Sheoran, I; Kaminskyj, SGW; Sanders, DAR				Dalrymple, Sean A.; Ko, John; Sheoran, Inder; Kaminskyj, Susan G. W.; Sanders, David A. R.			Elucidation of Substrate Specificity in Aspergillus nidulans UDP-Galactose-4-Epimerase	PLOS ONE			English	Article							UDP-GALACTOSE 4-EPIMERASE; N-ACETYLGLUCOSAMINE 4-EPIMERASE; FUMIGATUS CELL-WALL; GALACTOPYRANOSE MUTASE; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; GLUCOSE 4-EPIMERASE; FUNGAL-INFECTIONS; ESCHERICHIA-COLI; POTENTIAL TARGET	The frequency of invasive fungal infections has rapidly increased in recent years. Current clinical treatments are experiencing decreased potency due to severe host toxicity and the emergence of fungal drug resistance. As such, new targets and their corresponding synthetic pathways need to be explored for drug development purposes. In this context, galactofuranose residues, which are employed in fungal cell wall construction, but are notably absent in animals, represent an appealing target. Herein we present the structural and biochemical characterization of UDP-galactose-4-epimerase from Aspergillus nidulans which produces the precursor UDP-galactopyranose required for galactofuranose synthesis. Examination of the structural model revealed both NAD(+) and UDP-glucopyranose were bound within the active site cleft in a near identical fashion to that found in the Human epimerase. Mutational studies on the conserved catalytic motif support a similar mechanism to that established for the Human counterpart is likely operational within the A. nidulans epimerase. While the K-m and k(cat) for the enzyme were determined to be 0.11 mM and 12.8 s(-1), respectively, a single point mutation, namely L320C, activated the enzyme towards larger N-acetylated substrates. Docking studies designed to probe active site affinity corroborate the experimentally determined activity profiles and support the kinetic inhibition results.	[Dalrymple, Sean A.; Ko, John; Sheoran, Inder; Sanders, David A. R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 0W0, Canada; [Kaminskyj, Susan G. W.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Sanders, DAR (corresponding author), Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 0W0, Canada.	david.sanders@usask.ca	Sanders, David A.R./I-5668-2016		CIHR; SHRF	CIHR(Canadian Institutes of Health Research (CIHR)); SHRF	This work was supported by a CIHR-Regional Partnership Program grant to DARS and SGWK. Additionally, SAD would like to acknowledge funding from SHRF through a Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alphey MS, 2006, ACTA CRYSTALLOGR F, V62, P829, DOI 10.1107/S1744309106028740; BAKER ME, 1992, FEBS LETT, V301, P89, DOI 10.1016/0014-5793(92)80216-4; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Cappelletty D, 2007, PHARMACOTHERAPY, V27, P369, DOI 10.1592/phco.27.3.369; Dalrymple SA, 2011, ACTA CRYSTALLOGR F, V67, P885, DOI 10.1107/S1744309111020914; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dixon DM, 1996, PUBLIC HEALTH REP, V111, P226; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; FUKASAWA T, 1980, J BIOL CHEM, V255, P2705; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Gullo A, 2009, DRUGS, V69, P65, DOI 10.2165/11315530-000000000-00000; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; HOLM L, 1994, NAT STRUCT BIOL, V1, P146, DOI 10.1038/nsb0394-146; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Klis FM, 2007, MYCOTA, P95; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Latge JP, 2009, ASPERGILLUS FUMIGATU; Liu YJ, 1997, BIOCHEMISTRY-US, V36, P10675, DOI 10.1021/bi970430a; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MALEY F, 1959, BIOCHIM BIOPHYS ACTA, V31, P577, DOI 10.1016/0006-3002(59)90047-2; Maor BP, 2004, BIOCHEM J, V381, P131, DOI 10.1042/BJ20031075; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Momany M, 2004, MICROBIOL-SGM, V150, P3261, DOI 10.1099/mic.0.27318-0; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Moyrand F, 2008, EUKARYOT CELL, V7, P2069, DOI 10.1128/EC.00189-08; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PILLER F, 1983, J BIOL CHEM, V258, P774; Poulin MB, 2010, J BIOL CHEM, V285, P493, DOI 10.1074/jbc.M109.072157; RAY M, 1975, J BIOL CHEM, V250, P4373; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Sakuraba H, 2011, ARCH BIOCHEM BIOPHYS, V512, P126, DOI 10.1016/j.abb.2011.05.013; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schrodinger L., 2020, PYMOL; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; Scott A, 2007, FEMS YEAST RES, V7, P366, DOI 10.1111/j.1567-1364.2006.00204.x; Shapiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044734; Shaw MP, 2003, MOL BIOCHEM PARASIT, V126, P173, DOI 10.1016/S0166-6851(02)00243-8; TEIPEL JW, 1968, J BIOL CHEM, V243, P5684; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Thoden JB, 2005, J BIOL CHEM, V280, P21900, DOI 10.1074/jbc.M502411200; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P10685, DOI 10.1021/bi9704313; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l; Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102; Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027; Timson DJ, 2005, FEBS J, V272, P6170, DOI 10.1111/j.1742-4658.2005.05017.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wallis GLF, 2001, FEMS MICROBIOL LETT, V201, P21, DOI 10.1016/S0378-1097(01)00219-1; WILSON DB, 1964, J BIOL CHEM, V239, P2469; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlers TM, 2000, J INHERIT METAB DIS, V23, P713, DOI 10.1023/A:1005682913784	76	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76803	10.1371/journal.pone.0076803	http://dx.doi.org/10.1371/journal.pone.0076803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116166	Green Published, gold			2022-12-27	WOS:000325501300098
J	Drazic, A; Tsoutsoulopoulos, A; Peschek, J; Gundlach, J; Krause, M; Bach, NC; Gebendorfer, KM; Winter, J				Drazic, Adrian; Tsoutsoulopoulos, Amelie; Peschek, Jirka; Gundlach, Jasmin; Krause, Maike; Bach, Nina C.; Gebendorfer, Katharina M.; Winter, Jeannette			Role of Cysteines in the Stability and DNA-Binding Activity of the Hypochlorite-Specific Transcription Factor HypT	PLOS ONE			English	Article							REDOX-REGULATED CHAPERONE; HYDROGEN-PEROXIDE; DISULFIDE BOND; HYDROXYL RADICALS; THIOL; SUPEROXIDE; ACID; SWITCH; INACTIVATION; OXIDATION	Reactive oxygen species are important components of the immune response. Hypochlorite (HOCl) is produced by neutrophils to kill invading microorganisms. The bactericidal activity of HOCl is due to proteome-wide unfolding and oxidation of proteins at cysteine and methionine residues. Escherichia coli cells are protected from HOCl-killing by the previously identified dodecameric transcription factor HypT (YjiE). Here, we aimed to unravel whether HOCl activates HypT directly or via a reaction product of HOCl with a cellular component. Bacterial viability assays and analysis of target gene regulation indicate that HypT is highly specific to activation by HOCl and that no reaction products of HOCl such as monochloramine, hydroxyl radicals, or methionine sulfoxide activate HypT in vivo. Surprisingly, purified HypT lost its DNA-binding activity upon incubation with HOCl or reaction products that oxidize HypT to form a disulfide-linked dimer, and regained DNA-binding activity upon reduction. Thus, we postulate that the cysteines in HypT contribute to control the DNA-binding activity of HypT in vitro. HypT contains five cysteine residues; a HypT mutant with all cysteines substituted by serine is aggregation-prone and forms tetramers in addition to the typical dodecamers. Using single and multiple cysteine-to-serine mutants, we identified Cys150 to be required for stability and Cys4 being important for oligomerization of HypT to dodecamers. Further, oxidation of Cys4 is responsible for the loss of DNA-binding of HypT upon oxidation in vitro. It appears that Cys4 oxidation upon conditions that are insufficient to stimulate the DNA-binding activity of HypT prevents unproductive interactions of HypT with DNA. Thus, Cys4 oxidation may be a check point in the activation process of HypT.	[Drazic, Adrian; Tsoutsoulopoulos, Amelie; Peschek, Jirka; Gundlach, Jasmin; Krause, Maike; Bach, Nina C.; Gebendorfer, Katharina M.; Winter, Jeannette] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Garching, Germany	Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Garching, Germany.	jeannette.winter@tum.de	Drazic, Adrian/AAC-6120-2019	Drazic, Adrian/0000-0001-9263-5502; Peschek, Jirka/0000-0001-8158-9301; Krause, Maike/0000-0003-4068-8172	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft [WI 3200/1-1]; Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; Studienstiftung des deutschen Volkes;  [SFB1035]	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; Studienstiftung des deutschen Volkes; 	The study was funded by the Emmy-Noether Program of the Deutsche Forschungsgemeinschaft (Grant number: WI 3200/1-1) and the Center for Integrated Protein Science Munich. AD, JG and KMG were supported by the Elitenetzwerk Bayern, JP was supported by the Studienstiftung des deutschen Volkes, MK was supported by SFB1035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRICH JM, 1986, J CLIN INVEST, V78, P177, DOI 10.1172/JCI112548; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; BORS W, 1979, EUR J BIOCHEM, V95, P621, DOI 10.1111/j.1432-1033.1979.tb13003.x; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Foit L, 2011, ANTIOXID REDOX SIGN, V14, P973, DOI 10.1089/ars.2010.3712; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Gonzalez-Segura L, 2005, BIOCHIMIE, V87, P1056, DOI 10.1016/j.biochi.2005.06.007; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kaur Y, 2004, PROTEIN J, V23, P255, DOI 10.1023/B:JOPC.0000027850.01893.2e; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; Schulenburg C, 2010, CHEMBIOCHEM, V11, P978, DOI 10.1002/cbic.200900773; Sivey JD, 2013, BIOCHEMISTRY-US, V52, P1260, DOI 10.1021/bi301523s; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winter J, 2011, PROTEIN SCI, V20, P588, DOI 10.1002/pro.592; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322	61	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75683	10.1371/journal.pone.0075683	http://dx.doi.org/10.1371/journal.pone.0075683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116067	Green Published, Green Submitted, gold			2022-12-27	WOS:000325501300039
J	Gu, SH; Chen, DD; Zhang, JN; Lv, XM; Wang, K; Duan, LP; Nie, Y; Wu, XL				Gu, Shenghua; Chen, Dandan; Zhang, Jin-Na; Lv, Xiaoman; Wang, Kun; Duan, Li-Ping; Nie, Yong; Wu, Xiao-Lei			Bacterial Community Mapping of the Mouse Gastrointestinal Tract	PLOS ONE			English	Article							GUT MICROBIOTA; MICE; DIET; DIVERSITY; PHENOTYPE; RESISTANT; EVOLUTION; MUTUALISM; SEQUENCES; DISEASE	Keeping mammalian gastrointestinal (GI) tract communities in balance is crucial for host health maintenance. However, our understanding of microbial communities in the GI tract is still very limited. In this study, samples taken from the GI tracts of C57BL/6 mice were subjected to 16S rRNA gene sequence-based analysis to examine the characteristic bacterial communities along the mouse GI tract, including those present in the stomach, duodenum, jejunum, ileum, cecum, colon and feces. Further analyses of the 283,234 valid sequences obtained from pyrosequencing revealed that the gastric, duodenal, large intestinal and fecal samples had higher phylogenetic diversity than the jejunum and ileum samples did. The microbial communities found in the small intestine and stomach were different from those seen in the large intestine and fecal samples. A greater proportion of Lactobacillaceae were found in the stomach and small intestine, while a larger proportion of anaerobes such as Bacteroidaceae, Prevotellaceae, Rikenellaceae, Lachnospiraceae, and Ruminococcaceae were found in the large intestine and feces. In addition, inter-mouse variations of microbiota were observed between the large intestinal and fecal samples, which were much smaller than those between the gastric and small intestinal samples. As far as we can ascertain, ours is the first study to systematically characterize bacterial communities from the GI tracts of C57BL/6 mice.	[Gu, Shenghua; Chen, Dandan; Zhang, Jin-Na; Nie, Yong; Wu, Xiao-Lei] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Zhang, Jin-Na] Kunming Med Univ, Kunming, Yunnan, Peoples R China; [Lv, Xiaoman] Yunnan Univ Tradit Chinese Med, Kunming, Yunnan, Peoples R China; [Wang, Kun; Duan, Li-Ping] Peking Univ, Hosp 3, Beijing 100871, Peoples R China	Peking University; Kunming Medical University; Yunnan University of Chinese Medicine; Peking University	Nie, Y (corresponding author), Peking Univ, Coll Engn, Beijing 100871, Peoples R China.	nieyong@gmail.com; xiaolei_wu@pku.edu.cn	Chen, Dan/GRY-2691-2022; Wu, Xiao-Lei/G-6882-2011	Chen, Dan/0000-0002-1570-9034; Wu, Xiao-Lei/0000-0002-9897-6903	National "Twelfth Five-Year'' Plan for Science & Technology of China [2012BAI06B02]	National "Twelfth Five-Year'' Plan for Science & Technology of China	This study was supported by the National "Twelfth Five-Year'' Plan for Science & Technology of China (2012BAI06B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Deiteren A, 2010, NEUROGASTROENT MOTIL, V22, P413, DOI 10.1111/j.1365-2982.2009.01441.x; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	31	225	237	5	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74957	10.1371/journal.pone.0074957	http://dx.doi.org/10.1371/journal.pone.0074957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116019	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300019
J	Kooij, V; Zhang, PB; Piersma, SR; Sequeira, V; Boontje, NM; Wijnker, PJM; Jimenez, CR; Jaquet, KE; dos Remedios, C; Murphy, AM; van Eyk, JE; van der Velden, J; Stienen, GJM				Kooij, Viola; Zhang, Pingbo; Piersma, Sander R.; Sequeira, Vasco; Boontje, Nicky M.; Wijnker, Paul J. M.; Jimenez, Connie R.; Jaquet, Kornelia E.; dos Remedios, Cris; Murphy, Anne M.; van Eyk, Jennifer E.; van der Velden, Jolanda; Stienen, Ger J. M.			PKC alpha-Specific Phosphorylation of the Troponin Complex in Human Myocardium: A Functional and Proteomics Analysis	PLOS ONE			English	Article							PROTEIN-KINASE-C; FAILING HUMAN HEART; CARDIAC CONTRACTILITY; DIASTOLIC FUNCTION; SITES; IDENTIFICATION; FAILURE; MUSCLE; SENSITIVITY; FILAMENT	Aims: Protein kinase C alpha (PKC alpha) is one of the predominant PKC isoforms that phosphorylate cardiac troponin. PKC alpha is implicated in heart failure and serves as a potential therapeutic target, however, the exact consequences for contractile function in human myocardium are unclear. This study aimed to investigate the effects of PKC alpha phosphorylation of cardiac troponin (cTn) on myofilament function in human failing cardiomyocytes and to resolve the potential targets involved. Methods and Results: Endogenous cTn from permeabilized cardiomyocytes from patients with end-stage idiopathic dilated cardiomyopathy was exchanged (similar to 69%) with PKC alpha-treated recombinant human cTn (cTn (DD+PKC alpha)). This complex has Ser23/24 on cTnI mutated into aspartic acids (D) to rule out in vitro cross-phosphorylation of the PKA sites by PKC alpha. Isometric force was measured at various [Ca2+] after exchange. The maximal force (F-max) in the cTn (DD+PKC alpha) group (17.1 +/- 1.9 kN/m(2)) was significantly reduced compared to the cTn (DD) group (26.1 +/- 1.9 kN/m(2)). Exchange of endogenous cTn with cTn (DD+PKC alpha) increased Ca2+-sensitivity of force (pCa(50) = 5.59 +/- 0.02) compared to cTn (DD) (pCa(50) = 5.51 +/- 0.02). In contrast, subsequent PKC alpha treatment of the cells exchanged with cTn (DD+PKC alpha) reduced pCa(50) to 5.45 +/- 0.02. Two PKC alpha-phosphorylated residues were identified with mass spectrometry: Ser198 on cTnI and Ser179 on cTnT, although phosphorylation of Ser198 is very low. Using mass spectrometry based-multiple reaction monitoring, the extent of phosphorylation of the cTnI sites was quantified before and after treatment with PKC alpha and showed the highest phosphorylation increase on Thr143. Conclusion: PKC alpha-mediated phosphorylation of the cTn complex decreases F-max and increases myofilament Ca2+-sensitivity, while subsequent treatment with PKC alpha in situ decreased myofilament Ca2+-sensitivity. The known PKC sites as well as two sites which have not been previously linked to PKC alpha are phosphorylated in human cTn complex treated with PKC alpha with a high degree of specificity for Thr143.	[Kooij, Viola; Sequeira, Vasco; Boontje, Nicky M.; Wijnker, Paul J. M.; van der Velden, Jolanda; Stienen, Ger J. M.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands; [Kooij, Viola; Zhang, Pingbo; van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Bayview Prote Ctr, Baltimore, MD 21205 USA; [Piersma, Sander R.; Jimenez, Connie R.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, OncoProte Lab, Amsterdam, Netherlands; [Jaquet, Kornelia E.] Clin Ruhr Univ Bochum, St Josef Hosp Bergmannsheil, Bochum, Germany; [dos Remedios, Cris] Univ Sydney, Inst Biomed Res, Muscle Res Unit, Sydney, NSW 2006, Australia; [Murphy, Anne M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Inst Mol Cardiobiol, Baltimore, MD 21205 USA; [Stienen, Ger J. M.] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johns Hopkins University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ruhr University Bochum; University of Sydney; Johns Hopkins University; Vrije Universiteit Amsterdam	Kooij, V (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands.	vkooij1@jhmi.edu	Jimenez, Connie/AAI-3763-2020; Sequeira, Vasco/AAU-4724-2020; van der Velden, J/D-1925-2016	Sequeira, Vasco/0000-0002-9192-7674; Jimenez, Connie R/0000-0002-3103-4508; van der Velden, Jolanda/0000-0001-5224-5788; Stienen, Ger/0000-0001-5829-0328	National Institutes of Health [R01 HL 63038]; American Heart Association [12POST11520006]; Netherlands Foundation "De Drie Lichten"; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Netherlands Foundation "De Drie Lichten"; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 HL 63038; and in part by American Heart Association post-doctoral fellowship 12POST11520006 (V. K.); and this project has been supported by a travel grant from the Netherlands Foundation "De Drie Lichten:. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465; HOFMANN PA, 1993, CIRC RES, V72, P50, DOI 10.1161/01.RES.72.1.50; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kooij V, 2010, J MOL CELL CARDIOL, V48, P954, DOI 10.1016/j.yjmcc.2010.01.002; Kooij V, 2010, BASIC RES CARDIOL, V105, P289, DOI 10.1007/s00395-009-0053-z; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; McClellan G, 2004, J MOL CELL CARDIOL, V37, P823, DOI 10.1016/j.yjmcc.2004.05.023; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; NOLAND TA, 1993, BIOCHEM BIOPH RES CO, V193, P254, DOI 10.1006/bbrc.1993.1617; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; Pyle WG, 2002, AM J PHYSIOL-HEART C, V283, pH1215, DOI 10.1152/ajpheart.00128.2002; Solis RS, 2008, J MUSCLE RES CELL M, V29, P203, DOI 10.1007/s10974-009-9168-y; Steinberg SF, 2012, PHYSIOLOGY, V27, P130, DOI 10.1152/physiol.00009.2012; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; van der Velden J, 1998, CARDIOVASC RES, V38, P414, DOI 10.1016/S0008-6363(98)00019-4; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388	31	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74847	10.1371/journal.pone.0074847	http://dx.doi.org/10.1371/journal.pone.0074847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116014	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300015
J	Kurumop, SF; Bullen, C; Whittaker, R; Betuela, I; Hetzel, MW; Pulford, J				Kurumop, Serah F.; Bullen, Chris; Whittaker, Robyn; Betuela, Inoni; Hetzel, Manuel W.; Pulford, Justin			Improving Health Worker Adherence to Malaria Treatment Guidelines in Papua New Guinea: Feasibility and Acceptability of a Text Message Reminder Service	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CASE-MANAGEMENT; PERFORMANCE; CHILDREN; QUALITY; TRIAL; KENYA	The aim of this study is to assess whether a text message reminder service designed to support health worker adherence to a revised malaria treatment protocol is feasible and acceptable in Papua New Guinea (PNG). The study took place in six purposively selected health facilities located in the Eastern Highlands Province (EHP) of PNG. Ten text messages designed to remind participants of key elements of the new NMTP were transmitted to 42 health workers twice over a two week period (two text messages per day, Monday to Friday) via the country's largest mobile network provider. The feasibility and acceptability of the text message reminder service was assessed by transmission reports, participant diaries and group discussions. Findings indicate that the vast majority of text messages were successfully transmitted, participants' had regular mobile phone access and that most text messages were read most of the time and were considered both acceptable and clinically useful. Nevertheless, the study found that PNG health workers may tire of the service if the same messages are repeated too many times and that health workers may be reluctant to utilize more comprehensive, yet complementary, resources. In conclusion, a text message reminder service to support health worker adherence to the new malaria treatment protocol is feasible and acceptable in PNG. A rigorous pragmatic, effectiveness trial would be justified on the basis of these findings.	[Kurumop, Serah F.; Betuela, Inoni; Pulford, Justin] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Bullen, Chris; Whittaker, Robyn] Univ Auckland, Natl Inst Hlth Innovat, Sch Populat Hlth, Auckland 1, New Zealand; [Hetzel, Manuel W.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hetzel, Manuel W.] Univ Basel, Basel, Switzerland; [Pulford, Justin] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	PNG Institute Of Medical Research; University of Auckland; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Queensland	Pulford, J (corresponding author), Papua New Guinea Inst Med Res, POB 60, Goroka, Eastern Highlan, Papua N Guinea.	justin.pulford@pngimr.org.pg	Bullen, Chris/E-4594-2017	Bullen, Chris/0000-0001-6807-2930; Hetzel, Manuel W./0000-0002-5285-3254; Pulford, Justin/0000-0003-4756-8480	Internal Competitive Research Award Scheme (ICRAS) of the Papua New Guinea Institute of Medical Research	Internal Competitive Research Award Scheme (ICRAS) of the Papua New Guinea Institute of Medical Research	The study was funded by the Internal Competitive Research Award Scheme (ICRAS) of the Papua New Guinea Institute of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Hensen B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-218; Jones COH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038636; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kurumop SF, PAPUA NEW G IN PRESS; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Marfurt J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-8; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Namagembe A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-44; Papua New Guinea National Department of Health, 2009, NAT MAL TREATM PROT; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Pulford J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-157; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; WHO, 2010, GUID TREATM MAL, V2nd; Youngster I, 2010, DRUG SAFETY, V33, P713, DOI 10.2165/11536520-000000000-00000; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633; Zurovac D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052045; Zurovac D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001176; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	23	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76578	10.1371/journal.pone.0076578	http://dx.doi.org/10.1371/journal.pone.0076578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116122	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000325501300068
J	Palepu, A; Gadermann, A; Hubley, AM; Farrell, S; Gogosis, E; Aubry, T; Hwang, SW				Palepu, Anita; Gadermann, Anne; Hubley, Anita M.; Farrell, Susan; Gogosis, Evie; Aubry, Tim; Hwang, Stephen W.			Substance Use and Access to Health Care and Addiction Treatment among Homeless and Vulnerably Housed Persons in Three Canadian Cities	PLOS ONE			English	Article							INJECTION-DRUG USERS; ABUSE SCREENING-TEST; USE DISORDERS; FOLLOW-UP; EMERGENCY-DEPARTMENT; MENTAL-ILLNESS; HIGH-RATES; ADULTS; POPULATION; MORTALITY	Introduction: We examined the prevalence of substance use disorders among homeless and vulnerably housed persons in three Canadian cities and its association with unmet health care needs and access to addiction treatment using baseline data from the Health and Housing in Transition Study. Methods: In 2009, 1191 homeless and vulnerably housed persons were recruited in Vancouver, Toronto, and Ottawa, Canada. Interviewer administered questionnaires collected data on socio-demographics, housing history, chronic health conditions, mental health diagnoses, problematic drug use (DAST-10 >= 6), problematic alcohol use (AUDIT >= 20), unmet physical and mental health care needs, addiction treatment in the past 12 months. Three multiple logistic regression models were fit to examine the independent association of substance use with unmet physical health care need, unmet mental health care need, and addiction treatment. Results: Substance use was highly prevalent, with over half (53%) screening positive for the DAST-10 and 38% screening positive for the AUDIT. Problematic drug use was 29%, problematic alcohol use was lower at 16% and 7% had both problematic drug and alcohol use. In multiple regression models for unmet need, we found that problematic drug use was independently associated with unmet physical (adjusted odds ratio [AOR] 1.95; 95% confidence interval [CI] 1.43-2.64) and unmet mental (AOR 3.06; 95% CI 2.17-4.30) health care needs. Problematic alcohol use was not associated with unmet health care needs. Among those with problematic substance use, problematic drug use was associated with a greater likelihood of accessing addiction treatment compared to those with problematic alcohol use alone (AOR 2.32; 95% CI 1.18-4.54). Conclusions: Problematic drug use among homeless and vulnerably housed individuals was associated with having unmet health care needs and accessing addiction treatment. Strategies to provide comprehensive health services including addiction treatment should be developed and integrated within community supported models of care.	[Palepu, Anita; Gadermann, Anne] Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Hubley, Anita M.] Univ British Columbia, Dept Educ & Counseling Psychol & Special Educ, Vancouver, BC V5Z 1M9, Canada; [Farrell, Susan] Univ Ottawa, Dept Psychiat, Royal Ottawa Hlth Care Grp, Ottawa, ON K1N 6N5, Canada; [Gogosis, Evie; Hwang, Stephen W.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Aubry, Tim] Univ Ottawa, Sch Psychol, Ctr Res Educ & Community Serv, Ottawa, ON K1N 6N5, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of British Columbia; University of British Columbia; University of Ottawa; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; University of Toronto	Palepu, A (corresponding author), Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.	apalepu@hivnet.ubc.ca	Hwang, Stephen W./GVR-7773-2022; Aubry, Tim/ABB-9932-2021; Hwang, Stephen W./D-2297-2011	Aubry, Tim/0000-0002-6204-3773; Hwang, Stephen W./0000-0002-1276-1101	operating grant from the Canadian Institutes of Health Research [MOP-86765]; Michael Smith Foundation for Health Research	operating grant from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This project was supported by an operating grant (MOP-86765) from the Canadian Institutes of Health Research. Dr Anne Gadermann was supported by a post-doctoral fellowship award from the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance to End Homelessness, 2012, REP CARD END HOM OTT; Ardilly P, 2001, SURVEY METHODOL, V27, P109; Aubry T, 2012, AM J COMMUN PSYCHOL, V49, P142, DOI 10.1007/s10464-011-9444-z; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Barbor T., 1992, AUDIT ALCOHOL USE DI; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Coumans M, 2003, SUBST USE MISUSE, V38, P311, DOI 10.1081/JA-120017376; Culhane DP, 2002, HOUS POLICY DEBATE, V13, P107, DOI 10.1080/10511482.2002.9521437; Donovan DM, 2006, ADDICTION, V101, P1696, DOI 10.1111/j.1360-0443.2006.01606.x; Edens EL, 2011, WOMEN HEALTH ISS, V21, P383, DOI 10.1016/j.whi.2011.03.004; Farrell SJ, 2005, COMMUNITY MENT HLT J, V41, P737, DOI 10.1007/s10597-005-6430-7; FISCHER PJ, 1991, AM PSYCHOL, V46, P1115, DOI 10.1037/0003-066X.46.11.1115; French MT, 2001, SUBST USE MISUSE, V36, P927, DOI 10.1081/JA-100104096; Glasser I, 2003, SUBST USE MISUSE, V38, P551, DOI 10.1081/JA-120017385; Gossop M, 2005, DRUG ALCOHOL DEPEN, V79, P295, DOI 10.1016/j.drugalcdep.2005.01.023; Grinman MN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-94; Hodgetts D, 2007, J HEALTH PSYCHOL, V12, P709, DOI 10.1177/1359105307080593; Hwang SW, 2011, INT J PUBLIC HEALTH, V56, P609, DOI 10.1007/s00038-011-0283-3; Hwang SW, 2010, AM J PUBLIC HEALTH, V100, P1454, DOI 10.2105/AJPH.2009.182022; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 2003, CAN J PUBLIC HEALTH, V94, P436, DOI 10.1007/BF03405081; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Kertesz SG, 2009, MILBANK Q, V87, P495, DOI 10.1111/j.1468-0009.2009.00565.x; Kertesz SG, 2009, JAMA-J AM MED ASSOC, V301, P1822, DOI 10.1001/jama.2009.596; Kertesz SG, 2009, J GEN INTERN MED, V24, P841, DOI 10.1007/s11606-009-0990-0; Khandor Erika, 2011, Open Med, V5, pe94; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; Maisto SA, 2000, PSYCHOL ASSESSMENT, V12, P186, DOI 10.1037/1040-3590.12.2.186; Marshall EG, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-46; Moniruzzaman, 2012, MENTAL HLTH SUBSTANC, V5, P85, DOI [10.1080/17523281.2011.618143, DOI 10.1080/17523281.2011.618143]; North CS, 2010, SOC PSYCH PSYCH EPID, V45, P1055, DOI 10.1007/s00127-009-0144-z; O'Connell MJ, 2012, PSYCHIAT SERV, V63, P1195, DOI 10.1176/appi.ps.201000229; Palepu A, 1999, J URBAN HEALTH, V76, P409, DOI 10.1007/BF02351499; Palepu A, 2001, AIDS, V15, P423, DOI 10.1097/00002030-200102160-00021; Palepu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011697; Robertson MJ, 1997, AM J PUBLIC HEALTH, V87, P221, DOI 10.2105/AJPH.87.2.221; Sanmartin Claudia, 2002, Health Rep, V13, P15; Strehlau V, 2012, J PSYCHIATR PRACT, V18, P349, DOI 10.1097/01.pra.0000419819.60505.dc; SUSSER E, 1989, ARCH GEN PSYCHIAT, V46, P845; The Metro Vancouver Regional Steering Committee on Homelessness, 2012, ON STEP FORW RES 201; Toronto Shelter Support and Housing Administration, 2009, STREET NEEDS ASS RES; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; Velasquez MM, 2000, J SUBST ABUSE TREAT, V19, P395, DOI 10.1016/S0740-5472(00)00133-1; Vuchinich R, 2009, EXP CLIN PSYCHOPHARM, V17, P165, DOI 10.1037/a0015296; Winn JL, 2013, PSYCHOL SERV, V10, P233, DOI 10.1037/a0031051; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	49	50	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75133	10.1371/journal.pone.0075133	http://dx.doi.org/10.1371/journal.pone.0075133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124470	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100027
J	Aguilera, O; Lundberg, J; Birindelli, J; Perez, MS; Jaramillo, C; Sanchez-Villagra, MR				Aguilera, Orangel; Lundberg, John; Birindelli, Jose; Perez, Mark Sabaj; Jaramillo, Carlos; Sanchez-Villagra, Marcelo R.			Palaeontological Evidence for the Last Temporal Occurrence of the Ancient Western Amazonian River Outflow into the Caribbean	PLOS ONE			English	Article							ANDEAN TECTONICS; EARLY MIOCENE; FALCON STATE; BASIN; SILURIFORMES; VENEZUELA; NEOGENE; URUMACO; SEDIMENTATION; CATFISHES	Fossil catfishes from fluvio-lacustrine facies of late Miocene Urumaco, early Pliocene Castilletes and late Pliocene San Gregorio formations provide evidence of a hydrographic connection in what is today desert regions of northern Colombia and Venezuela. New discoveries and reevaluation of existing materials leads to the recognition of two new records of the pimelodid Brachyplatystoma cf. vaillantii, and of three distinct doradid taxa: Doraops sp., Rhinodoras sp., and an unidentified third form. The presence of fossil goliath long-whiskered catfishes and thorny catfishes are indicative of the persistence of a fluvial drainage system inflow into the South Caribbean during the Pliocene/Pleistocene boundary, complementary to the previous western Amazonian hydrographic system described from the Middle Miocene Villavieja Formation in central Colombia and Late Miocene Urumaco Formation in northwestern Venezuela. The Pliocene Castilletes and San Gregorio formations potentially represent the last lithostratigraphic units related with an ancient western Amazonian fish fauna and that drainage system in the Caribbean. Alternatively, it may preserve faunas from a smaller, peripheral river basin that was cut off earlier from the Amazon-Orinoco, today found in the Maracaibo basin and the Magdalena Rivers.	[Aguilera, Orangel] Univ Fed Fluminense, Inst Biol, Programa Posgrad Biol Marinha, Rio De Janeiro, Brazil; [Lundberg, John; Perez, Mark Sabaj] Acad Nat Sci Philadelphia, Dept Ichthyol, Philadelphia, PA 19103 USA; [Birindelli, Jose] Univ Estadual Londrina, Dept Biol Anim & Vegetal, Londrina, Parana, Brazil; [Jaramillo, Carlos] Smithsonian Trop Res Inst, Ancon, Panama, Panama; [Sanchez-Villagra, Marcelo R.] Univ Zurich, Palaeontol Inst & Museum, Zurich, Switzerland	Universidade Federal Fluminense; Drexel University; Universidade Estadual de Londrina; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Zurich	Sanchez-Villagra, MR (corresponding author), Univ Zurich, Palaeontol Inst & Museum, Zurich, Switzerland.	m.sanchez@pim.uzh.ch	Birindelli, Jose LO/F-4991-2015; Aguilera, Orangel/D-5055-2013; Birindelli, José L.O./AAS-7096-2020	Birindelli, José L.O./0000-0001-9646-9636; Sanchez-Villagra, Marcelo Ricardo/0000-0001-7587-3648; Aguilera, Orangel/0000-0003-4418-8351	Museum Paraense Emilio Goeldi (MPEG); Universidade Federal Fluminense (UFF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [CNPq 311783/2011-2]; Universidad Francisco de Miranda (UNEFM) in Venezuela; Smithsonian Tropical Research Institute (STRI) in Panama; U.S. National Science Foundation [DEB-1257813, DEB-0315963]; Swiss National Science Foundation Sinergia [CRSII3-136293]; Direct For Biological Sciences [1257813] Funding Source: National Science Foundation	Museum Paraense Emilio Goeldi (MPEG); Universidade Federal Fluminense (UFF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidad Francisco de Miranda (UNEFM) in Venezuela; Smithsonian Tropical Research Institute (STRI) in Panama; U.S. National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Museum Paraense Emilio Goeldi (MPEG)(http://www.museu-goeldi.br/), the Universidade Federal Fluminense (UFF)(http://www.uff.br/), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Process CNPq 311783/2011-2 to OA) in Brazil (http://www.cnpq.br/), the Universidad Francisco de Miranda (UNEFM) in Venezuela (www.unefm.edu.ve), the Smithsonian Tropical Research Institute (STRI) in Panama (http://www.stri.si.edu), and the U.S. National Science Foundation (DEB-1257813 and DEB-0315963, All Catfish Species Inventory) (http://www.nsf.gov/). Marcelo R. Sanchez-Villagra was supported by the Swiss National Science Foundation Sinergia (CRSII3-136293)(www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O.A., 2004, TESOROS PALEONTOLOGI; Aguilera OA, 2008, PALAEONTOL Z, V82, P231, DOI 10.1007/BF02988412; Aguilera Orangel Antonio, 2013, Swiss Journal of Palaeontology, V132, P45, DOI 10.1007/s13358-013-0052-4; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P1; Arce HM, 2013, MOL PHYLOGENET EVOL, V67, P560, DOI 10.1016/j.ympev.2013.02.021; Audemard FA, 1999, TECTONOPHYSICS, V308, P23, DOI 10.1016/S0040-1951(99)00081-5; Berg L.S., 1940, TRAVAUX I ZOOLOGIQUE, V5, P1; Betancur-R R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011566; Birindelli J. L. O., 2010, THESIS U SAO PAULO S; Birindelli JLO, 2008, NEOTROP ICHTHYOL, V6, P465, DOI 10.1590/S1679-62252008000300020; Bleeker, 1862, ATLAS ICHTHYOLOGIQUE, VII; BORDYNE B, 1974, THESIS LOUISIANA STA; Burgl H., 1960, Boletin Geologico Instituto Geologico Nacional Colombia, V6, P129; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Chardon M., 1968, Annls Mus r Afr cent (Ser Zool), VNo. 169, P1; Cushman JA, 1919, FOSSIL FORAMINIFERA, V291, P21; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Estratigrafico de Lexico, 1997, LEXICO ESTRATIGRAFIC, V12, P1; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Frailey C.D., 1986, CONTRIBUTIONS SCI NA, V374, P1; Garner AH, 1926, AM MIN METALL ENG T, P677; GAYET M, 1990, Journal of African Zoology, V104, P241; GIEGENGACK R, 1984, GEOL SOC AM MEM, V162, P343; Vucetich MG, 2010, J MAMM EVOL, V17, P265, DOI 10.1007/s10914-010-9142-x; Guzman J, 2006, AAPG BULL, P625; Hedberg HD, 1937, B GEOL MIN VENEZUELA, V1, P73; Higgs R., 2008, AAPG ANN CONV SAN AN; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V109, P1, DOI 10.1016/0031-0182(94)90117-1; Hovikoski J, 2005, GEOLOGY, V33, P177, DOI 10.1130/G21102.1; Irving E.M., 1972, MAPA GEOLOGICO PENIN; Jaramillo C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P317; Johnson KG, 2009, PALAIOS, V24, P59, DOI 10.2110/palo.2008.p08-004r; Kay R., 1997, VERTEBRATE PALEONTOL; KELLOGG JN, 1984, GEOL SOC AM MEM, V162, P239; Kullander SO., 2003, CHECK LIST FRESHWATE, P437; Lund Judith H., 2010, AMERICAN OFFSHORE WH, P1; Lundberg JG, 2005, COPEIA, P492; Lundberg John G., 1998, P13; Lundberg John G., 2005, Neotrop. ichthyol., V3, P597, DOI 10.1590/S1679-62252005000400017; Lundberg John G., 2003, Neotrop. ichthyol., V1, P97, DOI 10.1590/S1679-62252003000200004; Lundberg John G., 1997, P67; MACELLARI CE, 1995, AAPG MEMOIR, V62, P757; Ministerio de Energia y Minas, 1997, B GEOLOGICO PUBLICAC, V12, P1; Nogueira A.C.R., 2008, SCI AM BRASIL, P22; Perez MHS, 2007, P ACAD NAT SCI PHILA, V156, P157, DOI 10.1635/0097-3157(2007)156[157:FCOTFD]2.0.CO;2; Potter PE, 1997, J S AM EARTH SCI, V10, P331, DOI 10.1016/S0895-9811(97)00031-X; Quiroz L.I, 2010, URUMACO VENEZUELAN P, P153; Renz O., 1960, B GEOLOGICO PUBLICAC, V3, P317; Restrepo JD, 2000, J HYDROL, V235, P137, DOI 10.1016/S0022-1694(00)00269-9; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Rod E, 1981, GEOS, V26, P54; Roddaz M, 2005, TECTONOPHYSICS, V399, P87, DOI 10.1016/j.tecto.2004.12.017; Roddaz M, 2005, EARTH PLANET SC LETT, V239, P57, DOI 10.1016/j.epsl.2005.08.007; Rollins J. F., 1965, University of Nebraska Studies NS, VNo. 30, P1; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Sabaj M.H., 2003, CHECK LIST FRESHWATE, P456; Sanchez-Villagra MR, 2006, J SYST PALAEONTOL, V4, P213, DOI 10.1017/S1477201906001829; Sanchez-Villagra MR., 2010, URUMACO VENEZUELAN P; Scheyer TM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2940; Schultz Leonard P., 1944, PROC U S NATION MUS, V94, P173; Shephard GE, 2010, MIOCENE DRAINAGE AMA, DOI [10.1038/NGEO1017, DOI 10.1038/NGE01017]; Smith CJ, 2010, J FORAMIN RES, V40, P266, DOI 10.2113/gsjfr.40.3.266; STEPHAN JF, 1990, B SOC GEOL FR, V6, P915; TAPHORN DC, 1984, REV UNELLEZ CIENCIA, V2, P87; Valenciennes A, 1840, SILUROIDES, V14, P1; VERNETTE G, 1992, TECTONOPHYSICS, V202, P335, DOI 10.1016/0040-1951(92)90118-P; Villamil T, 1999, PALAEOGEOGR PALAEOCL, V153, P239, DOI 10.1016/S0031-0182(99)00075-9; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Zrbani F, 2004, GEOLOGICAL MAP VENEZ	73	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76202	10.1371/journal.pone.0076202	http://dx.doi.org/10.1371/journal.pone.0076202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098778	Green Published, gold, Green Accepted			2022-12-27	WOS:000325423500148
J	Colledge, FMA; Elger, BS; Shaw, DM				Colledge, Flora M. A.; Elger, Bernice S.; Shaw, David M.			"Conferring Authorship": Biobank Stakeholders' Experiences with Publication Credit in Collaborative Research	PLOS ONE			English	Article							SCIENTIFIC MISCONDUCT; JOURNALS; VIEWS; ORDER; NEED	Background: Multi-collaborator research is increasingly becoming the norm in the field of biomedicine. With this trend comes the imperative to award recognition to all those who contribute to a study; however, there is a gap in the current "gold standard" in authorship guidelines with regards to the efforts of those who provide high quality biosamples and data, yet do not play a role in the intellectual development of the final publication. Methods and findings: We carried out interviews with 36 individuals working in, or with links to, biobanks in Switzerland, in order to understand how they interpret, apply and value authorship criteria in studies involving biosamples. The majority of respondents feel that authorship is an important motivating factor in working and publishing collaboratively. However, our findings suggest that in some cases, authorship guidelines are being ignored in favor of departmental standards which recognize "scientific work" as meriting authorship. Conclusions: Our results support the current calls in the literature for an alternative method of crediting biomaterial contributions, in order to ensure appropriate authorship inclusion and promote collaborative research involving biobanks.	[Colledge, Flora M. A.; Elger, Bernice S.; Shaw, David M.] Univ Basel, Inst Biomed Eth, Basel, Switzerland	University of Basel	Colledge, FMA (corresponding author), Univ Basel, Inst Biomed Eth, Basel, Switzerland.	flora.colledge@unibas.ch	Elger, Bernice Simone/V-7265-2017	Elger, Bernice Simone/0000-0002-4249-7399	University of Basel; Kathe-Zingg Schwichtenberg Fund of the Swiss Academy of Medical Science	University of Basel; Kathe-Zingg Schwichtenberg Fund of the Swiss Academy of Medical Science	The salaries of all authors are paid by the University of Basel. Flora Colledge's doctoral research is funded in part by the Kathe-Zingg Schwichtenberg Fund of the Swiss Academy of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; [Anonymous], 2011, COD AC INT GOOD PRAC; Barrett Kirsten A, 2005, Account Res, V12, P193, DOI 10.1080/08989620500217321; Bennett Dianne M, 2003, Emerg Med (Fremantle), V15, P263, DOI 10.1046/j.1442-2026.2003.00432.x; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1605, DOI 10.2106/00004623-200308000-00024; Bhopal R, 1997, BRIT MED J, V314, P1009, DOI 10.1136/bmj.314.7086.1009; Cambon-Thomsen A, 2011, NAT GENET, V43, P503, DOI 10.1038/ng.831; Erlen JA, 1997, J PROF NURS, V13, P262, DOI 10.1016/S8755-7223(97)80097-X; Geggie D, 2001, J MED ETHICS, V27, P344; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; ICoMJ Editors, 2009, BIOMEDICAL J UNPUB; Jacob MA, 2011, AM J BIOETHICS, V11, P28, DOI 10.1080/15265161.2011.603812; Jones AH, 2003, SCI ENG ETHICS, V9, P243, DOI 10.1007/s11948-003-0011-3; King JT, 2000, NEUROSURGERY, V47, P435, DOI 10.1097/00006123-200008000-00032; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laudel G, 2001, INT J TECHNOL MANAGE, V22, P762, DOI 10.1504/IJTM.2001.002990; Leopold SS, 2013, CLIN ORTHOP RELAT R, V471, P701, DOI 10.1007/s11999-013-2796-y; Mabile L, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-7; Marris E, 2006, NATURE, V439, P768, DOI 10.1038/439768b; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pignatelli B, 2005, J MED ETHICS, V31, P578, DOI 10.1136/jme.2004.009449; Riegman PHJ, 2008, MOL ONCOL, V2, P213, DOI 10.1016/j.molonc.2008.07.004; RIESENBERG D, 1990, JAMA-J AM MED ASSOC, V264, P1857, DOI 10.1001/jama.264.14.1857; Shickle D, 2010, PATHOBIOLOGY, V77, P181, DOI 10.1159/000292651; Smith J, 2005, BMJ-BRIT MED J, V331, P245, DOI 10.1136/bmj.331.7511.245; Smith R, 1997, BRIT MED J, V314, P992, DOI 10.1136/bmj.314.7086.992; Smith R, 1997, BRIT MED J, V315, P696, DOI 10.1136/bmj.315.7110.696; Strange K, 2008, AM J PHYSIOL-CELL PH, V295, pC567, DOI 10.1152/ajpcell.00208.2008; Thomas GA, 2011, CLIN ONCOL-UK, V23, P276, DOI 10.1016/j.clon.2011.01.503; Vaught J, 2009, BIOPRESERV BIOBANK, V7, P143, DOI 10.1089/bio.2010.0003; Wager E, 2006, J ROY SOC MED, V99, P542, DOI 10.1258/jrsm.99.11.542; Wilcox LJ, 1998, JAMA-J AM MED ASSOC, V280, P216, DOI 10.1001/jama.280.3.216; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128	34	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76686	10.1371/journal.pone.0076686	http://dx.doi.org/10.1371/journal.pone.0076686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098803	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500174
J	Adhikari, D; Risal, S; Liu, K; Shen, Y				Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan			Pharmacological Inhibition of mTORC1 Prevents Over-Activation of the Primordial Follicle Pool in Response to Elevated PI3K Signaling	PLOS ONE			English	Article							OVARIAN TOXICITY; MOUSE OVARY; OOCYTES; CHEMOTHERAPY; OVOTOXICITY; SURVIVAL; PATHWAY; GROWTH	The majority of ovarian primordial follicles must be preserved in a quiescent state to allow for the regular production of gametes over the female reproductive lifespan. However, the molecular mechanism that maintains the long quiescence of primordial follicles is poorly understood. Under certain pathological conditions, the entire pool of primordial follicles matures simultaneously leading to an accelerated loss of primordial follicles and to premature ovarian failure (POF). We have previously shown that loss of Pten (phosphatase and tensin homolog deleted on chromosome ten) in mouse oocytes leads to premature activation of the entire pool of primordial follicles, subsequent follicular depletion in early adulthood, and the onset of POF. Lack of PTEN leads to increased phosphatidylinositol 3-kinase (PI3K)-Akt and mammalian target of rapamycin complex 1 (mTORC1) signaling in the oocytes. To study the functional and pathological roles of elevated mTORC1 signaling in the oocytes, we treated the Pten-mutant mice with the specific mTORC1 inhibitor rapamycin. When administered to Pten-deficient mice prior to the activation of the primordial follicles, rapamycin effectively prevented global follicular activation and preserved the ovarian reserve. These results provide a rationale for exploring the possible use of rapamycin as a drug for the preservation of the primordial follicle pool, and the possible prevention of POF.	[Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Adhikari, D (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	deepak.adhikari@medchem.umu.se; yan.shen@vgregion.se	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609				Adhikari D, 2010, CELL CYCLE, V9, P1673, DOI 10.4161/cc.9.9.11626; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Ben-Aharon I, 2012, REPRODUCTION, V144, P153, DOI 10.1530/REP-12-0121; Braun M, 2012, NEW ENGL J MED, V366, P1062, DOI 10.1056/NEJMc1113145; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Jagarlamudi K, 2010, MOL CELL ENDOCRINOL, V315, P1, DOI 10.1016/j.mce.2009.07.016; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Sobinoff AP, 2011, TOXICOL SCI, V123, P563, DOI 10.1093/toxsci/kfr195; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	28	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53810	10.1371/journal.pone.0053810	http://dx.doi.org/10.1371/journal.pone.0053810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	24124466	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800077
J	Seo, EH; Lee, DY; Lee, JM; Park, JS; Sohn, BK; Lee, DS; Choe, YM; Woo, JI				Seo, Eun Hyun; Lee, Dong Young; Lee, Jong-Min; Park, Jun-Sung; Sohn, Bo Kyung; Lee, Dong Soo; Choe, Young Min; Woo, Jong Inn			Whole-brain Functional Networks in Cognitively Normal, Mild Cognitive Impairment, and Alzheimer's Disease	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; RESTING-STATE NETWORKS; DEFAULT-MODE NETWORK; NEUROPSYCHOLOGICAL ASSESSMENT; TOPOLOGICAL PATTERNS; CORTICAL NETWORKS; CEREBRAL-CORTEX; BLOOD-FLOW; CONNECTIVITY; DEMENTIA	The conceptual significance of understanding functional brain alterations and cognitive deficits associated with Alzheimer's disease (AD) process has been widely established. However, the whole-brain functional networks of AD and its prodromal stage, mild cognitive impairment (MCI), are not well clarified yet. In this study, we compared the characteristics of the whole-brain functional networks among cognitively normal (CN), MCI, and AD individuals by applying graph theoretical analyses to [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) data. Ninety-four CN elderly, 183 with MCI, and 216 with AD underwent clinical evaluation and FDG-PET scan. The overall small-world property as seen in the CN whole-brain network was preserved in MCI and AD. In contrast, individual parameters of the network were altered with the following patterns of changes: local clustering of networks was lower in both MCI and AD compared to CN, while path length was not different among the three groups. Then, MCI had a lower level of local clustering than AD. Subgroup analyses for AD also revealed that very mild AD had lower local clustering and shorter path length compared to mild AD. Regarding the local properties of the whole-brain networks, MCI and AD had significantly decreased normalized betweenness centrality in several hubs regionally associated with the default mode network compared to CN. Our results suggest that the functional integration in whole-brain network progressively declines due to the AD process. On the other hand, functional relatedness between neighboring brain regions may not gradually decrease, but be the most severely altered in MCI stage and gradually re-increase in clinical AD stages.	[Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Woo, Jong Inn] Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Lee, Jong-Min; Park, Jun-Sung] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Lee, Dong Soo] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hanyang University; Seoul National University (SNU); Seoul National University Hospital	Lee, DS (corresponding author), Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea.	selfpsy@snu.ac.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777; Kim, Jae Ho/0000-0003-4323-4790; Jang, Il Ho/0000-0002-0820-3035	Seoul National University Hospital [2011-0564]; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [A092145]; Korea government (MEST) [2011-0028333]	Seoul National University Hospital; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Seoul National University Hospital (Grant No. 2011-0564), a grant from the Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (Grant No. A092145), and a grant from the Korea government (MEST) (Grant No. 2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Choo IH, 2007, ALZ DIS ASSOC DIS, V21, P77, DOI 10.1097/WAD.0b013e3180687418; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Golob EJ, 2001, NEUROBIOL AGING, V22, P755, DOI 10.1016/S0197-4580(01)00244-5; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; GRADY CL, 1989, ARCH NEUROL-CHICAGO, V46, P317, DOI 10.1001/archneur.1989.00520390083021; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Ishii K, 2003, J NEUROL SCI, V215, P71, DOI 10.1016/S0022-510X(03)00206-5; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHR E, 1990, J CLIN EXP NEUROPSYC, V12, P235, DOI 10.1080/01688639008400970; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Pihlajamaki M, 2009, BEHAV NEUROL, V21, P77, DOI 10.3233/BEN-2009-0231; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Sydykova D, 2007, CEREB CORTEX, V17, P2276, DOI 10.1093/cercor/bhl136; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vecchio Fabrizio, 2011, Int J Alzheimers Dis, V2011, P214580, DOI 10.4061/2011/214580; Wada Y, 1998, ALZ DIS ASSOC DIS, V12, P175, DOI 10.1097/00002093-199809000-00009; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yun JY, 2011, DEMENT GER COGN D EX, V1, P190, DOI 10.1159/000329517; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	73	109	111	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53922	10.1371/journal.pone.0053922	http://dx.doi.org/10.1371/journal.pone.0053922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	24098810	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700038
J	Kirchner, SM; Hiltunen, L; Doring, TF; Virtanen, E; Palohuhta, JP; Valkonen, JPT				Kirchner, Sascha M.; Hiltunen, Lea; Doering, Thomas F.; Virtanen, Elina; Palohuhta, Jukka P.; Valkonen, Jari P. T.			Seasonal Phenology and Species Composition of the Aphid Fauna in a Northern Crop Production Area	PLOS ONE			English	Article							POTATO-VIRUS-Y; HEMIPTERA APHIDIDAE; RHOPALOSIPHUM-PADI; NEW-BRUNSWICK; STRAW MULCH; VECTOR; FLIGHT; EPIDEMIOLOGY; TRANSMISSION; SELECTION	Background: The species diversity of aphids and seasonal timing of their flight activity can have significant impacts on crop production, as aphid species differ in their ability to transmit plant viruses and flight timing affects virus epidemiology. The aim of the study was to characterise the species composition and phenology of aphid fauna in Finland in one of the northernmost intensive crop production areas of the world (latitude 64 degrees). Methodology/Principal Findings: Flight activity was monitored in four growing seasons (2007-010) using yellow pan traps (YPTs) placed in 4-8 seed potato fields and a Rothamsted suction trap. A total of 58,528 winged aphids were obtained, identified to 83 taxa based on morphology, and 34 species were additionally characterised by DNA barcoding. Seasonal flight activity patterns analysed based on YPT catch fell into three main phenology clusters. Monoecious taxa showed early or middle-season flight activity and belonged to species living on shrubs/trees or herbaceous plants, respectively. Heteroecious taxa occurred over the entire potato growing season (ca. 90 days). Abundance of aphids followed a clear 3-year cycle based on suction trap data covering a decade. Rhopalosiphum padi occurring at the end of the potato growing season was the most abundant species. The flight activity of Aphis fabae, the main vector of Potato virus Y in the region, and Aphis gossypii peaked in the beginning of potato growing season. Conclusions/Significance: Detailed information was obtained on phenology of a large number aphid species, of which many are agriculturally important pests acting as vectors of plant viruses. Aphis gossypii is known as a pest in greenhouses, but our study shows that it occurs also in the field, even far in the north. The novel information on aphid phenology and ecology has wide implications for prospective pest management, particularly in light of climate change.	[Kirchner, Sascha M.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Kirchner, Sascha M.; Hiltunen, Lea; Virtanen, Elina] MTT AgriFood Res Finland, Oulu, Finland; [Doering, Thomas F.] Humboldt Univ, Dept Crop & Anim Sci, D-10099 Berlin, Germany; [Palohuhta, Jukka P.] Finnish Seed Potato Ctr, Tyrnava, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); Humboldt University of Berlin	Kirchner, SM (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	sascha.kirchner@helsinki.fi	; Wittbrodt, Joachim/D-4735-2014	Kirchmaier, Stephan/0000-0002-3870-8624; Valkonen, Jari/0000-0002-3704-9911; Lust, Katharina/0000-0002-2580-5492; Wittbrodt, Joachim/0000-0001-8550-7377; Doring, Thomas/0000-0001-9074-5978	Ministry of Agriculture and Forestry, Finland [618/502/2008, 2383/312/2009]	Ministry of Agriculture and Forestry, Finland	This work was supported by the Ministry of Agriculture and Forestry, Finland (grants 618/502/2008 and 2383/312/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2012, ATLAS APHIDS FINLAND; BAGNALL RH, 1992, CAN J PLANT PATHOL, V14, P137, DOI 10.1080/07060669209500890; Bagnall RH, 1991, ADV DIS VECTOR RES, P53; Bale Jeffrey S., 1999, Ecological Bulletins, V47, P38; Basky Z, 2003, ANZ SCHADL-J PEST SC, V76, P83, DOI 10.1046/j.1439-0280.2003.03019.x; BEEMSTER, 1972, Virus translocation in Potato plants and mature-plant resistance., P144; Bisnieks M, 2004, ARCH VIROL, V149, P843, DOI 10.1007/s00705-003-0242-2; Blackman R.L., 2000, J ECON ENTOMOL, V2; BLACKMAN RL, 1974, B ENTOMOL RES, V63, P595, DOI 10.1017/S0007485300047830; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; BOITEAU G, 1988, AM POTATO J, V65, P639, DOI 10.1007/BF02854832; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CHAN CK, 1991, AGR CAN RES BRANCH T; Chittka L, 2007, PLOS BIOL, V5, P1640, DOI 10.1371/journal.pbio.0050187; Cocu N, 2005, AGR FOREST ENTOMOL, V7, P31, DOI 10.1111/j.1461-9555.2005.00245.x; Cocuzza G, 2008, B INSECTOL, V61, P125; DEGUINE JP, 1997, SERIE DEPREDATEURS C, V11; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Doring TF, 2011, POTATO RES, V54, P341, DOI 10.1007/s11540-011-9195-0; Doring TF, 2009, P ROY SOC B-BIOL SCI, V276, P121, DOI 10.1098/rspb.2008.0858; Doring TF, 2004, ENTOMOL EXP APPL, V113, P53, DOI 10.1111/j.0013-8703.2004.00208.x; EASTOP VF, 1955, NATURE, V176, P936, DOI 10.1038/176936b0; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; GONZALEZ D, 1968, J ECON ENTOMOL, V61, P109, DOI 10.1093/jee/61.1.109; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Halkka A, 2010, SUOMEN LUONTO, V5, P8; HARDIE J, 1989, J INSECT PHYSIOL, V35, P619, DOI 10.1016/0022-1910(89)90124-8; Harrington R., 1995, P125; Heie O.E., 1980, APHIDOIDEA HEMIPTERA, V9; Heie O.E., 1995, APHIDOIDEA HEMIPTE 3; Heie OE, 1986, APHIDOIDEA HEMIPTE 1, VIII; Heie OE, 1982, APHIDOIDEA HEMIPTE 1; HEIE OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1992, APHIDOIDEA HEMIPTE 1; Holman J, 2009, HOST PLANT CATALOG A; HULLE M, 1994, J APPL ECOL, V31, P49, DOI 10.2307/2404598; Huusela-Veistola E, 2009, 8 INT S APH CAT, P167; Kindlmann P, 2007, APHIDS AS CROP PESTS, P311, DOI 10.1079/9780851998190.0311; Kirchner SM, 2011, ANN APPL BIOL, V159, P414, DOI 10.1111/j.1744-7348.2011.00501.x; KRING JB, 1972, ANNU REV ENTOMOL, V17, P461, DOI 10.1146/annurev.en.17.010172.002333; KURPPA A, 1989, ANN AGR FENN, V28, P309; KURPPA S, 1989, ANN AGR FENN, V28, P349; KURPPA S, 1986, ANN AGR FENN, V25, P199; Lambers DHR, 1955, ANN APPL BIOL, V42, P355, DOI 10.1111/j.1744-7348.1955.tb02440.x; LAMBERS DHR, 1966, ANNU REV ENTOMOL, V11, P47, DOI 10.1146/annurev.en.11.010166.000403; MACAULAY EDM, 1988, B ENTOMOL RES, V78, P121, DOI 10.1017/S0007485300016126; MOERICKE V, 1969, ENTOMOL EXP APPL, V12, P524, DOI 10.1007/BF00297083; Moericke V., 1955, Zeitschrift fuer Angewandte Entomologie, V37, P29; MOERICKE V., 1962, Zeitschrift fur Angewandte Entomologie, V50, P70; Mueller EE, 2010, J ECON ENTOMOL, V103, P1670, DOI 10.1603/EC09411; Official Statistics of Finland, 2012, CROP PROD STAT; Peltonen-Sainio P, 2009, AGR FOOD SCI, V18, P171, DOI 10.2137/145960609790059479; PERRY JN, 1983, ECOL ENTOMOL, V8, P383, DOI 10.1111/j.1365-2311.1983.tb00518.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Saucke H, 2009, ANN APPL BIOL, V154, P239, DOI 10.1111/j.1744-7348.2008.00288.x; Saucke H, 2004, ANN APPL BIOL, V144, P347, DOI 10.1111/j.1744-7348.2004.tb00350.x; SIGVALD R, 1985, POTATO RES, V28, P135, DOI 10.1007/BF02357439; SIGVALD R, 1987, POTATO RES, V30, P267, DOI 10.1007/BF02357668; Simola H, 2012, COMMUNICATION; STROYAN H.L.G., 1984, HDB IDENTIFICATION 6; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taylor L. R., 1974, Report of the Rothamsted Experimental Station 1973, P202; Taylor L.R., 1984, HDB APHID IDENTIFICA; Thieme Th., 1994, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V46, P65; Vanninen I, 2011, AGR FOOD SCI, V20, P96, DOI 10.2137/145960611795163033; WIKTELIUS S, 1987, ANN APPL BIOL, V110, P1, DOI 10.1111/j.1744-7348.1987.tb03226.x; Williams IS, 2007, APHIDS AS CROP PESTS, P69, DOI 10.1079/9780851998190.0069; ZHOU XL, 1995, GLOB CHANGE BIOL, V1, P303, DOI 10.1111/j.1365-2486.1995.tb00029.x	68	42	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71030	10.1371/journal.pone.0071030	http://dx.doi.org/10.1371/journal.pone.0071030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	24116091	Green Published, gold, Green Submitted			2022-12-27	WOS:000323115800033
J	Xu, C; Wang, CS; Sun, XY; Zhang, R; Gleason, ML; Eiji, T; Sun, GY				Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Gleason, Mark L.; Eiji, Tanaka; Sun, Guangyu			Multiple Group I Introns in the Small-Subunit rDNA of Botryosphaeria dothidea: Implication for Intraspecific Genetic Diversity	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; SCYTALIDIUM-DIMIDIATUM; TERTIARY INTERACTIONS; POPULATION-STRUCTURE; SECONDARY; PISTACHIO; REPRESENTATION; PATHOGENICITY; HYALINUM; BINDING	Botryosphaeria dothidea is a widespread and economically important pathogen on various fruit trees, and it often causes die-back and canker on limbs and fruit rot. In characterizing intraspecies genetic variation within this fungus, group I introns, rich in rDNA of fungi, may provide a productive region for exploration. In this research, we analysed complete small subunit (SSU) ribosomal DNA (rDNA) sequences of 37 B. dothidea strains, and found four insertions, designated Bdo.S943, Bdo.S1199-A, Bdo.S1199-B and Bdo.S1506, at three positions. Sequence analysis and structure prediction revealed that both Bdo.S943 and Bdo.S1506 belonged to subgroup IC1 of group I introns, whereas Bdo.S1199-A and Bdo.S1199-B corresponded to group IE introns. Moreover, Bdo.S1199-A was found to host an open reading frame (ORF) for encoding the homing endonuclease (HE), whereas Bdo.S1199-B, an evolutionary descendant of Bdo.S1199-A, included a degenerate HE. The above four introns were novel, and were the first group I introns observed and characterized in this species. Differential distribution of these introns revealed that all strains could be separated into four genotypes. Genotype III (no intron) and genotype IV (Bdo.S1199-B) were each found in only one strain, whereas genotype I (Bdo.S1199-A) and genotype II (Bdo.S943 and Bdo.S1506) occurred in 95% of the strains. There is a correlation between B. dothidea genotypes and hosts or geographic locations. Thus, these newly discovered group I introns can help to advance understanding of genetic differentiation within B. dothidea.	[Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Gleason, Mark L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Eiji, Tanaka] Ishikawa Prefectural Univ, Nonoichi, Ishikawa, Japan	Northwest A&F University - China; Iowa State University; Ishikawa Prefecture University	Sun, GY (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	sgy@nwsuaf.edu.cn	Zhang, Xinyu/S-4946-2016	Zhang, Xinyu/0000-0001-8154-9334; CAI, LEI/0000-0002-8131-7274; chao, xu/0000-0002-6398-4129; Tanaka, Eiji/0000-0003-4752-8825	National Natural Science Foundation of China [31170015, 31171797]; 111 Project from Education Ministry of China [B07049]; Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System [nycytx-08-04-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from Education Ministry of China(Ministry of Education, China - 111 Project); Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System	This work was supported by National Natural Science Foundation of China (31170015, 31171797), the 111 Project from Education Ministry of China (B07049), Top Talent Project of Northwest A&F University and the earmarked fund for Modern Agro-industry Technology Research System (nycytx-08-04-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr ME, 1972, PRELIMINARY STUDIES, P525; Belfort M, 1995, J BIOL CHEM, V270, P30237, DOI 10.1074/jbc.270.51.30237; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; Choi IY, 2011, PLANT DIS, V95, P227, DOI 10.1094/PDIS-05-10-0371; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hall TA., NUCL ACIDS S SER OXF, V41, P95; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, MOL BIOL EVOL, V21, P129, DOI 10.1093/molbev/msh005; Haugen P, 2002, EUR J BIOCHEM, V269, P1641, DOI 10.1046/j.1432-1327.2002.02802.x; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Li ZJ, 2005, NUCLEIC ACIDS RES, V33, P2118, DOI 10.1093/nar/gki517; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma ZH, 2004, PHYTOPATHOLOGY, V94, P326, DOI 10.1094/PHYTO.2004.94.4.326; Ma ZH, 2002, PHYTOPATHOLOGY, V92, P519, DOI 10.1094/PHYTO.2002.92.5.519; Ma ZH, 2001, PHYTOPATHOLOGY, V91, P665, DOI 10.1094/PHYTO.2001.91.7.665; Machouart M, 2004, FEMS MICROBIOL LETT, V238, P455, DOI 10.1016/j.femsle.2004.08.011; Machouart M, 2011, FUNGAL BIOL-UK, V115, P1038, DOI 10.1016/j.funbio.2011.05.002; Machouart-Dubach M, 2002, FEMS MICROBIOL LETT, V208, P187, DOI 10.1111/j.1574-6968.2002.tb11080.x; MICHAILIDES TJ, 1991, PHYTOPATHOLOGY, V81, P566, DOI 10.1094/Phyto-81-566; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Muller KM, 2001, MOL BIOL EVOL, V18, P1654, DOI 10.1093/oxfordjournals.molbev.a003954; Nikoh N, 2001, MOL BIOL EVOL, V18, P1631, DOI 10.1093/oxfordjournals.molbev.a003952; Slippers B, 2004, MYCOLOGIA, V96, P83, DOI 10.2307/3761991; Suh SO, 1999, J MOL EVOL, V48, P493, DOI 10.1007/PL00006493; Takizawa K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-94; Tang W, 2012, PLANT DIS, V96, P486, DOI 10.1094/PDIS-08-11-0635; Taylor A, 2005, AUSTRALAS PLANT PATH, V34, P187, DOI 10.1071/AP05018; WEAVER DJ, 1974, PHYTOPATHOLOGY, V64, P1429, DOI 10.1094/Phyto-64-1429; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhang Y, 2000, RNA, V6, P937, DOI 10.1017/S1355838200991726; Zhang Y, 2009, FEBS LETT, V583; Zhou Z, 2011, SCI AGR SINICA, V6, P009; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	28	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67808	10.1371/journal.pone.0067808	http://dx.doi.org/10.1371/journal.pone.0067808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	24098811	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000101
J	Zhang, JX; Guo, LY; Feng, L; Jiang, WD; Kuang, SY; Liu, Y; Hu, K; Jiang, J; Li, SH; Tang, L; Zhou, XQ				Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Kuang, Sheng-Yao; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Tang, Ling; Zhou, Xiao-Qiu			Soybean beta-Conglycinin Induces Inflammation and Oxidation and Causes Dysfunction of Intestinal Digestion and Absorption in Fish	PLOS ONE			English	Article							SALMON SALMO-SALAR; TROUT ONCORHYNCHUS-MYKISS; MORHUA FED STANDARD; FED GRADED-LEVELS; JUVENILE JIAN; ENZYME-ACTIVITIES; ATLANTIC SALMON; BODY-COMPOSITION; RAINBOW-TROUT; GLUTAMINE SUPPLEMENTATION	beta-conglycinin has been identified as one of the major feed allergens. However, studies of beta-conglycinin on fish are scarce. This study investigated the effects of b-conglycinin on the growth, digestive and absorptive ability, inflammatory response, oxidative status and gene expression of juvenile Jian carp (Cyprinus carpio var. Jian) in vivo and their enterocytes in vitro. The results indicated that the specific growth rate (SGR), feed intake, and feed efficiency were reduced by beta-conglycinin. In addition, activities of trypsin, chymotrypsin, lipase, creatine kinase, Na+, K+-ATPase and alkaline phosphatase in the intestine showed similar tendencies. The protein content of the hepatopancreas and intestines, and the weight and length of the intestines were all reduced by beta-conglycinin. beta-conglycinin increased lipid and protein oxidation in the detected tissues and cells. However, beta-conglycinin decreased superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione peroxidase (GPx) and glutathione reductase (GR) activities and glutathione (GSH) content in the intestine and enterocytes. Similar antioxidant activity in the hepatopancreas was observed, except for GST. The expression of target of rapamycin (TOR) gene was reduced by beta-conglycinin. Furthermore, mRNA levels of interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta (TGF-beta) genes were increased by beta-conglycinin. However, beta-conglycinin increased CuZnSOD, MnSOD, CAT, and GPx1b gene expression. In conclusion, this study indicates that beta-conglycinin induces inflammation and oxidation, and causes dysfunction of intestinal digestion and absorption in fish, and finally reduces fish growth. The results of this study provide some information to the mechanism of beta-conglycinin-induced negative effects.	[Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhou, XQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	xqzhouqq@tom.com	jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022		National Science Foundation of China [3087192]; National Department Public Benefit Research Foundation (Agriculture) of China [2010003020]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-08-0905]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation (Agriculture) of China; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This study was financially supported by the National Science Foundation of China (3087192), National Department Public Benefit Research Foundation (Agriculture) of China (2010003020) and Project supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-08-0905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHUSSAINI AH, 1949, Q J MICROSC SCI, V90, P323; Bakke-McKellep AM, 2007, J FISH DIS, V30, P65, DOI 10.1111/j.1365-2761.2007.00782.x; Baltacioglu E, 2008, ARCH ORAL BIOL, V53, P716, DOI 10.1016/j.archoralbio.2008.02.002; Baudry N, 1996, FEBS LETT, V396, P223, DOI 10.1016/0014-5793(96)01107-6; Bhor VM, 2004, INT J BIOCHEM CELL B, V36, P89, DOI 10.1016/S1357-2725(03)00142-0; Bicho A, 1999, J EXP BIOL, V202, P39; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttle LG, 2001, VET IMMUNOL IMMUNOP, V80, P237, DOI 10.1016/S0165-2427(01)00269-0; Cao YH, 1998, JPEN-PARENTER ENTER, V22, P224, DOI 10.1177/0148607198022004224; Chen F, 2011, J ANIM SCI, V89, P743, DOI 10.2527/jas.2010-3146; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Chen J, 2009, AQUACULTURE, V288, P285, DOI 10.1016/j.aquaculture.2008.10.053; DALY JG, 1995, FISH SHELLFISH IMMUN, V5, P265, DOI 10.1006/fsim.1995.0026; Feng L, 2009, THESIS SICHUAN AGR U; Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246; Furne M, 2005, AQUACULTURE, V250, P391, DOI 10.1016/j.aquaculture.2005.05.017; Gamboa-Delgado J, 2009, AQUACULTURE, V291, P115, DOI 10.1016/j.aquaculture.2009.03.012; Guillaume J., 2001, NUTR FEEDING FISH CR, P35; Guo PF, 2008, INT ARCH ALLERGY IMM, V145, P102, DOI 10.1159/000108135; Han PF, 2010, ARCH ANIM NUTR, V64, P254, DOI 10.1080/17450391003625003; Hao Y, 2009, ARCH ANIM NUTR, V63, P188, DOI 10.1080/17450390902860026; He W, 2009, AQUACULT NUTR, V15, P402, DOI 10.1111/j.1365-2095.2008.00604.x; Hegazi MM, 2010, AQUAT TOXICOL, V99, P118, DOI 10.1016/j.aquatox.2010.04.007; Huang HH, 2011, AQUACULT NUTR, V17, pE233, DOI 10.1111/j.1365-2095.2010.00756.x; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; ILENCHUK TT, 1982, INSECT BIOCHEM, V12, P675, DOI 10.1016/0020-1790(82)90056-7; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang J., 2005, THESIS SICHUAN AGR U; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Jiang WD, 2009, AQUAC RES, V40, P955, DOI 10.1111/j.1365-2109.2009.02191.x; Johnson AT, 2003, J SURG RES, V115, P242, DOI 10.1016/j.jss.2003.07.003; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; LI DF, 1990, J ANIM SCI, V68, P1790; Li W, 2010, AQUACULT NUTR, V16, P137, DOI 10.1111/j.1365-2095.2008.00645.x; Lilleeng E, 2007, AQUACULTURE, V267, P269, DOI 10.1016/j.aquaculture.2007.01.048; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Lin SM, 2011, ANIM FEED SCI TECH, V168, P80, DOI 10.1016/j.anifeedsci.2011.03.012; Lin Y, 2006, AQUACULTURE, V256, P389, DOI 10.1016/j.aquaculture.2006.02.011; Ling J, 2010, AQUACULT NUTR, V16, P616, DOI 10.1111/j.1365-2095.2009.00699.x; Liu ZQ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1105, DOI 10.1152/ajpendo.00337.2002; Lushchak V I, 2001, Am J Physiol Regul Integr Comp Physiol, V280, pR100; Moellering D, 1999, FEBS LETT, V448, P292, DOI 10.1016/S0014-5793(99)00371-3; Mulier B, 1998, EUR RESPIR J, V11, P384, DOI 10.1183/09031936.98.11020384; National Research Council, 1993, NUTR REQ FISH; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishi T, 2003, J NUTR, V133, P352, DOI 10.1093/jn/133.2.352; Ostaszewska T, 2005, AQUACULTURE, V245, P273, DOI 10.1016/j.aquaculture.2004.12.005; Refstie S, 2006, AQUACULTURE, V261, P269, DOI 10.1016/j.aquaculture.2006.07.011; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Salze G, 2010, AQUACULTURE, V298, P294, DOI 10.1016/j.aquaculture.2009.11.003; Satoh J, 2003, J GASTROEN HEPATOL, V18, P719, DOI 10.1046/j.1440-1746.2003.03042.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sun P, 2008, J NUTR BIOCHEM, V19, P627, DOI 10.1016/j.jnutbio.2007.08.007; Tan LN, 2011, AQUACULT NUTR, V17, P338, DOI 10.1111/j.1365-2095.2010.00793.x; Tang L, 2009, AQUACULT NUTR, V15, P477, DOI 10.1111/j.1365-2095.2008.00613.x; Turan A, 2007, DIGEST DIS SCI, V52, P1840, DOI 10.1007/s10620-006-9633-z; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; Utsumi S., 1997, FOOD PROTEINS THEIR, P257; Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039; Wasa M, 2005, J SURG RES, V123, P75, DOI 10.1016/j.jss.2004.07.018; Wen ZP, 2009, AQUACULT NUTR, V15, P470, DOI 10.1111/j.1365-2095.2008.00612.x; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; WINDMUELLER HG, 1982, ADV ENZYMOL RAMB, V53, P201; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Xiao WW, 2011, AQUACULT NUTR, V17, P408, DOI 10.1111/j.1365-2095.2010.00818.x; Xu J, 2010, J ANIM PLANT SCI, V20, P170; Zhang J-X, 2007, AQUACULT SCI, V2, P315; Zhang J-X, 2003, THESIS SICHUAN AGR U; Zhang XD, 2008, AQUACULTURE, V280, P136, DOI 10.1016/j.aquaculture.2008.05.010; Zhao Y, 2010, FOOD AGR IMMUNOL, V21, P209, DOI 10.1080/09540101003596644; Zhou XQ, 2008, AQUACULT NUTR, V14, P381, DOI 10.1111/j.1365-2095.2007.00535.x; Zhu Q, 2012, J APPL ICHTHYOL, DOI [10.1111/j.1439-0426.2011.011676.x, DOI 10.1111/J.1439-0426.2011.011676.X]	76	265	280	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58115	10.1371/journal.pone.0058115	http://dx.doi.org/10.1371/journal.pone.0058115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	24124552	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900047
J	Adhikari, BN; Hamilton, JP; Zerillo, MM; Tisserat, N; Levesque, CA; Buell, CR				Adhikari, Bishwo N.; Hamilton, John P.; Zerillo, Marcelo M.; Tisserat, Ned; Levesque, C. Andre; Buell, C. Robin			Comparative Genomics Reveals Insight into Virulence Strategies of Plant Pathogenic Oomycetes	PLOS ONE			English	Article							PYTHIUM-OLIGANDRUM; BIOLOGICAL-CONTROL; EFFECTOR PROTEINS; PHYLOGENETIC-RELATIONSHIPS; PHYTOPHTHORA-INFESTANS; MOLECULAR PHYLOGENY; EVOLUTION; SEQUENCE; DISEASE; WHEAT	The kingdom Stramenopile includes diatoms, brown algae, and oomycetes. Plant pathogenic oomycetes, including Phytophthora, Pythium and downy mildew species, cause devastating diseases on a wide range of host species and have a significant impact on agriculture. Here, we report comparative analyses on the genomes of thirteen straminipilous species, including eleven plant pathogenic oomycetes, to explore common features linked to their pathogenic lifestyle. We report the sequencing, assembly, and annotation of six Pythium genomes and comparison with other stramenopiles including photosynthetic diatoms, and other plant pathogenic oomycetes such as Phytophthora species, Hyaloperonospora arabidopsidis, and Pythium ultimum var. ultimum. Novel features of the oomycete genomes include an expansion of genes encoding secreted effectors and plant cell wall degrading enzymes in Phytophthora species and an over-representation of genes involved in proteolytic degradation and signal transduction in Pythium species. A complete lack of classical RxLR effectors was observed in the seven surveyed Pythium genomes along with an overall reduction of pathogenesis-related gene families in H. arabidopsidis. Comparative analyses revealed fewer genes encoding enzymes involved in carbohydrate metabolism in Pythium species and H. arabidopsidis as compared to Phytophthora species, suggesting variation in virulence mechanisms within plant pathogenic oomycete species. Shared features between the oomycetes and diatoms revealed common mechanisms of intracellular signaling and transportation. Our analyses demonstrate the value of comparative genome analyses for exploring the evolution of pathogenesis and survival mechanisms in the oomycetes. The comparative analyses of seven Pythium species with the closely related oomycetes, Phytophthora species and H. arabidopsidis, and distantly related diatoms provide insight into genes that underlie virulence.	[Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Zerillo, Marcelo M.; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Levesque, C. Andre] Agr & Agri Food Canada, Ottawa, ON, Canada; [Levesque, C. Andre] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Michigan State University; Colorado State University; Agriculture & Agri Food Canada; Carleton University	Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program [2007-35600-17774, 2007-35600-18886]	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program	Funding for the work was provided by the United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program to CRB and NT (2007-35600-17774 and 2007-35600-18886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; ADAMS PB, 1990, ANNU REV PHYTOPATHOL, V28, P59, DOI 10.1146/annurev.py.28.090190.000423; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bouwmeester K, 2009, ANNU PLANT REV, V34, P102, DOI 10.1111/b.9781405175326.2009.00005.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bradley A, 2007, REF USER SERV Q, V47, P133; BRASIER CM, 1992, ANNU REV PHYTOPATHOL, V30, P173, DOI 10.1146/annurev.py.30.090192.001133; Bridge PD, 2008, PLANT PATHOL, V57, P1066, DOI 10.1111/j.1365-3059.2008.01868.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capra John A, 2010, Genome Biol, V11, P306, DOI 10.1186/gb-2010-11-6-306; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RJ, 1987, PHYTOPATHOLOGY, V77, P1192, DOI 10.1094/Phyto-77-1192; COOK RJ, 1980, PLANT DIS, V64, P102, DOI 10.1094/PD-64-1061; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dick MW, 2001, STRAMINIPILOUS FUNGI; Dieguez-Uribeondo J, 2009, FUNGAL GENET BIOL, V46, P365, DOI 10.1016/j.fgb.2009.02.004; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; GOLD SE, 1985, PHYTOPATHOLOGY, V75, P333, DOI 10.1094/Phyto-75-333; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harvey P., 2008, Outlooks on Pest Management, V19, P127, DOI 10.1564/19jun09; Harvey PR, 2000, PLANT PATHOL, V49, P619, DOI 10.1046/j.1365-3059.2000.00493.x; Harvey PR, 2001, MYCOL RES, V105, P85, DOI 10.1017/S0953756200002902; Horner NR, 2012, FUNGAL BIOL-UK, V116, P24, DOI 10.1016/j.funbio.2011.09.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwayama S, 1933, NEW SNOW ROT DIS CER; Kale SD, 2012, NEW PHYTOL, V193, P874, DOI 10.1111/j.1469-8137.2011.03968.x; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Koike S.T., 2006, VEGETABLE DIS COLOR; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARKIN RP, 1995, PHYTOPATHOLOGY, V85, P430, DOI 10.1094/Phyto-85-430; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; Martin F.N., 2009, OOMYCETE GENETICS GE, P574; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martin FN, 1999, CRIT REV PLANT SCI, V18, P111, DOI 10.1016/S0735-2689(99)00389-5; MARTIN FN, 1987, PHYTOPATHOLOGY, V77, P1013, DOI 10.1094/Phyto-77-1013; McLeod A, 2009, MYCOL RES, V113, P933, DOI 10.1016/j.mycres.2009.04.009; Mendoza L, 1996, J MYCOL MED, V6, P151; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Mulder Nicola, 2007, V396, P59; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Paulitz TC, 2003, PHYTOPATHOLOGY, V93, P867, DOI 10.1094/PHYTO.2003.93.7.867; Quinn E, 2012, RESOLVING PYTHIUM UL; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SAUNDERS GA, 1988, J INVERTEBR PATHOL, V52, P360, DOI 10.1016/0022-2011(88)90148-6; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Snowdon A. L., 1990, COLOUR ATLAS POSTHAR, V1; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P1210, DOI 10.1016/j.funbio.2011.08.006; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P157, DOI 10.1016/j.funbio.2010.11.005; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; SUMNER DR, 1990, PLANT DIS, V74, P704, DOI 10.1094/PD-74-0704; TAKAHASHI M, 1977, T MYCOL SOC JPN, V18, P279; Takenaka S, 2008, PHYTOPATHOLOGY, V98, P187, DOI 10.1094/PHYTO-98-2-0187; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2011, EFFECTORS PLANT MICR, P101; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Vawdrey LL, 2005, AUSTRALAS PLANT PATH, V34, P127, DOI 10.1071/AP04093; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng HC, 2005, MYCOPATHOLOGIA, V159, P601, DOI 10.1007/s11046-005-5258-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	107	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75072	10.1371/journal.pone.0075072	http://dx.doi.org/10.1371/journal.pone.0075072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124466	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100023
J	Toh, HS; Cao, MJ; Daniels, E; Bateman, A				Toh, Huishi; Cao, Mingju; Daniels, Eugene; Bateman, Andrew			Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; PERLECAN PROTEIN CORE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; BREAST-CANCER; HOST-DEFENSE; IN-VIVO; ANGIOGENESIS; VASCULOGENESIS	Progranulin is a secreted glycoprotein that regulates cell proliferation, migration and survival. It has roles in development, tumorigenesis, wound healing, neurodegeneration and inflammation. Endothelia in tumors, wounds and placenta express elevated levels of progranulin. In culture, progranulin activates endothelial proliferation and migration. This suggested that progranulin might regulate angiogenesis. It was, however, unclear how elevated endothelial progranulin levels influence vascular growth in vivo. To address this issue, we generated mice with progranulin expression targeted specifically to developing endothelial cells using a Tie2-promoter/enhancer construct. Three Tie2-Grn mouse lines were generated with varying Tie2-Grn copy number, and were called GrnLo, GrnMid, and GrnHi. All three lines showed increased mortality that correlates with Tie2-Grn copy number, with greatest mortality and lowest germline transmission in the GrnHi line. Death of the transgenic animals occurred around birth, and continued for three days after birth. Those that survived beyond day 3 survived into adulthood. Transgenic neonates that died showed vascular abnormalities of varying severity. Some exhibited bleeding into body cavities such as the pericardial space. Smaller localized hemorrhages were seen in many organs. Blood vessels were often dilated and thin-walled. To establish the development of these abnormalities, we examined mice at early (E10.5-14.5) and later (E15.5-17.5) developmental phases. Early events during vasculogenesis appear unaffected by Tie2-Grn as apparently normal primary vasculature had been established at E10.5. The earliest onset of vascular abnormality was at E15.5, with focal cerebral hemorrhage and enlarged vessels in various organs. Aberrant Tie2-Grn positive vessels showed thinning of the basement membrane and reduced investiture with mural cells. We conclude that progranulin promotes exaggerated vessel growth in vivo, with subsequent effects in the formation of the mural cell layer and weakening of vessel integrity. These results demonstrate that overexpression of progranulin in endothelial cells influences normal angiogenesis in vivo.	[Toh, Huishi; Cao, Mingju; Bateman, Andrew] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Med,Div Endocrinol & Metab, Montreal, PQ, Canada; [Daniels, Eugene] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University	Bateman, A (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Med,Div Endocrinol & Metab, Montreal, PQ, Canada.	andrew.bateman@muhc.mcgill.ca		Bateman, Andrew/0000-0003-0597-769X; Toh, Huishi/0000-0002-8843-8263	Canadian Institute of Health Sciences (CIHR); Canadian Cancer Society Research Institute [CCSRI 700379]	Canadian Institute of Health Sciences (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This study was supported by grants from Canadian Institute of Health Sciences (CIHR) and Canadian Cancer Society Research Institute (CCSRI 700379.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2002, CIRCULATION, V105, P112, DOI 10.1161/hc0102.101437; Andres AC, 2010, J MAMMARY GLAND BIOL, V15, P319, DOI 10.1007/s10911-010-9186-9; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bishop A, 2008, J Wound Care, V17, P399; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen XY, 2008, CHINESE MED J-PEKING, V121, P881, DOI 10.1097/00029330-200805020-00004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Davidson B, 2004, CANCER-AM CANCER SOC, V100, P2139, DOI 10.1002/cncr.20219; Demir R, 2010, ACTA HISTOCHEM, V112, P203, DOI 10.1016/j.acthis.2009.04.004; Desmarais JA, 2008, REPRODUCTION, V136, P247, DOI 10.1530/REP-08-0044; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Evans V, 2000, PHYSIOL GENOMICS, V2, P67, DOI 10.1152/physiolgenomics.2000.2.2.67; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Khalid MEM, 1997, INT J GYNECOL OBSTET, V57, P259, DOI 10.1016/S0020-7292(97)00067-2; Li LQ, 2012, PATHOL RES PRACT, V208, P210, DOI 10.1016/j.prp.2012.02.001; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Miko I., 2008, NATURE ED, V1; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; PEREIRA R, 1994, J CLIN INVEST, V93, P1765, DOI 10.1172/JCI117161; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Ponce ML, 2001, ANGIOGENESIS PROTOCO; Praidou A, 2010, CURR DIABETES REV, V6, P304, DOI 10.2174/157339910793360815; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Silver L.M., 1995, MOUSE GENETICS CONCE; Sullivan DD, 2003, BRIT J CANCER, V89, P228, DOI 10.1038/sj.bjc.6601107; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Trampont P, 2004, HUM PATHOL, V35, P1353, DOI 10.1016/j.humpath.2004.07.003; Wang M, 2012, MED ONCOLOGY; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zeng X, 1998, DEV DYNAM, V211, P215, DOI 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	55	101	105	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64989	10.1371/journal.pone.0064989	http://dx.doi.org/10.1371/journal.pone.0064989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	24116025	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900154
J	Abdallah, K; Artola, A; Monconduit, L; Dallel, R; Luccarini, P				Abdallah, Khaled; Artola, Alain; Monconduit, Lenaic; Dallel, Radhouane; Luccarini, Philippe			Bilateral Descending Hypothalamic Projections to the Spinal Trigeminal Nucleus Caudalis in Rats	PLOS ONE			English	Article							DIENCEPHALIC DOPAMINE NEURONS; TOOTH-PULP STIMULATION; MEDULLARY DORSAL HORN; PARAVENTRICULAR NUCLEUS; BRAIN-STEM; ELECTRICAL-STIMULATION; LATERAL HYPOTHALAMUS; RETROCHIASMATIC AREA; SUPRACHIASMATIC NUCLEUS; ANTINOCICEPTIVE ACTIONS	Several lines of evidence suggest that the hypothalamus is involved in trigeminal pain processing. However, the organization of descending hypothalamic projections to the spinal trigeminal nucleus caudalis (Sp5C) remains poorly understood. Microinjections of the retrograde tracer, fluorogold (FG), into the Sp5C, in rats, reveal that five hypothalamic nuclei project to the Sp5C: the paraventricular nucleus, the lateral hypothalamic area, the perifornical hypothalamic area, the A11 nucleus and the retrochiasmatic area. Descending hypothalamic projections to the Sp5C are bilateral, except those from the paraventricular nucleus which exhibit a clear ipsilateral predominance. Moreover, the density of retrogradely FG-labeled neurons in the hypothalamus varies according to the dorso-ventral localization of the Sp5C injection site. There are much more labeled neurons after injections into the ventrolateral part of the Sp5C (where ophthalmic afferents project) than after injections into its dorsomedial or intermediate parts (where mandibular and maxillary afferents, respectively, project). These results demonstrate that the organization of descending hypothalamic projections to the spinal dorsal horn and Sp5C are different. Whereas the former are ipsilateral, the latter are bilateral. Moreover, hypothalamic projections to the Sp5C display somatotopy, suggesting that these projections are preferentially involved in the processing of meningeal and cutaneous inputs from the ophthalmic branch of the trigeminal nerve in rats. Therefore, our results suggest that the control of trigeminal and spinal dorsal horn processing of nociceptive information by hypothalamic neurons is different and raise the question of the role of bilateral, rather than unilateral, hypothalamic control.	[Abdallah, Khaled; Artola, Alain; Monconduit, Lenaic; Dallel, Radhouane; Luccarini, Philippe] Univ Auvergne, Clermont Univ, NEURO DOL, INSERM,U1107, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Dallel, R (corresponding author), Univ Auvergne, Clermont Univ, NEURO DOL, INSERM,U1107, BP 10448, Clermont Ferrand, France.	radhouane.dallel@udamail.fr; Philippe.luccarini@udamail.fr	Dallel, Radhouane/W-4599-2017; monconduit, lenaic/GYV-2004-2022	Dallel, Radhouane/0000-0001-7494-116X; monconduit, lenaic/0000-0001-8856-3809; ARTOLA, Alain/0000-0003-4717-4297; Luccarini, philippe/0000-0002-7213-0088	Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de l'Enseignement Superieur et de la Recherche; Universite d'Auvergne-Clermont-Ferrand; Region Auvergne	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Universite d'Auvergne-Clermont-Ferrand; Region Auvergne(Region Auvergne-Rhone-Alpes)	The work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Enseignement Superieur et de la Recherche, Universite d'Auvergne-Clermont-Ferrand and Region Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Bellasio S, 2003, EUR J PHARMACOL, V482, P127, DOI 10.1016/j.ejphar.2003.09.017; Benjamin L, 2004, NEUROBIOL DIS, V16, P500, DOI 10.1016/j.nbd.2004.03.015; BERK ML, 1981, BRAIN RES, V226, P1, DOI 10.1016/0006-8993(81)91079-9; BERKOWITZ BA, 1982, J PHARMACOL EXP THER, V220, P329; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Breton JD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-19; BROTON JG, 1988, J NEUROPHYSIOL, V59, P1575, DOI 10.1152/jn.1988.59.5.1575; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; CARD JP, 1989, J COMP NEUROL, V284, P135, DOI 10.1002/cne.902840110; CECHETTO DF, 1988, J COMP NEUROL, V272, P579, DOI 10.1002/cne.902720410; Charbit AR, 2009, J NEUROSCI, V29, P12532, DOI 10.1523/JNEUROSCI.2887-09.2009; Chiou LC, 2010, CURR PHARM DESIGN, V16, P3089, DOI 10.2174/138161210793292483; DADO RJ, 1990, BRAIN RES, V533, P329, DOI 10.1016/0006-8993(90)91358-N; Dafny N, 1996, NEUROSCIENCE, V70, P449, DOI 10.1016/0306-4522(95)00358-4; Denuelle M, 2007, HEADACHE, V47, P1418, DOI 10.1111/j.1526-4610.2007.00776.x; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Fontaine D, 2010, BRAIN, V133, P1214, DOI 10.1093/brain/awq041; Franco ACJ, 1996, BRAZ J MED BIOL RES, V29, P1531; Gura EV, 2000, NEUROPHYSIOLOGY+, V32, P371, DOI 10.1023/A:1010487932269; HAMBA M, 1990, BRAIN RES BULL, V25, P355, DOI 10.1016/0361-9230(90)90220-T; Holland PR, 2006, EUR J NEUROSCI, V24, P2825, DOI 10.1111/j.1460-9568.2006.05168.x; Holle D, 2011, CURR PAIN HEADACHE R, V15, P101, DOI 10.1007/s11916-010-0166-y; Holstege JC, 1996, J COMP NEUROL, V376, P631, DOI 10.1002/(SICI)1096-9861(19961223)376:4<631::AID-CNE10>3.0.CO;2-P; HOSOYA Y, 1979, EXP BRAIN RES, V35, P315; HOSOYA Y, 1980, EXP BRAIN RES, V40, P79; HOSOYA Y, 1981, NEUROSCI LETT, V24, P111, DOI 10.1016/0304-3940(81)90232-9; HU JW, 1990, PAIN, V41, P331, DOI 10.1016/0304-3959(90)90010-B; IWATA K, 1992, J COMP NEUROL, V321, P404, DOI 10.1002/cne.903210308; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Leone M, 2001, NEW ENGL J MED, V345, P1428, DOI 10.1056/NEJM200111083451915; Leone M, 2013, PAIN, V154, P89, DOI 10.1016/j.pain.2012.09.011; LEVINE JD, 1991, J COMP NEUROL, V306, P344, DOI 10.1002/cne.903060210; Li JL, 1997, J COMP NEUROL, V378, P508, DOI 10.1002/(SICI)1096-9861(19970224)378:4<508::AID-CNE6>3.0.CO;2-6; Malick A, 1998, J COMP NEUROL, V400, P125, DOI 10.1002/(SICI)1096-9861(19981012)400:1<125::AID-CNE9>3.0.CO;2-B; Malick A, 2001, P NATL ACAD SCI USA, V98, P9930, DOI 10.1073/pnas.171616898; Malick A, 2000, J NEUROPHYSIOL, V84, P2078, DOI 10.1152/jn.2000.84.4.2078; MATSUMOTO N, 1993, LIFE SCI, V53, P1235, DOI 10.1016/0024-3205(93)90542-B; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; Mazzuca M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00003; Meng ID, 1997, J NEUROPHYSIOL, V77, P43, DOI 10.1152/jn.1997.77.1.43; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Miranda-Cardenas Y, 2006, PAIN, V122, P182, DOI 10.1016/j.pain.2006.01.029; Mogil JS, 2011, NAT NEUROSCI, V14, P1569, DOI 10.1038/nn.2941; MOLANDER C, 1989, J COMP NEUROL, V289, P375, DOI 10.1002/cne.902890303; MORIN LP, 1994, NEUROSCIENCE, V61, P391, DOI 10.1016/0306-4522(94)90240-2; MORITA N, 1977, BRAIN RES, V134, P158, DOI 10.1016/0006-8993(77)90934-9; Newman HM, 1996, J COMP NEUROL, V365, P640, DOI 10.1002/(SICI)1096-9861(19960219)365:4<640::AID-CNE10>3.0.CO;2-L; NILAVER G, 1980, NEUROENDOCRINOLOGY, V30, P150, DOI 10.1159/000122991; Nylen A, 2001, BRAIN RES, V908, P10, DOI 10.1016/S0006-8993(01)02539-2; Ondo WG, 2000, MOVEMENT DISORD, V15, P154, DOI 10.1002/1531-8257(200001)15:1<154::AID-MDS1025>3.0.CO;2-Q; Pappas SS, 2010, J COMP NEUROL, V518, P2423, DOI 10.1002/cne.22340; PASQUIER DA, 1979, BRAIN RES BULL, V4, P765, DOI 10.1016/0361-9230(79)90010-8; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peterlin BL, 2010, HEADACHE, V50, P631, DOI 10.1111/j.1526-4610.2009.01554.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Pinto-Ribeiro F, 2008, BRAIN RES, V1197, P63, DOI 10.1016/j.brainres.2007.12.038; Portillo F, 1998, J CHEM NEUROANAT, V14, P95, DOI 10.1016/S0891-0618(97)10022-9; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; RABOISSON P, 1995, J NEUROPHYSIOL, V73, P496, DOI 10.1152/jn.1995.73.2.496; Rainero I, 2011, J HEADACHE PAIN, V12, P193, DOI 10.1007/s10194-011-0314-8; RUDOMIN P, 1965, ARCH ITAL BIOL, V103, P60; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAPER CB, 2012, HYPOTHALAMUS HUMAN N, P549; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; SCHMUED LC, 1990, J HISTOCHEM CYTOCHEM, V38, P721, DOI 10.1177/38.5.2332627; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Shafton AD, 1998, BRAIN RES, V801, P239, DOI 10.1016/S0006-8993(98)00587-3; SHIGENAGA Y, 1973, BRAIN RES, V63, P402, DOI 10.1016/0006-8993(73)90113-3; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; SKAGERBERG G, 1982, BRAIN RES BULL, V9, P237, DOI 10.1016/0361-9230(82)90136-8; STEPHAN FK, 1981, NEUROSCIENCE, V6, P2625, DOI 10.1016/0306-4522(81)90108-1; STRASSMAN AM, 1993, J COMP NEUROL, V331, P495, DOI 10.1002/cne.903310406; Swanson LW, 2005, NEUROSCI LETT, V387, P80, DOI 10.1016/j.neulet.2005.06.066; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1979, J COMP NEUROL, V188, P87, DOI 10.1002/cne.901880108; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1980, NEUROSCI LETT, V17, P307, DOI 10.1016/0304-3940(80)90041-5; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Ter Horst GJ, 2001, CEPHALALGIA, V21, P963, DOI 10.1046/j.1468-2982.2001.00285.x; TRUESDELL LS, 1987, PHYSIOL BEHAV, V39, P727, DOI 10.1016/0031-9384(87)90257-5; van den Pol AN, 1999, J NEUROSCI, V19, P3171; WAGNER CK, 1993, J NEUROENDOCRINOL, V5, P545, DOI 10.1111/j.1365-2826.1993.tb00520.x; WANG Q, 1990, BRAIN RES, V526, P221, DOI 10.1016/0006-8993(90)91225-6; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; Wei H, 2009, PHARMACOL RES, V59, P355, DOI 10.1016/j.phrs.2009.01.001; Yang J, 2006, BRAIN RES, V1069, P127, DOI 10.1016/j.brainres.2005.11.045; YIRMIYA R, 1990, BRAIN RES, V537, P169, DOI 10.1016/0006-8993(90)90354-E; YOSHIDA A, 1991, J COMP NEUROL, V307, P609, DOI 10.1002/cne.903070408; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zubrzycka M, 2008, PHYSIOL RES, V57, P769, DOI 10.33549/physiolres.931287; Zubrzycka M, 2005, BRAIN RES, V1051, P112, DOI 10.1016/j.brainres.2005.05.058	98	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e73022	10.1371/journal.pone.0073022	http://dx.doi.org/10.1371/journal.pone.0073022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951340	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700140
J	Fan, JB; Park, H; Tan, S; Lee, M				Fan, Jiabing; Park, Hyejin; Tan, Steven; Lee, Min			Enhanced Osteogenesis of Adipose Derived Stem Cells with Noggin Suppression and Delivery of BMP-2	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; COMBINATORIAL GENE-THERAPY; IN-VITRO; STROMAL CELLS; DIFFERENTIATION; EXPRESSION; COMPLICATIONS; OSTEOBLAST; INDUCE; MATRIX	Bone morphogenetic proteins (BMPs) are believed to be the most potent osteoinductive factors. However, BMPs are highly pleiotropic molecules and their supra-physiological high dose requirement leads to adverse side effects and inefficient bone formation. Thus, there is a need to develop alternative osteoinductive growth factor strategies that can effectively complement BMP activity. In this study, we intrinsically stimulated BMP signaling in adipose derived stem cells (ASCs) by downregulating noggin, a potent BMP antagonist, using an RNAi strategy. ASCs transduced with noggin shRNA significantly enhanced osteogenic differentiation of cells. The potency of endogenous BMPs was subsequently enhanced by stimulating ASCs with exogenous BMPs at a significantly reduced dose. The level of mineralization in noggin shRNA treated ASCs when treated with BMP-2 was comparable to that of control shRNA treated cell treated with 10-fold more BMP-2. The complementary strategy of noggin suppression + BMP-2 to enhance osteogenesis was further confirmed in 3D in vitro environments using scaffolds consisting of chitosan (CH), chondroitin sulfate (CS), and apatite layer on their surfaces designed to slowly release BMP-2. This finding supports the novel therapeutic potential of this complementary strategy in bone regeneration.	[Fan, Jiabing; Park, Hyejin; Tan, Steven; Lee, Min] Univ Calif Los Angeles, Div Adv Prosthodont, Los Angeles, CA 90024 USA; [Lee, Min] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, M (corresponding author), Univ Calif Los Angeles, Div Adv Prosthodont, Los Angeles, CA 90024 USA.	leemin@ucla.edu	Fan, Jiabing/J-6581-2015; Fan, Jinjiang/C-2010-2009	Fan, Jinjiang/0000-0003-3102-4833; Papadopoulos, Vassilios/0000-0002-1183-8568	National Institutes of Health [R01 AR060213, R21 DE021819]; International Association for Dental Research; Academy of Osseointegration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Association for Dental Research; Academy of Osseointegration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants R01 AR060213 and R21 DE021819, the International Association for Dental Research, and the Academy of Osseointegration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Aghaloo T, 2007, MOL THER, V15, P1872, DOI 10.1038/sj.mt.6300270; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Carlisle Elliot, 2005, Spine J, V5, p240S, DOI 10.1016/j.spinee.2005.02.014; Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Fan JB, 2010, ACTA BIOMATER, V6, P1178, DOI 10.1016/j.actbio.2009.08.042; Gazzerro E, 2003, BONE, V32, P111, DOI 10.1016/S8756-3282(02)00948-1; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hannallah D, 2004, J BONE JOINT SURG AM, V86A, P80, DOI 10.2106/00004623-200401000-00013; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu JL, 2012, J BIOMED MATER RES A, V100A, P1680, DOI 10.1002/jbm.a.34115; James AW, 2011, STEM CELLS DEV, V20, P427, DOI 10.1089/scd.2010.0082; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Kilgore ML, 2009, J BONE MINER RES, V24, P2050, DOI [10.1359/jbmr.090523, 10.1359/JBMR.090523]; Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906; Kuwahara K, 2011, TISSUE ENG PT A, V17, P2955, DOI 10.1089/ten.tea.2011.0290; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062; Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004; McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/00007632-200208151-00014; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Park H, 2013, CARBOHYD POLYM, DOI DOI 10.1016/J.CARBP0L.2013.05.023; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Stafford DA, 2011, DEVELOPMENT, V138, P1005, DOI 10.1242/dev.051938; Sun Yubo, 2012, Open Rheumatol J, V6, P24, DOI 10.2174/1874312901206010024; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	41	60	62	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72474	10.1371/journal.pone.0072474	http://dx.doi.org/10.1371/journal.pone.0072474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24124589	gold, Green Submitted, Green Published			2022-12-27	WOS:000323378000098
